<SEC-DOCUMENT>0001193125-20-275596.txt : 20201023
<SEC-HEADER>0001193125-20-275596.hdr.sgml : 20201023
<ACCEPTANCE-DATETIME>20201023171822
ACCESSION NUMBER:		0001193125-20-275596
CONFORMED SUBMISSION TYPE:	S-4/A
PUBLIC DOCUMENT COUNT:		53
FILED AS OF DATE:		20201023
DATE AS OF CHANGE:		20201023

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kensington Capital Acquisition Corp.
		CENTRAL INDEX KEY:			0001811414
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
		IRS NUMBER:				850796578
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-4/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-248930
		FILM NUMBER:		201258513

	BUSINESS ADDRESS:	
		STREET 1:		1400 OLD COUNTRY ROAD
		STREET 2:		SUITE 301
		CITY:			WESTBURY
		STATE:			NY
		ZIP:			11590
		BUSINESS PHONE:		703-674-6514

	MAIL ADDRESS:	
		STREET 1:		1400 OLD COUNTRY ROAD
		STREET 2:		SUITE 301
		CITY:			WESTBURY
		STATE:			NY
		ZIP:			11590
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-4/A
<SEQUENCE>1
<FILENAME>d14810ds4a.htm
<DESCRIPTION>AMENDMENT NO.1 TO FORM S-4
<TEXT>
<HTML><HEAD>
<TITLE>Amendment No.1 to Form S-4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on October 23, 2020 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration Statement No.&nbsp;333-248930 </B></P>  <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES
AND EXCHANGE COMMISSION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>  <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Amendment
No.&nbsp;1 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>to </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">Form&nbsp;S-4</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF&nbsp;1933 </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name of Registrant as Specified in Its Charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>6770</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">85-0796578</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Jurisdiction of<BR>Incorporation or Organization)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Primary Standard Industrial<BR>Classification Code Number)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(I.R.S. Employer<BR>Identification Number)</B></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1400 Old Country Road, Suite 301 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Westbury, NY 11590 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">(703)&nbsp;674-6514</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address, including zip code, and telephone number, including area code, of
Registrant&#146;s principal executive offices) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Justin Mirro
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>c/o Kensington Capital Acquisition Corp. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1400 Old Country Road, Suite 301 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Westbury, NY 11590 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">(703)&nbsp;674-6514</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, address, including zip code, and telephone number, including area code,
of agent for service) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Copies to: </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Charles A. Samuelson<BR>Hughes Hubbard&nbsp;&amp; Reed&nbsp;LLP<BR>One Battery Park Plaza<BR>New York, NY 10004<BR>Tel: <FONT STYLE="white-space:nowrap">(212)&nbsp;837-6200</FONT><BR></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Michael J. Danaher</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Mark B. Baudler<BR>Wilson Sonsini Goodrich&nbsp;&amp; Rosati, P.C.<BR>650 Page Mill Road<BR>Palo Alto, CA 94304<BR>Tel: <FONT
STYLE="white-space:nowrap">(650)&nbsp;493-9300</FONT></B></P></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Approximate date of commencement of proposed sale to the public: As soon as practicable after this
Registration Statement becomes effective and on the consummation of the business combination described in the enclosed proxy statement/prospectus/information statement. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the securities being registered on this Form are to be offered in connection with the formation of a holding company and there is compliance
with General Instruction&nbsp;G, check the following box.&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If this Form is filed to register additional securities for
an offering pursuant to Rule&nbsp;462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If this Form is a post-effective amendment filed pursuant to Rule&nbsp;462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT> filer, a smaller reporting company or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting
company&#148; and &#147;emerging growth company&#148; in <FONT STYLE="white-space:nowrap">Rule&nbsp;12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated&nbsp;filer</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If applicable, place an X in the box to designate the appropriate rule provision relied upon in conducting this transaction: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Exchange Act <FONT STYLE="white-space:nowrap">Rule&nbsp;13e-4(i)</FONT> (Cross-Border Issuer Tender Offer)&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Exchange Act <FONT STYLE="white-space:nowrap">Rule&nbsp;14d-1(d)</FONT> (Cross-Border Third-Party Tender Offer)&nbsp;&nbsp;&#9744; </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION OF REGISTRATION FEE </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Title of Each Class&nbsp;of<BR>Securities to be Registered</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Amount<BR>to be<BR>Registered</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Proposed<BR>Maximum<BR>Offering Price<BR>per Share</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Proposed<BR>Maximum Aggregate<BR>Offering Price&nbsp;(3)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Amount of<BR>Registration Fee&nbsp;(4)</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Class&nbsp;A Common Stock, par value $0.0001 per
share</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">199,527,807&nbsp;(1)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">N/A</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$3,616,441,486.44</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$469,414.10&nbsp;(7)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Class&nbsp;B Common Stock, par value $0.0001 per
share</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">169,272,193&nbsp;(2)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">N/A</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$3,068,058,486.33</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$398,233.95&nbsp;(7)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Class A Common Stock, par value $0.0001 per share</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">169,272,193&nbsp;(5)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">&#151;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">&#151;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">&#151;(6)</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on the maximum number of shares of Class&nbsp;A common stock, par value $0.0001 per share
(&#147;Kensington Class&nbsp;A Common Stock&#148;), of the registrant (&#147;Kensington&#148;) estimated to be issued, or issuable, or subject to options or other equity-based awards that are to be assumed, by Kensington upon the consummation of the
business combination described herein (the &#147;Business Combination&#148;). This number is based on the product of (i) 49,841,846, the aggregate number of shares of Class&nbsp;A common stock, par value $0.0001 per share (&#147;QuantumScape
Class&nbsp;A Common Stock&#148;), of QuantumScape Corporation (&#147;QuantumScape&#148;), outstanding as of September&nbsp;14, 2020 or expected to be issued prior to the Business Combination (including shares issuable, or subject to options or other
equity-based awards, that are to be assumed by Kensington upon consummation of the Business Combination), which number includes 11,388,090 shares of convertible Series C preferred stock, par value $0.0001 per share, 2,983,189 shares of convertible
Series D preferred stock, par value $0.0001 per share, 5,500,000 shares of convertible Series E preferred stock, par value $0.0001 per share, and 14,684,843 shares of convertible Series F preferred stock, par value $0.0001 (&#147;Series F Preferred
Stock&#148; and together with QuantumScape&#146;s Series C preferred stock, Series D preferred stock and Series E preferred stock, the &#147;QuantumScape Class&nbsp;A Preferred Stock&#148;), par value $0.0001 per share, of QuantumScape and
(ii)&nbsp;an exchange ratio of 4.0032186234 shares of Kensington Class&nbsp;A Common Stock for each share of QuantumScape Class&nbsp;A Common Stock or QuantumScape Class&nbsp;A Preferred Stock, as applicable (this exchange ratio assumes that
14,684,843 shares of Series F Preferred Stock will be outstanding immediately prior to the consummation of the Business Combination). </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on the maximum number of shares of Class&nbsp;B common stock, par value $0.0001 per share
(&#147;Kensington Class&nbsp;B Common Stock&#148;), of Kensington estimated to be issued, or issuable, or subject to options or other equity-based awards that are to be assumed, by Kensington upon the consummation of the Business Combination. This
number is based on the product of (i) 42,284,024, the aggregate number of shares of Class&nbsp;B common stock, par value $0.0001 per share (&#147;QuantumScape Class&nbsp;B Common Stock&#148;), of QuantumScape, outstanding as of September&nbsp;14,
2020 or expected to be issued prior to the Business Combination (including shares issuable, or subject to options or other equity-based awards, that are to be assumed by Kensington upon consummation of the Business Combination), which number
includes 12,316,831 shares of convertible Series A preferred stock, par value $0.0001 per share (including such shares issuable upon exercise of warrants), 12,381,008 shares of convertible Series B preferred stock, par value $0.0001 per share, and
4,076,037 shares of convertible Series <FONT STYLE="white-space:nowrap">B-1</FONT> preferred stock, par value $0.0001 per share of QuantumScape (&#147;Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock,&#148; and together with
QuantumScape&#146;s Series A preferred stock and Series B preferred stock, the &#147;QuantumScape Class&nbsp;B Preferred Stock&#148;) and (ii)&nbsp;an exchange ratio of 4.0032186234 shares of Kensington Class&nbsp;B Common Stock for each share of
QuantumScape Class&nbsp;B Common Stock or QuantumScape Class&nbsp;B Preferred Stock, as applicable. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pursuant to Rules 457(c) and 457(f)(1) promulgated under the Securities Act and solely for the purpose of
calculating the registration fee, the proposed maximum aggregate offering price is calculated as the product of (i)&nbsp;the sum of 199,527,807 shares of Kensington Class&nbsp;A Common Stock and 169,272,193 shares of Kensington Class&nbsp;B Common
Stock, the estimated maximum number of shares of Kensington Class&nbsp;A Common Stock and Kensington Class&nbsp;B Common Stock, respectively, that may be issued in the Business Combination in exchange for cancelled shares of QuantumScape
Class&nbsp;A Common Stock, QuantumScape Class&nbsp;A Preferred Stock, QuantumScape Class&nbsp;B Common Stock and QuantumScape Class&nbsp;B Preferred Stock or are subject to options or other equity-based awards that are to be assumed by Kensington in
the Business Combination (calculated as shown in notes (1)&nbsp;and (2) above) and (ii)&nbsp;$18.13, the average of the high and low trading prices of Kensington Class&nbsp;A Common Stock on September&nbsp;17, 2020 (within five business days prior
to the date of this Registration Statement). For purposes of calculating the registration fee, the Kensington Class&nbsp;B Common Stock is treated as having the same value as the Kensington Class&nbsp;A Common Stock as each share of Kensington
Class&nbsp;B Common Stock is convertible into one share of Kensington Class&nbsp;A Common Stock upon transfer. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Calculated pursuant to Rule 457 of the Securities Act by calculating the product of (i)&nbsp;the proposed
maximum aggregate offering price and (ii)&nbsp;0.0001298. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Kensington Class A Common Stock issuable upon conversion of Kensington Class B Common Stock.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pursuant to Rule 457(i) promulgated under the Securities Act, no separate registration fee is required.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Previously paid. The &#147;Amount of Registration Fee&#148; assumes the maximum number of securities is
offered. Since the exchange ratio upon consummation of the Business Combination is subject to adjustment, it is possible that the number of securities offered could be less (but not more) than the number set forth in the table. In the event the
number of securities registered is decreased, then consistent with Rule 457(p) the aggregate total dollar amount of the filing fee associated with those unsold securities will be offset against the total filing fee due for a subsequent registration
statement or registration statements. </P></TD></TR></TABLE>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The Registrant hereby amends this Registration Statement on such date or
dates as may be necessary to delay its effective date until the Registrant shall file&nbsp;a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section&nbsp;8(a) of the
Securities Act of 1933, or until this Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section&nbsp;8(a), may determine. </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow"><FONT COLOR="#ff4338"><B>The information in this preliminary proxy statement/prospectus/information statement
is not complete and may be changed. These securities described herein may not be sold until the registration statement filed with the U.S. Securities and Exchange Commission is declared effective. This preliminary proxy
statement/prospectus/information statement is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. </B></FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ff4338"><B>PRELIMINARY PROXY STATEMENT, PROSPECTUS AND
INFORMATION STATEMENT </B></FONT></P>  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ff4338"><B>SUBJECT TO COMPLETION, DATED OCTOBER&nbsp;23, 2020 </B></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:20pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>1400 Old Country Road, Suite 301 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Westbury, NY 11590 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Kensington Capital
Acquisition Corp. Stockholders and QuantumScape Corporation Stockholders: </P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington Capital Acquisition Corp., a Delaware corporation
(&#147;Kensington&#148;), Kensington Merger Sub Corp., a Delaware corporation and a wholly-owned subsidiary of Kensington (&#147;Merger Sub&#148;), and QuantumScape Corporation, a Delaware corporation (&#147;QuantumScape&#148;), have entered into a
Business Combination Agreement (as may be amended from time to time, the &#147;Business Combination Agreement&#148;) pursuant to which, among other things, Merger Sub will merge with and into QuantumScape, with QuantumScape surviving the merger and
becoming a wholly-owned direct subsidiary of Kensington (collectively with the other transactions described in the Business Combination Agreement, the &#147;Business Combination&#148;). At the closing of the Business Combination (the
&#147;Closing&#148;), each outstanding share of QuantumScape Class&nbsp;A common stock, together with each share of QuantumScape preferred stock that is outstanding immediately prior to the Closing and convertible into a share of QuantumScape
Class&nbsp;A common stock pursuant to the provisions of QuantumScape&#146;s certificate of incorporation, and each outstanding share of QuantumScape Class&nbsp;B common stock, together with each share of QuantumScape preferred stock that is
outstanding immediately prior to the Closing and convertible into a share of QuantumScape Class&nbsp;B common stock pursuant to the provisions of QuantumScape&#146;s certificate of incorporation, will be cancelled and automatically converted into
the right to receive a number of shares of Kensington Class&nbsp;A common stock or shares of Kensington Class&nbsp;B common stock, as applicable, determined in each case by reference to an &#147;Exchange Ratio,&#148; calculated in accordance with
the Business Combination Agreement. As of the date of the initial signing of the Business Combination Agreement, the Exchange Ratio was 4.0032186234. Kensington will file with the U.S. Securities and Exchange Commission (the &#147;SEC&#148;) a
Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> announcing the final Exchange Ratio no later than four business days prior to the special meeting of its stockholders described below. See the section entitled &#147;<I>The Business
Combination</I>&#148; on page&nbsp;93 of the attached proxy statement/prospectus/information statement for further information on the consideration being paid to the stockholders of QuantumScape. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>From and after the Closing, the Kensington Class&nbsp;A common stock will have one vote per share and the Kensington Class&nbsp;B common
stock will have 10&nbsp;votes per share. As a result of the Business Combination, the current stockholders of Kensington will own shares of Kensington Class&nbsp;A common stock representing approximately 6.11% of the total shares then outstanding in
the aggregate and approximately 1.28% of the vote. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington&#146;s units, Class&nbsp;A common stock and warrants are currently
listed on The New York Stock Exchange, under the symbols &#147;KCAC.U,&#148; &#147;KCAC,&#148; and &#147;KCAC WS,&#148; respectively. Kensington intends to apply to list shares of Kensington Class&nbsp;A common stock and Kensington warrants on The
New York Stock Exchange under the symbols &#147;QS&#148; and &#147;QS.W,&#148; respectively, upon the Closing. At the Closing, each Kensington unit will separate into its components consisting of one share of Kensington Class&nbsp;A common stock and
<FONT STYLE="white-space:nowrap">one-half</FONT> of one redeemable warrant. </P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington is holding a special meeting of its
stockholders in order to obtain the stockholder approvals necessary to consummate the Business Combination. At the Kensington special meeting of stockholders, which will be held on [&nbsp;&nbsp;&nbsp;&nbsp;], 2020, at 10:00&nbsp;a.m., Eastern time,
at the offices of Hughes Hubbard&nbsp;&amp; Reed&nbsp;LLP, One Battery Park Plaza, New York, NY 10004, unless postponed or adjourned to a later date, Kensington will ask its stockholders to adopt the Business Combination Agreement, thereby approving
the Business Combination, and approve the other proposals described in this proxy statement/prospec</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">tus/information statement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Kensington special meeting is currently scheduled to be held in person as indicated above. However, Kensington is actively monitoring the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic and if Kensington determines that it is not possible </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or advisable to hold the special meeting in person, or to hold the meeting on the time or date or at the location indicated above, Kensington will announce alternative arrangements for the
meeting as promptly as practicable, which may include switching to a virtual meeting format, or changing the time, date or location of the special meeting. Any such change will be announced via press release and the filing of additional proxy
materials with the SEC. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, as promptly as practicable after this proxy statement/prospectus/information statement becomes
effective, QuantumScape will seek an irrevocable written consent of QuantumScape&#146;s stockholders as required to approve and adopt the Business Combination Agreement, the Business Combination and other proposed transactions contemplated by the
Business Combination Agreement (together, the &#147;Proposed Transactions&#148;). Such approval will be sought from and requires the affirmative vote of the holders of at least (a)&nbsp;a majority of the outstanding shares of QuantumScape capital
stock, (b)&nbsp;a majority of the outstanding shares of QuantumScape Class&nbsp;A common stock and the outstanding shares of QuantumScape Class&nbsp;B common stock, each voting separately as a class, (c)&nbsp;a majority of the outstanding shares of
QuantumScape Class&nbsp;A common stock and shares of QuantumScape preferred stock that are convertible into shares of QuantumScape Class&nbsp;A common stock, voting as a single class, and (d)&nbsp;a majority of the outstanding shares of QuantumScape
Class&nbsp;B common stock and the outstanding shares of QuantumScape preferred stock that are convertible into shares of QuantumScape Class&nbsp;B common stock, voting together as a single class. No additional approval or vote from any holders of
any class or series of stock of QuantumScape will be necessary to adopt and approve the Business Combination Agreement, the Business Combination and the Proposed Transactions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As described in this proxy statement/prospectus/information statement, certain stockholders of QuantumScape are parties to support agreements
with Kensington whereby such stockholders agreed to vote all of their shares of QuantumScape common stock and QuantumScape preferred stock in favor of approving the Business Combination and the Proposed Transactions. These stockholders collectively
have a sufficient number of votes to obtain the approvals set forth in the preceding paragraph. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After careful consideration, the
respective Kensington and QuantumScape boards of directors have unanimously approved the Business Combination Agreement, the Kensington board of directors has approved the other proposals described in this proxy statement/prospectus/information
statement, and each of the Kensington and QuantumScape boards of directors has determined that it is advisable to consummate the Business Combination. The Kensington board of directors recommends that its stockholders vote &#147;FOR&#148; the
proposals described in this proxy statement/prospectus/information statement, and the QuantumScape board of directors recommends that its stockholders sign and return to QuantumScape the written consent indicating their approval of the Business
Combination Agreement, the Business Combination and the Proposed Transactions. </P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>More information about Kensington, QuantumScape, the
Business Combination Agreement, the Business Combination and the Proposed Transactions is contained in this proxy statement/prospectus/information statement. Kensington and QuantumScape urge you to read the accompanying proxy
statement/prospectus/information statement, including the financial statements and annexes and other documents referred to herein, carefully and in their entirety. IN PARTICULAR, YOU SHOULD CAREFULLY CONSIDER THE MATTERS DISCUSSED UNDER THE SECTION
ENTITLED &#147;</B><B><I><A HREF="#rom14810_9">RISK FACTORS</A></I></B><B>&#148; BEGINNING ON PAGE&nbsp;40 OF THIS PROXY STATEMENT/PROSPECTUS/INFORMATION STATEMENT. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you have any questions regarding the accompanying proxy statement/prospectus/information statement, you may contact D.F. King&nbsp;&amp;
Co., Inc., Kensington&#146;s proxy solicitor, toll-free at (877) <FONT STYLE="white-space:nowrap">478-5045</FONT> or collect at (212) <FONT STYLE="white-space:nowrap">269-5550</FONT> or email at KCAC@dfking.com. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On behalf of our board of directors, I thank you for your support and look forward to the successful consummation of the Business Combination.
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Justin Mirro</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Chairman and Chief Executive Officer</I></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This proxy statement/prospectus/information statement is dated
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2020 and is first being mailed to the stockholders of Kensington on or about that date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NEITHER THE U.S. SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES REGULATORY AGENCY HAS APPROVED OR DISAPPROVED THE TRANSACTIONS
DESCRIBED IN THIS PROXY STATEMENT/PROSPECTUS/INFORMATION STATEMENT OR ANY OF THE SECURITIES TO BE ISSUED IN THE BUSINESS COMBINATION, PASSED UPON THE MERITS OR FAIRNESS OF THE BUSINESS COMBINATION OR RELATED TRANSACTIONS OR PASSED UPON THE ADEQUACY
OR ACCURACY OF THE DISCLOSURE IN THIS PROXY STATEMENT/PROSPECTUS/INFORMATION STATEMENT. ANY REPRESENTATION TO THE CONTRARY CONSTITUTES A CRIMINAL OFFENSE. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1400 Old Country Road, Suite 301 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Westbury, NY 11590 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF SPECIAL MEETING IN LIEU OF&nbsp;2020 ANNUAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO BE HELD ON [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;],
2020 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Stockholders of Kensington Capital Acquisition Corp.: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOTICE IS HEREBY GIVEN that a special meeting in lieu of the 2020 annual meeting of stockholders (the &#147;special meeting&#148;) of
Kensington Capital Acquisition Corp., a Delaware corporation (&#147;Kensington,&#148; &#147;we,&#148; &#147;our&#148; or &#147;us&#148;), will be held on
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2020, at 10:00&nbsp;a.m., Eastern time, at the offices of Hughes Hubbard&nbsp;&amp; Reed LLP, located at One Battery Park
Plaza, New York, NY 10004. You are cordially invited to attend the special meeting for the following purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 1&#151;The &#147;Business Combination Proposal&#148;&#151;to approve and adopt the Business
Combination Agreement, dated as of September&nbsp;2, 2020 (as may be amended from time to time, the &#147;Business Combination Agreement&#148;), by and among Kensington, QuantumScape Corporation, a Delaware corporation (&#147;QuantumScape&#148;),
and Kensington Merger Sub Corp., a Delaware corporation (&#147;Merger Sub&#148;), and the transactions contemplated thereby, pursuant to which Merger Sub will merge with and into QuantumScape, with QuantumScape surviving the merger and becoming a
wholly-owned direct subsidiary of Kensington (collectively with the other transactions described in the Business Combination Agreement, the &#147;Business Combination&#148;). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 2&#151;The &#147;Authorized Share Charter Proposal&#148;&#151;to approve a proposal to amend
Kensington&#146;s amended and restated certificate of incorporation to increase the number of authorized shares of Kensington&#146;s common stock and preferred stock. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 3&#151;The &#147;Director Declassification Charter Proposal&#148;&#151;to approve a proposal to
amend Kensington&#146;s amended and restated certificate of incorporation to declassify Kensington&#146;s board of directors. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 4&#151;The &#147;Dual Class&nbsp;Charter Proposal&#148;&#151;to approve a proposal to amend
Kensington&#146;s amended and restated certificate of incorporation to implement a dual class stock structure comprised of New QuantumScape Class&nbsp;A Common Stock (as defined below), which will carry one vote per share, and New QuantumScape
Class&nbsp;B Common Stock (as defined below), which will carry 10 votes per share. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 5&#151;The &#147;Additional Charter Proposal&#148;&#151;to approve a proposal to amend
Kensington&#146;s amended and restated certificate of incorporation to eliminate provisions in the amended and restated certificate of incorporation relating to the Business Combination that will no longer be applicable following the closing of the
Business Combination (the &#147;Closing&#148;), change New QuantumScape&#146;s (as defined below) name to &#147;QuantumScape Corporation&#148; and make certain other changes that Kensington&#146;s board of directors deems appropriate for a public
operating company (the &#147;Additional Charter Proposal,&#148; together with the Authorized Share Charter Proposal, the Director Declassification Charter Proposal and the Dual Class&nbsp;Charter Proposal, the &#147;Charter Proposals&#148;).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 6&#151;The &#147;Election of Directors Proposal&#148;&#151;to elect, effective at the Closing,
nine directors to serve on the New QuantumScape Board (as defined below). </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 7&#151;The &#147;Equity Incentive Plan Proposal&#148;&#151;to approve and adopt the equity
incentive award plan established to be effective upon the Closing. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 8&#151;The &#147;NYSE Proposal&#148;&#151;to issue New QuantumScape Common Stock (as defined
below) to the QuantumScape stockholders in the Merger (as defined below) pursuant to the Business Combination Agreement and to the investors in the PIPE (as defined below). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 9&#151;The &#147;Employee Stock Purchase Plan Proposal&#148;&#151;to approve and adopt the
employee stock purchase plan established to be effective upon the Closing. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 10&#151;The &#147;Adjournment Proposal&#148;&#151;to adjourn the special meeting to a later date
or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the special meeting, there are not sufficient votes to approve one or more proposals presented to stockholders for a vote.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Charter Proposals, Election of Directors Proposal, Equity Incentive Plan Proposal, NYSE Proposal and Employee Stock
Purchase Plan Proposal are all conditioned on the approval of the Business Combination Proposal. If the Charter Proposals are approved, the Proposed Certificate of Incorporation (as defined below) will be approved and adopted in its entirety. The
Adjournment Proposal does not require the approval of the Business Combination Proposal and Business Combination to be effective. It is important for you to note that in the event the Business Combination Proposal is not approved, Kensington will
not consummate the Business Combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your attention is directed to the proxy statement/prospectus/information statement accompanying
this notice (including the financial statements and annexes attached thereto) for a more complete description of the proposed Business Combination and related transactions and each of our proposals. We encourage you to read this proxy
statement/prospectus/information statement carefully. If you have any questions or need assistance voting your shares, please call our proxy solicitor, D.F. King&nbsp;&amp; Co., Inc., toll-free at (877)
<FONT STYLE="white-space:nowrap">478-5045;</FONT> banks and brokers can call collect at (212) <FONT STYLE="white-space:nowrap">269-5550</FONT> or email at KCAC@dfking.com. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>YOUR VOTE IS VERY IMPORTANT, REGARDLESS OF THE NUMBER OF SHARES OF KENSINGTON COMMON STOCK YOU OWN. </B>In light of the ongoing health
concerns relating to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and to best protect the health and welfare of Kensington&#146;s stockholders and personnel, Kensington urges that stockholders do not attend the special meeting in
person. Stockholders are nevertheless urged to vote their proxies by completing, signing, dating and returning the enclosed proxy card in the accompanying <FONT STYLE="white-space:nowrap">pre-addressed</FONT> postage paid envelope. You may also
submit a proxy by telephone or via the internet by following the instructions printed on your proxy card. If you hold your shares through a brokerage firm, bank or other nominee, you should direct the vote of your shares in accordance with the
voting instruction form provided by the broker, bank or nominee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The special meeting is currently scheduled to be held in person as
indicated above. However, we are actively monitoring the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and if we determine that it is not possible or advisable to hold the special meeting in person, or to hold the meeting on the time or
date or at the location indicated above, we will announce alternative arrangements for the meeting as promptly as practicable, which may include switching to a virtual meeting format, or changing the time, date or location of the special meeting.
Any such change will be announced via press release and the filing of additional proxy materials with the U.S. Securities and Exchange Commission. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">By Order of the Board of Directors,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Justin Mirro</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><I>Chairman and Chief Executive Officer</I></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_1">ABOUT THIS PROXY STATEMENT/PROSPECTUS/INFORMATION STATEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_2">FREQUENTLY USED TERMS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_3">QUESTIONS AND ANSWERS ABOUT THE BUSINESS COMBINATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_4">SUMMARY OF THE PROXY STATEMENT/PROSPECTUS/INFORMATION
STATEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_5">SELECTED HISTORICAL CONSOLIDATED FINANCIAL INFORMATION OF
QUANTUMSCAPE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_6">SELECTED HISTORICAL FINANCIAL INFORMATION OF KENSINGTON</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_7">SUMMARY UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL
INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_8">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_9">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_10">Risks Related to QuantumScape</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_11">Risks Related to Kensington</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_12">UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL
INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_13">THE SPECIAL MEETING OF KENSINGTON STOCKHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_14">The Kensington Special Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_15">Date, Time and Place of the Special Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_16">Purpose of the Special Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_17">Recommendation of the Kensington Board</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_18">Record Date and Voting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_19">Voting Your Shares</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_20">Who Can Answer Your Questions About Voting Your Shares</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_21">Quorum and Vote Required for the Kensington Proposals</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_22">Abstentions and Broker
<FONT STYLE="white-space:nowrap">Non-Votes</FONT></A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_23">Revocability of Proxies</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_24">Redemption Rights</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_25">Appraisal or Dissenters&#146; Rights</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_26">Solicitation of Proxies</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_27">Stock Ownership</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_28">PROPOSALS TO BE CONSIDERED BY KENSINGTON&#146;S STOCKHOLDERS: PROPOSAL NO.
 1&#151;THE BUSINESS COMBINATION PROPOSAL</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_29">THE BUSINESS COMBINATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_30">The Background of the Business Combination</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_31">Certain QuantumScape Projected Financial Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_32">Interests of Kensington&#146;s Directors and Officers in the Business Combination
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_33">Interests of QuantumScape&#146;s Directors and Officers in the Business Combination
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_34">Potential Actions to Secure Requisite Stockholder Approvals</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_35">Regulatory Approvals Required for the Business Combination</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_36">Accounting Treatment of the Business Combination</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_37">THE BUSINESS COMBINATION AGREEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">107</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_38">CERTAIN AGREEMENTS RELATED TO THE BUSINESS COMBINATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_39">Stockholder Support Agreements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_40">Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_41">Subscription Agreements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_42">Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_43">CERTAIN U.S. FEDERAL INCOME TAX CONSIDERATIONS OF THE REDEMPTION AND THE BUSINESS
COMBINATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">124</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_44">PROPOSAL NO. 2&#151;THE AUTHORIZED SHARE CHARTER PROPOSAL</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_45">PROPOSAL NO. 3&#151;THE DIRECTOR DECLASSIFICATION CHARTER
PROPOSAL</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_46">PROPOSAL NO. 4&#151;THE DUAL CLASS CHARTER PROPOSAL</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">134</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_47">PROPOSAL NO. 5&#151;THE ADDITIONAL CHARTER PROPOSAL</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_48">PROPOSAL NO. 6&#151;THE ELECTION OF DIRECTORS PROPOSAL</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_49">PROPOSAL NO. 7&#151;THE EQUITY INCENTIVE PLAN PROPOSAL</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_50">PROPOSAL NO. 8&#151;THE NYSE PROPOSAL</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_51">PROPOSAL NO. 9&#151;THE EMPLOYEE STOCK PURCHASE PLAN
PROPOSAL</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_52">PROPOSAL NO. 10&#151;THE ADJOURNMENT PROPOSAL</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_53">INFORMATION ABOUT QUANTUMSCAPE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_54">QUANTUMSCAPE&#146;S EXECUTIVE COMPENSATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_55">QUANTUMSCAPE MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
 AND RESULTS OF OPERATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_56">CERTAIN QUANTUMSCAPE RELATIONSHIPS AND RELATED PARTY
TRANSACTIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_57">INFORMATION ABOUT KENSINGTON</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">198</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_58">KENSINGTON MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
 AND RESULTS OF OPERATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">212</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_59">CERTAIN KENSINGTON RELATIONSHIPS AND RELATED PARTY
TRANSACTIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">216</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_60">MANAGEMENT AFTER THE BUSINESS COMBINATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_61">DESCRIPTION OF KENSINGTON&#146;S SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_62">SHARES ELIGIBLE FOR FUTURE SALE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_63">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">253</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_64">PRICE RANGE OF SECURITIES AND DIVIDENDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_65">ADDITIONAL INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_66">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_67">INDEX TO FINANCIAL STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_68">QUANTUMSCAPE FINANCIAL STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-30</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom14810_69">KENSINGTON FINANCIAL STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-64</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><A HREF="#rom14810_70">ANNEX A: Business Combination Agreement (including Amendment No.&nbsp;1 thereto)</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><A HREF="#rom14810_71">ANNEX B: Second Amended and Restated Certificate of Incorporation</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><A HREF="#rom14810_72">ANNEX C: Form of Amended and Restated Bylaws</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><A HREF="#rom14810_73">ANNEX D: 2020 Equity Incentive Plan</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><A HREF="#rom14810_74">ANNEX E: 2020 Employee Stock Purchase Plan</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_1"></A>ABOUT THIS PROXY STATEMENT/PROSPECTUS/INFORMATION STATEMENT
</B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This document, which forms part of a registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-4</FONT> filed with
the SEC, by Kensington (File No.&nbsp;333-248930) (the &#147;Registration Statement&#148;), constitutes a prospectus of Kensington under Section&nbsp;5 of the Securities Act, with respect to the shares of New QuantumScape Class&nbsp;A Common Stock
(as defined below) and New QuantumScape Class&nbsp;B Common Stock (as defined below) to be issued if the Business Combination described below is consummated. This document also constitutes a notice of meeting and a proxy statement under
Section&nbsp;14(a) of the Exchange Act with respect to the special meeting of Kensington stockholders at which Kensington stockholders will be asked to consider and vote upon a proposal to approve the Business Combination by the approval and
adoption of the Business Combination Agreement, among other matters. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_2"></A>FREQUENTLY USED TERMS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this document: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;2010
Plan&#148; means the QuantumScape 2010 Equity Incentive Plan, as amended, supplemented or modified from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Adjournment
Proposal&#148; means a proposal to adjourn the special meeting of stockholders of Kensington to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the special
meeting, there are not sufficient votes to approve one or more proposals presented to stockholders for vote at such special meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;broker <FONT STYLE="white-space:nowrap">non-vote&#148;</FONT> means the failure of a Kensington stockholder, who holds his or her shares
in &#147;street name&#148; through a broker or other nominee, to give voting instructions to such broker or other nominee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Business
Combination&#148; means the transactions contemplated by the Business Combination Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Business Combination Agreement&#148;
means the Business Combination Agreement, dated as of September&nbsp;2, 2020, as may be amended from time to time, among QuantumScape, Kensington and Merger Sub. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Business Combination Proposal&#148; means the proposal to approve the adoption of the Business Combination Agreement and the Business
Combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Closing&#148; means the consummation of the Business Combination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Closing Date&#148; means the date on which the Closing occurs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Code&#148; means the Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;DGCL&#148; means the General Corporation Law of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Employee Stock Purchase Plan Proposal&#148; means the proposal to approve the adoption of the QuantumScape Corporation 2020 Employee
Stock Purchase Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Equity Incentive Plan Proposal&#148; means the proposal to approve the adoption of the QuantumScape
Corporation 2020 Equity Incentive Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Exchange Act&#148; means the U.S. Securities Exchange Act of 1934, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Existing Certificate of Incorporation&#148; means Kensington&#146;s current amended and restated certificate of incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Extension Period&#148; means any extended time that Kensington has to consummate a business combination beyond 24 months as a result of
a stockholder vote to amend Kensington&#146;s amended and restated certificate of incorporation, as then in effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;GAAP&#148;
means United States generally accepted accounting principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Investment Company Act&#148; means the Investment Company Act of
1940, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;IPO&#148; means Kensington&#146;s initial public offering of units, consummated on June&nbsp;30, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;JOBS Act&#148; means the Jumpstart Our Business Startups Act of 2012, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Kensington&#148; means Kensington Capital Acquisition Corp., a Delaware corporation.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Kensington Board&#148; means the board of directors of Kensington, prior to the Business Combination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Kensington Class&nbsp;A Common Stock&#148; means Kensington&#146;s Class&nbsp;A common stock, par value $0.0001 per share, as in effect
immediately prior to the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Kensington Class&nbsp;B Common Stock&#148; means Kensington&#146;s Class&nbsp;B common stock, par
value $0.0001 per share, as in effect immediately prior to the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Kensington Common Stock&#148; means the Kensington
Class&nbsp;A Common Stock and Kensington Class&nbsp;B Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Kensington Initial Stockholders&#148; means the Sponsor,
Kensington&#146;s officers and Kensington&#146;s directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Kensington Unit&#148; means one share of Kensington Class&nbsp;A Common
Stock and <FONT STYLE="white-space:nowrap">one-half</FONT> of one Kensington Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Kensington Warrant Agreement&#148; means the
Warrant Agreement dated as of June&nbsp;30, 2020 by and between Kensington and Continental Stock Transfer&nbsp;&amp; Trust Company, governing the Kensington Warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Kensington Warrants&#148; means the warrants to purchase shares of Kensington Class&nbsp;A Common Stock contemplated by the Kensington
Warrant Agreement, with each warrant exercisable for one share of Kensington Class&nbsp;A Common Stock at an exercise price of $11.50. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Merger&#148; means the merging of Merger Sub with and into QuantumScape with QuantumScape surviving the Merger as a wholly-owned
subsidiary of Kensington. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Merger Sub&#148; means Kensington Merger Sub Corp., a Delaware corporation and wholly-owned direct
subsidiary of Kensington. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Merger Sub Common Stock&#148; means Merger Sub&#146;s common stock, par value $0.01 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;New QuantumScape&#148; means Kensington, immediately upon the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;New QuantumScape Board&#148; means the board of directors of New QuantumScape, immediately upon the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;New QuantumScape Class&nbsp;A Common Stock&#148; means Kensington&#146;s Class&nbsp;A common stock, par value $0.0001 per share, as in
effect immediately after the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;New QuantumScape Class&nbsp;B Common Stock&#148; means Kensington&#146;s Class&nbsp;B common
stock, par value $0.0001 per share, as in effect immediately after the Closing. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;New QuantumScape Common Stock&#148; means New
QuantumScape Class&nbsp;A Common Stock and New QuantumScape Class&nbsp;B Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;New QuantumScape Preferred Stock&#148; means
New QuantumScape preferred stock, par value $0.0001 per share, as in effect immediately after the Closing. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;NYSE&#148; means
The New York Stock Exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;PCAOB&#148; means the Public Company Accounting Oversight Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;PCAOB Audited Financials&#148; means the audited consolidated balance sheet of
QuantumScape and its consolidated subsidiaries as of December&nbsp;31, 2018 and December&nbsp;31, 2019, and the related audited consolidated statements of income and cash flows of QuantumScape and its consolidated subsidiaries for such years, each
audited in accordance with the auditing standards of the PCAOB. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;PIPE&#148; means the sale of PIPE Shares to the Subscribers, for a
purchase price of $10.00 per share and an aggregate purchase price of $500&nbsp;million, in a private placement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;PIPE Shares&#148;
means an aggregate of 50,000,000 shares of Kensington Class&nbsp;A Common Stock to be issued to Subscribers in the PIPE. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Private
Warrants&#148; means the warrants to purchase shares of Kensington Class&nbsp;A Common Stock owned by the Sponsor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Proposed
Bylaws&#148; means the proposed bylaws of New QuantumScape which will be effective upon the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Proposed Certificate of
Incorporation&#148; means the proposed certificate of incorporation of New QuantumScape which will be effective upon the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Proposed Transactions&#148; means the Business Combination and other proposed transactions contemplated by the Business Combination
Agreement. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;prospectus&#148; means the prospectus included in the Registration Statement on
<FONT STYLE="white-space:nowrap">Form&nbsp;S-4</FONT> (Registration No.&nbsp;333-248930) filed with the SEC. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Public
Shares&#148; means shares of Kensington Class&nbsp;A Common Stock issued as part of the Kensington Units sold in the IPO. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Public
Stockholders&#148; means the holders of shares of Kensington Class&nbsp;A Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Public Warrants&#148; means the warrants
included in the Kensington Units sold in the IPO, each of which is exercisable for one share of Kensington Class&nbsp;A Common Stock, in accordance with its terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;QuantumScape&#148; means QuantumScape Corporation, a Delaware corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;QuantumScape Board&#148; means the board of directors of QuantumScape, prior to the Business Combination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;QuantumScape Capital Stock&#148; means QuantumScape Common Stock and QuantumScape Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;QuantumScape Class&nbsp;A Common Stock&#148; means QuantumScape&#146;s Class&nbsp;A common stock, par value $0.0001 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;QuantumScape Class&nbsp;A Preferred Stock&#148; means Series C Preferred Stock, Series D Preferred Stock, Series&nbsp;E Preferred Stock
and Series F Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;QuantumScape Class&nbsp;B Common Stock&#148; means QuantumScape&#146;s Class&nbsp;B common stock, par
value $0.0001 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;QuantumScape Class&nbsp;B Preferred Stock&#148; means Series A Preferred Stock, Series B Preferred Stock
and Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;QuantumScape Common Stock&#148; means QuantumScape Class&nbsp;A Common Stock and
QuantumScape Class&nbsp;B common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;QuantumScape Options&#148; means all options to purchase outstanding shares of QuantumScape
Common Stock, whether or not exercisable and whether or not vested, immediately prior to the Closing under QuantumScape option plans or otherwise, other than the QuantumScape Warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;QuantumScape Preferred Stock&#148; means Series A Preferred Stock, Series B Preferred Stock, Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;QuantumScape Restricted Stock&#148; means all outstanding shares of restricted stock granted under QuantumScape option plans or acquired
via the early exercise of QuantumScape Options, immediately prior to the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;QuantumScape RSUs&#148; means all outstanding
restricted stock units granted by QuantumScape, immediately prior to the Closing under QuantumScape option plans or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;QuantumScape Warrants&#148; means all outstanding and unexercised warrants to purchase shares of QuantumScape Capital Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;SEC&#148; means the U.S. Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Securities Act&#148; means the U.S. Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Series A Preferred Stock&#148; means QuantumScape&#146;s Series A preferred stock, par value $0.0001 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Series B Preferred Stock&#148; means QuantumScape&#146;s Series B preferred stock, par value $0.0001 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock&#148; means QuantumScape&#146;s Series
<FONT STYLE="white-space:nowrap">B-1</FONT> preferred stock, par value $0.0001 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Series C Preferred Stock&#148; means
QuantumScape&#146;s Series C preferred stock, par value $0.0001 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Series D Preferred Stock&#148; means QuantumScape&#146;s
Series D preferred stock, par value $0.0001 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Series E Preferred Stock&#148; means QuantumScape&#146;s Series E preferred
stock, par value $0.0001 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Series F Preferred Stock&#148; means QuantumScape&#146;s Series F preferred stock, par value
$0.0001 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Series F Subscription Amount&#148; means $388&nbsp;million, which is the aggregate amount of funding and funding
commitments received by QuantumScape as of the Closing Date with respect to private sales of its Series F Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Sponsor&#148; means Kensington Capital Sponsor LLC, a Delaware limited liability company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Sponsor Shares&#148; means the 5,750,000 shares of Kensington Class&nbsp;B Common Stock purchased by the Sponsor in a private placement
prior to the IPO, after giving effect to a stock dividend prior to the IPO. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Stockholder Support Agreements&#148; means, together
(i)&nbsp;the Stockholder Support Agreement, dated as of September&nbsp;2, 2020, by and between Kensington and Volkswagen Group of America Investments, LLC and (ii)&nbsp;the Stockholder Support Agreement, dated as of September&nbsp;2, 2020, by and
among Kensington and certain of QuantumScape&#146;s stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Subscribers&#148; means the purchasers of the PIPE Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Surviving Corporation&#148; means the entity surviving the Merger as a wholly-owned subsidiary of New QuantumScape. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Trust Account&#148; means the trust account that holds a portion of the proceeds of the IPO and the concurrent sale of the Private
Warrants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_3"></A>QUESTIONS AND ANSWERS ABOUT THE BUSINESS COMBINATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following questions and answers briefly address some commonly asked questions about the proposals to be presented at the special
meeting of stockholders, including with respect to the proposed Business Combination. The following questions and answers may not include all the information that is important to Kensington stockholders. Stockholders are urged to read carefully this
entire proxy statement/prospectus/information statement, including the financial statements and annexes attached hereto and the other documents referred to herein. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Questions and Answers About the Special Meeting of Kensington&#146;s Stockholders and the Related Proposals </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Why am I receiving this proxy statement/prospectus/information statement? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Kensington has entered into the Business Combination Agreement with QuantumScape and Merger Sub pursuant to
which Merger Sub will be merged with and into QuantumScape, with QuantumScape surviving the Merger as a wholly-owned subsidiary of Kensington. A copy of the Business Combination Agreement is attached to this proxy statement/prospectus/information
statement as Annex A. </P></TD></TR></TABLE>  <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At the Closing, as a result of the Business Combination, (i)&nbsp;each outstanding share of
QuantumScape Class&nbsp;A Common Stock and QuantumScape Class&nbsp;A Preferred Stock will be cancelled and automatically converted into the right to receive a number of shares of New QuantumScape Class&nbsp;A Common Stock, and (ii)&nbsp;each
outstanding share of QuantumScape Class&nbsp;B Common Stock and QuantumScape Class&nbsp;B Preferred Stock will be cancelled and automatically converted into the right to receive a number of shares of New QuantumScape Class&nbsp;B Common Stock,
determined in each case by reference to an &#147;Exchange Ratio,&#148; as calculated in accordance with the Business Combination Agreement. As of the date of the initial signing of the Business Combination Agreement, the Exchange Ratio was
4.0032186234. Kensington will file with the SEC a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> announcing the final Exchange Ratio no later than four business days prior to the special meeting of its stockholders. See the
sections entitled &#147;<I>Summary of the proxy statement/prospectus/information statement&#151;Ownership of New QuantumScape After the Closing</I>&#148; and &#147;<I>Unaudited Pro Forma Condensed Combined Financial Information</I>&#148; for further
information. </P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Kensington stockholders are being asked to consider and vote upon the Business Combination Proposal to approve the
adoption of the Business Combination Agreement and the Business Combination, among other proposals. </P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Kensington Class&nbsp;A Common
Stock, Kensington Warrants and Kensington Units are currently listed on the NYSE under the symbols &#147;KCAC,&#148; &#147;KCAC WS&#148; and &#147;KCAC.U,&#148; respectively. At the Closing, as a result of the Business Combination, each outstanding
share of Kensington Class&nbsp;B Common Stock will convert into Kensington Class&nbsp;A Common Stock, and all Kensington Class&nbsp;A Common Stock will become New QuantumScape Class&nbsp;A Common Stock. Kensington intends to apply to list shares of
New QuantumScape Class&nbsp;A Common Stock on the NYSE under the symbol &#147;QS&#148; in connection with the Closing. All outstanding Kensington Units will be separated into their underlying securities following the Closing. Accordingly, there will
be no Kensington Units nor any NYSE listing of Kensington Units following the Closing. </P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">This proxy statement/prospectus/information
statement and its annexes contain important information about the proposed Business Combination and the proposals to be acted upon at the special meeting. You should read this proxy statement/prospectus/information statement and its annexes
carefully and in their entirety. This document also constitutes a prospectus of Kensington with respect to the Kensington Common Stock issuable in connection with the Business Combination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What matters will stockholders consider at the special meeting? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At the Kensington special meeting of stockholders, Kensington will ask its stockholders to vote in favor of the
following proposals (the &#147;Kensington Proposals&#148;): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 1&#151;The Business Combination Proposal&#151;a proposal to approve and adopt the Business
Combination Agreement and the Business Combination. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 2&#151;The Authorized Share Charter Proposal&#151;a proposal to amend the Existing Certificate of
Incorporation to increase the number of authorized shares of Kensington Common Stock and Kensington&#146;s preferred stock. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 3&#151;The Director Declassification Charter Proposal&#151;a proposal to amend the Existing
Certificate of Incorporation to declassify the Kensington Board. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 4&#151;The Dual Class&nbsp;Charter Proposal&#151;a proposal to amend the Existing Certificate of
Incorporation to implement a dual class stock structure comprised of New QuantumScape Class&nbsp;A Common Stock, which will carry one vote per share, and New QuantumScape Class&nbsp;B Common Stock, which will carry 10 votes per share.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 5&#151;The Additional Charter Proposal&#151;a proposal to amend the Existing Certificate of
Incorporation to eliminate provisions in the Existing Certificate of Incorporation relating to the Business Combination that will no longer be applicable following the Closing, change New QuantumScape&#146;s name to &#147;QuantumScape
Corporation&#148; and make certain other changes that the Kensington Board deems appropriate for a public operating company (the Additional Charter Proposal, together with the Authorized Share Charter Proposal, the Director Declassification Charter
Proposal and the Dual Class&nbsp;Charter Proposal, the &#147;Charter Proposals&#148;). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 6&#151;The Election of Directors Proposal&#151;a proposal to elect, effective at the Closing, nine
directors to serve on the New QuantumScape Board. </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 7&#151;The Equity Incentive Plan Proposal&#151;a proposal to approve and adopt the equity
incentive award plan established to be effective upon the Closing. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 8&#151;The NYSE Proposal&#151;a proposal to issue New QuantumScape Common Stock to the
QuantumScape stockholders in the Merger pursuant to the Business Combination Agreement and to the investors in the PIPE. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 9&#151;The Employee Stock Purchase Plan Proposal&#151;a proposal to approve and adopt the employee
stock purchase plan established to be effective upon the Closing. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Proposal No. 10&#151;The Adjournment Proposal&#151;a proposal to adjourn the special meeting to a later date or
dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the special meeting, there are not sufficient votes to approve one or more proposals presented to stockholders for vote.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Are any of the proposals conditioned on one another? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Charter Proposals, Election of Directors Proposal, Equity Incentive Plan Proposal, NYSE Proposal and
Employee Stock Purchase Plan Proposal are all conditioned on the approval of the Business Combination Proposal. If the Charter Proposals are approved, the Proposed Certificate of Incorporation will be approved and adopted in its entirety. The
Adjournment Proposal does not require the approval of the Business Combination Proposal and Business Combination to be effective. It is important for you to note that in the event the Business Combination Proposal is not approved, Kensington will
not consummate the Business Combination. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What will happen upon the Closing? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On the Closing Date, Merger Sub will merge into QuantumScape, whereupon Merger Sub will cease to exist and
QuantumScape will continue as the Surviving Corporation. In addition, Kensington will change its name from &#147;Kensington Capital Acquisition Corp.&#148; to &#147;QuantumScape Corporation&#148; upon the Closing. The Merger will have the effects
specified under Delaware law. As consideration for the Business Combination, each outstanding share of QuantumScape Class&nbsp;A Common Stock and QuantumScape Class&nbsp;A Preferred Stock that is outstanding immediately prior to the Closing and
convertible into a share of QuantumScape Class&nbsp;A Common Stock pursuant to the provisions of QuantumScape&#146;s certificate of incorporation, and each outstanding share of QuantumScape Class&nbsp;B Common Stock and QuantumScape Class&nbsp;B
Preferred Stock that is outstanding immediately prior to the Closing and convertible into a share of QuantumScape Class&nbsp;B Common Stock pursuant to the provisions of QuantumScape&#146;s certificate of incorporation, will be cancelled and
automatically converted into the right to receive a number of shares of New QuantumScape Class&nbsp;A Common Stock or shares of New QuantumScape Class&nbsp;B Common Stock, as applicable, determined in each case by reference to an &#147;Exchange
Ratio,&#148; calculated in accordance with the Business Combination Agreement. As of the date of the initial signing of the Business Combination Agreement, the Exchange Ratio was 4.0032186234. Kensington will file with the SEC a Current Report on
Form <FONT STYLE="white-space:nowrap">8-K</FONT> announcing the final Exchange Ratio no later than four business days prior to the special meeting of its stockholders. In addition, automatically upon the Closing, each share of Kensington
Class&nbsp;B Common Stock outstanding will be converted into a share of New QuantumScape Class&nbsp;A Common Stock on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Why is Kensington proposing the Business Combination Proposal? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Kensington was organized for the purpose of effecting a merger, capital stock exchange, asset acquisition,
stock purchase, reorganization or similar business combination with one or more businesses. Kensington is not limited to any particular industry or sector, but intended to focus in the North America automotive and automotive-related sector.
</P></TD></TR></TABLE>  <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Kensington received $230,000,000 from its IPO (including net proceeds from the exercise in full by the underwriters
of their over-allotment option) and sale of the Private Warrants, which was placed into the Trust Account immediately following the IPO. In accordance with the Existing Certificate of Incorporation, the funds held in the Trust Account will be
released upon the Closing. See the question entitled &#147;<I>What happens to the funds held in the Trust Account upon the Closing?</I>&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">There currently are 28,750,000 shares of Kensington Common Stock outstanding, consisting of 23,000,000 Public Shares and 5,750,000 Sponsor
Shares. In addition, there currently are 18,075,000 Kensington Warrants outstanding, consisting of 11,500,000 Public Warrants and 6,575,000 Private Warrants. Each whole Kensington Warrant entitles the holder thereof to purchase one share of
Kensington Class&nbsp;A Common Stock at a price of $11.50 per share. The Kensington Warrants will become exercisable 30&nbsp;days after the Closing, and expire at 5:00&nbsp;p.m., New York City time, five years after the Closing or earlier upon
redemption or liquidation. The Private Warrants, however, are <FONT STYLE="white-space:nowrap">non-redeemable</FONT> so long as they are held by the Sponsor or its permitted transferees (except as described in the section entitled
&#147;<I>Description of Kensington&#146;s Securities&#151;Kensington Warrants&#151; Redemption of Kensington Warrants when the price per share of Kensington Class</I><I></I><I>&nbsp;A Common Stock equals or exceeds $10.00</I>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under the Existing Certificate of Incorporation, Kensington must generally provide the holders of Public Shares with the opportunity to have
their Public Shares redeemed upon the consummation of Kensington&#146;s initial business combination in conjunction with a stockholder vote. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Who is QuantumScape? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">QuantumScape is developing next generation battery technology for electric vehicles (&#147;EVs&#148;) and other
applications. It believes that its technology will enable a new category of battery that meets the requirements for broader market adoption. The lithium-metal solid-state battery technology that QuantumScape is developing is being designed to offer
greater energy density, longer life, faster charging, and greater safety when compared to today&#146;s conventional lithium-ion batteries.</P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">QuantumScape is a development stage company with no revenue to date that has incurred a net loss of approximately $51.3 million for the year
ended December 31, 2019 and an accumulated deficit of approximately $295.9 million from its inception through the year ended December 31, 2019. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">QuantumScape was incorporated in Delaware in 2010. The mailing address of QuantumScape&#146;s principal executive office is 1730 Technology
Dr., San Jose, CA 95110, and its telephone number is <FONT STYLE="white-space:nowrap">(408)&nbsp;452-2000.</FONT> </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What equity stake will current Kensington stockholders and QuantumScape stockholders have in New
QuantumScape after the Closing, assuming no redemption? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">It is anticipated that, upon the Closing, there will be approximately 218,880,613 shares of New QuantumScape
Class A Common Stock and 157,511,179 shares of New QuantumScape Class B Common Stock outstanding, and the ownership of New QuantumScape will be as follows: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">current holders of QuantumScape Class A Common Stock and QuantumScape Class A Preferred Stock will own
140,130,613 shares of New QuantumScape Class A Common Stock, representing approximately 37.23% of the total shares then outstanding in the aggregate and approximately 7.81% of the vote; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">current holders of QuantumScape Class B Common Stock and QuantumScape Class B Preferred Stock will own
157,511,179 shares of New QuantumScape Class B Common Stock, representing approximately 41.85% of the total shares then outstanding in the aggregate and approximately 87.8% of the vote; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">current holders of QuantumScape Common Stock and QuantumScape Preferred Stock will own 297,641,792 shares of New
QuantumScape Common Stock, representing approximately 79.08% of the total shares then outstanding in the aggregate and approximately 95.61% of the vote; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Volkswagen will own 67,921,684 shares of New QuantumScape Class A Common Stock, representing approximately 31.03%
of the total shares of New QuantumScape Class A Common Stock then outstanding and 17,897,585 shares of New QuantumScape Class B Common Stock, representing 11.36% of the total shares of New QuantumScape Class B Common Stock then outstanding. In the
aggregate, Volkswagen will own 85,819,269 shares of New QuantumScape Common Stock, representing approximately 22.80% of the total shares then outstanding in the aggregate and approximately 13.76% of the vote; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the PIPE investors will own 50,000,000 shares of New QuantumScape Class A Common Stock, representing
approximately 13.28% of the total shares then outstanding in the aggregate and approximately 2.79% of the vote; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Public Stockholders will own 23,000,000 shares of New QuantumScape Class A Common Stock, representing
approximately 6.11% of the total shares then outstanding in the aggregate and approximately 1.28% of the vote; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the holder of Sponsor Shares will own 5,750,000 shares of New QuantumScape Class A Common Stock, representing
approximately 1.53% of the total shares then outstanding in the aggregate and approximately 0.32% of the vote. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The numbers of shares and percentage interests set forth above are based on a number of
assumptions, including that (i)&nbsp;none of the Public Stockholders exercise their redemption rights, (ii)&nbsp;QuantumScape does not issue any additional equity securities prior to the Merger, other than the issuance of 14,684,843 shares of Series
F Preferred Stock pursuant to certain Series F Stock Purchase Agreements by and between QuantumScape and the investors thereto, and that no other event occurs that would change the Exchange Ratio from what it would have been as of the date of the
initial signing of the Business Combination Agreement and (iii)&nbsp;there are no future exercises of the Kensington Warrants. If the actual facts differ from these assumptions, the numbers of shares and percentage interests set forth above will be
different. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What are the material differences in the rights of securityholders as a result of the dual-class structure?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares of New QuantumScape Class B Common Stock will have 10 votes per share, while shares of New QuantumScape
Class A Common Stock have one vote per share. Although no one holder or group of holders will control more than 30% of the voting power of New QuantumScape&#146;s capital stock, the holders of the QuantumScape Class B Common Stock will control
approximately 87.8% of the voting power of New QuantumScape&#146;s capital stock and will collectively be able to control matters submitted to its stockholders for approval, including the election of directors, amendments of its organizational
documents and any merger, consolidation, sale of all or substantially all of New QuantumScape&#146;s assets or other major corporate transactions. Even though these holders are not party to any agreement that requires them to vote together, they may
have interests that differ from yours and may vote in a way with which you disagree and which may be adverse to your interests. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Additionally, New QuantumScape cannot predict whether its dual class structure will result in a lower or more volatile market price of New
QuantumScape Class A Common Stock or in adverse publicity or other adverse consequences. For example, certain index providers have announced restrictions on including companies with multiple-class share structures in certain of their indexes.
S&amp;P Dow Jones and FTSE Russell have announced changes to their eligibility criteria for inclusion of shares of public companies on certain indices, including the S&amp;P 500, pursuant to which companies with multiple classes of shares of common
stock are excluded. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">See the sections entitled &#147;<I>Description of Kensington&#146;s Securities</I>&#148; and &#147;<I>Risk
Factors&#151;The dual class structure of New QuantumScape&#146;s Common Stock has the effect of concentrating voting control with the current holders of QuantumScape Class B Common Stock. This will limit or preclude your ability to influence
corporate matters, including the outcome of important transactions, including a change in control&#148; and &#147;&#151;New QuantumScape&#146;s dual class structure may depress the trading price of New QuantumScape Class A Common Stock</I>.&#148;
</P>  <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Who will be the officers and directors of Kensington if the Business Combination is consummated?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Business Combination Agreement provides that, immediately following the Closing, the New QuantumScape Board
shall consist of Jagdeep Singh as Chairman, one member to be selected by Kensington, who will be Justin Mirro, and additional members to be selected by QuantumScape, who are expected to be Prof. Fritz Prinz, Frank Blome, Brad Buss, John Doerr, Prof.
Dr.&nbsp;J&uuml;rgen Leohold, Dipender Saluja and J.B. Straubel. </P></TD></TR></TABLE>  <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Immediately following the Closing, we expect that
the following will be the officers of New QuantumScape: Jagdeep Singh, as Chief Executive Officer; Dr.&nbsp;Timothy Holme, as Chief Technology Officer; Dr.&nbsp;Mohit Singh, as Chief Development Officer; Kevin Hettrich, as Chief Financial Officer;
Howard Lukens, as Chief Sales Officer; and Michael McCarthy, as Chief Legal Officer and Head of Corporate Development. See the section entitled &#147;<I>Management After the Business Combination.</I>&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What conditions must be satisfied to complete the Business Combination? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">There are a number of closing conditions in the Business Combination Agreement, including that
Kensington&#146;s stockholders have approved and adopted the Business Combination Agreement. For a summary of the conditions that must be satisfied or waived prior to the Closing, see the section entitled &#147;<I>The Business Combination
Agreement&#151;Conditions to Closing</I>.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What happens if I sell my shares of Kensington Common Stock before the special meeting of stockholders?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The record date for the special meeting of stockholders is earlier than the expected Closing Date. If you
transfer your shares of Kensington Common Stock after the record date, but before the special meeting of stockholders, unless the transferee obtains from you a proxy to vote those shares, you will retain your right to vote at the special meeting of
stockholders. However, you will not be entitled to receive any shares of New QuantumScape Common Stock following the Closing because only Kensington&#146;s stockholders and QuantumScape&#146;s stockholders on the date of the Closing will be entitled
to receive shares of New QuantumScape Common Stock in connection with the Closing. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What vote is required to approve the proposals presented at the special meeting of stockholders?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The approval of the Business Combination Proposal and the Charter Proposals require the affirmative vote (in
person or by proxy) of the holders of a majority of all outstanding shares of Kensington Common Stock entitled to vote thereon at the special meeting. Accordingly, a Kensington stockholder&#146;s failure to vote by proxy or to vote in person at the
special meeting of stockholders, an abstention from voting or a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will have the same effect as a vote against these proposals. Our Sponsor, officers, directors and independent directors have
agreed to vote any shares of Kensington Common Stock held by them in favor of the Business Combination. Kensington expects that the Sponsor, officers, directors and independent directors (and their permitted transferees) will own at least
approximately 20% of the outstanding shares of Kensington Common Stock at the time of any such stockholder vote. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The approval of the Equity Incentive Plan Proposal, NYSE Proposal, Employee Stock Purchase Plan Proposal and Adjournment Proposal require the
affirmative vote (in person or by proxy) of the holders of a majority of the shares of Kensington Common Stock that are voted at the special meeting of stockholders. Accordingly, a Kensington stockholder&#146;s failure to vote by proxy or to vote in
person at the special meeting of stockholders, an abstention from voting, or a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will have no effect on the outcome of any vote on these proposals. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The approval of the election of each director nominee pursuant to the Election of Directors Proposal requires the affirmative vote of the
holders of a plurality of the outstanding shares of Kensington Common Stock entitled to vote and actually voted thereon at the special meeting. Accordingly, a Kensington stockholder&#146;s failure to vote by proxy or to vote in person at the special
meeting of stockholders, an abstention from voting, or a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will have no effect on the outcome of any vote on the Election of Directors Proposal. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Charter Proposals, Election of Directors Proposal, Equity Incentive Plan Proposal, NYSE Proposal and Employee Stock Purchase Plan Proposal
are all conditioned on the approval of the Business Combination Proposal. If the Charter Proposals are approved, the Proposed Certificate of Incorporation will be approved and adopted in its entirety. The Adjournment Proposal does not require the
approval of the Business Combination Proposal and Business Combination to be effective. It is important for you to note that in the event the Business Combination Proposal is not approved, Kensington will not consummate the Business Combination.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Have any QuantumScape stockholders entered into agreements with Kensington to vote in favor of the Business
Combination? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Yes. On September&nbsp;2, 2020, (i) Kensington and Volkswagen Group of America Investments, LLC
(&#147;VGA&#148;) entered into a stockholder support agreement, (the &#147;Volkswagen Support Agreement&#148;), pursuant to which, among other things, VGA agreed to vote its shares of QuantumScape Preferred Stock in favor of the Business Combination
Agreement and the Proposed Transactions, and (ii)&nbsp;Kensington and certain QuantumScape stockholders (together with VGA) with a sufficient number of votes to approve the Business Combination and other transactions that require the approval of
QuantumScape&#146;s stockholders (the &#147;Key QuantumScape Stockholders&#148;) entered into a stockholder support agreement (the &#147;Key Stockholder Support Agreement&#148;), pursuant to which, among other things, the Key QuantumScape
Stockholders agreed, among other things, to vote their shares of QuantumScape Common Stock and QuantumScape Preferred Stock in favor of the Business Combination Agreement and the Proposed Transactions. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of September 14, 2020, VGA and the Key QuantumScape Stockholders collectively held approximately 59.35% of the QuantumScape Class A Common
Stock, 78.16% of the QuantumScape Class B Common Stock and 76.62% of the total QuantumScape Capital Stock then outstanding, which represents a sufficient number of votes for QuantumScape&#146;s stockholders to approve the Business Combination. </P>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The numbers of shares and percentage interests set forth above are based on a number of assumptions, including that (i) none of the Public
Stockholders exercise their redemption rights, (ii) QuantumScape does not issue any additional equity securities prior to the Merger, other than the issuance of 14,684,843 shares of Series F Preferred Stock pursuant to certain Series F Stock
Purchase Agreements by and between QuantumScape and the investors thereto, and that no other event occurs that would change the Exchange Ratio from what it would have been as of the date of the initial signing of the Business Combination Agreement
and (iii) there are no future exercises of the Kensington Warrants. If the actual facts differ from these assumptions, the numbers of shares and percentage interests set forth above will be different. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For further information, please see the section entitled &#147;<I>Certain Agreements Related to the Business Combination&#151;Stockholder
Support Agreements</I>.&#148; </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>If the Business Combination Agreement is terminated, will QuantumScape be required to pay a termination fee
to Kensington? </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Yes. If the Business Combination Agreement is terminated under certain circumstances, QuantumScape
will be required to pay Kensington a termination fee in the amount of $82&nbsp;million. For further information, please see the section entitled &#147;<I>The Business Combination Agreement&#151;Termination</I>.&#148; </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>May Kensington or Kensington&#146;s directors, officers or advisors, or their affiliates, purchase shares in
connection with the Business Combination? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In connection with the stockholder vote to approve the proposed Business Combination, the Sponsor and
Kensington&#146;s directors, officers, advisors or their affiliates may privately negotiate transactions to purchase shares or warrants or a combination thereof prior to the Closing from stockholders who would have otherwise elected to have their
shares redeemed in conjunction with a proxy solicitation pursuant to the proxy rules for a per share pro rata portion of the Trust Account without the prior written consent of QuantumScape. None of the Sponsor, directors, officers or advisors, or
their respective affiliates, will make any such purchases when they are in possession of any material <FONT STYLE="white-space:nowrap">non-public</FONT> information not disclosed to the seller of such shares. Such a purchase would include a
contractual acknowledgement that such stockholder, although still the record holder of such shares, is no longer the beneficial owner thereof and therefore agrees not to exercise his, her or its redemption rights. In the event that the Sponsor,
directors, officers or advisors, or their affiliates, purchase shares in privately negotiated transactions from Public Stockholders who have already elected to exercise their redemption rights, such selling stockholders would be required to revoke
their prior elections to redeem their shares. Any such privately negotiated purchases may be effected at purchase prices that are in excess of the per </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
share pro rata portion of the Trust Account. The purpose of these purchases would be to increase the amount of cash available to Kensington for use in the Business Combination. </TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How many votes do I have at the special meeting of stockholders? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Kensington&#146;s stockholders are entitled to one vote at the special meeting for each share of Kensington
Common Stock held of record as of the record date. As of the close of business on the record date, there were 28,750,000 outstanding shares of Kensington Common Stock. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What interests do Kensington&#146;s current officers and directors have in the Business Combination?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Kensington&#146;s executive officers and directors may have interests in the Business Combination that are
different from, in addition to or in conflict with, yours. These interests include: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the beneficial ownership of the Sponsor of an aggregate of 5,750,000 Sponsor Shares and 6,575,000 Private
Warrants, which shares and warrants would become worthless if Kensington does not complete a business combination within the applicable time period, as the Sponsor has waived any right to redemption with respect to these shares. The Sponsor paid an
aggregate of $25,000 for the Sponsor Shares and $6,575,000 for the Private Warrants. Such shares and warrants have an aggregate market value of approximately $83,605,000 and $24,919,250, respectively, based on the closing price of Kensington
Class&nbsp;A Common Stock and Public Warrants of $14.54 and $3.79, respectively, on the NYSE on October 19, 2020; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Justin Mirro, Kensington&#146;s Chief Executive Officer and Chairman is the managing member of the managing
member of the Sponsor. Consequently, he may be deemed the beneficial owner of the 5,750,000 Sponsor Shares and 6,575,000 Private Warrants and to have voting and dispositive control over such securities. Mr.&nbsp;Mirro disclaims beneficial ownership
of any securities other than to the extent he may have a pecuniary interest therein, directly or indirectly. Each of Kensington&#146;s other officers and directors are <FONT STYLE="white-space:nowrap">non-managing</FONT> members of the Sponsor;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Sponsor has made a loan of $75,000 to Kensington; the Sponsor has informed Kensington that the Sponsor
intends to convert the loan into 75,000 warrants on the same terms as the Private Warrants (as contemplated by the warrant agreement pursuant to which the Private Warrants were issued) at the same time the Business Combination is completed and for
such warrants to be issued to Justin Mirro, who had advanced such amount to the Sponsor in order for the loan to be made. Such warrants have an aggregate market value of approximately $284,250 based on the closing price of the Public Warrants of
$3.79 on the NYSE on October 19, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Sponsor and Kensington&#146;s directors and executive officers and their respective affiliates will not
receive reimbursement for any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by them on Kensington&#146;s behalf incident to identifying, investigating and completing a business
combination to the extent such expenses exceed the amount not required to be retained in the Trust Account, unless a business combination is consummated. As of September 30, 2020, the Sponsor and Kensington&#146;s directors and executive officers
and their respective affiliates had incurred approximately $29,000 of such reimburseable out-of-pocket expenses; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the anticipated continuation of Justin Mirro, Kensington&#146;s Chairman and Chief Executive Officer, as a
director of New QuantumScape following the Closing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">DEHC LLC (&#147;DEHC&#148;), an affiliate of Daniel Huber, Kensington&#146;s Chief Financial Officer and
Secretary and Simon Boag, Kensington&#146;s Chief Technology Officer, entered into services agreements with Kensington to provide administrative and other services as may be reasonably requested by Kensington for one year after the Closing in order
to assist it in connection with the post-Closing integration of QuantumScape into New QuantumScape. In consideration of the agreements by DEHC and Mr. Boag to provide such services, Kensington agreed to pay each of them $240,000 at the
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Closing. The foregoing amounts are subject to recoupment by Kensington in the event DEHC or Mr. Boag, as applicable, fails to satisfy its obligations under the agreements; and
</P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the continued indemnification of current directors and officers of Kensington and the continuation of
directors&#146; and officers&#146; liability insurance after the Business Combination. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">These interests may influence
Kensington&#146;s directors in making their recommendation that you vote in favor of the approval of the Business Combination Proposal. You should also read the section entitled &#147;<I>The Business Combination&#151;Interests of Kensington&#146;s
Directors and Officers in the Business Combination</I>.&#148; </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Did the Kensington Board obtain a third-party valuation or fairness opinion in determining whether or not to
proceed with the Business Combination? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Kensington Board did not obtain a third-party valuation or fairness opinion in connection with its
determination to approve the Business Combination. The Kensington Board believes that based upon the financial skills and background of its directors, it was qualified to conclude that the Business Combination was fair from a financial perspective
to its stockholders. The Kensington Board also determined, without seeking a valuation from a financial advisor, that QuantumScape&#146;s fair market value was at least 80% of Kensington&#146;s net assets, excluding any taxes payable on interest
earned. Accordingly, investors will be relying on the judgment of the Kensington Board as described above in valuing QuantumScape&#146;s business and assuming the risk that the Kensington Board may not have properly valued such business.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What factors did the Kensington Board consider in determining whether or not to proceed with the Business
Combination? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Kensington Board considered a number of factors pertaining to the Business Combination as generally
supporting its decision to enter into the Business Combination Agreement and the transactions contemplated thereby, including, but not limited to: (i) the due diligence conducted by Kensington&#146;s management and the Kensington Board; (ii)
QuantumScape&#146;s outlook, financial plan, cash position, absence of indebtedness, customer contracts and capital expenditure plan; (iii) the public trading market valuation of comparable pure-play EV/component companies; (iv) QuantumScape&#146;s
management team, which is expected to remain with New QuantumScape to seek to execute the strategic and growth goals of the combined business; (v) other business combination opportunities reasonably available to Kensington; and (vi) the financial
and other terms of the Business Combination Agreement and the fact that such terms and conditions are reasonable and were the product of arm&#146;s length negotiations between Kensington and QuantumScape. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Kensington Board also considered a variety of uncertainties and risks and other potentially negative factors concerning the Business
Combination including, but not limited to: (i) QuantumScape&#146;s status as a pre-revenue company, and the risk that it may not be able to execute on its business plan; (ii) macroeconomic uncertainty and the effects it could have on the revenues of
the combined business; (iii) the potential that a significant number of Kensington stockholders elect to redeem their shares prior to the Closing and pursuant to Kensington&#146;s existing charter; (iv) the risk that Kensington&#146;s or
QuantumScape&#146;s stockholders may fail to provide the respective votes and written consents, respectively, necessary to effect the Business Combination; (v) the fact that the Closing is conditioned on the satisfaction of certain closing
conditions that are not within Kensington&#146;s control; (vi) the possibility of litigation challenging the Business Combination or that an adverse judgment granting permanent injunctive relief could indefinitely enjoin the Closing; (vii) the risks
that the potential benefits of the Business Combination may not be fully achieved or may not be achieved within the expected timeframe; (viii) the risk that Kensington did not obtain a third-party valuation or fairness opinion in connection with the
Business Combination; (ix) the fact that Kensington stockholders will hold a minority position in New QuantumScape; (x) the interests of the Kensington Board and officers in the Business Combination (see &#147;<I>&#151;Interests of Kensington&#146;s
Directors and Officers in the Business Combination</I>&#148;); and (xi) various other risk factors associated with QuantumScape&#146;s business, as described in the section entitled &#147;<I>Risk Factors</I>&#148; appearing elsewhere in this proxy
statement/prospectus/information statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">See the sections entitled &#147;<I>The Business Combination&#151;Kensington&#146;s Board
of Directors&#146; Reasons for the Approval of the Business Combination</I>.&#148; </P>  <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What happens if the Business Combination Proposal is not approved? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the Business Combination Proposal is not approved, Kensington will look for other opportunities to
consummate an initial business combination by June&nbsp;30, 2022, pursuant to its amended and restated certificate of incorporation, as then in effect. If Kensington does not consummate an initial business combination by such date, Kensington will
either amend its amended and restated certificate of incorporation to extend the date by which Kensington must consummate an initial business combination, or Kensington will be required to dissolve and liquidate the Trust Account.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Do I have redemption rights? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If you are a holder of Public Shares, you may redeem your Public Shares for cash equal to their pro rata share
of the aggregate amount then on deposit in the Trust Account, calculated as of two business days prior to the Closing, including interest earned on the funds held in the Trust Account and not previously released to Kensington to pay
Kensington&#146;s taxes, net of taxes payable, upon the Closing. The per share amount Kensington will distribute to holders who properly redeem their shares will not be reduced by the deferred underwriting commissions Kensington will pay to the
underwriters of its IPO if the Business Combination is consummated. Holders of the outstanding Public Warrants do not have redemption rights with respect to such warrants in connection with the Business Combination. The Sponsor and Kensington&#146;s
officers and directors have agreed to waive their redemption rights with respect to their Sponsor Shares and any Public Shares that they may have acquired during or after the IPO in connection with the completion of Kensington&#146;s initial
business combination. The Sponsor Shares will be excluded from the pro rata calculation used to determine the per share redemption price. For illustrative purposes, based on funds in the Trust Account of $230&nbsp;million on June&nbsp;30, 2020, the
per share redemption price would have been $10.00. Additionally, Public Shares properly tendered for redemption will only be redeemed if the Business Combination is consummated; otherwise, holders of such shares will only be entitled to a pro rata
portion of the Trust Account, including interest (which interest shall be net of taxes payable by Kensington and up to $100,000 of interest to pay dissolution expenses), in connection with the liquidation of the Trust Account. </P></TD></TR></TABLE>
 <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Is there a limit on the number of shares I may redeem? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A Public Stockholder, together with any affiliate of such stockholder or any other person with whom such
stockholder is acting in concert or as a &#147;group&#148; (as defined in Section&nbsp;13 of the Exchange Act) will be restricted from redeeming his or her shares with respect to more than an aggregate of 15% of the Public Shares without
Kensington&#146;s prior consent. Accordingly, all shares in excess of 15% of the Public Shares owned by a holder will not be redeemed. On the other hand, a Public Stockholder who holds 15% or less of the Public Shares may redeem all of the Public
Shares held by him or her for cash. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Will how I vote affect my ability to exercise redemption rights? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No. You may exercise your redemption rights whether you vote your Public Shares for or against the Business
Combination Proposal or do not vote your shares. As a result, the Business Combination Proposal can be approved by stockholders who will redeem their Public Shares and no longer remain stockholders, leaving stockholders who choose not to redeem
their Public Shares holding shares in a company with a less liquid trading market, fewer stockholders, less cash and the potential inability to meet the listing standards of the NYSE. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How do I exercise my redemption rights? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In order to exercise your redemption rights, you must, prior to 4:30 p.m. Eastern time on
[&nbsp;&nbsp;&nbsp;&nbsp;], 2020 (two&nbsp;business days before the special meeting), (i)&nbsp;submit a written request to Kensington&#146;s transfer agent </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
that Kensington redeem your Public Shares for cash, and (ii)&nbsp;deliver your stock to Kensington&#146;s transfer agent physically or electronically through The Depository Trust Company
(&#147;DTC&#148;). The address of Continental Stock Transfer&nbsp;&amp; Trust Company, Kensington&#146;s transfer agent, is listed under the question &#147;<I>Who can help answer my questions?</I>&#148; below. Kensington requests that any requests
for redemption include the identity as to the beneficial owner making such request. Electronic delivery of your stock generally will be faster than delivery of physical stock certificates. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A physical stock certificate will not be needed if your stock is delivered to Kensington&#146;s transfer agent electronically. In order to
obtain a physical stock certificate, a stockholder&#146;s broker and/or clearing broker, DTC and Kensington&#146;s transfer agent will need to act to facilitate the request. It is Kensington&#146;s understanding that stockholders should generally
allot at least one week to obtain physical certificates from the transfer agent. However, because Kensington does not have any control over this process or over the brokers or DTC, it may take significantly longer than one week to obtain a physical
stock certificate. If it takes longer than anticipated to obtain a physical certificate, stockholders who wish to redeem their shares may be unable to obtain physical certificates by the deadline for exercising their redemption rights and thus will
be unable to redeem their shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Any demand for redemption, once made, may be withdrawn at any time until the deadline for exercising
redemption requests and thereafter, with Kensington&#146;s consent, until the vote is taken with respect to the Business Combination. If you delivered your shares for redemption to Kensington&#146;s transfer agent and decide within the required
timeframe not to exercise your redemption rights, you may request that Kensington&#146;s transfer agent return the shares (physically or electronically). You may make such request by contacting Kensington&#146;s transfer agent at the phone number or
address listed under the question &#147;<I>Who can help answer my questions?</I>&#148; </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What are the U.S. federal income tax consequences of exercising my redemption rights?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Kensington stockholders who exercise their redemption rights to receive cash from the Trust Account in exchange
for their Public Shares generally will be required to treat the transaction as a sale of such shares and recognize gain or loss upon the redemption in an amount equal to the difference, if any, between the amount of cash received and the tax basis
of the shares of Kensington Class&nbsp;A Common Stock redeemed. Such gain or loss should be treated as capital gain or loss if such shares were held as a capital asset on the date of the redemption. A stockholder&#146;s tax basis in his, her or its
shares of Kensington Class&nbsp;A Common Stock generally will equal the cost of such shares. A stockholder who purchased Kensington Units will have to allocate the cost between the shares of Kensington Class&nbsp;A Common Stock or Kensington
Warrants comprising the Kensington Units based on their relative fair market values at the time of the purchase. See the section entitled &#147;<I>Certain U.S. Federal Income Tax Considerations of the Redemption and the Business
Combination</I>&#148; and &#147;<I>Risk Factors&#151;There is uncertainty regarding the federal income tax consequences of the redemption to the holders of Kensington Class</I><I></I><I>&nbsp;A Common Stock.</I>&#148; </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>If I hold Kensington Warrants, can I exercise redemption rights with respect to my warrants?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No. There are no redemption rights with respect to the Kensington Warrants. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Do I have appraisal rights if I object to the proposed Business Combination? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No. There are no appraisal rights available to holders of shares of Kensington Common Stock in connection with
the Business Combination, except to the extent available under the DGCL. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What happens to the funds held in the Trust Account upon Closing? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the Business Combination is consummated, the funds held in the Trust Account will be released to pay
(i)&nbsp;Kensington stockholders who properly exercise their redemption rights and (ii)&nbsp;expenses incurred by </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
QuantumScape and Kensington in connection with the Proposed Transactions, to the extent not otherwise paid prior to the Closing. Any additional funds available for release from the Trust Account
will be used for general corporate purposes of Kensington following the Business Combination. </TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What happens if the Business Combination is not consummated? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">There are certain circumstances under which the Business Combination Agreement may be terminated. If, as a
result of the termination of the Business Combination Agreement or otherwise, the Business Combination is not consummated, Kensington will look for other opportunities to consummate an initial business combination by June&nbsp;30, 2022, pursuant to
its amended and restated certificate of incorporation, as then in effect. If Kensington does not consummate an initial business combination by then, Kensington will either amend its amended and restated certificate of incorporation to extend the
date by which Kensington must consummate an initial business combination, or Kensington will be required to dissolve and liquidate the Trust Account. See the section entitled &#147;<I>The Business Combination Agreement&#151;Termination</I>&#148; for
information regarding the parties&#146; specific termination rights. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>When is the Business Combination expected to be consummated? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">It is currently anticipated that the Business Combination will be consummated promptly following the special
meeting of stockholders, provided that all other conditions to the Closing have been satisfied or waived. </P></TD></TR></TABLE>  <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For a
description of the conditions to the completion of the Business Combination, see the section entitled &#147;<I>The Business Combination Agreement&#151;Conditions to Closing</I>.&#148; </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What do I need to do now? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You are urged to carefully read and consider the information contained in this proxy
statement/prospectus/information statement, including the financial statements and annexes attached hereto, and to consider how the Business Combination will affect you as a stockholder. You should then vote as soon as possible in accordance with
the instructions provided in this proxy statement/prospectus/information statement on the enclosed proxy card or, if you hold your shares through a brokerage firm, bank or other nominee, on the voting instruction form provided by the broker, bank or
nominee. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How do I vote? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If you were a holder of record of Kensington Common Stock on
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2020, the record date for the special meeting of stockholders, you may vote with respect to the applicable proposals in any of the following ways, if
available: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Vote by Mail: </I>by signing, dating and returning the enclosed proxy card in the accompanying postage-paid
envelope; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Vote by Internet</I>: visit
http://www.[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;].com, 24 hours a day, seven days a week, until 11:59 p.m. Eastern Time on
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2020 (have your proxy card in hand when you visit the website); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Vote by Phone</I>: by calling toll-free (within the United States or Canada)
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] (have your proxy card in hand when you call); or </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Vote at the Special Meeting</I>: by attending the special meeting and voting in person. You will be given a
ballot when you arrive. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If your shares are held in &#147;street name&#148; through a broker, bank or other nominee, your
broker, bank or other nominee will send you separate instructions describing the procedure for voting your shares. Simply complete, sign and date your voting instruction card and return it in the postage-paid envelope provided to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
ensure that your vote is counted. Alternatively, you may vote by telephone or over the internet as instructed by your broker, bank or other nominee. If you wish to attend the special meeting of
stockholders and vote in person, you must obtain a proxy from your broker, bank or nominee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In light of the ongoing health concerns
relating to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and to best protect the health and welfare of Kensington&#146;s stockholders and personnel, Kensington urges that stockholders do not attend the special meeting in person.
Stockholders are nevertheless urged to vote their proxies by completing, signing, dating and returning the enclosed proxy card in the accompanying <FONT STYLE="white-space:nowrap">pre-addressed</FONT> postage paid envelope, or to direct their
brokers or other agents on how to vote the shares in their accounts, as applicable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The special meeting is currently scheduled to be held
in person as indicated above. However, we are actively monitoring the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and if we determine that it is not possible or advisable to hold the special meeting in person, or to hold the meeting on
the time or date or at the location indicated above, we will announce alternative arrangements for the meeting as promptly as practicable, which may include switching to a virtual meeting format, or changing the time, date or location of the special
meeting. Any such change will be announced via press release and the filing of additional proxy materials with the SEC. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What will happen if I abstain from voting or fail to vote at the special meeting? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At the special meeting of stockholders, Kensington will count a properly executed proxy marked
&#147;ABSTAIN&#148; with respect to a particular proposal as present for purposes of determining whether a quorum is present. For purposes of approval, an abstention or failure to vote will have the same effect as a vote against each of the Business
Combination Proposal and the Charter Proposals, and will have no effect on any of the other proposals. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What will happen if I sign and return my proxy card without indicating how I wish to vote?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Signed and dated proxies received by Kensington without an indication of how the stockholder intends to vote on
a proposal will be voted in favor of each proposal presented to the stockholders. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Do I need to attend the special meeting of stockholders to vote my shares? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No. You are invited to attend the special meeting to vote on the proposals described in this proxy
statement/prospectus/information statement. However, you do not need to attend the special meeting of stockholders to vote your shares. Instead, you may submit your proxy by signing, dating and returning the applicable enclosed proxy card(s) in the <FONT
STYLE="white-space:nowrap">pre-addressed</FONT> postage-paid envelope or vote by internet or phone as described above. Your vote is important. Kensington encourages you to vote as soon as possible after carefully reading this proxy
statement/prospectus/information statement. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>If I am not going to attend the special meeting of stockholders in person, should I return my proxy card
instead? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Yes. After carefully reading and considering the information contained in this proxy
statement/prospectus/information statement, please submit your proxy, as applicable, by completing, signing, dating and returning the enclosed proxy card in the postage-paid envelope provided. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>If my shares are held in &#147;street name,&#148; will my broker, bank or nominee automatically vote my
shares for me? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No. If your broker holds your shares in its name and you do not give the broker voting instructions, under the
applicable stock exchange rules, your broker may not vote your shares on any of the Kensington Proposals. If you do not give your broker voting instructions and the broker does not vote your shares, this is referred to as a &#147;broker <FONT
STYLE="white-space:nowrap">non-vote.&#148;</FONT> Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will be counted for purposes of determining the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
presence of a quorum at the special meeting of stockholders. Your bank, broker, or other nominee can vote your shares only if you provide instructions on how to vote. You should instruct your
broker to vote your shares in accordance with directions you provide. In addition, in no event will a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> have the effect of exercising your redemption rights for a <I>pro rata</I> portion of the
Trust Account, and therefore no shares as to which a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> occurs will be redeemed in connection with the proposed Business Combination. </TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>May I change my vote after I have mailed my signed proxy card? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Yes. You may change your vote by sending a later-dated, signed proxy card to Kensington&#146;s secretary at the
address listed below prior to the vote at the special meeting of stockholders, or attending the special meeting and voting in person. You also may revoke your proxy by sending a notice of revocation to Kensington&#146;s secretary, provided such
revocation is received prior to the vote at the special meeting. If your shares are held in street name by a broker or other nominee, you must contact the broker or nominee to change your vote. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What should I do if I receive more than one set of voting materials? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You may receive more than one set of voting materials, including multiple copies of this proxy
statement/prospectus/information statement and multiple proxy cards or voting instruction cards. For example, if you hold your shares in more than one brokerage account, you will receive a separate voting instruction card for each brokerage account
in which you hold shares. If you are a holder of record and your shares are registered in more than one name, you will receive more than one proxy card. Please complete, sign, date and return each proxy card and voting instruction card that you
receive in order to cast your vote with respect to all of your shares. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What is the quorum requirement for the special meeting of stockholders? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A quorum will be present at the special meeting of stockholders if a majority of the Kensington Common Stock
outstanding and entitled to vote at the meeting is represented in person or by proxy. In the absence of a quorum, a majority of Kensington&#146;s stockholders, present in person or represented by proxy, and voting thereon will have the power to
adjourn the special meeting. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of the record date for the special meeting, 14,375,001 shares of Kensington Common Stock
would be required to achieve a quorum. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Your shares will be counted towards the quorum only if you submit a valid proxy (or your broker,
bank or other nominee submits one on your behalf) or if you vote in person at the special meeting of stockholders. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will be counted towards the quorum requirement. If there is
no quorum, a majority of the shares represented by stockholders present at the special meeting or by proxy may authorize adjournment of the special meeting to another date. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What happens to the Kensington Warrants I hold if I vote my shares of Kensington Class&nbsp;A Common Stock
against approval of the Business Combination Proposal and validly exercise my redemption rights? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A holder voting his, her or its Kensington Class&nbsp;A Common Stock against the Business Combination Proposal
and/or exercising his, her or its redemption rights will not affect any Kensington Warrants held by such holder, which will remain outstanding following the Closing. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Who will solicit and pay the cost of soliciting proxies? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Kensington will pay the cost of soliciting proxies for the special meeting. Kensington has engaged D.F.
King&nbsp;&amp; Co., Inc. (&#147;D.F. King&#148;) to assist in the solicitation of proxies for the special meeting. Kensington </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
has agreed to pay D.F. King a fee of $20,000. Kensington will reimburse D.F. King for reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT>
expenses and will indemnify D.F. King and its affiliates against certain claims, liabilities, losses, damages and expenses. Kensington also will reimburse banks, brokers and other custodians, nominees and fiduciaries representing beneficial owners
of shares of Kensington Common Stock for their expenses in forwarding soliciting materials to beneficial owners of Kensington Common Stock and in obtaining voting instructions from those owners. Kensington&#146;s directors, officers and employees
may also solicit proxies by telephone, by facsimile, by mail, on the internet or in person. They will not be paid any additional amounts for soliciting proxies. </TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Who can help answer my questions? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If you have questions about the stockholder proposals, or if you need additional copies of this proxy
statement/prospectus/information statement, the proxy card or the consent card you should contact our proxy solicitor at: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D.F. King&nbsp;&amp; Co., Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48
Wall Street, 22<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, NY 10005 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Call Toll-Free: (877) <FONT STYLE="white-space:nowrap">478-5045</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Banks and Brokers Call: (212) <FONT STYLE="white-space:nowrap">269-5550</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">KCAC@dfking.com </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">You may also
contact Kensington at: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Kensington Capital Acquisition Corp. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1400 Old Country Road, Suite 301 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Westbury, NY 11590 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Telephone: <FONT
STYLE="white-space:nowrap">(703)&nbsp;674-6514</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Secretary </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To obtain timely delivery, Kensington&#146;s stockholders and warrant holders must request the materials no later than five business days prior
to the special meeting. </P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">You may also obtain additional information about Kensington from documents filed with the SEC by following
the instructions in the section entitled &#147;<I>Where You Can Find More Information</I>.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If you intend to seek redemption of your
Public Shares, you will need to send a letter demanding redemption and deliver your stock (either physically or electronically) to Kensington&#146;s transfer agent prior to 4:30&nbsp;p.m., New York time, on the second business day prior to the
special meeting of stockholders. If you have questions regarding the certification of your position or delivery of your stock, please contact: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Continental Stock Transfer&nbsp;&amp; Trust Company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One State Street Plaza, 30<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>&nbsp;Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, NY 10004 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention:
Francis Wolf </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="white-space:nowrap">E-mail:</FONT> fwolf@continentalstock.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_4"></A>SUMMARY OF THE PROXY STATEMENT/PROSPECTUS/INFORMATION STATEMENT
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights selected information from this proxy statement/prospectus/information statement and does not contain all
of the information that is important to you. To better understand the Business Combination and the proposals to be considered at the special meeting, you should read this entire proxy statement/prospectus/information statement carefully, including
the annexes. See also the section entitled &#147;Where You Can Find More Information.&#148; </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Parties to the Business Combination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Kensington </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington is a
Delaware corporation formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, recapitalization or other similar business combination with one or more businesses, referred to throughout this
proxy statement/prospectus/information statement as its initial business combination. Although Kensington may pursue its initial business combination in any business, industry or geographic location, it has focused on opportunities to capitalize on
the ability of its management team, particularly its executive officers, to identify, acquire and operate a business in the North America automotive and automotive-related sector. Upon the Closing, we intend to change our name from &#147;Kensington
Capital Acquisition Corp.&#148; to &#147;QuantumScape Corporation.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington Class&nbsp;A Common Stock, Kensington Warrants and
Kensington Units, consisting of one share of Kensington Class&nbsp;A Common Stock and <FONT STYLE="white-space:nowrap">one-half</FONT> of a Kensington Warrant, are traded on the NYSE under the ticker symbols &#147;KCAC,&#148; &#147;KCAC WS&#148; and
&#147;KCAC.U,&#148; respectively. We intend to apply to continue the listing of the Kensington Class&nbsp;A Common Stock and Kensington Warrants on the NYSE under the symbols &#147;QS&#148; and &#147;QS.W,&#148; respectively, upon the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The mailing address of Kensington&#146;s principal executive office is 1400 Old Country Road, Suite 301, Westbury, NY 11590, and its telephone
number is <FONT STYLE="white-space:nowrap">(703)&nbsp;674-6514.</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape is developing next generation battery technology for EVs and other applications. It believes that its technology will enable a new
category of battery that meets the requirements for broader market adoption. The lithium-metal solid-state battery technology that QuantumScape is developing is being designed to offer greater energy density, longer life, faster charging, and
greater safety when compared to today&#146;s conventional lithium-ion batteries.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape is a development stage company with no
revenue to date that has incurred a net loss of approximately $51.3 million for the year ended December 31, 2019 and an accumulated deficit of approximately $295.9 million from its inception through the year ended December 31, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape was incorporated in Delaware in 2010. The mailing address of QuantumScape&#146;s principal executive office is 1730 Technology
Dr., San Jose, CA 95110, and its telephone number is <FONT STYLE="white-space:nowrap">(408)&nbsp;452-2000.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information
about QuantumScape, see the sections entitled &#147;<I>Information About QuantumScape</I>&#148; and &#147;<I>QuantumScape Management&#146;s Discussion and Analysis of Financial Condition and Results of Operation</I>.&#148; </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Business Combination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Business Combination Agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Kensington, Merger Sub and QuantumScape entered into the Business Combination Agreement, pursuant to which
Kensington and QuantumScape will consummate the Business Combination. The Business Combination Agreement contains customary representations and warranties, covenants, closing conditions, termination fee provisions and other terms relating to the
Merger and the other transactions contemplated thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Merger is to become effective by the filing of a certificate of merger with
the Secretary of State of the State of Delaware and will be effective immediately upon such filing or upon such later time as may be agreed by the parties and specified in such certificate of merger (such time, the &#147;Effective Time&#148;). The
parties will hold the Closing immediately prior to such filing of a certificate of merger, on the Closing Date to be specified by Kensington and QuantumScape, as promptly as practicable following the satisfaction or waiver (to the extent such waiver
is permitted by applicable law) of the conditions set forth in the Business Combination Agreement (other than those conditions that by their nature are to be satisfied at Closing, but subject to the satisfaction or waiver of those conditions at such
time), but in no event later than the third business day after the satisfaction or waiver, if legally permissible, of each of the conditions to the completion of the Business Combination (or on such other date, time or place as Kensington and
QuantumScape may mutually agree). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Effective Time, by virtue of the Merger and without any action on the part of Kensington, Merger
Sub, QuantumScape or the holders of any of QuantumScape&#146;s securities: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each share of QuantumScape Class&nbsp;A Common Stock and QuantumScape Class&nbsp;A Preferred Stock outstanding
immediately prior to the Effective Time and convertible into a share of QuantumScape Class&nbsp;A Common Stock pursuant to the provisions of QuantumScape&#146;s certificate of incorporation, will be cancelled and converted into the right to receive
the number of shares of New QuantumScape Class&nbsp;A Common Stock equal to the Exchange Ratio (as described below), with each holder&#146;s shares rounded down to the nearest whole number; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each share of QuantumScape Class&nbsp;B Common Stock and QuantumScape Class&nbsp;B Preferred Stock outstanding
immediately prior to the Effective Time and convertible into a share of QuantumScape Class&nbsp;B Common Stock pursuant to the provisions of QuantumScape&#146;s certificate of incorporation, will be cancelled and converted into the right to receive
the number of shares of New QuantumScape Class&nbsp;B Common Stock equal to the Exchange Ratio (as described below), with each holder&#146;s shares rounded down to the nearest whole number; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all shares of QuantumScape Capital Stock held in the treasury of QuantumScape will be cancelled without any
conversion thereof and no payment or distribution will be made with respect thereto; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each share of Merger Sub Common Stock outstanding immediately prior to the Effective Time will be converted into
and exchanged for one validly issued, fully paid and nonassessable share of common stock, par value $0.01 per share, of the Surviving Corporation; and </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each QuantumScape Option that is outstanding immediately prior to the Effective Time, whether vested or unvested,
will be converted into an option to purchase a number of shares of the applicable class of New QuantumScape Common Stock that the <FONT STYLE="white-space:nowrap">pre-conversion</FONT> QuantumScape Option covers (such option, an &#147;Exchanged
Option&#148;) equal to the product (rounded down to the nearest whole number) of (i)&nbsp;the number of shares of QuantumScape Common Stock subject to such QuantumScape Option immediately prior to the Effective Time multiplied by (ii)&nbsp;the
Exchange Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A)&nbsp;the exercise price per share of such QuantumScape Option immediately prior to the Effective Time divided by (B)&nbsp;the Exchange Ratio.
</P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Except as specifically provided in the Business Combination Agreement, following the Effective Time, each Exchanged Option will continue to be governed by the same terms and conditions (including
vesting and exercisability terms) as were applicable to the corresponding former QuantumScape Option immediately prior to the Effective Time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each share of QuantumScape Restricted Stock that is outstanding immediately prior to the Effective Time will be
converted into restricted shares of the applicable class of New QuantumScape Common Stock that the <FONT STYLE="white-space:nowrap">pre-conversion</FONT> QuantumScape Restricted Stock covers (such share of restricted New QuantumScape Common Stock,
an &#147;Exchanged Restricted Stock&#148;) equal to the product (rounded down to the nearest whole number) of (i)&nbsp;the number of shares subject to a QuantumScape Restricted Stock immediately prior to the Effective Time multiplied by
(ii)&nbsp;the Exchange Ratio. Except as specifically provided above, following the Effective Time, each Exchanged Restricted Stock shall continue to be governed by the same terms and conditions (including transfer restrictions and repurchase right
terms) as were applicable to the corresponding former QuantumScape Restricted Stock immediately prior to the Effective Time; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each QuantumScape RSU that is outstanding immediately prior to the Effective Time will be converted into
restricted stock units of the applicable class of New QuantumScape Common Stock that the <FONT STYLE="white-space:nowrap">pre-conversion</FONT> QuantumScape RSU covers (such restricted stock unit award covering New QuantumScape Common Stock, an
&#147;Exchanged RSU&#148;) equal to the product (rounded down to the nearest whole number) of (i)&nbsp;the number of shares of QuantumScape RSU immediately prior to the Effective Time multiplied by (ii)&nbsp;the Exchange Ratio. Except as
specifically provided above, following the Effective Time, each Exchanged RSU shall continue to be governed by the same terms and conditions (including transfer restrictions and repurchase right terms) as were applicable to the corresponding former
QuantumScape RSU immediately prior to the Effective Time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the obligation to purchase shares of Series F Preferred Stock upon satisfaction of certain milestones, if still
outstanding, will become an obligation to purchase, upon satisfaction of the milestones, shares of New QuantumScape Class&nbsp;A Common Stock equal in number to the shares of New QuantumScape Class A Common Stock that would have been issued in the
Merger in exchange for such shares of Series F Preferred Stock if such shares of Series F Preferred Stock had been outstanding prior to the Merger; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each QuantumScape Warrant that is outstanding immediately prior to the Effective Time shall be converted into a
warrant to purchase a number of shares of the applicable class of New QuantumScape Common Stock (such warrant, the &#147;Exchanged Warrant&#148;) equal to the product (rounded down to the nearest whole number) of (i)&nbsp;the number of shares of
QuantumScape Common Stock subject to such QuantumScape Warrant immediately prior to the Effective Time multiplied by (ii)&nbsp;the Exchange Ratio. Except as specifically provided above, following the Effective Time, each Exchanged Warrant shall
continue to be governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former QuantumScape Warrant immediately prior to the Effective Time. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The &#147;Exchange Ratio&#148; is defined in the Business Combination Agreement as a quotient that is calculated on the basis of: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(i) the &#147;Target Share Amount,&#148; which means an amount equal to (a) 360,000,000, plus or minus (b)&nbsp;the quotient obtained by
dividing (x)&nbsp;the amount, if any, by which the Series F Subscription Amount is greater than or less than, as applicable, $300,000,000, by (y) $10. As of the date of the initial signing of the Business Combination Agreement, the Target Share
Amount was equal to 368,799,998; </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">divided by </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ii) QuantumScape&#146;s &#147;Fully-Diluted Company Shares&#148; (with such &#147;Fully-Diluted Company Shares&#148; being, as of the date of
the initial signing of the Business Combination Agreement, equal to 92,125,870). </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the date of the initial signing of the Business Combination
Agreement, the Exchange Ratio was 4.0032186234. The Exchange Ratio will be finally calculated in accordance with the methodology and procedures set forth in the Business Combination Agreement, and Kensington will file with the SEC a Current Report
on Form <FONT STYLE="white-space:nowrap">8-K</FONT> announcing the final Exchange Ratio no later than four business days prior to the special meeting of its stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information about the Business Combination Agreement and the Business Combination and other transactions contemplated thereby, see
the sections entitled &#147;<I>Proposal No.</I><I></I><I>&nbsp;1&#151;The Business Combination Proposal</I>&#148; and &#147;<I>The Business Combination Agreement</I>.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Conditions to the Closing </I></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the
Business Combination Agreement, the Closing is subject to customary and other conditions, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our stockholders having approved, among other things, the Proposed Transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of any governmental order that would prohibit the Business Combination; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the expiration of the waiting period (or extension thereof) under the Hart-Scott-Rodino Antitrust Improvements
Act of 1976 (as amended, the &#147;HSR Act&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Series F Subscription Amount shall be at least $300&nbsp;million in the aggregate; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape having no indebtedness for borrowed money; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Kensington having at least $500&nbsp;million in the aggregate in (A)&nbsp;its Trust Account (after giving effect
to any Redemption Rights (as defined in the Business Combination Agreement) that are actually perfected) plus (B)&nbsp;cash proceeds received in connection with the PIPE (calculated without reduction for any payments in respect of Outstanding
Kensington Transaction Expenses (as defined in the Business Combination Agreement)); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the representations and warranties of the parties to the Business Combination Agreement being true and correct,
subject to the materiality and material adverse effect standards contained in the Business Combination Agreement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">compliance by the parties in all material respects with their respective covenants. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Regulatory Matters </I></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To complete the
Business Combination, Kensington and QuantumScape must obtain approvals or consents from, or make filings with certain U.S. federal authorities. The Business Combination is subject to the requirements of the HSR Act, which prevents Kensington and
QuantumScape from completing the Business Combination until required information and materials are furnished to the Antitrust Division of the Department of Justice (the &#147;DOJ&#148;) and the Federal Trade Commission (the &#147;FTC&#148;) and
specified waiting period requirements have been satisfied. On September 30, 2020, Kensington filed a Premerger Notification and Report Form pursuant to the HSR Act with the DOJ and FTC and requested early termination of the waiting period under the
HSR Act. On October 14, the FTC granted early termination of the waiting period under the HSR Act. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information, see the
section entitled &#147;<I>The Business Combination&#151;Regulatory Approvals Required for the Business Combination</I>.&#148; </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Litigation Relating to the Business Combination </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October 2, 2020, a putative class action lawsuit was filed in the Supreme Court of the State of New York by a purported Kensington
stockholder in connection with the Business Combination: Sanchez v. Kensington Capital Acquisition Corp., et al., Index No. 654941/2020 (Sup. Ct. N.Y. Cnty.). The complaint names Kensington and certain current and former members of the Kensington
Board as defendants. The complaint alleges, among other things, breach of fiduciary duty claims against the Kensington Board in connection with the Business Combination. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Termination Rights </I></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business
Combination Agreement is subject to termination prior to Effective Time as follows: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by the mutual written consent of Kensington and QuantumScape; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Kensington or QuantumScape, if (i)&nbsp;the Effective Time shall not have occurred prior to the Outside Date
(as defined in the Business Combination Agreement); provided, however, that the Business Combination Agreement may not be terminated by any party that either directly or indirectly through its affiliates is in breach or violation of any
representation, warranty, covenant, agreement or obligation contained in the Business Combination Agreement and such breach or violation is the principal cause of the failure of a the conditions to the Merger on or prior to the Outside Date;
(ii)&nbsp;any governmental authority in the United States has enacted, issued, promulgated, enforced or entered any injunction, order, decree or ruling (whether temporary, preliminary or permanent) which has become final and nonappealable and has
the effect of making the Closing illegal or otherwise preventing or prohibiting the Closing and the Merger; or (iii)&nbsp;any of the Kensington Proposals fail to receive the requisite vote for approval at the special meeting; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by QuantumScape if (i)&nbsp;there is an occurrence of a breach of any representation, warranty, covenant or
agreement on the part of Kensington and Merger Sub set forth in the Business Combination Agreement, or if any representation or warranty of Kensington and Merger Sub shall have become untrue, in either case such that the conditions described in
subsections&nbsp;(a) and (b)&nbsp;under the heading &#147;<I>The Business Combination Agreement&#151;Conditions to Closing; The Company</I>&#148; would not be satisfied (a &#147;Terminating Kensington Breach&#148;); provided that QuantumScape has
not waived such Terminating Kensington Breach and QuantumScape is not then in material breach of their representations, warranties, covenants or agreements in the Business Combination Agreement; provided, however, that, if such Terminating
Kensington Breach is curable by Kensington and Merger Sub, QuantumScape may not terminate the Business Combination Agreement under the applicable section for so long as Kensington and Merger Sub continue to exercise their reasonable efforts to cure
such breach, unless such breach is not cured within thirty days after notice of such breach is provided by QuantumScape to Kensington; or (ii)&nbsp;at any time prior to receipt of the irrevocable written consent of QuantumScape stockholders holding
the requisite approval in favor of the approval and adoption of the Business Combination Agreement and the Proposed Transactions (the &#147;Written Consent&#148;), in connection with entering into any agreement in principle, letter of intent,
memorandum of understanding, term sheet, acquisition agreement, merger agreement, option agreement, joint venture agreement, partnership agreement or other written arrangement relating to any acquisition proposal or any proposal or offer that could
reasonably be expected to lead to an acquisition proposal (each, a &#147;QuantumScape Acquisition Agreement&#148;) with respect to a Superior Proposal (as defined in the section entitled &#147;<I>The Business Combination Agreement&#151;No
Solicitation; Change in Recommendation</I>&#148;) in accordance with Section&nbsp;7.05(d) of the Business Combination Agreement; provided, that prior to or concurrently with such termination QuantumScape pays the Termination Fee (as defined in the
Business Combination Agreement and below); and </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Kensington if (i)&nbsp;the QuantumScape Board or a committee thereof, prior to obtaining the Written Consent
has made an Adverse Recommendation Change (as defined in the section entitled &#147;<I>The Business Combination Agreement&#151;No Solicitation; Change in Recommendation</I>&#148;); provided, however, that Kensington&#146;s right to terminate the
Business Combination Agreement will expire at the end of the tenth (10th) business day following the date on which the Adverse Recommendation Change occurs; or (ii)&nbsp;QuantumScape&nbsp;has failed to deliver the Written Consent to Kensington
within 24&nbsp;hours after the Registration Statement becomes effective; provided, however, that Kensington&#146;s right to terminate the Business Combination Agreement will expire at the end of the fifth (5th) business day following the date on
which the Written Consent is delivered to Kensington; or (iii)&nbsp;there is an occurrence of a breach of any representation, warranty, covenant or agreement on the part of QuantumScape set forth in the Business Combination Agreement, or if any
representation or warranty of QuantumScape has become untrue, in either case such that the conditions described in subsections&nbsp;(a) and (b)&nbsp;under the heading &#147;<I>The Business Combination Agreement&#151;Conditions to Closing; Kensington
and Merger Sub</I>&#148; would not be satisfied (a &#147;Terminating Company Breach&#148;); provided that Kensington has not waived such Terminating Company Breach and Kensington and Merger Sub are not then in material breach of their
representations, warranties, covenants or agreements in the Business Combination Agreement; provided further that, if such Terminating Company Breach is curable by QuantumScape, Kensington may not terminate the Business Combination Agreement under
this provision for so long as QuantumScape continues to exercise its reasonable efforts to cure such breach, unless such breach is not cured within thirty days after notice of such breach is provided by Kensington to QuantumScape.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Business Combination Agreement is terminated, the agreement will forthwith become void, and there will be no
liability under the Business Combination Agreement on the part of any party to the Business Combination Agreement, except as set forth in the Business Combination Agreement or in the case of termination subsequent to a willful material breach of the
Business Combination Agreement by a party thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape shall pay a termination fee in the amount of $82&nbsp;million (the
&#147;Termination Fee&#148;) in the event that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(i) the Business Combination Agreement is terminated (A)&nbsp;by QuantumScape or Kensington, if the Effective
Time did not occur prior to the Outside Date (as defined in the Business Combination Agreement), (B) by Kensington, if QuantumScape failed to deliver the Written Consent to Kensington within 24&nbsp;hours after the Registration Statement became
effective or (C)&nbsp;pursuant to a Terminating Company Breach, (ii)&nbsp;a bona fide Acquisition Proposal (as defined in the section entitled &#147;<I>The Business Combination Agreement&#151;No Solicitation; Change in Recommendation</I>&#148;) has
been made, proposed or otherwise communicated to QuantumScape after the date of the Business Combination Agreement but before the date of termination, and (iii)&nbsp;within six months of the date the Business Combination Agreement is terminated,
QuantumScape enters into a definitive agreement with respect to such Acquisition Proposal; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Business Combination Agreement is terminated (x)&nbsp;by Kensington if the QuantumScape Board or a
committee thereof, prior to obtaining the Written Consent, shall have made an Adverse Recommendation Change; or (y)&nbsp;by QuantumScape, if at any time prior to receiving the Written Consent, QuantumScape enters into a QuantumScape Acquisition
Agreement with respect to a Superior Proposal. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information, see the section entitled &#147;<I>The Business
Combination Agreement&#151;Termination</I>.&#148; </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amendments to the Existing Certificate of Incorporation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Business Combination Agreement, at the Effective Time, if the Charter Proposals are all approved, the Existing Certificate of
Incorporation will be amended and restated in the form attached hereto as Annex B and incorporated herein by reference to, among other things: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increase the number of authorized shares of our common stock and preferred stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">declassify our board of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">implement a dual class stock structure comprised of New QuantumScape Class&nbsp;A Common Stock, which will carry
one vote per share, and New QuantumScape Class&nbsp;B Common Stock, which will carry 10 votes per share; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">eliminate provisions in the Existing Certificate of Incorporation relating to the Business Combination that will
no longer be applicable following the Closing, change New QuantumScape&#146;s name to &#147;QuantumScape Corporation,&#148; and make certain other changes that the Kensington Board deems appropriate for a public operating company.
</P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information about these amendments to the Existing Certificate of Incorporation, see the sections
entitled &#147;<I>Proposal No. 2&#151;The Authorized Share Charter Proposal</I>,&#148; &#147;<I>Proposal No. 3&#151;The Director Declassification Charter Proposal</I>,&#148; &#147;<I>Proposal No. 4&#151;The Dual Class</I><I></I><I>&nbsp;Charter
Proposal</I>&#148; and &#147;<I>Proposal No. 5&#151;The Additional Charter Proposal</I>.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Agreements Related to the Business Combination
Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stockholder Support Agreements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, (i) Kensington and VGA entered into the Volkswagen Support Agreement, pursuant to which, among other things, VGA
agreed to vote its shares of QuantumScape Preferred Stock in favor of the Business Combination Agreement and the Proposed Transactions, and (ii)&nbsp;Kensington and the Key QuantumScape Stockholders entered into the Key Stockholder Support
Agreement, pursuant to which, among other things, the Key QuantumScape Stockholders agreed to vote their shares of QuantumScape Common Stock and QuantumScape Preferred Stock in favor of the Business Combination Agreement and the Proposed
Transactions. As of September 14, 2020, VGA and the Key QuantumScape Stockholders collectively held approximately 59.35% of the QuantumScape Class&nbsp;A Common Stock, 78.16% of the QuantumScape Class&nbsp;B Common Stock and 76.62% of the total
QuantumScape Capital Stock then outstanding. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The numbers of shares and percentage interests set forth above are based on a number of
assumptions, including that (i) none of the Public Stockholders exercise their redemption rights, (ii) QuantumScape does not issue any additional equity securities prior to the Merger, other than the issuance of 14,684,843 shares of Series F
Preferred Stock pursuant to certain Series F Stock Purchase Agreements by and between QuantumScape and the investors thereto, and that no other event occurs that would change the Exchange Ratio from what it would have been as of the date of the
initial signing of the Business Combination Agreement and (iii) there are no future exercises of the Kensington Warrants. If the actual facts differ from these assumptions, the numbers of shares and percentage interests set forth above will be
different. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information about the Stockholder Support Agreements, see the section entitled &#147;<I>Certain Agreements Related to
the Business Combination&#151;Stockholder Support Agreements</I>.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT>
Agreement </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Kensington, the Sponsor and certain stockholders of QuantumScape (the
&#147;New&nbsp;Holders&#148; and, collectively with the Sponsor, the &#147;Holders&#148;) entered into a Registration Rights and </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement, which shall be effective at the Closing. Pursuant to the terms of the Registration Rights and
<FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement, Kensington will be obligated to file&nbsp;a registration statement to register the resale of certain shares of Kensington Common Stock held by the Holders after the Closing. In addition,
pursuant to the terms of the Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement and subject to certain requirements and customary conditions, including with regard to the number of demand rights that may be exercised,
the Holders may demand at any time or from time to time, that Kensington file&nbsp;a registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> (or on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> if <FONT
STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> is not available) to register the securities of Kensington held by such Holders, and Kensington is separately required at all times to maintain an effective resale registration statement for the
benefit of the Holders. The Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement will also provide the Holders with &#147;piggy-back&#148; registration rights, subject to certain requirements and customary conditions.
</P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement further provides for the securities of
Kensington held by the Holders to be <FONT STYLE="white-space:nowrap">locked-up</FONT> for a period of time following the Closing, subject to certain exceptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information about the Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement, see the section entitled
&#147;<I>Certain Agreements Related to the Business Combination&#151;Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement</I>.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Subscription Agreements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
connection with the execution of the Business Combination Agreement, effective as of September&nbsp;2, 2020, Kensington entered into separate subscription agreements (each, a &#147;Subscription Agreement&#148;) with a number of Subscribers, pursuant
to which the Subscribers agreed to purchase, and Kensington agreed to sell to the Subscribers, the PIPE Shares, for a purchase price of $10.00 per share and an aggregate purchase price of $500&nbsp;million. Pursuant to the terms of the Subscription
Agreements and subject to certain requirements and customary conditions, Kensington is required to file and maintain an effective resale registration statement with respect to the PIPE Shares for the benefit of the Subscribers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The closing of the sale of the PIPE Shares pursuant to the Subscription Agreements is contingent upon, among other customary closing
conditions, the substantially concurrent Closing. The purpose of the PIPE is to raise additional capital for use by New QuantumScape following the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information about the Subscription Agreements, see the section entitled &#147;<I>Certain Agreements Related to the Business
Combination&#151;Subscription Agreements</I>.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Kensington entered into separate Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements with
certain senior level employees of QuantumScape (the &#147;Senior Employees&#148;), including QuantumScape&#146;s executive officers.&nbsp;The Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements provide that the securities of
Kensington owned of record or beneficially by the Senior Employees (including certain securities that may be granted or issued to a Senior Employee after the Effective Time) (collectively, the <FONT STYLE="white-space:nowrap">&#147;Lock-Up</FONT>
Shares&#148;) may generally not be transferred for at least 180 days after the Closing (the &#147;Initial <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period&#148;) and up to four years after the Closing, subject to certain
exceptions.&nbsp;Following the Initial <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, Senior Employees may transfer <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares without restriction as follows: (i)&nbsp;during the first year after
the Effective Time, up to 25% of the total number of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares, (ii)&nbsp;following the first anniversary of the Effective Time until the earlier of four years after the Closing or the occurrence of an
event described below, up to 50% of the total number of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares (taking into account any transfers under clause (i)&nbsp;above), and (iii)&nbsp;up to an additional 50% of the total number of <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Shares following satisfaction of agreed delivery requirements between QuantumScape and VGA.</P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These transfer restrictions are subject to earlier release if (i)&nbsp;New QuantumScape
completes a liquidation, merger, stock exchange or other similar transaction after the Closing that results in all of New QuantumScape&#146;s stockholders having the right to exchange their shares of common stock for cash, securities or other
property; (ii)&nbsp;VGA terminates for any reason the Amended and Restated Joint Venture Agreement, dated as of May&nbsp;14, 2020, by and among QuantumScape and VGA; (iii)&nbsp;VGA issues a critical or negative statement regarding New QuantumScape
and its technology unless such statement is required to be made by VGA under applicable law and is truthful and accurate; or (iv)&nbsp;VGA transfers certain New QuantumScape securities in excess of the amounts set forth in the Senior Employee <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Agreements.&nbsp;The Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements also provide that, upon consummation of the Merger, Kensington or QuantumScape shall pay to each Senior
Employee a <FONT STYLE="white-space:nowrap">one-time</FONT> cash bonus equal to 20% of the Senior Employee&#146;s then annual base salary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information about the Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements, see the section entitled
&#147;<I>Certain Agreements Related to the Business Combination&#151;Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements</I>.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Interests of Certain Persons in the Business Combination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In considering the recommendation of the Kensington Board to vote in favor of the Business Combination, stockholders should be aware that,
aside from their interests as stockholders, the Sponsor and our directors and officers have interests in the Business Combination that are different from, or in addition to, those of other stockholders generally. Our directors were aware of and
considered these interests, among other matters, in evaluating the Business Combination, and in recommending to stockholders that they approve the Business Combination. Stockholders should take these interests into account in deciding whether to
approve the Business Combination. These interests include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the beneficial ownership of the Sponsor of an aggregate of 5,750,000 Sponsor Shares and 6,575,000 Private
Warrants, which shares and warrants would become worthless if Kensington does not complete a business combination within the applicable time period, as the Sponsor has waived any right to redemption with respect to these shares. The Sponsor paid an
aggregate of $25,000 for the Sponsor Shares and $6,575,000 for the Private Warrants. Such shares and warrants have an aggregate market value of approximately $83,605,000 and $24,919,250, respectively, based on the closing price of Kensington
Class&nbsp;A Common Stock and Public Warrants of $14.54 and $3.79, respectively, on the NYSE on October 19, 2020; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Justin Mirro, Kensington&#146;s Chief Executive Officer and Chairman is the managing member of the managing
member of the Sponsor. Consequently, he may be deemed the beneficial owner of the 5,750,000 Sponsor Shares and 6,575,000 Private Warrants and to have voting and dispositive control over such securities. Mr.&nbsp;Mirro disclaims beneficial ownership
of any securities other than to the extent he may have a pecuniary interest therein, directly or indirectly. Each of Kensington&#146;s other officers and directors are <FONT STYLE="white-space:nowrap">non-managing</FONT> members of the Sponsor;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Sponsor has made a loan of $75,000 to Kensington; the Sponsor has informed Kensington that the Sponsor
intends to convert the loan into 75,000 warrants on the same terms as the Private Warrants (as contemplated by the warrant agreement pursuant to which the Private Warrants were issued) at the same time the Business Combination is completed and for
such warrants to be issued to Justin Mirro, who had advanced such amount to the Sponsor in order for the loan to be made. Such warrants have an aggregate market value of approximately $284,250 based on the closing price of the Public Warrants of
$3.79 on the NYSE on October 19, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Sponsor and Kensington&#146;s directors and executive officers will not receive reimbursement for any <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by them on Kensington&#146;s behalf incident to identifying, investigating and completing a business combination to the extent such expenses
exceed the amount not required to be retained in the Trust Account, unless a business combination is consummated. As of September&nbsp;30, </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
2020, the Sponsor and Kensington&#146;s directors and executive officers and their respective affiliates had incurred approximately $29,000 of such reimburseable out-of-pocket expenses;
</P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the anticipated continuation of Justin Mirro, Kensington&#146;s Chairman and Chief Executive Officer, as a
director of New QuantumScape following the Closing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">DEHC, an affiliate of Daniel Huber, Kensington&#146;s Chief Financial Officer and Secretary and Simon Boag,
Kensington&#146;s Chief Technology Officer, entered into services agreements with Kensington to provide administrative and other services as may be reasonably requested by Kensington for one year after the Closing in order to assist it in connection
with the post Closing integration of QuantumScape into New QuantumScape. In consideration of the agreements by DEHC and Mr. Boag to provide such services, Kensington agreed to pay each of them $240,000 at the Closing. The foregoing amounts are
subject to recoupment by Kensington in the event DEHC or Mr. Boag, as applicable, fails to satisfy its obligations under the agreements; and </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the continued indemnification of current directors and officers of Kensington and the continuation of
directors&#146; and officers&#146; liability insurance after the Business Combination. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These interests may influence
Kensington&#146;s directors in making their recommendation that you vote in favor of the approval of the Business Combination Proposal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reasons for
the Approval of the Business Combination </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After careful consideration, the Kensington Board recommends that Kensington stockholders
vote &#147;FOR&#148; each Kensington Proposal at the Kensington special meeting of stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a description of Kensington&#146;s
reasons for the approval of the Business Combination and the recommendation of our board of directors, see the section entitled &#147;<I>The Business Combination&#151;Kensington&#146;s Board of Directors&#146; Reasons for the Approval of the
Business Combination</I>.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Redemption Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Existing Certificate of Incorporation, holders of Kensington Class&nbsp;A Common Stock may elect to have their shares redeemed for
cash at the applicable redemption price per share equal to the quotient obtained by dividing (a)&nbsp;the aggregate amount on deposit in the Trust Account as of two business days prior to the Closing, including interest not previously released to
Kensington to pay its franchise and income taxes, by (b)&nbsp;the total number of shares of Kensington Class&nbsp;A Common Stock included as part of the Kensington Units issued in the IPO. However, Kensington will not redeem any public shares to the
extent that such redemption would result in Kensington having net tangible assets (as determined in accordance with <FONT STYLE="white-space:nowrap">Rule&nbsp;3a51-1(g)(1)</FONT> of the Exchange Act) of less than $5,000,001. For illustrative
purposes, based on funds in the Trust Account of $230&nbsp;million on June&nbsp;30, 2020, the per share redemption price would have been $10.00. Under the Existing Certificate of Incorporation, in connection with an initial business combination, a
public stockholder, together with any affiliate or any other person with whom such stockholder is acting in concert of as a &#147;group&#148; (as defined under Section&nbsp;13(d)(3) of the Exchange Act), is restricted from seeking redemption rights
with respect to more than 15% of the public shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a holder exercises his, her or its redemption rights, then such holder will be
exchanging his, her or its shares of Kensington Class&nbsp;A Common Stock for cash and will no longer own shares of Kensington Class&nbsp;A Common Stock and will not participate in the future growth of Kensington, if any. Such a holder will be
entitled to receive cash for its public shares only if it properly demands redemption and delivers its shares (either physically or electronically) to Kensington&#146;s transfer agent in accordance with the procedures described herein. See the
section entitled &#147;<I>The Special Meeting of Kensington Stockholders&#151;Redemption Rights</I>&#148; for the procedures to be followed if you wish to redeem your shares for cash. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Ownership of New QuantumScape After the Closing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is anticipated that, upon the Closing, there will be approximately 218,880,613&nbsp;shares of New QuantumScape Class&nbsp;A Common Stock and
157,511,179&nbsp;shares of New QuantumScape Class&nbsp;B Common Stock outstanding, and the ownership of New QuantumScape will be as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">current holders of QuantumScape Class A Common Stock and QuantumScape Class&nbsp;A Preferred Stock will own
140,130,613&nbsp;shares of New QuantumScape Class&nbsp;A Common Stock, representing approximately 37.23% of the total shares then outstanding in the aggregate and approximately 7.81% of the vote; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">current holders of QuantumScape Class&nbsp;B Common Stock and QuantumScape Class&nbsp;B Preferred Stock will own
157,511,179&nbsp;shares of New QuantumScape Class&nbsp;B Common Stock, representing approximately 41.85% of the total shares then outstanding in the aggregate and approximately 87.8% of the vote; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">current holders of QuantumScape Common Stock and QuantumScape Preferred Stock will own 297,641,792&nbsp;shares of
New QuantumScape Common Stock, representing approximately 79.08% of the total shares then outstanding in the aggregate and approximately 95.61% of the vote; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Volkswagen will own 85,819,269&nbsp;shares of New QuantumScape Common Stock, representing approximately 22.80% of
the total shares then outstanding in the aggregate and approximately 13.76% of the vote; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Volkswagen will own 67,921,684&nbsp;shares of New QuantumScape Class&nbsp;A Common Stock, representing
approximately 31.03% of the total shares of New QuantumScape Class&nbsp;A Common Stock then outstanding and 17,897,585&nbsp;shares of New QuantumScape Class&nbsp;B Common Stock, representing 11.36% of the total shares of New QuantumScape
Class&nbsp;B Common Stock then outstanding. In the aggregate, Volkswagen will own 85,819,269&nbsp;shares of New QuantumScape Common Stock, representing approximately 22.80% of the total shares then outstanding in the aggregate and approximately
13.76% of the vote; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the PIPE investors will own 50,000,000&nbsp;shares of New QuantumScape Class&nbsp;A Common Stock, representing
approximately 13.28% of the total shares then outstanding in the aggregate and approximately 2.79% of the vote; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Public Stockholders will own 23,000,000&nbsp;shares of New QuantumScape Class&nbsp;A Common Stock,
representing approximately 6.11% of the total shares then outstanding in the aggregate and approximately 1.28% of the vote; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the holder of Sponsor Shares will own 5,750,000&nbsp;shares of New QuantumScape Class&nbsp;A Common Stock,
representing approximately 1.53% of the total shares then outstanding in the aggregate and approximately 0.32% of the vote. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The numbers of shares and percentage interests set forth above are based on a number of assumptions, including that (i)&nbsp;none of the
Public Stockholders exercise their redemption rights, (ii)&nbsp;QuantumScape does not issue any additional equity securities prior to the Merger, other than the issuance of 14,684,843 shares of its Series F Preferred Stock pursuant to certain Series
F Stock Purchase Agreements by and between QuantumScape and the investors thereto, some of which are subject to achievement of a specified technical milestone, and that no other event occurs that would change the Exchange Ratio from what it would
have been as of the date of the initial signing of the Business Combination Agreement, and (iii)&nbsp;there are no future exercises of the Kensington Warrants. If the actual facts differ from these assumptions, the numbers of shares and percentage
interests set forth above will be different. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please see the section entitled &#147;<I>Unaudited Pro Forma Condensed Combined
Financial Information</I>&#148; for further information. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_5"></A>SELECTED HISTORICAL CONSOLIDATED FINANCIAL INFORMATION OF
QUANTUMSCAPE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selected historical consolidated statements of operations data of QuantumScape for the years ended December&nbsp;31,
2019 and 2018 and the historical consolidated balance sheet data as of December&nbsp;31, 2019 and 2018 are derived from QuantumScape&#146;s audited consolidated financial statements included elsewhere in this proxy statement/prospectus/information
statement. The selected historical condensed consolidated statements of operations data of QuantumScape for the six months ended June&nbsp;30, 2020 and 2019 and the condensed consolidated balance sheet data as of June&nbsp;30, 2020 are derived from
QuantumScape&#146;s unaudited interim condensed consolidated financial statements included elsewhere in this proxy statement/prospectus/information statement. In QuantumScape management&#146;s opinion, the unaudited interim condensed consolidated
financial statements include all adjustments necessary to state fairly QuantumScape&#146;s financial position as of June&nbsp;30, 2020 and the results of operations for the six months ended June&nbsp;30, 2020 and 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape&#146;s historical results are not necessarily indicative of the results that may be expected in the future and
QuantumScape&#146;s results for the six months ended June&nbsp;30, 2020 are not necessarily indicative of the results that may be expected for the full year ending December&nbsp;31, 2020 or any other period. You should read the following selected
historical consolidated financial data together with &#147;<I>QuantumScape</I> <I>Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; </I>and QuantumScape&#146;s consolidated financial statements and
related notes included elsewhere in this proxy statement/prospectus/information statement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Statement of Operations Data</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Six<BR>Months&nbsp;Ended<BR>June&nbsp;30, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Six<BR>Months&nbsp;Ended<BR>June&nbsp;30, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Year<BR>Ended<BR>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the Year<BR>Ended<BR>December&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><I>(In thousand, except Share and per Share Amounts)</I></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,203</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">45,944</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">35,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,747</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,927</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,874</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,768</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,143</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,130</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55,818</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(45,453</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense):</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(94</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,520</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,608</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,324</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,493</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51,263</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,144</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Net (loss) income attributable to <FONT STYLE="white-space:nowrap">non-controlling</FONT>
interest, net of tax of $0 </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss attributable to common stockholders</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(29,319</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(23,501</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(51,283</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(44,149</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average shares outstanding of common stock&#151;basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,233,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,181,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,194,183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,108,638</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share of common stock&#151;basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2.61</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2.10</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.58</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(3.97</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Balance Sheet Data</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B></B><I>(In thousand) </I><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">146,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">172,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">211,214</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,673</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,982</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,294</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total redeemable convertible preferred stock and stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,402</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">192,920</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_6"></A>SELECTED HISTORICAL FINANCIAL INFORMATION OF KENSINGTON </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows selected historical financial information of Kensington for the periods and as of the dates indicated. The selected
historical financial information of Kensington as of May&nbsp;1, 2020 and for the period from April&nbsp;17, 2020 (inception) through May&nbsp;1, 2020 was derived from the audited historical financial statements of Kensington included elsewhere in
this proxy statement/prospectus/information statement. The selected historical interim financial information of Kensington as of June&nbsp;30, 2020 and for the period from April&nbsp;17, 2020 (inception) through June&nbsp;30, 2020 was derived from
the unaudited interim consolidated financial statements of Kensington included elsewhere in this proxy statement/prospectus/information statement. The following table should be read in conjunction with &#147;<I>Kensington Management&#146;s
Discussion and Analysis of Financial Condition and Results of Operations</I>&#148; and our historical financial statements and the notes and schedules related thereto, included elsewhere in this proxy statement/prospectus/information statement. The
historical results presented below are not necessarily indicative of financial results to be achieved by New QuantumScape following the Business Combination. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of and for<BR>the&nbsp;period from<BR>April&nbsp;17, 2020<BR>(inception)&nbsp;through<BR>June&nbsp;30, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of and for<BR>the&nbsp;period&nbsp;from<BR>April&nbsp;17,&nbsp;2020<BR>(inception)&nbsp;through<BR>May&nbsp;1, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Statement of Operations Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 22,314</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 2,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Franchise tax expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,548</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(62,862</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average shares outstanding, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,031,247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,375,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted net loss per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.01</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.00</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance Sheet Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,739,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">237,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">231,977,494</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,538,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_7"></A>SUMMARY UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL
INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following summary unaudited pro forma condensed combined financial data (the &#147;summary pro forma data&#148;)
gives effect to the Business Combination and related transactions described in the section entitled &#147;<I>Unaudited Pro Forma Condensed Combined Financial Information</I>.&#148; The Business Combination will be accounted for as a reverse
recapitalization, with no goodwill or other intangible assets recorded, in accordance with GAAP. Under this method of accounting, Kensington will be treated as the &#147;acquired&#148; company for financial reporting purposes. Accordingly, for
accounting purposes, the Business Combination will be treated as the equivalent of QuantumScape issuing stock for the net assets of Kensington, accompanied by a recapitalization whereby no goodwill or other intangible assets are recorded. The
summary unaudited pro forma condensed combined balance sheet data as of June&nbsp;30, 2020 gives pro forma effect to the Business Combination and related transactions as if they had occurred on June&nbsp;30, 2020. The summary unaudited pro forma
condensed combined statement of operations data for the six months ended June&nbsp;30, 2020 and year ended December&nbsp;31, 2019 give pro forma effect to the Business Combination and related transactions as if they had been consummated on
January&nbsp;1, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The summary pro forma data have been derived from, and should be read in conjunction with, the unaudited pro forma
condensed combined financial information of New QuantumScape appearing elsewhere in this proxy statement/prospectus/information statement and the accompanying notes. The unaudited pro forma condensed combined financial information is based upon, and
should be read in conjunction with, the historical consolidated financial statements of Kensington and QuantumScape and related notes included in this proxy statement/prospectus/information statement. The summary pro forma data have been presented
for informational purposes only and are not necessarily indicative of what New QuantumScape&#146;s financial position or results of operations actually would have been had the Business Combination and related transactions been completed as of the
dates indicated. In addition, the summary pro forma data do not purport to project the future financial position or operating results of New QuantumScape. The summary pro forma data does not include the issuance of 3,784,754 shares of Series F
Preferred Stock subject to the achievement of a specified technical milestone (15,151,197 shares of New QuantumScape Class A Common Stock converted at the Exchange Ratio). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents summary pro forma data after giving effect to the Business Combination and related transactions, assuming two
redemption scenarios as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Assuming No Redemption&#151;this scenario assumes that no shares of Kensington Common Stock are redeemed; and
</P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Assuming Maximum Redemption&#151;this scenario assumes that 23,000,000 shares of Kensington Common Stock are
redeemed for an aggregate payment of approximately $230.0&nbsp;million (based on the estimated per share redemption price of approximately $10.00 per share) from the Trust Account. The Business Combination Agreement includes a condition to the
Closing that, at the Closing, Kensington will have a minimum of $500&nbsp;million in cash comprising (i)&nbsp;the cash held in the Trust Account after giving effect to any Kensington share redemptions and (ii)&nbsp;gross proceeds from the PIPE. The
gross proceeds from the PIPE of $500&nbsp;million is sufficient to satisfy this closing condition, and accordingly, this scenario results in public share redemptions of 23,000,000 shares of Kensington Class&nbsp;A Common Stock.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;Forma<BR>Combined<BR>(Assuming No<BR>Redemptions)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma<BR>Combined<BR>(Assuming<BR>Maximum<BR>Redemptions)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center">(in thousands, except share and per<BR>share data)</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Summary Unaudited Pro Forma Condensed Combined</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Statement of Operations Data Six Months Ended June&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 30,790</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 30,790</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted net loss per share&#151;Class&nbsp;A and Class&nbsp;B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.08</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.09</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted weighted average shares outstanding&#151;Class&nbsp;A and Class&nbsp;B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">361,240,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">338,240,595 </TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Statement of Operations Data Year Ended December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 57,026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 57,026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted net loss per share&#151;Class&nbsp;A and Class&nbsp;B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.15</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted weighted average shares outstanding&#151;Class&nbsp;A and Class&nbsp;B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">361,240,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">338,240,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Selected Unaudited Pro Forma Condensed Combined</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance Sheet Data as of June&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,107,842</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 877,842</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 21,087</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 21,087</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,086,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 856,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Comparative Historical and Unaudited Pro Forma Combined Per Share Financial Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth selected historical comparative share information for Kensington and QuantumScape and unaudited pro forma
condensed combined per share information of New QuantumScape after giving effect to the Business Combination and related transactions, assuming two redemption scenarios as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Assuming No Redemption&#151;this scenario assumes that no shares of Kensington Common Stock are redeemed; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Assuming Maximum Redemption&#151;this scenario assumes that 23,000,000 shares of Kensington Common Stock are
redeemed for an aggregate payment of approximately $230.0&nbsp;million (based on the estimated per share redemption price of approximately $10.00 per share) from the Trust Account. The
</P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Business Combination Agreement includes a condition to the Closing that, at the Closing, Kensington will have a minimum of $500&nbsp;million in cash comprising (i)&nbsp;the cash held in the Trust
Account after giving effect to any Kensington share redemptions and (ii)&nbsp;gross proceeds from the PIPE. The gross proceeds from the PIPE of $500&nbsp;million is sufficient to satisfy this closing condition, and accordingly, this scenario results
in public share redemptions of 23,000,000 shares of Kensington Class&nbsp;A Common Stock. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The pro forma book value
information reflects the Business Combination and related transactions as if they had occurred on June&nbsp;30, 2020. The weighted average shares outstanding and net loss per share information give pro forma effect to the Business Combination and
related transactions as if they had occurred on January&nbsp;1, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This information is only a summary and should be read together with
the selected historical financial information included elsewhere in this proxy statement/prospectus/information statement and the historical financial statements of Kensington and QuantumScape and related notes that are included elsewhere in this
proxy statement/prospectus/information statement. The unaudited pro forma combined per share information of Kensington and QuantumScape is derived from, and should be read in conjunction with, the unaudited pro forma condensed combined financial
statements and related notes included elsewhere in this proxy statement/prospectus/information statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma
combined earnings per share information below does not purport to represent the earnings per share which would have occurred had the companies been combined during the periods presented, nor earnings per share for any future date or period. The
unaudited pro forma combined book value per share information below does not purport to represent what the value of Kensington and QuantumScape would have been had the companies been combined during the periods presented. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="42%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Combined Pro Forma</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>QuantumScape equivalent<BR>pro&nbsp;forma&nbsp;per&nbsp;share&nbsp;data&nbsp;(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Kensington<BR>(Historical)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>QuantumScape<BR>(Historical)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(Assuming<BR>No<BR>Redemption)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(Assuming<BR>Maximum<BR>Redemption)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(Assuming<BR>No<BR>Redemption)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(Assuming<BR>Maximum<BR>Redemption)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>As of and for the Six Months Ended June&nbsp;30, 2020 (3)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Book value per share (1)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24.93</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Weighted average common shares outstanding&#151;basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,031,247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,233,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">361,240,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">338,240,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">282,490,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">282,490,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net income (loss) per share&#151;basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.01</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2.61</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.08</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.09</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.33</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.35</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>As of and for the Year Ended December&nbsp;31, 2019 (3)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Weighted average common shares outstanding&#151;basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">N/A </TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,194,183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">361,240,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">338,240,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">282,490,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">282,490,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net income (loss) per share&#151;basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">N/A </TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4.58</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.15</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.58</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.62</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Book value per share = Total equity/shares outstanding. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The equivalent pro forma basic and diluted per share data for QuantumScape is based on the Exchange Ratio set
forth in the Business Combination Agreement. The weighted average shares outstanding includes QuantumScape preferred stock, which will be converted into shares of Kensington common stock at the Effective Time. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">There were no cash dividends declared in the period presented. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Not applicable as Kensington was incorporated on April 17, 2020. </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_8"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain statements in this proxy statement/prospectus/information statement may constitute &#147;forward-looking statements&#148; for purposes
of the federal securities laws. Our forward-looking statements include, but are not limited to, statements regarding our, our management team&#146;s, QuantumScape&#146;s and QuantumScape&#146;s management team&#146;s expectations, hopes, beliefs,
intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The
words &#147;anticipate,&#148; &#147;believe,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;intends,&#148; &#147;may,&#148; &#147;might,&#148; &#147;plan,&#148; &#147;possible,&#148;
&#147;potential,&#148; &#147;predict,&#148; &#147;project,&#148; &#147;should,&#148; &#147;will,&#148; &#147;would&#148; and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement
is not forward-looking. Forward-looking statements in this proxy statement/prospectus/information statement may include, for example, statements about: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to consummate the Business Combination; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the expected benefits of the Business Combination; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">New QuantumScape&#146;s financial and business performance following the Business Combination, including
financial projections and business metrics; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in New QuantumScape&#146;s strategy, future operations, financial position, estimated revenues and
losses, projected costs, prospects and plans; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the implementation, market acceptance and success of New QuantumScape&#146;s business model;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">New QuantumScape&#146;s ability to scale in a cost-effective manner; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developments and projections relating to QuantumScape&#146;s competitors and industry; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of health epidemics, including the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, on
QuantumScape&#146;s business and the actions QuantumScape may take in response thereto; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s expectations regarding its ability to obtain and maintain intellectual property protection
and not infringe on the rights of others; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expectations regarding the time during which we will be an emerging growth company under the JOBS Act;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s future capital requirements and sources and uses of cash; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s ability to obtain funding for its operations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s business, expansion plans and opportunities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the outcome of any known and unknown litigation and regulatory proceedings; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s relationship with Volkswagen, including the development of its joint venture arrangements
with Volkswagen, and Kensington&#146;s expectations and plans with respect to QuantumScape&#146;s future cooperation with Volkswagen, including as a potential customer. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These forward-looking statements are based on information available as of the date of this proxy statement/prospectus/information statement,
and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not
undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities
laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should not place undue reliance on these forward-looking statements in deciding how to vote your proxy or instruct how your
vote should be cast on the proposals set forth in this proxy statement/prospectus/</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
information statement. As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these
forward-looking statements. Some factors that could cause actual results to differ include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the occurrence of any event, change or other circumstances that could delay, impede or prevent the Business
Combination or give rise to the termination of the Business Combination Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the outcome of any legal proceedings that may be instituted against Kensington or New QuantumScape following
announcement of the proposed Business Combination and transactions contemplated thereby; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inability to complete the Business Combination due to the failure to obtain approval of the stockholders of
Kensington or of the parties to satisfy other conditions to the Closing in the Business Combination Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to obtain or maintain the listing of New QuantumScape Class&nbsp;A Common Stock on the NYSE following
the Business Combination; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that the proposed Business Combination disrupts current plans and operations of QuantumScape as a result
of the announcement and consummation of the transactions described herein; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among
other things, competition and the ability of New QuantumScape to grow and manage growth profitably following the Business Combination; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs related to the Business Combination; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in applicable laws or regulations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effect of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on QuantumScape&#146;s business;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of QuantumScape to execute its business model, including market acceptance of its planned products
and services; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">New QuantumScape&#146;s ability to raise capital; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possibility that Kensington or New QuantumScape may be adversely affected by other economic, business, and/or
competitive factors; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other risks and uncertainties described in this proxy statement/prospectus/information statement, including those
under the section entitled &#147;<I>Risk Factors</I>.&#148; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_9"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>New QuantumScape will face a market environment that cannot be predicted and that involves significant risks, many of which will be beyond
its control. In addition to the other information contained in this proxy statement/prospectus/information statement, you should carefully consider the material risks described below before deciding how to vote your shares of stock. In addition, you
should read and consider the risks associated with the business of Kensington because these risks may also affect New QuantumScape&#151;these risks can be found in Kensington&#146;s final prospectus filed with the SEC on June&nbsp;26, 2020, as
updated by subsequent Quarterly Reports on <FONT STYLE="white-space:nowrap">Form&nbsp;10-Q,</FONT> all of which are filed with the SEC. You should also read and consider the other information in this proxy statement/prospectus/information statement
and the other documents incorporated by reference into this proxy statement/prospectus/information statement. Please see the section entitled &#147;Where You Can Find More Information&#148; in this proxy statement/prospectus/information statement.
The references to QuantumScape in the below section entitled &#147;Risk Factors&#151;Risks Related to QuantumScape&#148; will apply to New QuantumScape upon Closing. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUMMARY RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following summary risk factors and other information included in this proxy statement/prospectus/information statement should be
carefully considered. The summary risks and uncertainties described below are not the only ones QuantumScape faces. Additional risks and uncertainties not currently known to QuantumScape or that it currently deems less significant may also affect
QuantumScape&#146;s business operations or financial results. If any of the following risks actually occur, QuantumScape&#146;s stock price, business, operating results and financial condition could be materially adversely affected. For more
information, see below for more detailed descriptions of each risk factor. </I></P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_10"></A>Risks Related to QuantumScape </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape faces significant barriers in its attempts to produce a solid-state battery cell and may not be able
to successfully develop its solid-state battery cell. If QuantumScape cannot successfully overcome those barriers, its business will be negatively impacted and could fail. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape may encounter substantial delays in the design, manufacture, regulatory approval, and launch of
QuantumScape&#146;s solid-state battery cells, which could prevent QuantumScape from commercializing any products it determines to develop on a timely basis, if at all. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape may not be able to establish supply relationships for necessary components or may be required to pay
costs for components that are more expensive than anticipated, which could delay the introduction of QuantumScape&#146;s product and negatively impact its business. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape may be unable to adequately control the costs associated with its operations and the components
necessary to build its solid-state battery cells. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape relies on complex machinery for its operations and production involves a significant degree of risk
and uncertainty in terms of operational performance and costs. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s relationship with Volkswagen is subject to various risks which could adversely affect
QuantumScape&#146;s business and future prospects. There are no assurances that QuantumScape will be able to commercialize solid-state batteries from its joint development relationship with Volkswagen. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If QuantumScape&#146;s batteries fail to perform as expected, QuantumScape&#146;s ability to develop, market and
sell its batteries could be harmed. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s future growth and success are dependent upon consumers&#146; willingness to adopt EVs.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape may not be able to accurately estimate the future supply and demand for its batteries, which could
result in a variety of inefficiencies in its business and hinder its ability to generate revenue. If </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
QuantumScape fails to accurately predict its manufacturing requirements, it could incur additional costs or experience delays. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape relies heavily on its intellectual property portfolio. If QuantumScape is unable to protect its
intellectual property rights, its business and competitive position would be harmed. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape may need to defend itself against intellectual property infringement claims, which may be
time-consuming and could cause it to incur substantial costs. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The battery market continues to evolve, is highly competitive, and QuantumScape may not be successful in
competing in this industry or establishing and maintaining confidence in its long-term business prospectus among current and future partners and customers. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to QuantumScape&#146;s Technology Development and Scale-Up </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape faces significant barriers in its attempts to produce a solid-state battery cell and may not be able to successfully develop its solid-state
battery cell. If QuantumScape cannot successfully overcome those barriers, its business will be negatively impacted and could fail. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Producing lithium-metal solid-state batteries that meet the requirements for wide adoption by automotive original equipment manufacturers
(&#147;OEMs&#148;) is a difficult undertaking. QuantumScape is still in development stage and faces significant challenges in completing development of its battery and in producing battery cells in commercial volumes. Some of the development
challenges that could prevent the introduction of QuantumScape&#146;s solid-state battery cell include difficulties with increasing the yield of its separators and single-layer cells, multi-layer cell stacking, packaging engineering to ensure
adequate cycle life, cost reduction, completion of the rigorous and challenging specifications required by QuantumScape&#146;s automotive partners, including but not limited to, calendar life, mechanical testing, and abuse testing and development of
the final manufacturing processes. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape&#146;s solid-state separators are in the development stage. These separators have
never been used before for battery applications (or to QuantumScape&#146;s knowledge, for any other applications) and there are significant yield, cost, performance and manufacturing process challenges to be solved in order for the separators to be
produced and used commercially. QuantumScape is likely to encounter engineering challenges as QuantumScape increases the dimensions and reduces the thickness of its solid-state separators. If QuantumScape is not able to overcome these barriers in
developing and producing its solid-state separators, QuantumScape&#146;s business could fail. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To achieve target energy density,
QuantumScape needs to stack its single-layer cells in a multi-layer format, which is enclosed within a single battery package. QuantumScape&#146;s battery cell will require over one hundred single-layer battery cells within each battery package.
QuantumScape has not yet built a multi-layer solid-state battery cell in the dimensions required for automotive applications. There are significant developmental and mechanical challenges that QuantumScape must overcome to build its multi-layer
battery cell for automotive application. In addition, QuantumScape will need to acquire certain tools that it currently does not possess and develop the manufacturing process necessary to make these multi-layer battery cells in high volume. If
QuantumScape is not able to overcome these developmental hurdles in building its multi-layer cells, QuantumScape&#146;s business is likely to fail. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I></I></B>QuantumScape is evaluating multiple cathode material compositions for inclusion in its solid-state battery cells and has not yet
finalized the cathode composition or formulation. QuantumScape also has not validated that the current cell design, with the inclusion of an organic gel made of an organic polymer and organic liquid catholyte as part of the cathode, meets all
automotive requirements. QuantumScape has not yet validated a manufacturing process or acquired the tools necessary to produce high volumes of its cathode material that meets all commercial requirements. If QuantumScape is not able to overcome these
developmental and manufacturing hurdles its business likely will fail. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if QuantumScape completes development and achieves volume production of its
solid-state battery, if the cost, performance characteristics or other specifications of the battery fall short of QuantumScape&#146;s targets, QuantumScape&#146;s sales, product pricing and margins would likely be adversely affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape may encounter substantial delays in the design, manufacture, regulatory approval, and launch of QuantumScape&#146;s solid-state battery
cells, which could prevent QuantumScape from commercializing any products it determines to develop on a timely basis, if at all. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any delay in the development and manufacturing scale-up of QuantumScape&#146;s solid-state battery cells would negatively impact its business
as it will delay time to revenue and negatively impact QuantumScape&#146;s customer relationships. Additionally, QuantumScape may encounter delays in obtaining the necessary regulatory approvals or launching its solid-state battery on the market,
including delays in entering into agreements for the supply of component parts and manufacturing tools and supplies. Delays in the launching of QuantumScape&#146;s product would materially damage its business, prospects, financial condition,
operating results and brand. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape may not be able to establish supply relationships for necessary components or may be required to pay
costs for components that are more expensive than anticipated, which could delay the introduction of QuantumScape&#146;s product and negatively impact its business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape relies on third-party suppliers for components necessary to develop and manufacture its solid-state batteries, including key
supplies, such as QuantumScape&#146;s cathode material and manufacturing tools for both QuantumScape&#146;s separator and solid-state battery cells. QuantumScape is collaborating with key suppliers but has not yet entered into agreements for the
supply of production quantities of these materials. To the extent that QuantumScape is unable to enter into commercial agreements with these suppliers on beneficial terms, or these suppliers experience difficulties ramping up their supply of
materials to meet QuantumScape&#146;s requirements, the introduction of QuantumScape&#146;s battery will be delayed. To the extent QuantumScape&#146;s suppliers experience any delays in providing or developing the necessary materials, QuantumScape
could experience delays in delivering on its timelines. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape expects to incur significant costs related to procuring
materials required to manufacture and assemble its batteries. QuantumScape expects to use various materials in its batteries that will require QuantumScape to negotiate purchase agreements and delivery lead-times on advantageous terms. QuantumScape
may not be able to control fluctuation in the prices for these materials or negotiate agreement with suppliers on terms that are beneficial to QuantumScape. QuantumScape&#146;s business depends on the continued supply of certain proprietary
materials for its products. QuantumScape is exposed to multiple risks relating to the availability and pricing of such materials and components. Substantial increases in the prices for QuantumScape&#146;s raw materials or components would increase
its operating costs and negatively impact QuantumScape&#146;s prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any disruption in the supply of components or materials could
temporarily disrupt research and development activities or production of QuantumScape&#146;s batteries until an alternative supplier is able to supply the required material. Changes in business conditions, unforeseen circumstances, governmental
changes, and other factors beyond QuantumScape&#146;s control or which it does not presently anticipate, could also affect its suppliers&#146; ability to deliver components to QuantumScape on a timely basis. Any of the foregoing could materially and
adversely affect QuantumScape&#146;s results of operations, financial condition and prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Currency fluctuations, trade barriers,
tariffs or shortages and other general economic or political conditions may limit QuantumScape&#146;s ability to obtain key components for its solid-state batteries or significantly increase freight charges, raw material costs and other expenses
associated with QuantumScape&#146;s business, which could further materially and adversely affect its results of operations, financial condition and prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape may be unable to adequately control the costs associated with its operations and the
components necessary to build its solid-state battery cells. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape will require significant capital to develop and grow
its business and expects to incur significant expenses, including those relating to research and development, raw material procurement, leases, sales and distribution as it builds its brand and markets its batteries, and general and administrative
costs as it scales its operations. QuantumScape&#146;s ability to become profitable in the future will not only depend on its ability to successfully market its solid-state batteries and services, but also to control its costs. If QuantumScape is
unable to cost efficiently design, manufacture, market, sell and distribute its solid-state batteries and services, its margins, profitability and prospects would be materially and adversely affected. QuantumScape has not yet produced any
solid-state battery cells at volume and its forecasted cost advantage for the production of these cells at scale, compared to conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> cells, will require QuantumScape to achieve rates of
throughput, use of electricity and consumables, yield, and rate of automation demonstrated for mature battery, battery material, and ceramic manufacturing processes, that QuantumScape has not yet achieved. If QuantumScape is unable to achieve these
targeted rates, its business will be adversely impacted. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape relies on complex machinery for its operations and production involves a
significant degree of risk and uncertainty in terms of operational performance and costs. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape relies heavily on complex
machinery for its operations and the production of its solid-state battery cells, all of which has not yet been qualified to operate at large-scale manufacturing. The work required to integrate this equipment into the production of
QuantumScape&#146;s solid-state battery cells is time intensive and requires QuantumScape to work closely with the equipment provider to ensure that it works properly for QuantumScape&#146;s unique battery technology. This integration work will
involve a significant degree of uncertainty and risk and may result in the delay in the scaling up of production or result in additional cost to QuantumScape&#146;s battery cells.&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Both QuantumScape&#146;s pilot manufacturing facilities and its large-scale manufacturing facility will require large-scale machinery. Such
machinery is likely to suffer unexpected malfunctions from time to time and will require repairs and spare parts to resume operations, which may not be available when needed. Unexpected malfunctions of QuantumScape&#146;s production equipment may
significantly affect the intended operational efficiency. In addition, because this equipment has not been used to build solid-state battery cells, the operational performance and costs associated with this equipment can be difficult to predict and
may be influenced by factors outside of QuantumScape&#146;s control, such as, but not limited to, failures by suppliers to deliver necessary components of QuantumScape&#146;s products in a timely manner and at prices and volumes acceptable to
QuantumScape, environmental hazards and remediation, difficulty or delays in obtaining governmental permits, damages or defects in systems, industrial accidents, fires, seismic activity and other natural disasters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Operational problems with QuantumScape&#146;s manufacturing equipment could result in the personal injury to or death of workers, the loss of
production equipment, damage to manufacturing facilities, monetary losses, delays and unanticipated fluctuations in production. In addition, operational problems may result in environmental damage, administrative fines, increased insurance costs and
potential legal liabilities. All of these operational problems could have a material adverse effect on QuantumScape&#146;s business, results of operations, cash flows, financial condition or prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Customer Risks and Risks Related to QuantumScape&#146;s Partnership with Volkswagen </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape&#146;s relationship with Volkswagen is subject to various risks which could adversely affect QuantumScape&#146;s business and future
prospects. There are no assurances that QuantumScape will be able to commercialize solid-state batteries from its joint development relationship with Volkswagen. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Volkswagen and QuantumScape formed a joint venture to collaborate on the manufacturing ramp up of QuantumScape&#146;s solid-state battery
cell. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is no assurance that QuantumScape will be able to complete the development of the
solid-state battery cells in the time frame required by the joint venture arrangements. If QuantumScape does not complete this development in a timely manner, Volkswagen may terminate its participation in the joint venture. QuantumScape&#146;s joint
venture arrangements with Volkswagen provide a framework for QuantumScape&#146;s cooperation and require that QuantumScape and Volkswagen enter into certain additional arrangements regarding the purchase by the joint venture of solid-state
separators from QuantumScape, the purchase and pricing of the solid-state battery cells that will be produced by the joint venture and sold to Volkswagen, and the terms for licensing QuantumScape technology to the joint venture. There can be no
assurance that the parties will be able to agree to the pricing for these key elements on terms that are financially beneficial for QuantumScape or to enter into the additional arrangements, including any purchase orders, with Volkswagen for
commercialization under the joint venture arrangements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purchase by Volkswagen of the output of the joint venture will depend on the
performance of QuantumScape&#146;s solid-state battery and the demand for the vehicles that Volkswagen develops to utilize the solid-state battery cells that will be produced by the joint venture. If Volkswagen does not select QuantumScape&#146;s
solid-state battery cell or if there is a delay in the introduction of the Volkswagen vehicles that intend to use QuantumScape&#146;s solid-state battery cells, QuantumScape&#146;s business will be harmed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The strong relationship that QuantumScape has developed with Volkswagen may deter other automotive OEMs from working closely with
QuantumScape. If QuantumScape is not able to expand its relationship over time to include other customer relationships, or if QuantumScape becomes too dependent on Volkswagen for QuantumScape&#146;s revenue, QuantumScape&#146;s business could be
harmed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Volkswagen, and any other partners in the future, may have economic, business or legal interests or goals that are inconsistent
with QuantumScape&#146;s goals. Any disagreements with Volkswagen or other future business partners may impede QuantumScape&#146;s ability to maximize the benefits of its partnerships and slow the commercialization of QuantumScape&#146;s solid-state
battery. QuantumScape&#146;s joint venture arrangements may require it, among other things, to pay certain costs or to make certain capital investments or to seek the joint venture partner&#146;s consent to take certain actions. In addition, if
Volkswagen is unable or unwilling to meet its economic or other obligations under the joint venture arrangements, QuantumScape may be required to either fulfill those obligations alone to ensure the ongoing success of the joint venture or to
dissolve and liquidate the joint venture. These factors could result in a material adverse effect on QuantumScape&#146;s business and financial results. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If QuantumScape&#146;s batteries fail to perform as expected, QuantumScape&#146;s ability to develop, market, and sell its batteries could be harmed.
</I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once commercial production of QuantumScape&#146;s solid-state battery cells commences, its batteries may contain defects in
design and manufacture that may cause them to not perform as expected or that may require repairs, recalls, and design changes. QuantumScape&#146;s batteries are inherently complex and incorporate technology and components that have not been used
for other applications and that may contain defects and errors, particularly when first introduced. QuantumScape has a limited frame of reference from which to evaluate the long-term performance of its solid-state batteries. There can be no
assurance that QuantumScape will be able to detect and fix any defects in its solid-state batteries prior to the sale to potential consumers. If QuantumScape&#146;s batteries fail to perform as expected, it could lose design wins and customers may
delay deliveries, terminate further orders or initiate product recalls, each of which could adversely affect QuantumScape&#146;s sales and brand and could adversely affect QuantumScape&#146;s business, prospects, and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape future growth and success are dependent upon consumers&#146; willingness to adopt EVs. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape&#146;s growth and future demand for QuantumScape&#146;s products is highly dependent upon the adoption by consumers of alternative
fuel vehicles in general and EVs in particular. The market for new energy </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
vehicles is still rapidly evolving, characterized by rapidly changing technologies, competitive pricing and competitive factors, evolving government regulation and industry standards, and
changing consumer demands and behaviors. If the market for EVs in general does not develop as expected, or develops more slowly than expected, QuantumScape&#146;s business, prospects, financial condition and operating results could be harmed. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape&#146;s future growth and success depend on its ability to sell effectively to large customers. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape&#146;s potential customers are manufacturers of EVs that tend to be large enterprises. Therefore, QuantumScape&#146;s future
success will depend on its ability to effectively sell its products to such large customers. Sales to these end-customers involve risks that may not be present (or that are present to a lesser extent) with sales to smaller customers. These risks
include, but are not limited to, (i) increased purchasing power and leverage held by large customers in negotiating contractual arrangements with QuantumScape and (ii) longer sales cycles and the associated risk that substantial time and resources
may be spent on a potential end-customer that elects not to purchase QuantumScape&#146;s solutions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Large organizations often undertake a
significant evaluation process that results in a lengthy sales cycle. In addition, product purchases by large organizations are frequently subject to budget constraints, multiple approvals and unanticipated administrative, processing and other
delays. Finally, large organizations typically have longer implementation cycles, require greater product functionality and scalability, require a broader range of services, demand that vendors take on a larger share of risks, require acceptance
provisions that can lead to a delay in revenue recognition and expect greater payment flexibility. All of these factors can add further risk to business conducted with these potential customers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape may not be able to accurately estimate the future supply and demand for its batteries, which could result in a variety of inefficiencies in
its business and hinder its ability to generate revenue. If QuantumScape fails to accurately predict its manufacturing requirements, it could incur additional costs or experience delays. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is difficult to predict QuantumScape&#146;s future revenues and appropriately budget for its expenses, and QuantumScape may have limited
insight into trends that may emerge and affect its business. QuantumScape anticipates being required to provide forecasts of its demand to its current and future suppliers prior to the scheduled delivery of products to potential customers.
Currently, there is no historical basis for making judgments on the demand for QuantumScape&#146;s batteries or its ability to develop, manufacture, and deliver batteries, or QuantumScape&#146;s profitability in the future. If QuantumScape
overestimates its requirements, its suppliers may have excess inventory, which indirectly would increase QuantumScape&#146;s costs. If QuantumScape underestimates its requirements, its suppliers may have inadequate inventory, which could interrupt
manufacturing of its products and result in delays in shipments and revenues. In addition, lead times for materials and components that QuantumScape&#146;s suppliers order may vary significantly and depend on factors such as the specific supplier,
contract terms and demand for each component at a given time. If QuantumScape fails to order sufficient quantities of product components in a timely manner, the delivery of batteries to its potential customers could be delayed, which would harm
QuantumScape&#146;s business, financial condition and operating results. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>QuantumScape&#146;s Intellectual Property Risks </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape relies heavily on its intellectual property portfolio. If QuantumScape is unable to protect its intellectual property rights, its business
and competitive position would be harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape may not be able to prevent unauthorized use of its intellectual property,
which could harm its business and competitive position. QuantumScape relies upon a combination of the intellectual property protections afforded by patent, copyright, trademark and trade secret laws in the United States and other jurisdictions, as
well as license agreements and other contractual protections, to establish, maintain and enforce rights in its proprietary technologies. In addition, QuantumScape seeks to protect its intellectual property rights
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
through nondisclosure and invention assignment agreements with its employees and consultants, and through <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements with business partners
and other third parties. Despite QuantumScape&#146;s efforts to protect its proprietary rights, third parties may attempt to copy or otherwise obtain and use QuantumScape&#146;s intellectual property. Monitoring unauthorized use of
QuantumScape&#146;s intellectual property is difficult and costly, and the steps QuantumScape has taken or will take to prevent misappropriation may not be sufficient. Any enforcement efforts QuantumScape undertakes, including litigation, could be
time-consuming and expensive and could divert management&#146;s attention, which could harm its business, results of operations and financial condition. In addition, existing intellectual property laws and contractual remedies may afford less
protection than needed to safeguard QuantumScape&#146;s intellectual property portfolio. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Patent, copyright, trademark and trade
secret laws vary significantly throughout the world. A number of foreign countries do not protect intellectual property rights to the same extent as do the laws of the United States. Therefore, QuantumScape&#146;s intellectual property rights may
not be as strong or as easily enforced outside of the United States and efforts to protect against the unauthorized use of QuantumScape&#146;s intellectual property rights, technology and other proprietary rights may be more expensive and difficult
outside of the United States. Failure to adequately protect QuantumScape&#146;s intellectual property rights could result in its competitors using QuantumScape&#146;s intellectual property to offer products, potentially resulting in the loss of some
of QuantumScape&#146;s competitive advantage and a decrease in its revenue which, would adversely affect its business, prospects, financial condition and operating results. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape may need to defend itself against intellectual property infringement claims, which may be time-consuming and could cause it to incur
substantial costs. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Companies, organizations or individuals, including QuantumScape&#146;s current and future competitors, may hold
or obtain patents, trademarks or other proprietary rights that would prevent, limit or interfere with QuantumScape&#146;s ability to make, use, develop or sell its products, which could make it more difficult for QuantumScape to operate its
business. From time to time, QuantumScape may receive inquiries from holders of patents or trademarks inquiring whether QuantumScape is infringing their proprietary rights and/or seek court declarations that they do not infringe upon
QuantumScape&#146;s intellectual property rights. Companies holding patents or other intellectual property rights relating to batteries, electric motors or electronic power management systems may bring suits alleging infringement of such rights or
otherwise asserting their rights and seeking licenses. In addition, if QuantumScape is determined to have infringed upon a third party&#146;s intellectual property rights, QuantumScape may be required to do one or more of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cease selling, incorporating or using products that incorporate the challenged intellectual property;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pay substantial damages; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtain a license from the holder of the infringed intellectual property right, which license may not be available
on reasonable terms or at all; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">redesign its batteries. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a successful claim of infringement against QuantumScape and its failure or inability to obtain a license to the infringed
technology, QuantumScape&#146;s business, prospects, operating results and financial condition could be materially adversely affected. In addition, any litigation or claims, whether or not valid, could result in substantial costs and diversion of
resources and management&#146;s attention. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape also licenses patents and other intellectual property from third parties, and it
may face claims that its use of this intellectual property infringes the rights of others. In such cases, QuantumScape may seek indemnification from its licensors under its license contracts with them. However, QuantumScape&#146;s rights to
indemnification may be unavailable or insufficient to cover its costs and losses, depending on its use of the technology, whether it chooses to retain control over conduct of the litigation, and other factors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape&#146;s patent applications may not result in issued patents or its patent rights may be
contested, circumvented, invalidated or limited in scope, any of which could have a material adverse effect on QuantumScape&#146;s ability to prevent others from interfering with its commercialization of its products. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape&#146;s patent applications may not result in issued patents, which may have a material adverse effect on its ability to prevent
others from commercially exploiting products similar to QuantumScape&#146;s. The status of patents involves complex legal and factual questions and the breadth of claims allowed is uncertain. As a result, QuantumScape cannot be certain that the
patent applications that it files will result in patents being issued, or that its patents and any patents that may be issued to QuantumScape will afford protection against competitors with similar technology. Numerous patents and pending patent
applications owned by others exist in the fields in which QuantumScape has developed and is developing its technology. In addition to those who may claim priority, any of QuantumScape existing or pending patents may also be challenged by others on
the basis that they are otherwise invalid or unenforceable. Furthermore, patent applications filed in foreign countries are subject to laws, rules and procedures that differ from those of the United States, and thus QuantumScape cannot be certain
that foreign patent applications related to issued U.S. patents will be issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if QuantumScape&#146;s patent applications succeed
and it is issued patents in accordance with them, it is still uncertain whether these patents will be contested, circumvented, invalidated or limited in scope in the future. The rights granted under any issued patents may not provide QuantumScape
with meaningful protection or competitive advantages, and some foreign countries provide significantly less effective patent enforcement than in the United States. In addition, the claims under any patents that issue from QuantumScape&#146;s patent
applications may not be broad enough to prevent others from developing technologies that are similar or that achieve results similar to QuantumScape&#146;s. The intellectual property rights of others could also bar QuantumScape from licensing and
exploiting any patents that issue from its pending applications. In addition, patents issued to QuantumScape may be infringed upon or designed around by others and others may obtain patents that it needs to license or design around, either of which
would increase costs and may adversely affect its business, prospects, financial condition and operating results. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>QuantumScape&#146;s Business
Risks </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The battery market continues to evolve, is highly competitive, and QuantumScape may not be successful in competing in this industry or
establishing and maintaining confidence in its long-term business prospects among current and future partners and customers. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
battery market in which QuantumScape competes continues to evolve and is highly competitive. To date, QuantumScape has focused its efforts on its lithium-metal solid-state battery technology, which is being designed to outperform conventional
lithium-ion battery technology. However, lithium-ion battery technology has been widely adopted and QuantumScape&#146;s current competitors have, and future competitors may have, greater resources than QuantumScape does and may also be able to
devote greater resources to the development of their current and future technologies. These competitors also may have greater access to customers and may be able to establish cooperative or strategic relationships amongst themselves or with third
parties that may further enhance their resources and competitive positioning. In addition, lithium-ion battery manufacturers may continue to reduce cost and expand supply of conventional batteries and therefore reduce the prospects for
QuantumScape&#146;s business or negatively impact the ability for QuantumScape to sell its products at a market-competitive price and yet at sufficient margins. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Most automotive OEMs are researching and investing in solid-state battery efforts and, in some cases, in battery development and production.
There are a number of companies seeking to develop alternative approaches to solid-state battery technology, including lithium-metal batteries. QuantumScape expects competition in battery technology and EVs to intensify due to increased demand for
these vehicles and a regulatory push for EVs, continuing globalization, and consolidation in the worldwide automotive industry. Developments in alternative technologies or improvements in batteries technology made by competitors may materially
adversely affect the sales, pricing and gross margins of QuantumScape&#146;s batteries. If a competing technology is developed that has </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
superior operational or price performance, QuantumScape&#146;s business will be harmed. Similarly, if QuantumScape fails to accurately predict and ensure that its battery technology can address
customers&#146; changing needs or emerging technological trends, or if QuantumScape&#146;s customers fail to achieve the benefits expected from QuantumScape&#146;s solid-state batteries, QuantumScape&#146;s business will be harmed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape must continue to commit significant resources to develop its battery technology in order to establish a competitive position, and
these commitments will be made without knowing whether such investments will result in products potential customers will accept. There is no assurance QuantumScape will successfully identify new customer requirements, develop and bring its batteries
to market on a timely basis, or that products and technologies developed by others will not render QuantumScape&#146;s batteries obsolete or noncompetitive, any of which would adversely affect QuantumScape&#146;s business and operating results. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customers will be less likely to purchase QuantumScape&#146;s batteries if they are not convinced that its business will succeed in the long
term. Similarly, suppliers and other third parties will be less likely to invest time and resources in developing business relationships with QuantumScape if they are not convinced that QuantumScape&#146;s business will succeed in the long term.
Accordingly, in order to build and maintain its business, QuantumScape must maintain confidence among current and future partners, customers, suppliers, analysts, ratings agencies and other parties in its long-term financial viability and business
prospects. Maintaining such confidence may be particularly complicated by certain factors including those that are largely outside of QuantumScape&#146;s control, such as its limited operating history, market unfamiliarity with its products, any
delays in scaling manufacturing, delivery and service operations to meet demand, competition and uncertainty regarding the future of EVs and QuantumScape&#146;s eventual production and sales performance compared with market expectations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If QuantumScape is unable to attract and retain key employees and qualified personnel, its ability to compete could be harmed. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape&#146;s success depends on its ability to attract and retain its executive officers, key employees and other qualified personnel,
and its operations may be severely disrupted if it lost their services. As QuantumScape builds its brand and becomes more well known, there is increased risk that competitors or other companies will seek to hire QuantumScape personnel. None of
QuantumScape&#146;s employees are bound by a non-competition agreement. The failure to attract, integrate, train, motivate and retain these personnel could seriously harm QuantumScape&#146;s business and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, QuantumScape is highly dependent on the services of Jagdeep Singh, its Chief Executive Officer, and other senior technical and
management personnel, including its executive officers, who would be difficult to replace. If Mr.&nbsp;Singh or other key personnel were to depart, QuantumScape may not be able to successfully attract and retain senior leadership necessary to grow
its business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape is an early stage company with a history of financial losses and expects to incur significant expenses and continuing
losses for the foreseeable future. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape incurred a net loss of approximately $51.3&nbsp;million for the year ended
December&nbsp;31, 2019 and an accumulated deficit of approximately $295.9 million from its inception in 2010 through the year ended December&nbsp;31, 2019. QuantumScape believes that it will continue to incur operating and net losses each quarter
until at least the time it begins significant production of its lithium-metal solid-state batteries, which is not expected to occur until 2024, and may occur later. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape expects the rate at which it will incur losses to be significantly higher in future periods as it, among other things, continues
to incur significant expenses in connection with the design, development and manufacturing of its batteries; and as it expands its research and development activities; invests in manufacturing capabilities; builds up inventories of components for
its batteries; increases its sales and marketing activities; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
develops its distribution infrastructure; and increases its general and administrative functions to support its growing operations. QuantumScape may find that these efforts are more expensive
than it currently anticipates or that these efforts may not result in revenues, which would further increase QuantumScape&#146;s losses. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape has been, and may in the future be, adversely affected by the global <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape faces various risks related to epidemics, pandemics, and other outbreaks, including the recent <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic. The impact of <FONT STYLE="white-space:nowrap">COVID-19,</FONT> including changes in consumer and business behavior, pandemic fears and market downturns, and restrictions on business and
individual activities, has created significant volatility in the global economy and led to reduced economic activity. The spread of <FONT STYLE="white-space:nowrap">COVID-19</FONT> has also impacted QuantumScape&#146;s potential customers and
suppliers by disrupting the manufacturing, delivery and overall supply chain of battery and EV manufacturers and suppliers and has led to a global decrease in battery and EV sales in markets around the world. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The pandemic has resulted in government authorities implementing numerous measures to try to contain the virus, such as travel bans and
restrictions, quarantines, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">stay-at-home</FONT></FONT> or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">shelter-in-place</FONT></FONT> orders, and business
shutdowns. For example, some employees at QuantumScape&#146;s headquarters located in San Jose, California are generally subject to a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">stay-at-home</FONT></FONT> order from the state
government. These measures have and may continue to adversely impact QuantumScape&#146;s employees, research and development activities and operations and the operations of its suppliers, vendors and business partners, and may negatively impact its
sales and marketing activities. In addition, various aspects of QuantumScape&#146;s business cannot be conducted remotely. These measures by government authorities may remain in place for a significant period of time and they are likely to continue
to adversely affect QuantumScape&#146;s future manufacturing plans, sales and marketing activities, business and results of operations. QuantumScape may take further actions as may be required by government authorities or that it determines are in
the best interests of its employees, suppliers, vendors and business partners. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The extent to which the
<FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic continues to impact QuantumScape&#146;s business, prospects and results of operations will depend on future developments, which are highly uncertain and cannot be predicted, including the
duration and spread of the pandemic, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating activities can resume. Even after the
<FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic has subsided, QuantumScape may continue to experience an adverse impact to its business as a result of its global economic impact, including any recession that has occurred or may occur in
the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no comparable recent events that may provide guidance as to the effect of the spread of <FONT
STYLE="white-space:nowrap">COVID-19</FONT> and a pandemic, and, as a result, the ultimate impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic or a similar health epidemic is highly uncertain. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape&#146;s operating and financial results forecast relies in large part upon assumptions and analyses developed by QuantumScape. If these
assumptions or analyses prove to be incorrect, QuantumScape&#146;s actual operating results may be materially different from its forecasted results. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The projected financial and operating information appearing elsewhere in this proxy statement/prospectus/information statement reflect current
estimates of future performance. Whether actual operating and financial results and business developments will be consistent with QuantumScape&#146;s expectations and assumptions as reflected in its forecasts depends on a number of factors, many of
which are outside QuantumScape&#146;s control, including, but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">success and timing of development activity; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">customer acceptance of QuantumScape&#146;s products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">competition, including from established and future competitors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether QuantumScape can obtain sufficient capital to build its manufacturing facilities and sustain and grow its
business; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s ability to manage its growth; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether QuantumScape can manage relationships with key suppliers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s ability to retain existing key management, integrate recent hires and attract, retain and
motivate qualified personnel; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the overall strength and stability of domestic and international economies. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unfavorable changes in any of these or other factors, most of which are beyond QuantumScape&#146;s control, could materially and adversely
affect its business, results of operations and financial results. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>From time to time, QuantumScape may be involved in legal proceedings and
commercial or contractual disputes, which could have an adverse impact on QuantumScape&#146;s profitability and consolidated financial position. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape may be involved in legal proceedings and commercial or contractual disputes that, from time to time, are significant. These are
typically claims arise in the normal course of business including, without limitation, commercial or contractual disputes, including warranty claims and other disputes with potential customers and suppliers; intellectual property matters; personal
injury claims; environmental issues; tax matters; and employment matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is difficult to predict the outcome or ultimate financial
exposure, if any, represented by these matters, and there can be no assurance that any such exposure will not be material. Such claims may also negatively affect QuantumScape&#146;s reputation.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape may become subject to product liability claims, which could harm its financial condition and liquidity if it is not able to successfully
defend or insure against such claims. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape may become subject to product liability claims, even those without merit, which
could harm its business, prospects, operating results, and financial condition. QuantumScape faces inherent risk of exposure to claims in the event its batteries do not perform as expected or malfunction resulting in personal injury or death.
QuantumScape&#146;s risks in this area are particularly pronounced given its batteries have not yet been commercially tested or mass produced. A successful product liability claim against QuantumScape could require QuantumScape to pay a substantial
monetary award. Moreover, a product liability claim could generate substantial negative publicity about QuantumScape&#146;s batteries and business and inhibit or prevent commercialization of other future battery candidates, which would have material
adverse effect on QuantumScape&#146;s brand, business, prospects and operating results. Any insurance coverage might not be sufficient to cover all potential product liability claims. Any lawsuit seeking significant monetary damages either in excess
of QuantumScape&#146;s coverage, or outside of QuantumScape&#146;s coverage, may have a material adverse effect on QuantumScape&#146;s reputation, business and financial condition. QuantumScape may not be able to secure additional product liability
insurance coverage on commercially acceptable terms or at reasonable costs when needed, particularly if it does face liability for its products and are forced to make a claim under its policy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape&#146;s batteries and its website, systems, and data it maintains may be subject to intentional disruption, other security incidents, or
alleged violations of laws, regulations, or other obligations relating to data handling that could result in liability and adversely impact its reputation and future sales. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape expects to face significant challenges with respect to information security and maintaining the security and integrity of its
systems and other systems used in its business, as well as with respect to the data stored on or processed by these systems. Advances in technology, an increased level of sophistication, and an increased level of expertise of hackers, new
discoveries in the field of cryptography or others can result in a compromise or breach of the systems used in its business or of security measures used in its business to protect confidential information, personal information, and other data. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The availability and effectiveness of QuantumScape&#146;s batteries, and QuantumScape&#146;s
ability to conduct its business and operations, depend on the continued operation of information technology and communications systems, some of which QuantumScape has yet to develop or otherwise obtain the ability to use. Systems used in
QuantumScape&#146;s business, including data centers and other information technology systems, will be vulnerable to damage or interruption. Such systems could also be subject to <FONT STYLE="white-space:nowrap">break-ins,</FONT> sabotage and
intentional acts of vandalism, as well as disruptions and security incidents as a result of <FONT STYLE="white-space:nowrap">non-technical</FONT> issues, including intentional or inadvertent acts or omissions by employees, service providers, or
others. QuantumScape anticipates using outsourced service providers to help provide certain services, and any such outsourced service providers face similar security and system disruption risks as QuantumScape. Some of the systems used in
QuantumScape&#146;s business will not be fully redundant, and its disaster recovery planning cannot account for all eventualities. Any data security incidents or other disruptions to any data centers or other systems used in QuantumScape&#146;s
business could result in lengthy interruptions in its service. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape facilities or operations could be damaged or adversely affected as a
result of natural disasters and other catastrophic events. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape&#146;s facilities or operations could be adversely
affected by events outside of its control, such as natural disasters, wars, health epidemics such as the ongoing <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, and other calamities<I>. </I>QuantumScape cannot assure you that any backup
systems will be adequate to protect it from the effects of fire, floods, typhoons, earthquakes, power loss, telecommunications failures, <FONT STYLE="white-space:nowrap">break-ins,</FONT> war, riots, terrorist attacks or similar events. Any of the
foregoing events may give rise to interruptions, breakdowns, system failures, technology platform failures or internet failures, which could cause the loss or corruption of data or malfunctions of software or hardware as well as adversely affect
QuantumScape&#146;s ability to provide services.<I> </I> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Any financial or economic crisis, or perceived threat of such a crisis, including a
significant decrease in consumer confidence, may materially and adversely affect QuantumScape&#146;s business, financial condition, and results of operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In recent years, the United States and global economies suffered dramatic downturns as the result of the COVID-19 pandemic, a deterioration in
the credit markets and related financial crisis as well as a variety of other factors including, among other things, extreme volatility in security prices, severely diminished liquidity and credit availability, ratings downgrades of certain
investments and declining valuations of others. The United States and certain foreign governments have taken unprecedented actions in an attempt to address and rectify these extreme market and economic conditions by providing liquidity and stability
to the financial markets. If the actions taken by these governments are not successful, the return of adverse economic conditions may negatively impact the demand for QuantumScape&#146;s solid-state battery cells and may negatively impact
QuantumScape&#146;s ability to raise capital, if needed, on a timely basis and on acceptable terms or at all. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape&#146;s ability to
utilize its net operating loss and tax credit carryforwards to offset future taxable income may be subject to certain limitations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, under Section&nbsp;382 of the Code, a corporation that undergoes an &#147;ownership change&#148; is subject to limitations on its
ability to use its <FONT STYLE="white-space:nowrap">pre-change</FONT> net operating loss carryforwards, or NOLs, to offset future taxable income. The limitations apply if a corporation undergoes an &#147;ownership change,&#148; which is generally
defined as a greater than 50 percentage point change (by value) in its equity ownership by certain stockholders over a three-year period. If QuantumScape has experienced an ownership change at any time since its incorporation, New QuantumScape may
already be subject to limitations on its ability to utilize QuantumScape&#146;s existing NOLs and other tax attributes to offset taxable income or tax liability. In addition, the Business Combination and future changes in New QuantumScape&#146;s
stock ownership, which may be outside of New QuantumScape&#146;s control, may trigger an ownership change. Similar provisions of state tax law may also apply to limit New QuantumScape&#146;s use of accumulated state tax attributes. As a result, even
if New QuantumScape earns net taxable income in the future, its ability to use its or QuantumScape&#146;s <FONT STYLE="white-space:nowrap">pre-change</FONT> NOL carryforwards and other tax attributes to offset
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such taxable income or tax liability may be subject to limitations, which could potentially result in increased future income tax liability to New QuantumScape. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is also a risk that changes in law or regulatory changes made in response to the need for some jurisdictions to raise additional revenue
to help counter the fiscal impact from the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic or for other unforeseen reasons, including suspensions on the use of net operating losses or tax credits, possibly with retroactive effect, may
result in New QuantumScape and QuantumScape&#146;s existing net operating losses or tax credits expiring or otherwise being unavailable to offset future income tax liabilities. A temporary suspension of the use of certain net operating losses and
tax credits has been enacted in California, and other states may enact suspensions as well. </P>   <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape is or will be subject to
anti-corruption, anti-bribery, anti-money laundering, financial and economic sanctions and similar laws, and <FONT STYLE="white-space:nowrap">non-compliance</FONT> with such laws can subject QuantumScape to administrative, civil and criminal fines
and penalties, collateral consequences, remedial measures and legal expenses, all of which could adversely affect its business, results of operations, financial condition and reputation. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape is or will be subject to anti-corruption, anti-bribery, anti-money laundering, financial and economic sanctions and similar laws
and regulations in various jurisdictions in which it conducts or in the future may conduct activities, including the U.S. Foreign Corrupt Practices Act (&#147;FCPA&#148;), the U.K. Bribery Act 2010, and other anti-corruption laws and regulations.
The FCPA and the U.K. Bribery Act 2010 prohibit QuantumScape and its officers, directors, employees and business partners acting on its behalf, including agents, from corruptly offering, promising, authorizing or providing anything of value to a
&#147;foreign official&#148; for the purposes of influencing official decisions or obtaining or retaining business or otherwise obtaining favorable treatment. The FCPA also requires companies to make and keep books, records and accounts that
accurately reflect transactions and dispositions of assets and to maintain a system of adequate internal accounting controls. The U.K. Bribery Act also prohibits <FONT STYLE="white-space:nowrap">non-governmental</FONT> &#147;commercial&#148; bribery
and soliciting or accepting bribes. A violation of these laws or regulations could adversely affect QuantumScape&#146;s business, results of operations, financial condition and reputation. QuantumScape&#146;s policies and procedures designed to
ensure compliance with these regulations may not be sufficient and its directors, officers, employees, representatives, consultants, agents, and business partners could engage in improper conduct for which it may be held responsible. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-compliance</FONT> with anti-corruption, anti-bribery, anti-money laundering or financial and economic
sanctions laws could subject QuantumScape to whistleblower complaints, adverse media coverage, investigations, and severe administrative, civil and criminal sanctions, collateral consequences, remedial measures and legal expenses, all of which could
materially and adversely affect QuantumScape&#146;s business, results of operations, financial condition and reputation. In addition, changes in economic sanctions laws in the future could adversely impact QuantumScape&#146;s business and
investments in its common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape&#146;s insurance coverage may not be adequate to protect it from all business risks. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape may be subject, in the ordinary course of business, to losses resulting from products liability, accidents, acts of God, and other
claims against QuantumScape, for which QuantumScape may have no insurance coverage. As a general matter, the policies that QuantumScape does have may include significant deductibles or self-insured retentions, and QuantumScape cannot be certain that
its insurance coverage will be sufficient to cover all future losses or claims against it. A loss that is uninsured or which exceeds policy limits may require QuantumScape to pay substantial amounts, which could adversely affect its financial
condition and operating results. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>QuantumScape&#146;s Regulatory Risks </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape is subject to substantial regulation and unfavorable changes to, or failure by QuantumScape to comply with, these regulations could
substantially harm its business and operating results. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape&#146;s batteries, and the sale of EVs and motor vehicles in
general, are subject to substantial regulation under international, federal, state and local laws, including export control laws. QuantumScape expects to incur significant costs in complying with these regulations. Regulations related to the battery
and EV industry and alternative energy are currently evolving and QuantumScape faces risks associated with changes to these regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent the laws change, QuantumScape&#146;s products may not comply with applicable international, federal, state or local laws, which
would have an adverse effect on its business. Compliance with changing regulations could be burdensome, time consuming, and expensive. To the extent compliance with new regulations is cost prohibitive, QuantumScape&#146;s business, prospects,
financial condition and operating results would be adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Internationally, there may be laws in jurisdictions QuantumScape
has not yet entered or laws it is unaware of in jurisdictions it has entered that may restrict its sales or other business practices. The laws in this area can be complex, difficult to interpret and may change over time. Continued regulatory
limitations and other obstacles that may interfere with QuantumScape&#146;s ability to commercialize its products could have a negative and material impact on its business, prospects, financial condition and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape is subject to requirements relating to environmental and safety regulations and environmental remediation matters which could adversely
affect its business, results of operation and reputation. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape is subject to numerous federal, state and local
environmental laws and regulations governing, among other things, solid and hazardous waste storage, treatment and disposal, and remediation of releases of hazardous materials. There are significant capital, operating and other costs associated with
compliance with these environmental laws and regulations. Environmental laws and regulations may become more stringent in the future, which could increase costs of compliance or require QuantumScape to manufacture with alternative technologies and
materials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Federal, state and local authorities also regulate a variety of matters, including, but not limited to, health, safety and
permitting in addition to the environmental matters discussed above. New legislation and regulations may require QuantumScape to make material changes to its operations, resulting in significant increases to the cost of production. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape&#146;s manufacturing process will have hazards such as but not limited to hazardous materials, machines with moving parts, and
high voltage and/or high current electrical systems typical of large manufacturing equipment and related safety incidents. There may be safety incidents that damage machinery or product, slow or stop production, or harm employees. Consequences may
include litigation, regulation, fines, increased insurance premiums, mandates to temporarily halt production, workers&#146; compensation claims, or other actions that impact the company brand, finances, or ability to operate. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks related to Ownership of Common Stock of QuantumScape </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape&#146;s business model of manufacturing solid-state batteries is capital-intensive, and QuantumScape may not be able to raise additional
capital on attractive terms, if at all, which could be dilutive to stockholders. If QuantumScape cannot raise additional capital when needed, its operations and prospects could be materially and adversely affected. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The development, design, manufacture and sale of batteries is a capital-intensive business, which QuantumScape currently finances through joint
venture arrangements and other third-party financings. As a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
result of the capital-intensive nature of QuantumScape&#146;s business, it can be expected to continue to sustain substantial operating expenses without generating sufficient revenues to cover
expenditures. Over time, QuantumScape expects that it will need to raise additional funds, including through entry into new or extending existing joint venture arrangements, through the issuance of equity, equity-related or debt securities or
through obtaining credit from financial institutions to fund, together with QuantumScape&#146;s principal sources of liquidity, ongoing costs such as research and development relating to its batteries, the construction of large factories, any
significant unplanned or accelerated expenses, and new strategic investments. QuantumScape cannot be certain that additional capital will be available on attractive terms, if at all, when needed, which could be dilutive to stockholders, and its
financial condition, results of operations, business and prospects could be materially and adversely affected. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_11"></A>Risks
Related to Kensington </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>New QuantumScape may redeem your unexpired Kensington Warrants prior to their exercise at a time that is disadvantageous
to you, thereby making your Kensington Warrants worthless. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New QuantumScape will have the ability to redeem outstanding Kensington
Warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per warrant, provided that the last reported sales price of Kensington Class&nbsp;A Common Stock equals or exceeds $18.00 per share for any 20
trading days within a <FONT STYLE="white-space:nowrap">30-trading</FONT> day period ending on the third trading day prior to the date New QuantumScape sends the notice of redemption to Kensington Warrant holders and provided certain other conditions
are met. If and when the Kensington Warrants become redeemable by New QuantumScape, New QuantumScape may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state
securities laws. As a result, New QuantumScape may redeem the Kensington Warrants as set forth above even if the holders are otherwise unable to exercise the Kensington Warrants. Redemption of the outstanding Kensington Warrants could force you
(i)&nbsp;to exercise your Kensington Warrants and pay the exercise price therefor at a time when it may be disadvantageous for you to do so, (ii)&nbsp;to sell your Kensington Warrants at the then-current market price when you might otherwise wish to
hold your Kensington Warrants or (iii)&nbsp;to accept the nominal redemption price which, at the time the outstanding Kensington Warrants are called for redemption, Kensington expects would be substantially less than the market value of your
Kensington Warrants. None of the Private Warrants will be redeemable by New QuantumScape so long as they are held by the Sponsor or its permitted transferees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, Kensington has the ability to redeem outstanding Kensington Warrants ninety days after they become exercisable for $0.10 per
warrant upon a minimum of 30 days&#146; prior written notice of redemption provided that holders will be able to exercise their Kensington Warrants prior to redemption for a number of Kensington Class&nbsp;A Common Stock determined based on the
redemption date and the fair market value of Kensington Class&nbsp;A Common Stock and provided certain other conditions are met. Kensington would redeem the Kensington Warrants in this manner when Kensington believes it is in Kensington&#146;s best
interest to update its capital structure to remove the Kensington Warrants and pay fair market value to the Kensington Warrant holders. Kensington can also redeem the Kensington Warrants for Kensington Common Stock when the Kensington Class&nbsp;A
Common Stock is trading at a price starting at $10, which is below the exercise price of $11.50, because it will provide certainty with respect to Kensington&#146;s capital structure and cash position while providing Kensington Warrant holders with
fair market value in the form of shares of Kensington Class&nbsp;A Common Stock. If Kensington chooses to redeem the Kensington Warrants when the Kensington Class&nbsp;A Common Stock is trading at a price below the exercise price of the Kensington
Warrants, this could result in the Kensington Warrant holders receiving fewer shares of Kensington Class&nbsp;A Common Stock than they would have received if they had chosen to wait to exercise their Kensington Warrants for shares of Kensington
Class&nbsp;A Common Stock if and when the Kensington Class&nbsp;A Common Stock trades at a price higher than the exercise price of $11.50. Any such redemption may have similar consequences to a cash redemption described above. In addition, such
redemption may occur at a time when the Kensington Warrants are <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;out-of-the-money,&#148;</FONT></FONT></FONT> in which case you would lose any
potential embedded value from a subsequent increase in the value of the Kensington </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Class&nbsp;A Common Stock had your Kensington Warrants remained outstanding. Finally, this redemption feature provides a ceiling to the value of your Kensington Warrants since it locks in the
redemption price in the number of Kensington Class&nbsp;A Common Stock to be received if Kensington chooses to redeem the Kensington Warrants for Kensington Common Stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We will require Public Stockholders who wish to redeem their shares of Kensington Class&nbsp;A Common Stock in connection with the Business Combination
to comply with specific requirements for redemption that may make it more difficult for them to exercise their redemption rights prior to the deadline for exercising their rights. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will require the Public Stockholders seeking to exercise their redemption rights, whether they are record holders or hold their shares in
&#147;street name,&#148; to either tender their certificates to Kensington&#146;s transfer agent prior to the expiration date set forth in the tender offer documents mailed to such holders, or in the event Kensington distributes proxy materials, up
to two business days prior to the vote on the proposal to approve the Business Combination, or to deliver their shares to the transfer agent electronically using DTC&#146;s Deposit/Withdrawal At Custodian System (&#147;DWAC System&#148;), at the
holder&#146;s option. In order to obtain a physical stock certificate, a stockholder&#146;s broker and/or clearing broker, DTC and Kensington&#146;s transfer agent will need to act to facilitate this request. It is Kensington&#146;s understanding
that stockholders should generally allot at least one week to obtain physical certificates from the transfer agent. However, because Kensington does not have any control over this process or over the brokers or DTC, it may take significantly longer
than one week to obtain a physical stock certificate. While Kensington has been advised that it takes a short time to deliver shares through the DWAC System, this may not be the case. Under Kensington&#146;s bylaws, Kensington is required to provide
at least 10&nbsp;days advance notice of any stockholder meeting, which would be the minimum amount of time a stockholder would have to determine whether to exercise redemption rights. Accordingly, if it takes longer than Kensington anticipates for
stockholders to deliver their shares, stockholders who wish to redeem may be unable to meet the deadline for exercising their redemption rights and thus may be unable to redeem their shares. In the event that a stockholder fails to comply with the
various procedures that must be complied with in order to validly tender or redeem Public Shares, its shares may not be redeemed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, despite Kensington&#146;s compliance with the proxy rules, stockholders may not become aware of the opportunity to redeem their
shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If a Public Stockholder fails to receive notice of Kensington&#146;s offer to redeem their shares of Kensington Class&nbsp;A Common Stock
in connection with the Business Combination, or fails to comply with the procedures for tendering its share of Kensington Class&nbsp;A Common Stock, such shares may not be redeemed. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will comply with the tender offer rules or proxy rules, as applicable, when conducting redemptions in connection with the initial business
combination. Despite Kensington&#146;s compliance with these rules, if a stockholder fails to receive Kensington&#146;s tender offer or proxy materials, as applicable, such stockholder may not become aware of the opportunity to redeem its shares. In
addition, the tender offer documents or proxy materials, as applicable, that Kensington will furnish to holders of its Public Shares in connection with the initial business combination will describe the various procedures that must be complied with
in order to validly tender or redeem Public Shares. For example, Kensington may require Kensington&#146;s Public Stockholders seeking to exercise their redemption rights, whether they are record holders or hold their shares in &#147;street
name,&#148; to either tender their certificates to Kensington&#146;s transfer agent prior to the date set forth in the tender offer documents mailed to such holders, or up to two business days prior to the vote on the proposal to approve the
Business Combination in the event Kensington distributes proxy materials, or to deliver their shares to the transfer agent electronically. In the event that a stockholder fails to comply with these or any other procedures, its shares may not be
redeemed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>There is uncertainty regarding the federal income tax consequences of the redemption to the holders of
Kensington Class&nbsp;A Common Stock. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is some uncertainty regarding the federal income tax consequences to holders of
Kensington Class&nbsp;A Common Stock who exercise their redemption rights. The uncertainty of tax consequences relates primarily to the individual circumstances of the taxpayer and include whether the redemption results in a dividend, taxable as
ordinary income, or a sale, taxable as capital gain. Whether the redemption qualifies for sale treatment, resulting in taxation as capital gain rather than ordinary income, will depend largely on whether the holder owns (or is deemed to own) any
shares of Kensington Class&nbsp;A Common Stock following the redemption, and if so, the total number of shares of Kensington Class&nbsp;A Common Stock held by the holder both before and after the redemption relative to all shares of Kensington
Class&nbsp;A Common Stock outstanding both before and after the redemption. The redemption generally will be treated as a sale, rather than a dividend, if the redemption (i)&nbsp;is &#147;substantially disproportionate&#148; with respect to the
holder, (ii)&nbsp;results in a &#147;complete termination&#148; of the holder&#146;s interest in Kensington or (iii)&nbsp;is &#147;not essentially equivalent to a dividend&#148; with respect to the holder. Due to the personal and subjective nature
of certain of such tests and the absence of clear guidance from the Internal Revenue Services (&#147;IRS&#148;), there is uncertainty as to whether a holder who elects to exercise his, her or its redemption rights will be taxed on any gain from the
redemption as ordinary income or capital gain. See the section entitled &#147;<I>Certain U.S. Federal Income Tax Considerations of the Redemption and the Business Combination.&#148;</I> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Kensington does not have a specified maximum redemption threshold. The absence of such a redemption threshold may make it possible for Kensington to
complete the Business Combination even if a substantial majority of Kensington&#146;s stockholders do not agree. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Existing
Certificate of Incorporation does not provide a specified maximum redemption threshold, except that Kensington will only redeem its Public Shares so long as (after such redemption) Kensington&#146;s net tangible assets will be at least $5,000,001
either immediately prior to or upon consummation of its initial business combination and after payment of underwriters&#146; fees and commissions (so that Kensington does not then become subject to the SEC&#146;s &#147;penny stock&#148; rules) or
any greater net tangible asset or cash requirement which may be contained in the agreement relating to the Business Combination. As a result, Kensington may be able to complete the Business Combination even if a substantial majority of the Public
Stockholders do not agree with the Business Combination and have redeemed their shares. In the event the aggregate cash consideration Kensington would be required to pay for all shares of Kensington Class&nbsp;A Common Stock that are validly
submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the Business Combination exceed the aggregate amount of cash available to Kensington, Kensington will not complete the Business Combination or
redeem any shares, all shares of Kensington Class&nbsp;A Common Stock submitted for redemption will be returned to the holders thereof, and Kensington instead may search for an alternate business combination. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If a stockholder or a &#147;group&#148; of stockholders are deemed to hold in excess of 15% of the Kensington Class&nbsp;A Common Stock, such
stockholder or group will lose the ability to redeem all such shares in excess of 15% of the Kensington Class&nbsp;A Common Stock. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Existing Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other
person with whom such stockholder is acting in concert or as a &#147;group&#148; (as defined under Section&nbsp;13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the shares sold in
the IPO, which Kensington refers to as the &#147;Excess Shares,&#148; without Kensington&#146;s prior written consent. However, the Existing Certificate of Incorporation does not restrict Kensington stockholders&#146; ability to vote all of their
shares (including Excess Shares) for or against Kensington&#146;s initial business combination. The inability of a stockholder to redeem the Excess Shares will reduce its influence over Kensington&#146;s ability to complete its initial business
combination and such stockholder could suffer a material loss on its investment in Kensington if it sells such Excess Shares in open market transactions. Additionally, a stockholder will not receive redemption distributions with respect to the
Excess Shares if </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Kensington completes its initial business combination. And as a result, such stockholder will continue to hold that number of shares exceeding 15% and, in order to dispose of such shares, would
be required to sell its stock in open market transactions, potentially at a loss. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>There can be no assurance that New QuantumScape&#146;s
Class&nbsp;A Common Stock will be approved for listing on the NYSE or that New QuantumScape will be able to comply with the continued listing standards of the NYSE. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Closing, Kensington intends to list the New QuantumScape Class&nbsp;A Common Stock and warrants on the NYSE under the
symbols &#147;QS&#148; and &#147;QS.W,&#148; respectively. New QuantumScape&#146;s continued eligibility for listing may depend on the number of Kensington&#146;s shares that are redeemed. If, after the Business Combination, the NYSE delists New
QuantumScape&#146;s shares from trading on its exchange for failure to meet the listing standards and Kensington is not able to list such securities on another national securities exchange, Kensington expects such securities could be quoted on an <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market. If this were to occur, New QuantumScape and its stockholders could face significant material adverse consequences including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a limited availability of market quotations for New QuantumScape&#146;s securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduced liquidity for New QuantumScape&#146;s securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a determination that the New QuantumScape Class&nbsp;A Common Stock is a &#147;penny stock&#148; which will
require brokers trading the New QuantumScape Class&nbsp;A Common Stock to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for shares of New QuantumScape Class&nbsp;A Common
Stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a limited amount of news and analyst coverage; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a decreased ability to issue additional securities or obtain additional financing in the future.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Kensington&#146;s Sponsor, officers, directors and independent directors have agreed to vote in favor of the Business
Combination, regardless of how the Public Stockholders vote. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Sponsor, officers, directors and independent directors have
agreed to vote any shares of Kensington Common Stock held by them in favor of the Business Combination. Kensington expects that Kensington&#146;s Sponsor, officers, directors and independent directors (and their permitted transferees) will own at
least approximately 20% of the outstanding shares of Kensington Common Stock at the time of any such stockholder vote. Accordingly, it is more likely that the necessary stockholder approval will be received than would be the case if such persons
agreed to vote their Sponsor Shares in accordance with the majority of the votes cast by the Public Stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape&#146;s management
has limited experience in operating a public company. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape&#146;s executive officers have limited experience in the
management of a publicly traded company. QuantumScape&#146;s management team may not successfully or effectively manage its transition to a public company that will be subject to significant regulatory oversight and reporting obligations under
federal securities laws. Their limited experience in dealing with the increasingly complex laws pertaining to public companies could be a significant disadvantage in that it is likely that an increasing amount of their time may be devoted to these
activities which will result in less time being devoted to the management and growth of New QuantumScape. QuantumScape may not have adequate personnel with the appropriate level of knowledge, experience, and training in the accounting policies,
practices or internal controls over financial reporting required of public companies in the United States. The development and implementation of the standards and controls necessary for New QuantumScape to achieve the level of accounting standards
required of a public company in the United States may require costs greater than expected. It is possible that New QuantumScape will be required to expand its employee base and hire additional employees to support its operations as a public company
which will increase its operating costs in future periods. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The dual class structure of New QuantumScape&#146;s Common Stock has the effect of concentrating
voting control with the current holders of QuantumScape Class B Common Stock. This will limit or preclude your ability to influence corporate matters, including the outcome of important transactions, including a change in control. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of New QuantumScape Class B Common Stock will have 10 votes per share, while shares of New QuantumScape Class A Common Stock have one
vote per share. Although no one holder or group of holders will control more than 30% of the voting power of New QuantumScape&#146;s capital stock, the holders of the QuantumScape Class B Common Stock will control approximately 87.80% of the voting
power of New QuantumScape&#146;s capital stock and will collectively be able to control matters submitted to its stockholders for approval, including the election of directors, amendments of its organizational documents and any merger,
consolidation, sale of all or substantially all of New QuantumScape&#146;s assets or other major corporate transactions. Even though these holders are not party to any agreement that requires them to vote together, they may have interests that
differ from yours and may vote in a way with which you disagree and which may be adverse to your interests. This concentrated control may have the effect of delaying, preventing or deterring a change in control of New QuantumScape, could deprive its
stockholders of an opportunity to receive a premium for their capital stock as part of a sale of New QuantumScape, and might ultimately affect the market price of shares of New QuantumScape Class A Common Stock. For information about New
QuantumScape&#146;s dual class structure, see the section entitled &#147;<I>Description of Kensington&#146;s Securities</I>.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>New
QuantumScape&#146;s dual class structure may depress the trading price of New QuantumScape Class A Common Stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New QuantumScape
cannot predict whether its dual class structure will result in a lower or more volatile market price of New QuantumScape Class A Common Stock or in adverse publicity or other adverse consequences. For example, certain index providers have announced
restrictions on including companies with multiple-class share structures in certain of their indexes. S&amp;P Dow Jones and FTSE Russell have announced changes to their eligibility criteria for inclusion of shares of public companies on certain
indices, including the S&amp;P 500, pursuant to which companies with multiple classes of shares of common stock are excluded. In addition, several stockholder advisory firms have announced their opposition to the use of multiple class structures. As
a result, the dual class structure of New QuantumScape Common Stock may cause stockholder advisory firms to publish negative commentary about New QuantumScape&#146;s corporate governance practices or otherwise seek to cause New QuantumScape to
change its capital structure. Any such exclusion from indices or any actions or publications by stockholder advisory firms critical of New QuantumScape&#146;s corporate governance practices or capital structure could adversely affect the value and
trading market of New QuantumScape Class A Common Stock. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Kensington&#146;s ability to successfully effect the Business Combination and New
QuantumScape&#146;s ability to successfully operate the business thereafter will be largely dependent upon the efforts of certain key personnel of QuantumScape. The loss of such key personnel could negatively impact the operations and financial
results of the combined business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington&#146;s ability to successfully effect the Business Combination and New
QuantumScape&#146;s ability to successfully operate the business following the Closing is dependent upon the efforts of certain key personnel of QuantumScape. Although Kensington expect key personnel to remain with New QuantumScape following the
Business Combination, there can be no assurance that they will do so. It is possible that QuantumScape will lose some key personnel, the loss of which could negatively impact the operations and profitability of New QuantumScape. Furthermore,
following the Closing, certain of the key personnel of QuantumScape may be unfamiliar with the requirements of operating a company regulated by the SEC, which could cause New QuantumScape to have to expend time and resources helping them become
familiar with such requirements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Kensington Board did not obtain a fairness opinion in determining whether or not to proceed with
the Business Combination and, as a result, the terms may not be fair from a financial point of view to the Public Stockholders. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
analyzing the Business Combination, the Kensington Board conducted significant due diligence on QuantumScape. For a complete discussion of the factors utilized by the Kensington Board in approving the Business Combination, see the section entitled,
&#147;<I>The Business Combination&#151;Kensington&#146;s Board of Directors&#146; Reasons for the Approval of the Business Combination.</I>&#148; The Kensington Board believes because of the financial skills and background of its directors, it was
qualified to conclude that the Business Combination was fair from a financial perspective to its stockholders and that QuantumScape&#146;s fair market value was at least 80% of the value of the Trust Account (excluding any taxes payable on interest
earned). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the Kensington Board did not obtain a fairness opinion to assist it in its determination.
Accordingly, the Kensington Board may be incorrect in its assessment of the Business Combination. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Kensington&#146;s Sponsor, directors, officers,
advisors or their affiliates may enter into certain transactions, including purchasing shares or warrants from the public, which may influence the outcome of the Business Combination and reduce the public &#147;float&#148; of the Kensington
Class&nbsp;A Common Stock. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington&#146;s Sponsor, directors, officers, advisors or their affiliates may purchase Public
Shares or Public Warrants or a combination thereof in privately negotiated transactions or in the open market either prior to or following the Closing, although they are under no obligation to do so. Such a purchase may include a contractual
acknowledgement that such stockholder, although still the record holder of Kensington&#146;s shares is no longer the beneficial owner thereof and therefore agrees not to exercise his, her or its redemption rights. In the event that Kensington&#146;s
Sponsor, directors, officers, advisors or their affiliates purchase shares in privately negotiated transactions from Public Stockholders who have already elected to exercise their redemption rights, such selling stockholders would be required to
revoke their prior elections to redeem their shares. Additionally, at any time at or prior to the Business Combination, subject to applicable securities laws (including with respect to material nonpublic information), Kensington&#146;s Sponsor,
directors, officers, advisors or their affiliates may enter into transactions with investors and others to provide them with incentives to acquire Public Shares, vote their Public Shares in favor of the Business Combination or not redeem their
Public Shares. However, they have no current commitments, plans or intentions to engage in such transactions and have not formulated any terms or conditions for any such transactions. The purpose of any such transaction could be to (a)&nbsp;vote
such shares in favor of the Business Combination and thereby increase the likelihood of obtaining stockholder approval of the Business Combination, or (b)&nbsp;reduce the number of Kensington Warrants outstanding or to vote such Kensington Warrants
on any matters submitted to the Kensington Warrant holders for approval in connection with the Business Combination, where it appears that such requirement would otherwise not be met. This may result in the Closing that may not otherwise have been
possible. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, if such purchases are made, the public &#147;float&#148; of Kensington Class&nbsp;A Common Stock or
Kensington Warrants and the number of beneficial holders of Kensington&#146;s securities may be reduced, possibly making it difficult to obtain or maintain the quotation, listing or trading of Kensington&#146;s securities on a national securities
exchange. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Existing Certificate of Incorporation requires, to the fullest extent permitted by law, that derivative actions brought in
Kensington&#146;s name, actions against Kensington&#146;s directors, officers, other employees or stockholders for breach of fiduciary duty and other similar actions be brought only in the Court of Chancery in the State of Delaware and, if brought
outside of Delaware, the stockholder bringing the suit will be deemed to have consented to service of process on such stockholder&#146;s counsel, which may have the effect of discouraging lawsuits against Kensington&#146;s directors, officers, other
employees or stockholders. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Existing Certificate of Incorporation requires, to the fullest extent permitted by law, that
derivative actions brought in Kensington&#146;s name, actions against Kensington&#146;s directors, officers, other employees or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stockholders for breach of fiduciary duty and other similar actions be brought only in the Court of Chancery in the State of Delaware and, if brought outside of Delaware, the stockholder bringing
the suit will be deemed to have consented to service of process on such stockholder&#146;s counsel except any action (A)&nbsp;as to which the Court of Chancery in the State of Delaware determines that there is an indispensable party not subject to
the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), (B) which is vested in the exclusive jurisdiction of a court
or forum other than the Court of Chancery, (C)&nbsp;for which the Court of Chancery does not have subject matter jurisdiction, or (D)&nbsp;any action arising under the Securities Act, as to which the Court of Chancery and the federal district court
for the District of Delaware shall have concurrent jurisdiction. Any person or entity purchasing or otherwise acquiring any interest in shares of Kensington&#146;s capital stock is deemed to have notice of and consented to the forum provisions in
the Existing Certificate of Incorporation. This choice of forum provision may make it more costly for a stockholder to bring a claim, and it may also limit a stockholder&#146;s ability to bring a claim in a judicial forum that it finds favorable for
disputes with Kensington or any of its directors, officers, other employees or stockholders, which may discourage lawsuits with respect to such claims, although Kensington&#146;s stockholders cannot waive Kensington&#146;s compliance with federal
securities laws and the rules and regulations thereunder. Alternatively, if a court were to find the choice of forum provision contained in the Existing Certificate of Incorporation invalid, Kensington may incur additional costs associated with
resolving such action in other jurisdictions, which could harm Kensington&#146;s business, operating results and financial condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Existing Certificate of Incorporation provides that the exclusive forum provision will be applicable to the fullest extent permitted by applicable law. Section&nbsp;27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought
to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. As a result, the exclusive forum provision will not apply to suits brought to enforce any duty or liability created by the Exchange Act or any
other claim for which the federal courts have exclusive jurisdiction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If third parties bring claims against Kensington, the proceeds held in the
Trust Account could be reduced and the <FONT STYLE="white-space:nowrap">per-share</FONT> redemption amount received by stockholders may be less than $10.00 per share. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington&#146;s placing of funds in the Trust Account may not protect those funds from third-party claims against Kensington. Although
Kensington has sought to have all vendors, service providers, prospective target businesses and other entities with which it does business execute agreements with Kensington waiving any right, title, interest or claim of any kind in or to any monies
held in the Trust Account for the benefit of the Public Stockholders, such parties may not execute such agreements, or even if they execute such agreements they may not be prevented from bringing claims against the Trust Account, including, but not
limited to, fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain an advantage with respect to a claim against
Kensington&#146;s assets, including the funds held in the Trust Account. If any third party refuses to execute an agreement waiving such claims to the monies held in the Trust Account, Kensington&#146;s management will perform an analysis of the
alternatives available to it and will only enter into an agreement with a third party that has not executed a waiver if management believes that such third party&#146;s engagement would be significantly more beneficial to Kensington than any
alternative. Making such a request of potential target businesses may make Kensington&#146;s acquisition proposal less attractive to them and, to the extent prospective target businesses refuse to execute such a waiver, it may limit the field of
potential target businesses that Kensington might pursue. Marcum LLP, Kensington&#146;s independent registered public accounting firm, will not execute agreements with Kensington waiving such claims to the monies held in the trust account. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Examples of possible instances where Kensington may engage a third party that refuses to execute a waiver include the engagement of a
third-party consultant whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would agree to execute a waiver or in cases where management is unable to find a service provider
willing to execute a waiver. In addition, there is no </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with Kensington and will not
seek recourse against the Trust Account for any reason. Upon redemption of the Public Shares, if Kensington has not completed its initial business combination within the prescribed timeframe, or upon the exercise of a redemption right in connection
with its initial business combination, Kensington will be required to provide for payment of claims of creditors that were not waived that may be brought against Kensington within the 10&nbsp;years following redemption. Accordingly, the per share
redemption amount received by Public Stockholders could be less than the $10.00 per share initially held in the Trust Account, due to claims of such creditors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sponsor has agreed that it will be liable to Kensington if and to the extent any claims by a third party (except for Kensington&#146;s
independent registered public accounting firm) for services rendered or products sold to us, or by a prospective target business with which Kensington has discussed entering into a transaction agreement, reduce the amount of funds in the Trust
Account to below (i)&nbsp;$10.00 per public share or (ii)&nbsp;such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net
of the amount of interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims
under Kensington&#146;s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, then
the Sponsor will not be responsible to the extent of any liability for such third-party claims. Kensington has not independently verified whether the Sponsor, which is a newly formed entity, has sufficient funds to satisfy its indemnity obligations
and believes that the Sponsor&#146;s only assets are securities of Kensington. Kensington has not asked the Sponsor to reserve for such indemnification obligations. Therefore, Kensington cannot assure you that the Sponsor would be able to satisfy
those obligations. As a result, if any such claims were successfully made against the Trust Account, the funds available for Kensington&#146;s initial business combination and redemptions could be reduced to less than $10.00 per public share. In
such event, Kensington may not be able to complete its initial business combination, and its stockholders would receive such lesser amount per Public Share in connection with any redemption of their Public Shares. None of Kensington&#146;s officers
will indemnify Kensington for claims by third parties including, without limitation, claims by vendors and prospective target businesses. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Legal
proceedings in connection with the business combination, the outcomes of which are uncertain, could delay or prevent the completion of the business combination. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October 2, 2020, a putative class action lawsuit was filed in the Supreme Court of the State of New York by a purported Kensington
stockholder in connection with the Business Combination: Sanchez v. Kensington Capital Acquisition Corp., et al., Index No. 654941/2020 (Sup. Ct. N.Y. Cnty.). The complaint names Kensington and certain current and former members of the Kensington
Board as defendants. The complaint alleges, among other things, breach of fiduciary duty claims against the Kensington Board in connection with the Business Combination. The complaint also alleges that this proxy statement/prospectus/information
statement is misleading and/or omits material information concerning the Business Combination. The complaint generally seeks, among other things, injunctive relief and an award of attorneys&#146; fees. Additionally, on October 12, 2020, Kensington
received a letter from attorneys representing a different purported Kensington stockholder demanding certain &#147;corrective disclosures&#148; be made in this proxy statement/prospectus/information statement. Additional lawsuits may be filed
against Kensington or its directors and officers in connection with the Business Combination. Defending such additional lawsuits could require Kensington to incur significant costs and draw the attention of Kensington&#146;s management team away
from the Business Combination. Further, the defense or settlement of any lawsuit or claim that remains unresolved at the Closing may adversely affect the combined company&#146;s business, financial condition, results of operations and cash flows.
Such legal proceedings could delay or prevent the Closing from occuring within the contemplated timeframe. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Public Stockholders will not have any rights or interests in funds from the Trust Account, except
under certain limited circumstances. To liquidate their investment, therefore, Public Stockholders may be forced to sell their Public Shares or Public Warrants, potentially at a loss. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Public Stockholders will be entitled to receive funds from the Trust Account only upon the earliest to occur of: (a)&nbsp;the consummation of
Kensington&#146;s initial business combination, and then only in connection with those shares of Kensington Class&nbsp;A Common Stock that such Public Stockholder elected to redeem, subject to the limitations described herein, (b)&nbsp;the
redemption of any Public Shares properly submitted in connection with a stockholder vote to amend Kensington&#146;s amended and restated certificate of incorporation (i)&nbsp;to modify the substance or timing of Kensington&#146;s obligation to allow
redemption in connection with its initial business combination or to redeem 100% of the Public Shares if Kensington does not complete its initial business combination within 24&nbsp;months from the closing of the IPO or (ii)&nbsp;with respect to any
other provisions relating to stockholders&#146; rights or <FONT STYLE="white-space:nowrap">pre-initial</FONT> business combination activity and (c)&nbsp;the redemption of the Public Shares if Kensington has not completed its initial business
combination within 24 months from the closing of the IPO, subject to applicable law and as further described herein. In addition, if Kensington has not completed an initial business combination within the allocated time period for any reason,
compliance with Delaware law may require that Kensington submit a plan of dissolution to its then-existing stockholders for approval prior to the distribution of the proceeds held in the Trust Account. In that case, Public Stockholders may be forced
to wait beyond the end of such period before they receive funds from the Trust Account. In no other circumstances will a stockholder have any right or interest of any kind to the funds in the Trust Account. Holders of Kensington Warrants will not
have any right to the proceeds held in the Trust Account with respect to the Kensington Warrants. Accordingly, to liquidate their investment, the Public Stockholders may be forced to sell their Public Shares or Public Warrants, potentially at a
loss. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Kensington&#146;s independent directors may decide not to enforce the indemnification obligations of the Sponsor, resulting in a reduction in
the amount of funds in the Trust Account available for distribution to the Public Stockholders. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that the proceeds in
the Trust Account are reduced below the lesser of (i)&nbsp;$10.00 per public share or (ii)&nbsp;such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of
the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, and the Sponsor asserts that it is unable to satisfy its obligations or that it has no indemnification obligations related to a particular claim,
Kensington&#146;s independent directors would determine whether to take legal action against the Sponsor to enforce its indemnification obligations. While Kensington currently expects that its independent directors would take legal action on
Kensington&#146;s behalf against the Sponsor to enforce its indemnification obligations to Kensington, it is possible that Kensington&#146;s independent directors in exercising their business judgment may choose not to do so if, for example, the
cost of such legal action is deemed by the independent directors to be too high relative to the amount recoverable or if the independent directors determine that a favorable outcome is not likely. If Kensington&#146;s independent directors choose
not to enforce these indemnification obligations, the amount of funds in the Trust Account available for distribution to the Public Stockholders may be reduced below $10.00 per share. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Kensington&#146;s stockholders may be held liable for claims by third parties against Kensington to the extent of distributions received by them upon
redemption of their shares. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the DGCL, stockholders may be held liable for claims by third parties against a corporation to
the extent of distributions received by them in a dissolution. The pro rata portion of the Trust Account distributed to the Public Stockholders upon the redemption of the Public Shares in the event Kensington does not complete the initial business
combination within the required time period may be considered a liquidating distribution under Delaware law. If a corporation complies with certain procedures set forth in Section&nbsp;280 of the DGCL intended to ensure that it makes reasonable
provision for all claims against it, including a <FONT STYLE="white-space:nowrap">60-day</FONT> notice period during which any third-party claims can be brought against the corporation, a <FONT STYLE="white-space:nowrap">90-day</FONT> period during
which the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
corporation may reject any claims brought, and an additional <FONT STYLE="white-space:nowrap">150-day</FONT> waiting period before any liquidating distributions are made to stockholders, any
liability of stockholders with respect to a liquidating distribution is limited to the lesser of such stockholder&#146;s pro rata share of the claim or the amount distributed to the stockholder, and any liability of the stockholder would be barred
after the third anniversary of the dissolution. However, it is Kensington&#146;s intention to redeem the Public Shares as soon as reasonably possible following the 24th month from the closing of the IPO (or the end of any Extension Period) in the
event Kensington does not complete the initial business combination and, therefore, Kensington does not intend to comply with the foregoing procedures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because Kensington will not be complying with Section&nbsp;280, Section&nbsp;281(b) of the DGCL requires Kensington to adopt a plan, based on
facts known to Kensington at such time that will provide for Kensington&#146;s payment of all existing and pending claims or claims that may be potentially brought against Kensington within the 10 years following its dissolution. However, because
Kensington is a blank check company, rather than an operating company, and Kensington&#146;s operations will be limited to searching for prospective target businesses to acquire, the only likely claims to arise would be from Kensington&#146;s
vendors (such as lawyers, investment bankers, etc.) or prospective target businesses. If Kensington&#146;s plan of distribution complies with Section&nbsp;281(b) of the DGCL, any liability of stockholders with respect to a liquidating distribution
is limited to the lesser of such stockholder&#146;s pro rata share of the claim or the amount distributed to the stockholder, and any liability of the stockholder would likely be barred after the third anniversary of the dissolution. Kensington
cannot assure you that it will properly assess all claims that may be potentially brought against us. As such, Kensington&#146;s stockholders could potentially be liable for any claims to the extent of distributions received by them (but no more)
and any liability of Kensington&#146;s stockholders may extend beyond the third anniversary of such date. Furthermore, if the pro rata portion of the Trust Account distributed to Kensington&#146;s Public Stockholders upon the redemption of the
Public Shares in the event Kensington does not complete the initial business combination within the required time period is not considered a liquidating distribution under Delaware law and such redemption distribution is deemed to be unlawful, then
pursuant to Section&nbsp;174 of the DGCL, the statute of limitations for claims of creditors could then be six years after the unlawful redemption distribution, instead of three years, as in the case of a liquidating distribution. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If, after Kensington distributes the proceeds in the Trust Account to Kensington&#146;s Public Stockholders, Kensington files a bankruptcy petition or
an involuntary bankruptcy petition is filed against Kensington that is not dismissed, a bankruptcy court may seek to recover such proceeds, and Kensington and the Kensington Board may be exposed to claims of punitive damages. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, after Kensington distributes the proceeds in the Trust Account to Kensington&#146;s Public Stockholders, Kensington files a bankruptcy
petition or an involuntary bankruptcy petition is filed against Kensington that is not dismissed, any distributions received by stockholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as either a &#147;preferential
transfer&#148; or a &#147;fraudulent conveyance.&#148; As a result, a bankruptcy court could seek to recover some or all amounts received by Kensington&#146;s stockholders. In addition, the Kensington Board may be viewed as having breached its
fiduciary duty to Kensington&#146;s creditors and/or having acted in bad faith, by paying Public Stockholders from the Trust Account prior to addressing the claims of creditors, thereby exposing itself and Kensington to claims of punitive damages.
If, before distributing the proceeds in the trust account to Kensington&#146;s public stockholders, Kensington files a bankruptcy petition or an involuntary bankruptcy petition is filed against Kensington that is not dismissed, the claims of
creditors in such proceeding may have priority over the claims of Kensington&#146;s stockholders and the <FONT STYLE="white-space:nowrap">per-share</FONT> amount that would otherwise be received by Kensington&#146;s stockholders in connection with
Kensington&#146;s liquidation may be reduced. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If, before distributing the proceeds in the Trust Account to Kensington&#146;s Public Stockholders,
Kensington files a bankruptcy petition or an involuntary bankruptcy petition is filed against it that is not dismissed, the proceeds held in the Trust Account could be subject to applicable bankruptcy law, and may be included in Kensington&#146;s
bankruptcy estate and subject to the claims of third parties with priority over the claims of</I></B> <B><I>Kensington&#146;s stockholders. To the extent any bankruptcy claims deplete the Trust Account, the
<FONT STYLE="white-space:nowrap">per-share</FONT> amount that would otherwise be received by Kensington&#146;s stockholders in connection with Kensington&#146;s liquidation may be reduced</I></B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, before distributing the proceeds in the Trust Account to Kensington&#146;s Public Stockholders, Kensington files a bankruptcy petition or
an involuntary bankruptcy petition is filed against Kensington that is not dismissed, the proceeds held in the Trust Account could be subject to applicable bankruptcy law, and may be included in Kensington&#146;s bankruptcy estate and subject to the
claims of third parties with priority over the claims of Kensington&#146;s stockholders. To the extent any bankruptcy claims deplete the Trust Account, the <FONT STYLE="white-space:nowrap">per-share</FONT> amount that would otherwise be received by
Kensington&#146;s stockholders in connection with Kensington&#146;s liquidation may be reduced. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When considering the Kensington
Board&#146;s recommendation that Kensington&#146;s stockholders vote in favor of the approval of the Business Combination Proposal, Kensington&#146;s stockholders should be aware that certain of Kensington&#146;s Sponsor, executive officers and
directors have interests in the Business Combination that may be different from, or in addition to, the interests of Kensington&#146;s stockholders. These interests include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the beneficial ownership of the Sponsor of an aggregate of 5,750,000 Sponsor Shares and 6,575,000 Private
Warrants, which shares and warrants would become worthless if Kensington does not complete a business combination within the applicable time period, as the Sponsor has waived any right to redemption with respect to these shares. The Sponsor paid an
aggregate of $25,000 for the Sponsor Shares and $6,575,000 for the Private Warrants. Such shares and warrants have an aggregate market value of approximately $83,605,000 and $24,919,250, respectively, based on the closing price of the Kensington
Class&nbsp;A Common Stock and Public Warrants of $14.54 and $3.79, respectively, on the NYSE on&nbsp;October&nbsp;19, 2020; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Justin Mirro, Kensington&#146;s Chief Executive Officer and Chairman is the managing member of the managing
member of the Sponsor. Consequently, he may be deemed the beneficial owner of the 5,750,000 Sponsor Shares and 6,575,000 Private Warrants and to have voting and dispositive control over such securities. Mr.&nbsp;Mirro disclaims beneficial ownership
of any securities other than to the extent he may have a pecuniary interest therein, directly or indirectly. Each of Kensington&#146;s other officers and directors are <FONT STYLE="white-space:nowrap">non-managing</FONT> members of the Sponsor;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Sponsor has made a loan of $75,000 to Kensington; the Sponsor has informed Kensington that the Sponsor
intends to convert the loan into 75,000 warrants on the same terms as the Private Warrants (as contemplated by the warrant agreement pursuant to which the Private Warrants were issued) at the same time the Business Combination is completed and for
such warrants to be issued to Justin Mirro, who had advanced such amount to the Sponsor in order for the loan to be made. Such warrants have an aggregate market value of approximately $284,250 based on the closing price of the Public Warrants of
$3.79 on the NYSE on October 19, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Sponsor and Kensington&#146;s directors and executive officers will not receive reimbursement for any <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by them on Kensington&#146;s behalf incident to identifying, investigating and completing a business combination to the extent such expenses
exceed the amount not required to be retained in the Trust Account, unless a business combination is consummated. As of September 30, 2020, the Sponsor and Kensington&#146;s directors and executive officers and their respective affiliates had
incurred approximately $29,000 of such reimburseable out-of-pocket expenses; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the anticipated continuation of Justin Mirro, Kensington&#146;s Chairman and Chief Executive Officer, as a
director of New QuantumScape following the Closing; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">DEHC, an affiliate of Daniel Huber, Kensington&#146;s Chief Financial Officer and Secretary and Simon Boag,
Kensington&#146;s Chief Technology Officer, entered into services agreements with Kensington to provide administrative and other services as may be reasonably requested by Kensington for one year after the Closing in order to assist it in connection
with the post-closing integration of New QuantumScape. In consideration of the agreements by DEHC and Mr. Boag to provide such services, Kensington agreed to pay each of them $240,000 at the Closing. The foregoing amounts are subject to recoupment
by Kensington in the event DEHC or Mr. Boag, as applicable, fails to satisfy its obligations under the agreements; and </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the continued indemnification of current directors and officers of Kensington and the continuation of
directors&#146; and officers&#146; liability insurance after the Business Combination. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These interests may influence Kensington&#146;s
directors in making their recommendation that you vote in favor of the Business Combination Proposal, and the transactions contemplated thereby. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We
may amend the terms of the Kensington Warrants in a manner that may be adverse to holders of Public Warrants with the approval by the holders of at least 50% of the then outstanding Public Warrants. As a result, the exercise price of your Kensington
Warrants could be increased, the exercise period could be shortened and the number of shares of Kensington Class&nbsp;A Common Stock purchasable upon exercise of a Kensington Warrant could be decreased, all without your approval. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Kensington Warrants were issued in registered form under the Kensington Warrant Agreement between Continental Stock Transfer&nbsp;&amp;
Trust Company, as warrant agent, and us. The Kensington Warrant Agreement provides that the terms of the Kensington Warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision but requires the
approval by the holders of at least 50% of the then outstanding Public Warrants to make any change that adversely affects the interests of the registered holders of Public Warrants and, solely with respect to any amendment to the terms of the
Private Warrants or working capital warrants or any provision of the Kensington Warrant Agreement with respect to the Private Warrants or working capital warrants, 50% of the number of the then outstanding Private Warrants or working capital
warrants, as applicable. Accordingly, Kensington may amend the terms of the Public Warrants in a manner adverse to a holder if holders of at least 50% of the then outstanding Public Warrants approve of such amendment. Although Kensington&#146;s
ability to amend the terms of the Public Warrants with the consent of at least 50% of the then outstanding Public Warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the
Kensington Warrants, convert the Kensington Warrants into cash or stock, shorten the exercise period or decrease the number of shares of Kensington Class&nbsp;A Common Stock issuable upon exercise of a Kensington Warrant. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may issue additional common stock or preferred stock to complete the Business Combination or under an employee incentive plan after the Closing.
Kensington may also issue shares of Kensington Class&nbsp;A Common Stock upon the conversion of the Kensington Class&nbsp;B Common Stock at a ratio greater than
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-to-one</FONT></FONT> at the time of the Business Combination as a result of the anti-dilution provisions contained in the Existing Certificate of Incorporation. Any such issuances
would dilute the interest of Kensington&#146;s stockholders. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Existing Certificate of Incorporation authorizes the issuance of
up to 100,000,000 shares of Kensington Class&nbsp;A Common Stock, 10,000,000 shares of Kensington Class&nbsp;B Common Stock and 1,000,000 shares of preferred stock, par value $0.0001 per share. Kensington may issue a substantial number of additional
shares of common stock or shares of preferred stock, par value $0.0001 per share, to complete the Business Combination (including pursuant to a specified future issuance) or under an employee incentive plan after the Closing. Kensington may also
issue shares of Kensington Class&nbsp;A Common Stock to redeem the Kensington Warrants when the price per share of Kensington Class&nbsp;A Common Stock equals or exceeds $10.00 or upon conversion of the Kensington Class&nbsp;B Common Stock at a
ratio greater than <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-to-one</FONT></FONT> at the time of the Business Combination as a result of the anti-dilution provisions contained in the Existing Certificate of Incorporation.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Kensington Class&nbsp;B Common Stock shall only be convertible at the time of the Business Combination. However, the Existing Certificate of Incorporation provides, among other things, that prior
to the Business Combination, Kensington may not issue additional securities that would entitle the holders thereof to (i)&nbsp;receive funds from the Trust Account or (ii)&nbsp;vote as a class with Kensington&#146;s Public Shares (a)&nbsp;on any
initial business combination or (b)&nbsp;to approve an amendment to Kensington&#146;s amended and restated certificate of incorporation. The restriction on issuing additional shares of securities described in the prior sentence will expire upon
consummation of the initial business combination. The issuance of additional shares of common or preferred stock: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may significantly dilute the equity interest of investors from the IPO, which dilution would increase if the
anti-dilution provisions in the Kensington Class&nbsp;B Common Stock resulted in the issuance of Kensington Class&nbsp;A Common Stock on a greater than <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-to-one</FONT></FONT> basis
upon conversion of the Kensington Class&nbsp;B Common Stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may subordinate the rights of holders of common stock if preferred stock is issued with rights senior to those
afforded Kensington Common Stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">could cause a change of control if a substantial number of shares of Kensington Common Stock is issued, which may
affect, among other things, Kensington&#146;s ability to use its net operating loss carry forwards, if any, and could result in the resignation or removal of Kensington&#146;s present officers and directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may have the effect of delaying or preventing a change of control of Kensington by diluting the stock ownership
or voting rights of a person seeking to obtain control of Kensington; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may adversely affect prevailing market prices for the Kensington Units, Kensington Class&nbsp;A Common Stock
and/or Kensington Warrants; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may not result in adjustment to the exercise price of Kensington Warrants. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Anti-takeover provisions in the Proposed Certificate of Incorporation, Proposed Bylaws and Delaware law could make an acquisition of New QuantumScape
more difficult, limit attempts by New QuantumScape stockholders to replace or remove New QuantumScape&#146;s management and limit the market price of New QuantumScape Class&nbsp;A Common Stock. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Proposed Certificate of Incorporation, Proposed Bylaws and Delaware law contain provisions which could have the effect of rendering more
difficult, delaying or preventing an acquisition deemed undesirable by the New QuantumScape Board. These provisions include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">authorizing &#147;blank check&#148; preferred stock, which could be issued by the New QuantumScape Board without
stockholder approval and may contain voting, liquidation, dividend and other rights superior to New QuantumScape Common Stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limiting the liability of, and providing indemnification to, New QuantumScape&#146;s directors and officers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibiting cumulative voting in the election of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">providing that vacancies on the New QuantumScape Board may be filled only by majority of directors then in office
of the New QuantumScape Board, even though less than a quorum; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibiting the ability of New QuantumScape stockholders to call special meetings; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing an advance notice procedure for stockholder proposals to be brought before an annual meeting,
including proposed nominations of persons for election to the New QuantumScape Board; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">requiring that, once there are no longer any outstanding shares of New QuantumScape Class&nbsp;B Common Stock,
any action to be taken by New QuantumScape stockholders be effected at a duly called annual or special meeting and not by written consent; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">specifying that special meetings of New QuantumScape stockholders can be called only by a majority of the New
QuantumScape Board, the chair of the New QuantumScape Board, or the Chief Executive Officer of New QuantumScape; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">requiring that, once there are no longer any outstanding shares of New QuantumScape Class&nbsp;B Common Stock,
the approval of holders of at least two-thirds of the outstanding voting securities to amend the Proposed Bylaws and certain provisions of the Proposed Certificate of Incorporation; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reflecting two classes of New QuantumScape Common Stock, as discussed in &#147;<I>Proposal No. 2&#151;the
Authorized Share Charter Proposal</I>&#148; and &#147;<I>Description of Kensington&#146;s Securities</I>.&#148; </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These
provisions may frustrate or prevent any attempts by New QuantumScape stockholders to replace or remove New QuantumScape&#146;s current management by making it more difficult for stockholders to replace members of the New QuantumScape Board, which is
responsible for appointing the members of New QuantumScape&#146;s management. In addition, because New QuantumScape is incorporated in Delaware, it is governed by the provisions of Section&nbsp;203 of the DGCL, which generally prohibits a Delaware
corporation from engaging in any of a broad range of business combinations with any &#147;interested&#148; stockholder for a period of three years following the date on which the stockholder became an &#147;interested&#148; stockholder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Proposed Bylaws provide, subject to limited exceptions, that the Court of Chancery of the State of Delaware and the federal district courts of the
United States will be the sole and exclusive forum for certain stockholder litigation matters, which could limit New QuantumScape stockholders&#146; ability to obtain a chosen judicial forum for disputes with New QuantumScape or its directors,
officers, employees or stockholders. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Proposed Bylaws provide that, unless otherwise consented to by New QuantumScape in
writing, the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another State court in Delaware or the federal district court for the District of Delaware) shall, to the fullest extent permitted by
law, be the sole and exclusive forum for the following types of actions or proceedings: (i) any derivative action or proceeding brought on behalf of New QuantumScape; (ii) any action asserting a claim of breach of a fiduciary duty owed by, or
otherwise wrongdoing by, any of New QuantumScape&#146;s directors, officers, or other employees to New QuantumScape or its stockholders; (iii) any action arising pursuant to any provision of the DGCL or the Proposed Certificate of Incorporation or
the Proposed Bylaws; (iv) any action to interpret, apply, enforce or determine the validity of the Proposed Certificate of Incorporation or the Proposed Bylaws; or (v) any other action asserting a claim that is governed by the internal affairs
doctrine, in all cases subject to the court having jurisdiction over indispensable parties named as defendants. This provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which
the U.S. federal courts have exclusive jurisdiction. The Proposed Bylaws further provide that, unless otherwise consented to by New QuantumScape in writing, the federal district courts of the United States will be the sole and exclusive forum for
the resolution of any complaint asserting a cause of action arising under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any person or entity purchasing or
otherwise acquiring any interest in New QuantumScape&#146;s securities shall be deemed to have notice of and consented to this provision. This choice of forum provision may limit a stockholder&#146;s ability to bring a claim in a judicial forum of
its choosing for disputes with New QuantumScape or any of its directors, officers, other employees or stockholders, which may discourage lawsuits with respect to such claims. There is uncertainty as to whether a court would enforce such provisions,
and the enforceability of similar choice of forum provisions in other companies&#146; charter documents has been challenged in legal proceedings. It is possible that a court could find these types of provisions to be inapplicable or unenforceable,
and if a court were to find the choice of forum provision contained in the Proposed Bylaws to be inapplicable or unenforceable in an action, New QuantumScape may incur additional costs associated with resolving such action in other jurisdictions,
which could harm its business, operating results and financial condition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Concentration of ownership among Volkswagen and New QuantumScape&#146;s executive officers,
directors and their affiliates may prevent new investors from influencing significant corporate decisions. </I></B></P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the Closing, Volkswagen will beneficially own approximately 31.03% of New QuantumScape Class&nbsp;A Common Stock and 11.36% of New
QuantumScape Class B Common Stock outstanding, representing 13.76% of the vote, and New QuantumScape&#146;s executive officers, directors and their affiliates as a group will beneficially own approximately 37.46% of New QuantumScape Class A Common
Stock and 41.39% New QuantumScape Class B Common Stock outstanding, representing 41.21% of the vote. As a result, these stockholders will be able to exercise a significant level of control over all matters requiring stockholder approval, including
the election of directors, any amendment of the Proposed Certificate of Incorporation and approval of significant corporate transactions. In addition, Volkswagen will hold the right to designate two directors to the New QuantumScape Board following
the Closing. This control could have the effect of delaying or preventing a change of control of New QuantumScape or changes in its management and will make the approval of certain transactions difficult or impossible without the support of these
stockholders and of their votes. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The numbers of shares and percentage interests set forth above are based on a number of
assumptions, including that (i) none of the Public Stockholders exercise their redemption rights, (ii) QuantumScape does not issue any additional equity securities prior to the Merger, other than the issuance of 14,684,843 shares of Series F
Preferred Stock pursuant to certain Series F Stock Purchase Agreements by and between QuantumScape and the investors thereto, and that no other event occurs that would change the Exchange Ratio from what it would have been as of the date of the
initial signing of the Business Combination Agreement and (iii) there are no future exercises of the Kensington Warrants. If the actual facts differ from these assumptions, the numbers of shares and percentage interests set forth above will be
different. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Because Kensington has no current plans to pay cash dividends on Kensington Class&nbsp;A Common Stock for the foreseeable future, you
may not receive any return on investment unless you sell Kensington Class&nbsp;A Common Stock for a price greater than that which you paid for it. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may retain future earnings, if any, for future operations, expansion and debt repayment and have no current plans to pay any cash dividends
for the foreseeable future. Any decision to declare and pay dividends as a public company in the future will be made at the discretion of the Kensington Board and will depend on, among other things, Kensington&#146;s results of operations, financial
condition, cash requirements, contractual restrictions and other factors that the Kensington Board may deem relevant. In addition, Kensington&#146;s ability to pay dividends may be limited by covenants of any existing and future outstanding
indebtedness Kensington or its subsidiaries incur. As a result, you may not receive any return on an investment in Kensington Class&nbsp;A Common Stock unless you sell Kensington Class&nbsp;A Common Stock for a price greater than that which you paid
for it. See the section entitled &#147;<I>Price Range of Securities and Dividends&#151;Dividends</I>.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>New QuantumScape does not expect to
declare any dividends in the foreseeable future. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After the Closing, New QuantumScape does not anticipate declaring any cash
dividends to holders of its common stock in the foreseeable future. Consequently, investors may need to rely on sales of their shares after price appreciation, which may never occur, as the only way to realize any future gains on their investment.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If the Business Combination&#146;s benefits do not meet the expectations of investors or securities analysts, the market price of New
QuantumScape&#146;s securities may decline. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the perceived benefits of the Business Combination do not meet the expectations of
investors or securities analysts, the market price of Kensington&#146;s securities prior to the Closing may decline. The market values of New QuantumScape&#146;s securities at the time of the Business Combination may vary significantly from their
prices on the date the Business Combination Agreement was executed, the date of this proxy statement/prospectus/information statement, or the date on which Kensington&#146;s stockholders vote on the Business Combination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, following the Business Combination, fluctuations in the price of New QuantumScape&#146;s securities could contribute to the loss
of all or part of your investment. Prior to the Business Combination, there has not been a public market for QuantumScape&#146;s capital stock. Accordingly, the valuation Kensington has </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
ascribed to QuantumScape in the Business Combination may not be indicative of the price that will be implied in the trading market for New QuantumScape&#146;s securities following the Business
Combination. If an active market for New QuantumScape&#146;s securities develops and continues after the Business Combination, the trading price of such securities could be volatile and subject to wide fluctuations in response to various factors,
some of which are beyond New QuantumScape&#146;s control. Any of the factors listed below could have a material adverse effect on your investment in New QuantumScape&#146;s securities and New QuantumScape&#146;s securities may trade at prices
significantly below the price you paid for them or that were implied by the conversion of QuantumScape Capital Stock you owned into New QuantumScape&#146;s securities as a result of the Business Combination. In such circumstances, the trading price
of New QuantumScape&#146;s securities may not recover and may experience a further decline. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Factors affecting the trading price of New
QuantumScape&#146;s securities may include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">actual or anticipated fluctuations in New QuantumScape&#146;s quarterly financial results or the quarterly
financial results of companies perceived to be similar to it; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the market&#146;s expectations about New QuantumScape&#146;s operating results; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">success of competitors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">New QuantumScape&#146;s operating results failing to meet the expectation of securities analysts or investors in
a particular period; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in financial estimates and recommendations by securities analysts concerning New QuantumScape or the
battery industry in general; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">operating and share price performance of other companies that investors deem comparable to New QuantumScape;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">New QuantumScape&#146;s ability to bring its products and technologies to market on a timely basis, or at all;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in laws and regulations affecting New QuantumScape&#146;s business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">New QuantumScape&#146;s ability to meet compliance requirements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">commencement of, or involvement in, litigation involving New QuantumScape; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in New QuantumScape&#146;s capital structure, such as future issuances of securities or the incurrence of
additional debt; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the volume of New QuantumScape&#146;s shares of common stock available for public sale; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any major change in the New QuantumScape Board or management; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sales of substantial amounts of New QuantumScape&#146;s shares of common stock by New QuantumScape&#146;s
directors, executive officers or significant stockholders or the perception that such sales could occur; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">general economic and political conditions such as recessions, interest rates, fuel prices, international currency
fluctuations and acts of war or terrorism. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Broad market and industry factors may materially harm the market price of
New QuantumScape&#146;s securities irrespective of New QuantumScape&#146;s operating performance. The stock market in general, and the NYSE in particular, have experienced price and volume fluctuations that have often been unrelated or
disproportionate to the operating performance of the particular companies affected. The trading prices and valuations of these stocks, and of New QuantumScape&#146;s securities, may not be predictable. A loss of investor confidence in the market for
retail stocks or the stocks of other companies which investors perceive to be similar to New QuantumScape could depress New QuantumScape&#146;s share price regardless of New QuantumScape&#146;s business, prospects, financial
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conditions or results of operations. A decline in the market price of New QuantumScape&#146;s securities also could adversely affect New QuantumScape&#146;s ability to issue additional securities
and New QuantumScape&#146;s ability to obtain additional financing in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Following the Closing, New QuantumScape will incur significant
increased expenses and administrative burdens as a public company, which could have an adverse effect on its business, financial condition and results of operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the Closing, New QuantumScape will face increased legal, accounting, administrative and other costs and expenses as a public company
that QuantumScape does not incur as a private company. The Sarbanes-Oxley Act of 2002 (the &#147;Sarbanes-Oxley Act&#148;), including the requirements of Section&nbsp;404, as well as rules and regulations subsequently implemented by the SEC, the
Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and the rules and regulations promulgated and to be promulgated thereunder, the PCAOB and the securities exchanges, impose additional reporting and other obligations on public
companies. Compliance with public company requirements will increase costs and make certain activities more time-consuming. A number of those requirements will require New QuantumScape to carry out activities QuantumScape has not done previously.
For example, New QuantumScape will create new board committees and adopt new internal controls and disclosure controls and procedures. In addition, expenses associated with SEC reporting requirements will be incurred. Furthermore, if any issues in
complying with those requirements are identified (for example, if the auditors identify a material weakness or significant deficiency in the internal control over financial reporting), New QuantumScape could incur additional costs rectifying those
issues, and the existence of those issues could adversely affect New QuantumScape&#146;s reputation or investor perceptions of it. It may also be more expensive to obtain director and officer liability insurance. Risks associated with New
QuantumScape&#146;s status as a public company may make it more difficult to attract and retain qualified persons to serve on New QuantumScape&#146;s board of directors or as executive officers. The additional reporting and other obligations imposed
by these rules and regulations will increase legal and financial compliance costs and the costs of related legal, accounting and administrative activities. These increased costs will require New QuantumScape to divert a significant amount of money
that could otherwise be used to expand the business and achieve strategic objectives. Advocacy efforts by stockholders and third parties may also prompt additional changes in governance and reporting requirements, which could further increase costs.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If, following the Business Combination, securities or industry analysts do not publish or cease publishing research or reports about New
QuantumScape, its business, or its market, or if they change their recommendations regarding New QuantumScape&#146;s securities adversely, the price and trading volume of New QuantumScape&#146;s securities could decline. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trading market for New QuantumScape&#146;s securities will be influenced by the research and reports that industry or securities analysts
may publish about New QuantumScape, its business, market or competitors. Securities and industry analysts do not currently, and may never, publish research on New QuantumScape. If no securities or industry analysts commence coverage of New
QuantumScape, New QuantumScape&#146;s share price and trading volume would likely be negatively impacted. If any of the analysts who may cover New QuantumScape change their recommendation regarding New QuantumScape&#146;s shares of common stock
adversely, or provide more favorable relative recommendations about New QuantumScape&#146;s competitors, the price of New QuantumScape&#146;s shares of common stock would likely decline. If any analyst who may cover New QuantumScape were to cease
coverage of New QuantumScape or fail to regularly publish reports on it, New QuantumScape could lose visibility in the financial markets, which in turn could cause its share price or trading volume to decline. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Subsequent to the Closing, New QuantumScape may be required to take write-downs or write-offs,
restructuring, impairment or other charges that could have a significant negative effect on New QuantumScape&#146;s financial condition, results of operations and the price of New QuantumScape Common Stock, which could cause you to lose some or all
of your investment. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although Kensington has conducted due diligence on QuantumScape, Kensington cannot assure you that this
diligence will surface all material issues that may be present with QuantumScape&#146;s business, that it would be possible to uncover all material issues through a customary amount of due diligence, or that factors outside of QuantumScape&#146;s
and outside of Kensington&#146;s control will not later arise. As a result of these factors, New QuantumScape may be forced to later write-down or <FONT STYLE="white-space:nowrap">write-off</FONT> assets (including the equity it owns in the
Surviving Corporation), restructure its operations, or incur impairment or other charges that could result in New QuantumScape reporting losses. Even if Kensington&#146;s due diligence successfully identified certain risks, unexpected risks may
arise, and previously known risks may materialize in a manner not consistent with Kensington&#146;s preliminary risk analysis. Even though these charges may be <FONT STYLE="white-space:nowrap">non-cash</FONT> items and therefore not have an
immediate impact on New QuantumScape&#146;s liquidity, the fact that New QuantumScape reports charges of this nature could contribute to negative market perceptions about New QuantumScape or its securities. In addition, charges of this nature may
cause New QuantumScape to be unable to obtain future financing on favorable terms or at all. Accordingly, any stockholders or Kensington Warrant holders who choose to remain a stockholder or Kensington Warrant holder following the initial business
combination could suffer a reduction in the value of their securities. Such security holders are unlikely to have a remedy for such reduction in value. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>New QuantumScape&#146;s failure to timely and effectively implement controls and procedures required by Section&nbsp;404(a) of the Sarbanes-Oxley Act
that will be applicable to it after the Closing could have a material adverse effect on its business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape is currently
not subject to Section&nbsp;404 of the Sarbanes-Oxley Act. However, following the Closing, New QuantumScape will be required to provide management&#146;s attestation on internal controls. The standards required for a public company under
Section&nbsp;404(a) of the Sarbanes-Oxley Act are significantly more stringent than those required of QuantumScape as a privately-held company. Management may not be able to effectively and timely implement controls and procedures that adequately
respond to the increased regulatory compliance and reporting requirements that will be applicable after the Business Combination. If New QuantumScape is not able to implement the additional requirements of Section&nbsp;404(a) in a timely manner or
with adequate compliance, it may not be able to assess whether its internal controls over financial reporting are effective, which may subject it to adverse regulatory consequences and could harm investor confidence and the market price of its
securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>New QuantumScape will qualify as an &#147;emerging growth company&#148; within the meaning of the Securities Act, and if it takes
advantage of certain exemptions from disclosure requirements available to emerging growth companies, this could make New QuantumScape&#146;s securities less attractive to investors and may make it more difficult to compare New QuantumScape&#146;s
performance with other public companies. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New QuantumScape will qualify as an &#147;emerging growth company&#148; as defined in
Section&nbsp;2(a)(19) of the Securities Act, as modified by the JOBS Act. As such, New QuantumScape will be eligible for and intends to take advantage of certain exemptions from various reporting requirements applicable to other public companies
that are not emerging growth companies for as long as it continues to be an emerging growth company, including (i)&nbsp;the exemption from the auditor attestation requirements with respect to internal control over financial reporting under
Section&nbsp;404(b) of the Sarbanes-Oxley Act, (ii)&nbsp;the exemptions from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay,</FONT></FONT>
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-frequency</FONT></FONT> and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-golden</FONT></FONT> parachute voting requirements and (iii)&nbsp;reduced
disclosure obligations regarding executive compensation in its periodic reports and proxy statements. As a result, the stockholders may not have access to certain information they may deem important. New QuantumScape will remain an emerging growth
company until the earliest of (i)&nbsp;the last day of the fiscal year in which the market value of New QuantumScape Common Stock that are held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeds $700&nbsp;million as of June&nbsp;30 of
that fiscal </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
year, (ii)&nbsp;the last day of the fiscal year in which it has total annual gross revenue of $1.07&nbsp;billion or more during such fiscal year (as indexed for inflation), (iii)&nbsp;the date on
which it has issued more than $1&nbsp;billion in <FONT STYLE="white-space:nowrap">non-convertible</FONT> debt in the prior three-year period or (iv)&nbsp;the last day of the fiscal year following the fifth anniversary of the date of the first sale
of Kensington Units in the IPO. In addition, Section&nbsp;107 of the JOBS Act also provides that an emerging growth company can take advantage of the exemption from complying with new or revised accounting standards provided in
Section&nbsp;7(a)(2)(B) of the Securities Act as long as New QuantumScape is an emerging growth company. An emerging growth company can therefore delay the adoption of certain accounting standards until those standards would otherwise apply to
private companies. Kensington has elected not to opt out of such extended transition period and, therefore, New QuantumScape may not be subject to the same new or revised accounting standards as other public companies that are not emerging growth
companies. Investors may find New QuantumScape Class&nbsp;A Common Stock less attractive because New QuantumScape will rely on these exemptions, which may result in a less active trading market for the New QuantumScape Class&nbsp;A Common Stock and
its price may be more volatile. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The unaudited pro forma financial information included herein may not be indicative of what New QuantumScape&#146;s
actual financial position or results of operations would have been. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma financial information included herein
is presented for illustrative purposes only and is not necessarily indicative of what New QuantumScape&#146;s actual financial position or results of operations would have been had the Business Combination been completed on the dates indicated. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_12"></A>UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Defined terms included below have the same meaning as terms defined and included elsewhere in this proxy
statement/prospectus/information statement. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following unaudited pro forma condensed combined financial information presents the
combination of the financial information of Kensington and QuantumScape adjusted to give effect to the Business Combination and related transactions. The following unaudited pro forma condensed combined financial information has been prepared in
accordance with Article 11 of Regulation <FONT STYLE="white-space:nowrap">S-X.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed combined balance
sheet as of June&nbsp;30, 2020 combines the historical balance sheet of Kensington and the historical balance sheet of QuantumScape on a pro forma basis as if the Business Combination and related transactions, summarized below, had been consummated
on June&nbsp;30, 2020. The unaudited pro forma condensed combined statements of operations for the six months ended June&nbsp;30, 2020 and the year ended December&nbsp;31, 2019 combine the historical statements of operations of Kensington and
historical statements of operations of QuantumScape for such periods on a pro forma basis as if the Business Combination and related transactions, summarized below, had been consummated on January&nbsp;1, 2019, the beginning of the earliest period
presented: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Merger; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuance and sale of 50,000,000 shares of Kensington Class&nbsp;A Common Stock for a purchase price of $10.00
per share and an aggregate purchase price of $500&nbsp;million in the PIPE pursuant to the Subscription Agreements; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuance and sale of 10,900,089 shares of Series F Preferred Stock, which includes 3,784,754 shares that are
due to be issued on December&nbsp;1, 2020, and 7,115,335 shares that are expected to be issued concurrent with the Closing of the Business Combination. Refer to Note 2 of this unaudited pro forma condensed combined financial information for further
discussion. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The historical financial statements have been adjusted in the unaudited pro forma condensed combined
financial statements to give pro forma effect to events that are: (i)&nbsp;directly attributable to the Business Combination; (ii)&nbsp;factually supportable; and (iii)&nbsp;with respect to the statements of operations, expected to have a continuing
impact on the post-combination company&#146;s results following the completion of the Business Combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma
condensed combined financial statements have been developed from and should be read in conjunction with: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the accompanying notes to the unaudited pro forma condensed combined financial statements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the historical unaudited financial statements of Kensington as of June&nbsp;30, 2020 and for the period from
April&nbsp;17, 2020 (inception) through June&nbsp;30, 2020 and the related notes included elsewhere in this proxy statement/prospectus/information statement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the historical audited financial statements of QuantumScape as of and for the year ended December&nbsp;31, 2019
and the related notes included elsewhere in this proxy statement/prospectus/information statement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the historical unaudited financial statements of QuantumScape as of and for the six months ended June&nbsp;30,
2020 and the related notes included elsewhere in this proxy statement/prospectus/information statement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other information relating to Kensington and QuantumScape contained in this proxy
statement/prospectus/information statement, including the Business Combination Agreement and the description of certain terms thereof set forth in the section entitled &#147;<I>The Business Combination</I>.&#148; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the legal form of the Business Combination pursuant to the Business
Combination Agreement, the Business Combination will be accounted for as a reverse recapitalization in accordance with GAAP. Under this method of accounting, Kensington is treated as the acquired company and QuantumScape is treated as the acquirer
for financial statement reporting purposes. QuantumScape has been determined to be the accounting acquirer based on evaluation of the following facts and circumstances: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s existing stockholders will have the greatest voting interest in the combined entity under the
no redemption and maximum redemption scenarios with over 95% of the voting interest in each scenario; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s directors will represent the majority of the New QuantumScape Board; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s senior management will be the senior management of New QuantumScape; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape is the larger entity based on historical operating activity and has the larger employee base.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Existing Certificate of Incorporation, public stockholders are being offered the opportunity to redeem,
upon the closing of the Business Combination, shares of Kensington Common Stock then held by them for cash equal to their pro rata share of the aggregate amount on deposit (as of two business days prior to the Closing) in the Trust Account. For
illustrative purposes, based on the cash held in the Trust Account as of June&nbsp;30, 2020 of approximately $230&nbsp;million, the estimated per share redemption price would have been $10.00 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed combined financial statements present two redemption scenarios as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Assuming No Redemption&#151;this scenario assumes that no shares of Kensington Common Stock are redeemed; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Assuming Maximum Redemption&#151;this scenario assumes that 23,000,000 shares of Kensington Common Stock are
redeemed for an aggregate payment of approximately $230.0&nbsp;million (based on the estimated per share redemption price of approximately $10.00 per share) from the Trust Account. The Business Combination Agreement includes a condition to the
Closing that, at the Closing, Kensington will have a minimum of $500&nbsp;million in cash comprising (i)&nbsp;the cash held in the Trust Account after giving effect to any Kensington share redemptions and (ii)&nbsp;gross proceeds from the PIPE. The
gross proceeds from the PIPE of $500&nbsp;million is sufficient to satisfy this closing condition, and accordingly, this scenario results in public share redemptions of 23,000,000 shares of Kensington Class&nbsp;A Common Stock.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Description of the Business Combination </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Kensington, Merger Sub and QuantumScape entered into the Business Combination Agreement, pursuant to which
Kensington and QuantumScape will consummate the Business Combination. At the Effective Time, by virtue of the Merger and without any action on the part of Kensington, Merger Sub, QuantumScape or the holders of any of QuantumScape&#146;s securities:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each share of QuantumScape Class&nbsp;A Common Stock and QuantumScape Class&nbsp;A Preferred Stock outstanding
immediately prior to the Effective Time and convertible into a share of QuantumScape Class&nbsp;A Common Stock pursuant to the provisions of QuantumScape&#146;s certificate of incorporation, will be cancelled and converted into the right to receive
the number of shares of New QuantumScape Class&nbsp;A Common Stock equal to the Exchange Ratio (as described below), with each holder&#146;s shares rounded down to the nearest whole number; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each share of QuantumScape Class&nbsp;B Common Stock and QuantumScape Class&nbsp;B Preferred Stock outstanding
immediately prior to the Effective Time and convertible into a share of QuantumScape </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Class&nbsp;B Common Stock pursuant to the provisions of QuantumScape&#146;s certificate of incorporation, will be cancelled and converted into the right to receive the number of shares of New
QuantumScape Class&nbsp;B Common Stock equal to the Exchange Ratio (as described below), with each holder&#146;s shares rounded down to the nearest whole number; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all shares of QuantumScape Capital Stock held in the treasury of QuantumScape will be cancelled without any
conversion thereof and no payment or distribution will be made with respect thereto; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each share of Merger Sub Common Stock outstanding immediately prior to the Effective Time will be converted into
and exchanged for one validly issued, fully paid and nonassessable share of common stock, par value $0.01 per share, of the Surviving Corporation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each QuantumScape Option that is outstanding immediately prior to the Effective Time, whether vested or unvested,
will be converted into an option to purchase a number of shares of the applicable class of New QuantumScape Common Stock that the <FONT STYLE="white-space:nowrap">pre-conversion</FONT> QuantumScape Option covers (such option, an &#147;Exchanged
Option&#148;) equal to the product (rounded down to the nearest whole number) of (i)&nbsp;the number of shares of QuantumScape Common Stock subject to such QuantumScape Option immediately prior to the Effective Time multiplied by (ii)&nbsp;the
Exchange Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A)&nbsp;the exercise price per share of such QuantumScape Option immediately prior to the Effective Time divided by (B)&nbsp;the Exchange Ratio. Except
as specifically provided in the Business Combination Agreement, following the Effective Time, each Exchanged Option will continue to be governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the
corresponding former QuantumScape Option immediately prior to the Effective Time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each share of QuantumScape Restricted Stock that is outstanding immediately prior to the Effective Time will be
converted into restricted shares of the applicable class of New QuantumScape Common Stock that the <FONT STYLE="white-space:nowrap">pre-conversion</FONT> QuantumScape Restricted Stock covers (such share of restricted New QuantumScape Common Stock,
an &#147;Exchanged Restricted Stock&#148;) equal to the product (rounded down to the nearest whole number) of (i)&nbsp;the number of shares of QuantumScape Restricted Stock immediately prior to the Effective Time multiplied by (ii)&nbsp;the Exchange
Ratio. Except as specifically provided above, following the Effective Time, each Exchanged Restricted Stock shall continue to be governed by the same terms and conditions (including transfer restrictions and repurchase right terms) as were
applicable to the corresponding former QuantumScape Restricted Stock immediately prior to the Effective Time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each QuantumScape RSU that is outstanding immediately prior to the Effective Time will be converted into
restricted stock units of the applicable class of New QuantumScape Common Stock that the <FONT STYLE="white-space:nowrap">pre-conversion</FONT> QuantumScape RSU covers (such restricted stock unit award covering New QuantumScape Common Stock, an
&#147;Exchanged RSU&#148;) equal to the product (rounded down to the nearest whole number) of (i)&nbsp;the number of shares subject to a QuantumScape RSU immediately prior to the Effective Time multiplied by (ii)&nbsp;the Exchange Ratio. Except as
specifically provided above, following the Effective Time, each Exchanged RSU shall continue to be governed by the same terms and conditions (including transfer restrictions and repurchase right terms) as were applicable to the corresponding former
QuantumScape RSU immediately prior to the Effective Time; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the obligation to purchase shares of Series F Preferred Stock upon satisfaction of certain milestones, if still
outstanding, will become an obligation to purchase, upon satisfaction of the milestones, shares of New QuantumScape Class&nbsp;A Common Stock equal in number to the shares of New QuantumScape Class A Common Stock that would have been issued in the
Merger in exchange for such shares of Series F Preferred Stock if such shares of Series F Preferred Stock had been outstanding prior to the Merger; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each QuantumScape Warrant that is outstanding immediately prior to the Effective Time shall be converted into a
warrant to purchase a number of shares of the applicable class of New QuantumScape </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Common Stock (such warrant, the &#147;Exchanged Warrant&#148;) equal to the product (rounded down to the nearest whole number) of (i)&nbsp;the number of shares of QuantumScape Common Stock
subject to such QuantumScape Warrant immediately prior to the Effective Time multiplied by (ii)&nbsp;the Exchange Ratio. Except as specifically provided above, following the Effective Time, each Exchanged Warrant shall continue to be governed by the
same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former QuantumScape Warrant immediately prior to the Effective Time. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The &#147;Exchange Ratio&#148; is defined in the Business Combination Agreement as a quotient that is calculated on the basis of: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(i) the &#147;Target Share Amount,&#148; which means an amount equal to (a) 360,000,000, plus or minus (b)&nbsp;the quotient obtained by
dividing (x)&nbsp;the amount, if any, by which the Series F Subscription Amount is greater than or less than, as applicable, $300,000,000, by (y) $10. As of the date of the initial signing of the Business Combination Agreement, the Target Share
Amount was equal to 368,799,998; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">divided by </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(ii) QuantumScape&#146;s &#147;Fully-Diluted Company Shares&#148; (with such &#147;Fully-Diluted Company Shares&#148; being, as of the date of
initial signing of the Business Combination Agreement, equal to 92,125,870). </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of the initial signing of the Business
Combination Agreement, the Exchange Ratio was 4.0032186234. The Exchange Ratio will be finally calculated in accordance with the methodology and procedures set forth in the Business Combination Agreement, and Kensington will file with the SEC a
Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> announcing the final Exchange Ratio no later than four business days prior to the special meeting of its stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The aggregate consideration for the Business Combination is estimated to be $3.7&nbsp;billion, payable in the form of New QuantumScape Common
Stock. The following summarizes the consideration in both the no redemption and maximum redemption scenarios: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">(in thousands, except for share and per share amounts)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares transferred at Closing (1)(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">368,799,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Value per share (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 10.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Share Consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,687,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Actual shares transferred is subject to an adjustment prior to Closing. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Share consideration is calculated using a $10.00 reference price. Actual total share consideration will be
dependent on the value of the Kensington Common Stock at Closing. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares transferred at Closing include the following QuantumScape securities which are subject to future
exercise, service conditions, contingent issuance provisions, or a combination thereof, and will not be legally outstanding at Closing: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">57,203,214 unexercised stock options </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,018,033 unexercised warrants </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">12,936,901 shares issuable for restricted stock units </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">15,151,197 shares issuable upon the completion of a specified technical milestone pursuant to the Series F Stock
Purchase Agreement with VGA, as described in Note 2 </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following summarizes the pro forma New QuantumScape Common Stock shares outstanding
under the two redemption scenarios: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Assuming&nbsp;No<BR>Redemptions<BR>(Shares)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Assuming&nbsp;Max<BR>Redemptions<BR>(Shares)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">QuantumScape shareholders - New QuantumScape Class&nbsp;A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,979,416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,979,416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">QuantumScape shareholders - New QuantumScape Class&nbsp;B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">157,511,179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">157,511,179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">QuantumScape warrants, options, RSUs and contingently issuable Series&nbsp;F preferred
stock&nbsp;(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86,309,345</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86,309,345</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total QuantumScape Business Combination shares</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>368,799,940</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>82.4</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>368,799,940</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>86.9</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kensington public stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holders of Kensington sponsor shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PIPE Investors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Pro Forma Common Stock</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>447,549,940</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100.0</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>424,549,940</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100.0</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the following QuantumScape securities which are subject to future exercise, service conditions,
contingent issuance provisions, or a combination thereof, and will not be legally outstanding at Closing: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">57,203,214 unexercised stock options </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,018,033 unexercised warrants </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">12,936,901 shares issuable for restricted stock units </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">15,151,197 shares issuable upon the completion of a specified technical milestone pursuant to the Series F Stock
Purchase Agreement with VGA, as described in Note 2 </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assumptions and estimates underlying the unaudited pro forma
adjustments set forth in the unaudited pro forma condensed combined financial statements are described in the accompanying notes. The unaudited pro forma condensed combined financial statements have been presented for illustrative purposes only and
are not necessarily indicative of the operating results and financial position that would have been achieved had the Business Combination occurred on the dates indicated. Further, the unaudited pro forma condensed combined financial statements do
not purport to project the future operating results or financial position of Kensington following the completion of the Business Combination. The unaudited pro forma adjustments represent Kensington management&#146;s estimates based on information
available as of the date of these unaudited pro forma condensed combined financial statements and are subject to change as additional information becomes available and analyses are performed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AS OF JUNE&nbsp;30, 2020 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="6" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="4" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series F<BR>Preferred<BR>Stock<BR>Financing</B><br><B>Adjustments</B><br><B>(Note 2)</B></TD>
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="4" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma<BR>Adjustments<BR>(Assuming<BR>No</B><br><B>Redemptions)</B><br><B>(Note&nbsp;3)</B></TD>
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>June&nbsp;30, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="4" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR>Pro&nbsp;Forma<BR>Adjustments<BR>(Assuming<BR>Maximum</B><br><B>Redemptions)</B><br><B>(Note 3)</B></TD>
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>June&nbsp;30,&nbsp;2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of June&nbsp;30, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma<BR>Combined<BR>(Assuming</B><br><B>No</B><br><B>Redemptions)</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma<BR>Combined<BR>(Assuming</B><br><B>Maximum</B><br><B>Redemptions)</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>KENSINGTON</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>QUANTUMSCAPE</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(Historical)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(Historical)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 29,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">276,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 230,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(a</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 990,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(230,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(k</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 760,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,050</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(b</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,890</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(c</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">482,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(d</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,512</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,512</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,512</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,703</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,941</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,941</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Total current assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,978</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100,390</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>276,100</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>683,560</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,062,028</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(230,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>832,028</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash held in Trust Account</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">230,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(230,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(a</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> lease
asset</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Total assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>231,978</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>146,204</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>276,100</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>453,560</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,107,842</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(230,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>877,842</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">256</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,490</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,987</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accrued compensation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,349</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,349</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,349</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Operating lease liability, short-term</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Strategic premium, short-term</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">655</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">655</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">655</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Franchise tax payable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Note payable - related party</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(75</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(h</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Total current liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>489</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,629</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(75</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,043</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,043</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Operating lease liability, long-term</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,866</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,866</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,866</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Convertible preferred stock warrant liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Strategic premium, long-term and other liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Deferred underwriting compensation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,050</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(b</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Total liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>8,539</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>20,673</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(8,125</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>21,087</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>21,087</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="6" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="4" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series F<BR>Preferred<BR>Stock<BR>Financing</B><br><B>Adjustments</B><br><B>(Note 2)</B></TD>
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="4" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma<BR>Adjustments<BR>(Assuming<BR>No</B><br><B>Redemptions)</B><br><B>(Note&nbsp;3)</B></TD>
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>June&nbsp;30, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="4" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR>Pro&nbsp;Forma<BR>Adjustments<BR>(Assuming<BR>Maximum</B><br><B>Redemptions)</B><br><B>(Note 3)</B></TD>
<TD VALIGN="bottom" ROWSPAN="4">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>June&nbsp;30,&nbsp;2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of June&nbsp;30, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma<BR>Combined<BR>(Assuming</B><br><B>No</B><br><B>Redemptions)</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma<BR>Combined<BR>(Assuming</B><br><B>Maximum</B><br><B>Redemptions)</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>KENSINGTON</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>QUANTUMSCAPE</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(Historical)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(Historical)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Commitments and contingencies</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Class&nbsp;A common shares subject to possible redemption</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">
&#036;
</TD>
<TD VALIGN="bottom" ALIGN="right">218,439</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">
&#036;
</TD>
<TD VALIGN="bottom" ALIGN="right">(218,439</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(e</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">
&#036;
</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">
&#036;
</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Redeemable convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">
&#036;
</TD>
<TD VALIGN="bottom" ALIGN="right">405,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">
&#036;
</TD>
<TD VALIGN="bottom" ALIGN="right">276,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(681,675</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(f</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Stockholders&#146; equity (deficit)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Class&nbsp;A common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(d</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">
&#036;
</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(k</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(e</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(f</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(g</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Class&nbsp;B common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(f</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(g</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(i</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(f</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Additional paid in capital</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,890</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(c</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,410,048</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(229,998</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(k</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,180,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">482,495</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(d</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">218,437</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(e</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">681,648</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(f</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(h</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,189</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(i</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(63</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(j</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Treasury stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,189</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(i</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accumulated other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(63</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(325,181</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(j</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(325,181</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(325,181</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Total stockholders&#146; equity (deficit) to common shareholders</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(281,749</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,361,799</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,085,050</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(230,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>855,050</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-controlling</FONT> interest</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,705</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,705</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,705</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Total stockholders&#146; equity (deficit)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(280,044</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,361,799</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,086,755</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(230,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>856,755</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Total liabilities and stockholders&#146; equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>231,978</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>146,204</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>276,100</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B> 453,560</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,107,842</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(230,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>877,842</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE SIX MONTHS ENDED JUNE&nbsp;30, 2020 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands, except share and per share data) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD ROWSPAN="3" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>For&nbsp;the&nbsp;period<BR>from<BR>April&nbsp;17,&nbsp;2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six&nbsp;Months&nbsp;Ended<BR>June&nbsp;30, 2020</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma</B><br><B>Adjustments<BR>(Assuming<BR>No</B><br><B>Redemptions)</B><br><B>(Note 3)</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD COLSPAN="2" ROWSPAN="3" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six&nbsp;Months<BR>Ended</B><br><B>June&nbsp;30,</B><br><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR>Pro Forma</B><br><B>Adjustments<BR>(Assuming<BR>Maximum</B><br><B>Redemptions)</B><br><B>(Note 3)</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six&nbsp;Months<BR>Ended</B><br><B>June&nbsp;30,</B><br><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(inception)</B><br><B>through<BR>June&nbsp;30,&nbsp;2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma<BR>Combined<BR>(Assuming</B><br><B>No</B><br><B>Redemptions)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma<BR>Combined<BR>(Assuming</B><br><B>Maximum</B><br><B>Redemptions)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>KENSINGTON<BR>(Historical)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>QUANTUMSCAPE<BR>(Historical)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman"><B>Operating expenses:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 25,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 25,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 25,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,747</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(aa)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(bb)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Franchise tax expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman"><B>Total operating expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>63</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>30,143</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>584</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>30,790</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>30,790</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman"><B>Loss from operations</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(63</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(30,143</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(584</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(30,790</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(30,790</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman"><B>Other income (expense)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman"><B>Total other income (expense)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>819</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>819</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>819</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman"><B>Net loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(63</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(29,324</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(584</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(29,971</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(29,971</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Less: Net loss attributable to noncontrolling interest</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman"><B>Net loss attributable to common shareholders</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(63</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(29,319</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(584</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(29,966</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(29,966</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Basic and diluted weighted average shares outstanding - Class&nbsp;A and Class&nbsp;B</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">361,240,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">338,240,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Basic and diluted net loss per share - Class&nbsp;A and Class&nbsp;B</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.08</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.09</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE YEAR ENDED DECEMBER&nbsp;31, 2019 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands, except share and per share data) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt" ALIGN="center">


<TR>

<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="6" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma</B><br><B>Adjustments</B><br><B>(Assuming<BR>No</B><br><B>Redemptions)<BR>(Note 3)</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD COLSPAN="2" ROWSPAN="3" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR>Pro Forma</B><br><B>Adjustments</B><br><B>(Assuming<BR>Maximum</B><br><B>Redemptions)<BR>(Note 3)</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma</B><br><B>Combined<BR>(Assuming</B><br><B>No<BR>Redemptions)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma</B><br><B>Combined<BR>(Assuming</B><br><B>Maximum<BR>Redemptions)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>KENSINGTON<BR>(Historical)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>QUANTUMSCAPE<BR>(Historical)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman"><B>Operating expenses:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 45,944</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 45,944</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 45,944</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,874</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(bb)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,082</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,082</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman"><B>Total operating expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>55,818</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,208</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>57,026</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>57,026</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman"><B>Loss from operations</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(55,818</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,208</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(57,026</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(57,026</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman"><B>Other income (expense)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(94</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(94</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(94</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,608</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,608</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,608</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Other income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman"><B>Total other income (expense)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,555</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,555</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,555</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman"><B>Net loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(51,263</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,208</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(52,471</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(52,471</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Less: Net loss attributable to noncontrolling interest</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman"><B>Net loss attributable to common shareholders</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(51,283</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(1,208</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(52,491</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(52,491</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Basic and diluted weighted average shares
<FONT STYLE="white-space:nowrap">outstanding&nbsp;-</FONT> Class&nbsp;A and Class&nbsp;B</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">361,240,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">338,240,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Basic and diluted net loss per share - Class&nbsp;A and Class&nbsp;B</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.15</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notes to Unaudited Pro Forma Condensed Combined Financial Statements </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Basis of Presentation </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business Combination will be accounted for as a reverse recapitalization, with no goodwill or other intangible assets recorded, in
accordance with GAAP. Under this method of accounting, Kensington will be treated as the &#147;acquired&#148; company for financial reporting purposes. Accordingly, for accounting purposes, the Business Combination will be treated as the equivalent
of QuantumScape issuing stock for the net assets of Kensington, accompanied by a recapitalization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The net assets of QuantumScape will be
stated at historical cost, with no goodwill or other intangible assets recorded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed combined balance sheet
as of June&nbsp;30, 2020 gives pro forma effect to the Business Combination as if it had been consummated on June&nbsp;30, 2020. The unaudited pro forma condensed combined statements of operations for the six months ended June&nbsp;30, 2020 and year
ended December&nbsp;31, 2019 give pro forma effect to the Business Combination as if it had been consummated on January&nbsp;1, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
unaudited pro forma condensed combined balance sheet as of June&nbsp;30, 2020 has been prepared using, and should be read in conjunction with, the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Kensington&#146;s unaudited balance sheet as of June&nbsp;30, 2020 and the related notes included elsewhere in
this proxy statement/prospectus/information statement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s unaudited balance sheet as of June&nbsp;30, 2020 and the related notes included elsewhere in
this proxy statement/prospectus/information statement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed combined statement of
operations for the six months ended June&nbsp;30, 2020 has been prepared using, and should be read in conjunction with, the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Kensington&#146;s unaudited statement of operations for the period April&nbsp;17, 2020 (inception) through
June&nbsp;30, 2020 and the related notes included elsewhere in this proxy statement/prospectus/information statement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s unaudited statement of operations for the six months ended June&nbsp;30, 2020 and the related
notes included elsewhere in this proxy statement/prospectus/information statement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed
combined statement of operations for the year ended December&nbsp;31, 2019 has been prepared using, and should be read in conjunction with, the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s audited statement of operations for the year ended December&nbsp;31, 2019 and the related
notes included elsewhere in this proxy statement/prospectus/information statement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Management has made significant
estimates and assumptions in its determination of the pro forma adjustments. As the unaudited pro forma condensed combined financial information has been prepared based on these preliminary estimates, the final amounts recorded may differ materially
from the information presented. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed combined financial information does not give effect to any
anticipated synergies, operating efficiencies, tax savings or cost savings that may be associated with the Business Combination. The pro forma adjustments reflecting the Closing are based on certain currently available information and certain
assumptions and methodologies that Kensington believes are reasonable under the circumstances. The unaudited condensed pro forma adjustments, which are described in the accompanying notes, may be revised as additional information becomes available
and is evaluated. Therefore, it is likely that the actual adjustments will differ from the pro forma adjustments and it is possible the difference may be material. Kensington believes that its assumptions and methodologies provide a reasonable basis
for presenting all of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
significant effects of the Business Combination based on information available to management at the time and that the pro forma adjustments give appropriate effect to those assumptions and are
properly applied in the unaudited pro forma condensed combined financial information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed combined
financial information is not necessarily indicative of what the actual results of operations and financial position would have been had the Business Combination taken place on the dates indicated, nor are they indicative of the future consolidated
results of operations or financial position of the post-combination company. They should be read in conjunction with the historical financial statements and notes thereto of Kensington and QuantumScape. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Adjustments for Series F Preferred Stock Financing </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In May 2020 and September 2020, QuantumScape and VGA entered into a Series F Preferred Stock Purchase Agreement and related agreements and
amendments thereto, pursuant to which it agreed to sell, and VGA agreed to purchase, up to a total of 7,569,508 shares of Series F Preferred Stock at $26.4218 per share for an aggregate purchase price of $200&nbsp;million. Pursuant to the terms of
the Series F Preferred Stock Purchase Agreement with VGA, the Series F Preferred Stock issued to VGA will fund in two tranches: (1) 3,784,754 shares of Series F Preferred Stock will be issued for $100&nbsp;million on December&nbsp;1, 2020, and (2)
3,784,754 shares of Series F Preferred Stock will be issued for $100&nbsp;million subject to certain conditions including the achievement of a specified technical milestone by March 31, 2021, as set forth in such agreements. The Series F Preferred
Stock Purchase Agreement with VGA, as amended, contains provisions pursuant to which, if the relevant closing of such Series F Preferred Stock Purchase Agreement (in whole or in part) were to occur only after effectiveness of the Merger, VGA has
agreed to purchase, and Kensington has agreed to issue, instead of the relevant number of shares of Series F Preferred Stock to be purchased at such closing, such number of shares of New QuantumScape Class&nbsp;A Common Stock as would have been
issued in the Merger in exchange for such shares of Series F Preferred Stock if they had been outstanding prior to the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In August
2020, QuantumScape entered into Series F Preferred Stock Purchase Agreements and related agreements thereto with several investors, pursuant to which it agreed to sell, and the investors agreed to purchase, an aggregate of 7,115,335 shares of Series
F Preferred Stock at $26.4218 per share for an aggregate purchase price of $188&nbsp;million. Pursuant to the terms of these Series F Preferred Stock Purchase Agreements, funding is expected to occur concurrent with the Closing of the Business
Combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Series F Preferred Stock Financing Adjustment reflects the pro forma adjustment for the issuance of 3,784,754 shares of
Series F Preferred Stock to VGA for $100&nbsp;million on December&nbsp;1, 2020, and the issuance of 7,115,335 shares for $188&nbsp;million to various investors concurrent with the Closing of the Business Combination, net of issuance costs of
$11.9&nbsp;million. In total, the 10,900,089 shares of Series F Preferred Stock included in the Series F Preferred Stock Financing Adjustment will convert into an aggregate 43,635,433 shares of New QuantumScape Class&nbsp;A Common Stock, based on
the Exchange Ratio. The Series F Preferred Stock Financing Adjustment does not include the issuance of 3,784,754 shares of Series F Preferred Stock subject to the achievement of a specified technical milestone (15,151,197 shares of New QuantumScape
Class&nbsp;A Common Stock converted at the Exchange Ratio). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Adjustments to Unaudited Pro Forma Condensed Combined Financial Information </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed combined financial information has been prepared to illustrate the effect of the Business Combination and has
been prepared for informational purposes only. The historical financial statements have been adjusted in the unaudited pro forma condensed combined financial information to give pro forma effect to events that are (1)&nbsp;directly attributable to
the Business Combination, (2)&nbsp;factually supportable, and (3)&nbsp;with respect to the statements of operations, expected to have a continuing impact on the results of the post-combination company. Kensington and QuantumScape have not had any
historical relationship prior to the Business Combination. Accordingly, no pro forma adjustments were required to eliminate activities between the companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The pro forma combined provision for income taxes does not necessarily reflect the amounts
that would have resulted had the post-combination company filed consolidated income tax returns during the periods presented. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Adjustments to
Unaudited Pro Forma Condensed Combined Balance Sheet </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The adjustments included in the unaudited pro forma condensed combined
balance sheet as of June&nbsp;30, 2020 are as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the reclassification of cash held in the Trust Account that becomes available following the Business
Combination, assuming no redemption. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the settlement of $8.1&nbsp;million in deferred underwriting compensation. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents preliminary estimated transaction costs incurred by Kensington and QuantumScape of approximately
$4.9&nbsp;million and $16&nbsp;million, respectively, for legal, financial advisory and other professional fees incurred in consummating the Business Combination. The unaudited pro forma condensed combined balance sheet reflects these costs as a
reduction of cash with a corresponding decrease in additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects proceeds of $500&nbsp;million from the issuance and sale of 50,000,000 shares of Kensington
Class&nbsp;A Common Stock at $10.00 per shares in the PIPE pursuant to the Subscription Agreements, net of issuance costs of $17.5&nbsp;million. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the reclassification of $218.4&nbsp;million of Kensington Class&nbsp;A Common Stock subject to
possible redemption to permanent equity. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the conversion of 59,290,940 shares of QuantumScape Preferred Stock, including 10,900,089 shares of
Series F Preferred Stock as described in Note 2, and 11,274,941 shares of QuantumScape Common Stock into 124,979,416 shares of New QuantumScape Class&nbsp;A Common Stock and 157,511,179 shares of New QuantumScape Class&nbsp;B Common Stock.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the conversion of Kensington Class&nbsp;B Common Stock held by the Sponsor into New QuantumScape
Class&nbsp;A Common Stock. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the conversion of the loan made from the Sponsor to Kensington into 75,000 warrants on the same terms
as the Private Warrants. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the retirement of 438,191 shares of QuantumScape Capital Stock held in treasury.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the elimination of Kensington&#146;s historical retained earnings. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the redemption of the maximum number of shares of 23,000,000 shares of Kensington Class&nbsp;A
Common Stock for $230.0&nbsp;million allocated to Class&nbsp;A common stock and additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital using par value of $0.0001 per share and at a redemption price of $10.00 per share (based on the cash
held in the Trust Account as of June&nbsp;30, 2020 of $230 million). </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Adjustments to Unaudited Pro Forma Condensed Combined
Statements of Operations </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The pro forma adjustments included in the unaudited pro forma condensed combined statements of operations
for the six months ended June&nbsp;30, 2020 and year ended December&nbsp;31, 2019 are as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(aa)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents pro forma adjustment to eliminate historical expenses related to Kensington&#146;s general
administrative services paid to an affiliate of Kensington&#146;s Chief Financial Officer, which will terminate upon the Closing. </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(bb)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects the amortization of share-based awards granted in connection with the Business Combination. The
estimated grant date fair value of $6.0&nbsp;million associated with the share-based awards was calculated using a Black-Scholes option pricing model and will be recognized over an estimated five-year service period. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Loss per Share </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Represents the net loss per share calculated using the historical weighted average shares outstanding, and the issuance of additional shares in
connection with the Business Combination, assuming the shares were outstanding since January&nbsp;1, 2019. As the Business Combination is being reflected as if it had occurred at the beginning of the periods presented, the calculation of weighted
average shares outstanding for basic and diluted net loss per share assumes that the shares issuable relating to the Business Combination have been outstanding for the entire periods presented. When assuming maximum redemption, this calculation is
adjusted to eliminate such shares for the entire period. Basic and diluted earnings per share are the same for each class of common stock because they are entitled to the same liquidation and dividend rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed combined financial information has been prepared assuming two alternative levels of redemption for the six
months ended June&nbsp;30, 2020 and for the year ended December&nbsp;31, 2019: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six Months Ended<BR>June&nbsp;30, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Assuming&nbsp;No<BR>Redemptions</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Assuming<BR>Maximum<BR>Redemptions</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Assuming&nbsp;No<BR>Redemptions</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Assuming<BR>Maximum<BR>Redemptions</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss attributable to common shareholders (in thousands)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(29,966</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(29,966</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(52,491</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(52,491</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average shares outstanding, basic and diluted - Class&nbsp;A and Class&nbsp;B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">361,240,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">338,240,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR></TD>
<TD VALIGN="bottom" ALIGN="right">361,240,595<BR></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">338,240,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share, basic and diluted - Class&nbsp;A and Class&nbsp;B&nbsp;(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.08</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.09</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.15</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Weighted average shares calculation, basis and diluted - Class&nbsp;A and
Class&nbsp;B</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kensington public stockholders - Class&nbsp;A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Holders of Kensington sponsor shares - Class&nbsp;A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PIPE Investors - Class&nbsp;A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">QuantumScape stockholders - Class&nbsp;A&nbsp;(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,979,416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,979,416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,979,416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,979,416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">QuantumScape stockholders - Class&nbsp;B&nbsp;(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">157,511,179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">157,511,179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">157,511,179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">157,511,179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">361,240,595</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">338,240,595</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">361,240,595</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">338,240,595</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For the purpose of calculating diluted loss per share, it was assumed that all outstanding Kensington Warrants
sold in the IPO are exchanged for Kensington Class&nbsp;A Common Stock. However, since this results in anti-dilution, the effect of such exchange was not included in the calculation of diluted loss per share. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The pro forma basic and diluted shares of current QuantumScape stockholders exclude the following as these are
contingently issuable shares and would reduce diluted loss per share: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">57,203,214 unexercised stock options </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,018,033 unexercised warrants </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">12,936,901 shares issuable for restricted stock units </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">15,151,197 shares issuable upon the completion of a specified technical milestone pursuant to the Series F Stock
Purchase Agreement with VGA, as described in Note 2 </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_13"></A>THE SPECIAL MEETING OF KENSINGTON STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_14"></A>The Kensington Special Meeting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington is furnishing this proxy statement/prospectus/information statement to you as part of the solicitation of proxies by our board of
directors for use at the special meeting of stockholders to be held on [&nbsp;&nbsp;&nbsp;&nbsp;], 2020, and at any adjournment or postponement thereof. This proxy statement/prospectus/information statement is first being furnished to
Kensington&#146;s stockholders on or about [&nbsp;&nbsp;&nbsp;&nbsp;], 2020. This proxy statement/prospectus/information statement provides you with information you need to know to be able to vote or instruct your vote to be cast at the special
meeting of stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_15"></A>Date, Time and Place of the Special Meeting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The special meeting of stockholders of Kensington will be held at 10:00&nbsp;a.m., Eastern time, on [&nbsp;&nbsp;&nbsp;&nbsp;], 2020, at the
offices of Hughes Hubbard&nbsp;&amp; Reed&nbsp;LLP, located at One Battery Park Plaza, New York, NY 10004, or such other date, time and place to which such meeting may be adjourned or postponed, for the purpose of considering and voting upon the
proposals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In light of the ongoing health concerns relating to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and to best
protect the health and welfare of Kensington&#146;s stockholders and personnel, Kensington urges that stockholders do not attend the special meeting in person. Stockholders are nevertheless urged to vote their proxies by completing, signing, dating
and returning the enclosed proxy card in the accompanying <FONT STYLE="white-space:nowrap">pre-addressed</FONT> postage paid envelope, or to direct their brokers or other agents on how to vote the shares in their accounts, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The special meeting is currently scheduled to be held in person as indicated above. However, we are actively monitoring the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic and if we determine that it is not possible or advisable to hold the special meeting in person, or to hold the meeting on the time or date or at the location indicated above, we will announce
alternative arrangements for the meeting as promptly as practicable, which may include switching to a virtual meeting format, or changing the time, date or location of the special meeting. Any such change will be announced via press release and the
filing of additional proxy materials with the SEC. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_16"></A>Purpose of the Special Meeting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Kensington special meeting of stockholders, Kensington will ask the Kensington stockholders to vote in favor of the following proposals:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Proposal No. 1&#151;The Business Combination Proposal&#151;a proposal to approve and adopt the Business
Combination Agreement and the Business Combination. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Proposal No. 2&#151;The Authorized Share Charter Proposal&#151;a proposal to amend the Existing Certificate of
Incorporation to increase the number of authorized shares of Kensington Common Stock and Kensington&#146;s preferred stock. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Proposal No. 3&#151;The Director Declassification Charter Proposal&#151;a proposal to amend the Existing
Certificate of Incorporation to declassify the Kensington Board. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Proposal No. 4&#151;The Dual Class&nbsp;Charter Proposal&#151;a proposal to amend the Existing Certificate of
Incorporation to implement a dual class stock structure comprised of New QuantumScape Class&nbsp;A Common Stock, which will carry one vote per share, and New QuantumScape Class&nbsp;B Common Stock, which will carry 10 votes per share.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Proposal No. 5&#151;The Additional Charter Proposal&#151;a proposal to amend the Existing Certificate of
Incorporation to eliminate provisions in the Existing Certificate of Incorporation relating to the Business Combination that will no longer be applicable following the Closing, change New QuantumScape&#146;s name to &#147;QuantumScape
Corporation&#148; and make certain other changes that the Kensington Board deems appropriate for a public operating company. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Proposal No. 6&#151;The Election of Directors Proposal&#151;a proposal to elect, effective at the Closing, nine
directors to serve on the New QuantumScape Board. </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Proposal No. 7&#151;The Equity Incentive Plan Proposal&#151;a proposal to approve and adopt the equity incentive
award plan established to be effective upon the Closing. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Proposal No. 8&#151;The NYSE Proposal&#151;a proposal to issue New QuantumScape Common Stock to the QuantumScape
stockholders in the Merger pursuant to the Business Combination Agreement and to the investors in the PIPE. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Proposal No. 9&#151;The Employee Stock Purchase Plan Proposal&#151;a proposal to approve and adopt the employee
stock purchase plan established to be effective upon the Closing. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Proposal No. 10&#151;The Adjournment Proposal&#151;a proposal to adjourn the special meeting to a later date or
dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the special meeting, there are not sufficient votes to approve one or more proposals presented to stockholders for a vote.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_17"></A>Recommendation of the Kensington Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Kensington Board believes that each of the proposals to be presented at the special meeting of stockholders is in the best interests of
Kensington and its stockholders and unanimously recommends that its stockholders vote &#147;FOR&#148; each of the proposals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When you
consider the recommendation of the Kensington Board in favor of approval of the Business Combination Proposal, you should keep in mind that certain of Kensington&#146;s directors and officers have interests in the Business Combination that are
different from, or in addition to, your interests as a stockholder. These interests include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the beneficial ownership of the Sponsor of an aggregate of 5,750,000 Sponsor Shares and 6,575,000 Private
Warrants, which shares and warrants would become worthless if Kensington does not complete a business combination within the applicable time period, as the Sponsor has waived any right to redemption with respect to these shares. The Sponsor paid an
aggregate of $25,000 for the Sponsor Shares and $6,575,000 for the Private Warrants. Such shares and warrants have an aggregate market value of approximately $83,605,000 and $24,919,250, respectively, based on the closing price of Kensington
Class&nbsp;A Common Stock and Public Warrants of $14.54 and $3.79, respectively, on the NYSE on October 19, 2020; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Justin Mirro, Kensington&#146;s Chief Executive Officer and Chairman is the managing member of the managing
member of the Sponsor. Consequently, he may be deemed the beneficial owner of the 5,750,000 Sponsor Shares and 6,575,000 Private Warrants and to have voting and dispositive control over such securities. Mr.&nbsp;Mirro disclaims beneficial ownership
of any securities other than to the extent he may have a pecuniary interest therein, directly or indirectly. Each of Kensington&#146;s other officers and directors are <FONT STYLE="white-space:nowrap">non-managing</FONT> members of the Sponsor;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Sponsor has made a loan of $75,000 to Kensington; the Sponsor has informed Kensington that the Sponsor
intends to convert the loan into 75,000 warrants on the same terms as the Private Warrants (as contemplated by the warrant agreement pursuant to which the Private Warrants were issued) at the same time the Business Combination is completed and for
such warrants to be issued to Justin Mirro, who had advanced such amount to the Sponsor in order for the loan to be made. Such warrants have an aggregate market value of approximately $284,250 based on the closing price of the Public Warrants of
$3.79 on the NYSE on October 19, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Sponsor and Kensington&#146;s directors and executive officers will not receive reimbursement for any <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by them on Kensington&#146;s behalf incident to identifying, investigating and completing a business combination to the extent such expenses
exceed the amount not required to be retained in the Trust Account, unless a business combination is consummated. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
As of September 30, 2020, the Sponsor and Kensington&#146;s directors and executive officers and their respective affiliates had incurred approximately $29,000 of such reimburseable out-of-pocket
expenses; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the anticipated continuation of Justin Mirro, Kensington&#146;s Chairman and Chief Executive Officer, as a
director of New QuantumScape following the Closing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">DEHC, an affiliate of Daniel Huber, Kensington&#146;s Chief Financial Officer and Secretary and Simon Boag,
Kensington&#146;s Chief Technology Officer, entered into services agreements with Kensington to provide administrative and other services as may be reasonably requested by Kensington for one year after the Closing in order to assist it in connection
with the post-closing integration of the New QuantumScape. In consideration of the agreements by DEHC and Mr. Boag to provide such services, Kensington agreed to pay each of them $240,000 at the Closing. The foregoing amounts are subject to
recoupment by Kensington in the event DEHC or Mr. Boag, as applicable, fails to satisfy its obligations under the agreements; and </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the continued indemnification of current directors and officers of Kensington and the continuation of
directors&#146; and officers&#146; liability insurance after the Business Combination. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_18"></A>Record Date and
Voting </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You will be entitled to vote or direct votes to be cast at the special meeting of stockholders if you owned shares of
Kensington Common Stock at the close of business on [&nbsp;&nbsp;&nbsp;&nbsp;], 2020, which is the record date for the special meeting of stockholders. You are entitled to one vote for each share of Kensington Common Stock that you owned as of the
close of business on the record date. If your shares are held in &#147;street name&#148; or are in a margin or similar account, you should contact your broker, bank or other nominee to ensure that votes related to the shares you beneficially own are
properly counted. On the record date, there were 28,750,000 shares of Kensington Common Stock outstanding, of which 23,000,000 are shares of Kensington Class&nbsp;A Common Stock and 5,750,000 are Sponsor Shares held by Kensington Initial
Stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sponsor has agreed to vote all of its Sponsor Shares and any Public Shares acquired by it in favor of the Business
Combination Proposal. Kensington&#146;s outstanding Kensington Warrants do not have voting rights at the special meeting of stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_19">
</A>Voting Your Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each share of Kensington Common Stock that you own in your name entitles you to one vote on each of the
proposals for the special meeting of stockholders. Your one or more proxy cards show the number of shares of Kensington Common Stock that you own. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you were a holder of record of Kensington Common Stock on [&nbsp;&nbsp;&nbsp;&nbsp;], 2020, the record date for the special meeting of
stockholders, you may vote with respect to the applicable proposals in any of the following ways, if available: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Vote by Mail</I>: by signing, dating and returning the enclosed proxy card in the accompanying postage-paid
envelope; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Vote by Internet</I>: visit http://www. [&nbsp;&nbsp;&nbsp;&nbsp;].com, 24 hours a day, seven days a week,
until 11:59 p.m. Eastern Time on [&nbsp;&nbsp;&nbsp;&nbsp;], 2020 (have your proxy card in hand when you visit the website); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Vote by Phone</I>: by calling toll-free (within the United States or Canada) [&nbsp;&nbsp;&nbsp;&nbsp;] (have
your proxy card in hand when you call); or </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Vote at the Special Meeting</I>: by attending the special meeting and voting in person. You will be given a
ballot when you arrive. However, if your shares of Kensington Common Stock are held in the name of </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
your broker, bank or other nominee, you must get a proxy from the broker, bank or other nominee. That is the only way we can be sure that the broker, bank or nominee has not already voted your
shares of Kensington Common Stock. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If your shares are held in &#147;street name&#148; through a broker, bank or other
nominee, your broker, bank or other nominee will send you separate instructions describing the procedure for voting your shares. Simply complete, sign and date your voting instruction card and return it in the postage-paid envelope provided to
ensure that your vote is counted. Alternatively, you may vote by telephone or over the internet as instructed by your broker, bank or other nominee. If you wish to attend the special meeting of stockholders and vote in person, you must obtain a
proxy from your broker, bank or nominee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you sign and return the proxy card but do not give instructions on how to vote your shares,
your shares of Kensington Common Stock will be voted as recommended by the Kensington Board. With respect to proposals for the special meeting of stockholders, that means: &#147;FOR&#148; the Business Combination Proposal, &#147;FOR&#148; the
Authorized Share Charter Proposal, &#147;FOR&#148; the Director Declassification Charter Proposal, &#147;FOR&#148; the Dual Class&nbsp;Charter Proposal, &#147;FOR&#148; the Additional Charter Proposal, &#147;FOR&#148; the Election of Directors
Proposal, &#147;FOR&#148; the Equity Incentive Plan Proposal, &#147;FOR&#148; the NYSE Proposal, &#147;FOR&#148; the Employee Stock Purchase Plan Proposal and &#147;FOR&#148; the Adjournment Proposal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_20"></A>Who Can Answer Your Questions About Voting Your Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you have any questions about how to vote or direct a vote in respect of your shares of Kensington Common Stock, you may contact D.F.
King&nbsp;&amp; Co., Inc., our proxy solicitor, toll-free at (877) <FONT STYLE="white-space:nowrap">478-5045</FONT> (banks and brokers call (212) <FONT STYLE="white-space:nowrap">269-5550)</FONT> or email at KCAC@dfking.com. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_21"></A>Quorum and Vote Required for the Kensington Proposals </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A quorum of Kensington&#146;s stockholders is necessary to hold a valid meeting. A quorum will be present at the special meeting of
stockholders if a majority of the Kensington Common Stock outstanding and entitled to vote at the meeting is represented in person or by proxy. Abstentions will count as present for the purposes of establishing a quorum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The approval of the Business Combination Proposal and the Charter Proposals require the affirmative vote (in person or by proxy) of the
holders of a majority of all outstanding shares of Kensington Common Stock entitled to vote thereon at the special meeting. Accordingly, a Kensington stockholder&#146;s failure to vote by proxy or to vote in person at the special meeting of
stockholders, an abstention from voting or a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will have the same effect as a vote against these proposals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The approval of the Equity Incentive Plan Proposal, NYSE Proposal, Employee Stock Purchase Plan Proposal and Adjournment Proposal require the
affirmative vote (in person or by proxy) of the holders of a majority of the shares of Kensington Common Stock that are voted at the special meeting of stockholders. Accordingly, a Kensington stockholder&#146;s failure to vote by proxy or to vote in
person at the special meeting of stockholders, an abstention from voting, or a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will have no effect on the outcome of any vote on these proposals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The approval of the election of each director nominee pursuant to the Election of Directors Proposal requires the affirmative vote of the
holders of a plurality of the outstanding shares of Common Stock entitled to vote and actually voted thereon at the special meeting. Accordingly, a Kensington stockholder&#146;s failure to vote by proxy or to vote in person at the special meeting of
stockholders, an abstention from voting, or a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will have no effect on the outcome of any vote on the Election of Directors Proposal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_22"></A>Abstentions and Broker <FONT STYLE="white-space:nowrap">Non-Votes</FONT>
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the rules of various national and regional securities exchanges, your broker, bank or nominee cannot vote your shares with
respect to <FONT STYLE="white-space:nowrap">non-discretionary</FONT> matters unless you provide instructions on how to vote in accordance with the information and procedures provided to you by your broker, bank or nominee. Kensington believes all of
the proposals presented to its stockholders at the special meeting will be considered <FONT STYLE="white-space:nowrap">non-discretionary</FONT> and, therefore, your broker, bank or nominee cannot vote your shares without your instruction. If you do
not provide instructions with your proxy, your bank, broker or other nominee may deliver a proxy card expressly indicating that it is NOT voting your shares; this indication that a bank, broker or nominee is not voting your shares is referred to as
a &#147;broker <FONT STYLE="white-space:nowrap">non-vote.&#148;</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abstentions and broker
<FONT STYLE="white-space:nowrap">non-votes</FONT> will be counted for purposes of determining the presence of a quorum at the special meeting of Kensington stockholders. For purposes of approval, an abstention or broker <FONT
STYLE="white-space:nowrap">non-vote</FONT> will have the same effect as a vote against each of the Business Combination Proposal and the Charter Proposals, and will have no effect on any of the other proposals. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_23"></A>Revocability of Proxies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you have submitted a proxy to vote your shares and wish to change your vote, you may do so by delivering a later-dated, signed proxy card to
Kensington&#146;s secretary, at 1400 Old Country Road, Suite 301, Westbury, NY 11590, prior to the date of the special meeting or by voting in person at the special meeting. Attendance at the special meeting alone will not change your vote. You also
may revoke your proxy by sending a notice of revocation to Kensington&#146;s secretary at the above address. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_24"></A>Redemption
Rights </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Existing Certificate of Incorporation, any holders of Public Shares may demand that such shares be redeemed
in exchange for a pro rata share of the aggregate amount then on deposit in the Trust Account, calculated as of two business days prior to the Closing, including interest earned on the funds held in the Trust Account and not previously released to
Kensington to pay Kensington&#146;s taxes, net of taxes payable, provided that such stockholders follow the specific procedures for redemption set forth in this proxy statement/prospectus/information statement relating to the stockholder vote on the
Business Combination. If demand is properly made and the Business Combination is consummated, these shares, immediately prior to the Closing, will cease to be outstanding and will represent only the right to receive a pro rata share of the aggregate
amount then on deposit in the Trust Account, calculated as of two business days prior to the Closing, including any amounts representing interest earned on the funds held in the Trust Account and not previously released to Kensington to pay
Kensington&#146;s taxes, net of taxes payable, upon the Closing. For illustrative purposes, based on funds in the Trust Account of $230&nbsp;million on June&nbsp;30, 2020, the per share redemption price would have been $10.00. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Redemption rights are not available to holders of Kensington Warrants in connection with the Business Combination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to exercise your redemption rights, you must, prior to 4:30&nbsp;p.m., Eastern time, on [&nbsp;&nbsp;&nbsp;&nbsp;], 2020 (two
business days before the special meeting), both: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Submit a request in writing that Kensington redeem your Public Shares for cash to Continental Stock
Transfer&nbsp;&amp; Trust Company, Kensington&#146;s transfer agent, at the following address: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Continental Stock
Transfer&nbsp;&amp; Trust Company </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">One State Street Plaza, 30<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>&nbsp;Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, NY 10004 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention:
Francis Wolf </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="white-space:nowrap">E-mail:</FONT> fwolf@continentalstock.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Deliver your Public Shares either physically or electronically through DTC to Kensington&#146;s transfer agent.
Stockholders seeking to exercise their redemption rights and opting to deliver physical certificates should allot sufficient time to obtain physical certificates from the transfer agent. It is Kensington&#146;s understanding that stockholders should
generally allot at least one week to obtain physical certificates from the transfer agent. However, Kensington does not have any control over this process and it may take longer than one week. Stockholders who hold their shares in street name will
have to coordinate with their bank, broker or other nominee to have the shares certificated or delivered electronically. If you do not submit a written request and deliver your Public Shares as described above, your shares will not be redeemed.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any demand for redemption, once made, may be withdrawn at any time until the deadline for exercising redemption
requests and thereafter, with Kensington&#146;s consent, until the vote is taken with respect to the Business Combination. If you delivered your shares for redemption to Kensington&#146;s transfer agent and decide within the required timeframe not
to exercise your redemption rights, you may request that Kensington&#146;s transfer agent return the shares (physically or electronically). You may make such request by contacting Kensington&#146;s transfer agent at the phone number or address
listed above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each redemption of Public Shares by the Public Stockholders will decrease the amount in the Trust Account. In no event,
however, will Kensington redeem Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001 upon the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to exercising redemption rights, stockholders should verify the market price of their Kensington Class&nbsp;A Common Stock as they may
receive higher proceeds from the sale of their Kensington Class&nbsp;A Common Stock in the public market than from exercising their redemption rights if the market price per share is higher than the redemption price. Kensington cannot assure you
that you will be able to sell your shares of Kensington Class&nbsp;A Common Stock in the open market, even if the market price per share is higher than the redemption price stated above, as there may not be sufficient liquidity in Kensington
Class&nbsp;A Common Stock when you wish to sell your shares. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you exercise your redemption rights, your shares of Kensington
Class&nbsp;A Common Stock will cease to be outstanding immediately prior to the Closing and will only represent the right to receive a pro rata share of the aggregate amount then on deposit in the Trust Account, calculated as of two business days
prior to the Closing, including interest earned on the funds held in the Trust Account and not previously released to Kensington to pay Kensington&#146;s taxes, net of taxes payable. You will no longer own those shares, and you will be entitled to
receive cash for those shares only if you properly demand redemption. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_25"></A>Appraisal or Dissenters&#146; Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No appraisal or dissenters&#146; rights are available to holders of shares of Kensington Common Stock or Kensington Warrants or holders of
QuantumScape Capital Stock in connection with the Business Combination, except to the extent available under the DGCL. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_26"></A>Solicitation of Proxies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington will pay the cost of soliciting proxies for the special meeting. Kensington has engaged D.F. King to assist in the solicitation of
proxies for the special meeting. Kensington has agreed to pay D.F. King a fee of $20,000. Kensington will reimburse D.F. King for reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses and
will indemnify D.F. King and its affiliates against certain claims, liabilities, losses, damages and expenses. Kensington also will reimburse banks, brokers and other custodians, nominees and fiduciaries representing beneficial owners of shares of
Kensington Common Stock for their expenses in forwarding soliciting materials to beneficial owners of Kensington Common Stock and in obtaining voting instructions from those owners. Kensington&#146;s directors, officers and employees may also
solicit proxies by telephone, by facsimile, by mail, on the Internet or in person. They will not be paid any additional amounts for soliciting proxies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_27"></A>Stock Ownership </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the record date, the Sponsor beneficially owns an aggregate of approximately 20% of the outstanding shares of Kensington Common Stock.
The Sponsor has agreed to vote all of its Sponsor Shares and any Public Shares acquired by it in favor of the Business Combination Proposal. As of the date of this proxy statement/prospectus/information statement, the Sponsor has not acquired any
Public Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_28"></A>PROPOSALS TO BE CONSIDERED BY KENSINGTON&#146;S STOCKHOLDERS
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL NO. 1&#151;THE BUSINESS COMBINATION PROPOSAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_29"></A>THE BUSINESS COMBINATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_30"></A>The Background of the Business Combination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms of the Business Combination Agreement are the result of <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> negotiations
between representatives of Kensington and QuantumScape. The following is a brief discussion of the background of these negotiations, the Business Combination Agreement and related transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington was formed for the purpose of effecting a combination, share exchange, asset acquisition, stock purchase, recapitalization,
reorganization or similar business combination with one or more businesses. While Kensington may pursue a business combination in any industry or geographic region, it intended to focus its search for a target business operating in the North America
automotive and automotive-related sector. Kensington believed there were 10,000 companies that met its criteria and had identified 313 target companies that it believed were larger than $500&nbsp;million in value. Of these 313 companies, Kensington
identified 63 targets that met one or more of its six acquisition criteria and prioritized 48 companies to initially approach. Kensington had identified the following six criteria that it believed would provide for attractive acquisition candidates
(i) a North America-based automotive business valued at greater than $1.0 billion, (ii) a business that benefits from emerging automotive technology, (iii) validated technical, commercial and financial capabilities based upon global automotive
standards, (iv) valuation supported by fundamental analysis of future profitability and comparable companies, (v) a world-class management team and board with expertise in leading and running public companies, and (vi) a business that could be
enhanced by Kensington&#146;s automotive industry expertise in order to accelerate commercial success. The entry into the Business Combination Agreement with QuantumScape is a result of an extensive search for a potential transaction from these 313
companies using the global network, automotive, investing and transaction experience of the Kensington Board and management team. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
June 2020, Kensington completed its IPO of 23,000,000 Kensington Units (including 3,000,000 Kensington Units sold upon the exercise in full of the underwriters&#146; over-allotment option), each Kensington Unit consisting of one share of Kensington
Class&nbsp;A Common Stock and <FONT STYLE="white-space:nowrap">one-half</FONT> of one redeemable Kensington Warrant, generating gross proceeds of $230&nbsp;million (before underwriting discounts and commissions and offering expenses). Simultaneously
with the closing of the IPO (including the exercise in full of the underwriters&#146; over-allotment option), Kensington completed a private placement of 6,575,000 Private Warrants issued to the Sponsor, generating total proceeds of
$6.6&nbsp;million. A total of $230&nbsp;million of the net proceeds from the IPO and the private placement were placed in the Trust Account. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except for a portion of the interest earned on the funds held in the Trust Account that may be released to us to pay taxes, none of the funds
held in the Trust Account will be released until the earlier of the consummation of our initial business combination and the redemption of 100% of our Public Shares if we are unable to consummate a business combination by June&nbsp;25, 2022 or
obtain the approval of Kensington stockholders to extend the deadline for us to consummate an initial business combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the
consummation of the IPO, neither Kensington, nor anyone on its behalf, contacted any prospective target business or had any substantive discussions, formal or otherwise, with respect to a transaction with Kensington. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After the IPO was consummated on June&nbsp;30, 2020, Kensington began contacting the 48 prioritized targets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;1, 2020, as part of Kensington&#146;s initial outreach to acquisition targets, Kensington&#146;s management team held an initial
videoconference with QuantumScape&#146;s management team to introduce the Kensington team </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to QuantumScape and to learn more about QuantumScape. Simon Boag, Kensington&#146;s Chief Technology Officer, initially identified QuantumScape as a business combination target that could
potentially achieve Kensington&#146;s six investment criteria identified above. Based upon this initial assessment, Mr. Boag arranged an introductory video call between Kensington and QuantumScape on July 1, 2020 where QuantumScape&#146;s management
team presented materials to Kensington and the team engaged in a discussion around QuantumScape&#146;s business. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;3,
2020, Kensington held its first <FONT STYLE="white-space:nowrap">post-IPO</FONT> weekly meeting via videoconference with its management team and the Kensington Board to provide an update on the acquisition process. At the meeting, the management
team and the Kensington Board discussed six potential acquisition candidates, including QuantumScape. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the week of July&nbsp;6,
2020, Kensington&#146;s Chairman and Chief Executive Officer, Justin Mirro, met <FONT STYLE="white-space:nowrap">in-person</FONT> with QuantumScape&#146;s Chief Executive Officer, Jagdeep Singh, and Chief Legal Officer and Head of Corporate
Development, Michael McCarthy, in Maryland to discuss a potential business combination, during which Mr.&nbsp;Mirro walked through the framework of a proposal for a business combination with Kensington. The original proposal ascribed an enterprise
value of $3.3 billion to the company, assumed there would be a $320 million PIPE, a single class of stock, and two to three board seats for the Kensington management team. The enterprise valuation was initially determined by reviewing
QuantumScape&#146;s summary financials and performing a comparable company analysis with NIO, Tesla, Inc. and Contemporary Amperex Technology Co., Limited (CATL). Kensington ultimately validated this valuation upon completion of further due
diligence of QuantumScape&#146;s technical, commercial and financial results. Kensington also determined that QuantumScape needed an additional $500 million of capital to fulfill its business plan (which resulted in the initial proposal for a $320
million PIPE that, together with cash in Kensington&#146;s trust account of $230 million, would provide $550 million of additional capital before deducting transaction fees and expenses). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;10, 2020, Kensington held its regularly scheduled weekly videoconference with its management team and the Kensington Board. At
the meeting, the management team and the Kensington Board discussed the status of the 48 potential acquisition targets, including the recent meeting with QuantumScape. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the week of July&nbsp;13, 2020, members of the management teams from Kensington and QuantumScape continued discussions around due
diligence and discussed the QuantumScape business plan. On July&nbsp;17, 2020, Kensington held its regularly scheduled videoconference with its management team and the Kensington Board to provide an update on the acquisition process. At the meeting,
the management team and the Kensington Board discussed the 48 potential acquisition targets, of which six acquisition targets were identified by management as &#147;active,&#148; 35 were identified by management as
<FONT STYLE="white-space:nowrap">&#147;in-process&#148;</FONT> and seven were identified by management as &#147;inactive.&#148; Of the six &#147;active&#148; candidates, there were three that were determined to be worth further exploring by
Kensington, including QuantumScape. After this meeting, Kensington sent <FONT STYLE="white-space:nowrap">non-binding</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">letters-of-intent</FONT></FONT> to these three targets,
including QuantumScape. The non-binding letter of intent sent to QuantumScape valued QuantumScape&#146;s equity at $3.6 billion. This equity value included the capital raise of at least $300 million in cash from the Series F Preferred Stock
financing. Kensington engaged in due diligence discussion directly with the three potential acquisition targets that received <FONT STYLE="white-space:nowrap">non-binding</FONT> letters of intent from Kensington. All three non-binding letters of
intent were sent to pre revenue companies with similar valuation in the electric vehicle segment of the automotive industry that met some or all of Kensington&#146;s six investment criteria. Kensington ultimately pursued only QuantumScape because
Kensington believed that QuantumScape was the only one to meet all six of Kensington&#146;s investment criteria and also demonstrated the most compelling business combination based upon its business prospects, technology leadership, strong and
visionary management team, large addressable market and growth potential into the foreseeable future. Kensington believes that QuantumScape&#146;s patented technology in solid-state lithium-metal batteries and partnership with Volkswagen positions
QuantumScape to capitalize on the automotive industry&#146;s expected shift to EVs. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;20, 2020, the Kensington management
team and its lawyers at Hughes Hubbard&nbsp;&amp; Reed LLP (&#147;Hughes Hubbard&#148;) had a call with the QuantumScape management team and QuantumScape&#146;s lawyers at </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Wilson Sonsini Goodrich&nbsp;&amp; Rosati, Professional Corporation (&#147;Wilson Sonsini&#148;) to discuss the proposed <FONT STYLE="white-space:nowrap">non-binding</FONT> letter of intent. </P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;21, 2020, the QuantumScape Board held a special board meeting via teleconference, with all members present, where
QuantumScape&#146;s fundraising activities to date were discussed. At this meeting, the QuantumScape Board also discussed the possibility of a business combination with Kensington. As part of this discussion, the QuantumScape Board discussed
alternatives to a business combination with Kensington with members of management and with representatives of Goldman Sachs &amp; Co. LLC (&#147;Goldman Sachs&#148;) in its role as exclusive financial advisor to QuantumScape. Goldman Sachs also
provided the QuantumScape Board with a comparison of the advantages and disadvantages of a potential business combination versus the potential for an initial public offering of QuantumScape&#146;s stock. The QuantumScape Board and members of
management and Goldman Sachs also discussed the potential strategic fit with Kensington and alternative SPAC partners. Finally, the QuantumScape Board discussed with members of management and Goldman Sachs the details of Kensington&#146;s
non-binding letter of intent, including the proposed valuation, timing and risk associated with a potential transaction. After this board meeting QuantumScape notified Kensington that they would accept Kensington&#146;s proposal only if it was
modified to include a &#147;dual-class&#148; structure, and only one board seat for Kensington management. The dual-class structure was required by QuantumScape&#146;s management and board. Kensington also accepted the single board seat
representation once Kensington became aware of the significant experience provided by the existing QuantumScape board members. After Kensington and QuantumScape reached agreement on the foregoing terms, the QuantumScape Board voted in favor of
entering into the letter of intent with Kensington and further pursuing discussions with Kensington to determine if a business combination and concurrent PIPE transaction was a viable alternative. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;21, 2020, Kensington and QuantumScape signed a <FONT STYLE="white-space:nowrap">non-binding</FONT> letter of intent. The letter
of intent contemplated a $320&nbsp;million PIPE and provided Kensington with exclusivity through August&nbsp;31, 2020. On the same day, lawyers from Hughes Hubbard and Wilson Sonsini had a call to discuss the timeline to complete the documentation
required for the transaction and Kensington&#146;s due diligence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the weeks from the execution of the letter of intent until the
approval of the Business Combination Agreement, the management teams of Kensington and QuantumScape met on a regular &#150; almost daily &#150; basis for the purposes of reviewing QuantumScape&#146;s technology and business and discussing the
contemplated business combination transaction. During this period, the parties also met with potential PIPE investors to review QuantumScape&#146;s business and address questions from potential investors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;24, 2020, Kensington held a meeting of its board, and the management team provided an update on the status of discussions with
QuantumScape and next steps in its diligence efforts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;28, 2020, Hughes Hubbard sent an initial draft of the proposed
Business Combination Agreement to QuantumScape. During the next several weeks, several drafts of the Business Combination Agreement and related documents (including the Stockholder Support Agreements, the Registration Rights and <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Agreement and the form of Subscription Agreement) were negotiated by the parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
July&nbsp;29, 2020 and July&nbsp;30, 2020, members of Kensington&#146;s management team and the Kensington Board met in person at QuantumScape&#146;s offices in San Jose, California to discuss the QuantumScape technology and related matters,
including the contemplated business combination transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;31, 2020, Kensington held its regularly-scheduled weekly
videoconference with its management team and the Kensington Board, and the management team provided an update on the status of discussion with, and diligence of, QuantumScape and discussed engaging financial advisors in the proposed PIPE
transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the week of August&nbsp;2, 2020, Kensington engaged UBS Securities LLC to provide financial advisory services and
assistance with the PIPE that would close at the same time as the business combination transaction </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with QuantumScape. Due to the successful initial public offering, Kensington engaged UBS to be joint-lead placement agent in its PIPE transaction given its knowledge of Kensington and its
investor base. Kensington agreed to pay UBS a fee of 1.75% of the amount raised in the PIPE and to reimburse it for reasonable out-of-pocket expenses in exchange for performing such services. Kensington also agreed to pay UBS a fee of $1,000,000
upon closing of the Business Combination with QuantumScape. UBS had been engaged as Kensington&#146;s lead advisor on its initial public offering due to its strong equity capital markets capabilities, dedicated SPAC effort and highly-ranked
automotive industry coverage team. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Due to Goldman Sachs&#146; knowledge of QuantumScape, Kensington hired Goldman Sachs to be joint-lead
placement agent with UBS on its PIPE. Kensington agreed to pay Goldman Sachs a fee of 1.75% of the amount raised in the PIPE and to reimburse it for reasonable out-of-pocket expenses in exchange for performing such services. Goldman Sachs had been
hired by QuantumScape to provide advice to its board in connection with the Business Combination. Goldman Sachs did not provide any advice to Kensington regarding the valuation or business combination terms with QuantumScape. However, Goldman Sachs
did advise QuantumScape in connection with the Business Combination. QuantumScape and Kensington each also signed a consent letter with Goldman Sachs acknowledging Goldman Sachs&#146; role as placement agent in connection with the PIPE, and as an
advisor to QuantumScape, and waiving any conflicts. During the same week that Kensington engaged UBS and Goldman Sachs, Kensington began negotiating confidentiality agreements with potential investors in the PIPE and conducting preliminary meetings
with them. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;7, 2020, the QuantumScape Board met via teleconference, with all members present to review with its
management the status of the contemplated business combination transaction with Kensington. As part of this meeting, the QuantumScape Board reviewed and approved the signing of an engagement letter with Goldman Sachs to act as an advisor to
QuantumScape in connection with the proposed business combination transaction. In connection with such approval, the QuantumScape Board was informed of Goldman Sachs&#146; role as placement agent to Kensington in connection with the PIPE. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On each of August&nbsp;7, 2020, August&nbsp;14, 2020, and August&nbsp;21, 2020, Kensington held its regularly-scheduled weekly videoconference
with its management team and the Kensington Board, and the management team provided an update on the status of discussions with, and diligence of, QuantumScape and the status of the PIPE and diligence-related matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;22, 2020, Kensington and QuantumScape agreed to amend the <FONT STYLE="white-space:nowrap">non-binding</FONT> <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">letter-of-intent</FONT></FONT> to extend the exclusivity period to September&nbsp;30, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;28, 2020, the Kensington Board met via videoconference, with all board members present. Also present were representatives of
Hughes Hubbard, who reviewed the terms of the Business Combination Agreement, Subscription Agreement and related documents with the Kensington Board. The Kensington Board also discussed the valuation ascribed to QuantumScape in the proposed
transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;1, 2020, the audit committee and compensation committee of the Kensington Board met, with all committee
members present, to consider the Service Agreements with DEHC, an affiliate of Daniel Huber, Kensington&#146;s Chief Financial Officer and Secretary, and Simon Boag, Kensington&#146;s Chief Technology Officer. At the meeting, the committees
discussed Kensington&#146;s need to coordinate with the members of the Kensington Board after completion of the Business Combination in order to provide the new board with access to Kensington&#146;s financial and strategic expertise in the auto
industry. Following the discussion, the committees approved the service agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, the QuantumScape Board met
via teleconference, with all board members present, to consider and discuss the proposed transaction with Kensington. Also present were representatives of Wilson Sonsini. Following a thorough review and discussion, the Business Combination Agreement
and related documents and agreements were unanimously approved by all QuantumScape Board members who voted on the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
matters, and the QuantumScape Board determined to recommend the approval of the Business Combination Agreement to QuantumScape&#146;s stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, the Kensington Board met via videoconference, with all board members present, as well as representatives of Hughes
Hubbard, to review the terms of the Business Combination Agreement, the form of the Subscription Agreement and related documents and changes that had been made since the prior board meeting. The final version of the Business Combination Agreement
did not include a maximum amount of redemptions as a condition to the obligation of QuantumScape to close the transaction, and included a requirement for QuantumScape to pay a termination fee of $82 million in order to, under certain circumstances,
terminate the Business Combination Agreement and accept a &#147;superior proposal.&#148; QuantumScape had originally requested the termination fee to be $50&nbsp;million. The Kensington Board also concluded that the fair market value of QuantumScape
was equal to at least 80% of the funds held in the Trust Account. In making such determination, the Kensington Board considered, among other things, the implied valuation of QuantumScape based on the market valuation of comparable companies (as
discussed below under &#147;&#151;<I>Kensington&#146;s Board of Directors&#146; Reasons for the Approval of the Business Combination&#151;Attractive Market Valuation of Comparable Companies</I>&#148;) the price to be paid by purchasers of
Series&nbsp;F Preferred Stock and the price to be paid by purchasers in the PIPE. The Kensington Board unanimously approved the Business Combination Agreement, the Subscription Agreement and related documents and agreements and recommended approval
of the Business Combination Agreement to Kensington&#146;s stockholders. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business Combination Agreement and related documents
and agreements were executed on September&nbsp;2, 2020. Prior to the market open on September&nbsp;3, 2020, Kensington and QuantumScape issued a joint press release announcing the execution of the Business Combination Agreement and Kensington filed
with the SEC a Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> announcing the execution of the Business Combination Agreement. On September&nbsp;3, 2020, representatives of Kensington and QuantumScape conducted an investor
conference call to announce the proposed Business Combination. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;15, 2020, the Kensington Board unanimously
re-confirmed its approval of the Business Combination Agreement and approved Amendment No. 1 to the Business Combination Agreement. Amendment No. 1 (i) provided the name of the surviving corporation in the merger contemplated by the Business
Combination Agreement will be as designated by QuantumScape prior to the Closing, and (ii) clarified certain of the events that will cause the automatic conversion of the New QuantumScape Class B Common Stock, which has 10 votes per share, into New
QuantumScape Class A Common Stock which has one vote per share. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;17, 2020, the QuantumScape Board unanimously <FONT
STYLE="white-space:nowrap">re-confirmed</FONT> its approval of the Business Combination Agreement and approved Amendment No.&nbsp;1 to the Business Combination Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Kensington&#146;s Board of Directors&#146; Reasons for the Approval of the Business Combination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As described under &#147;<I>The Background of the Business Combination</I>&#148; above, the Kensington Board, in evaluating the Business
Combination, consulted with Kensington&#146;s management and financial and legal advisors. In reaching its unanimous decision to approve the Business Combination Agreement and the Proposed Transactions, the Kensington Board considered a range of
factors, including, but not limited to, the factors discussed below. In light of the number and wide variety of factors considered in connection with its evaluation of the Business Combination, the Kensington Board did not consider it practicable
to, and did not attempt to, quantify or otherwise assign relative weights to the specific factors that it considered in reaching its determination and supporting its decision. The Kensington Board viewed its decision as being based on all of the
information available and the factors presented to and considered by it. In addition, individual directors may have given different weight to different factors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This explanation of Kensington&#146;s reasons for the Business Combination and all other information presented in this section is
forward-looking in nature and, therefore, should be read in light of the factors discussed under the section entitled &#147;<I>Cautionary Note Regarding Forward-Looking Statements</I>.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In approving the Business Combination, the Kensington Board determined not to obtain a
fairness opinion. The officers and directors of Kensington have substantial experience in evaluating the operating and financial merits of companies from a wide range of industries, including the automotive sector, and concluded that their
experience and background enabled them to make the necessary analyses and determinations regarding the Business Combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Kensington Board considered a number of factors pertaining to the Business Combination as generally supporting its decision to enter into the Business Combination Agreement and the transactions contemplated thereby, including, but not limited to,
the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Due Diligence.</I>&nbsp;Kensington&#146;s management and the Kensington Board conducted due diligence
examinations of QuantumScape and discussions with QuantumScape&#146;s management and Kensington&#146;s financial and legal advisors concerning Kensington&#146;s due diligence examination of QuantumScape; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Financial Condition.</I>&nbsp;Kensington&#146;s management and the Kensington Board considered factors such as
QuantumScape&#146;s outlook, financial plan, cash position, absence of indebtedness, customer contracts and capital expenditure plan (see the section entitled &#147;&#151;<I>Certain QuantumScape Projected Financial Information</I>&#148;);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Attractive Market Valuation of Comparable Companies.</I>&nbsp;The public trading market valuation of
comparable pure-play EV/component companies (consisting of NIO, Tesla, Inc. and Contemporary Amperex Technology Co., Limited (CATL), which we refer to collectively as the &#147;Comparable EV Companies&#148;) have expected 2021 enterprise
value/revenue multiples and enterprise value/EBITDA multiples (in each case based on market data as of August&nbsp;31, 2020) ranging from 6.5x to 13.4x (and a median of 6.9x) and 33.9x to 82.7x (and a median of 58.3x), respectively. The Kensington
Board believes that these multiples compare favorably to an initial market valuation of the post-Business Combination company reflected in the terms of the Business Combination corresponding to projected enterprise value/revenue multiples of 1.0x
and 0.5x in 2027 and 2028, respectively; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Experienced and Proven Management Team.</I>&nbsp;Kensington&#146;s management and the Kensington Board believe
that QuantumScape has a strong management team which is expected to remain with New QuantumScape to seek to execute the strategic and growth goals of the combined business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Other Alternatives.</I>&nbsp;The Kensington Board believes, after a thorough review of other business
combination opportunities reasonably available to Kensington, that the proposed Business Combination represents the best potential business combination for Kensington and the most attractive opportunity for Kensington based upon the process utilized
to evaluate and assess other potential combination targets, and the Kensington Board&#146;s belief that such process has not presented a better alternative; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Negotiated Transaction.</I>&nbsp;The financial and other terms of the Business Combination Agreement and the
fact that such terms and conditions are reasonable and were the product of arm&#146;s length negotiations between Kensington and QuantumScape. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Kensington Board also considered a variety of uncertainties and risks and other potentially negative factors concerning the Business
Combination including, but not limited to, the following: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Development Stage Company.</I>&nbsp;QuantumScape&#146;s status as a
<FONT STYLE="white-space:nowrap">pre-revenue</FONT> company, and the risk that it may not be able to execute on its business plan; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Macroeconomic Risks.</I>&nbsp;Macroeconomic uncertainty and the effects it could have on the revenues of the
combined business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Redemption Risk.</I>&nbsp;The potential that a significant number of Kensington stockholders elect to redeem
their shares prior to the consummation of the combination and pursuant to Kensington&#146;s existing charter, which would potentially make the combination more difficult or impossible to complete, and/or reduce the amount of cash available to the
combined business following the Closing; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Stockholder Vote and Written Consent.</I>&nbsp;The risk that Kensington&#146;s or QuantumScape&#146;s
stockholders may fail to provide the respective votes and written consents, respectively, necessary to effect the Business Combination; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Closing Conditions.</I>&nbsp;The fact that the Closing is conditioned on the satisfaction of certain closing
conditions that are not within Kensington&#146;s control; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Litigation.</I>&nbsp;The possibility of litigation challenging the Business Combination or that an adverse
judgment granting permanent injunctive relief could indefinitely enjoin the Closing; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Benefits May Not Be Achieved.</I>&nbsp;The risks that the potential benefits of the Business Combination may
not be fully achieved or may not be achieved within the expected timeframe; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>No Third</I>-<I>Party Valuation</I>.&nbsp;The risk that Kensington did not obtain a third-party valuation or
fairness opinion in connection with the Business Combination; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Kensington Stockholders Receiving a Minority Position.</I><I></I>&nbsp;The fact that Kensington stockholders
will hold a minority position in New QuantumScape; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Interests of Kensington&#146;s Directors and Officers.</I>&nbsp;The interests of the Kensington Board and
officers in the Business Combination (see &#147;&#151;<I>Interests of Kensington&#146;s Directors and Officers in the Business Combination</I>&#148;); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Other Risks Factors.</I>&nbsp;Various other risk factors associated with QuantumScape&#146;s business, as
described in the section entitled &#147;<I>Risk Factors</I>&#148; appearing elsewhere in this proxy statement/prospectus/information statement. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with analyzing the Business Combination, Kensington&#146;s management, based on its experience and judgment, selected the
Comparable EV Companies. Kensington&#146;s management selected these companies because they are publicly traded companies with certain operations, results, business mixes or size and scale that, for the purposes of analysis, may be considered
similar to certain operations, results, business mixes or size and scale of QuantumScape. None of the Comparable EV Companies is identical or directly comparable to QuantumScape. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with its analysis of the Business Combination, Kensington&#146;s management reviewed and compared, using publicly available
information, certain current, projected and historical financial information for QuantumScape corresponding to current and historical financial information, ratios and public market multiples for the Comparable EV Companies, as described above. </P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Kensington Board also considered the Business Combination in light of the investment criteria set forth in Kensington&#146;s final
prospectus for its IPO including, without limitation, that based upon Kensington&#146;s analyses and due diligence, QuantumScape has the potential to be a market leader and has substantial future growth opportunities, all of which the Kensington
Board believed have a strong potential to create meaningful stockholder value following the Closing. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The above discussion of the
material factors considered by the Kensington Board is not intended to be exhaustive but does set forth the principal factors considered by the Kensington Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_31"></A>Certain QuantumScape Projected Financial Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape provided Kensington with its internally prepared forecasts for each of the years in the seven-year period ending December&nbsp;31,
2028 (and assuming start of production of the QuantumScape solid-state batteries in 2024). Kensington&#146;s management reviewed the forecasts and presented key elements of the forecasts to the Kensington Board as part of the Kensington Board&#146;s
review and subsequent approval of the Business Combination. QuantumScape and Kensington do not, as a matter of general practice, publicly disclose long-term forecasts or internal projections of future performance, revenue, financial condition or
other results. However, in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
connection with the proposed Business Combination, Kensington&#146;s management used the financial forecasts set forth below as part of its comprehensive analysis. The forecasts were prepared
solely for internal use and not with a view toward public disclosure, the published guidelines of the SEC regarding projections or the guidelines established by the American Institute of Certified Public Accountants for preparation and presentation
of prospective financial information but, in the view of QuantumScape&#146;s management, was prepared on a reasonable basis, reflects the best currently available estimates and judgments, and presents, to the best of QuantumScape management&#146;s
knowledge and belief, the expected course of action and the expected future financial performance of QuantumScape. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The inclusion of
financial projections in this proxy<I> </I>statement/prospectus/information statement<I> </I>should not be regarded as an indication that Kensington, QuantumScape, their respective directors, officers, advisors or other representatives considered,
or now considers, such financial projections necessarily to be predictive of actual future results or to support or fail to support your decision whether to vote for or against the Business Combination Proposal. The financial projections are not
fact and should not be relied upon as being necessarily indicative of future results, and readers of this proxy<I> </I>statement/prospectus/information statement, including investors or stockholders, are cautioned not to place undue reliance on this
information. You are cautioned not to rely on the projections in making a decision regarding the Business Combination, as the projections may be materially different than actual results. We will not refer back to the financial projections in our
future periodic reports filed under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial projections reflect numerous estimates and assumptions with respect
to general business, economic, regulatory, market and financial conditions and other future events, as well as matters specific to QuantumScape&#146;s business, all of which are difficult to predict and many of which are beyond QuantumScape&#146;s
and Kensington&#146;s control. The financial projections are forward-looking statements that are inherently subject to significant uncertainties and contingencies, many of which are beyond QuantumScape&#146;s control, including those described or
incorporated by reference in the sections entitled &#147;<I>Risk Factors</I>,&#148; &#147;<I>QuantumScape</I> <I>Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations</I>&#148; and &#147;<I>Cautionary Note
Regarding Forward-Looking Statements</I>.&#148; As a result, there can be no assurance that the projected results will be realized or that actual results will not be significantly higher or lower than projected. Since the financial projections cover
multiple years, such information by its nature becomes less reliable with each successive year. These financial projections are subjective in many respects and thus are susceptible to multiple interpretations and periodic revisions based on actual
experience and business developments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, the financial projections do not take into account any circumstances or events
occurring after the date they were prepared. None of QuantumScape&#146;s independent registered public accounting firm, Kensington&#146;s independent registered accounting firm or any other independent accountants, have compiled, examined or
performed any procedures with respect to the financial projections included below, nor have they expressed any opinion or any other form of assurance on such information or their accuracy or achievability, and they assume no responsibility for, and
disclaim any association with, the financial projections. Nonetheless, a summary of the financial projections is provided in this proxy<I> </I>statement/prospectus/information statement<I> </I>because they were made available to Kensington and the
Kensington Board in connection with their review of the proposed Business Combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">EXCEPT TO THE EXTENT REQUIRED BY APPLICABLE
FEDERAL SECURITIES LAWS, BY INCLUDING IN THIS PROXY STATEMENT/PROSPECTUS/INFORMATION STATEMENT A SUMMARY OF THE FINANCIAL PROJECTIONS FOR QUANTUMSCAPE, KENSINGTON UNDERTAKES NO OBLIGATIONS AND EXPRESSLY DISCLAIMS ANY RESPONSIBILITY TO UPDATE OR
REVISE, OR PUBLICLY DISCLOSE ANY UPDATE OR REVISION TO, THESE FINANCIAL PROJECTIONS TO REFLECT CIRCUMSTANCES OR EVENTS, INCLUDING UNANTICIPATED EVENTS, THAT MAY HAVE OCCURRED OR THAT MAY OCCUR AFTER THE PREPARATION OF THESE FINANCIAL PROJECTIONS,
EVEN IN THE EVENT THAT ANY OR ALL OF THE ASSUMPTIONS UNDERLYING THE FINANCIAL PROJECTIONS ARE SHOWN TO BE IN ERROR OR CHANGE </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The projections were prepared by, and are the responsibility of, QuantumScape. Neither
Ernst&nbsp;&amp; Young LLP, QuantumScape&#146;s independent registered public accounting firm, nor Marcum LLP, Kensington&#146;s independent auditor, have examined, compiled or otherwise applied procedures with respect to the accompanying
prospective financial information presented herein and, accordingly, express no opinion or any other form of assurance on it or its achievability, and assume no responsibility for, and disclaim any association with, the prospective financial
information. The Ernst&nbsp;&amp; Young report included in this proxy<I> </I>statement/prospectus/information statement relates to historical financial information of QuantumScape. It does not extend to the projections and should not be read as if
it does. The key elements of the forecasts provided by Kensington&#146;s management to the Kensington Board, which assumes that QuantumScape&#146;s initial 1GWh pilot facility (the &#147;Pilot Facility,&#148; and also referred to as the
&#147;QS-1&#148;) production commences in 2024, are summarized in the tables below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="26" ALIGN="center">Forecast</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="26" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Year Ended December&nbsp;31,</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2022</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2023</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2024</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2025</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2026</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2027</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2028</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="26" ALIGN="center">(in millions)</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Revenue <SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,210</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,439</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EBITDA <SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(102</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(114</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(130</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(120</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(59</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">808</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,622</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EBITDA % <SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">nm</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">nm</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">nm</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">nm</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">nm</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Free Cash Flow <SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(137</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(222</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(691</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,346</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(533</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">563</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Free Cash Flow assuming no capacity expansion after <FONT STYLE="white-space:nowrap">QS-1</FONT>
Expansion (20 GWh) <SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(137</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(169</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(222</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(312</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(289</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Revenue includes margin for sale of separator to QSV Operations LLC. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">QuantumScape defines EBITDA as net income (loss), before interest expense, income tax provision (benefits),
depreciation and amortization expense. EBITDA is not a financial measure prepared in accordance with GAAP and should not be considered a substitute for the net income (loss) prepared in accordance with GAAP. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">QuantumScape defines EBITDA % as EBITDA divided by total revenue. EBITDA % is not a financial measure prepared
in accordance with GAAP and should not be considered a substitute for the net income (loss) margin prepared in accordance with GAAP. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">QuantumScape defines free cash flow as cash provided by operating activities less payments for capital
expenditures net of asset financing. Free cash flow is not a financial measure prepared in accordance with GAAP and should not be considered a substitute for cash flow from operations prepared in accordance with GAAP. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">QuantumScape forecasts free cash flow assuming no additional capacity expansion after the 20GWh Expansion
Facility. Free cash flow is not a financial measure prepared in accordance with GAAP and should not be considered a substitute for cash flow from operations prepared in accordance with GAAP. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other <FONT STYLE="white-space:nowrap">Non-Financial</FONT> Metrics: </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="26" ALIGN="center">Forecast</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="26" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Year Ended December&nbsp;31,</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2022</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2023</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2024</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2025</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2026</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2027</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2028</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">QS-1</FONT> Pilot Facility (1GWh)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">QS-1</FONT> Expansion Facility (20 GWh)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">QS-2</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Production capacity (GWh)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The projections above assume that the Pilot Facility and 20GWh expansion of the Pilot Facility (the
&#147;20GWh Expansion Facility&#148;) will be owned and operated by the joint venture between QuantumScape and Volkswagen, that QuantumScape will separately own and operate the QS-1 separator factory, and that
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
QuantumScape will separately own and operate a second manufacturing facility (&#147;QS-2&#148;). The forecast also assumes that selling prices and costs will decline by 5% per year and that debt
financing will be supported by offtake agreements with investment grade partners for the output of the 20GWh Expansion Facility and QS-2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The factory economics incorporated in the projections include the standalone financial forecast for the 20GWh Expansion Facility provided
below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>QuantumScape Factory Economics (QS-1, 20GWh) </B></P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g14810g12e25.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Note: Assumes 5% annual price and cost declines. Chart reflects 100% of factory financials. </I></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>(1)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Includes costs for planning, FAT/SAT, and start-up; excludes maintenance, capex, and interest expense.
</I></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>(2)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Assumes debt financing for the remainder; debt financing net of amortization. </I></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>(3)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Periods -4 to 9 reflect the years 2022 to 2035. </I></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The projections assume that development and manufacturing scale-up proceed on the following timeline. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Manufacturing Scale-Up Timeline </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g14810g68e14.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Forecast revenue is based on a variety of operational assumptions, including the number of battery
cells sold and the average sales price. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other key assumptions impacting the forecast include projected cost of material and
manufacturing, research and development, selling, general and administrative expenses, capital expenditures and asset financing, among others. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_32">
</A>Interests of Kensington&#146;s Directors and Officers in the Business Combination </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When you consider the recommendation of the
Kensington Board in favor of approval of the Business Combination Proposal, you should keep in mind that certain of Kensington&#146;s directors and officers have interests in the Business Combination that are different from, or in addition to, your
interests as a stockholder or warrant holder. These interests include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the beneficial ownership of the Sponsor of an aggregate of 5,750,000 Sponsor Shares and 6,575,000 Private
Warrants, which shares and warrants would become worthless if Kensington does not complete a business combination within the applicable time period, as the Sponsor has waived any right to redemption with respect to these shares. The Sponsor paid an
aggregate of $25,000 for the Sponsor Shares and $6,575,000 for the Private Warrants. Such shares and warrants have an aggregate market value of approximately $83,605,000 and $24,919,250, respectively, based on the closing price of Kensington
Class&nbsp;A Common Stock and Public Warrants of $14.54 and $3.79, respectively, on the NYSE on October 19, 2020; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Justin Mirro, Kensington&#146;s Chief Executive Officer and Chairman is the managing member of the managing
member of the Sponsor. Consequently, he may be deemed the beneficial owner of the 5,750,000 Sponsor Shares and 6,575,000 Private Warrants and to have voting and dispositive control over such securities. Mr.&nbsp;Mirro disclaims beneficial ownership
of any securities other than to the extent he may have a pecuniary interest therein, directly or indirectly. Each of Kensington&#146;s other officers and directors are <FONT STYLE="white-space:nowrap">non-managing</FONT> members of the Sponsor;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Sponsor has made a loan of $75,000 to Kensington; the Sponsor has informed Kensington that the Sponsor
intends to convert the loan into 75,000 warrants on the same terms as the Private Warrants (as contemplated by the warrant agreement pursuant to which the Private Warrants were issued) at the same time the Business Combination is completed and for
such warrants to be issued to Justin Mirro, who had advanced such amount to the Sponsor in order for the loan to be made. Such warrants have an aggregate market value of approximately $284,250 based on the closing price of Kensington Class A Common
Stock and Public Warrants of $14.54 and $3.79, respectively, on the NYSE on October 19, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Sponsor and Kensington&#146;s directors and executive officers will not receive reimbursement for any <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by them on Kensington&#146;s behalf incident to identifying, investigating and completing a business combination to the extent such expenses
exceed the amount not required to be retained in the Trust Account, unless a business combination is consummated. As of September 30, 2020, the Sponsor and Kensington&#146;s directors and executive officers and their respective affiliates had
incurred approximately $29,000 of such reimburseable out-of-pocket expenses; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the anticipated continuation of Justin Mirro, Kensington&#146;s Chairman and Chief Executive Officer, as a
director of New QuantumScape following the Closing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">DEHC, an affiliate of Daniel Huber, Kensington&#146;s Chief Financial Officer and Secretary, entered into a
services agreement with Kensington pursuant to which, among other things, DEHC agreed to provide such administrative and other services of Mr.&nbsp;Huber as may be reasonably requested by Kensington for one year after the closing of the Proposed
Transaction in order to assist it in connection with the post-closing integration of New QuantumScape. Such services will (without limitation) include the provision of auto industry expertise and coordination of access to Kensington&#146;s former
directors. DEHC also agreed not to compete with New QuantumScape during the <FONT STYLE="white-space:nowrap">one-year</FONT> term of the agreement. In consideration of the agreement by DEHC to provide such services, Kensington agreed to pay DEHC
$240,000 at the Closing. The foregoing amount is subject to recoupment by Kensington in the event DEHC fails to satisfy its obligations under the agreement; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Simon Boag, Kensington&#146;s Chief Technology Officer, entered into a services agreement with Kensington
pursuant to which, among other things, Mr.&nbsp;Boag agreed to provide such administrative and other services as may be reasonably requested by Kensington for one year after the Closing in order to assist it in connection with the post-closing
integration of New QuantumScape. Such services will (without limitation) include the provision of auto industry expertise and coordination of access to Kensington former directors. Mr.&nbsp;Boag also agreed not to compete with New QuantumScape
during the <FONT STYLE="white-space:nowrap">one-year</FONT> term of the agreement. In consideration of the agreement by Mr.&nbsp;Boag to provide such services, Kensington agreed to pay him $240,000 at the Closing. The foregoing amount is subject to
recoupment by Kensington in the event Mr.&nbsp;Boag fails to satisfy his obligations under the agreement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the continued indemnification of current directors and officers of Kensington and the continuation of
directors&#146; and officers&#146; liability insurance after the Business Combination. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_33"></A>Interests of
QuantumScape&#146;s Directors and Officers in the Business Combination </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When you consider the recommendation of QuantumScape&#146;s
Board in favor of approval of the Business Combination Proposal, you should keep in mind that certain of QuantumScape&#146;s directors and officers have interests in the Business Combination that are different from, or in addition to, those of
QuantumScape&#146;s stockholders. The QuantumScape Board was aware of such interests during its deliberations on the merits of the Business Combination Proposal and in deciding to recommend that QuantumScape stockholders submit written consents in
favor of the Business Combination Proposal. These interests include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Certain of QuantumScape&#146;s directors and executive officers are expected to become directors and/or executive
officers of New QuantumScape upon the Closing. Specifically, the following individuals who are currently executive officers of QuantumScape are expected to become executive officers of New QuantumScape upon the Closing, serving in the offices set
forth opposite their names below. </P></TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Position</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jagdeep Singh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer and Chairman</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin Hettrich</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Timothy Holme</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Technology Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Mohit Singh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Development Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Howard Lukens</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Sales Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael McCarthy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Legal Officer and Head of Corporate Development</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In addition, the following individuals who are currently directors of QuantumScape are expected to become
directors of New QuantumScape upon the Closing: Jagdeep Singh, Prof. Fritz Prinz, Frank Blome, Brad Buss, John Doerr, Prof. Dr.&nbsp;J&uuml;rgen Leohold, Dipender Saluja and J.B. Straubel. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Certain of QuantumScape&#146;s executive officers and <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors hold restricted stock units and/or options to purchase shares of QuantumScape Class&nbsp;A Common Stock or QuantumScape Class&nbsp;B Common Stock, which will be assumed by Kensington upon the Closing. The treatment of such equity awards in
connection with the Business Combination is described in the section entitled &#147;<I>The Business Combination Agreement&#151;Conversion of Securities</I>,&#148; which description is incorporated by reference herein. The ownership of such awards by
QuantumScape&#146;s executive officers and <FONT STYLE="white-space:nowrap">non-employee</FONT> directors as of September 13, 2020, is set forth in the table below. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vested&nbsp;Stock<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unvested&nbsp;Stock<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Restricted&nbsp;Stock<BR>Units</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B></B><B><I>Named Executive Officers</I></B><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jagdeep Singh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,501,751</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">235,652</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Howard Lukens</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">954,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">127,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael McCarthy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">696,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">127,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>All Other Executive Officers as a Group</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,609,083</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">264,917</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B></B><B><I>Non-Employee Directors</I></B><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Frank Blome</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brad Buss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Doerr</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prof. Dr.&nbsp;J&#252;rgen Leohold</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">146,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prof. Fritz Prinz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dipender Saluja</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.B. Straubel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vinod Khosla</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Certain of QuantumScape&#146;s executive officers hold shares of QuantumScape Capital Stock, the treatment of
which is described in the section entitled &#147;<I>The Business Combination Agreement</I>,&#148; which description is incorporated herein by reference. Jagdeep Singh owns 419,118 shares of QuantumScape Class A Common Stock, 2,914,215 shares of
QuantumScape Class B Common Stock and 1,037,192 shares of QuantumScape Preferred Stock. Kevin Hettrich owns 33,939 shares of QuantumScape Class&nbsp;A Common Stock and 105,000 shares of QuantumScape Class&nbsp;B Common Stock. Dr.&nbsp;Timothy Holme
owns 3,353,016 shares of QuantumScape Class&nbsp;B Common Stock. Howard Lukens owns 190,000 shares of QuantumScape Class&nbsp;B Common Stock. Michael McCarthy owns 204,000 shares of QuantumScape Class&nbsp;B Common Stock. Dr.&nbsp;Mohit Singh holds
no shares of QuantumScape Capital Stock. </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The following <FONT STYLE="white-space:nowrap">non-employee</FONT> directors of QuantumScape have a direct or
indirect ownership interest in QuantumScape Capital Stock: Frank Blome, Brad Buss, John Doerr, Prof. Dr.&nbsp;J&uuml;rgen Leohold, Prof. Fritz Prinz, Dipender Saluja, Vinod Khosla and J.B. Straubel. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_34"></A>Potential Actions to Secure Requisite Stockholder Approvals </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the stockholder vote to approve the Business Combination, the Sponsor and Kensington&#146;s directors, officers, advisors or
their affiliates may privately negotiate transactions to purchase shares of Kensington Class&nbsp;A Common Stock from stockholders who would have otherwise elected to have their shares redeemed in conjunction with the Business Combination for a per
share pro rata portion of the Trust Account. None of the Sponsor or Kensington&#146;s directors, officers, advisors or their affiliates will make any such purchases when they are in possession of any material
<FONT STYLE="white-space:nowrap">non-public</FONT> information not disclosed to the seller of such shares. Such a purchase of shares may include a contractual acknowledgement that such stockholder, although still the record holder of the shares of
Kensington Class&nbsp;A Common Stock is no longer the beneficial owner thereof and therefore agrees not to exercise his, her or its redemption rights. In the event that the Sponsor or Kensington&#146;s directors, officers, advisors or their
affiliates purchase shares in privately negotiated transactions from Public Stockholders who have already elected to exercise their redemption rights, such selling stockholders would be required to revoke their prior elections to redeem their
shares. Any such privately negotiated purchases may be effected at </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purchase prices that are in excess of the per share pro rata portion of the Trust Account. The purpose of these purchases would be to increase the amount of cash available to Kensington for use
in the Business Combination. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_35"></A>Regulatory Approvals Required for the Business Combination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the HSR Act and related rules, certain transactions, including the Business Combination, may not be completed until notifications have
been given and information is furnished to the Antitrust Division of the DOJ and the FTC and all statutory waiting period requirements have been satisfied. The Closing is subject to the expiration or earlier termination of the applicable waiting
period under the HSR Act. On September 30, 2020, Kensington filed a Premerger Notification and Report Form pursuant to the HSR Act with the DOJ and FTC and requested early termination of the waiting period under the HSR Act. On October 14, the FTC
granted early termination of the waiting period under the HSR Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time before or after the expiration of the statutory waiting
periods under the HSR Act, the Antitrust Division of the DOJ and the FTC may take action under the antitrust laws, including seeking to enjoin the Closing, to rescind the Business Combination or to conditionally permit the Closing subject to
regulatory conditions or other remedies. In addition, <FONT STYLE="white-space:nowrap">non-U.S.</FONT> regulatory bodies and U.S. state attorneys general could take action under other applicable regulatory laws as they deem necessary or desirable in
the public interest, including, without limitation, seeking to enjoin or otherwise prevent the Closing or permitting consummation subject to regulatory conditions. Private parties may also seek to take legal action under regulatory laws under some
circumstances. There can be no assurance that a challenge to the Business Combination on antitrust grounds will not be made or, if such a challenge is made, that it would not be successful. Kensington and QuantumScape are not aware of any other
regulatory approvals in the United States required for the Closing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Litigation Relating to the Business Combination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October 2, 2020, a putative class action lawsuit was filed in the Supreme Court of the State of New York by a purported Kensington
stockholder in connection with the Business Combination: Sanchez v. Kensington Capital Acquisition Corp., et al., Index No. 654941/2020 (Sup. Ct. N.Y. Cnty.). The complaint names Kensington and certain current and former members of the Kensington
Board as defendants. The complaint alleges, among other things, breach of fiduciary duty claims against the Kensington Board in connection with the Business Combination. The complaint also alleges that this proxy statement/prospectus/information
statement is misleading and/or omits material information concerning the Business Combination. The complaint generally seeks, among other things, injunctive relief and an award of attorneys&#146; fees. Additionally, on October 12, 2020, Kensington
received a letter from attorneys representing a different purported Kensington stockholder demanding certain &#147;corrective disclosures&#148; be made in this proxy statement/prospectus/information statement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_36"></A>Accounting Treatment of the Business Combination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business Combination will be accounted for as a reverse recapitalization in accordance with GAAP. Under this method of accounting,
Kensington will be treated as the acquired company and QuantumScape will be treated as the acquirer for financial statement reporting purposes. QuantumScape has been determined to be the accounting acquirer based on evaluation of the following facts
and circumstances: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s existing stockholders will have the greatest voting interest in New QuantumScape under the no
redemption and maximum redemption scenarios with over 95% of the voting interest in each scenario; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s directors will represent the majority of the members on the New QuantumScape Board;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape&#146;s senior management will be the senior management of New QuantumScape; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape is the larger entity based on historical operating activity and has the larger employee base.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">106 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_37"></A>THE BUSINESS COMBINATION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following is a summary of the material terms of the Business Combination Agreement. A copy of the Business Combination Agreement is
attached as Annex&nbsp;A to this proxy statement/prospectus/information statement and is incorporated by reference into this proxy statement/prospectus/information statement. The Business Combination Agreement has been attached to this proxy
statement/prospectus/information statement to provide you with information regarding its terms. It is not intended to provide any other factual information about Kensington, QuantumScape or Merger Sub. The following description does not purport to
be complete and is qualified in its entirety by reference to the Business Combination Agreement. You should refer to the full text of the Business Combination Agreement for details of the Business Combination and the terms and conditions of the
Business Combination Agreement. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The Business Combination Agreement contains representations and warranties that Kensington and
Merger Sub, on the one hand, and QuantumScape, on the other hand, have made to one another as of specific dates. These representations and warranties have been made for the benefit of the other parties to the Business Combination Agreement and may
be intended not as statements of fact but rather as a way of allocating the risk to one of the parties if those statements prove to be incorrect. In addition, the assertions embodied in the representations and warranties are qualified by information
in confidential disclosure schedules exchanged by the parties in connection with signing the Business Combination Agreement. While Kensington and QuantumScape do not believe that these disclosure schedules contain information required to be publicly
disclosed under the applicable securities laws, other than information that has already been so disclosed, the disclosure schedules do contain information that modifies, qualifies and creates exceptions to the representations and warranties set
forth in the attached Business Combination Agreement. Accordingly, you should not rely on the representations and warranties as current characterizations of factual information about Kensington, Merger Sub or QuantumScape, because they were made as
of specific dates, may be intended merely as a risk allocation mechanism between Kensington and QuantumScape and are modified by the disclosure schedules. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General; Structure of the Business Combination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Kensington, Merger Sub and QuantumScape entered into the Business Combination Agreement, pursuant to which
Kensington and QuantumScape will enter into the Business Combination. The terms of the Business Combination Agreement, which contains customary representations and warranties, covenants, closing conditions, termination fee provisions and other terms
relating to the Merger and the other transactions contemplated thereby, are summarized below. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Merger is to become effective by
the filing of a certificate of merger with the Secretary of State of the State of Delaware and will be effective at the Effective Time. The parties will hold the Closing immediately prior to such filing of a certificate of merger, on the Closing
Date to be specified by Kensington and QuantumScape, as promptly as practicable following the satisfaction or waiver (to the extent such waiver is permitted by applicable law) of the conditions set forth in the Business Combination Agreement (other
than those conditions that by their nature are to be satisfied at Closing, but subject to the satisfaction or waiver of those conditions at such time), but in no event later than the third business day after the satisfaction or waiver, if legally
permissible, of each of the conditions to the Closing (or on such other date, time or place as Kensington and QuantumScape may mutually agree). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conversion of Securities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the
Effective Time, by virtue of the Merger and without any action on the part of Kensington, Merger Sub, QuantumScape or the holders of any of QuantumScape&#146;s securities: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each share of QuantumScape Class&nbsp;A Common Stock, together with each share of QuantumScape Class&nbsp;A
Preferred Stock that is outstanding immediately prior to the Effective Time and convertible </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">107 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
into a share of QuantumScape Class&nbsp;A Common Stock pursuant to the provisions of QuantumScape&#146;s certificate of incorporation, will be cancelled and converted into the right to receive
the number of shares of New QuantumScape Class&nbsp;A Common Stock equal to the Exchange Ratio (as described below), with each holder&#146;s shares rounded down to the nearest whole number; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each share of QuantumScape Class&nbsp;B Common Stock, together with and each share of QuantumScape Class&nbsp;B
Preferred Stock that is outstanding immediately prior to the Effective Time and convertible into a share of QuantumScape Class&nbsp;B Common Stock pursuant to the provisions of QuantumScape&#146;s certificate of incorporation, will be cancelled and
converted into the right to receive the number of shares of New QuantumScape Class&nbsp;B Common Stock equal to the Exchange Ratio (as described below), with each holder&#146;s shares rounded down to the nearest whole number; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all shares of QuantumScape Capital Stock held in the treasury of QuantumScape will be cancelled without any
conversion thereof and no payment or distribution will be made with respect thereto; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each share of Merger Sub Common Stock outstanding immediately prior to the Effective Time will be converted into
and exchanged for one validly issued, fully paid and nonassessable share of common stock, par value $0.01 per share, of the Surviving Corporation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each QuantumScape Option that is outstanding immediately prior to the Effective Time, whether vested or unvested,
will be converted into an Exchanged Option of the applicable class that the <FONT STYLE="white-space:nowrap">pre-conversion</FONT> QuantumScape Option covered, equal to the product (rounded down to the nearest whole number) of (i)&nbsp;the number of
shares of QuantumScape Common Stock subject to such QuantumScape Option immediately prior to the Effective Time multiplied by (ii)&nbsp;the Exchange Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A)&nbsp;the
exercise price per share of such QuantumScape Option immediately prior to the Effective Time divided by (B)&nbsp;the Exchange Ratio. Except as specifically provided in the Business Combination Agreement, following the Effective Time, each Exchanged
Option will continue to be governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former QuantumScape Option immediately prior to the Effective Time; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each share of QuantumScape Restricted Stock that is outstanding immediately prior to the Effective Time shall be
converted into Exchanged Restricted Stock of the applicable class that the <FONT STYLE="white-space:nowrap">pre-conversion</FONT> QuantumScape Restricted Stock covered equal to the product (rounded down to the nearest whole number) of (i)&nbsp;the
number of shares of QuantumScape Restricted Stock immediately prior to the Effective Time and (ii)&nbsp;the Exchange Ratio. Except as specifically provided in the Business Combination Agreement, following the Effective Time, each Exchanged
Restricted Stock shall continue to be governed by the same terms and conditions (including transfer restrictions and repurchase right terms) as were applicable to the corresponding former QuantumScape Restricted Stock immediately prior to the
Effective Time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each QuantumScape RSU that is outstanding immediately prior to the Effective Time shall be converted into
Exchanged RSUs of the applicable class that the <FONT STYLE="white-space:nowrap">pre-conversion</FONT> QuantumScape RSU covers equal to the product (rounded down to the nearest whole number) of (x)&nbsp;the number of shares subject to a QuantumScape
RSU immediately prior to the Effective Time and (y)&nbsp;the Exchange Ratio. Except as specifically provided in the Business Combination Agreement, following the Effective Time, each Exchanged RSU shall continue to be governed by the same terms and
conditions (including transfer restrictions and repurchase right terms) as were applicable to the corresponding former QuantumScape RSUs immediately prior to the Effective Time; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the obligation to purchase shares of Series F Preferred Stock upon satisfaction of certain milestones, if still
outstanding, will become an obligation to purchase, upon satisfaction of the milestones, shares of New QuantumScape Class&nbsp;A Common Stock equal in number to the shares of New QuantumScape Class A Common Stock that would have been issued in the
Merger in exchange for such shares of Series F Preferred Stock if such shares of Series F Preferred Stock had been outstanding prior to the Merger; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">108 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each QuantumScape Warrant that is outstanding immediately prior to the Effective Time shall be converted into an
Exchanged Warrant equal to the product (rounded down to the nearest whole number) of (x)&nbsp;the number of shares of such class of QuantumScape Common Stock subject to such QuantumScape Warrant immediately prior to the Effective Time and
(y)&nbsp;the Exchange Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A)&nbsp;the exercise price per share of such QuantumScape Warrant immediately prior to the Effective Time divided by (B)&nbsp;the Exchange
Ratio. Except as specifically provided in the Business Combination Agreement, following the Effective Time, each Exchanged Warrant shall continue to be governed by the same terms and conditions (including vesting and exercisability terms) as were
applicable to the corresponding former QuantumScape Warrant immediately prior to the Effective Time. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The &#147;Exchange
Ratio&#148; is defined in the Business Combination Agreement as a quotient that is calculated on the basis of: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(i) the &#147;Target Share
Amount,&#148; which means an amount equal to (a) 360,000,000, plus or minus (b)&nbsp;the quotient obtained by dividing (x)&nbsp;the amount, if any, by which the Series F Subscription Amount is greater than or less than, as applicable, $300,000,000,
by (y) $10. As of the date of the initial signing of the Business Combination Agreement, the Target Share Amount was equal to 368,799,998; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">divided by </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ii)
QuantumScape&#146;s &#147;Fully-Diluted Company Shares&#148; (with such &#147;Fully-Diluted Company Shares&#148; being, as of the date of initial signing of the Business Combination Agreement, equal to 92,125,870). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the date of the initial signing of the Business Combination Agreement, the Exchange Ratio was 4.0032186234. The Exchange Ratio will be finally
calculated in accordance with the methodology and procedures set forth in the Business Combination Agreement, and Kensington will file with the SEC a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> announcing the final Exchange
Ratio no later than four business days prior to the special meeting of its stockholders. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Closing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Closing will occur as promptly as practicable, but in no event later than three Business Days following the satisfaction, if permissible,
or waiver of all of the closing conditions (other than those conditions that by their nature are to be satisfied at Closing, but subject to the satisfaction or waiver of those conditions at such time). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Representations, Warranties and Covenants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business Combination Agreement contains customary representations, warranties and covenants of QuantumScape, Kensington and Merger Sub
relating to, among other things, their ability to enter into the Business Combination Agreement and their respective outstanding capitalization. These representations and warranties are subject to materiality, knowledge and other similar
qualifications in many respects and expire at the Effective Time. These representations and warranties have been made solely for the benefit of the other parties to the Business Combination Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business Combination Agreement contains representations and warranties made by QuantumScape to Kensington and Merger Sub relating to a
number of matters, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">organization and qualification to do business, subsidiaries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certification of incorporation and bylaws; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">capitalization; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">authority to enter into the Business Combination Agreement; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">109 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">absence of conflicts with organizational documents, applicable laws or certain other agreements and required
filings and consents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">permits and compliance; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">financial statements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">absence of certain changes or events; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">absence of litigation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">employee benefit plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">labor and employment matters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">real property and title to assets; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">intellectual property; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">taxes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">environmental matters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">material contracts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">insurance; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approval of the board and the stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain business practices; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interested party transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Exchange Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">absence of broker fees; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exclusivity of the representations and warranties made by QuantumScape. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business Combination Agreement contains representations and warranties made by Kensington and Merger Sub to QuantumScape relating to a
number of matters, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">corporate organization; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certificate of incorporation and bylaws; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">capitalization; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">authority to enter into the Business Combination Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">absence of conflicts with organizational documents, applicable laws or certain other agreements and required
filings and consents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">compliance; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">proper filing of documents with the SEC, financial statements and compliance with Sarbanes-Oxley Act;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">absence of certain changes or events; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">absence of litigation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approval of the board and the stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no prior operations of Merger Sub; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">absence of broker fees; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">110 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Trust Account; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">employees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">taxes; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the listing of Kensington Class&nbsp;A Common Stock, Kensington Warrants and Kensington Units; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">investigation and reliance. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conduct of Business Pending the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape has agreed that, prior to the Effective Time or the earlier termination of the Business Combination Agreement, it will conduct its
business in the ordinary course of business consistent with past practice. QuantumScape has also agreed to use its commercially reasonable efforts to preserve substantially intact its current business organization, keep available the services of its
current officers, key employees, and consultants, and preserve the existing relations with QuantumScape customers, suppliers, and any other significant business relations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the general covenants above, QuantumScape has agreed that prior to the Effective Time, subject to specified exceptions, it will
not, without the written consent of Kensington (which may not be unreasonably conditioned, withheld or delayed): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">change or amend its certificate of incorporation or bylaws; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issue, sell, pledge, dispose of, grant, encumber, or authorize the issuance, sale, pledge, disposition, grant or
encumbrance of, (a)&nbsp;any shares of any class of capital stock of QuantumScape, or any options, warrants, convertible securities or other rights of any kind to acquire any shares of such capital stock, or any other ownership interest (including,
without limitation, any phantom interest), of QuantumScape, provided that (i)&nbsp;the exercise or settlement of any grants of QuantumScape Options, grants of QuantumScape RSUs or grants of QuantumScape Restricted Stock in the ordinary course of
business consistent with past practice and (ii)&nbsp;the sale of shares of Series&nbsp;F Preferred Stock to investors who had signed stock purchase agreements with QuantumScape prior to the Business Combination Agreement at a price per share of at
least $26.42 shall not require the consent of Kensington; or (b)&nbsp;any material assets of QuantumScape; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">declare, set aside, make or pay any dividend or other distribution, payable in cash, stock, property or
otherwise, with respect to any of its capital stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reclassify, combine, split, subdivide or redeem, or purchase or otherwise acquire, directly or indirectly, any of
its capital stock, other than redemptions of equity securities from former employees upon the terms set forth in the underlying agreements governing such equity securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(a)&nbsp;acquire (including, without limitation, by merger, consolidation, or acquisition of stock or assets or
any other business combination) any corporation, partnership, other business organization or any division thereof in an amount in excess of $5,000,000; or (b)&nbsp;incur any indebtedness for borrowed money in excess of $5,000,000 or issue any debt
securities or assume, guarantee or endorse, or otherwise become responsible for, the obligations of any person, or make any loans or advances, or intentionally grant any security interest in any of its assets, in each case, except in the ordinary
course of business and consistent with past practice; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(a)&nbsp;grant any increase in the compensation, incentives or benefits payable or to become payable to any
current or former director, officer, employee or consultant of QuantumScape as of the date of the Business Combination Agreement, other than increases in base compensation of employees in the ordinary course of business, (b)&nbsp;enter into any new,
or materially amend any existing employment or severance or termination agreement with any current or former director, officer, employee or consultant, (c)&nbsp;accelerate or commit to accelerate the funding, payment, or vesting of any compensation
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">111 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
or benefits to any current or former director, officer, employee or consultant, (d)&nbsp;hire or otherwise enter into any employment or consulting agreement or arrangement with any person or
terminate any current or former director, officer, employee or consultant provider whose compensation would exceed, on an annualized basis, $300,000, or (e)&nbsp;enter into or amend any collective bargaining agreement or other labor agreement
covering QuantumScape&#146;s employees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other than as required by law or pursuant to employee benefit plans disclosed to Kensington, grant any severance
or termination pay to, any director or officer of QuantumScape, other than in the ordinary course of business consistent with past practice; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adopt, amend and/or terminate any material employee benefit plan except as may be required by applicable law, is
necessary in order to consummate the Proposed Transactions, or health and welfare plan renewals in the ordinary course of business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">materially amend other than reasonable and usual amendments in the ordinary course of business, with respect to
accounting policies or procedures, other than as required by GAAP; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any material tax election, amend a material tax return or settle or compromise any material United States
federal, state, local or <FONT STYLE="white-space:nowrap">non-United</FONT> States income tax liability; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">materially amend, or modify or consent to the termination (excluding any expiration in accordance with its terms)
of any material contract or amend, waive, modify or consent to the termination (excluding any expiration in accordance with its terms) of QuantumScape material rights thereunder, in each case in a manner that is adverse to QuantumScape, taken as a
whole, except in the ordinary course of business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">intentionally permit any material item of QuantumScape owned intellectual property to lapse or to be abandoned,
invalidated, dedicated to the public, or disclaimed, or otherwise become unenforceable or fail to perform or make any applicable filings, recordings or other similar actions or filings, or fail to pay all required fees and taxes required to maintain
each and every material item of QuantumScape intellectual property; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into any formal or informal agreement or otherwise make a binding commitment to do any of the foregoing.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington has agreed that, prior to the earlier of the Effective Time or the termination of the Business Combination
Agreement, it will conduct its business, and cause Merger Sub to conduct their respective businesses, in the ordinary course of business consistent with past practice. In addition, Kensington has agreed that prior to the Effective Time, subject to
specified exceptions, it will not, and Merger Sub will not, without the written consent of QuantumScape (which may not be unreasonably withheld, conditioned or delayed): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">change, modify or amend the organizational documents of Kensington or the organizational documents of Merger Sub,
or form any subsidiary of Kensington other than the Merger Sub; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">declare, set aside, make or pay any dividend or other distribution, payable in cash, stock, property or
otherwise, with respect to any of its capital stock, other than redemptions from the trust fund that are required pursuant to Kensington&#146;s organizational documents; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reclassify, combine, split, subdivide, redeem, purchase or otherwise acquire, directly or indirectly, any of the
Kensington Common Stock or Kensington Warrants except for redemptions from the trust fund that are required pursuant to the Kensington organizational documents; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issue, sell, pledge, dispose of, grant, encumber or authorize the issuance, sale, pledge, disposition, grant or
encumbrance of, (a)&nbsp;any shares of any class of capital stock or other securities of Kensington or Merger Sub, or (b)&nbsp;any options, warrants, convertible securities or other rights of any kind to acquire any shares of such capital stock, or
any other ownership interest (including, without limitation, any phantom interest), of Kensington or Merger Sub; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">112 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acquire (including, without limitation, by merger, consolidation, or acquisition of stock or assets or any other
business combination) any corporation, partnership or other business organization or enter into any strategic joint ventures, partnerships or alliances with any other person; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">engage in any conduct in a new line of business or engage in any commercial activities (other than to consummate
the Business Combination); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">incur any indebtedness for borrowed money or guarantee any such indebtedness of another person or persons, issue
or sell any debt securities or options, warrants, calls or other rights to acquire any debt securities of Kensington or Merger Sub, as applicable, enter into any &#147;keep well&#148; or other agreement to maintain any financial statement condition
or enter into any arrangement having the economic effect of any of the foregoing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any change in any method of financial accounting or financial accounting principles, policies, procedures or
practices, except as required by a concurrent amendment in GAAP or applicable law made subsequent to the date hereof, as agreed to by its independent accountants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any material tax election or settle or compromise any material United States federal, state, local or <FONT
STYLE="white-space:nowrap">non-United</FONT> States income tax liability, except in the ordinary course consistent with past practice; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">liquidate, dissolve, reorganize or otherwise wind up the business and operations of Kensington or Merger Sub;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">amend the trust agreement or any other agreement related to the Trust Account; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into any formal or informal agreement or otherwise make a binding commitment to do any of the foregoing.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amendment No. 1 to the Business Combination Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September 21, 2020, Kensington, Merger Sub and QuantumScape entered into Amendment No. 1 to the Business Combination Agreement, by which,
among other things, the form of amended and restated certificate included in the initial Business Combination Agreement dated September 2, 2020 was replaced in its entirety with the Proposed Certificate of Incorporation. The Proposed Certificate of
Incorporation, among other things, provides that the New QuantumScape Class B Common Stock will automatically convert into New QuantumScape Class A Common Stock on the earliest to occur of certain events, as specified in the Proposed Certificate of
Incorporation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Proxy
Statement; Registration Statement </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As promptly as practicable after the execution of the Business Combination Agreement and receipt
of the PCAOB Audited Financials, Kensington and QuantumScape agreed to prepare and file with the SEC this proxy statement/prospectus/information statement to be sent to the stockholders of Kensington and to the stockholders of QuantumScape as an
information statement relating (a)&nbsp;with respect to QuantumScape&#146;s stockholders, the action to be taken by certain stockholders of QuantumScape pursuant to the Written Consent and (b)&nbsp;with respect to Kensington&#146;s stockholders, the
special meeting of Kensington&#146;s stockholders to be held to consider approval and adoption of the Kensington Proposals. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Kensington
Stockholders&#146; Meetings; Merger Sub Stockholder&#146;s Approval; QuantumScape&#146;s Stockholder&#146;s Written Consent </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington has agreed to call and hold the special meeting as promptly as practicable after the date on which this Registration Statement
becomes effective (no later than thirty&nbsp;days after the date on which this proxy statement/prospectus/information statement is mailed to the stockholders of Kensington). Kensington has agreed, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">113 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
through the Kensington Board, to recommend to its stockholders that they approve the Kensington Proposals contained in this proxy statement/prospectus/information statement and agreed to include
the recommendation of the Kensington Board in this proxy statement/prospectus/information statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape has agreed to solicit
the Written Consent as soon as reasonably practicable after this Registration Statement becomes effective, and in any event within 24&nbsp;hours after it becomes effective. QuantumScape has agreed to solicit the consent of its stockholders even if
there has been an Adverse Recommendation Change, unless the Business Combination Agreement has been terminated pursuant to its terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>No
Solicitation; Change in Recommendation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms of the Business Combination Agreement, QuantumScape has agreed on behalf of
itself and its subsidiaries not to (a)&nbsp;initiate, solicit, facilitate or encourage (including by way of furnishing <FONT STYLE="white-space:nowrap">non-public</FONT> information), whether publicly or otherwise, any inquiries with respect to, or
the making of, any Acquisition Proposal (as defined below), (b)&nbsp;engage in any negotiations or discussions concerning, or provide access to its properties, books and records or any confidential information or data to, any person relating to an
Acquisition Proposal, (c)&nbsp;enter into, engage in and maintain discussions or negotiations with respect to any Acquisition Proposal (or inquiries, proposals or offers or other efforts that would reasonably be expected to lead to any Acquisition
Proposal) or otherwise cooperate with or assist or participate in, or facilitate any such inquiries, proposals, offers, efforts, discussions or negotiations, (d)&nbsp;amend or grant any waiver or release under any standstill or similar agreement
with respect to any class of equity securities of QuantumScape, (e)&nbsp;approve, endorse or recommend, or propose publicly to approve, endorse or recommend, any Acquisition Proposal, (f)&nbsp;approve, endorse, recommend, execute or enter into a
QuantumScape Acquisition Agreement or any proposal or offer that could reasonably be expected to lead to an Acquisition Proposal, or (g)&nbsp;resolve or agree to do any of the foregoing or otherwise authorize or permit any of its representatives to
take any such action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape also agreed that immediately following the execution of the Business Combination Agreement it shall
cause its representatives to cease any solicitations, discussions or negotiations with any person or entity conducted prior to the Business Combination Agreement in connection with an Acquisition Proposal or any inquiry or request for information
that could reasonably be expected to lead to, or result in, an Acquisition Proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape also agreed that it will promptly
request each person that has prior to the date of the Business Combination Agreement executed a confidentiality agreement in connection with its consideration of acquiring QuantumScape to return or destroy all confidential information furnished to
such person by or on behalf of it prior to the date of the Business Combination Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape has agreed to promptly (and in
any event within 24&nbsp;hours) notify, Kensington of the receipt of any Acquisition Proposal received after the date of the Business Combination Agreement, which notice shall identify the third party making such Acquisition Proposal include a
summary of the material terms and conditions of any material developments, discussions or negotiations relating to such Acquisition Proposal as well as any modifications to such Acquisition Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the restrictions set forth above, the Business Combination Agreement provides that, the QuantumScape Board may participate in
negotiations or discussions with any third party that has made (and not withdrawn) a bona fide, unsolicited Acquisition Proposal that the QuantumScape Board reasonably believes, in good faith, after consultation with outside legal counsel,
constitutes or would reasonably be expected to result in a Superior Proposal (as defined below), and thereafter furnish to such third party <FONT STYLE="white-space:nowrap">non-public</FONT> information related to QuantumScape pursuant to a
confidentiality agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as set forth below, the QuantumScape Board has agreed that neither it nor any of its committees shall
(a)(i) fail to make, change, withdraw, withhold, amend, modify or qualify, or publicly propose to make, change, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">114 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
withdraw, withhold, amend, modify or qualify, in a manner adverse to Kensington, the QuantumScape Board recommendation, or (ii)&nbsp;adopt, approve, endorse or recommend, or publicly propose to
adopt, approve, endorse or recommend to the stockholders of QuantumScape any Acquisition Proposal or Superior Proposal, (b)&nbsp;make any public statement inconsistent with the QuantumScape Board recommendation, (c)&nbsp;resolve or agree to take any
of the foregoing actions (any of the foregoing, a &#147;Adverse Recommendation Change&#148;), or (d)&nbsp;authorize, cause or permit QuantumScape or any of its respective representatives to enter into any QuantumScape Acquisition Agreement.
Notwithstanding the foregoing, prior to the receipt of the Written Consent, but not after, the QuantumScape Board may make an Adverse Recommendation Change or cause QuantumScape to terminate the Business Combination Agreement to enter into a
QuantumScape Acquisition Agreement, only if the QuantumScape Board has reasonably determined in good faith, after consultation with its outside financial advisor and legal counsel, that (A)&nbsp;the failure to take such action would reasonably be
expected to be inconsistent with the QuantumScape Board&#146;s fiduciary duties under applicable law, and (B)&nbsp;that such Acquisition Proposal constitutes a Superior Proposal. Prior to taking such action, (1)&nbsp;QuantumScape promptly notifies
Kensington, in writing, at least three Business Days (the &#147;QuantumScape Notice Period&#148;) before making an Adverse Recommendation Change or entering into a QuantumScape Acquisition Agreement, of its intention to take such action with respect
to a Superior Proposal, which notice shall (x)&nbsp;state expressly that QuantumScape has received an Acquisition Proposal that the QuantumScape Board intends to declare a Superior Proposal and that the QuantumScape Board intends to make an Adverse
Recommendation Change and/or QuantumScape intends to enter into a QuantumScape Acquisition Agreement, and (y)&nbsp;include a copy of the most current version of the proposed agreement relating to such Superior Proposal (which version shall be
updated on a prompt basis), and a description of any financing commitments relating thereto; (2)&nbsp;QuantumScape shall, and shall cause its representatives to, during the QuantumScape Notice Period, negotiate with Kensington in good faith in
respect of adjustments in the terms and conditions of the Business Combination Agreement such that such Acquisition Proposal would cease to constitute a Superior Proposal, if Kensington, in its discretion, proposes to make such adjustments (it being
agreed that in the event that, after commencement of the QuantumScape Notice Period, there is any material revision to the terms of a Superior Proposal, including, any revision in price, the QuantumScape Notice Period shall be extended, if
applicable, to ensure that at least two business days remains in the QuantumScape Notice Period subsequent to the time QuantumScape notifies Kensington of any such material revision (it being understood that there may be multiple extensions)); and
(3)&nbsp;following the end of such QuantumScape Notice Period (as extended pursuant to the preceding clause&nbsp;(2)) the QuantumScape Board determines in good faith, after consulting with outside financial advisor and legal counsel, that such
Acquisition Proposal continues to constitute a Superior Proposal after taking into account any adjustments made by Kensington during the QuantumScape Notice Period in the terms and conditions of the Business Combination Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the restrictions set forth above, if, at any time prior to obtaining the Written Consent, the QuantumScape Board determines in
good faith, in response to an intervening event, after consultation with its outside legal counsel, that the failure to make an Adverse Recommendation Change would be inconsistent with its fiduciary duties under applicable law, the QuantumScape
Board may, prior to obtaining the Written Consent, make an Adverse Recommendation Change, provided, however, that QuantumScape will not be entitled to make, or agree or resolve to make, an Adverse Recommendation Change unless (i)&nbsp;QuantumScape
promptly notifies Kensington in writing, at least three (3)&nbsp;business days (the &#147;Intervening Event Notice Period&#148;) advising Kensington that the QuantumScape Board proposes to take such action and containing the material facts
underlying the QuantumScape Board&#146;s determination that an intervening event has occurred, and (ii)&nbsp;following the end of such Intervening Event Notice Period (subject to extension in the event of material developments), the QuantumScape
Board determines in good faith, after consulting with outside financial advisors and legal counsel, that the failure to make an Adverse Recommendation Change in response to such intervening event would be inconsistent with the QuantumScape
Board&#146;s fiduciary duties. If requested by Kensington, QuantumScape shall, and shall cause its Representatives (as defined in the Business Combination Agreement) to, during the Intervening Event Notice Period, negotiate with Kensington in good
faith to make such adjustments in the terms and conditions of the Business Combination Agreement so as to obviate the need for an Adverse Recommendation Change. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">115 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used above: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;Acquisition Proposal&#148; means any proposal or offer from any person or group of persons (other than
Kensington, Merger Sub or their respective affiliates) relating to, in a single transaction or a series of related transactions, any direct or indirect acquisition or purchase of a business that constitutes 10% or more of the assets of QuantumScape
or 10% or more of the total voting power of the equity securities of QuantumScape, whether by way of merger, asset purchase, equity purchase or otherwise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;Superior Proposal&#148; means a bona fide, written Acquisition Proposal, not solicited, received, initiated
or facilitated in violation of <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions of the Business Combination Agreement, involving (a)&nbsp;assets that generate more than 50% of the consolidated total revenues of QuantumScape,
(b)&nbsp;assets that constitute more than 50% of the consolidated total assets of QuantumScape, or (c)&nbsp;more than 50% of the total voting power of the equity securities of QuantumScape, in each case, that QuantumScape Board (after consultation
with outside legal counsel) reasonably determines, in good faith, would, if consummated, result in a transaction that is more favorable to QuantumScape than the Proposed Transactions after taking into account all such factors and matters deemed
relevant in good faith by the QuantumScape Board, including legal, financial (including the financing terms of any such proposal), regulatory, timing or other aspects of such proposal and the transactions contemplated thereby and after taking into
account any changes to the terms of Business Combination Agreement irrevocably offered in writing by Kensington in response to such Superior Proposal pursuant to the terms of the Business Combination Agreement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;intervening event&#148; means an event, circumstance, change, development, effect or occurrence (but
specifically excluding any Acquisition Proposal or Superior Proposal) that was not known and was not reasonably foreseeable to QuantumScape or the QuantumScape Board as of the date of the Business Combination Agreement (or the consequences of which
were not reasonably foreseeable to the QuantumScape Board as of the date of the Business Combination Agreement), and that becomes known to QuantumScape or the QuantumScape Board after the date of the Business Combination Agreement.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Exclusivity </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington has agreed that until the earlier of the Closing and the termination of the Business Combination Agreement, but only to the extent
not inconsistent with the fiduciary duties of the Kensington Board, to not, and to cause its representatives not to, directly or indirectly, (i)&nbsp;enter into, knowingly solicit, initiate or continue any discussions or negotiations with, or
knowingly encourage or respond to any inquiries or proposals by, or participate in any negotiations with, or provide any information to, or otherwise cooperate in any way with, any person or other entity or &#147;group&#148; within the meaning of
Section&nbsp;13(d) of the Exchange Act, concerning any sale of any material assets of such party or any of the outstanding capital stock or any conversion, consolidation, liquidation, dissolution or similar transaction involving such party other
than with the other parties to the Business Combination Agreement and their respective representatives (an &#147;Alternative Transaction&#148;), (ii) enter into any agreement regarding, continue or otherwise knowingly participate in any discussions
regarding, or furnish to any person any information with respect to, or cooperate in any way that would otherwise reasonably be expected to lead to, any Alternative Transaction or (iii)&nbsp;commence, continue or renew any due diligence
investigation regarding any Alternative Transaction. Kensington has agreed that it shall, and shall cause its affiliates and their respective representatives to, immediately cease any and all existing discussions or negotiations with any person
conducted heretofore with respect to any Alternative Transaction. Kensington also agrees that it will promptly request each person (other than the parties to the Business Combination Agreement and their respective representatives) that has prior to
the date of the Business Combination Agreement executed a confidentiality agreement in connection with its consideration of an Alternative Transaction to return or destroy all confidential information furnished to such person by or on behalf of it
prior to the date hereof (to the extent so permitted under, and in accordance with the terms of, such confidentiality agreement). If Kensington or any of its affiliates or its or their respective representatives receives any inquiry or proposal with
respect to an Alternative </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">116 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Transaction at any time prior to the Closing, then Kensington or QuantumScape, as applicable, shall promptly (and in no event later than 24 hours after it becomes aware of such inquiry or
proposal) notify such person in writing that it is subject to an exclusivity agreement with respect to the Business Combination that prohibits such party from considering such inquiry or proposal, but only, in the case of Kensington, to the extent
not inconsistent with the fiduciary duties of the Kensington Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock Exchange Listing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington will use its reasonable best efforts to cause the shares of New QuantumScape Class&nbsp;A Common Stock to be issued in connection
with the Business Combination to be approved for listing on the NYSE at Closing. Until the Closing, Kensington shall use its reasonable best efforts to keep the Kensington Class&nbsp;A Common Stock and Kensington Warrants listed for trading on the
NYSE. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Covenants and Agreements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business Combination Agreement contains other covenants and agreements, including covenants related to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape and Kensington providing access to books and records and furnishing relevant information to the
other party, subject to certain limitations and confidentiality provisions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Certain employee benefit matters including the establishment of an equity incentive award plan to be effective
after the Closing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Director and officer indemnification; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Prompt notification of certain matters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape and Kensington using reasonable best efforts to consummate the Business Combination;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Public announcement relating the Business Combination; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Agreement relating to the intended tax treatment of the Business Combination; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Cooperation regarding any filings required under the HSR Act; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The delivery by QuantumScape of audited financial statements on or before October&nbsp;2, 2020; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Kensington making disbursements from the Trust Account. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Conditions to Closing </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Mutual </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The obligations of QuantumScape, Kensington and Merger Sub to consummate the Business Combination, including the Merger, are subject to the
satisfaction or waiver (where permissible) at or prior to the Closing of the following conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Written Consent shall have been delivered to Kensington; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Kensington Proposals shall have been approved and adopted by the requisite affirmative vote of the
Kensington stockholders in accordance with this proxy statement/prospectus/information statement, the DGCL, the Kensington organizational documents and the rules and regulations of the NYSE; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No governmental authority shall have enacted, issued, promulgated, enforced or entered any law, rule,
regulation, judgment, decree, executive order or award which is then in effect and has the effect of making the Business Combination illegal or otherwise prohibiting the Closing; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">117 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All required filings under the HSR Act shall have been completed and any applicable waiting period (and any
extension thereof) applicable to the Closing under the HSR Act shall have expired or been terminated, and any <FONT STYLE="white-space:nowrap">pre-Closing</FONT> approvals or clearances reasonably required thereunder shall have been obtained;
</P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Certain consents, approvals and authorizations set forth in the Business Combination Agreement shall have been
obtained from and made with all governmental authorities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Registration Statement shall have been declared effective under the Securities Act. No stop order
suspending the effectiveness of the Registration Statement shall be in effect, and no proceedings for purposes of suspending the effectiveness of the Registration Statement shall have been initiated or be threatened by the SEC; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The shares of New QuantumScape Class&nbsp;A Common Stock shall be approved for listing on the NYSE as of the
Closing Date. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Kensington and Merger Sub </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The obligations of Kensington and Merger Sub to consummate the Business Combination are subject to the satisfaction or waiver (where legally
permissible) at or prior to the Closing of the following additional conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The representations and warranties of QuantumScape contained in the sections of the Business Combination
Agreement titled &#147;Organization and Qualification; Subsidiaries,&#148; &#147;Capitalization,&#148; &#147;Authority Relative to the Business Combination Agreement&#148; and &#147;Brokers in the Business Combination Agreement&#148; shall each be
true and correct in all material respects as of the Closing Date as though made on the Closing Date (without giving effect to any limitation as to &#147;materiality&#148; or &#147;Company Material Adverse Effect,&#148; each as defined in the
Business Combination Agreement, or any similar limitation set forth therein), except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and
correct in all material respects as of such earlier date. All other representations and warranties of QuantumScape contained in the Business Combination Agreement shall be true and correct (without giving any effect to any limitation as to
&#147;materiality&#148; or &#147;Company Material Adverse Effect&#148; or any similar limitation set forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except (A)&nbsp;to the extent that any such
representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date and (B)&nbsp;where the failure of such representations and warranties to be true and
correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in a Company Material Adverse Effect; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">QuantumScape shall have performed or complied in all material respects with all agreements and covenants
required by the Business Combination Agreement to be performed or complied with by it on or prior to the Effective Time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">QuantumScape shall have delivered to Kensington a customary officer&#146;s certificate, dated the date of the
Closing, certifying as to the satisfaction of certain conditions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No Company Material Adverse Effect shall have occurred between the date of the Business Combination Agreement
and the Closing Date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On or prior to the Closing, QuantumScape shall have delivered to Kensington a properly executed certification
that shares of QuantumScape Common Stock are not &#147;U.S. real property interests&#148; in accordance with the Treasury Regulations under Sections 897 and 1445 of the Code, together with a notice to the IRS (which will be filed by Kensington with
the IRS following the Closing) in accordance with the provisions of <FONT STYLE="white-space:nowrap">Section&nbsp;1.897-2(h)(2)</FONT> of the Treasury Regulations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">QuantumScape shall have delivered to Kensington the PCAOB Audited Financials; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">118 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Series F Subscription Amount shall be at least $300&nbsp;million in the aggregate; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">QuantumScape shall have no indebtedness for borrowed money. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>QuantumScape </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The obligations of
QuantumScape to consummate the Business Combination are subject to the satisfaction or waiver (where permissible) at or prior to Closing of the following additional conditions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The representations and warranties of Kensington and Merger Sub contained in the sections of the Business
Combination Agreement titled &#147;Corporate Organization,&#148; &#147;Capitalization,&#148; &#147;Authority Relative to the Business Combination Agreement&#148; and &#147;Brokers in the Business Combination Agreement&#148; shall each be true and
correct in all material respects as of the Closing Date as though made on the Closing Date (without giving effect to any limitation as to &#147;materiality&#148; or &#147;Kensington Material Adverse Effect&#148; or any similar limitation set forth
therein), except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date. All other
representations and warranties of Kensington and Merger Sub contained in the Business Combination Agreement shall be true and correct (without giving any effect to any limitation as to &#147;materiality&#148; or &#147;Kensington Material Adverse
Effect,&#148; each as defined in the Business Combination Agreement, or any similar limitation set forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except (A)&nbsp;to the extent that any such
representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date and (B)&nbsp;where the failure of such representations and warranties to be true and
correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in a Kensington Material Adverse Effect; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Kensington and Merger Sub shall have performed or complied in all material respects with all agreements and
covenants required by the Business Combination Agreement to be performed or complied with by it on or prior to the Effective Time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Kensington shall have delivered to QuantumScape a customary officer&#146;s certificate (signed by the President
of Kensington), dated the date of the Closing, certifying as to the satisfaction of certain conditions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Other than those persons identified as continuing directors in accordance with the Business Combination
Agreement, all members of the Kensington Board shall have executed written resignations effective as of the Effective Time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No Kensington Material Adverse Effect shall have occurred between the date of the Business Combination
Agreement and the Closing Date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Kensington shall have at least $500&nbsp;million in the aggregate in (A)&nbsp;its Trust Account (after giving
effect to any Redemption Rights (as defined in the Business Combination Agreement) that are actually perfected) plus (B)&nbsp;cash proceeds received in connection with the PIPE (calculated without reduction for any payments in respect of Outstanding
Kensington Transaction Expenses (as defined in the Business Combination Agreement)); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A supplemental listing shall have been filed with the NYSE Capital Market as of the Closing Date to list the
shares of New QuantumScape Class&nbsp;A Common Stock issuable in connection with the Business Combination. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Termination
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business Combination Agreement may be terminated and the Business Combination may be abandoned at any time prior to the
Effective Time, notwithstanding any requisite approval and adoption of the Business </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">119 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Combination Agreement and the Business Combination by the QuantumScape Stockholders or Kensington Stockholders, respectively, as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">By mutual written consent of Kensington and QuantumScape; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">By Kensington or QuantumScape, if (i)&nbsp;the Effective Time shall not have occurred prior to the Outside Date
(as defined in the Business Combination Agreement); provided, however, that the Business Combination Agreement may not be terminated by any party (A)&nbsp;that directly or indirectly through its affiliates is in breach or violation of any
representation, warranty, covenant, agreement or obligation contained in the Business Combination Agreement and such breach or violation is the principal cause of the failure of a condition to the Merger on or prior to the Outside Date; or
(B)&nbsp;against which any legal proceeding is brought by a party hereto for specific performance or injunctive or other forms of equitable relief in connection herewith (which prohibition on such party&#146;s right to terminate the Business
Combination Agreement shall continue throughout the pendency of such legal proceeding); (ii)&nbsp;any governmental authority in the United States has enacted, issued, promulgated, enforced or entered any injunction, order, decree or ruling (whether
temporary, preliminary or permanent) which has become final and nonappealable and has the effect of making the Closing illegal or otherwise preventing or prohibiting the Closing and the Merger; or (iii)&nbsp;any of the Kensington Proposals fail to
receive the requisite vote for approval at the special meeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">By QuantumScape if (i)&nbsp;there is an occurrence of a breach of any representation, warranty, covenant or
agreement on the part of Kensington and Merger Sub set forth in the Business Combination Agreement, or if any representation or warranty of Kensington and Merger Sub shall have become untrue, in either case such that the conditions described in
subsections (a)&nbsp;and (b) under the heading &#147;<I>Conditions to Closing; The Company</I>&#148; would not be satisfied (a &#147;Terminating Kensington Breach&#148;); provided that QuantumScape has not waived such Terminating Kensington Breach
and QuantumScape is not then in material breach of their representations, warranties, covenants or agreements in the Business Combination Agreement; provided, however, that, if such Terminating Kensington Breach is curable by Kensington and Merger
Sub, QuantumScape may not terminate the Business Combination Agreement under the applicable section for so long as Kensington and Merger Sub continue to exercise their reasonable efforts to cure such breach, unless such breach is not cured within
thirty days after notice of such breach is provided by QuantumScape to Kensington; or (ii)&nbsp;at any time prior to receipt of the Written Consent, in connection with entering into a QuantumScape Acquisition Agreement with respect to a Superior
Proposal in accordance with Section&nbsp;7.05(d) of the Business Combination Agreement; provided, that prior to or concurrently with such termination QuantumScape pays the Termination Fee (as defined in the Business Combination Agreement and below);
</P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">By Kensington if (i)&nbsp;the QuantumScape Board or a committee thereof, prior to obtaining the Written Consent
has made an Adverse Recommendation Change; (ii)&nbsp;QuantumScape has failed to deliver the Written Consent to Kensington within 24 hours after the Registration Statement becomes effective; or (iii)&nbsp;there is a Terminating Company Breach (as
defined in the Business Combination Agreement); provided that Kensington has not waived such Terminating Company Breach and Kensington and Merger Sub are not then in material breach of their representations, warranties, covenants or agreements in
the Business Combination Agreement; provided further that, if such Terminating Company Breach is curable by QuantumScape, Kensington may not terminate the Business Combination Agreement under this provision for so long as QuantumScape continues to
exercise its reasonable efforts to cure such breach, unless such breach is not cured within thirty days after notice of such breach is provided by Kensington to QuantumScape. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Effect of Termination </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the
Business Combination Agreement is terminated, the agreement will forthwith become void, and there will be no liability under the Business Combination Agreement on the part of any party to the Business
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">120 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Combination Agreement, except as set forth in the Business Combination Agreement or in the case of termination subsequent to a willful material breach of the Business Combination Agreement by a
party thereto. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Termination Fee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape shall pay a termination fee in the amount of $82&nbsp;million (the &#147;Termination Fee&#148;) in the event that: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(x) The Business Combination Agreement is terminated (A)&nbsp;by QuantumScape or Kensington, if the Effective
Time did not occur prior to the Outside Date (as defined in the Business Combination Agreement), (B) by Kensington, if QuantumScape failed to deliver the Written Consent to Kensington within 24 hours after the Registration Statement became effective
or (C)&nbsp;pursuant to a Terminating Company Breach, (y)&nbsp;a bona fide Acquisition Proposal (as defined in the Business Combination Agreement) has been made, proposed or otherwise communicated to QuantumScape after the date of the Business
Combination Agreement but before the date of termination, and (z)&nbsp;within six months of the date the Business Combination Agreement is terminated, QuantumScape enters into a definitive agreement with respect to such Acquisition Proposal; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Business Combination Agreement is terminated (x)&nbsp;by Kensington if the QuantumScape Board or a
committee thereof, prior to obtaining the Written Consent, shall have made an Adverse Recommendation Change; or (y)&nbsp;by QuantumScape, if at any time prior to receiving the Written Consent, QuantumScape enters into a QuantumScape Acquisition
Agreement with respect to a Superior Proposal. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendation of the Board </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE KENSINGTON BOARD UNANIMOUSLY RECOMMENDS THAT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCKHOLDERS VOTE &#147;FOR&#148; THE APPROVAL OF THE BUSINESS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMBINATION PROPOSAL. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">121 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_38"></A>CERTAIN AGREEMENTS RELATED TO THE BUSINESS COMBINATION </B></P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This section describes the material provisions of certain additional agreements entered into or to be entered into pursuant to or in
connection with the Proposed Transactions, which are referred to as the &#147;Related Agreements,&#148; but does not purport to describe all of the terms thereof. The descriptions below are qualified by reference to the actual text of these
agreements. You are encouraged to read the Related Agreements in their entirety. </I></P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_39"></A>Stockholder Support Agreements
</B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, (i) Kensington and VGA entered into the Volkswagen Support Agreement, pursuant to which, among other
things, VGA agreed to vote its shares of QuantumScape Preferred Stock in favor of the Business Combination Agreement and the Proposed Transactions, and (ii)&nbsp;Kensington and the Key QuantumScape Stockholders entered into the Key Stockholder
Support Agreement, pursuant to which, among other things, the Key QuantumScape Stockholders agreed to vote their shares of QuantumScape Common Stock and QuantumScape Preferred Stock in favor of the Business Combination Agreement and the Proposed
Transactions. As of September&nbsp;14, 2020, VGA and the Key QuantumScape Stockholders collectively held approximately 59.35% of the QuantumScape Class A Common Stock, 78.16% of the QuantumScape Class&nbsp;B Common Stock 76.62% of the QuantumScape
Capital Stock then outstanding, which represents a sufficient number of votes for QuantumScape&#146;s stockholders to approve the Business Combination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The numbers of shares and percentage interests set forth above are based on a number of assumptions, including that (i) none of the Public
Stockholders exercise their redemption rights, (ii) QuantumScape does not issue any additional equity securities prior to the Merger, other than the issuance of 14,684,843 shares of Series F Preferred Stock pursuant to certain Series F Stock
Purchase Agreements by and between QuantumScape and the investors thereto, and that no other event occurs that would change the Exchange Ratio from what it would have been as of the date of the initial signing of the Business Combination Agreement
and (iii) there are no future exercises of the Kensington Warrants. If the actual facts differ from these assumptions, the numbers of shares and percentage interests set forth above will be different. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_40"></A>Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Kensington and the Holders entered into a Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT>
Agreement, which shall be effective at the Closing. Pursuant to the terms of the Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement, Kensington will be obligated to file&nbsp;a registration statement to register the
resale of certain shares of Kensington Common Stock held by the Holders after the Closing. In addition, pursuant to the terms of the Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement and subject to certain
requirements and customary conditions, including with regard to the number of demand rights that may be exercised, the Holders may demand at any time or from time to time, that Kensington file&nbsp;a registration statement on <FONT
STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> (or on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> if <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> is not available) to register the securities of Kensington held by such Holders,
and Kensington is separately required at all times to maintain an effective resale registration statement for the benefit of the Holders. The Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement will also provide the
Holders with &#147;piggy-back&#148; registration rights, subject to certain requirements and customary conditions. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Registration
Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement further provides for the securities of Kensington held by the Holders to be <FONT STYLE="white-space:nowrap">locked-up</FONT> for a period of time following the Closing, as
described below, subject to certain exceptions. The securities held by the Sponsor will be <FONT STYLE="white-space:nowrap">locked-up</FONT> for one year following the Closing, subject to earlier release if (i)&nbsp;the reported last sale price of
New QuantumScape Class&nbsp;A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any
<FONT STYLE="white-space:nowrap">30-trading</FONT> day period commencing at least 150&nbsp;days after the Closing or (ii)&nbsp;if New QuantumScape consummates a liquidation, merger, stock exchange or other similar transaction after the Closing which
results in all of New QuantumScape&#146;s stockholders having the right to exchange their shares of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">122 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
common stock for cash, securities or other property. The securities held by the New Holders will be <FONT STYLE="white-space:nowrap">locked-up</FONT> for 180 days after the Closing, subject to
earlier release if (i)&nbsp;the reported last sale price of New QuantumScape Class&nbsp;A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20
trading days within any <FONT STYLE="white-space:nowrap">30-trading</FONT> day period commencing at least 150 days after the Closing or (ii)&nbsp;if New QuantumScape consummates a liquidation, merger, stock exchange or other similar transaction
after the Closing which results in all of New QuantumScape&#146;s stockholders having the right to exchange their shares of common stock for cash, securities or other property. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_41"></A>Subscription Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the execution of the Business Combination Agreement, effective as of September&nbsp;2, 2020, Kensington entered into
separate Subscription Agreements with a number of Subscribers, pursuant to which the Subscribers agreed to purchase, and Kensington agreed to sell to the Subscribers, the PIPE Shares, for a purchase price of $10.00 per share and an aggregate
purchase price of $500&nbsp;million. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The closing of the sale of the PIPE Shares pursuant to the Subscription Agreements is contingent
upon, among other customary closing conditions, the substantially concurrent Closing. The purpose of the PIPE is to raise additional capital for use by New QuantumScape following the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Subscription Agreements, Kensington agreed that, within 15 business days after the Closing (the &#147;Filing Deadline&#148;),
Kensington will file with the SEC (at Kensington&#146;s sole cost and expense) a registration statement registering the resale of the PIPE Shares, and Kensington shall use its commercially reasonable efforts to have such resale registration
statement declared effective as soon as practicable after the filing thereof. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom14810_42"></A>Senior Employee <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Kensington entered into separate Senior Employee <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Agreements with certain Senior Employees, including QuantumScape&#146;s executive officers.&nbsp;The Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements provide that the <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Shares owned of record or beneficially by the Senior Employees (including certain securities that may be granted or issued to a Senior Employee after the Effective Time) may generally not be transferred
during the Initial <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period and up to four years after the Closing, subject to certain exceptions.&nbsp;Following the Initial <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, Senior Employees may
transfer <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares without restriction as follows: (i)&nbsp;during the first year after the Effective Time, up to 25% of the total number of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares,
(ii)&nbsp;following the first anniversary of the Effective Time until the earlier of four years after the Closing or the occurrence of an event described below, up to 50% of the total number of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares
(taking into account any transfers under clause (i)&nbsp;above), and (iii)&nbsp;up to an additional 50% of the total number of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares following satisfaction of agreed delivery requirements between
QuantumScape and VGA.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These transfer restrictions are subject to earlier release if (i)&nbsp;New QuantumScape completes a liquidation,
merger, stock exchange or other similar transaction after the Closing that results in all of New QuantumScape&#146;s stockholders having the right to exchange their shares of common stock for cash, securities or other property; (ii)&nbsp;VGA
terminates for any reason the Amended and Restated Joint Venture Agreement, dated as of May&nbsp;14, 2020, by and among QuantumScape and VGA; (iii)&nbsp;VGA issues a critical or negative statement regarding New QuantumScape and its technology unless
such statement is required to be made by VGA under applicable law and is truthful and accurate; or (iv)&nbsp;VGA transfers certain New QuantumScape securities in excess of the amounts set forth in the Senior Employee
<FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements.&nbsp;The Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements also provide that, upon consummation of the Merger, Kensington or QuantumScape shall pay to each Senior
Employee a <FONT STYLE="white-space:nowrap">one-time</FONT> cash bonus equal to 20% of the Senior Employee&#146;s then annual base salary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">123 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_43"></A>CERTAIN U.S. FEDERAL INCOME TAX CONSIDERATIONS OF THE REDEMPTION
AND THE BUSINESS COMBINATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a discussion of certain U.S. federal income tax consequences for (i)&nbsp;holders of
Kensington Common Stock that elect to have their Kensington Common Stock redeemed for cash if the Business Combination is completed and (ii)&nbsp;holders of QuantumScape Capital Stock who exchange their QuantumScape Capital Stock for Kensington
Common Stock in the Business Combination. This discussion applies only to shares of Kensington Common Stock or QuantumScape Capital Stock, as the case may be, held as a capital asset within the meaning of Section&nbsp;1221 of the Code (generally,
property held for investment). Further, with respect to the redemption of Kensington Common Stock, the discussion is applicable only to holders who purchased Kensington Common Stock in the IPO. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion does not address all U.S. federal income tax consequences that may be relevant to a holder&#146;s particular circumstances,
including the impact of the Medicare contribution tax on net investment income. In addition, it does not address consequences relevant to holders subject to special rules, including, without limitation: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">U.S. expatriates and former citizens or long-term residents of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons subject to the alternative minimum tax; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons holding Kensington Common Stock or QuantumScape Capital Stock as part of a hedge, straddle or other risk
reduction strategy or as part of a conversion transaction or other integrated transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">banks, insurance companies and other financial institutions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">brokers, dealers or traders in securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;controlled foreign corporations,&#148; &#147;passive foreign investment companies&#148; and corporations
that accumulate earnings to avoid U.S. federal income tax; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and
investors therein); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-exempt</FONT> organizations or governmental organizations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons subject to special tax accounting rules as a result of any item of gross income with respect to
Kensington Common Stock or QuantumScape Capital Stock being taken into account in an applicable financial statement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">U.S. holders (as defined below) whose functional currency is not the U.S. dollar; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulated investment companies (RICs) or real estate investment trusts (REITs); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement plans; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;qualified foreign pension funds&#148; as defined in Section&nbsp;897(l)(2) of the Code and entities all of
the interests of which are held by qualified foreign pension funds. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an entity or arrangement is treated as a
partnership (or other pass-through entity) for U.S. federal income tax purposes, the tax treatment of the persons treated as partners (or other owners) will generally depend on the status of the partners, the activities of the partnership and
certain determinations made at the partner level. Accordingly, partnerships (or other pass-through entities) and the partners (or other owners) in such partnerships (or such other pass-through entities) should consult their own tax advisors
regarding the U.S. federal income tax consequences to them relating to the matters discussed below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">124 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, a &#147;U.S. holder&#148; is a beneficial owner of shares
of Kensington Common Stock or QuantumScape Common Stock, as the case may be, who or that is, for U.S. federal income tax purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual who is a citizen or resident of the United States, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) organized in or
under the laws of the United States, any state thereof or the District of Columbia, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate, the income of which is subject to U.S. federal income tax regardless of its source, or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an entity treated as a trust that (1)&nbsp;is subject to the primary supervision of a U.S. court and the control
of one or more &#147;United States persons&#148; (within the meaning of Section&nbsp;7701(a)(30) of the Code) or (2)&nbsp;was in existence on August&nbsp;20, 1996 and has a valid election in effect to be treated as a United States person for U.S.
federal income tax purposes. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Also, for purposes of this discussion, a
<FONT STYLE="white-space:nowrap">&#147;Non-U.S.</FONT> holder&#148; is any beneficial owner of Kensington Common Stock or QuantumScape Capital Stock, as the case may be, who or that is neither a U.S. holder nor an entity classified as a partnership
for U.S. federal income tax purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS DISCUSSION IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT TAX ADVICE. INVESTORS SHOULD
CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE,
LOCAL OR <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. Federal Income Tax
Considerations of the Redemption to the Holders of Kensington Common Stock </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following does not purport to be a complete
analysis of all potential tax effects stemming from the Closing that are associated with certain redemptions of Kensington Common Stock. The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local or
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax laws are not discussed. This discussion is based on the Code, Treasury Regulations promulgated thereunder, judicial decisions and published rulings and administrative pronouncements of the IRS, in
each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect holders to which
this section applies and could affect the accuracy of the statements herein. Kensington has not sought and will not seek any rulings from the IRS regarding the matters discussed below. There can be no assurance that the IRS or a court will not take
a contrary position to that regarding tax consequences discussed below. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This section is not applicable to holders of Kensington
Common Stock who do not exercise their redemption rights. Neither Kensington nor QuantumScape has obtained a tax opinion regarding the U.S. federal income tax consequences of the Business Combination, including the Redemption. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>U.S. Holders </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Redemption of
Kensington Common Stock. </I>In the event that a U.S. holder&#146;s Kensington Common Stock is redeemed pursuant to the redemption provisions described in the section entitled &#147;<I>The Special Meeting of Kensington Stockholders&#151;Redemption
Rights</I>,&#148; the treatment of the transaction for U.S. federal income tax purposes will depend on whether the redemption qualifies as a sale of the Kensington Common Stock under Section&nbsp;302 of the Code. If the redemption qualifies as a
sale of the Kensington Common Stock, the U.S. holder will be treated as described under &#147;&#151;<I>U.S. Holders&#151;Gain or Loss on Redemption Treated as a Sale of Kensington Common Stock</I>&#148; below. If the redemption does not qualify as a
sale of the Kensington Common Stock, the U.S. holder will be treated as receiving a corporate distribution with the tax consequences described below under &#147;&#151;<I>U.S. Holders&#151;Taxation of Redemption Treated as a Distribution</I>.&#148;
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">125 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whether a redemption qualifies for sale treatment will depend largely on whether the U.S.
holder owns any of Kensington&#146;s stock following the redemption (including any stock treated as constructively owned by the U.S. holder as a result of owning warrants or by attribution from certain related individuals and entities), and if so,
the total number of shares of Kensington&#146;s stock held by the U.S. holder both before and after the redemption (including any stock constructively treated as owned by the U.S. holder as a result of owning warrants or by attribution from certain
related individuals and entities) relative to all of Kensington&#146;s shares outstanding both before and after the redemption. The redemption of Kensington Common Stock generally will be treated as a sale of the Kensington Common Stock (rather than
as a corporate distribution) if the redemption (i)&nbsp;is &#147;substantially disproportionate&#148; with respect to the U.S. holder, (ii)&nbsp;results in a &#147;complete termination&#148; of the U.S. holder&#146;s interest in us or (iii)&nbsp;is
&#147;not essentially equivalent to a dividend&#148; with respect to the U.S. holder. These tests are explained more fully below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
determining whether any of the foregoing tests is satisfied, a U.S. holder takes into account not only stock actually owned by the U.S. holder, but also shares of our stock that are constructively owned by it. A U.S. holder may constructively own,
in addition to stock owned directly, stock owned by certain related individuals and entities in which the U.S. holder has an interest or that have an interest in such U.S. holder, as well as any stock that the U.S. holder has a right to acquire by
exercise of an option, which would generally include Kensington Common Stock that could be acquired pursuant to the exercise of the warrants. Moreover, any Kensington stock that a U.S. holder directly or constructively acquires pursuant to the
Business Combination generally should be included in determining the U.S. federal income tax treatment of the redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to
meet the substantially disproportionate test, the percentage of Kensington&#146;s outstanding voting stock actually and constructively owned by the U.S. holder immediately following the redemption of Kensington Common Stock must, among other
requirements, be less than 80% of the percentage of Kensington&#146;s outstanding voting stock actually and constructively owned by such U.S. holder immediately before the redemption (taking into account both redemptions by other holders of
Kensington Common Stock and the shares of Kensington Common Stock to be issued pursuant to the Business Combination). There will be a complete termination of a U.S. holder&#146;s interest if either (i)&nbsp;all of the shares of our capital stock
actually and constructively owned by the U.S. holder are redeemed or (ii)&nbsp;all of the shares of our capital stock actually owned by the U.S. holder are redeemed, the U.S. holder is eligible to waive, and effectively waives in accordance with
specific rules, the attribution of stock owned by certain family members and the U.S. holder does not constructively own any other stock. The redemption of Kensington Common Stock will not be essentially equivalent to a dividend if a U.S.
holder&#146;s redemption results in a &#147;meaningful reduction&#148; of the U.S. holder&#146;s proportionate interest in Kensington. Whether the redemption will result in a meaningful reduction in a U.S. holder&#146;s proportionate interest in
Kensington will depend on the particular facts and circumstances. However, the IRS has indicated in a published ruling that even a small reduction in the proportionate interest of a small minority stockholder in a publicly held corporation who
exercises no control over corporate affairs may constitute such a &#147;meaningful reduction.&#148; A U.S. holder should consult with its own tax advisors as to the tax consequences of a redemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If none of the foregoing tests is satisfied, then the redemption will be treated as a corporate distribution, and the tax effects will be as
described under &#147;&#151;<I>U.S. Holders&#151;Taxation of Redemption Treated as a Distribution</I>&#148; below. After the application of those rules, any remaining tax basis of the U.S. holder in the redeemed Kensington Common Stock will be added
to the U.S. holder&#146;s adjusted tax basis in its remaining stock, or, if it has none, to the U.S. holder&#146;s adjusted tax basis in its warrants or possibly in other stock constructively owned by it. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Gain or Loss on Redemption Treated as a Sale of Kensington Common Stock. </I>If the redemption qualifies as a sale of Kensington Common
Stock, a U.S. holder generally will recognize capital gain or loss in an amount equal to the difference between the amount of cash received in the redemption and the U.S. holder&#146;s adjusted tax basis in its redeemed Kensington Common Stock. A
U.S. holder&#146;s adjusted tax basis in its Kensington Common Stock generally will equal the U.S. holder&#146;s acquisition cost. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any
such capital gain or loss generally will be long-term capital gain or loss if the U.S. holder&#146;s holding period for the Kensington Common Stock so disposed of exceeds one year. It is unclear, however, whether the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">126 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
redemption rights with respect to the Kensington Common Stock may suspend the running of the applicable holding period for this purpose. Long-term capital gains recognized by <FONT
STYLE="white-space:nowrap">non-corporate</FONT> U.S. holders will be eligible to be taxed at reduced rates. The deductibility of capital losses is subject to limitations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Taxation of Redemption Treated as a Distribution. </I>If the redemption does not qualify as a sale of Kensington Common Stock, a U.S.
holder will generally be treated as receiving a distribution. Such distributions generally will constitute dividends for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under
U.S. federal income tax principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Distributions in excess of our current and accumulated earnings and profits will constitute a return
of capital that will be applied against and reduce (but not below zero) the U.S. holder&#146;s adjusted tax basis in Kensington Common Stock. Any remaining excess will be treated as gain realized on the sale or other disposition of the Kensington
Common Stock as described under &#147;&#151;<I>U.S. Holders&#151;Gain or Loss on Redemption Treated as a Sale of Kensington Common Stock</I>&#148; above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividends (including amounts treated as dividends paid pursuant to a redemption of Kensington Common Stock) Kensington pays to a U.S. holder
that is a taxable corporation generally will qualify for the dividends received deduction if the requisite holding period is satisfied. With certain exceptions (including, but not limited to, dividends (including constructive dividends paid pursuant
to a redemption of Kensington Common Stock) treated as investment income for purposes of investment interest deduction limitations), and provided that certain holding period requirements are met, dividends Kensington pays to a <FONT
STYLE="white-space:nowrap">non-corporate</FONT> U.S. holder generally will constitute &#147;qualified dividends&#148; that will be subject to tax at the maximum tax rate accorded to long-term capital gains. It is unclear whether the redemption
rights with respect to the Kensington Common Stock described in this proxy statement/prospectus/information statement may prevent a U.S. holder from satisfying the applicable holding period requirements with respect to the dividends received
deduction or the preferential tax rate on qualified dividend income, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Information Reporting and Backup Withholding.
</I>In general, information reporting requirements will generally apply to dividends (including constructive dividends paid pursuant to a redemption of Kensington Common Stock) paid to a U.S. holder and to the proceeds of the sale or other
disposition of shares of Kensington Common Stock, unless the U.S. holder is an exempt recipient. Backup withholding may apply to such payments if the U.S. holder fails to provide a taxpayer identification number, a certification of exempt status or
has been notified by the IRS that it is subject to backup withholding (and such notification has not been withdrawn). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Backup withholding
is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit against a U.S. holder&#146;s federal income tax liability provided that the required information is timely furnished to the IRS.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Redemption of Kensington Common Stock. </I>The characterization for U.S. federal income tax purposes of the redemption of a <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> holder&#146;s Kensington Common Stock pursuant to the redemption provisions described in the section entitled &#147;<I>The Special Meeting of Kensington Stockholders&#151;Redemption Rights</I>&#148;
generally will correspond to the U.S. federal income tax characterization of such a redemption of a U.S. holder&#146;s Kensington Common Stock, as described under &#147;<I>U.S. Holders&#151;Redemption of Kensington Common Stock</I>&#148; above, and
the consequences of the redemption to the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder will be as described below under &#147;<I><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders&#151;Gain on Redemption Treated as a Sale of
Kensington Common Stock</I>&#148; and &#147;<I><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders&#151;Taxation of Redemption Treated as a Distribution</I>,&#148; as applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">127 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Gain on Redemption Treated as a Sale of Kensington Common Stock. </I>A <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> holder will not be subject to U.S. federal income tax on any gain realized on a redemption treated as a sale of Kensington Common Stock unless: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the gain is effectively connected with the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder&#146;s conduct
of a trade or business within the United States (and, if required by an applicable income tax treaty, the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder maintains a permanent establishment or fixed place of business in the United States to
which such gain is attributable); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder is a nonresident alien individual present in the
United States for 183&nbsp;days or more during the taxable year of the redemption and certain other requirements are met. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gain described in the first bullet point above generally will be subject to U.S. federal income tax on a net income basis at the regular
graduated rates. A <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder that is a corporation may also be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively
connected gain, as adjusted for certain items. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gain described in the second bullet point above will be subject to U.S. federal income tax
at a rate of 30% (or such lower rate specified by an applicable income tax treaty), which may be offset by U.S. source capital losses of the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder (even though the individual is not considered a
resident of the United States) provided that the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder has timely filed U.S. federal income tax returns with respect to such losses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Taxation of Redemption Treated as a Distribution. </I>If the redemption does not qualify as a sale of Kensington Common Stock, a <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> holder will generally be treated as receiving a distribution. Such distributions generally will constitute dividends for U.S. federal income tax purposes to the extent paid from Kensington&#146;s current or
accumulated earnings and profits, as determined under U.S. federal income tax principles. Distributions in excess of Kensington&#146;s current and accumulated earnings and profits, will constitute a return of capital that will be applied against and
reduce (but not below zero) the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder&#146;s adjusted tax basis in Kensington Common Stock. Any remaining excess will be treated as gain realized on the sale or other disposition of the Kensington
Common Stock and will be treated as described under &#147;<I><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders&#151;Gain on Redemption Treated as a Sale of Kensington Common Stock</I>&#148; above. In general, with respect to any distributions
that constitute dividends for U.S. federal income tax purposes and are not effectively connected with the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder&#146;s conduct of a trade or business within the United States, we will be required to
withhold tax from the gross amount of the dividend at a rate of 30%, unless such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder is eligible for a reduced rate of withholding tax under an applicable income tax treaty and provides proper
certification of its eligibility for such reduced rate (on an IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN</FONT> or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or other applicable
documentation). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If dividends paid to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder are effectively connected with the <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> holder&#146;s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder maintains a permanent
establishment or fixed place of business in the United States to which such dividends are attributable), the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder will be exempt from the 30% U.S. federal withholding tax described above if such <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> holder furnishes to the applicable withholding agent a valid IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8ECI,</FONT> certifying that the dividends are effectively connected with the <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> holder&#146;s conduct of a trade or business within the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any such effectively
connected dividends will be subject to U.S. federal income tax on a net income basis at the regular graduated rates. A <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder that is a corporation also may be subject to a branch profits tax at a
rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected dividends, as adjusted for certain items. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax advisors
regarding any applicable tax treaties that may provide for different rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Information Reporting and Backup Withholding. </I>Payments
of dividends (including constructive dividends received pursuant to a redemption of Kensington Common Stock) on Kensington Common Stock will not be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">128 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
subject to backup withholding, provided that the applicable withholding agent does not have actual knowledge or reason to know the holder is a United States person and the holder either certifies
its <FONT STYLE="white-space:nowrap">non-U.S.</FONT> status, such as by furnishing a valid IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN,</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or <FONT
STYLE="white-space:nowrap">W-8ECI,</FONT> or otherwise establishes an exemption. However, information returns are required to be filed with the IRS in connection with any payments of dividends on Kensington Common Stock paid to the <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> holder, regardless of whether any tax was actually withheld. In addition, proceeds of the sale or other taxable disposition of Kensington Common Stock within the United States or conducted through certain
U.S.-related brokers generally will not be subject to backup withholding or information reporting, if the applicable withholding agent receives the certification described above and does not have actual knowledge or reason to know that such holder
is a United States person, or the holder otherwise establishes an exemption. Proceeds of a disposition of Kensington Common Stock conducted through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> broker generally will not be subject to backup withholding or information reporting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Copies of information returns that are filed with the IRS may also be made available under the provisions of an applicable treaty or agreement
to the tax authorities of the country in which the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder resides or is established. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit
against a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder&#146;s U.S. federal income tax liability, provided that the required information is timely furnished to the IRS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>FATCA Withholding Taxes. </I>Sections 1471 through 1474 of the Code and the Treasury Regulations and administrative guidance promulgated
thereunder (commonly referred as the &#147;Foreign Account Tax Compliance Act&#148; or &#147;FATCA&#148;) generally impose withholding at a rate of 30% in certain circumstances on dividends (including amounts paid in redemption of Kensington Common
Stock that are treated as dividends) paid to &#147;foreign financial institutions&#148; (which is broadly defined for this purpose and in general includes investment vehicles) and certain other <FONT STYLE="white-space:nowrap">Non-U.S.</FONT>
entities unless various U.S. information reporting and due diligence requirements (generally relating to ownership by U.S. persons of interests in or accounts with those entities) have been satisfied, or an exemption applies (typically certified by
the delivery of a properly completed IRS Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E).</FONT></FONT> . An intergovernmental agreement between the United States and an applicable foreign country may modify these
requirements. The IRS has issued proposed regulations (on which taxpayers may rely until final regulations are issued) that would generally not apply these withholding requirements to gross proceeds from sales or other disposition proceeds of
Kensington Common Stock. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax advisors regarding the possible implications of FATCA on the redemption of Kensington Common Stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. Federal Income Tax Considerations of The Business Combination for QuantumScape Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following does not purport to be a complete analysis of all potential tax effects for holders of QuantumScape Capital Stock stemming from
the Closing. The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax laws are not discussed. This discussion is based on the Code, Treasury
Regulations promulgated thereunder, judicial decisions and published rulings and administrative pronouncements of the IRS, in each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any
such change or differing interpretation may be applied retroactively in a manner that could adversely affect holders to which this section applies and could affect the accuracy of the statements herein. Neither Kensington nor QuantumScape has sought
and neither of them will seek any rulings from the IRS regarding the matters discussed below. There can be no assurance that the IRS or a court will not take a contrary position to that regarding tax consequences discussed below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither Kensington nor QuantumScape has obtained a tax opinion regarding the U.S. federal income tax consequences of the Business Combination.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">129 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Characterization of the Business Combination </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of Kensington and QuantumScape intends the Business Combination to qualify for U.S. federal income tax purposes as a
&#147;reorganization&#148; within the meaning of Section&nbsp;368(a) of the Code. In the Business Combination Agreement, each of Kensington, Merger Sub and QuantumScape agrees to use its commercially reasonable efforts to cause the Business
Combination to qualify, and agrees not to take, and not to permit or cause any of its affiliates or subsidiaries to take any action which to its knowledge could reasonably be expected to prevent or impede the Business Combination from qualifying, as
a reorganization within the meaning of Section&nbsp;368(a) of the Code. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>U.S. Federal Income Tax Consequences for U.S. Holders </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Business Combination qualifies as a reorganization, the U.S. federal income tax consequences to U.S. holders of QuantumScape Capital
Stock will be as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a U.S. holder will not recognize gain or loss upon the exchange of QuantumScape Capital Stock for New
QuantumScape Class&nbsp;A Common Stock pursuant to the Business Combination; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a U.S. holder&#146;s aggregate tax basis for the shares of New QuantumScape Class&nbsp;A Common Stock received in
the Business Combination will equal the U.S. holder&#146;s aggregate tax basis in the shares of QuantumScape Capital Stock surrendered in the Business Combination; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the holding period of the shares New QuantumScape Class&nbsp;A Common Stock received by a U.S. holder in the
Business Combination will include the holding period of the shares of QuantumScape Capital Stock surrendered in exchange therefor. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the above discussion regarding the determination of the bases and holding periods for shares of New QuantumScape Class&nbsp;A
Common Stock received in the Business Combination, U.S. holders who acquired different blocks of QuantumScape Capital Stock at different times for different prices must calculate their bases and holding periods in their shares of QuantumScape
Capital Stock separately for each identifiable block of such stock exchanged in the Business Combination. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As provided in Treasury
Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.368-3(d),</FONT> each U.S. holder who receives shares of New QuantumScape Class&nbsp;A Common Stock in the Business Combination is required to retain permanent records pertaining to the
Business Combination, and make such records available to any authorized IRS officers and employees. Such records should specifically include information regarding the amount, basis, and fair market value of all transferred property, and relevant
facts regarding any liabilities assumed or extinguished as part of such reorganization. Additionally, U.S. holders who owned immediately before the Closing at least 1% (by vote or value) of the total outstanding stock of QuantumScape, or
QuantumScape &#147;securities&#148; (as specially defined for U.S. federal income tax purposes) the aggregate federal income tax basis of which was at least $1&nbsp;million, are required to attach a statement to their tax returns for the year in
which the Business Combination is completed that contains the information listed in Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.368-3(b).</FONT> Such statement must include the U.S. holder&#146;s tax basis in and fair market
value of such U.S. holder&#146;s shares of QuantumScape Capital Stock, and any such &#147;securities&#148; surrendered in the Business Combination, the date of the Closing and the name and employer identification number of each of QuantumScape and
Kensington. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Business Combination fails to qualify as a reorganization within the meaning of Section&nbsp;368(a) of the Code,
then a U.S. holder would recognize gain or loss upon the exchange of the holder&#146;s shares of QuantumScape Capital Stock for shares of New QuantumScape Class&nbsp;A Common Stock equal to the difference between the fair market value, at the time
of the exchange, of the New QuantumScape Class&nbsp;A Common Stock received in the Business Combination and such U.S. holder&#146;s tax basis in the shares of QuantumScape Capital Stock surrendered in the Business Combination. Such gain or loss
would be long-term capital gain or loss if the QuantumScape stock was held for more than one year at the time of the Business Combination. In addition, the U.S. holder&#146;s aggregate </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">130 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
tax basis in the shares of New QuantumScape Class&nbsp;A Common Stock received in the Business Combination would equal their fair market value at the time of the closing of the Business
Combination, and the U.S. holder&#146;s holding period of such shares of New QuantumScape Class&nbsp;A Common Stock would commence the day after the closing of the Business Combination. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The U.S. federal income tax consequences of the Business Combination for <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders of
QuantumScape Capital Stock will generally be the same as for U.S. holders except as noted below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders will not be subject to U.S. federal income tax on any gain recognized as a result of
the Business Combination (<I>i.e.,</I>&nbsp;if the Business Combination does not qualify as a reorganization under Section&nbsp;368(a) of the Code) unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the gain is effectively connected with the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder&#146;s conduct
of a trade or business within the United States (and, if required by an applicable income tax treaty, the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder maintains a permanent establishment in the United States to which such gain is
attributable); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder is a nonresident alien individual present in the
United States for 183&nbsp;days or more during the taxable year of the Business Combination and certain other requirements are met; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">QuantumScape is or has been a &#147;United States real property holding corporation&#148; (&#147;USRPHC&#148;)
for U.S. federal income tax purposes at any time during the shorter of the five-year period ending on the date of the Business Combination or the period that the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder held QuantumScape Capital
Stock. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gain described in the first bullet point above generally will be subject to U.S. federal income tax on a net
income basis at the regular graduated rates. A <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax
treaty) on such effectively connected gain, as adjusted for certain items. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gain described in the second bullet point above will be
subject to U.S. federal income tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty), which may be offset by U.S. source capital losses of the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder (even though the
individual is not considered a resident of the United States) provided that the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder has timely filed U.S. federal income tax returns with respect to such losses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the third bullet point above applied to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holder, any gain recognized by such holder with
respect to such holder&#146;s QuantumScape Capital Stock as a result of the Business Combination generally would be subject to tax on a net income basis at the rates and in the manner generally applicable to United States persons (as defined under
the Code) unless an applicable income tax treaty provides otherwise. Generally, a corporation is a USRPHC if the fair market value of its United States real property interests equals or exceeds 50% of the sum of the fair market value of its
worldwide real property interests and its other assets used or held for use in a trade or business. QuantumScape believes that it is not and has not been a USRPHC for U.S. federal income tax purposes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">131 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_44"></A>PROPOSAL NO. 2&#151;THE AUTHORIZED SHARE CHARTER PROPOSAL
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assuming the Business
Combination Proposal and the NYSE Proposal are approved, the Kensington stockholders are also being asked to approve and adopt an amendment and restatement of the Existing Certificate of Incorporation to (a)&nbsp;increase the number of authorized
shares of the New QuantumScape Class&nbsp;A Common Stock from 100,000,000 shares to 1,000,000,000 shares, (b)&nbsp;increase the number of authorized shares of New QuantumScape Class&nbsp;B Common Stock from 10,000,000 shares to 250,000,000 shares,
and (c)&nbsp;increase the number of authorized shares of New QuantumScape Preferred Stock from 1,000,000 shares to 100,000,000 shares. The full text of the Proposed Certificate of Incorporation reflecting the proposed amendment pursuant to the
Authorized Share Charter Proposal is attached to this proxy statement/prospectus/information statement as&nbsp;Annex B. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reasons for the Amendments
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Authorized Share Charter Proposal is intended to provide adequate authorized share capital to (a)&nbsp;accommodate the issuance of
shares of New QuantumScape Class&nbsp;A Common Stock and New QuantumScape Class&nbsp;B Common Stock as part of the exchange for outstanding securities of QuantumScape at Closing (or reservation for issuance in respect of New QuantumScape options,
New QuantumScape RSUs, or New QuantumScape warrants issued in exchange for <FONT STYLE="white-space:nowrap">outstanding&nbsp;pre-merger&nbsp;QuantumScape</FONT> Options, <FONT STYLE="white-space:nowrap">pre-merger</FONT> QuantumScape RSUs or <FONT
STYLE="white-space:nowrap">pre-merger</FONT> QuantumScape Warrants) pursuant to the Business Combination Agreement, the PIPE, the 2020 Plan, the ESPP, the exercise of outstanding Kensington Warrants for shares of New QuantumScape Class&nbsp;A Common
Stock and the future conversion of shares of New QuantumScape Class&nbsp;B Common Stock into shares of New QuantumScape Class&nbsp;A Common Stock and (b)&nbsp;provide flexibility for future issuances of New QuantumScape Class&nbsp;A Common Stock,
New QuantumScape Class&nbsp;B Common Stock and New QuantumScape Preferred Stock if determined by the New QuantumScape Board to be in the best interests of New QuantumScape without incurring the risk, delay and potential expense incident to obtaining
stockholder approval for a particular issuance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required for Approval </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Authorized Share Charter Proposal is conditioned on the approval of the Business Combination Proposal and the NYSE Proposal at the special
meeting. If the Charter Proposals are approved, the Proposed Certificate of Incorporation will be approved and adopted in its entirety. If the Business Combination Proposal or the NYSE Proposal is not approved, this Proposal No.&nbsp;2 will have no
effect, even if approved by the Kensington stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The approval of the Authorized Share Charter Proposal requires the affirmative
vote (in person or by proxy) of holders of a majority of the outstanding shares of Kensington Class&nbsp;A Common Stock and Kensington Class&nbsp;B Common Stock entitled to vote thereon at the special meeting, voting as a single class. Failure to
vote by proxy or to vote in person at the special meeting, an abstention from voting or a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will have the same effect as a vote &#147;AGAINST&#148; this proposal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendation of the Board </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE
KENSINGTON BOARD UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE &#147;FOR&#148; THE APPROVAL OF THE AUTHORIZED SHARE CHARTER PROPOSAL. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">132 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_45"></A>PROPOSAL NO. 3&#151;THE DIRECTOR DECLASSIFICATION CHARTER
PROPOSAL </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assuming the
Business Combination Proposal and the NYSE Proposal are approved, the Kensington stockholders are also being asked to approve and adopt an amendment and restatement of the Existing Certificate of Incorporation to declassify the terms of office of
the directors. The Kensington Board regularly reviews Kensington&#146;s corporate governance practices. After careful consideration, the Kensington Board determined that it would be in the best interests of Kensington and its stockholders to
declassify the Kensington Board which will allow the stockholders to vote on the election of the entire board each year, rather than on a staggered basis as with the current classified board structure. The full text of the Proposed Certificate of
Incorporation reflecting the proposed amendment pursuant to the Authorized Share Charter Proposal is attached to this proxy statement/prospectus/information statement as&nbsp;Annex B. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reasons for the Amendments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Currently,
the Existing Certificate of Incorporation divides the Kensington Board into three classes, with only one class of directors being elected in each year and each class (except for those directors appointed prior to our first annual meeting of
stockholders) serving a three-year term. If the Director Declassification Charter Proposal is approved, all directors will be up for election at each annual stockholder meeting held after the Closing. The Kensington Board has considered the
advantages and disadvantages of maintaining a classified board structure and has concluded that an unclassified board would be in the best interests of New QuantumScape and its stockholders. There are valid arguments in favor of and in opposition to
a classified board structure. Proponents of a classified board structure believe it promotes continuity and stability in the management of the business and affairs of a company, reducing the company&#146;s vulnerability to coercive takeover tactics
and special interest groups who may not be acting in the best interests of all stockholders, encouraging directors to take a long-term perspective and enhancing the independence of <FONT STYLE="white-space:nowrap">non-management</FONT> directors by
providing them with a longer term of office and insulating them against pressure from management or special interest groups. On the other hand, the Kensington Board believes that corporate governance standards continue to evolve and that many
investors and commentators currently believe that the election of directors is the primary means for stockholders to influence corporate governance policies and increase the board&#146;s and management&#146;s accountability to stockholders. Annual
elections of directors will provide stockholders with the opportunity to register their views on the performance of the entire board each year. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote
Required for Approval </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Director Declassification Charter Proposal is conditioned on the approval of the Business Combination
Proposal and the NYSE Proposal at the special meeting. If the Charter Proposals are approved, the Proposed Certificate of Incorporation will be approved and adopted in its entirety. If the Business Combination Proposal or the NYSE Proposal is not
approved, this Proposal No.&nbsp;3 will have no effect, even if approved by the Kensington stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The approval of the Director
Declassification Charter Proposal requires the affirmative vote (in person or by proxy) of holders of a majority of the outstanding shares of Kensington Class&nbsp;A Common Stock and Kensington Class&nbsp;B Common Stock entitled to vote thereon at
the special meeting, voting as a single class. Failure to vote by proxy or to vote in person at the special meeting, an abstention from voting or a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will have the same effect as a vote
&#147;AGAINST&#148; this proposal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendation of the Board </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE KENSINGTON BOARD UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE &#147;FOR&#148; THE APPROVAL OF THE DIRECTOR DECLASSIFICATION CHARTER
PROPOSAL. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">133 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_46"></A>PROPOSAL NO. 4&#151;THE DUAL CLASS CHARTER PROPOSAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assuming the Business
Combination Proposal and the NYSE Proposal are approved, Kensington&#146;s stockholders are also being asked to approve and adopt an amendment and restatement of the Existing Certificate of Incorporation to implement a dual class stock structure
comprised of New QuantumScape Class&nbsp;A Common Stock, which will carry one vote per share, and New QuantumScape Class&nbsp;B Common Stock, which will carry 10 votes per share. The full text of the Proposed Certificate of Incorporation reflecting
the proposed amendments pursuant to the Dual Class&nbsp;Charter Proposal is attached to this proxy statement/prospectus/information statement as&nbsp;Annex B. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reasons for the Amendment </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because,
upon the Closing, QuantumScape&#146;s <FONT STYLE="white-space:nowrap">co-founders</FONT> and certain of QuantumScape&#146;s investors, which include certain of QuantumScape&#146;s executive officers, employees, directors, and/or their affiliates,
will be beneficial owners of shares of New QuantumScape Class&nbsp;B Common Stock, those shares are generally restricted from transfers, except in limited circumstances, and the &#147;sunset&#148; provisions pertaining to the final conversion of the
New QuantumScape Class&nbsp;B Common Stock into New QuantumScape Class&nbsp;A Common Stock are conditioned in part on QuantumScape&#146;s <FONT STYLE="white-space:nowrap">co-founders</FONT> and certain of QuantumScape&#146;s investors&#146;
ownership of New QuantumScape Class&nbsp;B Common Stock, this dual class stock structure provides the QuantumScape <FONT STYLE="white-space:nowrap">co-founders&#146;</FONT> and certain of QuantumScape&#146;s investors with significant ability to
affect the outcome of matters requiring stockholder approval. Kensington believes that its success rests on Kensington&#146;s ability to undertake a long-term view, and this will enhance New QuantumScape&#146;s ability to focus on long-term value
creation and help insulate New QuantumScape from short-term outside influences. This structure will also provide New QuantumScape with flexibility to employ various financing and transaction strategies involving the issuance of equity securities,
while maintaining the QuantumScape co-founders&#146; and certain QuantumScape investors&#146; control. Specifically, the holders of New QuantumScape Class B Common Stock will hold approximately 87.8% of the voting power of New QuantumScape
outstanding capital stock immediately following the Closing, and New QuantumScape&#146;s executive officers, directors and their affiliates as a group will hold approximately 41.21% of the voting power of New QuantumScape outstanding capital stock
immediately following the Closing. The holders of New QuantumScape Class B Common Stock collectively will continue to control a substantial majority of the combined voting power of New QuantumScape outstanding capital stock following the Closing and
therefore, assuming no material sales of such shares, will be able to control all matters submitted to our stockholders for approval, including the election of directors, amendments of our organizational documents and approval of significant
corporate transactions. This concentrated control will limit or preclude the ability of holders of New QuantumScape Class A Common Stock to influence corporate matters for the foreseeable future. In addition, this may prevent or discourage
unsolicited acquisition proposals or offers for New QuantumScape capital stock that you may feel are in your best interest as one of our stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington believes that its success rests on Kensington&#146;s ability to undertake a long-term view, and this will enhance New
QuantumScape&#146;s ability to focus on long-term value creation and help insulate New QuantumScape from short-term outside influences. This structure will also provide New QuantumScape with flexibility to employ various financing and transaction
strategies involving the issuance of equity securities, while maintaining the QuantumScape <FONT STYLE="white-space:nowrap">co-founders&#146;</FONT> and certain QuantumScape investors&#146; control. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required for Approval </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Dual
Class&nbsp;Charter Proposal is conditioned on the approval of the Business Combination Proposal and the NYSE Proposal at the special meeting. If the Charter Proposals are approved, the Proposed Certificate of Incorporation will be approved and
adopted in its entirety. If the Business Combination Proposal or the NYSE Proposal is not approved, this Proposal No.&nbsp;4 will have no effect, even if approved by the Kensington stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">134 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The approval of the Dual Class&nbsp;Charter Proposal requires the affirmative vote (in
person or by proxy) of the holders of a majority of the outstanding shares of Kensington Class&nbsp;A Common Stock and Kensington Class&nbsp;B Common Stock entitled to vote thereon at the special meeting, voting as a single class. Failure to vote by
proxy or to vote in person at the special meeting, an abstention from voting or a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will have the same effect as a vote &#147;AGAINST&#148; this proposal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendation of the Board </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE
KENSINGTON BOARD UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE &#147;FOR&#148; THE APPROVAL OF THE DUAL CLASS CHARTER PROPOSAL</B>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">135 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_47"></A>PROPOSAL NO. 5&#151;THE ADDITIONAL CHARTER PROPOSAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assuming the Business
Combination Proposal and the NYSE Proposal are approved, Kensington&#146;s stockholders are also being asked to approve and adopt an amendment and restatement of the Existing Certificate of Incorporation to, among other things, (a)&nbsp;eliminate
certain provisions relating to an initial business combination that will no longer be applicable to us following the Closing, (b)&nbsp;change New QuantumScape&#146;s name to &#147;QuantumScape Corporation&#148; and (c)&nbsp;make such other changes
that the Kensington Board deems appropriate for a public operating company. The full text of the Proposed Certificate of Incorporation reflecting the proposed amendments pursuant to the Additional Charter Proposal is attached to this proxy
statement/prospectus/information statement as&nbsp;Annex B. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reasons for the Amendment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Kensington Board believes the proposed amendment is appropriate to adequately update the Existing Certificate of Incorporation for New
QuantumScape, because it will eliminate obsolete language that will no longer be applicable following the Closing and make such other changes that are more appropriate for a public operating company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following more specifically identifies the proposed amendments to the Existing Certificate of Incorporation made pursuant to the
Additional Charter Proposal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Eliminate Certain Provisions Relating to an Initial Business Combination </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington&#146;s stockholders are being asked to approve amendments to the Existing Certificate of Incorporation to eliminate certain
provisions relating to an initial business combination that will no longer be applicable to us following the Closing. Specifically, Article IX and Article X of the Existing Certificate of Incorporation are removed from the Proposed Certificate of
Incorporation. Article IX contains, for example, provisions relating to a trust account established for the benefit of Kensington&#146;s stockholders that are applicable only prior to a Business Combination (as defined in the Existing Certificate of
Incorporation), as well as redemption rights and requirements for certain transactions and the initial Business Combination of Kensington. Article IX by its terms terminates upon the consummation of the initial Business Combination and can be
removed following the initial Business Combination. In addition, the Proposed Certificate of Incorporation removes Article X of the Existing Certificate of Incorporation, which waives certain aspects of the corporate opportunity doctrine under the
DGCL for Kensington&#146;s officers and directors, as it is more appropriate for a SPAC company and less so for a public operating company. The Proposed Certificate of Incorporation also removes Article XII, relating to exclusive forums for certain
lawsuits, as those provisions will be included in the Proposed Bylaws. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Change New QuantumScape&#146;s Name </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington&#146;s stockholders are also being asked to approve amendments to the Existing Certificate of Incorporation to change New
QuantumScape&#146;s name to &#147;QuantumScape Corporation.&#148; On the Closing Date, Merger Sub, a wholly owned subsidiary of Kensington, will merge into QuantumScape, whereupon Merger Sub will cease to exist and QuantumScape will continue as the
Surviving Corporation. Following the Business Combination, the ongoing business strategy of New QuantumScape will be QuantumScape&#146;s strategy of developing next generation battery technology for EVs and other applications; the management of New
QuantumScape will be comprised of QuantumScape&#146;s current management; and the directors of New QuantumScape will mostly be comprised of members selected by QuantumScape. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">136 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Changes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington&#146;s stockholders are also being asked to approve amendments to the Existing Certificate of Incorporation to make such other
changes that the Kensington Board deems appropriate for a public operating company. These changes include: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Special Meetings of Stockholders
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Proposed Certificate of Incorporation includes clarifying language, consistent with the DGCL, regarding how special meetings
of stockholders may be cancelled, postponed or rescheduled. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amendment of Bylaws </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Consistent with the Existing Certificate of Incorporation, the Proposed Certificate of Incorporation provides that the holders of at least a
majority of the total voting power of the outstanding voting securities of New QuantumScape, voting together as a single class, shall be required for the stockholders to alter, amend or repeal the bylaws of New QuantumScape. The Proposed Certificate
of Incorporation provides further that from and after the elimination of the dual class structure in the Proposed Certificate of Incorporation, or the Final Conversion Date (as defined below), the affirmative vote of holders of at least two-thirds
of the total voting power of the outstanding voting securities of New QuantumScape, voting together as a single class, shall be required for the stockholders to alter, amend or repeal the bylaws of New QuantumScape. This supermajority voting
requirement for stockholders to alter, amend or repeal the bylaws is consistent with other newly public operating companies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stockholder Action by
Written Consent </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Existing Certificate of Incorporation does not permit actions by written consent of the stockholders other
than with respect to holders of Kensington&#146;s Class B Common Stock. The Proposed Certificate of Incorporation provides that before the Final Conversion Date, any action required or permitted to be taken by the stockholders of New QuantumScape
may be taken without a meeting only if the action is first recommended or approved by a majority of the Whole Board, as defined in the Proposed Certificate of Incorporation. This provision would permit stockholder actions by written consent that
receive appropriate board approval while the dual class structure in the Proposed Certificate of Incorporation is in place. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amendment of Proposed
Certificate of Incorporation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Consistent with the Existing Certificate of Incorporation, the Proposed Certificate of Incorporation
provides that the holders of at least a majority of the total voting power of the outstanding voting securities of New QuantumScape, voting together as a single class, shall be required to amend, alter, change or repeal any provision contained in
the Proposed Certificate of Incorporation. The Proposed Certificate of Incorporation provides further that from and after the Final Conversion Date, the affirmative vote of the holders of at least two-thirds of the voting power of the outstanding
shares of stock of New QuantumScape entitled to vote generally in the election of directors, voting together as a single class, shall be required to amend or repeal, or adopt any provision of the Proposed Certificate of Incorporation inconsistent
with, Article III (purpose of the corporation), Article V (rights, powers, preferences, privileges, restrictions and other matters relating to the New QuantumScape common stock), Article VI (rights of New QuantumScape preferred stock), Article VII
(matters regarding directors of New QuantumScape), Article VIII (management and conduct of the business of New QuantumScape) or Article X (amending the Proposed Certificate of Incorporation). This supermajority voting requirement for stockholders to
alter, amend or repeal the bylaws is consistent with other newly public operating companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">137 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required for Approval </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Additional Charter Proposal is conditioned on the approval of the Business Combination Proposal and the NYSE Proposal at the special
meeting. If the Charter Proposals are approved, the Proposed Certificate of Incorporation will be approved and adopted in its entirety. If the Business Combination Proposal or the NYSE Proposal is not approved, this Proposal No.&nbsp;5 will have no
effect, even if approved by the Kensington stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The approval of the Additional Charter Proposal requires the affirmative vote
(in person or by proxy) of the holders of a majority of the outstanding shares of Kensington Class&nbsp;A Common Stock and Kensington Class&nbsp;B Common Stock entitled to vote thereon at the special meeting, voting as a single class. Failure to
vote by proxy or to vote in person at the special meeting, an abstention from voting or a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will have the same effect as a vote &#147;AGAINST&#148; this proposal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendation of the Board </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE
KENSINGTON BOARD UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE &#147;FOR&#148; THE APPROVAL OF THE ADDITIONAL CHARTER PROPOSAL</B>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">138 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_48"></A>PROPOSAL NO. 6&#151;THE ELECTION OF DIRECTORS PROPOSAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Existing
Certificate of Incorporation, the Kensington Board is currently divided into three classes, Class&nbsp;I, Class&nbsp;II and Class&nbsp;III, with only one class of directors being elected in each year and each class (except for those directors
appointed prior to our first annual meeting of stockholders) serving a three-year term. The Proposed Certificate of Incorporation provides that the authorized number of directors shall be fixed solely by resolution of the New QuantumScape Board.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Proposed Certificate of Incorporation provides that other than for those directors elected by the holders of any series
of New QuantumScape Preferred Stock, each director shall be annually elected and serve until his or her successor shall be duly elected and qualified or until his or her earlier resignation, removal from office or death. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Business Combination Agreement, at the Closing, the New QuantumScape Board shall consist of Jagdeep Singh as Chairman, one
member to be selected by Kensington, who will be Justin Mirro, and&nbsp;additional members to be selected by QuantumScape, who are expected to be Frank Blome, Brad Buss, John Doerr, Prof.&nbsp;Dr.&nbsp;J&uuml;rgen Leohold, Prof. Fritz Prinz,
Dipender Saluja and J.B. Straubel. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information regarding each nominee is set forth in the section entitled &#147;<I>Management After
the Business Combination.</I>&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required for Approval </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Election of Directors Proposal is conditioned on the approval of the Business Combination Proposal and the Director Declassification
Charter Proposal at the special meeting and is expected to be acted upon following the Director Declassification Charter Proposal at the special meeting in order to elect each nominee to serve until his or her successor shall be duly elected and
qualified or until his or her earlier resignation, removal from office, death or incapacity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Election of Directors Proposal will be
approved and adopted if the holders of a plurality of the shares of Kensington Common Stock represented in person or by proxy and voted thereon at the special meeting vote &#147;FOR&#148; the Election of Directors Proposal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendation of the Board </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE
KENSINGTON BOARD UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE &#147;FOR&#148; ALL NOMINEES NAMED IN THE ELECTION OF DIRECTORS PROPOSAL. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">139 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_49"></A>PROPOSAL NO. 7&#151;THE EQUITY INCENTIVE PLAN PROPOSAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are seeking stockholder approval for the QuantumScape Corporation 2020 Equity Incentive Plan, or the &#147;2020 Plan.&#148; The 2020 Plan
is being adopted in connection with the Business Combination Agreement and will become effective upon the Closing. The 2020 Plan is intended to replace the QuantumScape 2010 Equity Incentive Plan, as amended, or the 2010 Plan, which will expire as
to future grants as of the effective date of the Merger. Approval of the 2020 Plan will allow New QuantumScape to provide equity awards as part of New QuantumScape&#146;s compensation program, an important tool for motivating, attracting and
retaining talented employees and for creating stockholder value. <FONT STYLE="white-space:nowrap">Non-approval</FONT> of the 2020 Plan will compel New QuantumScape to significantly increase the cash component of employee compensation following the
Closing to attract and retain key employees because New QuantumScape would need to replace components of compensation QuantumScape previously delivered in equity awards, which would therefore reduce New QuantumScape&#146;s operating cash flow. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Kensington Board believes that long-term incentive compensation programs align the interests of management, employees and stockholders to
create long-term stockholder value. Equity plans such as the 2020 Plan increase New QuantumScape&#146;s ability to achieve this objective, and, by allowing for several different forms of long-term incentive awards, helps New QuantumScape to recruit,
reward, motive, and retain talented personnel. The Kensington Board believes that the approval of the 2020 Plan is essential to New QuantumScape&#146;s continued success, and in particular, New QuantumScape&#146;s ability to attract and retain
outstanding and highly skilled individuals in the extremely competitive labor marks in which New QuantumScape will compete. Such awards are also crucial to New QuantumScape&#146;s ability to motivate employees to achieve its goals. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Key Plan Provisions </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The 2020 Plan will continue until terminated by the New QuantumScape Board or New QuantumScape&#146;s
compensation committee; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The 2020 Plan provides for the grant of stock options, both incentive stock options and nonqualified stock
options, stock appreciation rights, restricted stock, restricted stock units, and performance awards; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">41,500,000 shares of New QuantumScape Class&nbsp;A Common Stock will be authorized for issuance pursuant to
awards under the 2020 Plan, plus up to 69,846,580 shares of New QuantumScape Class&nbsp;A Common Stock that may become available for issuance as a result of recycling of awards under the 2010 Plan, as described below; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The 2020 Plan provides for an automatic share reserve increase feature, whereby the share reserve will
automatically be increased on the first day of each fiscal year beginning with the 2021 fiscal year, in an amount equal to the least of (i) 41,500,000 shares, (ii) 5% of the total number of shares of all classes of New QuantumScape Common Stock
outstanding on the last day of the immediately preceding fiscal year, and (iii)&nbsp;a lesser number of shares as determined by the administrator. The automatic share reserve feature will cease immediately after the increase on the first day of the
2030 fiscal year. </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The 2020 Plan will be administered by the New QuantumScape Board or, if designated by the New QuantumScape Board,
New QuantumScape&#146;s compensation committee. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary of the 2020 Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following paragraphs provide a summary of the principal features of the 2020 Plan and its operation. However, this summary is not a
complete description of all of the provisions of the 2020 Plan and is qualified in its entirety by the specific language of the 2020 Plan. A copy of the 2020 Plan is attached to this proxy statement/prospectus/information statement as Annex D. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">140 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Purposes of the 2020 Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purposes of the 2020 Plan are to attract and retain personnel for positions with New QuantumScape, any parent or subsidiary, and any entity
that is in control of, is controlled by or is under common control with New QuantumScape (such entities are referred to herein as, the company group); to provide additional incentive to employees, directors, and consultants; and to promote the
success of our business. These incentives will be provided through the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, and performance awards as the administrator of the 2020 Plan may determine. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Eligibility </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2020 Plan
provides for the grant of incentive stock options, within the meaning of Section&nbsp;422 of the Code, to New QuantumScape&#146;s employees and any parent and subsidiary corporations&#146; employees, and for the grant of nonstatutory stock options,
restricted stock, restricted stock units, stock appreciation rights, performance units and performance shares to employees, directors and consultants of New QuantumScape and the company group. Following the Closing, we expect New QuantumScape to
have, collectively, eight <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and approximately 237 full-time employees (including our employee directors) and eight part-time employees. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Authorized Shares </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to
the adjustment provisions contained in the 2020 Plan and the evergreen provision described below, the maximum number of shares of New QuantumScape Class&nbsp;A Common Stock that may be issued pursuant to awards under the 2020 Plan is (i) 41,500,000
shares of New QuantumScape Class&nbsp;A Common Stock, plus (ii)&nbsp;any shares of New QuantumScape Common Stock subject to stock options, restricted stock units or other awards that were assumed in the Merger and terminate as a result of being
unexercised or are forfeited to or repurchased by New QuantumScape, with the maximum number of shares to be added to the 2020 Plan pursuant to clause (ii)&nbsp;equal to 69,846,580 shares of New QuantumScape Class&nbsp;A Common Stock. The 2020 Plan
also includes an evergreen provision that provides for an automatic annual increase to the number of shares of New QuantumScape Class&nbsp;A Common Stock available for issuance under the 2020 Plan on the first day of each fiscal year beginning with
the 2021 fiscal year, equal to the least of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">41,500,000 shares of New QuantumScape Class&nbsp;A Common Stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">5% of the total number of shares of all classes of New QuantumScape Common Stock as of the last day of our
immediately preceding fiscal year; or </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Such lesser amount determined by the administrator. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2020 Plan provides that the evergreen provision will terminate following the increase on the first day of the 2030 fiscal year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, if an award expires or becomes unexercisable without having been exercised in full, is surrendered under an exchange program
described below, or, with respect to restricted stock, restricted stock units or performance awards, is forfeited to or reacquired by us due to the failure to vest, the unpurchased shares (or for awards other than options or stock appreciation
rights, the forfeited or repurchased shares) that were subject to such awards will become available for future grant or sale under the 2020 Plan (unless it has terminated). With respect to stock appreciation rights, only shares actually issued will
cease to be available. Shares that actually have been issued under the 2020 Plan under any award will not be returned to the 2020 Plan and will not become available for future distribution under the 2020 Plan; provided, however, that if shares
issued pursuant to awards of restricted stock, restricted stock units, performance shares or performance units are repurchased by New QuantumScape or are forfeited to New QuantumScape, such shares will become available for future grant under the
2020 Plan. Shares used to pay the exercise price of an award or to satisfy the tax withholding obligations related to an award will become available for future grant or sale. To the extent an award is paid out in cash rather than shares, such cash
payment will not reduce the number of shares available for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">141 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
issuance. If the New QuantumScape Board, or a committee appointed by the New QuantumScape Board, grants awards in substitution for equity compensation awards outstanding under a plan maintained
by an entity acquired by or that becomes a part of any member of the company group, the grant of those substitute awards will not decrease the number of shares available for issuance under the 2020 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any extraordinary dividend or other extraordinary distribution (whether in cash, shares, other securities, or other property),
recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, <FONT STYLE="white-space:nowrap">split-up,</FONT> <FONT STYLE="white-space:nowrap">spin-off,</FONT> combination, reclassification, repurchase, or exchange of
shares or other securities of New QuantumScape, issuance of warrants or other rights to acquire securities of New QuantumScape, other change in the corporate structure of New QuantumScape affecting the shares, or any similar equity restructuring
transaction affecting the shares occurs, the administrator, to prevent diminution or enlargement of the benefits or potential benefits intended to be provided under the 2020 Plan, will adjust the number and class of shares that may be delivered
under the 2020 Plan; the number, class, and price of shares covered by each outstanding award; and the numerical share limits contained in the 2020 Plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Plan Administration </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The New
QuantumScape Board or a committee appointed by the New QuantumScape Board will administer the 2020 Plan and are referred to as the administrator. Different administrators may administer the 2020 Plan with respect to different groups of service
providers. The New QuantumScape Board may retain the authority to concurrently administer the 2020 Plan and revoke the delegation of some or all authority previously delegated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the terms of the 2020 Plan and applicable laws, the administrator generally will have the power in its sole discretion to make any
determinations and perform any actions deemed necessary or advisable for administering the 2020 Plan. The administrator will have the power to administer the 2020 Plan, including but not limited to the power to construe and interpret the 2020 Plan
and awards granted under the 2020 Plan, and determine the terms of awards, including but not limited to the exercise price (if any), the number of shares of New QuantumScape Common Stock subject to each award, the time when awards may vest or be
exercised (including the ability to accelerate the vesting and exercisability of awards), and the form of consideration payable upon exercise, if applicable. The administrator may select the service providers to whom awards may be granted and
approve forms of awards agreements under the 2020 Plan. The administrator will also have the authority to amend awards (including but not limited to the discretionary authority to extend the post-termination exercisability period of awards and to
extend the maximum term of an option) and to temporarily suspend the exercisability of an award if the administrator deems such suspension to be necessary or appropriate for administrative purposes, subject to the provisions of the 2020 Plan. The
administrator may institute and determine the terms and conditions of an exchange program under which (i)&nbsp;outstanding awards are surrendered or cancelled in exchange for awards of the same type (which may have higher or lower exercise prices
and different terms), awards of a different type, and/or cash, (ii)&nbsp;participants have the opportunity to transfer any outstanding awards to a financial institution or other person or entity selected by the administrator, (iii)&nbsp;and/or the
exercise price of an outstanding award is increased or reduced. Unless a participant is on an approved leave of absence, the administrator will have sole discretion to determine the date on which a participant stops actively providing services to
New QuantumScape or the company group. The administrator&#146;s decisions, determinations, and interpretations are final and binding on all participants and any other holders of awards. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock Options </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Options may be
granted under the 2020 Plan. Subject to the provisions of the 2020 Plan, the administrator will determine the terms and conditions of options, including when such options vest and become exercisable (and the administrator will have the discretion to
accelerate the time at which such options will vest or become exercisable). The per share exercise price of any option generally must be at least 100% of the fair market value of a share on the date of grant, and the term of an incentive stock
option may not be more than 10 years. However, with respect to any incentive stock option granted to an individual who owns 10% of the voting power </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">142 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of all classes of stock of New QuantumScape or any of its parent or subsidiary corporations, the term of such option must not exceed 5 years, and the per share exercise price of such incentive
stock option must be at least 110% of the fair market value of a share on the grant date. After a participant&#146;s service terminates, he or she generally may exercise the vested portion of his or her option for the period of time stated in his or
her option agreement. Generally, the fair market value of a share is the closing sales price of a share on the relevant date as quoted on the NYSE. In no event may an option be exercised later than the expiration of its term, except in certain
circumstances where the expiration occurs during a period where exercise is not permitted under applicable law, as described more fully in the 2020 Plan. Subject to the provisions of the 2020 Plan, the administrator will determine the other terms of
options, including but not limited to the acceptable forms of consideration for exercising an option. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock Appreciation Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock appreciation rights may be granted under the 2020 Plan. Stock appreciation rights allow the recipient to receive the appreciation in the
fair market value of New QuantumScape Class&nbsp;A Common Stock between the exercise date and the date of grant. Subject to the provisions of the 2020 Plan, the administrator will determine the terms and conditions of stock appreciation rights,
including when such rights vest and become exercisable (and the administrator will have the discretion to accelerate the time at which such rights will vest or become exercisable) and whether to pay any increased appreciation in cash, shares, or a
combination of both. The per share exercise price of a stock appreciation right must be at least 100% of the fair market value a share on the date of grant with respect to United States taxpayers, and the term of a stock appreciation right will be
10 years. After a participant&#146;s service terminates, he or she generally may exercise the vested portion of his or her stock appreciation right for the period of time stated in his or her option agreement. However, in no event may a stock
appreciation right be exercised later than the expiration of its terms, except in certain circumstances where the expiration occurs during a period where exercise is not permitted under applicable law, as described more fully in the 2020 Plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Restricted Stock </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Restricted stock
may be granted under the 2020 Plan. Restricted stock awards are grants of shares that vest in accordance with terms and conditions established by the administrator. The administrator will determine the number of shares of restricted stock granted to
any employee, director or consultant. The administrator may impose whatever conditions to vesting it determines to be appropriate (for example, the administrator may set restrictions based on the achievement of specific performance goals or
continued service to us or members of the company group), and the administrator will have the discretion to accelerate the time at which any restrictions will lapse or be removed. Recipients of restricted stock awards generally will have voting but
will not have dividend rights with respect to such shares upon grant without regard to the restriction, unless the administrator provides otherwise. Shares of restricted stock as to which the restrictions have not lapsed are subject to our right of
repurchase or forfeiture. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Restricted Stock Units </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Restricted stock units may be granted under the 2020 Plan. Restricted stock units are bookkeeping entries representing an amount equal to the
fair market value of one Share. The administrator will determine the terms and conditions of restricted stock units including the vesting criteria (which may include accomplishing specified performance criteria or continued service to us) and the
form and timing of payment. The administrator will have the discretion to accelerate the time at which any restrictions will lapse or be removed and to settle earned restricted stock units in cash, shares, or a combination of both. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Performance Awards </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Performance
awards may be granted under the 2020 Plan. Performance awards are awards that will result in a payment to a participant only if objectives established by the administrator are achieved or the awards </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">143 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
otherwise vest. The administrator will establish organizational or individual performance objectives in its discretion, which, depending on the extent to which they are met, will determine the
value of the payout for the performance awards to be paid out to participants. The administrator will have the discretion to reduce or waive any performance objectives or other vesting provisions for performance awards. Performance awards will have
a threshold, target, and maximum payout value established by the administrator on or before to the grant date. The administrator will have the discretion to pay earned performance awards in the form of cash, shares, or in some combination of both.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2020 Plan provides that any <FONT STYLE="white-space:nowrap">non-employee</FONT> director, in any fiscal year, may not be paid, issued or
granted cash compensation and equity awards under the 2020 Plan with an aggregate value of more than $750,000, increased to $1,000,000 in connection with the <FONT STYLE="white-space:nowrap">non-employee</FONT> director&#146;s initial service, with
the value of each equity award based on its grant date fair value. For purposes of this limitation, the grant date fair value is determined in accordance with GAAP. Any cash compensation or equity awards granted under the 2020 Plan to a <FONT
STYLE="white-space:nowrap">non-employee</FONT> director for his or her services as an employee, or for his or her services as a consultant (other than as a <FONT STYLE="white-space:nowrap">non-employee</FONT> director), will not count for purposes
of the limitation. The maximum limit does not reflect the intended size of any potential compensation or equity awards to our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-Transferability</FONT> of Awards </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the administrator provides otherwise, the 2020 Plan generally does not allow for the transfer or disposal of awards and only the
recipient of an award may exercise an award during his or her lifetime. Any unauthorized transfer will be void. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Dissolution or Liquidation.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If there is a proposed liquidation or dissolution of New QuantumScape, the administrator will notify participants at such time
before the effective date of such event as the administrator determines and all awards, to the extent that they have not been previously exercised, will terminate immediately before the consummation of such event. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Merger or Change in Control </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
2020 Plan provides that if there is a merger or a &#147;change in control&#148; (as defined under the 2020 Plan) of New QuantumScape, each outstanding award will be treated as the administrator determines (subject to the following paragraph) without
a participant&#146;s consent, including that an award be continued by the successor corporation or that vesting of awards may accelerate automatically upon consummation of the transaction. The administrator will not be required to treat all awards,
portions of awards or participants similarly and may modify awards, subject to the provisions of the 2020 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the successor
corporation does not continue an award (or some portion of such award), the participant will fully vest in (and have the right to exercise) 100% of the then-unvested shares subject to his or her outstanding options and stock appreciation rights, all
restrictions on 100% of the participant&#146;s outstanding restricted stock and restricted stock units will lapse, and, regarding 100% of participant&#146;s outstanding awards with performance-based vesting, all performance goals or other vesting
criteria will be treated as achieved at 100% of target levels and all other terms and conditions met. In no event will vesting of an award accelerate as to more than 100% of the award. If options or stock appreciation rights are not continued when a
change in control or a merger of New QuantumScape with or into another corporation or other entity occurs, the administrator will notify the participant in writing or electronically that the participant&#146;s vested options or stock appreciation
rights (after considering the foregoing vesting acceleration, if any) will be exercisable for a period of time determined by the administrator in its sole discretion and all of the participant&#146;s options or stock appreciation rights will
terminate upon the expiration of such period (whether vested or unvested). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">144 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to awards held by a <FONT STYLE="white-space:nowrap">non-employee</FONT>
director, in the event of a change in control, the <FONT STYLE="white-space:nowrap">non-employee</FONT> director will fully vest in and have the right to exercise his or her options and/or stock appreciation rights, all restrictions on his or her
restricted stock and restricted stock units will lapse, and, with respect to awards with performance-based vesting, all performance goals or other vesting criteria will be deemed achieved at 100% of target levels and all other terms and conditions
met, unless specifically provided otherwise under the applicable award agreement or other written agreement with the participant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Forfeiture and
Clawback </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All awards granted under the 2020 Plan will be subject to recoupment under any clawback policy that we are required to
adopt under applicable law or listing standards. In addition, the administrator may provide in an award agreement that the recipient&#146;s rights, payments, and benefits with respect to such award shall be subject to reduction, cancellation,
forfeiture, or recoupment upon the occurrence of specified events. If New QuantumScape is required to prepare an accounting restatement due to the material noncompliance of New QuantumScape with any applicable securities laws as a result of a
participant&#146;s misconduct or if a participant is subject to forfeiture under applicable law, the participant must reimburse New QuantumScape in the amount of any payment in settlement of an award earned or accrued during the <FONT
STYLE="white-space:nowrap">12-month</FONT> period following the first public issuance or filing with the United States Securities and Exchange Commission (whichever first occurred) of the financial document embodying such financial reporting
requirement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amendment or Termination </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2020 Plan will become effective upon the Closing and will continue in effect until terminated by the administrator, however no incentive
stock options may be granted after the ten (10)&nbsp;year anniversary of the adoption of the 2020 Plan by the Kensington Board, and the evergreen feature of the 2020 Plan will terminate following the increase on the first day of the 2030 fiscal
year. In addition, the New QuantumScape Board will have the authority to amend, suspend, or terminate the 2020 Plan, but such action generally may not materially impair the rights of any participant without his or her written consent. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary of U.S. Federal Income Tax Consequences </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following summary is intended only as a general guide to the U.S. federal income tax consequences of participation in the 2020 Plan. The
summary is based on existing U.S. laws and regulations as of October&nbsp;2020, and there can be no assurance that those laws and regulations will not change in the future. The summary does not purport to be complete and does not discuss the tax
consequences upon a participant&#146;s death, or the provisions of the income tax laws of any municipality, state or foreign country in which the participant may reside. As a result, tax consequences for any particular participant may vary based on
individual circumstances. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Incentive Stock Options </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A participant recognizes no taxable income for regular income tax purposes as a result of the grant or exercise of an option that qualifies as
incentive stock option under Section&nbsp;422 of the Code. If a participant exercises the option and then later sells or otherwise disposes of the shares acquired through the exercise the option after both the
<FONT STYLE="white-space:nowrap">two-year</FONT> anniversary of the date the option was granted and the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the exercise, the participant will recognize a capital gain or loss equal to the
difference between the sale price of the shares and the exercise price, and we will not be entitled to any deduction for federal income tax purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, if the participant disposes of such shares either on or before the <FONT STYLE="white-space:nowrap">two-year</FONT> anniversary of
the date of grant or on or before the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the date of exercise (a &#147;disqualifying disposition&#148;), any gain up to the excess of the fair market value of the shares on the date of
exercise over the exercise price generally will be taxed as ordinary income, unless the shares are disposed of in a transaction in which the participant would </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">145 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
not recognize a gain (such as a gift). Any gain in excess of that amount will be a capital gain. If a loss is recognized, there will be no ordinary income, and such loss will be a capital loss.
Any ordinary income recognized by the participant upon the disqualifying disposition of the shares generally should be deductible by us for federal income tax purposes, except to the extent such deduction is limited by applicable provisions of the
Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the alternative minimum tax, the difference between the option exercise price and the fair market value of the
shares on the exercise date is treated as an adjustment item in computing the participant&#146;s alternative minimum taxable income in the year of exercise. In addition, special alternative minimum tax rules may apply to certain subsequent
disqualifying dispositions of the shares or provide certain basis adjustments or tax credits for purposes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nonstatutory Stock Options </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A participant generally recognizes no taxable income as the result of the grant of such an option. However, upon exercising the option, the
participant normally recognizes ordinary income equal to the amount that the fair market value of the shares on such date exceeds the exercise price. If the participant is an employee, such ordinary income generally is subject to withholding of
income and employment taxes. Upon the sale of the shares acquired by the exercise of a nonstatutory stock option, any gain or loss (based on the difference between the sale price and the fair market value on the exercise date) will be taxed as
capital gain or loss. No tax deduction is available to us with respect to the grant of a nonstatutory stock option or the sale of the shares acquired through the exercise of the nonstatutory stock option. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock Appreciation Rights </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
general, no taxable income is reportable when a stock appreciation right is granted to a participant. Upon exercise, the participant generally will recognize ordinary income in an amount equal to the fair market value of any shares received. Any
additional gain or loss recognized upon any later disposition of the shares would be capital gain or loss. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Restricted Stock Awards </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A participant acquiring shares of restricted stock generally will recognize ordinary income equal to the fair market value of the shares on the
vesting date. If the participant is an employee, such ordinary income generally is subject to withholding of income and employment taxes. The participant may elect, pursuant to Section&nbsp;83(b) of the Code to accelerate the ordinary income tax
event to the date of acquisition by filing an election with the IRS no later than thirty days after the date the shares are acquired. Upon the sale of shares acquired pursuant to a restricted stock award, any gain or loss, based on the difference
between the sale price and the fair market value on the date the ordinary income tax event occurs, will be taxed as capital gain or loss. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Restricted Stock Unit Awards </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no immediate tax consequences of receiving an award of restricted stock units. A participant who is awarded restricted stock units
generally will be required to recognize ordinary income in an amount equal to the fair market value of shares issued to such participant at the end of the applicable vesting period or, if later, the settlement date elected by the administrator or a
participant. Any additional gain or loss recognized upon any later disposition of any shares received would be capital gain or loss. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Performance
Awards </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A participant generally will recognize no income upon the grant of a performance award. Upon the settlement of such awards,
participants normally will recognize ordinary income in the year of receipt in an </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">146 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amount equal to the cash received and the fair market value of any unrestricted shares received. If the participant is an employee, such ordinary income generally is subject to withholding of
income and employment taxes. Upon the sale of any shares received, any gain or loss, based on the difference between the sale price and the fair market value on the date the ordinary income tax event occurs, will be taxed as capital gain or loss.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Section&nbsp;409A </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;409A of the Code provides certain requirements for <FONT STYLE="white-space:nowrap">non-qualified</FONT> deferred compensation
arrangements with respect to an individual&#146;s deferral and distribution elections and permissible distribution events. Awards granted under the 2020 Plan with a deferral feature will be subject to the requirements of Section&nbsp;409A. If an
award is subject to and fails to satisfy the requirements of Section&nbsp;409A, the recipient of that award may recognize ordinary income on the amounts deferred under the award, to the extent vested, which may be prior to when the compensation is
actually or constructively received. Also, if an award that is subject to Section&nbsp;409A fails to comply with Section&nbsp;409A&#146;s provisions, Section&nbsp;409A imposes an additional 20% federal income tax on compensation recognized as
ordinary income, as well as interest on such deferred compensation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Tax Effect for New QuantumScape </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New QuantumScape generally will be entitled to a tax deduction in connection with an award under the 2020 Plan in an amount equal to the
ordinary income realized by a participant and at the time the participant recognizes such income (for example, the exercise of a nonstatutory stock option) except to the extent such deduction is limited by applicable provisions of the Code. Special
rules limit the deductibility of compensation paid to our chief executive officer and certain &#147;covered employees&#148; as determined under Section&nbsp;162(m) and applicable guidance. Under Section&nbsp;162(m), the annual compensation paid to
any of these specified individuals will be deductible only to the extent that it does not exceed $1,000,000. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">THE FOREGOING IS ONLY A
SUMMARY OF THE EFFECT OF U.S. FEDERAL INCOME TAXATION UPON PARTICIPANTS AND NEW QUANTUMSCAPE WITH RESPECT TO AWARDS UNDER THE 2020 PLAN. IT DOES NOT PURPORT TO BE COMPLETE AND DOES NOT DISCUSS THE IMPACT OF EMPLOYMENT OR OTHER TAX REQUIREMENTS, THE
TAX CONSEQUENCES OF A PARTICIPANT&#146;S DEATH, OR THE PROVISIONS OF THE INCOME TAX LAWS OF ANY MUNICIPALITY, STATE, OR FOREIGN COUNTRY IN WHICH THE PARTICIPANT MAY RESIDE. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Number of Awards Granted to Employees, Consultants and Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of awards that an employee, director, or consultant may receive under the 2020 Plan is in the discretion of the administrator and
therefore cannot be determined in advance. We have not previously sponsored an equity incentive plan, and, therefore, the aggregate number of shares of New QuantumScape Class&nbsp;A Common Stock which would have been received by or allocated to our
named executive officers; executive officers, as a group; directors who are not executive officers, as a group; and all other current employees who are not executive officers, as a group is not determinable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required for Approval </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approval of
the 2020 Plan requires the affirmative vote (in person or by proxy) of the holders of a majority of the shares entitled to vote at the special meeting. Failure to vote by proxy or to vote in person at the special meeting, or a broker <FONT
STYLE="white-space:nowrap">non-vote</FONT> will have no effect on the outcome of the vote on this proposal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendation of the Board </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE KENSINGTON BOARD UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE &#147;FOR&#148; THE APPROVAL OF THE EQUITY INCENTIVE PLAN PROPOSAL.
</B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">147 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_50"></A>PROPOSAL NO. 8&#151;THE NYSE PROPOSAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Business
Combination, we intend to effect (subject to customary terms and conditions) at the Closing: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuance, pursuant to the Business Combination Agreement, of 199,527,779 shares of New QuantumScape
Class&nbsp;A Common Stock to the holders of QuantumScape Class&nbsp;A Common Stock and holders of QuantumScape Class&nbsp;A Preferred Stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuance, pursuant to the Business Combination Agreement, of 169,272,161 shares of New QuantumScape
Class&nbsp;B Common Stock to the holders of QuantumScape Class&nbsp;B Common Stock and holders of QuantumScape Class&nbsp;B Preferred Stock; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuance of 50,000,000 shares of New QuantumScape Class&nbsp;A Common Stock to the investors in the PIPE,
which will be consummated concurrently with the Closing. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For further information, please see the section entitled
&#147;<I>Proposal No.</I><I></I><I>&nbsp;1&#151;The Business Combination Proposal</I>,&#148; as well as Annex A to this proxy statement/prospectus/information statement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why Kensington Needs Stockholder Approval </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are seeking stockholder approval in order to comply with Section&nbsp;312.03(c) of the NYSE Listed Company Manual. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Section&nbsp;312.03(c) of the NYSE Listed Company Manual, stockholder approval is required prior to the issuance of common stock, or of
securities convertible into or exercisable for common stock, in any transaction or series of related transactions if such securities are not issued in a public offering for cash and (a)&nbsp;have, or will have upon issuance, voting power equal to or
in excess of 20% of the voting power outstanding before the issuance of such stock or securities convertible into or exercisable for common stock; or (b)&nbsp;the number of shares of common stock to be issued is, or will be upon the issuance, equal
to or in excess of 20% of the number of shares of common stock outstanding before the issuance of the common stock or securities convertible into or exercisable for common stock. Kensington will issue shares representing 20% or more of the number of
outstanding shares of Kensington Class&nbsp;A Common Stock and Kensington Class&nbsp;B Common Stock prior to the issuance, or 20% or more of its voting power prior to the issuance, pursuant to the Business Combination Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholder approval of the NYSE Proposal is also a condition to the Closing under the Business Combination Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Effect of Proposal on Current Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the NYSE Proposal is adopted, upon the Closing, we will issue an aggregate of 199,527,779 shares of New QuantumScape Class&nbsp;A Common
Stock and 169,272,161 shares of New QuantumScape Class&nbsp;B Common Stock to the holders of QuantumScape Capital Stock. We will also issue 50,000,000&nbsp;shares of New QuantumScape Class&nbsp;A Common Stock to the PIPE investors upon the
consummation of the PIPE. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The issuance of the shares of New QuantumScape Common Stock described above will result in significant
dilution to Kensington stockholders and result in Kensington stockholders having a smaller percentage interest in the voting power, liquidation value and aggregate book value of Kensington. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">148 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required for Approval </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The NYSE Proposal is conditioned on the approval of the Business Combination Proposal at the special meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approval of the NYSE Proposal requires the affirmative vote (in person or by proxy) of holders of a majority of the outstanding shares of
Kensington Common Stock entitled to vote and actually voted thereon at the special meeting. Failure to vote by proxy or to vote in person at the special meeting, an abstention from voting or a broker <FONT STYLE="white-space:nowrap">non-vote</FONT>
will have no effect on the outcome of the vote on the NYSE Proposal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendation of our Board of Directors </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE KENSINGTON BOARD UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE &#147;FOR&#148; THE APPROVAL THE NYSE PROPOSAL. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">149 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_51"></A>PROPOSAL NO. 9&#151;THE EMPLOYEE STOCK PURCHASE PLAN PROPOSAL
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are seeking stockholder approval for the QuantumScape Corporation 2020 Employee Stock Purchase Plan, or the &#147;ESPP.&#148; The
ESPP is being adopted in connection with the Business Combination and will become effective upon the Closing, but the first offering period will commence at a later date determined by the administrator of the ESPP. The ESPP will provide eligible
employees an opportunity to purchase New QuantumScape Class&nbsp;A Common Stock at a discount through accumulated contributions of their earned compensation. The Kensington Board and its compensation committee have determined that offering an
employee stock purchase plan is important to our ability to compete for talent. The ESPP will become a significant part of our overall equity compensation strategy (especially with respect to our nonexecutive employees) if it is approved by
Kensington&#146;s stockholders. If Kensington&#146;s stockholders do not approve the ESPP, we may not be able to offer competitive compensation to existing employees and qualified candidates, which could prevent us from successfully attracting and
retaining highly skilled employees. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ESPP&#146;s initial share reserve which we are asking the stockholders to approve is
7,600,000 shares of New QuantumScape Class&nbsp;A Common Stock. Following the ESPP&#146;s effectiveness, offering periods will not commence under the ESPP until determined by the New QuantumScape Board or its compensation committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Kensington Board and its compensation committee believe that an employee stock purchase plan will be an important factor in attracting,
motivating, and retaining qualified personnel who are essential to our success. The ESPP provides a significant incentive by allowing employees to purchase shares of New QuantumScape Class&nbsp;A Common Stock at a discount. The Kensington Board has
approved the ESPP, subject to the approval of Kensington&#146;s stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary of the 2020 Employee Stock Purchase Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the principal features of the ESPP and its operation. This summary does not contain all of the terms and
conditions of the ESPP and is qualified in its entirety by reference to the ESPP as set forth in Annex E attached to this proxy statement/prospectus/information statement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Purpose </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose of the ESPP
is to provide eligible employees with an opportunity to purchase shares of the New QuantumScape Class&nbsp;A Common Stock through accumulated contributions, which generally will be made through payroll deductions. The ESPP permits the administrator
(as discussed below) to grant purchase rights that qualify for preferential tax treatment under Section&nbsp;423 of the Code. In addition, the ESPP authorizes the grant of purchase rights that do not qualify under Code Section&nbsp;423 pursuant to
rules, procedures or <FONT STYLE="white-space:nowrap">sub-plans</FONT> adopted by the administrator that are designed to achieve desired tax or other objectives. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Shares Available for Issuance </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If Kensington&#146;s stockholders approve the ESPP, and subject to adjustment upon certain changes in our capitalization as described in the
ESPP, the maximum number of shares of New QuantumScape Class&nbsp;A Common Stock that will be available for issuance under the ESPP will be 7,600,000 shares. The shares may be authorized, but unissued, or reacquired New QuantumScape Class&nbsp;A
Common Stock. The number of shares of New QuantumScape Class&nbsp;A Common Stock available for issuance under the ESPP will be increased on the first day of each fiscal year beginning with the 2021 fiscal year equal to the least of (i) 7,600,000
shares of New QuantumScape Class&nbsp;A Common Stock, (ii) one percent (1%) of the outstanding shares of all classes of New QuantumScape Common Stock on the last day of the immediately preceding fiscal year, or (iii)&nbsp;an amount determined by the
administrator. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently are unable to determine how long this share reserve may last because the number of shares that will be
issued in any year or offering period depends on a variety of factors that cannot be predicted with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">150 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
certainty, including, for example, the number of employees who elect to participate in the ESPP, the level of contributions made by participants and the future price of shares of New QuantumScape
Class&nbsp;A Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If Kensington&#146;s stockholders do not approve the ESPP, then the ESPP will not become effective and no
shares of New QuantumScape Class&nbsp;A Common Stock will be available for issuance thereunder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Administration </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ESPP will be administered by the New QuantumScape Board or a committee appointed by the New QuantumScape Board that is constituted to
comply with applicable laws (including the compensation committee). We expect the compensation committee to be the administrator of the ESPP. Subject to the terms of the ESPP, the administrator will have full and exclusive discretionary authority to
construe, interpret and apply the terms of the ESPP, to delegate ministerial duties to any of our employees, to designate separate offerings under the ESPP, to designate subsidiaries and affiliates as participating in the Section&nbsp;423 Component
and the <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component, to determine eligibility, to adjudicate all disputed claims filed under the ESPP and to establish such procedures that it deems necessary or advisable for the administration
of the ESPP. The administrator is authorized to adopt rules and procedures in order to: determine eligibility to participate, determine the definition of compensation for the purposes of contributions to the ESPP, handle contributions to the ESPP,
coordinate the making of contributions to the ESPP, establish bank or trust accounts to hold contributions to the ESPP, effect the payment of interest, effect the conversion of local currency, satisfy obligations to pay payroll tax, determine
beneficiary designation requirements, implement and determine withholding procedures and determine procedures for the handling of stock certificates that vary with applicable local requirements. The administrator will also be authorized to determine
that, to the extent permitted by applicable law, the terms of a purchase right granted under the ESPP or an offering to citizens or residents of a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdiction will be less favorable than the terms of
options granted under the ESPP or the same offering to employees resident solely in the United States. Every finding, decision and determination made by the administrator will, to the full extent permitted by law, be final and binding upon all
parties. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Eligibility </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, all of our employees will be eligible to participate if they are customarily employed by us, or any participating subsidiary or
affiliate, for at least 20 hours per week and more than five months in any calendar year. The administrator, in its discretion, may, prior to an enrollment date, for all options to be granted on such enrollment date in an offering, determine that an
employee who (i)&nbsp;has not completed at least two years of service (or a lesser period of time determined by the administrator) since his or her last hire date, (ii)&nbsp;customarily works not more than 20 hours per week (or a lesser period of
time determined by the administrator), (iii) customarily works not more than five months per calendar year (or a lesser period of time determined by the administrator), (iv) is a highly compensated employee within the meaning of Section&nbsp;414(q)
of the Code, or (v)&nbsp;is a highly compensated employee within the meaning of Section&nbsp;414(q) of the Code with compensation above a certain level or is an officer or subject to disclosure requirements under Section&nbsp;16(a) of the Exchange
Act, is or is not eligible to participate in such offering period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, an employee may not be granted rights to purchase shares of
New QuantumScape Class&nbsp;A Common Stock under the ESPP if such employee: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">immediately after the grant would own capital stock and/or hold outstanding options to purchase such stock
possessing 5% or more of the total combined voting power or value of all classes of capital stock of ours or of any parent or subsidiary of ours; or </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">holds rights to purchase shares of New QuantumScape Common Stock under all employee stock purchase plans of ours
or any parent or subsidiary of ours that accrue at a rate that exceeds $25,000 worth of shares of New QuantumScape Common Stock for each calendar year in which such rights are outstanding at any time. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">151 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Offering Periods </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ESPP will include a component that allows us to make offerings intended to qualify under Section&nbsp;423 of the Code and a component that
allows us to make offerings not intended to qualify under Section&nbsp;423 of the Code to designated companies, as described in the ESPP. Offering periods will begin and end on such dates as may be determined by the administrator in its discretion,
in each case on a uniform and nondiscriminatory basis, and may contain one or more purchase periods. The administrator may change the duration of offering periods (including commencement dates) with respect to future offerings so long as such change
is announced prior to the scheduled beginning of the first offering period affected. No offering period may last more than 27 months. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Contributions
</I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ESPP will permit participants to purchase shares of New QuantumScape Class&nbsp;A Common Stock through contributions (in
the form of payroll deductions or otherwise to the extent permitted by the administrator) of up to 15% of their eligible compensation, or such other limit established by the administrator from time to time in its discretion and on a uniform and
nondiscretionary basis for all options to be granted on an enrollment date in an offering, which includes a participant&#146;s base straight time gross earnings but excludes payments for commissions, incentive compensation, bonuses, payments for
overtime and shift premium, equity compensation income and other similar compensation. Unless otherwise determined by the administrator, during any offering period, a participant may not increase the rate of his or her contributions and may only
decrease the rate of his or her contributions (including to 0%) one time. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Exercise of Purchase Right </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Amounts contributed and accumulated by the participant will be used to purchase shares of New QuantumScape Class&nbsp;A Common Stock at the end
of each purchase period. A participant may purchase a maximum number of shares of New QuantumScape Class&nbsp;A Common Stock during a purchase period as determined by the administrator in its discretion and on a uniform and nondiscriminatory basis.
The purchase price of the shares will be determined by the administrator from time to time, in its discretion and on a uniform and nondiscriminatory basis for all options to be granted on an enrollment date, provided that in no event may the
purchase price be less than 85% of the lower of the fair market value of New QuantumScape Class&nbsp;A Common Stock on the first trading day of the offering period or on the exercise date, which is generally the last trading day of a purchase
period. Participants may end their participation at any time during an offering period and will be paid their accrued contributions that have not yet been used to purchase shares of New QuantumScape Class&nbsp;A Common Stock. Participation ends
automatically upon termination of employment with us. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Termination of Participation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Participation in the ESPP generally will terminate when a participating employee&#146;s employment with us or a designated company ceases for
any reason, the employee withdraws from the ESPP or we terminate or amend the ESPP such that the employee no longer is eligible to participate. An employee may withdraw his or her participation in the ESPP at any time in accordance with procedures,
and prior to any applicable deadline, specified by the administrator. Upon withdrawal from the ESPP, in general the employee will receive all amounts credited to his or her account without interest (unless otherwise required under applicable law)
and his or her payroll withholdings or contributions under the ESPP will cease. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-Transferability</FONT>
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither contributions credited to a participant&#146;s account nor rights to purchase shares of New QuantumScape Class&nbsp;A
Common Stock and any other rights and interests under the ESPP may be assigned, transferred, pledged or otherwise disposed of (other than by will, the laws of descent and distribution or beneficiary designation in the event of death). Any attempt at
such prohibited disposition will be without effect, except that we may treat such act as an election to withdraw participation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">152 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain Transactions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that any dividend or other distribution (whether in the form of cash, New QuantumScape Class&nbsp;A Common Stock, other
securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, <FONT STYLE="white-space:nowrap">split-up,</FONT> <FONT STYLE="white-space:nowrap">spin-off,</FONT> combination,
reclassification, repurchase, or exchange of shares of New QuantumScape Class&nbsp;A Common Stock or our other securities, or other change in our corporate structure affecting the New QuantumScape Class&nbsp;A Common Stock occurs (other than any
ordinary dividends or other ordinary distributions), the administrator, in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made available under the ESPP in such manner it may deem equitable, will
adjust the number and class of New QuantumScape Class&nbsp;A Common Stock that may be delivered under the ESPP, the purchase price per share, the number of shares of New QuantumScape Class&nbsp;A Common Stock covered by each purchase right under the
ESPP that has not yet been exercised, and the numerical limits of the ESPP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of our proposed dissolution or liquidation, any
ongoing offering periods will be shortened and will terminate immediately before consummation of the proposed dissolution or liquidation following the purchase of shares of New QuantumScape Class&nbsp;A Common Stock under the shortened offering
periods, unless provided otherwise by the administrator. Prior to the new exercise date, the administrator will notify participants regarding the new exercise date and the exercise to occur on such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a merger or &#147;change in control&#148; (as defined in the ESPP), each outstanding option under the ESPP will be assumed or
substituted for by the successor corporation or its parent or subsidiary. In the event that options are not assumed or substituted for, the offering period will be shortened by setting a new exercise date on which the offering period will end, which
will occur prior to the closing of the merger or change in control. Prior to the new exercise date, the administrator will notify participants regarding the new exercise date and the exercise to occur on such date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amendment; Termination </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
administrator will have the authority to amend, suspend or terminate the ESPP. The ESPP automatically will terminate in 2040, unless we terminate it sooner. If the administrator determines that the ongoing operation of the ESPP may result in
unfavorable financial accounting consequences, the administrator may modify, amend or terminate the ESPP to reduce or eliminate such accounting consequence. If the ESPP is terminated, the administrator in its discretion may terminate all outstanding
offering periods either immediately or after consummation of the purchase of shares of New QuantumScape Class&nbsp;A Common Stock under the ESPP (which may be adjusted to occur sooner than originally scheduled), or in accordance with their terms. If
options are terminated prior to their expiration, then all amounts credited to participants that have not been used to purchase shares of New QuantumScape Class&nbsp;A Common Stock will be returned, without interest (unless otherwise required under
applicable law), as soon as administratively practicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary of U.S. Federal Income Tax Consequences </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following summary is intended only as a general guide to the material U.S. federal income tax consequences of participation in the ESPP.
The summary is based on existing U.S. laws and regulations, and there can be no assurance that those laws and regulations will not change in the future. The summary does not purport to be complete and does not discuss the tax consequences upon a
participant&#146;s death, or the provisions of the income tax laws of any municipality, state or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdiction to which the participant may be subject. As a result, tax consequences for any particular
participant may vary based on individual circumstances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ESPP is intended to qualify as an employee stock purchase plan within the
meaning of Section&nbsp;423 of the Code. Under an employee stock purchase plan that so qualifies, no taxable income will be recognized by a participant, and no deductions will be allowable to New QuantumScape, upon either the grant or the exercise
of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">153 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the purchase rights. Taxable income will not be recognized until there is a sale or other disposition of the shares of New QuantumScape Class&nbsp;A Common Stock acquired under the ESPP or in the
event of the participant&#146;s death while still owning the purchased shares of New QuantumScape Class&nbsp;A Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the
participant sells or otherwise disposes of the purchased shares of New QuantumScape Class&nbsp;A Common Stock within two years after the start date of the offering period in which the shares of Common Stock were acquired or within one year after the
actual purchase date of those shares of New QuantumScape Class&nbsp;A Common Stock, then the participant generally will recognize ordinary income in the year of sale or disposition equal to the amount by which the fair market value of the shares of
New QuantumScape Class&nbsp;A Common Stock on the purchase date exceeded the purchase price paid for those shares of New QuantumScape Class&nbsp;A Common Stock, and we will be entitled to an income tax deduction equal in amount to such excess, for
the taxable year in which such disposition occurs. The amount of this ordinary income will be added to the participant&#146;s basis in the shares of New QuantumScape Class&nbsp;A Common Stock, and any resulting gain or loss recognized upon the sale
or disposition will be a capital gain or loss. If the shares of New QuantumScape Class&nbsp;A Common Stock have been held for more than one year since the date of purchase, the gain or loss will be long-term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the participant sells or disposes of the purchased shares of New QuantumScape Class&nbsp;A Common Stock more than two years after the start
date of the offering period in which the shares of New QuantumScape Class&nbsp;A Common Stock were acquired and more than one year after the actual purchase date of those shares of New QuantumScape Class&nbsp;A Common Stock, then the participant
generally will recognize ordinary income in the year of sale or disposition equal to the lesser of (a)&nbsp;the amount by which the fair market value of the shares of New QuantumScape Class&nbsp;A Common Stock on the sale or disposition date
exceeded the purchase price paid for those shares of New QuantumScape Class&nbsp;A Common Stock, or (b) 15% of the fair market value of the shares of New QuantumScape Class&nbsp;A Common Stock on the start date of that offering period. Any
additional gain upon the disposition will be taxed as a long-term capital gain. Alternatively, if the fair market value of the shares of New QuantumScape Class&nbsp;A Common Stock on the date of the sale or disposition is less than the purchase
price, there will be no ordinary income and any loss recognized will be a long-term capital loss. We will not be entitled to an income tax deduction with respect to such disposition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, a participant&#146;s annual &#147;net investment income,&#148; as defined in Section&nbsp;1411 of the Code, may be subject to a
3.8% U.S. federal surtax. Net investment income may include capital gain and/or loss arising from the disposition of shares of New QuantumScape Class&nbsp;A Common Stock purchased under the ESPP. Whether a participant&#146;s net investment income
will be subject to this surtax will depend on the participant&#146;s level of annual income and other factors. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the participant
still owns the purchased shares of New QuantumScape Class&nbsp;A Common Stock at the time of death, the lesser of (i)&nbsp;the amount by which the fair market value of the shares of New QuantumScape Class&nbsp;A Common Stock on the date of death
exceeds the purchase price or (ii) 15% of the fair market value of the shares of New QuantumScape Class&nbsp;A Common Stock on the start date of the offering period in which those shares of New QuantumScape Class&nbsp;A Common Stock were acquired
will constitute ordinary income in the year of death. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Plan Benefits </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Participation in the ESPP is voluntary and dependent on each eligible employee&#146;s election to participate, the amount of his or her
eligible compensation, and his or her determination as to the portion of his or her eligible compensation to contribute to the ESPP. Further, the number of shares of New QuantumScape Class&nbsp;A Common Stock that may be purchased under the ESPP is
determined, in part, by the price of our shares of New QuantumScape Class&nbsp;A Common Stock on the first day of each offering period and applicable exercise date of each purchase period. Accordingly, the actual number of shares of New QuantumScape
Class&nbsp;A Common Stock that would be purchased by any individual under the ESPP in the future is not determinable. We have not previously sponsored an employee stock purchase plan, and, therefore, the number of shares of New QuantumScape
Class&nbsp;A Common Stock which would have been received by or allocated to our named executive </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">154 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
officers, all current executive officers as a group, and all other current employees who may participate in the ESPP as a group are not determinable.
<FONT STYLE="white-space:nowrap">Non-employee</FONT> directors are not eligible to participate in the ESPP. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required for Approval </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approval of the ESPP requires the affirmative vote (in person or by proxy) of the holders of a majority of the shares entitled to vote at the
special meeting. Failure to vote by proxy or to vote in person at the special meeting, or a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will have no effect on the outcome of the vote on this proposal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendation of the Board </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE
KENSINGTON BOARD UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE &#147;FOR&#148; THE APPROVAL OF THE EMPLOYEE STOCK PURCHASE PLAN PROPOSAL. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">155 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_52"></A>PROPOSAL NO. 10&#151;THE ADJOURNMENT PROPOSAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Adjournment Proposal </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Adjournment
Proposal, if adopted, will allow the Kensington Board to adjourn the special meeting of stockholders to a later date or dates to permit further solicitation of proxies. The Adjournment Proposal will only be presented to Kensington&#146;s
stockholders in the event that, based on the tabulated votes, there are not sufficient votes at the time of the special meeting of stockholders to approve one or more of the proposals presented at the special meeting or Public Stockholders have
elected to redeem an amount of Public Shares such that the minimum available cash condition to QuantumScape&#146;s obligation to effect the closing of the Business Combination would not be satisfied. In no event will the Kensington Board adjourn the
special meeting of stockholders or consummate the Business Combination beyond the date by which it may properly do so under the Existing Certificate of Incorporation and Delaware law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consequences if the Adjournment Proposal is Not Approved </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Adjournment Proposal is not approved by Kensington&#146;s stockholders, the Kensington Board may not be able to adjourn the special
meeting of stockholders to a later date in the event that, based on the tabulated votes, there are not sufficient votes at the time of the special meeting of stockholders to approve the Business Combination Proposal or Public Stockholders have
elected to redeem an amount of Public Shares such that the minimum available cash condition to the obligation to closing of the Business Combination would not be satisfied. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required for Approval </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approval of
the Adjournment Proposal requires the affirmative vote (in person or by proxy) of holders of a majority of the outstanding shares of Kensington Common Stock entitled to vote and actually voted thereon at the special meeting. Failure to vote by proxy
or to vote in person at the special meeting, an abstention from voting or a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will have no effect on the outcome of the vote on the NYSE Proposal. Adoption of the Adjournment Proposal is not
conditioned upon the adoption of any of the other proposals. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendation of the Board </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE KENSINGTON BOARD UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE &#147;FOR&#148; THE APPROVAL OF THE ADJOURNMENT PROPOSAL. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">156 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_53"></A>INFORMATION ABOUT QUANTUMSCAPE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Unless the context otherwise requires, all references in this section to &#147;we,&#148; &#147;us,&#148; or &#147;our&#148; refer to
QuantumScape and its subsidiaries prior to the Closing. </I></P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape is developing next generation battery technology for EVs and other applications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are at the beginning of a forecasted
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">once-in-a-century</FONT></FONT></FONT> shift in automotive powertrains, from internal combustion engines to clean, EVs. While current battery
technology has demonstrated the benefits of EVs, principally in the premium passenger car market, there are fundamental limitations inhibiting widespread adoption of battery technology. As a result, today, approximately 2% of global light-vehicles
are electrified. We believe a new battery technology represents the most promising path to enable a mass market shift.</P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After 30 years
of gradual improvements in conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries we believe the market needs a step change in battery technology to make mass market EVs competitive with the fossil fuel alternative. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have spent the last decade developing a proprietary solid-state battery technology to meet this challenge. We believe that our technology
enables a new category of battery that meets the requirements for broader market adoption. The lithium-metal solid-state battery technology that we are developing is being designed to offer greater energy density, longer life, faster charging, and
greater safety when compared to today&#146;s conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries.</P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Over the last
eight years we have been fortunate to have developed a strong partnership with Volkswagen. Volkswagen is one of the largest car companies in the world and intends to be a leader in EVs. Volkswagen has announced plans to launch more than 70 new EV
models and build more than 25&nbsp;million vehicles on electric platforms by the end of the decade. Over the last eight years Volkswagen has invested and committed to invest, subject, in certain cases, to certain closing conditions that have not yet
been satisfied, a total of more than $300&nbsp;million in QuantumScape and has established a <FONT STYLE="white-space:nowrap">50-50</FONT> joint venture with QuantumScape to enable an industrial level of production of our solid-state batteries. As
50-50 partners in the joint venture with Volkswagen, we expect to share equally in the revenue and profit from the joint venture. Over the course of our relationship, Volkswagen has successfully tested multiple generations of certain of our
single-layer, laboratory cells at industry-accepted automotive rates of power (power is the rate at which a battery can be charged and discharged). We believe no other lithium-metal battery technology has demonstrated the capability of achieving
automotive rates of power with acceptable battery life.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While we expect Volkswagen will be the first to commercialize vehicles using our
battery technology, over the next few years as we build our Pilot Facility, we intend to work closely with other automotive OEMs to make our solid-state battery cells widely available over time. As part of our joint venture agreement we have agreed
that the Pilot Facility will be the first facility to manufacture our battery technology for automotive applications, but, subject to the other terms of the joint venture arrangements, we are not limited from working in parallel with other
automotive OEMs to commercialize our technology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our development uses earth-abundant materials and processes suitable for high volume
production. Our processes use tools which are already used at scale in the battery or ceramics industries. Outside of the separator, our battery is being designed to use many of the materials and processes that are standard across today&#146;s
battery manufacturers. As a result, we expect to benefit from the projected industry-wide cost declines for these materials that result from process improvements and economies of scale. We believe that the manufacturing of our solid-state battery
cells provides us with a structural cost advantage because our battery cells are manufactured without an anode. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are government
regulations pertaining to battery safety, transportation of batteries, use of batteries in cars, factory safety, and disposal of hazardous materials. We will ultimately have to comply with these regulations to sell our batteries into the market. The
license and sale of our batteries abroad is likely to be subject to export controls in the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">157 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Industry Background</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Shift to EVs</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that
evolving consumer preferences coupled with growing government incentives and regulations are driving a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">once-in-a-century</FONT></FONT></FONT> shift to
EVs. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Countries around the world are promoting EVs. The dependence on gasoline-powered internal combustion engine (&#147;ICE&#148;)
vehicles has heightened environmental concerns, created reliance among industrialized and developing nations on large oil imports, and exposed consumers to unstable fuel prices and health concerns related to heightened emissions.&nbsp;Many national
and regional regulatory bodies have adopted legislation to incentivize or require a shift to lower-emission and <FONT STYLE="white-space:nowrap">zero-emission</FONT> vehicles. For example, countries such as the United Kingdom, the Netherlands,
Sweden, Germany, and France have announced intentions to either increase applicable environmental targets or outright ban the sale of new ICE vehicles in the next two decades. More recently, California passed regulations requiring half of trucks
sold in the state to be <FONT STYLE="white-space:nowrap">zero-emissions</FONT> by 2035 and 100% by 2045. This global push to transition from ICE vehicles, aided by favorable government incentives and regulations, is accelerating the growth in lower-
and <FONT STYLE="white-space:nowrap">zero-emission</FONT> vehicle markets.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, consumers are increasingly considering EVs for a
variety of reasons including better performance, growing EV charging infrastructure, significantly lighter environmental impact, and lower maintenance and operating costs. Automakers such as Tesla, Inc. have demonstrated that premium EVs can deliver
a compelling alternative to fossil fuels. As EVs become more competitive and more affordable, we believe that they will continue to take market share from ICE vehicles.&nbsp;We believe that this shift will occur across vehicle types and market
segments. However, some of the inherent limitations of <FONT STYLE="white-space:nowrap">lithium-ion</FONT> battery technology remain an impediment to meaningful improvements in EV competitiveness and cost.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Current Battery Technology Will Not Meet the Requirements for Broad Adoption of EVs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Despite the significant progress in the shift to EVs, the market remains dominated by ICE vehicles. According to the International Energy
Association, approximately 2% of light vehicles are EVs. For EVs to be adopted at scale across market segments batteries need to improve. In particular, we believe there are five key requirements to drive broad adoption of EVs: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Battery capacity (energy density).</I></B> EVs need to be able to drive over 300 miles on a single charge
to achieve broad market adoption.&nbsp;The volume required for conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> battery technology limits the range of many EVs.&nbsp;Higher energy density will enable automotive OEMs to increase
battery pack energy without increasing the size and weight of the vehicle&#146;s battery pack.</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Fast charging capability.</I></B> EV batteries need to be fast-charging to replicate the speed and ease
with which a gasoline car can be refueled. We believe this objective is achieved with the ability to charge to at least 80% capacity in under 15 minutes, without materially degrading battery life.</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Safety (nonflammable).</I></B> EV batteries need to replace as many of the flammable components in the
battery as possible with <FONT STYLE="white-space:nowrap">non-flammable</FONT> equivalents to reduce the risk of fire.&nbsp;With current batteries, many abuse conditions, including malfunctions that can result in overcharges and battery damage from
accidents, can result in fires.</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Cost.</I></B> Mass market adoption of EVs requires a battery that is capable of delivering long range while
remaining cost competitive with a vehicle price point of around $30,000. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Battery life.</I></B> Batteries need to be usable for the life of the vehicle, typically 12 years or
150,000 miles. If the battery fades prematurely, EVs will not be an economically practical alternative.</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since these
requirements have complex interlinkages, most manufacturers of conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries used in today&#146;s cars are forced to make trade-offs.&nbsp;For example, conventional batteries can be
fast-charged, but at the cost of significantly limiting their battery life.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">158 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that a battery technology that can meet these requirements will enable an EV
solution that is much more broadly competitive with internal combustion engines. With more than 90&nbsp;million ICE vehicles produced in 2019 across the auto industry, there is significant untapped demand for a battery that meets these goals &#150;
a potential market opportunity in excess of $450&nbsp;billion annually. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Limitations of Conventional
<FONT STYLE="white-space:nowrap">Lithium-ion</FONT> Battery Technologies </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The last significant development in battery technology
was the commercialization of <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries in the early 1990s which created a new class of batteries with higher energy density. <FONT STYLE="white-space:nowrap">Lithium-ion</FONT> batteries have
enabled a new generation of mobile electronics, efficient renewable energy storage, and the start of the transition to electrified mobility.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since the 1990s, conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries have seen a gradual improvement in energy density.
Most increases in cell energy density have come from improved cell design and incremental improvements in cathode and anode technology.&nbsp;However, there is no Moore&#146;s law in batteries &#150; it has taken conventional <FONT
STYLE="white-space:nowrap">lithium-ion</FONT> batteries at least 10 years to double in energy density and it has been approximately 30 years since the introduction of a major new chemistry.&nbsp;As the industry approaches the theoretical limit of
achievable energy density for <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries involving carbon or carbon/silicon anodes, we believe a new architecture is required to deliver meaningful gains in energy density.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Batteries have a cathode (the positive electrode), an anode (the negative electrode), a separator which prevents contact between the anode and
cathode, and an electrolyte which transports ions but not electrons. A conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> battery uses a liquid electrolyte, a polymer separator, and an anode made principally of carbon (graphite) or a
carbon/silicon composite. Lithium ions move from the cathode to the anode when the battery is charged and vice versa during discharge. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g14810g80i46.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The energy density of conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries is
fundamentally limited by the anode, which provides a host material to hold the lithium ions, preventing them from binding together into pure metallic lithium.&nbsp;Metallic lithium, when used with conventional liquid electrolytes and porous
separators, can form needle-like crystals of lithium known as dendrites, which can penetrate through the separator and short-circuit the cell.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">159 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While using a host material is an effective way to prevent dendrites, this host material
adds volume and mass to the cell, it adds cost to the battery, and it limits the battery life due to side reactions at the interface with the liquid electrolyte. The rate at which lithium diffuses through the anode also limits the maximum cell
power. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The addition of silicon to a carbon anode provides a modest boost to energy density relative to a pure carbon anode. However,
silicon is also a host material that not only suffers from the limitations of carbon as discussed above, but also introduces cycle life challenges as a result of the repeated expansion and contraction of the silicon particles, since silicon
undergoes significantly more expansion than carbon when hosting lithium ions. Furthermore, the voltage of the lithium-silicon reaction subtracts from the overall cell voltage, reducing cell energy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Lithium-Metal Anode Required to Unlock Highest Energy Density </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that a lithium-metal anode is the most promising approach that can break out of the current constraints inherent in conventional <FONT
STYLE="white-space:nowrap">lithium-ion</FONT> batteries and enable significant improvements in energy density. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In a lithium-metal
battery, the anode is made of metallic lithium; there is no host material. Eliminating the host material reduces the size and weight of the battery cell and eliminates the associated materials and manufacturing costs. This results in the highest
theoretical gravimetric energy density for a lithium-based battery system. <FONT STYLE="white-space:nowrap">Lithium-ion</FONT> batteries currently used in the auto industry have energy densities of less than 300 Wh/kg. We believe lithium-metal
batteries have the potential to significantly increase this energy density. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Lithium-metal anodes are compatible with conventional cathode
materials, and lithium-metal batteries will benefit from continued improvement in conventional cathodes.&nbsp;Moreover, lithium-metal anodes may enable future generations of higher energy cathodes that cannot achieve energy density gains when used
with <FONT STYLE="white-space:nowrap">lithium-ion</FONT> anodes, as shown in the figure below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g14810g23p54.jpg" ALT="LOGO">
 </P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Simulated
cell specific energy is based on traditional cell designs and architectures. Source: Andre et al, J Mater Chem A, (2015) 6709. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">160 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although the industry has understood for 40 years the potential benefits of lithium-metal
anodes, the industry has not been able to develop a separator that makes a lithium-metal anode practical. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Solid-State Separator Required to Enable
Lithium-Metal Anode </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that a lithium-metal battery requires that the porous separators used in current <FONT
STYLE="white-space:nowrap">lithium-ion</FONT> batteries be replaced with a solid-state separator capable of conducting lithium ions between the cathode and anode at rates comparable to conventional liquid electrolyte while also suppressing the
formation of lithium dendrites.&nbsp;While various solid-state separators have been shown to operate at low power densities, such low power densities are not useful for most practical applications. To our knowledge, QuantumScape is the only company
that has been able to demonstrate a solid-state separator for lithium-metal batteries that reliably prevents dendrite formation at higher power densities, such as those required for automotive applications and fast-charging.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that our ability to develop this proprietary solid-state separator will enable the shift from
<FONT STYLE="white-space:nowrap">lithium-ion</FONT> to lithium-metal batteries. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Technology </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g14810g82f86.jpg" ALT="LOGO">
 </P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Catholyte includes an organic gel made of an organic polymer and organic liquid. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our proprietary solid-state lithium-metal cell represents the next-generation of battery technology.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape battery cells have none of the host materials used in conventional anodes.&nbsp;In fact, when our cells are manufactured there is
no anode; lithium is present only in the cathode.&nbsp;When the cell is first charged, lithium moves out of the cathode, diffuses through our solid-state separator and plates in a thin metallic layer directly on the anode current collector, forming
an anode. When the battery cell is discharged, the lithium diffuses back into the cathode. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Eliminating the anode host material found in
conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> cells substantially increases the volumetric energy density. A pure lithium-metal anode also enables the theoretically highest gravimetric energy density for a lithium battery system.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our proprietary solid-state separator is the core technology breakthrough that enables reliable cycling of the lithium-metal anode
battery. Without a working solid-state separator, the lithium would form dendrites which would grow through a traditional porous separator and short circuit the cell. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">161 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An effective solid-state separator requires a solid material that is as conductive as a
liquid electrolyte, chemically stable next to lithium&#150;one of the most reactive elements&#150;and able to prevent the formation of dendrites. Our team worked almost ten years to develop a composition that meets these requirements and to develop
the techniques necessary to manufacture the separator material at scale using a continuous process.&nbsp;We have a number of patents covering both the composition of this material and key steps of the manufacturing process. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g14810g23g46.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our solid-state separator is a dense, entirely inorganic ceramic. It is made into a film that is thinner
than a human hair and then cut into pieces about the length and width of a playing card. Our solid-state separator is flexible because it has a low defect density and is thin. In contrast, typical household ceramics are brittle and can break due to
millions of microscopic defects which reduce structural integrity.</P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The separator is placed between a cathode and anode current
collector to form a single battery cell layer. These single layers will be stacked together into a multi-layer cell, about the size of a deck of cards, that will be the commercial form factor for EV batteries.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our cathodes use a combination of conventional cathode active materials (NMC) with an organic gel made of an organic polymer and organic
liquid catholyte.&nbsp;In the future, we may use other compositions of cathode active materials, including cobalt-free compositions.&nbsp;We have an ongoing research and development investigation into inorganic catholyte that could replace the
organic gel made of an organic polymer and organic liquid catholyte currently used. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">162 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our single-layer solid-state cells have been extensively tested for power density, cycle
life, and temperature performance. This is the only solid-state cell we are aware of that has been validated to run at automotive power densities by a leading automotive OEM. In addition, we believe our battery technology may provide significant
improvements in energy density compared to today&#146;s conventional lithium-ion batteries, as shown in the figure below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g14810g38x97.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Benefits of Our Technology </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe our battery technology will enable significant benefits across battery capacity, life, safety, and fast charging while minimizing
cost. We believe these benefits will provide significant value to automotive </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">163 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
OEMs by enabling greater customer adoption of their EVs. By solving key pain-points such as <FONT STYLE="white-space:nowrap">15-minute</FONT> fast charging, we believe our battery technology will
enable the delivery of an EV experience that is significantly more competitive with fossil fuel vehicles than what today&#146;s EVs can achieve with conventional batteries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our battery technology is intended to meet the five key requirements we believe will enable mass market adoption of EVs: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Energy density.</I></B> Our battery design is intended to significantly increase volumetric and gravimetric
energy density by eliminating the carbon/silicon anode host material found in conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> cells.&nbsp;This increased energy density will enable EV manufacturers to increase range without
increasing the size and weight of the battery pack, or to reduce the size and weight of the battery pack which will reduce the cost of the battery pack and other parts of the vehicle. For example, we estimate that our solid-state battery cells will
enable a car maker to increase the range of a luxury performance EV&#151;with 350 liters of available battery space&#151;from 250 miles (400 km) to 450 miles (730 km) without increasing the size and weight of the battery pack. In the same example,
our battery would enable the car maker to increase the maximum power output of such a vehicle from 420 kW to 650 kW without increasing the size of the battery pack. Alternatively, we believe that our solid-state battery cells will enable a car maker
to increase the range of a mass market sedan&#151;with 160 liters of available battery space&#151;from 123 miles (200km) to 233 miles (375km) without increasing the size and weight of the battery pack. Similarly, our battery would enable the car
maker to increase the maximum power output of such vehicle from 100 kW to 150 kW without increasing the size of the battery pack. </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Battery life.</I></B>&nbsp;Our technology is expected to enable increased battery life relative to
conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries. In a conventional cell, battery life is limited by the gradual irreversible loss of lithium due to side reactions between the liquid electrolyte and the anode.&nbsp;By
eliminating the anode host material, we expect to eliminate the side reaction and enable longer battery life.</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Fast charging capability.</I></B> Our battery technology is expected to enable 80% charging in less than 15
minutes, faster than any EV batteries on the market. In conventional EV batteries, the limiting factor for charge rate is the rate of diffusion of lithium ions into the anode. If a conventional battery is charged beyond these limits, lithium can
start plating on carbon particles of the anode rather than diffuse into the carbon particles. This causes a reaction between the plated lithium and liquid electrolyte which reduces cell capacity and increases the risk of dendrites that can short
circuit the cell. With a lithium-metal anode, using our solid-state separator, we expect the lithium can be plated as fast as the cathode can deliver it.</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Increased safety.</I></B> Our solid-state battery cell uses a ceramic separator which is not combustible
and is therefore safer than conventional polymer separators.&nbsp;This ceramic separator is also capable of withstanding temperatures considerably higher than those that would melt conventional polymer separators, providing an additional measure of
safety.</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Cost.</I></B> Our battery technology eliminates the anode host material and the associated manufacturing
costs, providing a structural cost advantage compared to traditional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries. We estimate that eliminating these costs will provide a savings of approximately 17% compared to the costs of
building traditional lithium-ion batteries at leading manufacturers.</P></TD></TR></TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Competitive Strengths </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Only proven lithium-metal battery technology for automotive applications.</I></B><B><I></I></B><B><I>&nbsp;</I></B>We have built and
tested over one hundred thousand single-layer battery cells and have demonstrated that our technology meets automotive requirements for power, cycle life, and temperature range. In 2018, Volkswagen announced it had successfully tested certain of our
single-layer, laboratory battery cells at automotive rates of power. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">164 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Partnership with one of the world&#146;s largest automotive
OEMs.</I></B><B><I></I></B>&nbsp;We are partnered with Volkswagen, one of the largest automakers in the world. Volkswagen has been a collaboration partner and major investor since 2012 and has invested or&nbsp;committed to invest, subject, in
certain cases, to certain closing conditions that have not yet been satisfied, a total of more than $300&nbsp;million in QuantumScape and has committed additional capital to fund our joint venture. Volkswagen plans to launch more than 70 new
electric models and build more than 25&nbsp;million vehicles on electric platforms by the end of the decade. Together with Volkswagen, we have established a joint venture to enable an industrial level of production of our solid-state batteries for
use in Volkswagen vehicles. As 50-50 partners in the joint venture with Volkswagen, we expect to share equally in the revenue and profit from the joint venture.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>High barriers to entry with extensive patent and intellectual property portfolio. </I></B>Over the course of 10 years, we have generated
more than 200 U.S. and foreign patents and patent applications &#150; including broad fundamental patents around our core technology. Our proprietary solid-state separator uses the only material we know of that can cycle lithium at automotive
current densities without forming dendrites. Our battery technology is protected by a range of patents, including patents that cover:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Composition of matter, including the optimal composition as well as wide-ranging coverage of a number of
variations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Enabling battery technology covering compositions and methods required to incorporate a solid-state separator
into a battery; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Manufacturing technology, protecting the only known way to make the separator at scale using <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">roll-to-roll</FONT></FONT> processes, without semiconductor style production or batch processes used in traditional ceramics; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Material dimensions, including our proprietary solid-state separator, covering any separator with commercially
practical thicknesses for a solid-state battery. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, as of October 19, 2020, we have approximately 100
trade secrets covering <FONT STYLE="white-space:nowrap">non-discoverable</FONT> aspects of critical manufacturing processes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Significant development focused on <FONT STYLE="white-space:nowrap">next-gen</FONT> technology for automotive applications. </I></B>We
have spent ten years and over $260&nbsp;million developing our battery technology. We have run over 2&nbsp;million tests on over 600,000 cells and cell components. Our technical team comprises more than 200 employees, many of whom have worked at
large battery manufacturers and automotive OEMs.&nbsp;Our team has deep technical <FONT STYLE="white-space:nowrap">know-how</FONT> and is supported by extensive facilities and equipment, development infrastructure, and data analytics.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Designed for volume production.</I></B> Our development uses earth-abundant materials and processes suitable for high volume production.
Our processes use tools which are already used at scale in the battery or ceramics industries. While preparing for scale production, we have purchased or tested production-intent tools from the world&#146;s leading vendors. In particular, we expect
to produce our proprietary separator using scalable continuous processing. Although our separator material is proprietary, the inputs are readily available and can be sourced from multiple suppliers across geographies.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Structural cost advantage leveraging industry cost trends.</I></B><B><I></I></B><B><I>&nbsp;</I></B>Outside of the separator, our
battery is being designed to use many of the materials and processes that are standard across today&#146;s battery manufacturers. As a result, we expect to benefit from the projected industry-wide cost declines for these materials that result from
process improvements and economies of scale. We believe that the manufacturing of our solid-state battery cells provides us with a structural cost advantage because our battery cells are manufactured without an anode.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">165 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Growth Strategy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Continue to develop our commercial battery technology</I></B>: We will continue developing our battery technology with the goal of
enabling commercial production in 2024. We have validated capabilities of our solid-state separator and battery technology in single-layer cells. We are now working to develop multi-layer cells, to continue improving yield and performance and to
optimize all components of the cell. We will continue to work to further develop the volume manufacturing processes to enable high volume manufacturing and minimize manufacturing costs. We will continue to work on increasing the yield of our
separators to reduce scrappage and to increase utilization of manufacturing tools. The funds available upon the Closing will enable us to expand and accelerate research and development activities and undertake additional initiatives. Finally, we
will continue to use our engineering line in San Jose, California to prepare for high volume manufacturing and plan our first commercial production Pilot Facility through our joint venture partnership with Volkswagen.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Meet Volkswagen battery demand</I></B>. The initial 1GWh Pilot Facility to be built and run by QSV Operations LLC and the subsequent
20GWh Expansion Facility would represent a small fraction of Volkswagen&#146;s demand for batteries and implies vehicle volumes under 2% of Volkswagen&#146;s total production in 2019, assuming a 100KWh pack size. Our goal is to significantly expand
the production capacity of the joint venture, in partnership with Volkswagen, to meet more of their projected demand.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Expand
partnerships with other automotive OEMs</I></B><B>.</B>&nbsp;While we expect Volkswagen will be the first to commercialize vehicles using our battery technology, over the next few years as we build our Pilot Facility, we intend to work closely with
other automotive OEMs to make our solid-state battery cells widely available over time. As part of our joint venture agreement we have agreed that the Pilot Facility will be the first facility to manufacture our battery technology for automotive
applications, but, subject to the other terms of the joint venture arrangements, we are not limited from working in parallel with other automotive OEMs to commercialize our technology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Expand target markets.</I></B> We are focused on automotive EV applications, which has the most stringent set of requirements for
batteries.&nbsp;However, we recognize that our solid-state battery technology has applicability in other large and growing markets including stationary storage and consumer electronics such as smartphones and wearables. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Expand commercialization models. </I></B>Our technology is being designed to enable a variety of business models. In addition to joint
ventures, such as the one with Volkswagen,<I> </I>we may operate solely-owned manufacturing facilities or license technology to other manufacturers. Where appropriate, we may build and sell separators rather than complete battery cells.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Continued investment in <FONT STYLE="white-space:nowrap">next-gen</FONT> battery innovation</I></B>. We intend to continue to invest in
research and development to improve battery cell performance, improve manufacturing processes, and reduce cost.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Manufacturing and Supply</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The QuantumScape battery manufacturing process is being designed to be very&nbsp;similar to that of conventional
<FONT STYLE="white-space:nowrap">lithium-ion</FONT> battery manufacturing, with a few exceptions:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We use a proprietary separator material instead of the polypropylene separator used in <FONT
STYLE="white-space:nowrap">lithium-ion</FONT> cells. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our architecture eliminates the need for anode manufacturing, reducing capital investment and lowering operating
costs. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We will build our multi-layer cells by sequentially stacking separators, cathodes and current collectors rather
than winding these materials together. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our cell design allows us to greatly shorten the weeks-long aging process required for conventional <FONT
STYLE="white-space:nowrap">lithium-ion</FONT> cells, thus decreasing manufacturing cycle time and reducing working capital needs. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">166 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our architecture depends on our proprietary separator, which we will manufacture ourselves.
Though our separator design is unique, its manufacturing relies on well-established, high-volume production processes currently deployed globally in other industries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We plan to source our input materials from industry leading suppliers to the <FONT STYLE="white-space:nowrap">lithium-ion</FONT> battery
industry, and we already have strategic relationships in place with the industry&#146;s leading vendors of cathode material, the most critical purchased input to our cell, along with leading vendors of other less critical inputs. Our separator is
made from abundant materials produced at industrial scale in multiple geographies. We do not anticipate any unique supply constraints for the foreseeable future. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g14810g15h45.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Partnerships</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Volkswagen Collaboration </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape has had a strong collaborative relationship with Volkswagen since 2012. Our collaboration initially focused on the testing and
evaluation of QuantumScape&#146;s battery technology.&nbsp;Volkswagen engineers worked closely with our engineering team and oversaw the progress on our technology development efforts and battery testing. Volkswagen made several rounds of equity
investments in QuantumScape, and senior executives of Volkswagen joined the QuantumScape Board, including two successive heads of group research for the Volkswagen Group. During the early part of this collaboration QuantumScape worked closely with
members of Volkswagen&#146;s global research and development team, and now the QuantumScape team works closely with the Volkswagen Battery Center of Excellence, which is tasked with commercializing battery technologies within Volkswagen. The Head of
Volkswagen&#146;s Battery Center of Excellence, Frank Blome, is a member of the QuantumScape Board. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Joint Venture Relationship </I></B></P>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In June 2018, QuantumScape and Volkswagen formed a <FONT STYLE="white-space:nowrap">50-50</FONT> joint venture entity, named QSV Operations
LLC (&#147;QSV&#148;), to facilitate the commercialization of QuantumScape&#146;s solid-state battery technology and enable Volkswagen to be the first automotive OEM to utilize this technology.&nbsp;In 2018, the parties collectively made an initial
equity investment in the joint venture of approximately $3&nbsp;million in total. Upon the occurrence of certain </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">167 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
development milestones and subject to the entry by QuantumScape, Volkswagen and QSV into certain related agreements, QuantumScape and Volkswagen have agreed to commit additional capital on a
50-50 basis to QSV to fund the buildout of the Pilot Facility and the 20GWh Expansion Facility. As 50-50 partners in the joint venture with Volkswagen, we expect to share equally in the revenue and profit from the joint venture, including from the
Pilot Facility and the 20GWh Expansion Facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The joint venture agreements were amended in 2020 in connection with a further
$200&nbsp;million investment commitment by Volkswagen in QuantumScape (subject to certain closing conditions).&nbsp;$100&nbsp;million of this equity investment by Volkswagen is due on December&nbsp;1, 2020 and the second $100&nbsp;million equity
investment is subject to completion of a certain technical milestone by the end of the first quarter of 2021.&nbsp;As part of the first tranche of this equity investment, Volkswagen will have the right to increase its representation on the
QuantumScape Board (or the New QuantumScape Board if the Business Combination is completed) from one member to two members.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The joint
venture agreements provide for the commercialization of QuantumScape&#146;s solid-state battery cells to occur in two phases.&nbsp;The first phase is the construction of the Pilot Facility with an annual capacity of 1GWh. QSV will begin construction
of the Pilot Facility when certain delivery and validation milestones are met for QuantumScape&#146;s solid-state battery cells. The second phase is the 20GWh Expansion Facility. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe the joint venture structure will enable Volkswagen to benefit from early access to QuantumScape&#146;s solid-state battery cells,
but also protect the intellectual property of QuantumScape.&nbsp;For example, certain key battery technology will continue to be owned by QuantumScape and will be provided to the joint venture through a limited license for purposes of the Pilot
Facility.&nbsp;The parties will agree on the license terms for a high-volume manufacturing facility for this battery technology license. The joint venture terminates upon the earliest to occur of (i) Volkswagen exercising specified put rights in the
event of, amongst others, (a) a change of control of QuantumScape, or (b) the failure by QuantumScape to meet specified development milestones within certain timeframes, (ii) QuantumScape or Volkswagen exercising specified call or put rights in the
event of, amongst others, if the parties cannot agree to commercial terms for the Pilot Facility or 20GWh Expansion Facility within certain timeframes, (iii) a certain date after commencement of production of a Volkswagen series production vehicle
using QuantumScape battery cells (or an alternative end date if no such production was commenced after certain technical milestones with respect to QuantumScape battery cell technology were reached) and (iv) December 31, 2028. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Volkswagen committed to purchase a certain portion of the output capacity of the Pilot Facility at a price for the solid-state battery cells
that is comparable to those of <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries, but with a premium for the outperformance of these battery cells based on certain key technical parameters. QuantumScape will sell separators to the joint
venture at a price to be agreed by the parties based on the provisions of the joint venture agreements. The joint venture agreements provide the framework for the commercial relationship. At the appropriate time, the parties will negotiate
agreements covering the details of these purchase commitments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 20GWh Expansion Facility is subject to meeting additional technical
milestones and agreement on commercial terms, including pricing for the battery cells, agreement on the terms of purchase or license for the separators, and agreement on terms of the license to our battery technology for the 20GWh Expansion
Facility. As 50-50 partners in the joint venture with Volkswagen, we expect to share equally in the capital contributions required for the 20GWh Expansion Facility and in the revenue and profit from the 20GWh Expansion Facility. We have agreed that
the pricing for the battery cells sold by the 20GWh Expansion Facility and the separators purchased by the 20GWh Expansion Facility may be different from the pricing set for the Pilot Facility, and we will need to agree on pricing at the appropriate
time.&nbsp;In addition, we will need to agree to the terms of the license to our battery technology. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Volkswagen is expected to have
a significant role in the manufacturing <FONT STYLE="white-space:nowrap">ramp-up</FONT> of QSV, and we have agreed that certain technology that is developed by QSV will be owned by the joint venture and licensed to each of QuantumScape and
Volkswagen on a royalty-free basis.&nbsp;None of this intellectual property has been developed </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">168 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to date. Although the parties have not commenced operations on the Pilot Facility, Volkswagen has offered to assist QuantumScape with supply chain, manufacturing
<FONT STYLE="white-space:nowrap">ramp-up</FONT> planning, and automation.&nbsp;In addition, the parties have collaborated on enabling QuantumScape to develop stronger relationships with battery component supply companies, such as cathode
manufacturers and equipment supply companies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Research and Development</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We conduct research and development at our headquarters facility in San Jose, California. Research and development activities concentrate on
making further improvements to our battery technology, including improvements to battery performance and cost.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our research and
development currently includes programs for the following areas: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Multi-layering.</I><I></I><I>&nbsp;</I>To date, QuantumScape has only produced single -layer solid-state
battery cells at the commercially required size. In order to produce commercially-viable solid-state battery cells for automotive applications, we must produce battery cells consisting of over one hundred layers. We will need to overcome the
developmental challenges to stack these layers and implement the appropriate cell design for our solid-state battery cell.</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Improved yields.</I><I></I><I>&nbsp;</I>We are focused on improving the yields (useful output) of both our
solid-state separators and our single-layer battery cells.&nbsp;We are automating our manufacturing process and purchasing larger-scale manufacturing equipment.&nbsp;We will need to significantly increase our yield before we can manufacture our
solid-state battery cells in volume. </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Continued improvement in the solid-state separator. </I>We are working to improve the reliability and
performance of our solid-state separator, including decreasing the thickness.&nbsp;QuantumScape has selected a method of continuous processing found at scale in both the battery and ceramic industries and is working on continuous improvement of this
process.&nbsp;In addition, QuantumScape is investigating alternative processing methods that may further increase the capital efficiency of the process. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Continued improvement of the cathode.</I> Our cathodes use a combination of conventional cathode active
materials (NMC) along with an organic gel made of an organic polymer and organic liquid catholyte. In the future, we may use other cathode active materials, including cobalt-free compositions.&nbsp;We have an ongoing research and development
investigation into inorganic catholyte that could replace the organic gel made of an organic polymer and organic liquid currently used. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Integration of advanced cathode materials.</I>&nbsp;QuantumScape benefits from industry cathode chemistry
improvements and/or cost reduction. Our solid-state separator platform is being designed to enable some of the most promising next-generation cathode technologies, including high voltage or high capacity cathode active materials, which when combined
with a lithium-metal anode, may further increase cell energy densities.</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The success of our business and technology leadership is supported by our proprietary battery technology. We rely upon a combination of patent,
trademark and trade secret laws in the United States and other jurisdictions, as well as license agreements and other contractual protections, to establish, maintain and enforce rights in our proprietary technologies. In addition, we seek to protect
our intellectual property rights through nondisclosure and invention assignment agreements with our employees and consultants and through <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements with business partners and other third
parties. We regularly file applications for patents and have a significant number of patents in the United States and other countries where we do business. Our patent portfolio is deepest in the area of solid-state separators with additional areas
of strength in anodes, next-generation cathode materials, and cell, module, and pack design specific to lithium-metal batteries. Our trade secrets primarily cover manufacturing methods. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">169 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of October 19, 2020, we own or license, on an exclusive basis, 78 issued U.S. patents
and 38 U.S. pending or allowed patent applications, 95 foreign patents and applications, and 3 registered U.S. trademark applications. Our issued patents start expiring in 2033. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competition </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The EV market, and the
battery segment in particular, is evolving and highly competitive. With the introduction of new technologies and the potential entry of new competitors into the market, we expect competition to increase in the future, which could harm our business,
results of operations, or financial condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape&#146;s prospective competitors include major manufacturers currently
supplying the industry, automotive OEMs and potential new entrants to the industry.&nbsp;Major companies now supplying&nbsp;batteries for the EV industry include Panasonic Corporation, Samsung SDI, Contemporary Amperex Technology Co. Limited, and <FONT
STYLE="white-space:nowrap">LG-Chem</FONT> Ltd. They supply conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries and in many cases are seeking to develop solid-state batteries, including potentially lithium-metal batteries. In
addition, because of the importance of electrification, most automotive OEMs are researching and investing in solid-state battery efforts and, in some cases, in battery development and production. For example, Tesla, Inc. is building multiple
battery gigafactories and potentially could supply batteries to other automotive OEMs, and Toyota Motors and a Japanese consortium have a multi-year initiative pursuing solid-state batteries.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A number of development-stage companies are also seeking to improve conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries
or to develop new technologies for solid-state batteries, including lithium-metal batteries.&nbsp;Potential new entrants are seeking to develop new technologies for cathodes, anodes, electrolytes and additives. Some of these companies have
established relationships with automotive OEMs and are in varying stages of development.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe our ability to compete successfully
with <FONT STYLE="white-space:nowrap">lithium-ion</FONT> battery manufacturers and with other companies seeking to develop solid-state batteries will depend on a number of factors including battery price, safety, energy density, charge rate and
cycle life, and on <FONT STYLE="white-space:nowrap">non-technical</FONT> factors such as brand, established customer relationships and financial and manufacturing resources.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many of the incumbents have, and future entrants may have, greater resources than we have and may also be able to devote greater resources to
the development of their current and future technologies. They may also have greater access to larger potential customer bases and have and may continue to establish cooperative or strategic relationships amongst themselves or with third parties
(including automotive OEMs) that may further enhance their resources and offerings. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Government Regulation and Compliance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are government regulations pertaining to battery safety, transportation of batteries, use of batteries in cars, factory safety, and
disposal of hazardous materials. We will ultimately have to comply with these regulations to sell our batteries into the market. The license and sale of our batteries abroad is likely to be subject to export controls in the future. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employees </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We pride ourselves on the
quality of our world-class team and seek to hire only employees dedicated to our strategic mission. Our employees typically have significant experience working with large battery manufacturers and automotive OEMS. As of October 19, 2020, we employed
237 full-time employees and eight temporary employees, based primarily in our headquarters in San Jose, California. Over 200 of our employees are engaged in research and development and related functions, and more than half of these employees hold
advanced engineering and scientific degrees, including many from the world&#146;s top universities.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">170 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We seek team members who want to help solve a significant problem that will positively
impact the world. We value diversity and recognize the importance of fostering a positive, inclusive culture. As such, we have actively taken steps towards eliminating unconscious bias in our hiring and promotion processes while enabling us to add
and promote team members who demonstrate behaviors aligned with our values (&#147;What we promote when we promote&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are
committed to maintaining equitable compensation programs. We offer market-competitive salaries and strong equity compensation aimed at attracting and retaining team members capable of making exceptional contributions to our success. Our compensation
decisions are guided by the external market, role criticality, and the contributions of each team member. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, QuantumScape has
not experienced any work stoppages and considers its relationship with its employees to be good. None of QuantumScape&#146;s employees are either represented by a labor union or subject to a collective bargaining agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Facilities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our corporate headquarters,
and our only facility, is in San Jose, California, where we lease approximately 87,125 square feet under a lease that expires in January 2023. Most of the facility is used for our research and development and prototype manufacturing.&nbsp;We believe
this facility is adequate to meet our current ongoing needs. However, in order to accommodate growth, including anticipated growth associated with our joint venture activities with Volkswagen, we will need to seek additional facilities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Legal Proceedings </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to time, we
may become involved in litigation or other legal proceedings. We are not currently a party to any litigation or legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless of
outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">171 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_54"></A>QUANTUMSCAPE&#146;S EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To achieve QuantumScape&#146;s goals, QuantumScape has designed, and intends to modify as necessary, its compensation and benefits program to
attract, retain, incentivize and reward deeply talented and qualified executives who share its philosophy and desire to work towards achieving these goals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape believes its compensation program should promote the success of the company and align executive incentives with the long-term
interests of its stockholders. QuantumScape&#146;s current compensation programs reflect its startup origins in that they consist primarily of salary and stock option awards. As QuantumScape&#146;s needs evolve, QuantumScape intends to continue to
evaluate its philosophy and compensation programs as circumstances require. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This section provides an overview of QuantumScape&#146;s
executive compensation programs, including a narrative description of the material factors necessary to understand the information disclosed in the summary compensation table below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The QuantumScape Board, with input from its Chief Executive Officer, has historically determined the compensation for QuantumScape&#146;s
named executive officers. For the year ended December&nbsp;31, 2019, QuantumScape&#146;s named executive officers were: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Jagdeep Singh, President and Chief Executive Officer </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Howard Lukens, Chief Sales Officer </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Michael McCarthy, Chief Legal Officer and Head of Corporate Development </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary Compensation Table </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following
table sets forth information concerning the compensation of the named executive officers for the year ended December&nbsp;31, 2019. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name and Principal Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jagdeep Singh <BR><I>Chief Executive Officer and Director</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">275,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">275,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Howard Lukens <BR><I>Chief Sales Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,960</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">906,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,257,220</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael McCarthy <BR><I>Chief Legal Officer</I> <I>and Head of Corporate Development</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">906,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,256,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts in this column represent the aggregate grant-date fair value of awards granted to each named
executive officer, computed in accordance with the Financial Accounting Standards Board&#146;s (&#147;FASB&#148;) Accounting Standards Codification (&#147;ASC&#148;) Topic 718. See Note 2 to QuantumScape&#146;s audited consolidated financial
statements included elsewhere in this proxy statement/prospectus/information statement for a discussion of the assumptions made by QuantumScape in determining the grant-date fair value of QuantumScape&#146;s equity awards. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Narrative Disclosure to Summary Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For 2019, the compensation program for QuantumScape&#146;s named executive officers consisted of base salary and incentive compensation
delivered in the form of stock option awards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">172 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Base Salary </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Base salary is set at a level that is commensurate with the executive&#146;s duties and authorities, contributions, prior experience and
sustained performance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Bonus </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape does not have any arrangements with its named executive officers providing for annual cash bonus awards. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock Option Awards </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock options
have been granted to QuantumScape&#146;s named executive officers under the 2010 Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape 2010 Equity Incentive Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2010 Plan allows QuantumScape to provide incentive stock options, within the meaning of Section&nbsp;422 of the Code, nonstatutory stock
options, stock appreciation rights, restricted stock awards and restricted stock units (each, an &#147;award&#148; and the recipient of such award, a &#147;participant&#148;) to eligible employees, directors, and consultants of QuantumScape and any
parent or subsidiary of QuantumScape. It is expected that as of one business day prior to the Closing, the 2010 Plan will be terminated and QuantumScape will not grant any additional awards under the 2010 Plan thereafter. However, the 2010 Plan will
continue to govern the terms and conditions of the outstanding awards previously granted under the 2010 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020,
stock options covering 10,826,814 shares of QuantumScape Class&nbsp;A Common Stock and 2,853,696 shares of QuantumScape Class&nbsp;B Common Stock were outstanding under the 2010 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Plan Administration</I>. The 2010 Plan is administered by the QuantumScape Board or one or more of its committees. Different committees may
administer the 2010 Plan with respect to different service providers. The administrator has all authority and discretion necessary or appropriate to administer the 2010 Plan and to control its operation, including the authority to construe and
interpret the terms of the 2010 Plan and the awards granted under the 2010 Plan. The administrator&#146;s decisions are final and binding on all participants and any other persons holding awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The administrator&#146;s powers include the power to institute an exchange program under which (i)&nbsp;outstanding awards are surrendered or
cancelled in exchange for awards of the same type (which may have higher or lower exercise prices and different terms), awards of a different type or cash, (ii)&nbsp;participants would have the opportunity to transfer any outstanding awards to a
financial institution or other person or entity selected by the administrator or (iii)&nbsp;the exercise price of an outstanding award is increased or reduced. The administrator&#146;s powers also include the power to prescribe, amend and rescind
rules and regulations relating to the 2010 Plan, to modify or amend each award and to make all other determinations deemed necessary or advisable for administering the 2010 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Eligibility</I>. Employees, directors and consultants of QuantumScape or its parent or subsidiary companies are eligible to receive awards,
provided such consultants render bona fide services not in connection with the offer and sale of securities in a capital-raising transaction and do not directly promote or maintain a market for QuantumScape securities. Only employees of QuantumScape
or its parent or subsidiary companies are eligible to receive incentive stock options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Stock Options</I>. Stock options have been
granted under the 2010 Plan. Subject to the provisions of the 2010 Plan, the administrator determines the term of an option, the number of shares and the class of shares subject to an option, and the time period in which an option may be exercised.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">173 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The term of an option is stated in the applicable award agreement, but the term of an option
may not exceed 10 years from the grant date. The administrator determines the exercise price of options, which generally may not be less than 100% of the fair market value of our common stock on the grant date, unless expressly determined in writing
by the administrator on the option&#146;s grant date. However, an incentive stock option granted to an individual who directly or by attribution owns more than 10% of the total combined voting power of all of our classes of stock or of any our
parent or subsidiary may have a term of no longer than 5 years from the grant date and will have an exercise price of at least 110% of the fair market value of our common stock on the grant date. In addition, to the extent that the aggregate fair
market value of the shares with respect to which incentive stock options are exercisable for the first time by an employee during any calendar year (under all our plans and any parent or subsidiary) exceeds $100,000, such options will be treated as
nonstatutory stock options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The administrator determines how a participant may pay the exercise price of an option, and the permissible
methods are generally set forth in the applicable award agreement. If a participant&#146;s status as a &#147;service provider&#148; (as defined in the 2010 Plan) terminates, that participant may exercise the vested portion of his or her option for
the period of time stated in the applicable award agreement. Vested options generally will remain exercisable for three months or such longer or shorter period of time as set forth in the applicable award agreement if a participant&#146;s status as
a service provider terminates for a reason other than death or disability. If a participant&#146;s status as a service provider terminates due to death or disability, vested options generally will remain exercisable for twelve months from the date
of termination (or such other longer or shorter period as set forth in the applicable award agreement). In no event will an option remain exercisable beyond its original term. If a participant does not exercise his or her option within the time
specified in the award agreement, the option will terminate. Except as described above, the administrator has the discretion to determine the post-termination exercisability periods for an option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-Transferability</FONT> of Awards</I>. Unless determined otherwise by the administrator, awards may not
be sold, pledged, assigned, hypothecated or otherwise transferred in any manner other than by will or by the laws of descent and distribution. In addition, during an applicable participant&#146;s lifetime, only that participant may exercise their
award. In the case of awards issued to California residents, if the administrator makes an award transferable, such award may only be transferred (i)&nbsp;by will, (ii)&nbsp;by the laws of descent and distribution or (iii)&nbsp;as permitted by
Rule&nbsp;701 of the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Certain Adjustments</I>. If there is a dividend or other distribution (whether in the form of
cash, shares, other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, <FONT STYLE="white-space:nowrap">split-up,</FONT> <FONT STYLE="white-space:nowrap">spin-off,</FONT>
combination, repurchase, exchange of shares or our other securities or other change in our corporate structure affecting the shares, the administrator, in order to prevent diminution or enlargement of the benefits or potential benefits intended to
be made available under the 2010 Plan, will adjust the number and class of shares that may be delivered under the 2010 Plan and/or the number, class, and price of shares covered by each outstanding award. In the case of awards issued to California
residents, the administrator will make such adjustments to an award required by Section&nbsp;25102(o) of the California Corporations Code to the extent we are relying upon the exemption afforded thereby with respect to the award. The
administrator&#146;s determination regarding such adjustments will be final, binding and conclusive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Dissolution or Liquidation</I>.
In the event of our proposed dissolution or liquidation, the administrator will notify each participant as soon as practicable prior to the effective date of such proposed transaction. To the extent it has not been previously exercised, an award
will terminate immediately prior to the consummation of such proposed action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Merger and Change of Control</I>. In the event of a
merger or a &#147;change in control&#148; (as defined in the 2010 Plan), each outstanding award will be treated as the administrator determines, including, without limitation, that (i)&nbsp;awards will be assumed, or substantially equivalent awards
will be substituted, by the acquiring or succeeding corporation (or an affiliate thereof) with appropriate adjustments as to the number and kind of shares and prices; (ii)&nbsp;upon written notice to a participant, the participant&#146;s awards will
terminate upon or immediately prior to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">174 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
consummation of such merger or change in control; (iii)&nbsp;outstanding awards will vest and become exercisable, realizable or payable, or restrictions applicable to an award will lapse, in
whole or in part, prior to or upon consummation of such merger or change in control, and, to the extent the administrator determines, terminate upon or immediately prior to the effectiveness of such merger or change in control; (iv)&nbsp;(A) the
termination of an award in exchange for an amount of cash or property, if any, equal to the amount that would have been attained upon the exercise of such award or realization of the participant&#146;s rights as of the date of the occurrence of the
transaction (and, for the avoidance of doubt, if as of the date of the occurrence of the transaction the administrator determines in good faith that no amount would have been attained upon the exercise of such award or realization of the
participant&#146;s rights, then such award may be terminated by us without payment) or (B)&nbsp;the replacement of such award with other rights or property selected by the administrator in its sole discretion; or (v)&nbsp;any combination of the
foregoing. The administrator will not be obligated to treat all awards, all awards a participant holds or all awards of the same type, similarly. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that the successor corporation does not assume or substitute for an award (or portion thereof), the participant will fully vest
in and have the right to exercise all of his or her outstanding options and stock appreciation rights, including shares as to which such awards would not otherwise be vested or exercisable, all restrictions on restricted stock and restricted stock
units will lapse, and, with respect to awards with performance-based vesting, all performance goals or other vesting criteria will be deemed achieved at 100% of target levels and all other terms and conditions met. In addition, if an option or stock
appreciation right is not assumed or substituted in the event of a merger or change in control, the administrator will notify the participant in writing or electronically that the option or stock appreciation right will be exercisable for a period
of time determined by the administrator in its sole discretion, and the option or stock appreciation right will terminate upon the expiration of such period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Amendment and Termination</I>. The QuantumScape Board may, at any time, terminate or amend the 2010 Plan in any respect, including, without
limitation, amendment of any form of award agreement or instrument to be executed pursuant to the 2010 Plan. To the extent necessary and desirable to comply with applicable laws, QuantumScape will obtain stockholder approval of any amendment to the
2010 Plan. No amendment or alteration of the 2010 Plan will impair the rights of a participant, unless mutually agreed otherwise between the participant and the administrator in writing. As noted above, it is expected that as of one business day
prior to the Closing, the 2010 Plan will be terminated and QuantumScape will not grant any additional awards under the 2010 Plan thereafter. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape 2020 Equity Incentive Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information about the 2020 Plan, see the section entitled &#147;<I>Proposal No.</I><I></I><I>&nbsp;7: The Equity Incentive Plan
Proposal</I>.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>QuantumScape 2020 Employee Stock Purchase Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information about the ESPP, see the section entitled &#147;<I>Proposal No.</I><I></I><I>&nbsp;9: The Employee Stock Purchase Plan
Proposal.</I>&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">175 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards at 2019 Year End </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents information regarding outstanding equity awards held by QuantumScape&#146;s named executive officers as of
December&nbsp;31, 2019. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>Exercisable<BR>(#)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>Unexercisable<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Exercise<BR>Price<BR>($)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jagdeep Singh(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">04/08/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">04/07/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jagdeep Singh(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">08/19/2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">621,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">08/19/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jagdeep Singh(5)(6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/15/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,077,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">538,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/15/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Howard Lukens(7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/15/2012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">395,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/11/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Howard Lukens(8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">04/08/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">04/07/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Howard Lukens(9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">02/27/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">02/26/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Howard Lukens(5)(10)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/15/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/15/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Howard Lukens(5)(11)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">06/05/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">06/05/2029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael McCarthy(12)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">05/01/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">04/30/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael McCarthy(13)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/18/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/17/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael McCarthy(9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">02/27/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">02/26/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael McCarthy(14)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">05/03/2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">05/03/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael McCarthy(5)(15)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/15/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/15/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael McCarthy(5)(16)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">06/05/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">06/05/2029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All stock options were granted pursuant to the 2010 Plan. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This column represents the fair market value of a share of QuantumScape Common Stock on the date of the grant,
as determined by the QuantumScape Board. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">75% of these option shares vested on February&nbsp;13, 2014, and the remainder were vested by February&nbsp;13,
2017. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These option shares vested by December&nbsp;10, 2018. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of a change in control, if optionee&#146;s employment is terminated by QuantumScape without cause
or if optionee is constructively terminated within six months following such event, then 50% of any unvested shares shall immediately vest. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These option shares vested as to 1/48th of the total shares subject to the option on May&nbsp;1, 2017, and the
remainder vested and will vest on each monthly anniversary thereafter, subject to the optionee&#146;s continued service through each vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">25% of these option shares vested on March&nbsp;12, 2013, and the remainder were vested by March&nbsp;12, 2016.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">75% of these option shares vested on February&nbsp;13, 2016, and the remainder were vested by February&nbsp;13,
2017. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These option shares vested on February&nbsp;27, 2018. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These option shares vested as to 1/48th of the total shares subject to the option on May&nbsp;1, 2017, and the
remainder vested and will vest on each monthly anniversary thereafter, subject to the optionee&#146;s continued service through each vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These option shares vested as to 1/48th of the total shares subject to the option on June&nbsp;5, 2019, and the
remainder vested and will vest on each monthly anniversary thereafter, subject to the optionee&#146;s continued service through each vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">25% of these option shares vested on April&nbsp;8, 2014, and the remainder were vested by April&nbsp;8, 2017.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">25% of these option shares vested on September&nbsp;18, 2014, and the remainder were vested by
September&nbsp;18, 2017. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These option shares vested on February&nbsp;18, 2019. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">176 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These option shares vested as to 1/48th of the total shares subject to the option on May&nbsp;1, 2017, and the
remainder vested and will vest on each monthly anniversary thereafter, subject to the optionee&#146;s continued service through each vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(16)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">These option shares vested as to 1/48th of the total shares subject to the option on June&nbsp;5, 2019, and the
remainder vested and will vest on each monthly anniversary thereafter, subject to the optionee&#146;s continued service through each vesting date. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Benefits and Perquisites </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape provides benefits to its named executive officers on the same basis as provided to all of its employees, including health, dental
and vision insurance; life insurance; accidental death and dismemberment insurance; critical illness insurance; <FONT STYLE="white-space:nowrap">short-and</FONT> long-term disability insurance; a health savings account; a wellness incentive; and a <FONT
STYLE="white-space:nowrap">tax-qualified</FONT> Section&nbsp;401(k) plan for which no match by QuantumScape is provided. QuantumScape does not maintain any executive-specific benefit or perquisite programs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Executive Letter Agreements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a
part of the Business Combination, QuantumScape will not enter into new executive employee agreements. Details of the current agreements are outlined below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Agreements with Howard Lukens </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
February&nbsp;13, 2012, Howard Lukens entered into an offer letter with QuantumScape to initially serve as Vice President, Sales (the &#147;Lukens Offer Letter&#148;). The Lukens Offer Letter has no specific term and provides that Mr.&nbsp;Lukens is
<FONT STYLE="white-space:nowrap">an&nbsp;at-will&nbsp;employee.</FONT> It also provides for an $180,000 annual base salary, no annual target bonus and initial stock and option grants.&nbsp;The Lukens Offer Letter contains customary confidentiality, <FONT
STYLE="white-space:nowrap">non-solicitation</FONT> and intellectual property assignment provisions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Agreements with Michael McCarthy </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;15, 2013, Michael McCarthy entered into an offer letter with QuantumScape to initially serve as General Counsel (the
&#147;McCarthy Offer Letter&#148;). The McCarthy Offer Letter has no specific term and provides that Mr.&nbsp;McCarthy is <FONT STYLE="white-space:nowrap">an&nbsp;at-will&nbsp;employee.</FONT> It also provides for a $225,000 annual base salary, no
annual target bonus and initial stock and option grants.&nbsp;The McCarthy Offer Letter contains customary confidentiality, <FONT STYLE="white-space:nowrap">non-solicitation</FONT> and intellectual property assignment provisions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Retirement Benefits </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape
provides a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> Section&nbsp;401(k) plan for all employees, including the named executive officers. QuantumScape does not provide a match for participants&#146; elective contributions to the 401(k)
plan, nor does QuantumScape provide to employees, including its named executive officers, any other retirement benefits, including but not limited to <FONT STYLE="white-space:nowrap">tax-qualified</FONT> defined benefit plans, supplemental executive
retirement plans and nonqualified defined contribution plans. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Potential Payments upon Termination or Change in Control </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Closing, QuantumScape did not have a formal plan with respect to severance benefits payable to its named executive officers and
other key employees. From time to time, QuantumScape granted equity awards to, or entered into offer letters with, certain key employees, including its named executive officers, that provide for accelerated vesting of equity awards in the event such
key employee&#146;s employment was involuntarily terminated under certain circumstances related to a change in control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">177 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape currently has no formal arrangements under which <FONT STYLE="white-space:nowrap">non-employee</FONT> directors receive
compensation for their service on the QuantumScape Board or its committees. QuantumScape&#146;s policy is to reimburse <FONT STYLE="white-space:nowrap">non-employee</FONT> directors for reasonable and necessary <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred in connection with attending board and committee meetings or performing other services in their capacities as <FONT STYLE="white-space:nowrap">non-employee</FONT> directors,
and occasionally grants stock options to <FONT STYLE="white-space:nowrap">QuantumScape&#146;s&nbsp;non-employee&nbsp;directors.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below summarizes the compensation of each person serving as a QuantumScape <FONT STYLE="white-space:nowrap">non-employee</FONT>
director for the year ended December&nbsp;31, 2019. Jagdeep Singh, QuantumScape&#146;s Chief Executive Officer, did not receive any additional compensation for his service as a director in 2019. The compensation of Mr.&nbsp;Singh as a named
executive officer is set forth above under &#147;<I>QuantumScape&#146;s Executive Compensation&#151;Summary Compensation Table</I>.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees&nbsp;Earned<BR>or&nbsp;Paid&nbsp;in&nbsp;Cash<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Frank Blome</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Doerr</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vinod Khosla</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prof. Dr.&nbsp;J&uuml;rgen Leohold</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">612,912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">662,912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dipender Saluja</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.B. Straubel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,532,279</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,532,279</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prof. Fritz Prinz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,000</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts in this column represent the aggregate grant-date fair value of awards granted to each named
executive officer, computed in accordance with the FASB&#146;s ASC Topic 718. See Note 2 to QuantumScape&#146;s audited consolidated financial statements included elsewhere in this proxy statement/prospectus/information statement for a discussion of
the assumptions made by QuantumScape in determining the grant-date fair value of QuantumScape&#146;s equity awards. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents fees for consulting services. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following lists all outstanding equity awards held by <FONT STYLE="white-space:nowrap">non-employee</FONT> directors as of December&nbsp;31, 2019: </P>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate<BR>Number&nbsp;of&nbsp;Shares<BR>Underlying<BR>Outstanding<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Frank Blome</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Doerr</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vinod Khosla</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prof. Dr. J&uuml;rgen Leohold</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dipender Saluja</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.B. Straubel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prof. Fritz Prinz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The QuantumScape Board expects to review director compensation periodically to ensure that director
compensation remains competitive such that QuantumScape is able to recruit and retain qualified directors. Following the Closing, New QuantumScape intends to develop a <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation
program that is designed to align compensation with New QuantumScape&#146;s business objectives and the creation of stockholder value, while enabling New QuantumScape to attract, retain, incentivize and reward directors who contribute to the
long-term success of New QuantumScape. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">178 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Developments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August 7, 2020, QuantumScape granted the following restricted stock units, or RSUs, to its named executive officers: Mr.&nbsp;Singh, RSUs
for 1,000,000 shares of QuantumScape Class&nbsp;A Common Stock; Mr.&nbsp;Lukens, RSUs for 100,000 shares of QuantumScape Class&nbsp;A Common Stock; and Mr.&nbsp;McCarthy, RSUs for 150,000 shares of QuantumScape Class&nbsp;A Common Stock. Each of the
agreements governing these RSUs provide that in the event of a change in control, if the employment of the holder of the RSUs is terminated by QuantumScape without cause or if the holder of the RSUs is constructively terminated within six months
following the change of control, then 50% of any unvested RSUs shall immediately vest. On September 2, 2020, QuantumScape also granted Brad Buss options to purchase 350,000 shares of QuantumScape Class&nbsp;A Common Stock in connection with
Mr.&nbsp;Buss joining the QuantumScape Board. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Post-Business Combination Executive Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the Closing, New QuantumScape intends to develop an executive compensation program that is designed to align compensation with New
QuantumScape business objectives and the creation of stockholder value, while enabling New QuantumScape to attract, retain, incentivize and reward individuals who contribute to the long-term success of New QuantumScape. Decisions on the executive
compensation program will be made by the New QuantumScape&#146;s compensation committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">179 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_55"></A>QUANTUMSCAPE MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS </B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following discussion and analysis provides information that
QuantumScape&#146;s management believes is relevant to an assessment and understanding of QuantumScape&#146;s consolidated results of operations and financial condition. The discussion should be read together with &#147;Selected Historical
Consolidated Financial Information of QuantumScape&#148; and the historical audited annual consolidated financial statements as of and for the years ended December&nbsp;31, 2019 and 2018 and unaudited interim condensed consolidated financial
statements as of June&nbsp;30, 2020 and the six months periods ended June&nbsp;30, 2020 and 2019, and the related respective notes thereto, included elsewhere in this proxy statement/prospectus/information statement. The discussion and analysis
should also be read together with QuantumScape&#146;s unaudited pro forma financial information for the year ended December&nbsp;31, 2019 and the six months ended June&nbsp;30, 2020. See &#147;Unaudited Pro Forma Condensed Combined Financial
Information.&#148; This discussion may contain forward-looking statements based upon current expectations that involve risks and uncertainties. QuantumScape&#146;s actual results may differ materially from those anticipated in these forward-looking
statements as a result of various factors, including those set forth in this &#147;QuantumScape Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations,&#148; under &#147;Risk Factors&#148; or in other parts of
this proxy statement/prospectus/information statement. Unless the context otherwise requires, references in this &#147;QuantumScape Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; to
&#147;QuantumScape&#148; and &#147;the Company&#148; refer to the business and operations of QuantumScape Corporation and its consolidated subsidiaries prior to the Business Combination and to New QuantumScape and its consolidated subsidiaries,
following the Closing. </I></P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape is developing next generation battery technology for EVs and other applications. It believes that its technology will enable a new
category of battery that meets the requirements for broader market adoption. The lithium-metal solid-state battery technology that QuantumScape is developing is being designed to offer greater energy density, longer life, faster charging, and
greater safety when compared to today&#146;s conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> batteries.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape is a
development stage company with no revenue to date that has incurred a net loss of approximately $51.3&nbsp;million for the year ended December&nbsp;31, 2019 and an accumulated deficit of approximately $295.9 million from its inception through the
year ended December&nbsp;31, 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Business Combination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape entered into a business combination agreement and plan of reorganization (as may be amended from time to time, the &#147;Business
Combination Agreement&#148;) with Kensington Acquisition Corp. (&#147;Kensington&#148;) on September&nbsp;2, 2020. Pursuant to the Business Combination Agreement, and assuming a favorable vote of Kensington&#146;s stockholders, Kensington Merger Sub
Inc. (&#147;Merger Sub&#148;), a newly formed subsidiary of Kensington, will be merged with and into QuantumScape (the &#147;Business Combination&#148;). Upon the Closing, the separate corporate existence of Merger Sub shall cease, QuantumScape will
survive and become a wholly-owned subsidiary of Kensington (&#147;New QuantumScape&#148;). The Business Combination is anticipated to be accounted for as a reverse recapitalization. QuantumScape will be deemed the accounting predecessor and the
combined entity will be the successor SEC registrant, meaning that QuantumScape&#146;s financial statements for previous periods will be disclosed in the registrant&#146;s future periodic reports filed with the SEC. Under this method of accounting,
Kensington will be treated as the acquired company for financial statement reporting purposes. The most significant change in the successor&#146;s future reported financial position and results, assuming no shareholder redemptions, are expected to
be an estimated $961 million net increase in cash and cash equivalents (as compared to QuantumScape&#146;s consolidated balance sheet at June&nbsp;30, 2020) and an estimated $1,367 million net increase in total stockholders&#146; equity (as compared
to QuantumScape&#146;s consolidated balance sheet at June 30, 2020) &#150; both of which include, $500&nbsp;million in gross proceeds from the PIPE and $288&nbsp;million </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">180 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in gross proceeds from the sale of Series F Preferred Stock that will close concurrent with the Closing or on December 1, 2020. Total transaction costs are estimated at approximately $46 million.
See the section entitled &#147;<I>Unaudited Pro Forma Condensed Combined Financial Information</I>.&#148; </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of the
Business Combination, QuantumScape will become the successor to an <FONT STYLE="white-space:nowrap">SEC-registered</FONT> and NYSE-listed company, which will require QuantumScape to hire additional personnel and implement procedures and processes to
address public company regulatory requirements and customary practices. QuantumScape expects to incur additional annual expenses as a public company for, among other things, directors&#146; and officers&#146; liability insurance, director fees, and
additional internal and external accounting, legal, and administrative resources, including increased personnel costs, audit and other professional service fees. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Key Trends, Opportunities and Uncertainties </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape is a <FONT STYLE="white-space:nowrap">pre-revenue</FONT> company; we believe that our performance and future success depend on
several factors that present significant opportunities for us but also pose risks and challenges, including those discussed below and in the section of this proxy statement/prospectus/information statement titled &#147;<I>Risk Factors</I>.&#148;
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Product Development </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Major
remaining development activities include, but are not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Multi-layering. </I>To date, QuantumScape has only produced single-layer solid-state battery cells at the
commercially required size. In order to produce commercially-viable solid-state battery cells, we must produce battery cells consisting of over one hundred layers. We will need to overcome the developmental challenges to stack these layers and
implement the appropriate cell design for our solid-state battery cell. </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Continued improvement in the solid-state separator. </I>We are working to improve the reliability and
performance of our solid-state separator, including decreasing the thickness. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Integration of advanced cathode materials.</I> QuantumScape benefits from industry cathode chemistry
improvements and/or cost reduction. Our solid-state separator platform is being designed to enable some of the most promising next-generation cathode technologies, including high voltage or high capacity cathode active materials, which when combined
with a lithium-metal anode, may enable cell energy densities that exceed 500Wh/kg. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our team of over 200 scientists,
engineers, technicians, and other staff is highly motivated and committed to solving these challenges ahead. However, any delays in the completion of these tasks will require additional cash use and delay market entry. For reference, QuantumScape is
forecasted to spend approximately $20&nbsp;million in the fourth quarter of 2020 on research and development and general and administrative expenses; accordingly, a <FONT STYLE="white-space:nowrap">six-month</FONT> delay at this rate of spending
would utilize approximately $40&nbsp;million. As QuantumScape grows its team, size of engineering pilot line, and materials consumption, the rate of cash utilization as a function of time will also increase significantly. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Process Development </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
architecture depends on our proprietary solid-state ceramic separator which we will manufacture ourselves. Though our separator&#146;s design is unique, its manufacturing relies on well-established, high-volume production processes currently
deployed globally in other industries at large scale. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">181 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The solid-state separator is being designed to enable our &#145;anode-free&#146;
architecture. As manufactured, the cell has no anode; the lithium-metal anode is formed during the first charge of the cell; 100% of the lithium that forms the anode comes from the cathode material we purchase. Eliminating the anode bill of
materials and associated manufacturing costs found in conventional <FONT STYLE="white-space:nowrap">lithium-ion</FONT> cells could result in a meaningful cost of goods sold advantage for QuantumScape. In addition, QuantumScape&#146;s solid-state
separator is being designed to reduce the time and capital-intensity of the formation process step as compared to conventional lithium-ion manufacturing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are focused on both the continued expansion of the throughput and capability of our San Jose engineering line as well as the planning and
execution of the Pilot Facility, our first commercial manufacturing facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Continued expansion of the throughput and capability of our
San Jose engineering line serves two purposes. First, the engineering line provides a sufficient quantity of solid-state separators and cells for internal development and for customer sampling. And second, our San Jose engineering line provides the
basis for continued manufacturing process development and helps inform tool selection and specifications for equipment for our Pilot Facility. Delays in the successful buildout of our San Jose engineering line may impact both our development and the
Pilot Facility timelines. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Capturing our forecasted cost advantage at scale as compared to conventional
<FONT STYLE="white-space:nowrap">lithium-ion</FONT> cells will require the QuantumScape team to continue process development to achieve rates of throughput, use of electricity and consumables, yield, and rate of automation demonstrated of mature
battery, battery material, and ceramic manufacturing processes. Notably, heat treatment of ceramic parts is a process step in ceramic manufacturing critical to both quality and product cost. We believe achieving required process cost advances is
possible; our processes are designed around tools which are already used at scale in the battery or ceramics industries. In addition, QuantumScape is investigating alternative processing methods that may further increase the capital efficiency of
the process. However, delay or failure on these fronts, and in particular with respect to ceramic heat treatment, would result in a higher cost of goods sold, which may limit our ability to profitably sell our batteries. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Commercialization </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will
continue developing our battery technology with the goal of enabling commercial production in 2024. We have validated the performance capabilities of our solid-state separator and battery technology in single-layer cells. We are now working to
develop multi-layer cells, to continue improving yield and performance and to optimize all components of the cell. We will continue to work to further develop the volume manufacturing processes to enable high volume manufacturing and minimize
manufacturing costs. We will continue to work on increasing the yield of our separators to reduce scrappage and to increase utilization of manufacturing tools. The funds available upon the Closing will enable us to expand and accelerate research and
development activities and undertake additional initiatives. Finally, we will continue to use our engineering line in San Jose, California to prepare for high volume manufacturing and plan our first commercial production Pilot Facility through our
joint venture partnership with Volkswagen.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Pilot Facility to be built and run by QSV and the 20GWh Expansion Facility would represent
a small fraction of Volkswagen&#146;s demand for batteries and implies vehicle volumes under 2% of Volkswagen&#146;s total production in 2019, assuming a 100KWh pack size. Our goal is to significantly expand the production capacity of the joint
venture, in partnership with Volkswagen, to meet more of their projected demand.&nbsp;While we expect Volkswagen will be the first to commercialize vehicles using our battery technology, we intend to work closely with other automotive OEMs to make
our solid-state battery cells widely available over time.&nbsp;We are focused on automotive EV applications, which has the most stringent set of requirements for batteries.&nbsp;However, we recognize that our solid-state battery technology has
applicability in other large and growing markets including stationary storage and consumer electronics such as smartphones and wearables. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">182 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our technology enables a variety of business models. In addition to joint ventures, such as
the one with Volkswagen,<I> </I>we may operate solely-owned manufacturing facilities or license technology to other manufacturers. Where appropriate, we may build and sell separators rather than complete battery cells.&nbsp;We intend to continue to
invest in research and development to improve battery cell performance, improve manufacturing processes, and reduce cost.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Market Focus </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are focused on automotive EV applications, which has the most stringent set of requirements for batteries. However, we recognize that our
solid-state battery technology has applicability in other large and growing markets including stationary storage and consumer electronics such as smartphones and wearables. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Access to Capital </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the
Business Combination and assuming we experience no significant delays in the research and development of our solid-state battery cells, we believe that our cash resources are sufficient to fund our start of production, including our share of
contributions to our Pilot Facility with Volkswagen. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Regulatory Landscape </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape operates in an industry that is subject to many established environmental regulations, which have generally become more stringent
over time, particularly in hazardous waste generation and disposal and pollution control. Regulations in QuantumScape&#146;s target markets include economic incentives to purchasers of EVs, tax credits for EV manufacturers, and economic penalties
that may apply to a car manufacturer based on its fleet-wide emissions which may indirectly benefit QuantumScape in that the regulations will expand the market size of EVs. While QuantumScape expects environmental regulations to provide a tailwind
to its growth, it is possible for certain regulations to result in margin pressures. Trade restrictions and tariffs, while historically minimal between the European Union and the United States where most of QuantumScape&#146;s production and sales
are expected, are subject to unknown and unpredictable change that could impact QuantumScape&#146;s ability to meet projected sales or margins. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis
of Presentation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape currently conducts its business through one operating segment. As a
<FONT STYLE="white-space:nowrap">pre-revenue</FONT> company with no commercial operations, QuantumScape&#146;s activities to date have been limited and were conducted primarily in the United States and its historical results are reported under GAAP
and in U.S. dollars. Upon commencement of commercial operations, QuantumScape expects to expand its global operations substantially, including in the United States and the European Union, and as a result QuantumScape expects its future results to be
sensitive to foreign currency transaction and translation risks and other financial risks that are not reflected in its historical financial statements. As a result, QuantumScape expects that the financial results it reports for periods after it
begins commercial operations will not be comparable to the financial results included in this proxy statement/prospectus/information statement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Components of Results of Operations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape is a research and development stage company and its historical results may not be indicative of its future results for reasons
that may be difficult to anticipate. Accordingly, the drivers of QuantumScape&#146;s future financial results, as well as the components of such results, may not be comparable to QuantumScape&#146;s historical or projected results of operations.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development Expense </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, QuantumScape&#146;s research and development expenses have consisted primarily of personnel-related expenses for scientists,
experienced engineers and technicians as well as costs associated with the expansion and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">183 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
ramp up of our engineering facility in San Jose, California, including the material and supplies to support the product development and process engineering efforts. As QuantumScape ramps up its
engineering operations to complete the development of our solid-state, lithium-metal batteries and required process engineering to meet automotive cost targets, QuantumScape anticipates that research and development expenses will increase
significantly for the foreseeable future as QuantumScape expands its hiring of scientists, engineers, and technicians and continues to invest in additional plant and equipment for product development (e.g. multi-layer cell stacking, packaging
engineering), building prototypes, and testing of battery cells as the team works to meet the full set of automotive product requirements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>General and Administrative Expense </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General and administrative expenses consist mainly of personnel-related expenses for QuantumScape&#146;s executive, sales and marketing and
other administrative functions and expenses for outside professional services, including legal, accounting and other advisory services. QuantumScape is rapidly expanding its personnel headcount, in anticipation of planning for and ramping up
commercial manufacturing operations and becoming a public company upon the Closing. Accordingly, in addition to the <FONT STYLE="white-space:nowrap">non-recurring</FONT> transaction costs discussed above, QuantumScape expects its general and
administrative expenses to increase significantly in the near term and for the foreseeable future. Upon commencement of commercial operations, QuantumScape also expects general and administrative expenses to include facilities, marketing and
advertising costs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Income (Expense) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape&#146;s other income (expense) consists of interest income from marketable securities, sublease income and interest expense for
facility lease prior to the adoption of ASC 842,<I> Leases</I> and interest expense related to fair value adjustments for outstanding convertible preferred stock warrants. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Income Tax Expense / Benefit </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape&#146;s income tax provision consists of an estimate for U.S. federal and state income taxes based on enacted rates, as adjusted
for allowable credits, deductions, uncertain tax positions, changes in deferred tax assets and liabilities, and changes in the tax law. QuantumScape maintains a valuation allowance against the full value of its U.S. and state net deferred tax assets
because QuantumScape believes the recoverability of the tax assets is not more likely than not. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">184 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Results of Operations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Six Months Ended June&nbsp;30, 2020 to the Six Months Ended June&nbsp;30, 2019 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth QuantumScape&#146;s historical operating results for the periods indicated: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six Months Ended<BR>June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B><br><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%</B><br><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2020&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in&nbsp;thousands,&nbsp;except&nbsp;Share&nbsp;and&nbsp;per&nbsp;Share&nbsp;Amounts)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 25,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 21,203</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 4,193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,747</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,927</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(180</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,143</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,130</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,013</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-900</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,235</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-60</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(592</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">819</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,637</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,818</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-69</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,324</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,493</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,831</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Net (loss) income attributable to <FONT STYLE="white-space:nowrap">non-controlling</FONT>
interest, net of tax of $0 </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-163</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (29,319</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (23,501</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(5,818</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (29,324</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (23,493</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(5,831</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income (loss):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized gain on marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(102</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-64</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,267</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,334</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,933</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Comprehensive (loss) income attributable to
<FONT STYLE="white-space:nowrap">non-controlling</FONT> interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-163</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (29,262</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (23,342</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(5,920</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and Diluted net loss per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (2.61</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (2.10</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (0.51</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and Diluted weighted-average common shares outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,233,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,181,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51,845</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research and development expenses increased by $4.2&nbsp;million, or 20%, from $21.2&nbsp;million in the first six months of 2019 to
$25.4&nbsp;million in the first six months of 2020. The increase primarily resulted from the $2.2&nbsp;million increase in personnel cost due to the growth in research and development headcount to support the increase of technology development and
an increase of $0.3&nbsp;million in material supplies to support the scale up of engineering cell builds to commercial form factor. Additionally, <FONT STYLE="white-space:nowrap">non-cash</FONT> stock-based compensation expense increased
$1.1&nbsp;million from $1.6&nbsp;million for the first six months of 2019 to $2.7&nbsp;million for the first six months of 2020 due to the effect of refresh option grants in June 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>General and Administrative </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General and administrative expenses decreased by $0.2&nbsp;million, or 4%, from $4.9&nbsp;million in the first six months of 2019 to
$4.7&nbsp;million in the first six months of 2020, primarily due to decrease in legal fees and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">185 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
partially offset by an increase of $0.4&nbsp;million for stock-based compensation in the first six months of 2020 due to the effect of employee refresh option grants in June 2019 and option
grants to QuantumScape directors in December 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest Income </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest income decreased $1.2&nbsp;million in the first six months of 2020 compared to the first six months of 2019. The decrease was due to
reduction of market interest rate and due to the decrease of our marketable securities balance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Fiscal Year Ended
December&nbsp;31, 2019 to the Fiscal Year Ended December&nbsp;31, 2018 </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth QuantumScape&#146;s
historical operating results for the periods indicated: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$</B><br><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%</B><br><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in&nbsp;thousands,&nbsp;except&nbsp;Share&nbsp;and&nbsp;per&nbsp;Share&nbsp;Amounts)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 45,944</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 35,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 10,310</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,874</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,768</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55,818</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(45,453</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,365</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(94</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,520</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,426</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-94</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,608</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,481</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,555</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,309</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">248</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51,263</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,144</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,119</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Net income attributable to <FONT STYLE="white-space:nowrap">non-controlling</FONT> interest<SUP
STYLE="font-size:85%; vertical-align:top"> </SUP>, net of tax of $0</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (51,283)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (44,149)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(7,134</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51,263</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,144</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,119</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income (loss):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized gain on marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51,142</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,055</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,087</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Comprehensive income attributable to <FONT STYLE="white-space:nowrap">non-controlling</FONT>
interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (51,162</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (44,060</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(7,102</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and Diluted net loss per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (4.58</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (3.97</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> (0.61</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and Diluted weighted-average common shares outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,194,183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,108,638</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,545</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research and development expenses increased by $10.3&nbsp;million or 29% from $35.6&nbsp;million in 2018 to $45.9&nbsp;million in 2019,
reflecting a significant <FONT STYLE="white-space:nowrap">ramp-up</FONT> of internal engineering resources as QuantumScape transitioned the prototypes from smaller form factor to the targeted commercial size. Research and development
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">186 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
personnel cost increased $4.9&nbsp;million from $17.0&nbsp;million in 2018 to $21.9&nbsp;million in 2019 due primarily to increase in headcount of 35%. Material and supplies expenses increased
$2.4&nbsp;million from $3.3&nbsp;million in 2018 to $5.7&nbsp;million in 2019 attributable to the higher consumptions of chemical, process gases, lab supplies and other material for cell assembly. Facility cost increased $2.6&nbsp;million due to
increase in our research and development lab spaces and the reclassification of expense from interest expense to research and development expense of $2.1&nbsp;million upon the early adoption of the lease accounting standard, ASC 842. We adopted ASC
842 in January 2019 and recorded rent expense of $2.1&nbsp;million in accordance with the accounting guidance. <FONT STYLE="white-space:nowrap">Non-cash</FONT> stock-based compensation also increased $1.4&nbsp;million year over year due to the stock
option grants in 2019. Research and development expenses in 2018 included $2.5&nbsp;million for a <FONT STYLE="white-space:nowrap">one-time</FONT> employee stock repurchase transaction that did not occur in 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>General and Administrative </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General and administrative expenses increased by $0.1&nbsp;million, or 1%, from $9.8&nbsp;million in 2018 to $9.9&nbsp;million in 2019.
Increases in personnel costs of $0.3&nbsp;million and professional fees of $0.7&nbsp;million were offset by a $0.5&nbsp;million decrease in <FONT STYLE="white-space:nowrap">non-cash</FONT> stock-based compensation and $0.5&nbsp;million <FONT
STYLE="white-space:nowrap">one-time</FONT> employee stock repurchase transaction in December 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest Expense </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest expense decreased from $1.5&nbsp;million in 2018 to $0.1&nbsp;million in 2019. The interest expense in 2018 consisted of mark to
market adjustment on the convertible preferred warrants of $0.5&nbsp;million and interest expense relating to our building lease of $0.9&nbsp;million. In January 2019, QuantumScape adopted ASC 842 Lease accounting which resulted in the facility
lease being accounted for as an operating lease and the related expense as rent expense rather than as interest expense under the previous accounting guidance, in which the lease was classified as a finance lease. The mark to market adjustment on
the convertible preferred warrants was only $0.1&nbsp;million in 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest Income </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest income increased $1.5&nbsp;million in 2019 due to favorable interest rate on the marketable securities and higher balance of our
marketable securities in 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Income </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other income increased $0.3&nbsp;million in 2019 due to increase in sublease income. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity and Capital Resources </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since
inception, we have financed our operations primarily from the sales of redeemable convertible preferred stock. As of June&nbsp;30, 2020, our principal sources of liquidity were our cash and cash equivalents and marketable securities in the amount of
$98.7&nbsp;million. Our cash equivalents are invested primarily in U.S. Treasury money market funds and our marketable securities are primarily invested in U.S. Treasury notes and bonds. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this proxy statement/prospectus/information statement, QuantumScape has yet to generate any revenue from its business
operations. To date, QuantumScape has funded its capital expenditure and working capital requirements through equity as further discussed below. QuantumScape&#146;s ability to successfully develop its products, commence commercial operations and
expand its business will depend on many factors, including its working capital needs, the availability of equity or debt financing and, over time, its ability to generate cash flows from operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">187 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, QuantumScape&#146;s cash and cash equivalents and marketable
securities amounted to $98.7&nbsp;million. On a pro forma basis, assuming the stockholder approval, the Closing and the closings of the Series F Preferred Stock financing, QuantumScape&#146;s cash and cash equivalents and marketable securities would
have amounted to approximately $1,060&nbsp;million on June&nbsp;30, 2020, assuming de minimis redemptions by SPAC stockholders. From May 2020 to August 2020, QuantumScape entered into agreements with existing and new investors to issue
14.7&nbsp;million shares of Series F Preferred Stock for an aggregate amount of $388&nbsp;million in cash. Of this amount $100&nbsp;million is due to be funded on December&nbsp;1, 2020, $188&nbsp;million is due to be funded on the date the Business
Combination closes, and the remaining $100&nbsp;million is subject to completion of a certain technical milestone by the end of the first quarter of 2021. If the funding date for the first and/or second tranche becomes due prior to the Closing, then
New QuantumScape will reserve shares of New QuantumScape Class&nbsp;A Common Stock to be issued in lieu of Series F Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape expects its capital expenditures and working capital requirements to increase materially in the near future, as it seeks to
accelerate its research and development efforts and scale up the phase 1 pilot production operations with its joint venture partner. QuantumScape believes that its cash on hand following the Closing, including the net proceeds from SPAC&#146;s cash
in trust (assuming de minimis redemptions by SPAC&#146;s stockholders), the PIPE and the Series F Preferred Stock financing will be sufficient to meet its working capital and capital expenditure requirements for a period of at least twelve months
from the date of this proxy statement/prospectus/information statement and sufficient to fund its operations until it commences production of the QuantumScape solid-state battery through the 20GWh Expansion Facility, assuming QuantumScape is able to
do so as currently contemplated. QuantumScape may, however, need additional cash resources due to changed business conditions or other developments, including unanticipated delays in negotiations with OEMs and
<FONT STYLE="white-space:nowrap">tier-one</FONT> automotive suppliers or other suppliers, supply chain challenges, disruptions due to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, competitive pressures, and regulatory developments,
among other developments. To the extent that QuantumScape&#146;s current resources are insufficient to satisfy its cash requirements, QuantumScape may need to seek additional equity or debt financing. If the financing is not available, or if the
terms of financing are less desirable than QuantumScape expects, QuantumScape may be forced to decrease its level of investment in product development or scale back its operations, which could have an adverse impact on its business and financial
prospects. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Flows </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides a summary of QuantumScape&#146;s cash flow data for the periods indicated: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Six Months Ended<BR>June&nbsp;30</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Amount in thousands</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash (used in) operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(22,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(19,797</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>27,758</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,864</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Year Ended<BR>December&nbsp;31</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Amount in thousands</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash (used in) operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(41,731</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(35,722</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by (used in) investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>33,301</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(74,694</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>394</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Flows from Operating Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape&#146;s cash flows used in operating activities to date have been primarily comprised of payroll, material and supplies, facilities
expense, and professional service related to research and development and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">188 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
general and administrative activities. As QuantumScape continues to ramp up hiring for technical headcounts to accelerate its engineering efforts ahead of starting the pilot line operations,
QuantumScape expects its cash used in operating activities to increase significantly before it starts to generate any material cash flows from its business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities was $22.0&nbsp;million in the first six months of 2020, up from $19.8&nbsp;million cash used in the
first six months of 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities was $41.7&nbsp;million in 2019, up from $35.7&nbsp;million in 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Flows from Investing Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape&#146;s cash flows from investing activities, to date, have been comprised of purchases of property and equipment and purchases and
maturities of our marketable securities. QuantumScape expects the costs to acquire property and equipment to increase substantially in the near future as it needs to fully build out its engineering lines as well as acquire the property and equipment
for the pilot line of the separator and cell manufacturing operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape net cash provided by investing activities was
$27.8&nbsp;million in the first six months of 2020 compared to $12.9&nbsp;million for the first six months of 2019. Cash used for property and equipment purchases in the first six months of 2020 was $9.9&nbsp;million, a significant increase over the
$2.8&nbsp;million of cash used for equipment purchases in the first six months of 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash from investing activities was
$33.3&nbsp;million in 2019 compared to $74.7&nbsp;million in 2018. Cash used for property and equipment purchases was $9.8&nbsp;million in 2019, representing an increase of $2.4&nbsp;million from 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Flows from Financing Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Through June&nbsp;30, 2020, QuantumScape has financed its operations primarily through the sale of equity securities. In addition, QuantumScape
has entered into agreements for the sale of Series F Preferred Stock for $388&nbsp;million (before fees and expenses) in gross proceeds, of which the purchase commitment for $100&nbsp;million is subject to completion of a certain technical milestone
by the end of the first quarter of 2021. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash from financing activities was negligible in the first six months of 2020 compared
with $0.2&nbsp;million from employee stock option exercises in the comparable period of 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash from financing activities was
$0.4&nbsp;million in 2019 from proceeds of employee stock option exercises. Net cash from financing activities was $120.8&nbsp;million in 2018. The 2018 cash provided by financing consists of $122.8&nbsp;million for the sales of Series E Preferred
Stock, $1.1&nbsp;million proceeds from employee stock option exercises, and $1.7&nbsp;million capital contribution from <FONT STYLE="white-space:nowrap">non-controlling</FONT> interest in joint venture. Partially offsetting these increases were
$4.2&nbsp;million in cash paid for treasury shares relating to employee stock repurchase and $0.6&nbsp;million repayment of lease financing obligations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contractual Obligations and Commitments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape currently leases its headquarters space in the San Jose, California area under a single lease classified as an operating lease
expiring on January 23, 2023. The lease contains provision for an extension of 60 months. QuantumScape has not commenced the lease extension negotiation yet and expects to do so prior to the expiration of its existing lease. However, as the exercise
of the option was reasonably certain, the option period has been included in the calculation of right of use and lease liability at the adoption date of January&nbsp;1, 2019 as well as the obligations table below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">189 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes QuantumScape&#146;s contractual obligations and other
commitments for cash expenditures as of December&nbsp;31, 2019 and the years in which these obligations are due: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Payments Due by Period</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Less&nbsp;than<BR>1 Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">1-3&nbsp;Years</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">3-5&nbsp;Years</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>More<BR>than<BR>5&nbsp;years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Contractual Obligations</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">17,927</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,994</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,168</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total </B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B></B>$</TD>
<TD VALIGN="bottom" ALIGN="right"><B></B>17,927</TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,994</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,168</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There have been no material changes since December&nbsp;31, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Off-Balance</FONT> Sheet Arrangements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape is not a party to any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet arrangements, as defined under SEC rules. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Critical Accounting Policies and Estimates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape&#146;s financial statements have been prepared in accordance with GAAP. In the preparation of these financial statements,
QuantumScape is required to use judgment in making estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements, as well as
the reported expenses incurred during the reporting periods. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape considers an accounting judgment, estimate or assumption to be
critical when (1)&nbsp;the estimate or assumption is complex in nature or requires a high degree of judgment and (2)&nbsp;the use of different judgments, estimates and assumptions could have a material impact on the consolidated financial
statements. QuantumScape&#146;s significant accounting policies are described in Note 2 to its audited consolidated financial statements included elsewhere in this proxy statement/prospectus/information statement. QuantumScape has the critical
accounting policies and estimates which are described below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock-Based Compensation and Common Stock Valuation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape recognizes the cost of share-based awards granted to employees and directors based on the estimated grant-date fair value of the
awards. Cost is recognized on a straight-line basis over the service period, which is generally the vesting period of the award. QuantumScape reverses previously recognized costs for unvested options in the period that forfeitures occur.
QuantumScape determines the fair value of stock options using the Black-Scholes option pricing model, which is impacted by the following assumptions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected Term</I>&#151;QuantumScape uses the simplified method when calculating the expected term due to
insufficient historical exercise data. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected Volatility</I>&#151;As QuantumScape&#146;s shares are not actively traded, the volatility is based on
a benchmark of comparable companies within the automotive and energy storage industries. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected Dividend Yield</I>&#151;The dividend rate used is zero as QuantumScape has never paid any cash
dividends on common stock and does not anticipate doing so in the foreseeable future. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Risk-Free Interest Rate</I>&#151;The interest rates used are based on the implied yield available on U.S.
Treasury <FONT STYLE="white-space:nowrap">zero-coupon</FONT> issues with an equivalent remaining term equal to the expected life of the award. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Common Stock Valuations </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The grant
date fair value of QuantumScape common stock will typically be determined by QuantumScape&#146;s board of directors with the assistance of management and a third-party valuation specialist. While QuantumScape
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">190 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
has not yet determined our valuation approach for future grants, given its <FONT STYLE="white-space:nowrap">pre-revenue</FONT> stage of development, management believes that an Option Pricing
Model (&#147;OPM&#148;) may be the most appropriate method for allocating enterprise value to determine the estimated fair value of QuantumScape common stock. Application of the OPM involves the use of estimates, judgment, and assumptions that are
highly complex and subjective, such as those regarding QuantumScape&#146;s expected future revenue, expenses, and cash flows, discount rates, market multiples, the selection of comparable companies, and the probability of future events. Once New
QuantumScape Common Stock is publicly traded, the New QuantumScape Board intends to determine the fair value of New QuantumScape Common Stock based on the closing market price on or around the date of grant. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Redeemable Convertible&nbsp;Preferred Stock Warrant Liabilities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Warrants to purchase shares of redeemable convertible preferred stock are classified as liabilities on the consolidated balance sheets at fair
value upon issuance because the underlying shares of redeemable convertible preferred stock are redeemable outside of the control of QuantumScape. The initial liability recorded is adjusted for changes in the fair value at each reporting date and
recorded as interest expense in the accompanying statements of operations and comprehensive loss. QuantumScape will continue to adjust the convertible preferred stock warrant liability for changes in fair value until the earlier of the exercise of
the warrants, at which time the liability will be reclassified to redeemable convertible preferred stock, or the expiration of the warrants, at which time the entire amount would be reversed and reflected in the accompanying statements
of&nbsp;operations and comprehensive loss. The redeemable convertible preferred stock warrant liabilities will increase or decrease each period based on the fluctuations of the fair value of the underlying security. We expect the fair value of the
warrants to increase leading up to the Business Combination, but we do not expect any future charges following the Closing as the redeemable convertible preferred stock warrants outstanding will automatically convert into common stock warrants upon
the Closing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Emerging Growth Company Status </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can choose not to take advantage of the extended transition period and comply with the requirements
that apply to <FONT STYLE="white-space:nowrap">non-emerging</FONT> growth companies, and any such election to not take advantage of the extended transition period is irrevocable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington is an &#147;emerging growth company&#148; as defined in Section&nbsp;2(a) of the Securities Act and has elected to take advantage
of the benefits of the extended transition period for new or revised financial accounting standards. Following the Closing, QuantumScape expects to remain an emerging growth company at least through the end of the 2020 fiscal year and QuantumScape
expects to continue to take advantage of the benefits of the extended transition period, although it may decide to early adopt such new or revised accounting standards to the extent permitted by such standards. This may make it difficult or
impossible to compare QuantumScape&#146;s financial results with the financial results of another public company that is either not an emerging growth company or is an emerging growth company that has chosen not to take advantage of the extended
transition period exemptions because of the potential differences in accounting standards used. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Accounting Pronouncements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See Note 3 to the audited consolidated financial statements included elsewhere in this proxy statement/prospectus/information statement for
more information about recent accounting pronouncements, the timing of their adoption, and QuantumScape&#146;s assessment, to the extent it has made one, of their potential impact on QuantumScape&#146;s financial condition and its results of
operations and cash flows. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">191 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Quantitative and Qualitative Disclosures About Market Risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape is exposed to a variety of markets and other risks including the effects of change in interest rates, inflation and foreign
currency translation and transaction risks as well as risks to the availability of funding sources, hazard events and specific asset risks. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Interest
Rate Risk </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The market interest risk in our financial instruments and our financial positions represents the potential loss arising from
adverse changes in interest rates. As of June&nbsp;30, 2020, we had cash and cash equivalents and marketable securities of $98.7&nbsp;million, consisting of interest-bearing money market accounts and marketable securities for which the fair market
value would be affected by change in the general level of U.S. interest rates. However, due to the short-term maturities and the <FONT STYLE="white-space:nowrap">low-risk</FONT> profile of our investments, an immediate 10% change in the interest
rate would not have a material effect on the fair market value of our cash and cash equivalents and marketable securities </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Foreign Currency Risk
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape&#146;s functional currency is the U.S. dollar, while certain of QuantumScape&#146;s current and future subsidiaries will
be expected to have other functional currencies, reflecting their principal operating markets. Once QuantumScape commences phase 1 pilot operations, it expects to be exposed to both currency transaction and translation risk. To date, QuantumScape
has not had material exposure to foreign currency fluctuations and has not hedged such exposure, although it may do so in the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">192 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_56"></A>CERTAIN QUANTUMSCAPE RELATIONSHIPS AND RELATED PARTY
TRANSACTIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholder Support Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, (i) Kensington and VGA entered into the Volkswagen Support Agreement, pursuant to which, among other things, VGA
agreed, among other things, to vote its shares of QuantumScape Preferred Stock in favor of the Business Combination Agreement and the Proposed Transactions, and (ii)&nbsp;Kensington and the Key QuantumScape Stockholders entered into the Key
Stockholder Support Agreement, pursuant to which, among other things, the Key QuantumScape Stockholders agreed, among other things, to vote their shares of QuantumScape Common Stock and QuantumScape Preferred Stock in favor of the Business
Combination Agreement and the Proposed Transactions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Kensington and the Holders entered into a Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT>
Agreement, which shall be effective at the Closing. Pursuant to the terms of the Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement, Kensington will be obligated to file&nbsp;a registration statement to register the
resale of certain shares of Kensington Common Stock held by the Holders after the Closing. In addition, pursuant to the terms of the Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement and subject to certain
requirements and customary conditions, including with regard to the number of demand rights that may be exercised, the Holders may demand at any time or from time to time, that Kensington file&nbsp;a registration statement on <FONT
STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> (or on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> if <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> is not available) to register the securities of Kensington held by such Holders,
and Kensington is separately required at all times to maintain an effective resale registration statement for the benefit of the Holders. The Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement will also provide the
Holders with &#147;piggy-back&#148; registration rights, subject to certain requirements and customary conditions. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Registration
Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement further provides for the securities of Kensington held by the Holders to be <FONT STYLE="white-space:nowrap">locked-up</FONT> for a period of time following the Closing, subject to
certain exceptions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Subscription Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the execution of the Business Combination Agreement, effective as of September&nbsp;2, 2020, Kensington entered into
separate subscription agreements (each, a &#147;Subscription Agreement&#148;) with a number of Subscribers, pursuant to which the Subscribers agreed to purchase, and Kensington agreed to sell to the Subscribers, the PIPE Shares, for a purchase price
of $10.00 per share and an aggregate purchase price of $500&nbsp;million. Pursuant to the terms of the Subscription Agreements and subject to certain requirements and customary conditions, Kensington is required to file and maintain an effective
resale registration statement with respect to the PIPE Shares for the benefit of the Subscribers. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The closing of the sale of the PIPE
Shares pursuant to the Subscription Agreements is contingent upon, among other customary closing conditions, the substantially concurrent Closing. The purpose of the PIPE is to raise additional capital for use by New QuantumScape following the
Closing. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Kensington entered into separate Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements with
certain senior level employees of QuantumScape (the &#147;Senior Employees&#148;), including QuantumScape&#146;s executive officers.&nbsp;The Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements provide that the securities of
Kensington owned of record or beneficially by the Senior Employees (including certain securities that may be granted or issued to a Senior Employee after the Effective Time) (collectively, the <FONT STYLE="white-space:nowrap">&#147;Lock-Up</FONT>
Shares&#148;) may generally not be transferred for at least 180 days after the Closing (the &#147;Initial <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period&#148;) and up to four years after the Closing, subject to certain
exceptions.&nbsp;Following the Initial <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, Senior Employees may transfer <FONT STYLE="white-space:nowrap">Lock-Up</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">193 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Shares without restriction as follows: (i)&nbsp;during the first year after the Effective Time, up to 25% of the total number of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares,
(ii)&nbsp;following the first anniversary of the Effective Time until the earlier of four years after the Closing or the occurrence of an event described below, up to 50% of the total number of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares
(taking into account any transfers under clause (i)&nbsp;above), and (iii)&nbsp;up to an additional 50% of the total number of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares following satisfaction of agreed delivery requirements between
QuantumScape and VGA.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These transfer restrictions are subject to earlier release if (i)&nbsp;New QuantumScape completes a liquidation,
merger, stock exchange or other similar transaction after the Closing that results in all of New QuantumScape&#146;s stockholders having the right to exchange their shares of common stock for cash, securities or other property; (ii)&nbsp;VGA
terminates for any reason the Amended and Restated Joint Venture Agreement, dated as of May&nbsp;14, 2020, by and among QuantumScape and VGA; (iii)&nbsp;VGA issues a critical or negative statement regarding New QuantumScape and its technology unless
such statement is required to be made by VGA under applicable law and is truthful and accurate; or (iv)&nbsp;VGA transfers certain New QuantumScape securities in excess of the amounts set forth in the Senior Employee
<FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements.&nbsp;The Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements also provide that, upon consummation of the Merger, Kensington or QuantumScape shall pay to each Senior
Employee a <FONT STYLE="white-space:nowrap">one-time</FONT> cash bonus equal to 20% of the Senior Employee&#146;s then annual base salary. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New
QuantumScape intends to enter into separate indemnification agreements with its directors and executive officers, in addition to the indemnification provided for in the Proposed Certificate of Incorporation and the Proposed Bylaws. These agreements,
among other things, will require New QuantumScape to indemnify New QuantumScape&#146;s directors and executive officers for certain expenses, including attorneys&#146; fees, judgments, fines and settlement amounts incurred by a director or executive
officer in any action or proceeding arising out of their services as one of New QuantumScape&#146;s directors or executive officers or as a director or executive officer of any other company or enterprise to which the person provides services at New
QuantumScape&#146;s request. For more information regarding these indemnification arrangements, see &#147;<I>Management After the Business Combination&#151;Limitation on Liability and Indemnification of Directors and Officers</I>.&#148; Kensington
believes that these charter provisions and indemnification agreements are necessary to attract and retain qualified persons as directors and officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The limitation of liability and indemnification provisions in the Proposed Certificate of Incorporation and the Proposed Bylaws may discourage
stockholders from bringing a lawsuit against directors for breach of their fiduciary duties. They may also reduce the likelihood of derivative litigation against directors and officers, even though an action, if successful, might benefit New
QuantumScape and its stockholders. A stockholder&#146;s investment may decline in value to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>VGA Letter Agreement on Board Representation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Kensington, QuantumScape and VGA entered into a letter agreement (the &#147;VGA Letter Agreement&#148;) pursuant to
which, subject to the terms of such letter agreement, Kensington shall cause to be nominated one designee of VGA for election to the New QuantumScape Board as part of New QuantumScape&#146;s slate and, from and after the First Closing (as defined
under the Series&nbsp;F Preferred Stock Purchase Agreement between QuantumScape and VGA, dated May&nbsp;14, 2020), a second designee of VGA. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>VGA
Letter Agreement on Earmarked Funds </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Kensington, QuantumScape and VGA entered into a letter agreement
pursuant to which, subject to the terms of such letter agreement, Kensington and QuantumScape covenant that New QuantumScape will reserve a certain portion of the proceeds from the Series F Preferred Stock financing and the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">194 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
capital obtained through the Merger (including any concurrent &#147;PIPE&#148; financing) in a separate account to fully fund QuantumScape&#146;s future contributions to QSV pursuant to
Section&nbsp;3.6 of the LLCA (as defined below). The parties agreed that the amount to be held in the separate account was $134 million as of the date of the VGA Letter Agreement.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Financings </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series&nbsp;F Preferred Stock
Financing </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From May&nbsp;14, 2020 through September&nbsp;3, 2020, QuantumScape entered into several Series&nbsp;F Preferred Stock
Purchase Agreements and related agreements and amendments thereto, pursuant to which it agreed to sell, and related persons, entities and their affiliates agreed to purchase, an aggregate of 14,041,437 shares of Series&nbsp;F Preferred Stock for an
aggregate purchase price of $371,000,040.17 as set forth below. The closing of these Series&nbsp;F Preferred Stock Purchase Agreements is subject to certain conditions including, with respect to VGA only, the achievement of a specified technical
milestone by March&nbsp;31, 2021, as set forth in such agreements. The Series F Preferred Stock Purchase Agreement with VGA (as amended) contains provisions pursuant to which, if the relevant closing of such Series F Preferred Stock Purchase
Agreement (in whole or in part) were to occur only after effectiveness of the Merger, VGA has agreed to purchase, and Kensington has agreed to issue, instead of the relevant number of shares of Series F Preferred Stock to be purchased at such
closing, such number of shares of New QuantumScape Class&nbsp;A Common Stock as would have been issued in the Merger in exchange for such shares of Series F Preferred Stock if they had been outstanding prior to the Merger. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Series&nbsp;F<BR>Preferred<BR>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Purchase Price<BR>Commitment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volkswagen Group of America Investments, LLC(1)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,569,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">200,000,026.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Al-Rayyan</FONT> Holding LLC(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,557,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">93,999,992.37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2011 Buss Family Trust(3)(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,695</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,999,998.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.B. Straubel(3)(5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,441,890.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TIGF Direct Strategies Fund, LLC(3)(6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">870,493</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,999,991.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Technology Impact Growth Fund, L.P.(3)(6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">264,933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,000,006.74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Quantum Partners LP(3)(7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">722,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19,086,130.72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Palindrome Master Fund LP(3)(7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101,921</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,692,936.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">JS Capital LLC(3)(7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">824,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,779,067.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Frank Blome is a member of the QuantumScape Board and an affiliate of VGA. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Includes shares committed to be purchased on or prior to the Closing. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">All such shares are committed to be purchased on or prior to the Closing. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Brad Buss is a member of the QuantumScape Board and an affiliate of 2011 Buss Family Trust.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">J.B. Straubel is a member of the QuantumScape Board. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Dipender Saluja is a member of the QuantumScape Board and an affiliate of TIGF Direct Strategies Fund, LLC and
Technology Impact Growth Fund, L.P. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Affiliate of Soros Fund. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series&nbsp;E Preferred Stock Financing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From September&nbsp;11, 2018 through December&nbsp;7, 2018, QuantumScape sold an aggregate of 4,806,296 shares of Series&nbsp;E Preferred Stock
for an aggregate purchase price of $107,390,435.95 to related persons, entities and their affiliates as set forth below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Series&nbsp;E<BR>Preferred<BR>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Purchase Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volkswagen Group of America Investments, LLC(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,475,534</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">99,999,989.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SAIC Technologies Fund I, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97,138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,170,422.34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Technology Impact Growth Fund, LP(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">233,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,220,024.57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">195 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Frank Blome is a member of the QuantumScape Board and an affiliate of VGA. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Dipender Saluja is a member of the QuantumScape Board and an affiliate of Impact Growth Fund, L.P.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series&nbsp;D Preferred Stock Financing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;15, 2017, QuantumScape sold an aggregate of 497,199 shares of Series&nbsp;D Preferred Stock for an aggregate purchase price of
$10,000,014.33 to VW Credit, Inc. Frank Blome is a member of the QuantumScape Board and is an affiliate of VW Credit, Inc. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Commercial Agreements
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Agreements with Volkswagen </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Joint
Venture Agreement </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In June 2018, QuantumScape and VGA formed a <FONT STYLE="white-space:nowrap">50-50</FONT> joint venture entity, QSV,
to facilitate the commercialization of QuantumScape&#146;s solid-state battery technology and enable Volkswagen to be the first automotive OEM to utilize this technology.&nbsp;In 2018, the parties made an initial equity investment to the joint
venture of approximately $3&nbsp;million in total. The joint venture agreements were amended in 2020 in connection with a further $200&nbsp;million investment commitment by VGA in Series F Preferred Stock.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Limited Liability Company Agreement </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
June 2018, in connection with the joint venture, QSV was organized in connection with entry into a Limited Liability Agreement (the &#147;LLCA&#148;), with QuantumScape and VGA designated as the members of QSV. In May 2020, the parties amended and
restated the LLCA in connection with the amendment to the joint venture agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Phase 1 License Agreement </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In May 2020, in connection with the joint venture, QuantumScape entered into a license agreement with QSV (which amended and restated a license
agreement entered into in September 2018) to license its battery technology. The battery technology that is licensed to the joint venture does not include the right to manufacture QuantumScape&#146;s proprietary solid-state separator.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Common IP License Agreements </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In May
2020, in connection with the joint venture, QuantumScape entered into a license agreement with Volkswagen Group of America, Inc. (which amended and restated a license agreement entered into in September 2018) to license certain intellectual property
on a royalty free basis in connection with production and manufacturing of solid-state battery cells in the automotive space. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Mutual <FONT
STYLE="white-space:nowrap">Non-Disclosure</FONT> Agreement </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In January 2017, QuantumScape entered into, and in April 2018 amended, a
mutual <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement with Volkswagen Group of America, Inc. to provide to each other certain proprietary, confidential and trade secret information in connection with discussion and negotiations
regarding potential cooperation in connection with the development and production of battery cells and related components, including research and development regarding production process. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">196 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employment Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QuantumScape has entered into employment agreements and offer letter agreements with certain of its executive officers. See the section
entitled &#147;<I>QuantumScape&#146;s Executive Compensation&#151;Executive Letter Agreements</I>.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Related Person Transactions Policy Following
the Business Combination </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the Closing, it is anticipated that the New QuantumScape Board will adopt a written Related Person
Transactions Policy that sets forth New QuantumScape&#146;s policies and procedures regarding the identification, review, consideration and oversight of &#147;related person transactions.&#148; For purposes of New QuantumScape&#146;s policy only, a
&#147;related person transaction&#148; is a transaction, arrangement or relationship (or any series of similar transactions, arrangements or relationships) in which New QuantumScape or any of its subsidiaries are participants involving an amount
that exceeds $120,000, in which any &#147;related person&#148; has a material interest. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Transactions involving compensation for
services provided to New QuantumScape as an employee, consultant or director will not be considered related person transactions under this policy. A related person is any executive officer, director, nominee to become a director or a holder of more
than 5% of any class of New QuantumScape&#146;s voting securities (including New QuantumScape Common Stock), including any of their immediate family members and affiliates, including entities owned or controlled by such persons. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the policy, the related person in question or, in the case of transactions with a holder of more than 5% of any class of New
QuantumScape&#146;s voting securities, an officer with knowledge of a proposed transaction, must present information regarding the proposed related person transaction to New QuantumScape&#146;s audit committee (or, where review by New
QuantumScape&#146;s audit committee would be inappropriate, to another independent body of the New QuantumScape Board) for review. To identify related person transactions in advance, New QuantumScape will rely on information supplied by New
QuantumScape&#146;s executive officers, directors and certain significant stockholders. In considering related person transactions, New QuantumScape&#146;s audit committee will take into account the relevant available facts and circumstances, which
may include, but are not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks, costs, and benefits to New QuantumScape; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact on a director&#146;s independence in the event the related person is a director, immediate family
member of a director or an entity with which a director is affiliated; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms of the transaction; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of other sources for comparable services or products; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms available to or from, as the case may be, unrelated third parties. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New QuantumScape&#146;s audit committee will approve only those transactions that it determines are fair to us and in New QuantumScape&#146;s best interests.
All of the transactions described above were entered into prior to the adoption of such policy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">197 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_57"></A>INFORMATION ABOUT KENSINGTON </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a Delaware corporation
formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, recapitalization or other similar business combination with one or more businesses, which we refer to throughout this proxy
statement/prospectus/information statement as our initial business combination. Although we may pursue our initial business combination in any business, industry or geographic location, we have focused on opportunities in target businesses operating
the North America automotive and automotive-related sector. Following our initial business combination, our objective will be to implement or support the acquired business&#146; growth and operating strategies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File
<FONT STYLE="white-space:nowrap">No.&nbsp;333-239053)</FONT> for our IPO was declared effective by the SEC on June&nbsp;25, 2020. On June&nbsp;30, 2020, we consummated our IPO of 23,000,000 Kensington Units (which includes 3,000,000 Kensington Units
sold pursuant to the underwriters exercising in full their over-allotment option on June&nbsp;30, 2020), with each Kensington Unit consisting of one share of Kensington Class&nbsp;A Common Stock and <FONT STYLE="white-space:nowrap">one-half</FONT>
of one redeemable Kensington Warrant. Each Kensington Warrant entitles the holder to purchase one share of Kensington Class&nbsp;A Common Stock, $0.0001 par value per share, at $11.50 per share. The Kensington Warrants will expire at 5:00&nbsp;p.m.,
New York City time, five years after the consummation of Kensington&#146;s initial business combination, or earlier upon redemption or liquidation. The Kensington Units in our IPO were sold at an offering price of $10.00 per unit, generating total
gross proceeds of $230,000,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Simultaneously with the consummation of our IPO, we consummated a private placement in which the Sponsor
purchased 6,575,000 Private Warrants, each exercisable to purchase one share of Class&nbsp;A Common Stock at $11.50 per share, subject to an adjustment, at a price of $1.00 per warrant, generating total gross proceeds of $6,575,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the IPO, we incurred transaction costs of approximately $13,100,000, including offering costs of approximately $8,100,000
in deferred underwriting commissions. A total of $230,000,000 from the net proceeds of the sale of the Kensington Units in the IPO and the private placement (which includes $6,575,000) were placed in the Trust Account, with Continental Stock
Transfer&nbsp;&amp; Trust Company acting as trustee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Initial Business Combination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our initial business combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the
net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting discount). The requirement that the target business or businesses together
have an aggregate fair market value equal to at least 80% of the assets held in the Trust Account is set forth in the Existing Certificate of Incorporation and will continue to apply to us even if our securities are no longer listed on the NYSE. If
our board of directors is not able to independently determine the fair market value of the target business or businesses, we will obtain an opinion from an independent investment banking firm that is a member of the Financial Industry Regulatory
Authority,&nbsp;Inc. (&#147;FINRA&#148;) or an independent accounting firm with respect to the satisfaction of such criteria. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Submission of Our
Initial Business Combination to a Stockholder Vote </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are providing the Public Stockholders with redemption rights upon the
Closing. Public Stockholders electing to exercise their redemption rights will be entitled to receive cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account, calculated as of two business days prior to the
Closing, including interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes, net of taxes payable, provided that such stockholders follow the specific procedures for redemption set forth in this proxy
statement/prospectus/information statement relating to the stockholder vote on the Business </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">198 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Combination. The Public Stockholders are not required to vote against the Business Combination in order to exercise their redemption rights. If the Business Combination is not approved or
completed for any reason, then Public Stockholders who elected to exercise their redemption rights would not be entitled to redeem their shares for the applicable pro rata share of the Trust Account. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Sponsor, officers and directors have agreed (i)&nbsp;to vote any shares of common stock owned by them in favor of any proposed business
combination and (ii)&nbsp;not to redeem any shares in connection with a stockholder vote to approve a proposed initial business combination. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Permitted
Purchases of Our Securities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of our Sponsor, directors, officers, advisors or their affiliates has indicated any intention to
purchase units or shares of common stock in the IPO or from persons in the open market or in private transactions. However, if we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our
initial business combination pursuant to the tender offer rules, our Sponsor, directors, officers, advisors or their affiliates may purchase Public Shares or Public Warrants or a combination thereof in privately negotiated transactions or in the
open market either prior to or following the consummation of our initial business combination. None of the funds held in the Trust Account will be used to purchase Public Shares or Public Warrants in such transactions. There is no limit on the
number of securities such persons may purchase, nor the price that they may pay. Any such price per share may be different than the amount per share a Public Stockholder would receive if it elected to redeem its shares in connection with our initial
business combination. Additionally, at any time at or prior to our initial business combination, subject to applicable securities laws (including with respect to material nonpublic information), Kensington Initial Stockholders, directors, officers,
advisors or their affiliates may enter into transactions with investors and others to provide them with incentives to acquire public shares, vote their public shares in favor of our initial business combination or not redeem their public shares.
However, such persons have no current commitments, plans or intentions to engage in such transactions and have not formulated any terms or conditions for any such transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of the funds in the Trust Account will be used to purchase Public Shares or Public Warrants in such transactions. Such persons will be
subject to restrictions in making any such purchases when they are in possession of any material <FONT STYLE="white-space:nowrap">non-public</FONT> information or if such purchases are prohibited by Regulation M under the Exchange Act. We cannot
currently determine whether any of our insiders will make such purchases pursuant to a <FONT STYLE="white-space:nowrap">Rule&nbsp;10b5-1</FONT> plan, as such purchases will be dependent upon several factors, including, but not limited to, the timing
and size of such purchases. Depending on the circumstances, our insiders may either make such purchases pursuant to a <FONT STYLE="white-space:nowrap">Rule&nbsp;10b5-1</FONT> plan or determine that such a plan is not necessary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Sponsor, officers, directors and/or their affiliates anticipate that they may identify the stockholders with whom our Sponsor, directors
or their affiliates may pursue privately negotiated purchases by either the stockholders contacting us directly or by our receipt of redemption requests submitted by stockholders (in the case of Public Shares) following our mailing of proxy
materials in connection with our initial business combination. To the extent that our Sponsor, officers, directors or their affiliates enter into a private purchase, they would identify and contact only potential selling or redeeming stockholders
who have expressed their election to redeem their shares for a pro rata share of the Trust Account or vote against our business combination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not currently anticipate that such purchases, if any, would constitute a tender offer subject to the tender offer rules under the
Exchange Act or a going-private transaction subject to the going-private rules under the Exchange Act; however, if the purchasers determine at the time of any such purchases that the purchases are subject to such rules, the purchasers will comply
with such rules. Our Sponsor, officers, directors and/or their affiliates will be restricted from making purchases of Kensington Common Stock if the purchases would violate Section&nbsp;9(a)(2) or
<FONT STYLE="white-space:nowrap">Rule&nbsp;10b-5</FONT> of the Exchange Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">199 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Redemption Rights for Public Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will provide the Public Stockholders with the opportunity to redeem all or a portion of their Public Shares upon the consummation of our
initial business combination at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, calculated as of two business days prior to the consummation of our initial business combination, including
interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes, net of taxes payable, divided by the number of then outstanding Public Shares, subject to the limitations described herein. As of
June&nbsp;30, 2020, the amount in the Trust Account was $230&nbsp;million, which is equal to $10.00 per Public Share. Our Sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive
(i)&nbsp;their redemption rights with respect to any Sponsor Shares and any Public Shares held by them in connection with the consummation of our initial business combination. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitation on Redemption Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the Existing Certificate of Incorporation provides that a public stockholder, together with any affiliate of
such stockholder or any other person with whom such&nbsp;stockholder is acting in concert or as a &#147;group&#148; (as defined under Section&nbsp;13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an
aggregate of 15% of the shares sold in the IPO, without our prior consent. We believe the restriction described above will discourage stockholders from accumulating large blocks of shares, and subsequent attempts by such holders to use their ability
to redeem their shares as a means to force us or our management to purchase their shares at a significant premium to the then-current market price or on other undesirable terms. Absent this provision, a public stockholder holding more than an
aggregate of 15% of the shares sold in the IPO could threaten to exercise his, her or its redemption rights against a business combination if such holder&#146;s shares are not purchased by us or our management at a premium to the then-current market
price or on other undesirable terms. By limiting our stockholders&#146; ability to redeem to no more than 15% of the shares sold in the IPO, we believe we will limit the ability of a small group of stockholders to unreasonably attempt to block our
ability to complete our initial business combination, particularly in connection with a business combination with a target that requires as a closing condition that we have a minimum net worth or a certain amount of cash. However, we would not be
restricting our stockholders&#146; ability to vote all of their shares (including all shares held by those stockholders that hold more than 15% of the shares sold in the IPO) for or against our initial business combination. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Redemption of Public Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Existing
Certificate of Incorporation provides that we will have until June&nbsp;30, 2022, to complete an initial business combination. If we have not completed an initial business combination by such date or during any Extension Period, we will
(i)&nbsp;cease all operations except for the purpose of winding up, (ii)&nbsp;as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a <FONT STYLE="white-space:nowrap">per-share</FONT> price,
payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes, net of taxes payable (less up to $100,000 of
interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders&#146; rights as stockholders (including the right to receive further liquidating
distributions, if any), subject to applicable law, and (iii)&nbsp;as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, dissolve and liquidate, subject (in the
case of (ii)&nbsp;and (iii)&nbsp;above) to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the
Kensington Warrants, which will expire worthless if we fail to complete our initial business combination within the prescribed time period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Sponsor, officers and directors have waived their rights to liquidating distributions from the Trust Account with respect to any Sponsor
Shares held by them if we fail to complete our initial business combination </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">200 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
within the prescribed time period. However, if our Sponsor, officers or directors acquired or acquire Public Shares in or after the IPO, they will be entitled to liquidating distributions from
the Trust Account with respect to such Public Shares if we fail to complete our initial business combination within the <FONT STYLE="white-space:nowrap">allotted&nbsp;24-month&nbsp;time</FONT> period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Sponsor, executive officers, directors and independent directors have agreed, pursuant to a letter agreement with us, that they will not
propose any amendment to our amended and restated certificate of incorporation (A)&nbsp;to modify the substance or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our Public
Shares if we have not completed our initial business combination within 24 months from the closing of the IPO or (B)&nbsp;with respect to any other provision relating to stockholders&#146; rights or
<FONT STYLE="white-space:nowrap">pre-initial</FONT> business combination activity modify the substance or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our Public Shares if we
do not complete our initial business combination within 24 months from the closing of the IPO, unless we provide the Public Stockholders with the opportunity to redeem their shares of Kensington Class&nbsp;A Common Stock upon approval of any such
amendment at a <FONT STYLE="white-space:nowrap">per-share</FONT> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net taxes payable) divided by the number of then
outstanding Public Shares. However, we will only redeem our Public Shares so long as (after such redemption) our net tangible assets will be at least $5,000,001 either immediately prior to or upon consummation of our initial business combination and
after payment of underwriters&#146; fees and commissions (so that we are do not then become subject to the SEC&#146;s &#147;penny stock&#148; rules) or any greater net tangible asset or cash requirement which may be contained in the agreement
relating to our initial business combination. If Public Stockholders tender more shares than we have offered to purchase, we will withdraw the tender offer and not complete the initial business combination, and instead may search for an alternate
business combination. We expect that all costs and expenses associated with implementing our plan of dissolution, as well as payments to any creditors, will be funded from amounts remaining out of the approximately $1,215,000 of IPO proceeds held
outside the Trust Account, although we cannot assure you that there will be sufficient funds for such purpose. However, if those funds are not sufficient to cover the costs and expenses associated with implementing our plan of dissolution, to the
extent that there is any interest accrued in the Trust Account not required to pay taxes on interest income earned on the Trust Account balance, we may request the trustee to release to us an additional amount of up to $100,000 of such accrued
interest to pay those costs and expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we were to expend all of the net proceeds of the IPO and the sale of the Private Warrants,
other than the proceeds deposited in the Trust Account, and without taking into account interest, if any, earned on the Trust Account&nbsp;and any tax payments or expenses for the dissolution of the trust,
<FONT STYLE="white-space:nowrap">the&nbsp;per-share&nbsp;redemption</FONT> amount received by stockholders upon our dissolution would be $10.00. The proceeds deposited in the Trust Account could, however, become subject to the claims of our
creditors which would have higher priority than the claims of the Public Stockholders. We cannot assure you that the <FONT STYLE="white-space:nowrap">actual&nbsp;per-share&nbsp;redemption</FONT> amount received by stockholders will not be
substantially less than $10.00. Under Section&nbsp;281(b) of the DGCL, our plan of dissolution must provide for all claims against us to be paid in full or make provision for payments to be made in full, as applicable, if there are sufficient
assets. These claims must be paid or provided for before we make any distribution of our remaining assets to our stockholders. While we intend to pay such amounts, if any, we cannot assure you that we will have funds sufficient to pay or provide for
all creditors&#146; claims. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although we will seek to have all vendors, service providers, prospective target businesses and other
entities with which we do business execute agreements with us waiving any right, title, interest and claim of any kind in or to any monies held in the Trust Account for the benefit of our Public Stockholders, there is no guarantee that they will
execute such agreements or even if they execute such agreements that they would be prevented from bringing claims against the Trust Account including but not limited to fraudulent inducement, breach of fiduciary responsibility or other similar
claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain an advantage with respect to a claim against our assets, including the funds held in the Trust Account. If any third party refuses to execute an
agreement waiving such claims to the monies held in the Trust Account, our management will perform an analysis of the alternatives available to it and will only enter into an </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">201 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
agreement with a third party that has not executed a waiver if management believes that such third party&#146;s engagement would be significantly more beneficial to us than any alternative.
Examples of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third-party consultant whose particular expertise or skills are believed by management to be significantly superior to
those of other consultants that would agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver. Marcum LLP, our independent registered public accounting firm, will not execute agreements
with us waiving such claims to the monies held in the Trust Account, nor did the underwriters of the IPO. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, there is no
guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with us and will not seek recourse against the Trust Account for any reason. Our
Sponsor has agreed that it will be liable to us if and to the extent any claims by a third party (except for Kensington&#146;s independent registered public accounting firm) for services rendered or products sold to us, or by a prospective target
business with which we have discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per Public Share or (ii)&nbsp;such lesser amount per Public Share held in the Trust Account as of the
date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third
party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under our indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act.
Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, then our Sponsor will not be responsible to the extent of any liability for such third-party claims. We have not independently verified whether our
Sponsor, which is a newly formed entity, has sufficient funds to satisfy its indemnity obligations and believe that our Sponsor&#146;s only assets are securities of our company. We have not asked our Sponsor to reserve for such indemnification
obligations. Therefore, we cannot assure you that our Sponsor would be able to satisfy those obligations. As a result, if any such claims were successfully made against the Trust Account, the funds available for our initial business combination and
redemptions could be reduced to less than $10.00 per Public Share. In such event, we may not be able to complete our initial business combination, and you would receive such lesser amount per Public Share in connection with any redemption of your
Public Shares. None of our officers will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target businesses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that the proceeds in the Trust Account are reduced below: (i)&nbsp;$10.00 per public share or (ii)&nbsp;such lesser amount per
public share held in the Trust Account as of the date of the liquidation of the Trust Account, due to reductions in the value of the trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes, and the Sponsor
asserts that it is unable to satisfy its indemnification obligations or that it has no indemnification obligations related to a particular claim, our independent directors would determine whether to take legal action against the Sponsor to enforce
its indemnification obligations. While we currently expect that our independent directors would take legal action on our behalf against the Sponsor to enforce its indemnification obligations to us, it is possible that our independent directors in
exercising their business judgment and subject to their fiduciary duties may choose not to do so if, for example, the cost of such legal action is deemed by the independent directors to be too high relative to the amount recoverable or if the
independent directors determine that a favorable outcome is not likely. We have not asked our sponsor to reserve for such indemnification obligations and we cannot assure you that our sponsor would be able to satisfy those obligations. Accordingly,
we cannot assure you that due to claims of creditors the actual value of the per share redemption price will not be less than $10.00 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to
have all vendors, service providers, prospective target businesses and other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. The Sponsor
will also not be liable as to any claims under our indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">202 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
We will have access to up to approximately $1,215,000 from the proceeds of the IPO and the sale of the Private Warrants with which to pay any such potential claims. In the event that we liquidate
and it is subsequently determined that the reserve for claims and liabilities is insufficient, stockholders who received funds from the Trust Account could be liable for claims made by creditors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the DGCL, stockholders may be held liable for claims by third parties against a corporation to the extent of distributions received by
them in a dissolution. The pro rata portion of the Trust Account distributed to the Public Stockholders upon the redemption of our Public Shares in the event we do not complete our initial business combination within the required time period may be
considered a liquidating distribution under Delaware law. If the corporation complies with certain procedures set forth in Section&nbsp;280 of the DGCL intended to ensure that it makes reasonable provision for all claims against it, including a <FONT
STYLE="white-space:nowrap">60-day</FONT> notice period during which any third-party claims can be brought against the corporation, a <FONT STYLE="white-space:nowrap">90-day</FONT> period during which the corporation may reject any claims brought,
and an additional <FONT STYLE="white-space:nowrap">150-day</FONT> waiting period before any liquidating distributions are made to stockholders, any liability of stockholders with respect to a liquidating distribution is limited to the lesser of such
stockholder&#146;s pro rata share of the claim or the amount distributed to the stockholder, and any liability of the stockholder would be barred after the third anniversary of the dissolution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, if the pro rata portion of the Trust Account distributed to the Public Stockholders upon the redemption of our Public Shares in
the event we do not complete our initial business combination within the required time period, is not considered a liquidating distribution under Delaware law and such redemption distribution is deemed to be unlawful, then pursuant to
Section&nbsp;174 of the DGCL, the statute of limitations for claims of creditors could then be six years after the unlawful redemption distribution, instead of three years, as in the case of a liquidating distribution. If we have not completed our
initial business combination within such time period or during any Extension Period, we will: (i)&nbsp;cease all operations except for the purpose of winding up, (ii)&nbsp;as promptly as reasonably possible but not more than ten business days
thereafter, redeem the Public Shares, at a <FONT STYLE="white-space:nowrap">per-share</FONT> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account
and not previously released to us to pay our taxes, net of taxes payable (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public
Stockholders&#146; rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii)&nbsp;as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders
and our board of directors, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. Accordingly, it is our intention to redeem our Public
Shares as soon as reasonably possible following the end of our acquisition period and, therefore, we do not intend to comply with those procedures. As such, our stockholders could potentially be liable for any claims to the extent of distributions
received by them (but no more) and any liability of our stockholders may extend well beyond the third anniversary of such date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because
we will not be complying with Section&nbsp;280, Section&nbsp;281(b) of the DGCL requires us to adopt a plan, based on facts known to us at such time that will provide for our payment of all existing and pending claims or claims that may be
potentially brought against us within the subsequent 10 years. However, because we are a blank check company, rather than an operating company, and our operations will be limited to searching for prospective target businesses to acquire, the only
likely claims to arise would be from our vendors (such as lawyers, investment bankers, etc.) or prospective target businesses. As described above, pursuant to the obligation contained in our underwriting agreement, we will seek to have all vendors,
service providers, prospective target businesses and other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the Trust Account. As a result of this
obligation, the claims that could be made against us are significantly limited and the likelihood that any claim that would result in any liability extending to the Trust Account is remote. Further, our Sponsor may be liable only to the extent
necessary to ensure that the amounts in the Trust Account are not reduced below (i) $10.00 per Public Share or (ii)&nbsp;such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, due to
reductions in value of the trust assets, in each case net of the amount of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">203 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
interest withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and
except as to any claims under our indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, our
sponsor will not be responsible to the extent of any liability for such third-party claims. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we file a bankruptcy petition or an
involuntary bankruptcy petition is filed against us that is not dismissed, the proceeds held in the Trust Account could be subject to applicable bankruptcy law, and may be included in our bankruptcy estate and subject to the claims of third parties
with priority over the claims of our stockholders. To the extent any bankruptcy claims deplete the Trust Account, we cannot assure you we will be able to return $10.00 per share to our Public Stockholders. Additionally, if we file a bankruptcy
petition or an involuntary bankruptcy petition is filed against us that is not dismissed, any distributions received by stockholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as either a &#147;preferential
transfer&#148; or a &#147;fraudulent conveyance.&#148; As a result, a bankruptcy court could seek to recover some or all amounts received by our stockholders. Furthermore, our board of directors may be viewed as having breached its fiduciary duty to
our creditors and/or may have acted in bad faith, thereby exposing itself and our company to claims of punitive damages, by paying Public Stockholders from the Trust Account prior to addressing the claims of creditors. We cannot assure you that
claims will not be brought against us for these reasons. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Public Stockholders will be entitled to receive funds from the Trust
Account only on the earliest of (a)&nbsp;the consummation of our initial business combination and then, only in connection with those Public Shares that such stockholder has properly elected to redeem, subject to the limitations described herein,
(b)&nbsp;the redemption of any Public Shares properly submitted in connection with a stockholder vote to amend our amended and restated certificate of incorporation (i)&nbsp;to modify the substance or timing of our obligation to allow redemption in
connection with our initial business combination or to redeem 100% of our Public Shares if we do not complete our initial business combination within 24 months from the closing of the IPO or (ii)&nbsp;with respect to any other provisions relating to
stockholders&#146; rights or <FONT STYLE="white-space:nowrap">pre-initial</FONT> business combination activity and (c)&nbsp;the redemption of our Public Shares if we have not completed our business combination within 24 months from the closing of
the IPO, subject to applicable law. Stockholders who do not exercise their rights to the funds in connection with an amendment to our certificate of incorporation would still have rights to the funds in connection with a subsequent business
combination. In no other circumstances will a stockholder have any right or interest of any kind to or in the Trust Account. In the event we seek stockholder approval in connection with our initial business combination, a stockholder&#146;s voting
in connection with the business combination alone will not result in a stockholder&#146;s redeeming its shares to us for an applicable pro rata share of the Trust Account. Such stockholder must have also exercised his, her or its redemption rights
as described above. Holders of Kensington Warrants will not have any rights of proceeds held in the Trust Account with respect to the Kensington Warrants. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Facilities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal executive
offices are located at 1400 Old Country Road, Suite 301, Westbury, NY 11590 and our telephone number is (703) <FONT STYLE="white-space:nowrap">674-6514.</FONT> Our principal executive offices are provided to us by an affiliate of our Sponsor. We
consider our current office space adequate for our current operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently have four executive officers. These individuals are not obligated to devote any specific number of hours to our matters and intend
to devote only as much time as they deem necessary to our affairs. The amount of time they will devote in any time period will vary based on whether a target business has been selected for the business combination and the stage of the business
combination process we are in. We do not intend to have any full-time employees prior to the consummation of a business combination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">204 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Directors and Executive Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our current directors and executive officers are listed below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="62%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Age</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Position</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Justin Mirro</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">51</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chairman and Chief Executive Officer and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Remenar</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">64</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Vice Chairman and President</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Daniel Huber</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">44</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Simon Boag</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">54</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Technology Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas LaSorda</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">65</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Anders Pettersson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">61</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mitchell Quain</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">68</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Donald Runkle</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">74</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Simoncini</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">59</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Justin Mirro</B> serves as our Chairman and Chief Executive Officer. Mr.&nbsp;Mirro has over 25 years of
operating, mergers and acquisitions and financing experience in the automotive and automotive-related sector. He began his career at General Motors Company (&#147;GM&#148;) as a Tool and Die Manufacturing Engineer, with successive positions at Car
and Driver Magazine, Toyota Motor Corporation and Itochu International Inc. prior to transitioning to automotive investment banking at Schroder&nbsp;&amp; Co. Inc. / Salomon Smith Barney, Inc. / ABN Amro Inc. in 1996. In 1999, Mr.&nbsp;Mirro formed
Kensington Capital Partners, LLC, where he has served as President since 2015, to invest in automotive and automotive-related sector businesses. In 2005, Mr.&nbsp;Mirro transitioned to Jefferies&nbsp;&amp; Company, Inc. as Head of Automotive
Investment Banking, and later served as the Head of Automotive Investment Banking at Moelis&nbsp;&amp; Company, LLC (&#147;Moelis&#148;) and RBC Capital Markets, LLC (&#147;RBC Capital Markets&#148;) from 2008 to 2011 and 2011 to 2014, respectively.
In his role, Mr.&nbsp;Mirro played a key role in leading and executing all aspects of capital raising, mergers and acquisitions and restructurings, and has advised on over 70 transactions totaling more than $60&nbsp;billion of value for OEMs,
suppliers and automotive-related industries. From 2016 to 2019, Mr.&nbsp;Mirro served as Chairman of the board of directors and audit committee of Pure Power Technologies, Inc. (&#147;Pure Power&#148;) one of the largest aftermarket suppliers of
diesel fuel injectors, which was later sold to Stanadyne LLC (&#147;Stanadyne&#148;). In his role, Mr.&nbsp;Mirro focused on deal sourcing, structuring, capital raising, executive recruitment and the eventual sale process. Mr.&nbsp;Mirro has sat on
the boards of Cooper-Standard Holdings Inc. (&#147;Cooper-Standard Holdings&#148;) and Transtar Industries, Inc., since 2015 and 2017, respectively, where he has focused on mergers and acquisitions, capital structuring and public market strategy.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Robert Remenar</B> serves as our Vice Chairman and President. Mr.&nbsp;Remenar has over 35 years of operational, manufacturing and
management experience within the automotive and automotive-related sector. Mr.&nbsp;Remenar has over two decades of experience leading global, multi-billion dollar manufacturing enterprises, serving as President and Chief Executive Officer of
Aludyne, Inc. (formerly known as Chassix Inc.) from 2012 to 2014, and as Chief Executive Officer and President of Nexteer Automotive Group Ltd (&#147;Nexteer Automotive&#148;) from 2009 to 2012 and from 2002 to 2009, respectively. In his leadership
roles, Mr.&nbsp;Remenar demonstrated a track record of turning distressed and developing businesses into profitable, successful and global enterprises through customer diversity, lean manufacturing, portfolio and footprint optimization and
competitive cost structures. Mr.&nbsp;Remenar previously held multiple executive positions within Delphi Corporation (&#147;Delphi&#148;) where he most notably served as Vice President and, as discussed above, President of Delphi&#146;s Steering
Division (now Nexteer Automotive) from 2002 to 2009. Prior to joining Delphi in 1998, Mr.&nbsp;Remenar held several executive and managerial positions at GM from 1985 to 1998. Mr.&nbsp;Remenar was formerly on the board of directors of Highland
Industries, Inc. (&#147;Highland Industries&#148;) Pure Power, Nexteer Automotive, Stackpole International Inc. (&#147;Stackpole International&#148;) and Blue Cross Blue Shield of Michigan, offering extensive leadership strategy and operational
experience. As a board member, Mr.&nbsp;Remenar provided strategic insight during the successful sales of Highland Industries, Pure Power and Stackpole International and Nexteer Automotive&#146;s Hong Kong initial public offering. Mr.&nbsp;Remenar
has served as a director of PKC Group Oyj, a subsidiary of the Samvardhana Motherson Group since 2012, and as a director of Cooper-Standard Holdings since 2015, serving as Chairman of the compensation committee since 2017. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">205 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Daniel Huber</B> serves as our Chief Financial Officer and Secretary. Mr.&nbsp;Huber has
over 20 years of experience in investment banking, consulting, business development and operational management across a wide range of industries. Mr.&nbsp;Huber began his career as a Lieutenant in the United States Navy as a Surface Warfare
(Nuclear) officer. While in the Navy, Mr.&nbsp;Huber led multiple divisions of sailors during complex missions and operations on U.S. warships in support of Operation Enduring Freedom and Operation Iraqi Freedom. Following his service,
Mr.&nbsp;Huber was a manager in the public services consulting group of BearingPoint Inc. managing projects and engagements within the Department of State. From 2009 to 2018, Mr.&nbsp;Huber worked across several investment banks within the
automotive and automotive-related investment banking industry, specifically at Moelis from 2009 to 2011, RBC Capital Markets from 2011 to 2014, Sterne Agee CRT (part of CRT Capital Group LLC) from 2015 to 2016 and PI Capital International LLC from
2016 to 2018. Mr.&nbsp;Huber has also served as the managing member of DEHC since 2014. Since 2018, Mr.&nbsp;Huber has served as Director of Corporate Development and Mergers and Acquisitions at Conduent, Inc., leading all aspects of deal execution
across multiple industry verticals including the preparation and presentation of materials to senior executives outlining the strategic rationale of potential transactions. Mr.&nbsp;Huber&#146;s transaction experience includes public and private
transactions across a variety of end markets, with a focus on automotive and automotive-related businesses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Simon Boag</B> serves as
our Chief Technology Officer. Mr.&nbsp;Boag has over 30 years of leadership, manufacturing, operational and technological experience, with an extensive understanding of automotive supply chains and emerging automotive technologies. Mr.&nbsp;Boag
served as President of CAMI Automotive Inc., a joint venture between GM and Suzuki Motor Corporation, from 2000 to 2002. From 2002 to 2009, Mr.&nbsp;Boag held multiple roles in the automotive and automotive-related sector, including President of GM
Argentina, Executive Vice President of Chrysler LLC (&#147;Chrysler&#148;) Purchasing, President of Chrysler Mopar (Chrysler&#146;s parts, service and customer care organization) and Executive Vice President of CNH Industrial N.V. (Case New Holland
Industrial). While Executive Vice President of Chrysler Purchasing, Mr.&nbsp;Boag was responsible for billions of dollars in annual purchases from numerous suppliers. Additionally, while President of Chrysler Mopar, Mr.&nbsp;Boag was responsible for
purchasing, promotion, distribution and sales of parts, accessories and services to dealer and the aftermarket. Since 2013, Mr.&nbsp;Boag has served as a Managing Partner at IncWell LLC (&#147;IncWell&#148;), a venture capital fund based in
Birmingham, MI, that invested in 40 companies across the automotive, industrial, healthcare, business services, software and consumer product segments. Since 2016, Mr.&nbsp;Boag has served as the Chief Executive Officer and Chairman of the board of
directors of iWater Tech LLC, a startup company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Thomas LaSorda</B> is the former Chief Executive Officer of Chrysler and provides
exceptional insights to traditional and emerging vehicle technologies and senior-level access to the executives running these companies. Mr.&nbsp;LaSorda has over 40 years of experience working with vehicle manufactures around the world, with
specific expertise evaluating management and technology. Mr.&nbsp;LaSorda started his career at GM in 1977, holding multiple manufacturing positions across the globe until 2000, when he transitioned to Chrysler. Mr.&nbsp;LaSorda served as Senior
Vice President of Powertrain Manufacturing from 2000 to 2002 and Executive Vice President of Manufacturing from 2002 to 2004, where he focused on manufacturing, procurement and global business development. In 2004, Mr.&nbsp;LaSorda became Chief
Operating Officer of Chrysler and a member of the Daimler AG Board of Management. In 2005, Mr.&nbsp;LaSorda was appointed Chief Executive Officer and President of Chrysler. In 2007, Daimler sold Chrysler to Cerberus Capital Management, L.P. and
Mr.&nbsp;LaSorda was appointed as President and Vice Chairman of Chrysler until his retirement from Chrysler in 2009. Mr.&nbsp;LaSorda was the Chief Executive Officer of Fisker Automotive (&#147;Fisker&#148;) in 2012 and was Chief Executive Officer
of HANS Power&nbsp;&amp; Water LLC from 2018 to 2019. Mr.&nbsp;LaSorda served on the boards of AGCO Corporation from 2009 to 2012, Fisker from 2011 to 2012 and United States Steel Corporation (&#147;US Steel&#148;) from 2013 to 2015.
Mr.&nbsp;LaSorda has served as Chairman of LaSorda Group LLC since 2009 and Chairman of IncWell since 2013. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Anders Pettersson</B> is
the former Chief Executive Officer of Thule Group AB (&#147;Thule&#148;), a leading automotive aftermarket company. Under Mr.&nbsp;Pettersson&#146;s leadership, he transformed Thule from an automotive aftermarket accessories business into a
lifestyle consumer brand company. Mr.&nbsp;Pettersson brings over 30 years of experience in sourcing, evaluating and acquiring automotive businesses around the world. Mr.&nbsp;Pettersson has served as Chairman of Brink Group B.V., a leading towing
hitch business in Europe, since 2014, and has served </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">206 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
as a director at ZetaDisplay AB since 2014, at KlaraBo Sverige AB since 2014, at Pure Safety Group Inc. since 2010, at Skabholmen Invest AB since 2009 and at PS Enterprise AB since 2005. As noted
above, Mr.&nbsp;Pettersson served as Chief Executive Officer of Thule from 2002 to 2010, where he oversaw international expansion through the strategic acquisitions of Konig, Omnistor, Case Logic, TrackRac, Chariot and Sportrack. Mr.&nbsp;Pettersson
has also served as Chief Executive Officer of Hilding Anders AB from 2011 to 2014 and Capital Safety Group Inc. from 2010 to 2012, and previously held executive and managerial positions with AkzoNobel N.V. and Trelleborg AB. Mr.&nbsp;Pettersson
served as a director of Pure Power from 2016 to 2019, a director of Alite International AB from 2014 to 2019, a director of Victoria Park AB from 2011 to 2019, Chairman of the board of directors of Hilding Anders AB from 2012 to 2014 and a member of
the operating review board of Arle Capital Partners Limited from 2012 to 2014. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Mitchell Quain</B> is an investor and board member of
multiple public companies serving the automotive and broader industrial segments, with vast knowledge of public equity markets. Mr.&nbsp;Quain has over 45 years of experience evaluating companies as both an equity research analyst and seasoned
private equity investor. Mr.&nbsp;Quain has served as a member of the Executive Council at American Securities Inc. since 2020, having retired as a Partner at One Equity Partners (part of JPMorgan Chase&nbsp;&amp; Co.). Previously, he served on the
boards of multiple public and private companies including DeCrane Aircraft Holdings Inc., Handy&nbsp;&amp; Harman Ltd, Hardinge, Inc., HEICO Corporation, MagneTek, Inc., Mechanical Dynamics, Inc., RBC Bearings, Inc., Strategic Distribution Inc.,
Tecumseh Products Company, Titan International, Inc. and Xerium, Inc., and was Executive Chairman of the board of directors of Register.com. Mr.&nbsp;Quain was a Senior Advisor at Carlyle Group Inc. from 2014 to 2020. He has served on the board of
directors of AstroNova, Inc., Digirad Corporation and Jason Industries, Inc. since 2009, 2019 and 2015, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Donald
Runkle</B> is a highly recognized vehicle engineer, with a deep understanding of emerging automotive technologies and broad relationships with automotive executives and investors globally. Mr.&nbsp;Runkle has over 50 years of experience, including
senior leadership experience as Chairman or Vice Chairman at public and private automotive companies such as Delphi, EaglePicher Holdings, Inc. (&#147;EaglePicher&#148;), Autocam Corporation (&#147;Autocam&#148;) and EcoMotors International Inc.
(&#147;EcoMotors&#148;) and as Vice President of GM&#146;s Advanced Engineering Staff. Mr.&nbsp;Runkle began his career at GM, where he held several roles, including Chief Engineer of Chevrolet, Chief Engineer of Powertrain and Racing in the Buick
Division, Director of Advanced Vehicle Engineering, Vice President of GM&#146;s Advanced Engineering Staff and Vice President of GM&#146;s North American Engineering Center. Mr.&nbsp;Runkle was President of Delphi&#146;s Steering Division (formerly
the Saginaw Steering Division of GM) in 1993, where he led a significant turnaround and divestiture of uncompetitive assets. From 1998 to 1999, he <FONT STYLE="white-space:nowrap">co-led</FONT> the initial public offering <FONT
STYLE="white-space:nowrap">spin-off</FONT> of Delphi from GM, subsequently assuming the role of Executive Vice President of the Dynamics&nbsp;&amp; Propulsion Sector in 2000. From 2003 to 2005, Mr.&nbsp;Runkle assumed the role of Vice Chairman and
Chief Technology Officer of Delphi, later transitioning to EaglePicher as Chairman from 2006 to 2011 and then Autocam as Chairman from 2007 to 2009. Additionally, Mr.&nbsp;Runkle served as Chief Executive Officer and Executive Chairman of EcoMotors
from 2009 to 2014 and Executive Chairman of Ioxus, Inc. from 2015 to 2017. Mr.&nbsp;Runkle previously served as a director of several public companies including Lear Corporation (&#147;Lear&#148;), Delphi and Outboard Marine Corporation, and was a
director of Asia Automotive Acquisition Corporation, a special purpose acquisition corporation from 2005 to 2008. Mr.&nbsp;Runkle has served as a director of VIA Motors Inc. since 2014 and Senior Consultant to Tennenbaum Capital Partners LLC since
2005. In addition, Mr.&nbsp;Runkle has served as an advisor to General Fusion Inc. since 2014, Tula Technology Inc. since 2014, Soar Technology, Inc. since 2017 and ClearFlame Engines, Inc. since 2019, on topics including technology and business
strategy, electronics, fuel cells, energy development and storage, electrified vehicles and lean implementation strategy. Mr.&nbsp;Runkle has also served as President of Runkle Enterprises LLC since 2005, a director of the nonprofit Lean Enterprise
Institute Inc., from 2008 to 2017, a director of WinCup Corporation from 2009 to 2015 and a director of Transonic Combustion Inc. from 2010 to 2015. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Matthew Simoncini </B>is the former President and Chief Executive Officer of Lear from 2011 to 2018, with significant strategic and
financial expertise in the automotive and automotive-related sector and extensive relationships with suppliers, business owners and intermediaries. Mr.&nbsp;Simoncini has over 35 years of experience </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">207 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in the automotive and automotive-related sector in evaluating companies, emerging technologies and management teams, with significant expertise in due diligence and assessing the suitability of
acquisition opportunities. While President and Chief Executive Officer of Lear, Mr.&nbsp;Simoncini was responsible for the strategic direction and operational leadership of the company. From 2007 to 2011, Mr.&nbsp;Simoncini was Chief Financial
Officer of Lear, responsible for Lear&#146;s global finance operations, including external financial reporting, corporate business planning, corporate strategy and business development. Mr.&nbsp;Simoncini joined Lear in 1999 after Lear acquired UT
Automotive (&#147;UTA&#148;), where he was director of global financial planning&nbsp;&amp; analysis. Before UTA, Mr.&nbsp;Simoncini held financial and manufacturing positions with Varity Corporation&#146;s Kelsey-Hayes Company and Horizon
Enterprises Inc., including Chief Financial Officer of Kelsey Hayes Company&#146;s European Operations. Mr.&nbsp;Simoncini began his career at Touche Ross&nbsp;&amp; Co. and is a certified public accountant. Mr.&nbsp;Simoncini served as a director
of Cooper-Standard Holdings from 2018 to 2020. Since 2020, Mr.&nbsp;Simoncini has served as a director of Luminar Technologies, Inc. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Number, Terms of
Office and Election of Executive Officers and Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Kensington Board is currently divided into three classes, each of which
will generally serve for a term of three years with only one class of directors being elected in each year and each class (except for those directors appointed prior to our first annual meeting of stockholders) serving a three-year term. The term of
office of the first class of directors, consisting of Messrs. Quain and Simoncini will expire at our first annual meeting of stockholders. The term of office of the second class of directors, consisting of Messrs. Remenar and Runkle, will expire at
the second annual meeting of stockholders. The term of office of the third class of directors, consisting of Messrs. LaSorda, Mirro and Pettersson, will expire at the third annual meeting of stockholders. We may not hold an annual meeting of
stockholders until after we consummate our initial business combination (unless required by NYSE). Prior to the completion of our initial business combination, only holders of Kensington Class&nbsp;B Common Stock will have the right to vote on the
election of directors. Holders of Public Shares will not be entitled to vote on the election of directors during such time. In addition, prior to the consummation of our initial business combination, holders of a majority of the outstanding shares
of Kensington Class&nbsp;B Common Stock may remove a member of the board of directors for any reason. These provisions of the Existing Certificate of Incorporation may only be amended by a resolution passed by the holders of a majority of shares of
Kensington Class&nbsp;B Common Stock. Our executive officers are elected by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint
persons to the offices set forth in our bylaws as it deems appropriate. Our bylaws provide that our executive officers may consist of one or more Chairmen (or Vice Chairmen) of the Board, one or more Chief Executive Officers, a President, a Chief
Financial Officer, Chief Technology Officer, Vice Presidents, a Secretary, a Treasurer and such other offices as may be determined by the board of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officer and Director Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of our executive officers or directors has received any cash compensation for services rendered to us. Other than the payment to DEHC, an
affiliate of Daniel Huber, our Chief Financial Officer, of service and administrative fees of $20,000 per month for up to 18 months commencing on June&nbsp;30, 2020, no compensation of any kind, including finder&#146;s and consulting fees, will be
paid by us to our Sponsor, executive officers and directors, or any of their respective affiliates, for services rendered prior to or in connection with the consummation of our initial business combination. Our audit committee will review on a
quarterly basis all payments that were made by us to our sponsor, officers or directors, or our or their affiliates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Committees of the Board of
Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has three standing committees: an audit committee, a compensation committee and a nominating and
corporate governance committee. Each of our audit committee and our nominating and corporate governance committee is composed solely of independent directors. Each committee operates under a charter that is approved by our board of directors and has
the composition and responsibilities described below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">208 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Audit Committee </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Messrs. Simoncini, Quain and Runkle serve as members of our audit committee. Mr.&nbsp;Simoncini serves as chair of the audit committee. Under
the NYSE listing standards and applicable SEC rules, we are required to have at least three members of the audit committee, all of whom must be independent. Messrs. Simoncini, Quain and Runkle meet the independent director standard under the NYSE
listing standards and under Rule <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">10-A-3(b)(1)</FONT></FONT> of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each member of the audit committee is financially literate, and our board of directors has determined that Mr.&nbsp;Simoncini qualifies as an
&#147;audit committee financial expert&#148; as defined in applicable SEC rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We adopted an audit committee charter, which details the
purpose and principal functions of the audit committee, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">assisting board oversight of (1)&nbsp;the integrity of our financial statements, (2)&nbsp;our compliance with
legal and regulatory requirements, (3)&nbsp;our independent auditor&#146;s qualifications and independence, and (4)&nbsp;the performance of our internal audit function and independent auditors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and
any other independent registered public accounting firm engaged by us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">pre-approving</FONT> all audit and
<FONT STYLE="white-space:nowrap">non-audit</FONT> services to be provided by the independent auditors or any other registered public accounting firm engaged by us, and establishing <FONT STYLE="white-space:nowrap">pre-approval</FONT> policies and
procedures; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and discussing with the independent auditors all relationships the auditors have with us in order to
evaluate their continued independence; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">setting clear hiring policies for employees or former employees of the independent auditors;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">setting clear policies for audit partner rotation in compliance with applicable laws and regulations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtaining and reviewing a report, at least annually, from the independent auditors describing the independent
auditor&#146;s internal quality-control procedures and any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities,
within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">meeting to review and discuss our annual audited financial statements and quarterly financial statements with
management and the independent auditor, including reviewing our specific disclosures under &#147;<I>Kensington Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations</I>&#148;; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving any related party transaction required to be disclosed pursuant to Item&nbsp;404 of <FONT
STYLE="white-space:nowrap">Regulation&nbsp;S-K</FONT> promulgated by the SEC prior to us entering into such transaction; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing with management, the independent auditors, and our legal advisors, as appropriate, any legal,
regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any
significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Compensation Committee </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Messrs. LaSorda
and Pettersson serve as members of our compensation committee. Mr.&nbsp;LaSorda serves as chair of the compensation committee. Under the NYSE listing standards and applicable SEC rules, we are required to have at least two members of the
compensation committee, all of whom must be independent, subject to certain <FONT STYLE="white-space:nowrap">phase-in</FONT> provisions. Messrs. LaSorda, and Pettersson meet the independent director standard under the NYSE listing standards
applicable to members of the compensation committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">209 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a compensation committee charter, which details the purpose and
responsibilities of the compensation committee, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive
Officer&#146;s compensation, evaluating our Chief Executive Officer&#146;s performance in light of such goals and objectives, and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving on an annual basis the compensation of all of our other officers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing our executive compensation policies and plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">implementing and administering our incentive compensation equity-based remuneration plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">assisting management in complying with our proxy statement and annual report disclosure requirements;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approving all special perquisites, special cash payments and other special compensation and benefit arrangements
for our executive officers and employees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if required, producing a report on executive compensation to be included in our annual proxy statement; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The charter also provides that the compensation committee may, in its sole discretion, retain or obtain the advice of a
compensation consultant, independent legal counsel or other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice from a compensation
consultant, external legal counsel or any other adviser, the compensation committee will consider the independence of each such adviser, including the factors required by the NYSE and the SEC. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Nominating and Corporate Governance Committee </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Messrs. Quain and Pettersson serve as members of our nominating and corporate governance committee. Mr.&nbsp;Quain serves as chair of the
nominating and corporate governance committee. We have adopted a nominating and corporate governance committee charter, which details the purpose and responsibilities of the nominating and corporate governance committee, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identifying, screening and reviewing individuals qualified to serve as directors, consistent with criteria
approved by the board, and recommending to the board of directors candidates for nomination for election at the annual meeting of stockholders or to fill vacancies on the board of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing and recommending to the board of directors and overseeing implementation of our corporate governance
guidelines; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">coordinating and overseeing the annual self-evaluation of the board of directors, its committees, individual
directors and management in the governance of the company; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing on a regular basis our overall corporate governance and recommending improvements as and when
necessary. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The charter also provides that the nominating and corporate governance committee may, in its sole
discretion, retain or obtain the advice of, and terminate, any search firm to be used to identify director candidates, and will be directly responsible for approving the search firm&#146;s fees and other retention terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess.
In general, in identifying and evaluating nominees for director, the board of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">210 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
directors considers educational background, diversity of professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom, and the ability to represent
the best interests of our stockholders. Prior to our initial business combination, holders of our Public Shares will not have the right to recommend director candidates for nomination to our board of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;16(a) Beneficial Ownership Reporting Compliance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;16(a) of the Exchange Act requires our officers, directors and persons who beneficially own more than ten percent of Kensington
Class&nbsp;A Common Stock to file reports of ownership and changes in ownership with the SEC. However, we were not a reporting company as of the end of the most recent fiscal year. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Code of Ethics </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a Code of
Ethics and Business Conduct (the &#147;Code of Ethics&#148;) that applies to our directors, officers and employees. We have filed copies of our Code of Ethics, our audit committee charter, our compensation committee charter and our nominating and
corporate governance committee charter as exhibits to our registration statement in connection with our IPO. You may review these documents by accessing our public filings at the SEC&#146;s web site at www.sec.gov. In addition, a copy of the Code of
Ethics will be provided without charge upon request to us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Audit Fees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The firm of Marcum&nbsp;LLP (&#147;Marcum&#148;) acts as our independent registered public accounting firm. The following is a summary of fees
paid to Marcum for services rendered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Audit Fees. </I>Audit fees consist of fees for professional services rendered for the audit of
our <FONT STYLE="white-space:nowrap">year-end</FONT> financial statements and services that are normally provided by Marcum in connection with regulatory filings. As we were not a reporting company as of the end of the most recent fiscal year, the
aggregate fees of Marcum for professional services rendered for the audit of our financial statements, review of the financial information included in our <FONT STYLE="white-space:nowrap">Forms&nbsp;10-Q</FONT> for the June&nbsp;30, 2020 period and
other required filings with the SEC for the period from April&nbsp;17, 2020 (date of inception) to June&nbsp;30, 2020 totaled approximately $15,450. The aggregate fees of Marcum related to audit services in connection with our IPO totaled
approximately $38,625. The above amounts include interim procedures and audit fees, as well as attendance at audit committee meetings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Audit-Related Fees. </I>Audit-related fees consist of fees billed for assurance and related services that are reasonably related to
performance of the audit or review of our financial statements and are not reported under &#147;<I>Audit Fees</I>.&#148; These services include attest services that are not required by statute or regulation and consultations concerning financial
accounting and reporting standards. During the period from April&nbsp;17, 2020 (date of inception) to June&nbsp;30, 2020, we did not pay Marcum any audit-related fees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Tax Fees. </I>We did not pay Marcum any fees for tax return services, planning and tax advice for the period from April&nbsp;17, 2020 (date
of inception) to June&nbsp;30, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>All Other Fees. </I>We did not pay Marcum for any other services for the period from
April&nbsp;17, 2020 (date of inception) to June&nbsp;30, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Legal Proceedings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">211 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_58"></A>KENSINGTON MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The statements in the discussion and analysis regarding industry outlook, our
expectations regarding the performance of our business and the forward-looking statements are subject to numerous risks and uncertainties, including, but not limited to, the risks and uncertainties described in &#147;Risk Factors&#148; and
&#147;Cautionary Note Regarding Forward-Looking Statements.&#148; Our actual results may differ materially from those contained in or implied by any forward-looking statements. You should read the following discussion together with the sections
entitled &#147;Risk Factors,&#148; &#147;Information About Kensington&#148; and the audited financial statements and the unaudited condensed financial statements, including the related respective notes thereto, appearing elsewhere in this proxy
statement/prospectus/information statement. As used in this section, unless the context suggests otherwise, &#147;we,&#148; &#147;us,&#148; &#147;our,&#148; &#147;the Company&#148; or &#147;Kensington&#148; refer to Kensington Capital Acquisition
Corp. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a blank
check company incorporated in&nbsp;Delaware on April&nbsp;17, 2020 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Although
we are not limited to a particular industry or sector for purposes of completing a business combination, we intend to focus our search for a target business in the automotive and automotive-related sector.&nbsp;We are an emerging growth company and,
as such, we are subject to all of the risks associated with emerging growth companies.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registration statement for our IPO was declared
effective on June&nbsp;25, 2020. On June&nbsp;30, 2020, we consummated its IPO of 23,000,000 Kensington Units, including 3,000,000 Over-Allotment Units to cover over-allotments, at $10.00 per Kensington Unit, generating gross proceeds of
$230&nbsp;million, and incurring offering costs of approximately $13.1&nbsp;million, inclusive of approximately $8.1&nbsp;million in deferred underwriting commissions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Simultaneously with the closing of the IPO, we consummated the private placement of&nbsp;6,575,000&nbsp;Private Warrants at a price of $1.00
per Private Warrant to our Sponsor, generating proceeds of approximately $6.6&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the closing of the IPO&nbsp;and the
private placement, $230&nbsp;million ($10.00 per Kensington Unit)&nbsp;of the net proceeds of the IPO and certain of the proceeds of the private placement&nbsp;was held in a Trust Account located in the United States with Continental Stock
Transfer&nbsp;&amp; Trust Company acting as trustee, and invested only in U.S. &#147;government securities,&#148; within the meaning set forth in Section&nbsp;2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in money
market funds meeting certain conditions under Rule <FONT STYLE="white-space:nowrap">2a-7</FONT> under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of:
(i)&nbsp;the consummation of a business combination and (ii)&nbsp;the distribution of the Trust Account as described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a
business combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If&nbsp;we are&nbsp;unable to complete a business combination within&nbsp;the combination period, which
is&nbsp;24&nbsp;months from the closing of the IPO, or June&nbsp;30, 2022 (the &#147;Combination Period&#148;),&nbsp;we&nbsp;will (i)&nbsp;cease all operations except for the purpose of winding up, (ii)&nbsp;as promptly as reasonably possible but
not more than ten business days thereafter, redeem the Public Shares, at <FONT STYLE="white-space:nowrap">a&nbsp;per-share&nbsp;price,</FONT> payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest
earned on the funds held in the Trust Account and not previously released to&nbsp;us&nbsp;to pay&nbsp;our&nbsp;taxes, net of taxes payable (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding
Public Shares, which redemption will completely extinguish Public </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">212 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Stockholders&#146;&nbsp;rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii)&nbsp;as promptly as reasonably possible following such
redemption, subject to the approval of&nbsp;our&nbsp;remaining stockholders and&nbsp;our&nbsp;board of directors, dissolve and liquidate, subject in each case to&nbsp;our&nbsp;obligations under Delaware law to provide for claims of creditors and the
requirements of other applicable law.&nbsp;There&nbsp;will be no redemption rights or liquidating distributions with respect to&nbsp;our&nbsp;warrants, which will expire worthless if&nbsp;we&nbsp;fail to complete our initial business combination
within the Combination Period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity and Capital Resources </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As indicated in the accompanying unaudited condensed financial statements, at June&nbsp;30, 2020, we had approximately $1.7&nbsp;million in
cash, and working capital of approximately $1.5&nbsp;million (not taking into account tax obligations). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our liquidity needs prior to the
consummation of the IPO were satisfied through the proceeds of $25,000 from the sale of the Sponsor Shares, and loan proceeds from our Sponsor of $75,000 (which is still outstanding to date).&nbsp;Subsequent from the consummation of the IPO, our
liquidity has been satisfied through the net proceeds from the consummation of the IPO and the private placement held outside of the Trust Account. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the foregoing, management believes that we will have sufficient working capital and borrowing capacity to meet its needs through the
earlier of the consummation of a business combination or one year from the filing of our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended June&nbsp;30, 2020. Over this time period, we will be using the
funds held outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective initial business combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures,
selecting the target business to merge with or acquire, and structuring, negotiating and completing a business combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Management is
currently evaluating the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on the industry and effect on our financial position, results of its operations and/or search for a target company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Results of Operations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our entire
activity since inception up to June&nbsp;30, 2020 was in preparation for our formation and the IPO. We will not be generating any operating revenues until the closing and consummation of our initial business combination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the period from April&nbsp;17, 2020 (inception) through June&nbsp;30, 2020, we had net loss of approximately $63,000, which consisted of
approximately $22,000 in general and administrative expenses and approximately $41,000 in franchise tax expense. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contractual Obligations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Service and Administrative Fees </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We agreed
to pay service and administrative fees of $20,000 per month to DEHC, an affiliate of Daniel Huber, the Company&#146;s Chief Financial Officer, for up to 18 months commencing on the date of consummation of the IPO.&nbsp;The Company believes that
these fees are being paid on arms&#146; length terms and comparable to fees typically paid for similar services by other special purpose acquisition companies.&nbsp;As of June&nbsp;30, 2020, we incurred $20,000&nbsp;in general and administrative
expenses in the accompanying condensed statement of operations and $20,000 in accounts payable in the accompanying balance sheet in connection with such services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Sponsor, executive officers and directors, or any of their respective affiliates, will be reimbursed for any <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business
combinations. Our audit committee will review on a quarterly basis all payments that were made by us to our Sponsor, officers, directors or their affiliates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">213 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Registration Rights </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of Sponsor Shares, Private Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, and any
shares of Kensington Class&nbsp;A Common Stock issuable upon the exercise of the Private Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Sponsor Shares will be entitled to registration
rights pursuant to a registration rights. These holders will be entitled to certain demand and &#147;piggyback&#148; registration rights. We will bear the expenses incurred in connection with the filing of any such registration statements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Underwriting Agreement </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters
were entitled to an underwriting discount of $0.20 per Kensington Unit, or $4.6&nbsp;million in the aggregate, paid upon the closing of the IPO. In addition, $0.35 per Kensington Unit, or approximately $8.1&nbsp;million in the aggregate will be
payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a business combination, subject to the terms
of the underwriting agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Critical Accounting Policies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Kensington Class&nbsp;A Common Stock subject to possible redemption </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We account for our Kensington Class&nbsp;A Common Stock subject to possible redemption in accordance with the guidance in ASC Topic 480
&#147;Distinguishing Liabilities from Equity.&#148; Kensington Class&nbsp;A Common Stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable&nbsp;Kensington
Class&nbsp;A Common Stock (including Kensington Class&nbsp;A Common Stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the
Company&#146;s control) are classified as temporary equity. At all other times, Class&nbsp;A common stock is classified as stockholders&#146; equity. Kensington Class&nbsp;A Common Stock feature certain redemption rights that are considered to be
outside of our control and subject to the occurrence of uncertain future events. Accordingly, at June&nbsp;30, 2020, 21,843,927 shares of Kensington Class&nbsp;A Common Stock subject to possible redemption is presented at redemption value as
temporary equity, outside of the stockholders&#146; equity section of the Company&#146;s balance sheet. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Net Loss Per Common Share </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We comply with accounting and disclosure requirements of FASB ASC Topic 260, &#147;Earnings Per Share.&#148; Net loss per share is computed by
dividing net loss by the weighted average number of shares of common stock outstanding during the period excluding common stock subject to forfeiture.&nbsp;An aggregate of 21,843,927 shares of Kensington Class&nbsp;A Common Stock subject to possible
redemption at June&nbsp;30, 2020 has been excluded from the calculation of basic loss per share of common stock, since such shares, if redeemed, only participate in their pro rata share of the trust earnings. We have not considered the effect of the
warrants sold in the IPO (including the consummation of the over-allotment Kensington Units) and private placement to purchase an aggregate of 18,075,000 shares of our Kensington Common Stock in the calculation of diluted loss per share, since the
exercise of the Kensington Warrants are contingent upon the occurrence of future events. As a result, diluted net loss per common share is the same as basic net loss per common share for the period presented. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Recent Accounting Standards </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted would have a material effect on the accompanying&nbsp;financial statements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Off-Balance</FONT> Sheet Arrangements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, we did not have any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet arrangements as defined in Item
303(a)(4)(ii) of Regulation <FONT STYLE="white-space:nowrap">S-K.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">214 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>JOBS Act </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as
an &#147;emerging growth company&#148; and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new
or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for <FONT STYLE="white-space:nowrap">non-emerging</FONT> growth
companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS
Act. Subject to certain conditions set forth in the JOBS Act, if, as an &#147;emerging growth company,&#148; we choose to rely on such exemptions we may not be required to, among other things, (i)&nbsp;provide an auditor&#146;s attestation report on
our system of internal controls over financial reporting pursuant to Section&nbsp;404, (ii) provide all of the compensation disclosure that may be required of <FONT STYLE="white-space:nowrap">non-emerging</FONT> growth public companies under the
Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii)&nbsp;comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor&#146;s report providing additional information
about the audit and the financial statements (auditor discussion and analysis) and (iv)&nbsp;disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the
CEO&#146;s compensation to median employee compensation. These exemptions will apply for a period of five years following the consummation of our IPO or until we are no longer an &#147;emerging growth company,&#148; whichever is earlier. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">215 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_59"></A>CERTAIN KENSINGTON RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>As used in this section, unless the context suggests otherwise, &#147;we,&#148; &#147;us,&#148; &#147;our,&#148; &#147;the
Company&#148; or &#147;Kensington&#148; refer to Kensington Capital Acquisition Corp. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In April 2020, the Sponsor subscribed to
purchase 5,031,250 Sponsor Shares for an aggregate purchase price of $25,000 and fully paid for these shares on May&nbsp;1, 2020. On June&nbsp;25, 2020, we effected a stock dividend of 718,750 shares with respect to Kensington Class&nbsp;B Common
Stock, resulting in the Sponsor holding an aggregate of 5,750,000 Sponsor Shares. Prior to the initial investment in Kensington of $25,000 by the Sponsor, Kensington had no assets, tangible or intangible. The number of Sponsor Shares issued was
determined based on the expectation that such Sponsor Shares would represent 20% of the outstanding shares upon consummation of the IPO. The Sponsor Shares (including the Kensington Class&nbsp;A Common Stock issuable upon exercise thereof) may not,
subject to certain limited exceptions, be transferred, assigned or sold by the holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sponsor purchased 6,575,000 Kensington
Warrants simultaneously with the consummation of the IPO. As such, the Sponsor&#146;s interest in the IPO was valued at $6,575,000. Each Private Warrant entitles the holder to purchase one share of Kensington Class&nbsp;A Common Stock at $11.50 per
share, subject to adjustment as provided herein. The Private Warrants (including the warrants that may be issued upon conversion of working capital loans and the Kensington Class&nbsp;A Common Stock issuable upon exercise of such Private Warrants)
may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder. There are no redemption rights or liquidating distributions with respect to the Sponsor Shares or Private Warrants, which will expire worthless if we
fail to complete a business combination within the <FONT STYLE="white-space:nowrap">24-month</FONT> time period after the consummation of the IPO or beyond such <FONT STYLE="white-space:nowrap">24-month</FONT> time period as a result of a
stockholder vote to amend the Existing Certificate of Incorporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any of our officers or directors becomes aware of a business
combination opportunity that falls within the line of business of any entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such opportunity
to such entity. Our officers and directors currently have certain relevant fiduciary duties or contractual obligations to other entities that may take priority over their duties to us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than the payment to DEHC, an affiliate of Daniel Huber, Kensington&#146;s Chief Financial Officer, of service and administrative fees of
$20,000 per month for up to 18 months, no compensation of any kind, including finder&#146;s and consulting fees, will be paid by us to our Sponsor, executive officers and directors, or any of their respective affiliates, for services rendered prior
to or in connection with the consummation of our initial business combination. Our audit committee will review on a quarterly basis all payments that were made by us to our Sponsor, officers, directors or our or their affiliates and will determine
which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">of&nbsp;out-of-pocket&nbsp;expenses</FONT></FONT> incurred by such
persons in connection with activities on our behalf. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;17, 2020, the Sponsor agreed to loan the Company an aggregate of
up to $300,000 to cover expenses related to the IPO pursuant to a note (the &#147;Note&#148;). This loan is <FONT STYLE="white-space:nowrap">non-interest</FONT> bearing and payable upon the consummation of the IPO. As of June&nbsp;30, 2020, the
Company has borrowed $75,000 under the Note. The value of the Sponsor&#146;s interest in this transaction corresponds to the principal amount outstanding under any such loan. To date, the balance of the Note remains outstanding. The Sponsor has
informed Kensington that the Sponsor intends to convert the loan into 75,000 warrants on the same terms as the Private Warrants (as contemplated by the warrant agreement pursuant to which the Private Warrants were issued) at the same time the
Business Combination is completed and for such warrants to be issued to Justin Mirro, who had advanced such amount to the Sponsor in order for the loan to be made. Such warrants have an aggregate market value of approximately $284,250 based on the
closing price of the Public Warrants of $3.79 on the NYSE on October&nbsp;19, 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">216 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in order to fund working capital deficiencies or finance transaction costs in
connection with an intended initial business combination, the Sponsor or an affiliate of Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial business
combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to
repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.00 per warrant at the option of the lender. The warrants would be
identical to the Private Warrants. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than the Sponsor
or an affiliate of Sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After our initial business combination, members of our management team who remain with us, if any, may be paid consulting, management or other
fees from the combined company with any and all amounts being fully disclosed to our stockholders, to the extent then known, in the tender offer or proxy solicitation materials, as applicable, furnished to our stockholders. It is unlikely the amount
of such compensation will be known at the time of distribution of such tender offer materials or at the time of a stockholder meeting held to consider our initial business combination, as applicable, as it will be up to the directors of the
post-combination business to determine executive and director compensation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Sponsor, officers and directors have entered into a
letter agreement with us, pursuant to which they have agreed to waive (i)&nbsp;their redemption rights with respect to any Sponsor Shares and any Public Shares held by them in connection with the consummation of our initial business combination,
(ii)&nbsp;their redemption rights with respect to any Sponsor Shares and any Public Shares held by them in connection with a stockholder vote to approve an amendment to our Existing Certificate of Incorporation (A)&nbsp;to modify the substance or
timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our Public Shares if we have not completed our initial business combination within 24 months from the closing of the IPO or
(B)&nbsp;with respect to any other provision relating to stockholders&#146; rights or <FONT STYLE="white-space:nowrap">pre-initial</FONT> business combination activity and (iii)&nbsp;their rights to liquidating distributions from the trust account
with respect to any Sponsor Shares held by them if we fail to complete our initial business combination within 24 months from the closing of the IPO or beyond such <FONT STYLE="white-space:nowrap">24-month</FONT> time period as a result of a
stockholder vote to amend the Existing Certificate of Incorporation, although they will be entitled to liquidating distributions from the trust account with respect to any Public Shares they hold if we fail to complete our initial business
combination within the prescribed time frame. If we submit our initial business combination to our public stockholders for a vote, we will complete our initial business combination only if a majority of the outstanding shares of common stock voted
by the stockholders at a duly held stockholders meeting are voted to approve the initial business combination. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholder Support Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, (i) Kensington and VGA entered into the Volkswagen Support Agreement, pursuant to which, among other things, VGA
agreed, among other things, to vote its shares of QuantumScape Preferred Stock in favor of the Business Combination Agreement and the Proposed Transactions, and (ii)&nbsp;Kensington and the Key QuantumScape Stockholders entered into the Key
Stockholder Support Agreement, pursuant to which, among other things, the Key QuantumScape Stockholders agreed, among other things, to vote their shares of QuantumScape Common Stock and QuantumScape Preferred Stock in favor of the Business
Combination Agreement and the Proposed Transactions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Kensington and the holders entered into a Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT>
Agreement, which shall be effective at the Closing. Pursuant to the terms of the Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">217 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement, Kensington will be obligated to file&nbsp;a registration statement to register the resale of certain shares of Kensington Common Stock held by the Holders after the Closing. In
addition, pursuant to the terms of the Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement and subject to certain requirements and customary conditions, including with regard to the number of demand rights that may be
exercised, the Holders may demand at any time or from time to time, that Kensington file&nbsp;a registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> (or on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> if <FONT
STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> is not available) to register the securities of Kensington held by such Holders, and Kensington is separately required at all times to maintain an effective resale registration statement for the
benefit of the Holders. The Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement will also provide the Holders with &#147;piggy-back&#148; registration rights, subject to certain requirements and customary conditions.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement further provides for the securities of Kensington
held by the Holders to be <FONT STYLE="white-space:nowrap">locked-up</FONT> for a period of time following the Closing, subject to certain exceptions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Subscription Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection
with the execution of the Business Combination Agreement, effective as of September&nbsp;2, 2020, Kensington entered into separate subscription agreements (each, a &#147;Subscription Agreement&#148;) with a number of Subscribers, pursuant to which
the Subscribers agreed to purchase, and Kensington agreed to sell to the Subscribers, the PIPE Shares, for a purchase price of $10.00 per share and an aggregate purchase price of $500&nbsp;million. Pursuant to the terms of the Subscription
Agreements and subject to certain requirements and customary conditions, Kensington is required to file and maintain an effective resale registration statement with respect to the PIPE Shares for the benefit of the Subscribers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The closing of the sale of the PIPE Shares pursuant to the Subscription Agreements is contingent upon, among other customary closing
conditions, the substantially concurrent Closing. The purpose of the PIPE is to raise additional capital for use by New QuantumScape following the Closing. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Kensington entered into separate Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements with
certain senior level employees of QuantumScape (the &#147;Senior Employees&#148;), including QuantumScape&#146;s executive officers.&nbsp;The Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements provide that the securities of
Kensington owned of record or beneficially by the Senior Employees (including certain securities that may be granted or issued to a Senior Employee after the Effective Time) (collectively, the <FONT STYLE="white-space:nowrap">&#147;Lock-Up</FONT>
Shares&#148;) may generally not be transferred for at least 180 days after the Closing (the &#147;Initial <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period&#148;) and up to four years after the Closing, subject to certain
exceptions.&nbsp;Following the Initial <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, Senior Employees may transfer <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares without restriction as follows: (i)&nbsp;during the first year after
the Effective Time, up to 25% of the total number of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares, (ii)&nbsp;following the first anniversary of the Effective Time until the earlier of four years after the Closing or the occurrence of an
event described below, up to 50% of the total number of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Shares (taking into account any transfers under clause (i)&nbsp;above), and (iii)&nbsp;up to an additional 50% of the total number of <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Shares following satisfaction of agreed delivery requirements between QuantumScape and VGA.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">These transfer restrictions are subject to earlier release if (i)&nbsp;New QuantumScape completes a liquidation, merger, stock exchange or
other similar transaction after the Closing that results in all of New QuantumScape&#146;s stockholders having the right to exchange their shares of common stock for cash, securities or other property; (ii)&nbsp;VGA terminates for any reason the
Amended and Restated Joint Venture Agreement, dated as of May&nbsp;14, 2020, by and among QuantumScape and VGA; (iii)&nbsp;VGA issues a critical or negative statement regarding New QuantumScape and its technology unless such statement is required to
be made by VGA under applicable law and is truthful and accurate; or (iv)&nbsp;VGA transfers certain New QuantumScape securities in excess of the amounts set forth in the Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT>
Agreements.&nbsp;The Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements also provide that, upon consummation of the Merger, Kensington or QuantumScape shall pay to each Senior Employee a
<FONT STYLE="white-space:nowrap">one-time</FONT> cash bonus equal to 20% of the Senior Employee&#146;s then annual base salary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">218 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New QuantumScape intends to enter into separate indemnification agreements with its directors and executive officers, in addition to the
indemnification provided for in the Proposed Certificate of Incorporation and the Proposed Bylaws. These agreements, among other things, will require New QuantumScape to indemnify New QuantumScape&#146;s directors and executive officers for certain
expenses, including attorneys&#146; fees, judgments, fines and settlement amounts incurred by a director or executive officer in any action or proceeding arising out of their services as one of New QuantumScape&#146;s directors or executive officers
or as a director or executive officer of any other company or enterprise to which the person provides services at New QuantumScape&#146;s request. For more information regarding these indemnification arrangements, see &#147;<I>Management After the
Business Combination&#151;Limitation on Liability and Indemnification of Directors and Officers</I>.&#148; Kensington believes that these charter provisions and indemnification agreements are necessary to attract and retain qualified persons as
directors and officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The limitation of liability and indemnification provisions in the Proposed Certificate of Incorporation and the
Proposed Bylaws may discourage stockholders from bringing a lawsuit against directors for breach of their fiduciary duties. They may also reduce the likelihood of derivative litigation against directors and officers, even though an action, if
successful, might benefit New QuantumScape and its stockholders. A stockholder&#146;s investment may decline in value to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification
provisions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>VGA Letter Agreement on Board Representation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Kensington, QuantumScape and VGA entered into a letter agreement pursuant to which, subject to the terms of such
letter agreement, Kensington shall cause to be nominated one designee of VGA for election to the New QuantumScape Board as part of New QuantumScape&#146;s slate and, from and after the First Closing (as defined under the Series&nbsp;F Preferred
Stock Purchase Agreement between QuantumScape and VGA, dated May&nbsp;14, 2020), a second designee of VGA. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>VGA Letter Agreement on Earmarked Funds
</B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Kensington, QuantumScape and VGA entered into a letter agreement pursuant to which, subject to the
terms of such letter agreement, Kensington and QuantumScape covenant that New QuantumScape will reserve a certain portion of the proceeds from the Series F Preferred Stock financing and the capital obtained through the Merger (including any
concurrent &#147;PIPE&#148; financing) in a separate account to fully fund QuantumScape&#146;s future contributions to QSV pursuant to Section&nbsp;3.6 of the LLCA. The parties agreed that the amount to be held in the separate account was $134
million as of the date of the VGA Letter Agreement.</P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Related Party Policy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted our Code of Ethics requiring us to avoid, wherever possible, all conflicts of interests, except under guidelines or resolutions
approved by the Kensington Board (or the appropriate committee of the Kensington Board) or as disclosed in our public filings with the SEC. Under our Code of Ethics, conflict of interest situations include any financial transaction, arrangement or
relationship (including any indebtedness or guarantee of indebtedness) involving the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, our audit committee, pursuant
to its written charter, is responsible for reviewing and approving related party transactions to the extent that we enter into such transactions. An affirmative vote of a majority of the members of the audit committee present at a meeting at which a
quorum is present is required in order to approve a related party transaction. A majority of the members of the entire audit committee will constitute a quorum. Without a meeting, the unanimous written consent of all of the members of the audit
committee will be required to approve a related party transaction. The audit committee charter is available on our website. We have also required each of our directors and executive officers to complete a directors&#146; and officers&#146;
questionnaire that elicits information about related party transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These procedures are intended to determine whether any such
related party transaction impairs the independence of a director or presents a conflict of interest on the part of a director, employee or officer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">219 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In light of the involvement of the Sponsor, officers and directors with other entities, we
may decide to acquire one or more businesses affiliated with our sponsor (or its affiliates), officers or directors or otherwise acquire a business that later becomes affiliated with our sponsor (or its affiliates) or otherwise carry out <FONT
STYLE="white-space:nowrap">non-arm&#146;s</FONT> length transactions with any of such parties. To minimize conflicts of interest, we have agreed not to consummate an initial business combination with an entity that is affiliated with any of our
Sponsor, officers or directors unless we, or a committee of independent directors, have obtained an opinion from an independent investment banking firm that is a member of FINRA or an independent accounting firm that our initial business combination
is fair to our company from a financial point of view. Furthermore, no finder&#146;s fees, reimbursements or cash payments made by us to our Sponsor, officers or directors, or our or their affiliates, for services rendered to us prior to or in
connection with the consummation of our initial business combination. However, the following payments will be made to our Sponsor, officers or directors, or our or their affiliates, none of which will be made from the proceeds of the IPO and the
sale of the Private Warrants held in the trust account prior to the consummation of our initial business combination: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Repayment of an aggregate of up to $300,000 in loans made to us by our sponsor under the Note; as of
June&nbsp;30, 2020, there was $75,000 outstanding under the Note; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Payment of service and administrative fees to DEHC, an affiliate of Daniel Huber, our Chief Financial Officer, of
$20,000 per month for up to 18 months; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reimbursement for any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses related to identifying, investigating and completing an initial business combination; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Repayment of loans which may be made by our sponsor or an affiliate of our Sponsor or certain of our officers and
directors to finance transaction costs in connection with an intended initial business combination, the terms of which have not been determined nor have any written agreements been executed with respect thereto. Up to $1,500,000 of such loans may be
convertible into Kensington Warrants, at a price of $1.00 per Kensington Warrant at the option of the lender. The Kensington Warrants would be identical to the Private Warrants. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">220 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_60"></A>MANAGEMENT AFTER THE BUSINESS COMBINATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officers and Directors After the Business Combination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the Closing, the business and affairs of New QuantumScape will be managed by or under the direction of the New QuantumScape Board.
QuantumScape is currently evaluating potential director nominees and executive officer appointments, but expects that the directors and executive officers of New QuantumScape upon the Closing will include the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="63%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Position</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="7"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B></B><B><I>Executive Officers</I></B><B></B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jagdeep Singh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer and Chairman</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Timothy Holme</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Technology Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Mohit Singh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Development Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin Hettrich</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Howard Lukens</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Sales Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael McCarthy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Legal Officer and Head of Corporate Development</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B></B><B><I><FONT STYLE="white-space:nowrap">Non-Employee</FONT>
Directors</I></B><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Frank Blome (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brad Buss (1)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Doerr (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prof. Dr.&nbsp;J&uuml;rgen Leohold (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prof. Fritz Prinz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Justin Mirro (1)(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.B. Straubel (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dipender Saluja (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the audit committee, effective upon the Closing. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the compensation committee, effective upon the Closing. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the nominating and corporate governance committee, effective upon the Closing. </P></TD></TR></TABLE>
 <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>VGA Letter Agreement on Board Representation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Kensington, QuantumScape and VGA entered into a letter agreement pursuant to which, subject to the terms of such
letter agreement, Kensington shall cause to be nominated one designee of VGA for election to the New QuantumScape Board as part of New QuantumScape&#146;s slate and, from and after the First Closing (as defined under the Series&nbsp;F Preferred
Stock Purchase Agreement between QuantumScape and VGA, dated May&nbsp;14, 2020), a second designee of VGA. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B><B>Jagdeep Singh </B>will serve as New QuantumScape&#146;s Chief Executive Officer and the Chairman of the New QuantumScape Board upon
the Closing. Mr. Singh joined the QuantumScape Board in May 2010. Mr. Singh co-founded QuantumScape and has served as its Chief Executive Officer since QuantumScape&#146;s incorporation in May 2010. Prior to joining QuantumScape, he was the founder
and Chief Executive Officer at Infinera Corporation (NASDAQ: INFN), a telecommunications company, from 2001 to 2009. Mr. Singh holds a B.S. in Computer Science from the University of Maryland College Park, an M.B.A. from the University of
California, Berkeley, Haas School of Business, and a M.S. in Computer Science from Stanford University. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe Mr. Singh is
qualified to serve on the New QuantumScape Board because of the perspective and experience he brings as QuantumScape&#146;s Chief Executive Officer, his leadership experience in the energy storage industry, his educational background and his strong
scientific knowledge. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">221 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Dr. Timothy Holme</B> will serve as New QuantumScape&#146;s Chief Technology Officer
upon the Closing. Dr.&nbsp;Holme has served as QuantumScape&#146;s Chief Technology Officer since January 2011. Prior to joining QuantumScape, he was a Research Associate at Stanford University from June 2008 to January 2011. Dr. Holme holds a B.S.
in Physics, a M.S. in Mechanical Engineering, and a Ph.D. in Mechanical Engineering from Stanford University. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Dr. Mohit Singh </B>will
serve as New QuantumScape&#146;s Chief Development Officer upon the Closing. Dr.&nbsp;Singh has served as QuantumScape&#146;s Chief Development Officer since June 2015. Prior to this, Dr. Singh served as QuantumScape&#146;s Vice President, Research
and Development and Engineering from April 2014 to June 2015. From 2004 to 2007, Dr. Singh conducted post doctorate research in Chemical Engineering at the Lawrence Berkeley National Laboratory for the University of California, Berkeley. Dr. Singh
holds a B. Tech in Chemical Engineering from the Indian Institute of Technology Bombay and a Ph.D. in Chemical and Biomolecular Engineering from Tulane University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Kevin Hettrich</B> will serve as New QuantumScape&#146;s Chief Financial Officer upon the Closing. Mr. Hettrich has served as
QuantumScape&#146;s Chief Financial Officer and head of Business Operations since September 2018. Prior to this, Mr. Hettrich served as QuantumScape&#146;s Vice President of Business Operations from March 2016 to March 2018, as Senior Director of
Finance and Product Management from March 2014 to March 2016, as a Director of Product Management from March 2013 to March 2014, and as&nbsp;a Manager of Product Management from January 2012 to March 2013. Prior to joining QuantumScape,
Mr.&nbsp;Hettrich served as a Private Equity Associate of Bain Capital, an investment firm, from September 2007 to July 2009. Mr. Hettrich also served as a Business Analyst at McKinsey &amp; Company, a management consulting firm, from September 2004
to July 2007. Mr. Hettrich holds a B.A. in Economics from Pomona College, a M.B.A. from Stanford Graduate School of Business, and a M.S. in Environment and Resources from Stanford University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Howard Lukens</B> will serve as New QuantumScape&#146;s Chief Sales Officer upon the Closing. Mr. Lukens has served as QuantumScape&#146;s
Chief Sales Officer since March 2012. Prior to joining QuantumScape, Mr. Lukens served as Vice President, Strategic Sales at Infinera Corporation from January 2005 to January 2011 and as Vice President, Worldwide Sales from September 2002 to
December 2004. Previously he served as Vice President of Worldwide Sales at Lightera Corporation and Vice President of Strategic Sales at Ciena Corporation. Mr. Lukens holds a B.S. in Management from George Mason University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Michael McCarthy </B>will serve as New QuantumScape&#146;s Chief Legal Officer and Head of Corporate Development upon the Closing. Mr.
McCarthy has served as QuantumScape&#146;s Chief Legal Officer and Head of Corporate Development since March 2013. Mr. McCarthy also currently serves on the board of QSV Operations LLC. Prior to joining QuantumScape, he was the Chief Administrative
Officer at Infinera Corporation from April 2003 to March 2013. From September 1997 to April 2003, Mr. McCarthy served as Senior Vice President and General Counsel of Ciena Corporation, a network strategy and technology company. Mr. McCarthy
currently serves as a member of the boards of several privately-held companies. Mr. McCarthy holds a B.A. in Mathematical Economics from Colgate University and a J.D. from Vanderbilt University Law School. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Non-Employee Directors </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Frank
Blome </B>will serve as a member of the New QuantumScape Board upon the Closing. He joined the QuantumScape Board as well as the board of QSV Operations LLC in September 2020. Mr. Blome has 25 years of professional experience in the automotive
industry, with a particular focus on alternative powertrain technologies and battery cell technology. Since January 2018, Mr. Blome has served as the Head of the Battery Center of Excellence of Volkswagen AG. Prior to this, Mr. Blome served from May
2016 to June 2016 as Chief Executive Officer at Mercedes-Benz Energy GmbH, a subsidiary of the Daimler Group active in the EV battery storage space. From July 2013 to June 2017, Mr. Blome served as Chief Executive Officer of LiTec Battery GmbH, a
battery cell manufacturing company started as a joint venture between Daimler Group and Evonik Industries AG, a specialty chemicals company. In addition to these roles, Mr. Blome served from June 2009 to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">222 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
June 2017 as the Chief Executive Officer of Deutsche Accumotive GmbH &amp; Co KG, a subsidiary of Daimler Group, producing batteries for hybrid and EVs, after which Mr. Blome was on garden leave
until January 2018 when he started in his current position at Volkswagen. Mr. Blome holds a diploma in electrical engineering from the University of Applied Sciences Bielefeld. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe Mr.&nbsp;Blome is qualified to serve on the New QuantumScape Board due to his vast experience in the automotive and alternative
powertrain industries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Brad Buss </B>will serve as a member of the New QuantumScape Board upon the Closing. Mr. Buss joined the
QuantumScape Board in August 2020. From August 2014 until his retirement in February 2016, Mr. Buss served as the Executive Vice President and Chief Financial Officer of SolarCity Corporation, a solar energy company acquired by Tesla, Inc. (NASDAQ:
TSLA), a high-performance electric vehicle company. Mr. Buss also served as the Executive, Vice President and Chief Financial Officer of Cypress Semiconductor Corporation (NASDAQ: CY), a semiconductor design and manufacturing company, from August
2005 to June 2014. Mr. Buss has served on the boards of Advance Auto Parts, Inc. (NYSE: AAP) (&#147;Advance&#148;), an automotive parts and accessories provider, since March 2016, Marvell Technology Group Ltd. (NASDAQ: MRVL) (&#147;Marvell&#148;), a
semiconductor company, since July 2018, and AECOM (NYSE: ACM), an engineering firm, since August 2020. Mr. Buss serves as Chair of the Audit Committee of Advance, a member of the Audit Committee of Marvell, and a member of the Nominating and
Governance Committee and Compensation and Organization Committee of AECOM. Mr. Buss previously served on the boards of Tesla, Inc. from November 2009 to June 2019, Cavium, Inc., a semiconductor company, from July 2016 until its acquisition by
Marvell in July 2018, and CafePress Inc. (NASDAQ: PRSS), an e-commerce company, from October 2007 to July 2016. He served on the Audit Committee, Compensation Committee, Nominating and Corporate Governance Committee, and Disclosure Committee of
Tesla, the Audit Committee and Compensation Committee of Cavium, Inc., and the Audit Committee and Compensation Committee of CafePress Inc. Mr. Buss holds a B.A. in Economics from McMaster University and a Honors Business Administration degree from
University of Windsor. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe Mr. Buss is qualified to serve on the New QuantumScape Board because of his vast leadership
expertise and experience on the boards of major automotive companies. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>John Doerr</B> will serve as a member of the New
QuantumScape Board upon the Closing. Mr.<B> </B>Doerr<B> </B>joined the QuantumScape Board in December 2010. Mr. Doerr currently serves as Chairman at Kleiner Perkins, a venture capital firm, and previously served as a Partner from August 1980 to
March 2016. Mr. Doerr currently serves on the boards of Amyris, Inc. (NASDAQ: AMRS), a biotechnology company, since May 2006, Bloom Energy Corporation (NYSE: BE), an energy solutions company, since April 2002, and Alphabet, Inc. (NASDAQ: GOOGL), a
multinational technology company, since May 1999. He serves as Chair of the Nominating and Corporate Governance Committee of Amyris, Inc., a member of the Compensation and Organizational Development Committee of Bloom Energy Corporation, and Chair
of the Leadership Development and Compensation Committee of Alphabet, Inc. Mr Doerr previously served on the boards of Zynga, Inc. (NASDAQ: ZNGA), a social game developer, from March 2013 to May 2017, and Amazon.com, Inc. (NASDAQ: AMZN), a
multinational technology company, from June 1996 to May 2010. Mr. Doerr holds a B.S. and an M.E.E. in Electrical Engineering from Rice University and an M.B.A. from Harvard Business School. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe Mr. Doerr is qualified to serve on the New QuantumScape Board because of his extensive investment experience in the technology
industry and extensive expertise and skills in strategy, finance and management. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Prof. Dr. J&#252;rgen Leohold</B> will serve as a
member of the New QuantumScape Board upon the Closing. Prof. Dr. Leohold<B> </B>joined the QuantumScape Board in May 2015. From October 2012 to December 2017, Prof. Dr. Leohold served as the Head of the Volkswagen AutoUni, an advanced training and
research institution for Volkswagen Aktiengesellschaft, a German automobile manufacturer. He continued to serve as a consultant for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">223 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Volkswagen AutoUni&#146;s research and development group from January 2018 until retiring in May 2019. He also served as the Executive Director of Group Research at Volkswagen Aktiengesellschaft
from April 2006 to July 2016. Prof. Dr. Leohold holds a degree in Electrical Engineering from the University of Hannover, a M.S. in&nbsp;Electrical Engineering from the Georgia Institute of Technology and a doctoral degree from the University of
Hannover. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe Prof. Dr. Leohold is qualified to serve on the New QuantumScape Board because of his leadership experience and
his expertise in the energy technology and automotive fields. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Justin Mirro </B>will serve as a member of the New QuantumScape
Board upon the Closing. Mr. Mirro has served as Kensington&#146;s Chairman and Chief Executive Officer since April 2020. Mr. Mirro has over 25 years of operating, mergers and acquisitions and financing experience in the automotive and
automotive-related sector. He began his career at General Motors Company (&#147;GM&#148;) as a Tool and Die Manufacturing Engineer, with successive positions at Car and Driver Magazine, Toyota Motor Corporation and Itochu International Inc. prior to
transitioning to automotive investment banking at Schroder &amp; Co. Inc./Salomon Smith Barney, Inc./ABN Amro Inc. in 1996. In 1999, Mr. Mirro formed Kensington Capital Partners, LLC, where he has served as President since 2015, to invest in
automotive and automotive-related sector businesses. In 2005, Mr. Mirro transitioned to Jefferies &amp; Company, Inc. as Head of Automotive Investment Banking, and later served as the Head of Automotive Investment Banking at Moelis &amp; Company,
LLC (&#147;Moelis&#148;) and RBC Capital Markets, LLC (&#147;RBC Capital Markets&#148;) from 2008 to 2011 and 2011 to 2014, respectively. In his role, Mr. Mirro played a key role in leading and executing all aspects of capital raising, mergers and
acquisitions and restructurings, and has advised on over 70 transactions totaling more than $60&nbsp;billion of value for OEMs, suppliers and automotive-related industries. From 2016 to 2019, Mr. Mirro served as Chairman of the board of directors
and audit committee of Pure Power Technologies, Inc. (&#147;Pure Power&#148;) one of the largest aftermarket suppliers of diesel fuel injectors, which was later sold to Stanadyne LLC (&#147;Stanadyne&#148;). In his role, Mr. Mirro focused on deal
sourcing, structuring, capital raising, executive recruitment and the eventual sale process. Mr. Mirro has sat on the boards of Cooper-Standard Holdings Inc. (&#147;Cooper-Standard Holdings&#148;) and Transtar Industries, Inc., since 2015 and 2017,
respectively, where he has focused on mergers and acquisitions, capital structuring and public market strategy. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe Mr. Mirro
is qualified to serve on the New QuantumScape Board due to his experience serving as Kensington&#146;s Chairman and Chief Executive Officer, as well as his extensive skills in strategy, finance and management. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Prof. Fritz Prinz</B> will serve as a member of the New QuantumScape Board upon the Closing. Prof. Prinz joined the QuantumScape Board in
December 2010. Prof. Prinz has served as Professor of Materials Science and Engineering, Professor of Mechanical Engineering, and Senior Fellow at the Precourt Institute for Energy since September 2010. He has also served as the Finmeccanica
Professor at the School of Engineering at Stanford University since September 1994. Prof. Prinz holds a Ph.D. in Physics and Mathematics from the University of Vienna, Austria. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe Prof. Prinz is qualified to serve on the New QuantumScape Board because of his in-depth educational expertise and his broad insight
and research into energy conservation. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>J.B. Straubel</B> will serve as a member of the New QuantumScape Board upon the Closing.
Mr. Straubel joined the QuantumScape Board in December 2019. Mr. Straubel has served as the Founder and Chief Executive Officer of Redwood Materials Inc., an electronic recycling and development company, since May 2017. Prior to joining
QuantumScape, Mr. Straubel also co-founded and served as the Chief Technology Officer of Tesla, Inc. from May 2005 to July 2019. Mr. Straubel previously served on the board of SolarCity Corporation and as a member of its Nominating and Corporate
Governance Committee from August 2006 until its acquisition by Tesla, Inc. in November 2016. Mr. Straubel holds a B.S. in Energy Systems Engineering and a M.S. in Engineering, with an emphasis on energy conversion, from Stanford University. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">224 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe Mr. Straubel is qualified to serve on the New QuantumScape Board because of his
technical and manufacturing expertise along with his leadership experience in electronic companies. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Dipender Saluja</B> will serve
as a member of the New QuantumScape Board upon the Closing. Mr. Saluja joined the QuantumScape Board in August 2012 and has served as Managing Director of Capricorn Investment Group, an investment firm, since 2006. Prior to Capricorn Investment
Group, he served in various positions from 1990 to 2006 at Cadence Design Systems, an electronic design company. Mr. Saluja also currently serves as a Commissioner of the Global Commission to End Energy Poverty, a non-profit organization dedicated
to providing electricity services to under-served communities, and also on the boards of several private companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe Mr. Saluja
is qualified to serve on the New QuantumScape Board because of his extensive investment experience in the technology industry and extensive expertise and skills in strategy, finance and management. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Composition </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New
QuantumScape&#146;s business and affairs will be organized under the direction of the New QuantumScape Board. We anticipate that the New QuantumScape Board will consist of nine members upon the Closing. Mr.&nbsp;Singh will serve as Chairman of the
New QuantumScape Board. The primary responsibilities of the New QuantumScape Board will be to provide oversight, strategic guidance, counseling and direction to New QuantumScape&#146;s management. The New QuantumScape Board will meet on a regular
basis and additionally as required. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the terms of the Proposed Bylaws, which will be effective upon the Closing, each
director, including a director elected to fill a vacancy, shall hold office until the expiration of the term for which elected and until such director&#146;s successor is elected and qualified or until such director&#146;s earlier death, resignation
or removal. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any director may be removed from office by the stockholders of New QuantumScape as provided in Section&nbsp;141(k) of
the DGCL. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Independence </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the Closing, the New QuantumScape Board is expected to determine that each of the directors on the New QuantumScape Board other than
Messrs. Singh and Prinz will qualify as independent directors, as defined under the rules of the NYSE, and the New QuantumScape Board will consist of a majority of &#147;independent directors,&#148; as defined under the rules of the SEC and the NYSE
relating to director independence requirements. In addition, New QuantumScape will be subject to the rules of the SEC and the NYSE relating to the membership, qualifications, and operations of the audit committee, as discussed below. Mr. Mirro will
be the New QuantumScape lead independent director under the NYSE rules. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Role of the New QuantumScape Board in Risk Oversight/Risk Committee
</B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the Closing, one of the key functions of the New QuantumScape Board will be informed oversight of New QuantumScape&#146;s
risk management process. The New QuantumScape Board does not anticipate having a standing risk management committee, but rather anticipates administering this oversight function directly through the New QuantumScape Board as a whole, as well as
through various standing committees of the New QuantumScape Board that address risks inherent in their respective areas of oversight. In particular, the New QuantumScape Board will be responsible for monitoring and assessing strategic risk exposure
and New QuantumScape&#146;s audit committee will have the responsibility to consider and discuss New QuantumScape&#146;s major financial risk exposures and the steps its management will take to monitor and control such exposures, including
guidelines and policies to govern the process by which risk assessment and management is undertaken. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">225 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The audit committee will also monitor compliance with legal and regulatory requirements. New QuantumScape&#146;s compensation committee will also assess and monitor whether New
QuantumScape&#146;s compensation plans, policies and programs comply with applicable legal and regulatory requirements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Board Committees
</I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective upon the Closing, the New QuantumScape Board will have three standing committees&#151;an audit committee, a
compensation committee, and a nominating and corporate governance committee. Following the Closing, copies of the charters for each committee will be available on New QuantumScape&#146;s website. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New
QuantumScape&#146;s audit committee will consist of Messrs. Buss, Saluja and Mirro. The New QuantumScape Board will determine that each of the members of the audit committee will satisfy the independence requirements of the NYSE and <FONT
STYLE="white-space:nowrap">Rule&nbsp;10A-3</FONT> under the Exchange Act and be able to read and understand fundamental financial statements in accordance with the NYSE audit committee requirements. In arriving at this determination, the New
QuantumScape Board will examine each audit committee member&#146;s scope of experience and the nature of their prior and/or current employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr. Buss will serve as the chair of the audit committee. The New QuantumScape Board will determine that Mr. Buss qualifies as an audit
committee financial expert within the meaning of SEC regulations and meets the financial sophistication requirements of the NYSE rules. In making this determination, the New QuantumScape Board will consider Mr. Buss&#146; formal education and
previous experience in financial roles. Both Kensington&#146;s independent registered public accounting firm and management will periodically meet privately with New QuantumScape&#146;s audit committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The functions of this committee are expected to include, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating the performance, independence and qualifications of New QuantumScape&#146;s independent auditors and
determining whether to retain New QuantumScape&#146;s existing independent auditors or engage new independent auditors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing New QuantumScape&#146;s financial reporting processes and disclosure controls; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the engagement of New QuantumScape&#146;s independent auditors to perform audit services
and any permissible <FONT STYLE="white-space:nowrap">non-audit</FONT> services; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing the adequacy and effectiveness of New QuantumScape&#146;s internal control policies and procedures,
including the responsibilities, budget, staffing and effectiveness of New QuantumScape&#146;s internal audit function; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing with the independent auditors the annual audit plan, including the scope of audit activities and all
critical accounting policies and practices to be used by New QuantumScape; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtaining and reviewing at least annually a report by New QuantumScape&#146;s independent auditors describing the
independent auditors&#146; internal quality control procedures and any material issues raised by the most recent internal quality-control review; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">monitoring the rotation of partners of New QuantumScape&#146;s independent auditors on New QuantumScape&#146;s
engagement team as required by law; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prior to engagement of any independent auditor, and at least annually thereafter, reviewing relationships that
may reasonably be thought to bear on their independence, and assessing and otherwise taking the appropriate action to oversee the independence of New QuantumScape&#146;s independent auditor; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">226 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing New QuantumScape&#146;s annual and quarterly financial statements and reports, including the
disclosures contained in &#147;<I>QuantumScape Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations</I>,&#148; and discussing the statements and reports with New QuantumScape&#146;s independent auditors and
management; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing with New QuantumScape&#146;s independent auditors and management significant issues that arise
regarding accounting principles and financial statement presentation and matters concerning the scope, adequacy, and effectiveness of New QuantumScape&#146;s financial controls and critical accounting policies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing with management and New QuantumScape&#146;s auditors any earnings announcements and other public
announcements regarding material developments; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing procedures for the receipt, retention and treatment of complaints received by New QuantumScape
regarding financial controls, accounting, auditing or other matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparing the report that the SEC requires in New QuantumScape&#146;s annual proxy statement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and providing oversight of any related party transactions in accordance with New QuantumScape&#146;s
related party transaction policy and reviewing and monitoring compliance with legal and regulatory responsibilities, including New QuantumScape&#146;s code of ethics; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing New QuantumScape&#146;s major financial risk exposures, including the guidelines and policies to govern
the process by which risk assessment and risk management is implemented; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and evaluating on an annual basis the performance of the audit committee and the audit committee
charter. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The composition and function of the audit committee will comply with all applicable requirements of the
Sarbanes-Oxley Act and all applicable SEC rules and regulations. New QuantumScape will comply with future requirements to the extent they become applicable to New QuantumScape. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New
QuantumScape&#146;s compensation committee will consist of Messrs. Straubel, Leohold and Buss. Mr.&nbsp;Straubel will serve as the chair of the compensation committee. The New QuantumScape Board will determine that each of the members of the
compensation committee will be a <FONT STYLE="white-space:nowrap">non-employee</FONT> director, as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3</FONT> promulgated under the Exchange Act and will satisfy the independence requirements
of the NYSE. The functions of the committee are expected to include, among other things: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the corporate objectives that pertain to the determination of executive compensation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the compensation and other terms of employment of New QuantumScape&#146;s executive
officers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving performance goals and objectives relevant to the compensation of New QuantumScape&#146;s
executive officers and assessing their performance against these goals and objectives; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">making recommendations to the New QuantumScape Board regarding the adoption or amendment of equity and cash
incentive plans and approving amendments to such plans to the extent authorized by the New QuantumScape Board; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and making recommendations to the New QuantumScape Board regarding the type and amount of compensation
to be paid or awarded to New QuantumScape&#146;s <FONT STYLE="white-space:nowrap">non-employee</FONT> board members; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and assessing the independence of compensation consultants, legal counsel and other advisors as
required by Section&nbsp;10C of the Exchange Act; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">227 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">administering New QuantumScape&#146;s equity incentive plans, to the extent such authority is delegated by the
New QuantumScape Board; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the terms of any employment agreements, severance arrangements, change in control
protections, indemnification agreements and any other material arrangements for New QuantumScape&#146;s executive officers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing with management New QuantumScape&#146;s disclosures under the caption &#147;<I>Compensation Discussion
and Analysis</I>&#148; in New QuantumScape&#146;s periodic reports or proxy statements to be filed with the SEC, to the extent such caption is included in any such report or proxy statement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparing an annual report on executive compensation that the SEC requires in New QuantumScape&#146;s annual
proxy statement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and evaluating on an annual basis the performance of the compensation committee and recommending such
changes as deemed necessary with the New QuantumScape Board. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The composition and function of its compensation committee
will comply with all applicable requirements of the Sarbanes-Oxley Act and all applicable SEC and the NYSE rules and regulations. New QuantumScape will comply with future requirements to the extent they become applicable to New QuantumScape. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Corporate Governance Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New QuantumScape&#146;s nominating and corporate governance committee will consist of Messrs. Mirro, Doerr and Blome. The New QuantumScape
Board will determine that each of the members of New QuantumScape&#146;s nominating and corporate governance committee will satisfy the independence requirements of the NYSE. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr. Mirro will serve as the chair of New QuantumScape&#146;s nominating and corporate governance committee. The functions of this committee
are expected to include, among other things: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identifying, reviewing and making recommendations of candidates to serve on the New QuantumScape Board;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating the performance of the New QuantumScape Board, committees of the New QuantumScape Board and individual
directors and determining whether continued service on the New QuantumScape Board is appropriate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating nominations by stockholders of candidates for election to the New QuantumScape Board;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating the current size, composition and organization of the New QuantumScape Board and its committees and
making recommendations to the New QuantumScape Board for approvals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing a set of corporate governance policies and principles and recommending to the New QuantumScape Board
any changes to such policies and principles; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing issues and developments related to corporate governance and identifying and bringing to the attention
of the New QuantumScape Board current and emerging corporate governance trends; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing periodically the nominating and corporate governance committee charter, structure and membership
requirements and recommending any proposed changes to the New QuantumScape Board, including undertaking an annual review of its own performance. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The composition and function of the nominating and corporate governance committee will comply with all applicable requirements of the
Sarbanes-Oxley Act and all applicable SEC and the NYSE rules and regulations. New QuantumScape will comply with future requirements to the extent they become applicable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee Interlocks and Insider Participation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of the intended members of New QuantumScape&#146;s compensation committee has ever been an executive officer or employee of New
QuantumScape. None of New QuantumScape&#146;s intended executive </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">228 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
officers currently serves, or has served during the last completed fiscal year, on the compensation committee or board of directors of any other entity that has one or more executive officers
that will serve as a member of the New QuantumScape Board or compensation committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitation on Liability and Indemnification of Directors and
Officers </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Proposed Certificate of Incorporation which will be effective upon Closing limits New QuantumScape&#146;s
directors&#146; liability to the fullest extent permitted under the DGCL. The DGCL provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors, except for liability:
</P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for any transaction from which the director derives an improper personal benefit; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for any unlawful payment of dividends or redemption of shares; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for any breach of a director&#146;s duty of loyalty to the corporation or its stockholders.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of
directors, then the liability of New QuantumScape&#146;s directors will be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. The DGCL and the Proposed Bylaws provide that New QuantumScape will, in certain situations,
indemnify New QuantumScape&#146;s directors and officers and may indemnify other employees and other agents, to the fullest extent permitted by law. Any indemnified person is also entitled, subject to certain limitations, to advancement, direct
payment, or reimbursement of reasonable expenses (including attorneys&#146; fees and disbursements) in advance of the final disposition of the proceeding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, New QuantumScape will enter into separate indemnification agreements with New QuantumScape&#146;s directors and officers. These
agreements, among other things, require New QuantumScape to indemnify its directors and officers for certain expenses, including attorneys&#146; fees, judgments, fines, and settlement amounts incurred by a director or officer in any action or
proceeding arising out of their services as one of New QuantumScape&#146;s directors or officers or any other company or enterprise to which the person provides services at New QuantumScape&#146;s request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New QuantumScape plans to maintain a directors&#146; and officers&#146; insurance policy pursuant to which New QuantumScape s directors and
officers are insured against liability for actions taken in their capacities as directors and officers. Kensington believes these provisions in the Proposed Certificate of Incorporation and the Proposed Bylaws and these indemnification agreements
are necessary to attract and retain qualified persons as directors and officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under
the Securities Act may be permitted to directors, officers, or control persons, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Code of Business Conduct and Ethics for Employees, Executive Officers, and Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The New QuantumScape Board will adopt a code of business conduct and ethics, or the Code of Conduct, applicable to all of New
QuantumScape&#146;s employees, executive officers and directors. The Code of Conduct will be available on New QuantumScape&#146;s website. Information contained on or accessible through New QuantumScape&#146;s website is not a part of this proxy
statement/prospectus/information statement, and the inclusion of New QuantumScape&#146;s website address in this proxy statement/prospectus/information statement is an inactive textual reference only. The nominating and corporate governance
committee of the New QuantumScape Board will be responsible for overseeing the Code of Conduct and must approve any waivers of the Code of Conduct for employees, executive officers and directors. New QuantumScape expects that any amendments to the
Code of Conduct, or any waivers of its requirements, will be disclosed on its website. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">229 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The New QuantumScape Board expects to review director compensation periodically to ensure that director compensation remains competitive such
that New QuantumScape is able to recruit and retain qualified directors. Following the Closing, New QuantumScape intends to develop a <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation program that is designed to align
compensation with New QuantumScape&#146;s business objectives and the creation of stockholder value, while enabling New QuantumScape to attract, retain, incentivize and reward directors who contribute to the long-term success of New QuantumScape.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">230 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_61"></A>DESCRIPTION OF KENSINGTON&#146;S SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following summary of the material terms of Kensington&#146;s securities following the Business Combination is not intended to be a
complete summary of the rights and preferences of such securities. Kensington urges you to read the Proposed Certificate of Incorporation and the Proposed Bylaws in their entirety for a complete description of the rights and preferences of
Kensington&#146;s securities following the Business Combination. The full text of the Proposed Certificate of Incorporation is attached as Annex B to this proxy statement/prospectus/information statement. The Proposed Bylaws will be adopted by the
New QuantumScape Board immediately following the Closing. The affirmative vote of a majority of the New QuantumScape Board is required to adopt, amend, alter or repeal the Proposed Bylaws. The full text of the Proposed Bylaws is attached as Annex C
to this proxy statement/prospectus/information statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information about the Charter Proposals, see the sections entitled
&#147;<I>Proposal No. 2&#151;The Authorized Share Charter Proposal</I>,&#148; &#147;<I>Proposal No. 3&#151;The Director Declassification Charter Proposal</I>,&#148; &#147;<I>Proposal No. 4&#151;The Dual Class</I><I></I><I>&nbsp;Charter
Proposal</I>&#148; and &#147;<I>Proposal No. 5&#151;The Additional Charter Proposal</I>.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The authorized capital stock of New QuantumScape will consist of 1,350,000,000 shares, $0.0001 par value per share, of which: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,000,000,000 shares will be designated as New QuantumScape Class&nbsp;A Common Stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">250,000,000 shares will be designated as New QuantumScape Class&nbsp;B Common Stock; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">100,000,000 shares will be designated as New QuantumScape Preferred Stock. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Proposed Certificate of
Incorporation authorizes two classes of New QuantumScape Common Stock, New QuantumScape Class&nbsp;A Common Stock and New QuantumScape Class&nbsp;B Common Stock. The rights of the holders of New QuantumScape Class&nbsp;A Common Stock and New
QuantumScape Class&nbsp;B common stock will be identical, except with respect to voting and conversion. Some of the terms of these classes of New QuantumScape Common Stock are discussed in greater detail below.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dividend Rights </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to preferences
that may apply to any shares of New QuantumScape Preferred Stock outstanding at the time, the holders of New QuantumScape Common Stock will be entitled to receive dividends out of funds legally available if the New QuantumScape Board, in its
discretion, determines to issue dividends and then only at the times and in the amounts that the New QuantumScape Board may determine. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Voting Rights
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of New QuantumScape Class&nbsp;A Common Stock will be entitled to one vote for each share held as of the record date for the
determination of the stockholders entitled to vote on such matters and holders of New QuantumScape Class&nbsp;B Common Stock will be entitled to ten votes for each share held at the record date for the determination of the stockholders entitled to
vote on such matters, except as otherwise required by law. The holders of New QuantumScape Class&nbsp;A Common Stock and New QuantumScape Class&nbsp;B Common Stock will vote together as a single class, unless otherwise expressly provided in the
certificate of incorporation of New QuantumScape or required by law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">231 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Proposed Certificate of Incorporation would require either holders of New QuantumScape
Class&nbsp;A Common Stock or of New QuantumScape Class&nbsp;B Common Stock to vote separately as a single class in the following circumstances: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if New QuantumScape were to seek to amend the Proposed Certificate of Incorporation to increase or decrease the
authorized number of shares of New QuantumScape Class&nbsp;B Common Stock, then the holders of New QuantumScape Class&nbsp;B Common Stock would be required to vote separately to approve the proposed amendment; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if New QuantumScape were to seek to declare or pay any dividend or make certain other distributions and to treat
the holders of New QuantumScape Common Stock differently than is set forth in the Proposed Certificate of Incorporation in connection with such dividend or other distribution, then the holders of New QuantumScape Class&nbsp;A Common Stock and the
holders of New QuantumScape Class&nbsp;B Common Stock could be required to vote separately to approve such different treatment of the shares of New QuantumScape Common Stock. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Delaware law could require either holders of New QuantumScape Class&nbsp;A Common Stock or of New QuantumScape Class&nbsp;B Common Stock to
vote separately as a single class. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if New QuantumScape were to seek to amend the certificate of incorporation of New QuantumScape in a manner that
alters or changes the powers, preferences, or special rights of such type of Common Stock in a manner that affected such shares adversely but does not so affect the shares of the other type of Common Stock. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the rights of holders of any series of New QuantumScape Preferred Stock with respect to the election of directors, the number of
directors that constitutes the New QuantumScape Board will be fixed solely by resolution of the New QuantumScape Board. Each director of the New QuantumScape Board will be elected to hold office for a <FONT STYLE="white-space:nowrap">one-year</FONT>
term expiring at the next annual meeting of stockholders. There is no cumulative voting with respect to the election of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Right to Receive
Liquidation Distributions </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If New QuantumScape becomes subject to a liquidation, dissolution, or
<FONT STYLE="white-space:nowrap">winding-up,</FONT> the assets legally available for distribution to New QuantumScape&#146;s stockholders would be distributable ratably among the holders of New QuantumScape Common Stock and any participating series
of New QuantumScape Preferred Stock outstanding at that time, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights of and the payment of liquidation preferences, if any, on any outstanding shares of New
QuantumScape Preferred Stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Conversion of New QuantumScape Class&nbsp;B Common Stock </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of New QuantumScape Class&nbsp;A Common Stock will not be convertible into any other shares of capital stock of New QuantumScape. Each
share of New QuantumScape Class&nbsp;B Common Stock will be convertible at any time at the option of the holder into one share of New QuantumScape Class&nbsp;A Common Stock. In addition, shares of New QuantumScape Class&nbsp;B Common Stock will
automatically convert into shares of New QuantumScape Class&nbsp;A Common Stock (i)&nbsp;upon the sale or transfer of such shares, but excluding certain transfers permitted by the Proposed Certificate of Incorporation, or (ii)&nbsp;upon the death of
the holder of such shares or, solely with respect to shares of New QuantumScape Class&nbsp;B Common Stock held by the Excluded Parties (defined as any of Timothy Holme, Prof. Fritz Prinz and Jagdeep Singh) or certain of their permitted entities,
upon the death or disability of such Excluded Party, except that such shares held by an Excluded Party or such Excluded Party&#146;s permitted entities will automatically convert into shares of New QuantumScape Class&nbsp;A Common Stock upon the
earlier of (x) 9 months following the date of death or disability of such Excluded Party, and (y)&nbsp;the date upon which a voting trustee designated by such Excluded Party and approved by the New QuantumScape Board ceases to hold exclusive voting
control over such shares of New QuantumScape Class&nbsp;B Common Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">232 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, all outstanding shares of New QuantumScape Class&nbsp;B
Common Stock will convert into shares of New QuantumScape Class&nbsp;A Common Stock upon the earliest to occur of: (i)&nbsp;the date fixed by the New QuantumScape Board that is no less than 61 days and no more than 180 days following the date after
the issuance of the New QuantumScape Common Stock pursuant to the Business Combination Agreement that the total number of outstanding shares of New QuantumScape Class&nbsp;B Common Stock held by the Excluded Parties and certain of their permitted
entities and permitted transferees represents less than 20% of the number of shares of New QuantumScape Class&nbsp;B Common Stock (as equitably adjusted for any stock dividend, stock split, combination of shares, reorganization, recapitalization,
reclassification or other similar event) issued pursuant to the Business Combination Agreement; (ii) 9 months following the death or disability of all Excluded Parties and the date upon which a voting trustee designated by the last Excluded Party to
die or become disabled and approved by the New QuantumScape Board ceases to hold exclusive voting control over such shares of New QuantumScape Class&nbsp;B Common Stock; or (iii)&nbsp;the date specified by the holders of a majority of the then
outstanding shares of New QuantumScape Class&nbsp;B Common Stock, which majority must include each of the Excluded Parties to the extent that he or she is then living and nondisabled and holds, together with his respective permitted transferees, at
least 20% of the number of shares of New QuantumScape Class&nbsp;B Common Stock held by them as of the date the Proposed Certificate of Incorporation becomes effective (the &#147;Final Conversion Date&#148;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Matters </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All outstanding shares of
the New QuantumScape Common Stock will be fully paid and nonassessable. The New QuantumScape Common Stock will not be entitled to preemptive rights and will not be subject to redemption or sinking fund provisions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The New QuantumScape
Board will be authorized, subject to limitations prescribed by the DGCL, to issue New QuantumScape Preferred Stock in one or more series, to establish from time to time the number of shares to be included in each series, and to fix the designation,
powers, preferences, and rights of the shares of each series and any of its qualifications, limitations, or restrictions, in each case without further vote or action by the New QuantumScape stockholders. The New QuantumScape Board will be empowered
to increase or decrease the number of shares of any series of New QuantumScape Preferred Stock, but not below the number of shares of that series then outstanding, without any further vote or action by the New QuantumScape stockholders. The New
QuantumScape Board will be able to authorize the issuance of New QuantumScape Preferred Stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of the New QuantumScape Common Stock. The
issuance of New QuantumScape Preferred Stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring, or preventing a change in control of
New QuantumScape and might adversely affect the market price of New QuantumScape Common Stock and the voting and other rights of the holders of the New QuantumScape Common Stock. There are currently no plans to issue any shares of New QuantumScape
Preferred Stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Provisions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain provisions of Delaware law, the Proposed Certificate of Incorporation, and the Proposed Bylaws, which are summarized below, may have
the effect of delaying, deferring, or discouraging another person from acquiring control of New QuantumScape. They are also designed, in part, to encourage persons seeking to acquire control of New QuantumScape to negotiate first with the New
QuantumScape Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Section&nbsp;203 of the DGCL </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington is currently governed by the provisions of Section&nbsp;203 of the DGCL, and New QuantumScape will also be governed by the
provisions of Section&nbsp;203 of the DGCL. In general, Section&nbsp;203 of the DGCL </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">233 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
prohibits a public Delaware corporation from engaging in a &#147;business combination&#148; with an &#147;interested stockholder&#148; for a period of three years after the date of the
transaction in which the person became an interested stockholder, unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">either the business combination or the transaction which resulted in the stockholder becoming an interested
stockholder was approved by the board of directors prior to the time that the stockholder became an interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the
interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding shares owned by directors who are also officers of the corporation and shares owned by employee stock plans
in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at or subsequent to the time the stockholder became an interested stockholder, the business combination was
approved by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding voting stock
which is not owned by the interested stockholder. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, Section&nbsp;203 defines a &#147;business
combination&#148; to include mergers, asset sales, and other transactions resulting in financial benefit to a stockholder and an &#147;interested stockholder&#148; as a person who, together with affiliates and associates, owns, or, within the prior
three years, did own, 15% or more of the corporation&#146;s outstanding voting stock. These provisions may have the effect of delaying, deferring, or preventing changes in control of New QuantumScape. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposed Certificate of Incorporation and Proposed Bylaws Provisions </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Proposed Certificate of Incorporation and the Proposed Bylaws include a number of provisions that could deter hostile takeovers or delay or
prevent changes in control of the New QuantumScape Board or management team, including the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Dual-class stock</U><I>.</I>&nbsp;As described
above, the New QuantumScape Class&nbsp;B Common Stock will have 10 votes per share, while the New QuantumScape Class&nbsp;A Common Stock, which will be the only class of New QuantumScape capital stock that will be publicly traded, will have 1 vote
per share. As a result of this dual class structure, the QuantumScape <FONT STYLE="white-space:nowrap">co-founders</FONT> and certain QuantumScape&#146;s investors, which include certain QuantumScape&#146;s executive officers, employees, directors,
and/or their affiliates, will have significant influence over matters requiring stockholder approval, including the election of directors and significant corporate transactions, such as a merger or other sale of New QuantumScape or its assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Board of Directors vacancies</U>. The Proposed Certificate of Incorporation and Proposed Bylaws authorize only a majority of the remaining members of the
New QuantumScape Board, although less than a quorum, to fill vacant directorships, including newly created seats. In addition, subject to the rights of holders of any series of New QuantumScape Preferred Stock, the number of directors constituting
the New QuantumScape Board will be permitted to be set only by a resolution of the New QuantumScape Board. These provisions would prevent a stockholder from increasing the size of the New QuantumScape Board and then gaining control of the New
QuantumScape Board by filling the resulting vacancies with its own nominees. This will make it more difficult to change the composition of the New QuantumScape Board and will promote continuity of management. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Stockholder action; special meeting of stockholders</U>. The Proposed Certificate of Incorporation and Proposed Bylaws provide that, from and after the
Final Conversion Date, the New QuantumScape stockholders may not take action by written consent but may only take action at annual or special meetings of the stockholders. As a result, following the Final Conversion Date, a holder controlling a
majority of the New QuantumScape capital </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">234 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stock would not be able to amend the Proposed Bylaws, amend the Proposed Certificate of Incorporation or remove directors without holding a meeting of New QuantumScape stockholders called in
accordance with the Proposed Certificate of Incorporation and Proposed Bylaws. The Proposed Certificate of Incorporation and Proposed Bylaws further provide that special meetings of New QuantumScape stockholders may be called only by a majority of
the New QuantumScape Board, the chair of the New QuantumScape Board, or the Chief Executive Officer of New QuantumScape, thus prohibiting stockholder action to call a special meeting. These provisions might delay the ability of New QuantumScape
stockholders to force consideration of a proposal or for stockholders controlling a majority of New QuantumScape capital stock to take any action, including the removal of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Advance notice requirements for stockholder proposals and director nominations</U>. The Proposed Bylaws provide advance notice procedures for stockholders
seeking to bring business before the annual meeting of stockholders or to nominate candidates for election as directors at the annual meeting of stockholders. The Proposed Bylaws also specify certain requirements regarding the form and content of a
stockholder&#146;s notice. These provisions might preclude New QuantumScape stockholders from bringing matters before the annual meeting of stockholders or from making nominations for directors at the annual meeting of stockholders if the proper
procedures are not followed. These provisions may also discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#146;s own slate of directors or otherwise attempting to obtain control of New
QuantumScape. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>No cumulative voting</U>. The DGCL provides that stockholders are not entitled to cumulate votes in the election of directors unless a
corporation&#146;s certificate of incorporation provides otherwise. The Proposed Certificate of Incorporation does not provide for cumulative voting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Amendment of charter and bylaws provisions</U>. From and after the Final Conversion Date, any amendment of the above provisions in the Proposed Certificate
of Incorporation and Proposed Bylaws will require approval by holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the voting power of New QuantumScape&#146;s then outstanding capital stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Issuance of undesignated preferred stock</U>. The Proposed Certificate of Incorporation provides that the New QuantumScape Board will have the authority,
without further action by New QuantumScape stockholders, to issue up to 100,000,000 shares of undesignated New QuantumScape Preferred Stock with rights and preferences, including voting rights, designated from time to time by the New QuantumScape
Board. The existence of authorized but unissued shares of New QuantumScape Preferred Stock would enable the New QuantumScape Board to render more difficult or to discourage an attempt to obtain control of New QuantumScape by means of a tender offer,
proxy contest, or other means. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Exclusive forum</U><I>.</I><I></I>&nbsp;The Proposed Bylaws provide that, unless otherwise consented to by New
QuantumScape in writing, the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another State court in Delaware or the federal district court for the District of Delaware) shall, to the fullest
extent permitted by law be the sole and exclusive forum for the following types of actions or proceedings: (i)&nbsp;any derivative action or proceeding brought on behalf of New QuantumScape; (ii)&nbsp;any action asserting a claim of breach of a
fiduciary duty owed by, or otherwise wrongdoing by, any of New QuantumScape&#146;s directors, officers, or other employees to New QuantumScape or its stockholders; (iii)&nbsp;any action arising pursuant to any provision of the DGCL or the Proposed
Certificate of Incorporation or the Proposed Bylaws; (iv)&nbsp;any action to interpret, apply, enforce or determine the validity of the Proposed Certificate of Incorporation or the Proposed Bylaws; or (v)&nbsp;any other action asserting a claim that
is governed by the internal affairs doctrine, in all cases subject to the court having jurisdiction over indispensable parties named as defendants. This provision would not apply to suits brought to enforce a duty or liability created by the
Exchange Act or any other claim for which the U.S. federal courts have exclusive jurisdiction. The Proposed Bylaws further provide that, unless otherwise consented to by New QuantumScape in writing, the federal district courts of the United States
will be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. Any person or entity purchasing or otherwise acquiring any interest in New QuantumScape&#146;s securities shall be
deemed to have notice of and consented to this provision. These provisions may have the effect of discouraging lawsuits against New QuantumScape or New QuantumScape&#146;s directors and officers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">235 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Description of Securities Prior to the Business Combination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Common Stock Prior to the Business Combination </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington is providing stockholders with the opportunity for redemption of their shares upon the Closing at a per share price, payable in
cash, equal to the aggregate amount then on deposit in the Trust Account, including interest but net of taxes payable, divided by the number of then outstanding Public Shares, subject to the limitations described herein. The Sponsor has agreed to
waive its redemption rights with respect to its Sponsor Shares and the Kensington Initial Stockholders, other than Kensington&#146;s independent directors, have agreed to waive their redemption rights with respect to any Public Shares that they may
have acquired during or after Kensington&#146;s IPO in connection with the Closing. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will consummate the Business Combination only
if a majority of the outstanding shares of Kensington Common Stock voted at the special meeting are voted in favor of the Business Combination Proposal. However, the participation of the Sponsor and certain officers, directors, or advisors of
Kensington or their affiliates in privately-negotiated transactions (as described in this proxy statement/prospectus/information statement), if any, could result in the approval of the Business Combination even if a majority of the remaining
stockholders vote, or indicate their intention to vote, against the Business Combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Kensington Initial Stockholders have agreed
to vote the Sponsor Shares and any Public Shares purchased during or after the IPO held by the Kensington Initial Stockholders in favor of the Business Combination. Public stockholders may elect the redemption of their Public Shares whether they
vote for or against the Business Combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sponsor and Kensington&#146;s executive officers and directors have entered into a
letter agreement with Kensington, pursuant to which they have agreed to (1)&nbsp;waive their redemption rights with respect to any Kensington Common Stock held by them in connection with the consummation of the initial business combination or any
amendment to the provisions of the Existing Certificate of Incorporation relating to <FONT STYLE="white-space:nowrap">pre-initial</FONT> business combination activity and related stockholders&#146; rights and (2)&nbsp;waive their rights to
liquidating distributions from the Trust Account with respect to its Sponsor Shares, if applicable, if Kensington fails to complete its initial business combination within the prescribed timeframe (although they will be entitled to liquidating
distributions from the Trust Account with respect to any Public Shares they hold). </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a liquidation, dissolution or
winding up of Kensington after the Business Combination, Kensington&#146;s stockholders are entitled to share ratably in all assets remaining available for distribution to them after payment of liabilities and after provision is made for each class
of stock, if any, having preference over the Kensington Common Stock. Kensington&#146;s stockholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the Kensington Common Stock, except that
Kensington will provide its stockholders with the opportunity for the redemption of all or a portion of their Public Shares upon the Closing at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as
of two business days prior to the Closing, including interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable by us), divided by the number of then outstanding Public Shares, subject to the limitations
described herein. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Sponsor Shares </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sponsor Shares are identical to the shares of Kensington Class&nbsp;A Common Stock included in the Kensington Units sold in the IPO, and
the Sponsor has the same stockholder rights as Public Stockholders, except that (i)&nbsp;prior to the consummation of the initial business combination, only holders of the Kensington Class&nbsp;B Common Stock have the right to vote on the election
of directors and holders of a majority of the outstanding shares of Kensington Class&nbsp;B Common Stock may remove members of the Kensington Board for any reason; (ii)&nbsp;the Sponsor Shares are subject to certain transfer restrictions, as
described in more detail below; (iii)&nbsp;Kensington&#146;s Sponsor, officers and directors have entered into a letter agreement with us, pursuant to which </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">236 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
they have agreed to waive (A)&nbsp;their redemption rights with respect to any Sponsor Shares and any Public Shares held by them in connection with the consummation of Kensington&#146;s IPO,
(B)&nbsp;their redemption rights with respect to any Sponsor Shares and any Public Shares held by them in connection with a stockholder vote to approve an amendment to the Existing Certificate of Incorporation (x)&nbsp;to modify the substance or
timing of Kensington&#146;s obligation to allow redemption in connection with Kensington&#146;s initial business combination or to redeem 100% of Kensington&#146;s Public Shares if Kensington has not completed its initial business combination within
24 months from the closing of the IPO or (y)&nbsp;with respect to any other provision relating to stockholders&#146; rights or <FONT STYLE="white-space:nowrap">pre-initial</FONT> business combination activity and (C)&nbsp;their rights to liquidating
distributions from the Trust Account with respect to any Sponsor Shares held by them if Kensington fails to complete the initial business combination within 24 months from the closing of the IPO or beyond such
<FONT STYLE="white-space:nowrap">24-month</FONT> time period as a result of a stockholder vote to amend the Existing Certificate of Incorporation, although they will be entitled to liquidating distributions from the Trust Account with respect to any
public shares they hold if Kensington fails to complete the initial business combination within the prescribed time frame; (iv)&nbsp;the Sponsor Shares are shares of Kensington Class&nbsp;B Common Stock that will automatically convert into shares of
Kensington Class&nbsp;A Common Stock at the time of Kensington&#146;s initial business combination, or earlier, at the option of the holders, on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis,
subject to adjustment pursuant to certain anti-dilution rights as described herein, which conversion, for the avoidance of doubt, will occur upon the Closing; (v)&nbsp;are entitled to registration rights; and (vi)&nbsp;if Kensington submits its
initial business combination to its public stockholders for a vote, Kensington&#146;s Sponsor, officers and directors have agreed pursuant to the letter agreement to vote any Sponsor Shares and any Public Shares held by them in favor of
Kensington&#146;s initial business combination. Permitted transferees of the Sponsor Shares and Private Warrants and their component securities will be subject to the same restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All outstanding shares of Kensington Class&nbsp;B Common Stock will automatically convert into shares of Kensington Class&nbsp;A Common Stock
at the time of the initial business combination, or earlier, at the option of the holders, on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis, subject to adjustment for stock splits, stock
dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as described herein. In the case that additional shares of Kensington Class&nbsp;A Common Stock, or equity-linked securities, are issued or deemed issued
in excess of the amounts issued in the IPO and related to the closing of Kensington&#146;s initial business combination, including pursuant to a specified future issuance, the ratio at which shares of Kensington Class&nbsp;B Common Stock shall
convert into shares of Kensington Class&nbsp;A Common Stock will be adjusted (unless the holders of a majority of the then outstanding shares of Kensington Class&nbsp;B Common Stock agree to waive such adjustment with respect to any such issuance or
deemed issuance, including a specified future issuance) so that the number of shares of Kensington Class&nbsp;A Common Stock issuable upon conversion of all shares of Kensington Class&nbsp;B Common Stock will equal, in the aggregate, on an <FONT
STYLE="white-space:nowrap">as-converted</FONT> basis, 20% of the sum of the total number of all shares of Kensington Common Stock outstanding upon the consummation of the IPO plus all shares of Kensington Class&nbsp;A Common Stock and equity-linked
securities issued or deemed issued in connection with Kensington&#146;s initial business combination (excluding any shares or equity-linked securities issued or issuable to any seller in the initial business combination). Kensington cannot determine
at this time whether a majority of the holders of Kensington Class&nbsp;B Common Stock at the time of any future issuance would agree to waive such adjustment to the conversion ratio. They may waive such adjustment due to (but not limited to) the
following: (i)&nbsp;closing conditions which are part of the agreement for Kensington&#146;s initial business combination; (ii)&nbsp;negotiation with holders of Kensington Class&nbsp;A Common Stock on structuring an initial business combination; or
(iii)&nbsp;negotiation with parties providing financing which would trigger the anti-dilution provisions of the Kensington Class&nbsp;B Common Stock. If such adjustment is not waived, the issuance would not reduce the percentage ownership of holders
of Kensington Class&nbsp;B Common Stock, but would reduce the percentage ownership of the Public Stockholders. If such adjustment is waived, the issuance would reduce the percentage ownership of holders of both classes of Kensington Common Stock.
Securities could be &#147;deemed issued&#148; for purposes of the conversion rate adjustment if such shares are issuable upon the conversion or exercise of convertible securities, warrants or similar securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With certain limited exceptions, the Sponsor Shares are not transferable, assignable or saleable (except to Kensington&#146;s officers and
directors and other persons or entities affiliated with the Sponsor, each of whom will </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">237 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be subject to the same transfer restrictions) until the earlier of (A)&nbsp;one year after the consummation of the initial business combination and (B)&nbsp;subsequent to the Kensington initial
business combination, (x)&nbsp;if the last reported sale price of Kensington Class&nbsp;A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20
trading days within any <FONT STYLE="white-space:nowrap">30-trading</FONT> day period commencing at least 150 days after Kensington&#146;s initial business combination, or (y)&nbsp;the date on which Kensington completes a liquidation, merger,
capital stock exchange, reorganization or other similar transaction that results in all of Kensington&#146;s stockholders having the right to exchange their shares of common stock for cash, securities or other property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the consummation of the initial business combination, only holders of Kensington Class&nbsp;B Common Stock will have the right to
vote on the election of directors. Holders of Kensington&#146;s Public Shares will not be entitled to vote on the election of directors during such time. In addition, prior to the consummation of the initial business combination, holders of a
majority of the outstanding shares of the Kensington Class&nbsp;B Common Stock may remove a member of the Kensington Board for any reason. These provisions of the Existing Certificate of Incorporation may only be amended by a resolution passed by
the holders of a majority of shares of the Kensington Class&nbsp;B Common Stock. With respect to any other matter submitted to a vote of Kensington&#146;s stockholders, including any vote in connection with the initial business combination, holders
of the Kensington Class&nbsp;A Common Stock and holders of the Kensington Class&nbsp;B Common Stock will vote together as a single class on all matters submitted to a vote of Kensington&#146;s stockholders, except as required by law. Each share of
Kensington Common Stock will have one vote on all such matters. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Preferred Stock </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Existing Certificate of Incorporation provides that shares of Kensington preferred stock may be issued from time to time in one or more
series by Kensington. The Kensington Board is authorized to fix the voting rights, if any, designations, powers and preferences, the relative, participating, optional or other special rights, and any qualifications, limitations and restrictions
thereof, applicable to the shares of each series of Kensington preferred stock. The Kensington Board is able to, without stockholder approval, issue preferred stock with voting and other rights that could adversely affect the voting power and other
rights of the holders of the Kensington Common Stock and could have anti-takeover effects. The ability of the Kensington Board to issue Kensington preferred stock without stockholder approval could have the effect of delaying, deferring or
preventing a change of control of Kensington or the removal of existing management. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington has no preferred stock outstanding at the
date hereof, and will have no preferred stock outstanding immediately after the Closing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Kensington Warrants </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this proxy statement/prospectus/information statement, there were 18,075,000 Kensington Warrants to purchase Kensington
Class&nbsp;A Common Stock outstanding, consisting of 11,500,000 Public Warrants and 6,575,000 Private Warrants held by the Sponsor. Each Kensington Warrant entitles the registered holder to purchase one share of Kensington Class&nbsp;A Common Stock
at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing 30&nbsp;days after the consummation of the initial business combination. The Kensington Warrants will expire at 5:00&nbsp;p.m., New York City time, on
the fifth anniversary of the consummation of an initial business combination, or earlier upon redemption or liquidation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of
Kensington&#146;s Public Warrants cannot exercise their Public Warrants unless Kensington has an effective and current registration statement covering the issuance of the shares underlying such warrants and a current prospectus relating thereto or a
valid exemption from registration is available (including, an exemption in the event of exercise on a cashless basis). Notwithstanding the foregoing, if a registration statement covering the issuance of the shares issuable upon exercise of the
Public Warrants is not effective within 60&nbsp;days from the closing of the initial business combination, warrant holders may, until such time as there is an effective </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">238 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
registration statement and during any period when Kensington shall have failed to maintain an effective registration statement or a current prospectus, exercise warrants on a cashless basis
pursuant to an available exemption from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their warrants on a cashless basis. In no event will Kensington be required to
net cash settle any warrant, or issue securities or other compensation in exchange for the warrants in the event that Kensington is unable to register or qualify the shares underlying the warrants under the Securities Act or applicable state
securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Private Warrants are identical to the Public Warrants underlying the Kensington Units sold in Kensington&#146;s IPO
except that such Private Warrants: (i)&nbsp;will not be redeemable by Kensington, (ii) (including the Kensington Class&nbsp;A Common Stock issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred,
assigned or sold by the Sponsor until 30 days after the consummation of the initial business combination, (iii)&nbsp;may be exercised by the holders on a cashless basis, and (iv)&nbsp;the holders thereof (including with respect to the shares of
common stock issuable upon exercise of these warrants) are entitled to registration rights, in each case so long as they are still held by the Sponsor or its permitted transferees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Redemption of Kensington Warrants when the price per share of Kensington Class</I><I></I><I>&nbsp;A Common Stock equals or exceeds
$18.00.</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Once the warrants become exercisable, Kensington may redeem the outstanding warrants (excluding the Private Warrants):
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in whole and not in part; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at a price of $0.01 per Kensington Warrant; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon a minimum of 30&nbsp;days&#146; prior written notice of redemption, which Kensington refers to as the <FONT
STYLE="white-space:nowrap">30-day</FONT> redemption period; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, and only if, the last reported sale price of Kensington Class&nbsp;A Common Stock equals or exceeds $18.00
per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a <FONT STYLE="white-space:nowrap">30-trading</FONT> day period ending on the third trading day prior to the
date on which Kensington sends the notice of redemption to the Kensington Warrant holders. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If and when the Kensington
Warrants become redeemable by Kensington, Kensington may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing conditions are satisfied and Kensington issues a notice of redemption, each Kensington Warrant holder may exercise his, her
or its Kensington Warrants prior to the scheduled redemption date. However, the price of the shares of Kensington Class&nbsp;A Common Stock may fall below the $18.00 trigger price (as adjusted) as well as the $11.50 exercise price (as adjusted)
after the redemption notice is issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If Kensington calls the Kensington Warrants for redemption as described above, Kensington&#146;s
management will have the option to require all holders that wish to exercise warrants to do so on a &#147;cashless basis.&#148; In making such determination, Kensington&#146;s management will consider, among other factors, Kensington&#146;s cash
position, the number of Kensington Warrants that are outstanding and the dilutive effect on Kensington&#146;s stockholders of issuing the maximum number of warrant shares issuable upon exercise of outstanding warrants. In such event, the holder
would pay the exercise price by surrendering the Kensington Warrants for that number of shares of Kensington Class&nbsp;A Common Stock equal to the quotient obtained by dividing (x)&nbsp;the product of the number of warrant shares underlying the
Kensington Warrants to be so exercised, and the difference between the exercise price of the Kensington Warrants and the fair market value by (y)&nbsp;the fair market value. The &#147;fair market value&#148; shall mean the average last reported sale
price of the Kensington Class&nbsp;A Common Stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">239 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
warrants. If Kensington&#146;s management takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of shares of Kensington
Class&nbsp;A Common Stock to be received upon exercise of the warrants, including the &#147;fair market value&#148; in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the
dilutive effect of a warrant redemption. Kensington believes this feature is an attractive option to Kensington if Kensington does not need the cash from the exercise of the warrants after the initial business combination. If Kensington calls the
Kensington Warrants for redemption and Kensington&#146;s management does not take advantage of this option, the Sponsor and its permitted transferees would still be entitled to exercise its Private Warrants for cash or on a cashless basis using the
same formula described above that other warrant holders would have been required to use had all warrant holders been required to exercise their Kensington Warrants on a cashless basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A holder of a Kensington Warrant may notify Kensington in writing in the event it elects to be subject to a requirement that such holder will
not have the right to exercise such Kensington Warrant, to the extent that after giving effect to such exercise, such person (together with such person&#146;s affiliates), to the warrant agent&#146;s actual knowledge, would beneficially own in
excess of 4.9% or 9.8% (or such other amount as a holder may specify) of the shares of common stock outstanding immediately after giving effect to such exercise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the number of outstanding shares of Kensington Class&nbsp;A Common Stock is increased by a stock dividend payable in shares of Kensington
Class&nbsp;A Common Stock, or by a <FONT STYLE="white-space:nowrap">split-up</FONT> of shares of Kensington Class&nbsp;A Common Stock or other similar event, then, on the effective date of such stock dividend,
<FONT STYLE="white-space:nowrap">split-up</FONT> or similar event, the number of shares of Kensington Class&nbsp;A Common Stock issuable on exercise of each Kensington Warrant will be increased in proportion to such increase in the outstanding
shares of Kensington Class&nbsp;A Common Stock. A rights offering to holders of Kensington Class&nbsp;A Common Stock entitling holders to purchase shares of Kensington Class&nbsp;A Common Stock at a price less than the fair market value will be
deemed a stock dividend of a number of shares of Kensington Class&nbsp;A Common Stock equal to the product of (i)&nbsp;the number of shares of Kensington Class&nbsp;A Common Stock actually sold in such rights offering (or issuable under any other
equity securities sold in such rights offering that are convertible into or exercisable for common stock) multiplied by (ii)&nbsp;one (1)&nbsp;minus the quotient of (x)&nbsp;the price per share of Kensington Class&nbsp;A Common Stock paid in such
rights offering divided by (y)&nbsp;the fair market value. For these purposes (i)&nbsp;if the rights offering is for securities convertible into or exercisable for Kensington Class&nbsp;A Common Stock, in determining the price payable for Kensington
Class&nbsp;A Common Stock, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii)&nbsp;fair market value means the volume weighted average price of
common stock as reported during the 10 trading day period ending on the trading day prior to the first date on which the shares of Kensington Class&nbsp;A Common Stock trade on the applicable exchange or in the applicable market, regular way,
without the right to receive such rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, if we, at any time while the Kensington Warrants are outstanding and unexpired,
pay a dividend or make a distribution in cash, securities or other assets to the holders of Kensington Class&nbsp;A Common Stock on account of such shares of Kensington Class&nbsp;A Common Stock (or other shares of Kensington&#146;s capital stock
into which the Kensington Warrants are convertible), other than (a)&nbsp;as described above, (b)&nbsp;certain ordinary cash dividends, (c)&nbsp;to satisfy the redemption rights of the holders of Kensington Class&nbsp;A Common Stock in connection
with a proposed initial business combination or the approval of any amendment to the provisions of the Existing Certificate of Incorporation relating to Kensington&#146;s <FONT STYLE="white-space:nowrap">pre-initial</FONT> business combination
activity and related stockholders&#146; rights, including the substance or timing of Kensington&#146;s obligation to redeem 100% of its Public Shares if Kensington does not complete the initial business combination within the required time period,
(d)&nbsp;as a result of the repurchase of shares of common stock by Kensington if the proposed initial business combination is presented to Kensington&#146;s stockholders for approval, or (e)&nbsp;in connection with the redemption of
Kensington&#146;s Public Shares upon Kensington&#146;s failure to complete the initial business combination, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash
and/or the fair market value of any securities or other assets paid on each share of common stock in respect of such event. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">240 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the number of outstanding shares of Kensington Class&nbsp;A Common Stock is decreased by
a consolidation, combination, reverse stock split or reclassification of shares of Kensington Class&nbsp;A Common Stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or
similar event, the number of shares of Kensington Class&nbsp;A Common Stock issuable on exercise of each Kensington Warrant will be decreased in proportion to such decrease in outstanding shares of common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever the number of shares of Kensington Class&nbsp;A Common Stock purchasable upon the exercise of the Kensington Warrant is adjusted, as
described above, the Kensington Warrant exercise price will be adjusted by multiplying the Kensington Warrant exercise price immediately prior to such adjustment by a fraction (x)&nbsp;the numerator of which will be the number of shares of
Kensington Class&nbsp;A Common Stock purchasable upon the exercise of the Kensington Warrant immediately prior to such adjustment, and (y)&nbsp;the denominator of which will be the number of shares of Kensington Class&nbsp;A Common Stock so
purchasable immediately thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case of any reclassification or reorganization of the outstanding shares of Kensington
Class&nbsp;A Common Stock (other than those described above or that solely affects the par value of such shares of common stock), or in the case of any merger or consolidation of Kensington with or into another corporation (other than a
consolidation or merger in which Kensington is the resulting or Surviving Corporation and that does not result in any reclassification or reorganization of Kensington&#146;s outstanding shares of Kensington Common Stock), or in the case of any sale
or conveyance to another corporation or entity of the assets or other property of Kensington as an entirety or substantially as an entirety in connection with which Kensington is dissolved, the holders of the warrants will thereafter have the right
to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the shares of Kensington Class&nbsp;A Common Stock immediately theretofore purchasable and receivable upon the exercise of the rights
represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer,
that the holder of the warrants would have received if such holder had exercised their warrants immediately prior to such event. However, if such holders were entitled to exercise a right of election as to the kind or amount of securities, cash or
other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets for which each Kensington Warrant will become exercisable will be deemed to be the weighted average of the kind and amount
received per share by such holders in such consolidation or merger that affirmatively make such election, and if a tender, exchange or redemption offer has been made to and accepted by such holders (other than a tender, exchange or redemption offer
made by Kensington in connection with redemption rights held by stockholders of Kensington as provided for in the Existing Certificate of Incorporation or as a result of the repurchase of shares of Kensington Class&nbsp;A Common Stock by Kensington
if a proposed initial business combination is presented to the stockholders of Kensington for approval) under circumstances in which, upon consummation of such tender or exchange offer, the maker thereof, together with members of any group (within
the meaning of <FONT STYLE="white-space:nowrap">Rule&nbsp;13d-5(b)(1)</FONT> under the Exchange Act) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of
<FONT STYLE="white-space:nowrap">Rule&nbsp;12b-2</FONT> under the Exchange Act) and any members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of
<FONT STYLE="white-space:nowrap">Rule&nbsp;13d-3</FONT> under the Exchange Act) more than 50% of the outstanding shares of Kensington Class&nbsp;A Common Stock, the holder of a warrant will be entitled to receive the highest amount of cash,
securities or other property to which such holder would actually have been entitled as a stockholder if such warrant holder had exercised the Kensington Warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of
the Kensington Class&nbsp;A Common Stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to
the adjustments provided for in the Kensington Warrant Agreement. Additionally, if less than 70% of the consideration receivable by the holders of Kensington Class&nbsp;A Common Stock in such a transaction is payable in the form of common stock in
the successor entity that is listed for trading on a national securities exchange or is quoted in an established <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, or is to be so listed for
trading or quoted immediately following such event, and if the registered holder of the warrant properly exercises the warrant within 30&nbsp;days following public disclosure of such transaction, the warrant exercise price
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">241 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
will be reduced as specified in the Kensington Warrant Agreement based on the Black-Scholes Value (as defined in the Kensington Warrant Agreement) of the Kensington Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Kensington Warrants are issued in registered form under the Kensington Warrant Agreement. The Kensington Warrant Agreement provides that
the terms of the Kensington Warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of at least 50% of the then outstanding Kensington Warrants to
make any change that adversely affects the interests of the registered holders of Public Warrants and, solely with respect to any amendment to the terms of the Private Warrants or working capital warrants or any provision of the Kensington Warrant
Agreement with respect to the Private Warrants or working capital warrants, 50% of the number of the then outstanding Private Warrants or working capital warrants, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Kensington Warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the
warrant agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless basis, if applicable), by certified or official bank check
payable to us, for the number of warrants being exercised. The Kensington Warrant holders do not have the rights or privileges of holders of Kensington Class&nbsp;A Common Stock or any voting rights until they exercise their warrants and receive
shares of Kensington Class&nbsp;A Common Stock. After the issuance of shares of Kensington Class&nbsp;A Common Stock upon exercise of the Kensington Warrants, each holder will be entitled to one vote for each share held of record on all matters to
be voted on by stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Redemption of Kensington Warrants when the price per share of Kensington Class&nbsp;A Common Stock equals or exceeds
$10.00. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Commencing ninety days after the Kensington Warrants become exercisable, Kensington may redeem the outstanding Kensington
Warrants: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in whole and not in part; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at $0.10 per Kensington Warrant upon a minimum of 30 days&#146; prior written notice of redemption provided that
holders will be able to exercise their Kensington Warrants prior to redemption and receive that number of shares of Kensington Class&nbsp;A Common Stock to be determined by reference to the table below, based on the redemption date and the
&#147;fair market value&#148; of the Kensington Class&nbsp;A Common Stock (as defined below) except as otherwise described below; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, and only if, the last reported sale price of the Kensington Class&nbsp;A Common Stock equals or exceeds
$10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which Kensington sends the notice of redemption to the Kensington Warrant holders;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, and only if, the Private Warrants are also concurrently called for redemption at the same price (equal to a
number of shares of Kensington Class&nbsp;A Common Stock) as the outstanding Kensington Warrants, as described above; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, and only if, there is an effective registration statement covering the issuance of the shares of Kensington
Class&nbsp;A Common Stock (or a security other than the Kensington Class&nbsp;A Common Stock into which the Kensington Class&nbsp;A common stock has been converted or exchanged for in the event Kensington is not the surviving company in the initial
business combination) issuable upon exercise of the Kensington Warrants and a current prospectus relating thereto available throughout the <FONT STYLE="white-space:nowrap">30-day</FONT> period after written notice of redemption is given.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The numbers in the table below represent the number of shares of Kensington Class&nbsp;A Common Stock that a Kensington
Warrant holder will receive upon exercise in connection with a redemption by Kensington pursuant </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">242 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to this redemption feature, based on the &#147;fair market value&#148; of the Kensington Class&nbsp;A Common Stock on the corresponding redemption date (assuming holders elect to exercise their
warrants and such Kensington Warrants are not redeemed for $0.10 per Kensington Warrant), determined based on the average of the last reported sales price for the 10 trading days ending on the third trading day prior to the date on which the notice
of redemption is sent to the holders of Kensington Warrants, and the number of months that the corresponding redemption date precedes the expiration date of the Kensington Warrants, each as set forth in the table below. The numbers in the table
below will not be adjusted when determining the number of such securities to issue upon exercise of the Kensington Warrants if Kensington is not the surviving entity following the initial business combination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Kensington Warrant Agreement, references above to Kensington Class&nbsp;A Common Stock shall include a security other than
Kensington Class&nbsp;A Common Stock into which the Kensington Class&nbsp;A Common Stock has been converted or exchanged for in the event Kensington is not the surviving company in the initial business combination. The numbers in the tables below
will not be adjusted solely as a result of Kensington not being the surviving entity following the initial business combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
stock prices set forth in the column headings of the table below will be adjusted as of any date on which the number of shares issuable upon exercise of a Kensington Warrant is adjusted as set forth in the first three paragraphs under the heading
&#147;<I> &#151;Anti-dilution Adjustments</I>&#148; below. The adjusted stock prices in the column headings will equal the stock prices immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the number of shares
deliverable upon exercise of a Kensington Warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon exercise of a Kensington Warrant as so adjusted. The number of shares in the table below
shall be adjusted in the same manner and at the same time as the number of shares issuable upon exercise of a Kensington Warrant. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Redemption Date (period to expiration
of<BR>warrants)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="34" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair Market Value of Kensington Class&nbsp;A Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B><FONT STYLE="FONT-FAMILY:SYMBOL">&#163;</FONT><B></B><B>$10.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$11.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$12.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$13.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$14.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$15.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$16.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$17.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B><FONT STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT><B></B><B>$18.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">57 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.277</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.294</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.324</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.337</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">54 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.347</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.357</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">51 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.287</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.346</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.357</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">48 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.283</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.301</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.317</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.332</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.344</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.356</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">45 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.235</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.279</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.298</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.315</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.343</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.356</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">42 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.294</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.312</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.328</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.342</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.355</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">39 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.269</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.309</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.354</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">36 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.213</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.305</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">33 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.205</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.232</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.301</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.337</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">30 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.297</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.316</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.351</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">27 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.214</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.332</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">24 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.173</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.329</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">21 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.279</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.326</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.347</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">18 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.211</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.271</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.298</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.345</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.164</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.197</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.317</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.342</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.181</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.216</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.282</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.312</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.09</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.162</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.199</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.305</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.362</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.065</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.219</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.296</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.362</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.065</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.197</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.286</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.326</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">0 months</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.281</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exact fair market value and redemption date may not be set forth in the table above, in which case, if the
fair market value is between two values in the table or the redemption date is between two redemption dates in the table, the number of shares of Kensington Class&nbsp;A Common Stock to be issued for each Kensington Warrant exercised will be
determined by a straight-line interpolation between the number of shares set forth for the higher and lower fair market values and the earlier and later redemption dates, as applicable, based on a 365 or
<FONT STYLE="white-space:nowrap">366-day</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">243 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
year, as applicable. For example, if the average last reported sale price of the Kensington Class&nbsp;A Common Stock for the 10 trading days ending on the third trading date prior to the date on
which the notice of redemption is sent to the holders of the warrants is $11 per share, and at such time there are 57 months until the expiration of the Kensington Warrants, holders may choose to, in connection with this redemption feature, exercise
their warrants for 0.277 shares of Kensington Class&nbsp;A Common Stock for each whole Kensington Warrant. For an example where the exact fair market value and redemption date are not as set forth in the table above, if the average last reported
sale price of the Kensington Class&nbsp;A Common Stock for the 10 trading days ending on the third trading date prior to the date on which the notice of redemption is sent to the holders of the Kensington Warrants is $13.50 per share, and at such
time there are 38 months until the expiration of the Kensington Warrants, holders may choose to, in connection with this redemption feature, exercise their warrants for 0.298 shares of Kensington Class&nbsp;A Common Stock for each whole Kensington
Warrant. In no event will the Kensington Warrants be exercisable in connection with this redemption feature for more than 0.365 shares of Kensington Class&nbsp;A Common Stock per Kensington Warrant. Finally, as reflected in the table above, if the
Kensington Warrants are out of the money and about to expire, they cannot be exercised on a cashless basis in connection with a redemption by Kensington pursuant to this redemption feature, since they will not be exercisable for any shares of
Kensington Class&nbsp;A Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This redemption feature differs from the typical warrant redemption features used in other blank
check companies, which typically only provide for a redemption of warrants for cash when the trading price for common stock exceeds $18.00 per share for a specified period of time. This redemption feature is structured to allow for all of the
outstanding Kensington Warrants to be redeemed when the Kensington Class&nbsp;A Common Stock is trading at or above $10.00 per share, which may be at a time when the trading price of the Kensington Class&nbsp;A Common Stock is below the exercise
price of the Kensington Warrants. Kensington has established this redemption feature to provide Kensington with the flexibility to redeem the Kensington Warrants without the Kensington Warrants having to reach the $18.00 per share threshold set
forth above under &#147;&#151;<I>Redemption of Kensington Warrants when the price per share of Kensington Class</I><I></I><I>&nbsp;A Common Stock equals or exceeds $18.00</I>.&#148; Holders choosing to exercise their Kensington Warrants in
connection with a redemption pursuant to this feature will, in effect, receive a number of shares representing the applicable redemption price for their Kensington Warrants based on an option pricing model with a fixed volatility input as of the
date of this prospectus. This redemption right provides Kensington with an additional mechanism by which to redeem all of the outstanding Kensington Warrants, and therefore have certainty as to Kensington&#146;s capital structure as the Kensington
Warrants would no longer be outstanding and would have been exercised or redeemed and Kensington will be required to pay the redemption price to Kensington Warrant holders if Kensington chooses to exercise this redemption right and it will allow
Kensington to quickly proceed with a redemption of the Kensington Warrants if Kensington determines it is in Kensington&#146;s best interest to do so. As such, Kensington would redeem the Kensington Warrants in this manner when Kensington believes
it is in Kensington&#146;s best interest to update its capital structure to remove the Kensington Warrants and pay the redemption price to the Kensington Warrants holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As stated above, Kensington can redeem the Kensington Warrants when the Kensington Class&nbsp;A Common Stock is trading at a price starting at
$10.00, which is below the exercise price of $11.50, because it will provide certainty with respect to Kensington&#146;s capital structure and cash position while providing warrant holders with the opportunity to exercise their Kensington Warrants
on a cashless basis for the applicable number of shares. If Kensington chooses to redeem the Kensington Warrants when the Kensington Class&nbsp;A Common Stock is trading at a price below the exercise price of the Kensington Warrants, this could
result in the Kensington Warrants holders receiving fewer shares of Kensington Class&nbsp;A Common Stock than they would have received if they had chosen to wait to exercise their Kensington Warrants for shares of Kensington Class&nbsp;A Common
Stock if and when such Kensington Class&nbsp;A Common Stock trades at a price higher than the exercise price of $11.50. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No fractional
shares of Kensington Class&nbsp;A Common Stock will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional interest in a share, Kensington will round down to the nearest whole number of the number of shares of
Kensington Class&nbsp;A Common Stock to be issued to the holder. If, at the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">244 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
time of redemption, the Kensington Warrants are exercisable for a security other than the shares of Kensington Class&nbsp;A Common Stock pursuant to the Kensington Warrant Agreement (for
instance, if Kensington is not the surviving company in the initial business combination), the Kensington Warrants may be exercised for such security. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Exercise Limitation. A holder of a Kensington Warrant may notify Kensington in writing in the event it elects to be subject to a requirement
that such holder will not have the right to exercise such Kensington Warrant, to the extent that after giving effect to such exercise, such person (together with such person&#146;s affiliates), to the warrant agent&#146;s actual knowledge, would
beneficially own in excess of 4.8% or 9.8% (or such other amount as a holder may specify) of the shares of Kensington Class&nbsp;A Common Stock outstanding immediately after giving effect to such exercise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Anti-Dilution Adjustments. If the number of outstanding shares of Kensington Class&nbsp;A Common Stock is increased by a stock dividend
payable in shares of Kensington Class&nbsp;A Common Stock, or by a <FONT STYLE="white-space:nowrap">split-up</FONT> of shares of Kensington Class&nbsp;A Common Stock or other similar event, then, on the effective date of such stock dividend, <FONT
STYLE="white-space:nowrap">split-up</FONT> or similar event, the number of shares of Kensington Class&nbsp;A Common Stock issuable on exercise of each Kensington Warrant will be increased in proportion to such increase in the outstanding shares of
Kensington Class&nbsp;A Common Stock. A rights offering to holders of Kensington Class&nbsp;A Common Stock entitling holders to purchase shares of Kensington Class&nbsp;A Common Stock at a price less than the fair market value will be deemed a stock
dividend of a number of shares of Kensington Class&nbsp;A Common Stock equal to the product of (i)&nbsp;the number of shares of Kensington Class&nbsp;A Common Stock actually sold in such rights offering (or issuable under any other equity securities
sold in such rights offering that are convertible into or exercisable for Kensington Class&nbsp;A Common Stock) multiplied by (ii)&nbsp;one (1) minus the quotient of (x)&nbsp;the price per share of Kensington Class&nbsp;A Common Stock paid in such
rights offering divided by (y)&nbsp;the fair market value. For these purposes (i)&nbsp;if the rights offering is for securities convertible into or exercisable for Kensington Class&nbsp;A Common Stock, in determining the price payable for Kensington
Class&nbsp;A Common Stock, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii)&nbsp;fair market value means the volume weighted average price of
Kensington Class&nbsp;A Common Stock as reported during the ten (10)&nbsp;trading day period ending on the trading day prior to the first date on which the shares of Kensington Class&nbsp;A Common Stock trade on the applicable exchange or in the
applicable market, regular way, without the right to receive such rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, if we, at any time while the Kensington Warrants
are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to the holders of Kensington Class&nbsp;A Common Stock on account of such shares of Kensington Class&nbsp;A Common Stock (or other shares of
Kensington&#146;s capital stock into which the Kensington Warrants are convertible), other than (a)&nbsp;as described above, (b)&nbsp;certain ordinary cash dividends, (c)&nbsp;to satisfy the redemption rights of the holders of Kensington
Class&nbsp;A Common Stock in connection with a proposed initial business combination, (d)&nbsp;to satisfy the redemption rights of the holders of Kensington Class&nbsp;A Common Stock in connection with a stockholder vote to amend the Existing
Certificate of Incorporation (i)&nbsp;to modify the substance or timing of Kensington&#146;s obligation to allow redemption in connection with the initial business combination or to redeem 100% of Kensington&#146;s Public Shares if Kensington has
not completed the initial business combination within 24 months from the closing of the IPO or (ii)&nbsp;with respect to any other provision relating to stockholders&#146; rights or <FONT STYLE="white-space:nowrap">pre-initial</FONT> business
combination activity, or (e)&nbsp;in connection with the redemption of Kensington&#146;s Public Shares upon Kensington&#146;s failure to complete the initial business combination, then the warrant exercise price will be decreased, effective
immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each share of Kensington Class&nbsp;A Common Stock in respect of such event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the number of outstanding shares of the Kensington Class&nbsp;A Common Stock is decreased by a consolidation, combination, reverse stock
split or reclassification of shares of Kensington Class&nbsp;A Common Stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of shares of
Kensington Class&nbsp;A Common Stock issuable on </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">245 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
exercise of each Kensington Warrant will be decreased in proportion to such decrease in outstanding shares of Kensington Class&nbsp;A Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever the number of shares of Kensington Class&nbsp;A Common Stock purchasable upon the exercise of the Kensington Warrants is adjusted, as
described above, the Kensington Warrant exercise price will be adjusted by multiplying the Kensington Warrant exercise price immediately prior to such adjustment by a fraction (x)&nbsp;the numerator of which will be the number of shares of
Kensington Class&nbsp;A Common Stock purchasable upon the exercise of the Kensington Warrants immediately prior to such adjustment, and (y)&nbsp;the denominator of which will be the number of shares of Kensington Class&nbsp;A Common Stock so
purchasable immediately thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case of any reclassification or reorganization of the outstanding shares of Kensington
Class&nbsp;A Common Stock (other than those described above or that solely affects the par value of such shares of Kensington Class&nbsp;A Common Stock), or in the case of any merger or consolidation of Kensington with or into another corporation
(other than a consolidation or merger in which Kensington is the resulting or surviving corporation and that does not result in any reclassification or reorganization of the outstanding shares of Kensington Class&nbsp;A Common Stock), or in the case
of any sale or conveyance to another corporation or entity of the assets or other property of Kensington as an entirety or substantially as an entirety in connection with which Kensington is dissolved, the holders of the Kensington Warrants will
thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Kensington Warrants and in lieu of the shares of the Kensington Class&nbsp;A Common Stock immediately theretofore purchasable and
receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a
dissolution following any such sale or transfer, that the holder of the Kensington Warrants would have received if such holder had exercised their Kensington Warrants immediately prior to such event. However, if the holders of the Kensington
Class&nbsp;A Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets for which
each warrant will become exercisable will be deemed to be the weighted average of the kind and amount received per share by such holders of Kensington Class&nbsp;A Common Stock in such consolidation or merger that affirmatively make such election,
and if a tender, exchange or redemption offer has been made to and accepted by such holders (other than a tender, exchange or redemption offer made by Kensington in connection with redemption rights held by Kensington&#146;s stockholders as provided
for in the Existing Certificate of Incorporation or as a result of the redemption of shares of Kensington Class&nbsp;A Common Stock by Kensington if a proposed initial business combination is presented to Kensington&#146;s stockholders for approval)
under circumstances in which, upon consummation of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-5(b)(1)</FONT> under the Exchange Act (or any
successor rule)) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> under the Exchange Act (or any successor rule)) and any members of
any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act (or any successor rule)) more than 50% of the outstanding shares of
Kensington Class&nbsp;A Common Stock, the holder of a Kensington Warrant will be entitled to receive the highest amount of cash, securities or other property to which such holder would actually have been entitled as a stockholder if such Kensington
Warrant holder had exercised the warrant prior to the expiration of such tender or exchange offer, accepted such offer and all of the Kensington Class&nbsp;A Common Stock held by such holder had been purchased pursuant to such tender or exchange
offer, subject to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in the Kensington Warrant Agreement. Additionally, if less than 70% of the
consideration receivable by the holders of Kensington Class&nbsp;A Common Stock in such a transaction is payable in the form of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an
established <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of the Kensington Warrant
properly exercises the Kensington Warrant within thirty days following public disclosure of such transaction, the Kensington Warrant exercise price will be reduced as specified in the Kensington Warrant Agreement based on the Black-Scholes value (as
defined in the Kensington Warrant Agreement) of the Kensington Warrant. The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">246 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Kensington Warrants will be issued in registered form under the Kensington Warrant Agreement. You should review a copy of the Kensington Warrant Agreement, which will be filed as an exhibit to
the registration statement of which this prospectus is a part, for a complete description of the terms and conditions applicable to the Kensington Warrants. The Kensington Warrant Agreement provides that the terms of the Kensington Warrants may be
amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of at least 50% of the then outstanding Kensington Warrants to make any change that adversely affects the
interests of the registered holders of Kensington Warrants and, solely with respect to any amendment to the terms of the Private Warrants or working capital warrants or any provision of the Kensington Warrant Agreement with respect to the Private
Warrants or working capital warrants, 50% of the number of the then outstanding Private Warrants or working capital warrants, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, if (x)&nbsp;Kensington issues additional shares or equity-linked securities for capital raising purposes in connection with the
closing of the initial business combination at a Newly Issued Price (as defined in the Kensington Warrant Agreement) of less than $9.20 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations,
recapitalizations and the like), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial business combination on the date of the
consummation of the initial business combination (net of redemptions), and the Market Value (as defined in the Kensington Warrant Agreement) is below $9.20 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions,
reorganizations, recapitalizations and the like), then the exercise price of each Kensington Warrant will be adjusted (to the nearest cent) such that the effective exercise price per full share will be equal to 115% of the higher of the Market Value
and the Newly Issued Price, and the $18.00 per share redemption trigger price described under &#147;<I> &#151;Redemption of warrants when the price per share of Kensington Class</I><I></I><I>&nbsp;A Common Stock equals or exceeds $18.00</I>&#148;
will be adjusted (to the nearest cent) to be equal to 180% of the higher of the market value and the newly issued price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Kensington
Warrant holders do not have the rights or privileges of holders of Kensington Class&nbsp;A Common Stock or any voting rights until they exercise their warrants and receive shares of Kensington Class&nbsp;A Common Stock. After the issuance of shares
of Kensington Class&nbsp;A Common Stock upon exercise of the Kensington Warrants, each holder will be entitled to one (1)&nbsp;vote for each share held of record on all matters to be voted on by stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No fractional shares will be issued upon exercise of the Kensington Warrants. If, upon exercise of the Kensington Warrants, a holder would be
entitled to receive a fractional interest in a share, Kensington will, upon exercise, round down to the nearest whole number of shares of Kensington Class&nbsp;A Common Stock to be issued to the Kensington Warrant holder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dividends </I></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&nbsp;25, 2020,
Kensington effected a stock dividend of 718,750 shares with respect to the Kensington Class&nbsp;B Common Stock, resulting in the Sponsor holding an aggregate of 5,750,000 Sponsor Shares. Kensington has not paid any cash dividends on Kensington
Common Stock to date and does not intend to pay cash dividends prior to the Closing. The payment of cash dividends in the future will be dependent upon Kensington&#146;s revenues and earnings, if any, capital requirements and general financial
condition subsequent to consummation of a business combination. The payment of any dividends subsequent to a business combination will be within the discretion of Kensington&#146;s then board of directors. It is the present intention of the
Kensington Board to retain all earnings, if any, for use in Kensington&#146;s business operations and, accordingly, the Kensington Board does not anticipate declaring any dividends in the foreseeable future. Further, if Kensington or New
QuantumScape incurs any indebtedness, the ability of Kensington or New QuantumScape, as applicable, to declare dividends may be limited by restrictive covenants that may be agreed to in connection therewith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">247 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Certain Anti-Takeover Provisions of Delaware Law </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Special Meetings of Stockholders</U>. The Existing Certificate of Incorporation provides that special meetings of the Kensington stockholders may be called
only by a majority vote of the Kensington Board, by Kensington&#146;s Chief Executive Officer or by Kensington&#146;s Chairman. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Advance Notice
Requirements for Stockholder Proposals and Director Nominations</U>. Kensington&#146;s current bylaws provide that stockholders seeking to bring business before Kensington&#146;s annual meeting of stockholders, or to nominate candidates for election
as directors at Kensington&#146;s annual meeting of stockholders, must provide timely notice of their intent in writing. To be timely under Kensington&#146;s current bylaws, a stockholder&#146;s notice will need to be received by the company
secretary at Kensington&#146;s principal executive offices not later than the close of business on the 90th&nbsp;day nor earlier than the open of business on the 120th&nbsp;day prior to the anniversary date of the immediately preceding annual
meeting of stockholders. Pursuant to <FONT STYLE="white-space:nowrap">Rule&nbsp;14a-8</FONT> of the Exchange Act, proposals seeking inclusion in Kensington&#146;s annual proxy statement must comply with the notice periods contained therein. The
Existing Certificate of Incorporation specifies certain requirements as to the form and content of a stockholders&#146; notice. These provisions may preclude Kensington&#146;s stockholders from bringing matters before Kensington&#146;s annual
meeting of stockholders or from making nominations for directors at Kensington&#146;s annual meeting of stockholders if the proper procedures are not followed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Authorized but Unissued Shares</U>. Kensington&#146;s authorized but unissued Kensington Common Stock and Kensington preferred stock are available for
future issuances without stockholder approval and could be utilized for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized but unissued and
unreserved Kensington Common Stock and Kensington preferred stock could render more difficult or discourage an attempt to obtain control of Kensington by means of a proxy contest, tender offer, merger or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Exclusive Forum Selection</U><I>. </I>The Existing Certificate of Incorporation requires, to the fullest extent permitted by law, that derivative actions
brought in Kensington&#146;s name, actions against directors, officers and employees for breach of fiduciary duty and other similar actions may be brought only in the Court of Chancery in the State of Delaware, except any action (i) as to which the
Court of Chancery in the State of Delaware determines that there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery
within ten days following such determination), (ii) which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery, (iii) for which the Court of Chancery does not have subject matter jurisdiction, or (iv) any
action arising under the Securities Act, as to which the Court of Chancery and the federal district court for the District of Delaware shall have concurrent jurisdiction. If an action is brought outside of Delaware, the stockholder bringing the suit
will be deemed to have consented to service of process on such stockholder&#146;s counsel. Although Kensington&#146;s directors believe this provision benefits Kensington by providing increased consistency in the application of Delaware law in the
types of lawsuits to which it applies, a court may determine that this provision is unenforceable, and to the extent it is enforceable, the provision may have the effect of discouraging lawsuits against Kensington&#146;s directors and officers,
although Kensington&#146;s stockholders cannot waive compliance with federal securities laws and the rules and regulations thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Existing
Certificate of Incorporation provides that the exclusive forum provision will be applicable to the fullest extent permitted by applicable law. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce
any duty or liability created by the Exchange Act or the rules and regulations thereunder. As a result, the exclusive forum provision will not apply to suits brought to enforce any duty or liability created by the Exchange Act or any other claim for
which the federal courts have exclusive jurisdiction. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Limitation on Liability and Indemnification of Directors and Officers </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Existing Certificate of Incorporation provides that Kensington&#146;s directors and officers will be indemnified by Kensington to the
fullest extent authorized by Delaware law as it now exists or may in the future </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">248 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be amended. In addition, the Existing Certificate of Incorporation provides that Kensington&#146;s directors will not be personally liable for monetary damages to Kensington for breaches of their
fiduciary duty as directors, unless they violated their duty of loyalty to Kensington or its stockholders, acted in bad faith, knowingly or intentionally violated the law, authorized unlawful payments of dividends, unlawful stock purchases or
unlawful redemptions, or derived an improper personal benefit from their actions as directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington&#146;s current bylaws also
permit Kensington to secure insurance on behalf of any officer, director or employee for any liability arising out of his or her actions, regardless of whether Delaware law would permit indemnification. Kensington may purchase a policy of
directors&#146; and officers&#146; liability insurance that insures Kensington&#146;s directors and officers against the cost of defense, settlement or payment of a judgment in some circumstances and insures Kensington against its obligations to
indemnify the directors and officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These provisions may discourage stockholders from bringing a lawsuit against Kensington&#146;s
directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action, if successful, might otherwise benefit Kensington
and its stockholders. Furthermore, a stockholder&#146;s investment may be adversely affected to the extent Kensington pays the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions.
Kensington believes that these provisions, the insurance and the indemnity agreements are necessary to attract and retain talented and experienced directors and officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to Kensington&#146;s directors, officers and
controlling persons pursuant to the foregoing provisions, or otherwise, Kensington has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">249 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_62"></A>SHARES ELIGIBLE FOR FUTURE SALE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the Closing, New QuantumScape will have 1,350,000,000 shares of NewQuantumScape Common Stock authorized and, based on the assumptions set
out elsewhere in this proxy statement/prospectus/information statement, up to 376,391,792 shares of New QuantumScape Common Stock outstanding, assuming no shares of Kensington Class&nbsp;A Common Stock are redeemed in connection with the Business
Combination. All of the shares of New QuantumScape Class&nbsp;A Common Stock issued in connection with the Business Combination will be freely transferable by persons other than by New QuantumScape&#146;s &#147;affiliates&#148; without restriction
or further registration under the Securities Act. Sales of substantial amounts of New QuantumScape Class&nbsp;A Common Stock in the public market could adversely affect prevailing market prices of the New QuantumScape Class&nbsp;A Common Stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights and Lock-Up Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;2, 2020, Kensington and the Holders have entered into a Registration Rights and
<FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement, to be effective at the Closing. Pursuant to the terms of the Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement, Kensington will be obligated to file&nbsp;a
registration statement to register the resale of certain securities of Kensington held by the Holders. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The securities held by the
Sponsor will be <FONT STYLE="white-space:nowrap">locked-up</FONT> for one year following the Closing, subject to earlier release if (i)&nbsp;the reported last sale price of New QuantumScape Class&nbsp;A Common Stock equals or exceeds $12.00 per
share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any <FONT STYLE="white-space:nowrap">30-trading</FONT> day period commencing at least 150&nbsp;days after the
Closing or (ii)&nbsp;if we consummate a liquidation, merger, stock exchange or other similar transaction after the Closing which results in all of stockholders having the right to exchange their shares of common stock for cash, securities or other
property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The securities held by the New Holders will be <FONT STYLE="white-space:nowrap">locked-up</FONT> for 180&nbsp;days after the
Closing subject to earlier release if (i)&nbsp;the reported last sale price of New QuantumScape Class&nbsp;A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the
like) for any 20 trading days within any <FONT STYLE="white-space:nowrap">30-trading</FONT> day period commencing at least 150&nbsp;days after the Closing or (ii)&nbsp;if we consummate a liquidation, merger, stock exchange or other similar
transaction after the Closing which results in all of stockholders having the right to exchange their shares of common stock for cash, securities or other property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information about the Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement, see the section entitled
&#147;<I>Certain Agreements Related to the Business Combination&#151;Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement</I>.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Senior Employee Lock-Up Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
September&nbsp;2, 2020, Kensington entered into separate Senior Employee Lock-Up Agreements with certain Senior Employees, including QuantumScape&#146;s executive officers.&nbsp;The Senior Employee Lock-Up Agreements provide that the Lock-Up Shares
owned of record or beneficially by the Senior Employees (including certain securities that may be granted or issued to a Senior Employee after the Effective Time) may generally not be transferred during the Initial Lock-Up Period and up to four
years after the Closing, subject to certain exceptions.&nbsp;Following the Initial Lock-Up Period, Senior Employees may transfer Lock-Up Shares without restriction as follows: (i)&nbsp;during the first year after the Effective Time, up to 25% of the
total number of Lock-Up Shares, (ii)&nbsp;following the first anniversary of the Effective Time until the earlier of four years after the Closing or the occurrence of an event described below, up to 50% of the total number of Lock-Up Shares (taking
into account any transfers under clause (i)&nbsp;above), and (iii)&nbsp;up to an additional 50% of the total number of Lock-Up Shares following satisfaction of agreed delivery requirements between QuantumScape and VGA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">250 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These transfer restrictions are subject to earlier release if (i)&nbsp;New QuantumScape
completes a liquidation, merger, stock exchange or other similar transaction after the Closing that results in all of New QuantumScape&#146;s stockholders having the right to exchange their shares of common stock for cash, securities or other
property; (ii)&nbsp;VGA terminates for any reason the Amended and Restated Joint Venture Agreement, dated as of May&nbsp;14, 2020, by and among QuantumScape and VGA; (iii)&nbsp;VGA issues a critical or negative statement regarding New QuantumScape
and its technology unless such statement is required to be made by VGA under applicable law and is truthful and accurate; or (iv)&nbsp;VGA transfers certain New QuantumScape securities in excess of the amounts set forth in the Senior Employee
Lock-Up Agreements.&nbsp;The Senior Employee Lock-Up Agreements also provide that, upon consummation of the Merger, Kensington or QuantumScape shall pay to each Senior Employee a one-time cash bonus equal to 20% of the Senior Employee&#146;s then
annual base salary </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule&nbsp;144 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A person who has beneficially owned restricted shares of Kensington Common Stock or restricted Kensington Warrants for at least six months
would be entitled to sell their securities provided that (i)&nbsp;such person is not deemed to have been one of our affiliates at the time of, or at any time during the three months preceding, a sale and (ii)&nbsp;we are subject to the Exchange Act
periodic reporting requirements for at least three months before the sale. Persons who have beneficially owned restricted shares of Kensington Common Stock or restricted Kensington Warrants for at least six months but who are our affiliates at the
time of, or any time during the three months preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three-month period a number of securities that does not exceed the greater of
either of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1% of the then outstanding equity shares of the same class which, immediately after the Business Combination,
will equal 29,765 shares of Kensington Common Stock and 1,815 Kensington Warrants; or </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the average weekly trading volume of Kensington Common Stock of the same class or Kensington Warrants, as
applicable, during the four calendar weeks preceding the date on which notice of the sale is filed with the SEC. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales
by affiliates of Kensington under Rule&nbsp;144 are also subject to certain requirements relating to manner of sale, notice and the availability of current public information about Kensington. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Restrictions on the Use of Rule&nbsp;144 by Shell Companies or Former Shell Companies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rule&nbsp;144 is not available for the resale of securities initially issued by shell companies (other than business combination related shell companies) or
issuers that have been at any time previously a shell company. However, Rule&nbsp;144 also includes an important exception to this prohibition if the following conditions are met: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuer of the securities that was formerly a shell company has ceased to be a shell company;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuer of the securities is subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange
Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable,
during the preceding 12&nbsp;months (or such shorter period that the issuer was required to file such reports and materials), other than <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> reports; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at least one year has elapsed from the time that the issuer filed current Form&nbsp;10 type information with the
SEC, which is expected to be filed promptly after Closing, reflecting its status as an entity that is not a shell company. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of
the date of this proxy statement/prospectus/information statement, there are 23,000,000 shares of Kensington Class&nbsp;A Common Stock outstanding and 5,750,000 shares of Kensington Class&nbsp;B Common Stock </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">251 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">outstanding. Of these shares, the 23,000,000 shares sold in the IPO are freely tradable without restriction
or further registration under the Securities Act, except for any shares purchased by one of our affiliates within the meaning of Rule&nbsp;144 under the Securities Act. All of the remaining 5,750,000 shares are owned by the Sponsor and are
restricted securities under Rule&nbsp;144, in that they were issued in private transactions not involving a public offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the date of this proxy
statement/prospectus/information statement, there are a total of 18,075,000 Kensington Warrants outstanding. Each warrant is exercisable for one share of Kensington Class&nbsp;A Common Stock, in accordance with the terms of the Kensington Warrant
Agreement. 11,500,000 of these Kensington Warrants are public warrants and are freely tradable, except for any warrants purchased by one of our affiliates within the meaning of Rule&nbsp;144 under the Securities Act. In addition, we will be
obligated to maintain an effective registration statement under the Securities Act covering the 11,500,000 shares of Kensington Class&nbsp;A Common Stock that may be issued upon the exercise of the public Kensington Warrants. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule&nbsp;701 </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, under
Rule&nbsp;701 of the Securities Act as currently in effect, each of QuantumScape&#146;s employees, consultants or advisors who purchases equity shares from Kensington in connection with a compensatory stock plan or other written agreement executed
prior to the Closing is eligible to resell those equity shares in reliance on Rule&nbsp;144, but without compliance with some of the restrictions, including the holding period, contained in Rule&nbsp;144. However, the Rule&nbsp;701 shares would
remain subject to <FONT STYLE="white-space:nowrap">lock-up</FONT> arrangements and would only become eligible for sale when the <FONT STYLE="white-space:nowrap">lock-up</FONT> period expires. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">252 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
    <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_63"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding (i)&nbsp;the actual beneficial ownership of Kensington Common Stock
as of September&nbsp;14, 2020 and (ii)&nbsp;the expected beneficial ownership of New QuantumScape Common Stock immediately following the Closing, assuming that no Public Shares are redeemed, and alternatively that all Public Shares are redeemed, by:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each person who is, or is expected to be, the beneficial owner of more than 5% of outstanding shares
of&nbsp;Kensington Common Stock or of New QuantumScape Common Stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our current executive officers and directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each person who will become an executive officer or director of New QuantumScape; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all executive officers and directors of Kensington as a group
<FONT STYLE="white-space:nowrap">pre-Business</FONT> Combination and all executive officers and directors of New QuantumScape. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a
security if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60&nbsp;days. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The beneficial ownership of shares of Kensington Common Stock <FONT STYLE="white-space:nowrap">pre-Business</FONT> Combination is based on
23,000,000 shares of Kensington Class&nbsp;A Common Stock and 5,750,000 shares of Kensington Class&nbsp;B Common Stock outstanding as of September&nbsp;14, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The expected beneficial ownership of shares of New QuantumScape Common Stock immediately following the Closing, assuming none of the Public
Shares is redeemed, is based on an aggregate of 376,391,792 shares of New QuantumScape Common Stock to be issued and outstanding immediately following the Closing, which assumes the following: (A)&nbsp;none of the investors set forth in the table
below has purchased or purchases shares of Kensington Common Stock <FONT STYLE="white-space:nowrap">(pre-Business</FONT> Combination) or New QuantumScape Common Stock (post-Business Combination), (B)&nbsp;50,000,000 shares of New QuantumScape
Class&nbsp;A Common Stock are issued to the PIPE investors, (C)&nbsp;140,130,613 shares of New QuantumScape Class&nbsp;A Common Stock are issued to the holders of QuantumScape Class&nbsp;A Common Stock and QuantumScape Class&nbsp;A Preferred Stock,
(D) 157,511,179 shares of New QuantumScape Class&nbsp;B Common Stock are issued to the holders of QuantumScape Class&nbsp;B Common Stock and QuantumScape Class&nbsp;B Preferred Stock, (E)&nbsp;QuantumScape does not issue any additional equity
securities prior to the Merger, other than the issuance of 14,684,843 shares of its Series F Preferred Stock pursuant to certain Series F Stock Purchase Agreements by and between QuantumScape and the investors thereto, which are subject to specified
closing conditions, including in some cases achievement of a specified technical milestone, and that no other event occurs that would change the Exchange Ratio from what it would have been as of the date of the Business Combination Agreement, and
(F)&nbsp;there are no future exercises of the Kensington Warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The expected beneficial ownership of shares of New QuantumScape Common
Stock immediately following the Closing, assuming the maximum of the Public Shares are redeemed, is based on an aggregate of 376,391,792 shares of New QuantumScape Common Stock to be issued and outstanding immediately following the Closing, which
assumes the following: (A)&nbsp;none of the investors set forth in the table below has purchased or purchases shares of Kensington Common Stock <FONT STYLE="white-space:nowrap">(pre-Business</FONT> Combination) or New QuantumScape Common Stock
(post-Business Combination), (B)&nbsp;50,000,000 shares of New QuantumScape Class&nbsp;A Common Stock are issued to the PIPE investors, (C)&nbsp;140,130,613 shares of New QuantumScape Class&nbsp;A Common Stock are issued to the holders of
QuantumScape Class&nbsp;A Common Stock and QuantumScape Class&nbsp;A Preferred Stock, (D) 157,511,179 shares of New QuantumScape Class&nbsp;B Common Stock are issued to the holders of QuantumScape Class&nbsp;B Common Stock and QuantumScape
Class&nbsp;B Preferred Stock, (E)&nbsp;QuantumScape does not issue any additional equity securities prior to the Merger, other than the issuance of 14,684,843 shares of its Series F Preferred Stock pursuant to certain Series F Stock Purchase
Agreements by and between QuantumScape </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">253 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and the investors thereto, which are subject to specified closing conditions, including in some cases achievement of a specified technical milestone, and that no other event occurs that would
change the Exchange Ratio from what it would have been as of the date of the Business Combination Agreement, and (F)&nbsp;there are no future exercises of the Kensington Warrants. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="22" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>After the Business Combination</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Before the Business<BR>Combination</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Assuming No Redemption</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Assuming Maximum Redemption</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of Beneficial Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>shares of<BR>Kensington<BR>Common<BR>Stock(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>shares of New<BR>QuantumScape<BR>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>% of<BR>Total<BR>Voting<BR>Power</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>shares of New<BR>QuantumScape<BR>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>% of<BR>Total<BR>Voting<BR>Power</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B><I>Five Percent Holders</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Volkswagen Group of America Investments, LLC(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,819,269</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,819,269</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Khosla Ventures III, LP(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,277,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,277,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Capricorn-Libra Investment Group, LLC(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,311,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,311,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR></TD>
<TD VALIGN="bottom" ALIGN="right">8.41<BR></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">KPCB Holdings, Inc., as nominee(5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,188,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,188,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Kensington Capital Sponsor LLC(6)(7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B><I>Directors and Executive Officers of Kensington</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Justin Mirro(6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Robert Remenar</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Simon Boag</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Daniel Huber</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Thomas LaSorda</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Anders Pettersson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Mitchell Quain</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Donald Runkle</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Matthew Simoncini</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>All Directors and Executive Officers of Kensington as a Group (9 Individuals)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B><I>Directors and Named Executive Officers of New QuantumScape After the Closing</I></B></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Jagdeep Singh(8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,780,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,780,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Howard Lukens(9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,641,303</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,641,303</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Michael McCarthy(10)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,664,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,664,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Prof. Fritz Prinz(11)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,422,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,422,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Frank Blome(12)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,819,269</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,819,269</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Brad Buss(13)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">303,023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">303,023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">John Doerr(14)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Prof. Dr.&nbsp;J&uuml;rgen Leohold(15)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">226,849</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">226,849</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Justin Mirro(6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">J.B. Straubel(16)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400,321</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400,321</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Dipender Saluja(17)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>All Directors and Executive Officers of New QuantumScape as a Group
(14&nbsp;Individuals)(18)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">162,167,190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">162,167,190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41.72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">254 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents beneficial ownership of less than 1%. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Interests shown consist solely of Sponsor Shares, classified as shares of Kensington Class&nbsp;B Common Stock.
Shares of Kensington Class&nbsp;B Common Stock are convertible into shares of Kensington Class&nbsp;A Common Stock on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis, subject to adjustment.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 67,921,684 shares of New QuantumScape Class&nbsp;A Common Stock and 17,897,585 shares of New
QuantumScape Class&nbsp;B Common Stock. The business address of Volkswagen Group of America Investments, LLC is 220 Ferdinand Porsche Dr.&nbsp;Herndon, VA 20171. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 4,808,245 shares of New QuantumScape Class&nbsp;A Common Stock and 30,468,856 shares of
New&nbsp;QuantumScape Class&nbsp;B Common Stock. The business address of Khosla Ventures III, LP is 2128 Sand Hill Road Menlo Park, CA 94025. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 1,060,584 shares of New QuantumScape Class&nbsp;A Common Stock held by Technology Impact Growth
Fund, LP, 3,484,773 shares of New QuantumScape Class&nbsp;A Common Stock held by TIGF Direct Strategies Fund LLC and 4,808,245 shares of New QuantumScape Class&nbsp;A Common Stock and 13,958,222&nbsp;shares of New QuantumScape Class&nbsp;B Common
stock held by Capricorn-Libra Investment Group, LLC. TIGF Partners, LLC is the general partner of Technology Impact Growth Fund, LP and the manager of TIGF Direct Strategies Fund LLC. TIGF Partners, LLC is wholly owned by Capricorn-Libra Investment
Group, LLC. The business address of Technology Impact Growth Fund, LP is 250 University Avenue Palo Alto, CA 94301. The business address of TIGF Direct Strategies Fund LLC is 250 University Avenue Palo Alto, CA 94301. The business address of
Capricorn-Libra Investment Group, LLC is 250&nbsp;University Avenue Palo Alto, CA 94301. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 1,923,298 shares of New QuantumScape Class&nbsp;A Common Stock and 18,265,377 shares of
New&nbsp;QuantumScape Class&nbsp;B Common Stock. The business address of KPCB Holdings, Inc., as nominee is 2750 Sand Hill Road, Menlo Park, CA 94025. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Sponsor is the record holder of such shares. Justin Mirro, Kensington&#146;s Chief Executive Officer and
Chairman is the managing member of the managing member of the Sponsor. Consequently, Mr.&nbsp;Mirro may be deemed the beneficial owner of the shares held by the Sponsor and to have voting and dispositive control over such securities. Mr.&nbsp;Mirro
disclaims beneficial ownership of any shares other than to the extent he may have a pecuniary interest therein, directly or indirectly. Each of Kensington&#146;s other officers and directors are <FONT STYLE="white-space:nowrap">non-managing</FONT>
members of the Sponsor. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The address of Kensington Capital Sponsor LLC is c/o Kensington Capital Acquisition Corp., 1400 Old Country
Road, Suite 301, Westbury, New York 11590. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (a)&nbsp;options to purchase 8,282,977 shares of New QuantumScape Class&nbsp;A Common Stock that
are exercisable within 60 days of September&nbsp;14, 2020, (b) 2,001,608 shares of New QuantumScape Class&nbsp;B Common Stock that are exercisable within 60 days of September&nbsp;14, 2020, (c) 1,334,404 shares of New&nbsp;QuantumScape Class&nbsp;B
Common Stock held by Mr.&nbsp;Singh, (d) 4,003,218 shares of New QuantumScape Class&nbsp;B Common Stock held in trust by Jagdeep Singh, Trustee of the Roshni Singh 2020 Annuity Trust A dated September&nbsp;1, 2020, (e) 4,003,218 shares of New
QuantumScape Class&nbsp;B Common Stock held in trust by Jagdeep Singh, Trustee of the Jagdeep Singh 2020 Annuity Trust A dated September&nbsp;1, 2020, (f) 961,649 shares of New QuantumScape Class&nbsp;A Common Stock and 5,515,853 shares of New
QuantumScape Class&nbsp;B Common Stock held in trust by Jagdeep Singh&nbsp;&amp; Roshni Singh, Trustees of the Singh Family Trust UDT dated October&nbsp;3, 1996, (g) 559,273 shares of New QuantumScape Class&nbsp;A Common Stock held in trust by
Tejbir Singh Phool, Trustee of the Kismet Diya Singh 2013 Trust dated July&nbsp;31, 2013, (h) 559,273 shares of New QuantumScape Class&nbsp;A Common Stock held in trust by Tejbir Singh Phool, Trustee of the Nageena Singh 2013 Trust dated
July&nbsp;31, 2013 and (i) 559,273 shares of New QuantumScape Class&nbsp;A Common Stock held in trust by Tejbir Singh Phool, Trustee of the Noor Deepika Singh 2013 Trust dated July&nbsp;31, 2013. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (a)&nbsp;options to purchase 1,146,496 shares of New QuantumScape Class&nbsp;A Common Stock that
are exercisable within 60 days of September&nbsp;14, 2020, (b) 2,734,196 shares of New QuantumScape Class&nbsp;B Common Stock that are exercisable within 60 days of September&nbsp;14, 2020 and (c) 760,611 shares of New QuantumScape Class&nbsp;B
Common Stock held by Mr.&nbsp;Lukens. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">255 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (a)&nbsp;options to purchase 1,847,056 shares of New QuantumScape Class&nbsp;A Common Stock that
are exercisable within 60 days of September&nbsp;14, 2020, (b) 1,000,804 shares of New QuantumScape Class&nbsp;B Common Stock that are exercisable within 60 days of September&nbsp;14, 2020 and (c) 816,656 shares of New QuantumScape Class&nbsp;B
Common Stock held by Mr.&nbsp;McCarthy. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (a) 8,351,666 shares of New QuantumScape Class&nbsp;B Common Stock held by Prof. Prinz,
(b)&nbsp;1,334,404 shares of New QuantumScape Class&nbsp;B Common Stock held in trust by Friedrich Prinz and Jagdeep Singh, Trustees of the Marie Helen Prinz 2019 Trust dated June&nbsp;17, 2019, (c) 1,334,404 shares of New QuantumScape Class&nbsp;B
Common Stock held in trust by Friedrich Prinz and Jagdeep Singh, Trustees of the Benedikt Prinz 2019 Trust dated June&nbsp;17, 2019, (d) 1,200,965 shares of New QuantumScape Class&nbsp;B Common Stock held in trust by Friedrich Prinz, Trustee of the
Gertrude Prinz Annuity Trust dated August&nbsp;31, 2020, and (e) 1,200,965 shares of New QuantumScape Class&nbsp;B Common Stock held in trust by Friedrich Prinz, Trustee of the Friedrich Prinz Annuity Trust dated August&nbsp;31, 2020.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 67,921,684 shares of New QuantumScape Class&nbsp;A Common Stock and 17,897,585 shares of New
QuantumScape Class&nbsp;B Common Stock held by Volkswagen. Mr.&nbsp;Blome, a member of our board of directors, is Head of Volkswagen&#146;s Battery Center of Excellence. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 303,023 shares of New QuantumScape Class&nbsp;A Common Stock held by Mr.&nbsp;Buss.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Doerr, a member of our board of directors, is the Chairman at Kleiner Perkins. Mr.&nbsp;Doerr
disclaims beneficial ownership of all shares held by KPCB Holdings, Inc., as nominee referred to in footnote (5)&nbsp;above. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of options to purchase 226,849 New QuantumScape Class&nbsp;A Common Stock that are exercisable within
60 days of September&nbsp;14, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(16)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 218,463 shares of New QuantumScape Class&nbsp;A Common Stock and 181,858 shares of New QuantumScape
Class&nbsp;B Common Stock held by Mr.&nbsp;Straubel. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(17)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Saluja, a member of our board of directors, is Managing Director of Capricorn-Libra Investment Group,
LLC. Mr.&nbsp;Saluja disclaims beneficial ownership of all shares held by Capricorn-Libra Investment Group, LLC referred to in footnote (4)&nbsp;above. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(18)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (a)&nbsp;options to purchase 17,290,765 shares of New QuantumScape Class&nbsp;A Common Stock that
are exercisable within 60 days of September&nbsp;14, 2020, (b) 6,549,259 shares of New QuantumScape Class&nbsp;B Common Stock that are exercisable within 60 days of September&nbsp;14, 2020, (c) 76,968,503 shares of New QuantumScape Class&nbsp;A
Common Stock and (d) 61,358,663 shares of New QuantumScape Class&nbsp;B Common Stock. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">256 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_64"></A>PRICE RANGE OF SECURITIES AND DIVIDENDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Price Range of Kensington Securities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
following table shows, for the periods indicated, the high and low sales prices per share of the Kensington Units, Kensington Class&nbsp;A Common Stock and Kensington Warrants as reported by the NYSE. Prior to June&nbsp;30, 2020, there was no
established public trading market for Kensington&#146;s securities. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Units</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Kensington&nbsp;Class&nbsp;A<BR>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Quarter Ended</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second quarter(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third quarter(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fourth quarter (through October&nbsp;22, 2020)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Reflects the high and low trade prices of Kensington Units on June&nbsp;30, 2020, the first day that the
Kensington Units began trading on the NYSE. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Reflects the high and low trade prices of Kensington Class&nbsp;A Common Stock and Kensington Warrants beginning
as of August&nbsp;17, 2020, the first day that the Kensington Class&nbsp;A Common Stock and the Kensington Warrants began trading on the NYSE. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>QuantumScape Securities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Historical
market price information regarding QuantumScape is not provided because there is no public market for QuantumScape Class&nbsp;A Common Stock, QuantumScape Class&nbsp;B Common Stock or QuantumScape Preferred Stock. See <I>&#147;QuantumScape
Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations.&#148;</I> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividends </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington has not paid any cash dividends on the Kensington Common Stock to date and does not intend to pay cash dividends prior to the
Closing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">257 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_65"></A>ADDITIONAL INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Submission of Future Stockholder Proposals </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Kensington Board is aware of no other matter that may be brought before the special meeting. Under Delaware law, only business that is
specified in the notice of special meeting to stockholders may be transacted at the special meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington does not expect to hold a
2020 annual meeting of stockholders because it will be a separate public company if the Business Combination is completed. However, if the Business Combination is not completed, Kensington stockholders will continue to be entitled to attend and
participate in meetings of stockholders. If the Business Combination is not completed or if Kensington is otherwise required to do so under applicable law, Kensington will take such action as it deems necessary or appropriate to call and convene
future meetings of Kensington stockholders, and stockholder proposals will be eligible for consideration for inclusion in the proxy statement and form of proxy for such future meetings of Kensington stockholders in accordance with Rule <FONT
STYLE="white-space:nowrap">14a-8</FONT> of the Exchange Act. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Legal Matters </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the shares of New QuantumScape Common Stock to be issued in connection with the Business Combination will be passed upon by
Hughes Hubbard&nbsp;&amp; Reed&nbsp;LLP. An affiliate of a partner at Hughes Hubbard&nbsp;&amp;&nbsp;Reed LLP owns equity interests in the Sponsor. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Experts </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial
statements of QuantumScape Corporation at December&nbsp;31, 2019 and 2018, and for each of the two years in the period ended December&nbsp;31, 2019, included in this proxy statement/prospectus/information statement, which is referred to and made a
part of this proxy statement/prospectus/information statement, have been audited by Ernst&nbsp;&amp; Young&nbsp;LLP, independent registered public accounting firm, as set forth in their report appearing elsewhere herein, and are included in reliance
upon such report given on the authority of such firm as experts in accounting and auditing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements of Kensington as of
May 1, 2020, and for the period from April&nbsp;17, 2020 (inception) through May&nbsp;1, 2020, appearing in this proxy statement/prospectus/information statement have been audited by Marcum LLP, an independent registered public accounting firm, as
stated in their report, which includes an explanatory paragraph as to Kensington&#146;s ability to continue as a going concern, thereon and included in this proxy statement/prospectus/information statement, in reliance upon such report and upon the
authority of such firm as experts in accounting and auditing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Delivery of Documents to Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the rules of the SEC, Kensington and servicers that it employs to deliver communications to its stockholders are permitted to
deliver to two or more stockholders sharing the same address a single copy of the proxy statement. Upon written or oral request, Kensington will deliver a separate copy of the proxy statement to any stockholder at a shared address to which a single
copy of the proxy statement was delivered and who wishes to receive separate copies in the future. Stockholders receiving multiple copies of the proxy statement may likewise request delivery of single copies of the proxy statement in the future.
Stockholders may notify Kensington of their requests by calling or writing Kensington at its principal executive offices at <FONT STYLE="white-space:nowrap">(703)&nbsp;674-6514</FONT> and 1400 Old Country Road, Suite 301, Westbury, NY&nbsp;11590.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">258 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent; Warrant Agent and Registrar </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registrar and transfer agent for the shares of common stock of Kensington and the warrant agent for Kensington Warrants is Continental
Stock Transfer&nbsp;&amp; Trust Company. Kensington has agreed to indemnify Continental Stock Transfer&nbsp;&amp; Trust Company in its roles as transfer agent and warrant agent against all liabilities, including judgments, costs and reasonable
counsel fees that may arise out of acts performed or omitted for its activities in that capacity, except for any liability due to any gross negligence, willful misconduct or bad faith of the indemnified person or entity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">259 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom14810_66"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington files reports, proxy statements, prospectuses and other information with the SEC as required by the Exchange Act. You can read
Kensington&#146;s SEC filings, including this proxy statement/prospectus/information statement, over the internet at the SEC&#146;s website at http://www.sec.gov. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you would like additional copies of this proxy statement/prospectus/information statement or if you have questions about the Business
Combination or the proposals to be presented at the special meeting, you should contact us by telephone or in writing: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Kensington Capital
Acquisition Corp. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1400 Old Country Road, Suite 301 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Westbury, NY 11590 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Telephone: <FONT
STYLE="white-space:nowrap">(703)&nbsp;674-6514</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Secretary </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may also obtain these documents by requesting them in writing or by telephone from our proxy solicitor at: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D.F. King&nbsp;&amp; Co., Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48
Wall Street, 22<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, NY 10005 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Call Toll-Free: (877) <FONT STYLE="white-space:nowrap">478-5045</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Banks and Brokers Call: (212) <FONT STYLE="white-space:nowrap">269-5550</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Email: KCAC@dfking.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you
are a stockholder of Kensington and would like to request documents, please do so by [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2020 to receive them before the
Kensington special meeting of stockholders. If you request any documents from us, we will mail them to you by first class mail, or another equally prompt means. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All information contained or incorporated by reference in this proxy statement/prospectus/information statement relating to Kensington has
been supplied by Kensington, and all such information relating to QuantumScape has been supplied by QuantumScape. Information provided by either Kensington or QuantumScape does not constitute any representation, estimate or projection of any other
party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither Kensington nor QuantumScape has authorized anyone to give any information or make any representation about the Business
Combination or their companies that is different from, or in addition to, that contained in this proxy statement/prospectus/information statement or in any of the materials that have been incorporated in this proxy statement/prospectus/information
statement. Therefore, if anyone does give you information of this sort, you should not rely on it. If you are in a jurisdiction where offers to exchange or sell, or solicitations of offers to exchange or purchase, the securities offered by this
proxy statement/prospectus/information statement or the solicitation of proxies is unlawful, or if you are a person to whom it is unlawful to direct these types of activities, then the offer presented in this proxy statement/prospectus/information
statement does not extend to you. The information contained in this proxy statement/prospectus/information statement speaks only as of the date of this proxy statement/prospectus/information statement unless the information specifically indicates
that another date applies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">260 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="index"></A><A NAME="rom14810_67"></A>INDEX TO FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>QUANTUMSCAPE FINANCIAL STATEMENTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>QuantumScape
Corporation Audited Financial Statements </B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audited Consolidated Financial Statements for the Years Ended December&nbsp;31, 2019 and
2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_6">Report of Independent Registered Public Accounting Firm</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-2</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_7">Consolidated Balance Sheets</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-3</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_8">Consolidated Statements of Operations and Comprehensive
Loss</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_9">Consolidated Statements of Redeemable Convertible Preferred Stock and Common
 Stockholders&#146; Deficit</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-5</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_10">Consolidated Statements of Cash Flows</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-6</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_11">Notes to Consolidated Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>QuantumScape Corporation Unaudited Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unaudited Condensed Consolidated Financial Statements as of June&nbsp;30, 2020 </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_1">Condensed Consolidated Balance Sheets as of June&nbsp;
30, 2020 (unaudited) and December&nbsp;31, 2019</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-30</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_2">Condensed Consolidated Statements of Operations and Comprehensive Loss for
the six months ended June&nbsp;30, 2020 and 2019 (unaudited)</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-31</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_3">Condensed Consolidated Statements of Redeemable Convertible Preferred Stock
 and Stockholders&#146; Deficit for the six months ended June&nbsp;30, 2020 and 2019 (unaudited)</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-32</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_4">Condensed Consolidated Statements of Cash Flows for the six months ended
 June&nbsp;30, 2020 and 2019 (unaudited)</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-33</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_5">Notes to the Condensed Consolidated Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-34</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>KENSINGTON FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Kensington Capital Acquisition Corp. Audited Financial Statements </B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_17a">Report of Independent Registered Public Accounting Firm </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_17">Balance Sheet as of May&nbsp;1, 2020</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-50</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_18">Statement of Operations for the period from April&nbsp;
17, 2020 (inception) through May&nbsp;1, 2020</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-51</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_19">Statement of Changes in Stockholders&#146; Equity for the period from April&nbsp;17,
2020 (inception) through May&nbsp;1, 2020</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-52</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_20">Statement of Cash Flows for the period from April&nbsp;
17, 2020 (inception) through May&nbsp;1, 2020</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-53</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_21">Notes to Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-54</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Kensington Capital Acquisition Corp. Unaudited Condensed Financial Statements </B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_12">Unaudited Condensed Balance Sheet as of June&nbsp;30,
2020</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-64</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_13">Unaudited Condensed Statement of Operations for the period from April&nbsp;17,
 2020 (inception) through June&nbsp;30, 2020</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-65</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_14">Unaudited Condensed Statement of Changes in Stockholders&#146; Equity for
the period from April&nbsp;17, 2020 (inception) through June&nbsp;30, 2020</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-66</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fintoc14810_15">Unaudited Condensed Statement of Cash Flows for the period from April&nbsp;17,
 2020 (inception) through June&nbsp;30, 2020</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-67</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><A HREF="#fintoc14810_16">Notes to Unaudited Condensed Financial Statements</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">F-68</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_6"></A>Report of Independent Registered Public Accounting Firm
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Stockholders and the Board of Directors of QuantumScape Corporation </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Opinion on the Financial Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have audited the
accompanying consolidated balance sheets of QuantumScape Corporation (the Company) as of December&nbsp;31, 2019 and 2018, the related consolidated statements of operations and comprehensive loss, redeemable convertible preferred stock and common
stockholders&#146; deficit and cash flows for each of the two years in the period ended December&nbsp;31, 2019, and the related notes (collectively referred to as the &#147;consolidated financial statements&#148;).<B><SUP
STYLE="font-size:85%; vertical-align:top"> </SUP></B>In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December&nbsp;31, 2019 and 2018, and the results of its
operations and its cash flows for each of the two years in the period ended December&nbsp;31, 2019, in conformity with U.S. generally accepted accounting principles. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis for Opinion </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These financial statements are the
responsibility of the Company&#146;s management. Our responsibility is to express an opinion on the Company&#146;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight
Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As
part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#146;s internal control over financial reporting.
Accordingly, we express no such opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our audits included performing procedures to assess the risks of material misstatement of the financial
statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also
included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Ernst&nbsp;&amp; Young LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have served as QuantumScape
Corporation&#146;s auditor since 2012. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Redwood City, California </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September 21, 2020 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_7"></A>QuantumScape Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consolidated Balance Sheets </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(In&nbsp;Thousands, Except Share and per Share Amounts) </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2019</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2018</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents ($3,409 and $3,368 as of December&nbsp;31, 2019 and 2018, respectively,
for joint venture)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,822</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">148,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">706</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">179,919</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> lease
asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,774</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,593</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">172,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">211,214</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Liabilities, redeemable convertible preferred stock and stockholders&#146; deficit</B></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">802</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liability, short-term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,080</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease financing obligation, short-term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Strategic premium, short-term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">873</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,087</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent expense, long-term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">316</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liability, long-term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,463</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease financing obligation, long-term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock warrant liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Strategic premium, long-term and other liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">436</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,982</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,294</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commitment and contingencies (see Note 7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redeemable convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redeemable convertible preferred stock, par value of $0.0001 per share, 49,073,189 and 49,073,189
shares authorized as of December&nbsp;31, 2019 and 2018, respectively, 48,390,851 and 48,390,851 shares issued and outstanding with aggregate liquidation preference of $414,335 and $414,335 as of December&nbsp;31, 2019 and 2018,
respectively</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">405,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">405,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock&#151;$0.0001 par value; 128,000,000 shares authorized (81,000,000 Class&nbsp;A and
47,000,000 Class&nbsp;B); 11,229,241 and 11,075,476 Class&nbsp;A and Class&nbsp;B shares issued and outstanding at December&nbsp;31, 2019 and 2018, respectively</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">paid-in-capital</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,957</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Treasury stock- fair market value at repurchase; 438,191 shares at December 31, 2019 and
2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,189</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,189</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive income (loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(31</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(295,862</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(246,083</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total QuantumScape stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(256,883</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214,345</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-controlling</FONT> interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,710</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(255,173</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(212,655</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities, redeemable convertible preferred stock and stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">172,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">211,214</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_8"></A>QuantumScape Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consolidated Statements of Operations and Comprehensive Loss </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(In&nbsp;Thousands, Except Share and per Share Amounts) </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">45,944</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">35,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,874</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,768</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55,818</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(45,453</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(94</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,520</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,608</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,555</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,309</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51,263</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,144</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Net income attributable to <FONT STYLE="white-space:nowrap">non-controlling</FONT> interest
, net of tax of $0 for the years ended December&nbsp;31, 2019 and 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(51,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(44,149</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(51,263</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(44,144</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income (loss):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized gain on marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51,142</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,055</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Comprehensive income attributable to <FONT STYLE="white-space:nowrap">non-controlling</FONT>
interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(51,162</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(44,060</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and Diluted net loss per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.58</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(3.97</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and Diluted weighted-average common shares outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,194,183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,108,638</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_9"></A>QuantumScape Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consolidated Statements of Redeemable Convertible Preferred Stock and Common Stockholders&#146; Deficit </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(In&nbsp;Thousands, Except Share and per Share Amounts) </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Redeemable</B><br><B>Convertible</B><br><B>Preferred Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Treasury Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR><FONT STYLE="white-space:nowrap">Paid-In</FONT></B><br><B>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Other</B><br><B>Comprehensive<BR>Loss</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>QuantumScape</B><br><B>Stockholders&#146;<BR>deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Non-<BR>Controlling</B><br><B>interest</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Stockholders&#146;</B><br><B>deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>42,890,851</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>282,822</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,077,614</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>28,991</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(201,934</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(120</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(173,062</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(173,062</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Proceeds from issuance of Series E convertible preferred stock for cash at $22.3437 per share in
September 2018, through December 2018, net of issuance cost of $137</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122,753</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Repurchase of common stock, reserved for future issuance</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(438,191</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">438,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,189</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,189</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,189</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Exercise of stock option</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">436,053</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Capital contribution from <FONT STYLE="white-space:nowrap">non-controlling</FONT> interest in joint
venture</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,685</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,685</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,149</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,149</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,144</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Unrealized gain on marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>48,390,851</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>405,575</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,075,476</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>438,191</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(4,189</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>35,957</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(246,083</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(31</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(214,345</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,690</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(212,655</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Exercise of stock option</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">153,765</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,726</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Adoption of ASC 842</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51,263</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Unrealized gain on marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>48,390,851</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>405,575</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,229,241</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>438,191</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(4,189</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>43,077</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(295,862</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>90 </B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(256,883</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,710</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(255,173</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_10"></A>QuantumScape Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consolidated Statements of Cash Flows </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(In&nbsp;Thousands, Except Share and per Share Amounts) </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(51,263</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(44,144</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net loss to net cash used in operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,577</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,681</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on property and equipment disposal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(90</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of discount on marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,964</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,334</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of strategic premium</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(873</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,455</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in fair value of convertible preferred stock warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(550</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(174</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable, accrued liabilities and accrued compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">319</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(808</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(951</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(41,731</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35,722</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,846</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,402</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from maturities of marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">239,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(196,353</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(190,042</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by (used in) investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,301</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(74,694</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of common stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of preferred stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capital contribution from <FONT STYLE="white-space:nowrap">non-controlling</FONT> interest in
joint venture</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,685</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repurchase of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,189</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayment of lease financing obligation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(578</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (decrease) increase in cash, cash equivalents and restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,036</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,341</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents and restricted cash at beginning of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,632</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents and restricted cash at end of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$<B></B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>25,596 </B></TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$<B></B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>33,632 </B></TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Supplemental disclosure of cash flow information</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">878</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-cash</FONT> investing and financing
activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of property and equipment, accrued but not paid</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">517</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following presents the Company&#146;s cash, cash equivalents and restricted cash by category in the Company&#146;s
Consolidated Balance Sheets: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;Year&nbsp;Ended&nbsp;December&nbsp;31&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,822</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,774</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total cash, cash equivalents and restricted cash</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>25,596</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>33,632</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_11"></A>QuantumScape Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">December&nbsp;31, 2019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Nature of Business
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Organization </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">QuantumScape Corporation (the
Company) was incorporated in&nbsp;Delaware in May&nbsp;2010. The Company is a leader in the development of next generation solid-state lithium-metal batteries for use in electric vehicles. The Company is headquartered in
San&nbsp;Jose,&nbsp;California. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is focused on the development and commercialization of its solid-state lithium-metal batteries. Planned
principal operations have not yet commenced. As of December&nbsp;31, 2019, the Company has not derived revenue from its principal business activities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Summary of Significant Accounting Policies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis
of Presentation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s consolidated financial statements have been prepared in conformity with accounting principles generally accepted in
the United States of America (GAAP) as determined by the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) and pursuant to the regulations of the U.S. Securities and Exchange Commission (SEC). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Use of Estimates </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of financial statements
in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of commitments and contingencies at the date of the financial statements as well as reported
amounts of expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to the valuation of common stock and valuation of convertible preferred stock warrants, among others. The Company
bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities
that are not readily apparent from other sources. Actual results could differ from those estimates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Principles of Consolidation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s policy is to consolidate all entities that it controls by ownership of a majority of the outstanding voting stock. In addition, the Company
consolidates entities that meet the definition of a variable interest entity (&#147;VIE&#148;) for which the Company is the related party most closely associated with and is the primary beneficiary. The primary beneficiary is the party who has the
power to direct the activities of a VIE that most significantly impact the entity&#146;s economic performance and who has an obligation to absorb losses of the entity or a right to receive benefits from the entity that could potentially be
significant to the entity. For consolidated entities that are less than wholly owned, the third party&#146;s holding of an equity interest is presented as Noncontrolling interests in the Company&#146;s Consolidated Balance Sheet and Consolidated
Statements of Redeemable Convertible Preferred Stock and Stockholders&#146; Deficit. The portion of net earnings attributable to the noncontrolling interests is presented as Net income (loss) attributable to noncontrolling interests in the
Company&#146;s Consolidated Statements of Operations and Comprehensive Loss. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company was a single-legal entity prior to becoming a partner with
Volkswagen in QSV Operations LLC (the &#147;JV entity&#148;). As noted in &#147;Joint Venture&#148; discussion, the Company determined the JV entity was a VIE for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
which it was required to consolidate the operations upon its formation in 2018. The Company continued to consolidate the operations of the JV entity in 2019 as the determination of the variable
interest entity has not changed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Joint Venture </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;18, 2018, the JV entity was incorporated as a limited liability company. Volkswagen Group of America, Inc. (&#147;VWGoA&#148;), Volkswagen Group
of America Investments, LLC (&#147;VGA&#148;) and QuantumScape executed a Joint Venture Agreement (&#147;JVA&#148;), effective September 2018, with the goal of jointly establishing a manufacturing facility in the United States to produce the pilot
line of the Company&#146;s product through the JV entity. Volkswagen is a related party stockholder (13.1% voting interest holder in the Company as of December&nbsp;31, 2019 and 2018 and as of the formation of the JV entity), and also participated
in the Company&#146;s Series E convertible preferred stock financing which closed concurrently with the effectiveness of the JV entity and the JVA. Upon the effectiveness of the JVA, each party contributed $1.7&nbsp;million in cash to capitalize the
JV entity in exchange for 50% equity interests. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The joint venture is considered a variable interest entity with a related party and therefore the
related party whose business is more closely related to the planned operations of the joint venture is required to consolidate the operations. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company determined its operations were most closely aligned with the operations of the joint venture and therefore has consolidated the results of the JV entity&#146;s operations in its consolidated balance sheet, statement of operations and
statement of stockholders&#146; equity. The JV entity has had minimal operations in 2019 and 2018. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Concentrations of Credit Risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to credit risk consist principally of cash and cash equivalents, of which $18.7&nbsp;million is held
in a US government Money Market fund and through a repurchase agreement, and marketable securities, of which $107.1&nbsp;million is invested in US government and agency securities. The Company seeks to mitigate its credit risk with respect to cash
and cash equivalents and marketable securities by making deposits with large, reputable financial institutions and investing in shorter-term instruments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash and Cash Equivalents and Restricted Cash </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management
considers all highly liquid investments with an insignificant interest rate risk and original maturities of three months or less to be cash equivalents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted cash, if the date of availability or disbursement is longer than one year and the balances are maintained under an agreement that legally restricts
the use of such funds, is not included within cash and cash equivalents and is reported within other assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted cash is comprised of
$2.8&nbsp;million, of which $2.0&nbsp;million is pledged as a form of security for the Company&#146;s facility lease agreement and $0.8&nbsp;million as collateral for two commercial letters of credits issued to an equipment supplier as of
December&nbsp;31, 2019. As of December&nbsp;31, 2018, restricted cash was $2.6&nbsp;million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Marketable Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s investment policy is consistent with the definition of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> securities. The Company does not buy and hold securities principally for the purpose of selling them in the near future. The Company&#146;s policy is
focused on the preservation of capital, liquidity, and return. From time to time, the Company may sell certain securities, but the objectives are generally not to generate profits on short-term differences in price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These debt securities are carried at estimated fair value with unrealized holding gains and losses included in other comprehensive loss in stockholders&#146;
deficit until realized. Gains and losses on marketable security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fair Value Measurement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company applies fair value accounting for all financial assets and liabilities measured on a recurring and nonrecurring basis. Fair value is defined as an
exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should
be determined based on assumptions that market participants would use in pricing an asset or a liability. The accounting guidance established a fair value hierarchy based on three levels of inputs, of which the first two are considered observable
and the last unobservable, used to determine the fair value of its financial instruments. A financial instrument&#146;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value
measurement. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level&nbsp;1&nbsp;&#150; Quoted prices in active markets for identical assets or liabilities that the entity has
the ability to access. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level&nbsp;2&nbsp;&#150; Inputs other than Level&nbsp;1 that are observable, either directly or indirectly, such
as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets and liabilities.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level&nbsp;3&nbsp;&#150; Unobservable inputs that are supported by little or no market activity and that are
significant to the fair value of the assets and liabilities. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019 and 2018, the carrying values of cash and
cash equivalents, accounts payable and accrued liabilities approximate their respective fair values due to their short-term nature. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Property and
Equipment </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the
estimated useful life of the related asset. The estimated useful lives of assets are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computers and hardware</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3 years</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture and fixtures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7 years</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lab equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5 years</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Building and improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">25 years</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shorter of the lease term (including estimated renewals) or the estimated useful lives of the
improvements</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Maintenance and repairs are charged to expense as incurred, and improvements are capitalized. When assets are retired or
otherwise disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in the accompanying statements of operations and comprehensive loss in the period realized. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intangible Assets </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Licensed technology intangible assets
are amortized over the estimated economic life following the pattern in which the economic benefits of the license are utilized. The licensed technology assets acquired during the previous years were determined to have a useful life of five years
and have been amortized using a straight-line method to operating expenses. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Impairment of Long-Lived Assets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company evaluates the carrying value of long-lived assets when indicators of impairment exist. The carrying value of a long-lived asset is considered
impaired when the estimated separately identifiable, undiscounted cash </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
flows from such an asset are less than the carrying value of the asset. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the
long-lived asset. Fair value is determined primarily using the estimated cash flows discounted at a rate commensurate with the risk involved. No impairment charges have been recorded in any of the periods presented. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Leases </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective January&nbsp;1, 2019, the Company
accounts for its leases under ASC 842, Leases. Under this guidance, lessees classify arrangements meeting the definition of a lease as operating or financing leases, and leases are recorded on the consolidated balance sheet as both a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease or the Company&#146;s incremental
borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the right of use asset is amortized over the lease term. For operating leases, interest on the lease liability and the amortization of the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset result in straight-line rent expense over the lease term. For finance leases, interest on the lease liability and the amortization of the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset results in front-loaded expense over the lease term. Variable lease expenses, including common maintenance fees, insurance and property tax, are recorded
when incurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In calculating the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset and lease liability,
the Company elects to combine lease and <FONT STYLE="white-space:nowrap">non-lease</FONT> components for all classes of assets. The Company excludes short-term leases having initial terms of 12 months or less as an accounting policy election, and
instead recognizes rent expense on a straight-line basis over the lease term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to the adoption of ASC 842, Leases, the Company accounted for leases
in accordance with ASC 840, Leases, as more fully described in Note 6. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Convertible Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company records shares of convertible preferred stock at their respective fair values on the dates of issuance, net of issuance costs. The Company has
applied the guidance in ASC <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">480-10-S99-3A,</FONT></FONT></FONT> <I>SEC Staff Announcement: Classification and Measurement of Redeemable Securities</I>
and has therefore classified all of its outstanding convertible preferred stock as temporary equity. The convertible preferred stock is recorded outside of stockholders&#146; deficit because, in the event of certain deemed liquidation events
considered not solely within the Company&#146;s control, such as a merger, acquisition and sale of all or substantially all of the Company&#146;s assets, the convertible preferred stock will become redeemable at the option of the holders. In the
event of a change of control of the Company, proceeds received from the sale of such shares will be distributed in accordance with the liquidation preferences set forth in the Company&#146;s Amended and Restated Certificate of Incorporation. The
Company has determined not to adjust the carrying values of the convertible preferred stock to the liquidation preferences of such shares because of the uncertainty of whether or when such an event would occur. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Free-Standing Convertible Preferred Stock Warrants Liability </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Free-standing warrants issued by the Company for the purchase of shares of its convertible preferred stock are classified as liabilities on the accompanying
balance sheets at fair value using an <FONT STYLE="white-space:nowrap">Option-Pricing</FONT> Model (OPM). The initial liability recorded is adjusted for changes in the fair value at each reporting date and recorded as interest expense in the
accompanying statements of operations and comprehensive loss. The Company will continue to adjust the convertible preferred stock warrant liability for changes in fair value until the earlier of the exercise of the warrants, at which time the
liability will be reclassified to equity, or the expiration of the warrants, at which time the entire amount would be reversed and reflected in the accompanying statements of&nbsp;operations and comprehensive loss. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Segments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief
Operating Decision Maker (&#147;CODM&#148;) in deciding how to allocate resources to an individual segment and in assessing performance. The Company&#146;s CODM is its Chief Executive Officer. The Company has determined that it operates in one
operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Research and Development Cost </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Costs related to research
and development are expensed as incurred. The Company records payments received (if any) for research and development effort as contra research and development. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Battery Cell Development and Evaluation Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
October 2015, the Company entered into<B> </B>a development and evaluation agreement with VWGoA. Pursuant to the agreement, the parties agree to conclude the phase of the previous collaboration and to continue their collaboration on the development
of a new project of mutual interest. The Company was eligible to receive up to $0.5&nbsp;million, payable with the achievement of milestones. These payments were intended to offset some of the Company&#146;s incremental cost associated with the
battery cell development project for items such as personnel and materials. In exchange, the Company will have some restriction and limitation in providing product developed under the Project to companies other than VWGoA or its affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In September 2018, the Company, VWGoA and VGA entered into a JVA as more fully described below. For the mutual promises contained in the JVA, the parties
amended the Battery Cell Development and Evaluation Agreement by replacing some provisions in the original agreement including among other items the deletion of the $0.5&nbsp;million fee payment provision. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stock-Based Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company measures and
recognizes compensation expense for all stock-based awards made to employees, directors, and <FONT STYLE="white-space:nowrap">non-employees</FONT> (beginning in the year ended December&nbsp;31, 2019), including stock options and restricted shares,
based on estimated fair values recognized over the requisite service period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of options granted is estimated on the grant date using the
Black-Scholes option valuation model. This valuation model for stock-based compensation expense requires the Company to make assumptions and judgments about the variables used in the calculation, including the expected term (weighted-average period
of time that the options granted are expected to be outstanding), the volatility of the Company&#146;s common stock, and an assumed risk-free interest rate. The Company accounts for forfeitures when they occur. The Company uses the simplified
calculation of the expected life, which takes into consideration the grant&#146;s contractual life and vesting period and assumes that all options will be exercised between the vesting date and the contractual term of the option. No awards have been
issued with a market condition or other <FONT STYLE="white-space:nowrap">non-standard</FONT> terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to January&nbsp;1, 2019, stock-based awards
granted to <FONT STYLE="white-space:nowrap">non-employees</FONT> were subject to periodic <FONT STYLE="white-space:nowrap">re-measurement</FONT> over the period that services are rendered. Beginning January&nbsp;1, 2019 upon the adoption of
Accounting Standards Update (&#147;ASU&#148;) <FONT STYLE="white-space:nowrap">2018-07</FONT><I>. Compensation &#150; Stock Compensation (Topic 718): Improvements to Nonemployee</I> <I>Share-Based Payment Accounting</I> as described in Note 3, the
measurement of equity-classified nonemployee awards is fixed at the grant date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no public market for the Company&#146;s stock. The estimate for
volatility is based on an average of the historical volatilities of the common stock of several entities with characteristics similar to those of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company. Since these comparable companies operate in the same industry segment, the Company expects that it would share similar characteristics, such as risks profiles, volatility, capital
intensity, clientele, and market growth patterns and drivers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant
for periods corresponding with the expected life of the option. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Income Taxes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for income taxes under an asset and liability approach. Deferred income taxes reflect the net tax effects of temporary differences between
the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and operating loss carryforwards, measured by applying currently enacted tax laws. Valuation allowances are provided when
necessary to reduce net deferred tax assets to an amount that is more likely than not to be realized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recognizes tax liabilities based upon
its estimate of whether, and the extent to which, additional taxes will be due when such estimates are more likely than not to be sustained. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being
sustained. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Comprehensive Income or Loss </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company&#146;s comprehensive income or loss consists of net income or loss and other comprehensive loss. Unrealized gains or losses on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> investments are
included in the Company&#146;s other comprehensive income or loss. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Net Loss per Share of Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Basic and diluted net loss per share attributable to common stockholders is presented in conformity with the <FONT STYLE="white-space:nowrap">two-class</FONT>
method required for participating securities. The Company considers all series of its redeemable convertible preferred stock to be participating securities. Net loss is attributed to common stockholders and participating securities based on their
participation rights. Net loss attributable to common stockholders is not allocated to the redeemable convertible preferred stock as the holders of the redeemable convertible preferred stock do not have a contractual obligation to share in any
losses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the
weighted-average number of shares of common stock outstanding during the period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Diluted earnings per share attributable to common stockholders adjusts
basic earnings per share for the potentially dilutive impact of redeemable convertible preferred stock, stock options and warrants. As the Company has reported losses for all periods presented, all potentially dilutive securities including
redeemable convertible preferred stock, stock options and warrants, are antidilutive and accordingly, basic net loss per share equals diluted net loss per share. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Recent Accounting Pronouncements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2014, the
FASB issued ASU <FONT STYLE="white-space:nowrap">2014-09&cedil;</FONT><I>Revenue from Contracts with Customers (Topic 606)</I>, a new standard to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue
model to be applied by reporting companies under U.S. GAAP. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to
be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The new
standard was effective for the Company for the fiscal year ended December&nbsp;31, 2019. There was no impact to its consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In February 2016, the FASB issued ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-02,</FONT> <I>Leases
(Topic 842 or ASC 842)</I>, which supersedes the guidance in former ASC 840, <I>Leases</I>. The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not
the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also
required to record a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term
of 12 months or less will be accounted for similar to existing guidance for operating leases. The Company early adopted the standard as of January&nbsp;1, 2019, using the modified retrospective transition approach by recognizing a cumulative effect
adjustment to the opening balance of retained earnings as of January&nbsp;1, 2019. The Company availed itself of&nbsp;the practical expedients provided under ASC 842&nbsp;regarding identification of leases, lease classification, indirect costs, and
the combination of lease and <FONT STYLE="white-space:nowrap">non-lease</FONT> components for all classes of assets. The Company continues to account for leases in the prior period financial statements under ASC 840. The following table summarizes
the cumulative effect of adopting ASC 842 as of January&nbsp;1, 2019: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Consolidated Balance Sheet</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As reported<BR>December&nbsp;31,&nbsp;2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>ASC 842<BR>adjustments</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;adjusted<BR>January&nbsp;1,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,611</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,091</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> lease
asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Liabilities, temporary equity and stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,402</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(77</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liability, short-term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">951</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">951</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease financing obligation, <FONT STYLE="white-space:nowrap">short-term</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(669</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent expense, long-term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">316</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(316</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liability, long-term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease financing obligation, <FONT STYLE="white-space:nowrap">long-term</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,361</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(246,083</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(244,664</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The adoption of Topic 842 included the evaluation of existing leases, including the Company&#146;s headquarters building which
was previously accounting for as a financing lease (see further discussion in Note 6). The headquarters lease was accounted for as a financing lease due to the Company&#146;s involvement in the construction for the building improvements and it did
not meet the sales-leaseback criteria for de-recognition of the building assets and liabilities under Topic 840. As the construction was complete prior to the adoption of Topic 842 and all other operating lease criteria were met at the date of
adoption, the headquarters lease was classified as an operating lease. On January&nbsp;1, 2019, the Company <FONT STYLE="white-space:nowrap">de-recognized</FONT> the existing building improvements (deemed owner) of $9.6&nbsp;million included within
property, plant and equipment, net, and the related lease financing obligations of $11.0&nbsp;million. This change resulted in a $1.4&nbsp;million net decrease to accumulated deficit. In addition, on January&nbsp;1, 2019, the Company recognized a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset of $14.1&nbsp;million, net of deferred rent of $0.4&nbsp;million, and operating lease liabilities of $14.5&nbsp;million. The Company determined that the
lease term would include the renewal extension option, as it is reasonably certain that it would exercise the option, and included the estimated lease payments for the extension period in the calculation of the right of use asset and the related
operating lease liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2018, the FASB issued ASU <FONT STYLE="white-space:nowrap">2018-07,</FONT><I>&nbsp;Compensation&#151;Stock
Compensation (Topic 718):</I><I></I><I>&nbsp;Improvements to Nonemployee Share-Based Payment Accounting</I>&nbsp;which simplifies the accounting for share-based payment awards issued to nonemployees for goods and services, including fixing the
estimated fair value of the stock </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
award at the date of grant. ASU <FONT STYLE="white-space:nowrap">2018-07</FONT> expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from <FONT
STYLE="white-space:nowrap">non-employees.</FONT> Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. The adoption of ASU <FONT STYLE="white-space:nowrap">2018-07</FONT> requires a
modified retrospective transition approach, with a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The Company early adopted this guidance as of January&nbsp;1, 2019 with an immaterial impact
upon adoption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2016, the FASB issued ASU <FONT STYLE="white-space:nowrap">2016-13,</FONT> <I>Financial Instruments- Credit Losses (Topic 326):
Measurement of Credit Losses on Financial Instruments</I>. This guidance introduces a new model for recognizing credit losses on financial instruments based on an estimate of current expected credit losses. ASU
<FONT STYLE="white-space:nowrap">2016-13</FONT> also provides updated guidance regarding the impairment of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> debt securities and includes additional
disclosure requirements. The Company plans to early adopt this guidance as of January&nbsp;1, 2020 with no financial statement impact upon adoption expected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In November 2018, the FASB issued ASU <FONT STYLE="white-space:nowrap">2018-18,</FONT> <I>Collaborative Arrangement (Topic 808):</I> <I>clarifying the
Interaction between Topic 808 and Topic 606</I>, which clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under ASC Topic 606 when the counterparty is a customer. In addition, Topic 808
precludes an entity from presenting consideration from a transaction in a collaborative arrangement as revenue from contracts with customers if the counterparty is not a customer for that transaction. This guidance will be effective beginning
January&nbsp;1, 2020. The Company currently has no transactions which fall under this guidance upon adoption and therefore there is no financial statement impact upon adoption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2019, the FASB issued ASU <FONT STYLE="white-space:nowrap">2019-12,</FONT> <I>Income Taxes (Topic 740): Simplifying the Accounting for Income
Taxes</I>, which is intended to simplify various aspects related to accounting for income taxes. ASU <FONT STYLE="white-space:nowrap">2019-12</FONT> removes certain exceptions to the general principles in ASC 740 and also clarifies and amends
existing guidance to improve consistent application. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December&nbsp;15, 2020, with early adoption permitted. The Company is currently
evaluating the impact of this standard on its consolidated financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2020, the FASB issued ASU
<FONT STYLE="white-space:nowrap">2020-06,</FONT><I>&nbsp;Debt&#151;Debt with Conversion and Other Options (Subtopic <FONT STYLE="white-space:nowrap">470-20)</FONT> and Derivatives and Hedging&#151;Contracts in Entity&#146;s Own Equity (Subtopic <FONT
STYLE="white-space:nowrap">815-40):</FONT> Accounting for Convertible Instruments and Contracts in an Entity&#146;s Own Equity</I>, which simplifies accounting for convertible instruments by removing major separation models required under current
GAAP. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas.&nbsp;The ASU is effective
for fiscal years beginning after December&nbsp;15, 2023, including interim periods within those fiscal years.&nbsp;Early adoption is permitted, but no earlier than fiscal years beginning after December&nbsp;15, 2021 and adoption must be as of the
beginning of the Company&#146;s annual fiscal year.&nbsp;The Company is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Fair Value Measurement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Marketable Securities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes, by
major security type, the Company&#146;s assets that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. Amortized cost net of unrealized gain is equal to fair value as of December&nbsp;31, 2019. The
fair value as of December&nbsp;31, 2019 and 2018, are as follows (amounts in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amortized&nbsp;Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized&nbsp;Gain</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;1 securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money market fund</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;2 securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repurchase agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">US government securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Level&nbsp;2 securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,599</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">125,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">125,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31, 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amortized&nbsp;Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized&nbsp;Loss</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;1 securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money market fund</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;2 securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repurchase agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">US government securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">148,192</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(31</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">148,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Level&nbsp;2 securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">162,192</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(31</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">162,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">175,451</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(31</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">175,420</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any realized gains and losses and interest income are included in interest income. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, the Company did not have any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT>
securities in an unrealized loss position. The estimated amortized cost and fair value of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> securities by contractual maturity as of December&nbsp;31,
2019, are as follows (amount in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="22" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Less than 12 months</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>12 months or greater</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amortized&nbsp;Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amortized&nbsp;Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amortized&nbsp;Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money market fund</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repurchase agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">US government securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">125,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">125,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">125,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">125,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2011 through
2013, in connection with an equipment and loan security agreement with TriplePoint Capital, the Company issued warrants to purchase 124,586 shares of Series A convertible preferred stock at $2.20131 per share (&#147;the TPC1 warrants&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The TPC1 warrants expire at the later of 7 years from effective date or five years after an initial public
offering or acquisition. The Company recorded the fair value of the warrants upon issuance as debt issuance cost and amortized the amount over the term of the agreement to interest expense in the statement of operations and comprehensive loss. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In January 2015, the Company entered into another equipment loan and security agreement with TriplePoint Capital. In connection with the borrowing of funds
per the agreement, the Company issued warrants to purchase 129,718 shares of Series C convertible preferred stock at $10.40717 per share (&#147;TPC2 warrants&#148;). The TPC2 warrants expire at the later of 2022 or five years after an initial public
offering or acquisition. The Company recorded the fair value of the warrants upon issuance as debt issuance cost and amortized the amount over the term of the agreement to interest expense in the statement of operations and comprehensive loss. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As the underlying convertible preferred shares of the outstanding TPC warrants are redeemable outside the control of the Company, the fair value of the TPC
warrants are reported on the Company&#146;s balance sheets as a long-term liability as of December&nbsp;31, 2019 and 2018, in the amount noted in the table below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company <FONT STYLE="white-space:nowrap">re-measured</FONT> the fair value of the outstanding TPC1 and TPC2 warrants at December&nbsp;31, 2019 with the
difference recorded in interest expense. The TPC1 warrants were <FONT STYLE="white-space:nowrap">re-measured</FONT> at December&nbsp;31, 2019, using the OPM with the following assumptions: option term of 5 years, volatility of 58.5%, risk-free
interest rate of 1.69% and no expected dividends. The TPC2 warrants were <FONT STYLE="white-space:nowrap">re-measured</FONT> at December&nbsp;31, 2019, using the OPM with the following assumptions: option term of 5 years, volatility of 45.0%,
risk-free interest rate of 1.69% and no expected dividends. The 5-year term was derived based on the Company&#146;s estimation of the timing of the exercise of the warrants. The Company applied a 35% discount for lack of marketability to the OPM
values. Significant changes in the option term and volatility would result in a significantly higher or lower fair value measurement, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The TPC1 and TPC2 warrants are classified as Level&nbsp;3 in the fair value hierarchy. The following table (amount in thousands) presents the reconciliation
of the Company&#146;s liabilities measured and recorded at fair value on a recurring basis using the significant observable inputs outlined above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TPC1&nbsp;Warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TPC2&nbsp;Warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Liability</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at January&nbsp;1, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">609</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Re-measurement</FONT> loss included in interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">782</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Re-measurement</FONT> loss included in interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,036</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>824</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,860</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Property and Equipment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Property and equipment at December&nbsp;31, 2019 and 2018, consisted of the following (amounts in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computers and hardware</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">598</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">505</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture and fixtures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,730</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lab equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,919</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Building and improvements (deemed owner)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,964</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,817</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Construction-in-progress</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,739</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51,887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,305</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,395</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,603</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment,&nbsp;net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28,702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depreciation and amortization expense related to property and equipment was $5.6&nbsp;million and $5.7&nbsp;million for the
years ended December&nbsp;31, 2019 and 2018, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The terms of the Company&#146;s lease agreement for its headquarters site required the
Company&#146;s involvement in the construction funding of the building improvements, therefore the Company is the &#147;deemed owner&#148; (for accounting purposes only) of this building prior to the Company&#146;s adoption of ASC 842,
<I>Leases</I>. Accordingly, it recorded an asset of $12.0&nbsp;million, representing the total costs of the building and improvements, including the costs paid by the lessor (the legal owner of the building), with corresponding liabilities in 2013
upon commencement of the lease. Upon the Company&#146;s adoption of ASC 842, <I>Leases,</I> the Company derecognized the net building assets of $9.6&nbsp;million, as discussed in see Note 3. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Leases </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company currently leases its headquarters
under a single lease classified as an operating lease expiring in January 2023. Fixed rent escalates each year and the Company is responsible for a portion of the landlord&#146;s operating expenses such as property tax, insurance and common area
maintenance. Under the lease, the Company has one <FONT STYLE="white-space:nowrap">60-month</FONT> renewal option, which has been included in the calculation of lease liabilities and right of use assets at the adoption date as the exercise of the
option was reasonably certain. As the renewal rent has not been negotiated, the Company uses an estimated rent rate which approximates the fair market rent at adoption for the extension period. This lease does not have any contingent rent payments
and does not contain residual value guarantees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the adoption of ASC 842, <I>Leases, </I>on January&nbsp;1, 2019 (as discussed in Note 3 and further
below) the headquarters building lease was reclassified from a financing lease to an operating lease. The Company does not have any other leases classified as financing leases during the years ended December&nbsp;31, 2019 and 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At December&nbsp;31, 2019, the Company had operating lease liabilities of $13.5&nbsp;million and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets of $12.9&nbsp;million. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The components of lease related expense are as follows (amounts in
thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="20%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease cost</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Variable lease cost</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,568</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The components of supplemental cash flow information related to leases are as follows (amounts in
thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="18%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating cash flows&#151;operating leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,936</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT>
assets obtained in exchange for operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="22%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average remaining lease term&#151;operating leases (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average discount rate&#151;operating leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, future minimum payments during the next five years and thereafter are as follows (amounts in
thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Operating<BR>Leases</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Year Ended December&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,994</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Year Ended December&nbsp;31, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,053</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Year Ended December&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Year Ended December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,301</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Year Ended December&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,318</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,927</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less present value discount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,384</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s lease agreement does not provide an implicit rate, so the Company used an estimated incremental borrowing
rate, which was derived from third-party information available at the time the Company adopted ASC 842, <I>Leases,</I> in determining the present value of&nbsp;lease<I></I>&nbsp;payments. The rate used is for
a&nbsp;secured<I></I>&nbsp;borrowing<I></I>&nbsp;of a similar term as the<I></I>&nbsp;lease<I>.</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to the Company&#146;s adoption of ASC 842,
<I>Leases, </I>the terms of the Company&#146;s lease agreement at the singing of the agreement required the Company&#146;s involvement in the construction funding of the building improvements, the Company was the &#147;deemed owner&#148; (for
accounting purposes only) of this building. Upon completion of construction of the building improvements in 2014, the Company did not meet the sales-leaseback criteria for <FONT STYLE="white-space:nowrap">de-recognition</FONT> of the building assets
and liabilities. Therefore, the lease was accounted for as a financing obligation of $12.0&nbsp;million with a corresponding asset for the same amount. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The future minimum payments under the financing obligation at December&nbsp;31, 2018 are as follows (amount
in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Land<BR>Rental</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Financing<BR>Obligations</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Payments</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Year Ended December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">437</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,936</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Year Ended December&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,994</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Year Ended December&nbsp;31, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">463</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,053</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Year Ended December&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">477</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,638</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Year Ended December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total minimum payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,377</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,235</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less amount representing interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,004</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,004</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Present value of lease financing obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,373</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sublease </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2017,
the Company entered into an agreement to sublet approximately 15,000 square feet of the Company&#146;s leased space for the sublease term of 3 years. In March 2018, the sublease agreement was amended to add approximately another 11,000 square feet
to the sublease. The Company received $0.9&nbsp;million and $0.7&nbsp;million for the years ended December&nbsp;31, 2019 and 2018 in sublease income and the amounts have been recorded in other income (expense). The sublease was terminated at the end
of 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Commitments and Contingencies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company is currently not aware of any investigations, claims, or lawsuits that it believes could have a material adverse effect on the financial position or on the results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Redeemable Convertible Preferred Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company&#146;s certificate of incorporation, as amended and restated as of September&nbsp;7, 2018 authorizes the issuance of 49,073,189 shares of $0.0001 par value convertible preferred stock. The following table summarizes the convertible preferred
stock outstanding as of December&nbsp;31, 2019, and the rights and preferences of the respective series: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Issued</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series&nbsp;A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,600,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,192,245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series&nbsp;B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,381,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,080,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,076,037</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series&nbsp;C</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,510,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,258,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,983,189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,983,189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series E</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,073,189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,390,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2016, the Board of Directors and stockholders approved the issuance of additional 2,983,189 shares of Series&nbsp;D
convertible preferred stock at a price of $20.1127 per share and 2,485,990 shares were sold for net proceeds of&nbsp;$49.7&nbsp;million to two new strategic investors. In March 2017, the Company sold 497,199 shares of Series D convertible preferred
stock to an existing strategic investor for net proceeds of $10.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company determined that Series D convertible preferred stock share
purchase agreements with the two new investors executed in 2016 contained strategic terms. Both companies had strategic interests in the Company&#146;s </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
technology and negotiated specific strategic terms expected to benefit these new investors, over and above the value that would be expected to be realized from the equity investment itself. Thus,
the sale of the Series D convertible preferred stock to these two investors reflected a higher price (&#147;strategic premium&#148;) than what a market participant who did not receive these strategic benefits would be willing to pay. The Company
allocated the net proceeds of $49.7&nbsp;million from these two investors between the Series D convertible preferred stock and the strategic premium. Based on the Company&#146;s valuation of the Series D convertible preferred stock, the Company
calculated the strategic premium to be approximately $6.2&nbsp;million which it recorded as a deferred liability on the balance sheet. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The sales of
Series D convertible preferred stock in March 2017 to an existing investor was also determined to have included strategic terms as the investor is expected to benefit over and above the value to be realized from the equity investment itself. The
Company allocated approximately $1.7&nbsp;million of the proceeds as a strategic premium and recorded it as a deferred liability on the balance sheet. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The strategic premium is considered akin to payment for research and development efforts as the strategic premium will be used to pay for incremental costs
associated with the Company&#146;s battery cell development. The Company has an accounting policy to record research and development effort payments as contra research and development. Therefore, the Company records the benefits (amortization of the
strategic premium) over the estimated period of the development agreements with the investors which was originally estimated to be three years at March 2016 and two years at March 2017. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In Q1 of 2018, the Company <FONT STYLE="white-space:nowrap">re-assessed</FONT> the estimated period of the development agreements as part of its annual
forecast process and determined that the period shall be extended for one more year. The updated period of the development agreements was utilized to amortize the remaining strategic premium during 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In Q1 of 2019, the Company <FONT STYLE="white-space:nowrap">re-assessed</FONT> the estimated period of the development agreements as part of its annual
forecast process and determined that the period shall be extended for one more year. The updated period of the development agreement will be utilized to amortize the remaining strategic premium. For the year ended December&nbsp;31, 2019 and
December&nbsp;31, 2018, the Company recorded amortization of $0.9&nbsp;million and $1.5&nbsp;million, respectively, as a reduction to research and development expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In Q1 of 2020, the Company <FONT STYLE="white-space:nowrap">re-assessed</FONT> the estimated period of the development agreements as part of its annual
forecast process and determined that the period shall be extended for 6 months. The updated period of the development agreement will be utilized to amortize the remaining strategic premium. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In September 2018, the Board of Directors and stockholders approved the issuance of 5,500,000 shares of Series E convertible preferred stock at a price of
$22.3437 per share. The Company sold the Series E convertible stock to VGA and four other investors between September and December 2018 for gross proceeds of $122.9&nbsp;million of which VGA represented $100.0&nbsp;million of the sale. The Company
determined that the price VGA and other investors paid for Series E convertible preferred stock was at fair market value and that there was no strategic premium or discount in the transaction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dividends </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of shares of Series&nbsp;A, Series
B, Series <FONT STYLE="white-space:nowrap">B-1,</FONT> Series C, Series D and Series E convertible preferred stock are entitled to receive <FONT STYLE="white-space:nowrap">non-cumulative</FONT> dividends, out of any assets legally available for such
purpose, prior and in preference to any declaration or payment of any dividend on the common stock, when, as, and if, declared by the Board of Directors in the amount equal to at least $0.1761408, $0.402, $0.4965296, $0.8325736, $1.6090 and $1.787
per share, respectively on each outstanding share of preferred stock. No distributions shall be made with respect to the common stock unless declared dividends on the preferred stock have been paid or set aside. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Conversion </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each share of Series&nbsp;A, Series B, and Series <FONT STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock is convertible, at the option of the
holder thereof, at any time after the date of issuance of such share, into such number of fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares of Class&nbsp;B common stock as is determined by dividing the applicable original
issue price by the conversion price applicable to such share in effect on the date of conversion (Series A at $2.20131 as of December&nbsp;31, 2019 and 2018; Series B at $5.01900 as of December&nbsp;31, 2019 and 2018; and Series <FONT
STYLE="white-space:nowrap">B-1</FONT> at $6.20662 as of December&nbsp;31, 2019 and 2018). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each share of Series&nbsp;C, Series D and Series E convertible
preferred stock is convertible, at the option of the holder thereof, at any time after the date of issuance of such share, into such number of fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares of Class&nbsp;A common stock
as is determined by dividing the applicable original issue price by the conversion price applicable to such share in effect on the date of conversion (Series C at $10.40717 as of December&nbsp;31, 2019 and 2018 , Series D at $20.1127 as of
December&nbsp;31 2019 and 2018, and Series E at $22.3437 as of December&nbsp;31, 2019 and 2018). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The conversion price of each series of preferred stock
may be subject to adjustment from time to time under certain circumstances. The preferred stock issued to date was sold at a price of $2.20131, $5.01900, $6.20662, $10.40717, $20.1127 and $22.3437 per share for Series A, Series B, Series <FONT
STYLE="white-space:nowrap">B-1,</FONT> Series C , Series D and Series E convertible preferred stock, respectively, which exceeded the fair value of the common stock. Accordingly, there was no intrinsic value associated with the issuance of the
preferred stock through December&nbsp;31, 2019, and there were no other separate instruments issued with the preferred stock that required further evaluation of a beneficial conversion option. Each share of convertible preferred stock shall
automatically be converted into fully paid, <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares of common stock immediately upon the earlier of: (i)&nbsp;the sale by the Company of its common stock in a firm commitment, underwritten public
offering pursuant to a registration statement under the Securities Act of 1933, as amended (the Securities Act), the public offering price of which results in the aggregate cash proceeds to the Company of not less than $50.0&nbsp;million (net of
underwriting discounts and commissions); or (ii)&nbsp;upon the receipt by the Company of a written request for such conversion from the holders of a majority of the preferred stock then outstanding. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Liquidation Preferences </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event the Company
liquidates, dissolves, or winds up its business, either voluntarily or involuntarily, the holders of its Series&nbsp;A, Series B, Series <FONT STYLE="white-space:nowrap">B-1,</FONT> Series C, Series D and Series E convertible preferred stock shall
be entitled to receive, prior and in preference to any distribution of any of its assets to the holders of common stock, $2.20131, $5.019, $6.20662, $10.40717, $20.1127 and $22.3437 per share, respectively, plus any declared but unpaid dividends. If
the assets are insufficient to distribute this liquidation preference, then the entire assets of the Company shall be distributed on a pro rata basis to the convertible preferred stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If there are any remaining assets upon the completion of the liquidating distribution to the Series&nbsp;A, Series B, Series
<FONT STYLE="white-space:nowrap">B-1,</FONT> Series C, Series D and Series E convertible preferred stockholders, the holders of the Company&#146;s common stock will receive all of its remaining assets on a pro rata basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The merger or consolidation of the Company into another entity in which the Company&#146;s stockholders own less than 50% of the voting stock of the surviving
company, or the sale, transfer, or lease of substantially all the Company&#146;s assets, shall be deemed a liquidation, dissolution, or winding up of the Company. However, the treatment of a liquidation, dissolution, or winding up may be waived by
consent or vote of a majority of the outstanding preferred stockholders (voting as one class on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis). The underlying Series&nbsp;A, Series B, Series
<FONT STYLE="white-space:nowrap">B-1,</FONT> Series C, Series D and Series E convertible preferred shares are considered redeemable outside of the Company&#146;s control (i.e.,&nbsp;the Series&nbsp;A, Series B, Series
<FONT STYLE="white-space:nowrap">B-1,</FONT> and Series C convertible stockholders control a majority of the Board of Directors, and a majority vote of Series&nbsp;A convertible stockholders can cause a liquidation). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Voting Rights </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each holder of convertible preferred stock Series A, Series B, and Series <FONT STYLE="white-space:nowrap">B-1</FONT> will convert into Class&nbsp;B common
stock. Each holder of Series C, Series D and Series E convertible preferred stock will convert into Class&nbsp;A common stock. Each holder of Class&nbsp;B common stock shall be entitled to ten (10)&nbsp;votes per share of Class&nbsp;B common stock
held by such holder as of the applicable record date. Each holder of Class&nbsp;A common stock shall be entitled to one (1)&nbsp;vote for each share of Class&nbsp;A common stock held by such holder as of the applicable record date. Except as
otherwise expressly provided or by applicable law, the holders of Class&nbsp;A common stock and the holders of Class&nbsp;B common stock shall at all times vote together as one class on all matters submitted to a vote or for the written consent of
the stockholders of the corporation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Stockholders&#146; Equity </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s certificate of
incorporation authorizes the issuance of two classes of common stock, which are designated &#147;Class&nbsp;A common stock,&#148; and &#147;Class&nbsp;B common stock.&#148; The Company is authorized to issue 81,000,000 shares of Class&nbsp;A common
stock, and 47,000,000 shares of Class&nbsp;B common stock, each with a par value of $0.0001 per share. Holders of the common stock are entitled to dividends when, as, and if, declared by the Company&#146;s Board of Directors, subject to the rights
of the holders of all classes of stock outstanding having priority rights to dividends. As of December&nbsp;31, 2019, the Company had not declared any dividends. The holder of each share of Class&nbsp;A common stock is entitled to one&nbsp;vote, and
the holder of each share of Class&nbsp;B common stock is entitled to ten votes. All common stock outstanding as of December&nbsp;31, 2019 consists of 10,651,152 Class&nbsp;B common stock and 578,089 Class&nbsp;A common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Repurchase of Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&nbsp;13, 2018,
the Board of Directors approved a Common Stock Repurchase Program to recognize the progress the Company has made and to provide liquidity to employees. Through this one time and a limited period offer, eligible employees were able to sell, at the
employee&#146;s election up to 15% of their vested options as of September&nbsp;30, 2018, limited to 15,000 shares per employee, at $16.76 per share. The program was for 448,997 shares in aggregate with a maximum aggregate purchase price of
$7.5&nbsp;million. At the end of the offering period in December 2018, 438,191 shares were repurchased for an aggregate repurchase amount of $7.2&nbsp;million in cash. As the repurchase price was greater than the fair value of the common stock at
the date of the repurchase, the Company recorded $3.0&nbsp;million in incremental compensation expense in the statement of operations ($2.5&nbsp;million in research and development expense and $0.5&nbsp;million in general and administrative
expense). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Eligible employees were able to participate in the Common Stock Repurchase Program by selling existing shares, exercising stock option with
cash payment for the cost of option exercise or cashless exercising stock options with the cost of the option exercise deducted from the repurchase payment. The 438,191 repurchased shares consisted of 199,839 shares of Class&nbsp;A common stock
shares and 238,352 shares of Class&nbsp;B common stock. Shares of Class&nbsp;B common stock were converted into shares of Class&nbsp;A common stock and together with the shares of Class&nbsp;A common stock were reserved as treasury shares for future
issuance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2010 Equity Incentive Plan </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the
Company&#146;s 2010 Equity Incentive Plan (the Plan), the Company may grant options to purchase or directly issue shares of common stock to employees, directors, and <FONT STYLE="white-space:nowrap">non-employees.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Options may be granted at a price per share not less than 100% of the fair market value at the date of grant. If the option is granted to a 10% stockholder,
then the purchase or exercise price per share shall not be less than 110% of the fair market value per share of the common stock on the grant date. Options granted generally vest over a period of four years and have
<FONT STYLE="white-space:nowrap">ten-year</FONT> contractual terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock option activity under the Plan is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>of&nbsp;Shares&nbsp;Available<BR>for Issuance</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted<BR>Average<BR>Exercise&nbsp;Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;Average<BR>Remaining<BR>Contractual Term<BR>(Years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at January&nbsp;1, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,294,107</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,616,386</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7.26</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted <SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(350,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cancelled and forfeited&nbsp;<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">418,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(418,667</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(436,053</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,361,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,112,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6.44</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase of option pool</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted <SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,972,750</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,972,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cancelled and forfeited&nbsp;<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">142,143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(142,143</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(153,765</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,031,367</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,789,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6.32</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested and exercisable&#151;December 31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,376,316</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All option grants approved after July 2013 are from the Class&nbsp;A option pool. Class&nbsp;B cancellation and
forfeitures are converted from Class&nbsp;B to Class&nbsp;A upon return to the option pool. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There were 153,765 options exercised during
the year ended December&nbsp;31, 2019 at the aggregate intrinsic value of $1.1&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Options with a fair value of $6.8&nbsp;million and
$8.2&nbsp;million vested in 2019 and 2018, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional information regarding options outstanding at December&nbsp;31, 2019, is as follows:
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Exercise Price per Share</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Options<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;Average<BR>Remaining<BR>Contractual Life<BR>(Years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">$0.44</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">418,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;0.52</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">792,775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;1.84</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">362,880</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;2.59</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,678,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;4.22</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">730,162</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;4.24</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,258,691</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;5.28</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,138,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;5.33</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,110,238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;5.41</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;9.56</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,254,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,789,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense is based on the grant-date fair value. The Company recognizes compensation
expense for all stock-based awards on a straight-line basis over the requisite service period of the awards, which is generally the option vesting term of four years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following weighted average assumptions were used as inputs to the Black-Scholes OPM in determining the estimated grant-date fair value of the
Company&#146;s stock options to employees: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average fair value at grant date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5.78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total employee stock-based compensation expense recognized in the accompanying statements of operations and comprehensive loss
for stock options totaled $6.6&nbsp;million and $5.7&nbsp;million for the years ended December&nbsp;31, 2019 and 2018, respectively. Total <FONT STYLE="white-space:nowrap">non-employee</FONT> stock-based compensation expense includes
$0.2&nbsp;million and $0.2&nbsp;million for the years ended December&nbsp;31, 2019 and 2018, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, the Company had
employee and <FONT STYLE="white-space:nowrap">non-employee</FONT> stock-based compensation of $21.6&nbsp;million related to unvested stock options not yet recognized that are expected to be recognized over an estimated weighted average period of
3.03&nbsp;years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total stock-based compensation expense recognized in the accompanying statements of operations and comprehensive loss for all equity
awards is as follows (amounts in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,725</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Earnings (Loss) Per Share </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company computes earnings (loss) per share of the Class&nbsp;A common stock and Class&nbsp;B common stock using the
<FONT STYLE="white-space:nowrap">two-class</FONT> method required for participating securities. Basic and diluted earnings per share was the same for each period presented as the inclusion of all potential Class&nbsp;A common stock and Class&nbsp;B
common stock outstanding would have been anti-dilutive. Basic and diluted earnings per share are the same for each class of common stock because they are entitled to the same liquidation and dividend rights. The following table sets
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
forth the computation of basic and diluted loss per Class&nbsp;A common stock and Class&nbsp;B common stock (amounts in thousands, except share and per share amounts): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Numerator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(51,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(44,149</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Denominator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average Class&nbsp;A and Class&nbsp;B common shares stockholders - Basic and
Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,194,183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,108,638</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share attributable to Class&nbsp;A and Class&nbsp;B Common stockholders - Basic and
Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.58</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(3.97</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table presents the potential common stock outstanding that was excluded from the computation of diluted net
loss per share of common stock as of the periods presented because including them would have been antidilutive: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series&nbsp;A convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,192,245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,192,245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series&nbsp;B convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,381,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,381,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,076,037</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,076,037</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series&nbsp;C convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,258,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,258,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series D convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,983,189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,983,189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series E convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants to purchase Series A convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,586</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,586</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants to purchase Series C convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">129,718</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">129,718</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,789,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,112,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,434,463</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,757,621</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. Joint Venture and <FONT STYLE="white-space:nowrap">Non-controlling</FONT> interest </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As described in Note 2, on September&nbsp;11, 2018, the Company entered into a JVA with VWGoA and VGA and formed the JV entity. The Company determined the
entity was a variable interest entity with a related party, and the Company&#146;s operations were more closely associated with the JV entity. As such, the Company consolidated the JV entity for financial reporting purposes, and a <FONT
STYLE="white-space:nowrap">non-controlling</FONT> interest was recorded for VGA&#146;s interest in the net assets and operations of QSV operations to the extent of VGA&#146;s investment. The Company&#146;s consolidated balance sheet includes
$3.4&nbsp;million cash and cash equivalents and $0.01&nbsp;million prepaid expenses of the JV entity at December&nbsp;31, 2019 ($3.4&nbsp;million and $0.1&nbsp;million, respectively at December&nbsp;31, 2018). Although the Company has consolidated
the net assets of the JV entity, it has no right to the use of those assets for its standalone operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the change in <FONT STYLE="white-space:nowrap">non-controlling</FONT>
interest for the year ended December&nbsp;31, 2019 (amounts in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="25%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-controlling&nbsp;interest</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at January&nbsp;1, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income attributable to <FONT STYLE="white-space:nowrap">non-controlling</FONT> interest in
consolidated JV</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-controlling</FONT> interest in a consolidated JV</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,685</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income attributable to non-controlling interest in consolidated JV</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,710</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Income Taxes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company has no provision for income taxes for the years ended December&nbsp;31, 2019 and 2018. The Company has no current tax expense from losses and no deferred expense from the valuation allowance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A reconciliation from U.S statutory rate of 21% to the effective rate is below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended</B><br><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Federal Statutory rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State tax expense (Fed effected)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.03</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.03</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permanent tax items</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-2.20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-0.52</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R&amp;D tax credit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.54</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.80</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change to valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-30.37</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-32.31</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effective tax rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Significant components of the Company&#146;s net deferred tax assets as of December&nbsp;31, 2019 and 2018, are as follows
(amounts in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating losses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">71,374</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">58,873</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax credits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,219</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,891</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accruals and stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,198</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,796</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangibles</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,056</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(85,677</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,340</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Right of use assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,627</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fixed assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(846</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(716</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total deferred tax liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,473</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(716</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total net deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Recognition of deferred tax assets is appropriate when realization of such assets is more likely than not.
Based upon the weight of available evidence, which includes the Company&#146;s historical operating performance, cumulative net losses, and projected future losses, the Company has provided a full valuation allowance against its deferred tax assets.
The Company&#146;s valuation allowance increased by $14.3&nbsp;million and $14.4&nbsp;million for the years ended December&nbsp;31, 2019 and 2018, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At December&nbsp;31, 2019, the Company had federal and state net operating loss carryforwards of approximately $259.4&nbsp;million and $231.2&nbsp;million,
respectively. The federal net operating loss carryforwards generated prior to 2018 will expire at various dates beginning in 2030, if not utilized. We have federal net operating loss carryforwards of $89.2 million, which can be carried forward
indefinitely. For the year ended December&nbsp;31, 2019 and 2018, the Company has used 100% apportionment factor for California net operating losses. The state net operating loss carryforwards of $231.2&nbsp;million will expire beginning in 2030, if
not utilized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Coronavirus Aid, Relief, and Economic Security Act (&#147;CARES Act&#148;) signed in to law on March&nbsp;27, 2020, provided that NOLs
generated in a taxable year beginning in 2018, 2019, or 2020, may now be carried back five years and forward indefinitely. In addition, the 80% taxable income limitation is temporarily removed, allowing NOLs to fully offset net taxable income. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The federal and state net operating loss carryforwards and research and development credit carryforwards may be subject to significant limitations under
Section&nbsp;382 and Section&nbsp;383 of the Internal Revenue Code and similar provisions under state law. The Tax Reform Act contains provisions that limit the federal net operating loss carryforwards that may be used in any given year in the event
of special occurrences, including significant ownership changes. A Section&nbsp;382 &#147;ownership change&#148; generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of the Company&#146;s stock, increase their
ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period. The Company has not performed Section&nbsp;382 analyses due to continued losses since inception. For the year ending
December&nbsp;31, 2019, the Company did not have any equity events which may cause an ownership change. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;9, 2019, the Treasury
Department and the IRS issued proposed regulations under Section&nbsp;382 of the Internal Revenue Code which, if finalized, will severely limit the ability of corporations to avail themselves of net operating losses (NOLs) following an ownership
change. Specifically, the regulations would eliminate a safe harbor established in Notice <FONT STYLE="white-space:nowrap">2003-65</FONT> that allows corporations to increase their Section&nbsp;382 limitation by the gain inherent in their assets,
even if those assets were not actually sold. The Company is still evaluating the effect of the proposed regulations and may perform a high-level analysis of the potential impact to utilize its tax attributes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, the Company also has Federal and California research and development credits of $9.8&nbsp;million and $8.6&nbsp;million,
respectively. The federal tax credit carryforwards will expire beginning in 2031, if not utilized. The state tax credit carryforwards do not expire. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company records unrecognized tax benefits in accordance with ASC <FONT STYLE="white-space:nowrap">740-10,</FONT> <I>Income Taxes</I>. <FONT STYLE="white-space:nowrap">ASC&nbsp;740-10</FONT> which prescribes a recognition threshold and measurement
attribute for the financial statement recognition and measurement of uncertain tax positions taken or expected to be taken in the Company&#146;s income tax return and also provides guidance on <FONT STYLE="white-space:nowrap">de-recognition,</FONT>
classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company had total unrecognized tax benefits of $7.1&nbsp;million and $5.4&nbsp;million as of December&nbsp;31, 2019 and 2018, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A reconciliation of the beginning and ending balances of unrecognized tax benefits is as follows (amounts in
thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Beginning of the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase&#151;current year positions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,704</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,552</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Decrease&#151;current year positions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase&#151;prior year positions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Decrease&#151;prior year positions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">End of the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company does not anticipate the total amounts of unrecognized tax benefits will significantly increase or decrease in the
next 12 months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s policy is to classify interest and penalties associated with uncertain tax positions, if any, as a component of its
income tax provision. For the years ended December&nbsp;31, 2019 and 2018, the Company had no interest or penalties related to unrecognized tax benefits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The federal and state income tax returns are open under the statute of limitations subject to tax examinations for the tax years ended December&nbsp;31, 2015
through December&nbsp;31, 2018. To the extent the Company has tax attribute carryforwards, the tax year in which the attribute was generated may still be adjusted upon examination by the IRS or state tax authorities to the extent utilized in a
future period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. Related Party Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Battery Development and Evaluation Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October
2015, the Company entered into a Battery development and evaluation agreement with VWGoA. In September 2018, certain amendments were made to this agreement. See Note 2 for further discussion. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Joint Venture Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In September&nbsp;11, 2018, the
Company entered into a JVA with VWGoA and VGA as described in Note 2. In connection with this agreement, the parties also have entered into two operating agreements: (i)&nbsp;the Limited Liability Company Agreement of the JV entity to govern the
respective rights and obligations as Members of the JV entity and (ii)&nbsp;the Common IP License Agreement for the Company to license certain intellectual property rights pertaining to automotive battery cells as defined in the JVA to VWGoA, VGA
and the JV Entity. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Related Parties </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One of
the members of the Board of Directors is also a consultant to the Company, providing expertise in the area of science and materials. This board member was paid $0.2&nbsp;million under a consulting agreement during the years ended December&nbsp;31,
2019 and 2018. This member of the Board of Directors participated in the Company&#146;s stock repurchase program selling 15,000 shares of Common Stock for total proceeds of $0.3&nbsp;million in 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Subsequent Events </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has evaluated
subsequent events through September 21, 2020, the date the financial statements were available to be issued. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beginning in March 2020, the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and the measures
imposed to contain this pandemic have disrupted and are expected to continue to impact the Company&#146;s business. The magnitude of the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on the Company&#146;s productivity,
results of operations and financial position, and its disruption to the Company&#146;s business and battery development and timeline, will depend in part, on the length and severity of these restrictions and on the Company&#146;s ability to conduct
business in the ordinary course. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2020, the Board of Directors and stockholders approved the sale of up to 11,354,260 shares of Series F
convertible preferred stock at the price of $26.4218 per share for gross proceeds of approximately $300.0&nbsp;million to VGA and other new and existing investors. In July 2020, Board of Directors and stockholders increased the approved sale of
Series F to up to 14,684,843 shares for gross proceeds of approximately $388.0&nbsp;million. The proceeds are expected to be received in December 2020 and Q1 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2020, we settled an outstanding legal matter regarding a former employee pursuant to which the Company received $0.8&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From January through September 2020, the Company granted 3,231,625 restricted stock units to employees as part of its annual refresh program and 961,530 stock
options to new employees and an independent Board of Director member. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;3, 2020, Kensington Capital Acquisition Corp
(&#147;Kensington&#148;) (NYSE:KCACU), together with Merger Sub, its fully owned subsidiary, announced that the Company has entered into a business combination transaction pursuant to which Merger Sub will merge with and into the Company with the
Company surviving the merger as a wholly owned subsidiary of Kensington. If such business combination is ultimately completed, the Company would effectively comprise all of Kensington&#146;s material operations. The business combination agreement
requires the investment of $500.0&nbsp;million from other private investors (PIPE) in addition to the $230.0&nbsp;million already available in KCAC account. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_1"></A><A NAME="rom14810_68"></A>QuantumScape Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Unaudited Condensed Consolidated Balance Sheets </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(In Thousands, Except Share and per Share Amounts) </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Unaudited</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash and cash equivalents ($3,406 and $3,409 as of June&nbsp;30, 2020 and December&nbsp;31, 2019,
respectively, for joint venture)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 29,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 22,822</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,512</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,703</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,390</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> lease
asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,774</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">146,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">172,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Liabilities, redeemable convertible preferred stock and stockholders&#146; deficit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,490</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 2,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,987</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accrued compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,349</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Operating lease liability, short-term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,080</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Strategic premium, short-term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">655</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">873</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,629</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Operating lease liability, long-term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,866</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,463</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Convertible preferred stock warrant liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Strategic premium, long-term and other liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">436</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,673</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,982</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Commitment and contingencies (see Note 7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Redeemable convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Redeemable convertible preferred stock, par value of $0.0001 per share, 60,427,449 and 49,073,189
shares authorized as of June&nbsp;30, 2020 and December&nbsp;31, 2019, respectively, 48,390,851 and 48,390,851 shares issued and outstanding with aggregate liquidation preference of $414,335 and $414,335 as of June&nbsp;30, 2020 and
December&nbsp;31, 2019, respectively.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">405,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">405,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Common stock &#150; $0.0001 par value; 139,354,260 shares authorized (92,354,260 Class&nbsp;A and
47,000,000 Class&nbsp;B); 11,234,541 and 11,229,241 Class&nbsp;A and Class&nbsp;B shares issued and outstanding at June&nbsp;30, 2020 and December&nbsp;31, 2019, respectively</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Additional
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">paid-in-capital</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Treasury stock- fair market value at repurchase; 438,191 shares at June&nbsp;30, 2020 and
December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,189</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,189</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accumulated other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(325,181</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(295,862</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total QuantumScape stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(281,749</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(256,883</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-controlling</FONT> interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,705</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,710</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(280,044</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(255,173</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total liabilities, redeemable convertible preferred stock and stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 146,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 172,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_2"></A>QuantumScape Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(In Thousands, Except Share and per Share Amounts)</I> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six Months Ended June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Unaudited</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 25,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 21,203</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,747</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,927</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,143</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,130</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">819</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,637</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,324</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,493</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Net (loss) income attributable to <FONT STYLE="white-space:nowrap">non-controlling</FONT>
interest, net of tax of $0 for the six months ended June&nbsp;30, 2020 and 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(29,319</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(23,501</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(29,324</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(23,493</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income (loss):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized gain on marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,267</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,334</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Comprehensive (loss) income attributable to
<FONT STYLE="white-space:nowrap">non-controlling</FONT> interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(29,262</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(23,342</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and Diluted net loss per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2.61</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2.10</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and Diluted weighted-average common shares outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,233,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,181,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_3"></A>QuantumScape Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Unaudited Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#146; Deficit </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(In Thousands, Except Share and per Share Amounts)</I> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preferred Stock</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Treasury Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR><FONT STYLE="white-space:nowrap">Paid-In</FONT></B><br><B>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated&nbsp;other<BR>Comprehensive</B><br><B>gain (loss)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>QuantumScape</B><br><B>Stockholders&#146;<BR>deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Non-<BR>Controlling</B><br><B>interest</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>48,390,851</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>405,575</B></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,229,241</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B> 1</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>438,191</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(4,189</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>43,077</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(295,862</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B> 90</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(256,883</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,710</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(255,173</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Exercise of stock option</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,382</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,382</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,382</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,319</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,319</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,324</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Unrealized gain on marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Balance at June&nbsp;30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>48,390,851</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>405,575</B></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,234,541</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B> 1</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>438,191</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(4,189</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>47,473</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(325,181</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>147</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(281,749</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,705</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(280,044</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="8" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="8"></TD>
<TD HEIGHT="16" COLSPAN="8"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Redeemable Convertible<BR>Preferred Stock</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Treasury Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR><FONT STYLE="white-space:nowrap">Paid-In</FONT></B><br><B>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated other<BR>Comprehensive</B><br><B>gain (loss)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>QuantumScape</B><br><B>Stockholders&#146;<BR>deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Non-<BR>Controlling</B><br><B>interest</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>48,390,851</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>405,575</B></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,075,476</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B> 1</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>438,191</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(4,189</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>35,957</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(246,083</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(31</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(214,345</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,690</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(212,655</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Exercise of stock option</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">116,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,867</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,867</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,867</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Adoption of ASC 842</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,501</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,501</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23,493</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Unrealized gain on marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Balance at June&nbsp;30, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>48,390,851</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>405,575</B></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,192,334</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B> 1</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>438,191</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(4,189</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>39,065</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(268,165</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>128</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(233,160</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,698</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(231,462</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_4"></A>QuantumScape Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Unaudited Condensed Consolidated Statements of Cash Flows </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(In Thousands, Except Share and per Share Amounts) </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six Month Ended<BR>June&nbsp;30</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Unaudited</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(29,324</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(23,493</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Adjustments to reconcile net loss to net cash used in operating&nbsp;activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,075</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,909</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Gain on property and equipment disposal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(90</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Amortization of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">606</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">571</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Amortization of discount on marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,398</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Amortization of strategic premium</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(327</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(436</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,382</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,867</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Change in fair value of convertible preferred stock warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Prepaid expenses and other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(448</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(643</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accounts payable, accrued liabilities and accrued compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">579</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">381</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Operating lease liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(529</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(465</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,797</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Purchases of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,891</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,813</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Proceeds from maturities of marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">141,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Purchases of marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,351</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,323</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net cash provided by investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,864</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Financing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Proceeds from issuance of common stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net increase (decrease) in cash, cash equivalents and restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,772</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,692</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash, cash equivalents and restricted cash at beginning of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,596</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,632</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash, cash equivalents and restricted cash at end of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 31,368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 26,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Supplemental disclosure of cash flow information</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash paid for interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-cash</FONT> investing and financing activities</B></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Purchases of property and equipment, accrued but not paid</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following presents the Company&#146;s cash, cash
equivalents and restricted cash by category in the Company&#146;s Consolidated Balance Sheets: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">29,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,822</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,774</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Total cash, cash equivalents and restricted cash</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>31,368</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>25,596</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_5"></A>QuantumScape Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">June&nbsp;30, 2020 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Nature of Business
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Organization </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">QuantumScape Corporation (the
Company) was incorporated in&nbsp;Delaware in May&nbsp;2010. The Company is a leader in the development of next generation solid-state lithium-metal batteries for use in electric vehicles. The Company is headquartered in
San&nbsp;Jose,&nbsp;California. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is focused on the development and commercialization of its solid-state lithium-metal batteries. Planned
principal operations have not yet commenced. As of June&nbsp;30, 2020, the Company has not derived revenue from its principal business activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beginning in March 2020, the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and the measures imposed to contain this pandemic have disrupted and
are expected to continue to impact the Company&#146;s business. To date, our business operations have been slowed due to the government restrictions, however there has not been a direct impact on our financial operations. The magnitude of the impact
of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on the Company&#146;s productivity, results of operations and financial position, and its disruption to the Company&#146;s business and battery development and timeline, will depend in
part, on the length and severity of these restrictions and on the Company&#146;s ability to conduct business in the ordinary course. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Summary of
Significant Accounting Policies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis of Presentation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United
States of America (GAAP) as determined by the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) for interim financial information and pursuant to the regulations of the U.S. Securities and Exchange Commission (SEC).
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Use of Estimates </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of the condensed
consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of commitments and contingencies at the date of the financial
statements as well as reported amounts of expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to the valuation of common stock and valuation of convertible preferred stock
warrants, among others. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying
amounts of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Unaudited Interim Condensed Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying interim condensed consolidated balance sheet as of June&nbsp;30, 2020, the interim condensed consolidated statements of redeemable preferred
stock and stockholders&#146; deficit, the interim condensed consolidated statements of operations, and the interim condensed consolidated statements of cash flows for the six months ended June&nbsp;30, 2020 and 2019, are unaudited. The unaudited
interim condensed consolidated financial statements have been prepared on the same basis as the audited annual consolidated financial statements and, in management&#146;s opinion, include all adjustments consisting of only normal recurring
adjustments necessary </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for the fair statement of the Company&#146;s financial position as of June&nbsp;30, 2020 and its results of operations and cash flows for the six months ended June&nbsp;30, 2020 and 2019. The
financial data and the other financial information disclosed in the notes to these condensed consolidated financial statements related to the six month periods are also unaudited. The results of operations for the six months ended June&nbsp;30, 2020
are not necessarily indicative of the results to be expected for the full fiscal year or any other period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These unaudited interim condensed consolidated
financial statements should be read in conjunction with the consolidated financial statements and the related notes included in the Company&#146;s annual consolidated financial statements for the fiscal year ended December&nbsp;31, 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Principles of Consolidation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s policy is
to consolidate all entities that it controls by ownership of a majority of the outstanding voting stock. In addition, the Company consolidates entities that meet the definition of a variable interest entity (&#147;VIE&#148;) for which the Company is
the related party most closely associated with and is the primary beneficiary. The primary beneficiary is the party who has the power to direct the activities of a VIE that most significantly impact the entity&#146;s economic performance and who has
an obligation to absorb losses of the entity or a right to receive benefits from the entity that could potentially be significant to the entity. For consolidated entities that are less than wholly owned, the third party&#146;s holding of an equity
interest is presented as Noncontrolling interests in the Company&#146;s Consolidated Balance Sheet and Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#146; Deficit. The portion of net earnings attributable to the
noncontrolling interests is presented as Net income (loss) attributable to noncontrolling interests in the Company&#146;s Consolidated Statements of Operations and Comprehensive Loss. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company was a single-legal entity prior to becoming a partner with Volkswagen Group of America (VWGoA) in the JV entity. As noted in &#147;Joint
Venture&#148; discussion, the Company determined the JV entity was a VIE for which it was required to consolidate the operations upon its formation in 2018. The Company continued to consolidate the operations of the JV entity in 2019 through
June&nbsp;30, 2020 as the determination of the variable interest entity has not changed. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Joint Venture </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;18, 2018, the JV entity was incorporated as a limited liability company. VWGoA, VGA and QuantumScape executed a Joint Venture Agreement
(&#147;JVA&#148;), effective September 2018, with the goal of jointly establishing a manufacturing facility in the United States to produce the pilot line of the Company&#146;s product through the JV entity. Volkswagen is a related party stockholder
(13.1% voting interest holder of the Company as of June&nbsp;30, 2020, December&nbsp;31, 2019 and as of the formation of the JV entity), and also participated in the Company&#146;s Series E convertible preferred stock financing which closed
concurrently with the effectiveness of the JV entity and the JVA. Upon the effectiveness of the JVA, each party contributed $1.7&nbsp;million in cash to capitalize the JV entity in exchange for 50% equity interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The joint venture is considered a variable interest entity with a related party and therefore the related party whose business is more closely related to the
planned operations of the joint venture is required to consolidate the operations. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company determined its operations were most closely aligned
with the operations of the joint venture and therefore has consolidated the results of the JV entity&#146;s operations in its consolidated balance sheet, statement of operations and statement of stockholders&#146; equity. The JV entity has had
minimal operations in through June&nbsp;30, 2020. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Concentrations of Credit Risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to credit risk consist principally of cash and cash equivalents, of which $24.9&nbsp;million is held
a US government Money Market fund, and marketable securities, all </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of which are invested in US government securities. The Company seeks to mitigate its credit risk with respect to cash and cash equivalents and marketable securities by making deposits with large,
reputable financial institutions and investing in shorter term and highly rated instruments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Credit Impairment Implementation on Available For Sales
Securities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An available for sales debt security is impaired when its fair value is less than its amortized cost basis. The portion of impairment due
to a credit loss is recorded to net income through an allowance for credit losses, while any portion of impairment that is due to factors other than a credit loss (e.g., changes in market rates) is recognized in other comprehensive income, net of
applicable taxes. However, if an entity intends to sell the debt security (that is, it has decided to sell the security), or more likely than not will be required to sell the security before recovery of its amortized cost basis, any allowance for
credit losses shall be written off and the amortized cost basis shall be written down to the debt security&#146;s fair value with any incremental impairment reported in earnings. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Restricted Cash </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted cash, if the date of
availability or disbursement is longer than one year and the balances are maintained under an agreement that legally restricts the use of such funds, is not included within cash and cash equivalents and is reported within other assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, restricted cash is comprised of $2.2&nbsp;million of which $2.0&nbsp;million was pledged as a form of security for the
Company&#146;s facility lease agreement and $0.2&nbsp;million as collateral for a commercial letter of credits issued to an equipment supplier. As of December&nbsp;31, 2019, restricted cash was $2.8&nbsp;million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Convertible Preferred Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company records shares
of convertible preferred stock at their respective fair values on the dates of issuance, net of issuance costs. The Company has applied the guidance in ASC <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">480-10-S99-3A,</FONT></FONT></FONT> <I>SEC Staff Announcement: Classification and Measurement of Redeemable Securities</I> and has therefore classified all of its outstanding convertible preferred stock as temporary
equity. The convertible preferred stock is recorded outside of stockholders&#146; deficit because, in the event of certain deemed liquidation events considered not solely within the Company&#146;s control, such as a merger, acquisition and sale of
all or substantially all of the Company&#146;s assets, the convertible preferred stock will become redeemable at the option of the holders. In the event of a change of control of the Company, proceeds received from the sale of such shares will be
distributed in accordance with the liquidation preferences set forth in the Company&#146;s Amended and Restated Certificate of Incorporation. The Company has determined not to adjust the carrying values of the convertible preferred stock to the
liquidation preferences of such shares because of the uncertainty of whether or when such an event would occur. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stock-Based Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company measures and recognizes compensation expense for all stock-based awards made to employees, directors, and
<FONT STYLE="white-space:nowrap">non-employees</FONT> (beginning in the year ended December&nbsp;31, 2019), including stock options and restricted shares, based on estimated fair values recognized over the requisite service period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of options granted is estimated on the grant date using the Black-Scholes option valuation model. This valuation model for stock-based
compensation expense requires the Company to make assumptions and judgments about the variables used in the calculation, including the expected term (weighted-average period of time that the options granted are expected to be outstanding), the
volatility of the Company&#146;s common stock, and an assumed risk-free interest rate. The Company accounts for forfeitures when they occur. The Company uses the simplified calculation of the expected life, which takes into consideration the
grant&#146;s contractual life and vesting period and assumes that all options will be exercised between the vesting date and the contractual term of the option. No awards have been issued with a market condition or other <FONT
STYLE="white-space:nowrap">non-standard</FONT> terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to January&nbsp;1, 2019, stock-based awards granted to
<FONT STYLE="white-space:nowrap">non-employees</FONT> were subject to periodic <FONT STYLE="white-space:nowrap">re-measurement</FONT> over the period that services are rendered. Beginning January&nbsp;1, 2019 upon the adoption of Accounting
Standards Update (&#147;ASU&#148;) <FONT STYLE="white-space:nowrap">2018-07</FONT><I>. Compensation &#150; Stock Compensation (Topic 718): Improvements to Nonemployee</I> <I>Share-Based Payment Accounting</I> as described in Note 3, the measurement
of equity-classified nonemployee awards is fixed at the grant date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no public market for the Company&#146;s stock. The estimate for volatility
is based on an average of the historical volatilities of the common stock of several entities with characteristics similar to those of the Company. Since these comparable companies operate in the same industry segment, the Company expects that it
would share similar characteristics, such as risks profiles, volatility, capital intensity, clientele, and market growth patterns and drivers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the option. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock Tranche Liability </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has
determined that its obligation to issue, and the Company&#146;s investors&#146; right to purchase shares of Series F convertible preferred stock pursuant to the future time-based and milestone closings (see Note 8) represent a freestanding financial
instrument (the &#147;tranche liability&#148;). The tranche liability was initially recorded at fair value and is remeasured at each reporting period and upon the exercise or expiration of the obligation, with gains and losses arising from
subsequent changes in its fair value recognized in other expense, net, in the unaudited condensed consolidated statement of operations. At the time of the exercise or expiration of the tranche liability, the fair value of the tranche liability is
reclassified to convertible preferred stock on the unaudited condensed consolidated balance sheet with no further remeasurement required. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Recent
Accounting Pronouncements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2016, the FASB issued ASU <FONT STYLE="white-space:nowrap">2016-13,</FONT> <I>Financial Instruments- Credit Losses
(Topic 326): Measurement of Credit Losses on Financial Instruments</I>. This guidance introduces a new model for recognizing credit losses on financial instruments based on an estimate of current expected credit losses. ASU <FONT
STYLE="white-space:nowrap">2016-13</FONT> also provides updated guidance regarding the impairment of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> debt securities and includes additional
disclosure requirements. The Company adopted this guidance as of January&nbsp;1, 2020 with no impact upon adoption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In November 2018, the FASB issued ASU
<FONT STYLE="white-space:nowrap">2018-18,</FONT> <I>Collaborative Arrangement (Topic 808):</I> <I>clarifying the Interaction between Topic 808 and Topic 606</I>, which clarifies that certain transactions between participants in a collaborative
arrangement should be accounted for under ASC Topic 606 when the counterparty is a customer. In addition, Topic 808 precludes an entity from presenting consideration from a transaction in a collaborative arrangement as revenue from contracts with
customers if the counterparty is not a customer for that transaction. The Company adopted this guidance as of January&nbsp;1, 2020 with no impact upon adoption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2019, the FASB issued ASU <FONT STYLE="white-space:nowrap">2019-12,</FONT> <I>Income Taxes (Topic 740): Simplifying the Accounting for Income
Taxes</I>, which is intended to simplify various aspects related to accounting for income taxes. ASU <FONT STYLE="white-space:nowrap">2019-12</FONT> removes certain exceptions to the general principles in ASC 740 and also clarifies and amends
existing guidance to improve consistent application. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December&nbsp;15, 2020, with early adoption permitted. The Company is currently
evaluating the impact of this standard on its consolidated financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2020, the FASB issued ASU
<FONT STYLE="white-space:nowrap">2020-06,</FONT><I>&nbsp;Debt&#151;Debt with Conversion and Other Options (Subtopic <FONT STYLE="white-space:nowrap">470-20)</FONT> and Derivatives and Hedging&#151;Contracts in Entity&#146;s Own Equity (Subtopic <FONT
STYLE="white-space:nowrap">815-40):</FONT> Accounting for</I> <I>Convertible Instruments and Contracts in an Entity&#146;s Own Equity</I>, which simplifies accounting for convertible </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
instruments by removing major separation models required under current GAAP. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative
scope exception and it also simplifies the diluted earnings per share calculation in certain areas.&nbsp;The ASU is effective for fiscal years beginning after December&nbsp;15, 2023, including interim periods within those fiscal years.&nbsp;Early
adoption is permitted, but no earlier than fiscal years beginning after December&nbsp;15, 2021 and adoption must be as of the beginning of the Company&#146;s annual fiscal year.&nbsp;The Company is currently evaluating the impact of this standard on
its consolidated financial statements and related disclosures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Fair Value Measurement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Marketable Securities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes, by
major security type, the Company&#146;s assets that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. Amortized cost net of unrealized gain is equal to fair value as of June&nbsp;30, 2020 and
December&nbsp;31, 2019. The fair value as of June&nbsp;30, 2020 and December&nbsp;31, 2019, are as follows (amounts in thousands). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>June&nbsp;30, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amortized&nbsp;Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized&nbsp;Gain</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;1 securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money market fund</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,852</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,852</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;2 securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">US government securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,512</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">94,217</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">94,364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amortized&nbsp;Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized&nbsp;Gain</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;1 securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money market fund</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 5,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 5,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;2 securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repurchase agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">US government securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Level&nbsp;2 securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,599</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">125,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">125,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any realized gains and losses and interest income are included in interest income. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We regularly review our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> marketable securities in an
unrealized loss position and evaluate the current expected credit loss by considering factors such as historical experience, market data, issuer-specific factors, and current economic conditions. As of June&nbsp;30, 2020, no expected credit losses
were recorded as there was no individual security in an unrealized loss position </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The estimated amortized cost and fair value of marketable securities by
contractual maturity as of June&nbsp;30, 2020 is as follows (amounts in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amortized&nbsp;Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due within one year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">94,217</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">94,364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due after one year and through five years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">94,217</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">94,364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020 and December&nbsp;31, 2019, the carrying values of cash and cash equivalents,
accounts payable and accrued liabilities approximate their respective fair values due to their short-term nature. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2011 through 2013, in connection with an equipment and loan security agreement with TriplePoint Capital, the Company issued warrants to purchase 124,586
shares of Series A convertible preferred stock at $2.20131 per share (&#147;the TPC1 warrants&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The TPC1 warrants expire at the later of 7 years
from effective date or five years after an initial public offering or acquisition. The Company recorded the fair value of the warrants upon issuance as debt issuance cost and amortized the amount over the term of the agreement to interest expense in
the statement of operations and comprehensive loss. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In January 2015, the Company entered into another equipment loan and security agreement with
TriplePoint Capital. In connection with the borrowing of funds per the agreement, the Company issued warrants to purchase 129,718 shares of Series C convertible preferred stock at $10.40717 per share (&#147;TPC2 warrants&#148;). The TPC2 warrants
expire at the later of 2022 or five years after an initial public offering or acquisition. The Company recorded the fair value of the warrants upon issuance as debt issuance cost and amortized the amount over the term of the agreement to interest
expense in the statement of operations and comprehensive loss </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As the underlying convertible preferred shares of the outstanding TPC warrants are
redeemable outside the control of the Company, the fair value of the TPC warrants are reported on the Company&#146;s balance sheets as a long-term liability as of June&nbsp;30, 2020 and December&nbsp;31, 2019, in the amount noted in the table below.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company <FONT STYLE="white-space:nowrap">re-measured</FONT> the fair value of the outstanding TPC1 and TPC2 warrants at June&nbsp;30, 2020 and 2019
with the difference recorded in interest expense using an Option Pricing Model (OPM). The TPC1 warrants were <FONT STYLE="white-space:nowrap">re-measured</FONT> at June&nbsp;30, 2020, using the Option Pricing Model (OPM) with the following
assumptions: option term of 5 years, volatility of 64.4&nbsp;%, risk-free interest rate of 0.34% and no expected dividends. The TPC2 warrants were <FONT STYLE="white-space:nowrap">re-measured</FONT> at June&nbsp;30, 2020, using the OPM with the
following assumptions: option term of 5 years, volatility of 49.4%, risk-free interest rate of 0.34% and no expected dividends. There was no <FONT STYLE="white-space:nowrap">re-measurement</FONT> as of June&nbsp;30, 2019 for the TPC1 and TPC2
warrants as there were no changes to the underlying assumptions. The 5 years term was derived based on the Company&#146;s estimation of the timing of the exercise of the warrants. The Company applied a 35% discount for lack of marketability to the
OPM values. Significant changes in the option term and volatility would result in a significantly higher or lower fair value measurement, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The TPC1 and TPC2 warrants are classified as Level&nbsp;3 in the fair value hierarchy. The following table presents the reconciliation of the Company&#146;s
liabilities measured and recorded at fair value on a recurring basis using the significant observable inputs (Level 3) outlined above (amounts in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TPC1<BR>Warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TPC2<BR>Warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Liability</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">782</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Re-measurement</FONT> loss included in interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at June&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">782</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TPC1<BR>Warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TPC2<BR>Warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>Liability</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,036</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Re-measurement</FONT> loss included in interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at June&nbsp;30, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Property and Equipment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Property and equipment as of June&nbsp;30, 2020 and December&nbsp;31, 2019, consisted of the following (amounts in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>June&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computers and hardware</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 598</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture and fixtures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lab equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,924</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,919</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Construction-in-progress</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51,887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,470</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,395</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment,&nbsp;net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 31,285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 25,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depreciation and amortization expense related to property and equipment was $3.1&nbsp;million and $2.9&nbsp;million for the
six months ended June&nbsp;30, 2020 and 2019, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Leases </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company currently leases its headquarters under a single lease classified as an operating lease expiring in January 2023. Fixed rent escalates each year,
but the Company is responsible for a portion of the landlord&#146;s operating expenses such as property tax, insurance and common area maintenance which are considered variable costs. Under the lease, the Company has one <FONT
STYLE="white-space:nowrap">60-month</FONT> renewal option, which has been included in the calculation of lease liabilities and right of use assets at the adoption date as the exercise of the option was reasonably certain. As the renewal rent has not
been negotiated, the Company uses an estimated rent rate which approximates the fair market rent at adoption for the extension period. This lease does not have any contingent rent payments and does not contain residual value guarantees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company does not have any leases classified as financing leases. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The components of lease related expense are as follows (amounts in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six Months Ended<BR>June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease cost</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,072</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,072</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Variable lease cost</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">201</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">212</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The components of supplemental cash flow information related to leases are as follows (amounts in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six Months Ended<BR>June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating cash flows&#151;operating leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 966</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT>
assets obtained in exchange for operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, future minimum payments during the next five years and thereafter are as follows
(amounts in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Operating<BR>Leases</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Six Months Ended December&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Year Ended December&nbsp;31, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,053</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Year Ended December&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Year Ended December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,301</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Year Ended December&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,318</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,932</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less present value discount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,918</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Commitments and Contingencies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contingencies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is currently not aware of any
investigations, claims, or lawsuits that it believes could have a material adverse effect on the financial position or on the results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Redeemable Convertible Preferred Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company&#146;s certificate of incorporation, as amended and restated as of May&nbsp;14, 2020 authorizes the issuance of 60,427,449 shares of $0.0001 par value convertible preferred stock. The following table summarizes the convertible preferred
stock outstanding as of June&nbsp;30, 2020, and the rights and preferences of the respective series: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Issued</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series&nbsp;A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,600,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,192,245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series&nbsp;B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,381,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,080,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,076,037</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series&nbsp;C</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,510,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,258,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,983,189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,983,189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series E</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series F</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,354,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,427,449</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,390,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2016, the Board of Directors and stockholders approved the issuance of additional 2,983,189 shares of Series&nbsp;D
convertible preferred stock at a price of $20.1127 per share and 2,485,990 shares were sold for net proceeds of&nbsp;$49.7&nbsp;million to two new strategic investors. In March 2017, the Company sold 497,199 shares of Series D convertible preferred
stock to an existing strategic investor for net proceeds of $10.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company determined that Series D convertible preferred stock share
purchase agreements with the two new investors executed in 2016 contained strategic terms. Both companies had strategic interest in the Company&#146;s technology and have negotiated specific strategic terms expected to benefit these new investors,
over and above the value that would be expected to be realized from the equity investment itself. Thus, the sale of the Series D convertible preferred stock to these two new investors reflected a higher price (&#147;strategic premium&#148;) than
what a market participant who did not receive these strategic benefits would be willing to pay. The Company allocated </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the net proceeds of $49.7&nbsp;million from these two investors between the Series D convertible preferred stock and the strategic premium. Based on the Company&#146;s valuation of the Series D
convertible preferred stock, the Company calculated the strategic premium to be approximately $6.2&nbsp;million which it recorded as a deferred liability on the balance sheet. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The sales of Series D convertible preferred stock in March 2017 to an existing investor was also determined to have included strategic terms as the investor
is expected to benefit over and above the value to be realized from the equity investment itself. The Company allocated approximately $1.7&nbsp;million of the proceeds as a strategic premium and recorded it as a deferred liability on the balance
sheet. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The strategic premium is considered akin to payment for research and development efforts as the strategic premium will be used to pay for
incremental cost associated with the Company&#146;s battery cell development. The Company has an accounting policy to record research and development effort payments as contra research and development. Therefore, the Company records the benefits
(amortization of the strategic premium) over the estimated period of the development agreements with the investors which was originally estimated to be three years at March 2016 and two years at March 2017. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subsequent to the Series D issuance, in 2018, 2019 and in the six months ended June&nbsp;30, 2020, the Company
<FONT STYLE="white-space:nowrap">re-assessed</FONT> the estimated period of the development agreements as part of its annual forecast process and determined that the period should be extended. The updated period of the estimated period of the
development agreements was utilized to amortize the remaining strategic premium during those periods. For the six months ended June&nbsp;30, 2020 and June&nbsp;30, 2019, the Company recorded amortization of $0.3&nbsp;million and $0.4&nbsp;million,
respectively, as a reduction to research and development expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2020, the Board of Directors and stockholders approved the sale of up to
11,354,260 shares of Series F convertible preferred stock at the price of $26.4218 per share for gross proceeds of approximately $300.0&nbsp;million to VGA and other new and existing investors. In July 2020, the Board of Directors and stockholders
increased the Series F approved sale to up to 14,684,843 shares for gross proceeds of approximately $388.0&nbsp;million. The proceeds are expected to be received in December 2020 and Q1 2021. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dividends </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of shares of Series&nbsp;A, Series
B, Series <FONT STYLE="white-space:nowrap">B-1,</FONT> Series C, Series D and Series E convertible preferred stock are entitled to receive <FONT STYLE="white-space:nowrap">non-cumulative</FONT> dividends, out of any assets legally available for such
purpose, prior and in preference to any declaration or payment of any dividend on the common stock, when, as, and if, declared by the Board of Directors in the amount equal to at least $0.1761408, $0.402, $0.4965296, $0.8325736, $1.6090 and $1.787
per share, respectively on each outstanding share of preferred stock. No distributions shall be made with respect to the common stock unless declared dividends on the preferred stock have been paid or set aside. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Conversion </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each share of Series&nbsp;A, Series B, and
Series <FONT STYLE="white-space:nowrap">B-1</FONT> convertible preferred stock is convertible, at the option of the holder thereof, at any time after the date of issuance of such share, into such number of fully paid and <FONT
STYLE="white-space:nowrap">non-assessable</FONT> shares of Class&nbsp;B common stock as is determined by dividing the applicable original issue price by the conversion price applicable to such share in effect on the date of conversion (Series A at
$2.20131 as of June&nbsp;30, 2020 and December&nbsp;31, 2019; Series B at $5.01900 as of June&nbsp;30, 2020 and December&nbsp;31, 2019; and Series <FONT STYLE="white-space:nowrap">B-1</FONT> at $6.20662 as of June&nbsp;30, 2020 and December&nbsp;31,
2019). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each share of Series&nbsp;C, Series D and Series E convertible preferred stock is convertible, at the option of the holder thereof, at any time
after the date of issuance of such share, into such number of fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares of Class&nbsp;A common stock as is determined by dividing the applicable original issue price by the
conversion price applicable to such share in effect on the date of conversion (Series C at $10.40717 as of June&nbsp;30, 2020 and December&nbsp;31, 2019 , Series D at $20.1127 as of June&nbsp;30, 2020 and December&nbsp;31, 2019, and Series E at
$22.3437 as of June&nbsp;30, 2020 and December&nbsp;31, 2019). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The conversion price of each series of preferred stock may be subject to adjustment from time to time under
certain circumstances. The preferred stock issued to date was sold at a price of $2.20131, $5.01900, $6.20662, $10.40717, $20.1127 and $22.3437 per share for Series A, Series B, Series <FONT STYLE="white-space:nowrap">B-1,</FONT> Series C , Series D
and Series E convertible preferred stock, respectively, which exceeded the fair value of the common stock. Accordingly, there was no intrinsic value associated with the issuance of the preferred stock through June&nbsp;30, 2020, and there were no
other separate instruments issued with the preferred stock that required further evaluation of a beneficial conversion option. Each share of convertible preferred stock shall automatically be converted into fully paid,
<FONT STYLE="white-space:nowrap">non-assessable</FONT> shares of common stock immediately upon the earlier of: (i)&nbsp;the sale by the Company of its common stock in a firm commitment, underwritten public offering pursuant to a registration
statement under the Securities Act of 1933, as amended (the Securities Act), the public offering price of which results in the aggregate cash proceeds to the Company of not less than $50,000,000 (net of underwriting discounts and commissions); or
(ii)&nbsp;upon the receipt by the Company of a written request for such conversion from the holders of a majority of the preferred stock then outstanding. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Liquidation Preferences </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event the Company
liquidates, dissolves, or winds up its business, either voluntarily or involuntarily, the holders of its Series&nbsp;A, Series B, Series <FONT STYLE="white-space:nowrap">B-1,</FONT> Series C, Series D and Series E convertible preferred stock shall
be entitled to receive, prior and in preference to any distribution of any of its assets to the holders of common stock, $2.20131, $5.019, $6.20662, $10.40717, $20.1127 and $22.3437 per share, respectively, plus any declared but unpaid dividends. If
the assets are insufficient to distribute this liquidation preference, then the entire assets of the Company shall be distributed on a pro rata basis to the convertible preferred stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If there are any remaining assets upon the completion of the liquidating distribution to the Series&nbsp;A, Series B, Series
<FONT STYLE="white-space:nowrap">B-1,</FONT> Series C, Series D and Series E convertible preferred stockholders, the holders of the Company&#146;s common stock will receive all of its remaining assets on a pro rata basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The merger or consolidation of the Company into another entity in which the Company&#146;s stockholders own less than 50% of the voting stock of the surviving
company, or the sale, transfer, or lease of substantially all the Company&#146;s assets, shall be deemed a liquidation, dissolution, or winding up of the Company. However, the treatment of a liquidation, dissolution, or winding up may be waived by
consent or vote of a majority of the outstanding preferred stockholders (voting as one class on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis). The underlying Series&nbsp;A, Series B, Series
<FONT STYLE="white-space:nowrap">B-1,</FONT> Series C, Series D and Series E convertible preferred shares are considered redeemable outside of the Company&#146;s control (i.e.,&nbsp;the Series&nbsp;A, Series B, Series
<FONT STYLE="white-space:nowrap">B-1,</FONT> and Series C convertible stockholders control a majority of the Board of Directors, and a majority vote of Series&nbsp;A convertible stockholders can cause a liquidation). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Voting Rights </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each holder of convertible preferred stock
Series A, Series B, and Series <FONT STYLE="white-space:nowrap">B-1</FONT> will convert into Class&nbsp;B common stock. Each holder of Series C, Series D and Series E convertible preferred stock will convert into Class&nbsp;A common stock. Each
holder of Class&nbsp;B common stock shall be entitled to ten (10)&nbsp;votes per share of Class&nbsp;B common stock held by such holder as of the applicable record date. Each holder of Class&nbsp;A common stock shall be entitled to one (1)&nbsp;vote
for each share of Class&nbsp;A common stock held by such holder as of the applicable record date. Except as otherwise expressly provided or by applicable law, the holders of Class&nbsp;A common stock and the holders of Class&nbsp;B common stock
shall at all times vote together as one class on all matters submitted to a vote or for the written consent of the stockholders of the corporation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Series F Tranche Liability </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2020, the Company
executed a stock purchase agreement and other related agreements with VGA for the investment of $200&nbsp;million in the Company&#146;s Series F convertible preferred stock. The transaction will be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
funded in two tranches with the first tranche to occur on December&nbsp;1, 2020 and second tranche contingent on the occurrence of two milestones. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The stock purchase agreement with VGA obligates the Company to issue and sell, and VGA to purchase, up to a total of 7,569,508 shares of Series F convertible
preferred stock (the &#147;tranche shares&#148;) at $26.4218 per share, on December&nbsp;1, 2020 for half of the obligation (the time based portion of the agreement) and upon the occurrence of certain milestones for the remainder of the obligation
(the &#147;tranche liability&#148;). The Company concluded that the Series F tranche liability met the definition of a freestanding financial instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company estimated the fair value of the Series F tranche liability at the initial issuance date and at subsequent remeasurement date of June&nbsp;30, 2020
and determined that the Series F tranche liability had no value at either date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Stockholders&#146; Equity </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, the Company is
authorized to issue 92,354,260 shares of Class&nbsp;A common stock, and 47,000,000 shares of Class&nbsp;B common stock, each with a par value of $0.0001 per share. As of June&nbsp;30, 2020 and December&nbsp;31, 2019, common stock outstanding
consists of 10,656,452 and 10,651,152 shares of Class&nbsp;B common stock, respectively and 578,089 and 578,089 shares of Class&nbsp;A common stock, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2010 Equity Incentive Plan </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Company&#146;s 2010
Equity Incentive Plan (the Plan), the Company may grant options to purchase or directly issue shares of common stock to employees, directors, and <FONT STYLE="white-space:nowrap">non-employees.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Options may be granted at a price per share not less than 100% of the fair market value at the date of grant. If the option is granted to a 10% stockholder,
then the purchase or exercise price per share shall not be less than 110% of the fair market value per share of the common stock on the grant date. Options granted generally vest over a period of four years and have
<FONT STYLE="white-space:nowrap">ten-year</FONT> contractual terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock option activity under the Plan is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares<BR>Available<BR>for&nbsp;Issuance</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted<BR>Average<BR>Exercise<BR>Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;Average<BR>Remaining<BR>Contractual Term<BR>(Years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,031,367</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,789,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6.32</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(288,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">288,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cancelled and forfeited<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">392,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(392,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,300</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at June&nbsp;30, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,134,867</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,680,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5.96</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested and exercisable&#151;June&nbsp;30, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,925,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All option grants approved after July 2013 are from the Class&nbsp;A option pool. Class&nbsp;B cancellation and
forfeitures are converted from Class&nbsp;B to Class&nbsp;A upon return to the option pool. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There were 5,300 vested shares exercised
during the six months ended June&nbsp;30, 2020 at the aggregate intrinsic value of less than $0.1&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Options with a fair value of
$4.4&nbsp;million and $2.9&nbsp;million vested in the six months ended June&nbsp;30, 2020 and 2019, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional information regarding options outstanding at June&nbsp;30, 2020, is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Exercise&nbsp;Price&nbsp;per&nbsp;Share</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Options</B><br><B>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;Average</B><br><B>Remaining</B><br><B>Contractual Life</B><br><B>(Years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">$ 0.44</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">418,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;0.52</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">792,775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;1.84</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">162,880</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;2.59</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,673,035</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;4.22</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">663,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;4.24</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,238,691</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;5.28</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,113,399</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;5.33</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,075,197</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;5.41</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,417</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;9.56</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,215,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;9.58</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">283,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,680,510</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following weighted average assumptions were used as inputs to the Black-Scholes OPM in determining the estimated
grant-date fair value of the Company&#146;s stock options to employees: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six Months<BR>Ended June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.43</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average fair value at grant date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, the Company had employee and <FONT STYLE="white-space:nowrap">non-employee</FONT> stock-based
compensation of $18.6&nbsp;million related to unvested stock options not yet recognized that are expected to be recognized over an estimated weighted average period of 2.74&nbsp;years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total stock-based compensation expense recognized in the accompanying statements of operations and comprehensive loss for all equity awards is as follows
(amounts in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six Months Ended<BR>June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,382</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,867</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Earnings (Loss) Per Share </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Basic and diluted earnings per share were the same for each period presented as the inclusion of all potential Class&nbsp;A common stock and Class&nbsp;B
common stock outstanding would have been anti-dilutive. Basic and diluted earnings per share are the same for each class of common stock because they are entitled to the same liquidation and dividend rights. Since the Company has net loss, there are
no dilutive equity awards. The following table sets </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
forth the computation of basic and diluted loss per Class&nbsp;A common stock and Class&nbsp;B common stock (amounts in thousands, except share and per share amounts): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six Months Ended June 30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Numerator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(29,319</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(23,501</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Denominator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average Class A and Class B common shares outstanding-Basic and Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,233,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,181,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share attributable to Class A and Class&nbsp;B Common stockholders- Basic and
Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2.61</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2.10</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table presents the potential common shares outstanding that were excluded from the computation of diluted net
loss per share of common stock as of the periods presented because including them would have been antidilutive: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Six Months Ended June&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series&nbsp;A convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,192,245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,192,245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series&nbsp;B convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,381,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,381,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Series&nbsp;B-1</FONT> convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,076,037</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,076,037</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series&nbsp;C convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,258,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,258,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series D convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,983,189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,983,189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series E convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants to purchase Series A convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,586</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,586</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants to purchase Series C convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">129,718</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">129,718</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,680,510</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,961,529</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,325,665</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,606,684</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. Joint Venture and <FONT STYLE="white-space:nowrap">Non-controlling</FONT> interest </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company entered into a JVA with VGA and formed the JV entity. The Company determined the entity was a variable interest entity with a related party, and
the Company&#146;s operations were more closely associated with the JV entity. As such, the Company consolidated the JV entity for financial reporting purposes, and a <FONT STYLE="white-space:nowrap">non-controlling</FONT> interest was recorded for
VGA&#146;s interest in the net assets and operations of QSV operations to the extent of the VGA investment. The Company&#146;s consolidated balance sheet includes $3.4&nbsp;million cash and cash equivalents and less than $0.1&nbsp;million of prepaid
expenses of the JV entity at June&nbsp;30, 2020 ($3.4&nbsp;million and less than $0.1&nbsp;million, respectively at December&nbsp;31, 2019). Although the Company has consolidated the net assets of the JV entity, it has no right to the use of those
assets for its standalone operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the change in <FONT STYLE="white-space:nowrap">non-controlling</FONT>
interest for the six months ended June&nbsp;30, 2020 (amounts in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-controlling</FONT><BR>interest</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,710</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to <FONT STYLE="white-space:nowrap">non-controlling</FONT> interest in
consolidated JV</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at June&nbsp;30, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,705</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&nbsp;14, 2020, the Company amended the JVA and other related agreements regarding the JV entity in connection with
VGA&#146;s investment of $200.0&nbsp;million in the Company&#146;s Series F convertible preferred stock as described in Note 8. The Company determined the amendments represented a reconsideration event and determined that the JV entity is still a
variable interest entity. As the significance and nature of the business of the JV entity continues to be more aligned with the core business of the Company and the Company continues to absorb a majority of the variability associated with the JV
entity&#146;s anticipated economic performance, the Company continues to be the related party most closely associated with the JV entity. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Income
Taxes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;27, 2020, the U.S. President signed into law the CARES Act, an economic stimulus package in response to the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> global pandemic. The CARES Act contains several corporate income tax provisions, including making remaining alternative minimum tax credits immediately refundable; providing a
<FONT STYLE="white-space:nowrap">5-year</FONT> carryback of net operating loss carryforwards (&#147;NOLs&#148;) generated in tax years 2018, 2019, and 2020, and removing the 80% taxable income limitation on utilization of those NOLs if carried back
to prior tax years or utilized in tax years beginning before 2021; and temporarily liberalizing the interest deductibility rules under Section&nbsp;163(j) of the Tax Cuts and Jobs Act, by raising the adjusted taxable income limitation from 30% to
50% for tax years 2019 and 2020 and giving taxpayers the election of using 2019 adjusted taxable income for purposes of computing 2020 interest deductibility. The Company is still evaluating the impact but does not currently expect the provisions of
the CARES Act to have a material effect on the realizability of deferred income tax assets or tax expense. There is no material impact for the six months ended June&nbsp;30, 2020. As additional guidance is released, the Company will evaluate whether
there would need to be a change in the period when such guidance is issued. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. Related Parties Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Joint Venture Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In September&nbsp;11, 2018, the
Company entered into a Joint Venture Agreement with VWGoA and VGA as described in Note 2 and Note 11. In connection with this agreement, the parties also have entered into 2 operative agreements: (i)&nbsp;the Limited Liability Company Agreement of
the JV entity to govern the respective rights and obligations as Members of the JV entity and (ii)&nbsp;the Common IP License Agreement for the Company to license certain intellectual property rights pertaining to automotive battery cells as defined
in the JV Agreement to VWGoA, VGA and the JV Entity. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Related Parties </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One of the members of the Board of Directors is also a consultant to the Company, providing expertise in the area of science and materials. This board member
was paid $0.1&nbsp;million under a consulting agreement during the six months ended June&nbsp;30, 2020 and 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Subsequent Events </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has evaluated subsequent events through September&nbsp;21, 2020, the date the financial statements were available to be issued. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2020, we settled an outstanding legal matter regarding a former employee pursuant to which the Company received $0.8&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From July through September 2020, the Company granted 3,231,625 restricted stock units to employees as part of the annual refresh program and 673,030 stock
options to new employees and an independent Board of Director member. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&nbsp;3, 2020, Kensington Capital Acquisition Corp
(&#147;Kensington&#148;), together with Merger Sub, its fully owned subsidiary, announced that the Company will enter into a business combination transaction pursuant to which Merger Sub will merge with and into the Company with the Company
surviving the merger as a wholly owned subsidiary of Kensington. If such business combination is ultimately completed, the Company would effectively comprise all of Kensington&#146;s material operations. The business combination agreement requires
the investment of $500.0&nbsp;million from other private investors (PIPE) in addition to the $230.0&nbsp;million already available in KCAC account. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_17a"></A>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Shareholders and Board of Directors of </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kensington Capital Acquisition Corp. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Opinion on the
Financial Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have audited the accompanying balance sheet of Kensington Capital Acquisition Corp. (the &#147;Company&#148;) as of
May&nbsp;1, 2020, the related statements of operations, changes in stockholder&#146;s equity and cash flows for the period<B> </B>from April&nbsp;17, 2020 (inception) through May&nbsp;1, 2020, and the related notes (collectively referred to as the
&#147;financial statements&#148;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of May&nbsp;1, 2020, and the results of its operations and its cash flows for the period
from April&nbsp;17, 2020 (inception) through May&nbsp;1, 2020, in conformity with accounting principles generally accepted in the United States of America. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Explanatory Paragraph&#151;Going Concern </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 1 to the financial statements, the Company&#146;s ability to execute its business plan is dependent upon
its completion of the proposed initial public offering described in Note 3 to the financial statements. The Company had a working capital deficit as of May&nbsp;1, 2020 of $39,000 and lacks the financial resources it needs to sustain operations for
a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. These conditions raise substantial doubt about the Company&#146;s ability to continue as a going concern. Management&#146;s plans in
regard to these matters are also described in Note 1 and 3. The financial statements do not include any adjustments that might become necessary should the Company be unable to continue as a going concern. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis for Opinion </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These financial statements are the
responsibility of the Company&#146;s management. Our responsibility is to express an opinion on the Company&#146;s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (&#147;PCAOB&#148;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As
part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#146;s internal control over financial reporting.
Accordingly, we express no such opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our audit included performing procedures to assess the risks of material misstatement of the financial
statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also
included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>/s/ Marcum <SMALL>LLP</SMALL> </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Marcum <SMALL>LLP</SMALL>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have served as the Company&#146;s auditor since 2020 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May&nbsp;8, 2020, except for Note 7 as to which
the date is June&nbsp;26, 2020 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_17"></A>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BALANCE SHEET </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>May&nbsp;1, 2020 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Current assets:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred offering costs associated with the proposed public offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">86,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Liabilities and Stockholders&#146; Equity:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Current liabilities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">64,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total current liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">64,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Commitments</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Stockholders&#146; Equity:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and
outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Class A common stock, $0.0001 par value; 100,000,000 shares authorized; none issued and
outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 5,750,000 shares issued and
outstanding <SUP STYLE="font-size:85%; vertical-align:top">(1)(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total stockholders&#146; equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Liabilities and Stockholders&#146; Equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>86,500</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This number includes up to 750,000 Class&nbsp;B common stock subject to forfeiture if the over-allotment option
is not exercised in full or in part by the underwriters. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On June&nbsp;25, 2020, the Company effected a stock dividend with respect to the Class&nbsp;B common stock,
resulting in the sponsor holding an aggregate of 5,750,000 founder shares . All shares and associated amounts have been retroactively restated to reflect the share capitalization (see Note 4). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>See accompanying notes to financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_18"></A>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STATEMENT OF OPERATIONS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the period from April&nbsp;17, 2020 (inception) through May&nbsp;1, 2020 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Weighted average shares outstanding, basic and diluted <SUP
STYLE="font-size:85%; vertical-align:top">(1)(2)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Basic and diluted net loss per share</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.00</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>(1)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>This number excludes an aggregate of up to 750,000 Class&nbsp;B common stock subject to forfeiture if the
over-allotment option is not exercised in full or in part by the underwriters. </I></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>(2)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>On June&nbsp;25, 2020, the Company effected a stock dividend with respect to the Class&nbsp;B common stock,
resulting in the sponsor holding an aggregate of 5,750,000 founder shares . All shares and associated amounts have been retroactively restated to reflect the share capitalization (see Note 4). </I></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>See accompanying notes to financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_19"></A>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STATEMENT OF CHANGES IN STOCKHOLDER&#146;S EQUITY </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the period from April&nbsp;17, 2020 (inception) through May&nbsp;1, 2020 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Additional&nbsp;Paid-In</FONT></B><br><B>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Stockholder&#146;s</B><br><B>Equity</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Class&nbsp;A</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Class&nbsp;B</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance - April 17, 2020 (inception)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Class&nbsp;B common stock to Sponsor
<SUP STYLE="font-size:85%; vertical-align:top">(1)(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance - May 1, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>(1)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>This number includes up to 750,000 Class&nbsp;B common stock subject to forfeiture if the over-allotment
option is not exercised in full or in part by the underwriters. </I></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>(2)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>On June&nbsp;25, 2020, the Company effected a stock dividend with respect to the Class&nbsp;B common stock,
resulting in the sponsor holding an aggregate of 5,750,000 founder shares . All shares and associated amounts have been retroactively restated to reflect the share capitalization (see Note 4). </I></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>See accompanying notes to financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_20"></A>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STATEMENT OF CASH FLOWS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the period from April&nbsp;17, 2020 (inception) through May&nbsp;1, 2020 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash Flows from Operating Activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash provided by (used in) operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash Flows from Financing Activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of Class&nbsp;B common stock to Sponsor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash provided by financing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net change in cash</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash - beginning of the period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash - end of the period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>25,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Supplemental disclosure of noncash activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred offering costs included in accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">61,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>See accompanying notes to financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="fintoc14810_21"></A>Note 1&#151;Description of Organization, Business Operations and Basis of
Presentation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kensington Capital Acquisition Corp. (the &#147;Company&#148;) was incorporated in Delaware on April&nbsp;17, 2020. The Company was
formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the&nbsp;&#147;Business Combination&#148;). Although the Company is
not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company intends to focus its search for a target business in the automotive and automotive-related sector. The Company is an emerging growth
company and, as such, the Company is subject to all of the risks associated with emerging growth companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of May&nbsp;1, 2020, the Company had not
commenced any operations. All activity for the period from April&nbsp;17, 2020 (inception) through May&nbsp;1, 2020 relates to the Company&#146;s formation and the proposed initial public offering described below. The Company will not generate any
operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will <FONT STYLE="white-space:nowrap">generate&nbsp;non-operating&nbsp;income&nbsp;in</FONT> the form of interest income on cash and cash
equivalents from the proceeds derived from the Proposed Public Offering (as&nbsp;defined below). The Company has selected December&nbsp;31 as its fiscal year end. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s sponsor is Kensington Capital Sponsor LLC, a Delaware limited liability company (the &#147;Sponsor&#148;). The Company&#146;s ability to
commence operations is contingent upon obtaining adequate financial resources through a proposed public offering (the &#147;Proposed Public Offering&#148;) of 20,000,000 units (each, a &#147;Unit&#148; and collectively, the &#147;Units&#148;) at
$10.00 per Unit (or 23,000,000 units if the underwriters&#146; over-allotment&nbsp;option is exercised in full), which is discussed in Note&nbsp;3, and the sale of 5,975,000 warrants (or 6,575,000 warrants if the underwriters&#146;
over-allotment&nbsp;option is exercised in full) (each, a &#147;Private Placement Warrant&#148; and collectively, the &#147;Private Placement Warrants&#148;), at a price of $1.00 per Private Placement Warrant in a private placement to the Sponsor
that will close simultaneously with the Proposed Public Offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s management has broad discretion with respect to the specific
application of the net proceeds of the Proposed Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is
no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete an initial Business Combination with one or more operating businesses or assets with a fair market value equal to at least 80% of
the net assets held in the Trust Account (as defined below) (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting discount). However, the Company will only complete
a Business Combination if the post-transaction&nbsp;company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to
register as an investment company under the Investment Company Act 1940, as amended (the &#147;Investment Company Act&#148;). Upon the closing of the Proposed Public Offering, management has agreed that an amount equal to at least $10.00 per Unit
sold in the Proposed Public Offering, including proceeds from the sale of the Private Placement Warrants to the Sponsor, will be held in a trust account (&#147;Trust Account&#148;) located in the United States with Continental Stock
Transfer&nbsp;&amp; Trust Company acting as trustee, and invested only in U.S. &#147;government securities,&#148; within the meaning set forth in Section&nbsp;2(a)(16)&nbsp;of the Investment Company Act, with a maturity of 185 days or less, or in
money market funds meeting certain conditions under <FONT STYLE="white-space:nowrap">Rule&nbsp;2a-7&nbsp;under&nbsp;the</FONT> Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the Company,
until the earlier of: (i)&nbsp;the completion of a Business Combination and (ii)&nbsp;the distribution of the Trust Account as described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company will provide holders of the Company&#146;s outstanding shares of Class&nbsp;A common stock, par value $0.0001 per share, sold in the Proposed Public Offering (the &#147;Public Stockholders&#148;) with the opportunity to redeem all or a
portion of their Public Shares (as defined below) upon the completion of a Business Combination either (i)&nbsp;in&nbsp;connection with a stockholder meeting called to approve the Business Combination or (ii)&nbsp;by means of a tender offer. The
decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially anticipated to be $10.00 per Public Share), calculated
as of two business days prior to the initial Business Combination, including interest earned on the funds held in the trust account and not previously released to the Company to pay the Company&#146;s taxes, net of taxes payable. <FONT
STYLE="white-space:nowrap">The&nbsp;per-share&nbsp;amount&nbsp;to</FONT> be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as
discussed in Note 5). These Public Shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Proposed Public Offering in accordance with the Financial Accounting Standards Board&#146;s
(&#147;FASB&#148;) Accounting Standards Codification (&#147;ASC&#148;) Topic 480 &#147;Distinguishing Liabilities from Equity.&#148; The Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the
Business Combination. The Company will not redeem the Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. If a stockholder vote is not required by applicable law or stock exchange rule and the Company does
not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its amended and restated certificate of incorporation (the &#147;Certificate of Incorporation&#148;), conduct the redemptions pursuant to the tender
offer rules of the U.S. Securities and Exchange Commission (&#147;SEC&#148;) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law
or stock exchange rule, or the Company decides to obtain stockholder approval for business or reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer
rules. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in
connection with a Business Combination, the initial stockholders (as defined below) have agreed to vote any Founder Shares (as defined below in Note 4) and any Public Shares held by them in favor of a Business Combination. In addition, the initial
stockholders have agreed to waive their redemption rights with respect to any Founder Shares and any Public Shares held by them in connection with the completion of a Business Combination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such
stockholder is acting in concert or as a &#147;group&#148; (as defined under Section&nbsp;13 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;)), will be restricted from redeeming its shares with respect to more than
an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sponsor and the Company&#146;s officers and directors
(the &#147;initial stockholders&#148;) have agreed, pursuant to a letter agreement with the Company, that they will not propose any amendment to the Certificate of Incorporation (A)&nbsp;to modify the substance or timing of the Company&#146;s
obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (B)&nbsp;with
respect to any other provision relating to stockholders&#146; rights <FONT STYLE="white-space:nowrap">or&nbsp;pre-initial&nbsp;Business</FONT> Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem
their Public Shares upon approval of any such amendment at a <FONT STYLE="white-space:nowrap">per-share</FONT> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be
net of taxes payable) divided by the number of then outstanding Public Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Company is unable to complete a Business Combination within
24&nbsp;months from the closing of the Proposed Public Offering (as such period may be extended pursuant to the Certificate of Incorporation, the &#147;Combination Period&#148;), the Company will (i)&nbsp;cease all operations except for the purpose
of winding up, (ii)&nbsp;as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at <FONT STYLE="white-space:nowrap">a&nbsp;per-share&nbsp;price,</FONT> payable in cash, equal to the aggregate
amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company&#146;s taxes, net of taxes payable (less up to $100,000 of interest to pay
dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders&#146; rights as stockholders (including the right to receive further liquidating distributions, if any),
and (iii)&nbsp;as promptly </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
as reasonably possible following such redemption, subject to the approval of the Company&#146;s remaining stockholders and the Company&#146;s board of directors, dissolve and liquidate, subject
in each case to the Company&#146;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company&#146;s
warrants, which will expire worthless if the Company fails to complete its initial Business Combination within the Combination Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The initial
stockholders have agreed to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete a Business Combination within the Combination Period. However, if the
initial stockholders acquire Public Shares in or after the Proposed Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination
within the Combination Period. The underwriters have agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within in the
Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per
share value of the residual assets remaining available for distribution (including Trust Account assets) will be only, or less than, $10.00. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the
Company if and to the extent any claims by a third party (except for the Company&#146;s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has
discussed entering into a transaction agreement (a &#147;Target&#148;), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii)&nbsp;the actual amount per Public Share held in the Trust Account as
of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target
that executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company&#146;s indemnity of the underwriters of the Proposed Public Offering against certain liabilities, including
liabilities under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, then the Sponsor will not be responsible to the extent of
any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target
businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Going Concern Consideration </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of May&nbsp;1, 2020, the
Company had $25,000 in cash and a working capital deficiency of $39,000. Further, the Company has incurred and expect to continue to incur significant costs in pursuit of its financing and acquisition plans. Management&#146;s plans to address this
need for capital through the Proposed Public Offering. The Company cannot assure that its plans to raise capital or to consummate an initial Business Combination will be successful. These factors, among others, raise substantial doubt about the
Company&#146;s ability to continue as a going concern. The financial statements do not include any adjustments that might result from its inability to consummate the Proposed Public Offering or its inability to continue as a going concern. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis of Presentation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying financial
statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (&#147;U.S. GAAP&#148;) and pursuant to the rules and regulations of the SEC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Emerging Growth Company </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is an &#147;emerging growth company,&#148; as defined in Section&nbsp;2(a) of the Securities Act, as modified by the Jumpstart Our Business
Startups Act of 2012 (the &#147;JOBS Act&#148;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to,
not being required to comply with the independent registered public accounting firm attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and
proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, Section&nbsp;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised
financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to <FONT STYLE="white-space:nowrap">non-emerging</FONT> growth
companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or
private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This may make comparison of the Company&#146;s financial statements with another public company that is neither an emerging growth company nor an emerging
growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 2&#151;Summary of Significant Accounting Policies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Concentration of Credit Risk </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that
potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. At May&nbsp;1, 2020, the Company has not
experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial Instruments
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the Company&#146;s assets and liabilities, which qualify as financial instruments under FASB ASC 820, &#147;Fair Value Measurements
and Disclosures,&#148; approximates the carrying amounts represented in the balance sheet. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Use of Estimates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with U.S. GAAP requires the Company&#146;s management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities during the reporting period. Actual results could differ from those estimates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Deferred Offering Costs Associated with the Proposed Public Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to
the Proposed Public Offering and that will be charged to stockholder&#146;s equity upon the completion of the Proposed Public Offering. Should the Proposed Public Offering prove to be unsuccessful, these deferred costs, as well as additional
expenses to be incurred, will be charged to operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Net Loss Per Common Share </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#147;Earnings Per Share.&#148; Net loss per share is computed by
dividing net loss by the weighted average number of shares of common stock outstanding during the period excluding common stock subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 750,000 shares of common
stock that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (Note 5). At May&nbsp;1, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or
converted into shares of common stock and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Income Taxes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company follows the asset and liability
method of accounting for income taxes under FASB ASC 740, &#147;Income Taxes.&#148; Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying
amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax
assets to the amount expected to be realized. Deferred tax assets were deemed immaterial as of May&nbsp;1, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FASB ASC 740 prescribes a recognition
threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of May&nbsp;1, 2020. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were
accrued for the payment of interest and penalties as of May&nbsp;1, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is
subject to income tax examinations by major taxing authorities since inception. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Accounting Pronouncements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material
effect on the accompanying financial statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 3&#151;Proposed Public Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Proposed Public Offering, the Company intends to offer for sale 20,000,000 units at a price of $10.00 per Unit. Each Unit consists of one share
of Class&nbsp;A common stock (such shares of common stock included in the Units being offered, the &#147;Public Shares&#148;), <FONT STYLE="white-space:nowrap">and&nbsp;one-half&nbsp;of&nbsp;one</FONT> redeemable warrant (each, a &#147;Public
Warrant&#148;). Each whole Public Warrant entitles the holder to purchase one share of Class&nbsp;A common stock at a price of $11.50 per share, subject to adjustment (see Note 6). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will grant the underwriters <FONT STYLE="white-space:nowrap">a&nbsp;45-day&nbsp;option&nbsp;from</FONT> the date of the final prospectus relating
to the Proposed Public Offering to purchase up to 3,000,000 additional Units to cover over-allotments, if any, at the Proposed Public Offering price, less underwriting discounts and commissions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 4&#151;Related Party Transactions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Founder Shares
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;17, 2020, the Sponsor subscribed to purchase 5,031,250&nbsp;shares of the Company&#146;s Class&nbsp;B common stock, par value $0.0001
per share (the &#147;Founder Shares&#148;), and fully paid for those shares on May&nbsp;1, 2020. On </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
June&nbsp;25, 2020, the Company effected a stock dividend with respect to the Class&nbsp;B common stock, resulting in the Sponsor holding an aggregate of 5,750,000 founder shares. All shares and
associated amounts have been retroactively restated to reflect the share capitalization. The initial stockholders have agreed to forfeit up to 750,000 Founder Shares to the extent that the over-allotment&nbsp;option is not exercised in full by the
underwriters. The forfeiture will be adjusted to the extent that the over-allotment&nbsp;option is not exercised in full by the underwriters so that the Founder Shares will represent 20.0% of the Company&#146;s issued and outstanding shares of
common stock after the Proposed Public Offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The initial stockholders will agree, subject to limited exceptions, not to transfer, assign or sell any
of the Founder Shares until the earlier to occur of: (A)&nbsp;one year after the completion of the initial Business Combination or (B)&nbsp;subsequent to the initial Business Combination, (x)&nbsp;if the last reported sale price of the Class&nbsp;A
common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within <FONT STYLE="white-space:nowrap">any&nbsp;30-trading&nbsp;day</FONT>
period commencing at least 150 days after the initial Business Combination, or (y)&nbsp;the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the
Company&#146;s stockholders having the right to exchange their shares of common stock for cash, securities or other property. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Private Placement
Warrants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sponsor will agree to purchase an aggregate of 5,975,000 Private Placement Warrants (or 6,575,000 Private Placement Warrants if the
underwriters&#146; over-allotment&nbsp;option is exercised in full), at a price of $1.00 per Private Placement Warrant ($5,975,000 in the aggregate, or $6,575,000 if the underwriters&#146; over-allotment&nbsp;option is exercised in full) in a
private placement that will occur simultaneously with the closing of the Proposed Public Offering. Each whole Private Placement Warrant is exercisable for one whole share of Class&nbsp;A&nbsp;common stock at a price of $11.50 per share, subject to
adjustment. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor will be added to the proceeds from the Proposed Public Offering to be held in the Trust Account. If the Company does not complete a Business
Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will <FONT STYLE="white-space:nowrap">be&nbsp;non-redeemable&nbsp;for&nbsp;cash</FONT> (except as described below) and
exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sponsor will agree, subject to limited
exceptions, not to transfer, assign or sell the Private Placement Warrants until 30 days after the completion of the initial Business Combination. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Related Party Loans </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;17, 2020, the Sponsor
agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Proposed Public Offering pursuant to a promissory note (the &#147;Note&#148;). This loan
<FONT STYLE="white-space:nowrap">is&nbsp;non-interest&nbsp;bearing&nbsp;and</FONT> payable on the earlier of October&nbsp;31, 2020 and the completion of the Proposed Public Offering. As of May&nbsp;5, 2020, the Company has borrowed $75,000 under the
Note. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or
an affiliate of the Sponsor, or certain of the Company&#146;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#147;Working Capital Loans&#148;). If the Company completes a Business Combination, the
Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans could be repaid only out of funds held outside the Trust Account. In the event that a Business
Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital
Loans would either be repaid upon consummation of a Business Combination or, at the lender&#146;s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00
per warrant. The warrants would be identical to the Private </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the
Company had no borrowings under the Working Capital Loans. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Service and Administrative Fees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has agreed to pay service and administrative fees of $20,000 per month to DEHC LLC, an affiliate of Daniel Huber, the Company&#146;s Chief
Financial Officer, for up to 18 months commencing on the date of consummation of the Proposed Public Offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sponsor, executive officers and
directors, or any of their respective affiliates, will be reimbursed for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">any&nbsp;out-of-pocket&nbsp;expenses&nbsp;incurred</FONT></FONT> in connection with activities on the
Company&#146;s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company&#146;s audit committee will review on a quarterly basis all payments that were made by the Company to
the Sponsor, officers, directors or their affiliates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 5&#151;Commitments&nbsp;&amp; Contingencies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of Founder Shares,
Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, and any shares of Class&nbsp;A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued
upon conversion of Working Capital Loans and upon conversion of the Founder Shares will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to the consummation of the Proposed Public Offering. These
holders will be entitled to certain demand and &#147;piggyback&#148; registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Underwriting Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriters will be entitled
to an underwriting discount of $0.20 per unit, or $4,000,000 in the aggregate (or approximately $4,600,000 in the aggregate if the underwriters&#146; over-allotment&nbsp;option is exercised in full), payable upon the closing of the Proposed Public
Offering. $0.35 per unit, or approximately $7,000,000 in the aggregate (or approximately $8,050,000 in the aggregate if the underwriters&#146; over-allotment&nbsp;option is exercised in full) will be payable to the underwriters for deferred
underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 6&#151;Stockholder&#146;s Equity </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Class</I></B><B><I></I></B><B><I>&nbsp;A Common Stock</I></B>&#151;The Company is authorized to issue 100,000,000&nbsp;shares of Class&nbsp;A common
stock with a par value of $0.0001 per share. As of May&nbsp;1, 2020, there were no shares of Class&nbsp;A common stock issued or outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Class</I></B><B><I></I></B><B><I>&nbsp;B Common Stock</I></B>&#151;The Company is authorized to issue 10,000,000 shares of Class&nbsp;B common stock
with a par value of $0.0001 per share. On April&nbsp;17, 2020, the Sponsor subscribed to purchase 5,031,250&nbsp;shares of Class&nbsp;B common stock, which was fully paid on May&nbsp;1, 2020. On June&nbsp;25, 2020, the Company effected a stock
dividend with respect to the Class&nbsp;B common stock, resulting in the Sponsor holding an aggregate of 5,750,000 founder shares. All shares and associated amounts have been retroactively restated to reflect the share capitalization. Of these, an
aggregate of up to 750,000 shares of Class&nbsp;B common stock that are subject to forfeiture to the Company by the initial stockholders for no consideration to the extent that the underwriters&#146; over-allotment&nbsp;option is not exercised in
full or in part, so that the number of Founder Shares will equal 20% of the Company&#146;s issued and outstanding shares of common stock after the Proposed Public Offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders of record are entitled to one vote for each share held on all matters to be voted on by
stockholders; provided that, prior to the completion of the initial Business Combination, holders of the Class&nbsp;B common stock will have the right to elect all of the Company&#146;s directors and remove members of the Company&#146;s board of
directors for any reason. Prior to the completion of the initial Business Combination, only holders of the Class&nbsp;B common stock will have the right to vote on the Company&#146;s election of directors. Holders of the Public Shares will not be
entitled to vote on the Company&#146;s election of directors during such time. In addition, prior to the completion of the initial Business Combination, holders of a majority of the outstanding shares of the Class&nbsp;B common stock may remove a
member of the Company&#146;s board of directors for any reason. These provisions of the Certificate of Incorporation may only be amended by a resolution passed by the holders of a majority of shares of the Class&nbsp;B common stock. With respect to
any other matter submitted to a vote of the Company&#146;s stockholders, including any vote in connection with the initial Business Combination, holders of the Class&nbsp;A common stock and holders of the Class&nbsp;B common stock will vote together
as a single class on all matters submitted to a vote of the Company&#146;s stockholders, except as required by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Class&nbsp;B common stock will
automatically convert into Class&nbsp;A common stock at the time of the initial Business Combination, or earlier at the option of the holders, on
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">a&nbsp;one-for-one&nbsp;basis,&nbsp;subject</FONT></FONT> to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further
adjustment as described herein. In the case that additional shares of Class&nbsp;A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Proposed Offering and related to the closing of the
initial Business Combination, including pursuant to a specified future issuance, the ratio at which shares of Class&nbsp;B common stock shall convert into shares of Class&nbsp;A common stock will be adjusted (unless the holders of a majority of the
then-outstanding shares of Class&nbsp;B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance, including a specified future issuance) so that the number of shares of Class&nbsp;A common stock issuable upon
conversion of all shares of Class&nbsp;B common stock will equal, in the aggregate, on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of
the Proposed Public Offering plus all shares of Class&nbsp;A common stock and equity-linked securities issued or deemed issued in connection with the initial Business Combination (excluding any shares or equity-linked securities issued or issuable
to any seller in the initial Business Combination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Preferred Stock</I></B>&#151;The Company is authorized to issue 1,000,000&nbsp;shares of
preferred stock, par value $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company&#146;s board of directors. As of May&nbsp;1, 2020, there were no shares of preferred
stock issued or outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Warrants</I></B>&#151;Public Warrants may only be exercised for a whole number of shares. No fractional Public
Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12&nbsp;months from the
closing of the Proposed Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the issuance of the shares of Class&nbsp;A common stock issuable upon exercise of the Public
Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to
exercise their Public Warrants on a cashless basis under the circumstances specified in the warrant agreement). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business
Combination, the Company will use its commercially reasonable efforts to file, and within 60 business days following the initial Business Combination to have declared effective, a registration statement covering the issuance of the shares of
Class&nbsp;A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class&nbsp;A common stock until the warrants expire or are redeemed; provided, that if the Class&nbsp;A common stock is
at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a &#147;covered security&#148; under Section&nbsp;18(b)(1) of the Securities Act, the Company may, at its option, require
holders of Public Warrants who exercise their warrants to do so on a &#147;cashless basis&#148; in accordance with Section&nbsp;3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
required to file or maintain in effect a registration statement, but it will be required to use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an
exemption is not available. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The warrants will have an exercise price of $11.50 per share. If (x)&nbsp;the Company issue additional shares or equity-linked securities for capital raising
purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations,
recapitalizations and the like) (with such issue price or effective issue price to be determined in good faith by the Company&#146;s board of directors, and in the case of any such issuance to the Sponsor, initial stockholders or their affiliates,
without taking into account any Founder Shares held by them prior to such issuance) (the &#147;Newly Issued Price&#148;), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest
thereon, available for the funding of the initial Business Combination on the date of the consummation of the Initial Business Combination (net of redemptions), and (z)&nbsp;the volume weighted average trading price of the Company&#146;s shares of
Class&nbsp;A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the &#147;Market Value&#148;) is below $9.20 per share, the
exercise price of each warrant will be adjusted (to the nearest cent) such that the effective exercise price per full share will be equal to 115% of the higher of (i)&nbsp;the Market Value and (ii)&nbsp;the Newly Issued Price, and the $18.00 per
share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of (i)&nbsp;the Market Value and (ii)&nbsp;the Newly Issued Price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Private Placement Warrants will be identical to the Public Warrants, except that (1)&nbsp;the Private Placement Warrants and the shares of Class&nbsp;A
common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (2)&nbsp;the Private Placement
Warrants will <FONT STYLE="white-space:nowrap">be&nbsp;non-redeemable</FONT> (except as described below) so&nbsp;long as they are held by the Sponsor or its permitted transferees, (3)&nbsp;the Private Placement Warrants may be exercised by the
holders on a cashless basis and (4)&nbsp;the holders of the Private Placement Warrants (including with respect to the shares of common stock issuable upon exercise of the Private Placement Warrants) are entitled to registration rights. If the
Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by such holders on the same basis as the
Public Warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may call the Public Warrants for redemption: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in whole and not in part; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at a price of $0.01 per warrant; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon a minimum of 30 days&#146; prior written notice of redemption; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, and only if, the last reported sale price of the Class&nbsp;A common stock equals or exceeds $18.00 per share
(as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within <FONT STYLE="white-space:nowrap">the&nbsp;30-trading&nbsp;day&nbsp;period</FONT> ending on the third business day prior
to the date on which the Company sends the notice of redemption to the warrant holders. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Company calls the Public Warrants for
redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#147;cashless basis,&#148; as described in the warrant agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, commencing ninety days after the warrants become exercisable, the Company may redeem the outstanding warrants: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in whole and not in part; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at $0.10 per warrant upon a minimum of 30 days&#146; prior written notice of redemption provided that holders
will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares of Class&nbsp;A common stock to be determined by reference to a table in the warrant agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, and only if, the last reported sale price of the Company&#146;s Class&nbsp;A common stock equals or exceeds
$10.00&nbsp;per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, and only if, the Private Placement Warrants are also concurrently called for redemption at the same price
(equal to a number of shares of Class&nbsp;A common stock) as the outstanding Public Warrants, as described above; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, and only if, there is an effective registration statement covering the shares of Class&nbsp;A common stock
(or a security other than the Class&nbsp;A common stock into which the Class&nbsp;A common stock has been converted or exchanged for in the event the Company is not the surviving company in the initial Business Combination) issuable upon exercise of
the warrants and a current prospectus relating thereto available throughout the <FONT STYLE="white-space:nowrap">30-day</FONT> period after written notice of redemption is given. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination
Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company&#146;s assets held outside of the
Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 7&#151;Subsequent Events </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subsequent to May&nbsp;1, 2020, the Company has borrowed $75,000 under the Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company evaluated events that have occurred after the balance sheet date through May&nbsp;8, 2020, which is the date on which these financial statements
were issued. Based upon this review, except as below, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;25, 2020, the Company effected a stock dividend of 718,750 shares, resulting in the Sponsor holding an aggregate of 5,750,000 Founder Shares, of
which an aggregate of up to 750,000 shares are subject to forfeiture. All share and <FONT STYLE="white-space:nowrap">per-share</FONT> amounts have been retroactively restated to reflect the stock dividend. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of the execution of the underwriting agreement on June&nbsp;25, 2020, the financial statements have been modified to reflect the final terms of
the agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_12"></A><A NAME="rom14810_69"></A>KENSINGTON CAPITAL ACQUISITION
CORP. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNAUDITED CONDENSED BALANCE SHEET </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>JUNE&nbsp;30, 2020 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,739,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">237,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total current assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,977,494</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash held in Trust Account</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">230,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>231,977,494</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Liabilities and Stockholders&#146; Equity:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">255,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Franchise tax payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,548</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Note payable - related party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total current liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">488,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred underwriting commissions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,050,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,538,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Commitments and Contingencies</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Class&nbsp;A common stock, par value $0.0001 per share; 21,843,927 shares subject to possible
redemption at $10.00 per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">218,439,270</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Stockholders&#146; Equity:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock, par value $0.0001 per share; 1,000,000 shares authorized; none issued and
outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Class&nbsp;A common stock, par value $0.0001 per share; 100,000,000 shares authorized;
1,156,073&nbsp;shares issued and outstanding (excluding 21,843,927 shares subject to possible redemption)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Class&nbsp;B common stock, par value $0.0001 per share; 10,000,000 shares authorized;
5,750,000&nbsp;shares issued and outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,062,172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(62,862</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total stockholders&#146; equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Liabilities and Stockholders&#146; Equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>231,977,494</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these unaudited condensed financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_13"></A>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNAUDITED CONDENSED STATEMENT OF OPERATIONS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE PERIOD FROM APRIL&nbsp;17, 2020 (INCEPTION) THROUGH JUNE&nbsp;30, 2020 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,314</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Franchise tax expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,548</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(62,862</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Weighted average shares outstanding, basic and diluted <SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,031,247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Basic and diluted net loss per share</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.01</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>(1)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>This number excludes an aggregate of up to 21,843,927 shares of Class&nbsp;A common stock subject to
possible redemption. </I></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these unaudited condensed financial
statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_14"></A>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNAUDITED CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS&#146; EQUITY </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE PERIOD FROM APRIL&nbsp;17, 2020 (INCEPTION) THROUGH JUNE&nbsp;30, 2020 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional</B><br><B><FONT STYLE="white-space:nowrap">Paid-In</FONT></B><br><B>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>Stockholders&#146;</B><br><B>Equity</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Class&nbsp;A</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Class&nbsp;B</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance - April 17, 2020 (inception)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Class&nbsp;B common stock to Sponsor</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sale of units in initial public offering, gross</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">229,997,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">230,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Offering costs</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,097,867</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,097,867</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sale of private placement warrants to Sponsor in private placement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,575,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,575,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock subject to possible redemption</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21,843,927</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,184</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(218,437,086</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(218,439,270</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(62,862</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(62,862</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance - June 30, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,156,073</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>116</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,750,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>575</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,062,172</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(62,862</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,000,001</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these unaudited condensed financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_15"></A>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNAUDITED CONDENSED STATEMENT OF CASH FLOWS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE PERIOD FROM APRIL&nbsp;17, 2020 (INCEPTION) THROUGH JUNE&nbsp;30, 2020 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash Flows from Operating Activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(62,862</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,297</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">227,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(207,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Franchise tax payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,548</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash used in operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,611</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash Flows from Investing Activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash deposited in Trust Account</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(230,000,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash used in investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(230,000,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash Flows from Financing Activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of Class&nbsp;B common stock to Sponsor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds received from note payable to related party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds received from initial public offering, gross</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">230,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds received from private placement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,575,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Offering costs paid</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,907,692</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash provided by financing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">231,767,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net change in cash</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,739,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash - beginning of the period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash - end of the period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,739,697</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Supplemental disclosure of noncash activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Offering costs included in accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">117,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Offering costs included in accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred underwriting commissions in connection with the initial public offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,050,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial value of common stock subject to possible redemption</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">218,439,270</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses included in accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">207,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses included in accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these unaudited condensed financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fintoc14810_16"></A>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 1&#151;Description of Organization, Business Operations and Basis of Presentation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kensington Capital Acquisition Corp. (the &#147;Company&#148;) was incorporated in Delaware on April&nbsp;17, 2020. The Company was formed for the purpose of
effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the &#147;Business Combination&#148;). Although the Company is not limited to a particular
industry or sector for purposes of consummating a Business Combination, the Company intends to focus its search for a target business in the automotive and automotive-related sector. The Company is an emerging growth company and, as such, the
Company is subject to all of the risks associated with emerging growth companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, the Company had not commenced any operations.
All activity for the period from April&nbsp;17, 2020 (inception) through June&nbsp;30, 2020 relates to the Company&#146;s formation and the initial public offering (the &#147;Initial Public Offering&#148;) described below. The Company will not
generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate <FONT STYLE="white-space:nowrap">non-operating</FONT> income in the form of interest income on cash and cash
equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December&nbsp;31 as its fiscal year end. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company&#146;s sponsor is Kensington Capital Sponsor LLC, a Delaware limited liability company (the &#147;Sponsor&#148;). The registration statement for the Company&#146;s Initial Public Offering was declared effective on June&nbsp;25, 2020. On
June&nbsp;30, 2020, the Company consummated its Initial Public Offering of 23,000,000 units (the &#147;Units&#148; and, with respect to the Class&nbsp;A common stock included in the Units sold, the &#147;Public Shares&#148;), including 3,000,000
additional Units to cover over-allotments (the &#147;Over-Allotment Units&#148;), at $10.00 per Unit, generating gross proceeds of $230.0&nbsp;million, and incurring offering costs of approximately $13.1&nbsp;million, inclusive of approximately
$8.1&nbsp;million in deferred underwriting commissions (Note 5). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Simultaneously with the closing of the Initial Public Offering, the Company consummated
the private placement (&#147;Private Placement&#148;) of 6,575,000 warrants (each, a &#147;Private Placement Warrant&#148; and collectively, the &#147;Private Placement Warrants&#148;) at a price of $1.00 per Private Placement Warrant to the
Sponsor, generating proceeds of approximately $6.6&nbsp;million (Note 4). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the closing of the Initial Public Offering and the Private Placement,
$230.0&nbsp;million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was held in a trust account (&#147;Trust Account&#148;) located in the United States with Continental Stock
Transfer&nbsp;&amp; Trust Company acting as trustee, and invested only in U.S. &#147;government securities,&#148; within the meaning set forth in Section&nbsp;2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in money
market funds meeting certain conditions under Rule <FONT STYLE="white-space:nowrap">2a-7</FONT> under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of:
(i)&nbsp;the completion of a Business Combination and (ii)&nbsp;the distribution of the Trust Account as described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s management
has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally
toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete an initial Business Combination with one or more operating businesses or
assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred
underwriting discount). However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the
&#147;Investment Company Act&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will provide holders of the Company&#146;s outstanding shares of Class&nbsp;A common stock, par value
$0.0001 per share, sold in the Initial Public Offering (the &#147;Public Stockholders&#148;) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i)&nbsp;in connection with a
stockholder meeting called to approve the Business Combination or (ii)&nbsp;by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the
Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially $10.00 per Public Share), calculated as of two business days
prior to the initial Business Combination, including interest earned on the funds held in the trust account and not previously released to the Company to pay the Company&#146;s taxes, net of taxes payable. The
<FONT STYLE="white-space:nowrap">per-share</FONT> amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in
Note 5). These Public Shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board&#146;s (&#147;FASB&#148;)
Accounting Standards Codification (&#147;ASC&#148;) Topic 480 &#147;Distinguishing Liabilities from Equity.&#148; The Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination.
The Company will not redeem the Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. If a stockholder vote is not required by applicable law or stock exchange rule and the Company does not decide to hold a
stockholder vote for business or other reasons, the Company will, pursuant to its amended and restated certificate of incorporation (the &#147;Certificate of Incorporation&#148;), conduct the redemptions pursuant to the tender offer rules of the
U.S. Securities and Exchange Commission (&#147;SEC&#148;) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange
rule, or the Company decides to obtain stockholder approval for business or reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules.
Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection
with a Business Combination, the initial stockholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares held by them in favor of a Business Combination. In addition, the initial
stockholders have agreed to waive their redemption rights with respect to any Founder Shares and any Public Shares held by them in connection with the completion of a Business Combination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Certificate of Incorporation provided that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such
stockholder is acting in concert or as a &#147;group&#148; (as defined under Section&nbsp;13 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;)), will be restricted from redeeming its shares with respect to more than
an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sponsor and the Company&#146;s officers and directors
(the &#147;initial stockholders&#148;) agreed, pursuant to a letter agreement with the Company, that they will not propose any amendment to the Certificate of Incorporation (A)&nbsp;to modify the substance or timing of the Company&#146;s obligation
to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (B)&nbsp;with respect to any
other provision relating to stockholders&#146; rights or <FONT STYLE="white-space:nowrap">pre-initial</FONT> Business Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares upon
approval of any such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amendment at a <FONT STYLE="white-space:nowrap">per-share</FONT> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest
shall be net of taxes payable) divided by the number of then outstanding Public Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Company is unable to complete a Business Combination
within 24 months from the closing of the Initial Public Offering, or June&nbsp;30, 2022, (as such period may be extended pursuant to the Certificate of Incorporation, the &#147;Combination Period&#148;), the Company will (i)&nbsp;cease all
operations except for the purpose of winding up, (ii)&nbsp;as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a <FONT STYLE="white-space:nowrap">per-share</FONT> price, payable in cash,
equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company&#146;s taxes, net of taxes payable (less up to $100,000
of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders&#146; rights as stockholders (including the right to receive further liquidating
distributions, if any), and (iii)&nbsp;as promptly as reasonably possible following such redemption, subject to the approval of the Company&#146;s remaining stockholders and the Company&#146;s board of directors, dissolve and liquidate, subject in
each case to the Company&#146;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company&#146;s
warrants, which will expire worthless if the Company fails to complete its initial Business Combination within the Combination Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The initial
stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares held by them if the Company fails to complete a Business Combination within the Combination Period. However, if the
initial stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination
within the Combination Period. The underwriters have agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within in the
Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per
share value of the residual assets remaining available for distribution (including Trust Account assets) will be only, or less than, $10.00. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the
Company if and to the extent any claims by a third party (except for the Company&#146;s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has
discussed entering into a transaction agreement (a &#147;Target&#148;), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii)&nbsp;the actual amount per Public Share held in the Trust Account as
of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target
that executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company&#146;s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including
liabilities under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, then the Sponsor will not be responsible to the extent of
any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target
businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity and Capital Resources </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As indicated in the accompanying unaudited condensed financial statements, at June&nbsp;30, 2020, the Company had approximately $1.7&nbsp;million in cash, and
working capital of approximately $1.5&nbsp;million (not taken into account tax obligations). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s liquidity needs prior to the consummation
of the Initial Public Offering were satisfied through the proceeds of $25,000 from the sale of the Founders Shares (as defined in Note 4), and loan proceeds from the Sponsor of $75,000 (which is still outstanding to date). Subsequent from the
consummation of the Initial Public Offering, the Company&#146;s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier
of the consummation of a Business Combination or one&nbsp;year from this filing. Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable, identifying and evaluating
prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the
Business Combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management is currently evaluating the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on the industry and
effect on the Company&#146;s financial position, results of its operations and/or search for a target company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 2&#151;Summary of Significant
Accounting Policies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis of Presentation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (&#147;GAAP&#148;) for financial information and pursuant to the rules
and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal
recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the period for the period from April&nbsp;17, 2020 (inception) through June&nbsp;30, 2020 are not necessarily
indicative of the results that may be expected through December&nbsp;31, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying unaudited condensed financial statements should be read
in conjunction with the audited financial statements and notes thereto included in the Form <FONT STYLE="white-space:nowrap">8-K</FONT> and the final prospectus filed by the Company with the SEC on July&nbsp;7, 2020 and June&nbsp;26, 2020,
respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Emerging Growth Company </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company
is an &#147;emerging growth company,&#148; as defined in Section&nbsp;2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#147;JOBS Act&#148;), and it may take advantage of certain exemptions from various
reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements
of Section&nbsp;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and stockholder approval of any golden parachute payments not previously approved. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, Section&nbsp;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to
comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act)
are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to <FONT
STYLE="white-space:nowrap">non-emerging</FONT> growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and
it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This may make comparison of the Company&#146;s financial statements with another public company that is neither an emerging growth company nor an emerging
growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash and Cash Equivalents </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company considers all
short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of June&nbsp;30, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash held in Trust Account </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At June&nbsp;30, 2020, the
Company had $230.0&nbsp;million in cash held in the Trust Account. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Concentration of Credit Risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at
times, may exceed the Federal Depository Insurance Coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial Instruments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the
Company&#146;s assets and liabilities, which qualify as financial instruments under FASB ASC&nbsp;820, &#147;Fair Value Measurements and Disclosures,&#148; approximates the carrying amounts represented in the condensed financial statements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Use of Estimates </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of the financial
statements in conformity with U.S. GAAP requires the Company&#146;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the
financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Offering Costs Associated with the Initial Public Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial
Public Offering and that were charged to stockholders&#146; equity upon the completion of the Initial Public Offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Class&nbsp;A common stock subject to possible redemption </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for its Class&nbsp;A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 &#147;Distinguishing
Liabilities from Equity.&#148; Class&nbsp;A common stock subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class&nbsp;A common stock (including Class&nbsp;A
common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#146;s control) are classified as temporary equity. At all
other times, Class&nbsp;A common stock is classified as stockholders&#146; equity. The Company&#146;s Class&nbsp;A common stock feature certain redemption rights that are considered to be outside of the Company&#146;s control and subject to the
occurrence of uncertain future events. Accordingly, at June&nbsp;30, 2020, 21,843,927 shares of Class&nbsp;A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders&#146; equity
section of the Company&#146;s balance sheet. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Net Loss Per Common Share </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#147;Earnings Per Share.&#148; Net loss per share is computed by
dividing net loss by the weighted average number of shares of common stock outstanding during the period excluding common stock subject to forfeiture. An aggregate of 21,843,927 shares of Class&nbsp;A common stock subject to possible redemption at
June&nbsp;30, 2020 has been excluded from the calculation of basic loss per share of common stock, since such shares, if redeemed, only participate in their pro rata share of the trust earnings. The Company has not considered the effect of the
warrants sold in the Initial Public Offering (including the consummation of the Over-Allotment Units) and Private Placement to purchase an aggregate of 18,075,000 shares of the Company&#146;s common stock in the calculation of diluted loss per
share, since the exercise of the warrants are contingent upon the occurrence of future events. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Reconciliation of net loss per common share
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s net loss is adjusted for the portion of income (loss) that is attributable to Class&nbsp;A common stock subject to redemption,
as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per common share is calculated as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For&nbsp;The&nbsp;Period&nbsp;From</B><br><B>April&nbsp;17, 2020</B><br><B>(inception)&nbsp;through</B><br><B>June&nbsp;30, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(62,862</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Income attributable to Class&nbsp;A ordinary shares subject to possible redemption</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(62,862</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average ordinary shares outstanding, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,031,247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted net loss per ordinary share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(0.01</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Income Taxes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company
follows the asset and liability method of accounting for income taxes under FASB ASC 740, &#147;Income Taxes.&#148; Deferred tax assets and liabilities are recognized for the estimated future tax consequences
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured
using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income
in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed immaterial as of June&nbsp;30, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or
expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June&nbsp;30, 2020. The
Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June&nbsp;30, 2020. The Company is currently not aware of any
issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;27, 2020, President Trump signed the Coronavirus Aid, Relief, and Economic Security &#147;CARES&#148; Act into law. The CARES Act includes
several significant business tax provisions that, among other things, would eliminate the taxable income limit for certain net operating losses (&#147;NOL) and allow businesses to carry back NOLs arising in 2018, 2019 and 2020 to the five prior
years, suspend the excess business loss rules, accelerate refunds of previously generated corporate alternative minimum tax credits, generally loosen the business interest limitation under IRC section 163(j) from 30&nbsp;percent to 50&nbsp;percent
among other technical corrections included in the Tax Cuts and Jobs Act tax provisions. The Company does not believe that the CARES Act will have a significant impact on Company&#146;s financial position or statement of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Accounting Standards </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s
management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted would have a material effect on the accompanying financial statements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 3&#151;Initial Public Offering </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&nbsp;30,
2020, the Company sold 23,000,000 Units, including 3,000,000 Over-Allotment Units, at a price of $10.00 per Unit, generating gross proceeds of $230.00&nbsp;million, and incurring offering costs of approximately $13.1&nbsp;million, inclusive of
approximately $8.1&nbsp;million in deferred underwriting commissions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Unit consists of one share of Class&nbsp;A common stock and <FONT
STYLE="white-space:nowrap">one-half</FONT> of one redeemable warrant (each, a &#147;Public Warrant&#148;). Each whole Public Warrant entitles the holder to purchase one share of Class&nbsp;A common stock at a price of $11.50 per share, subject to
adjustment (see Note 6). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 4&#151;Related Party Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Founder Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;17, 2020, the Sponsor
subscribed to purchase 5,031,250 shares of the Company&#146;s Class&nbsp;B common stock, par value $0.0001 per share (the &#147;Founder Shares&#148;), and fully paid for those shares on June&nbsp;30, 2020. On June&nbsp;25, 2020, the Company effected
a stock dividend with respect to the Class&nbsp;B common stock, resulting in the Sponsor holding an aggregate of 5,750,000 founder shares. All shares and associated amounts have been </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
retroactively restated to reflect the share capitalization. The initial stockholders agreed to forfeit up to 750,000 Founder Shares to the extent that the over-allotment option is not exercised
in full by the underwriters so that the Founder Shares represented 20.0% of the Company&#146;s issued and outstanding shares of common stock after the Initial Public Offering. The underwriter exercised its over-allotment option in full on
June&nbsp;30, 2020; thus, the 750,000 Founder Shares were no longer subject to forfeiture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The initial stockholders agreed, subject to limited
exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A)&nbsp;one year after the completion of the initial Business Combination or (B)&nbsp;subsequent to the initial Business Combination, (x)&nbsp;if
the last reported sale price of the Class&nbsp;A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any <FONT
STYLE="white-space:nowrap">30-trading</FONT> day period commencing at least 150&nbsp;days after the initial Business Combination, or (y)&nbsp;the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or
other similar transaction that results in all of the Company&#146;s stockholders having the right to exchange their shares of common stock for cash, securities or other property. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Private Placement Warrants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Simultaneously with the
closing of the Initial Public Offering, the Company sold 6,575,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant to the Sponsor, generating gross proceeds of approximately $6.6&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each whole Private Placement Warrant is exercisable for one whole share of Class&nbsp;A common stock at a price of $11.50 per share, subject to adjustment. A
portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the
Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be <FONT STYLE="white-space:nowrap">non-redeemable</FONT> for cash (except as described below) and exercisable on a cashless basis so long
as they are held by the Sponsor or its permitted transferees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sponsor agreed, subject to limited exceptions, not to transfer, assign or sell the
Private Placement Warrants until 30 days after the completion of the initial Business Combination. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Related Party Loans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;17, 2020, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant
to a promissory note (the &#147;Note&#148;). This loan is <FONT STYLE="white-space:nowrap">non-interest</FONT> bearing and payable upon the completion of the Initial Public Offering. As of June&nbsp;30, 2020, the Company has borrowed $75,000 under
the Note. To date, the balance of the Note remains outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in order to fund working capital deficiencies or finance transaction costs
in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#146;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#147;Working Capital
Loans&#148;). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans could be repaid only out of funds
held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be
used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender&#146;s </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be
identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the Company had no borrowings under
the Working Capital Loans. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Service and Administrative Fees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has agreed to pay service and administrative fees of $20,000 per month to DEHC LLC, an affiliate of Daniel Huber, the Company&#146;s Chief
Financial Officer, for up to 18 months commencing on the date of consummation of the Initial Public Offering. The Company believes that these fees are being paid on arms&#146; length terms and comparable to fees typically paid for similar services
by other special purpose acquisition companies. As of June&nbsp;30, 2020, the Company incurred $20,000 in general and administrative expenses in the accompanying condensed statement of operations and $20,000 in accounts payable in the accompanying
balance sheet in connection with such services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sponsor, executive officers and directors, or any of their respective affiliates, will be reimbursed
for any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred in connection with activities on the Company&#146;s behalf such as identifying potential target businesses and performing due
diligence on suitable Business Combinations. The Company&#146;s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, officers, directors or their affiliates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 5&#151;Commitments&nbsp;&amp; Contingencies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of Founder Shares,
Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, and any shares of Class&nbsp;A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued
upon conversion of Working Capital Loans and upon conversion of the Founder Shares will be entitled to registration rights pursuant to a registration rights. These holders will be entitled to certain demand and &#147;piggyback&#148; registration
rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Underwriting Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriters were entitled to an underwriting discount of $0.20 per unit, or $4.6&nbsp;million in the aggregate, paid upon the closing of the Initial
Public Offering. In addition, $0.35 per unit, or approximately $8.1&nbsp;million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts
held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 6&#151;Stockholders&#146; Equity </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Preferred
Stock</I></B>&#151;The Company is authorized to issue 1,000,000 shares of preferred stock, par value $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company&#146;s
board of directors. As of June&nbsp;30, 2020, there were no shares of preferred stock issued or outstanding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Class</I></B><B><I></I></B><B><I>&nbsp;A Common Stock</I></B>&#151;The Company is authorized to issue
100,000,000 shares of Class&nbsp;A common stock with a par value of $0.0001 per share. As of June&nbsp;30, 2020, there were 23,000,000 shares of Class&nbsp;A common stock issued or outstanding, including 21,843,927 shares of Class&nbsp;A common
stock subject to possible redemption, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Class</I></B><B><I></I></B><B><I>&nbsp;B Common Stock</I></B>&#151;The Company is authorized to
issue 10,000,000 shares of Class&nbsp;B common stock with a par value of $0.0001 per share. On April&nbsp;17, 2020, the Sponsor subscribed to purchase 5,031,250 shares of Class&nbsp;B common stock, which was fully paid on June&nbsp;30, 2020. On
June&nbsp;25, 2020, the Company effected a stock dividend with respect to the Class&nbsp;B common stock, resulting in the Sponsor holding an aggregate of 5,750,000 founder shares. All shares and associated amounts have been retroactively restated to
reflect the share capitalization. Of these, an aggregate of up to 750,000 shares of Class&nbsp;B common stock that were subject to forfeiture to the Company by the initial stockholders for no consideration to the extent that the underwriters&#146;
over-allotment option is not exercised in full or in part, so that the number of Founder Shares equals 20% of the Company&#146;s issued and outstanding shares of common stock after the Initial Public Offering. The underwriter exercised its
over-allotment option in full on June&nbsp;30, 2020; thus, the 750,000 Founder Shares were no longer subject to forfeiture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders of record are
entitled to one vote for each share held on all matters to be voted on by stockholders; provided that, prior to the completion of the initial Business Combination, holders of the Class&nbsp;B common stock will have the right to elect all of the
Company&#146;s directors and remove members of the Company&#146;s board of directors for any reason. Prior to the completion of the initial Business Combination, only holders of the Class&nbsp;B common stock will have the right to vote on the
Company&#146;s election of directors. Holders of the Public Shares will not be entitled to vote on the Company&#146;s election of directors during such time. In addition, prior to the completion of the initial Business Combination, holders of a
majority of the outstanding shares of the Class&nbsp;B common stock may remove a member of the Company&#146;s board of directors for any reason. These provisions of the Certificate of Incorporation may only be amended by a resolution passed by the
holders of a majority of shares of the Class&nbsp;B common stock. With respect to any other matter submitted to a vote of the Company&#146;s stockholders, including any vote in connection with the initial Business Combination, holders of the
Class&nbsp;A common stock and holders of the Class&nbsp;B common stock will vote together as a single class on all matters submitted to a vote of the Company&#146;s stockholders, except as required by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Class&nbsp;B common stock will automatically convert into Class&nbsp;A common stock at the time of the initial Business Combination, or earlier at the
option of the holders, on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to
further adjustment as described herein. In the case that additional shares of Class&nbsp;A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Proposed Offering and related to the closing of
the initial Business Combination, including pursuant to a specified future issuance, the ratio at which shares of Class&nbsp;B common stock shall convert into shares of Class&nbsp;A common stock will be adjusted (unless the holders of a majority of
the then-outstanding shares of Class&nbsp;B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance, including a specified future issuance) so that the number of shares of Class&nbsp;A common stock issuable
upon conversion of all shares of Class&nbsp;B common stock will equal, in the aggregate, on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, 20% of the sum of the total number of all shares of common stock outstanding upon the
completion of the Initial Public Offering plus all shares of Class&nbsp;A common stock and equity-linked securities issued or deemed issued in connection with the initial Business Combination (excluding any shares or equity-linked securities issued
or issuable to any seller in the initial Business Combination). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Warrants</I></B>&#151;Public Warrants may only be exercised for a whole number of
shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering; provided in each case that the
Company has an effective registration statement under the Securities Act covering the issuance of the shares of Class&nbsp;A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such
shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their Public Warrants on a cashless basis under the
circumstances specified in the warrant agreement). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use its commercially
reasonable efforts to file, and within 60 business days following the initial Business Combination to have declared effective, a registration statement covering the issuance of the shares of Class&nbsp;A common stock issuable upon exercise of the
warrants and to maintain a current prospectus relating to those shares of Class&nbsp;A common stock until the warrants expire or are redeemed; provided, that if the Class&nbsp;A common stock is at the time of any exercise of a warrant not listed on
a national securities exchange such that it satisfies the definition of a &#147;covered security&#148; under Section&nbsp;18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants
to do so on a &#147;cashless basis&#148; in accordance with Section&nbsp;3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, but it will be required
to use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon
redemption or liquidation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The warrants have an exercise price of $11.50 per share. If (x)&nbsp;the Company issue additional shares or equity-linked
securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (as adjusted for stock splits, stock dividends, rights issuances,
subdivisions, reorganizations, recapitalizations and the like) (with such issue price or effective issue price to be determined in good faith by the Company&#146;s board of directors, and in the case of any such issuance to the Sponsor, initial
stockholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance) (the &#147;Newly Issued Price&#148;), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total
equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the Initial Business Combination (net of redemptions), and (z)&nbsp;the volume weighted average trading price of
the Company&#146;s shares of Class&nbsp;A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the &#147;Market Value&#148;) is
below $9.20 per share, the exercise price of each warrant will be adjusted (to the nearest cent) such that the effective exercise price per full share will be equal to 115% of the higher of (i)&nbsp;the Market Value and (ii)&nbsp;the Newly Issued
Price, and the $18.00&nbsp;per share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of (i)&nbsp;the Market Value and (ii)&nbsp;the Newly Issued Price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Private Placement Warrants are identical to the Public Warrants, except that (1)&nbsp;the Private Placement Warrants and the shares of Class&nbsp;A common
stock issuable upon exercise of the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (2)&nbsp;the Private Placement Warrants
are be <FONT STYLE="white-space:nowrap">non-redeemable</FONT> (except as described below) so long as they are held by the Sponsor or its permitted transferees, (3)&nbsp;the Private Placement Warrants may be exercised by the holders on a cashless
basis and (4)&nbsp;the holders of the Private Placement Warrants (including with respect to the shares of common stock issuable upon exercise of the Private Placement Warrants) are entitled to registration rights. If the Private Placement Warrants
are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by such holders on the same basis as the Public Warrants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may call the Public Warrants for redemption: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in whole and not in part; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at a price of $0.01 per warrant; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon a minimum of 30 days&#146; prior written notice of redemption; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, and only if, the last reported sale price of the Class&nbsp;A common stock equals or exceeds $18.00 per share
(as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within the <FONT STYLE="white-space:nowrap">30-trading</FONT> day period ending on the third business day prior to the date on
which the Company sends the notice of redemption to the warrant holders. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Company calls the Public Warrants for redemption,
management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#147;cashless basis,&#148; as described in the warrant agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, commencing ninety days after the warrants become exercisable, the Company may redeem the outstanding warrants: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in whole and not in part; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at $0.10 per warrant upon a minimum of 30 days&#146; prior written notice of redemption provided that holders
will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares of Class&nbsp;A common stock to be determined by reference to a table in the warrant agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, and only if, the last reported sale price of the Company&#146;s Class&nbsp;A common stock equals or exceeds
$10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, and only if, the Private Placement Warrants are also concurrently called for redemption at the same price
(equal to a number of shares of Class&nbsp;A common stock) as the outstanding Public Warrants, as described above; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, and only if, there is an effective registration statement covering the shares of Class&nbsp;A common stock
(or a security other than the Class&nbsp;A common stock into which the Class&nbsp;A common stock has been converted or exchanged for in the event the Company is not the surviving company in the initial Business Combination) issuable upon exercise of
the warrants and a current prospectus relating thereto available throughout the <FONT STYLE="white-space:nowrap">30-day</FONT> period after written notice of redemption is given. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination
Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company&#146;s assets held outside of the
Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 7&#151;Fair Value Measurements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company follows the guidance in ASC 820 for its financial assets and liabilities that are <FONT STYLE="white-space:nowrap">re-measured</FONT> and reported
at fair value at each reporting period, and <FONT STYLE="white-space:nowrap">non-financial</FONT> assets and liabilities that are <FONT STYLE="white-space:nowrap">re-measured</FONT> and reported at fair value at least annually. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the Company&#146;s financial assets and liabilities reflects management&#146;s estimate of
amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with
measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market
participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or
liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level 2: Observable inputs other than Level&nbsp;1 inputs. Examples of Level&nbsp;2 inputs include quoted prices
in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level 3: Unobservable inputs based on the Company&#146;s assessment of the assumptions that market participants
would use in pricing the asset or liability. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>June&nbsp;30, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash held in Trust Account</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">230,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note 8&#151;Subsequent Events </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October 2, 2020, a putative class action lawsuit was filed against the Company. The complaint names the Company and certain members of the Company&#146;s
board as defendants. The complaint alleges, among other things, breach of fiduciary duty claims in connection with the proposed business combination with QuantumScape Corporation. Management with its legal counsel are currently evaluating the merits
of the complaint and as of June 30, 2020, the Company had not accrued any amounts for this contingency. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="rom14810_70"></A>Annex A
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">BUSINESS COMBINATION AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">among </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Kensington Capital
Acquisition Corp. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Kensington Capital Merger Sub Corp. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">QuantumScape Corporation
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of September&nbsp;2, 2020 </P> <P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:48pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="94%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE I. DEFINITIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 1.01. Certain Definitions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 1.02. Further Definitions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 1.03. Construction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE II. AGREEMENT AND PLAN OF MERGER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 2.01. The Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 2.02. Effective Time; Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 2.03. Effect of the Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 2.04. Certificate of Incorporation; Bylaws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 2.05. Directors and Officers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE III. CONVERSION OF SECURITIES; EXCHANGE OF CERTIFICATES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 3.01. Conversion of Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 3.02. Exchange of Certificates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 3.03. Stock Transfer Books</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 3.04. Payment of Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 3.05. Appraisal Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 3.06. Calculation of Exchange Ratio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IV. REPRESENTATIONS AND WARRANTIES OF THE COMPANY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.01. Organization and Qualification; Subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.02. Certificate of Incorporation and Bylaws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.03. Capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.04. Authority Relative to this Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.05. No Conflict; Required Filings and Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.06. Permits; Compliance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.07. Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.08. Absence of Certain Changes or Events</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.09. Absence of Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.10. Employee Benefit Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.11. Labor and Employment Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.12. Real Property; Title to Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.13. Intellectual Property Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.14. Taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.15. Environmental Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.16. Material Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.17. Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.18. Board Approval; Vote Required</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.19. Certain Business Practices</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.20. Interested Party Transactions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.21. Exchange Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.22. Brokers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 4.23. Exclusivity of Representations and Warranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="94%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE V. REPRESENTATIONS AND WARRANTIES OF KENSINGTON AND MERGER SUB</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.01. Corporate Organization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.02. Certificate of Incorporation and Bylaws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.03. Capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.04. Authority Relative to This Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.05. No Conflict; Required Filings and Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.06. Compliance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.07. SEC Filings; Financial Statements; Sarbanes-Oxley</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.08. Absence of Certain Changes or Events</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.09. Absence of Litigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.10. Board Approval; Vote Required</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.11. No Prior Operations of Merger Sub</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.12. Brokers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.13. Kensington Trust Fund</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.14. Employees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.15. Taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.16. Listing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 5.17. Kensington and Merger Sub&#146;s Investigation and Reliance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VI. CONDUCT OF BUSINESS PENDING THE MERGER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 6.01. Conduct of Business by the Company Pending the Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 6.02. Conduct of Business by Kensington and Merger Sub Pending the Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 6.03. Claims Against Trust Account</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VII. ADDITIONAL AGREEMENTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 7.01. Proxy Statement; Registration Statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 7.02. Kensington Stockholders&#146; Meetings; and Merger Sub Stockholder&#146;s
Approval</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 7.03. Company Stockholders&#146; Written Consent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 7.04. Access to Information; Confidentiality</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 7.05. Company Solicitation; Change in Recommendation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 7.06. Kensington Exclusivity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 7.07. Employee Benefits Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 7.08. Directors&#146; and Officers&#146; Indemnification</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 7.09. Notification of Certain Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 7.10. Further Action; Reasonable Best Efforts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 7.11. Public Announcements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 7.12. Tax Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 7.13. Stock Exchange Listing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 7.14. Antitrust</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 7.15. PCAOB Audited Financials</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 7.16. Trust Account</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 7.17. Governance Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VIII. CONDITIONS TO THE MERGER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 8.01. Conditions to the Obligations of Each Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 8.02. Conditions to the Obligations of Kensington and Merger Sub</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 8.03. Conditions to the Obligations of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="94%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IX. TERMINATION, AMENDMENT AND WAIVER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 9.01. Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 9.02. Effect of Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 9.03. Termination Fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE X. GENERAL PROVISIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 10.01. Notices</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 10.02. Nonsurvival of Representations, Warranties and Covenants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 10.03. Severability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 10.04. Entire Agreement; Assignment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 10.05. Parties in Interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 10.06. Governing Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 10.07. Waiver of Jury Trial</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 10.08. Headings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 10.09. Counterparts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 10.10. Specific Performance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 10.11. Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 10.12. Amendment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION 10.13. Waiver</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EXHIBIT A Form of Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EXHIBIT B Form of Certificate of Incorporation of Kensington </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SCHEDULE A Key Company Stockholders </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SCHEDULE B Company
Knowledge Parties </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>BUSINESS COMBINATION AGREEMENT </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Business Combination Agreement dated as of September&nbsp;2, 2020 (this &#147;<B>Agreement</B>&#148;) is among Kensington Capital
Acquisition Corp., a Delaware corporation (&#147;<B>Kensington</B>&#148;), Kensington Capital Merger Sub Corp., a Delaware corporation (&#147;<B>Merger Sub</B>&#148;) and QuantumScape Corporation, a Delaware corporation (the
&#147;<B>Company</B>&#148;).&nbsp;Capitalized terms used but not defined elsewhere herein have the meanings assigned to them in <U>Section</U><U></U><U>&nbsp;1.01</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Merger Sub is a wholly-owned direct subsidiary of Kensington; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, upon the terms and subject to the conditions of this Agreement and in accordance with the General Corporation Law of the State of
Delaware (the &#147;<B>DGCL</B>&#148;), Kensington and the Company will enter into a business combination transaction pursuant to which Merger Sub will merge with and into the Company (the &#147;<B>Merger</B>&#148;), with the Company surviving the
Merger as a wholly owned subsidiary of Kensington; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board of Directors of the Company (the &#147;<B>Company Board</B>&#148;)
has unanimously (a)&nbsp;determined that this Agreement and the Merger are fair to, and in the best interests of, the Company and its stockholders, (b)&nbsp;approved and adopted this Agreement and the Merger and declared their advisability,
(c)&nbsp;approved the Merger and the other Transactions, (d)&nbsp;recommended the approval and adoption of this Agreement and the Merger by the stockholders of the Company, and (e)&nbsp;directed that, unless this Agreement has been terminated in
accordance with <U>Section</U><U></U><U>&nbsp;9.01</U>, that this Agreement and the Transactions (including the Merger) be submitted for consideration by the Company&#146;s stockholders; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board of Directors of Kensington (the &#147;<B>Kensington Board</B>&#148;) has (a)&nbsp;approved and adopted this Agreement and
declared its advisability and approved the payment of the Per Share Merger Consideration pursuant to this Agreement and the other Transactions, and (b)&nbsp;recommended the approval and adoption of this Agreement and the Transactions by the
stockholders of Kensington; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board of Directors of Merger Sub (the &#147;<B>Merger Sub Board</B>&#148;) has
(a)&nbsp;determined that this Agreement and the Merger are fair to, and in the best interests of, Merger Sub and its sole stockholder, (b)&nbsp;approved and adopted this Agreement and the Merger and declared their advisability, (c)&nbsp;approved the
Merger and the other Transactions, (d)&nbsp;recommended the approval and adoption of this Agreement and the Merger by the sole stockholder of Merger Sub, and (e)&nbsp;directed that this Agreement and the Transactions (including the Merger) be
submitted for consideration by the sole stockholder of Merger Sub; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Kensington, the Company and the Key Company Stockholders (as
defined below), concurrently with the execution and delivery of this Agreement, are entering into the Stockholder Support Agreement, dated as of the date of this Agreement (the &#147;<B>Stockholder Support Agreement</B>&#148;), pursuant to which,
among other things, the Key Company Stockholders will vote their shares of Company Common Stock and Company Preferred Stock in favor of this Agreement, the Merger and the other Transactions at the time specified therein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Kensington, certain stockholders of the Company and one of the stockholders of Kensington, concurrently with the execution and
delivery of this Agreement, are entering into a Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement (the &#147;<B>Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement</B>&#148;) in the form
attached as <U>Exhibit A</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Kensington will enter into subscription agreements (the &#147;<B>Subscription
Agreements</B>&#148;) with certain investors pursuant to which such investors, upon the terms and subject to the conditions set forth therein, will purchase shares of Kensington Common Stock at a purchase price of $10.00 in a private placement or
placements (the &#147;<B>Private Placements</B>&#148;) to be consummated immediately prior to the consummation of the transactions contemplated hereby; and </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, for United States federal income tax purposes, it is intended that the Merger shall
qualify as a reorganization within the meaning of Section&nbsp;368(a) of the Code, that the Company, Merger Sub and Kensington are parties to such reorganization within the meaning of Section&nbsp;368(b) of the Code and that this Agreement
constitutes a plan of reorganization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing, the parties hereby agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION 1.01.<U>&nbsp;Certain Definitions</U>.&nbsp;For purposes of this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Acceptable Confidentiality Agreement</B>&#148; means a confidentiality agreement that contains confidentiality and standstill
provisions on terms no less favorable in any substantive respect to the Company than those contained in the Confidentiality Agreement (except for such changes specifically necessary in order for the Company to be able to comply with its obligations
under this Agreement and such <FONT STYLE="white-space:nowrap">non-material</FONT> changes requested by the counterparty to ensure the confidentiality agreement is consistent with its organization&#146;s customary policies, procedures and practices
with respect to confidentiality agreements). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>affiliate</B>&#148; of a specified person means a person who, directly or
indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, such specified person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Ancillary Agreements</B>&#148; means the Stockholder Support Agreement, the Registration Rights and
<FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement and all other agreements, certificates and instruments executed and delivered by Kensington, Merger Sub or the Company in connection with the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Data</B>&#148; means all business information and data, including Personal Information (whether of employees, contractors,
consultants, customers, consumers, or other persons and whether in electronic or any other form or medium) that is accessed, collected, used, processed, stored, shared, distributed, transferred, disclosed, destroyed, or disposed of by any of the
Business Systems or otherwise in the course of the conduct of the business of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Day</B>&#148; means any day
on which the principal offices of the SEC in Washington, D.C. are open to accept filings, or, in the case of determining a date when any payment is due, any day on which banks are not required or authorized to close in New York, NY. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Systems</B>&#148; means all Software, computer hardware (whether general or special purpose), electronic data processing,
information, record keeping, communications, telecommunications, networks, interfaces, platforms, servers, peripherals, and computer systems, including any outsourced systems and processes, that are owned or used in the conduct of the business of
the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Acquisition Proposal</B>&#148; means any proposal or offer from any person or group of persons (other than
Kensington, Merger Sub or their respective affiliates) relating to, in a single transaction or a series of related transactions, any direct or indirect acquisition or purchase of a business that constitutes 10% or more of the assets of the Company
or 10% or more of the total voting power of the equity securities of the Company, whether by way of merger, asset purchase, equity purchase or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Capital Stock</B>&#148; means the Company&#146;s Common Stock and the Company&#146;s Preferred Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Certificate of Incorporation</B>&#148; means the Company&#146;s certificate
of incorporation dated September&nbsp;2, as such may have been amended, supplemented or modified from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company
Class</B><B></B><B>&nbsp;A Common Stock</B>&#148; means the Company&#146;s Class&nbsp;A common stock, par value of $0.0001 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Class</B><B></B><B>&nbsp;A Preferred Stock</B>&#148; means shares of Company Preferred Stock that constitute
&#147;Class&nbsp;A Preferred Stock&#148; (as such term is used in the Company Certificate of Incorporation). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company
Class</B><B></B><B>&nbsp;B Common Stock</B>&#148; means the Company&#146;s Class&nbsp;B common stock, par value of $0.0001 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Class</B><B></B><B>&nbsp;B Preferred Stock</B>&#148; means shares of Company Preferred Stock that constitute
&#147;Class&nbsp;B Preferred Stock&#148; (as such term is used in the Company Certificate of Incorporation). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Common
Stock</B>&#148; means the Company Class&nbsp;A Common Stock and Company Class&nbsp;B Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company IP</B>&#148; means,
collectively, all Company-Owned IP and Company-Licensed IP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company JV</B>&#148; means QSV Operations LLC, a Delaware limited
liability company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company-Licensed IP</B>&#148; means all Intellectual Property Rights owned or purported to be owned by a
third party and licensed to the Company or to which the Company otherwise has a right to use. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Material Adverse
Effect</B>&#148; means any event, circumstance, change, development, effect or occurrence (collectively &#147;<B>Effect</B>&#148;) that, individually or in the aggregate with all other Effects, is or would reasonably be expected to (a)&nbsp;have a
material adverse effect on the business, condition (financial or otherwise), assets, liabilities or operations of the Company or (b)&nbsp;would prevent, materially delay or materially impede the performance by the Company of its obligations under
this Agreement or the consummation of the Merger or any of the other Transactions; <U>provided</U>, <U>however</U>, that none of the following shall be deemed to constitute, alone or in combination, or be taken into account in the determination of
whether, there has been or will be a Company Material Adverse Effect: (i)&nbsp;any change or proposed change in or change in the interpretation of any Law (including any <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures) or GAAP;
(ii)&nbsp;events or conditions generally affecting the industries or geographic areas in which the Company operates; (iii)&nbsp;any downturn in general economic conditions, including changes in the credit, debt, securities, financial or capital
markets (including changes in interest or exchange rates, prices of any security or market index or commodity or any disruption of such markets); (iv) acts of war, sabotage, civil unrest, terrorism, epidemics, pandemics or disease outbreaks
(including <FONT STYLE="white-space:nowrap">COVID-19),</FONT> or any escalation or worsening of any such acts of war, sabotage, civil unrest, terrorism epidemics, pandemics or disease outbreaks, or changes in global, national, regional, state or
local political or social conditions; (v)&nbsp;any hurricane, tornado, flood, earthquake, natural disaster, or other acts of God; (vi)&nbsp;any actions taken or not taken by the Company as required by this Agreement or any Ancillary Agreement;
(vii)&nbsp;any Effect attributable to the announcement or execution, pendency, negotiation or consummation of the Merger or any of the other Transactions (including the impact thereof on relationships with customers, suppliers, employees or
Governmental Authorities); (viii) any failure in and of itself to meet any projections, forecasts, guidance, estimates, milestones, budgets or financial or operating predictions of revenue, earnings, cash flow or cash position, provided that this
clause (viii)&nbsp;shall not prevent a determination that any change, event, or occurrence underlying such failure has resulted in a Company Material Adverse Effect; or (ix)&nbsp;any actions taken, or failures to take action, in each case, which
Kensington has requested or to which it has consented or which actions are contemplated by this Agreement, except in the cases of clauses (i)&nbsp;through (iii), to the extent that the Company is materially and disproportionately affected thereby as
compared with other participants in the industries in which the Company operates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Option Plan</B>&#148; means the QuantumScape 2010 Equity Incentive Plan, as
amended and restated on May&nbsp;1, 2013, as such may have been amended, supplemented or modified from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company
Options</B>&#148; means all options to purchase outstanding shares of Company Common Stock, whether or not exercisable and whether or not vested, immediately prior to the Closing under the Company Option Plan or otherwise, other than the Company
Warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Restricted Stock</B>&#148; means all outstanding shares of restricted stock granted under the Company Option
Plan or acquired via the early exercise of Company Options, immediately prior to the Closing under the Company Option Plan or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company RSUs&#148;</B> means all outstanding restricted stock units granted under the Company Option Plan, immediately prior to the
Closing under the Company Option Plan or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company-Owned IP</B>&#148; means all Intellectual Property Rights owned or
purported to be owned by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Preferred Stock</B>&#148; means the shares of the Company&#146;s preferred stock,
par value $0.0001 per share, including Series A Preferred Stock, Series B Preferred Stock, Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F
Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Superior Proposal</B>&#148; means a <U>bona</U> <U>fide</U>, written Company Acquisition Proposal, not
solicited, received, initiated or facilitated in violation of <U>Section</U><U></U><U>&nbsp;7.05</U> that the Company Board (after consultation with outside legal counsel) reasonably determines, in good faith, would, if consummated, result in a
transaction that is more favorable to the stockholders of the Company than the Transactions, after taking into account all such factors and matters deemed relevant by the Company Board, including legal, financial (including the financing terms of
any such proposal), regulatory, timing or other aspects of such proposal and the Transactions and after taking into account any changes to the terms of this Agreement irrevocably offered in writing by Kensington in response to such Company Superior
Proposal; <U>provided</U> that for purposes of this definition, all references to &#147;10%&#148; in the definition of &#147;Company Acquisition Proposal&#148; will be deemed to be references to &#147;50%&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company Warrants</B>&#148; means all outstanding and unexercised warrants to purchase shares of Company Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Confidential Information</B>&#148; means any proprietary information, knowledge or data concerning the businesses and affairs of the
Company or any Suppliers or customers of the Company or Kensington or its subsidiaries (as applicable) that is not already generally available to the public. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>control</B>&#148; (including the terms &#147;<B>controlled by</B>&#148; and &#147;<B>under common control with</B>&#148;) means the
possession, directly or indirectly, or as trustee or executor, of the power to direct or cause the direction of the management and policies of a person, whether through the ownership of voting securities, as trustee or executor, by contract or
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">COVID-19</FONT></B>&#148; shall mean <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> or <FONT STYLE="white-space:nowrap">COVID-19,</FONT> and any evolutions or mutations thereof or related or associated epidemics, pandemic or disease outbreaks. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures</B>&#148; means any quarantine, &#147;shelter in place,&#148; &#147;stay at
home,&#148; workforce reduction, social distancing, shut down, closure, sequester, workplace safety or similar Law promulgated by any Governmental Authority, including the Centers for Disease Control and Prevention and the World Health Organization,
in each case, in connection with or in response to <FONT STYLE="white-space:nowrap">COVID-19,</FONT> including the CARES Act and Families First Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Disabling Devices</B>&#148; means undisclosed Software viruses, time bombs, logic
bombs, trojan horses, trap doors, back doors, or other computer instructions, intentional devices or techniques that are designed to threaten, infect, assault, vandalize, defraud, disrupt, damage, disable, maliciously encumber, hack into,
incapacitate, infiltrate or slow or shut down a computer system or any component of such computer system, including any such device affecting system security or compromising or disclosing user data in an unauthorized manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Environmental Laws</B>&#148; means any United States federal, state or local or <FONT STYLE="white-space:nowrap">non-United</FONT>
States laws relating to: (a)&nbsp;releases or threatened releases of Hazardous Substances or materials containing Hazardous Substances; (b)&nbsp;the manufacture, handling, transport, use, treatment, storage or disposal of Hazardous Substances or
materials containing Hazardous Substances; or (c)&nbsp;pollution or protection of the environment or natural resources. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange
Ratio</B>&#148; means the quotient obtained by <I>dividing</I> (x)&nbsp;the Target Share Amount, <I>by</I> (y)&nbsp;the number of Fully-Diluted Company Shares. As of the date of this Agreement, assuming the Target Share Amount is as set forth in the
second sentence of the definition thereof, the Exchange Ratio would be 4.0032186234. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Fully-Diluted Company Shares</B>&#148;
means an amount equal to, without duplication, (i)&nbsp;the aggregate number of shares of Company Capital Stock that are issued and outstanding as of immediately prior to the Effective Time on a fully-diluted, as <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">converted-to-Company-Common-Stock</FONT></FONT> basis, <I>plus</I> (ii)&nbsp;the aggregate number of shares of Company Common Stock issuable upon the full exercise, exchange or conversion of Company Options and Company
RSUs that are outstanding and exercisable as of immediately prior to the Effective Time, <I>plus</I> (iii)&nbsp;the aggregate number of shares of Company Common Stock that are issuable upon the conversion of its Series F Preferred Stock issuable in
respect of executed funded commitments received by the Company as of the Effective Time with respect to the private sale of its Series F Preferred Stock, to the extent the Series F Subscription Amount with respect thereto was included in the
calculation of the &#147;Target Share Amount&#148;.&nbsp;As of the date of this Agreement there are 92,125,870 Fully-Diluted Company Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Hazardous Substance(s)</B>&#148; means: (a)&nbsp;those substances defined in or regulated under the following United States federal
statutes and their state counterparts, as each may be amended from time to time, and all regulations thereunder: the Hazardous Materials Transportation Act, the Resource Conservation and Recovery Act, the Comprehensive Environmental Response,
Compensation and Liability Act, the Clean Water Act, the Safe Drinking Water Act, the Atomic Energy Act, the Federal Insecticide, Fungicide, and Rodenticide Act and the Clean Air Act; (b)&nbsp;petroleum and petroleum products, including crude oil
and any fractions thereof; (c)&nbsp;natural gas, synthetic gas, and any mixtures thereof; (d)&nbsp;polychlorinated biphenyls, asbestos and radon; and (e)&nbsp;any substance, material or waste regulated by any Governmental Authority pursuant to any
Environmental Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>HSR Act</B>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Intellectual Property Rights</B>&#148; means any and all of the following and all rights in, arising out of, or associated therewith,
throughout the world: patents, utility models, and applications therefor and all reissues, divisions, <FONT STYLE="white-space:nowrap">re-examinations,</FONT> renewals, extensions, provisionals, continuations and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">continuations-in-part</FONT></FONT> thereof and equivalent or similar rights in inventions and discoveries anywhere in the world, including invention disclosures, common law and statutory rights associated with trade
secrets, confidential and proprietary information and <FONT STYLE="white-space:nowrap">know-how,</FONT> industrial designs and any registrations and applications therefor, trade names, logos, trade dress, trademarks and service marks, trademark,
service mark, trade name, logo, and trade dress registrations, trademark, service mark, trade name, logo and trade dress applications and any and all goodwill associated with and symbolized by the foregoing items, Internet domain name applications
and registrations, Internet and World Wide Web URLs or addresses copyrights or other rights related to works of authorship, copyright registrations and applications therefor and all other rights corresponding thereto, database rights, mask works,
mask work registrations and applications therefor and any equivalent or similar rights in semiconductor masks, layouts, architectures or topology, moral and economic rights of authors and inventors, however denominated and any similar or equivalent
rights to any of the foregoing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Intervening Event</B>&#148; means any Effect (but specifically excluding any
Company Acquisition Proposal or Company Superior Proposal) that was not known and was not reasonably foreseeable to the Company Board as of the date of this Agreement (or the consequences of which were not reasonably foreseeable to the Company Board
as of the date of this Agreement), and that becomes known to the Company or the Company Board after the date of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Kensington Capital Stock</B>&#148; means Kensington&#146;s Common Stock and Kensington&#146;s Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Kensington Cash Amount</B>&#148; means the amount equal to (i)&nbsp;the aggregate amount of cash in the Trust Account that will be
available to Kensington for unrestricted use as of immediately following the Effective Time (for clarity, after giving effect to any Redemption Rights that are actually perfected), plus (ii)&nbsp;the aggregate amount of cash proceeds received from
investors as of the Effective Time in connection with the Private Placements; <U>provided</U>, <U>however</U>, that &#147;Kensington Cash Amount&#148; shall be calculated without reduction for any payments in respect of Outstanding Kensington
Transaction Expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Kensington Certificate of Incorporation</B>&#148; means Kensington&#146;s amended and restated certificate
of incorporation dated June&nbsp;25, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Kensington Class</B><B></B><B>&nbsp;A Common Stock</B>&#148; means Kensington&#146;s
Class&nbsp;A common stock, par value $0.0001 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Kensington Class</B><B></B><B>&nbsp;B Common Stock</B>&#148; means
Kensington&#146;s Class&nbsp;B common stock, par value $0.0001 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Kensington Common Stock</B>&#148; means the Kensington
Class&nbsp;A Common Stock and Kensington Class&nbsp;B Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Kensington Material Adverse Effect</B>&#148; means any
Effect that, individually or in the aggregate with all other Effects, is or would reasonably be expected to (a)&nbsp;have a material adverse effect on the business, condition (financial or otherwise), assets, liabilities or operations of Kensington;
or (b)&nbsp;prevent, materially delay or materially impede the performance by Kensington or Merger Sub of their respective obligations under this Agreement or the consummation of the Merger or any of the other Transactions; <U>provided</U>,
<U>however</U>, that none of the following shall be deemed to constitute, alone or in combination, or be taken into account in the determination of whether, there has been or will be a Kensington Material Adverse Effect: (i)&nbsp;any change or
proposed change in or change in the interpretation of any Law (including any <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures) or GAAP; (ii)&nbsp;events or conditions generally affecting the industries or geographic areas in which
Kensington operates; (iii)&nbsp;any downturn in general economic conditions, including changes in the credit, debt, securities, financial or capital markets (including changes in interest or exchange rates, prices of any security or market index or
commodity or any disruption of such markets); (iv) acts of war, sabotage, civil unrest, terrorism, epidemics, pandemics or disease outbreaks (including <FONT STYLE="white-space:nowrap">COVID-19)</FONT> or any escalation or worsening of any such acts
of war, sabotage, civil unrest, terrorism, epidemics, pandemics or disease outbreaks, or changes in global, national, regional, state or local political or social conditions; (v)&nbsp;any hurricane, tornado, flood, earthquake, natural disaster, or
other acts of God, (vi)&nbsp;any actions taken or not taken by Kensington as required by this Agreement or any Ancillary Agreement; (vii)&nbsp;any Effect attributable to the announcement or execution, pendency, negotiation or consummation of the
Merger or any of the other Transactions; or (ix)&nbsp;any actions taken, or failures to take action, in each case, which the Company has requested or to which it has consented or which actions are contemplated by this Agreement, except in the cases
of clauses (i)&nbsp;through (iii), to the extent that Kensington is materially and disproportionately affected thereby as compared with other participants in the industries in which Kensington operates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Kensington Organizational Documents</B>&#148; means the Kensington Certificate of Incorporation, bylaws, and Trust Agreement, in each
case as amended, modified or supplemented from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Kensington Units</B>&#148; means one share of Kensington Class&nbsp;A Common Stock
and <FONT STYLE="white-space:nowrap">one-half</FONT> of one Kensington Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Kensington Warrant Agreement</B>&#148; means the
warrant agreement dated June&nbsp;30, 2020 between Kensington and Continental Stock Transfer and Trust Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Kensington
Warrants</B>&#148; means the warrants to purchase shares of Kensington Class&nbsp;A Common Stock contemplated by the Kensington Warrant Agreement, with each warrant exercisable for one share of Kensington Class&nbsp;A Common Stock at an exercise
price of $11.50. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Key Company Stockholders</B>&#148; means the persons and entities listed on <U>Schedule A</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>knowledge</B>&#148; or &#147;<B>to the knowledge</B>&#148; of a person means in the case of the Company, the actual knowledge of the
persons listed on <U>Schedule B</U> after reasonable inquiry, and in the case of Kensington, the actual knowledge of Justin Mirro, Robert Remenar, Simon Boag and Daniel Huber after reasonable inquiry. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Leased Real Property</B>&#148; means the real property leased by the Company as tenant, together with, to the extent leased by the
Company, all buildings and other structures, facilities or improvements located thereon and all easements, licenses, rights and appurtenances of the Company relating to the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Lien</B>&#148; means any lien, security interest, mortgage, pledge, adverse claim or other encumbrance of any kind that secures the
payment or performance of an obligation (other than those created under applicable securities laws, and not including any license of Intellectual Property). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Merger Sub Organizational Documents</B>&#148; means the certificate of incorporation and bylaws of Merger Sub, as amended, modified
or supplemented from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Open Source Software</B>&#148; means any Software that is licensed pursuant to: (a)&nbsp;any
license that is a license now or in the future approved by the open source initiative and listed at http://www.opensource.org/licenses, which licenses include all versions of the GNU General Public License (GPL), the GNU Lesser General Public
License (LGPL), the GNU Affero GPL, the MIT license, the Eclipse Public License, the Common Public License, the CDDL, the Mozilla Public License (MPL), the Artistic License, the Netscape Public License, the Sun Community Source License (SCSL), and
the Sun Industry Standards License (SISL); or (b)&nbsp;any license to Software that is considered &#147;free&#148; or &#147;open source software&#148; by the open source foundation or the free software foundation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>PCAOB</B>&#148; means the Public Company Accounting Oversight Board and any division or subdivision thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Per Share Merger Consideration</B>&#148; means, (a)&nbsp;with respect to shares of Company Class&nbsp;A Common Stock and shares of
Company Class&nbsp;A Preferred Stock issued and outstanding immediately prior to the Effective Time, the right to receive the number of shares of New Kensington Class&nbsp;A Common Stock set forth in <U>Section</U><U></U><U>&nbsp;3.01(b)(i)</U> and
(b)&nbsp;with respect to shares of Company Class&nbsp;B Common Stock and shares of Company Class&nbsp;B Preferred Stock issued and outstanding immediately prior to the Effective Time, the right to receive the number of shares of New Kensington
Class&nbsp;B Common Stock set forth in <U>Section</U><U></U><U>&nbsp;3.01(b)(ii)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Permitted Liens</B>&#148; means:
(a)&nbsp;such imperfections of title, easements, encumbrances, Liens or restrictions that do not materially impair the current use of the Company&#146;s assets that are subject thereto; (b)&nbsp;materialmen&#146;s, mechanics&#146;, carriers&#146;,
workmen&#146;s, warehousemen&#146;s, repairmen&#146;s, landlord&#146;s and other similar Liens arising in the ordinary course of business, or deposits to obtain the release of such Liens; (c)&nbsp;Liens for Taxes not yet due and payable, or being
contested in good faith; (d)&nbsp;zoning, entitlement, conservation restriction and other land use and environmental regulations promulgated by Governmental Authorities, <FONT STYLE="white-space:nowrap">(e)&nbsp;non-exclusive</FONT> licenses,
sublicenses or other rights to Intellectual Property owned by or licensed to the Company granted to any licensee in the ordinary course of business <FONT STYLE="white-space:nowrap">(f)&nbsp;non-monetary</FONT> Liens, encumbrances and restrictions on
real property (including easements, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
covenants, rights of way and similar restrictions of record) that do not materially interfere with the present uses of such real property, (g)&nbsp;Liens identified in the Audited Financial
Statements and (h)&nbsp;Liens on leases, subleases, easements, licenses, rights of use, rights to access and rights of way arising from the provisions of such agreements or benefiting or created by any superior estate, right or interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>person</B>&#148; means an individual, corporation, partnership, limited partnership, limited liability company, syndicate, person
(including, without limitation, a &#147;person&#148; as defined in Section&nbsp;13(d)(3) of the Exchange Act), trust, association or entity or government, political subdivision, agency or instrumentality of a government. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Personal Information</B>&#148; means (a)&nbsp;information related to an identified or identifiable individual (e.g., name, address
telephone number, email address, financial account number, government-issued identifier), (b) any other data used or intended to be used or which allows one to identify, contact, or precisely locate an individual, including any internet protocol
address or other persistent identifier, and (c)&nbsp;any other, similar information or data regulated by Privacy/Data Security Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Privacy/Data Security Laws</B>&#148; means all laws governing the receipt, collection, use, storage, processing, sharing, security,
disclosure, or transfer of Personal Information or the security of Company&#146;s Business Systems or Business Data. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Products</B>&#148; mean any products or services, developed, manufactured, performed,
<FONT STYLE="white-space:nowrap">out-licensed,</FONT> sold, distributed or otherwise made available by or on behalf of the Company, from which the Company has derived previously, is currently deriving or is scheduled to derive, revenue from the sale
or provision thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Redemption Rights</B>&#148; means the redemption rights provided for in Section&nbsp;9.2 of Article IX of
the Kensington Certificate of Incorporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Requisite Approval</B>&#148; means the affirmative vote of the holders of at least
a (a)&nbsp;majority of the shares of the Company Capital Stock outstanding, (b)&nbsp;a majority of the shares of the Company Class&nbsp;A Common Stock and Company Class&nbsp;B Common Stock, each voting separately as a class, (c)&nbsp;a majority of
the shares of Company Class&nbsp;A Common Stock and Class&nbsp;A Preferred Stock outstanding, voting together as a single class, and (d)&nbsp;a majority of the shares of the Company Class&nbsp;B Common Stock and Company Class&nbsp;B Preferred Stock
outstanding, voting together as a single class. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series A Preferred Stock</B>&#148; means the shares of the Company&#146;s
preferred stock, par value $0.0001 per share, designated as Series A Preferred Stock in the Company Certificate of Incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series B Preferred Stock</B>&#148; means the shares of the Company&#146;s preferred stock, par value $0.0001 per share, designated as
Series B Preferred Stock in the Company Certificate of Incorporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Preferred Stock</B>&#148; means the shares of the Company&#146;s preferred stock, par value $0.0001 per share, designated as Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock in the Company Certificate of Incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series C Preferred Stock</B>&#148; means the shares of the Company&#146;s preferred stock, par value $0.0001 per share, designated as
Series C Preferred Stock in the Company Certificate of Incorporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series D Preferred Stock</B>&#148; means the shares of the
Company&#146;s preferred stock, par value $0.0001 per share, designated as Series D Preferred Stock in the Company Certificate of Incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series E Preferred Stock</B>&#148; means the shares of the Company&#146;s preferred stock, par value $0.0001 per share, designated as
Series E Preferred Stock in the Company Certificate of Incorporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series F Preferred Stock</B>&#148; means the shares of the
Company&#146;s preferred stock, par value $0.0001 per share, designated as Series F Preferred Stock in the Company Certificate of Incorporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Series F Subscription Amount</B>&#148; means the aggregate amount of funding and
executed funding commitments received by the Company as of the Effective Time with respect to private sales of its Series F Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Software</B>&#148; means all computer software (in object code or source code format), data and databases, and related documentation
and materials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>subsidiary</B>&#148; or &#147;<B>subsidiaries</B>&#148; of the Company, the Surviving Corporation, Kensington or
any other person means an affiliate controlled by such person, directly or indirectly, through one or more intermediaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Supplier</B>&#148; means any person that supplies inventory or other materials or personal property, components, or other goods or
services that are utilized in or comprise the Products of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Target Share Amount</B>&#148; means an amount equal to
(i)&nbsp;three hundred and sixty million (360,000,000), <I>plus</I> or <I>minus</I> (ii)&nbsp;the quotient obtained by <I>dividing</I> (x)&nbsp;the amount, if any, by which the Series F Subscription Amount is <I>greater than</I> or <I>less than</I>,
as applicable, three hundred million dollars ($300,000,000), <I>by</I> (y)&nbsp;ten dollars ($10).&nbsp;As of the date of this Agreement, the Target Share Amount is three hundred and sixty eight million, seven hundred and ninety-nine thousand, nine
hundred and ninety-eight (368,799,998). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Technology</B>&#148; means: (a)&nbsp;patents, patent applications and patent
disclosures, together with all reissues, continuations, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> divisionals, revisions, extensions or reexaminations thereof; (b)&nbsp;trademarks and
service marks, trade dress, logos, trade names, corporate names, brands, slogans, and other source identifiers together with all translations, adaptations, derivations, combinations and other variants of the foregoing; (c)&nbsp;works of authorship
(whether or not copyrightable), and moral rights; (d)&nbsp;trade secrets and <FONT STYLE="white-space:nowrap">know-how</FONT> (including ideas, formulas, compositions, inventions (whether or not patentable or reduced to practice)), customer and
supplier lists, improvements, protocols, processes, methods and techniques, research and development information, industry analyses, algorithms, architectures, layouts, drawings, specifications, designs, plans, methodologies, proposals, industrial
models, technical data, financial and accounting and all other data, databases, database rights, including Personal Information, pricing and cost information, business and marketing plans and proposals, and customer and supplier lists (including
lists of prospects) and related information; (e)&nbsp;Internet domain names and social media accounts; and (f)&nbsp;copies and tangible embodiments of any of the foregoing, in whatever form or medium;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transaction Documents</B>&#148; means this Agreement, including all Schedules and Exhibits hereto, the Company Disclosure Schedule,
the Ancillary Agreements, and all other agreements, certificates and instruments executed and delivered by Kensington, Merger Sub or the Company in connection with the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Transactions</B>&#148; means the transactions contemplated by this Agreement and the Transaction Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Treasury Regulations</B>&#148; means the United States Treasury regulations issued pursuant to the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 1.02.<U>&nbsp;Further Definitions</U>.&nbsp;The following terms have the meaning set
forth in the Sections set forth below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="20%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:10pt; font-family:Times New Roman; ">Defined Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Location&nbsp;of&nbsp;Definition</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting Firm</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.06(e)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Action</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.09</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alternative Transaction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.06</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amended and Restated Kensington Certificate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.04(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Anticipated Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.06(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Antitrust Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.14(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audited Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.07(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Blue Sky Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.05(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.02(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Claims</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.03</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.02(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.02(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Code</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.02(h)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Acquisition Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.05(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Adverse Recommendation Change</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.05(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Board</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Board Approval</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.18</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Disclosure Schedule</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Article IV</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Notice Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.05(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Permits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.06</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Share Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.03(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Stockholder Approval</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.18</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidentiality Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.04(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continuing Employees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.07(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Data Security Requirements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.13(h)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Determination Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.06(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DGCL</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dispute Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.06(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.01</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effective Time</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Environmental Permits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.15</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(a))</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ERISA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.10(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ERISA Affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.10(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.21</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange Agent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange Fund</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange Ratio Announcement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.01(e)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange Ratio Calculation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.06(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchanged Option</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.01(b)(v)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchanged Restricted Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.01(b)(vi)</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="20%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:10pt; font-family:Times New Roman; ">Defined Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Location&nbsp;of&nbsp;Definition</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchanged RSU</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.01(b)(vii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchanged Warrant</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.01(b)(viii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GAAP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.07(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governmental Authority</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.05(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Health Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.10(k)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intervening Event Notice Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.05(e)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IRS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.10(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June Balance Sheet</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.07(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kensington</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kensington Board</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kensington Certificate Amendment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.04(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kensington Disclosure Schedule</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Article V</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kensington Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.03(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kensington Proposals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.01(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kensington SEC Reports</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.07(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kensington Stockholder Approval</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.10(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kensington Stockholders&#146; Meeting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.01(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.05(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.12(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease Documents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.12(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Letter of Transmittal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.02(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Material Contracts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.16(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger Sub</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger Sub Board</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger Sub Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.03(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New Kensington Class&nbsp;A Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.04(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New Kensington Class&nbsp;B Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.04(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New Kensington Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.04(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outside Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding Company Transaction Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.04(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding Kensington Transaction Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.04(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PCAOB Audited Financials</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.15</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.10(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PPACA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.10(k)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Private Placements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proxy Statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.01(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Registration Rights and <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Registration Statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.01(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Remedies Exceptions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.04</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Representatives</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.04(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Response Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.06(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.07(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Securities Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.07(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholder Support Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Subscription Agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Surviving Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.01</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="20%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:10pt; font-family:Times New Roman; ">Defined Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Location&nbsp;of&nbsp;Definition</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.14(p)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Return</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.14(p)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.14(p)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Terminating Company Breach</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.01(g)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Terminating Kensington Breach</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.01(h)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer Agent Cancellation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.02(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trust Account</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.13</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trust Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.13</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trust Fund</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.13</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trustee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.13</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WARN Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.11(g)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Written Consent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.03</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 1.03.<U>&nbsp;Construction.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Unless the context of this Agreement otherwise requires, (i)&nbsp;words of any gender include each other gender, (ii)&nbsp;words using the
singular or plural number also include the plural or singular number, respectively, (iii)&nbsp;the terms &#147;hereof,&#148; &#147;herein,&#148; &#147;hereby,&#148; &#147;hereto&#148; and derivative or similar words refer to this entire Agreement,
(iv)&nbsp;the terms &#147;Article,&#148; &#147;Section,&#148; &#147;Schedule&#148; and &#147;Exhibit&#148; refer to the specified Article, Section, Schedule or Exhibit of or to this Agreement, (v)&nbsp;the word &#147;including&#148; means
&#147;including without limitation,&#148; (vi) the word &#147;or&#148; shall be disjunctive but not exclusive, (vii)&nbsp;references to agreements and other documents shall be deemed to include all subsequent amendments and other modifications
thereto and (viii)&nbsp;references to statutes shall include all regulations promulgated thereunder and references to statutes or regulations shall be construed as including all statutory and regulatory provisions consolidating, amending or
replacing the statute or regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The language used in this Agreement shall be deemed to be the language chosen by the parties to
express their mutual intent and no rule of strict construction shall be applied against any party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Whenever this Agreement refers to
a number of days, such number shall refer to calendar days unless Business Days are specified.&nbsp;If any action is to be taken or given on or by a particular calendar day, and such calendar day is not a Business Day, then such action may be
deferred until the next Business Day. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) All accounting terms used herein and not expressly defined herein shall have the meanings given
to them under GAAP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) With regard to each and every term and condition of this Agreement and any and all agreements and instruments
subject to the terms hereof, the parties hereto understand and agree that the same have or has been mutually negotiated, prepared and drafted, and if at any time the parties hereto desire or are required to interpret or construe any such term or
condition or any agreement or instrument subject hereto, no consideration will be given to the issue of which party hereto actually prepared, drafted or requested any term or condition of this Agreement or any agreement or instrument subject hereto.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 2.01.<U>&nbsp;The Merger</U>.&nbsp;Upon the terms and subject to the conditions set forth in <U>Article VIII</U>, and in accordance
with the DGCL, at the Effective Time, Merger Sub shall be merged with and into the Company.&nbsp;As a result of the Merger, the separate corporate existence of Merger Sub shall cease and the Company shall continue as the surviving corporation of the
Merger (the &#147;<B>Surviving Corporation</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 2.02.<U>&nbsp;Effective Time; Closing</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As promptly as practicable, but in no event later than three (3)&nbsp;Business Days, after the satisfaction or, if permissible, waiver of
the conditions set forth in Article VIII (other than those conditions that by their nature are to be satisfied at the Closing, it being understood that the occurrence of the Closing shall remain subject to the satisfaction or waiver of such
conditions at the Closing), the parties hereto shall cause the Merger to be consummated by filing a certificate of merger (a &#147;<B>Certificate of Merger</B>&#148;) with the Secretary of State of the State of Delaware, in such form as is required
by, and executed in accordance with, the relevant provisions of the DGCL and mutually agreed by the parties (the date and time of the filing of such Certificate of Merger (or such later time as may be agreed by each of the parties hereto and
specified in such Certificate of Merger) being the &#147;<B>Effective Time</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Immediately prior to such filing of a
Certificate of Merger in accordance with <U>Section</U><U></U><U>&nbsp;2.02(a)</U>, a closing (the &#147;<B>Closing</B>&#148;) shall be held at the offices of Hughes Hubbard&nbsp;&amp; Reed LLP, One Battery Park Plaza, New York, New York 10004, or
such other place as the parties shall agree, for the purpose of confirming the satisfaction or waiver, as the case may be, of the conditions set forth in Article VIII.&nbsp;The date on which the Closing shall occur is referred to herein as the
&#147;<B>Closing Date</B>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 2.03.<U>&nbsp;Effect of the Merger</U>.&nbsp;At the Effective Time, the effect of the Merger
shall be as provided in the applicable provisions of the DGCL.&nbsp;Without limiting the generality of the foregoing, and subject thereto, at the Effective Time, the Surviving Corporation shall possess all of the property, rights, privileges, powers
and franchises, and all other interests of the Company and Merger Sub shall be the property of the Surviving Corporation, and all debts, liabilities and duties of each of the Company and Merger Sub shall be the debts, liabilities and duties of the
Surviving Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 2.04.<U>&nbsp;Certificate of Incorporation; Bylaws</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) At the Effective Time, the certificate of incorporation of the Company, as in effect immediately prior to the Effective Time, shall be the
certificate of incorporation of the Surviving Corporation, until thereafter amended as provided by law and such certificate of incorporation.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) At the Effective Time, the bylaws of Merger Sub, as in effect immediately prior to the Effective Time, shall be the bylaws of the
Surviving Corporation until thereafter amended as provided by law, the certificate of incorporation of the Surviving Corporation and such bylaws, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) At the Closing, Kensington shall amend and restate, effective as of the Effective Time, its certificate of incorporation to be as set
forth on <U>Exhibit B</U> (such amendment, the &#147;<B>Kensington Certificate Amendment</B>&#148; and such certificate of incorporation, the &#147;<B>Amended and Restated Kensington Certificate</B>&#148;), pursuant to which Kensington shall have a
dual class structure with shares of Class&nbsp;A common stock, par value $0.0001 per share, having voting rights of one (1)&nbsp;vote per share (the &#147;<B>New Kensington Class</B><B></B><B>&nbsp;A Common Stock</B>&#148;) and shares of
Class&nbsp;B common stock, par value $0.0001 per share, having voting rights of ten (10)&nbsp;votes per share (the &#147;<B>New Kensington Class</B><B></B><B>&nbsp;B Common Stock</B>&#148; and, together with the New Kensington Class&nbsp;A Common
Stock, the &#147;<B>New Kensington Common Stock</B>&#148;).</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 2.05.<U>&nbsp;Directors and Officers</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The initial directors of the Surviving Corporation shall be the individuals selected by the Company or Kensington, as the case may be, in
accordance with <U>Section</U><U></U><U>&nbsp;7.17(a)</U>, and the initial officers of the Surviving Corporation shall be the officers of the Company as of the date of this Agreement, or, in the event any of them is not an officer as of the
Effective Time, then such other individual designated by the Company, each such director and officer to hold office in accordance with the certificate of incorporation and bylaws of the Surviving Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The parties shall cause the Kensington Board as of immediately following the Effective
Time to be comprised of the individuals selected by the Company or Kensington, as the case may be, in accordance with <U>Section</U><U></U><U>&nbsp;7.17(a)</U>, and the officers of Kensington to be the officers of the Company as of immediately prior
to the Effective Time, each such director and officer to hold office in accordance with the certificate of incorporation and bylaws of Kensington. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONVERSION OF SECURITIES; Exchange of certificates </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 3.01.<U>&nbsp;Conversion of Securities</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) At the Effective Time, by virtue of the Merger and without any action on the part of Kensington, Merger Sub, the Company or the holders of
any of the following securities: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) each share of Company Class&nbsp;A Common Stock and each share of Company
Class&nbsp;A Preferred Stock issued and outstanding immediately prior to the Effective Time shall be canceled and converted into the right to receive the number of shares of New Kensington Class&nbsp;A Common Stock equal to the Exchange Ratio
(determined in accordance with <U>Section</U><U></U><U>&nbsp;3.06</U>); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) each share of Company Class&nbsp;B Common
Stock and each share of Company Class&nbsp;B Preferred Stock issued and outstanding immediately prior to the Effective Time shall be canceled and converted into the right to receive the number of shares of New Kensington Class&nbsp;B Common Stock
equal to the Exchange Ratio (determined in accordance with <U>Section</U><U></U><U>&nbsp;3.06</U>); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) all shares of
Company Capital Stock held in the treasury of the Company shall be canceled without any conversion thereof and no payment or distribution shall be made with respect thereto; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) each share of Merger Sub Common Stock issued and outstanding immediately prior to the Effective Time shall be converted
into and exchanged for one validly issued, fully paid and nonassessable share of common stock, par value $0.01 per share, of the Surviving Corporation; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) each Company Option that is outstanding immediately prior to the Effective Time, whether vested or unvested, shall be
converted into an option to purchase a number of shares of the applicable class of New Kensington Common Stock that the <FONT STYLE="white-space:nowrap">pre-conversion</FONT> Company Option covers (such option, an &#147;<B>Exchanged
Option</B>&#148;) equal to the product (rounded down to the nearest whole number) of (x)&nbsp;the number of shares of the applicable class of Company Common Stock subject to such Company Option immediately prior to the Effective Time and
(y)&nbsp;the Exchange Ratio (determined in accordance with <U>Section</U><U></U><U>&nbsp;3.06</U>), at an exercise price per share (rounded up to the nearest whole cent) equal to (A)&nbsp;the exercise price per share of such Company Option
immediately prior to the Effective Time divided by (B)&nbsp;the Exchange Ratio (determined in accordance with <U>Section</U><U></U><U>&nbsp;3.06</U>); <U>provided</U>, <U>however</U>, that the exercise price and the number of shares of the
applicable class of New Kensington Common Stock purchasable pursuant to the Exchanged Options shall be determined in a manner consistent with the requirements of Section&nbsp;409A of the Code; <U>provided</U>, <U>further</U>, <U>however</U>, that in
the case of any Exchanged Option to which Section&nbsp;422 of the Code applies, the exercise price and the number of shares of the Surviving Corporation stock purchasable pursuant to such option shall be determined in accordance with the foregoing,
subject to such adjustments as are necessary in order to satisfy the requirements of Section&nbsp;424(a) of the Code.&nbsp;Except as specifically provided above, following the Effective Time, each Exchanged Option shall continue to be governed by
the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former Company Option immediately prior to the Effective Time.&nbsp;At or prior to the Effective Time, the parties and their boards,
as applicable, shall adopt any resolutions and take any actions that are necessary to effectuate the treatment of the Company Options pursuant to this subsection. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) each share of Company Restricted Stock that is outstanding immediately
prior to the Effective Time shall be converted into restricted shares of the applicable class of New Kensington Common Stock that the <FONT STYLE="white-space:nowrap">pre-conversion</FONT> Company Restricted Stock covers (such share of restricted
New Kensington Common Stock, an &#147;<B>Exchanged Restricted Stock</B>&#148;) equal to the product (rounded down to the nearest whole number) of (x)&nbsp;the number of shares of Company Restricted Stock immediately prior to the Effective Time and
(y)&nbsp;the Exchange Ratio (determined in accordance with <U>Section</U><U></U><U>&nbsp;3.06</U>).&nbsp;Except as specifically provided above, following the Effective Time, each Exchanged Restricted Stock shall continue to be governed by the same
terms and conditions (including transfer restrictions and repurchase right terms) as were applicable to the corresponding former Company Restricted Stock immediately prior to the Effective Time.&nbsp;At or prior to the Effective Time, the parties
and their boards, as applicable, shall adopt any resolutions and take any actions that are necessary to effectuate the treatment of the Company Restricted Stock pursuant to this subsection. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) each Company RSU that is outstanding immediately prior to the Effective Time shall be converted into restricted stock
units of the applicable class of New Kensington Common Stock that the <FONT STYLE="white-space:nowrap">pre-conversion</FONT> Company RSU covers (such restricted stock unit award covering Common Stock, an &#147;<B>Exchanged RSU</B>&#148;) equal to
the product (rounded down to the nearest whole number) of (x)&nbsp;the number of shares subject to a Company RSU immediately prior to the Effective Time and (y)&nbsp;the Exchange Ratio (determined in accordance with
<U>Section</U><U></U><U>&nbsp;3.06</U>).&nbsp;Except as specifically provided above, following the Effective Time, each Exchanged RSU shall continue to be governed by the same terms and conditions (including transfer restrictions and repurchase
right terms) as were applicable to the corresponding former Company RSUs immediately prior to the Effective Time.&nbsp;At or prior to the Effective Time, the parties and their boards, as applicable, shall adopt any resolutions and take any actions
that are necessary to effectuate the treatment of the Company RSUs pursuant to this subsection. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) each Company
Warrant that is outstanding immediately prior to the Effective Time shall be converted into warrants of the applicable class of New Kensington Common Stock that the <FONT STYLE="white-space:nowrap">pre-conversion</FONT> Company Warrant covers (such
warrant, an &#147;<B>Exchanged Warrant</B>&#148;) equal to the product (rounded down to the nearest whole number) of (x)&nbsp;the number of shares of such class subject to such Company Warrant immediately prior to the Effective Time and (y)&nbsp;the
Exchange Ratio (determined in accordance with <U>Section</U><U></U><U>&nbsp;3.06</U>), at an exercise price per share (rounded up to the nearest whole cent) equal to (A)&nbsp;the exercise price per share of such Company Warrant immediately prior to
the Effective Time divided by (B)&nbsp;the Exchange Ratio (determined in accordance with <U>Section</U><U></U><U>&nbsp;3.06</U>).&nbsp;Except as specifically provided above, following the Effective Time, each Exchanged Warrant shall continue to be
governed by the same terms and conditions (including vesting and exercisability terms) as were applicable to the corresponding former Company Warrant immediately prior to the Effective Time.&nbsp;At or prior to the Effective Time, the parties and
their boards, as applicable, shall adopt any resolutions and take any actions that are necessary to effectuate the treatment of the Company Warrants pursuant to this subsection. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) For purposes of calculating the aggregate amount of shares of New Kensington Class&nbsp;A Common Stock or New Kensington Class&nbsp;B
Common Stock, as the case may be, issuable to each holder of shares of Company Capital Stock pursuant to the terms of this Section&nbsp;3.01, all shares of Company Class&nbsp;A Common Stock and all shares of Company Class&nbsp;A Preferred Stock held
by such holder shall be aggregated amongst themselves, and all shares of Company Class&nbsp;B Common Stock and all shares of Company Class&nbsp;B Preferred Stock held by such holder shall be aggregated amongst themselves, and the aggregate number of
shares of New Kensington Class&nbsp;A Common Stock or New Kensington Class&nbsp;B Common Stock, as the case may be, to be issued in respect of such aggregate number of shares held by such holder shall be rounded down to the nearest whole number.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 3.02.<U>&nbsp;Exchange of Certificates</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)<U> Exchange Agent</U>.&nbsp;On the Closing Date, Kensington shall deposit, or shall cause to be deposited, with a bank or trust company
that shall be designated by Kensington and is reasonably satisfactory to the Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(the &#147;<B>Exchange Agent</B>&#148;), (i) for the benefit of the holders of Company Class&nbsp;A Common Stock and Company Class&nbsp;A Preferred Stock, for exchange in accordance with this
<U>Article III</U>, the number of shares of New Kensington Class&nbsp;A Common Stock sufficient to deliver the aggregate Per Share Merger Consideration payable with respect thereto pursuant to Section&nbsp;3.01(b)(i) of this Agreement and
(ii)&nbsp;for the benefit of the holders of Company Class&nbsp;B Common Stock and Company Class&nbsp;B Preferred Stock, for exchange in accordance with this <U>Article III</U>, the number of shares of New Kensington Class&nbsp;B Common Stock
sufficient to deliver the aggregate Per Share Merger Consideration payable with respect thereto pursuant to Section&nbsp;3.01(b)(ii) of this Agreement (such shares of New Kensington Class&nbsp;A Common Stock and New Kensington Class&nbsp;B Common
Stock, in each case referred to in the preceding clauses (i)&nbsp;and (ii), together with any dividends or distributions with respect thereto (pursuant to <U>Section</U><U></U><U>&nbsp;3.02(c)</U>, being hereinafter referred to as the
&#147;<B>Exchange Fund</B>&#148;).&nbsp;Kensington shall cause the Exchange Agent pursuant to irrevocable instructions, to pay the Per Share Merger Consideration out of the Exchange Fund in accordance with this Agreement.&nbsp;Except as contemplated
by <U>Section</U><U></U><U>&nbsp;3.02(c)</U> hereof, the Exchange Fund shall not be used for any other purpose.&nbsp;All shares deposited hereunder shall <U>not</U> be certificated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Exchange Procedures</U>.&nbsp;As promptly as practicable after the Effective Time, Kensington shall use its reasonable best efforts to
cause the Exchange Agent to mail to each holder of Company Capital Stock entitled to receive the Per Share Merger Consideration pursuant to <U>Section</U><U></U><U>&nbsp;3.01</U>:&nbsp;a letter of transmittal, which shall be in a form reasonably
acceptable to Kensington and the Company (the &#147;<B>Letter of Transmittal</B>&#148;) and shall specify (i)&nbsp;that delivery shall be effected, and risk of loss and title to the certificates evidencing such shares of Company Capital Stock (the
&#147;<B>Certificates</B>&#148;) shall pass, only upon proper delivery of the Certificates to the Exchange Agent or confirmation of cancellation of such Certificates from the Company&#146;s transfer agent, Solium Capital ULC and its affiliates,
d/b/a Shareworks (each, a &#147;<B>Transfer Agent Cancellation</B>&#148;); and (ii)&nbsp;instructions for use in effecting the surrender of the Certificates pursuant to the Letter of Transmittal.&nbsp;Within two (2)&nbsp;Business Days (but in no
event prior to the Effective Time) after the surrender to the Exchange Agent of all Certificates held by such holder for cancellation (or a Transfer Agent Cancellation), together with a Letter of Transmittal, duly completed and validly executed in
accordance with the instructions thereto and such other documents as may be required pursuant to such instructions, the holder of such Certificates shall be entitled to receive in exchange therefore, and Kensington shall cause the Exchange Agent to
deliver, the applicable Per Share Merger Consideration in accordance with the provisions of <U>Section</U><U></U><U>&nbsp;3.01</U>, and the Certificate(s) so surrendered shall forthwith be cancelled.&nbsp;Until surrendered as contemplated by this
<U>Section</U><U></U><U>&nbsp;3.02</U>, each Certificate entitled to receive the applicable Per Share Merger Consideration in accordance with <U>Section</U><U></U><U>&nbsp;3.01</U> shall be deemed at all times after the Effective Time to represent
only the right to receive upon such surrender the applicable Per Share Merger Consideration that such holder is entitled to receive in accordance with the provisions of <U>Section</U><U></U><U>&nbsp;3.01</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Distributions with Respect to Unexchanged Shares of Kensington Common Stock</U>.&nbsp;No dividends or other distributions declared or
made after the Effective Time with respect to the New Kensington Common Stock with a record date after the Effective Time shall be paid to the holder of any unsurrendered Certificate with respect to the shares of New Kensington Common Stock
represented thereby until the holder of such Certificate shall surrender such Certificate in accordance with <U>Section</U><U></U><U>&nbsp;3.02(b)</U>.&nbsp;Subject to the effect of escheat, tax or other applicable Laws, following surrender of any
such Certificate, Kensington shall pay or cause to be paid to the holder of shares of New Kensington Common Stock issued in exchange therefore, without interest, (i)&nbsp;promptly, but in any event within five (5)&nbsp;Business Days of such
surrender, the amount of dividends or other distributions with a record date after the Effective Time and theretofore paid with respect to such shares of New Kensington Common Stock, and (ii)&nbsp;at the appropriate payment date, the amount of
dividends or other distributions, with a record date after the Effective Time but prior to surrender and a payment date occurring after surrender, payable with respect to such shares of New Kensington Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>No Further Rights in Company Common Stock and Company Preferred Stock</U>.&nbsp;The Per Share Merger Consideration payable upon
conversion of the Company Capital Stock in accordance with the terms hereof shall be deemed to have been paid and issued in full satisfaction of all rights pertaining to such Company Capital Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Adjustments to Per Share Merger Consideration</U>.&nbsp;The Per Share Merger
Consideration shall be adjusted to reflect appropriately the effect of any stock split, reverse stock split, stock dividend, reorganization, recapitalization, reclassification, combination, exchange of shares or other like change with respect to
Kensington Capital Stock occurring on or after the date of this Agreement and prior to the Effective Time (but, for the avoidance of doubt, shall not be adjusted to reflect any change in the capitalization of the Company, except to the extent
expressly set forth in the definition of &#147;Exchange Ratio&#148; and its components as determined in accordance with <U>Section</U><U></U><U>&nbsp;3.06</U>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Termination of Exchange Fund</U>.&nbsp;Any portion of the Exchange Fund that remains undistributed to the holders of Company Capital
Stock for one year after the Effective Time shall be delivered to Kensington, upon demand, and any holders of Company Capital Stock who have not theretofore complied with this <U>Section</U><U></U><U>&nbsp;3.02</U> shall thereafter look only to
Kensington for the Per Share Merger Consideration.&nbsp;Any portion of the Exchange Fund remaining unclaimed by holders of Company Capital Stock as of a date which is immediately prior to such time as such amounts would otherwise escheat to or
become property of any government entity shall, to the extent permitted by applicable law, become the property of Kensington free and clear of any claims or interest of any person previously entitled thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>No Liability</U>.&nbsp;None of the Exchange Agent, Kensington or the Surviving Corporation shall be liable to any holder of Company
Capital Stock for any such Company Capital Stock (or dividends or distributions with respect thereto) or cash delivered to a public official pursuant to any abandoned property, escheat or similar Law in accordance with
<U>Section</U><U></U><U>&nbsp;3.02</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Withholding Rights</U>.&nbsp;Each of the Surviving Corporation and Kensington shall be
entitled to deduct and withhold from the consideration otherwise payable pursuant to this Agreement to any holder of Company Capital Stock such amounts as it is required to deduct and withhold with respect to the making of such payment under the
United States Internal Revenue Code of 1986, as amended (the &#147;<B>Code</B>&#148;), or any provision of state, local or foreign tax law.&nbsp;To the extent that amounts are so withheld by the Surviving Corporation or Kensington, as the case may
be, such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the holder of the Company Capital Stock (or intended recipients of compensatory payments) in respect of which such deduction and withholding was
made by the Surviving Corporation or Kensington, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Lost Certificates</U>.&nbsp;If any Certificate shall have
been lost, stolen or destroyed, upon the making of an affidavit of that fact and related indemnity by the person claiming such Certificate to be lost, stolen or destroyed (such affidavit and indemnity to be in form and substance reasonably
satisfactory to Kensington and the Surviving Corporation but in any case to not require the delivery of a bond), the Exchange Agent will issue in exchange for such lost, stolen or destroyed Certificate, the applicable Per Share Merger Consideration
that such holder is otherwise entitled to receive pursuant to, and in accordance with, the provisions of <U>Section</U><U></U><U>&nbsp;3.01</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 3.03.<U>&nbsp;Stock Transfer Books</U>.&nbsp;At the Effective Time, the stock transfer books of the Company shall be closed and there
shall be no further registration of transfers of Company Capital Stock thereafter on the records of the Company.&nbsp;From and after the Effective Time, the holders of Certificates representing Company Capital Stock outstanding immediately prior to
the Effective Time shall cease to have any rights with respect to such Company Capital Stock, except as otherwise provided in this Agreement or by Law.&nbsp;On or after the Effective Time, any Certificates presented to the Exchange Agent or
Kensington for any reason shall be converted into the applicable Per Share Merger Consideration in accordance with the applicable provisions of <U>Section</U><U></U><U>&nbsp;3.01</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 3.04.<U>&nbsp;Payment of Expenses</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) No sooner than five (5)&nbsp;or later than two (2)&nbsp;Business Days prior to the Closing Date, the Company shall provide to Kensington a
written report setting forth a list of all of the following fees and expenses incurred by or on behalf of the Company in connection with the preparation, negotiation and execution of this Agreement and the consummation of the transactions
contemplated hereby (together with written invoices and wire transfer </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
instructions for the payment thereof), solely to the extent such fees and expenses are incurred and expected to remain unpaid as of the close of business on the Business Day immediately preceding
the Closing Date: (i)&nbsp;the fees and disbursements of outside counsel to the Company incurred in connection with the Transactions and (ii)&nbsp;the fees and expenses of any other agents, advisors, consultants, experts, financial advisors and
other service providers engaged by the Company in connection with the Transactions (collectively, the &#147;<B>Outstanding Company Transaction Expenses</B>&#148;).&nbsp;On the Closing Date following the Closing, Kensington shall pay or cause to be
paid by wire transfer of immediately available funds all such Outstanding Company Transaction Expenses.&nbsp;For the avoidance of doubt, the Outstanding Company Transaction Expenses shall not include any fees and expenses of the Company&#146;s
stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) No sooner than five (5)&nbsp;or later than two (2)&nbsp;Business Days prior to the Closing Date, Kensington shall
provide to the Company a written report setting forth a list of all fees, expenses and disbursements incurred by or on behalf of Kensington or Merger Sub for outside counsel, agents, advisors, consultants, experts, financial advisors and other
service providers engaged by or on behalf of Kensington or Merger Sub in connection with the Transactions or otherwise in connection with Kensington&#146;s operations (together with written invoices and wire transfer instructions for the payment
thereof) (collectively, the &#147;<B>Outstanding</B> <B>Kensington</B> <B>Transaction Expenses</B>&#148;).&nbsp;On the Closing Date following the Closing, Kensington shall pay or cause to be paid by wire transfer of immediately available funds all
such Outstanding Kensington Transaction Expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Kensington shall not pay or cause to be paid any Outstanding Kensington Transaction
Expenses or Outstanding Company Transaction Expenses other than in accordance with this <U>Section</U><U></U><U>&nbsp;3.04</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
3.05.<U>&nbsp;Appraisal Rights</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding any provision of this Agreement to the contrary and to the extent available under
the DGCL, shares of Company Common Stock and Company Preferred Stock that are outstanding immediately prior to the Effective Time and that are held by stockholders of the Company who shall have neither voted in favor of the Merger nor consented
thereto in writing and who shall have demanded properly in writing appraisal for such Company Common Stock or Company Preferred Stock in accordance with Section&nbsp;262 of the DGCL and otherwise complied with all of the provisions of the DGCL
relevant to the exercise and perfection of dissenters&#146; rights shall not be converted into, and such stockholders shall have no right to receive, the applicable Per Share Merger Consideration unless and until such stockholder fails to perfect or
withdraws or otherwise loses his, her or its right to appraisal and payment under the DGCL.&nbsp;Any stockholder of the Company who fails to perfect or who effectively withdraws or otherwise loses his, her or its rights to appraisal of such shares
of Company Common Stock or Company Preferred Stock under Section&nbsp;262 of the DGCL shall thereupon be deemed to have been converted into, and to have become exchangeable for, as of the Effective Time, the right to receive the applicable Per Share
Merger Consideration, without any interest thereon, upon surrender, in the manner provided in this <U>Article III</U>, of the Certificate or Certificates that formerly evidenced such shares of Company Common Stock or Company Preferred Stock (as the
case may be). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Prior to the Closing, the Company shall give Kensington (i)&nbsp;prompt notice of any demands for appraisal received by
the Company and any withdrawals of such demands, and (ii)&nbsp;the opportunity to participate in all negotiations and proceedings with respect to demands for appraisal under the DGCL.&nbsp;The Company shall not, except with the prior written consent
of Kensington (which consent shall not be unreasonably withheld), make any payment with respect to any demands for appraisal or offer to settle or settle any such demands. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 3.06.<U>&nbsp;Calculation of Exchange Ratio</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) For purposes of this Agreement, the &#147;<B>Determination Date</B>&#148; shall be the date that is ten (10)&nbsp;Business Days prior to
the anticipated date for Closing, as agreed upon by Kensington and the Company at least ten (10)&nbsp;Business Days prior to the date of the Kensington Stockholders&#146; Meeting (the &#147;<B>Anticipated Closing Date</B>&#148;).&nbsp;No later than
the Determination Date, the Company shall deliver to Kensington a calculation (the &#147;<B>Exchange Ratio Calculation</B>&#148;) setting forth the Company&#146;s good faith, estimated calculation of Exchange
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Ratio as of the Anticipated Closing Date (using an estimate of each component thereof as of such date, prepared and certified by the Company&#146;s chief financial officer or principal accounting
officer.&nbsp;The Company shall make relevant <FONT STYLE="white-space:nowrap">back-up</FONT> materials used or useful in preparing the Exchange Ratio Calculation, as reasonably requested in writing by Kensington, available to Kensington and, if
requested in writing by Kensington, its accountants and counsel at reasonable times and upon reasonable notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Within three
(3)&nbsp;Business Days after the Company delivers the Exchange Ratio Calculation (the &#147;<B>Response Date</B>&#148;), Kensington shall have the right to dispute any part of such Exchange Ratio Calculation by delivering a written notice to that
effect to the Company (a &#147;<B>Dispute Notice</B>&#148;). Any Dispute Notice shall identify in reasonable detail the nature of any proposed revisions to the Exchange Ratio Calculation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If on or prior to the Response Date, (i)&nbsp;Kensington notifies the Company in writing that it has no objections to the Exchange Ratio
Calculation or (ii)&nbsp;Kensington fails to deliver a Dispute Notice as provided in <U>Section</U><U></U><U>&nbsp;3.06(b)</U>, then the Exchange Ratio as set forth in the Exchange Ratio Calculation delivered to Kensington shall be deemed, subject
to the terms of <U>Section</U><U></U><U>&nbsp;3.06(f)</U>, to have been finally determined for purposes of this Agreement and to represent the Exchange Ratio at the Anticipated Closing Date for purposes of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If Kensington delivers a Dispute Notice on or prior to the Response Date, then Representatives of Kensington and the Company shall
promptly meet and attempt in good faith to resolve the disputed item(s) and negotiate an agreed-upon determination of the Exchange Ratio, which agreed upon Exchange Ratio amount shall be deemed to have been finally determined for purposes of this
Agreement and to represent the Exchange Ratio at the Anticipated Closing Date for purposes of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) If Representatives of
Kensington and the Company are unable to negotiate an agreed-upon determination of the Exchange Ratio at the Anticipated Closing Date pursuant to <U>Section</U><U></U><U>&nbsp;3.06(d)</U> within three (3)&nbsp;Business Days after delivery of the
Dispute Notice (or such other period as Kensington and the Company may mutually agree upon), then Kensington and the Company shall jointly select an independent auditor of recognized national standing (the &#147;<B>Accounting Firm</B>&#148;) to
resolve any remaining disagreements as to the Exchange Ratio Calculation. The Company shall promptly deliver to the Accounting Firm the relevant <FONT STYLE="white-space:nowrap">back-up</FONT> materials used in preparing the Exchange Ratio
Calculation, and Kensington and the Company shall use commercially reasonable efforts to cause the Accounting Firm to make its determination within five (5)&nbsp;Business Days of accepting its selection. Kensington and the Company shall be afforded
the opportunity to present to the Accounting Firm any material related to the unresolved disputes and to discuss the issues with the Accounting Firm; <U>provided</U>, <U>however</U>, that no such presentation or discussion shall occur without the
presence of a Representative of each of Kensington and the Company. The determination of the Accounting Firm shall be limited to the disagreements submitted to the Accounting Firm. The determination of the amount of the Exchange Ratio made by the
Accounting Firm shall be deemed to have been finally determined for purposes of this Agreement and to represent the Exchange Ratio at the Anticipated Closing Date for purposes of this Agreement, and the parties shall delay the Closing until the
resolution of the matters described in this <U>Section</U><U></U><U>&nbsp;3.06(e)</U>. The fees and expenses of the Accounting Firm shall be allocated between Kensington and the Company in the same proportion that the disputed amount of the Exchange
Ratio that was unsuccessfully disputed by such party (as finally determined by the Accounting Firm) bears to the total disputed amount of the Exchange Ratio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Following the final determination of Exchange Ratio as of the Anticipated Closing Date in accordance with this
<U>Section</U><U></U><U>&nbsp;3.06</U> (either as a result of the mutual agreement of the parties or the determination of the Accounting Firm), the parties shall not be required to determine the Exchange Ratio again even though the Closing Date may
occur later than the Anticipated Closing Date, except that either party may request a redetermination of the Exchange Ratio if the Closing Date is more than fifteen (15)&nbsp;Business Days after the Anticipated Closing Date (including as a result of
the engagement of the Accounting Firm), in which event the procedures set forth in this <U>Section</U><U></U><U>&nbsp;3.06</U> shall once again apply and the parties shall select a new Anticipated Closing Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as set forth in the Company&#146;s disclosure schedule delivered by Company in connection with this Agreement (the &#147;<B>Company
Disclosure Schedule</B>&#148;) (which disclosure in the Company Disclosure Schedule shall be deemed to qualify or provide disclosure in response to (i)&nbsp;the section or subsection of this <U>Article IV</U> that corresponds to the section or
subsection of the Company Disclosure Schedule in which any such disclosure is set forth and (ii)&nbsp;any other section or subsection of this <U>Article IV</U> to the extent that its relevance to such section or subsection is reasonably apparent on
the face of such disclosure), the Company hereby represents and warrants to Kensington and Merger Sub as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
4.01.<U>&nbsp;Organization and Qualification; Subsidiaries</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company is a corporation duly organized, validly existing and in
good standing under the laws of the State of Delaware and has the requisite corporate power and authority and all necessary governmental approvals to own, lease and operate its properties and to carry on its business as it is now being
conducted.&nbsp;The Company is duly qualified or licensed as a foreign corporation or other organization to do business, and is in good standing, in each jurisdiction where the character of the properties owned, leased or operated by it or the
nature of its business makes such qualification or licensing necessary, except for such failures to be so qualified or licensed and in good standing that would not have a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Other than the Company JV, the Company does not directly or indirectly own any equity or similar interest in, or any interest convertible
into or exchangeable or exercisable for any equity or similar interest in, any other corporation, partnership, joint venture or business association or other person.&nbsp;The Company JV does not own any material assets other than cash and has not in
any material respect engaged in any business activities or conducted in any material respect, any operations or incurred any obligation or liability, other than under insurance policies, those incident to its existence or as contemplated by its
limited liability company operating agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.02.<U>&nbsp;Certificate of Incorporation and</U> <U>Bylaws</U>.&nbsp;The Company
has prior to the date of this Agreement made available to Kensington a true, complete and correct copy of its certificate of incorporation and bylaws, each as amended to as of the date of this Agreement.&nbsp;Such certificate of incorporation and
bylaws are in full force and effect.&nbsp;The Company is not in violation of any of the provisions of its certificate of incorporation or bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.03.<U>&nbsp;Capitalization</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The authorized capital stock of the Company consists of ninety five million six hundred eighty four thousand eight hundred forty three
(95,684,843) shares of Company Class&nbsp;A Common Stock, forty-seven million (47,000,000) shares of Company Class&nbsp;B Common Stock and sixty three million three hundred twenty nine thousand nine hundred ninety eight (63,329,998) shares of
Company Preferred Stock, of which twelve million three hundred and sixteen thousand eight hundred and thirty one (12,316,831) shares are designated as Series A Preferred Stock, twelve million three hundred and eighty one thousand and eight
(12,381,008) shares are designated as Series B Preferred Stock, four million seventy six thousand thirty seven (4,076,037) shares are designated as Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, eleven million three hundred
eighty eight thousand ninety (11,388,090) shares are designated as Series C Preferred Stock, two million nine hundred eighty three thousand one hundred eighty nine (2,983,189) shares are designated as Series D Preferred Stock, five million five
hundred thousand (5,500,000) shares are designated as Series E Preferred Stock, and fourteen million six hundred eighty four thousand eight hundred forty three (14,684,843) shares are designated as Series F Preferred Stock.&nbsp;As of the date of
this Agreement, (i)&nbsp;five hundred and seventy eight thousand and eighty nine (578,089) shares of Company Class&nbsp;A Common Stock are issued and outstanding, (ii)&nbsp;ten million, six hundred and ninety six thousand, eight
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
hundred and fifty two (10,696,852) shares of Company Class&nbsp;B Common Stock are issued and outstanding, (iii)&nbsp;twelve million, one hundred and ninety two thousand, two hundred and forty
five (12,192,245) shares of Series A Preferred Stock are issued and outstanding, (iv)&nbsp;twelve million, three hundred and eighty one thousand and eight (12,381,008) shares of Series B Preferred Stock are issued and outstanding, (v)&nbsp;four
million, seventy six thousand and thirty seven (4,076,037) shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock are issued and outstanding, (vi)&nbsp;eleven million, two hundred and fifty eight thousand, three hundred and
seventy two (11,258,372) shares of Series C Preferred Stock are issued and outstanding, (vii)&nbsp;two million, nine hundred and eighty three thousand, one hundred and eighty nine (2,983,189) shares of Series D Preferred Stock are issued and
outstanding, (viii)&nbsp;five million and five hundred thousand (5,500,000) shares of Series E Preferred Stock are issued and outstanding, (ix)&nbsp;fourteen million, six hundred and eighty four thousand, eight hundred and forty three (14,684,843)
shares of Series F Preferred Stock committed but are not issued and outstanding, (x)&nbsp;four hundred and thirty eight thousand and one hundred and ninety one (438,191) shares of the Company&#146;s capital stock held in treasury will not be
converted and will be retired and (xi)&nbsp;eighteen million, nine hundred and fifteen thousand, one hundred and eighty two (18,915,182) shares of Company Common Stock have been reserved for issuance as Company Options, Company Restricted Stock,
Company RSUs and other purchase rights (the &#147;<B>Company Share Awards</B>&#148;) under the Company Option Plan, of which as of the date of this Agreement, (A)&nbsp;fifty one thousand, nine hundred and fifteen (51,915) shares of Company
Class&nbsp;A Common Stock and nine hundred and thirty four thousand and thirty three (934,033) shares of Company Class&nbsp;B Common Stock have been issued pursuant to the exercise of Company Options and have not been repurchased, (B)&nbsp;Company
Options to purchase eleven million, four hundred and seventy six thousand and ten (11,476,010) shares of Company Class&nbsp;A Common Stock and two million, eight hundred and thirteen thousand, two hundred and ninety six (2,813,296) shares of Company
Class&nbsp;B Common Stock are outstanding, (C)&nbsp;no shares of are issued and outstanding as Company Restricted Stock, (D)&nbsp;three million, two hundred and thirty one thousand, six hundred and twenty five (3,231,625) Company RSUs denominated in
Company Class&nbsp;A Common Stock and no Company RSUs denominated in Company Class&nbsp;B Common Stock are outstanding and (E)&nbsp;no shares of Company Common Stock remain available for issuance under the Company Option Plan.&nbsp;The Company has
issued and outstanding Company Warrants, of which one hundred and twenty four thousand, five hundred and eighty six (124,586)are with respect to shares of Series A Preferred Stock and one hundred and twenty nine thousand, seven hundred and eighteen
(129,718) are with respect to shares of Series C Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Other than the Company Options and the Company RSUs and other than
the conversion privileges of the Company Capital Stock pursuant to the Company Certificate of Incorporation, there are no options, warrants, preemptive rights, calls, convertible securities, conversion rights or other rights, agreements,
arrangements or commitments of any character relating to the issued or unissued capital stock of the Company or obligating the Company to issue or sell any shares of capital stock of the Company.&nbsp;The Company is not a party to, or otherwise
bound by, and the Company has not granted, any equity appreciation rights, participations, phantom equity or similar rights.&nbsp;There are no voting trusts, voting agreements, proxies, shareholder agreements or other agreements with respect to the
voting or transfer of the Company Common Stock, Company Preferred Stock or any of the equity interests or other securities of the Company.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Section 4.03(c)</U> of the Company Disclosure Schedule sets forth, as of the date of this Agreement, the following information with
respect to each Company Share Award outstanding: (i)&nbsp;the name of the Company Share Award recipient; (ii)&nbsp;the particular Company Option Plan, if any, pursuant to which such Company Share Award was granted; (iii)&nbsp;the number of shares of
the Company subject to such Company Share Award; (iv)&nbsp;the exercise or purchase price of such Company Share Award; (v)&nbsp;the date on which such Company Share Award was granted; (vi)&nbsp;the date on which such Company Share Award expires;
(vii)&nbsp;the vesting schedule of the Company Share Award, including the terms of any acceleration rights thereunder; and (viii)&nbsp;whether the shares underlying such Company Share Award are Company Class&nbsp;A Common Stock or Company
Class&nbsp;B Common Stock. The Company has prior to the date of this Agreement made available to Kensington true, complete and correct copies of the Company Option Plan as in effect as of the date of this Agreement pursuant to which the Company has
granted the Company Share Awards that are currently outstanding and the form of all stock award agreements and restricted share purchase agreements evidencing such Company Share Awards.&nbsp;No Company
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Option was granted with an exercise price per share less than the fair market value of the underlying Company Share Awards as of the date such Company Option was granted.&nbsp;All shares of the
Company subject to issuance as aforesaid, upon issuance on the terms and conditions specified in the instruments pursuant to which they are issuable, will be duly authorized, validly issued, fully paid and nonassessable.&nbsp;In addition,
<U>Section</U><U></U><U>&nbsp;4.03(c)</U> of the Company Disclosure Schedule sets forth all commitments the Company has made to grant Company Share Awards that have not yet been granted as of the date of this Agreement, specifying: (i)&nbsp;the name
of the person to whom Company Share Awards were promised by the Company; (ii)&nbsp;the type of Company Share Award promised by the Company; and (iii)&nbsp;the number of Company Options, Company RSUs and/or Company Restricted Stock promised by the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) There are no outstanding contractual obligations of the Company to repurchase, redeem or otherwise acquire any shares of the
Company or to provide funds to or make any investment (in the form of a loan, capital contribution or otherwise) in any person </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)(i)
There are no commitments or agreements of any character to which the Company is bound obligating the Company to accelerate the vesting of any Company Share Award, Company Option or Company Restricted Stock as a result of the proposed transactions
herein, and (ii)&nbsp;all outstanding shares of the Company, all outstanding Company Share Awards, Company Options and Company Restricted Stock have been issued and granted in compliance with (A)&nbsp;all applicable securities laws and other
applicable laws, (B)&nbsp;the terms of the Company Option Plan (if applicable) and (C)&nbsp;all <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights and other requirements set forth in applicable contracts to which the Company is a party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The stockholders of the Company collectively own directly and beneficially and of record, all of the equity of the Company (which are
represented by the issued and outstanding shares of the Company).&nbsp;Except for the shares of the Company held by the stockholders of the Company, no shares or other equity or voting interest of the Company, or options, warrants or other rights to
acquire any such shares or other equity or voting interest, of the Company is authorized or issued and outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) All outstanding
shares of Company Common Stock and Company Preferred Stock have been issued and granted in compliance with (A)&nbsp;applicable securities laws and other applicable laws and (B)&nbsp;any <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights and
other similar requirements set forth in applicable contracts to which the Company is a party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Section 4.03(h)</U> of the Company
Disclosure Schedule sets forth, as of the date of this Agreement, for each share of Company Preferred Stock, whether such share is a share of Company Class&nbsp;A Preferred Stock or a share of Company Class&nbsp;B Preferred Stock. After the
Effective Time, all of the shares of Company Preferred Stock shall no longer be outstanding and shall cease to exist, and each previous holder of Company Preferred Stock shall thereafter cease to have any rights with respect to such
securities.&nbsp;Each share of Company Class&nbsp;A Preferred Stock and each share of Company Class&nbsp;B Preferred Stock is convertible into either one (1)&nbsp;share of Company Class&nbsp;A Common Stock or one (1)&nbsp;share of Company
Class&nbsp;B Common Stock, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.04.<U>&nbsp;Authority Relative to this Agreement</U>.&nbsp;The Company has all
necessary power and authority to execute and deliver this Agreement and the other Transaction Documents to which it is or will at the Closing be a party, to perform its obligations hereunder and thereunder and, subject to receiving the Company
Stockholder Approval, to consummate the Transactions.&nbsp;The execution and delivery by the Company of this Agreement and the other Transaction Documents to which it is or will at the Closing be a party, the performance by the Company of its
obligations hereunder and thereunder and the consummation by the Company of the Transactions have been duly and validly authorized by all necessary corporate action, and no other corporate proceedings on the part of the Company are necessary to
authorize this Agreement or to consummate the Transactions (other than, with respect to the Merger, the Company Stockholder Approval, which the Written Consent shall satisfy, and the filing and recordation of appropriate merger documents as required
by the DGCL).&nbsp;This Agreement has been, and the other Transaction Documents to which the Company is or will at the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Closing be a party will, at the Closing, be duly and validly executed and delivered by the Company and, assuming the due authorization, execution and delivery by the other party or parties
thereto, constitutes (or will then constitute) a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as limited by applicable bankruptcy, insolvency, reorganization, moratorium and
other laws of general application affecting enforcement of creditors&#146; rights generally, by general equitable principles (the &#147;<B>Remedies Exceptions</B>&#148;).&nbsp;The Company Board Approval is sufficient so that the restrictions on
business combinations set forth in Section&nbsp;203 of the DGCL shall not apply to the Merger, this Agreement, the Stockholder Support Agreement, any Ancillary Agreement or any of the other Transactions.&nbsp;To the knowledge of the Company, no
other state takeover statute is applicable to the Merger or the other Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.05.<U>&nbsp;No Conflict; Required Filings
and Consents</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The execution and delivery by the Company of this Agreement and the other Transaction Documents to which the Company
is or will at the Closing be a party does not, and subject to receipt of the filing and recordation of appropriate merger documents as required by the DGCL and of the consents, approvals, authorizations or permits, filings and notifications
contemplated by <U>Section</U><U></U><U>&nbsp;4.05(b)</U>, the performance of this Agreement by the Company will not (i)&nbsp;conflict with or violate the certificate of incorporation or bylaws of the Company, (ii)&nbsp;conflict with or violate any
United States or <FONT STYLE="white-space:nowrap">non-United</FONT> States statute, law, ordinance, regulation, rule, code, executive order, injunction, judgment, decree or other order (&#147;<B>Law</B>&#148;) applicable to the Company or by which
any property or asset of the Company is bound or affected, or (iii)&nbsp;result in any breach of or constitute a default (or an event which, with notice or lapse of time or both, would become a default) under, or give to others any right of
termination, amendment, acceleration or cancellation of, or result in the creation of a Lien (other than any Permitted Lien) on any material property or asset of the Company pursuant to, any Material Contract, except, with respect to clauses
(ii)&nbsp;and (iii), for any such conflicts, violations, breaches, defaults or other occurrences that would not have a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The execution and delivery of this Agreement by the Company does not, and the performance of this Agreement by the Company will not,
require any consent, approval, authorization or permit of, or filing with or notification to, any United States federal, state, county or local or <FONT STYLE="white-space:nowrap">non-United</FONT> States government, governmental, regulatory or
administrative authority, agency, instrumentality or commission or any court, tribunal, or judicial or arbitral body (a &#147;<B>Governmental Authority</B>&#148;), except (i)&nbsp;for applicable requirements, if any, of the Exchange Act, state
securities or &#147;blue sky&#148; laws (&#147;<B>Blue Sky Laws</B>&#148;) and state takeover laws, the <FONT STYLE="white-space:nowrap">pre-merger</FONT> notification requirements of the HSR Act, and filing and recordation of appropriate merger
documents as required by the DGCL, and (ii)&nbsp;where the failure to obtain such consents, approvals, authorizations or permits, or to make such filings or notifications that would not have a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.06.<U>&nbsp;Permits; Compliance</U>.&nbsp;The Company is in possession of all material franchises, grants, authorizations, licenses,
permits, easements, variances, exceptions, consents, certificates, approvals and orders of any Governmental Authority necessary for the Company to own, lease and operate its properties or to carry on its business as it is now being conducted (the
&#147;<B>Company Permits</B>&#148;), except where the failure to have such Company Permits would not have a Company Material Adverse Effect.&nbsp;No suspension or cancellation of any of the Company Permits is pending or, to the knowledge of the
Company, threatened.&nbsp;The Company is not in conflict with, or in default, breach or violation of, (a)&nbsp;any Law applicable to the Company or by which any property or asset of the Company is bound or affected, or (b)&nbsp;any Material Contract
or Company Permit, except, in each case, for any such conflicts, defaults, breaches or violations that would not have a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.07.<U>&nbsp;Financial Statements</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company has prior to the date of this Agreement made available to Kensington true, complete and correct copies of the audited balance
sheet of the Company as of December&nbsp;31, 2017, December&nbsp;31, 2018 and December&nbsp;31, 2019, and the related audited statements of operations and comprehensive loss, cash flows and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stockholders&#146; equity of the Company for each of the years then ended (collectively, the &#147;<B>Audited Financial Statements</B>&#148;), which are attached as
<U>Section</U><U></U><U>&nbsp;4.07(a)</U> of the Company Disclosure Schedule, and which contain an unqualified report thereon of the Company&#146;s auditors.&nbsp;Each of the Audited Financial Statements (including the notes thereto)&nbsp;(i) was
prepared in accordance with United States generally accepted accounting principles (&#147;<B>GAAP</B>&#148;) applied on a consistent basis throughout the periods indicated (except as may be indicated in the notes thereto) and (ii)&nbsp;fairly
presents, in all material respects, the financial position, results of operations and cash flows of the Company as at the date thereof and for the period indicated therein, except as otherwise noted therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company has prior to the date of this Agreement made available to Kensington a true, complete and correct copy of the unaudited
balance sheet of the Company as of June&nbsp;30, 2020 (the &#147;<B>June Balance Sheet</B>&#148;), and the related unaudited statements of operations and comprehensive loss and cash flows of the Company for the
<FONT STYLE="white-space:nowrap">six-month</FONT> period then ended, which are attached as <U>Section</U><U></U><U>&nbsp;4.07(b)</U> of the Company Disclosure Schedule.&nbsp;Such unaudited financial statements were prepared in accordance with GAAP
applied on a consistent basis throughout the periods indicated (except for the omission of footnotes and subject to <FONT STYLE="white-space:nowrap">year-end</FONT> adjustments, none of which are individually or in the aggregate material) and fairly
present, in all material respects, the financial position, results of operations and cash flows of the Company as at the date thereof and for the period indicated therein, except as otherwise noted therein and subject to normal and recurring <FONT
STYLE="white-space:nowrap">year-end</FONT> adjustments (none of which are individually or in the aggregate material) and the absence of notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as and to the extent set forth on the Audited Financial Statements and the June Balance Sheet, the Company has no liability or
obligation of a nature (whether accrued, absolute, contingent or otherwise) required to be reflected on a balance sheet prepared in accordance with GAAP, except for: (i)&nbsp;liabilities that were incurred in the ordinary course of business since
the date of such June Balance Sheet, (ii)&nbsp;obligations for future performance under any contract to which the Company is a party or (iii)&nbsp;liabilities and obligations which would not have a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Since December&nbsp;31, 2017 (i) neither the Company nor, to the Company&#146;s knowledge, any director, officer, employee, auditor,
accountant or Representative of the Company, has received or otherwise had or obtained knowledge of any complaint, allegation, assertion or claim, whether written or, to the knowledge of the Company, oral, regarding the accounting or auditing
practices, procedures, methodologies or methods of the Company or its internal accounting controls, including any such complaint, allegation, assertion or claim that the Company has engaged in questionable accounting or auditing practices and
(ii)&nbsp;there have been no internal investigations regarding accounting or revenue recognition discussed with, reviewed by or initiated at the direction of the chief executive officer, chief financial officer, general counsel, the Company Board or
any committee thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) To the knowledge of the Company, no employee of the Company has provided or is providing information to any
law enforcement agency regarding the commission or possible commission of any crime or the violation or possible violation of any applicable Law.&nbsp;None of the Company or, to the knowledge of the Company any officer, employee, contractor,
subcontractor or agent of the Company has discharged, demoted, suspended, threatened, harassed or in any other manner discriminated against an employee of the Company in the terms and conditions of employment because of any act of such employee
described in 18 U.S.C. sec.&nbsp;1514A(a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) All accounts payable of the Company reflected on the June Balance Sheet or arising
thereafter are the result of <U>bona</U> <U>fide</U> transactions in the ordinary course of business and have been paid or are not yet due or payable.&nbsp;Since the date of the June Balance Sheet, the Company has not altered in any material
respects their practices for the payment of such accounts payable, including the timing of such payment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.08.<U>&nbsp;Absence of
Certain Changes or Events</U>.&nbsp;Since the June Balance Sheet Date and prior to the date of this Agreement, except as otherwise reflected in the Audited Financial Statements, or as expressly contemplated by this Agreement, (a)&nbsp;the Company
has conducted its business in all material respects in the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
ordinary course and in a manner consistent with past practice, (b)&nbsp;the Company has not sold, assigned or otherwise transferred any right, title, or interest in or to any of its material
assets (including ownership in Intellectual Property Rights and Business Systems) other than <FONT STYLE="white-space:nowrap">non-exclusive</FONT> licenses or assignments or transfers in the ordinary course of business, (c)&nbsp;there has not been
any Company Material Adverse Effect, and (d)&nbsp;the Company has not taken any action that, if taken after the date of this Agreement, would constitute a material breach of any of the covenants set forth in <U>Section</U><U></U><U>&nbsp;6.01</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.09.<U>&nbsp;Absence of Litigation</U>.&nbsp;There is no material litigation, suit, claim, action, proceeding or investigation
by or before any Governmental Authority (an &#147;<B>Action</B>&#148;) pending or, to the knowledge of the Company, threatened against the Company, or any property or asset of the Company, before any Governmental Authority.&nbsp;Neither the Company
nor any material property or asset of the Company is subject to any continuing order of, consent decree, settlement agreement or other similar written agreement with, or, to the knowledge of the Company, continuing investigation by, any Governmental
Authority, or any order, writ, judgment, injunction, decree, determination or award of any Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
4.10.<U>&nbsp;Employee Benefit Plans</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) True, correct and compete copies of all employment and consulting contracts or agreements to
which the Company is a party as of the date of this Agreement, and with respect to which the Company has any obligation have been made available to Kensington prior to the date of this Agreement.<U>&nbsp;Section 4.10(a)</U> of the Company Disclosure
Schedule lists, as of the date of this Agreement, all material Plans.&nbsp;For purposes herein, a &#147;<B>Plan</B>&#148; is defined as: (i)&nbsp;all employee benefit plans (as defined in Section&nbsp;3(3) of the Employee Retirement Income Security
Act of 1974, as amended (&#147;<B>ERISA</B>&#148;)), (ii) any other employee benefit plan, agreement, arrangement, program, policy or practice, including without limitation, any equity or equity-based compensation (including without limitation stock
option, stock purchase, stock award, stock appreciation, phantom stock, restricted stock or restricted stock unit), deferred compensation, pension, retirement, savings, bonus, profit sharing, incentive compensation, retention, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control,</FONT></FONT> medical, dental, vision, prescription drug, life insurance, death benefit, cafeteria, flexible spending, dependent care, fringe benefit, vacation, paid time
off, holiday pay, disability, sick pay, unemployment, severance, employee loan or educational assistance plan, agreement, arrangement, program, policy or practice, and (iii)&nbsp;any employment, consulting, indemnification or other individual
services agreement, which in the case of each of clauses (i), (ii) and (iii), is sponsored or maintained by the Company, or to which the Company contributes or is required to contribute or is a party, on behalf of current or former employees,
officers, independent contractors or directors of the Company or their spouses, beneficiaries or dependents, or with respect to which the Company has or may have any liability, contingent or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) With respect to each Plan in effect as of the date of this Agreement, the Company has prior to the date of this Agreement made available
to Kensington, if applicable (i)&nbsp;a true, complete and correct copy of the current plan document (or written summaries of any unwritten Plans) and all amendments thereto and each trust or other funding arrangement, (ii)&nbsp;true, complete and
correct copies of the most recent summary plan description and any summaries of material modifications, (iii)&nbsp;any administrative services, recordkeeping, investment advisory, investment management or other service agreement (iv)&nbsp;the last
three (3)&nbsp;annual financial statements, (v)&nbsp;the last three (3)&nbsp;annual reports on Internal Revenue Service (&#147;<B>IRS</B>&#148;) Form 5500 (including all required schedules, accountant&#146;s opinions and reports and other
attachments), (vi) the last three (3)&nbsp;actuarial valuations or reports, (vii)&nbsp;the last three (3)&nbsp;annual testings performed on any Plan, (viii)&nbsp;true, complete and correct copies of the most recently received IRS determination,
opinion or advisory letter for each such Plan, and (ix)&nbsp;any material <FONT STYLE="white-space:nowrap">non-routine</FONT> correspondence from any Governmental Authority with respect to any Plan since December&nbsp;31, 2017.&nbsp;The Company has
no express commitment to modify, change or terminate any Plan, other than with respect to a modification, change or termination required by ERISA or the Code, or other applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) None of the Plans is or was since December&nbsp;31, 2014, nor does the Company or any ERISA Affiliate have or reasonably expect to have
any liability or obligation under (i)&nbsp;a multiemployer plan (within the meaning </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of Section&nbsp;3(37) or 4001(a)(3) of ERISA), (ii) a single employer pension plan (within the meaning of Section&nbsp;4001(a)(15) of ERISA) subject to Section&nbsp;412 of the Code and/or Title
IV of ERISA, (iii)&nbsp;a multiple employer plan subject to Section&nbsp;413(c) of the Code, or (iv)&nbsp;a multiple employer welfare arrangement under ERISA.&nbsp;For purposes of this Agreement, &#147;<B>ERISA Affiliate</B>&#148; means any entity
that together with the Company would be deemed a &#147;single employer&#148; for purposes of Section&nbsp;4001(b)(1) of ERISA and/or Sections 414(b), (c) and/or (m)&nbsp;of the Code.&nbsp;No Plan is a &#147;defined benefit plan&#148;, within the
meaning of Section&nbsp;3(35) of ERISA, and the Company has no liability (contingent or otherwise) with respect to any such plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The
Company is not and will not be obligated, whether under any Plan or otherwise, to pay separation, severance, termination or similar benefits to any person directly as a result of any of the Transactions, nor will any of the Transactions accelerate
the time of payment or vesting, or increase the amount, of any benefit or other compensation due to any individual.&nbsp;The Transactions shall not be the direct or indirect cause of any amount paid or payable by the Company being classified as an
&#147;excess parachute payment&#148; under Section&nbsp;280G of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) None of the Plans provides, nor does the Company have or
reasonably expect to have any obligation to provide retiree medical to any current or former employee, officer, director or consultant of the Company after termination of employment or service except as may be required under Section&nbsp;4980B of
the Code and Parts 6 and 7 of Title I of ERISA and the regulations thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Each Plan is and has been since December&nbsp;31, 2017
operated and administered, in all material respects, in accordance with its terms and in compliance with the requirements of all applicable Laws including, without limitation, ERISA and the Code.&nbsp;The Company and the ERISA Affiliates have
performed, in all material respects, all obligations required to be performed by them under, are not in any material respect in default under or in violation of, and have no knowledge of any default or violation in any material respect by any party
to, any Plan.&nbsp;No Action is pending or, to the knowledge of the Company, threatened with respect to any Plan (other than claims for benefits in the ordinary course) and, to the knowledge of the Company, no fact or event exists that would
reasonably be expected to give rise to any such Action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Each Plan that is intended to be qualified under Section&nbsp;401(a) of the
Code or Section&nbsp;401(k) of the Code has (i)&nbsp;timely received a favorable determination letter from the IRS covering all of the provisions applicable to the Plan for which determination letters are currently available that the Plan is so
qualified and each trust established in connection with such Plan is exempt from federal income taxation under Section&nbsp;501(a) of the Code or (ii)&nbsp;is entitled to rely on a favorable opinion letter from the IRS, and to the knowledge of
Company, no fact or event has occurred since the date of such determination or opinion letter or letters from the IRS that would reasonably be expected to adversely affect the qualified status of any such Plan or the exempt status of any such trust.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) There has not been any prohibited transaction (within the meaning of Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code) nor
any reportable events (within the meaning of Section&nbsp;4043 of ERISA) with respect to any Plan that would reasonably be expected to result in material liability to the Company.&nbsp;There have been no acts or omissions by the Company or any ERISA
Affiliate that have given or would reasonably be expected to give rise to any material fines, penalties, taxes or related charges under Sections 502 or 4071 of ERISA or Section&nbsp;511 or Chapter 43 of the Code for which the Company or any ERISA
Affiliate may be liable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) All contributions, premiums or payments required to be made with respect to any Plan have been timely made
to the extent due or properly accrued on the consolidated financial statements of the Company, except as would not result in material liability to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) The Company and each ERISA Affiliate have each complied in all material respects with the notice and continuation coverage requirements,
and all other requirements, of Section&nbsp;4980B of the Code and Parts 6 and 7 of Title I of ERISA, and the regulations thereunder, with respect to each Plan that is, or was during any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
taxable year for which the statute of limitations on the assessment of federal income taxes remains open, by consent or otherwise, a group health plan within the meaning of
Section&nbsp;5000(b)(1) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) The Company and each Plan that is a &#147;group health plan&#148; as defined in
Section&nbsp;733(a)(1) of ERISA (each, a &#147;<B>Health Plan</B>&#148;) is and has been in compliance, in all material respects, with the Patient Protection and Affordable Care Act of 2010, P.L. <FONT STYLE="white-space:nowrap">111-148,</FONT> and
the Health Care and Education Reconciliation Act of 2010, P.L. <FONT STYLE="white-space:nowrap">111-152,</FONT> each as amended, and the regulations and other applicable regulatory guidance issued thereunder (&#147;<B>PPACA</B>&#148;), and no event
has occurred, and no condition or circumstance exists, that would reasonably be expected to subject the Company, any ERISA Affiliate or any Health Plan to any material liability for penalties, fines or excise taxes under Code Section&nbsp;4980D,
4980H or 4980I or any other provision of the PPACA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Each Plan that constitutes a nonqualified deferred compensation plan subject to
Section&nbsp;409A of the Code has been administered and operated, in all material respects, in compliance with the provisions of Section&nbsp;409A of the Code and the Treasury Regulations thereunder, and no additional Tax under
Section&nbsp;409A(a)(1)(B) of the Code has been or could reasonably be expected to be incurred by a participant in any such Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) The
Company does not have any obligation to gross up, indemnify or otherwise reimburse any current or former employee, officer, independent contractor, or director of the Company for any Taxes, interest or penalties incurred in connection with any Plan
(including any Taxes, interest or penalties incurred pursuant to Section&nbsp;409A or 4999 of the Code). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.11.<U>&nbsp;Labor and
Employment Matters</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Schedule 4.11(a)</U> of the Company Disclosure Schedule sets forth a true, complete and correct list of all
employees of the Company as of the date of this Agreement, including any employee who is on a leave of absence of any nature, authorized or unauthorized, and sets forth for each such individual the following: (i)&nbsp;name; (ii) title or position
(including whether full or part time); (iii) hire date; (iv)&nbsp;current annual base compensation rate; and (v)&nbsp;commission, bonus or other incentive based compensation.&nbsp;Except as set forth on <U>Schedule 4.11(a)</U> of the Company
Disclosure Schedule, as of the date of this Agreement, all compensation, including wages, commissions and bonuses, due and payable to all employees of the Company for services performed on or prior to the date of this Agreement have been paid in
full (or accrued in full in the Company&#146;s financial statements).&nbsp;No employee of the Company performs services for the Company outside of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Schedule 4.11(b)</U> of the Company Disclosure Schedule sets forth, as of the date of this Agreement, a true, complete and correct list
of all individuals who perform services for the Company as (i)&nbsp;an independent contractor, (ii)&nbsp;a leased employee, or (iii)&nbsp;an unpaid intern, including for each such individual, his or her name, the services he or she performs, his or
her rate of compensation and any bonus entitlement.&nbsp;No such person performs services for the Company outside of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The employment of each employee of the Company is terminable at the will of the Company and upon termination of the employment of any such
employees, no severance or other payments will become due.&nbsp;Each former employee whose employment was terminated by the Company has entered into an agreement with the Company providing for the full release of any claims against the Company or
any related party arising out of such employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) To the knowledge of the Company, no officer or executive of the Company intends to
terminate employment with the Company or is otherwise likely to become unavailable to continue as an officer or executive of the Company, nor does the Company have a present intention to terminate the employment of any of the foregoing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)(i) There are no material Actions pending or, to the knowledge of the Company, threatened
against the Company by any of its current or former employees, which Actions would be material to the Company; (ii)&nbsp;the Company is not, and has not been since December&nbsp;31, 2017, a party to, bound by, or negotiating any collective
bargaining agreement or other contract with a union, works council or labor organization applicable to persons employed by the Company, nor, to the knowledge of the Company, are there any activities or proceedings of any labor union to organize any
such employees; (iii)&nbsp;there are no unfair labor practice complaints pending against the Company before the National Labor Relations Board; and (iv)&nbsp;there has never been, nor, to the knowledge of the Company, has there been any threat of
any strike, slowdown, work stoppage, lockout, concerted refusal to work overtime or other similar labor disruption or dispute affecting, or, to the knowledge of the Company, threat thereof, by or with respect to any employees of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Company is and has been in compliance in all respects with all applicable Laws and applicable
<FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures relating to the employment of labor, including those relating to wages, hours, immigration, discrimination, labor relations, layoffs or plant closings, furloughs, collective bargaining,
proper classification of all persons who performed services on behalf of the Company for all purposes (including for Tax purposes, for purposes of determining eligibility to participate in any Plan and for purposes of the Fair Labor Standards Act),
the maintenance and handling of personnel records, occupational health and safety, sick time and leave, disability, privacy and the payment and withholding of Taxes, and have withheld and paid to the appropriate Governmental Authority, or are
holding for payment not yet due to such authority, all amounts required by Law or agreement to be withheld from the wages or salaries of the employees of the Company.&nbsp;All of the individual persons who have performed services for or on behalf of
the Company are and have been authorized to work for the Company in accordance with all applicable Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Company has never ever
effectuated a &#147;mass layoff&#148; or &#147;plant closing&#148; as those terms are defined in the Worker Adjustment and Retraining Notification Act of 1988, as amended (the &#147;<B>WARN Act</B>&#148;), or comparable group layoff or taken any
other action that would trigger notice or liability under any state, local or foreign plant closing notice Law, affecting in whole or in part any facility, site of employment, operating unit or employee of the Company.&nbsp;No employee of the
Company has suffered an &#147;employment loss&#148; (as defined in the WARN Act) during the <FONT STYLE="white-space:nowrap">ninety&nbsp;(90)-day</FONT> period ending on the date of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Except as has been mandated by Governmental Authority, as of the date of this Agreement, the Company has not had, any direct workforce
changes due to <FONT STYLE="white-space:nowrap">COVID-19</FONT> or applicable <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures, including any actual terminations, layoffs, furloughs, shutdowns (whether voluntary or by order of a
Governmental Authority), or any changes to benefit or compensation programs, nor are any such changes currently contemplated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
4.12.<U>&nbsp;Real Property; Title to Assets</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company does not own any real property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Section 4.12(b)</U> of the Company Disclosure Schedule lists as of the date of this Agreement the street address of each parcel of
Leased Real Property, and sets forth a list as of the date of this Agreement of each lease, sublease, and license pursuant to which the Company leases, subleases or licenses and real property (each, a &#147;<B>Lease</B>&#148;), with the name of the
lessor and the date of the Lease in connection therewith and each material amendment to any of the foregoing (collectively, the &#147;<B>Lease Documents</B>&#148;).&nbsp;True, complete and correct copies of all Lease Documents in effect as of the
date of this Agreement have prior to the date of this Agreement been made available to Kensington.&nbsp;(i) There are no leases, subleases, concessions or other contracts granting to any person any than the Company the right to use or occupy any
real property, and (ii)&nbsp;all such Leases are in full force and effect, are valid and enforceable in accordance with their respective terms, subject to the Remedies Exceptions, and there is not, under any of such Leases, any existing material
default or event of default (or event which, with notice or lapse of time, or both, would constitute a default) by the Company or, to the Company&#146;s knowledge, by the other party to such Leases, except as would not, individually or in the
aggregate, be material to the Company.&nbsp;The Company has not subleased, sublicensed or otherwise granted to any person any right to use, occupy or possess any portion of the Leased Real Property. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) There are no contractual or legal restrictions that preclude or restrict the ability of
the Company to use any Leased Real Property by such party for the purposes for which it is currently being used, except as would not, individually or in the aggregate, be material to the Company.&nbsp;There are no latent defects or adverse physical
conditions affecting the Leased Real Property, and improvements thereon, other than those that would not have a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company has legal and valid title to, or, in the case of Leased Real Property and assets, valid leasehold or subleasehold interests
in, all of its properties and assets, tangible and intangible, real, personal and mixed, used or held for use in its business, free and clear of all Liens other than Permitted Liens, except as would not, individually or in the aggregate, be material
to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.13.<U>&nbsp;Intellectual Property Rights</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Section 4.13(a)</U> of the Company Disclosure Schedule contains a true, complete and correct list of all of the following that are owned
or purported to be owned by the Company: (i)&nbsp;registered Intellectual Property Rights and applications for registrations of other Intellectual Property Rights (showing in each, as applicable, the filing date, date of issuance, expiration date
and registration or application number, and registrar), and (ii)&nbsp;any Software or Business Systems, owned or purported to be owned by the Company that is material to the business of, the Company as currently conducted that would have a
replacement cost of more than $75,000.&nbsp;To the knowledge of the Company, the Company IP constitutes all material Intellectual Property Rights used in the operation of the business of the Company and is sufficient for the conduct of such business
as currently conducted and contemplated to be conducted as of the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company solely and exclusively owns and
possesses, free and clear of all Liens (other than Permitted Liens), all right, title and interest in and to the Company-Owned IP and has the right to use pursuant to a valid and enforceable written license, all Company-Licensed IP.&nbsp;All
Company-Owned IP is subsisting and, to the knowledge of the Company, valid and enforceable.&nbsp;No loss or expiration of any of the Company-Owned IP, or, to the Company&#146;s knowledge, any of the Company-Licensed IP, is threatened, or pending.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company has taken and takes reasonable actions to maintain, protect and enforce Intellectual Property Rights, including the
secrecy, confidentiality and value of its trade secrets and other Confidential Information.&nbsp;The Company has not disclosed any trade secrets or other Confidential Information that is material to the business of the Company to any other person
other than pursuant to a written confidentiality agreement under which such other person agrees to maintain the confidentiality and protect such Confidential Information or intentionally in the conduct of the Company&#146;s business in the ordinary
course including the marketing, sale, distribution and maintenance of Products.&nbsp;The Company&#146;s trade secrets are kept in a restricted repository wherein only the CTO, Chief Legal Officer, and IP Manager have access.&nbsp;Additionally, trade
secrets are sent to outside counsel for recordation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)(i) There have been no claims properly filed and served, or threatened in writing
(including email) to be filed, against the Company in any forum, by any person (A)&nbsp;contesting the validity, use, ownership, enforceability, patentability or registrability of any of the Company IP, or (B)&nbsp;alleging any infringement or
misappropriation of, or other conflict with, any Intellectual Property Rights of other persons (including any material demands or offers to license any Intellectual Property Rights from any other person); (ii)&nbsp;to the Company&#146;s knowledge,
the operation of its business of the Company (including the Products) has not and does not infringe, misappropriate or violate, any Intellectual Property Rights of other persons; (iii)&nbsp;to the Company&#146;s knowledge, no other person has
infringed, misappropriated or violated any of the Company-Owned IP; and (iv)&nbsp;the Company has not received any formal written opinions of counsel regarding any of the foregoing (i), (ii), or (iii). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) All persons, including all current officers, management employees, and technical and professional employees of the Company, who have
contributed, developed or conceived any Company IP have executed valid, written agreements with the Company, substantially in the form made available to Kensington prior to the date of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
this Agreement, and pursuant to which such persons agreed to assign to the Company all of their entire right, title, and interest, including Intellectual Property Rights, in and to any Technology
created, conceived or otherwise developed by such person in the course of and related to his, her or its relationship with the Company, without further consideration or any restrictions or obligations whatsoever, including on the use or other
disposition or ownership of such Intellectual Property Rights, except as required by applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Company and does not use and
has not used any Open Source Software or any modification or derivative thereof (i)&nbsp;in a manner that would grant or purport to grant to any other person any rights to or immunities under any of the Company IP, or (ii)&nbsp;under any license
requiring the Company to disclose or distribute the source code to any Business Systems or Product components, to license or provide the source code to any of the Business Systems or Product components for the purpose of making derivative works, or
to make available for redistribution to any person the source code to any of the Business Systems or Product components at no or minimal charge. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Company owns, leases, licenses, or otherwise has the legal right to use all Business Systems, and such Business Systems are sufficient
for the immediate and anticipated future needs of the business of the Company as currently conducted by the Company.&nbsp;The Company maintains commercially reasonable disaster recovery and business continuity plans, procedures and facilities, and
since December&nbsp;31, 2017, there has not been any material failure with respect to any of the Business Systems that has not been remedied or replaced in all material respects.&nbsp;The Company has purchased a sufficient number of seat licenses
for their Business Systems. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Company currently and previously has complied in all material respects with (i)&nbsp;all applicable
Privacy/Data Security Laws, (ii)&nbsp;any applicable privacy or other policies of the Company concerning the collection, dissemination, storage or use of Personal Information or other Business Data, (iii)&nbsp;industry standards to which the Company
is bound, and (iv)&nbsp;all contractual commitments that the Company has entered into or is otherwise bound with respect to privacy and/or data security (collectively, the &#147;<B>Data Security Requirements</B>&#148;).&nbsp;The Company has
implemented reasonable data security safeguards designed to protect the security and integrity of its Business Systems and any Business Data, including implementing industry standard procedures preventing unauthorized access and the introduction of
Disabling Devices.&nbsp;The Company has not inserted and, to the knowledge of the Company, no other person has inserted or alleged to have inserted any Disabling Device in any of the Business Systems or Product components.&nbsp;Since
December&nbsp;31, 2017, the Company has not (x)&nbsp;experienced any data security breaches that were required to be reported under applicable Privacy/Data Security Laws or customer contracts; or (y)&nbsp;been subject to or received written notice
of any audits, proceedings or investigations by any Governmental Authority or any customer, or received any material claims or complaints regarding the collection, dissemination, storage or use of Personal Information, or the violation of any
applicable Data Security Requirements, and, to the Company&#146;s knowledge, there is no reasonable basis for the same. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company
(i)&nbsp;exclusively owns and possesses all right, title and interest in and to the Business Data free and clear of any restrictions of any nature or (ii)&nbsp;has all rights to use, exploit, publish, reproduce, distribute, license, sell, and create
derivative works of the Business Data, in whole or in part, in the manner in which the Company receives and use such Business Data prior to the Closing Date.&nbsp;The Company is not subject to any contractual requirements, privacy policies, or other
legal obligations, including based on the Transactions, that would prohibit Merger Sub or Kensington from receiving or using Personal Information or other Business Data, in the manner in which the Company receive and use such Personal Information
and other Business Data prior to the Closing Date or result in liabilities in connection with Data Security Requirements.&nbsp;No employee, officer, director, or agent of Merger Sub or Kensington has been debarred or otherwise forbidden by any
applicable Law or any Governmental Authority (including judicial or agency order) from involvement in the operations of a business such as that of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) All current officers, management employees, and technical and professional employees of the Company are under written obligation to the
Company to maintain in confidence all confidential or proprietary information acquired by them in the course of their employment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.14.<U>&nbsp;Taxes</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company: (i)&nbsp;has duly and timely filed (taking into account any extension of time within which to file) all material Tax Returns
required to be filed by any of them as of the date of this Agreement and all such filed Tax Returns are complete and accurate in all material respects; (ii)&nbsp;has timely paid all Taxes that are shown as due on such filed Tax Returns and any other
material Taxes that the Company is otherwise obligated to pay, except with respect to Taxes that are being contested in good faith and are disclosed in <U>Section</U><U></U><U>&nbsp;4.14(a)</U> of the Company Disclosure Schedule, and no material
penalties or charges are due with respect to the late filing of any Tax Return required to be filed by or with respect to it on or before the Effective Time; (iii)&nbsp;with respect to all material Tax Returns filed by or with respect to it, has not
waived any statute of limitations with respect to Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency; and (iv)&nbsp;does not have any deficiency, audit, examination, investigation or other proceeding in respect
of Taxes or Tax matters pending or proposed or threatened in writing, for a Tax period which the statute of limitations for assessments remains open. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company is not a party to, is not bound by and has no obligations under any Tax sharing agreement, Tax indemnification agreement, Tax
allocation agreement or similar contract or arrangement (including any agreement, contract or arrangement providing for the sharing or ceding of credits or losses, but excluding agreements, contracts, arrangements or commitments the primary purpose
of which do not relate to Taxes) and does not have a potential liability or obligation to any person as a result of or pursuant to any such agreement, contract, arrangement or commitment other than an agreement, contract, arrangement or commitment
the primary purpose of which does not relate to Taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company will not be required to include any material item of income in, or
exclude any material item of deduction from, taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any: (i)&nbsp;change in method of accounting for a taxable period ending on or prior to the Closing
Date under Code Section&nbsp;481(c) (or any corresponding or similar provision of state, local or foreign income Tax law); (ii) &#147;closing agreement&#148; as described in Code Section&nbsp;7121 (or any corresponding or similar provision of state,
local or foreign income Tax law) executed on or prior to the Closing Date; (iii)&nbsp;any prepaid amount received prior to the Closing Date or (iv)&nbsp;installment sale made on or prior to the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company has withheld and paid to the appropriate Tax authority all material Taxes required to have been withheld and paid in
connection with amounts paid or owing to any current or former employee, independent contractor, creditor, shareholder or other third party and has complied in all material respects with all applicable laws, rules and regulations relating to the
payment and withholding of Taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company has not been a member of an affiliated group filing a consolidated, combined or unitary
U.S. federal, state, local or foreign income Tax Return. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Company has no material liability for the Taxes of any person (other
than the Company) under Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any similar provision of state, local or foreign law), as a transferee or successor, by contract (but excluding contracts, the primary
purpose of which do not relate to taxes), or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Company has no request for a material ruling in respect of Taxes pending
between the Company and any Tax authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Company has prior to the date of this Agreement made available to Kensington true,
complete and correct copies of the U.S. federal income Tax Returns actually filed by the Company for tax years 2016, 2017, 2018 and 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company has not in any year for which the applicable statute of limitations remains open distributed stock of another person, or has
had its stock distributed by another person, in a transaction that was purported or intended to be governed in whole or in part by Section&nbsp;355 or Section&nbsp;361 of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) The Company has not engaged in or entered into a &#147;listed transaction&#148; within
the meaning of Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.6011-4(b)(2).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Neither the IRS nor any other
United States or <FONT STYLE="white-space:nowrap">non-United</FONT> States taxing authority or agency has asserted in writing or, to the knowledge of the Company, has threatened to assert against the Company any deficiency or claim for any Taxes or
interest thereon or penalties in connection therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) There are no Tax liens upon any assets of the Company except for Permitted
Liens. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) The Company has not been a United States real property holding corporation within the meaning of Section&nbsp;897(c)(2) of the
Code during the applicable period specified in Section&nbsp;897(c)(1)(A)(ii) of the Code.&nbsp;The Company has not received written notice from a <FONT STYLE="white-space:nowrap">non-United</FONT> States taxing authority that it has a permanent
establishment (within the meaning of an applicable Tax treaty) or otherwise has an office or fixed place of business in a country other than the country in which it is organized. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) QSV Operations, LLC is and has been since its formation treated as a partnership for U.S. federal income tax purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) As used in this Agreement, (i)&nbsp;the term &#147;<B>Tax</B>&#148; (including, with correlative meaning, the term
&#147;<B>Taxes</B>&#148;) includes all federal, state, local and foreign income, profits, franchise, gross receipts, environmental, capital stock, severances, stamp, payroll, sales, employment, unemployment, disability, use, property, withholding,
excise, production, value added, occupancy and other taxes, duties or assessments of any nature whatsoever, together with all interest, penalties and additions imposed with respect to such amounts and any interest in respect of such penalties and
additions, and (ii)&nbsp;the term &#147;<B>Tax Return</B>&#148; includes all returns and reports (including elections, declarations, disclosures, schedules, estimates and information returns, as well as attachments thereto and amendments thereof)
required to be supplied to a Tax authority relating to Taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.15.<U>&nbsp;Environmental Matters</U>.&nbsp;(a) The Company has
not materially violated since December&nbsp;31, 2017 and is not in material violation of applicable Environmental Law; (b)&nbsp;to the knowledge of the Company, none of the properties currently or formerly leased or operated by the Company
(including, without limitation, soils and surface and ground waters) are contaminated with any Hazardous Substance in violation of applicable Environmental Laws which requires reporting, investigation, remediation, monitoring or other response
action by the Company pursuant to applicable Environmental Laws; (c)&nbsp;to the Company&#146;s knowledge, the Company is not, in any material respect, actually, potentially or allegedly liable pursuant to applicable Environmental Laws for any <FONT
STYLE="white-space:nowrap">off-site</FONT> contamination by Hazardous Substances; (d)&nbsp;the Company has all material permits, licenses and other authorizations required of each of the Company under applicable Environmental Law
(&#147;<B>Environmental Permits</B>&#148;); and (e)&nbsp;the Company is in all material respects in compliance with its Environmental Permits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.16.<U>&nbsp;Material Contracts</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Section 4.16(a)</U> of the Company Disclosure Schedule lists, as of the date of this Agreement, the following types of contracts and
agreements to which the Company is a party (such contracts and agreements as are required to be set forth <U>Section</U><U></U><U>&nbsp;4.16(a)</U> of the Company Disclosure Schedule but excluding any Plan required to be listed on
<U>Section</U><U></U><U>&nbsp;4.10(a)</U> of the Company Disclosure Schedule being the &#147;<B>Material Contracts</B>&#148;): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) all contracts and agreements involving obligations of, or payments to, the Company in excess of $100,000 (other than
obligations of, or payments to, the Company arising from purchase or sale agreements entered into in the ordinary course of business); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) all contracts and agreements that involve the license of any Intellectual Property Rights to or from the Company (but
excluding any (A)&nbsp;nonexclusive licenses (or sublicenses) of Company-Owned IP granted to customers in the ordinary course of business that are substantially in the same form as the Company&#146;s standard form customer agreements as have been
provided to Kensington on or prior to the date of this Agreement; (B)&nbsp;licenses granted to service providers who access Company-Owned IP on behalf of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the Company as part of their provision of services; (C)&nbsp;nondisclosure agreements entered into in the ordinary course of business; and (D)&nbsp;unmodified, commercially available, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;off-the-shelf&#148;</FONT></FONT> Software with a replacement cost and/or aggregate annual license and maintenance fees of less than $75,000); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) all contracts and agreements that (A)&nbsp;involve the granting of rights to manufacture, produce, assemble, license,
market or sell the Company&#146;s products or pursuant to which the Company has granted or received any exclusive rights or (B)&nbsp;affect the Company&#146;s exclusive right to develop, manufacture, assemble, distribute, market or sell its products
or that otherwise limit, or purport to limit, the ability of the Company to compete in any line of business or with any person or entity or in any geographic area or during any period of time, excluding customary confidentiality agreements and
agreements that contain customary confidentiality clauses; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) all contracts and agreements involving indemnification by
the Company with respect to infringement of Intellectual Property Rights; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) all contracts and agreements involving the
disposition of a material portion of the Company&#146;s assets or the acquisition of the business or securities or ownership interests of another person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) all contracts and agreements involving material uncapped indemnity obligations of the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) all partnership, joint venture or similar agreements; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) all contracts and agreements with any Governmental Authority to which the Company is a party, other than any Company
Permits; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) all contracts or arrangements that result in any person or entity holding a power of attorney from the
Company that relate to the Company or its business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) all leases or master leases of personal property reasonably likely
to result in annual payments by or to the Company of $500,000 or more in a <FONT STYLE="white-space:nowrap">12-month</FONT> period; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xi) any collective bargaining agreements, or any other agreement, with any labor union. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;(i) each Material Contract is a legal, valid and binding obligation of the Company and, to the knowledge of the Company, the other
parties thereto, and the Company is not in any material respect in breach or violation of, or in any material respect in default under, any Material Contract nor has any Material Contract been canceled by the other party; (ii)&nbsp;to the
Company&#146;s knowledge, no other party is in any material respect in breach or violation of, or in any material respect in default under, any Material Contract; and (iii)&nbsp;the Company has not received any written, or to the knowledge of the
Company, oral claim of default under any such Material Contract.&nbsp;The Company has prior to the date of this Agreement furnished or made available to Kensington true, complete and correct copies of all Material Contracts in effect as of the date
of this Agreement, including amendments thereto that are material in nature. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.17.<U>&nbsp;Insurance</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Section 4.17(a)</U> of the Company Disclosure Schedule sets forth, with respect to each material insurance policy under which the
Company is an insured, a named insured or otherwise the principal beneficiary of coverage as of the date of this Agreement (i)&nbsp;the names of the insurer, the principal insured and each named insured, (ii)&nbsp;the policy number, (iii)&nbsp;the
period, scope and amount of coverage and (iv)&nbsp;the premium most recently charged. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) With respect to each such insurance policy,
except as would not have a Company Material Adverse Effect: (i)&nbsp;the policy is legal, valid, binding and enforceable in accordance with its terms (subject to the Remedies Exceptions) and, except for policies that have expired under their terms
in the ordinary course, is in full force and effect; (ii)&nbsp;the Company is not in material breach or default (including any such breach or default with respect to the payment of premiums or the giving of notice), and no event has occurred which,
with notice or the lapse of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
time, would constitute such a breach or default, or permit termination or modification, under the policy; and (iii)&nbsp;to the knowledge of the Company, no insurer on the policy has been
declared insolvent or placed in receivership, conservatorship or liquidation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.18.<U>&nbsp;Board Approval; Vote
Required</U>.&nbsp;The Company Board, by resolutions duly adopted by unanimous vote of those voting at a meeting duly called and held and not subsequently rescinded or modified in any way, or by unanimous written consent, has duly
(a)&nbsp;determined that this Agreement and the Merger are fair to and in the best interests of the Company and its stockholders, (b)&nbsp;approved and adopted this Agreement and the Merger and declared their advisability, (c)&nbsp;approved the
Merger and the other Transactions, (d)&nbsp;recommended the approval and adoption of this Agreement and the Merger by the stockholders of the Company, and (e)&nbsp;directed that, unless this Agreement has been terminated in accordance with
<U>Section</U><U></U><U>&nbsp;9.01</U>, that this Agreement and the Transactions (including the Merger) be submitted for consideration by the Company&#146;s stockholders (the &#147;<B>Company Board Approval</B>&#148;).&nbsp;The Requisite Approval
(the &#147;<B>Company Stockholder Approval</B>&#148;) is the only vote of the holders of any class or series of capital stock of the Company necessary to adopt this Agreement and approve the Transactions.&nbsp;The Written Consent, if executed and
delivered, would qualify as the Company Stockholder Approval and no additional approval or vote from any holders of any class or series of capital stock of the Company would then be necessary to adopt this Agreement and approve the Transactions.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.19.<U>&nbsp;Certain Business Practices</U>.&nbsp;Since December&nbsp;31, 2017, neither the Company nor, to the Company&#146;s
knowledge, any directors or officers, agents or employees of the Company, has: (a)&nbsp;used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to political activity; (b)&nbsp;made any unlawful payment to
foreign or domestic government officials or employees or to foreign or domestic political parties or campaigns or violated any provision of the Foreign Corrupt Practices Act of 1977, as amended; or (c)&nbsp;made any payment in the nature of criminal
bribery. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.20.<U>&nbsp;Interested Party Transactions</U>.&nbsp;Except for employment relationships and the payment of
compensation, benefits and expense reimbursements and advances in the ordinary course of business, no director, officer or other affiliate of the Company has or has had, directly or indirectly: (a)&nbsp;an economic interest in any person that has
furnished or sold, or furnishes or sells, services or Products that the Company furnishes or sells, or proposes to furnish or sell; (b)&nbsp;an economic interest in any person that purchases from or sells or furnishes to, or proposes to the Company
to purchase from or sell or furnish to, the Company, any goods or services; (c)&nbsp;a beneficial interest in any contract or agreement disclosed in <U>Section</U><U></U><U>&nbsp;4.16(a)</U> of the Company Disclosure Schedule; or (d)&nbsp;any
contractual or other arrangement with the Company, other than in the case of this clause (d)&nbsp;customary indemnity arrangements; <U>provided</U>, <U>however</U>, that ownership of no more than five percent (5%) of the outstanding voting stock of
a publicly traded corporation shall not be deemed an &#147;economic interest in any person&#148; for purposes of this <U>Section</U><U></U><U>&nbsp;4.20</U>.&nbsp;The Company has not, since December&nbsp;31, 2017, (i) extended or maintained credit,
arranged for the extension of credit or renewed an extension of credit in the form of a personal loan to or for any director or executive officer (or equivalent thereof) of the Company, or (ii)&nbsp;materially modified any term of any such extension
or maintenance of credit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.21.<U>&nbsp;Exchange Act</U>.&nbsp;The Company is not currently (and has not previously been) subject
to the requirements of Section&nbsp;12 of the Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
4.22.<U>&nbsp;Brokers</U>.&nbsp;No broker, finder or investment banker is entitled to any brokerage, finder&#146;s or other fee or commission in connection with the Transactions based upon arrangements made by or on behalf of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.23.<U>&nbsp;Exclusivity of Representations and Warranties</U>.&nbsp;Except as otherwise expressly provided in this <U>Article IV</U>
(as modified by the Company Disclosure Schedule), the Company hereby expressly disclaims and negates, any other express or implied representation or warranty whatsoever (whether at Law or in equity) with respect to the Company, its affiliates, and
any matter relating to any of them, including their affairs, the condition, value or quality of the assets, liabilities, financial condition or results of operations, or with respect to the accuracy or completeness of any other information made
available to Kensington, its affiliates or any of their </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respective Representatives by, or on behalf of, Company, and any such representations or warranties are expressly disclaimed.&nbsp;Without limiting the generality of the foregoing, except as
expressly set forth in this Agreement, neither Company nor any other person on behalf of Company has made or makes, any representation or warranty, whether express or implied, with respect to any projections, forecasts, estimates or budgets made
available to Kensington, its affiliates or any of their respective Representatives of future revenues, future results of operations (or any component thereof), future cash flows or future financial condition (or any component thereof) of the Company
(including the reasonableness of the assumptions underlying any of the foregoing), whether or not included in any management presentation or in any other information made available to Kensington, its affiliates or any of their respective
Representatives or any other person, and that any such representations or warranties are expressly disclaimed. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF KENSINGTON AND MERGER SUB </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as set forth in the Kensington SEC Reports publicly available prior to the date of this Agreement (to the extent the qualifying nature
of such disclosure is readily apparent from the content of such Kensington SEC Reports, but excluding disclosures referred to in &#147;Forward-Looking Statements&#148;, &#147;Risk Factors&#148; and any other disclosures therein to the extent they
are of a predictive or cautionary nature or related to forward-looking statements) (it being acknowledged that nothing disclosed in such a Kensington SEC Report will be deemed to modify or qualify the representations and warranties set forth in
<U>Section</U><U></U><U>&nbsp;5.01</U> (Corporate Organization), <U>Section</U><U></U><U>&nbsp;5.03</U> (Capitalization) and <U>Section</U><U></U><U>&nbsp;5.04</U> (Authority Relative to This Agreement)) and except as set forth in Kensington&#146;s
disclosure schedule delivered by Kensington in connection with this Agreement (the &#147;<B>Kensington</B> <B>Disclosure Schedule</B>&#148;) (which disclosure in the Kensington Disclosure Schedule shall be deemed to qualify or provide disclosure in
response to (i)&nbsp;the section or subsection of this <U>Article V</U> that corresponds to the section or subsection of the Kensington Disclosure Schedule in which any such disclosure is set forth and (ii)&nbsp;any other section or subsection of
this <U>Article</U> <U>V</U> to the extent that its relevance to such section or subsection is reasonably apparent on the face of such disclosure), Kensington hereby represents and warrants to the Company as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.01.<U>&nbsp;Corporate Organization</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of Kensington and Merger Sub is a corporation duly organized, validly existing and in good standing under the laws of the State of
Delaware and has the requisite corporate power and authority and all necessary governmental approvals to own, lease and operate its properties and to carry on its business as it is now being conducted, except where the failure to have such power,
authority and governmental approvals would not have a Kensington Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Merger Sub is the only subsidiary of
Kensington.&nbsp;Except for Merger Sub, Kensington does not directly or indirectly own any equity or similar interest in, or any interest convertible into or exchangeable or exercisable for any equity or similar interest in, any corporation,
partnership, joint venture or business association or other person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.02.<U>&nbsp;Certificate of Incorporation and
Bylaws</U>.&nbsp;Each of Kensington and Merger Sub has heretofore furnished to the Company true, complete and correct copies of the Kensington Organizational Documents and the Merger Sub Organizational Documents.&nbsp;The Kensington Organizational
Documents and the Merger Sub Organizational Documents are in full force and effect.&nbsp;Neither Kensington nor Merger Sub is in violation of any of the provisions of the Kensington Organizational Documents and the Merger Sub Organizational
Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.03.<U>&nbsp;Capitalization</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The authorized capital stock of Kensington consists of one hundred million (100,000,000) shares of Kensington Class&nbsp;A Common Stock,
ten million (10,000,000) shares of Kensington Class&nbsp;B Common Stock, and 1,000,000 shares of Kensington&#146;s preferred stock, par value $0.0001 per share (&#147;<B>Kensington Preferred</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<B>Stock</B>&#148;).&nbsp;As of the date of this Agreement, (i)&nbsp;twenty three million (23,000,000) shares of Kensington Class&nbsp;A Common Stock are issued and outstanding, (ii)&nbsp;five
million, seven hundred and fifty thousand (5,750,000) shares of Kensington Class&nbsp;B Common Stock are issued and outstanding, (iii)&nbsp;no shares of Kensington Preferred Stock are issued and outstanding, (iv)&nbsp;no shares of Kensington Common
Stock or Kensington Preferred Stock are held in treasury, (v)&nbsp;eighteen million seventy five thousand (18,075,000) Kensington Warrants are outstanding and (vi)&nbsp;nineteen million five hundred and seventy five thousand (19,575,000) shares of
Kensington Class&nbsp;A Common Stock are reserved for issuance on exercise of the Kensington Warrants.&nbsp;Each Kensington Warrant is exercisable for one share of Kensington Class&nbsp;A Common Stock at an exercise price of $11.50. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As of the date of this Agreement, the authorized capital stock of Merger Sub consists of 1,000 shares of common stock, par value $0.01 per
share (the &#147;<B>Merger Sub Common</B> <B>Stock</B>&#148;).&nbsp;As of the date of this Agreement, 100 shares of Merger Sub Common Stock are issued and outstanding.&nbsp;All outstanding shares of Merger Sub Common Stock have been duly authorized,
validly issued, fully paid and are <FONT STYLE="white-space:nowrap">non-assessable</FONT> and are not subject to preemptive rights, and are held by Kensington free and clear of all Liens, other than transfer restrictions under applicable securities
laws and the Merger Sub Organizational Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) All outstanding Kensington Units, shares of Kensington Common Stock and Kensington
Warrants have been issued and granted in compliance with all applicable securities laws and other applicable Laws and were issued free and clear of all Liens other than transfer restrictions under applicable securities laws and the Kensington
Organizational Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Per Share Merger Consideration being delivered by Kensington hereunder shall be duly and validly
issued, fully paid and nonassessable, and each such share or other security shall be issued free and clear of preemptive rights and all Liens, other than transfer restrictions under applicable securities laws and the Kensington Organizational
Documents.&nbsp;The Per Share Merger Consideration will be issued in compliance with all applicable securities Laws and other applicable Laws and without contravention of any other person&#146;s rights therein or with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except for securities issued pursuant to the Subscription Agreements, securities issued by Kensington as permitted by this Agreement and
the Kensington Warrants, Kensington has not issued any options, warrants, preemptive rights, calls, convertible securities, conversion rights or other rights, agreements, arrangements or commitments of any character relating to the issued or
unissued capital stock of Kensington or obligating Kensington to issue or sell any shares of capital stock of, or other equity interests in, Kensington.&nbsp;All shares of Kensington Common Stock subject to issuance as aforesaid, upon issuance on
the terms and conditions specified in the instruments pursuant to which they are issuable, will be duly authorized, validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable.&nbsp;Neither</FONT> Kensington nor any subsidiary of
Kensington is a party to, or otherwise bound by, and neither Kensington nor any subsidiary of Kensington has granted, any equity appreciation rights, participations, phantom equity or similar rights.&nbsp;Kensington is not a party to any voting
trusts, voting agreements, proxies, shareholder agreements or other agreements with respect to the voting or transfer of Kensington Common Stock or any of the equity interests or other securities of Kensington or any of its subsidiaries.&nbsp;There
are no outstanding contractual obligations of Kensington to repurchase, redeem or otherwise acquire any shares of Kensington Common Stock.&nbsp;There are no outstanding contractual obligations of Kensington to make any investment (in the form of a
loan, capital contribution or otherwise) in, any person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) As a result of the Kensington Certificate Amendment, following the Effective
Time, each share of Kensington Capital Stock shall be converted into one (1)&nbsp;share of New Kensington Class&nbsp;A Common Stock, and each Kensington Warrant shall be exercisable for one (1)&nbsp;share of New Kensington Class&nbsp;A Common Stock.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.04.<U>&nbsp;Authority Relative to This Agreement</U>.&nbsp;Each of Kensington, and Merger Sub have all necessary power and
authority to execute and deliver this Agreement and the other Transaction Documents to which it is or will at the Closing be a party, to perform its obligations hereunder and thereunder and to consummate the Transactions.&nbsp;The execution and
delivery by each of Kensington and Merger Sub of this Agreement and the other Transaction Documents to which each of Kensington and Merger Sub is or will at the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Closing be a party, the performance by each of Kensington and Merger Sub of its obligations hereunder and thereunder and the consummation by each of Kensington and Merger Sub of the Transactions,
have been duly and validly authorized by all necessary corporate action, and no other corporate proceedings on the part of Kensington or Merger Sub are necessary to authorize this Agreement or to consummate the Transactions (other than (a)&nbsp;with
respect to the Merger, the Kensington Stockholder Approval and the approval by Kensington as the sole stockholder of Merger Sub Common Stock, and the filing and recordation of appropriate merger documents as required by the DGCL, and (b)&nbsp;with
respect to the issuance of Kensington Common Stock and the Kensington Certificate Amendment, the Kensington Stockholder Approval).&nbsp;This Agreement has been, and the other Transaction Documents to which each of Kensington and Merger Sub is or
will at the Closing be a party will, at the Closing, be duly and validly executed and delivered by Kensington and Merger Sub and, assuming due authorization, execution and delivery by the other party or parties thereto, constitutes (or will then
constitute) a legal, valid and binding obligation of Kensington or Merger Sub, enforceable against Kensington or Merger Sub in accordance with its terms subject to the Remedies Exceptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.05.<U>&nbsp;No Conflict; Required Filings and Consents</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The execution and delivery by each of Kensington and Merger Sub of this Agreement and the other Transaction Documents to which each of
Kensington and Merger Sub is or will at the Closing be a party does not, and the performance of this Agreement by each of Kensington and Merger Sub will not, (i)&nbsp;conflict with or violate the Kensington Organizational Documents or the Merger Sub
Organizational Documents, (ii)&nbsp;assuming that all consents, approvals, authorizations and other actions described in <U>Section</U><U></U><U>&nbsp;5.05(b)</U> have been obtained and all filings and obligations described in
<U>Section</U><U></U><U>&nbsp;5.05(b)</U> have been made, conflict with or violate any Law, rule, regulation, order, judgment or decree applicable to each of Kensington or Merger Sub or by which any of their property or assets is bound or affected,
or (iii)&nbsp;result in any breach of, or constitute a default (or an event which, with notice or lapse of time or both, would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, or
result in the creation of a Lien on any property or asset of each of Kensington or Merger Sub pursuant to, any note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise or other instrument or obligation to which each of
Kensington or Merger Sub is a party or by which each of Kensington or Merger Sub or any of their property or assets is bound or affected, except, with respect to clauses (ii)&nbsp;and (iii), for any such conflicts, violations, breaches, defaults or
other occurrences that would not have a Kensington Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The execution and delivery of this Agreement by each of
Kensington and Merger Sub does not, and the performance of this Agreement by each of Kensington and Merger Sub will not, require any consent, approval, authorization or permit of, or filing with or notification to, any Governmental Authority, except
(i)&nbsp;for applicable requirements, if any, of the Exchange Act, Blue Sky Laws and state takeover laws, the <FONT STYLE="white-space:nowrap">pre-merger</FONT> notification requirements of the HSR Act, and filing and recordation of appropriate
merger documents as required by the DGCL and (ii)&nbsp;where the failure to obtain such consents, approvals, authorizations or permits, or to make such filings or notifications, would not, individually or in the aggregate, prevent or materially
delay consummation of any of the Transactions or otherwise prevent Kensington or Merger Sub from performing its material obligations under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.06.<U>&nbsp;Compliance</U>.&nbsp;Neither Kensington nor Merger Sub is or has been in conflict with, or in default, breach or
violation of, (a)&nbsp;any Law applicable to Kensington or Merger Sub or by which any property or asset of Kensington or Merger Sub is bound or affected, or (b)&nbsp;any note, bond, mortgage, indenture, contract, agreement, lease, license, permit,
franchise or other instrument or obligation to which Kensington or Merger Sub is a party or by which Kensington or Merger Sub or any property or asset of Kensington or Merger Sub is bound, except, in each case, for any such conflicts, defaults,
breaches or violations that would not have a Kensington Material Adverse Effect.&nbsp;Each of Kensington and Merger Sub is in possession of all material franchises, grants, authorizations, licenses, permits, easements, variances, exceptions,
consents, certificates, approvals and orders of any Governmental Authority necessary for Kensington or Merger Sub to own, lease and operate its properties or to carry on its business as it is now being conducted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.07.<U>&nbsp;SEC Filings; Financial Statements; Sarbanes-Oxley</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Kensington has filed all forms, reports, schedules, statements and other documents, including any exhibits thereto, required to be filed by
it with the Securities and Exchange Commission (the &#147;<B>SEC</B>&#148;) since June&nbsp;25, 2020, together with any amendments, restatements or supplements thereto (collectively, the &#147;<B>Kensington SEC Reports</B>&#148;).&nbsp;Kensington
has prior to the date of this Agreement furnished to the Company (with respect to amendments or modifications made on or prior to the date of this Agreement) and shall have promptly furnished to the Company (with respect to amendments or
modifications after the date of this Agreement) true, complete and correct copies of all amendments and modifications that have not been filed by Kensington with the SEC to all agreements, documents and other instruments that previously had been
filed by Kensington with the SEC and are then in effect.&nbsp;As of their respective dates, the Kensington SEC Reports (i)&nbsp;complied in all material respects with the applicable requirements of the Securities Act of 1933, as amended (the
&#147;<B>Securities Act</B>&#148;), the Exchange Act and the Sarbanes-Oxley Act, and the rules and regulations promulgated thereunder, and (ii)&nbsp;did not, at the time they were filed, or, if amended, as of the date of such amendment, contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading.&nbsp;Each
director and executive officer of Kensington has filed with the SEC on a timely basis all documents required with respect to Kensington by Section&nbsp;16(a) of the Exchange Act and the rules and regulations thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of the financial statements (including, in each case, any notes thereto) contained in the Kensington SEC Reports was prepared in
accordance with GAAP (applied on a consistent basis) and Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> and Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> as applicable, throughout the periods indicated (except as may be indicated
in the notes thereto or, in the case of unaudited financial statements, as permitted by Form <FONT STYLE="white-space:nowrap">10-Q</FONT> of the SEC) and each fairly presents, in all material respects, the financial position, results of operations,
changes in stockholders equity and cash flows of Kensington as at the respective dates thereof and for the respective periods indicated therein, (subject, in the case of unaudited statements, to normal and recurring
<FONT STYLE="white-space:nowrap">year-end</FONT> adjustments which have not had, and would not reasonably be expected to individually or in the aggregate be material).&nbsp;Kensington has no <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet
arrangements that are not disclosed in the Kensington SEC Reports.&nbsp;No financial statements other than those of Kensington are required by GAAP to be included in the consolidated financial statements of Kensington. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as and to the extent set forth in the Kensington SEC Reports, neither Kensington nor Merger Sub has any liability or obligation of
a nature (whether accrued, absolute, contingent or otherwise) required to be reflected on a balance sheet prepared in accordance with GAAP, except for liabilities and obligations arising in the ordinary course of Kensington&#146;s and Merger
Sub&#146;s business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Kensington is in compliance in all material respects with the applicable listing and corporate governance rules
and regulations of The New York Stock Exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Kensington has established and maintains disclosure controls and procedures (as
defined in Rule <FONT STYLE="white-space:nowrap">13a-15</FONT> under the Exchange Act).&nbsp;Such disclosure controls and procedures are designed to ensure that material information relating to Kensington and other material information required to
be disclosed by Kensington in the reports and other documents that it files or furnishes under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that all such
material information is accumulated and communicated to Kensington&#146;s principal executive officer and its principal financial officer as appropriate to allow timely decisions regarding required disclosure and to make the certifications required
pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act.&nbsp;Such disclosure controls and procedures are effective in timely alerting Kensington&#146;s principal executive officer and principal financial officer to material information required
to be included in Kensington&#146;s periodic reports required under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Kensington maintains systems of internal
control over financial reporting that are sufficient to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
statements for external purposes in accordance with GAAP, including policies and procedures sufficient to provide reasonable assurance: (i)&nbsp;that Kensington maintains records that in
reasonable detail accurately and fairly reflect, in all material respects, its transactions and dispositions of assets; (ii)&nbsp;that transactions are recorded as necessary to permit the preparation of financial statements in conformity with GAAP;
(iii)&nbsp;that receipts and expenditures are being made only in accordance with authorizations of management and its board of directors; and (iv)&nbsp;regarding prevention or timely detection of unauthorized acquisition, use or disposition of its
assets that could have a material effect on its financial statements.&nbsp;Kensington has prior to the date of this Agreement delivered to the Company (with respect to disclosure made on or prior to the date of this Agreement) and shall have
promptly furnished to the Company (with respect to disclosure made after the date of this Agreement) a true, complete and correct copy of any disclosure (or, if unwritten, a summary thereof) by any representative of Kensington to Kensington&#146;s
independent auditors relating to any material weaknesses in internal controls and any significant deficiencies in the design or operation of internal controls that would adversely affect the ability of Kensington to record, process, summarize and
report financial data.&nbsp;Kensington has no knowledge of any fraud or whistle-blower allegations, whether or not material, that involve management or other employees or consultants who have or had a significant role in the internal control over
financial reporting of Kensington.&nbsp;Since June&nbsp;25, 2020, there have been no material changes in Kensington&#146;s internal control over financial reporting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) There are no outstanding loans or other extensions of credit made by Kensington to any executive officer (as defined in Rule <FONT
STYLE="white-space:nowrap">3b-7</FONT> under the Exchange Act) or director of Kensington.&nbsp;Kensington has not taken any action prohibited by Section&nbsp;402 of the Sarbanes-Oxley Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Neither Kensington (including any employee thereof) nor Kensington&#146;s independent auditors has identified or been made aware of
(i)&nbsp;any significant deficiency or material weakness in the system of internal accounting controls utilized by Kensington, (ii)&nbsp;any fraud, whether or not material, that involves Kensington&#146;s management or other employees who have a
role in the preparation of financial statements or the internal accounting controls utilized by Kensington or (iii)&nbsp;any claim or allegation regarding any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) As of the date of this Agreement, there are no outstanding SEC comments from the SEC with respect to the Kensington SEC Reports.&nbsp;To
the knowledge of Kensington, none of the Kensington SEC Reports filed on or prior to the date of this Agreement is subject to ongoing SEC review or investigation as of the date of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.08.<U>&nbsp;Absence of Certain Changes or Events</U>.&nbsp;Since June&nbsp;25, 2020, except as expressly contemplated by this
Agreement, (a)&nbsp;Kensington has conducted its business in the ordinary course and in a manner consistent with past practice, and (b)&nbsp;there has not been any Kensington Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.09.<U>&nbsp;Absence of Litigation</U>.&nbsp;There is no Action pending or, to the knowledge of Kensington, threatened against
Kensington, or any property or asset of Kensington, before any Governmental Authority.&nbsp;Neither Kensington nor any material property or asset of Kensington is subject to any continuing order of, consent decree, settlement agreement or other
similar written agreement with, or, to the knowledge of Kensington, continuing investigation by, any Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
5.10.<U>&nbsp;Board Approval; Vote Required</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Kensington Board, by resolutions duly adopted by majority vote of those voting at
a meeting duly called and held and not subsequently rescinded or modified in any way, has duly (i)&nbsp;approved this Agreement and declared its advisability and approved the payment of the Per Share Merger Consideration pursuant to this Agreement
and the other Transactions and (iii)&nbsp;recommended the approval and adoption of this Agreement and the Transactions by the stockholders of Kensington; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The only vote of the holders of any class or series of capital stock of Kensington necessary to approve the Transactions is the
affirmative vote of a majority of the outstanding shares of Kensington Common Stock voted by the stockholders at a duly held stockholders meeting (the &#147;<B>Kensington Stockholder Approval</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Merger Sub Board, by resolutions duly adopted by written consent and not
subsequently rescinded or modified in any way, has duly (i)&nbsp;determined that this Agreement and the Merger are fair to and in the best interests of Merger Sub and its sole stockholder, (ii)&nbsp;approved and adopted this Agreement and the Merger
and declared their advisability, (iii)&nbsp;approved the Merger and the other Transactions, (iv)&nbsp;recommended the approval and adoption of this Agreement and the Merger by the sole stockholder of Merger Sub, and (v)&nbsp;directed that this
Agreement and the Transactions (including the Merger) be submitted for consideration by the sole stockholder of Merger Sub. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The only
vote of the holders of any class or series of capital stock of Merger Sub is necessary to approve this Agreement, the Merger and the other Transactions is the affirmative vote of the sole stockholder of Merger Sub. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.11.<U>&nbsp;No Prior Operations of Merger Sub</U>.&nbsp;Merger Sub was formed solely for the purpose of engaging in the Transactions
and has not engaged in any business activities or conducted any operations or incurred any obligation or liability, other than those incident to its existence or as contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.12.<U>&nbsp;Brokers</U>.&nbsp;Except for UBS Securities LLC, Goldman Sachs&nbsp;&amp; Co. LLC, Stifel, Nicolaus&nbsp;&amp; Company,
Incorporated and Robert W. Baird&nbsp;&amp; Co. Incorporated, no broker, finder or investment banker is entitled to any brokerage, finder&#146;s or other fee or commission in connection with the Transactions based upon arrangements made by or on
behalf of Kensington or Merger Sub. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.13.<U>&nbsp;Kensington Trust Fund</U>.&nbsp;As of the date of this Agreement, Kensington
has no less than $230,000,000.00 in the trust fund established by Kensington for the benefit of its public stockholders (the &#147;<B>Trust Fund</B>&#148;) maintained in a trust account at JP Morgan Chase Bank, N.A. (the &#147;<B>Trust
Account</B>&#148;).&nbsp;The monies of such Trust Account are invested in United States Government securities or money market funds meeting certain conditions under Rule <FONT STYLE="white-space:nowrap">2a-7</FONT> promulgated under the Investment
Company Act of 1940, as amended, and held in trust by Continental Stock Transfer&nbsp;&amp; Trust Company (the &#147;<B>Trustee</B>&#148;) pursuant to the Investment Management Trust Agreement, dated as of June&nbsp;30, 2020, between Kensington and
the Trustee (the &#147;<B>Trust Agreement</B>&#148;).&nbsp;The Trust Agreement has not been amended or modified and is valid and in full force and effect and is enforceable in accordance with its terms, subject to the Remedies
Exceptions.&nbsp;Kensington has complied in all material respects with the terms of the Trust Agreement and is not in breach thereof or default thereunder and there does not exist under the Trust Agreement any event which, with the giving of notice
or the lapse of time, would constitute such a breach or default by Kensington or the Trustee.&nbsp;There are no separate contracts, agreements, side letters or other understandings (whether written or unwritten, express or implied): (i) between
Kensington and the Trustee that would cause the description of the Trust Agreement in the Kensington SEC Reports to be inaccurate in any material respect; or (ii)&nbsp;to the knowledge of Kensington, that would entitle any person (other than
stockholders of Kensington who shall have elected to redeem their shares of Kensington Class&nbsp;A Common Stock pursuant to the Kensington Organizational Documents) to any portion of the proceeds in the Trust Account.&nbsp;Prior to the Closing,
none of the funds held in the Trust Account may be released except: (A)&nbsp;to pay income and franchise Taxes from any interest income earned in the Trust Account; and (B)&nbsp;upon the exercise of Redemption Rights in accordance with the
provisions of the Kensington Organizational Documents.&nbsp;As of the date of this Agreement, there are no Actions pending or, to the knowledge of Kensington, threatened in writing with respect to the Trust Account.&nbsp;Upon consummation of the
Merger and notice thereof to the Trustee pursuant to the Trust Agreement, Kensington shall cause the Trustee to, and the Trustee shall thereupon be obligated to, release to Kensington as promptly as practicable, the Trust Funds in accordance with
the Trust Agreement at which point the Trust Account shall terminate; <U>provided</U>, <U>however</U>, that the liabilities and obligations of Kensington due and owing or incurred at or prior to the Effective Time shall be paid as and when due,
including all amounts payable (a)&nbsp;to stockholders of Kensington who shall have exercised their Redemption Rights, (b)&nbsp;with respect to filings, applications and/or other actions taken pursuant to this Agreement required under Law,
(c)&nbsp;to the Trustee for fees and costs incurred in accordance with the Trust Agreement; and (d)&nbsp;to third parties (e.g., professionals, printers, etc.) who have rendered services to Kensington in connection with its efforts to effect the
Merger.&nbsp;As of the date </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of this Agreement, assuming the accuracy of the representations and warranties of the Company herein and the compliance by the Company with its respective obligations hereunder, Kensington has no
reason to believe that any of the conditions to the use of funds in the Trust Account will not be satisfied or funds available in the Trust Account will not be available to Kensington at the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.14.<U>&nbsp;Employees</U>.&nbsp;Other than any officers as described in the Kensington SEC Reports, Kensington and Merger Sub have
never employed any employees or retained any contractors.&nbsp;Other than amounts due as set forth in the Kensington SEC Reports or for reimbursement of any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by Kensington&#146;s officers and directors in connection with activities on Kensington&#146;s behalf in an aggregate amount not in
excess of the amount of cash held by Kensington outside of the Trust Account, Kensington has no unsatisfied material liability with respect to any employee, officer or director.&nbsp;Kensington and Merger Sub have never and do not currently
maintain, sponsor, contribute to or have any direct liability under any employee benefit plan (as defined in Section&nbsp;3(3) of ERISA), nonqualified deferred compensation plan subject to Section&nbsp;409A of the Code, bonus, stock option, stock
purchase, restricted stock, incentive, deferred compensation, retiree medical or life insurance, supplemental retirement, severance, change in control, fringe benefit, sick pay and vacation plans or arrangements or other employee benefit plans,
programs or arrangements.&nbsp;Neither the execution and delivery of this Agreement nor the other Ancillary Agreements nor the consummation of the Transactions will (i)&nbsp;result in any payment (including severance, unemployment compensation,
golden parachute, bonus or otherwise) becoming due to any director, officer or employee of Kensington, or (ii)&nbsp;result in the acceleration of the time of payment or vesting of any such benefits.&nbsp;The Transactions shall not be the direct or
indirect cause of any amount paid or payable by the Kensington, Merger Sub or any affiliate being classified as an &#147;excess parachute payment&#148; under Section&nbsp;280G of the Code or the imposition of any additional Tax under
Section&nbsp;409A(a)(1)(B) of the Code.&nbsp;There is no contract, agreement, plan or arrangement to which Kensington or Merger Sub is a party which requires payment by any party of a Tax <FONT STYLE="white-space:nowrap">gross-up</FONT> or Tax
reimbursement payment to any person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.15.<U>&nbsp;Taxes</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Kensington and Merger Sub (i)&nbsp;have duly and timely filed (taking into account any extension of time within which to file) all material
Tax Returns required to be filed by any of them as of the date of this Agreement and all such filed Tax Returns are complete and accurate in all material respects; (ii)&nbsp;have timely paid all Taxes that are shown as due on such filed Tax Returns
and any other material Taxes that Kensington or Merger Sub are otherwise obligated to pay, except with respect to current Taxes not yet due and payable or otherwise being contested in good faith; (iii)&nbsp;with respect to all material Tax Returns
filed by or with respect to any of them, have not waived any statute of limitations with respect to Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency; and (iv)&nbsp;do not have any deficiency, audit,
examination, investigation or other proceeding in respect of a material amount of Taxes or material Tax matters pending or threatened in writing, for a Tax period which the statute of limitations for assessments remains open. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Neither Kensington nor Merger Sub is a party to, is bound by or has an obligation under any Tax sharing agreement, Tax indemnification
agreement, Tax allocation agreement or similar contract or arrangement (including any agreement, contract or arrangement providing for the sharing or ceding of credits or losses, but excluding agreements, contracts, arrangements or commitments the
primary purpose of which do not relate to Taxes) or has a potential liability or obligation to any person as a result of or pursuant to any such agreement, contract, arrangement or commitment other than an agreement, contract, arrangement or
commitment the primary purpose of which does not relate to Taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) None of Kensington or Merger Sub will be required to include any
material item of income in, or exclude any material item of deduction from, taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any: (i)&nbsp;change in method of accounting for a taxable period
ending on or prior to the Closing Date under Section&nbsp;481(c) of the Code (or any corresponding or similar provision of state, local or foreign income Tax law); (ii) &#147;closing agreement&#148; as described in Section&nbsp;7121 of the Code (or
any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
corresponding or similar provision of state, local or foreign income Tax law) executed on or prior to the Closing Date; (iii)&nbsp;any prepaid amount received prior to the Closing Date; or
(iv)&nbsp;installment sale made on or prior to the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Neither Kensington nor Merger Sub has been a member of an affiliated
group filing a consolidated, combined or unitary U.S. federal, state, local or foreign income Tax Return. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Neither Kensington nor
Merger Sub has any material liability for the Taxes of any person under Treasury Regulation section <FONT STYLE="white-space:nowrap">1.1502-6</FONT> (or any similar provision of state, local or foreign law), as a transferee or successor, by contract
(but excluding contracts, the primary purpose of which do not relate to taxes), or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Neither Kensington nor Merger Sub has
any request for a material ruling in respect of Taxes pending between Kensington and/or Merger Sub, on the one hand, and any Tax authority, on the other hand. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Neither Kensington nor Merger Sub has in any year for which the applicable statute of limitations remains open distributed stock of
another person, or has had its stock distributed by another person, in a transaction that was purported or intended to be governed in whole or in part by Section&nbsp;355 or Section&nbsp;361 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Neither Kensington nor Merger Sub has engaged in or entered into a &#147;listed transaction&#148; within the meaning of Treasury
Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.6011-4(b)(2).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.16.<U>&nbsp;Listing</U>.&nbsp;The issued and
outstanding Kensington Units are registered pursuant to Section&nbsp;12(b) of the Exchange Act and are listed for trading on The New York Stock Exchange under the symbol &#147;KCAC.U.&#148; The issued and outstanding shares of Kensington Class A
Common Stock are registered pursuant to Section&nbsp;12(b) of the Exchange Act and are listed for trading on The New York Stock Exchange under the symbol &#147;KCAC&#148;.&nbsp;The issued and outstanding Kensington Warrants are registered pursuant
to Section&nbsp;12(b) of the Exchange Act and are listed for trading on The New York Stock Exchange under the symbol &#147;KCAC WS&#148;.&nbsp;As of the date of this Agreement, there is no Action pending or, to the knowledge of Kensington,
threatened in writing against Kensington by The New York Stock Exchange or the SEC with respect to any intention by such entity to deregister the Kensington Units, the shares of Kensington Class&nbsp;A Common Stock, or Kensington Warrants or
terminate the listing of Kensington on The New York Stock Exchange.&nbsp;None of Kensington or any of its affiliates has taken any action in an attempt to terminate the registration of the Kensington Units, the shares of Kensington Class&nbsp;A
Common Stock, or the Kensington Warrants under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.17.<U>&nbsp;Kensington and Merger Sub</U><U>&#146;</U><U>s
Investigation and Reliance</U>.&nbsp;Each of Kensington and Merger Sub is a sophisticated purchaser and has made its own independent investigation, review and analysis regarding the Company and the Transactions, which investigation, review and
analysis were conducted by Kensington and Merger Sub together with expert advisors, including legal counsel, that they have engaged for such purpose.&nbsp;Kensington, Merger Sub and their Representatives have been provided with full and complete
access to the Representatives, properties, offices, plants and other facilities, books and records of the Company and other information that they have requested in connection with their investigation of the Company and the Transactions.&nbsp;Neither
Kensington nor Merger Sub is relying on any statement, representation or warranty, oral or written, express or implied, made by the Company or any of its Representatives, except as expressly set forth in <U>Article IV</U> (as modified by the Company
Disclosure Schedule).&nbsp;Neither the Company nor any of its respective stockholders, affiliates or Representatives shall have any liability to Kensington, Merger Sub or any of their respective stockholders, affiliates or Representatives resulting
from the use of any information, documents or materials made available to Kensington or Merger Sub or any of their Representatives, whether orally or in writing, in any confidential information memoranda, &#147;data rooms,&#148; management
presentations, due diligence discussions or in any other form in expectation of the Transactions.&nbsp;Neither the Company nor any of its stockholders, affiliates or Representatives is making, directly or indirectly, any representation or warranty
with respect to any estimates, projections or forecasts involving the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDUCT OF BUSINESS PENDING THE MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.01.<U>&nbsp;Conduct of Business by the Company Pending the Merger</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the Company agrees that, between the date of this Agreement and the Effective Time or the earlier termination of this Agreement, except as
(1)&nbsp;expressly contemplated by any other provision of this Agreement or any Ancillary Agreement, (2)&nbsp;as set forth in <U>Section</U><U></U><U>&nbsp;6.01</U> of the Company Disclosure Schedule, or (3)&nbsp;as required by applicable Law
(including <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures or as may be requested or compelled by any Governmental Authority), unless Kensington shall otherwise consent in writing (which consent shall not be unreasonably conditioned,
withheld or delayed): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the Company shall conduct its business in the ordinary course of business and in a manner
consistent with past practice; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the Company shall use its commercially reasonable efforts to preserve
substantially intact the business organization of the Company, to keep available the services of the current officers, key employees and consultants of the Company and to preserve the current relationships of the Company with customers, suppliers
and other persons with which the Company has significant business relations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) By way of amplification and not limitation, except as
(1)&nbsp;expressly contemplated by any other provision of this Agreement, any Ancillary Agreement, (2)&nbsp;as set forth in <U>Section</U><U></U><U>&nbsp;6.01</U> of the Company Disclosure Schedule, and (3)&nbsp;as required by applicable Law
(including <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures or as may be requested or compelled by any Governmental Authority), the Company shall not, between the date of this Agreement and the Effective Time or the earlier termination of
this Agreement, directly or indirectly, do any of the following without the prior written consent of Kensington (which consent shall not be unreasonably conditioned, withheld or delayed): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) amend or otherwise change its certificate of incorporation or bylaws; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) issue, sell, pledge, dispose of, grant or encumber, or authorize the issuance, sale, pledge, disposition, grant or
encumbrance of, (A)&nbsp;any shares of any class of capital stock of the Company, or any options, warrants, convertible securities or other rights of any kind to acquire any shares of such capital stock, or any other ownership interest (including,
without limitation, any phantom interest), of the Company; <U>provided</U>, <U>however</U>, that (1)&nbsp;the exercise or settlement of any Company Options, grants of Company Options, Company RSUs or grants of Company Restricted Stock within the
limits of the Company Option Plan share reserve and (2)&nbsp;the sale (including executed commitments providing for sale) of shares of Series F Preferred Stock to investors at a price per share of at least $26.42 shall not require the consent of
Kensington; or (B)&nbsp;any material assets of the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) declare, set aside, make or pay any dividend or other
distribution, payable in cash, stock, property or otherwise, with respect to any of its capital stock; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) reclassify,
combine, split, subdivide or redeem, or purchase or otherwise acquire, directly or indirectly, any of its capital stock, other than redemptions of equity securities from former employees upon the terms set forth in the underlying agreements
governing such equity securities; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v)(A) acquire (including, without limitation, by merger, consolidation, or acquisition
of stock or assets or any other business combination) any corporation, partnership, other business organization or any division thereof in an amount in excess of $5,000,000; or (B)&nbsp;incur any indebtedness for borrowed money in excess of
$5,000,000 or issue any debt securities or assume, guarantee or endorse, or otherwise become responsible for, the obligations of any person, or make any loans or advances, or intentionally grant any security interest in any of its assets, in each
case, except with respect to accounts payable or indebtedness otherwise incurred in the ordinary course of business and consistent with past practice; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi)(A) grant any increase in the compensation, incentives or benefits
payable or to become payable to any current or former director, officer, employee or consultant of the Company as of the date of this Agreement, other than increases in base compensation of employees in the ordinary course of business,
(B)&nbsp;enter into any new, or materially amend any existing employment or severance or termination agreement with any current or former director, officer, employee or consultant, (C)&nbsp;accelerate or commit to accelerate the funding, payment or
vesting of any compensation or benefits to any current or former director, officer, employee or consultant, (D)&nbsp;hire or otherwise enter into any employment or consulting agreement or arrangement with any person or terminate any current or
former director, officer employee or consultant provider whose compensation would exceed, on an annualized basis, $300,000, or (E)&nbsp;enter into or amend any collective bargaining agreement or other labor agreement covering the Company&#146;s
employees; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) other than as required by Law or pursuant to the terms of an agreement entered into prior to the date of
this Agreement and reflected on <U>Section</U><U></U><U>&nbsp;4.10(a)</U> of the Company Disclosure Schedule or that the Company is not prohibited from entering into after the date of this Agreement grant any severance or termination pay to, any
director or officer of the Company, other than in the ordinary course of business consistent with past practice; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii)
adopt, amend and/or terminate any material Plan except as may be required by applicable Law, is necessary in order to consummate the Transactions, or health and welfare plan renewals in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) materially amend other than reasonable and usual amendments in the ordinary course of business, with respect to accounting
policies or procedures, other than as required by GAAP; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) make any material tax election, amend a material Tax Return or
settle or compromise any material United States federal, state, local or <FONT STYLE="white-space:nowrap">non-United</FONT> States income tax liability; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xi) materially amend, or modify or consent to the termination (excluding any expiration in accordance with its terms) of any
Material Contract or amend, waive, modify or consent to the termination (excluding any expiration in accordance with its terms) of the Company&#146;s material rights thereunder, in each case in a manner that is adverse to the Company, taken as a
whole, except in the ordinary course of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xii) intentionally permit any material item of Company Owned IP to
lapse or to be abandoned, invalidated, dedicated to the public, or disclaimed, or otherwise become unenforceable or fail to perform or make any applicable filings, recordings or other similar actions or filings, or fail to pay all required fees and
taxes required to maintain each and every material item of Company Owned IP; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xiii) enter into any formal or informal
agreement or otherwise make a binding commitment to do any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.02.<U>&nbsp;Conduct of Business by Kensington and
Merger Sub Pending the Merger</U>.&nbsp;Except as (i)&nbsp;expressly contemplated by any other provision of this Agreement or any Ancillary Agreement (including entering into various Subscription Agreements and consummating the Private Placements),
(ii)&nbsp;set forth on <U>Section</U><U></U><U>&nbsp;6.02</U> of the Kensington Disclosure Schedule or (iii)&nbsp;required by applicable Law (including any <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures or as may be requested or compelled
by any Governmental Authority), Kensington agrees that from the date of this Agreement until the earlier of the termination of this Agreement and the Effective Time, unless the Company shall otherwise consent in writing (which consent shall not be
unreasonably withheld, delayed or conditioned), the businesses of Kensington and Merger Sub shall be conducted in the ordinary course of business and in a manner consistent with past practice.&nbsp;By way of amplification and not limitation, except
as (i)&nbsp;expressly contemplated by any other provision of this Agreement or any Ancillary Agreement (including entering into various Subscription Agreements and consummating the Private Placements), or in connection with the terms and conditions
of, any Subscription Agreement, (ii)&nbsp;as set forth on <U>Section</U><U></U><U>&nbsp;6.02</U> of the Kensington Disclosure Schedule or (iii)&nbsp;required by applicable Law (including any <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures
or as may be requested or compelled by any Governmental Authority), neither Kensington nor Merger Sub shall, between the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
date of this Agreement and the Effective Time or the earlier termination of this Agreement, directly or indirectly, do any of the following without the prior written consent of the Company, which
consent shall not be unreasonably withheld, delayed or conditioned: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) amend or otherwise change the Kensington Organizational Documents
or the Merger Sub Organizational Documents or form any subsidiary of Kensington other than Merger Sub; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) declare, set aside, make or
pay any dividend or other distribution, payable in cash, stock, property or otherwise, with respect to any of its capital stock, other than redemptions from the Trust Fund that are required pursuant to the Kensington Organizational Documents; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) reclassify, combine, split, subdivide or redeem, or purchase or otherwise acquire, directly or indirectly, any of the Kensington Common
Stock or Kensington Warrants except for redemptions from the Trust Fund that are required pursuant to the Kensington Organizational Documents; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) issue, sell, pledge, dispose of, grant or encumber, or authorize the issuance, sale, pledge, disposition, grant or encumbrance of, any
shares of any class of capital stock or other securities of Kensington or Merger Sub, or any options, warrants, convertible securities or other rights of any kind to acquire any shares of such capital stock, or any other ownership interest
(including, without limitation, any phantom interest), of Kensington or Merger Sub; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) acquire (including, without limitation, by
merger, consolidation, or acquisition of stock or assets or any other business combination) any corporation, partnership, other business organization or enter into any strategic joint ventures, partnerships or alliances with any other person; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) engage in any conduct in a new line of business or engage in any commercial activities (other than to consummate the Transactions); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) incur any indebtedness for borrowed money or guarantee any such indebtedness of another person or persons, issue or sell any debt
securities or options, warrants, calls or other rights to acquire any debt securities of Kensington or Merger Sub, as applicable, enter into any &#147;keep well&#148; or other agreement to maintain any financial statement condition or enter into any
arrangement having the economic effect of any of the foregoing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) make any change in any method of financial accounting or financial
accounting principles, policies, procedures or practices, except as required by a concurrent amendment in GAAP or applicable Law made subsequent to the date of this Agreement, as agreed to by its independent accountants; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) make any material tax election or settle or compromise any material United States federal, state, local or
<FONT STYLE="white-space:nowrap">non-United</FONT> States income tax liability, except in the ordinary course consistent with past practice; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) liquidate, dissolve, reorganize or otherwise wind up the business and operations of Kensington or Merger Sub; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) amend the Trust Agreement or any other agreement related to the Trust Account; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) enter into any formal or informal agreement or otherwise make a binding commitment to do any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.03.<U>&nbsp;Claims </U><U>Against</U><U> Trust Account</U>.&nbsp;The Company agrees that, notwithstanding any other provision
contained in this Agreement, the Company does not now have, and shall not at any time prior to the Effective Time have, any claim to, or make any claim against, the Trust Fund, regardless of whether such claim arises as a result of, in connection
with or relating in any way to, the business relationship between the Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
on the one hand, and Kensington on the other hand, this Agreement, or any other agreement or any other matter, and regardless of whether such claim arises based on contract, tort, equity or any
other theory of legal liability (any and all such claims are collectively referred to in this <U>Section</U><U></U><U>&nbsp;6.03</U> as the &#147;<B>Claims</B>&#148;).&nbsp;Notwithstanding any other provision contained in this Agreement, the Company
hereby irrevocably waives any Claim it may have, now or in the future and will not seek recourse against the Trust Fund for any reason whatsoever in respect thereof; <U>provided</U>, <U>however</U>, that the foregoing waiver will not limit or
prohibit the Company from pursuing a claim against Kensington, Merger Sub or any other person (a)&nbsp;for legal relief against monies or other assets of Kensington or Merger Sub held outside of the Trust Account or for specific performance or other
equitable relief in connection with the Transactions or (b)&nbsp;for damages for breach of this Agreement against Kensington (or any successor entity) or Merger Sub in the event this Agreement is terminated for any reason and Kensington consummates
a business combination transaction with another party.&nbsp;In the event that the Company commences any action or proceeding against or involving the Trust Fund in violation of the foregoing, Kensington shall be entitled to recover from the Company
the associated reasonable legal fees and costs in connection with any such action, in the event Kensington prevails in such action or proceeding. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADDITIONAL AGREEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 7.01.<U>&nbsp;Proxy Statement; Registration Statement</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As promptly as practicable after the execution of this Agreement and receipt of the PCAOB Audited Financials, (i)&nbsp;Kensington and the
Company shall prepare and file with the SEC a joint information statement/proxy statement (as amended or supplemented, the &#147;<B>Proxy Statement</B>&#148;) to be sent to the stockholders of Kensington and to the stockholders of the Company as
information statements relating to (A)&nbsp;with respect to the Company&#146;s stockholders, the action to be taken by certain stockholders of the Company pursuant to the Written Consent and (B)&nbsp;with respect to Kensington&#146;s stockholders,
the meeting of Kensington&#146;s stockholders (the &#147;<B>Kensington Stockholders</B><B>&#146;</B><B> Meeting</B>&#148;) to be held to consider approval and adoption of (1)&nbsp;this Agreement and the Merger, (2)&nbsp;the issuance of the New
Kensington Common Stock as contemplated by this Agreement, (3)&nbsp;the Kensington Certificate Amendment and (4)&nbsp;any other proposals the parties deem necessary to effectuate the Merger (collectively, the &#147;<B>Kensington Proposals</B>&#148;)
and (ii)&nbsp;Kensington shall prepare and file with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> (together with all amendments thereto, the &#147;<B>Registration Statement</B>&#148;) in which the Proxy
Statement shall be included as a prospectus, in connection with the registration under the Securities Act of the shares of New Kensington Class&nbsp;A Common Stock (A)&nbsp;to be issued to certain stockholders of the Company pursuant to this
Agreement or (B)&nbsp;held by the stockholders of Kensington immediately prior to the Effective Time.&nbsp;The Company shall furnish all information concerning the Company as Kensington may reasonably request in connection with such actions and the
preparation of the Proxy Statement and Registration Statement.&nbsp;Kensington and the Company each shall use their reasonable best efforts to (i)&nbsp;cause the Registration Statement when filed with the SEC to comply in all material respects with
all Laws applicable thereto, (ii)&nbsp;respond as promptly as reasonably practicable to and resolve all comments received from the SEC concerning the Registration Statement, (iii)&nbsp;cause the Registration Statement to be declared effective under
the Securities Act as promptly as practicable and (iv)&nbsp;to keep the Registration Statement effective as long as is necessary to consummate the Transactions.&nbsp;Prior to the effective date of the Registration Statement, Kensington shall take
all or any action required under any applicable federal or state securities laws in connection with the issuance of shares of Kensington Common Stock, in each case to be issued or issuable to the stockholders of the Company pursuant to this
Agreement.&nbsp;As promptly as practicable after finalization of the Proxy Statement, each of the Company and Kensington shall mail the Proxy Statement to their stockholders.&nbsp;Each of Kensington and the Company shall furnish all information
concerning it as may reasonably be requested by the other party in connection with such actions and the preparation of the Registration Statement and the Proxy Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) No filing of, or amendment or supplement to the Proxy Statement or the Registration Statement will be made by Kensington or the Company
without the approval of the other party (such approval not to be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
unreasonably withheld, conditioned or delayed).&nbsp;Kensington and the Company each will advise the other, promptly after they receive notice thereof, of the time when the Registration Statement
has become effective or any supplement or amendment has been filed, of the issuance of any stop order, of the suspension of the qualification of the Kensington Common Stock to be issued or issuable to the stockholders of the Company in connection
with this Agreement for offering or sale in any jurisdiction, or of any request by the SEC for amendment of the Proxy Statement or the Registration Statement or comments thereon and responses thereto or requests by the SEC for additional information
and responses thereto.&nbsp;Each of Kensington and the Company shall cooperate and mutually agree upon (such agreement not to be unreasonably withheld or delayed), any response to comments of the SEC or its staff with respect to the Registration
Statement and any amendment to the Registration Statement filed in response thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Kensington represents that the information
supplied by Kensington for inclusion in the Registration Statement and the Proxy Statement shall not, at (i)&nbsp;the time the Registration Statement is declared effective, (ii)&nbsp;the time the Proxy Statement (or any amendment thereof or
supplement thereto) is first mailed to the stockholders of Kensington, (iii)&nbsp;the time of the Kensington Stockholders&#146; Meeting, and (iv)&nbsp;the Effective Time, contain any untrue statement of a material fact or fail to state any material
fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.&nbsp;If, at any time prior to the Effective Time, any event or circumstance relating
to Kensington or Merger Sub, or their respective officers or directors, should be discovered by Kensington which should be set forth in an amendment or a supplement to the Registration Statement or the Proxy Statement, Kensington shall promptly
inform the Company.&nbsp;All documents that Kensington is responsible for filing with the SEC in connection with the Transactions will comply as to form and substance in all material respects with the applicable requirements of the Securities Act
and the rules and regulations thereunder and the Exchange Act and the rules and regulations thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company represents that
the information supplied by the Company for inclusion in the Registration Statement and the Proxy Statement or any current report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> shall not, at (i)&nbsp;the time the Registration Statement is
declared effective (in the case of the Registration Statement or the Proxy Statement) or at the time filed (in the case of a current report on Form <FONT STYLE="white-space:nowrap">8-K),</FONT> (ii) the time the Proxy Statement (or any amendment
thereof or supplement thereto) is first mailed to the stockholders of Kensington (in the case of the Registration Statement or the Proxy Statement), (iii) the time of the Kensington Stockholders&#146; Meeting (in the case of the Registration
Statement or the Proxy Statement), and (iv)&nbsp;the Effective Time (in the case of the Registration Statement or the Proxy Statement), contain any untrue statement of a material fact or fail to state any material fact required to be stated therein
or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.&nbsp;If, at any time prior to the Effective Time, any event or circumstance relating to the Company, or its officers or
directors, should be discovered by the Company which should be set forth in an amendment or a supplement to the Registration Statement or the Proxy Statement, the Company shall promptly inform Kensington.&nbsp;All documents that the Company is
responsible for filing with the SEC in connection with the Transactions will comply as to form and substance in all material respects with the applicable requirements of the Securities Act and the rules and regulations thereunder and the Exchange
Act and the rules and regulations thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Following the final determination of the Exchange Ratio at the Anticipated Closing Date
in accordance with <U>Section</U><U></U><U>&nbsp;3.06</U> (either as a result of the mutual agreement of the parties or the determination of the Accounting Firm), Kensington and the Company shall mutually agree on the form and substance of a press
release setting forth the anticipated Exchange Ratio as of the Anticipated Closing Date (the &#147;<B>Exchange Ratio Announcement</B>&#148;), which the parties shall cause to be publicly disclosed (and which Kensington shall file on Form <FONT
STYLE="white-space:nowrap">8-K)</FONT> no later than four (4)&nbsp;Business Days prior to the Kensington Stockholders&#146; Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 7.02.<U>&nbsp;Kensington Stockholders</U><U>&#146;</U><U> Meetings; and Merger Sub Stockholder</U><U>&#146;</U><U>s Approval</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Kensington shall call and hold the Kensington Stockholders&#146; Meeting as promptly as practicable after the date on which the
Registration Statement becomes effective for the purpose of voting solely upon the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Kensington Proposals, and Kensington shall use its reasonable best efforts to hold the Kensington Stockholders&#146; Meeting as soon as practicable after the date on which the Registration
Statement becomes effective (but in any event no later than 30 days after the date on which the Proxy Statement is mailed to stockholders of Kensington).&nbsp;In the event the Kensington Stockholders&#146; Meeting is scheduled to occur less than
four (4)&nbsp;Business Days after the publication of the Exchange Ratio Announcement, Kensington may, or the Company may direct Kensington to, recess or adjourn the Kensington Stockholders&#146; Meeting until the date such that the meeting would be
held on the date that is four (4)&nbsp;Business Days following the publication of the Exchange Ratio Announcement (in each case to the extent the Kensington or the Company believes in good faith that such recess or adjournment is required by
applicable Law or the rules of The New York Stock Exchange). Kensington will ensure that all proxies solicited in connection with the Kensington Stockholders&#146; Meeting are solicited in compliance with all applicable Laws and the rules of The New
York Stock Exchange.&nbsp;Kensington shall use its reasonable best efforts to obtain the approval of the Kensington Proposals at the Kensington Stockholders&#146; Meeting, including by soliciting from its stockholders proxies as promptly as possible
in favor of the Kensington Proposals, and shall take all other action necessary or advisable to secure the required vote or consent of its stockholders.&nbsp;The Kensington Board shall recommend to its stockholders that they approve the Kensington
Proposals and shall include such recommendation in the Proxy Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Promptly following the execution of this Agreement,
Kensington shall approve and adopt this Agreement and approve the Transactions, as the sole stockholder of Merger Sub. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
7.03.<U>&nbsp;Company Stockholders</U><U>&#146;</U><U> Written Consent</U>.&nbsp;Unless this Agreement has been terminated in accordance with <U>Section</U><U></U><U>&nbsp;9.01</U>, upon the terms set forth in this Agreement, the Company shall seek
the irrevocable written consent, in form and substance reasonably acceptable to Kensington, of holders of the Requisite Approval (including the Key Company Stockholders) in favor of the approval and adoption of this Agreement and the Merger and all
other transactions contemplated by this Agreement (the &#147;<B>Written Consent</B>&#148;) as soon as reasonably practicable after the Registration Statement becomes effective, and in any event within twenty-four (24)&nbsp;hours after the
Registration Statement becomes effective.&nbsp;The Company shall not send the Registration Statement to the stockholders of the Company, other than Key Company Stockholders, until after delivery of the Written Consent to Kensington (it being agreed
that the Company shall seek the Written Consent even if there shall have been a Company Adverse Recommendation Change, except if this Agreement shall have been terminated pursuant to <U>Section</U><U></U><U>&nbsp;9.01</U>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 7.04.<U>&nbsp;Access to Information; Confidentiality</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) From the date of this Agreement until the Effective Time, the Company and Kensington shall (and shall cause their respective subsidiaries
(if any) to): (i) provide to the other party (and the other party&#146;s officers, directors, employees, accountants, consultants, legal counsel, agents and other representatives, collectively, &#147;<B>Representatives</B>&#148;) reasonable access
at reasonable times upon prior notice to the officers, employees, agents, properties, offices and other facilities of such party and its subsidiaries (if any) and to the books and records thereof; and (ii)&nbsp;furnish promptly to the other party
such information concerning the business, properties, contracts, assets, liabilities, personnel and other aspects of such party and its subsidiaries (if any) as the other party or its Representatives may reasonably request.&nbsp;Notwithstanding the
foregoing, neither the Company nor Kensington shall be required to provide access to or disclose information where the access or disclosure would (i)&nbsp;jeopardize the protection of attorney-client privilege or contravene applicable Law (including
<FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures) or (ii)&nbsp;require providing access that such party reasonably determines, in light of <FONT STYLE="white-space:nowrap">COVID-19</FONT> or <FONT STYLE="white-space:nowrap">COVID-19</FONT>
Measures, would jeopardize the health and safety of any employee of such party (it being agreed that the parties shall use their commercially reasonable efforts to cause such information to be provided in a manner that would not result in such
jeopardy or contravention). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All information obtained by the parties pursuant to this <U>Section</U><U></U><U>&nbsp;7.04</U> shall be
kept confidential in accordance with the confidentiality agreement, dated as of July&nbsp;1, 2020 (the &#147;<B>Confidentiality Agreement</B>&#148;), between Kensington and the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything in this Agreement to the contrary, each party (and its
Representatives) may consult any tax advisor regarding the tax treatment and tax structure of the Transactions and may disclose to any other person, without limitation of any kind, the tax treatment and tax structure of the Transactions and all
materials (including opinions or other tax analyses) that are provided relating to such treatment or structure, in each case in accordance with the Confidentiality Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 7.05.<U>&nbsp;Company Solicitation; Change in Recommendation</U>.</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) From and after the date of this Agreement and ending on the earlier of (a)&nbsp;the Effective Time and (b)&nbsp;the termination of this
Agreement in accordance with <U>Section</U><U></U><U>&nbsp;9.01</U>, the Company shall not, and shall cause its Representatives not to, (i)&nbsp;initiate, solicit, facilitate or encourage (including by way of furnishing <FONT
STYLE="white-space:nowrap">non-public</FONT> information), whether publicly or otherwise, any inquiries with respect to, or the making of, any Company Acquisition Proposal, (ii)&nbsp;engage in any negotiations or discussions concerning, or provide
access to its properties, books and records or any Confidential Information or data to, any person relating to a Company Acquisition Proposal, (iii)&nbsp;enter into, engage in and maintain discussions or negotiations with respect to any Company
Acquisition Proposal (or inquiries, proposals or offers or other efforts that would reasonably be expected to lead to any Company Acquisition Proposal) or otherwise cooperate with or assist or participate in, or facilitate or encourage any such
inquiries, proposals, offers, efforts, discussions or negotiations, (iv)&nbsp;amend or grant any waiver or release under any standstill or similar agreement with respect to any class of equity securities or the Company, (v)&nbsp;approve, endorse or
recommend, or propose publicly to approve, endorse or recommend, any Company Acquisition Proposal, (vi)&nbsp;approve, endorse, recommend, execute or enter into any agreement in principle, letter of intent, memorandum of understanding, term sheet,
acquisition agreement, merger agreement, option agreement, joint venture agreement, partnership agreement or other written arrangement relating to any Company Acquisition Proposal (each, a &#147;<B>Company Acquisition Agreement</B>&#148;) or any
proposal or offer that could reasonably be expected to lead to a Company Acquisition Proposal, or (vii)&nbsp;resolve or agree to do any of the foregoing or otherwise authorize or permit any of its Representatives to take any such action.&nbsp;The
Company shall, and shall instruct and cause each of its Representatives, to immediately cease any solicitations, discussions or negotiations with any person (other than the parties hereto and their respective Representatives) in connection with a
Company Acquisition Proposal.&nbsp;The Company also agrees that it will promptly request each person (other than the parties hereto and their respective Representatives) that has prior to the date of this Agreement executed a confidentiality
agreement in connection with its consideration of acquiring the Company to return or destroy all Confidential Information furnished to such person by or on behalf of it prior to the date of this Agreement.&nbsp;The Company shall promptly notify
Kensington (and in any event within twenty-four (24)&nbsp;hours) of the receipt of any Company Acquisition Proposal after the date of this Agreement, which notice shall identify the third party making any Company Acquisition Proposal and shall
include a summary of the material terms and conditions of any material developments, discussions or negotiations in connection therewith, and any material modifications to the financial or other terms and conditions of any such Company Acquisition
Proposal.&nbsp;Notwithstanding the foregoing, the Company may inform any person making a unsolicited proposal regarding a Company Acquisition Proposal of the terms of this <U>Section</U><U></U><U>&nbsp;7.05</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding <U>Section</U><U></U><U>&nbsp;7.05(a)</U>, prior to the receipt of the Written Consent, the Company Board, directly or
indirectly through any Representative, may, subject to <U>Section</U><U></U><U>&nbsp;7.05(c)</U>, (i) participate in, negotiations or discussions with any third party that has made (and not withdrawn) a <U>bona</U> <U>fide</U>, unsolicited Company
Acquisition Proposal in writing that the Company Board reasonably believes in good faith, after consultation with outside legal counsel, constitutes or would reasonably be expected to result in a Company Superior Proposal, and (ii)&nbsp;thereafter
furnish to such third party <FONT STYLE="white-space:nowrap">non-public</FONT> information relating to the Company pursuant to an executed Acceptable Confidentiality Agreement (a copy of such confidentiality agreement shall be promptly (in all
events within twenty-four (24)&nbsp;hours) provided to Kensington; provided that the Company shall promptly provide to Kensington material <FONT STYLE="white-space:nowrap">non-public</FONT> information that is provided to any such person which has
not previously been provided to Kensington and Merger Sub. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company shall notify Kensington promptly (but in no event later than
twenty-four (24)&nbsp;hours) after receipt by the Company Board of any Company Acquisition Proposal, any inquiry that would reasonably be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
expected to lead to an Company Acquisition Proposal or any request for <FONT STYLE="white-space:nowrap">non-public</FONT> information relating to the Company or for access to the business,
properties, assets, personnel, books or records of the Company by any third party.&nbsp;In such notice, the Company shall identify the third party making any such Company Acquisition Proposal, indication or request and provide the details of the
material terms and conditions of any such Company Acquisition Proposal, indication or request.&nbsp;The Company shall keep Kensington informed, on a current and prompt basis, of the status and material terms of any such Company Acquisition Proposal,
indication or request, including the material terms and conditions thereof any material amendments or proposed amendments.&nbsp;The Company shall promptly provide Kensington copies of any nonpublic information concerning the Company&#146;s business,
present or future performance, financial condition or results of operations provided to any third party to the extent such information has not been previously provided to Kensington. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except as set forth in this <U>Section</U><U></U><U>&nbsp;7.05(d)</U>, neither the Company Board nor any committee thereof shall (i)(A)
fail to make, change, withdraw, withhold, amend, modify or qualify, or publicly propose to make, change, withdraw, withhold, amend, modify or qualify, in a manner adverse to Kensington, the Company Board recommendation, or (B)&nbsp;adopt, approve,
endorse or recommend, or publicly propose to adopt, approve, endorse or recommend to the stockholders of the Company any Company Acquisition Proposal or Company Superior Proposal, (ii)&nbsp;make any public statement inconsistent with the Company
Board recommendation, (iii)&nbsp;resolve or agree to take any of the foregoing actions (any of the foregoing, a &#147;<B>Company Adverse Recommendation Change</B>&#148;), or (iv)&nbsp;authorize, cause or permit the Company or any of its
Representatives to enter into any Company Acquisition Agreement. Notwithstanding the foregoing, at any time prior to the receipt of the Written Consent, but not after, the Company Board may make a Company Adverse Recommendation Change or cause the
Company to terminate this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;9.01(</U><U>i</U><U>)</U> to enter into a Company Acquisition Agreement with respect to a Company Acquisition Proposal only if the Company Board has reasonably determined
in good faith, after consultation with its outside financial advisor and legal counsel, that (i)&nbsp;the failure to take such action would reasonably be expected to be inconsistent with the Company Board&#146;s fiduciary duties under applicable
Law, and (ii)&nbsp;that such Company Acquisition Proposal constitutes a Company Superior Proposal; <U>provided</U>, however, that prior to taking such action, (A)&nbsp;the Company promptly notifies Kensington, in writing, at least three
(3)&nbsp;Business Days (the &#147;<B>Company Notice Period</B>&#148;) before making a Company Adverse Recommendation Change or entering into a Company Acquisition Agreement, of its intention to take such action with respect to a Company Superior
Proposal, which notice shall (1)&nbsp;state expressly that the Company has received a Company Acquisition Proposal that the Company Board intends to declare a Company Superior Proposal and that the Company Board intends to make a Company Adverse
Recommendation Change and/or the Company intends to enter into a Company Acquisition Agreement and (2)&nbsp;include a copy of the most current version of the proposed agreement relating to such Company Superior Proposal (which version shall be
updated on a prompt basis), and a description of any financing commitments relating thereto; (B)&nbsp;the Company shall, and shall cause its Representatives to, during the Company Notice Period, negotiate with Kensington in good faith in respect of
adjustments in the terms and conditions of this Agreement such that such Company Acquisition Proposal would cease to constitute a Company Superior Proposal, if Kensington, in its discretion, proposes to make such adjustments (it being agreed that in
the event that, after commencement of the Company Notice Period, there is any material revision to the terms of a Company Superior Proposal, including, any revision in price, then the Company will provide a new notice to Kensington that complies
with the requirements of this <U>Section</U><U></U><U>&nbsp;7.05(d)</U> and that the &#147;Notice Period&#148; in respect of such new notice will be two (2)&nbsp;Business Days); and (C)&nbsp;following the end of such Company Notice Period the
Company Board determines in good faith, after consulting with outside financial advisor and legal counsel, that such Company Acquisition Proposal continues to constitute a Company Superior Proposal after taking into account any adjustments made by
Kensington during the Company Notice Period in the terms and conditions of this Agreement; and <U>provided</U>, <U>further</U>, that the Company shall have complied with its obligations under this <U>Section</U><U></U><U>&nbsp;7.05(d)</U> and if the
Company Board terminates this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;9.01(</U><U>i</U><U>)</U> to enter into a Company Acquisition Agreement, the Company pays or causes to be paid to Kensington the Termination Fee due in accordance with
<U>Section</U><U></U><U>&nbsp;9.03(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding the foregoing, if, at any time prior to obtaining the Written Consent, the
Company Board determines in good faith, in response to an Intervening Event, after consultation with its outside legal </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
counsel, that the failure to make a Company Adverse Recommendation Change would be inconsistent with its fiduciary duties under applicable Law, the Company Board may, prior to obtaining the
Written Consent, make a Company Adverse Recommendation Change; <U>provided</U>, <U>however</U>, that the Company will not be entitled to make, or agree or resolve to make, a Company Adverse Recommendation Change unless (i)&nbsp;the Company promptly
notifies Kensington in writing, at least three (3)&nbsp;Business Days (the &#147;<B>Intervening Event Notice Period</B>&#148;) advising Kensington that the Company Board proposes to take such action and containing the material facts underlying the
Company Board&#146;s determination that an Intervening Event has occurred, and (ii)&nbsp;following the end of such Intervening Event Notice Period (it being agreed that in the event after the commencement of the Intervening Event Notice Period,
there is any material development with respect to an Intervening Event, the Intervening Event Notice Period shall be extended, if applicable, to ensure that at least two (2)&nbsp;Business Days remains in the Intervening Event Notice Period
subsequent to the time the company notifies Kensington of any such material revision (it being understood that there may be multiple extensions)), the Company Board determines in good faith, after consulting with outside financial advisors and legal
counsel, that the failure to make a Company Adverse Recommendation Change in response to such Intervening Event would be inconsistent with the Company Board&#146;s fiduciary duties under applicable Law. If requested by Kensington, the Company shall,
and shall cause its Representatives to, during the Intervening Event Notice Period, negotiate with Kensington in good faith to make such adjustments in the terms and conditions of this Agreement so as to obviate the need for a Company Adverse
Recommendation Change.&nbsp;For the avoidance of doubt, none of (A)&nbsp;the determination by the Company Board that an Intervening Event may or has occurred or (B)&nbsp;the delivery by the Company to Kensington of any notice contemplated by this
<U>Section</U><U></U><U>&nbsp;7.05</U> will, in and of itself, constitute a Company Adverse Recommendation Change or violate this <U>Section</U><U></U><U>&nbsp;7.05.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The parties agree that any violation of the restrictions set forth in this <U>Section</U><U></U><U>&nbsp;7.05</U> by any of the
Company&#146;s Representatives shall be deemed to be a breach of this <U>Section</U><U></U><U>&nbsp;7.05</U> by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
7.06.<U>&nbsp;Kensington Exclusivity</U>.&nbsp;From the date of this Agreement and ending on the earlier of (a)&nbsp;the Closing and (b)&nbsp;the termination of this Agreement in accordance with <U>Section</U><U></U><U>&nbsp;9.01</U>, but only to
the extent not inconsistent with the fiduciary duties of the Kensington Board, Kensington shall not, and shall cause its Representatives not to, directly or indirectly, (i)&nbsp;enter into, knowingly solicit, initiate or continue any discussions or
negotiations with, or knowingly encourage or respond to any inquiries or proposals by, or participate in any negotiations with, or provide any information to, or otherwise cooperate in any way with, any person or other entity or &#147;group&#148;
within the meaning of Section&nbsp;13(d) of the Exchange Act, concerning any sale of any material assets of such person or any of the outstanding capital stock or any conversion, consolidation, liquidation, dissolution or similar transaction
involving such person other than with the Company and its Representatives (an &#147;<B>Alternative Transaction</B>&#148;), (ii) enter into any agreement regarding, continue or otherwise knowingly participate in any discussions regarding, or furnish
to any person any information with respect to, or cooperate in any way that would otherwise reasonably be expected to lead to, any Alternative Transaction or (iii)&nbsp;commence, continue or renew any due diligence investigation regarding any
Alternative Transaction; <U>provided</U>, <U>however</U>, that the execution, delivery and performance of this Agreement and the Transaction Documents and the consummation of the Transactions shall not be deemed a violation of this
<U>Section</U><U></U><U>&nbsp;7.06</U>. Kensington shall, and shall cause its affiliates and Representatives to, immediately cease any and all existing discussions or negotiations with any person conducted heretofore with respect to any Alternative
Transaction.&nbsp;Kensington also agrees that it will promptly request each person (other than the Company and its Representatives) that has prior to the date of this Agreement executed a confidentiality agreement in connection with its
consideration of an Alternative Transaction to return or destroy all Confidential Information furnished to such person by or on behalf of it prior to the date of this Agreement (to the extent so permitted under, and in accordance with the terms of,
such confidentiality agreement).&nbsp;If Kensington or any of its affiliates or its or their respective Representatives receives any inquiry or proposal with respect to an Alternative Transaction at any time prior to the Closing, then Kensington
shall promptly (and in no event later than one (1)&nbsp;Business Day after Kensington becomes aware of such inquiry or proposal) notify such person in writing that Kensington is subject to an exclusivity agreement with respect to the Transaction
that prohibits Kensington or any of its affiliates or its or their respective Representatives from considering such inquiry or proposal.&nbsp;Without limiting the foregoing, the parties agree that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any violation of the restrictions set forth in this <U>Section</U><U></U><U>&nbsp;7.06</U> by Kensington or any of its affiliates or its or their respective Representatives shall be deemed to be
a breach of this <U>Section</U><U></U><U>&nbsp;7.06</U> by Kensington. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 7.07.<U>&nbsp;Employee Benefits Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The parties shall cooperate to establish an equity incentive award plan and an employee stock purchase plan (the &#147;<B>Equity
Plans</B>&#148; ) for the Surviving Corporation to be effective at the Closing.&nbsp;Kensington shall have the Equity Plans approved by Kensington stockholders at the Kensington Stockholders&#146; Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Kensington shall, or shall cause the Surviving Corporation and each of its subsidiaries, as applicable, to provide the employees of the
Company who remain employed immediately after the Effective Time (the &#147;<B>Continuing Employees</B>&#148;) credit for purposes of eligibility to participate, vesting and determining the level of benefits, as applicable, under any employee
benefit plan, program or arrangement established or maintained by the Surviving Corporation or any of its subsidiaries (including, without limitation, any employee benefit plan as defined in Section&nbsp;3(3) of ERISA and any vacation or other paid <FONT
STYLE="white-space:nowrap">time-off</FONT> program or policy) for service accrued or deemed accrued prior to the Effective Time with the Company; <U>provided</U>, <U>however</U>, that such crediting of service shall not operate to duplicate any
benefit or the funding of any such benefit.&nbsp;In addition, Kensington shall use commercially reasonable efforts to (i)&nbsp;cause to be waived any eligibility waiting periods, any evidence of insurability requirements and the application of any <FONT
STYLE="white-space:nowrap">pre-existing</FONT> condition limitations under each of the employee benefit plans established or maintained by the Surviving Corporation or any of its subsidiaries that cover the Continuing Employees or their dependents,
and (ii)&nbsp;cause any eligible expenses incurred by any Continuing Employee and his or her covered dependents, during the portion of the plan year in which the Closing occurs, under those health and welfare benefit plans in which such Continuing
Employee currently participates to be taken into account under those health and welfare benefit plans in which such Continuing Employee participates subsequent to the Closing Date for purposes of satisfying all deductible, coinsurance, and maximum <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> requirements applicable to such Continuing Employee and his or her covered dependents for the applicable plan year.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following the Closing, Surviving Corporation will honor all accrued but unused vacation and other paid time off of the Continuing Employees that existed
immediately prior to the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The provisions of this <U>Section</U><U></U><U>&nbsp;7.07</U> are solely for the benefit of the
parties to the Agreement, and nothing contained in this Agreement, express or implied, shall confer upon any Continuing Employee or legal representative or beneficiary or dependent thereof, or any other person, any rights or remedies of any nature
or kind whatsoever under or by reason of this Agreement, whether as a third-party beneficiary or otherwise, including, without limitation, any right to employment or continued employment for any specified period, or level of compensation or
benefits.&nbsp;Nothing contained in this Agreement, express or implied, shall constitute an amendment or modification of any employee benefit plan of the Company or shall require the Company, Kensington, the Surviving Corporation and each of its
subsidiaries to continue any Plan or other employee benefit arrangements, or prevent their amendment, modification or termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 7.08.<U>&nbsp;Directors</U><U>&#146;</U><U> and Officers</U><U>&#146;</U><U> Indemnification</U>.</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The certificate of incorporation and bylaws of each of the Surviving Corporation and Kensington shall contain provisions no less favorable
with respect to indemnification, advancement or expense reimbursement than are set forth in the certificate of incorporation and bylaws of the Company or Kensington, as applicable, which provisions shall not be amended, repealed or otherwise
modified for a period of six years from the Effective Time in any manner that would affect adversely the rights thereunder of individuals who, at or prior to the Effective Time, were directors, officers, employees, fiduciaries or agents of the
Company or Kensington, as applicable, unless such modification shall be required by applicable Law.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) On the Closing Date, each of the
Company and Kensington shall obtain (at each such party&#146;s sole cost and expense) a <FONT STYLE="white-space:nowrap">non-cancelable</FONT> <FONT STYLE="white-space:nowrap">run-off</FONT> directors and officers &#147;tail&#148; insurance policy
(providing coverage </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that, taken as a whole, is no less favorable than under such person&#146;s policy as in effect on the date of this Agreement), for a period of six (6)&nbsp;years after the Closing Date to provide
insurance coverage for events, acts or omissions occurring on or prior to the Closing Date for all persons who were directors or officers of the Company or Kensington, as applicable, on or prior to the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) On the Closing Date, Kensington shall enter into customary indemnification agreements reasonably satisfactory to each of the Company and
Kensington with the post-Closing directors and officers of Kensington and the Surviving Corporation, which indemnification agreements shall continue to be effective following the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 7.09.<U>&nbsp;Notification of Certain Matters</U>.&nbsp;The Company shall give prompt notice to Kensington, and Kensington shall give
prompt notice to the Company, of any event which a party becomes aware of between the date of this Agreement and the Closing (or the earlier termination of this Agreement in accordance with <U>Article IX</U>), the occurrence, or <FONT
STYLE="white-space:nowrap">non-occurrence</FONT> of which causes or would reasonably be expected to cause any of the conditions set forth in <U>Article VIII</U> to fail to be satisfied at the Closing.&nbsp;It is understood and agreed that no such
notification will affect or be deemed to modify the conditions to the obligations of the parties to consummate the Merger or the remedies available to the parties under this Agreement.&nbsp;The terms and conditions of the Confidentiality Agreement
apply to any information provided under this Section&nbsp;7.09. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 7.10.<U>&nbsp;Further Action; Reasonable Best Efforts</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Upon the terms and subject to the conditions of this Agreement, each of the parties hereto shall use its reasonable best efforts to take,
or cause to be taken, appropriate action, and to do, or cause to be done, such things as are necessary, proper or advisable under applicable Laws or otherwise to consummate and make effective the Transactions, including, without limitation, using
its reasonable best efforts to obtain all permits, consents, approvals, authorizations, qualifications and orders of Governmental Authorities and parties to contracts with the Company as set forth in <U>Section</U><U></U><U>&nbsp;4.05</U> necessary
for the consummation of the Transactions and to fulfill the conditions to the Merger.&nbsp;In case, at any time after the Effective Time, any further action is necessary or desirable to carry out the purposes of this Agreement, the proper officers
and directors of each party shall use their reasonable best efforts to take all such action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of the parties shall keep each
other apprised of the status of matters relating to the Transactions, including promptly notifying the other parties of any communication it or any of its affiliates receives from any Governmental Authority relating to the matters that are the
subject of this Agreement and permitting the other parties to review in advance, and to the extent practicable consult about, any proposed communication by such party to any Governmental Authority in connection with the Transactions.&nbsp;No party
to this Agreement shall agree to participate in any meeting with any Governmental Authority in respect of any filings, investigation or other inquiry unless it consults with the other parties in advance and, to the extent permitted by such
Governmental Authority, gives the other parties the opportunity to attend and participate at such meeting.&nbsp;Subject to the terms of the Confidentiality Agreement, the parties will coordinate and cooperate fully with each other in exchanging such
information and providing such assistance as the other parties may reasonably request in connection with the foregoing.&nbsp;Subject to the terms of the Confidentiality Agreement, the parties will provide each other with copies of all material
correspondence, filings or communications, including any documents, information and data contained therewith, between them or any of their Representatives, on the one hand, and any Governmental Authority or members of its staff, on the other hand,
with respect to this Agreement and the Transactions.&nbsp;No party shall take or cause to be taken any action before any Governmental Authority that is inconsistent with or intended to delay its action on requests for a consent or the consummation
of the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 7.11.<U>&nbsp;Public Announcements</U>.&nbsp;The initial press release relating to this Agreement shall be a
joint press release the text of which has been agreed to by each of Kensington and the Company.&nbsp;Thereafter, between the date of this Agreement and the Closing Date (or the earlier termination of this Agreement in accordance with
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<U>Article IX</U>) unless otherwise prohibited by applicable Law or the requirements of The New York Stock Exchange, each of Kensington and the Company shall each use its reasonable best efforts
to consult with each other before issuing any press release or otherwise making any public statements with respect to this Agreement, the Merger or any of the other Transactions, and shall not issue any such press release or make any such public
statement without the prior written consent of the other party.&nbsp;Furthermore, nothing contained in this <U>Section</U><U></U><U>&nbsp;7.10</U> shall prevent Kensington or the Company and/or its respective affiliates from furnishing customary or
other reasonable information concerning the Transactions to their investors and prospective investors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 7.12.<U>&nbsp;Tax
Matters</U>. Each of Kensington, Merger Sub and the Company shall use their respective commercially reasonable efforts to cause the Merger to qualify, and agree not to, and not to permit or cause any of their affiliates or subsidiaries to, take any
action which to its knowledge could reasonably be expected to prevent or impede the Merger from qualifying, as a reorganization within the meaning of Section&nbsp;368(a) of the Code.&nbsp;This Agreement is intended to constitute, and the parties
hereto hereby adopt this Agreement as, a &#147;plan of reorganization&#148; within the meaning of Treasury Regulation Sections <FONT STYLE="white-space:nowrap">1.368-2(g)</FONT> and <FONT STYLE="white-space:nowrap">1.368-3(a).&nbsp;Each</FONT> of
Kensington, Merger Sub and the Company shall report the Merger as a reorganization within the meaning of Section&nbsp;368(a) of the Code unless otherwise required pursuant to a &#147;determination&#148; within the meaning of Section&nbsp;1313(a) of
the Code, including attaching the statement described in Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.368-3(a)</FONT> on or with its Tax Return for the taxable year of the Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 7.13.<U>&nbsp;Stock Exchange Listing</U>.&nbsp;Kensington will use its reasonable best efforts to cause the New Kensington
Class&nbsp;A Common Stock issued in connection with the Transactions to be approved for listing on The New York Stock Exchange at Closing.&nbsp;During the period from the date of this Agreement until the Closing, Kensington shall use its reasonable
best efforts to keep the Kensington Units, Kensington Class&nbsp;A Common Stock and Kensington Warrants listed for trading on The New York Stock Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 7.14.<U>&nbsp;Antitrust</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) To the extent required under any Laws that are designed to prohibit, restrict or regulate actions having the purpose or effect of
monopolization or restraint of trade, including the HSR Act (&#147;<B>Antitrust Laws</B>&#148;), each party hereto agrees to promptly make any required filing or application under Antitrust Laws, as applicable.&nbsp;The parties hereto agree to
supply as promptly as reasonably practicable any additional information and documentary material that may be requested pursuant to Antitrust Laws and to take all other actions necessary, proper or advisable to cause the expiration or termination of
the applicable waiting periods or obtain required approvals, as applicable under Antitrust Laws as soon as practicable, including by requesting early termination of the waiting period provided for under the HSR Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each party shall, in connection with its efforts to obtain all requisite approvals and authorizations for the Transactions under any
Antitrust Law, use its commercially reasonable efforts to: (i)&nbsp;cooperate in all respects with each other party or its affiliates in connection with any filing or submission and in connection with any investigation or other inquiry, including
any proceeding initiated by a private person; (ii)&nbsp;keep the other parties reasonably informed of any communication received by such party or its Representatives from, or given by such party or its Representatives to, any Governmental Authority
and of any communication received or given in connection with any proceeding by a private person, in each case regarding any of the Transactions; (iii)&nbsp;permit a Representative of the other parties and their respective outside counsel to review
any communication given by it to, and consult with each other in advance of any meeting or conference with, any Governmental Authority or, in connection with any proceeding by a private person, with any other person, and to the extent permitted by
such Governmental Authority or other person, give a Representative or Representatives of the other parties the opportunity to attend and participate in such meetings and conferences; (iv)&nbsp;in the event a party&#146;s Representative is prohibited
from participating in or attending any meetings or conferences, the other parties shall keep such party promptly and reasonably apprised with respect thereto; and (v)&nbsp;use commercially reasonable efforts to cooperate in the filing of any
memoranda, white papers, filings, correspondence or other written communications explaining or defending the Transactions, articulating any regulatory or competitive argument, and/or responding to requests or objections made by any Governmental
Authority. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) No party hereto shall take any action that could reasonably be expected to adversely
affect or materially delay the approval of any Governmental Authority of any required filings or applications under Antitrust Laws.&nbsp;The parties hereto further covenant and agree, with respect to a threatened or pending preliminary or permanent
injunction or other order, decree or ruling or statute, rule, regulation or executive order that would adversely affect the ability of the parties to consummate the Transactions, to use commercially reasonable efforts to prevent or lift the entry,
enactment or promulgation thereof, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 7.15.<U>&nbsp;PCAOB Audited Financials</U>.&nbsp;The Company shall use
reasonable best efforts to deliver true and complete copies of the audited balance sheet of the Company as of December&nbsp;31, 2017, December&nbsp;31, 2018 and December&nbsp;31, 2019, and the related audited statements of income and comprehensive
loss, cash flows and stockholders&#146; equity of the Company for such years, each audited in accordance with the auditing standards of the PCAOB (collectively, the &#147;<B>PCAOB Audited Financials</B>&#148;) not later than thirty (30)&nbsp;days
from the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 7.16.<U>&nbsp;Trust Account</U>.&nbsp;As of the Effective Time, the obligations of Kensington to
dissolve or liquidate within a specified time period as contained in Kensington&#146;s Certificate of Incorporation will be terminated and Kensington shall have no obligation whatsoever to dissolve and liquidate the assets of Kensington by reason of
the consummation of the Merger or otherwise, and no stockholder of Kensington shall be entitled to receive any amount from the Trust Account.&nbsp;At least 48 hours prior to the Effective Time, Kensington shall provide notice to the Trustee in
accordance with the Trust Agreement and shall deliver any other documents, opinions or notices required to be delivered to the Trustee pursuant to the Trust Agreement and cause the Trustee prior to the Effective Time to, and the Trustee shall
thereupon be obligated to, transfer all funds held in the Trust Account to Kensington (to be held as available cash on the balance sheet of Kensington, and to be used for working capital and other general corporate purposes of the business following
the Closing) and thereafter shall cause the Trust Account and the Trust Agreement to terminate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 7.17.<U>&nbsp;Governance
Matters</U>.</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Board of Directors</U>.&nbsp;Upon the Effective Time, the Kensington Board and the board of directors of the Surviving
Corporation shall consist of (i)&nbsp;Jagdeep Singh, as Chairman, (ii)&nbsp;one member to be selected by Kensington and (iii)&nbsp;additional members to be selected by the Company.&nbsp;The parties will make their respective selections as far in
advance of the filing of the Registration Statement as is reasonably practicable by providing written notice of such selections to the other parties; <U>provided</U>, <U>however</U>, that, following any such selection, in the event that any selected
individual is unable to serve as a director of Kensington at the Effective Time, then the Company, with respect to the individuals identified in clause (i)&nbsp;and (iii) of the immediately preceding sentence, and Kensington, with respect to the
individuals identified in clause (ii)&nbsp;of the immediately preceding sentence, shall have the right to designate another individual, as applicable, to serve as a director of Kensington in place of the individual originally selected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Effectuation</U>.&nbsp;Prior to the Effective Time, the parties shall take all action necessary to effectuate the provisions of this
<U>Section</U><U></U><U>&nbsp;7.17</U>. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDITIONS TO THE MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 8.01.<U>&nbsp;Conditions to the Obligations of Each Party</U>. The obligations of the Company, Kensington and Merger Sub to consummate
the Transactions, including the Merger, are subject to the satisfaction or waiver (where permissible) at or prior to the Closing of the following conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Written Consent</U>. The Written Consent shall have been delivered to Kensington. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Kensington Stockholders&#146; Approval</U>. The Kensington Proposals shall have been
approved and adopted by the requisite affirmative vote of the stockholders of Kensington in accordance with the Proxy Statement, the DGCL, the Kensington Organizational Documents and the rules and regulations of The New York Stock Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>No Order</U>. No Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law, rule, regulation,
judgment, decree, executive order or award which is then in effect and has the effect of making the Transactions, including the Merger, illegal or otherwise prohibiting consummation of the Transactions, including the Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Antitrust Approvals and Waiting Periods</U>. All required filings under the HSR Act shall have been completed and any applicable
waiting period (and any extension thereof) applicable to the consummation of the Transactions under the HSR Act shall have expired or been terminated, and any <FONT STYLE="white-space:nowrap">pre-Closing</FONT> approvals or clearances reasonably
required thereunder shall have been obtained. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Consents</U>. All consents, approvals and authorizations set forth on
<U>Section</U><U></U><U>&nbsp;8.01(e)</U> of the Company Disclosure Schedule shall have been obtained from and made with all Governmental Authorities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Registration Statement</U>. The Registration Statement shall have been declared effective under the Securities Act.&nbsp;No stop order
suspending the effectiveness of the Registration Statement shall be in effect, and no proceedings for purposes of suspending the effectiveness of the Registration Statement shall have been initiated or be threatened by the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)<U> Stock Exchange Listing</U>. The shares of New Kensington Class&nbsp;A Common Stock shall be approved for listing on The New York Stock
Exchange as of the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 8.02.<U>&nbsp;Conditions to the Obligations of Kensington and Merger Sub</U>.&nbsp;The
obligations of Kensington and Merger Sub to consummate the Transactions, including the Merger, are subject to the satisfaction or waiver (where permissible) at or prior to the Closing of the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Representations and Warranties</U>.&nbsp;The representations and warranties of the Company contained in
<U>Section</U><U></U><U>&nbsp;4.01(a)</U> (Organization and Qualification; Subsidiaries), <U>Section</U><U></U><U>&nbsp;4.03(a)</U> (Capitalization), <U>Section</U><U></U><U>&nbsp;4.04</U> (Authority Relative to this Agreement) and
<U>Section</U><U></U><U>&nbsp;4.22</U> (Brokers) shall each be true and correct in all material respects as of the Closing Date as though made on the Closing Date (without giving effect to any limitation as to &#147;materiality&#148; or
&#147;Company Material Adverse Effect&#148; or any similar limitation set forth therein), except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be
true and correct in all material respects as of such earlier date.&nbsp;All other representations and warranties of the Company contained in this Agreement shall be true and correct (without giving any effect to any limitation as to
&#147;materiality&#148; or &#147;Company Material Adverse Effect&#148; or any similar limitation set forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except (i)&nbsp;to the extent that any such
representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date and (ii)&nbsp;where the failure of such representations and warranties to be true
and correct (whether as of the Closing Date or such earlier date), taken as a whole, does not result in a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Agreements and Covenants</U>.&nbsp;The Company shall have performed or complied in all material respects with all agreements and
covenants required by this Agreement to be performed or complied with by it on or prior to the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Officer
Certificate</U>.&nbsp;The Company shall have delivered to Kensington a certificate, dated the date of the Closing, signed by an officer of the Company, certifying as to the satisfaction of the conditions specified in
<U>Section</U><U></U><U>&nbsp;8.02(a)</U> and <U>Section</U><U></U><U>&nbsp;8.02(b)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Material Adverse Effect</U>.&nbsp;No Company Material Adverse Effect shall have
occurred between the date of this Agreement and the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>FIRPTA Tax Certificates</U>.&nbsp;On or prior to the Closing,
the Company shall deliver to Kensington a properly executed certification that shares of Company Common Stock are not &#147;U.S. real property interests&#148; in accordance with the Treasury Regulations under Sections 897 and 1445 of the Code,
together with a notice to the IRS (which shall be filed by Kensington with the IRS following the Closing) in accordance with the provisions of <FONT STYLE="white-space:nowrap">Section&nbsp;1.897-2(h)(2)</FONT> of the Treasury Regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>PCAOB Audited Financials</U>. The Company shall have delivered to Kensington the PCAOB Audited Financials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Minimum Cash</U>.&nbsp;The Series F Subscription Amount shall be at least three hundred million dollars ($300,000,000) in the
aggregate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Series F Maximum</U>.&nbsp;The total amount of shares of Series F Preferred Stock outstanding as of immediately prior
to the Closing shall not exceed the amount of authorized shares of Series F Preferred Stock set forth in Section&nbsp;4.03(a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)
<U>Maximum Debt</U>.&nbsp;The Company shall have no indebtedness for borrowed money. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 8.03.<U>&nbsp;Conditions to the Obligations
of the Company</U>.&nbsp;The obligations of the Company to consummate the Transactions, including the Merger, are subject to the satisfaction or waiver (where permissible) at or prior to Closing of the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Representations and Warranties</U>.&nbsp;The representations and warranties of Kensington and Merger Sub contained in
<U>Section</U><U></U><U>&nbsp;5.01</U> (Corporation Organization), <U>Section</U><U></U><U>&nbsp;5.03</U> (Capitalization), <U>Section</U><U></U><U>&nbsp;5.04</U> (Authority Relative to this Agreement) and <U>Section</U><U></U><U>&nbsp;5.12</U>
(Brokers) shall each be true and correct in all material respects as of the Closing Date as though made on the Closing Date (without giving effect to any limitation as to &#147;materiality&#148; or &#147;Kensington Material Adverse Effect&#148; or
any similar limitation set forth therein), except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects as of
such earlier date.&nbsp;All other representations and warranties of Kensington and Merger Sub contained in this Agreement shall be true and correct (without giving any effect to any limitation as to &#147;materiality&#148; or &#147;Kensington
Material Adverse Effect&#148; or any similar limitation set forth therein) in all respects as of the Closing Date, as though made on and as of the Closing Date, except (i)&nbsp;to the extent that any such representation and warranty expressly speaks
as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date and (ii)&nbsp;where the failure of such representations and warranties to be true and correct (whether as of the Closing Date or
such earlier date), taken as a whole, does not result in a Kensington Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Agreements and
Covenants</U>.&nbsp;Kensington and Merger Sub shall have performed or complied in all material respects with all agreements and covenants required by this Agreement to be performed or complied with by it on or prior to the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Officer Certificate</U>.&nbsp;Kensington shall have delivered to the Company a certificate, dated the date of the Closing, signed by
the President of Kensington, certifying as to the satisfaction of the conditions specified in <U>Section</U><U></U><U>&nbsp;8.03(a)</U> and <U>Section</U><U></U><U>&nbsp;8.03(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Resignation</U>.&nbsp;Other than those persons identified as continuing directors in accordance with Section&nbsp;7.17, all members of
the Kensington Board shall have executed written resignations effective as of the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Material Adverse
Effect</U>.&nbsp;No Kensington Material Adverse Effect shall have occurred between the date of this Agreement and the Closing Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Stock Exchange Listing</U>.&nbsp;A supplemental listing shall have been filed with
The New York Stock Exchange as of the Closing Date to list the shares of New Kensington Class&nbsp;A Common Stock constituting the aggregate Per Share Merger Consideration pursuant to <U>Section</U><U></U><U>&nbsp;3.01(b)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Minimum Cash Amount</U>. The Kensington Cash Amount shall be at least five hundred million dollars ($500,000,000) in the aggregate.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TERMINATION, AMENDMENT AND WAIVER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 9.01.<U>&nbsp;Termination</U>.&nbsp;This Agreement may be terminated and the Merger and the other Transactions may be abandoned at any
time prior to the Effective Time, notwithstanding any requisite approval and adoption of this Agreement and the Transactions by the stockholders of the Company or Kensington, as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) by mutual written consent of Kensington and the Company; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) by either Kensington or the Company if the Effective Time shall not have occurred prior to the date that is six (6)&nbsp;months from the
date of this Agreement (the &#147;<B>Outside Date</B>&#148;); <U>provided</U>, <U>however</U>, that this Agreement may not be terminated under this <U>Section</U><U></U><U>&nbsp;9.01(b)</U> by or on behalf of any party (i)&nbsp;that either directly
or indirectly through its affiliates is in breach or violation of any representation, warranty, covenant, agreement or obligation contained herein and such breach or violation is the principal cause of the failure of a condition set forth in
<U>Article VIII</U> on or prior to the Outside Date or (ii)&nbsp;against which any legal proceeding is brought by a party hereto for specific performance or injunctive or other forms of equitable relief in connection herewith (which prohibition on
such party&#146;s right to terminate this Agreement shall continue throughout the pendency of such legal proceeding); or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) by either
Kensington or the Company if any Governmental Authority in the United States shall have enacted, issued, promulgated, enforced or entered any permanent injunction, order, decree or ruling which has become final and nonappealable and has the effect
of making consummation of the Transactions, including the Merger, illegal or otherwise preventing or prohibiting consummation of the Transactions, the Merger; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) by either Kensington or the Company if any of the Kensington Proposals shall fail to receive the requisite vote for approval at the
Kensington Stockholders&#146; Meeting; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) by Kensington if the Company Board or a committee thereof, prior to obtaining the Written
Consent, shall have made a Company Adverse Recommendation Change; <U>provided</U>, <U>however</U>, that Kensington&#146;s right to terminate this Agreement pursuant to this Section&nbsp;9.01(e) shall expire at the end of the tenth (10th) Business
Day following the date on which the Company Adverse Recommendation Change occurs; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) by Kensington if the Company shall have failed
to deliver the Written Consent to Kensington within twenty-four (24)&nbsp;hours after the Registration Statement becomes effective; <U>provided</U>, <U>however</U>, that Kensington&#146;s right to terminate this Agreement pursuant to this
Section&nbsp;9.01(f) shall expire at the end of the fifth (5th) Business Day following the date on which the Written Consent is delivered to Kensington; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) by Kensington upon a breach of any representation, warranty, covenant or agreement on the part of the Company set forth in this Agreement,
or if any representation or warranty of the Company shall have become untrue, in either case such that the conditions set forth in <U>Sections 8.02(a)</U> and <U>8.02(b)</U> would not be satisfied (&#147;<B>Terminating Company Breach</B>&#148;);
<U>provided</U>, <U>however</U>, that Kensington has not waived such Terminating Company Breach and Kensington and Merger Sub are not then in material breach of their representations, warranties, covenants or agreements in this Agreement; provided
further that, if such Terminating Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Breach is curable by the Company, Kensington may not terminate this Agreement under this <U>Section</U><U></U><U>&nbsp;9.01(f)</U> for so long as the Company continues to exercise its reasonable
efforts to cure such breach, unless such breach is not cured within thirty (30)&nbsp;days after notice of such breach is provided by Kensington to the Company; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) by the Company upon a breach of any representation, warranty, covenant or agreement on the part of Kensington and Merger Sub set forth in
this Agreement, or if any representation or warranty of Kensington and Merger Sub shall have become untrue, in either case such that the conditions set forth in <U>Sections 8.03(a)</U> and <U>8.03(b)</U> would not be satisfied (&#147;<B>Terminating
Kensington Breach</B>&#148;); <U>provided</U>, <U>however</U>, that the Company has not waived such Terminating Kensington Breach and the Company are not then in material breach of their representations, warranties, covenants or agreements in this
Agreement; <U>provided</U>, <U>however</U>, that, if such Terminating Kensington Breach is curable by Kensington and Merger Sub, the Company may not terminate this Agreement under this <U>Section</U><U></U><U>&nbsp;9.01(g)</U> for so long as
Kensington and Merger Sub continue to exercise their reasonable efforts to cure such breach, unless such breach is not cured within thirty (30)&nbsp;days after notice of such breach is provided by the Company to Kensington; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) by Kensington if the PCAOB Audited Financials shall not have been delivered to Kensington by the Company on or before not later than
thirty (30)&nbsp;days from the date of this Agreement; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) by the Company, at any time prior to receipt of the Written Consent, in
connection with entering into a Company Acquisition Agreement with respect to a Company Superior Proposal in accordance with <U>Section</U><U></U><U>&nbsp;7.05(d)</U>; <U>provided</U>, <U>however</U>, that prior to or concurrently with such
termination the Company pays or causes to be paid the Termination Fee due under <U>Section</U><U></U><U>&nbsp;9.03(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION
9.02.<U>&nbsp;Effect of Termination</U>.&nbsp;In the event of the termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;9.01</U>, this Agreement shall forthwith become void, and there shall be no liability under this Agreement on
the part of any party hereto, except as set forth in <U>Section</U><U></U><U>&nbsp;9.02</U>, <U>Section</U><U></U><U>&nbsp;9.03</U>, <U>Article X</U>, and any corresponding definitions set forth in <U>Article I</U>, or in the case of termination
subsequent to a willful material breach of this Agreement by a party hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 9.03.<U>&nbsp;Termination Fee</U>.</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In the event that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)(A) this Agreement is terminated by the Company or Kensington pursuant to <U>Section</U><U></U><U>&nbsp;9.01(b)</U> or by
Kensington pursuant to <U>Section</U><U></U><U>&nbsp;9.01(f)</U> or <U>Section</U><U></U><U>&nbsp;9.01(g)</U>; (B) a <U>bona</U> <U>fide</U> Company Acquisition Proposal shall have been made, proposed or otherwise communicated to the Company after
the date of this Agreement but before the date of such termination, and (C)&nbsp;within six (6)&nbsp;months of the date this Agreement is terminated, the Company enters into a definitive agreement with respect to such Company Acquisition Proposal;
<U>provided</U>, <U>however</U>, that, for purposes of clauses (B)&nbsp;and (C) of this <U>Section</U><U></U><U>&nbsp;9.03(a)(i)</U>, the references to &#147;10%&#148; in the definition of Company Acquisition Proposal shall be deemed to be
references to &#147;50%&#148;; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) this Agreement is terminated (A)&nbsp;by Kensington pursuant to
<U>Section</U><U></U><U>&nbsp;9.01(e)</U> or (B)&nbsp;by the Company pursuant to <U>Section</U><U></U><U>&nbsp;9.01(j)</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then, in any such event under
clause (i)&nbsp;or (ii) of this <U>Section</U><U></U><U>&nbsp;9.03(a)</U>, the Company shall pay or cause to be paid the Termination Fee to Kensington or its designee by wire transfer of same day funds (x)&nbsp;in the case of
<U>Section</U><U></U><U>&nbsp;9.03(a)(ii)(A)</U> within two (2)&nbsp;Business Days; after such termination, (y)&nbsp;in the case of <U>Section</U><U></U><U>&nbsp;9.03(a)(ii)(B)</U>, simultaneously with such termination or (z)&nbsp;in the case of
<U>Section</U><U></U><U>&nbsp;9.03(a)(i)</U>, upon entry into the definitive agreement with respect to the Company Acquisition Proposal referred to therein; it being understood that in no event shall the Company be required to pay the Termination
Fee on more than one occasion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used herein, &#147;Termination Fee&#148; means $82,000,000. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The parties acknowledge and agree that the provisions for payment of the Termination Fee
are an integral part of the Transactions and are included herein in order to induce the parties to enter into this Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE
X. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GENERAL PROVISIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 10.01.<U>&nbsp;Notices</U>.&nbsp;All notices, requests, claims, demands and other communications hereunder shall be in writing and
shall be given (and shall be deemed to have been duly given upon receipt) by delivery in person, by email or by registered or certified mail (postage prepaid, return receipt requested) to the respective parties at the following addresses (or at such
other address for a party as shall be specified in a notice given in accordance with this <U>Section</U><U></U><U>&nbsp;10.01</U>): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">if to
Kensington or Merger Sub: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Kensington Capital Acquisition Corp. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">1400 Old Country Road, Suite 301 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Westbury, NY 11590 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;Justin Mirro </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">Email:&nbsp;justin@kensington-cap.com</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">with a copy to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Hughes Hubbard&nbsp;&amp; Reed LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">One Battery Park Plaza </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">New York,
NY 10004 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;Charles A. Samuelson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email:&nbsp;chuck.samuelson@hugheshubbard.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">if to the Company: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">QuantumScape
Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">730 Technology Dr </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">San Jose, CA 95110 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;Jagdeep Singh </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email:&nbsp;JSingh@quantumscape.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">with a copy to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Wilson Sonsini
Goodrich&nbsp;&amp; Rosati </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">650 Page Mill Road </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Palo Alto, CA&nbsp;94304 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attention: Michael J. Danaher; Mark B. Baudler </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email:&nbsp;mdanaher@wsgr.com; mbaudler@wsgr.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">and with a copy to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Wilson
Sonsini Goodrich&nbsp;&amp; Rosati </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">One Market Plaza, Spear Tower, Suite 3300 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">San Francisco, CA&nbsp;94105 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attention: Ethan P. Lutske </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email: elutske@wsgr.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 10.02.<U>&nbsp;Nonsurvival</U><U> of Representations, Warranties and
Covenants</U>.&nbsp;None of the representations, warranties, covenants, obligations or other agreements in this Agreement or in any certificate, statement or instrument delivered pursuant to this Agreement, including any rights arising out of any
breach of such representations, warranties, covenants, obligations, agreements and other provisions, shall survive the Closing and all such representations, warranties, covenants, obligations or other agreements shall terminate and expire upon the
occurrence of the Closing (and there shall be no liability after the Closing in respect thereof), except for (a)&nbsp;those covenants and agreements contained herein that by their terms expressly apply in whole or in part after the Closing and then
only with respect to any breaches occurring after the Closing and (b)&nbsp;this <U>Article X</U> and any corresponding definitions set forth in <U>Article I</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 10.03.<U>&nbsp;Severability</U>.&nbsp;If any term or other provision of this Agreement is invalid, illegal or incapable of being
enforced by any rule of law, or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the Transactions is not affected in any manner
materially adverse to any party.&nbsp;Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original
intent of the parties as closely as possible in a mutually acceptable manner in order that the Transactions be consummated as originally contemplated to the fullest extent possible. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 10.04.<U>&nbsp;Entire Agreement; Assignment</U>.&nbsp;This Agreement and the Ancillary Agreements constitute the entire agreement
among the parties with respect to the subject matter hereof and supersede, except as set forth in <U>Section</U><U></U><U>&nbsp;7.04(b)</U>, all prior agreements and undertakings, both written and oral, among the parties, or any of them, with
respect to the subject matter hereof, except for the Confidentiality Agreement.&nbsp;This Agreement shall not be assigned (whether pursuant to a merger, by operation of law or otherwise) by any party without the prior express written consent of the
other parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 10.05.<U>&nbsp;Parties in Interest</U>.&nbsp;This Agreement shall be binding upon and inure solely to the
benefit of each party hereto, and nothing in this Agreement, express or implied, is intended to or shall confer upon any other person any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement, other than
<U>Section</U><U></U><U>&nbsp;7.08</U> (which is intended to be for the benefit of the persons covered thereby and may be enforced by such persons). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 10.06.<U>&nbsp;Governing Law</U>.&nbsp;This Agreement shall be governed by, and construed in accordance with, the laws of the State of
Delaware applicable to contracts executed in and to be performed in that State.&nbsp;All legal actions and proceedings arising out of or relating to this Agreement shall be heard and determined exclusively in any Delaware Chancery Court;
<U>provided</U>, <U>however</U>, that if jurisdiction is not then available in the Delaware Chancery Court, then any such legal Action may be brought in any federal court located in the State of Delaware or any other Delaware state court.&nbsp;The
parties hereto hereby (a)&nbsp;irrevocably submit to the exclusive jurisdiction of the aforesaid courts for themselves and with respect to their respective properties for the purpose of any Action arising out of or relating to this Agreement brought
by any party hereto, and (b)&nbsp;agree not to commence any Action relating thereto except in the courts described above in Delaware, other than Actions in any court of competent jurisdiction to enforce any judgment, decree or award rendered by any
such court in Delaware as described herein.&nbsp;Each of the parties further agrees that notice as provided herein shall constitute sufficient service of process and the parties further waive any argument that such service is insufficient.&nbsp;Each
of the parties hereby irrevocably and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any Action arising out of or relating to this Agreement or the Transactions, (a)&nbsp;any claim
that it is not personally subject to the jurisdiction of the courts in Delaware as described herein for any reason, (b)&nbsp;that it or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such
courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (c)&nbsp;that (i) the Action in any such court is brought in an inconvenient forum,
(ii)&nbsp;the venue of such Action is improper or (iii)&nbsp;this Agreement, or the subject matter hereof, may not be enforced in or by such courts. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 10.07.<U>&nbsp;Waiver of Jury Trial</U>.&nbsp;EACH OF THE PARTIES HERETO HEREBY
WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS.&nbsp;EACH OF THE
PARTIES HERETO (A)&nbsp;CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND
(B)&nbsp;ACKNOWLEDGES THAT IT AND THE OTHER HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <U>SECTION 10.07</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 10.08.<U>&nbsp;Headings</U>.&nbsp;The descriptive headings contained in this Agreement are included for convenience of reference only
and shall not affect in any way the meaning or interpretation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 10.09.<U>&nbsp;Counterparts</U>.&nbsp;This
Agreement may be executed and delivered (including by facsimile or portable document format (pdf) transmission) in one or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to
be an original but all of which taken together shall constitute one and the same agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 10.10.<U>&nbsp;Specific
Performance</U>.&nbsp;The parties agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with the terms hereof, and, accordingly, that the parties shall be entitled to an injunction or
injunctions to prevent breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof (including the parties&#146; obligation to consummate the Merger) in the Court of Chancery of the State of Delaware or,
if that court does not have jurisdiction, any court of the United States located in the State of Delaware without proof of actual damages or otherwise, in addition to any other remedy to which they are entitled at law or in equity as expressly
permitted in this Agreement.&nbsp;Each of the parties hereby further waives (a)&nbsp;any defense in any action for specific performance that a remedy at law would be adequate and (b)&nbsp;any requirement under any Law to post security or a bond as a
prerequisite to obtaining equitable relief. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 10.11.<U>&nbsp;Expenses</U>.&nbsp;Except as set forth in this
<U>Section</U><U></U><U>&nbsp;10.11</U> or elsewhere in this Agreement, all expenses incurred in connection with this Agreement and the Transactions shall be paid by the party incurring such expenses, whether or not the Merger or any other
Transaction is consummated, except that Kensington and the Company shall each pay <FONT STYLE="white-space:nowrap">one-half</FONT> of all expenses relating to (A)&nbsp;all SEC and other regulatory filing fees incurred in connection with the Proxy
Statement, (B)&nbsp;the filing fee for the Notification and Report Forms filed under the HSR Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
10.12.<U>&nbsp;Amendment</U>.&nbsp;This Agreement may be amended in writing by the parties hereto at any time prior to the Effective Time.&nbsp;This Agreement may not be amended except by an instrument in writing signed by each of the parties
hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 10.13.<U>&nbsp;Waiver</U>.&nbsp;At any time prior to the Effective Time, (i)&nbsp;Kensington may (a)&nbsp;extend the time
for the performance of any obligation or other act of the Company, (b)&nbsp;waive any inaccuracy in the representations and warranties of the Company contained herein or in any document delivered by the Company pursuant hereto and (c)&nbsp;waive
compliance with any agreement of the Company or any condition to its own obligations contained herein and (ii)&nbsp;the Company may (a)&nbsp;extend the time for the performance of any obligation or other act of Kensington or Merger Sub,
(b)&nbsp;waive any inaccuracy in the representations and warranties of Kensington or Merger Sub contained herein or in any document delivered by Kensington and/or Merger pursuant hereto and (c)&nbsp;waive compliance with any agreement of Kensington
or Merger Sub or any condition to its own obligations contained herein.&nbsp;Any such extension or waiver shall be valid if set forth in an instrument in writing signed by the party or parties to be bound thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page Follows.] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Kensington, Merger Sub, and the Company have caused this Agreement and
Plan of Merger to be executed as of the date first written above by their respective officers thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">KENSINGTON CAPITAL ACQUISITION CORP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Justin Mirro</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:&nbsp;Justin Mirro</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:&nbsp;Chief Executive Offer</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">KENSINGTON CAPITAL MERGER SUB CORP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Justin Mirro</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:&nbsp;Justin Mirro</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:&nbsp;President</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">QUANTUMSCAPE CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Jagdeep Singh</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:&nbsp;Jagdeep Singh</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:&nbsp;Chief Executive Officer</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXHIBIT A </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit A is omitted because the Registration Rights and Lock-up Agreement is included separately as Exhibit 10.3 to this proxy
statement/prospectus/information statement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
   <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXHIBIT B </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL
ACQUISITION CORP. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kensington Capital Acquisition Corp., a Delaware corporation, hereby certifies that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. The Corporation was incorporated under the name Kensington Capital Acquisition Corp. The original Certificate of Incorporation of the Corporation was filed
with the Secretary of State of the State of Delaware on April&nbsp;17, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. The Amended and Restated Certificate of Incorporation of the Corporation
attached hereto as Exhibit A, which is incorporated herein by this reference, and which restates, integrates and further amends the provisions of the Certificate of Incorporation of this Corporation as heretofore amended and restated, has been duly
adopted by the Corporation&#146;s Board of Directors and by the stockholders in accordance with Sections 242 and 245 of the General Corporation Law of the State of Delaware, with the approval of the Corporation&#146;s stockholders having been given
by written consent without a meeting in accordance with Section&nbsp;228 of the General Corporation Law of the State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. This Amended and
Restated Certificate of Incorporation of the Corporation shall be effective as of [&nbsp;&nbsp;&nbsp;&nbsp;]&nbsp;A.M. Eastern Time on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Corporation has caused this Amended and Restated Certificate of Incorporation to be signed by its duly authorized officer
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020 and the foregoing facts stated herein are true and correct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>KENSINGTON CAPITAL ACQUISITION CORP. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">B<SMALL>Y</SMALL>:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exh. <FONT
STYLE="white-space:nowrap">B-1</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL
ACQUISITION CORP. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
name of the corporation is Kensington Capital Acquisition Corp. (the &#147;<B><I>Corporation</I></B>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The address of the registered office of the Corporation in the State of Delaware is Corporation Trust Center, 1209 Orange Street, City of Wilmington, County
of New Castle, DE 19801. The name of its registered agent at such address is The Corporation Trust Company. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purpose of the Corporation is to engage in any lawful act or activity for which a corporation may be organized under the General Corporation Law of the
State of Delaware (the &#147;<B><I>Delaware General Corporation Law</I></B>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Corporation is authorized to issue [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] shares of common
stock, of which there are (i) [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] shares of Class&nbsp;A Common Stock, par value $[0.0001] per share (the
&#147;<B><I>Class</I></B><B><I></I></B><B><I>&nbsp;A Common Stock</I></B>&#148;) and (ii) [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] shares of Class&nbsp;B Common Stock, par value $[0.0001] per
share (the &#147;<B><I>Class</I></B><B><I></I></B><B><I>&nbsp;B Common Stock</I></B>&#148; and together with the Class&nbsp;A Common Stock, the &#147;<B><I>Common Stock</I></B>&#148;); and
[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] shares of Preferred Stock, par value $0.001 per share (the &#147;<B><I>Preferred Stock</I></B>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The rights, powers,
preferences, privileges, restrictions and other matters relating to the Common Stock are as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.<U>&nbsp;Definitions</U>. For purposes of this
Amended and Restated Certificate, the following definitions apply: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.1 &#147;<B><I>Acquisition</I></B>&#148; means (i)&nbsp;any consolidation or merger of
the Corporation with or into any other corporation or other entity or person, or any other corporate reorganization, other than any such consolidation, merger or reorganization in which the shares of capital stock of the Corporation immediately
prior to such consolidation, merger or reorganization continue to represent a majority of the voting power of the surviving entity (or, if the surviving entity is a wholly owned subsidiary, its Parent) immediately after such consolidation, merger or
reorganization; or (ii)&nbsp;any transaction or series of related transactions to which the Corporation is a party in which issued and outstanding shares of the Corporation are transferred or shares of the Corporation are issued, such that in excess
of fifty percent (50%) of the Corporation&#146;s voting power is transferred;<I>&nbsp;provided</I>&nbsp;that an Acquisition shall not include any transaction or series of transactions principally for bona fide equity financing purposes in which cash
is received by the Corporation or any successor or indebtedness of the Corporation is cancelled or converted or a combination thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exh. <FONT
STYLE="white-space:nowrap">B-2</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.2 &#147;<B><I>Amended and Restated Certificate</I></B>&#148; means this Amended and Restated Certificate
of Incorporation of the Corporation (including any Preferred Stock Designation, as defined below), as may be further amended and restated from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.3 &#147;<B><I>Asset Transfer</I></B>&#148; means a sale, lease, exclusive license or other disposition of all or substantially all of the assets of the
Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.4 &#147;<B><I>Board</I></B>&#148; means the Board of Directors of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.5 &#147;<B><I>Class</I></B><B><I></I></B><B><I>&nbsp;B Stockholder</I></B>&#148; shall mean [(i) the registered holder of a share of Class&nbsp;B Common
Stock as of immediately upon the effectiveness of this Amended and Restated Certificate (the &#147;<B><I>Effective Time</I></B>&#148;) and (ii)&nbsp;each natural person who Transferred shares of Class&nbsp;B Common Stock prior to the Effective Time
to a Permitted Entity that, as of the Effective Time, complies with the applicable exception for such Permitted Entity in Section&nbsp;1.15 of this Article V]/[those persons who have the right to receive shares of Class&nbsp;B Common Stock pursuant
to that certain Business Combination Agreement dated as of September&nbsp;2, 2020 among Kensington Capital Acquisition Corp., a Delaware corporation, Kensington Capital Merger Sub Corp., a Delaware corporation and QuantumScape Corporation, a
Delaware corporation]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.6 &#147;<B><I>Disability</I></B>&#148; or &#147;<B><I>Disabled</I></B>&#148; means the permanent and total disability such that
an Excluded Party is unable to engage in any substantial gainful activity by reason of any medically determinable mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of
not less than 12 months as determined by a licensed medical practitioner.&nbsp;In the event of a dispute whether an Excluded Party has suffered a Disability, no Disability of the Excluded Party shall be deemed to have occurred unless and until an
affirmative ruling regarding such Disability has been made by a court of competent jurisdiction, and such ruling has become final and <FONT STYLE="white-space:nowrap">non-appealable.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.7 &#147;<B><I>Excluded Party</I></B>&#148; means any of Timothy Holme, Fritz Prinz and Jagdeep Singh. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.8 &#147;<B><I>Excluded Party Trustee</I></B>&#148; means a person, designated by an Excluded Party and approved by the Board, in his or her capacity as a
voting trustee pursuant to a written voting trust agreement entered into by such Excluded Party prior to his death or Disability, contingent and effective upon the death or Disability of such Excluded Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.9 &#147;<B><I>Family Member</I></B>&#148; means, with respect to a natural person, whether related by blood or marriage, (i)&nbsp;such natural person&#146;s
spouse, <FONT STYLE="white-space:nowrap">ex-spouse</FONT> or domestic partner; (ii)&nbsp;such natural person&#146;s parents and grandparents; (iii)&nbsp;such natural person&#146;s siblings; (iv)&nbsp;such natural person&#146;s children and other
lineal descendants; and (v)&nbsp;the lineal descendants of such natural person&#146;s siblings. Lineal descendants shall include adopted persons, but only so long as they are adopted during minority, and step-children. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.10 &#147;<B><I>Final Conversion Date</I></B>&#148; means: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a)
the date fixed by the Board that is no less than 61 days and no more than 180 days following the date that the total number of outstanding shares of Class&nbsp;B Common Stock held by the Excluded Parties and their Permitted Entities and Permitted
Transferees represents less than 20% of the number of shares of Class&nbsp;B Common Stock (as equitably adjusted for any stock dividend, stock split, combination of shares, reorganization, recapitalization, reclassification or other similar event)
outstanding as of the Effective Time; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) the date that is the earlier of (i)&nbsp;nine (9) months after the death or Disability of the last to die or
become Disabled of the Excluded Parties and (ii)&nbsp;the date upon which such Excluded Party Trustee ceases to hold exclusive Voting Control over such shares of Class&nbsp;B Common Stock; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) the date specified by (i)&nbsp;the holders of a majority of the then outstanding shares of Class&nbsp;B Common Stock, voting as a separate class, or in an
affirmative written election executed by the holders of a majority of the then </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exh. <FONT
STYLE="white-space:nowrap">B-3</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
outstanding shares of Class&nbsp;B Common Stock and (ii)&nbsp;all of the Excluded Parties (but excluding any Excluded Party who is then deceased or Disabled or who, individually or through his
Permitted Entities or Permitted Transferees, holds less than 20% of the aggregate number of shares of Class&nbsp;B Common Stock that were held by such Excluded Party, individually or through his Permitted Entities or Permitted Transferees, as of the
Effective Time (as equitably adjusted for any stock dividend, stock split, combination of shares, reorganization, recapitalization, reclassification or other similar event)). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.11 &#147;<B><I>Liquidation Event</I></B>&#148; means any liquidation, dissolution, or winding up of the Corporation, whether voluntary or involuntary, or
any Acquisition or Asset Transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.12 &#147;<B><I>Listing Standards</I></B>&#148; means (i)&nbsp;the requirements of any national stock exchange under
which the Corporation&#146;s equity securities are listed for trading that are generally applicable to companies with common equity securities listed thereon or (ii)&nbsp;if the Corporation&#146;s equity securities are not listed for trading on a
national stock exchange, the requirements of the New York Stock Exchange generally applicable to companies with equity securities listed thereon. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.13
&#147;<B><I>Parent</I></B>&#148; of an entity means any entity that directly or indirectly owns or controls a majority of the voting power of the voting securities of such entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.14 &#147;<B><I>Permitted Entity</I></B>&#148; means (i)&nbsp;with respect to any Class&nbsp;B Stockholder, any trust, account, plan, corporation,
partnership, or limited liability company specified in Article V, Section&nbsp;1.15(b) established by or for such Class&nbsp;B Stockholder, so long as such entity meets the requirements set forth in Article V, Section&nbsp;1.15, (ii) a trust which
may be revoked by an Excluded Party, so long as the Excluded Party, respectively, remains a trustee or <FONT STYLE="white-space:nowrap">co-trustee</FONT> thereof and has sole voting power with respect to shares of the Corporation held by such trust,
(iii)&nbsp;the Bill&nbsp;&amp; Melinda Gates Foundation Asset Trust, so long as Bill Gates remains a trustee or <FONT STYLE="white-space:nowrap">co-trustee</FONT> thereof, and (iv)&nbsp;any trust or entity settled or formed by an Excluded Party, for
the primary benefit of his respective Family Members, so long as either (a)&nbsp;the Excluded Party remains a trustee or <FONT STYLE="white-space:nowrap">co-trustee</FONT> and holds sole voting power with respect to shares of the Corporation held by
any such trust or (b)&nbsp;the Excluded Party has both the power to remove the trustee or <FONT STYLE="white-space:nowrap">co-trustees</FONT> and any individual(s) holding voting power of any such trust, and the power to replace any such removed
trustee, <FONT STYLE="white-space:nowrap">co-trustees,</FONT> or individual(s) with any individual or entity of his choosing, other than an individual who is a related or subordinate party to the Excluded Party within the meaning of Internal Revenue
Code Section&nbsp;672(c). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.14.1&nbsp;&#147;<B><I>Permitted Foundation</I></B>&#148; shall mean with respect to a Class&nbsp;B Stockholder a domestic
U.S. charitable organization, foundation or similar entity, that was established by a Class&nbsp;B Stockholder and is intended to be <FONT STYLE="white-space:nowrap">tax-exempt</FONT> under the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.15 &#147;<B><I>Permitted Transfer</I></B>&#148; means </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) a
Transfer of Class&nbsp;B Common Stock by a Class&nbsp;B Stockholder or such Class&nbsp;B Stockholder&#146;s Permitted Entities to another Class&nbsp;B Stockholder or such Class&nbsp;B Stockholder&#146;s Permitted Entities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) a Transfer by a Class&nbsp;B Stockholder to any[ Permitted Entity, including by not limited to any] of the following Permitted Entities, and from any of
the Permitted Entities back to such Class&nbsp;B Stockholder and/or any other Permitted Entity by or for such Class&nbsp;B Stockholder: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) a trust for
the benefit of such Class&nbsp;B Stockholder and for the benefit of no other person, provided such Transfer does not involve any payment of cash, securities, property or other consideration (other than an interest in such trust) to the Class&nbsp;B
Stockholder; and, provided, further, that in the event such Class&nbsp;B Stockholder is no longer the exclusive beneficiary of such trust, each share of Class&nbsp;B Common Stock then held by such trust shall automatically convert into one
(1)&nbsp;fully paid and nonassessable share of Class&nbsp;A Common Stock; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) a trust for the benefit of persons other than the Class&nbsp;B Stockholder
so long as the Class&nbsp;B Stockholder has exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such trust, provided such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exh. <FONT
STYLE="white-space:nowrap">B-4</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Transfer does not involve any payment of cash, securities, property or other consideration (other than an interest in such trust) to the Class&nbsp;B Stockholder;
and,<I>&nbsp;provided</I>,<I>&nbsp;further</I>, that in the event the Class&nbsp;B Stockholder no longer has exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such trust, each share of Class&nbsp;B Common Stock
then held by such trust shall automatically convert into one (1)&nbsp;fully paid and nonassessable share of Class&nbsp;A Common Stock; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iii) a trust
under the terms of which such Class&nbsp;B Stockholder has retained a &#147;qualified interest&#148; within the meaning of &#167;2702(b)(1) of the Internal Revenue Code (the &#147;<B><I>Code</I></B>&#148;) and/or a reversionary interest so long as
the Class&nbsp;B Stockholder has exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such trust;<I>&nbsp;provided</I>,<I>&nbsp;however</I>, that in the event the Class&nbsp;B Stockholder no longer has exclusive
Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such trust, each share of Class&nbsp;B Common Stock then held by such trust shall automatically convert into one (1)&nbsp;fully paid and nonassessable share of
Class&nbsp;A Common Stock; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;an Individual Retirement Account, as defined in Section&nbsp;408(a)&nbsp;of the Code, or a pension, profit sharing,
stock bonus or other type of plan or trust of which such Class&nbsp;B Stockholder is a participant or beneficiary and which satisfies the requirements for qualification under Section&nbsp;401 of the Code;<I>&nbsp;provided</I>&nbsp;that in each case
such Class&nbsp;B Stockholder has exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held in such account, plan or trust, and<I>&nbsp;provided</I>,<I>&nbsp;further</I>, that in the event the Class&nbsp;B Stockholder no
longer has exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such account, plan or trust, each share of Class&nbsp;B Common Stock then held by such trust shall automatically convert into one (1)&nbsp;fully paid
and nonassessable share of Class&nbsp;A Common Stock; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(v) a corporation in which such Class&nbsp;B Stockholder directly, or indirectly through one or
more Permitted Entities, owns shares with sufficient Voting Control in the corporation, or otherwise has legally enforceable rights, such that the Class&nbsp;B Stockholder retains exclusive Voting Control with respect to the shares of Class&nbsp;B
Common Stock held by such corporation;<I>&nbsp;provided</I>&nbsp;that in the event the Class&nbsp;B Stockholder no longer owns sufficient shares or has sufficient legally enforceable rights to enable the Class&nbsp;B Stockholder to retain exclusive
Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such corporation, each share of Class&nbsp;B Common Stock then held by such corporation shall automatically convert into one (1)&nbsp;fully paid and nonassessable share
of Class&nbsp;A Common Stock; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(vi) a partnership in which such Class&nbsp;B Stockholder directly, or indirectly through one or more Permitted Entities,
owns partnership interests with sufficient Voting Control in the partnership, or otherwise has legally enforceable rights, such that the Class&nbsp;B Stockholder retains exclusive Voting Control with respect to the shares of Class&nbsp;B Common
Stock held by such partnership;<I>&nbsp;provided</I>&nbsp;that in the event the Class&nbsp;B Stockholder no longer owns sufficient partnership interests or has sufficient legally enforceable rights to enable the Class&nbsp;B Stockholder to retain
exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such partnership, each share of Class&nbsp;B Common Stock then held by such partnership shall automatically convert into one (1)&nbsp;fully paid and
nonassessable share of Class&nbsp;A Common Stock; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(vii) a limited liability company in which such Class&nbsp;B Stockholder directly, or indirectly
through one or more Permitted Entities, owns membership or limited liability company interests with sufficient Voting Control in the limited liability company, or otherwise has legally enforceable rights, such that the Class&nbsp;B Stockholder
retains exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such limited liability company;<I>&nbsp;provided</I>&nbsp;that in the event the Class&nbsp;B Stockholder no longer owns sufficient membership or limited
liability company interests or has sufficient legally enforceable rights to enable the Class&nbsp;B Stockholder to retain exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such limited liability company, each
share of Class&nbsp;B Common Stock then held by such limited liability company shall automatically convert into one (1)&nbsp;fully paid and nonassessable share of Class&nbsp;A Common Stock; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(viii) a Permitted Foundation so long as the Class&nbsp;B Stockholder has exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock
held by such Permitted Foundation, provided such Transfer does not involve </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exh. <FONT
STYLE="white-space:nowrap">B-5</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any payment of cash, securities, property or other consideration (other than an interest in such Permitted Foundation) to the Class&nbsp;B Stockholder;
and,<I>&nbsp;provided</I>,<I>&nbsp;further</I>, that in the event the Class&nbsp;B Stockholder no longer has exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such Permitted Foundation, each share of
Class&nbsp;B Common Stock then held by such Permitted Foundation shall automatically convert into one (1)&nbsp;fully paid and nonassessable share of Class&nbsp;A Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, to the extent any shares are deemed to be held by a trustee of a trust described in (i), (ii) or (iii)&nbsp;above, the Transfer
shall be a Permitted Transfer and the trustee shall be deemed a Permitted Entity so long as the other requirements of (i), (ii) or (iii)&nbsp;above, as the case may be, are otherwise satisfied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.16 &#147;<B><I>Permitted Transferee</I></B>&#148; means a transferee of shares of Class&nbsp;B Common Stock, or rights or interests therein, received in a
Transfer that constitutes a Permitted Transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.17 &#147;<B><I>Qualified Stockholder</I></B>&#148; means (a)&nbsp;any registered holder of a share of
Class&nbsp;B Common Stock as of the Effective Time; (b)&nbsp;any Permitted Transferee; and (c)&nbsp;the initial registered holder of any shares of Class&nbsp;B Common Stock that are originally issued by the Corporation after the Effective Time in
compliance with this Amended and Restated Certificate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.18 &#147;<B><I>Securities Exchange</I></B>&#148; means the New York Stock Exchange, the Nasdaq
Stock Market or any successor markets or exchanges. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.19 &#147;<B><I>Transfer</I></B>&#148; of a share of Class&nbsp;B Common Stock shall mean any sale,
assignment, transfer, conveyance, hypothecation or other transfer or disposition of such share or any legal or beneficial interest in such share, whether or not for value and whether voluntary or involuntary or by operation of law, whether directly
or indirectly, including by merger, consolidation or otherwise.&nbsp;A &#147;<B><I>Transfer</I></B>&#148; shall also include, without limitation, a transfer of a share of Class&nbsp;B Common Stock to a broker or other nominee (regardless of whether
or not there is a corresponding change in beneficial ownership), or the transfer of, or entering into a binding agreement with respect to, Voting Control over a share of Class&nbsp;B Common Stock by proxy or
otherwise;<I>&nbsp;provided</I>,<I>&nbsp;however</I>, that the following shall not be considered a &#147;<B><I>Transfer</I></B>&#148; within the meaning of this Article V, Section&nbsp;1.19: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) the granting of a proxy to officers or directors of the Corporation, or to other persons approved by the Board at the request of the Board in connection
with actions to be taken at an annual or special meeting of stockholders; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b)&nbsp;entering into a voting trust, agreement or arrangement (with or
without granting a proxy), or consummating the actions or transactions contemplated therein, solely with stockholders who are Class&nbsp;B Stockholders, that (i)&nbsp;is disclosed either in a Schedule 13D filed with the Securities and Exchange
Commission or in writing to the Secretary of the Corporation, (ii)&nbsp;either has a term not exceeding one (1)&nbsp;year or is terminable by the Class&nbsp;B Stockholder at any time and (iii)&nbsp;does not involve any payment of cash, securities,
property or other consideration to the Class&nbsp;B Stockholder other than the mutual promise to vote shares in a designated manner; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) the pledge of
shares of Class&nbsp;B Common Stock by a Class&nbsp;B Stockholder that creates a mere security interest in such shares pursuant to a bona fide loan or indebtedness transaction so long as the Class&nbsp;B Stockholder continues to exercise Voting
Control over such pledged shares;<I>&nbsp;provided</I>,<I>&nbsp;however</I>, that a foreclosure on such shares of Class&nbsp;B Common Stock or other similar action by the pledgee shall constitute a &#147;<B><I>Transfer</I></B>;&#148;[and] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) entering into any agreement with respect to supporting or voting in favor of or tendering shares with respect to any transaction proposed to be
consummated by the Corporation, or consummating the actions or transactions contemplated therein (including, without limitation, tendering shares of Class&nbsp;B Common Stock or voting such shares in favor of such transaction or in opposition to
other proposals that may be expected to delay or impair the ability to consummate such transaction), if the entry into such support or voting agreement is approved by the Board[;][.]</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[(e) granting a proxy by an Excluded Party, such Excluded Party&#146;s Permitted Entities or such Excluded Party&#146;s Permitted Transferees to another
Excluded Party to exercise Voting Control of shares of Class&nbsp;B Common Stock </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exh. <FONT
STYLE="white-space:nowrap">B-6</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
owned directly or indirectly, beneficially and of record, by such granting Excluded Party, such granting Excluded Party&#146;s Permitted Entities or such granting Excluded Party&#146;s Permitted
Transferees, and the exercise of such proxy by such other Excluded Party; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(f) granting a proxy by an Excluded Party, such Excluded Party&#146;s Permitted
Entities or such Excluded Party&#146;s Permitted Transferees to a person designated by such Excluded Party and approved by the Board, to exercise Voting Control of shares of Class&nbsp;B Common Stock owned directly or indirectly, beneficially and of
record, by such Excluded Party, such Excluded Party&#146;s Permitted Entities or such Excluded Party&#146;s Permitted Transferees, or over which such Excluded Party has Voting Control pursuant to proxy or voting agreements then in place, effective
either (i)&nbsp;on the death of such Excluded Party or (ii)&nbsp;during any Disability of such Excluded Party, including the exercise of such proxy by such person; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(g) entering into a trading plan pursuant to Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Securities Exchange Act of 1934, as amended, with a
broker or other nominee;<I>&nbsp;provided, however</I>, that a sale of such shares of Class&nbsp;B Common Stock pursuant to such plan shall constitute a &#147;<B><I>Transfer</I></B>&#148; at the time of such sale; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(h) the fact that the spouse of any Qualified Stockholder possesses or obtains an interest in such holder&#146;s shares of Class&nbsp;B Common Stock arising
solely by reason of the application of the community property laws of any jurisdiction, so long as no other event or circumstance shall exist or have occurred that constitutes a &#147;<B><I>Transfer</I></B>&#148; that is not a Permitted Transfer.]
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.20 &#147;<B><I>Voting Control</I></B>&#148; means the power to vote or direct the voting of the applicable voting security by proxy, voting agreement
or otherwise[;<I>&nbsp;provided</I>&nbsp;that, in the case of an Excluded Party and solely for purposes of Article V, Section&nbsp;1.15(b)(i) &#150; (iv), an Excluded Party shall be deemed to have exclusive Voting Control with respect to the shares
of Class&nbsp;B Common Stock if such Excluded Party has the power to terminate, remove or replace any person or entity having Voting Control over the applicable shares of Class&nbsp;B Common Stock]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.21 &#147;<B><I>Whole Board</I></B>&#148; means the total number of authorized directors whether or not there exist any vacancies or unfilled seats in
previously authorized directorships. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.<U>&nbsp;Identical Rights</U>. Except as otherwise provided in this Amended and Restated Certificate or required
by applicable law, shares of Common Stock shall have the same rights and powers, rank equally (including, without limitation, as to any dividends and distributions, any liquidation, dissolution or winding up of the Corporation and any voting of such
shares), share ratably and be identical in all respects as to all matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.<U>&nbsp;Dividends and Distributions.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.1 Subject to the prior rights of holders of all classes and series of stock at the time outstanding having prior rights as to dividends and subject to
Section&nbsp;3.2, the holders of the Common Stock shall be entitled to receive, when, as and if declared by the Board, out of any assets of the Corporation legally available therefor, such dividends as may be declared from time to time by the Board.
Any dividends paid to the holders of shares of Common Stock shall be paid pro rata, on an equal priority, pari passu basis, unless different treatment of the shares of any such class or series is approved by the affirmative vote of the holders of a
majority of the voting power of the outstanding shares of such applicable class or series of Common Stock treated adversely, voting separately as a class. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.2 The Corporation shall not declare or pay any dividend or make any other distribution to the holders of Common Stock payable in securities of the
Corporation unless the same dividend or distribution with the same record date and payment date shall be declared and paid on all shares of Common Stock, unless different treatment of the shares of Class&nbsp;A Common Stock or Class&nbsp;B Common
Stock, as applicable, is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class&nbsp;A Common Stock and Class&nbsp;B Common Stock, each voting separately as a
class;<I>&nbsp;provided</I>,<I>&nbsp;however</I>, that (i)&nbsp;dividends or other distributions </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exh. <FONT
STYLE="white-space:nowrap">B-7</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
payable in shares of Class&nbsp;A Common Stock or rights to acquire shares of Class&nbsp;A Common Stock may be declared and paid to the holders of Class&nbsp;A Common Stock without the same
dividend or distribution being declared and paid to the holders of the Class&nbsp;B Common Stock if, and only if, a dividend payable in shares of Class&nbsp;B Common Stock, or rights to acquire shares of Class&nbsp;B Common Stock, is declared and
paid to the holders of Class&nbsp;B Common Stock at the same rate and with the same record date and payment date; and (ii)&nbsp;dividends or other distributions payable in shares of Class&nbsp;B Common Stock or rights to acquire shares of
Class&nbsp;B Common Stock may be declared and paid to the holders of Class&nbsp;B Common Stock without the same dividend or distribution being declared and paid to the holders of the Class&nbsp;A Common Stock if, and only if, a dividend payable in
shares of Class&nbsp;A Common Stock, or rights to acquire shares of Class&nbsp;A Common Stock, is declared and paid to the holders of Class&nbsp;A Common Stock at the same rate and with the same record date and payment date;
and<I>&nbsp;provided</I>,<I>&nbsp;further</I>, that nothing in the foregoing shall prevent the Corporation from declaring and paying dividends or other distributions payable in shares of one class of Common Stock or rights to acquire one class of
Common Stock to holders of all classes of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.3 If the Corporation in any manner subdivides or combines the outstanding shares of
Class&nbsp;A Common Stock or Class&nbsp;B Common Stock, then the outstanding shares of all Common Stock will be subdivided or combined in the same proportion and manner, unless different treatment of the shares of Class&nbsp;A Common Stock or
Class&nbsp;B Common Stock, as applicable, is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class&nbsp;A Common Stock and Class&nbsp;B Common Stock, each voting separately as a class. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.<U>&nbsp;Voting Rights.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.1<U>&nbsp;Common Stock</U>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a)<U>&nbsp;Class A Common Stock</U>. Each holder of shares of Class&nbsp;A Common Stock will be entitled to one vote for each share thereof held at the
record date for the determination of the stockholders entitled to vote on such matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b)<U>&nbsp;Class B Common Stock</U>. Each holder of shares of
Class&nbsp;B Common Stock will be entitled to ten votes for each share thereof held at the record date for the determination of the stockholders entitled to vote on such matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.2<U>&nbsp;General</U>. Except as otherwise expressly provided herein or as required by law, the holders of Class&nbsp;A Common Stock and Class&nbsp;B Common
Stock will vote together as a single class and not as separate series or classes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.3<U>&nbsp;Authorized Shares</U>. The number of authorized shares of
Common Stock or any class or series thereof may be increased or decreased (but not below (i)&nbsp;the number of shares of Common Stock or, in the case of a class or series of Common Stock, such class or series, then outstanding plus (ii)&nbsp;with
respect to Class&nbsp;A Common Stock, the number of shares reserved for issuance pursuant to Article V, Section&nbsp;9) by the affirmative vote of the holders of a majority of the voting power of the Class&nbsp;A Common Stock and Class&nbsp;B Common
Stock, voting together as a single class, irrespective of the provisions of Section&nbsp;242(b)(2) of the Delaware General Corporation Law;<I>&nbsp;provided</I>&nbsp;that the number of authorized shares of Class&nbsp;B Common Stock shall not be
increased or decreased without the affirmative vote of the holders of a majority of the outstanding shares of Class&nbsp;B Common Stock, voting as a separate class. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.4<U>&nbsp;Election of Directors</U>. Subject to any rights of the holders of any series of Preferred Stock to elect directors under circumstances specified
in this Amended and Restated Certificate (as modified by any Preferred Stock Designation), (i) prior to the Final Conversion Date, the holders of Class&nbsp;A Common Stock and Class&nbsp;B Common Stock, voting together as a single class, shall be
entitled to elect and remove all directors of the Corporation, and (ii)&nbsp;from and after the Final Conversion Date, if any, the holders of Common Stock, voting together as a single class, shall be entitled to elect and remove all directors of the
Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exh. <FONT
STYLE="white-space:nowrap">B-8</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.<U>&nbsp;Liquidation Rights</U>. In the event of a Liquidation Event in connection with which the Board
has determined to effect a distribution of assets of the Corporation to any holder or holders of Common Stock, then, subject to the rights of any Preferred Stock that may then be outstanding, the assets of the Corporation legally available for
distribution to stockholders shall be distributed on an equal priority, pro rata basis (based on the number of shares of Common Stock held by each) to the holders of Common Stock, unless different treatment of the shares of each such class or series
of Common Stock is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class&nbsp;A Common Stock and Class&nbsp;B Common Stock, each voting separately as a class;<I>&nbsp;provided</I>,<I>&nbsp;however</I>, that
for the avoidance of doubt, payments to be made or received by a holder of Common Stock in connection with any such Liquidation Event pursuant to any employment, consulting, severance or similar services arrangement shall not be deemed to be a
distribution for the purpose of this Article V, Section&nbsp;5;<I></I><I>&nbsp;provided</I>,<I>&nbsp;further, however</I>, that shares of such classes may receive, or have the right to elect to receive, different or disproportionate consideration in
connection with such Liquidation Event if the only difference in the per share consideration to the holders of the Class&nbsp;A Common Stock and Class&nbsp;B Common Stock is that any securities distributed to the holder of a share of Class&nbsp;B
Common Stock have ten (10)&nbsp;times the voting power of any securities distributed to the holder of a share of Class&nbsp;A Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.<U>&nbsp;Conversion of the Class</U><U></U><U>&nbsp;B Common Stock</U>. The Class&nbsp;B Common Stock will be convertible into Class&nbsp;A Common Stock as
follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.1 Each share of Class&nbsp;B Common Stock will automatically convert into one fully paid and nonassessable share of Class&nbsp;A Common Stock
on the Final Conversion Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.2 With respect to any holder of Class&nbsp;B Common Stock, each share of Class&nbsp;B Common Stock held by such holder
will automatically be converted into one fully paid and nonassessable share of Class&nbsp;A Common Stock, as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) at the option of the holder
thereof at any time upon written notice to the transfer agent of the Corporation or, if such written notice specifies a later time, or the happening of a future event for such conversion, upon such time or the happening of such event; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) on the occurrence of a Transfer of such share of Class&nbsp;B Common Stock, other than a Permitted Transfer; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) upon the death of such Class&nbsp;B Stockholder, or solely with respect to each share of Class&nbsp;B Common Stock held of record by an Excluded Party, or
by an Excluded Party&#146;s Permitted Entities, upon the death or Disability of such Excluded Party;<I>&nbsp;provided</I>,<I>&nbsp;however</I>, that, with respect to the shares of Class&nbsp;B Common Stock held of record by such Excluded Party or
such Excluded Party&#146;s Permitted Entities, each share of Class&nbsp;B Common Stock held of record by an Excluded Party or an Excluded Party&#146;s Permitted Entities shall automatically convert into one (1)&nbsp;fully paid and nonassessable
share of Class&nbsp;A Common Stock upon that date which is the earlier of: (i)&nbsp;nine (9)&nbsp;months after the date of death or Disability of such Excluded Party, and (ii)&nbsp;the date upon which such Excluded Party Trustee ceases to hold
exclusive Voting Control over such shares of Class&nbsp;B Common Stock; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.3 Each outstanding share of Class&nbsp;B Common Stock shall automatically be
converted into one fully-paid, nonassessable share of Class&nbsp;A Common Stock as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) upon the affirmative vote or written consent of the
holders of a majority of the Class&nbsp;B Common Stock then outstanding, voting as a single class or, if later, the effective date for such conversion specified by such vote or written consent; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) upon the affirmative vote or written consent of the holders of a majority of the Class&nbsp;B Common Stock then outstanding and held by the Excluded
Parties and Permitted Entities of the Excluded Parties, or, if later, the effective date for such conversion specified by such vote or written consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.<U>&nbsp;Procedures</U>. The Corporation may, from time to time, establish such policies and procedures relating to the conversion of the Class&nbsp;B
Common Stock into Class&nbsp;A Common Stock and the general administration of this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exh. <FONT
STYLE="white-space:nowrap">B-9</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
dual-class stock structure, including the issuance of stock certificates with respect thereto, as it may deem necessary or advisable, and may from time to time request that holders of shares of
Class&nbsp;B Common Stock furnish certifications, affidavits or other proof to the Corporation as it deems necessary to verify the ownership of Class&nbsp;B Common Stock and to confirm that a conversion to Class&nbsp;A Common Stock has not occurred.
A determination by the Corporation as to whether or not a Transfer has occurred and results in a conversion to Class&nbsp;A Common Stock, or as to whether or not another conversion contemplated in the foregoing Section&nbsp;6 of this Article V has
occurred, shall be conclusive and binding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.<U>&nbsp;Effect of Conversion</U>. In the event of a conversion of shares of Class&nbsp;B Common Stock into
shares of Class&nbsp;A Common Stock pursuant to Article V, Section&nbsp;6, such conversion shall be deemed to have been made at the time that the Corporation&#146;s transfer agent receives the written notice required pursuant to Article V,
Section&nbsp;6.2(a)&nbsp;(or a later date specified by such notice), the time of the affirmative vote or written consent of the applicable holders of Class&nbsp;B Common Stock pursuant to Article V, Sections 6.3(a) or 6.3(b)&nbsp;(or a later date
specified by such vote or written consent), the time that the Transfer of such shares occurred or the death or Disability of the Class&nbsp;B Stockholder or as otherwise provided in Article V, Section&nbsp;6.2(c), as applicable.&nbsp;Upon any
conversion of Class&nbsp;B Common Stock to Class&nbsp;A Common Stock, all rights of the holder of such shares of Class&nbsp;B Common Stock shall cease and the person or persons in whose name or names the&nbsp;certificate or certificates representing
the shares of Class&nbsp;B Common Stock are to be issued, if any, shall be treated for all purposes as having become the record holder or holders of such number of shares of Class&nbsp;A Common Stock into which such Class&nbsp;B Common Stock were
convertible.&nbsp;Shares of Class&nbsp;B Common Stock that are converted into shares of Class&nbsp;A Common Stock as provided in Article V, Section&nbsp;6 shall be retired and shall not be reissued. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.<U>&nbsp;Reservation of Stock Issuable Upon Conversion</U>. The Corporation will at all times reserve and keep available out of its authorized but unissued
shares of Class&nbsp;A Common Stock, solely for the purpose of effecting the conversion of the shares of the Class&nbsp;B Common Stock such number of its shares of Class&nbsp;A Common Stock as shall from time to time be sufficient to effect the
conversion of all outstanding shares of Class&nbsp;B Common Stock; and if at any time the number of authorized but unissued shares of Class&nbsp;A Common Stock will not be sufficient to effect the conversion of all then-outstanding shares of
Class&nbsp;B Common Stock, the Corporation will take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Class&nbsp;A Common Stock into such number of shares as will be
sufficient for such purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.<U>&nbsp;Preemptive Rights</U>. No stockholder of the Corporation shall have a right to purchase shares of capital stock
of the Corporation sold or issued by the Corporation except to the extent that such a right may from time to time be set forth in a written agreement between the Corporation and a stockholder. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.<U>&nbsp;Rights of
Preferred Stock</U>. The Board is authorized, subject to any limitations prescribed by law or in any Preferred Stock Designation, to provide for the issuance of shares of Preferred Stock in series, and by filing a certificate pursuant to the
applicable law of the State of Delaware (such certificate being hereinafter referred to as a &#147;<B><I>Preferred Stock Designation</I></B>&#148;), to establish from time to time the number of shares to be included in each such series, and to fix
the designation, powers, preferences, and rights of the shares of each such series and any qualifications, limitations or restrictions thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.<U>&nbsp;Vote to Increase or Decrease Authorized Shares</U>. The number of authorized shares of Preferred Stock may be increased or decreased (but not below
the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority of the voting power of all of the outstanding shares of stock of the Corporation entitled to vote thereon, without a vote of the holders of the
Preferred Stock, or of any series thereof, unless a vote of any such holders is required pursuant to the terms of any Preferred Stock Designation, irrespective of the provisions of Section&nbsp;242(b)(2) of the Delaware General Corporation Law. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exh. <FONT
STYLE="white-space:nowrap">B-10</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.<U>&nbsp;Number of Directors; Election; Term</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) Subject
to the rights of holders of any series of Preferred Stock with respect to the election of directors, the number of directors that constitutes the entire Board of the Corporation shall be fixed solely by resolution of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) Each director shall be elected to hold office for a <FONT STYLE="white-space:nowrap">one-year</FONT> term expiring at the next annual meeting of
stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding the foregoing provisions of this Article VII, Section&nbsp;1, and subject to the rights of holders of any series of
Preferred Stock with respect to the election of directors, each director shall serve until his or her successor is duly elected and qualified or until his or her earlier death, resignation, or removal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) If the number of directors is increased at or following the 2021 annual meeting of stockholders, any additional director elected to fill a newly created
directorship shall hold office for a term expiring at the next annual meeting of stockholders. In no case shall a decrease in the number of directors remove or shorten the term of any incumbent director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) Elections of directors need not be by written ballot unless the Bylaws of the Corporation shall so provide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.<U>&nbsp;Vacancies and Newly Created Directorships</U>. Subject to the rights of holders of any series of Preferred Stock with respect to the election of
directors, and except as may be permitted in the specific case by resolution of a majority of the Whole Board, vacancies occurring on the Board for any reason and newly created directorships resulting from an increase in the authorized number of
directors may be filled only by vote of a majority of the remaining members of the Board, although less than a quorum, or by a sole remaining director, and not by stockholders. A person so elected by the Board to fill a vacancy or newly created
directorship shall hold office until the next election of the class for which such director shall have been assigned by the Board and until his or her successor shall be duly elected and qualified. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following provisions
are inserted for the management of the business and the conduct of the affairs of the Corporation, and for further definition, limitation and regulation of the powers of the Corporation and of its directors and stockholders: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.<U>&nbsp;Board Power</U>. The business and affairs of the Corporation shall be managed by or under the direction of the Board. In addition to the powers and
authority expressly conferred by statute or by this Amended and Restated Certificate or the Bylaws of the Corporation, the Board is hereby empowered to exercise all such powers and do all such acts and things as may be exercised or done by the
Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.<U>&nbsp;Written Ballot</U>. Elections of directors need not be by written ballot unless otherwise provided in the Bylaws of the
Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.<U>&nbsp;Amendment of Bylaws</U>. In furtherance and not in limitation of the powers conferred by the Delaware General Corporation Law,
the Board is expressly authorized to adopt, amend or repeal the Bylaws of the Corporation.&nbsp;The Bylaws of the Corporation may also be adopted, amended or repealed by the stockholders entitled to vote;<I>&nbsp;provided</I>,<I>&nbsp;however</I>,
that the affirmative vote of holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the total voting power of the outstanding voting securities of the Corporation, voting together as a single class, shall be required for the
stockholders to alter, amend or repeal the Bylaws of the Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exh. <FONT
STYLE="white-space:nowrap">B-11</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.<U>&nbsp;Special Meetings</U>. Special meetings of the stockholders may be called only by (i)&nbsp;the
Board pursuant to a resolution adopted by a majority of the Whole Board; (ii)&nbsp;the chair of the Board; [or] (iii)&nbsp;the chief executive officer of the Corporation; or (iv)&nbsp;prior to the Final Conversion Date, the holders of at least
[&nbsp;&nbsp;&nbsp;&nbsp; ] percent ([&nbsp;&nbsp;&nbsp;&nbsp;]%) of the voting power of the Class&nbsp;A Common Stock and Class&nbsp;B Common Stock, voting together as a single class and acting in compliance with the Bylaws of the Corporation. A
special meeting of stockholders may not be called by any other person or persons, and except as set forth above, any power of stockholders to call a special meeting of stockholders is specifically denied. The Board pursuant to a resolution adopted
by a majority of the Whole Board, or the chair of a meeting of stockholders, may cancel, postpone or reschedule any previously scheduled meeting of stockholders called pursuant to clauses (i)&nbsp;through (iii) at any time, before or after the
notice for such meeting has been sent to stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.<U>&nbsp;Stockholder Action by Written Consent</U>. Except for the rights of the holders of any
series of Preferred Stock, from and after the Final Conversion Date, any action required or permitted to be taken by the stockholders of the Corporation must be effected at a duly called annual or special meeting of stockholders of the Corporation
and may not be effected by any consent in writing by such stockholders. Subject to the rights of the holders of any series of Preferred Stock, before the Final Conversion Date, any action required or permitted to be taken by the stockholders of the
Corporation may be taken without a meeting only if the action is first recommended or approved by a majority of the Whole Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.<U>&nbsp;No Cumulative
Voting</U>. No stockholder will be permitted to cumulate votes at any election of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.<U>&nbsp;Advance Notice</U>. Advance notice of stockholder
nominations for the election of directors and of business to be brought by stockholders before any meeting of the stockholders of the Corporation shall be given in the manner provided in the Bylaws of the Corporation. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the fullest extent
permitted by law, no director of the Corporation shall be personally liable for monetary damages for breach of fiduciary duty as a director. Without limiting the effect of the preceding sentence, if the Delaware General Corporation Law is hereafter
amended to authorize the further elimination or limitation of the liability of a director, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent permitted by the Delaware General Corporation Law, as
so amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither any amendment, repeal nor elimination of this Article IX, nor the adoption of any provision of this Amended and Restated Certificate
inconsistent with this Article IX, shall eliminate, reduce or otherwise adversely affect any limitation on the personal liability of a director of the Corporation existing at the time of such amendment, repeal, elimination or adoption of such an
inconsistent provision. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE X </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any provision of this Amended and Restated Certificate becomes or is declared on any ground by a court of competent jurisdiction to be illegal,
unenforceable or void, portions of such provision, or such provision in its entirety, to the extent necessary, shall be severed from this Amended and Restated Certificate, and the court will replace such illegal, void or unenforceable provision of
this Amended and Restated Certificate with a valid and enforceable provision that most accurately reflects the Corporation&#146;s intent, in order to achieve, to the maximum extent possible, the same economic, business and other purposes of the
illegal, void or unenforceable provision. The balance of this Amended and Restated Certificate shall be enforceable in accordance with its terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except
as provided in Article IX above, the Corporation reserves the right to amend, alter, change or repeal any provision contained in this Amended and Restated Certificate, in the manner now or hereafter prescribed by
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exh. <FONT
STYLE="white-space:nowrap">B-12</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
statute, and all rights conferred upon stockholders herein are granted subject to this reservation;<I></I><I> provided</I>,<I></I><I> however</I>, that, notwithstanding any other provision of
this Amended and Restated Certificate or any provision of law that might otherwise permit a lesser vote, but in addition to any vote of the holders of any class or series of the stock of this Corporation required by law or by this Amended and
Restated Certificate, from and after the Final Conversion Date, the affirmative vote of the holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the voting power of the outstanding shares of stock of the Corporation entitled to
vote generally in the election of directors, voting together as a single class, shall be required to amend or repeal, or adopt any provision of this Amended and Restated Certificate inconsistent with, Article V, Article VI, Article VII, Article VIII
or this Article X. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exh. <FONT
STYLE="white-space:nowrap">B-13</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Key Company Stockholders </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">1.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capricorn-Libra Investment Group, L.P.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">2.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fritz Prinz</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Friedrich Prinz and Jagdeep Singh, Trustees of the Benedikt F. Prinz 2019 Trust dated
June&nbsp;17, 2019</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">4.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Friedrich Prinz and Jagdeep Singh, Trustees of the Marie Helene Prinz 2019 Trust dated
June&nbsp;17, 2019</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">5.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Friedrich Prinz, Trustee of the Friedrich Prinz Annuity Trust dated August&nbsp;31,
2020</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">6.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Friedrich Prinz, Trustee of the Gertrud Prinz Annuity Trust dated August&nbsp;31,
2020</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">7.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jagdeep Singh</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">8.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jagdeep Singh&nbsp;&amp; Roshni Singh, Trustees of the Singh Familiy Trust UDT dated
October&nbsp;3, 1996</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">9.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jagdeep Singh, Trustee of the Jagdeep Singh 2020 Annuity Trust A dated September&nbsp;1,
2020</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">10.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jagdeep Singh, Trustee of the Roshni Singh 2020 Annuity Trust A dated September&nbsp;1,
2020</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">11.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin Hettrich</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">12.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Khosla Ventures III, LP</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">13.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KPCB Holdings, Inc.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">14.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mike McCarthy</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">15.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Technology Impact Growth Fund, LP</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">16.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tejbir Singh Phool, Trustee of the&nbsp;Noor Deepika Singh 2013 Trust dated July&nbsp;31,
2013</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">17.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tejbir Singh Phool, Trustee of the Kismet Diya Singh 2013 Trust dated July&nbsp;31,
2013</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">18.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tejbir Singh Phool, Trustee of the Nageena Singh 2013 Trust dated July&nbsp;31, 2013</P></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">19.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Timothy Holme</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">20.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volkswagen Group of America Investments, LLC</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule A </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Company Knowledge Parties </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">1.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jagdeep Singh</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">2.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael McCarthy</P></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">3.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Timothy Holme</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule B </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 1 TO BUSINESS COMBINATION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Amendment No.&nbsp;1 to Business Combination Agreement dated as of September&nbsp;21, 2020 (this<B>&nbsp;&#147;Amendment&#148;</B>) is
among Kensington Capital Acquisition Corp., a Delaware corporation (<B>&#147;Kensington&#148;</B>), Kensington Capital Merger Sub Corp., a Delaware corporation and a wholly owned Subsidiary of Kensington (<B>&#147;Merger Sub&#148;</B>), and
QuantumScape Corporation, a Delaware corporation (the <B>&#147;Company&#148;</B>). Capitalized terms used but not defined in this Amendment have the meanings assigned to them in the Business Combination Agreement dated as of September&nbsp;2, 2020
(the <B>&#147;Business Combination Agreement&#148;</B>) among Kensington, Merger Sub and the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, pursuant to
Section&nbsp;10.12 of the Business Combination Agreement, the parties desire to amend the Business Combination Agreement as provided in this Amendment; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the respective boards of directors of Kensington, Merger Sub and the Company have approved this Amendment and the transactions
contemplated hereby; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the board of directors of each of Kensington and Merger Sub have approved this Amendment and declared
it advisable for Kensington and Merger Sub, respectively to enter into this Amendment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing,
the parties hereby agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 1. <U>Amendment to Kensington Certificate Amendment and Amended and Restated Kensington
Certificate</U>. The Amended and Restated Kensington Certificate shall be the certificate of incorporation as set forth on <U>Exhibit A</U> hereto, and the Kensington Certificate Amendment shall refer to Kensington amending and restating, effective
as of the Effective Time, its certificate of incorporation to be as set forth on <U>Exhibit A</U> hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 2. <U>Certificate of
Incorporation of the Surviving Corporation</U>. Section&nbsp;2.04(a) of the Business Combination Agreement is amended and restated to read in its entirety as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;(a) At the Effective Time, the certificate of incorporation of the Company, as in effect immediately prior to the Effective Time, shall
be the certificate of incorporation of the Surviving Corporation (except that the name of the Surviving Corporation shall be as designated by the Company prior to the Closing), until thereafter amended as provided by law and such certificate of
incorporation.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 3. <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Modification; Full Force and Effect</U>. Except as expressly modified and superseded by this Amendment, the terms, representations,
warranties, covenants and other provisions of the Business Combination Agreement are and shall continue to be in full force and effect in accordance with their respective terms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>References to the Business Combination Agreement</U>. Upon the entry into this Amendment, all references to &#147;this Agreement,&#148;
&#147;the transactions contemplated by this Agreement,&#148; the &#147;Business Combination Agreement&#148; and phrases of similar import, shall refer to the Business Combination Agreement as amended by this Amendment (it being understood that all
references to &#147;the date hereof&#148; or &#147;the date of this Agreement&#148; and phrases of similar import shall continue to refer to September&nbsp;2, 2020). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Other Miscellaneous Terms</U>. The provisions of Article X (General Provisions) of the Business Combination Agreement shall apply
<U>mutatis</U> <U>mutandis</U> to this Amendment, and to the Business Combination Agreement as modified by this Amendment, taken together as a single agreement, reflecting the terms therein as modified hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page Follows] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Amendment No.&nbsp;1 to Business
Combination Agreement to be duly executed and delivered as of the date first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">KENSINGTON CAPITAL ACQUISITION CORP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Justin Mirro</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Justin Mirro</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">KENSINGTON CAPITAL MERGER SUB CORP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Justin Mirro</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Justin Mirro</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">QUANTUMSCAPE CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jagdeep Singh</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Jagdeep Singh</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Executive Officer</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT A </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(see attached) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit A is omitted because the
Amended and Restated Certificate of Incorporation of Kensington is included separately as Annex B to this proxy statement/prospectus/information statement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="annex b"></A><A NAME="rom14810_71"></A>Annex B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL
ACQUISITION CORP. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kensington Capital Acquisition Corp., a Delaware corporation, hereby certifies that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. The Corporation was incorporated under the name Kensington Capital Acquisition Corp. The original Certificate of Incorporation of the Corporation was filed
with the Secretary of State of the State of Delaware on April&nbsp;17, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. The Amended and Restated Certificate of Incorporation of the Corporation
attached hereto as Exhibit&nbsp;A, which is incorporated herein by this reference, and which restates, integrates and further amends the provisions of the Certificate of Incorporation of this Corporation as heretofore amended and restated, has been
duly adopted by the Corporation&#146;s Board of Directors and by the stockholders in accordance with Sections&nbsp;242 and 245 of the General Corporation Law of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. This Amended and Restated Certificate of Incorporation of the Corporation shall be effective as of [___]&nbsp;A.M. Eastern Time
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Corporation has caused
this Amended and Restated Certificate of Incorporation to be signed by its duly authorized officer on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020 and the foregoing facts stated herein are
true and correct. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>KENSINGTON CAPITAL ACQUISITION CORP.</B></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL
ACQUISITION CORP. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
name of the corporation is QuantumScape Corporation (the &#147;<B><I>Corporation</I></B>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The address of the registered office of the Corporation in the State of Delaware is Corporation Trust Center, 1209&nbsp;Orange Street, City of Wilmington,
County of New Castle, DE 19801. The name of its registered agent at such address is The Corporation Trust Company. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purpose of the Corporation is to engage in any lawful act or activity for which a corporation may be organized under the General Corporation Law of the
State of Delaware (the &#147;<B><I>Delaware General Corporation Law</I></B>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Corporation is authorized to issue 1,250,000,000 shares of common stock, of which there are (i)&nbsp;1,000,000,000 shares of Class&nbsp;A Common Stock,
par value $0.0001 per share (the &#147;<B><I>Class</I></B><B><I></I></B><B><I>&nbsp;A Common Stock</I></B>&#148;) and (ii)&nbsp;250,000,000 shares of Class&nbsp;B Common Stock, par value $0.0001 per share (the
&#147;<B><I>Class</I></B><B><I></I></B><B><I>&nbsp;B Common Stock</I></B>&#148; and together with the Class&nbsp;A Common Stock, the &#147;<B><I>Common Stock</I></B>&#148;); and 100,000,000 shares of Preferred Stock, par value $0.0001 per share (the
&#147;<B><I>Preferred Stock</I></B>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The rights, powers, preferences, privileges, restrictions and other matters relating to the Common Stock are as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. <U>Definitions</U>. For purposes of this Amended and Restated Certificate, the following definitions apply: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.1 &#147;<B><I>Acquisition</I></B>&#148; means (i)&nbsp;any consolidation or merger of the Corporation with or into any other corporation or other entity or
person, or any other corporate reorganization, other than any such consolidation, merger or reorganization in which the shares of capital stock of the Corporation immediately prior to such consolidation, merger or reorganization continue to
represent a majority of the voting power of the surviving entity (or, if the surviving entity is a wholly owned subsidiary, its Parent) immediately after such consolidation, merger or reorganization; or (ii)&nbsp;any transaction or series of related
transactions to which the Corporation is a party in which issued and outstanding shares of the Corporation are transferred or shares of the Corporation are issued, such that in excess of fifty percent (50%) of the Corporation&#146;s voting power is
transferred; <I>provided</I> that an Acquisition shall not include any transaction or series of transactions principally for bona fide equity financing purposes in which cash is received by the Corporation or any successor or indebtedness of the
Corporation is cancelled or converted or a combination thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.2 &#147;<B><I>Amended and Restated Certificate</I></B>&#148; means this Amended and
Restated Certificate of Incorporation of the Corporation (including any Preferred Stock Designation, as defined below), as may be further amended and restated from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.3 &#147;<B><I>Asset Transfer</I></B>&#148; means a sale, lease, exclusive license or other disposition of
all or substantially all of the assets of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.4 &#147;<B><I>Board</I></B>&#148; means the Board of Directors of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.5 &#147;<B><I>Class</I></B><B><I></I></B><B><I>&nbsp;B Stockholder</I></B>&#148; shall mean those persons who have the right to receive shares of
Class&nbsp;B Common Stock pursuant to that certain Business Combination Agreement dated as of September 2, 2020 among Kensington Capital Acquisition Corp., a Delaware corporation, Kensington Capital Merger Sub Corp., a Delaware corporation and
QuantumScape Corporation, a Delaware corporation (the &#147;<B><I>BCA</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.6 &#147;<B><I>Disability</I></B>&#148; or
&#147;<B><I>Disabled</I></B>&#148; means the permanent and total disability such that an Excluded Party is unable to engage in any substantial gainful activity by reason of any medically determinable mental impairment which can be expected to result
in death or which has lasted or can be expected to last for a continuous period of not less than 12 months as determined by a licensed medical practitioner. In the event of a dispute whether an Excluded Party has suffered a Disability, no Disability
of the Excluded Party shall be deemed to have occurred unless and until an affirmative ruling regarding such Disability has been made by a court of competent jurisdiction, and such ruling has become final and
<FONT STYLE="white-space:nowrap">non-appealable.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.7 &#147;<B><I>Excluded Party</I></B>&#148; means any of Timothy Holme, Fritz Prinz and Jagdeep
Singh. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.8 &#147;<B><I>Excluded Party Trustee</I></B>&#148; means a person, designated by an Excluded Party and approved by the Board, in his or her
capacity as a voting trustee pursuant to a written voting trust agreement entered into by such Excluded Party prior to his death or Disability, contingent and effective upon the death or Disability of such Excluded Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.9 &#147;<B><I>Family Member</I></B>&#148; means, with respect to a natural person, whether related by blood or marriage, (i)&nbsp;such natural person&#146;s
spouse, <FONT STYLE="white-space:nowrap">ex-spouse</FONT> or domestic partner; (ii)&nbsp;such natural person&#146;s parents and grandparents; (iii)&nbsp;such natural person&#146;s siblings; (iv)&nbsp;such natural person&#146;s children and other
lineal descendants; and (v)&nbsp;the lineal descendants of such natural person&#146;s siblings. Lineal descendants shall include adopted persons, but only so long as they are adopted during minority, and step-children. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.10 &#147;<B><I>Final Conversion Date</I></B>&#148; means the earliest to occur of: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) the date fixed by the Board that is no less than 61 days and no more than 180 days following the first date to occur following the issuance of the Per
Share Merger Consideration (as defined in the BCA) on which the total number of outstanding shares of Class&nbsp;B Common Stock held by the Excluded Parties and their Permitted Transferees represents less than 20% of the total number of outstanding
shares of Class&nbsp;B Common Stock (each as equitably adjusted for any stock dividend, stock split, combination of shares, reorganization, recapitalization, reclassification or other similar event); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) if (i)&nbsp;the applicable Excluded Party has designated an Excluded Party Trustee, the date that is the earlier of (A)&nbsp;nine (9) months after the
death or Disability of the last to die or become Disabled of the Excluded Parties and (B)&nbsp;the date upon which such Excluded Party Trustee ceases to hold exclusive Voting Control over such shares of Class&nbsp;B Common Stock; and (ii)&nbsp;the
applicable Excluded Party has not designated an Excluded Party Trustee, the death or Disability of the last to die or become Disabled of the Excluded Parties; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) the date specified by (i)&nbsp;the holders of a majority of the then outstanding shares of Class&nbsp;B Common Stock, voting as a separate class, or in an
affirmative written election executed by the holders of a majority of the then outstanding shares of Class&nbsp;B Common Stock and (ii)&nbsp;all of the Excluded Parties (but excluding any Excluded Party who is then deceased or Disabled or who,
individually or through his Permitted Transferees, holds less than 20% of the aggregate number of shares of Class&nbsp;B Common Stock that were held by such Excluded Party, individually or through his Permitted Transferees, as of the Effective Time
(as equitably adjusted for any stock dividend, stock split, combination of shares, reorganization, recapitalization, reclassification or other similar event)). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.11 &#147;<B><I>Liquidation Event</I></B>&#148; means any liquidation, dissolution, or winding up of the Corporation, whether voluntary or involuntary, or
any Acquisition or Asset Transfer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.12 &#147;<B><I>Parent</I></B>&#148; of an entity means any entity that directly or indirectly owns or
controls a majority of the voting power of the voting securities of such entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.13 &#147;<B><I>Permitted Entity</I></B>&#148; means (i)&nbsp;with
respect to any Class&nbsp;B Stockholder, any trust, account, plan, corporation, partnership, or limited liability company specified in Article V, Section&nbsp;1.14(b) established by or for such Class&nbsp;B Stockholder, so long as such entity meets
the requirements set forth in Article V, Section&nbsp;1.14, (ii) a trust which may be revoked by an Excluded Party, so long as the Excluded Party, respectively, remains a trustee or <FONT STYLE="white-space:nowrap">co-trustee</FONT> thereof and has
sole voting power with respect to shares of the Corporation held by such trust, (iii)&nbsp;with respect to any stockholder who is an affiliate of Bill Gates, the Bill&nbsp;&amp; Melinda Gates Foundation Asset Trust, so long as Bill Gates remains a
trustee or <FONT STYLE="white-space:nowrap">co-trustee</FONT> thereof, and (iv)&nbsp;any trust or entity settled or formed by an Excluded Party, for the primary benefit of his respective Family Members, so long as either (a)&nbsp;the Excluded Party
remains a trustee or <FONT STYLE="white-space:nowrap">co-trustee</FONT> and holds sole voting power with respect to shares of the Corporation held by any such trust or (b)&nbsp;the Excluded Party has both the power to remove the trustee or <FONT
STYLE="white-space:nowrap">co-trustees</FONT> and any individual(s) holding voting power of any such trust, and the power to replace any such removed trustee, <FONT STYLE="white-space:nowrap">co-trustees,</FONT> or individual(s) with any individual
or entity of his choosing, other than an individual who is a related or subordinate party to the Excluded Party within the meaning of Internal Revenue Code Section&nbsp;672(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.13.1 &#147;<B><I>Permitted Foundation</I></B>&#148; shall mean with respect to a Class&nbsp;B Stockholder a domestic U.S. charitable organization,
foundation or similar entity, that was established by a Class&nbsp;B Stockholder and is intended to be <FONT STYLE="white-space:nowrap">tax-exempt</FONT> under the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.14 &#147;<B><I>Permitted Transfer</I></B>&#148; means </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) a
Transfer of Class&nbsp;B Common Stock by a Class&nbsp;B Stockholder or such Class&nbsp;B Stockholder&#146;s Permitted Entities to another Class&nbsp;B Stockholder or such other Class&nbsp;B Stockholder&#146;s Permitted Entities; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) a Transfer by a Class&nbsp;B Stockholder to any Permitted Entity, including but not limited to any of the following Permitted Entities, and from any of the
Permitted Entities back to such Class&nbsp;B Stockholder and/or any other Permitted Entity by or for such Class&nbsp;B Stockholder: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) a trust for the
benefit of such Class&nbsp;B Stockholder and for the benefit of no other person, provided such Transfer does not involve any payment of cash, securities, property or other consideration (other than an interest in such trust) to the Class&nbsp;B
Stockholder; and, provided, further, that in the event such Class&nbsp;B Stockholder is no longer the exclusive beneficiary of such trust, each share of Class&nbsp;B Common Stock then held by such trust shall automatically convert into one
(1)&nbsp;fully paid and nonassessable share of Class&nbsp;A Common Stock (as equitably adjusted for any stock dividend, stock split, combination of shares, reorganization, recapitalization, reclassification or other similar event); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) a trust for the benefit of persons other than the Class&nbsp;B Stockholder so long as the Class&nbsp;B Stockholder has exclusive Voting Control with
respect to the shares of Class&nbsp;B Common Stock held by such trust, provided such Transfer does not involve any payment of cash, securities, property or other consideration (other than an interest in such trust) to the Class&nbsp;B Stockholder;
and, <I>provided</I>, <I>further</I>, that in the event the Class&nbsp;B Stockholder no longer has exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such trust, each share of Class&nbsp;B Common Stock then held
by such trust shall automatically convert into one (1)&nbsp;fully paid and nonassessable share of Class&nbsp;A Common Stock (as equitably adjusted for any stock dividend, stock split, combination of shares, reorganization, recapitalization,
reclassification or other similar event); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iii) a trust under the terms of which such Class&nbsp;B Stockholder has retained a &#147;qualified
interest&#148; within the meaning of &#167;2702(b)(1) of the Internal Revenue Code (the &#147;<B><I>Code</I></B>&#148;) and/or a reversionary interest so long as the Class&nbsp;B Stockholder has exclusive Voting Control with respect to the shares of
Class&nbsp;B Common Stock held by such trust; <I>provided</I>, <I>however</I>, that in the event the Class&nbsp;B Stockholder no longer has exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such trust, each
share of Class&nbsp;B Common Stock then held by such trust shall automatically convert into one (1)&nbsp;fully paid and nonassessable share of Class&nbsp;A Common Stock (as equitably adjusted for any stock dividend, stock split, combination of
shares, reorganization, recapitalization, reclassification or other similar event); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iv) an Individual Retirement Account, as defined in Section&nbsp;408(a) of the Code, or a pension, profit
sharing, stock bonus or other type of plan or trust of which such Class&nbsp;B Stockholder is a participant or beneficiary and which satisfies the requirements for qualification under Section&nbsp;401 of the Code; <I>provided</I> that in each case
such Class&nbsp;B Stockholder has exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held in such account, plan or trust, and <I>provided</I>, <I>further</I>, that in the event the Class&nbsp;B Stockholder no longer has
exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such account, plan or trust, each share of Class&nbsp;B Common Stock then held by such trust shall automatically convert into one (1)&nbsp;fully paid and
nonassessable share of Class&nbsp;A Common Stock (as equitably adjusted for any stock dividend, stock split, combination of shares, reorganization, recapitalization, reclassification or other similar event); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(v) a corporation in which such Class&nbsp;B Stockholder directly, or indirectly through one or more Permitted Entities, owns shares with sufficient Voting
Control in the corporation, or otherwise has legally enforceable rights, such that the Class&nbsp;B Stockholder retains exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such corporation; <I>provided</I> that
in the event the Class&nbsp;B Stockholder no longer owns sufficient shares or has sufficient legally enforceable rights to enable the Class&nbsp;B Stockholder to retain exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock
held by such corporation, each share of Class&nbsp;B Common Stock then held by such corporation shall automatically convert into one (1)&nbsp;fully paid and nonassessable share of Class&nbsp;A Common Stock (as equitably adjusted for any stock
dividend, stock split, combination of shares, reorganization, recapitalization, reclassification or other similar event); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(vi) a partnership in which such
Class&nbsp;B Stockholder directly, or indirectly through one or more Permitted Entities, owns partnership interests with sufficient Voting Control in the partnership, or otherwise has legally enforceable rights, such that the Class&nbsp;B
Stockholder retains exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such partnership; <I>provided</I> that in the event the Class&nbsp;B Stockholder no longer owns sufficient partnership interests or has
sufficient legally enforceable rights to enable the Class&nbsp;B Stockholder to retain exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such partnership, each share of Class&nbsp;B Common Stock then held by
such partnership shall automatically convert into one (1)&nbsp;fully paid and nonassessable share of Class&nbsp;A Common Stock (as equitably adjusted for any stock dividend, stock split, combination of shares, reorganization, recapitalization,
reclassification or other similar event); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(vii) a limited liability company in which such Class&nbsp;B Stockholder directly, or indirectly through one or
more Permitted Entities, owns membership or limited liability company interests with sufficient Voting Control in the limited liability company, or otherwise has legally enforceable rights, such that the Class&nbsp;B Stockholder retains exclusive
Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such limited liability company; <I>provided</I> that in the event the Class&nbsp;B Stockholder no longer owns sufficient membership or limited liability company interests
or has sufficient legally enforceable rights to enable the Class&nbsp;B Stockholder to retain exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such limited liability company, each share of Class&nbsp;B Common
Stock then held by such limited liability company shall automatically convert into one (1)&nbsp;fully paid and nonassessable share of Class&nbsp;A Common Stock (as equitably adjusted for any stock dividend, stock split, combination of shares,
reorganization, recapitalization, reclassification or other similar event); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(viii) a Permitted Foundation so long as the Class&nbsp;B Stockholder has
exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held by such Permitted Foundation, provided such Transfer does not involve any payment of cash, securities, property or other consideration (other than an interest in
such Permitted Foundation) to the Class&nbsp;B Stockholder; and, <I>provided</I>, <I>further</I>, that in the event the Class&nbsp;B Stockholder no longer has exclusive Voting Control with respect to the shares of Class&nbsp;B Common Stock held by
such Permitted Foundation, each share of Class&nbsp;B Common Stock then held by such Permitted Foundation shall automatically convert into one (1)&nbsp;fully paid and nonassessable share of Class&nbsp;A Common Stock (as equitably adjusted for any
stock dividend, stock split, combination of shares, reorganization, recapitalization, reclassification or other similar event). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the avoidance of
doubt, to the extent any shares are deemed to be held by a trustee of a trust described in (i), (ii) or (iii)&nbsp;above, the Transfer shall be a Permitted Transfer and the trustee shall be deemed a Permitted Entity so long as the other requirements
of (i), (ii) or (iii)&nbsp;above, as the case may be, are otherwise satisfied. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.15 &#147;<B><I>Permitted Transferee</I></B>&#148; means a transferee of shares of Class&nbsp;B Common
Stock, or rights or interests therein, received in a Transfer that constitutes a Permitted Transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.16 &#147;<B><I>Qualified Stockholder</I></B>&#148;
means (a)&nbsp;any registered holder of a share of Class&nbsp;B Common Stock as of the Effective Time (as defined under the BCA); (b) any Permitted Transferee; and (c)&nbsp;the initial registered holder of any shares of Class&nbsp;B Common Stock
that are originally issued by the Corporation after the Effective Time in compliance with this Amended and Restated Certificate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.17
&#147;<B><I>Transfer</I></B>&#148; of a share of Class&nbsp;B Common Stock shall mean any sale, assignment, transfer, conveyance, hypothecation or other transfer or disposition of such share or any legal or beneficial interest in such share, whether
or not for value and whether voluntary or involuntary or by operation of law, whether directly or indirectly, including by merger, consolidation or otherwise. A &#147;<B><I>Transfer</I></B>&#148; shall also include, without limitation, a transfer of
a share of Class&nbsp;B Common Stock to a broker or other nominee (regardless of whether or not there is a corresponding change in beneficial ownership), or the transfer of, or entering into a binding agreement with respect to, Voting Control over a
share of Class&nbsp;B Common Stock by proxy or otherwise; <I>provided</I>, <I>however</I>, that the following shall not be considered a &#147;<B><I>Transfer</I></B>&#148; within the meaning of this Article V, Section&nbsp;1.17: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) the granting of a proxy to officers or directors of the Corporation, or to other persons approved by the Board at the request of the Board in connection
with actions to be taken at an annual or special meeting of stockholders; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) entering into a voting trust, agreement or arrangement (with or without
granting a proxy), or consummating the actions or transactions contemplated therein, solely with other stockholders who are Class&nbsp;B Stockholders, that (i)&nbsp;is disclosed either in a Schedule 13D filed with the Securities and Exchange
Commission or in writing to the Secretary of the Corporation, (ii)&nbsp;either has a term not exceeding one (1)&nbsp;year or is terminable by the Class&nbsp;B Stockholder at any time and (iii)&nbsp;does not involve any payment of cash, securities,
property or other consideration to the Class&nbsp;B Stockholder other than the mutual promise to vote shares in a designated manner; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) the pledge of
shares of Class&nbsp;B Common Stock by a Class&nbsp;B Stockholder that creates a mere security interest in such shares pursuant to a bona fide loan or indebtedness transaction so long as the Class&nbsp;B Stockholder continues to exercise Voting
Control over such pledged shares; <I>provided</I>, <I>however</I>, that a foreclosure on such shares of Class&nbsp;B Common Stock or other similar action by the pledgee shall constitute a &#147;<B><I>Transfer</I></B>;&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) entering into any agreement with respect to supporting or voting in favor of or tendering shares with respect to any transaction proposed to be consummated
by the Corporation, or consummating the actions or transactions contemplated therein (including, without limitation, tendering shares of Class&nbsp;B Common Stock or voting such shares in favor of such transaction or in opposition to other proposals
that may be expected to delay or impair the ability to consummate such transaction), if the entry into such support or voting agreement is approved by the Board; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) granting of a proxy by an Excluded Party or such Excluded Party&#146;s Permitted Transferees to another Excluded Party to exercise Voting Control of shares
of Class&nbsp;B Common Stock owned directly or indirectly, beneficially and of record, by such granting Excluded Party or such granting Excluded Party&#146;s Permitted Transferees, and the exercise of such proxy by such other Excluded Party; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(g) entering into a trading plan pursuant to Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Securities Exchange Act of 1934, as amended, with a
broker or other nominee; <I>provided, however</I>, that any sale of such shares of Class&nbsp;B Common Stock pursuant to such plan shall constitute a &#147;<B><I>Transfer</I></B>&#148; at the time of such sale; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(h) the fact that the spouse of any Qualified Stockholder possesses or obtains an interest in such holder&#146;s shares of Class&nbsp;B Common Stock arising
solely by reason of the application of the community property laws of any jurisdiction, so long as no other event or circumstance shall exist or have occurred that constitutes a &#147;<B><I>Transfer</I></B>&#148; that is not a Permitted Transfer.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.18 &#147;<B><I>Voting Control</I></B>&#148; means the power to vote or direct the voting of the applicable voting security by proxy, voting agreement
or otherwise; <I>provided</I> that, in the case of an Excluded Party and solely for purposes of Article V, Section&nbsp;1.14(b)(i) &#150; (iv), an Excluded Party shall be deemed to have exclusive Voting Control with respect to the shares of
Class&nbsp;B Common Stock if such Excluded Party has the power to terminate, remove or replace any person or entity having Voting Control over the applicable shares of Class&nbsp;B Common Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.19 &#147;<B><I>Whole Board</I></B>&#148; means the total number of authorized directors whether or not
there exist any vacancies or unfilled seats in previously authorized directorships. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <U>Identical Rights</U>. Except as otherwise provided in this
Amended and Restated Certificate or required by applicable law, shares of Common Stock shall have the same rights and powers, rank equally (including, without limitation, as to any dividends and distributions, any liquidation, dissolution or winding
up of the Corporation and any voting of such shares), share ratably and be identical in all respects as to all matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <U>Dividends and
Distributions.</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.1 Subject to the prior rights of holders of all classes and series of stock at the time outstanding having prior rights as to
dividends and subject to Section&nbsp;3.2, the holders of the Common Stock shall be entitled to receive, when, as and if declared by the Board, out of any assets of the Corporation legally available therefor, such dividends as may be declared from
time to time by the Board. Any dividends paid to the holders of shares of Common Stock shall be paid pro rata, on an equal priority, pari passu basis, unless different treatment of the shares of any such class or series is approved by the
affirmative vote of the holders of a majority of the voting power of the outstanding shares of such applicable class or series of Common Stock treated adversely, voting separately as a class. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.2 The Corporation shall not declare or pay any dividend or make any other distribution to any holders of Common Stock payable in securities of the
Corporation unless the same dividend or distribution with the same record date and payment date shall be declared and paid on all shares of Common Stock, unless different treatment of the shares of Class&nbsp;A Common Stock or Class&nbsp;B Common
Stock is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class&nbsp;A Common Stock and Class&nbsp;B Common Stock, each voting separately as a class; <I>provided</I>, <I>however</I>, that (i)&nbsp;dividends
or other distributions payable in shares of Class&nbsp;A Common Stock or rights to acquire shares of Class&nbsp;A Common Stock may be declared and paid to the holders of Class&nbsp;A Common Stock without the same dividend or distribution being
declared and paid to the holders of the Class&nbsp;B Common Stock if, and only if, a dividend payable in shares of Class&nbsp;B Common Stock, or rights to acquire shares of Class&nbsp;B Common Stock, is declared and paid to the holders of
Class&nbsp;B Common Stock at the same rate and with the same record date and payment date; and (ii)&nbsp;dividends or other distributions payable in shares of Class&nbsp;B Common Stock or rights to acquire shares of Class&nbsp;B Common Stock may be
declared and paid to the holders of Class&nbsp;B Common Stock without the same dividend or distribution being declared and paid to the holders of the Class&nbsp;A Common Stock if, and only if, a dividend payable in shares of Class&nbsp;A Common
Stock, or rights to acquire shares of Class&nbsp;A Common Stock, is declared and paid to the holders of Class&nbsp;A Common Stock at the same rate and with the same record date and payment date; and <I>provided</I>, <I>further</I>, that nothing in
the foregoing shall prevent the Corporation from declaring and paying dividends or other distributions payable in shares of one class of Common Stock or rights to acquire one class of Common Stock to holders of all classes of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.3 If the Corporation in any manner subdivides or combines the outstanding shares of Class&nbsp;A Common Stock or Class&nbsp;B Common Stock, then the
outstanding shares of all Common Stock will be subdivided or combined in the same proportion and manner, unless different treatment of the shares of Class&nbsp;A Common Stock or Class&nbsp;B Common Stock is approved by the affirmative vote of the
holders of a majority of the outstanding shares of Class&nbsp;A Common Stock and Class&nbsp;B Common Stock, each voting separately as a class. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.
<U>Voting Rights.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.1 <U>Common Stock</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a)
<U>Class</U><U></U><U>&nbsp;A Common Stock</U>. Each holder of shares of Class&nbsp;A Common Stock will be entitled to one vote for each share thereof held at the record date for the determination of the stockholders entitled to vote on such
matters. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) <U>Class</U><U></U><U>&nbsp;B Common Stock</U>. Each holder of shares of Class&nbsp;B Common Stock will be entitled to ten votes for each
share thereof held at the record date for the determination of the stockholders entitled to vote on such matters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.2 <U>General</U>. Except as otherwise expressly provided herein or as required by law, the holders of
Class&nbsp;A Common Stock and Class&nbsp;B Common Stock will vote together as a single class and not as separate series or classes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.3 <U>Authorized
Shares</U>. The number of authorized shares of Common Stock or any class or series thereof may be increased or decreased (but not below (i)&nbsp;the number of shares of Common Stock or, in the case of a class or series of Common Stock, such class or
series, then outstanding plus (ii)&nbsp;with respect to Class&nbsp;A Common Stock, the number of shares reserved for issuance pursuant to Article V, Section&nbsp;9) by the affirmative vote of the holders of a majority of the voting power of the
Class&nbsp;A Common Stock and Class&nbsp;B Common Stock, voting together as a single class, irrespective of the provisions of Section&nbsp;242(b)(2) of the Delaware General Corporation Law; <I>provided</I> that the number of authorized shares of
Class&nbsp;B Common Stock shall not be increased or decreased without the affirmative vote of the holders of a majority of the outstanding shares of Class&nbsp;B Common Stock, voting as a separate class. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.4 <U>Election of Directors</U>. Subject to any rights of the holders of any series of Preferred Stock to elect directors under circumstances specified in
this Amended and Restated Certificate (as modified by any Preferred Stock Designation), (i) prior to the Final Conversion Date, the holders of Class&nbsp;A Common Stock and Class&nbsp;B Common Stock, voting together as a single class, shall be
entitled to elect and remove all directors of the Corporation, and (ii)&nbsp;from and after the Final Conversion Date, if any, the holders of Common Stock, voting together as a single class, shall be entitled to elect and remove all directors of the
Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. <U>Liquidation Rights</U>. In the event of a Liquidation Event in connection with which the Board has determined to effect a distribution
of assets of the Corporation to any holder or holders of Common Stock, then, subject to the rights of any Preferred Stock that may then be outstanding, the assets of the Corporation legally available for distribution to stockholders shall be
distributed on an equal priority, pro rata basis (based on the number of shares of Common Stock held by each) to the holders of Common Stock, unless different treatment of the shares of each such class or series of Common Stock is approved by the
affirmative vote of the holders of a majority of the outstanding shares of Class&nbsp;A Common Stock and Class&nbsp;B Common Stock, each voting separately as a class; <I>provided</I>, <I>however</I>, that for the avoidance of doubt, payments to be
made or received by a holder of Common Stock in connection with any such Liquidation Event pursuant to any employment, consulting, severance or similar services arrangement shall not be deemed to be a distribution for the purpose of this Article V,
Section&nbsp;5;<I> provided</I>, <I>further, however</I>, that shares of such classes may receive, or have the right to elect to receive, different or disproportionate consideration in connection with such Liquidation Event if the only difference in
the per share consideration to the holders of the Class&nbsp;A Common Stock and Class&nbsp;B Common Stock is that any securities distributed to the holder of a share of Class&nbsp;B Common Stock have ten (10)&nbsp;times the voting power of any
securities distributed to the holder of a share of Class&nbsp;A Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. <U>Conversion of the Class</U><U></U><U>&nbsp;B Common Stock</U>. The
Class&nbsp;B Common Stock will be convertible into Class&nbsp;A Common Stock as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.1 Each outstanding share of Class&nbsp;B Common Stock will
automatically convert into one fully paid and nonassessable share of Class&nbsp;A Common Stock (as equitably adjusted for any stock dividend, stock split, combination of shares, reorganization, recapitalization, reclassification or other similar
event) on the Final Conversion Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.2 With respect to any holder of Class&nbsp;B Common Stock, each outstanding share of Class&nbsp;B Common Stock
held by such holder will automatically be converted into one fully paid and nonassessable share of Class&nbsp;A Common Stock (as equitably adjusted for any stock dividend, stock split, combination of shares, reorganization, recapitalization,
reclassification or other similar event), as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) at the option of the holder thereof at any time upon written notice to the transfer agent of the
Corporation or, if such written notice specifies a later time or the occurrence of a future event for such conversion, upon such time or the occurrence of such event; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) on the occurrence of any Transfer of such share of Class&nbsp;B Common Stock that is not a Permitted Transfer; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) upon the death of such Class&nbsp;B Stockholder, or solely with respect to each share of Class&nbsp;B
Common Stock held of record by an Excluded Party, or by an Excluded Party&#146;s Permitted Entities, upon the death or Disability of such Excluded Party; <I>provided</I>, <I>however</I>, that, with respect to the shares of Class&nbsp;B Common Stock
held of record by such Excluded Party or such Excluded Party&#146;s Permitted Entities, each share of Class&nbsp;B Common Stock held of record by an Excluded Party or an Excluded Party&#146;s Permitted Entities shall automatically convert into one
(1)&nbsp;fully paid and nonassessable share of Class&nbsp;A Common Stock (as equitably adjusted for any stock dividend, stock split, combination of shares, reorganization, recapitalization, reclassification or other similar event), if (i)&nbsp;the
applicable Excluded Party has designated an Excluded Party Trustee, upon that date which is the earlier of: (A)&nbsp;nine (9) months after the date of death or Disability of such Excluded Party, and (B)&nbsp;the date upon which such Excluded Party
Trustee ceases to hold exclusive Voting Control over such shares of Class&nbsp;B Common Stock; and (ii)&nbsp;the applicable Excluded Party has not designated an Excluded Party Trustee, the death or Disability of such Excluded Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. <U>Procedures</U>. The Corporation may, from time to time, establish such policies and procedures relating to the conversion of the Class&nbsp;B Common
Stock into Class&nbsp;A Common Stock and the general administration of this dual-class stock structure, including the issuance of stock certificates with respect thereto, as it may deem necessary or advisable, and may from time to time request that
holders of shares of Class&nbsp;B Common Stock furnish certifications, affidavits or other proof to the Corporation as it deems necessary to verify the ownership of Class&nbsp;B Common Stock and to confirm that a conversion to Class&nbsp;A Common
Stock has not occurred. A determination by the Corporation as to whether or not a Transfer has occurred and results in a conversion to Class&nbsp;A Common Stock, or as to whether or not another conversion contemplated in the foregoing Section&nbsp;6
of this Article V has occurred, shall be conclusive and binding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. <U>Effect of Conversion</U>. In the event of a conversion of shares of Class&nbsp;B
Common Stock into shares of Class&nbsp;A Common Stock pursuant to Article V, Section&nbsp;6, such conversion shall be deemed to have been made at (a)&nbsp;the open of business on the Final Conversion Date, in the case of Article V, Section&nbsp;6.1;
(b) the time that the Corporation&#146;s transfer agent receives the written notice required pursuant to Article V, Section&nbsp;6.2(a) (or a later date specified by such notice), (c) the time of the Transfer in the case of Article V,
Section&nbsp;6.2(b), or (d)&nbsp;the time that the death or Disability of the Class&nbsp;B Stockholder occurred or as otherwise provided in Article V, Section&nbsp;6.2(c), as applicable. Upon any conversion of Class&nbsp;B Common Stock to
Class&nbsp;A Common Stock, all rights of the holder of such shares of Class&nbsp;B Common Stock shall cease and the person or persons in whose name or names the certificate or certificates representing the shares of Class&nbsp;B Common Stock are to
be issued, if any, shall be treated for all purposes as having become the record holder or holders of such number of shares of Class&nbsp;A Common Stock into which such Class&nbsp;B Common Stock were convertible. Shares of Class&nbsp;B Common Stock
that are converted into shares of Class&nbsp;A Common Stock as provided in Article V, Section&nbsp;6 shall be retired and shall not be reissued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.
<U>Reservation of Stock Issuable Upon Conversion</U>. The Corporation will at all times reserve and keep available out of its authorized but unissued shares of Class&nbsp;A Common Stock, solely for the purpose of effecting the conversion of the
shares of the Class&nbsp;B Common Stock such number of its shares of Class&nbsp;A Common Stock as shall from time to time be sufficient to effect the conversion of all outstanding shares of Class&nbsp;B Common Stock; and if at any time the number of
authorized but unissued shares of Class&nbsp;A Common Stock will not be sufficient to effect the conversion of all then-outstanding shares of Class&nbsp;B Common Stock, the Corporation will take such corporate action as may, in the opinion of its
counsel, be necessary to increase its authorized but unissued shares of Class&nbsp;A Common Stock into such number of shares as will be sufficient for such purpose. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. <U>Preemptive Rights</U>. No stockholder of the Corporation shall have a right to purchase shares of capital stock of the Corporation sold or issued by
the Corporation except to the extent that such a right may from time to time be set forth in a written agreement between the Corporation and a stockholder. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. <U>Rights of Preferred
Stock</U>. The Board is authorized, subject to any limitations prescribed by law or in any Preferred Stock Designation, to provide for the issuance of shares of Preferred Stock in series, and by filing a
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
certificate pursuant to the applicable law of the State of Delaware (such certificate being hereinafter referred to as a &#147;<B><I>Preferred Stock Designation</I></B>&#148;), to establish from
time to time the number of shares to be included in each such series, and to fix the designation, powers, preferences and rights of the shares of each such series and any qualifications, limitations or restrictions thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <U>Vote to Increase or Decrease Authorized Shares</U>. The number of authorized shares of Preferred Stock may be increased or decreased (but not below the
number of shares thereof then outstanding) by the affirmative vote of the holders of a majority of the voting power of all of the outstanding shares of stock of the Corporation entitled to vote thereon, without a vote of the holders of the Preferred
Stock, or of any series thereof, unless a vote of any such holders is required pursuant to the terms of any Preferred Stock Designation, irrespective of the provisions of Section&nbsp;242(b)(2) of the Delaware General Corporation Law. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. <U>Number of Directors;
Election; Term</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) Subject to the rights of holders of any series of Preferred Stock with respect to the election of directors, the number of
directors that constitutes the entire Board of the Corporation shall be fixed solely by resolution of the Board. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) Each director shall be elected to
hold office for a <FONT STYLE="white-space:nowrap">one-year</FONT> term expiring at the next annual meeting of stockholders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding the
foregoing provisions of this Article VII, Section&nbsp;1, and subject to the rights of holders of any series of Preferred Stock with respect to the election of directors, each director shall serve until his or her successor is duly elected and
qualified or until his or her earlier death, resignation, or removal. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) If the number of directors is increased at or following the 2021 annual meeting
of stockholders, any additional director elected to fill a newly created directorship shall hold office for a term expiring at the next annual meeting of stockholders. In no case shall a decrease in the number of directors remove or shorten the term
of any incumbent director. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) Elections of directors need not be by written ballot unless the Bylaws of the Corporation shall so provide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <U>Vacancies and Newly Created Directorships</U>. Subject to the rights of holders of any series of Preferred Stock with respect to the election of
directors, and except as may be permitted in the specific case by resolution of a majority of the Whole Board, vacancies occurring on the Board for any reason and newly created directorships resulting from an increase in the authorized number of
directors may be filled only by vote of a majority of the remaining members of the Board, although less than a quorum, or by a sole remaining director, and not by stockholders. A person so elected by the Board to fill a vacancy or newly created
directorship shall hold office until the next election of the class for which such director shall have been assigned by the Board and until his or her successor shall be duly elected and qualified. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following provisions
are inserted for the management of the business and the conduct of the affairs of the Corporation, and for further definition, limitation and regulation of the powers of the Corporation and of its directors and stockholders: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. <U>Board Power</U>. The business and affairs of the Corporation shall be managed by or under the direction of the Board. In addition to the powers and
authority expressly conferred by statute or by this Amended and Restated Certificate or the Bylaws of the Corporation, the Board is hereby empowered to exercise all such powers and do all such acts and things as may be exercised or done by the
Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <U>Amendment of Bylaws</U>. In furtherance and not in limitation of the powers conferred by the Delaware General Corporation Law, the
Board is expressly authorized to adopt, amend or repeal the Bylaws of the Corporation. The Bylaws of the Corporation may also be adopted, amended or repealed by the stockholders entitled to vote; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<I>provided</I>, <I>however</I>, that from and after the Final Conversion Date, the affirmative vote of holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the total voting
power of the outstanding voting securities of the Corporation, voting together as a single class, shall be required for the stockholders to alter, amend or repeal the Bylaws of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <U>Special Meetings</U>. Special meetings of the stockholders may be called only by (i)&nbsp;the Board pursuant to a resolution adopted by a majority of
the Whole Board; (ii)&nbsp;the chair of the Board; or (iii)&nbsp;the chief executive officer of the Corporation. A special meeting of stockholders may not be called by any other person or persons, and any power of stockholders to call a special
meeting of stockholders is specifically denied. The Board pursuant to a resolution adopted by a majority of the Whole Board, or the chair of a meeting of stockholders, may cancel, postpone or reschedule any previously scheduled meeting of
stockholders at any time, before or after the notice for such meeting has been sent to stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. <U>Stockholder Action by Written Consent</U>.
Except for the rights of the holders of any series of Preferred Stock, from and after the Final Conversion Date, any action required or permitted to be taken by the stockholders of the Corporation must be effected at a duly called annual or special
meeting of stockholders of the Corporation and may not be effected by any consent in writing by such stockholders. Subject to the rights of the holders of any series of Preferred Stock, before the Final Conversion Date, any action required or
permitted to be taken by the stockholders of the Corporation may be taken without a meeting only if the action is first recommended or approved by a majority of the Whole Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. <U>No Cumulative Voting</U>. No stockholder will be permitted to cumulate votes at any election of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. <U>Advance Notice</U>. Advance notice of stockholder nominations for the election of directors and of business to be brought by stockholders before any
meeting of the stockholders of the Corporation shall be given in the manner provided in the Bylaws of the Corporation. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the fullest extent permitted by law, no director of the Corporation shall be personally liable for monetary damages for breach of fiduciary duty
as a director. Without limiting the effect of the preceding sentence, if the Delaware General Corporation Law is hereafter amended to authorize the further elimination or limitation of the liability of a director, then the liability of a director of
the Corporation shall be eliminated or limited to the fullest extent permitted by the Delaware General Corporation Law, as so amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither any
amendment, repeal nor elimination of this Article IX, nor the adoption of any provision of this Amended and Restated Certificate inconsistent with this Article IX, shall eliminate, reduce or otherwise adversely affect any limitation on the personal
liability of a director of the Corporation existing at the time of such amendment, repeal, elimination or adoption of such an inconsistent provision. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE X </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any provision of this
Amended and Restated Certificate becomes or is declared on any ground by a court of competent jurisdiction to be illegal, unenforceable or void, portions of such provision, or such provision in its entirety, to the extent necessary, shall be severed
from this Amended and Restated Certificate, and the court will replace such illegal, void or unenforceable provision of this Amended and Restated Certificate with a valid and enforceable provision that most accurately reflects the Corporation&#146;s
intent, in order to achieve, to the maximum extent possible, the same economic, business and other purposes of the illegal, void or unenforceable provision. The balance of this Amended and Restated Certificate shall be enforceable in accordance with
its terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as provided in Article IX above, the Corporation reserves the right to amend, alter, change or repeal
any provision contained in this Amended and Restated Certificate, in the manner now or hereafter prescribed by statute, and all rights conferred upon stockholders herein are granted subject to this reservation;<I> provided</I>,<I> however</I>, that,
notwithstanding any other provision of this Amended and Restated Certificate or any provision of law that might otherwise permit a lesser vote, but in addition to any vote of the holders of any class or series of the stock of this Corporation
required by law or by this Amended and Restated Certificate, from and after the Final Conversion Date, the affirmative vote of the holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the voting power of the outstanding shares
of stock of the Corporation entitled to vote generally in the election of directors, voting together as a single class, shall be required to amend or repeal, or adopt any provision of this Amended and Restated Certificate inconsistent with, Article
III, Article&nbsp;V, Article VI, Article VII, Article VIII or this Article&nbsp;X. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="annex c"></A><A NAME="rom14810_72"></A>Annex C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED BYLAWS OF </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Effective &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B></B><B><I>Page</I></B><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE I&#151;CORPORATE OFFICES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">REGISTERED OFFICE</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">OTHER OFFICES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE II&#151;MEETINGS OF STOCKHOLDERS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PLACE OF MEETINGS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ANNUAL MEETING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SPECIAL MEETING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ADVANCE NOTICE PROCEDURES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">NOTICE OF STOCKHOLDERS&#146; MEETINGS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-6</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">QUORUM</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-6</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ADJOURNED MEETING; NOTICE</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-6</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CONDUCT OF BUSINESS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">VOTING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">STOCKHOLDER ACTION BY WRITTEN CONSENT WITHOUT A MEETING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">RECORD DATES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PROXIES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-8</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">LIST OF STOCKHOLDERS ENTITLED TO VOTE</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-8</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">INSPECTORS OF ELECTION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-9</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE III&#151;DIRECTORS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-9</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">POWERS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-9</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">NUMBER OF DIRECTORS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-9</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ELECTION, QUALIFICATION AND TERM OF OFFICE OF DIRECTORS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-9</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">RESIGNATION AND VACANCIES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-9</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PLACE OF MEETINGS; MEETINGS BY TELEPHONE</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-10</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">REGULAR MEETINGS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-10</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SPECIAL MEETINGS; NOTICE</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-10</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">QUORUM; VOTING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-10</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">BOARD ACTION BY WRITTEN CONSENT WITHOUT A MEETING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-10</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">FEES AND COMPENSATION OF DIRECTORS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-11</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">REMOVAL OF DIRECTORS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-11</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IV&#151;COMMITTEES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-11</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">COMMITTEES OF DIRECTORS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-11</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">COMMITTEE MINUTES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-11</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">MEETINGS AND ACTION OF COMMITTEES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-11</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SUBCOMMITTEES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-12</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE V&#151;OFFICERS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-12</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">OFFICERS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-12</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">APPOINTMENT OF OFFICERS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-12</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-i</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SUBORDINATE OFFICERS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-12</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">REMOVAL AND RESIGNATION OF OFFICERS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-12</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">VACANCIES IN OFFICES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-12</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">REPRESENTATION OF SECURITIES OF OTHER ENTITIES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-13</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">AUTHORITY AND DUTIES OF OFFICERS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-13</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VI&#151;STOCK</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-13</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SHARES OF STOCK</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-13</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">DIVIDENDS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-13</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">STOCK TRANSFER AGREEMENTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-13</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">REGISTERED STOCKHOLDERS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-13</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VII&#151;MANNER OF GIVING NOTICE AND WAIVER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-13</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">NOTICE OF STOCKHOLDERS&#146; MEETINGS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-13</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">NOTICE TO STOCKHOLDERS SHARING AN ADDRESS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-14</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">NOTICE TO PERSON WITH WHOM COMMUNICATION IS UNLAWFUL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-14</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">WAIVER OF NOTICE</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-14</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VIII&#151;INDEMNIFICATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-14</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">INDEMNIFICATION OF DIRECTORS AND OFFICERS IN THIRD PARTY PROCEEDINGS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-14</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">INDEMNIFICATION OF DIRECTORS AND OFFICERS IN ACTIONS BY OR IN THE RIGHT OF THE CORPORATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-15</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SUCCESSFUL DEFENSE</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-15</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">INDEMNIFICATION OF OTHERS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-15</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ADVANCE PAYMENT OF EXPENSES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-15</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">LIMITATION ON INDEMNIFICATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-16</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">DETERMINATION; CLAIM</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-16</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">NON-EXCLUSIVITY</FONT> OF RIGHTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-16</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">INSURANCE</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-16</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SURVIVAL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-17</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">EFFECT OF REPEAL OR MODIFICATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-17</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CERTAIN DEFINITIONS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-17</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IX&#151;GENERAL MATTERS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-17</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">EXECUTION OF CORPORATE CONTRACTS AND INSTRUMENTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-17</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">FISCAL YEAR</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-17</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SEAL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-18</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CONSTRUCTION; DEFINITIONS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-18</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE X&#151;AMENDMENTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-18</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE XI&#151;EXCLUSIVE FORUM</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">C-18</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-ii</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BYLAWS OF KENSINGTON CAPITAL ACQUISITION CORP. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I&#151;CORPORATE OFFICES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1 REGISTERED OFFICE </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
registered office of Kensington Capital Acquisition Corp. (the &#147;<B>Corporation</B>&#148;) shall be fixed in the Corporation&#146;s certificate of incorporation, as the same may be amended from time to time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 OTHER OFFICES </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Corporation may at any time establish other offices at any place or places. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II&#151;MEETINGS OF STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 PLACE OF MEETINGS </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Meetings
of stockholders shall be held at a place, if any, within or outside the State of Delaware, designated by the board of directors of the Corporation (the &#147;<B>Board</B>&#148;). The Board may, in its sole discretion, determine that a meeting of
stockholders shall not be held at any place, but may instead be held solely by means of remote communication as authorized by Section&nbsp;211(a)(2) of the Delaware General Corporation Law (the &#147;<B>DGCL</B>&#148;) or any successor legislation.
In the absence of any such designation or determination, stockholders&#146; meetings shall be held at the Corporation&#146;s principal executive office. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 ANNUAL MEETING </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The annual
meeting of stockholders shall be held on such date, at such time, and at such place (if any) within or without the State of Delaware, as the Board shall designate from time to time and as stated in the Corporation&#146;s notice of the meeting. At
the annual meeting, directors shall be elected and any other proper business, brought in accordance with Section&nbsp;2.4 of these bylaws, may be transacted. The Board, acting pursuant to a resolution adopted by a majority of the Whole Board, or the
chair of the meeting, may cancel, postpone or reschedule any previously scheduled annual meeting at any time, before or after the notice for such meeting has been sent to the stockholders. For purposes of these bylaws, the term &#147;<B>Whole
Board</B>&#148; shall mean the total number of authorized directors whether or not there exist any vacancies or other unfilled seats in previously authorized directorships (provided for the avoidance of doubt that voting power shall be attributed to
any such vacancies or unfilled seats). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 SPECIAL MEETING </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) A special meeting of the stockholders, other than as required by the DGCL, may be called at any time by the Board, acting pursuant to a
resolution adopted by a majority of the Whole Board; the chair of the Board; or the chief executive officer; <I>provided</I> that a special meeting may not be called by any other person or persons and any power of stockholders to call a special
meeting is specifically denied, except as provided in the certificate of incorporation. The Board or the chair of the meeting may cancel, postpone or reschedule any previously scheduled special meeting at any time, before or after the notice for
such meeting has been sent to the stockholders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The notice of a special meeting shall include the purpose for which the meeting is
called. Only such business shall be conducted at a special meeting of stockholders as shall have been brought before the meeting by or at the direction of the Board, chair of the Board or chief executive officer. Nothing contained in this
Section&nbsp;2.3(b) shall be construed as limiting, fixing or affecting the time when a meeting of stockholders called by action of the Board may be held. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 ADVANCE NOTICE PROCEDURES </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Annual Meetings of Stockholders</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Nominations of persons for election to the Board or the proposal of other business to be transacted by the stockholders at an annual
meeting of stockholders may be made only (1)&nbsp;pursuant to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-1</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Corporation&#146;s notice of meeting (or any supplement thereto); (2) by or at the direction of the Board; (3)&nbsp;as may be provided in the certificate of designations for any class or series
of preferred stock; or (4)&nbsp;by any stockholder of the Corporation who (A)&nbsp;is a stockholder of record at the time of giving of the notice contemplated by Section&nbsp;2.4(a)(ii); (B) is a stockholder of record on the record date for the
determination of stockholders entitled to notice of the annual meeting; (C)&nbsp;is a stockholder of record on the record date for the determination of stockholders entitled to vote at the annual meeting; (D)&nbsp;is a stockholder of record at the
time of the annual meeting; and (E)&nbsp;complies with the procedures set forth in this Section&nbsp;2.4(a). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) For nominations or
other business to be properly brought before an annual meeting of stockholders by a stockholder pursuant to clause (4)&nbsp;of Section&nbsp;2.4(a)(i), the stockholder must have given timely notice in writing to the secretary and any such nomination
or proposed business must constitute a proper matter for stockholder action. To be timely, a stockholder&#146;s notice must be received by the secretary at the principal executive offices of the Corporation no earlier than 8:00 a.m., local time, on
the 120th day and no later than 5:00 p.m., local time, on the 90th day prior to the day of the first anniversary of the preceding year&#146;s annual meeting of stockholders. However, if no annual meeting of stockholders was held in the preceding
year, or if the date of the applicable annual meeting has been changed by more than 25 days from the first anniversary of the preceding year&#146;s annual meeting, then to be timely such notice must be received by the secretary at the principal
executive offices of the Corporation no earlier than 8:00 a.m., local time, on the 120th day prior to the day of the annual meeting and no later than 5:00 p.m., local time, on the 10th day following the day on which public announcement of the date
of the annual meeting was first made by the Corporation. In no event will the adjournment, rescheduling or postponement of any annual meeting, or any announcement thereof, commence a new time period (or extend any time period) for the giving of a
stockholder&#146;s notice as described above. If the number of directors to be elected to the Board is increased and there is no public announcement naming all of the nominees for director or specifying the size of the increased Board at least 10
days before the last day that a stockholder may deliver a notice of nomination pursuant to the foregoing provisions, then a stockholder&#146;s notice required by this Section&nbsp;2.4(a)(ii) will also be considered timely, but only with respect to
nominees for any new positions created by such increase, if it is received by the secretary at the principal executive offices of the Corporation no later than 5:00 p.m., local time, on the 10th day following the day on which such public
announcement is first made. &#147;<B>Public announcement</B>&#148; means disclosure in a press release reported by a national news service or in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to
Section&nbsp;13, 14 or 15(d) of the Securities Exchange Act of 1934 (as amended and inclusive of rules and regulations thereunder, the &#147;<B>1934 Act</B>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) A stockholder&#146;s notice to the secretary must set forth: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) as to each person whom the stockholder proposes to nominate for election as a director: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(A) such person&#146;s name, age, business address, residence address and principal occupation or employment; the class and number of shares
of the Corporation that are held of record or are beneficially owned by such person and a description of any Derivative Instruments (defined below) held or beneficially owned thereby or of any other agreement, arrangement or understanding (including
any short position or any borrowing or lending of shares), the effect or intent of which is to mitigate loss to, or to manage the risk or benefit of share price changes for, or to increase or decrease the voting power of such person; and all
information relating to such person that is required to be disclosed in solicitations of proxies for the contested election of directors, or is otherwise required, in each case pursuant to Section&nbsp;14 of the 1934 Act; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(B) such person&#146;s written consent to being named in such stockholder&#146;s proxy statement as a nominee of such stockholder and to
serving as a director of the Corporation if elected; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(C) a reasonably detailed description of any direct or indirect compensatory,
payment, indemnification or other financial agreement, arrangement or understanding that such person has, or has had within the past three years, with any person or entity other than the Corporation (including the amount of any payment or payments
received or receivable thereunder), in each case in connection with his or her candidacy or service as a director of the Corporation (a &#147;<B>Third-Party Compensation Arrangement</B>&#148;); and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-2</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(D) a description of any other material relationships between such person and such
person&#146;s respective affiliates and associates, or others acting in concert with them, on the one hand, and such stockholder giving the notice and the beneficial owner, if any, on whose behalf the nomination is made, and their respective
affiliates and associates, or others acting in concert with them, on the other hand; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) as to any other business that the stockholder
proposes to bring before the annual meeting: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(A) a brief description of the business desired to be brought before the annual meeting;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(B) the text of the proposal or business (including the text of any resolutions proposed for consideration and, if applicable, the text
of any proposed amendment to these bylaws or the Corporation&#146;s certificate of incorporation); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(C) the reasons for conducting such
business at the annual meeting; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(D) any material interest in such business of such stockholder giving the notice and the beneficial
owner, if any, on whose behalf the proposal is made, and their respective affiliates and associates, or others acting in concert with them; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(E) a description of all agreements, arrangements and understandings between such stockholder and the beneficial owner, if any, on whose
behalf the proposal is made, and their respective affiliates or associates or others acting in concert with them, and any other person or persons (including their names) in connection with the proposal of such business by such stockholder; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3) as to the stockholder giving the notice and the beneficial owner, if any, on whose behalf the nomination or proposal is made: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(A) the name and address of such stockholder (as they appear on the Corporation&#146;s books), of such beneficial owner and of their
respective affiliates or associates or others acting in concert with them; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(B) for each class or series, the number of shares of stock of
the Corporation that are, directly or indirectly, held of record or are beneficially owned by such stockholder, such beneficial owner or their respective affiliates or associates or others acting in concert with them; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(C) a description of any agreement, arrangement or understanding between such stockholder, such beneficial owner or their respective
affiliates or associates or others acting in concert with them, and any other person or persons (including, in each case, their names) in connection with the proposal of such nomination or other business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(D) a description of any agreement, arrangement or understanding (including, regardless of the form of settlement, any derivative, long or
short positions, profit interests, forwards, futures, swaps, options, warrants, convertible securities, stock appreciation or similar rights, hedging transactions and borrowed or loaned shares) that has been entered into by or on behalf of such
stockholder, such beneficial owner or their respective affiliates or associates or others acting in concert with them, with respect to the Corporation&#146;s securities (any of the foregoing, a &#147;<B>Derivative Instrument</B>&#148;), or any other
agreement, arrangement or understanding that has been made the effect or intent of which is to create or mitigate loss to, manage risk or benefit of share price changes for or increase or decrease the voting power of such stockholder, such
beneficial owner or their respective affiliates or associates or others acting in concert with them, with respect to the Corporation&#146;s securities; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(E) any rights to dividends on the Corporation&#146;s securities owned beneficially by such stockholder, such beneficial owner or their
respective affiliates or associates or others acting in concert with them, that are separated or separable from the underlying security; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(F) any proportionate interest in the Corporation&#146;s securities or Derivative Instruments held, directly or indirectly, by a general or
limited partnership in which such stockholder, such beneficial owner or their respective affiliates or associates or others acting in concert with them, is a general partner or, directly or indirectly, beneficially owns an interest in a general
partner of such general or limited partnership; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-3</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(G) any performance-related fees (other than an asset-based fee) that such stockholder,
such beneficial owner or their respective affiliates or associates or others acting in concert with, them is entitled to based on any increase or decrease in the value of the Corporation&#146;s securities or Derivative Instruments, including,
without limitation, any such interests held by members of the immediate family of such persons sharing the same household; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(H) any
significant equity interests or any Derivative Instruments in any principal competitor of the Corporation that are held by such stockholder, such beneficial owner or their respective affiliates or associates or others acting in concert with them;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(I) any direct or indirect interest of such stockholder, such beneficial owner or their respective affiliates or associates or others
acting in concert with them, in any contract with the Corporation, any affiliate of the Corporation or any principal competitor of the Corporation (in each case, including any employment agreement, collective bargaining agreement or consulting
agreement); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(J) a representation and undertaking that the stockholder is a holder of record of stock of the Corporation as of the date of
submission of the stockholder&#146;s notice and intends to appear in person or by proxy at the meeting to bring such nomination or other business before the meeting; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(K) a representation and undertaking that such stockholder or any such beneficial owner intends, or is part of a group that intends, to
(x)&nbsp;deliver a proxy statement or form of proxy to holders of at least the percentage of the voting power of the Corporation&#146;s then-outstanding stock required to approve or adopt the proposal or to elect each such nominee; or
(y)&nbsp;otherwise solicit proxies from stockholders in support of such proposal or nomination; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(L) any other information relating to
such stockholder, such beneficial owner, or their respective affiliates or associates or others acting in concert with them, or director nominee or proposed business that, in each case, would be required to be disclosed in a proxy statement or other
filing required to be made in connection with the solicitation of proxies in support of such nominee (in a contested election of directors) or proposal pursuant to Section&nbsp;14 of the 1934 Act; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(M) such other information relating to any proposed item of business as the Corporation may reasonably require to determine whether such
proposed item of business is a proper matter for stockholder action. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) In addition to the requirements of this Section&nbsp;2.4, to be
timely, a stockholder&#146;s notice (and any additional information submitted to the Corporation in connection therewith) must further be updated and supplemented (1)&nbsp;if necessary, so that the information provided or required to be provided in
such notice is true and correct as of the record date(s) for determining the stockholders entitled to notice of, and to vote at, the meeting and as of the date that is 10 business days prior to the meeting or any adjournment, rescheduling or
postponement thereof and (2)&nbsp;to provide any additional information that the Corporation may reasonably request. Such update and supplement or additional information, if applicable, must be received by the secretary at the principal executive
offices of the Corporation, in the case of a request for additional information, promptly following a request therefor, which response must be delivered not later than such reasonable time as is specified in any such request from the Corporation or,
in the case of any other update or supplement of any information, not later than five business days after the record date(s) for the meeting (in the case of any update and supplement required to be made as of the record date(s)), and not later than
eight business days prior to the date for the meeting or any adjournment, rescheduling or postponement thereof (in the case of the update and supplement required to be made as of 10 business days prior to the meeting or any adjournment, rescheduling
or postponement thereof). The failure to timely provide such update, supplement or additional information shall result in the nomination or proposal no longer being eligible for consideration at the meeting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Special Meetings of Stockholders</I>. Except to the extent required by the DGCL, special meetings of stockholders may be called only in
accordance with the Corporation&#146;s certificate of incorporation and these bylaws. Only such business will be conducted at a special meeting of stockholders as has been brought before the special meeting pursuant to the Corporation&#146;s notice
of meeting. If the election of directors is included as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-4</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
business to be brought before a special meeting in the Corporation&#146;s notice of meeting, then nominations of persons for election to the Board at such special meeting may be made by any
stockholder who (i)&nbsp;is a stockholder of record at the time of giving of the notice contemplated by this Section&nbsp;2.4(b); (ii) is a stockholder of record on the record date for the determination of stockholders entitled to notice of the
special meeting; (iii)&nbsp;is a stockholder of record on the record date for the determination of stockholders entitled to vote at the special meeting; (iv)&nbsp;is a stockholder of record at the time of the special meeting; and (v)&nbsp;complies
with the procedures set forth in this Section&nbsp;2.4(b). For nominations to be properly brought by a stockholder before a special meeting pursuant to this Section&nbsp;2.4(b), the stockholder&#146;s notice must be received by the secretary at the
principal executive offices of the Corporation no earlier than 8:00 a.m., local time, on the 120th day prior to the day of the special meeting and no later than 5:00 p.m., local time, on the 10th day following the day on which public announcement of
the date of the special meeting was first made. In no event will any adjournment, rescheduling or postponement of a special meeting or the announcement thereof commence a new time period (or extend any time period) for the giving of a
stockholder&#146;s notice. A stockholder&#146;s notice to the Secretary must comply with the applicable notice requirements of Sections 2.4(a)(iii) and 2.4(a)(iv). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Other Requirements</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) To be eligible to be a nominee by any stockholder for election as a director of the Corporation, the proposed nominee must provide to the
secretary, in accordance with the applicable time periods prescribed for delivery of notice under Section&nbsp;2.4(a)(ii) or Section&nbsp;2.4(b): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) a signed and completed written questionnaire (in the form provided by the secretary at the written request of the nominating stockholder,
which form will be provided by the secretary within 10 days of receiving such request) containing information regarding such nominee&#146;s background and qualifications and such other information as may reasonably be required by the Corporation to
determine the eligibility of such nominee to serve as a director of the Corporation or to serve as an independent director of the Corporation; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) a written representation and undertaking that, unless previously disclosed to the Corporation, such nominee is not, and will not become, a
party to any voting agreement, arrangement, commitment, assurance or understanding with any person or entity as to how such nominee, if elected as a director, will vote on any issue; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3) a written representation and undertaking that, unless previously disclosed to the Corporation, such nominee is not, and will not become, a
party to any Third-Party Compensation Arrangement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(4) a written representation and undertaking that, if elected as a director, such
nominee would be in compliance, and will continue to comply, with the Corporation&#146;s corporate governance guidelines as disclosed on the Corporation&#146;s website, as amended from time to time; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(5) a written representation and undertaking that such nominee, if elected, intends to serve a full term on the Board. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) At the request of the Board, any person nominated by the Board for election as a director must furnish to the secretary the information
that is required to be set forth in a stockholder&#146;s notice of nomination that pertains to such nominee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) No person will be
eligible to be nominated by a stockholder for election as a director of the Corporation unless nominated in accordance with the procedures set forth in this Section&nbsp;2.4. No business proposed by a stockholder will be conducted at a stockholder
meeting except in accordance with this Section&nbsp;2.4. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) The chairperson of the applicable meeting of stockholders will, if the
facts warrant, determine and declare to the meeting that a nomination was not made in accordance with the procedures prescribed by these bylaws or that business was not properly brought before the meeting. If the chairperson of the meeting should so
determine, then the chairperson of the meeting will so declare to the meeting and the defective nomination will be disregarded or such business will not be transacted, as the case may be. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) Notwithstanding anything to the contrary in this Section&nbsp;2.4, unless otherwise required by law, if the stockholder (or a qualified
representative of the stockholder) does not appear in person at the meeting to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-5</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
present a nomination or other proposed business, such nomination will be disregarded or such proposed business will not be transacted, as the case may be, notwithstanding that proxies in respect
of such nomination or business may have been received by the Corporation and counted for purposes of determining a quorum. For purposes of this Section&nbsp;2.4, to be considered a qualified representative of the stockholder, a person must be a duly
authorized officer, manager or partner of such stockholder or must be authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder as proxy at the meeting, and such
person must produce such writing or electronic transmission, or a reliable reproduction of the writing or electronic transmission, at the meeting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) Without limiting this Section&nbsp;2.4, a stockholder must also comply with all applicable requirements of the 1934 Act with respect to
the matters set forth in this Section&nbsp;2.4, it being understood that (1)&nbsp;any references in these bylaws to the 1934 Act are not intended to, and will not, limit any requirements applicable to nominations or proposals as to any other
business to be considered pursuant to this Section&nbsp;2.4; and (2)&nbsp;compliance with clause (4)&nbsp;of Section&nbsp;2.4(a)(i) and with Section&nbsp;2.4(b) are the exclusive means for a stockholder to make nominations or submit other business
(other than as provided in Section&nbsp;2.4(c)(vii)). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) Notwithstanding anything to the contrary in this Section&nbsp;2.4, the notice
requirements set forth in these bylaws with respect to the proposal of any business pursuant to this Section&nbsp;2.4 will be deemed to be satisfied by a stockholder if (1)&nbsp;such stockholder has submitted a proposal to the Corporation in
compliance with Rule 14a 8 under the 1934 Act; and (2)&nbsp;such stockholder&#146;s proposal has been included in a proxy statement that has been prepared by the Corporation to solicit proxies for the meeting of stockholders. Subject to Rule 14a 8
and other applicable rules and regulations under the 1934 Act, nothing in these bylaws will be construed to permit any stockholder, or give any stockholder the right, to include or have disseminated or described in the Corporation&#146;s proxy
statement any nomination of a director or any other business proposal. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5 NOTICE OF STOCKHOLDERS&#146; MEETINGS </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever stockholders are required or permitted to take any action at a meeting, a notice of the meeting shall be given which shall state the
place, if any, date and hour of the meeting, the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting, the record date for determining the stockholders
entitled to vote at the meeting, if such date is different from the record date for determining stockholders entitled to notice of the meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is called. Except as
otherwise provided in the DGCL, the certificate of incorporation or these bylaws, the notice of any meeting of stockholders shall be given not less than 10 nor more than 60 days before the date of the meeting to each stockholder entitled to vote at
such meeting as of the record date for determining the stockholders entitled to notice of the meeting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.6 QUORUM </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of a majority of the voting power of the capital stock of the Corporation issued and outstanding and entitled to vote, present in
person or represented by proxy, shall constitute a quorum for the transaction of business at all meetings of the stockholders. Where a separate vote by a class or series or classes or series is required, a majority of the voting power of the
outstanding shares of such class or series or classes or series, present in person or represented by proxy, shall constitute a quorum entitled to take action with respect to that vote on that matter, except as otherwise provided by law, the
certificate of incorporation or these bylaws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, however, such quorum is not present or represented at any meeting of the stockholders,
then either (i)&nbsp;the chair of the meeting, or (ii)&nbsp;the stockholders entitled to vote at the meeting, present in person or represented by proxy, shall have power to adjourn the meeting from time to time, without notice other than
announcement at the meeting, until a quorum is present or represented. At such adjourned meeting at which a quorum is present or represented, any business may be transacted that might have been transacted at the original meeting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.7 ADJOURNED MEETING; NOTICE </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When a meeting is adjourned to another time or place, unless these bylaws otherwise require, notice need not be given of the adjourned meeting
if the time, place, if any, thereof, and the means of remote </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-6</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such adjourned meeting are announced at the meeting at which the adjournment is
taken. At the adjourned meeting, the Corporation may transact any business which might have been transacted at the original meeting. If the adjournment is for more than 30 days, a notice of the adjourned meeting shall be given to each stockholder of
record entitled to vote at the meeting. If after the adjournment a new record date for stockholders entitled to vote is fixed for the adjourned meeting, the Board shall fix a new record date for notice of such adjourned meeting in accordance with
Section&nbsp;213(a) of the DGCL and Section&nbsp;2.11 of these bylaws, and shall give notice of the adjourned meeting to each stockholder of record entitled to vote at such adjourned meeting as of the record date fixed for notice of such adjourned
meeting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.8 CONDUCT OF BUSINESS </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The chair of any meeting of stockholders shall determine the order of business and the procedure at the meeting, including such regulation of
the manner of voting and the conduct of business and discussion as seem to the chair in order. The chair of any meeting of stockholders shall have the power to adjourn the meeting to another place, if any, date or time, whether or not a quorum is
present. The chair of any meeting of stockholders shall be designated by the Board; in the absence of such designation, the chair of the Board, if any, or the chief executive officer (in the absence of the chair of the Board), or in their absence
any other executive officer of the Corporation, shall serve as chair of the stockholder meeting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.9 VOTING </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The stockholders entitled to vote at any meeting of stockholders shall be determined in accordance with the provisions of Section&nbsp;2.11 of
these bylaws, subject to Section&nbsp;217 (relating to voting rights of fiduciaries, pledgors and joint owners of stock) and Section&nbsp;218 (relating to voting trusts and other voting agreements) of the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided by law, the certificate of incorporation, these bylaws or the rules of any applicable stock exchange, in all
matters other than the election of directors, the affirmative vote of a majority of the voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the subject matter shall be the act of the
stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise required by law, the certificate of incorporation or these bylaws, directors shall be elected by a
plurality of the voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the election of directors. Where a separate vote by a class or series or classes or series is required, in all matters other
than the election of directors, the affirmative vote of the majority of the voting power of the shares of such class or series or classes or series present in person or represented by proxy at the meeting and entitled to vote on the subject matter
shall be the act of such class or series or classes or series, except as otherwise provided by law, the certificate of incorporation, these bylaws or the rules of any applicable stock exchange. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.10 STOCKHOLDER ACTION BY WRITTEN CONSENT WITHOUT A MEETING </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the rights of the holders of the shares of any series of Preferred Stock and except as provided in the certificate of incorporation,
any action required or permitted to be taken by the stockholders of the Corporation must be effected at a duly called annual or special meeting of stockholders of the Corporation and may not be effected by any consent in writing by such
stockholders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.11 RECORD DATES </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order that the Corporation may determine the stockholders entitled to notice of any meeting of stockholders or any adjournment thereof, the
Board may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board and which record date shall not be more than 60 nor less than 10 days before the date of such meeting.
If the Board so fixes a date, such date shall also be the record date for determining the stockholders entitled to vote at such meeting unless the Board determines, at the time it fixes such record date, that a later date on or before the date of
the meeting shall be the date for making such determination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-7</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If no record date is fixed by the Board, the record date for determining stockholders
entitled to notice of and to vote at a meeting of stockholders shall be at the close of business on the day immediately preceding the day on which notice is given, or, if notice is waived, at the close of business on the day immediately preceding
the day on which the meeting is held. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A determination of stockholders of record entitled to notice of or to vote at a meeting of
stockholders shall apply to any adjournment of the meeting; <I>provided</I>, <I>however</I>, that the Board may fix a new record date for determination of stockholders entitled to vote at the adjourned meeting, and in such case shall also fix as the
record date for stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote in accordance with the provisions of Section&nbsp;213 of the DGCL and this
Section&nbsp;2.11 at the adjourned meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order that the Corporation may determine the stockholders entitled to receive payment of
any dividend or other distribution or allotment of any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock, or for the purpose of any other lawful action, the Board may fix a record
date, which record date shall not precede the date upon which the resolution fixing the record date is adopted, and which record date shall be not more than 60 days prior to such action. If no record date is fixed, the record date for determining
stockholders for any such purpose shall be at the close of business on the day on which the Board adopts the resolution relating thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.12 PROXIES </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each stockholder
entitled to vote at a meeting of stockholders, or such stockholder&#146;s authorized officer, director, employee or agent, may authorize another person or persons to act for such stockholder by proxy authorized by a document or by a transmission
permitted by law filed in accordance with the procedure established for the meeting, but no such proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period. The revocability of a proxy that
states on its face that it is irrevocable shall be governed by the provisions of Section&nbsp;212 of the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A written proxy may be in
the form of an electronic transmission (as defined in Section&nbsp;232 of the DGCL) which sets forth or is submitted with information from which it can be determined that the electronic transmission was authorized by the stockholder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.13 LIST OF STOCKHOLDERS ENTITLED TO VOTE </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation shall prepare, at least 10 days before every meeting of stockholders, a complete list of the stockholders entitled to vote at
the meeting; <I>provided</I>,<I> however</I>, if the record date for determining the stockholders entitled to vote is less than 10 days before the meeting date, the list shall reflect the stockholders entitled to vote as of the tenth day before the
meeting date, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder. The Corporation shall not be required to include electronic mail addresses or other
electronic contact information on such list. Such list shall be open to the examination of any stockholder for any purpose germane to the meeting for a period of at least 10 days prior to the meeting: (i)&nbsp;on a reasonably accessible electronic
network, <I>provided</I> that the information required to gain access to such list is provided with the notice of the meeting, or (ii)&nbsp;during ordinary business hours, at the Corporation&#146;s principal place of business. In the event that the
Corporation determines to make the list available on an electronic network, the Corporation may take reasonable steps to ensure that such information is available only to stockholders of the Corporation. If the meeting is to be held at a place, then
a list of stockholders entitled to vote at the meeting shall be produced and kept at the time and place of the meeting during the whole time thereof, and may be examined by any stockholder who is present. If the meeting is to be held solely by means
of remote communication, then such list shall also be open to the examination of any stockholder during the whole time of the meeting on a reasonably accessible electronic network, and the information required to access such list shall be provided
with the notice of the meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-8</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.14 INSPECTORS OF ELECTION </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before any meeting of stockholders, the Corporation shall appoint an inspector or inspectors of election to act at the meeting or its
adjournment. The Corporation may designate one or more persons as alternate inspectors to replace any inspector who fails to act. Such inspectors shall take all actions as contemplated under Section&nbsp;231 of the DGCL or any successor provision
thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The inspectors of election shall perform their duties impartially, in good faith, to the best of their ability and as
expeditiously as is practical. If there are multiple inspectors of election, the decision, act or certificate of a majority is effective in all respects as the decision, act or certificate of all. Any report or certificate made by the inspectors of
election is <I>prima facie</I> evidence of the facts stated therein. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III&#151;DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 POWERS </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The business and
affairs of the Corporation shall be managed by or under the direction of the Board, except as may be otherwise provided in the DGCL or the certificate of incorporation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 NUMBER OF DIRECTORS </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Board shall consist of one or more members, each of whom shall be a natural person. Unless the certificate of incorporation fixes the number of directors, the number of directors shall be determined from time to time by resolution adopted by a
majority of the Whole Board. No reduction of the authorized number of directors shall have the effect of removing any director before that director&#146;s term of office expires. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 ELECTION, QUALIFICATION AND TERM OF OFFICE OF DIRECTORS </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided in Section&nbsp;3.4 of these bylaws, each director, including a director elected to fill a vacancy, shall hold office until
the expiration of the term for which elected and until such director&#146;s successor is elected and qualified or until such director&#146;s earlier death, resignation or removal. Directors need not be stockholders unless so required by the
certificate of incorporation or these bylaws. The certificate of incorporation or these bylaws may prescribe other qualifications for directors. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4 RESIGNATION AND VACANCIES </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any director may resign at any time upon notice given in writing or by electronic transmission to the chair of the Board, chief executive
officer or secretary of the Corporation. A resignation is effective when the resignation is delivered unless the resignation specifies a later effective date or an effective date determined upon the happening of an event or events. A resignation
which is conditioned upon the director failing to receive a specified vote for reelection as a director may provide that it is irrevocable. Unless otherwise provided in the certificate of incorporation or these bylaws, when one or more directors
resign from the Board, effective at a future date, a majority of the directors then in office, including those who have so resigned, shall have power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation or
resignations shall become effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in the certificate of incorporation or these bylaws or permitted in the
specific case by resolution of the Board, and subject to the rights of holders of Preferred Stock, vacancies and newly created directorships resulting from any increase in the authorized number of directors elected by all of the stockholders having
the right to vote as a single class may be filled by a majority of the directors then in office, although less than a quorum, or by a sole remaining director, and not by stockholders. If the directors are divided into classes, a person so chosen to
fill a vacancy or newly created directorship shall hold office until the next election of the class for which such director shall have been chosen and until such person&#146;s successor shall have been duly elected and qualified. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-9</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.5 PLACE OF MEETINGS; MEETINGS BY TELEPHONE </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may hold meetings, both regular and special, either within or outside the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise restricted by the certificate of incorporation or these bylaws, members of the Board may participate in a meeting of the
Board by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other, and such participation in a meeting shall constitute presence in person at the meeting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.6 REGULAR MEETINGS </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Regular
meetings of the Board may be held without notice at such time and at such place as shall from time to time be determined by the Board. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.7
SPECIAL MEETINGS; NOTICE </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Special meetings of the Board for any purpose or purposes may be called at any time by the chair of the Board,
the chief executive officer, the secretary or a majority of the Whole Board, provided, that the person(s) authorized to call special meetings of the Board may authorize another person or persons to send notice of such meeting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of the time and place of special meetings shall be: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">delivered personally by hand, by courier or by telephone; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">sent by United States first-class mail, postage prepaid; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">sent by facsimile; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">sent by electronic mail; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">otherwise given by electronic transmission (as defined in Section&nbsp;232 of the DGCL), </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">directed to each director at that director&#146;s address, telephone number, facsimile number, electronic mail address or other contact for notice by
electronic transmission, as the case may be, as shown on the Corporation&#146;s records. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the notice is (i)&nbsp;delivered personally
by hand, by courier or by telephone, (ii)&nbsp;sent by facsimile, (iii)&nbsp;sent by electronic mail or (iv)&nbsp;otherwise given by electronic transmission, it shall be delivered, sent or otherwise directed to each director, as applicable, at least
36 hours before the time of the holding of the meeting. If the notice is sent by United States mail, it shall be deposited in the United States mail at least four days before the time of the holding of the meeting. Any oral notice may be
communicated to the director. The notice need not specify the place of the meeting (if the meeting is to be held at the Corporation&#146;s principal executive office) nor the purpose of the meeting, unless required by statute. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.8 QUORUM; VOTING </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At all
meetings of the Board, a majority of the Whole Board shall constitute a quorum for the transaction of business. If a quorum is not present at any meeting of the Board, then the directors present thereat may adjourn the meeting from time to time,
without notice other than announcement at the meeting, until a quorum is present. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The affirmative vote of a majority of the directors
present at any meeting at which a quorum is present shall be the act of the Board, except as may be otherwise specifically provided by statute, the certificate of incorporation or these bylaws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.9 BOARD ACTION BY WRITTEN CONSENT WITHOUT A MEETING </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise restricted by the certificate of incorporation or these bylaws, any action required or permitted to be taken at any meeting of
the Board, or of any committee thereof, may be taken without a meeting if all members of the Board or committee, as the case may be, consent thereto in writing, or by electronic transmission. Any person (whether or not then a director) may provide,
whether through instruction to an agent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-10</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or otherwise, that a consent to action will be effective at a future time (including a time determined upon the happening of an event), no later than 60 days after such instruction is given or
such provision is made and such consent shall be deemed to have been given for purposes of this Section&nbsp;3.9 at such effective time so long as such person is then a director and did not revoke the consent prior to such time. Any such consent
shall be revocable prior to it becoming effective. After an action is taken, the consent or consents relating thereto shall be filed with the minutes of proceedings of the Board or committee, as applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.10 FEES AND COMPENSATION OF DIRECTORS </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise restricted by the certificate of incorporation or these bylaws, the Board shall have the authority to fix the compensation of
directors. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.11 REMOVAL OF DIRECTORS </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any director may be removed from office by the stockholders of the Corporation as provided in Section&nbsp;141(k) of the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No reduction of the authorized number of directors shall have the effect of removing any director prior to the expiration of such
director&#146;s term of office. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV&#151;COMMITTEES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 COMMITTEES OF DIRECTORS </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Board may, by resolution passed by a majority of the Whole Board, designate one or more committees, each committee to consist of one or more of the directors of the Corporation. The Board may designate one or more directors as alternate members of
any committee, who may replace any absent or disqualified member at any meeting of the committee. In the absence or disqualification of a member of a committee, the member or members thereof present at any meeting and not disqualified from voting,
whether or not such member or members constitute a quorum, may unanimously appoint another member of the Board to act at the meeting in the place of any such absent or disqualified member. Any such committee, to the extent provided in the resolution
of the Board or in these bylaws, shall have and may exercise all the powers and authority of the Board in the management of the business and affairs of the Corporation, and may authorize the seal of the Corporation to be affixed to all papers that
may require it; but no such committee shall have the power or authority to (i)&nbsp;approve or adopt, or recommend to the stockholders, any action or matter (other than the election or removal of directors) expressly required by the DGCL to be
submitted to stockholders for approval, or (ii)&nbsp;adopt, amend or repeal any bylaw of the Corporation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 COMMITTEE MINUTES </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each committee and subcommittee shall keep regular minutes of its meetings. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 MEETINGS AND ACTION OF COMMITTEES </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Meetings and actions of committees and subcommittees shall be governed by, and held and taken in accordance with, the provisions of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Section&nbsp;3.5 (place of meetings and meetings by telephone); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Section&nbsp;3.6 (regular meetings); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Section&nbsp;3.7 (special meetings and notice); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Section&nbsp;3.8 (quorum; voting); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Section&nbsp;3.9 (action without a meeting); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Section&nbsp;7.4 (waiver of notice) </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-11</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">with such changes in the context of those bylaws as are necessary to substitute the committee or
subcommittees and its members for the Board and its members. <I>However</I>: (i)&nbsp;the time and place of regular meetings of committees or subcommittees or subcommittees may be determined either by the Board or by the committee; (ii)&nbsp;special
meetings of committees or subcommittees may also be called by the Board; and (iii)&nbsp;notice of special meetings of committees or subcommittees shall also be given to all alternate members, as applicable, who shall have the right to attend all
meetings of the committee or subcommittee. The Board may adopt rules for the government of any committee not inconsistent with the provisions of these bylaws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4 SUBCOMMITTEES </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless
otherwise provided in the certificate of incorporation, these bylaws or the resolutions of the Board designating the committee, a committee may create one or more subcommittees, each subcommittee to consist of one or more members of the committee,
and delegate to a subcommittee any or all of the powers and authority of the committee. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V&#151;OFFICERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 OFFICERS </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The officers of
the Corporation shall be a chief executive officer and a secretary. The Corporation may also have, at the discretion of the Board, a chair of the Board, a vice chair of the Board, a chief financial officer or treasurer, one or more vice presidents,
one or more assistant vice presidents, one or more assistant treasurers, one or more assistant secretaries, and any such other officers as may be appointed in accordance with the provisions of these bylaws. Any number of offices may be held by the
same person. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 APPOINTMENT OF OFFICERS </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board shall appoint the officers of the Corporation, except such officers as may be appointed in accordance with the provisions of
Section&nbsp;5.3 of these bylaws, subject to the rights, if any, of an officer under any contract of employment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 SUBORDINATE OFFICERS
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may appoint, or empower the chief executive officer, to appoint, such other officers as the business of the Corporation may
require. Each of such officers shall hold office for such period, have such authority, and perform such duties as are provided in these bylaws or as the Board may from time to time determine. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 REMOVAL AND RESIGNATION OF OFFICERS </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the rights, if any, of an officer under any contract of employment, any officer may be removed, either with or without cause, by the
Board or, for the avoidance of doubt, any duly authorized committee or subcommittee thereof or by any officer who has been conferred such power of removal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any officer may resign at any time by giving notice, in writing or by electronic transmission, to the Corporation. Any resignation shall take
effect at the date of the receipt of that notice or at any later time specified in that notice. Unless otherwise specified in the notice of resignation, the acceptance of the resignation shall not be necessary to make it effective. Any resignation
is without prejudice to the rights, if any, of the Corporation under any contract to which the officer is a party. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5 VACANCIES IN
OFFICES </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any vacancy occurring in any office of the Corporation shall be filled by the Board or as provided in Section&nbsp;5.3. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-12</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6 REPRESENTATION OF SECURITIES OF OTHER ENTITIES </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The chair of the Board, the chief executive officer, any vice president, the treasurer, the secretary or assistant secretary of this
Corporation, or any other person authorized by the Board or the chief executive officer or a vice president, is authorized to vote, represent, and exercise on behalf of this Corporation all rights incident to any and all shares or other securities
of any other entity or entities, and all rights incident to any management authority conferred on the Corporation in accordance with the governing documents of any entity or entities, standing in the name of this Corporation, including the right to
act by written consent. The authority granted herein may be exercised either by such person directly or by any other person authorized to do so by proxy or power of attorney duly executed by such person having the authority. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.7 AUTHORITY AND DUTIES OF OFFICERS </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All officers of the Corporation shall respectively have such authority and perform such duties in the management of the business of the
Corporation as may be designated from time to time by the Board and, to the extent not so provided, as generally pertain to their respective offices, subject to the control of the Board. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI&#151;STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1 SHARES OF STOCK </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as
otherwise provided in a resolution approved by the Board of Directors, all shares of capital stock of the Corporation shall be uncertificated shares. The Corporation may adopt a system of issuance, recordation and transfer of its shares of stock by
electronic or other means not involving the issuance of certificates, provided the use of such system by the Corporation is permitted in accordance with applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2 DIVIDENDS </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board, subject
to any restrictions contained in the certificate of incorporation or applicable law, may declare and pay dividends upon the shares of the Corporation&#146;s capital stock. Dividends may be paid in cash, in property, or in shares of the
Corporation&#146;s capital stock, subject to the provisions of the certificate of incorporation. The Board may set apart out of any of the funds of the Corporation available for dividends a reserve or reserves for any proper purpose and may abolish
any such reserve. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.3 STOCK TRANSFER AGREEMENTS </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation shall have power to enter into and perform any agreement with any number of stockholders of any one or more classes of stock of
the Corporation to restrict the transfer of shares of stock of the Corporation of any one or more classes owned by such stockholders in any manner not prohibited by the DGCL. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.4 REGISTERED STOCKHOLDERS </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Corporation: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to receive
dividends, to receive notifications and otherwise exercise rights and powers of an owner of such shares and to vote as such owner; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)
shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of another person, whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of Delaware.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII&#151;MANNER OF GIVING NOTICE AND WAIVER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1 NOTICE OF STOCKHOLDERS&#146; MEETINGS </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of any meeting of stockholders shall be given in the manner set forth in the DGCL. An affidavit of the secretary or an assistant
secretary of the Corporation or of the transfer agent or other agent of the Corporation that the notice has been given shall, in the absence of fraud, be <I>prima facie</I> evidence of the facts stated therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-13</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2 NOTICE TO STOCKHOLDERS SHARING AN ADDRESS </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise prohibited under the DGCL, without limiting the manner by which notice otherwise may be given effectively to stockholders,
any notice to stockholders given by the Corporation under the provisions of the DGCL, the certificate of incorporation or these bylaws shall be effective if given by a single written notice to stockholders who share an address if consented to by the
stockholders at that address to whom such notice is given. Any such consent shall be revocable by the stockholder by written notice to the Corporation. Any stockholder who fails to object in writing to the Corporation, within 60 days of having been
given written notice by the Corporation of its intention to send the single notice, shall be deemed to have consented to receiving such single written notice. This Section&nbsp;7.2 shall not apply to Sections 164, 296, 311, 312 or 324 of the DGCL.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3 NOTICE TO PERSON WITH WHOM COMMUNICATION IS UNLAWFUL </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever notice is required to be given, under the DGCL, the certificate of incorporation or these bylaws, to any person with whom
communication is unlawful, the giving of such notice to such person shall not be required and there shall be no duty to apply to any governmental authority or agency for a license or permit to give such notice to such person. Any action or meeting
which shall be taken or held without notice to any such person with whom communication is unlawful shall have the same force and effect as if such notice had been duly given. In the event that the action taken by the Corporation is such as to
require the filing of a certificate under the DGCL, the certificate shall state, if such is the fact and if notice is required, that notice was given to all persons entitled to receive notice except such persons with whom communication is unlawful.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.4 WAIVER OF NOTICE </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever notice is required to be given under any provision of the DGCL, the certificate of incorporation or these bylaws, a written waiver,
signed by the person entitled to notice, or a waiver by electronic transmission by the person entitled to notice, whether before or after the time of the event for which notice is to be given, shall be deemed equivalent to notice. Attendance of a
person at a meeting shall constitute a waiver of notice of such meeting, except if (and to the extent only) the person attends a meeting for the express purpose of objecting at the beginning of the meeting, to the transaction of any business because
the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the stockholders need be specified in any written waiver of notice or any waiver by electronic
transmission unless so required by the certificate of incorporation or these bylaws. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII&#151;INDEMNIFICATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1 INDEMNIFICATION OF DIRECTORS AND OFFICERS IN THIRD PARTY PROCEEDINGS </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the other provisions of this Article VIII, the Corporation shall indemnify, to the fullest extent permitted by the DGCL, as now or
hereinafter in effect, any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (a
&#147;<B>Proceeding</B>&#148;) (other than an action by or in the right of the Corporation) by reason of the fact that such person is or was a director or officer of the Corporation, or is or was a director or officer of the Corporation serving at
the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#146; fees), judgments, fines and amounts paid in
settlement actually and reasonably incurred by such person in connection with such Proceeding if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Corporation, and,
with respect to any criminal action or proceeding, had no reasonable cause to believe such person&#146;s conduct was unlawful. The termination of any Proceeding by judgment, order, settlement, conviction, or upon a plea of <I>nolo contendere</I> or
its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which such person reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any
criminal action or proceeding, had reasonable cause to believe that such person&#146;s conduct was unlawful. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-14</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2 INDEMNIFICATION OF DIRECTORS AND OFFICERS IN ACTIONS BY OR IN THE RIGHT OF THE
CORPORATION </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the other provisions of this Article VIII, the Corporation shall indemnify, to the fullest extent permitted by the
DGCL, as now or hereinafter in effect, any person who was or is a party or is threatened to be made a party to any threatened, pending or completed Proceeding by or in the right of the Corporation to procure a judgment in its favor by reason of the
fact that such person is or was a director or officer of the Corporation, or is or was a director or officer of the Corporation serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership,
joint venture, trust or other enterprise against expenses (including attorneys&#146; fees) actually and reasonably incurred by such person in connection with the defense or settlement of such Proceeding if such person acted in good faith and in a
manner such person reasonably believed to be in or not opposed to the best interests of the Corporation; except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be
liable to the Corporation unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the
circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.3 SUCCESSFUL DEFENSE </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the
extent that a present or former director or officer (for purposes of this Section&nbsp;8.3 only, as such term is defined in Section&nbsp;145(c)(1) of the DGCL) of the Corporation has been successful on the merits or otherwise in defense of any
action, suit or proceeding described in Section&nbsp;8.1 or Section&nbsp;8.2, or in defense of any claim, issue or matter therein, such person shall be indemnified against expenses (including attorneys&#146; fees) actually and reasonably incurred by
such person in connection therewith. The Corporation may indemnify any other person who is not a present or former officer of the Corporation against expenses (including attorneys&#146; fees) actually and reasonably incurred by such person to the
extent he or she has been successful on the merits or otherwise in defense of any suit or proceeding described in Section&nbsp;8.1 or Section&nbsp;8.2, or in defense of any claim, issue or matter therein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.4 INDEMNIFICATION OF OTHERS </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the other provisions of this Article VIII, the Corporation shall have power to indemnify its employees and agents, or any other
persons, to the extent not prohibited by the DGCL or other applicable law. The Board shall have the power to delegate to any person or persons identified in subsections (1)&nbsp;through (4) of Section&nbsp;145(d) of the DGCL the determination of
whether employees or agents shall be indemnified. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.5 ADVANCE PAYMENT OF EXPENSES </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Expenses (including attorneys&#146; fees) actually and reasonably incurred by an officer or director of the Corporation in defending any
Proceeding shall be paid by the Corporation in advance of the final disposition of such Proceeding upon receipt of a written request therefor (together with documentation reasonably evidencing such expenses) and an undertaking by or on behalf of the
person to repay such amounts if it shall ultimately be determined that the person is not entitled to be indemnified under this Article VIII or the DGCL. Such expenses (including attorneys&#146; fees) actually and reasonably incurred by former
directors and officers or other current or former employees and agents of the Corporation or by persons currently or formerly serving at the request of the Corporation as directors, officers, employees or agents of another corporation, partnership,
joint venture, trust or other enterprise may be so paid upon such terms and conditions, if any, as the Corporation deems appropriate. The right to advancement of expenses shall not apply to any Proceeding (or any part of any Proceeding) for which
indemnity is excluded pursuant to these bylaws, but shall apply to any Proceeding (or any part of any Proceeding) referenced in Section&nbsp;8.6(b) or 8.6(c) prior to a determination that the person is not entitled to be indemnified by the
Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-15</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.6 LIMITATION ON INDEMNIFICATION </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the requirements in Section&nbsp;8.3 and the DGCL, the Corporation shall not be obligated to indemnify any person pursuant to this
Article VIII in connection with any Proceeding (or any part of any Proceeding): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) for which payment has actually been made to or on
behalf of such person under any statute, insurance policy, indemnity provision, vote or otherwise, except with respect to any excess beyond the amount paid; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) for an accounting or disgorgement of profits pursuant to Section&nbsp;16(b) of the 1934 Act, or any successor thereto, or similar
provisions of federal, state or local statutory law or common law, if such person is held liable therefor (including pursuant to any settlement arrangements); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) for any reimbursement of the Corporation by such person of any bonus or other incentive-based or equity-based compensation or of any
profits realized by such person from the sale of securities of the Corporation, as required in each case under the 1934 Act, or any successor thereto (including any such reimbursements that arise from an accounting restatement of the Corporation
pursuant to Section&nbsp;304 of the Sarbanes-Oxley Act of 2002 (the &#147;<B>Sarbanes-Oxley Act</B>&#148;), or the payment to the Corporation of profits arising from the purchase and sale by such person of securities in violation of Section&nbsp;306
of the Sarbanes-Oxley Act), if such person is held liable therefor (including pursuant to any settlement arrangements); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) initiated by
such person, including any Proceeding (or any part of any Proceeding) initiated by such person against the Corporation or its directors, officers, employees, agents or other indemnitees, unless (a)&nbsp;the Board authorized the Proceeding (or the
relevant part of the Proceeding) prior to its initiation, (b)&nbsp;the Corporation provides the indemnification, in its sole discretion, pursuant to the powers vested in the Corporation under applicable law, (c)&nbsp;otherwise required to be made
under Section&nbsp;8.7 or (d)&nbsp;otherwise required by applicable law; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) if prohibited by applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.7 DETERMINATION; CLAIM </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a
claim for indemnification or advancement of expenses under this Article VIII is not paid in full within 90 days after receipt by the Corporation of the written request therefor, the claimant shall be entitled to an adjudication by a court of
competent jurisdiction of such claimant&#146;s entitlement to such indemnification or advancement of expenses. The Corporation shall indemnify such person against any and all expenses that are actually and reasonably incurred by such person in
connection with any action for indemnification or advancement of expenses from the Corporation under this Article VIII, to the extent such person is successful in such action, and to the extent not prohibited by law. In any such suit, the
Corporation shall, to the fullest extent not prohibited by law, have the burden of proving that the claimant is not entitled to the requested indemnification or advancement of expenses. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.8 <FONT STYLE="white-space:nowrap">NON-EXCLUSIVITY</FONT> OF RIGHTS </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indemnification and advancement of expenses provided by, or granted pursuant to, this Article VIII shall not be deemed exclusive of any
other rights to which those seeking indemnification or advancement of expenses may be entitled under the certificate of incorporation or any statute, bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action
in such person&#146;s official capacity and as to action in another capacity while holding such office. The Corporation is specifically authorized to enter into individual contracts with any or all of its directors, officers, employees or agents
respecting indemnification and advancement of expenses, to the fullest extent not prohibited by the DGCL or other applicable law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.9
INSURANCE </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent
of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-16</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
liability asserted against such person and incurred by such person in any such capacity, or arising out of such person&#146;s status as such, whether or not the Corporation would have the power
to indemnify such person against such liability under the provisions of the DGCL. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.10 SURVIVAL </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rights to indemnification and advancement of expenses conferred by this Article VIII shall continue as to a person who has ceased to be a
director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such a person. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.11
EFFECT OF REPEAL OR MODIFICATION </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A right to indemnification or to advancement of expenses arising under a provision of the certificate of
incorporation or a bylaw shall not be eliminated or impaired by an amendment to or repeal or elimination of the certificate of incorporation or these bylaws after the occurrence of the act or omission that is the subject of the civil, criminal,
administrative or investigative action, suit or proceeding for which indemnification or advancement of expenses is sought, unless the provision in effect at the time of such act or omission explicitly authorizes such elimination or impairment after
such action or omission has occurred. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.12 CERTAIN DEFINITIONS </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Article VIII, references to the &#147;<B>Corporation</B>&#148; shall include, in addition to the resulting Corporation,
any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, employees or
agents, so that any person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation,
partnership, joint venture, trust or other enterprise, shall stand in the same position under the provisions of this Article VIII with respect to the resulting or surviving Corporation as such person would have with respect to such constituent
corporation if its separate existence had continued. For purposes of this Article VIII, references to &#147;<B>other enterprises</B>&#148; shall include employee benefit plans; references to &#147;<B>fines</B>&#148; shall include any excise taxes
assessed on a person with respect to an employee benefit plan; and references to &#147;<B>serving at the request of the Corporation</B>&#148; shall include any service as a director, officer, employee or agent of the Corporation which imposes duties
on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner such person reasonably believed to be in the
interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner &#147;<B>not opposed to the best interests of the Corporation</B>&#148; as referred to in this Article VIII. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX&#151;GENERAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1 EXECUTION OF CORPORATE CONTRACTS AND INSTRUMENTS </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided by law, the certificate of incorporation or these bylaws, the Board may authorize any officer or officers, or
agent or agents, to enter into any contract or execute any document or instrument in the name of and on behalf of the Corporation; such authority may be general or confined to specific instances. Unless so authorized or ratified by the Board or
within the agency power of an officer, no officer, agent or employee shall have any power or authority to bind the Corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2 FISCAL YEAR </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fiscal year
of the Corporation shall be fixed by resolution of the Board and may be changed by the Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-17</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3 SEAL </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may adopt a corporate seal, which shall be adopted and which may be altered by the Board. The Corporation may use the corporate
seal by causing it or a facsimile thereof to be impressed or affixed or in any other manner reproduced. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.4 CONSTRUCTION; DEFINITIONS </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the context requires otherwise, the general provisions, rules of construction, and definitions in the DGCL shall govern the construction
of these bylaws. Without limiting the generality of this provision, the singular number includes the plural, the plural number includes the singular, and the term &#147;<B>person</B>&#148; includes a corporation, partnership, limited liability
company, joint venture, trust or other enterprise, and a natural person. Any reference in these bylaws to a section of the DGCL shall be deemed to refer to such section as amended from time to time and any successor provisions thereto. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE X&#151;AMENDMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These bylaws may be adopted, amended or repealed by the stockholders entitled to vote; <I>provided</I>,<I> however</I>, that from and after
the Final Conversion Date, the affirmative vote of the holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the total voting power of outstanding voting securities of the corporation, voting together as a single class, shall be
required for the stockholders of the Corporation to alter, amend or repeal, or adopt any provision of these bylaws. The Board shall also have the power to adopt, amend or repeal these bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A bylaw amendment adopted by stockholders shall not be further amended or repealed by the Board. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XI&#151;EXCLUSIVE FORUM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the fullest extent permitted by applicable law: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, if
the Court of Chancery does not have jurisdiction, another State court in Delaware or the federal district court for the District of Delaware) shall, to the fullest extent permitted by law, be the sole and exclusive forum for (i)&nbsp;any derivative
action or proceeding brought on behalf of the Corporation, (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by, or otherwise wrongdoing by, any director, stockholder, officer or other employee of the Corporation to the
Corporation or the Corporation&#146;s stockholders, (iii)&nbsp;any action arising pursuant to any provision of the DGCL or the Certificate of Incorporation or these bylaws (as either may be amended from time to time), (iv) any action to interpret,
apply, enforce or determine the validity of the Certificate of Incorporation or these bylaws (as either may be amended from time to time), or (v)&nbsp;any action asserting a claim governed by the internal affairs doctrine, except for, as to each of
(i)&nbsp;through (v) above, any claim as to which such court determines that there is an indispensable party not subject to the jurisdiction of such court (and the indispensable party does not consent to the personal jurisdiction of such court
within ten (10)&nbsp;days following such determination), which is vested in the exclusive jurisdiction of a court or forum other than such court, or for which such court does not have subject matter jurisdiction. Any person or entity purchasing or
otherwise acquiring any interest in any security of the Corporation shall be deemed to have notice of and consented to the provisions of this Article XI, Part (a). For the avoidance of doubt, this Article XI, Part (a)&nbsp;shall not apply to any
action brought to enforce a duty or liability created by the Securities Act of 1933, or any successor thereto (the &#147;<B>Securities Act</B>&#148;) or the 1934 Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Unless the Corporation consents in writing to the selection of an alternative forum, the federal district courts of the United States of
America shall be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any person or entity purchasing or otherwise acquiring or holding any interest in any security of the Corporation shall be deemed to have
notice of and consented to the provisions of this Article XI, Part (b). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">C-18</FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="rom14810_73"></A>Annex D </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>QUANTUMSCAPE CORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2020 EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Purposes of the Plan</U>. The purposes of this Plan are: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to attract and retain the best available personnel for positions of substantial responsibility,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to provide additional incentive to Employees, Directors and Consultants, and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to promote the success of the Company&#146;s business. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Plan permits the grant of Incentive Stock Options, Nonstatutory Stock Options, Restricted Stock, Restricted Stock Units, Stock
Appreciation Rights, Performance Units and Performance Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>. As used herein, the
following definitions will apply: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Administrator</U>&#148; means the Board or any of its Committees as
will be administering the Plan, in accordance with Section&nbsp;4 of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Applicable
Laws</U>&#148; means the legal and regulatory requirements relating to the administration of equity-based awards, including but not limited to the related issuance of shares of Common Stock, including but not limited to, under U.S. state corporate
laws, U.S. federal and state securities laws, the Code, any stock exchange or quotation system on which the Common Stock is listed or quoted and the applicable laws of any <FONT STYLE="white-space:nowrap">non-U.S.</FONT> country or jurisdiction
where Awards are, or will be, granted under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Award</U>&#148; means, individually or
collectively, a grant under the Plan of Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Units or Performance Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Award Agreement</U>&#148; means the written or electronic agreement setting forth the terms and provisions
applicable to each Award granted under the Plan. The Award Agreement is subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Board</U>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Change in Control</U>&#148; means the occurrence of any of the following events: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;A change in the ownership of the Company<I> </I>which occurs on the date that any one person, or more than one
person acting as a group (&#147;<U>Person</U>&#148;), acquires ownership of the stock of the Company that, together with the stock held by such Person, constitutes more than fifty percent (50%) of the total voting power of the stock of the Company;
provided, however, that for purposes of this subsection, (A)&nbsp;the acquisition of additional stock by any one Person, who is considered to own more than fifty percent (50%) of the total voting power of the stock of the Company will not be
considered a Change in Control, and (B)&nbsp;if the stockholders of the Company immediately before such change in ownership continue to retain immediately after the change in ownership, in substantially the same proportions as their ownership of
shares of the Company&#146;s voting stock immediately prior to the change in ownership, the direct or indirect beneficial ownership of fifty percent (50%) or more of the total voting power of the stock of the Company or of the ultimate parent entity
of the Company, such event will not be considered a Change in Control under this subsection (i). For this purpose, indirect beneficial ownership will include, without limitation, an interest resulting from ownership of the voting securities of one
or more corporations or other business entities which own the Company, as the case may be, either directly or through one or more subsidiary corporations or other business entities; or </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;A change in the effective control of the Company which occurs
on the date that a majority of members of the Board is replaced during any twelve (12)&nbsp;month period by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or
election. For purposes of this subsection (ii), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Change in Control; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;A change in the ownership of a substantial portion of the Company&#146;s assets which occurs on the date that
any Person acquires (or has acquired during the twelve (12)&nbsp;month period ending on the date of the most recent acquisition by such Person) assets from the Company that have a total gross fair market value equal to or more than fifty percent
(50%) of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions; provided, however, that for purposes of this subsection (iii), the following will not constitute a change in the
ownership of a substantial portion of the Company&#146;s assets: (A)&nbsp;a transfer to an entity that is controlled by the Company&#146;s stockholders immediately after the transfer, or (B)&nbsp;a transfer of assets by the Company to: (1)&nbsp;a
stockholder of the Company (immediately before the asset transfer) in exchange for or with respect to the Company&#146;s stock, (2)&nbsp;an entity, fifty percent (50%) or more of the total value or voting power of which is owned, directly or
indirectly, by the Company, (3)&nbsp;a Person, that owns, directly or indirectly, fifty percent (50%) or more of the total value or voting power of all the outstanding stock of the Company, or (4)&nbsp;an entity, at least fifty percent (50%) of the
total value or voting power of which is owned, directly or indirectly, by a Person described in this subsection (iii)(B)(3). For purposes of this subsection (iii), gross fair market value means the value of the assets of the Company, or the value of
the assets being disposed of, determined without regard to any liabilities associated with such assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">For purposes of this definition,
persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a transaction will not be deemed a Change in Control unless the transaction qualifies as a change in control
event within the meaning of Code Section&nbsp;409A, as it has been and may be amended from time to time, and any proposed or final Treasury Regulations and Internal Revenue Service guidance that has been promulgated or may be promulgated thereunder
from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Further and for the avoidance of doubt, a transaction will not constitute a Change in Control if: (i)&nbsp;its sole
purpose is to change the jurisdiction of the Company&#146;s incorporation, or (ii)&nbsp;its sole purpose is to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#146;s securities
immediately before such transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Code</U>&#148; means the U.S. Internal Revenue Code of 1986, as
amended. Reference to a specific section of the Code or regulation thereunder will include such section or regulation, any valid regulation promulgated under such section, and any comparable provision of any future legislation or regulation
amending, supplementing or superseding such section or regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Committee</U>&#148; means a
committee of Directors or of other individuals satisfying Applicable Laws appointed by the Board, or a duly authorized committee of the Board, in accordance with Section&nbsp;4 hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Common Stock</U>&#148; means the Class&nbsp;A common stock of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company</U>&#148; means Kensington Capital Acquisition Corp., a Delaware corporation, or any successor
thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Consultant</U>&#148; means any natural person, including an advisor, engaged by the Company
or a Parent or Subsidiary to render bona fide services to such entity, provided the services (i)&nbsp;are not in connection </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with the offer or sale of securities in a <FONT STYLE="white-space:nowrap">capital-raising</FONT> transaction, and (ii)&nbsp;do not directly promote or maintain a market for the Company&#146;s
securities, in each case, within the meaning of Form <FONT STYLE="white-space:nowrap">S-8</FONT> promulgated under the Securities Act, and provided, further, that a Consultant will include only those persons to whom the issuance of Shares may be
registered under Form <FONT STYLE="white-space:nowrap">S-8</FONT> promulgated under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Director</U>&#148; means a member of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Disability</U>&#148; means total and permanent disability as defined in Section&nbsp;22(e)(3) of the Code,
provided that in the case of Awards other than Incentive Stock Options, the Administrator in its discretion may determine whether a permanent and total disability exists in accordance with uniform and
<FONT STYLE="white-space:nowrap">non-discriminatory</FONT> standards adopted by the Administrator from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Effective Date</U>&#148; means the date of the consummation of the merger by and between the Company,
QuantumScape Corporation, and certain other parties, pursuant to that certain Business Combination Agreement dated September&nbsp;2, 2020 (such merger, the &#147;<U>Merger</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Employee</U>&#148; means any person, including Officers and Directors, providing services as an employee
to the Company or any Parent or Subsidiary of the Company. Neither service as a Director nor payment of a director&#146;s fee by the Company will be sufficient to constitute &#147;employment&#148; by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Exchange Act</U>&#148; means the U.S. Securities Exchange Act of 1934, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Exchange Program</U>&#148; means a program under which (i)&nbsp;outstanding Awards are surrendered or
cancelled in exchange for awards of the same type (which may have higher or lower exercise prices and different terms), awards of a different type, and/or cash, (ii)&nbsp;Participants would have the opportunity to transfer any outstanding Awards to
a financial institution or other person or entity selected by the Administrator, and/or (iii)&nbsp;the exercise price of an outstanding Award is increased or reduced. The Administrator will determine the terms and conditions of any Exchange Program
in its sole discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Fair Market Value</U>&#148; means, as of any date, the value of Common Stock
determined as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;If the Common Stock is listed on any established stock exchange or a national market
system, including without limitation the New York Stock Exchange, the NASDAQ Global Select Market, the NASDAQ Global Market or the NASDAQ Capital Market of The NASDAQ Stock Market, its Fair Market Value will be the closing sales price for such stock
(or the closing bid, if no sales were reported) as quoted on such exchange or system on the day of determination, as reported in <I>The Wall Street Journal</I> or such other source as the Administrator deems reliable; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;If the Common Stock is regularly quoted by a recognized securities dealer but selling prices are not reported,
the Fair Market Value of a Share will be the mean between the high bid and low asked prices for the Common Stock on the day of determination (or, if no bids and asks were reported on that date, as applicable, on the last trading date such bids and
asks were reported), as reported in <I>The Wall Street Journal</I> or such other source as the Administrator deems reliable; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;In the absence of an established market for the Common Stock, the Fair Market Value will be determined in good
faith by the Administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The determination of fair market value for purposes of tax withholding may be made in the
Administrator&#146;s discretion subject to Applicable Laws and is not required to be consistent with the determination of Fair Market Value for other purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Fiscal Year</U>&#148; means the fiscal year of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Incentive Stock Option</U>&#148; means an Option
intended to qualify as an incentive stock option within the meaning of Section&nbsp;422 of the Code and the regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Nonstatutory Stock Option</U>&#148; means an Option that by its terms does not qualify or is not intended
to qualify as an Incentive Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Officer</U>&#148; means a person who is an officer of the
Company within the meaning of Section&nbsp;16 of the Exchange Act and the rules and regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(w)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Option</U>&#148; means a stock option granted pursuant to the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Outside Director</U>&#148; means a Director who is not an Employee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(y)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Parent</U>&#148; means a &#147;parent corporation,&#148; whether now or hereafter existing, as defined in
Section&nbsp;424(e) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(z)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Participant</U>&#148; means the holder of an outstanding Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(aa)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Performance Share</U>&#148; means an Award denominated in Shares which may be earned in whole or in part
upon attainment of performance goals or other vesting criteria as the Administrator may determine pursuant to Section&nbsp;10. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(bb)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Performance Unit</U>&#148; means an Award which may be earned in whole or in part upon attainment of
performance goals or other vesting criteria as the Administrator may determine and which may be settled for cash, Shares or other securities or a combination of the foregoing pursuant to Section&nbsp;10. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(cc)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Period of Restriction</U>&#148; means the period during which the transfer of Shares of Restricted Stock
are subject to restrictions and therefore, the Shares are subject to a substantial risk of forfeiture. Such restrictions may be based on the passage of time, the achievement of target levels of performance, or the occurrence of other events as
determined by the Administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(dd)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Plan</U>&#148; means this QuantumScape Corporation 2020 Equity
Incentive Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ee)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Restricted Stock</U>&#148; means Shares issued pursuant to an Award of Restricted
Stock under Section&nbsp;7 of the Plan, or issued pursuant to the early exercise of an Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ff)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Restricted Stock Unit</U>&#148; means a bookkeeping entry representing an amount equal to the Fair Market
Value of one Share, granted pursuant to Section&nbsp;8. Each Restricted Stock Unit represents an unfunded and unsecured obligation of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(gg)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT></U>&#148; means Rule
<FONT STYLE="white-space:nowrap">16b-3</FONT> of the Exchange Act or any successor to Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> as in effect when discretion is being exercised with respect to the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(hh)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Section</U><U></U><U>&nbsp;16(b)</U>&#148; means Section&nbsp;16(b) of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Section</U><U></U><U>&nbsp;409A</U>&#148; means Code Section&nbsp;409A, as it has been and may be amended
from time to time, and any proposed or final Treasury Regulations and U.S. Internal Revenue Service guidance that has been promulgated or may be promulgated thereunder from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(jj)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Securities Act</U>&#148; means the U.S. Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(kk)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Service Provider</U>&#148; means an Employee, Director or Consultant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ll)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Share</U>&#148; means a share of the Common Stock, as adjusted in accordance with Section&nbsp;14 of the
Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(mm)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Stock Appreciation Right</U>&#148; means an Award,
granted alone or in connection with an Option, that pursuant to Section&nbsp;9 is designated as a Stock Appreciation Right. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(nn)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Subsidiary</U>&#148; means a &#147;subsidiary corporation,&#148; whether now or hereafter existing, as
defined in Section&nbsp;424(f) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Subject to the Plan</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Subject to the Plan</U>. Subject to the provisions of Section&nbsp;14 of the Plan and the automatic
increase set forth in Section&nbsp;3(b) of the Plan, the maximum aggregate number of Shares that may be issued under the Plan is (i) 41,500,000 Shares, plus (ii)&nbsp;any Shares subject to stock options, restricted stock units or other awards that
are assumed in the Merger (&#147;<U>Assumed Awards</U>&#148;) and that, on or after the Effective Date, expire or otherwise terminate without having been exercised or issued in full and any Assumed Awards, on or after the Effective Date, are
forfeited to or repurchased by the Company, with the maximum number of Shares to be added to the Plan pursuant to clause (ii)&nbsp;equal to 69,846,580 Shares. The Shares may be authorized, but unissued, or reacquired Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Automatic Share Reserve Increase</U>. Subject to the provisions of Section&nbsp;14 of the Plan, the number of
Shares available for issuance under the Plan will be increased on the first day of each Fiscal Year beginning with the 2022 Fiscal Year and ending with the 2030 Fiscal Year, in an amount equal to the least of (i) 41,500,000 Shares, (ii)&nbsp;five
percent (5%) of the outstanding shares of all classes of the Company&#146;s common stock on the last day of the immediately preceding Fiscal Year, or (iii)&nbsp;such number of Shares determined by the Administrator no later than the last day of the
immediately preceding Fiscal Year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Lapsed Awards</U>. If an Award expires or becomes unexercisable without
having been exercised in full, is surrendered pursuant to an Exchange Program, or, with respect to Restricted Stock, Restricted Stock Units, Performance Units or Performance Shares, is forfeited to or repurchased by the Company due to failure to
vest, the unpurchased Shares (or for Awards other than Options or Stock Appreciation Rights the forfeited or repurchased Shares), which were subject thereto will become available for future grant or sale under the Plan (unless the Plan has
terminated). With respect to Stock Appreciation Rights, only Shares actually issued (i.e., the net Shares issued) pursuant to a Stock Appreciation Right will cease to be available under the Plan; all remaining Shares under Stock Appreciation Rights
will remain available for future grant or sale under the Plan (unless the Plan has terminated). Shares that actually have been issued under the Plan under any Award will not be returned to the Plan and will not become available for future
distribution under the Plan; provided, however, that if Shares issued pursuant to Awards of Restricted Stock, Restricted Stock Units, Performance Shares or Performance Units are repurchased by the Company or are forfeited to the Company, such Shares
will become available for future grant under the Plan. Shares used to pay the exercise price of an Award or to satisfy the tax withholding obligations related to an Award will become available for future grant or sale under the Plan. To the extent
an Award under the Plan is paid out in cash rather than Shares, such cash payment will not result in reducing the number of Shares available for issuance under the Plan. Notwithstanding the foregoing and, subject to adjustment as provided in
Section&nbsp;14, the maximum number of Shares that may be issued upon the exercise of Incentive Stock Options will equal the aggregate Share number stated in Section&nbsp;3(a), plus, to the extent allowable under Section&nbsp;422 of the Code and the
Treasury Regulations promulgated thereunder, any Shares that become available for issuance under the Plan pursuant to Sections 3(b) and 3(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Share Reserve</U>. The Company, during the term of this Plan, will at all times reserve and keep available such
number of Shares as will be sufficient to satisfy the requirements of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Administration of the
Plan</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Procedure</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;<U>Multiple Administrative Bodies</U>. Different Committees with respect to different groups of Service Providers
may administer the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT></U>. To
the extent desirable to qualify transactions hereunder as exempt under Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> the transactions contemplated hereunder will be structured to satisfy the requirements for exemption under Rule <FONT
STYLE="white-space:nowrap">16b-3.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Other Administration</U>. Other than as provided above, the
Plan will be administered by (A)&nbsp;the Board or (B)&nbsp;a Committee, which committee will be constituted to satisfy Applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Powers of the Administrator</U>. Subject to the provisions of the Plan, and in the case of a Committee, subject
to the specific duties delegated by the Board to such Committee, the Administrator will have the authority, in its discretion: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;to determine the Fair Market Value; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;to select the Service Providers to whom Awards may be granted hereunder; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;to determine the number of Shares to be covered by each Award granted hereunder; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;to approve forms of Award Agreements for use under the Plan; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;to determine the terms and conditions, not inconsistent with the terms of the Plan, of any Award granted hereunder
(such terms and conditions include, but are not limited to, the exercise price, the time or times when Awards may be exercised (which may be based on performance criteria), any vesting acceleration or waiver of forfeiture restrictions, and any
restriction or limitation regarding any Award or the Shares relating thereto, based in each case on such factors as the Administrator will determine); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;to institute and determine the terms and conditions of an Exchange Program; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii)&nbsp;&nbsp;&nbsp;&nbsp;to construe and interpret the terms of the Plan and Awards granted pursuant to the Plan; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii)&nbsp;&nbsp;&nbsp;&nbsp;to prescribe, amend and rescind rules and regulations and adopt
<FONT STYLE="white-space:nowrap">sub-plans</FONT> relating to the Plan, including rules, regulations and <FONT STYLE="white-space:nowrap">sub-plans</FONT> for the purposes of facilitating compliance with foreign laws, easing the administration of
the Plan and/or taking advantage of <FONT STYLE="white-space:nowrap">tax-favorable</FONT> treatment for Awards granted to Service Providers outside the U.S., in each case as the Administrator may deem necessary or advisable; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix)&nbsp;&nbsp;&nbsp;&nbsp;to modify or amend each Award (subject to Section&nbsp;19 of the Plan), including but not limited to the
discretionary authority to extend the post-termination exercisability period of Awards and to extend the maximum term of an Option (subject to Section&nbsp;6(b) of the Plan regarding Incentive Stock Options); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;to allow Participants to satisfy tax withholding obligations in such manner as prescribed in Section&nbsp;15 of
the Plan; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi)&nbsp;&nbsp;&nbsp;&nbsp;to authorize any person to execute on behalf of the Company any instrument required to effect the
grant of an Award previously granted by the Administrator; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii)&nbsp;&nbsp;&nbsp;&nbsp;to allow a Participant to defer the receipt of
the payment of cash or the delivery of Shares that would otherwise be due to such Participant under an Award; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;to make all other determinations deemed necessary or advisable for administering the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect of Administrator</U><U>&#146;</U><U>s Decision</U>. The Administrator&#146;s decisions, determinations
and interpretations will be final and binding on all Participants and any other holders of Awards and will be given the maximum deference permitted by Applicable Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Eligibility</U>. Nonstatutory Stock Options, Stock Appreciation
Rights, Restricted Stock, Restricted Stock Units, Performance Shares and Performance Units may be granted to Service Providers. Incentive Stock Options may be granted only to Employees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Options</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitations</U>. Each Option will be designated in the Award Agreement as either an Incentive Stock Option or a
Nonstatutory Stock Option. However, notwithstanding such designation, to the extent that the aggregate fair market value of the Shares with respect to which Incentive Stock Options are exercisable for the first time by the Participant during any
calendar year (under all plans of the Company and any Parent or Subsidiary) exceeds one hundred thousand dollars ($100,000), such Options will be treated as Nonstatutory Stock Options. For purposes of this Section&nbsp;6(a), Incentive Stock Options
will be taken into account in the order in which they were granted. The fair market value of the Shares will be determined as of the time the Option with respect to such Shares is granted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Term of Option</U>. The term of each Option will be stated in the Award Agreement. In the case of an Incentive
Stock Option, the term will be ten (10)&nbsp;years from the date of grant or such shorter term as may be provided in the Award Agreement. Moreover, in the case of an Incentive Stock Option granted to a Participant who, at the time the Incentive
Stock Option is granted, owns stock representing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or any Parent or Subsidiary, the term of the Incentive Stock Option will be five (5)&nbsp;years
from the date of grant or such shorter term as may be provided in the Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Option Exercise
Price and Consideration</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise Price</U>. The per share exercise price for the Shares to be issued
pursuant to exercise of an Option will be determined by the Administrator, subject to the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;In the
case of an Incentive Stock Option </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;granted to an Employee who, at the time the Incentive Stock Option is
granted, owns stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company or any Parent or Subsidiary, the per Share exercise price will be no less than one hundred ten percent (110%) of the Fair Market
Value per Share on the date of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;granted to any Employee other than an Employee described in paragraph
(A)&nbsp;immediately above, the per Share exercise price will be no less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;In the case of a Nonstatutory Stock Option, the per Share exercise price will be no less than one hundred percent
(100%) of the Fair Market Value per Share on the date of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, Options may be
granted with a per Share exercise price of less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant pursuant to a transaction described in, and in a manner consistent with, Section&nbsp;424(a) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiting Period and Exercise Dates</U>. At the time an Option is granted, the Administrator will fix the period
within which the Option may be exercised and will determine any conditions that must be satisfied before the Option may be exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Form of Consideration</U>. The Administrator will determine the acceptable form of consideration for
exercising an Option, including the method of payment. In the case of an Incentive Stock </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Option, the Administrator will determine the acceptable form of consideration at the time of grant. Such consideration may consist entirely of: (1)&nbsp;cash; (2) check; (3)&nbsp;promissory note,
to the extent permitted by Applicable Laws; (4)&nbsp;other Shares, provided that such Shares have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which such Option will be exercised and provided
that accepting such Shares will not result in any adverse accounting consequences to the Company, as the Administrator determines in its sole discretion; (5)&nbsp;consideration received by the Company under a broker-assisted (or other) cashless
exercise program (whether through a broker or otherwise) implemented by the Company in connection with the Plan; (6)&nbsp;by net exercise; (7)&nbsp;such other consideration and method of payment for the issuance of Shares to the extent permitted by
Applicable Laws; or (8)&nbsp;any combination of the foregoing methods of payment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise of Option</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;<U>Procedure for Exercise; Rights as a Stockholder</U>. Any Option granted hereunder will be exercisable
according to the terms of the Plan and at such times and under such conditions as determined by the Administrator and set forth in the Award Agreement. An Option may not be exercised for a fraction of a Share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">An Option will be deemed exercised when the Company receives: (i)&nbsp;a notice of exercise (in such form as the Administrator may specify
from time to time) from the person entitled to exercise the Option, and (ii)&nbsp;full payment for the Shares with respect to which the Option is exercised (together with applicable tax withholdings). Full payment may consist of any consideration
and method of payment authorized by the Administrator and permitted by the Award Agreement and the Plan. Shares issued upon exercise of an Option will be issued in the name of the Participant or, if requested by the Participant, in the name of the
Participant and his or her spouse. Until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a
stockholder will exist with respect to the Shares subject to an Option, notwithstanding the exercise of the Option. The Company will issue (or cause to be issued) such Shares promptly after the Option is exercised. No adjustment will be made for a
dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section&nbsp;14 of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Exercising an Option in any manner will decrease the number of Shares thereafter available, both for purposes of the Plan and for sale under
the Option, by the number of Shares as to which the Option is exercised. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination of Relationship as a
Service Provider</U>. If a Participant ceases to be a Service Provider, other than upon the Participant&#146;s termination as the result of the Participant&#146;s death or Disability, the Participant may exercise his or her Option within such period
of time as is specified in the Award Agreement to the extent that the Option is vested on the date of termination (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement). In the absence of a
specified time in the Award Agreement, the Option will remain exercisable for three (3)&nbsp;months following the Participant&#146;s termination. Unless otherwise provided by the Administrator, if on the date of termination the Participant is not
vested as to his or her entire Option, the Shares covered by the unvested portion of the Option will revert to the Plan. If after termination the Participant does not exercise his or her Option within the time specified by the Administrator, the
Option will terminate, and the Shares covered by such Option will revert to the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Disability of
Participant</U>. If a Participant ceases to be a Service Provider as a result of the Participant&#146;s Disability, the Participant may exercise his or her Option within such period of time as is specified in the Award Agreement to the extent the
Option is vested on the date of termination (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement). In the absence of a specified time in the Award Agreement, the Option will remain exercisable for
twelve (12)&nbsp;months following the Participant&#146;s termination. Unless otherwise provided by the Administrator, if on the date of termination the Participant is not vested as to his or her entire Option, the Shares covered by the unvested
portion of the Option will revert to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Plan. If after termination the Participant does not exercise his or her Option within the time specified herein, the Option will terminate, and the Shares covered by such Option will revert to
the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;<U>Death</U><U> of Participant</U>. If a Participant dies while a Service Provider, the Option may
be exercised following the Participant&#146;s death within such period of time as is specified in the Award Agreement to the extent that the Option is vested on the date of death (but in no event may the Option be exercised later than the expiration
of the term of such Option as set forth in the Award Agreement), by the Participant&#146;s designated beneficiary, provided the Administrator has permitted the designation of a beneficiary and provided such beneficiary has been designated prior to
Participant&#146;s death in a form acceptable to the Administrator. If the Administrator has not permitted the designation of a beneficiary or if no such beneficiary has been designated by the Participant, then such Option may be exercised by the
personal representative of the Participant&#146;s estate or by the person(s) to whom the Option is transferred pursuant to the Participant&#146;s will or in accordance with the laws of descent and distribution. In the absence of a specified time in
the Award Agreement, the Option will remain exercisable for twelve (12)&nbsp;months following Participant&#146;s death. Unless otherwise provided by the Administrator, if at the time of death Participant is not vested as to his or her entire Option,
the Shares covered by the unvested portion of the Option will immediately revert to the Plan. If the Option is not so exercised within the time specified herein, the Option will terminate, and the Shares covered by such Option will revert to the
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;<U>Tolling Expiration</U>. A Participant&#146;s Award Agreement may also provide that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;if the exercise of the Option following the termination of Participant&#146;s status as a Service Provider (other
than upon the Participant&#146;s death or Disability) would result in liability under Section&nbsp;16(b), then the Option will terminate on the earlier of (A)&nbsp;the expiration of the term of the Option set forth in the Award Agreement, or
(B)&nbsp;the tenth (10<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) day after the last date on which such exercise would result in liability under Section&nbsp;16(b); or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;if the exercise of the Option following the termination of the Participant&#146;s status as a Service Provider
(other than upon the Participant&#146;s death or Disability) would be prohibited at any time solely because the issuance of Shares would violate the registration requirements under the Securities Act, then the Option will terminate on the earlier of
(A)&nbsp;the expiration of the term of the Option or (B)&nbsp;the expiration of a period of thirty <FONT STYLE="white-space:nowrap">(30)-day</FONT> period after the termination of the Participant&#146;s status as a Service Provider during which the
exercise of the Option would not be in violation of such registration requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Restricted Stock</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant of Restricted Stock</U>. Subject to the terms and provisions of the Plan, the Administrator, at any
time and from time to time, may grant Shares of Restricted Stock to Service Providers in such amounts as the Administrator, in its sole discretion, will determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Restricted Stock Agreement</U>. Each Award of Restricted Stock will be evidenced by an Award Agreement that will
specify the Period of Restriction, the number of Shares granted, and such other terms and conditions as the Administrator, in its sole discretion, will determine. Unless the Administrator determines otherwise, the Company as escrow agent will hold
Shares of Restricted Stock until the restrictions on such Shares have lapsed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Transferability</U>. Except
as provided in this Section&nbsp;7 or the Award Agreement, Shares of Restricted Stock may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated until the end of the applicable Period of Restriction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Other Restrictions</U>. The Administrator, in its sole discretion, may impose such other restrictions on Shares
of Restricted Stock as it may deem advisable or appropriate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Removal of Restrictions</U>. Except as otherwise provided in
this Section&nbsp;7, Shares of Restricted Stock covered by each Restricted Stock grant made under the Plan will be released from escrow as soon as practicable after the last day of the Period of Restriction or at such other time as the Administrator
may determine. The Administrator, in its discretion, may accelerate the time at which any restrictions will lapse or be removed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>Voting Rights</U>. During the Period of Restriction, Service Providers holding Shares of Restricted Stock
granted hereunder may exercise full voting rights with respect to those Shares, unless the Administrator determines otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;<U>Dividends and Other Distributions</U>. During the Period of Restriction, Service Providers holding Shares of
Restricted Stock will be entitled to receive all dividends and other distributions paid with respect to such Shares, unless the Administrator provides otherwise. If any such dividends or distributions are paid in Shares, the Shares will be subject
to the same restrictions on transferability and forfeitability as the Shares of Restricted Stock with respect to which they were paid. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;<U>Return of Restricted Stock to Company</U>. On the date set forth in the Award Agreement, the Restricted Stock
for which restrictions have not lapsed will revert to the Company and again will become available for grant under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Restricted Stock Units</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant</U>. Restricted Stock Units may be granted at any time and from time to time as determined by the
Administrator. After the Administrator determines that it will grant Restricted Stock Units under the Plan, it will advise the Participant in an Award Agreement of the terms, conditions, and restrictions related to the grant, including the number of
Restricted Stock Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Vesting Criteria and Other Terms</U>. The Administrator will set vesting criteria
in its discretion, which, depending on the extent to which the criteria are met, will determine the number of Restricted Stock Units that will be paid out to the Participant. The Administrator may set vesting criteria based upon the achievement of
Company-wide, divisional, business unit, or individual goals (including, but not limited to, continued employment or service), applicable federal or state securities laws or any other basis determined by the Administrator in its discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Earning Restricted Stock Units</U>. Upon meeting the applicable vesting criteria, the Participant will be
entitled to receive a payout as determined by the Administrator. Notwithstanding the foregoing, at any time after the grant of Restricted Stock Units, the Administrator, in its sole discretion, may reduce or waive any vesting criteria that must be
met to receive a payout. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Form and Timing of Payment</U>. Payment of earned Restricted Stock Units will be
made as soon as practicable after the date(s) determined by the Administrator and set forth in the Award Agreement. The Administrator, in its sole discretion, may only settle earned Restricted Stock Units in cash, Shares, or a combination of both.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Cancellation</U>. On the date set forth in the Award Agreement, all unearned Restricted Stock Units will be
forfeited to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Appreciation Rights</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant of Stock Appreciation Rights</U>. Subject to the terms and conditions of the Plan, a Stock Appreciation
Right may be granted to Service Providers at any time and from time to time as will be determined by the Administrator, in its sole discretion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Number of Shares</U>. The Administrator will have complete
discretion to determine the number of Stock Appreciation Rights granted to any Service Provider. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise
Price and Other Terms</U>. The per share exercise price for the Shares to be issued pursuant to exercise of a Stock Appreciation Right will be determined by the Administrator and will be no less than one hundred percent (100%) of the Fair Market
Value per Share on the date of grant. Otherwise, the Administrator, subject to the provisions of the Plan, will have complete discretion to determine the terms and conditions of Stock Appreciation Rights granted under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Appreciation Right Agreement</U>. Each Stock Appreciation Right grant will be evidenced by an Award
Agreement that will specify the exercise price, the term of the Stock Appreciation Right, the conditions of exercise, and such other terms and conditions as the Administrator, in its sole discretion, will determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Expiration of Stock Appreciation Rights</U>. A Stock Appreciation Right granted under the Plan will expire upon
the date determined by the Administrator, in its sole discretion, and set forth in the Award Agreement. Notwithstanding the foregoing, the rules of Section&nbsp;6(b) relating to the maximum term and Section&nbsp;6(d) relating to exercise also will
apply to Stock Appreciation Rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment of Stock Appreciation Right Amount</U>. Upon exercise of a
Stock Appreciation Right, a Participant will be entitled to receive payment from the Company in an amount determined by multiplying: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;The difference between the Fair Market Value of a Share on the date of exercise over the exercise price; times </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;The number of Shares with respect to which the Stock Appreciation Right is exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the discretion of the Administrator, the payment upon Stock Appreciation Right exercise may be in cash, in Shares of equivalent value, or
in some combination thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Performance Units and Performance Shares</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant of Performance Units/Shares</U>. Performance Units and Performance Shares may be granted to Service
Providers at any time and from time to time, as will be determined by the Administrator, in its sole discretion. The Administrator will have complete discretion in determining the number of Performance Units and Performance Shares granted to each
Participant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Value of Performance Units/Shares</U>. Each Performance Unit will have an initial value that
is established by the Administrator on or before the date of grant. Each Performance Share will have an initial value equal to the Fair Market Value of a Share on the date of grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Performance Objectives and Other Terms</U>. The Administrator will set performance objectives or other vesting
provisions (including, without limitation, continued status as a Service Provider) in its discretion which, depending on the extent to which they are met, will determine the number or value of Performance Units/Shares that will be paid out to the
Service Providers. The time period during which the performance objectives or other vesting provisions must be met will be called the &#147;<U>Performance Period</U>.&#148; Each Award of Performance Units/Shares will be evidenced by an Award
Agreement that will specify the Performance Period, and such other terms and conditions as the Administrator, in its sole discretion, will determine. The Administrator may set performance objectives based upon the achievement of Company-wide,
divisional, business unit or individual goals (including, but not limited to, continued employment or service), applicable federal or state securities laws, or any other basis determined by the Administrator in its discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Earning of Performance Units/Shares</U>. After the applicable Performance Period has ended, the holder of
Performance Units/Shares will be entitled to receive a payout of the number of Performance Units/</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Shares earned by the Participant over the Performance Period, to be determined as a function of the extent to which the corresponding performance objectives or other vesting provisions have been
achieved. After the grant of a Performance Unit/Share, the Administrator, in its sole discretion, may reduce or waive any performance objectives or other vesting provisions for such Performance Unit/Share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Form and Timing of Payment of Performance Units/Shares</U>. Payment of earned Performance Units/Shares will be
made as soon as practicable after the expiration of the applicable Performance Period. The Administrator, in its sole discretion, may pay earned Performance Units/Shares in the form of cash, in Shares (which have an aggregate Fair Market Value equal
to the value of the earned Performance Units/Shares at the close of the applicable Performance Period) or in a combination thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>Cancellation of Performance Units/Shares</U>. On the date set forth in the Award Agreement, all unearned or
unvested Performance Units/Shares will be forfeited to the Company, and again will be available for grant under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Outside</U><U> Director </U><U>Limitations</U>. No Outside Director may be paid, issued, or granted, in any
Fiscal Year, equity awards (including any Awards issued under this Plan) with an aggregate value (the value of which will be based on their grant date fair value determined in accordance with U.S. generally accepted accounting principles) that, in
the aggregate, exceed $750,000, increased to $1,000,000 in connection with his or her initial service. Any Awards or other compensation paid or provided to an individual for his or her services as an Employee, or for his or her services as a
Consultant (other than as an Outside Director), will not count for purposes of the limitation under this Section&nbsp;11. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Leaves of Absence/Transfer Between Locations</U>. Unless the Administrator provides otherwise and subject to
Applicable Laws, vesting of Awards granted hereunder will be suspended during any unpaid leave of absence. A Participant will not cease to be an Employee in the case of (i)&nbsp;any leave of absence approved by the Company or (ii)&nbsp;transfers
between locations of the Company or between the Company, its Parent, or any Subsidiary. For purposes of Incentive Stock Options, no such leave may exceed three (3)&nbsp;months, unless reemployment upon expiration of such leave is guaranteed by
statute or contract. If reemployment upon expiration of a leave of absence approved by the Company is not so guaranteed, then six (6)&nbsp;months following the first (1st) day of such leave any Incentive Stock Option held by the Participant will
cease to be treated as an Incentive Stock Option and will be treated for tax purposes as a Nonstatutory Stock Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Transferability of Awards</U>. Unless determined otherwise by the Administrator, an Award may not be sold,
pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the lifetime of the Participant, only by the Participant. If the Administrator makes
an Award transferable, such Award will contain such additional terms and conditions as the Administrator deems appropriate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustments; Dissolution or Liquidation; Merger or Change in Control</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustments</U>. In the event that any extraordinary dividend or other extraordinary distribution (whether in
the form of cash, Shares, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, <FONT STYLE="white-space:nowrap">split-up,</FONT>
<FONT STYLE="white-space:nowrap">spin-off,</FONT> combination, reclassification, repurchase, or exchange of Shares or other securities of the Company, or other change in the corporate structure of the Company affecting the Shares occurs, the
Administrator, in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made available under the Plan, will adjust the number and class of shares of stock that may be delivered under the Plan and/or the
number, class, and price of shares of stock covered by each outstanding Award, and the numerical Share limits in Sections 3 and 11 of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Dissolution or Liquidation</U>. In the event of the proposed dissolution or liquidation of the Company, the
Administrator will notify each Participant as soon as practicable prior to the effective date of such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
proposed transaction. To the extent it has not been previously exercised, an Award will terminate immediately prior to the consummation of such proposed action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Change in Control</U>. In the event of a merger of the Company with or into another corporation or other entity
or a Change in Control, each outstanding Award will be treated as the Administrator determines (subject to the provisions of the following paragraph) without a Participant&#146;s consent, including, without limitation, that (i)&nbsp;Awards will be
assumed, or substantially equivalent awards will be substituted, by the acquiring or succeeding corporation (or an affiliate thereof) with appropriate adjustments as to the number and kind of shares and prices; (ii)&nbsp;upon written notice to a
Participant, that the Participant&#146;s Awards will terminate upon or immediately prior to the consummation of such merger or Change in Control; (iii)&nbsp;outstanding Awards will vest and become exercisable, realizable, or payable, or restrictions
applicable to an Award will lapse, in whole or in part prior to or upon consummation of such merger or Change in Control, and, to the extent the Administrator determines, terminate upon or immediately prior to the effectiveness of such merger or
Change in Control; (iv)&nbsp;(A) the termination of an Award in exchange for an amount of cash and/or property, if any, equal to the amount that would have been attained upon the exercise of such Award or realization of the Participant&#146;s rights
as of the date of the occurrence of the transaction (and, for the avoidance of doubt, if as of the date of the occurrence of the transaction the Administrator determines in good faith that no amount would have been attained upon the exercise of such
Award or realization of the Participant&#146;s rights, then such Award may be terminated by the Company without payment), or (B)&nbsp;the replacement of such Award with other rights or property selected by the Administrator in its sole discretion;
or (v)&nbsp;any combination of the foregoing. In taking any of the actions permitted under this subsection 14(c), the Administrator will not be required to treat all Awards or Participants, all Awards held by a Participant, or all Awards of the same
type, similarly in the transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In the event that the successor corporation does not assume or substitute for the Award (or portion
thereof), the Participant will fully vest in and have the right to exercise such outstanding Option and Stock Appreciation Right not so assumed or substituted for, including Shares as to which such Award would not otherwise be vested or exercisable,
all restrictions on such Restricted Stock and Restricted Stock Units not so assumed or substituted for will lapse, and, with respect to such Awards with performance-based vesting, all performance goals or other vesting criteria will be deemed
achieved at one hundred percent (100%) of target levels and all other terms and conditions met, in all cases, unless specifically provided otherwise under the applicable Award Agreement or other written agreement between the Participant and the
Company or any of its Subsidiaries or Parents, as applicable. In addition, if an Option or Stock Appreciation Right is not assumed or substituted in the event of a merger or Change in Control, the Administrator will notify the Participant in writing
or electronically that such Option or Stock Appreciation Right not so assumed or substituted for will be exercisable for a period of time determined by the Administrator in its sole discretion, and the Option or Stock Appreciation Right will
terminate upon the expiration of such period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the purposes of this subsection (c), an Award will be considered assumed if, following
the merger or Change in Control, the Award confers the right to purchase or receive, for each Share subject to the Award immediately prior to the merger or Change in Control, the consideration (whether stock, cash, or other securities or property)
received in the merger or Change in Control by holders of Common Stock for each Share held on the effective date of the transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority
of the outstanding Shares); provided, however, that if such consideration received in the merger or Change in Control is not solely common stock of the successor corporation or its Parent, the Administrator may, with the consent of the successor
corporation, provide for the consideration to be received upon the exercise of an Option or Stock Appreciation Right or upon the payout of a Restricted Stock Unit, Performance Unit or Performance Share, for each Share subject to such Award, to be
solely common stock of the successor corporation or its Parent equal in fair market value to the per share consideration received by holders of Common Stock in the merger or Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in this Section&nbsp;14(c) to the contrary, and unless otherwise provided in an Award Agreement, an Award that vests,
is earned or <FONT STYLE="white-space:nowrap">paid-out</FONT> upon the satisfaction of one or more performance </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
goals will not be considered assumed if the Company or its successor modifies any of such performance goals without the Participant&#146;s consent; provided, however, a modification to such
performance goals only to reflect the successor corporation&#146;s post-Change in Control corporate structure will not be deemed to invalidate an otherwise valid Award assumption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in this Section&nbsp;14(c) to the contrary, if a payment under an Award Agreement is subject to Code
Section&nbsp;409A and if the change in control definition contained in the Award Agreement does not comply with the definition of &#147;change of control&#148; for purposes of a distribution under Code Section&nbsp;409A, then any payment of an
amount that is otherwise accelerated under this Section will be delayed until the earliest time that such payment would be permissible under Code Section&nbsp;409A without triggering any penalties applicable under Code Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Outside Director Awards</U>. In the event of a Change in Control, with respect to Awards granted to an Outside
Director, the Outside Director will fully vest in and have the right to exercise Options and/or Stock Appreciation Rights as to all of the Shares underlying such Award, including those Shares which would not otherwise be vested or exercisable, all
restrictions on Restricted Stock and Restricted Stock Units will lapse, and, with respect to Awards with performance-based vesting, all performance goals or other vesting criteria will be deemed achieved at one hundred percent (100%) of target
levels and all other terms and conditions met, unless specifically provided otherwise under the applicable Award Agreement or other written agreement between the Participant and the Company or any of its Subsidiaries or Parents, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Withholding Requirements</U>. Prior to the delivery of any Shares or cash pursuant to an Award (or exercise
thereof) or such earlier time as any tax withholding obligations are due, the Company will have the power and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy U.S. federal, state, or
local taxes, <FONT STYLE="white-space:nowrap">non-U.S.</FONT> taxes, or other taxes (including the Participant&#146;s FICA or other social insurance contribution obligation) required to be withheld with respect to such Award (or exercise thereof).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Withholding Arrangements</U>. The Administrator, in its sole discretion and pursuant to such procedures as
it may specify from time to time, may permit a Participant to satisfy such tax withholding obligation, in whole or in part by (without limitation)&nbsp;(i) paying cash, check or other cash equivalents, (ii)&nbsp;electing to have the Company withhold
otherwise deliverable cash or Shares having a fair market value equal to the minimum statutory amount required to be withheld or such greater amount as the Administrator may determine if such amount would not have adverse accounting consequences, as
the Administrator determines in its sole discretion, (c)&nbsp;delivering to the Company already-owned Shares having a fair market value equal to the minimum statutory amount required to be withheld or such greater amount as the Administrator may
determine, in each case, provided the delivery of such Shares will not result in any adverse accounting consequences, as the Administrator determines in its sole discretion, (d)&nbsp;selling a sufficient number of Shares otherwise deliverable to the
Participant through such means as the Administrator may determine in its sole discretion (whether through a broker or otherwise) equal to the amount required to be withheld, or (e)&nbsp;any combination of the foregoing methods of payment. The fair
market value of the Shares to be withheld or delivered will be determined as of the date that the taxes are required to be withheld. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance </U><U>With</U><U> Section</U><U></U><U>&nbsp;409A</U>. Awards will be designed and operated in such
a manner that they are either exempt from the application of, or comply with, the requirements of Section&nbsp;409A such that the grant, payment, settlement or deferral will not be subject to the additional tax or interest applicable under
Section&nbsp;409A, except as otherwise determined in the sole discretion of the Administrator. The Plan and each Award Agreement under the Plan is intended to meet the requirements of Section&nbsp;409A and will be construed and interpreted in
accordance with such intent, except as otherwise determined in the sole discretion of the Administrator. To the extent that an Award or payment, or the settlement or deferral thereof, is subject to Section&nbsp;409A the Award will
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be granted, paid, settled or deferred in a manner that will meet the requirements of Section&nbsp;409A, such that the grant, payment, settlement or deferral will not be subject to the additional
tax or interest applicable under Section&nbsp;409A. In no event will the Company or any of its Parent or Subsidiaries have any obligation under the terms of this Plan to reimburse, indemnify, or hold harmless a Participant for any taxes, interest or
penalties imposed, or other costs incurred, as a result of Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Effect on Employment or
Service</U>. Neither the Plan nor any Award will confer upon a Participant any right with respect to continuing the Participant&#146;s relationship as a Service Provider, nor will they interfere in any way with the Participant&#146;s right or the
right of the Company (or any Parent or Subsidiary of the Company) to terminate such relationship at any time, with or without cause, to the extent permitted by Applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.&nbsp;&nbsp;&nbsp;&nbsp;<U>Date of Grant</U>. The date of grant of an Award will be, for all purposes, the date on which the Administrator
makes the determination granting such Award, or such other later date as is determined by the Administrator. Notice of the determination will be provided to each Participant within a reasonable time after the date of such grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.&nbsp;&nbsp;&nbsp;&nbsp;<U>Term of Plan</U>. Subject to Section&nbsp;23<B> </B>of the Plan, the Plan will become effective upon the later
to occur of (i)&nbsp;its adoption by the Board, (ii)&nbsp;approval by the Company&#146;s stockholders or (iii)&nbsp;the Effective Date. It will continue in effect until terminated earlier under Section&nbsp;19<B> </B>of the Plan, but no Incentive
Stock Options may be granted after 10 years from the date the Plan is adopted by the Board and Section&nbsp;3(b) will operate only until the 10<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> anniversary of the date the Plan is adopted by the
Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment and Termination of the Plan</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment and Termination</U>. The Administrator may at any time amend, alter, suspend or terminate the Plan.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Stockholder Approval</U>. The Company will obtain stockholder approval of any Plan amendment to the extent
necessary and desirable to comply with Applicable Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect of Amendment or Termination</U>. No
amendment, alteration, suspension or termination of the Plan will materially impair the rights of any Participant, unless mutually agreed otherwise between the Participant and the Administrator, which agreement must be in writing and signed by the
Participant and the Company. Termination of the Plan will not affect the Administrator&#146;s ability to exercise the powers granted to it hereunder with respect to Awards granted under the Plan prior to the date of such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions </U><U>Upon</U><U> Issuance of Shares</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Legal Compliance</U>. Shares will not be issued pursuant to an Award unless the exercise or vesting of such
Award and the issuance and delivery of such Shares will comply with Applicable Laws and will be further subject to the approval of counsel for the Company with respect to such compliance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment Representations</U>. As a condition to the exercise or vesting of an Award, the Company may require
the person exercising or vesting in such Award to represent and warrant at the time of any such exercise or vesting that the Shares are being acquired only for investment and without any present intention to sell or distribute such Shares if, in the
opinion of counsel for the Company, such a representation is required. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21.&nbsp;&nbsp;&nbsp;&nbsp;<U>Inability to Obtain Authority</U>.
If the Company determines it to be impossible or impractical to obtain authority from any regulatory body having jurisdiction or to complete or comply with the requirements of any registration or other qualification of the Shares under any U.S.
federal or state law, any <FONT STYLE="white-space:nowrap">non-U.S.</FONT> law, or the rules and regulations of the U.S. Securities and Exchange Commission, the stock exchange on which Shares of the same class are then listed, or any other
governmental or regulatory body, which authority, registration, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
qualification or rule compliance is deemed by the Company&#146;s counsel to be necessary or advisable for the issuance and sale of any Shares hereunder, the Company will be relieved of any
liability in respect of the failure to issue or sell such Shares as to which such requisite authority, registration, qualification or rule compliance will not have been obtained. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22.&nbsp;&nbsp;&nbsp;&nbsp;<U>Forfeiture Events</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;All Awards under the Plan will be subject to recoupment under any clawback policy that the Company is required to
adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#146;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other
Applicable Laws. In addition, the Administrator may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Administrator determines necessary or appropriate, including but not limited to a reacquisition right
regarding previously acquired Shares or other cash or property. Unless this Section&nbsp;22 is specifically mentioned and waived in an Award Agreement or other document, no recovery of compensation under a clawback policy or otherwise will be an
event that triggers or contributes to any right of a Participant to resign for &#147;good reason&#148; or &#147;constructive termination&#148; (or similar term) under any agreement with the Company or a Subsidiary or Parent of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Administrator may specify in an Award Agreement that the Participant&#146;s rights, payments, and benefits with
respect to an Award will be subject to reduction, cancellation, forfeiture, or recoupment upon the occurrence of specified events, in addition to any otherwise applicable vesting or performance conditions of an Award. Such events may include, but
will not be limited to, termination of such Participant&#146;s status as Service Provider for cause or any specified action or inaction by a Participant, whether before or after such termination of service, that would constitute cause for
termination of such Participant&#146;s status as a Service Provider. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.&nbsp;&nbsp;&nbsp;&nbsp;<U>Stockholder Approval</U>. The Plan
will be subject to approval by the stockholders of the Company within twelve (12)&nbsp;months after the date the Plan is adopted by the Board. Such stockholder approval will be obtained in the manner and to the degree required under Applicable Laws.
</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;* </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="rom14810_74"></A>Annex E </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>QUANTUMSCAPE CORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2020 EMPLOYEE STOCK PURCHASE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Purpose</U>. The purpose of the Plan is to provide employees of the Company and its Designated Companies with an
opportunity to purchase Common Stock through accumulated Contributions. The Company intends for the Plan to have two components: a component that is intended to qualify as an &#147;employee stock purchase plan&#148; under Section&nbsp;423 of the
Code (the &#147;423 Component&#148;) and a component that is not intended to qualify as an &#147;employee stock purchase plan&#148; under Section&nbsp;423 of the Code (the &#147;Non-423 Component&#148;). The provisions of the 423 Component,
accordingly, will be construed so as to extend and limit Plan participation in a uniform and nondiscriminatory basis consistent with the requirements of Section&nbsp;423 of the Code. An option to purchase shares of Common Stock under the Non-423
Component will be granted pursuant to rules, procedures, or sub-plans adopted by the Administrator designed to achieve tax, securities laws, or other objectives for Eligible Employees and the Company. Except as otherwise provided herein or by the
Administrator, the Non-423 Component will operate and be administered in the same manner as the 423 Component. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Administrator</U>&#148; means the Board or any Committee designated by the Board to administer the Plan
pursuant to Section&nbsp;14. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Affiliate</U>&#148; means any entity, other than a Subsidiary, in which
the Company has an equity or other ownership interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Applicable Laws</U>&#148; means the legal and
regulatory requirements relating to the administration of equity-based awards, including but not limited to the related issuance of shares of Common Stock, including but not limited to, under U.S. federal and state corporate laws, U.S. federal and
state securities laws, the Code, any stock exchange or quotation system on which the Common Stock is listed or quoted and the applicable laws of any non-U.S. country or jurisdiction where options are, or will be, granted under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Board</U>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Change in Control</U>&#148; means the occurrence of any of the following events: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;A change in the ownership of the Company which occurs on the date that any one person, or more than one person
acting as a group (&#147;<U>Person</U>&#148;), acquires ownership of the stock of the Company that, together with the stock held by such Person, constitutes more than fifty percent (50%)&nbsp;of the total voting power of the stock of the Company;
provided, however, that for purposes of this subsection, the acquisition of additional stock by any one Person, who is considered to own more than fifty percent (50%)&nbsp;of the total voting power of the stock of the Company will not be considered
a Change in Control. Further, if the stockholders of the Company immediately before such change in ownership continue to retain immediately after the change in ownership, in substantially the same proportions as their ownership of shares of the
Company&#146;s voting stock immediately prior to the change in ownership, direct or indirect beneficial ownership of fifty percent (50%)&nbsp;or more of the total voting power of the stock of the Company or of the ultimate parent entity of the
Company, such event shall not be considered a Change in Control under this subsection (i). For this purpose, indirect beneficial ownership shall include, without limitation, an interest resulting from ownership of the voting securities of one or
more corporations or other business entities which own the Company, as the case may be, either directly or through one or more subsidiary corporations or other business entities; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;A change in the effective control of the Company which occurs on the date that a majority of members of the Board
is replaced during any twelve (12) month period by Directors whose appointment or </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purposes of this subsection (ii), if any Person is considered to be in
effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Change in Control; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;A change in the ownership of a substantial portion of the Company&#146;s assets which occurs on the date that
any Person acquires (or has acquired during the twelve <FONT STYLE="white-space:nowrap">(12)-month</FONT> period ending on the date of the most recent acquisition by such Person) assets from the Company that have a total gross fair market value
equal to or more than fifty percent (50%)&nbsp;of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions; provided, however, that for purposes of this subsection (iii), the
following will not constitute a change in the ownership of a substantial portion of the Company&#146;s assets: (A)&nbsp;a transfer to an entity that is controlled by the Company&#146;s stockholders immediately after the transfer, or (B)&nbsp;a
transfer of assets by the Company to: (1)&nbsp;a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect to the Company&#146;s stock, (2)&nbsp;an entity, fifty percent (50%)&nbsp;or more of the total value
or voting power of which is owned, directly or indirectly, by the Company, (3)&nbsp;a Person, that owns, directly or indirectly, fifty percent (50%)&nbsp;or more of the total value or voting power of all the outstanding stock of the Company, or
(4)&nbsp;an entity, at least fifty percent (50%)&nbsp;of the total value or voting power of which is owned, directly or indirectly, by a Person described in this subsection (iii)(B)(3). For purposes of this subsection (iii), gross fair market value
means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For purposes of this definition, persons will be considered to be acting as a group if they are owners of a corporation that enters into a
merger, consolidation, purchase, or acquisition of stock, or similar business transaction with the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notwithstanding the
foregoing, a transaction will not be deemed a Change in Control unless the transaction qualifies as a change in control event within the meaning of Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Further and for the avoidance of doubt, a transaction will not constitute a Change in Control if: (i)&nbsp;its sole purpose is to change the
jurisdiction of the Company&#146;s incorporation, or (ii)&nbsp;its sole purpose is to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#146;s securities immediately before such
transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Code</U>&#148; means the U.S. Internal Revenue Code of 1986, as amended. Reference to a
specific section of the Code or U.S. Treasury Regulation thereunder will include such section or regulation, any valid regulation or other official applicable guidance promulgated under such section, and any comparable provision of any future
legislation or regulation amending, supplementing or superseding such section or regulation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Committee</U>&#148; means a committee of the Board appointed in accordance with Section&nbsp;14 hereof.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Common Stock</U>&#148; means the Class&nbsp;A Common Stock of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company</U>&#148; means Kensington Capital Acquisition Corp., a Delaware corporation, or any successor
thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Compensation</U>&#148; includes a measure to be determined by the Administrator. The
Administrator, in its discretion, may, on a uniform and nondiscriminatory basis, establish a different definition of Compensation for a subsequent Offering Period. Further, the Administrator shall have discretion to determine the application of this
definition to Participants outside the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Contributions</U>&#148; means the payroll
deductions and other additional payments that the Company may permit to be made by a Participant to fund the exercise of options granted pursuant to the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Designated Company</U>&#148; means any Subsidiary or
Affiliate that has been designated by the Administrator from time to time in its sole discretion as eligible to participate in the Plan. For purposes of the 423 Component, only the Company and its Subsidiaries may be Designated Companies, provided,
however that at any given time, a Subsidiary that is a Designated Company under the 423 Component will not be a Designated Company under the <FONT STYLE="white-space:nowrap">Non-423</FONT> Component. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Director</U>&#148; means a member of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Effective Date</U>&#148; means the date of the consummation of the merger by and between the Company,
QuantumScape Corporation, and certain other parties, pursuant to that certain Business Combination Agreement dated September&nbsp;2, 2020 (such merger, the &#147;<U>Merger</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Eligible Employee</U>&#148; means any individual who is a common law employee providing services to the
Company or a Designated Company and is customarily employed for at least twenty (20)&nbsp;hours per week and more than five (5)&nbsp;months in any calendar year by the Employer, or any lesser number of hours per week and/or number of months in any
calendar year established by the Administrator (if required under Applicable Laws) for purposes of any separate Offering or for Participants in the Non-423 Component. For purposes of the Plan, the employment relationship will be treated as
continuing intact while the individual is on sick leave or other leave of absence that the Employer approves or is legally protected under Applicable Laws with respect to the Participant&#146;s participation in the Plan. Where the period of leave
exceeds three (3)&nbsp;months and the individual&#146;s right to reemployment is not guaranteed either by statute or by contract, the employment relationship will be deemed to have terminated three (3)&nbsp;months and one (1)&nbsp;day following the
commencement of such leave. The Administrator, in its discretion, from time to time may, prior to an Enrollment Date for all options to be granted on such Enrollment Date in an Offering, determine (for each Offering under the 423 Component, on a
uniform and nondiscriminatory basis or as otherwise permitted by U.S. Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.423-2)</FONT> that the definition of Eligible Employee will or will not include an individual if he or she:
(i)&nbsp;has not completed at least two (2)&nbsp;years of service since his or her last hire date (or such lesser period of time as may be determined by the Administrator in its discretion), (ii)&nbsp;customarily works not more than twenty
(20)&nbsp;hours per week (or such lesser period of time as may be determined by the Administrator in its discretion), (iii)&nbsp;customarily works not more than five (5)&nbsp;months per calendar year (or such lesser period of time as may be
determined by the Administrator in its discretion), (iv)&nbsp;is a highly compensated employee within the meaning of Section&nbsp;414(q) of the Code, or (v)&nbsp;is a highly compensated employee within the meaning of Section&nbsp;414(q) of the Code
with compensation above a certain level or is an officer or subject to the disclosure requirements of Section&nbsp;16(a) of the Exchange Act, provided the exclusion is applied with respect to each Offering under the 423 Component in an identical
manner to all highly compensated individuals of the Employer whose employees are participating in that Offering. Each exclusion will be applied with respect to an Offering under the 423 Component in a manner complying with U.S. Treasury Regulation <FONT
STYLE="white-space:nowrap">Section&nbsp;1.423-2(e)(2)(ii).</FONT> Such exclusions may be applied with respect to an Offering under the Non- 423 Component without regard to the limitations of U.S. Treasury Regulation
<FONT STYLE="white-space:nowrap">Section&nbsp;1.423-2.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Employer</U>&#148; means the employer
of the applicable Eligible Employee(s). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Enrollment Date</U>&#148; means the first Trading Day of each
Offering Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Exchange Act</U>&#148; means the U.S. Securities Exchange Act of 1934, as amended,
including the rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Exercise Date</U>&#148; means such dates
on which each outstanding option granted under the Plan will be exercised (except if the Plan has been terminated), as may be determined by the Administrator, in its discretion and on a uniform and nondiscriminatory basis from time to time prior to
an Enrollment Date for all options to be granted on such Enrollment Date. Unless otherwise determined by the Administration, each Exercise Date will be the last day of the applicable Offering Period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Fair Market Value</U>&#148; means, as of any date and
unless the Administrator determines otherwise, the value of a share of Common Stock determined as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;The
Fair Market Value will be the closing sales price for Common Stock as quoted on any established stock exchange or national market system (including without limitation the New York Stock Exchange, Nasdaq Global Select Market, the Nasdaq Global Market
or the Nasdaq Capital Market of The Nasdaq Stock Market) on which the Common Stock is listed on the date of determination (or the closing bid, if no sales were reported), as reported in <I>The Wall Street Journal</I> or such other source as the
Administrator deems reliable. If the determination date for the Fair Market Value occurs on a non-trading day (i.e., a weekend or holiday), the Fair Market Value will be such price on the immediately preceding trading day, unless otherwise
determined by the Administrator. In the absence of an established market for the Common Stock, the Fair Market Value thereof will be determined in good faith by the Administrator; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;In the absence of an established market for the Common Stock, the Fair Market Value thereof will be determined in
good faith by the Administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The determination of fair market value for purposes of tax withholding may be made in the
Administrator&#146;s discretion subject to Applicable Laws and is not required to be consistent with the determination of Fair Market Value for other purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Fiscal Year</U>&#148; means the fiscal year of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Exercise Date</U>&#148; means a new Exercise Date if the Administrator shortens any Offering Period
then in progress. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(w)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Offering</U>&#148; means an offer under the Plan of an option that may be exercised
during an Offering Period as further described in Section&nbsp;4. For purposes of the Plan, the Administrator may designate separate Offerings under the Plan (the terms of which need not be identical) in which Eligible Employees of one or more
Employers will participate, even if the dates of the applicable Offering Periods of each such Offering are identical and the provisions of the Plan will separately apply to each Offering. To the extent permitted by U.S. Treasury Regulation <FONT
STYLE="white-space:nowrap">Section&nbsp;1.423-2(a)(1),</FONT> the terms of each Offering need not be identical provided that the terms of the Plan and an Offering together satisfy U.S. Treasury Regulation
<FONT STYLE="white-space:nowrap">Section&nbsp;1.423-2(a)(2)</FONT> and (a)(3). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Offering
Periods</U>&#148; means certain periods during with Shares may be purchased under the Plan that will be determined by the Administrator. The duration and timing of Offering Periods may be changed pursuant to Sections 4, 20 and 30. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(y)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Parent</U>&#148; means a &#147;parent corporation,&#148; whether now or hereafter existing, as defined in
Section&nbsp;424(e) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(z)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Participant</U>&#148; means an Eligible Employee who participates in
the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(aa)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Plan</U>&#148; means this QuantumScape Corporation 2020 Employee Stock Purchase Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(bb)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Purchase Period</U>&#148; means the period, as determined by the Administrator in its discretion on a
uniform and nondiscriminatory basis, commencing on the Enrollment Date and ending with the next Exercise Date, except that if the Administrator determines that more than one Purchase Period should occur within an Offering Period, subsequent Purchase
Periods within such Offering Period commence after one Exercise Date and end with the next Exercise Date at such time or times as the Administrator determines prior to the commencement of the applicable Offering Period. Unless otherwise determined
by the Administrator, a Purchase Period shall have the same duration as the Offering Period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(cc)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Purchase Price</U>&#148; means the price per Share of
the Shares purchased under any option granted under the Plan as determined by the Administrator from time to time, in its discretion and on a uniform and nondiscriminatory basis for all options to be granted on an Enrollment Date. However, in no
event will the Purchase Price be less than eighty-five percent (85%)&nbsp;of the lower of the Fair Market Value of a Share on the Enrollment Date or the Fair Market Value of a Share on the Exercise Date and at all times in compliance with
Section&nbsp;423 of the Code (or any successor rule or provision or any other Applicable Law, regulation or stock exchange rule). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(dd)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Section 409A</U>&#148; means Section&nbsp;409A of the Code and the regulations and guidance thereunder,
and formal, effective guidance of either general applicability or direct applicability thereunder, and any applicable state law equivalent, as each may be promulgated, amended or modified from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ee)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Subsidiary</U>&#148; means a &#147;subsidiary corporation,&#148; whether now or hereafter existing, as
defined in Section&nbsp;424(f) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ff)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Trading Day</U>&#148; means a day that the primary stock
exchange (or national market system, or other trading platform, as applicable) upon which the Common Stock is listed is open for trading. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(gg)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>U.S. Treasury Regulations</U>&#148; means the Treasury Regulations of the Code. Reference to a specific
Treasury Regulation or Section of the Code shall include such Treasury Regulation or Section, any valid regulation promulgated under such Section, and any comparable provision of any future legislation or regulation amending, supplementing or
superseding such Section or regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Eligibility</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Generally</U>. Any individual who is an Eligible Employee on a given Enrollment Date subsequent to the first
Offering Period will be eligible to participate in the Plan, subject to the requirements of Section&nbsp;5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Non-U.S. Employees</U>. Eligible Employees who are citizens or residents of a non-U.S. jurisdiction (without
regard to whether they also are citizens or residents of the United States or resident aliens (within the meaning of Section&nbsp;7701(b)(1)(A) of the Code)) may be excluded from participation in the Plan or an Offering if the participation of such
Eligible Employees is prohibited under the laws of the applicable jurisdiction or if complying with the laws of the applicable jurisdiction would cause the Plan or an Offering to violate Section&nbsp;423 of the Code. In the case of the Non-423
Component, an Eligible Employee may be excluded from participation in the Plan or an Offering if the Administrator has determined that participation of such Eligible Employee is not advisable or practicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitations</U>. Any provisions of the Plan to the contrary notwithstanding, no Eligible Employee will be
granted an option under the Plan (i)&nbsp;to the extent that, immediately after the grant, such Eligible Employee (or any other person whose stock would be attributed to such Eligible Employee pursuant to Section&nbsp;424(d) of the Code) would own
capital stock of the Company or any Parent or Subsidiary of the Company and/or hold outstanding options to purchase such stock possessing five percent (5%)&nbsp;or more of the total combined voting power or value of all classes of the capital stock
of the Company or of any Parent or Subsidiary of the Company, or (ii)&nbsp;to the extent that his or her rights to purchase stock under all employee stock purchase plans (as defined in Section&nbsp;423 of the Code) of the Company or any Parent or
Subsidiary of the Company accrues at a rate, which exceeds twenty-five thousand dollars ($25,000) worth of stock (determined at the Fair Market Value of the stock at the time such option is granted) for each calendar year in which such option is
outstanding at any time, as determined in accordance with Section&nbsp;423 of the Code and the regulations thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Offering Periods</U>. Offering Periods will be periods, as will be determined by the Administrator from time to
time, in its discretion and on a uniform and nondiscriminatory basis, prior to an Enrollment Date for all options to be granted on such Enrollment Date. The Administrator will have the power to change the duration of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Offering Periods (including the commencement dates thereof) with respect to future Offerings without stockholder approval if such change is announced prior to the scheduled beginning of the first
Offering Period to be affected thereafter; provided, however, that no Offering Period may last more than twenty-seven (27)&nbsp;months. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Participation</U>. An Eligible Employee may participate in the Plan pursuant to Section&nbsp;3(b) by
(i)&nbsp;submitting to the Company&#146;s stock administration office (or its designee) a properly completed subscription agreement authorizing Contributions in the form provided by the Administrator for such purpose, or (ii)&nbsp;following an
electronic or other enrollment procedure determined by the Administrator, in either case, on or before a date determined by the Administrator prior to an applicable Enrollment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Contributions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;At the time a Participant enrolls in the Plan pursuant to Section&nbsp;5, he or she will elect to have
Contributions (in the form of payroll deductions or otherwise, to the extent permitted by the Administrator) made on each pay day during the Offering Period in an amount not exceeding fifteen percent (15%)&nbsp;of the Compensation, or such other
limit established by the Administrator from time to time in its discretion and on a uniform and nondiscretionary basis for all options to be granted on an Enrollment Date in an Offering, which he or she receives on each pay day during the Offering
Period; provided, however, that should a pay day occur on an Exercise Date, a Participant will have any Contributions made on such day applied to his or her account under the then-current Purchase Period or Offering Period with respect to which that
Exercise Date relates. The Administrator, in its sole discretion, may permit all Participants in a specified Offering to contribute amounts to the Plan through payment by cash, check or other means set forth in the subscription agreement prior to
each Exercise Date of each Purchase Period. A Participant&#146;s subscription agreement will remain in effect for successive Offering Periods unless terminated as provided in Section&nbsp;10 hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;In the event Contributions are made in the form of payroll deductions, such payroll deductions for a Participant
will commence on the first pay day following the Enrollment Date and will end on the last pay day on or prior to the last Exercise Date of such Offering Period to which such authorization is applicable, unless sooner terminated by the Participant as
provided in Section&nbsp;10 hereof; provided, however, that for the first Offering Period, payroll deductions will commence on the first pay day on or following the Enrollment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;All Contributions made for a Participant will be credited to his or her account under the Plan and Contributions
will be made in whole percentages of his or her Compensation only. A Participant may not make any additional payments into such account. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;A Participant may discontinue his or her participation in the Plan as provided under Section&nbsp;10. Until and
unless determined otherwise by the Administrator, in its sole discretion, during&nbsp;any&nbsp;Offering&nbsp;Period, a Participant&nbsp;may not increase&nbsp;the rate of his or her Contributions&nbsp;and may only decrease the rate of his or her
Contributions&nbsp;(including to zero percent (0%))&nbsp;one (1)&nbsp;time. A Participant may make&nbsp;a Contribution rate adjustment pursuant to this subsection (d)&nbsp;by&nbsp;(i) properly completing&nbsp;and submitting&nbsp;to the
Company&#146;s stock administration office (or its designee),&nbsp;a new subscription agreement authorizing the change in Contribution rate in the form provided by the Administrator for such purpose,&nbsp;or (ii)&nbsp;following&nbsp;an electronic or
other procedure prescribed by the Administrator, in either case,&nbsp;on or before a date determined by the Administrator prior to (x)&nbsp;the scheduled beginning of the first Offering Period to be affected or (y)&nbsp;an applicable Exercise Date,
as&nbsp;applicable. If a Participant has not followed such procedures to change the rate of Contributions, the rate of his or her Contributions will continue at the originally elected rate throughout the&nbsp;Offering&nbsp;Period and future Offering
Periods and Purchase Periods (unless the Participant&#146;s participation is terminated as provided in Sections 10&nbsp;or 11). The Administrator may, in its sole discretion, limit or amend the nature and/or number of Contribution rate changes
(including to permit, prohibit and/or limit increases and/or decreases to rate changes) that may be made by Participants during any Offering Period,&nbsp;and may establish such other conditions or limitations as it deems appropriate for Plan
administration. Any&nbsp;change in the rate of Contributions made pursuant to this Section&nbsp;6(d) will be effective as of the first full payroll period following five (5)&nbsp;business&nbsp;days </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
after the date on which the change is made by the Participant (unless the Administrator, in its sole discretion, elects to process a given change in payroll deduction&nbsp;rate more quickly).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, to the extent necessary to comply with Section&nbsp;423(b)(8) of the Code and
Section&nbsp;3(d), a Participant&#146;s Contributions may be decreased to zero percent (0%) by the Administrator at any time during a Purchase Period. Subject to Section&nbsp;423(b)(8) of the Code and Section&nbsp;3(d) hereof, Contributions will
recommence at the rate originally elected by the Participant effective as of the beginning of the first Purchase Period scheduled to end in the following calendar year, unless terminated by the Participant as provided in Section&nbsp;10. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any provisions to the contrary in the Plan, the Administrator may allow Participants to participate
in the Plan via cash contributions instead of payroll deductions if (i)&nbsp;payroll deductions are not permitted or advisable under Applicable Laws, (ii)&nbsp;the Administrator determines that cash contributions are permissible under
Section&nbsp;423 of the Code; or (iii)&nbsp;the Participants are participating in the Non-423 Component. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;At
the time the option is exercised, in whole or in part, or at the time some or all of the Common Stock issued under the Plan is disposed of (or any other time that a taxable event related to the Plan occurs), the Participant must make adequate
provision for the Company&#146;s or Employer&#146;s federal, state, local or any other tax liability payable to any authority including taxes imposed by jurisdictions outside of the U.S., national insurance, social security or other tax withholding
or payment on account obligations, if any, which arise upon the exercise of the option or the disposition of the Common Stock (or any other time that a taxable event related to the Plan occurs). At any time, the Company or the Employer may, but will
not be obligated to, withhold from the Participant&#146;s compensation the amount necessary for the Company or the Employer to meet applicable withholding obligations, including any withholding required to make available to the Company or the
Employer any tax deductions or benefits attributable to sale or early disposition of Common Stock by the Eligible Employee. In addition, the Company or the Employer may, but will not be obligated to, withhold from the proceeds of the sale of Common
Stock or any other method of withholding the Company or the Employer deems appropriate to the extent permitted by U.S. Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.423-2(f).</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant of Option</U>. On the Enrollment Date of each Offering Period, each Eligible Employee participating in such
Offering Period will be granted an option to purchase on each Exercise Date during such Offering Period (at the applicable Purchase Price) up to a number of shares of Common Stock determined by dividing such Eligible Employee&#146;s Contributions
accumulated prior to such Exercise Date and retained in the Eligible Employee&#146;s account as of the Exercise Date by the applicable Purchase Price; provided that in no event will an Eligible Employee be permitted to purchase during each Purchase
Period more than a maximum number shares of Common Stock to be determined by the Administrator (subject to any adjustment pursuant to Section&nbsp;18) and provided further that such purchase will be subject to the limitations set forth in Sections
3(d) and 13 and in the subscription agreement. The Eligible Employee may accept the grant of such option (i)&nbsp;with respect to the first Offering Period by submitting a properly completed subscription agreement in accordance with the requirements
of Section&nbsp;5 on or before the Enrollment Date, and (ii)&nbsp;with respect to any subsequent Offering Period under the Plan, by electing to participate in the Plan in accordance with the requirements of Section&nbsp;5. The Administrator may, for
future Offering Periods, increase or decrease, in its absolute discretion, the maximum number of shares of Common Stock that an Eligible Employee may purchase during each Purchase Period and/or Offering Period, as applicable. Exercise of the option
will occur as provided in Section&nbsp;8, unless the Participant has withdrawn pursuant to Section&nbsp;10 (or Participant&#146;s participation is terminated as provided in Section&nbsp;11). The option will expire on the last day of the Offering
Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise of Option</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Unless a Participant withdraws from the Plan as provided in Section&nbsp;10 (or Participant&#146;s participation is
terminated as provided in Section&nbsp;11), his or her option for the purchase of shares of Common </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Stock will be exercised automatically on each Exercise Date, and the maximum number of full shares of Common Stock subject to the option will be purchased for such Participant at the applicable
Purchase Price with the accumulated Contributions from his or her account. No fractional shares of Common Stock will be purchased; any Contributions accumulated in a Participant&#146;s account, which are not sufficient to purchase a full share will
be retained in the Participant&#146;s account for the subsequent Purchase Period or Offering Period, as applicable, subject to earlier withdrawal by the Participant as provided in Section&nbsp;10 (or the earlier termination of Participant&#146;s
participation as provided in Section&nbsp;11). Any other funds left over in a Participant&#146;s account after the Exercise Date will be returned to the Participant. During a Participant&#146;s lifetime, a Participant&#146;s option to purchase
shares of Common Stock hereunder is exercisable only by him or her. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;If the Administrator determines that, on a
given Exercise Date, the number of shares of Common Stock with respect to which options are to be exercised may exceed (i)&nbsp;the number of shares of Common Stock that were available for sale under the Plan on the Enrollment Date of the applicable
Offering Period, or (ii)&nbsp;the number of shares of Common Stock available for sale under the Plan on such Exercise Date, the Administrator may in its sole discretion (x)&nbsp;provide that the Company will make a pro rata allocation of the shares
of Common Stock available for purchase on such Enrollment Date or Exercise Date, as applicable, in as uniform a manner as will be practicable and as it will determine in its sole discretion to be equitable among all Participants exercising options
to purchase Common Stock on such Exercise Date, and continue all Offering Periods then in effect or (y)&nbsp;provide that the Company will make a pro rata allocation of the shares of Common Stock available for purchase on such Enrollment Date or
Exercise Date, as applicable, in as uniform a manner as will be practicable and as it will determine in its sole discretion to be equitable among all participants exercising options to purchase Common Stock on such Exercise Date, and terminate any
or all Offering Periods then in effect pursuant to Section&nbsp;20. The Company may make a pro rata allocation of the shares of Common Stock available on the Enrollment Date of any applicable Offering Period pursuant to the preceding sentence,
notwithstanding any authorization of additional shares of Common Stock for issuance under the Plan by the Company&#146;s stockholders subsequent to such Enrollment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery</U>. As soon as reasonably practicable after each Exercise Date on which a purchase of shares of Common
Stock occurs, the Company will arrange the delivery to each Participant of the shares purchased upon exercise of his or her option in a form determined by the Administrator (in its sole discretion) and pursuant to rules established by the
Administrator. The Company may permit or require that shares be deposited directly with a broker designated by the Company or with a trustee or designated agent of the Company, and the Company may utilize electronic or automated methods of share
transfer. The Company may require that shares be retained with such broker, trustee or agent for a designated period of time and/or may establish other procedures to permit tracking of disqualifying dispositions or other dispositions of such shares.
No Participant will have any voting, dividend, or other stockholder rights with respect to shares of Common Stock subject to any option granted under the Plan until such shares have been purchased and delivered to the Participant as provided in this
Section&nbsp;9. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Withdrawal</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;A Participant may withdraw all but not less than all the Contributions credited to his or her account and not yet
used to exercise his or her option under the Plan at any time by (i)&nbsp;submitting to the Company&#146;s stock administration office (or its designee) a written notice of withdrawal in the form determined by the Administrator for such purpose
(which may be similar to the form attached hereto as <U>Exhibit B</U>), or (ii)&nbsp;following an electronic or other withdrawal procedure determined by the Administrator. The Administrator may set forth a deadline of when a withdrawal must occur to
be effective prior to a given Exercise Date in accordance with policies it may approve from time to time. All of the Participant&#146;s Contributions credited to his or her account will be paid to such Participant as soon as administratively
practicable after receipt of notice of withdrawal and such Participant&#146;s option for the Offering Period will be automatically terminated, and no further Contributions for the purchase of shares will be made for such Offering Period. If a
Participant withdraws from an Offering Period, Contributions will not resume at the beginning of the succeeding Offering Period, unless the Participant re-enrolls in the Plan in accordance with the provisions of Section&nbsp;5. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;A Participant&#146;s withdrawal from an Offering Period will not
have any effect upon his or her eligibility to participate in any similar plan that may hereafter be adopted by the Company or in succeeding Offering Periods that commence after the termination of the Offering Period from which the Participant
withdraws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination of Employment</U>. Upon a Participant&#146;s ceasing to be an Eligible Employee, for
any reason, he or she will be deemed to have elected to withdraw from the Plan and the Contributions credited to such Participant&#146;s account during the Offering Period but not yet used to purchase shares of Common Stock under the Plan will be
returned to such Participant, or, in the case of his or her death, to the person or persons entitled thereto, and such Participant&#146;s option will be automatically terminated. Unless otherwise provided by the Administrator, a Participant whose
employment transfers between entities through a termination with an immediate rehire (with no break in service) by the Company or a Designated Company will not be treated as terminated under the Plan. The Administrator may establish rules to govern
transfers of employment among the Company and any Designated Company, consistent with any applicable requirements of Section&nbsp;423 of the Code and the terms of the Plan. In addition, the Administrator may establish rules to govern transfers of
employment among the Company and any Designated Company where such companies are participating in separate Offerings under the Plan. However, if a Participant transfers from an Offering under the 423 Component to the Non-423 Component, the exercise
of the option will be qualified under the 423 Component only to the extent it complies with Section&nbsp;423 of the Code, unless otherwise provided by the Administrator. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Interest</U>. No interest will accrue on the Contributions of a participant in the Plan, except as may be
required by Applicable Law, as determined by the Company, and if so required by the laws of a particular jurisdiction, will apply to all Participants in the relevant Offering under the 423 Component, except to the extent otherwise permitted by U.S.
Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.423-2(f).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Subject to adjustment upon changes in capitalization of the Company as provided in Section&nbsp;19 hereof, the
maximum number of shares of Common Stock that will be made available for sale under the Plan will be 7,600,000 shares of Common Stock. The number of shares of Common Stock available for issuance under the Plan will be increased on the first day of
each Fiscal Year beginning with the 2022 Fiscal Year equal to the least of (i)&nbsp;7,600,000 shares of Common Stock, (ii)&nbsp;one percent (1%)&nbsp;of the outstanding shares of all classes Company common stock on the last day of the immediately
preceding Fiscal Year, or (iii)&nbsp;an amount determined by the Administrator no later than the last day of the immediately preceding Fiscal Year. The shares of Common Stock may be authorized, but unissued, or reacquired Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Until the shares of Common Stock are issued (as evidenced by the appropriate entry on the books of the Company or
of a duly authorized transfer agent of the Company), a Participant will have only the rights of an unsecured creditor with respect to such shares, and no right to vote or receive dividends or any other rights as a stockholder will exist with respect
to such shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Shares of Common Stock to be delivered to a Participant under the Plan will be registered in
the name of the Participant or, if so required under Applicable Laws, in the name of the Participant and his or her spouse. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.&nbsp;&nbsp;&nbsp;&nbsp;<U>Administration</U>. The Plan will be administered by the Board or a Committee appointed by the Board, which
Committee will be constituted to comply with Applicable Laws. The Administrator will have full and exclusive discretionary authority to construe, interpret and apply the terms of the Plan, to delegate ministerial duties to any of the Company&#146;s
employees, to designate separate Offerings under the Plan, to designate Subsidiaries and Affiliates as participating in the 423 Component or Non-423 Component, to determine eligibility, to adjudicate all disputed claims filed under the Plan and to
establish such procedures that it deems necessary or advisable for the administration of the Plan (including, without limitation, to adopt such procedures, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sub-plans, and appendices to the enrollment agreement as are necessary or appropriate to permit the participation in the Plan by employees who are foreign nationals or employed outside the U.S.,
the terms of which rules, procedures, sub-plans and appendices may take precedence over other provisions of this Plan, with the exception of Section&nbsp;13(a) hereof, but unless otherwise superseded by the terms of such rules, procedures, sub-plan
or appendix, the provisions of this Plan will govern the operation of such rules, procedure, sub-plan or appendix). Unless otherwise determined by the Administrator, the Eligible Employees eligible to participate in each sub-plan will participate in
a separate Offering under the 423 Component, or if the terms would not qualify under the 423 Component, in the Non-423 Component, in either case unless such designation would cause the 423 Component to violate the requirements of Section&nbsp;423 of
the Code. Without limiting the generality of the foregoing, the Administrator is specifically authorized to adopt rules and procedures regarding eligibility to participate, the definition of Compensation, handling of Contributions, making of
Contributions to the Plan (including, without limitation, in forms other than payroll deductions), establishment of bank or trust accounts to hold Contributions, payment of interest, conversion of local currency, obligations to pay payroll tax,
determination of beneficiary designation requirements, withholding procedures and handling of stock certificates that vary with applicable local requirements. The Administrator also is authorized to determine that, to the extent permitted by U.S.
Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.423-2(f),</FONT> the terms of an option granted under the Plan or an Offering to citizens or residents of a non-U.S. jurisdiction will be less favorable than the terms of options
granted under the Plan or the same Offering to employees resident solely in the U.S. Every finding, decision, and determination made by the Administrator will, to the full extent permitted by law, be final and binding upon all parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.&nbsp;&nbsp;&nbsp;&nbsp;<U>Transferability</U>. Neither Contributions credited to a Participant&#146;s account nor any rights with regard
to the exercise of an option or to receive shares of Common Stock under the Plan may be assigned, transferred, pledged or otherwise disposed of in any way (other than by will or the laws of descent and distribution) by the Participant. Any such
attempt at assignment, transfer, pledge or other disposition will be without effect, except that the Company may treat such act as an election to withdraw funds from an Offering Period in accordance with Section&nbsp;10 hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.&nbsp;&nbsp;&nbsp;&nbsp;<U>Use of Funds</U>. The Company may use all Contributions received or held by it under the Plan for any corporate
purpose, and the Company will not be obligated to segregate such Contributions except under Offerings or for Participants in the Non-423 Component for which Applicable Laws require that Contributions to the Plan by Participants be segregated from
the Company&#146;s general corporate funds and/or deposited with an independent third party, provided that, if such segregation or deposit with an independent third party is required by Applicable Laws, it will apply to all Participants in the
relevant Offering under the 423 Component, except to the extent otherwise permitted by U.S. Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.423-2(f).</FONT> Until shares of Common Stock are issued, Participants will only have the
rights of an unsecured creditor with respect to such shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.&nbsp;&nbsp;&nbsp;&nbsp;<U>Reports</U>. Individual accounts will be
maintained for each Participant in the Plan. Statements of account will be given to participating Eligible Employees at least annually, which statements will set forth the amounts of Contributions, the Purchase Price, the number of shares of Common
Stock purchased and the remaining cash balance, if any. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustments, Dissolution, Liquidation, Merger or
Change in Control</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustments</U>. In the event that any dividend or other distribution (whether in
the form of cash, Common Stock, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, reclassification, repurchase, or exchange of Common
Stock or other securities of the Company, or other change in the corporate structure of the Company affecting the Common Stock occurs (other than any ordinary dividends or other ordinary distributions), the Administrator, in order to prevent
diminution or enlargement of the benefits or potential benefits intended to be made available under the Plan, will, in such manner as it may deem equitable, adjust the number and class of Common Stock that may be delivered under the Plan, the
Purchase Price per share, the class and the number of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shares of Common Stock covered by each option under the Plan that has not yet been exercised, and the numerical limits of Sections 7 and 13. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Dissolution or Liquidation</U>. In the event of the proposed dissolution or liquidation of the Company, any
Offering Period then in progress will be shortened by setting a New Exercise Date, and will terminate immediately prior to the consummation of such proposed dissolution or liquidation, unless provided otherwise by the Administrator. The New Exercise
Date will be before the date of the Company&#146;s proposed dissolution or liquidation. The Administrator will notify each Participant in writing or electronically, prior to the New Exercise Date, that the Exercise Date for the Participant&#146;s
option has been changed to the New Exercise Date and that the Participant&#146;s option will be exercised automatically on the New Exercise Date, unless prior to such date the Participant has withdrawn from the Offering Period as provided in
Section&nbsp;10 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Merger or Change in Control</U>. In the event of a merger or Change in Control,
each outstanding option will be assumed or an equivalent option substituted by the successor corporation or a Parent or Subsidiary of the successor corporation. In the event that the successor corporation refuses to assume or substitute for the
option, the Offering Period with respect to which such option relates will be shortened by setting a New Exercise Date on which such Offering Period shall end. The New Exercise Date will occur before the date of the Company&#146;s proposed merger or
Change in Control. The Administrator will notify each Participant in writing or electronically prior to the New Exercise Date, that the Exercise Date for the Participant&#146;s option has been changed to the New Exercise Date and that the
Participant&#146;s option will be exercised automatically on the New Exercise Date, unless prior to such date the Participant has withdrawn from the Offering Period as provided in Section&nbsp;10 hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment or Termination</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Administrator, in its sole discretion, may amend, suspend, or terminate the Plan, or any part thereof, at any
time and for any reason. If the Plan is terminated, the Administrator, in its discretion, may elect to terminate all outstanding Offering Periods either immediately or upon completion of the purchase of shares of Common Stock on the next Exercise
Date (which may be sooner than originally scheduled, if determined by the Administrator in its discretion), or may elect to permit Offering Periods to expire in accordance with their terms (and subject to any adjustment pursuant to Section&nbsp;18).
If the Offering Periods are terminated prior to expiration, all amounts then credited to Participants&#146; accounts that have not been used to purchase shares of Common Stock will be returned to the Participants (without interest thereon, except as
otherwise required under Applicable Laws, as further set forth in Section&nbsp;12 hereof) as soon as administratively practicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Without stockholder consent and without limiting Section&nbsp;19(a), the Administrator will be entitled to change
the Offering Periods or Purchase Periods, designate separate Offerings, limit the frequency and/or number of changes in the amount withheld during an Offering Period, establish the exchange rate applicable to amounts withheld in a currency other
than U.S. dollars, permit Contributions in excess of the amount designated by a Participant in order to adjust for delays or mistakes in the Company&#146;s processing of properly completed Contribution elections, establish reasonable waiting and
adjustment periods and/or accounting and crediting procedures to ensure that amounts applied toward the purchase of Common Stock for each Participant properly correspond with Contribution amounts, and establish such other limitations or procedures
as the Administrator determines in its sole discretion advisable that are consistent with the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;In the
event the Administrator determines that the ongoing operation of the Plan may result in unfavorable financial accounting consequences, the Administrator may, in its discretion and, to the extent necessary or desirable, modify, amend or terminate the
Plan to reduce or eliminate such accounting consequence including, but not limited to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;amending the Plan to
conform with the safe harbor definition under the Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto), including with respect to an Offering Period underway at the time; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;altering the Purchase Price for any Offering Period or Purchase
Period including an Offering Period or Purchase Period underway at the time of the change in Purchase Price; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;shortening any Offering Period or Purchase Period by setting a New Exercise Date, including an Offering Period
or Purchase Period underway at the time of the Administrator action; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;reducing the maximum percentage of
Compensation a Participant may elect to set aside as Contributions; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;reducing the maximum number of shares
of Common Stock a Participant may purchase during any Offering Period or Purchase Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Such modifications or amendments will not require stockholder
approval or the consent of any Participants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>. All notices or other communications by a
Participant to the Company under or in connection with the Plan will be deemed to have been duly given when received in the form and manner specified by the Company at the location, or by the person, designated by the Company for the receipt
thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21.&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions Upon Issuance of Shares</U>. Shares of Common Stock will not be issued with respect to
an option unless the exercise of such option and the issuance and delivery of such shares pursuant thereto will comply with all applicable provisions of law, domestic or foreign, including, without limitation, the U.S. Securities Act of 1933, as
amended, the Exchange Act, the rules and regulations promulgated thereunder, and the requirements of any stock exchange upon which the shares may then be listed, and will be further subject to the approval of counsel for the Company with respect to
such compliance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a condition to the exercise of an option, the Company may require the person exercising such option to represent and
warrant at the time of any such exercise that the shares are being purchased only for investment and without any present intention to sell or distribute such shares if, in the opinion of counsel for the Company, such a representation is required by
any of the aforementioned applicable provisions of law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22.&nbsp;&nbsp;&nbsp;&nbsp;<U>Section&nbsp;409A.</U> The 423 Component of the
Plan is intended to be exempt from the application of Section&nbsp;409A, and, to the extent not exempt, is intended to comply with Section&nbsp;409A and any ambiguities herein will be interpreted to so be exempt from, or comply with,
Section&nbsp;409A. In furtherance of the foregoing and notwithstanding any provision in the Plan to the contrary, if the Administrator determines that an option granted under the Plan may be subject to Section&nbsp;409A or that any provision in the
Plan would cause an option under the Plan to be subject to Section&nbsp;409A, the Administrator may amend the terms of the Plan and/or of an outstanding option granted under the Plan, or take such other action the Administrator determines is
necessary or appropriate, in each case, without the Participant&#146;s consent, to exempt any outstanding option or future option that may be granted under the Plan from or to allow any such options to comply with Section&nbsp;409A, but only to the
extent any such amendments or action by the Administrator would not violate Section&nbsp;409A. Notwithstanding the foregoing, the Company and any of its Parent or Subsidiaries shall have no obligation to reimburse, indemnify, or hold harmless a
Participant or any other party if the option to purchase Common Stock under the Plan that is intended to be exempt from or compliant with Section&nbsp;409A is not so exempt or compliant or for any action taken by the Administrator with respect
thereto. The Company makes no representation that the option to purchase Common Stock under the Plan is compliant with Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.&nbsp;&nbsp;&nbsp;&nbsp;<U>Term of Plan</U>. The Plan will become effective upon the later to occur of (a)&nbsp;its adoption by the Board,
(b)&nbsp;approval by the Company&#146;s stockholders or (c)&nbsp;the Effective Date. It will continue in effect for a term of twenty (20)&nbsp;years, unless sooner terminated under Section&nbsp;19. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24.&nbsp;&nbsp;&nbsp;&nbsp;<U>Stockholder Approval</U>. The Plan will be subject to approval by the stockholders of the Company within twelve
(12)&nbsp;months after the date the Plan is adopted by the Board. Such stockholder approval will be obtained in the manner and to the degree required under Applicable Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25.&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law</U>. The Plan will be governed by, and construed
in accordance with, the laws of the State of California (except its choice-of-law provisions). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Right to
Employment</U>. Participation in the Plan by a Participant will not be construed as giving a Participant the right to be retained as an employee of the Company or a Subsidiary or Affiliate, as applicable. Furthermore, the Company or a Subsidiary or
Affiliate may dismiss a Participant from employment at any time, free from any liability or any claim under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">27.&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>. If any provision of the Plan is or becomes or is deemed to be invalid, illegal, or
unenforceable for any reason in any jurisdiction or as to any Participant, such invalidity, illegality or unenforceability will not affect the remaining parts of the Plan, and the Plan will be construed and enforced as to such jurisdiction or
Participant as if the invalid, illegal or unenforceable provision had not been included. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">28.&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance with
Applicable Laws</U>. The terms of this Plan are intended to comply with all Applicable Laws and will be construed accordingly. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">29.&nbsp;&nbsp;&nbsp;&nbsp;<U>Automatic Transfer to Low Price Offering Period</U>. To the extent permitted by Applicable Laws, if the Fair
Market Value on any Exercise Date in an Offering Period is lower than the Fair Market Value on the Enrollment Date of such Offering Period, then all Participants in such Offering Period automatically will be withdrawn from such Offering Period
immediately after the exercise of their option on such Exercise Date and automatically re-enrolled in the immediately following Offering Period as of the first day thereof. </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>QUANTUMSCAPE CORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2020 EMPLOYEE STOCK PURCHASE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUBSCRIPTION AGREEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Original Application</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Offering Date: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in Payroll Deduction Rate </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> hereby
elects to participate in the QuantumScape Corporation 2020 Employee Stock Purchase Plan (the &#147;<U>Plan</U>&#148;) and subscribes to purchase shares of the Company&#146;s Common Stock in accordance with this Subscription Agreement and the Plan.
Unless otherwise defined herein, the terms defined in the 2020 Employee Stock Purchase Plan (the &#147;Plan&#148;) shall have the same defined meanings in this Subscription Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;I hereby authorize and consent to payroll deductions from each paycheck in the amount of
<U>&nbsp;&nbsp;&nbsp;&nbsp;</U>% (from 0 to fifteen percent (15%))&nbsp;of my Compensation on each payday during the Offering Period in accordance with the Plan. (Please note that no fractional percentages are permitted.) I understand that only my
first election to decrease the rate of my payroll deductions may be applied with respect to an ongoing Offering Period in accordance with the terms of the Plan, and any subsequent election to decrease the rate of my payroll deductions during the
same Offering Period, and any election to increase the rate of my payroll deductions during any Offering Period, will not be applied to the ongoing Offering Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;I understand that said payroll deductions will be accumulated for the purchase of shares of Common Stock at the
applicable Purchase Price determined in accordance with the Plan. I understand that if I do not withdraw from an Offering Period, any accumulated payroll deductions will be used to automatically exercise my option and purchase Common Stock under the
Plan. I further understand that if I am outside of the U.S., my payroll deductions will be converted to U.S. dollars at an exchange rate selected by the Company on the purchase date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;I have received a copy of the complete Plan and its accompanying prospectus. I understand that my participation in
the Plan is in all respects subject to the terms of the Plan. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;Shares of Common Stock purchased for me under
the Plan should be issued in the name(s) of <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;(Eligible Employee or Eligible Employee and spouse only). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;If I am a U.S. taxpayer, I understand that if I dispose of any shares received by me pursuant to the Plan within two
(2)&nbsp;years after the Enrollment Date (the first day of the Offering Period during which I purchased such shares) or one (1)&nbsp;year after the applicable Exercise Date, I will be treated for federal income tax purposes as having received
ordinary income at the time of such disposition in an amount equal to the excess of the fair market value of the shares at the time such shares were purchased by me over the price that I paid for the shares. <U>I hereby agree to notify the Company
in writing within thirty (30)&nbsp;days after the date of any disposition of my shares and I will make adequate provision for federal, state or other tax withholding obligations, if any, which arise upon the disposition of such shares</U>. The
Company may, but will not be obligated to, withhold from my compensation the amount necessary to meet any applicable withholding obligation including any withholding necessary to make available to the Company any tax deductions or benefits
attributable to sale or early disposition of Common Stock by me. If I dispose of such shares at any time after the expiration of the two (2)-year and one (1)-year holding periods, I understand that I will be treated for federal income tax purposes
as having received income only at the time of such disposition, and that such income will be taxed as ordinary income only to the extent of an amount equal to the lesser of (a)&nbsp;the excess of the fair market value of the shares at the time of
such disposition over the purchase price which I paid for the shares, or (b)&nbsp;15% of the fair market value of the shares on the first day of the Offering Period. The remainder of the gain, if any, recognized on such disposition will be taxed as
capital gain. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;I hereby agree to be bound by the terms of the Plan. The
effectiveness of this Subscription Agreement is dependent upon my eligibility to participate in the Plan. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Employee&#146;s ID Number:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Employee&#146;s Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I UNDERSTAND THAT THIS SUBSCRIPTION AGREEMENT WILL REMAIN IN EFFECT THROUGHOUT SUCCESSIVE OFFERING PERIODS
UNLESS TERMINATED BY ME. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Signature of Employee</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>QUANTUMSCAPE CORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2020 EMPLOYEE STOCK PURCHASE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF WITHDRAWAL </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise
defined herein, the terms defined in the 2020 Employee Stock Purchase Plan (the &#147;Plan&#148;) shall have the same defined meanings in this Notice of Withdrawal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned Participant in the Offering Period of the QuantumScape Corporation 2020 Employee Stock Purchase Plan that began on
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(the &#147;<U>Enrollment Date</U>&#148;) hereby
notifies the Company that he or she hereby withdraws from the Offering Period. He or she hereby directs the Company to pay to the undersigned as promptly as practicable all the payroll deductions credited to his or her account with respect to such
Offering Period. The undersigned understands and agrees that his or her option for such Offering Period will be terminated automatically. The undersigned understands further that no further payroll deductions will be made for the purchase of shares
in the current Offering Period and the undersigned will be eligible to participate in succeeding Offering Periods only by delivering to the Company a new Subscription Agreement. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name and Address of Participant:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Signature:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><I>Item&nbsp;20.</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Indemnification of Directors and Officers </I></B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;145(a) of the DGCL provides, in general, that a corporation may indemnify any person who was or is a party to or is threatened to
be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation), because he or she is or was a director,
officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses
(including attorneys&#146; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding, if he or she acted in good faith and in a manner he or she
reasonably believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;145(b) of the DGCL provides, in general, that a corporation may indemnify any person who was or is a party or is threatened to be
made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor because the person is or was a director, officer, employee or agent of the corporation, or is or was serving
at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#146; fees) actually and reasonably incurred by the
person in connection with the defense or settlement of such action or suit if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation, except that no
indemnification shall be made with respect to any claim, issue or matter as to which he or she shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines
that, despite the adjudication of liability but in view of all of the circumstances of the case, he or she is fairly and reasonably entitled to indemnity for such expenses that the Court of Chancery or other adjudicating court shall deem proper.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;145(g) of the DGCL provides, in general, that a corporation may purchase and maintain insurance on behalf of any person who
is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise
against any liability asserted against such person and incurred by such person in any such capacity, or arising out of his or her status as such, whether or not the corporation would have the power to indemnify the person against such liability
under Section&nbsp;145 of the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Business Combination, Kensington will enter into indemnification agreements
with each of its directors and executive officers. These agreements will provide that Kensington will indemnify each of its directors and such officers to the fullest extent permitted by law and its charter and its bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington will also maintain a general liability insurance policy, which will cover certain liabilities of directors and officers of
Kensington arising out of claims based on acts or omissions in their capacities as directors or officers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B><I>Item&nbsp;21.</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Exhibits and Financial Statement Schedules </I></B></P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit Index </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="91%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;1.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1811414/000156459020031281/cik1811414-ex11_6.htm">Underwriting Agreement, dated June&nbsp;
25, 2020, among Kensington Capital Acquisition Corp., UBS Securities LLC, and Stifel, Nicolaus&nbsp;&amp; Company, Incorporated. (1) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;2.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#rom14810_70">Business Combination Agreement, dated as of September&nbsp;2, 2020, by and among Kensington Capital Acquisition Corp., Kensington Capital Merger Sub Corp. and QuantumScape Corporation (included in Annex&nbsp;
A to this proxy statement/prospectus/information statement).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;2.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#rom14810_70">Amendment No.&nbsp;1 to Business Combination Agreement, dated as of September&nbsp;
21, 2020, by and among Kensington Capital Acquisition Corp., Kensington Capital Merger Sub Corp. and QuantumScape Corporation (included in Annex&nbsp;A to this proxy statement/prospectus/information statement). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1811414/000156459020031281/cik1811414-ex31_11.htm">Amended and Restated Certificate of Incorporation of Kensington Capital Acquisition Corp. (1) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1811414/000156459020029964/cik1811414-ex33_17.htm">Bylaws of Kensington Capital Acquisition Corp. (3) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#annex b">Form of Second Amended and Restated Certificate of Incorporation (included as Annex&nbsp;B to this proxy statement/prospectus/information statement). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#annex c">Form of Amended and Restated Bylaws (included as Annex C to this proxy statement/prospectus/information statement). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1811414/000156459020031281/cik1811414-ex41_12.htm">Warrant Agreement, dated June&nbsp;25, 2020, by and between the Registrant and Continental Stock Transfer&nbsp;
&amp; Trust Company. (1) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;5.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d14810dex51.htm">Form of opinion of Hughes Hubbard&nbsp;&amp; Reed&nbsp;LLP with respect to the legality of the securities being registered.</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;8.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d14810dex81.htm">Form of opinion of Hughes Hubbard&nbsp;&amp; Reed&nbsp;LLP regarding tax matters. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1811414/000156459020042442/kcac-ex101_59.htm">Stockholder Support Agreement, dated as of September&nbsp;
2, 2020, by and between Kensington Capital Acquisition Corp. and Volkswagen Group of America Investments, LLC. (2) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1811414/000156459020042442/kcac-ex102_62.htm">Stockholder Support Agreement, dated as of September&nbsp;
2, 2020, by and among Kensington Capital Acquisition Corp. and the persons named therein. (2) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1811414/000156459020042442/kcac-ex103_63.htm">Registration Rights and <FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreement, dated as of September&nbsp;
2, 2020, by and among Kensington Capital Acquisition Corp. and the persons named therein. (2) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1811414/000156459020042442/kcac-ex104_7.htm">Form of Subscription Agreement. (2) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1811414/000156459020042442/kcac-ex105_60.htm">Form of Senior Employee <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement. (2) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1811414/000156459020042442/kcac-ex106_57.htm">First Letter Agreement, dated as of September&nbsp;
2, 2020, by and among Kensington Capital Acquisition Corp., QuantumScape Corporation, and Volkswagen Group of America Investments, LLC. (2) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1811414/000156459020042442/kcac-ex107_55.htm">Second Letter Agreement, dated as of September&nbsp;
2, 2020, by and among Kensington Capital Acquisition Corp., QuantumScape Corporation, and Volkswagen Group of America Investments, LLC. (2) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1811414/000156459020042442/kcac-ex108_58.htm">Third Letter Agreement, dated as of September&nbsp;
2, 2020, by and among Kensington Capital Acquisition Corp., QuantumScape Corporation, and Volkswagen Group of America Investments, LLC. (2) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1811414/000156459020042442/kcac-ex109_8.htm">Services Agreement, dated as of September&nbsp;2, 2020, by and between Kensington Capital Acquisition Corp. and DEHC LLC. (2)
</A></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="88%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1811414/000156459020042442/kcac-ex1010_6.htm">Services Agreement, dated as of September&nbsp;2, 2020, by and between Kensington Capital Acquisition Corp. and Simon Boag. (2)
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.11#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#rom14810_73">2020 Equity Incentive Plan (included as Annex&nbsp;D to this proxy statement/prospectus/information statement). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.12#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#rom14810_74">2020 Employee Stock Purchase Plan (included as Annex&nbsp;E to this proxy statement/prospectus/information statement). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.13+#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex1013.htm">Offer Letter from QuantumScape Corporation to Timothy Holme, dated January&nbsp;1, 2011. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.14+#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex1014.htm">Offer Letter from QuantumScape Corporation to Kevin Hettrich, dated October&nbsp;11, 2011. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.15+#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex1015.htm">Offer Letter from QuantumScape Corporation to Howard Lukens, dated February&nbsp;13, 2012. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.16+#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex1016.htm">Offer Letter from QuantumScape Corporation to Michael McCarthy, dated December&nbsp;21, 2012. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.17+#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex1017.htm">Offer Letter from QuantumScape Corporation to Mohit Singh, dated April&nbsp;3, 2013. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.18+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex1018.htm">Lease, dated May&nbsp;31, 2013, by and between SI 55, LLC and QuantumScape Corporation. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.19+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex1019.htm">Amendment to Lease, dated May&nbsp;19, 2014, by and between SI 55, LLC and QuantumScape Corporation. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.20+*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex1020.htm">Amended and Restated Limited Liability Company Agreement of QSV Operations LLC, dated May 14, 2020, by and between QuantumScape Corporation
 and Volkswagen Group of America Investments, LLC. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.21+*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex1021.htm">Amended and Restated Joint Venture Agreement, dated May 14, 2020, by and among QuantumScape Corporation and the persons named therein.
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.22+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex1022.htm">First Amendment to Amended and Restated Joint Venture Agreement, dated September 21, 2020, by and among QuantumScape Corporation and the persons
 named therein. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.23+*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex1023.htm">Series F Preferred Stock Purchase Agreement, dated May 14, 2020, by and between QuantumScape Corporation and Volkswagen Group of America Investments,
 LLC. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.24+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex1024.htm">Amendment No. 1 to Series F Preferred Stock Purchase Agreement, dated September 3, 2020, by and among Kensington Capital Acquisition Corp.,
 QuantumScape Corporation and Volkswagen Group of America Investments, LLC. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d14810dex231.htm">Consent of Marcum&nbsp;LLP. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d14810dex232.htm">Consent of Independent Registered Accounting Firm, Ernst&nbsp;&amp; Young&nbsp;LLP. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1811414/000119312520249736/d14810ds4.htm#sig">Powers of Attorney. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex991.htm">Consent of Jagdeep Singh to be named as a director. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.2+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex992.htm">Consent of Prof. Fritz Prinz to be named as a director. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.3+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex993.htm">Consent of John Doerr to be named as a director. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.4+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex994.htm">Consent of J.B. Straubel to be named as a director. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.5+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex995.htm">Consent of Prof. Dr.&nbsp;J&uuml;rgen Leohold to be named as a director. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.6+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex996.htm">Consent of Brad Buss to be named as a director. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.7+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001811414/000119312520249736/d14810dex997.htm">Consent of Frank Blome to be named as a director. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d14810dex998.htm">Consent of Dipender Saluja to be named as a director</A>.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.9&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Proxy Card.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.INS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Instance Document</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.SCH</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Schema Document</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.CAL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Calculation Linkbase Document</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="88%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.DEF</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Definition Linkbase Document</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.LAB</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Label Linkbase Document</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.PRE</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Presentation Linkbase Document</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">#</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Indicates management contract or compensatory plan or arrangement. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">+</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Previously filed. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Portions of this exhibit have been omitted in accordance with Item 601 of Regulation <FONT
STYLE="white-space:nowrap">S-K.</FONT> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#134;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To be filed by amendment. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Incorporated by reference to an exhibit to Kensington Capital Acquisition Corp.&#146;s current report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on June&nbsp;30, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Incorporated by reference to an exhibit to Kensington Capital Acquisition Corp.&#146;s current report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on September&nbsp;3, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Incorporated by reference to an exhibit to Kensington Capital Acquisition Corp.&#146;s Form <FONT
STYLE="white-space:nowrap">S-1/A,</FONT> filed with the SEC on June&nbsp;19, 2020. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;22.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Undertakings </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned registrant hereby undertakes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To file, during any period in which offers or sales are being made, a post-effective amendment to this
registration statement: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To include any prospectus required by section 10(a)(3) of the Securities Act; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To reflect in the prospectus any facts or events arising after the effective date of the registration statement
(or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus
filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#147;Calculation of Registration Fee&#148; table in the
effective registration statement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To include any material information with respect to the plan of distribution not previously disclosed in the
registration statement or any material change to such information in the registration statement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment
shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">C.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To remove from registration by means of a post-effective amendment any of the securities being registered which
remain unsold at the termination of the offering. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">D.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That, for the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed
pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the
registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed
incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in
the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">E.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in
the initial distribution of the securities, that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the
securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be
filed pursuant to Rule 424; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or
used or referred to by the undersigned registrant; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The portion of any other free writing prospectus relating to the offering containing material information about
the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">F.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That prior to any public reoffering of the securities registered hereunder through use of a prospectus which is
a part of this registration statement, by any person or party who is deemed to be an underwriter within the meaning of Rule 145(c), the issuer undertakes that such reoffering prospectus will contain the information called for by the applicable
registration form with respect to reofferings by persons who may be deemed underwriters, in addition to the information called for by the other items of the applicable form. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">G.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That every prospectus (i)&nbsp;that is filed pursuant to paragraph (F)&nbsp;immediately preceding, or
(ii)&nbsp;that purports to meet the requirements of section 10(a)(3) of the Securities Act and is used in connection with an offering of securities subject to Rule 415, will be filed as a part of an amendment to the registration statement and will
not be used until such amendment is effective, and that, for purposes of determining any liability under the Securities Act , each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">H.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors,
officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act
and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the
successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">I.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The undersigned registrant hereby undertakes to respond to requests for information that is incorporated by
reference into the prospectus pursuant to Item 4, 10(b), 11, or 13 of this form, within one business day of receipt of such request, and to send the incorporated documents by first class mail or other equally prompt means. This includes information
contained in documents filed subsequent to the effective date of the registration statement through the date of responding to the request. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">J.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To supply by means of a post-effective amendment all information concerning a transaction, and the company
being acquired involved therein, that was not the subject of and included in the registration statement when it became effective. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant has duly caused this Registration Statement on <FONT
STYLE="white-space:nowrap">Form&nbsp;S-4</FONT> to be signed on its behalf by the undersigned, thereunto duly authorized, in New York City, New York, on October&nbsp;23, 2020. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>KENSINGTON CAPITAL ACQUISITION CORP.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-bottom:1pt; margin-top:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Justin Mirro</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: Justin Mirro</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: Chairman and Chief Executive Officer</TD></TR>
</TABLE></DIV>    <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration
Statement has been signed below by the following persons in the capacities indicated: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Justin Mirro</P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="2">Chairman and Chief Executive Officer (Principal Executive Officer)</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center">October&nbsp;23, 2020</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Justin Mirro</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Robert Remenar</P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="2">Vice Chairman and President</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center">October&nbsp;23, 2020</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Robert Remenar</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Daniel Huber</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">October&nbsp;23, 2020</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Daniel Huber</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">October&nbsp;23, 2020</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Thomas LaSorda</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">October&nbsp;23, 2020</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Anders Pettersson</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">October&nbsp;23, 2020</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Mitchell Quain</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">October&nbsp;23, 2020</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Donald Runkle</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">October&nbsp;23, 2020</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Matthew Simoncini</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">*By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Justin Mirro</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Justin Mirro</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Attorney-in-fact</I></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-6 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d14810dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">


<IMG SRC="g14810g1022070957348.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="right">Hughes Hubbard&nbsp;&amp; Reed LLP</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">One Battery Park Plaza</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">New York, New
York 10004-1482</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">Telephone: +1 (212) <FONT STYLE="white-space:nowrap">837-6000</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">Fax: +1 (212) <FONT STYLE="white-space:nowrap">422-4726</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">hugheshubbard.com</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">October 23, 2020 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kensington Capital Acquisition Corp. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1400 Old Country Road,
Suite 301 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Westbury, NY 11590 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Re:
<U>Registration Statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> (File No.</U><U></U><U><FONT STYLE="white-space:nowrap">&nbsp;333-248930)</FONT></U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as special
counsel to Kensington Capital Acquisition Corp., a Delaware corporation (&#147;<U>Kensington</U>&#148;), in connection with the preparation and filing of Kensington&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT>
(the &#147;<U>Registration Statement</U>,&#148; which term does not include any other document or agreement whether or not specifically referred to therein or attached as an exhibit or schedule thereto), relating to shares of Kensington class A
common stock, par value $0.0001 per share, and Kensington class B common stock, par value $0.0001 per share (collectively, the &#147;<U>Shares</U>&#148;), to be issued by Kensington pursuant to the terms of the Business Combination Agreement dated
as of September&nbsp;2, 2020, as amended by Amendment No.&nbsp;1 dated as of September&nbsp;21, 2020 (as it may be further amended or supplemented from time to time, the &#147;<U>Business Combination Agreement</U>&#148;) among Kensington, Kensington
Merger Sub Corp., a Delaware corporation and a wholly-owned subsidiary of Kensington, and QuantumScape Corporation, a Delaware corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of giving this opinion, we have examined the Registration Statement, the Business Combination Agreement, the Amended and Restated
Certificate of Incorporation of Kensington Capital Acquisition Corp., the Bylaws of Kensington Capital Acquisition Corp. and forms of the Second Amended and Restated Certificate of Incorporation of Kensington Capital Acquisition Corp. and the
Amended and Restated Bylaws of Kensington Capital Acquisition Corp., each of which is proposed in connection with the Business Combination Agreement. We have also examined the originals, or duplicates or certified or conformed copies, of such
corporate records, agreements, documents and other instruments and have made such other investigations as we have deemed relevant and necessary in connection with this opinion. As to questions of fact material to this opinion, we have relied, with
your approval, upon oral and written representations of Kensington and certificates or comparable documents of public officials and of officers and representatives of Kensington. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In making such examination and rendering this opinion, we have assumed without verification the genuineness of all signatures, the
authenticity of all documents submitted to us as originals, the authenticity of the originals of such documents submitted to us as certified copies, </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the conformity to originals of all documents submitted to us as copies, the authenticity of the originals of such documents, that all documents submitted to us as certified copies are true and
correct copies of such originals and the legal capacity of all individuals executing any of the foregoing documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon and
subject to the foregoing examination and in reliance thereon, and subject to the qualifications, assumptions and limitations stated herein and in reliance on statements of fact contained in the documents that we have examined or reviewed, we are of
the opinion that the Shares to be issued by Kensington pursuant to and in the manner contemplated by the terms of the Business Combination Agreement will be, upon issuance, duly authorized and, when the Registration Statement has been declared
effective by order of the Securities and Exchange Commission (the &#147;<U>SEC</U>&#148;) and the Shares have been issued and paid for in the manner contemplated by and upon the terms and conditions set forth in the Registration Statement and the
Business Combination Agreement, such Shares will be validly issued, fully paid and nonassessable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are members of the bar of the State
of New York. Kensington is a Delaware corporation, and we have not considered, and we express no opinion as to, any law other than the Delaware General Corporation Law (including the statutory provisions, and reported judicial decisions interpreting
the foregoing). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to be named in the Registration Statement and in the related proxy statement/prospectus/information
statement contained therein as the attorneys who passed upon the legality of the Shares to be issued pursuant to the Registration Statement and to the filing of a copy of this opinion as Exhibit 5.1 to the Registration Statement. In giving such
consent, we do not thereby admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act of 1933, as amended, and the rules and regulations of the SEC promulgated thereunder. This opinion speaks as
of its date, and we undertake no (and hereby disclaim any) obligation to update this opinion. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Very truly yours,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Hughes Hubbard&nbsp;&amp; Reed LLP</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hughes Hubbard&nbsp;&amp; Reed LLP</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>3
<FILENAME>d14810dex81.htm
<DESCRIPTION>EX-8.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-8.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 8.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle">


<IMG SRC="g14810g1022070957348.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">Hughes Hubbard&nbsp;&amp; Reed LLP</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">One Battery Park Plaza</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">New York, New
York 10004-1482</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">Telephone:+1 (212) <FONT STYLE="white-space:nowrap">837-6000</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">Fax: +1 (212) <FONT STYLE="white-space:nowrap">422-4726</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">hugheshubbard.com</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">October 23, 2020 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kensington Capital Acquisition Corp. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1400 Old Country Road,
Suite 301 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Westbury, NY 11590 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Re:
<U>Registration Statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> (File No.</U><U></U><U><FONT STYLE="white-space:nowrap">&nbsp;333-248930)</FONT></U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen:</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as special
counsel to Kensington Capital Acquisition Corp., a Delaware corporation (&#147;<U>Kensington</U>&#148;), in connection with the merger of Kensington Merger Sub Corp., a Delaware corporation and a wholly-owned subsidiary of Kensington
(&#147;<U>Merger Sub</U>&#148;), with and into QuantumScape Corporation, a Delaware corporation (&#147;<U>QuantumScape</U>&#148;), with QuantumScape surviving the merger and becoming a wholly-owned direct subsidiary of Kensington (the
&#147;<U>Business Combination</U>&#148;), and the preparation and filing of Kensington&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> (the &#147;<U>Registration Statement</U>,&#148; which term does not include any
other document or agreement whether or not specifically referred to therein or attached as an exhibit or schedule thereto), relating to shares of Kensington class A common stock, par value $0.0001 per share, and Kensington class B common stock, par
value $0.0001 per share (collectively, &#147;Kensington Common Stock&#148;), to be issued by Kensington in connection with the Business Combination pursuant to the terms of the Business Combination Agreement dated as of September&nbsp;2, 2020, as
amended by Amendment No.&nbsp;1 dated as of September&nbsp;21, 2020 (as it may be further amended or supplemented from time to time) among Kensington, Merger Sub and QuantumScape. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kensington has requested that we render our opinion as to certain tax matters relating to the Business Combination and the exercise by current
beneficial owners of Kensington Common Stock of their redemption rights in connection with the Business Combination (the &#147;<U>Redemptions</U>&#148;) in connection with the Registration Statement. Capitalized terms used but not defined herein
have the respective meanings ascribed to them in the Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of giving this opinion, we have examined
originals or copies, certified or otherwise identified to our satisfaction, of such agreements and other documents as we have deemed relevant and necessary and we have made such investigations of law as we have deemed appropriate as a basis for the
opinion expressed below. In our examination, we have assumed, without independent verification, (i)&nbsp;the authenticity of original documents, (ii)&nbsp;the accuracy of copies and the genuineness of signatures, (iii)&nbsp;that the execution and
delivery by each party to a document and the performance by such party of its obligations thereunder have been authorized by all necessary measures and do not violate or result in a breach of or default under such party&#146;s certificate or
instrument of formation and <FONT STYLE="white-space:nowrap">by-laws</FONT> or the laws of such party&#146;s jurisdiction of organization, (iv)&nbsp;that each agreement represents the entire agreement between the parties with respect to the subject
matter thereof, (v)&nbsp;that the parties to each agreement have complied, and will comply, with all of their respective covenants, agreements and undertakings contained </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
therein and (vi)&nbsp;that the transactions provided for by each agreement were and will be carried out in accordance with their terms. In rendering our opinion we have made no independent
investigation of the facts referred to herein and have relied for the purpose of rendering this opinion exclusively on those facts that have been provided to us by you and your agents, which we assume have been, and will continue to be, true. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The opinion set forth below is based on the Internal Revenue Code of 1986, as amended, administrative rulings, judicial decisions, Treasury
regulations and other applicable authorities, all as in effect on the effective date of the Registration Statement. The statutory provisions, regulations, and interpretations upon which our opinion is based are subject to change, and such changes
could apply retroactively. Any change in law or the facts regarding the Business Combination, the Redemptions or any of the transactions related thereto, or any inaccuracy in the facts or assumptions on which we relied, could affect the continuing
validity of the opinion set forth below. We assume no responsibility to inform you of any such changes or inaccuracy that may occur or come to our attention. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon and subject to the foregoing, and subject to the limitations and qualifications set forth herein and in the Registration Statement,
the discussion set forth under the caption &#147;Certain U.S. Federal Income Tax Considerations of the Redemption and the Business Combination&#148; in the Registration Statement, insofar as it expresses conclusions as to the application of United
States federal income tax law, is our opinion as to certain material United States federal income tax consequences of the Business Combination and the Redemptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to be named in the Registration Statement and in the related proxy statement/prospectus/information statement contained
therein and to the filing of a copy of this opinion as Exhibit 8.1 to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities
Act of 1933, as amended, and the rules&nbsp;and regulations of the Securities and Exchange Commission promulgated thereunder. This opinion speaks as of its date, and we undertake no (and hereby disclaim any) obligation to update this opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We express our opinion herein only as to those matters specifically set forth above and no opinion should be inferred as to the tax
consequences of the Redemptions or Business Combination under any state, local or foreign law, or with respect to other areas of U.S. federal taxation. We do not express any opinion herein concerning any law other than the federal law of the United
States. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Very truly yours,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Hughes Hubbard&nbsp;&amp; Reed LLP</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hughes Hubbard&nbsp;&amp; Reed LLP</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>d14810dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM&#146;S CONSENT </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the inclusion in this Registration Statement of Kensington Capital Acquisition Corp. on Form <FONT STYLE="white-space:nowrap">S-4</FONT>
Amendment No.&nbsp;1 [File <FONT STYLE="white-space:nowrap">No.&nbsp;333-248930]</FONT> of our report dated May&nbsp;8, 2020, except for Note 7 as to which the date is June&nbsp;26, 2020, which includes an explanatory paragraph as to the
Company&#146;s ability to continue as a going concern, with respect to our audit of the financial statements of Kensington Capital Acquisition Corp. as of May&nbsp;1, 2020 and for the period from April&nbsp;17, 2020 (inception) through May&nbsp;1,
2020, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading &#147;Experts&#148; in such Prospectus. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Marcum <SMALL>LLP</SMALL></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Marcum <SMALL>LLP</SMALL></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">New York, NY</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">October&nbsp;23, 2020</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>5
<FILENAME>d14810dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the reference to our firm under the caption &#147;Experts&#148; and to the use of our report dated October&nbsp;23, 2020, with respect to the
consolidated financial statements of QuantumScape Corporation included in the proxy statement/prospectus/information statement of Kensington Capital Acquisition Corp. that is made a part of the Amendment No.&nbsp;1 to the Registration Statement
(Form <FONT STYLE="white-space:nowrap">S-4</FONT> <FONT STYLE="white-space:nowrap">No.&nbsp;333-248930)</FONT> and related Prospectus of Kensington Capital Acquisition Corp. for the registration of shares of its Class&nbsp;A Common Stock and
Class&nbsp;B Common Stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Ernst&nbsp;&amp; Young LLP </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Redwood City, California </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October&nbsp;23, 2020 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.8
<SEQUENCE>6
<FILENAME>d14810dex998.htm
<DESCRIPTION>EX-99.8
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.8 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October&nbsp;23, 2020 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kensington Capital Acquisition Corp.
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1400 Old Country Road, Suite 301 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Westbury, NY 11590</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consent to Reference in Proxy Statement/Prospectus/Information Statement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kensington Capital Acquisition Corp. (the &#147;Company&#148;) is filing a Registration Statement on
<FONT STYLE="white-space:nowrap">Form&nbsp;S-4&nbsp;with</FONT> the Securities and Exchange Commission under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). In connection therewith,&nbsp;I hereby consent, pursuant to
Rule&nbsp;438 of the Securities Act, to the reference to me in the proxy statement/prospectus/information statement included in such Registration Statement as a future member of the board of directors of the Company, such appointment to commence
upon the effective time of the merger described in the proxy statement/prospectus/information statement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page Follows]
</I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>/s/ Dipender
Saluja&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dipender Saluja</P></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page for Consent to Reference in Proxy Statement/Prospectus/Information Statement] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>7
<FILENAME>kcac-20200630.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN Xcelerate Instance Document - https://www.dfinsolutions.com/ -->
<!-- Version:  6.23.6 -->
<!-- Round: f8c40bbb-ca51-4041-a5e5-af36f22d4c5e -->
<!-- Creation date: 2020-10-23T18:44:53Z -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:kcac="http://imetrix.edgar-online.com/20200630" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31">
  <xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="kcac-20200630.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" />
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200416_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_1007_1000001">0</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200416_0_4069234x4076805" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_1006_900001">0</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200416_0_4069234x4082574" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_1005_800001">0</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_0_20200416_0_4082399x4078608" unitRef="shares" decimals="INF" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_1001_400002">0</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200416_0_4082399x4078608" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_1001_500001">0</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_0_20200416_0_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_1003_600002">0</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200416_0_4082399x4078609" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_1003_700001">0</us-gaap:StockholdersEquity>
  <us-gaap:DebtInstrumentFaceAmount contextRef="eol_PE1119467-20S-4-0005_STD_0_20200417_0_4067272x4256605_4071742x4263611_4078716x4078717" unitRef="iso4217_USD" decimals="INF" id="id_14539602_5CE55E10-96BF-4837-BB3D-CFF2434DA71B_1001_0">300000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200417_0_4067272x4256605_4078739x4405944_4082399x4078609" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_4996F145-9A66-4D78-800C-E85742FE3A55_5001_1">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_0_20200417_0_4067272x4256605_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_8CD79573-6E17-401A-9878-35409A7A8938_4001_4">5750000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1_13">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="shares" decimals="INF" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1_14">1000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="shares" decimals="INF" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1_15">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="shares" decimals="INF" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1_16">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_ABA76F3B-A36D-41CB-AA45-92AAB93C0858_1001_10">25000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_3007_1000006">22500</us-gaap:StockholdersEquity>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1_27">24425</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_C36D14AE-75B0-4DEF-BAD3-04D8D9662717_1001_0">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1_30">86500</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" xsi:nil="true" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1_10" />
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1_28">-2500</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="INF" id="id_14539602_F544632E-E80F-4D18-81CB-5A17D58FC0DD_1_1">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
  <us-gaap:UnrecognizedTaxBenefits contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="INF" id="id_14539602_F544632E-E80F-4D18-81CB-5A17D58FC0DD_1_0">0</us-gaap:UnrecognizedTaxBenefits>
  <us-gaap:PreferredStockValue contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" xsi:nil="true" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1_12" />
  <us-gaap:AssetsCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1_3">25000</us-gaap:AssetsCurrent>
  <us-gaap:Assets contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1_5">86500</us-gaap:Assets>
  <us-gaap:Cash contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1_2">25000</us-gaap:Cash>
  <us-gaap:DeferredCosts contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1_4">61500</us-gaap:DeferredCosts>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1_9">64000</us-gaap:LiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1_8">64000</us-gaap:AccruedLiabilitiesCurrent>
  <kcac:WorkingCapital contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_DE4FFA7C-2C72-44C4-A9C7-E2BD151EA251_1_1">39000</kcac:WorkingCapital>
  <kcac:UnderwritingDiscountPerUnit contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_14539602_33DB9BB1-08B4-4EEF-9858-715AD085DDB2_2001_0">0.20</kcac:UnderwritingDiscountPerUnit>
  <kcac:DeferredUnderwritingCommissionPerUnit contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_14539602_33DB9BB1-08B4-4EEF-9858-715AD085DDB2_2001_3">0.35</kcac:DeferredUnderwritingCommissionPerUnit>
  <kcac:ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_C35448FE-A69C-45D1-8BE2-E87745EF1D58_1_0">250000</kcac:ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit>
  <kcac:MaximumNetTangibleAssetsForBusinessCombination contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="INF" id="id_14539602_05CEEA5E-7FBC-4EE9-8DDC-18B83C49C47F_1001_0">5000001</kcac:MaximumNetTangibleAssetsForBusinessCombination>
  <kcac:PricePerPrivatePlacementWarrant contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_5646C5EA-7CDF-4764-AAC4-578FBB5A870D_1001_5">1.00</kcac:PricePerPrivatePlacementWarrant>
  <kcac:DeferredUnderwritingCommissionsPayable contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_33DB9BB1-08B4-4EEF-9858-715AD085DDB2_2001_4">7000000</kcac:DeferredUnderwritingCommissionsPayable>
  <us-gaap:DueToRelatedPartiesCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4067272x4256605_4071742x4263611_4078716x4078717" unitRef="iso4217_USD" decimals="0" id="id_14539602_1016F333-70D8-408F-BBA2-F32E7CABCB1F_1002_1">75000</us-gaap:DueToRelatedPartiesCurrent>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4067272x4256605_4078716x4268695" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_D21C0E3C-7A34-4197-A50B-B11002795ABE_3001_2">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <kcac:ClassOfWarrantsOrRightsIssuePrice contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4067272x4256605_4078716x4268695" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_D21C0E3C-7A34-4197-A50B-B11002795ABE_3001_1">1.00</kcac:ClassOfWarrantsOrRightsIssuePrice>
  <us-gaap:SharePrice contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4067272x4256605_4082399x4078608" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_14E2FC80-928F-4134-902C-3878946F9E36_3001_0">12.00</us-gaap:SharePrice>
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4069234x4076805" unitRef="iso4217_USD" decimals="0" id="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_3006_900006">-2500</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4069234x4082574" unitRef="iso4217_USD" decimals="0" id="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_3005_800006">24425</us-gaap:StockholdersEquity>
  <us-gaap:BusinessAcquisitionSharePrice contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4070963x4072861" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_C36D14AE-75B0-4DEF-BAD3-04D8D9662717_2001_1">9.20</us-gaap:BusinessAcquisitionSharePrice>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4071742x4300621" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_BDF87981-5871-4F96-A86B-DE4D073F23E4_2001_1">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:LineOfCredit contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4071742x4300621" unitRef="iso4217_USD" decimals="INF" id="id_14539602_BDF87981-5871-4F96-A86B-DE4D073F23E4_2001_2">0</us-gaap:LineOfCredit>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4078716x4078717" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_BDE0B4B2-E69E-4AA3-98C7-C2F118C8AC12_2001_1">10.00</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4078716x4078717_4082399x4078608" unitRef="shares" decimals="INF" id="id_14539602_BDE0B4B2-E69E-4AA3-98C7-C2F118C8AC12_3001_2">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
  <kcac:DeferredUnderwritingCommissionsNoncurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4078716x4260553" unitRef="iso4217_USD" decimals="0" id="id_14539602_33DB9BB1-08B4-4EEF-9858-715AD085DDB2_3001_5">8050000</kcac:DeferredUnderwritingCommissionsNoncurrent>
  <kcac:WarrantsRedemptionPricePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4080964x4268695" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_6127FDE7-867B-4358-8606-10BBAB052C8E_3001_1">0.01</kcac:WarrantsRedemptionPricePerShare>
  <kcac:WarrantsRedemptionPricePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4080964x4319093_4082399x4078608" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_929FDCE4-2D07-44D1-A0B7-AA34668EC2FA_2001_1">0.10</kcac:WarrantsRedemptionPricePerShare>
  <us-gaap:TemporaryEquityRedemptionPricePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078608" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_5247B721-0BFC-4B0E-ACAF-2E618B1CCC7D_1001_1">10.00</us-gaap:TemporaryEquityRedemptionPricePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078608" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1001_18">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078608" unitRef="shares" decimals="INF" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1001_19">100000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078608" unitRef="shares" decimals="INF" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1001_20">0</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078608" unitRef="shares" decimals="INF" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_1001_21">0</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:SharePrice contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078608" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_BDE0B4B2-E69E-4AA3-98C7-C2F118C8AC12_4001_3">11.50</us-gaap:SharePrice>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078609" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_2001_23">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_2001_24">10000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_2001_25">5750000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_3003_600007">5750000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078609" unitRef="iso4217_USD" decimals="0" id="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_3003_700006">575</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockValue contextRef="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078609" unitRef="iso4217_USD" decimals="0" id="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_2001_22">575</us-gaap:CommonStockValue>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_0_20200625_0_4067272x4256605_4078739x4405944_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_4996F145-9A66-4D78-800C-E85742FE3A55_1002_2">5750000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_0_20200625_0_4067272x4256605_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_F2D74E10-835A-483B-9AA3-9FA6288BB40F_1001_0">5750000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_24">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="shares" decimals="INF" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_25">1000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="shares" decimals="INF" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_26">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="shares" decimals="INF" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_27">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:TemporaryEquityRedemptionPricePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_18">10.00</us-gaap:TemporaryEquityRedemptionPricePerShare>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1001_20">1739697</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
  <us-gaap:CashEquivalentsAtCarryingValue contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="INF" id="id_14539602_D1500FFF-3D5A-487E-AE85-7ED4D2AC353F_1_0">0</us-gaap:CashEquivalentsAtCarryingValue>
  <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_17">218439270</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_3007_1000012">5000001</us-gaap:StockholdersEquity>
  <us-gaap:PrepaidExpenseCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_3">237797</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_39">5062172</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_C143EBBD-B14F-4648-A730-8869FE542CB3_1001_0">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:Liabilities contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_15">8538223</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_42">231977494</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" xsi:nil="true" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_16" />
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_40">-62862</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="INF" id="id_14539602_9BD61714-B796-422A-869F-F8C7E4FF5D52_1_1">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
  <us-gaap:UnrecognizedTaxBenefits contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="INF" id="id_14539602_9BD61714-B796-422A-869F-F8C7E4FF5D52_1_0">0</us-gaap:UnrecognizedTaxBenefits>
  <us-gaap:DueToRelatedPartiesCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_12">75000</us-gaap:DueToRelatedPartiesCurrent>
  <us-gaap:PreferredStockValue contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" xsi:nil="true" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_23" />
  <us-gaap:AssetsCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_4">1977494</us-gaap:AssetsCurrent>
  <us-gaap:Assets contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_6">231977494</us-gaap:Assets>
  <us-gaap:Cash contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_2">1739697</us-gaap:Cash>
  <us-gaap:AssetsHeldInTrustNoncurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_5">230000000</us-gaap:AssetsHeldInTrustNoncurrent>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_13">488223</us-gaap:LiabilitiesCurrent>
  <us-gaap:AccountsPayableCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_9">255675</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_10">117000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_11">40548</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
  <kcac:WorkingCapital contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="-5" id="id_14539602_676B14D2-49D9-4E68-87C2-95288C5345CE_1_1">1500000</kcac:WorkingCapital>
  <kcac:DeferredUnderwritingCommissionsNoncurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1_14">8050000</kcac:DeferredUnderwritingCommissionsNoncurrent>
  <kcac:UnderwritingDiscountPerUnit contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_14539602_C5CA4AE8-4D85-4245-9DF4-E33CE363A8D6_1001_0">0.20</kcac:UnderwritingDiscountPerUnit>
  <kcac:DeferredUnderwritingCommissionPerUnit contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_14539602_C5CA4AE8-4D85-4245-9DF4-E33CE363A8D6_1001_2">0.35</kcac:DeferredUnderwritingCommissionPerUnit>
  <kcac:ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_70FF904C-F9C5-4BEA-A8C3-C4CA7AB005EF_1_0">250000</kcac:ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit>
  <kcac:MaximumNetTangibleAssetsForBusinessCombination contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0" unitRef="iso4217_USD" decimals="INF" id="id_14539602_1FF8F928-0D3A-4CFD-AEB3-CA29DB357FA7_1_2">5000001</kcac:MaximumNetTangibleAssetsForBusinessCombination>
  <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4067272x4084629" unitRef="iso4217_USD" decimals="0" id="id_14539602_E8CB687A-6C79-4675-9F4D-695E5D122748_3001_2">20000</us-gaap:AccountsPayableRelatedPartiesCurrent>
  <us-gaap:SharePrice contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4067272x4256605_4070963x4070892_4082399x4078608" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_38AFAB8D-03E3-4302-9AF6-F18C7033F20F_3001_3">12.00</us-gaap:SharePrice>
  <us-gaap:DueToRelatedPartiesCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4067272x4256605_4071742x4263611_4078716x4078717" unitRef="iso4217_USD" decimals="0" id="id_14539602_5CE55E10-96BF-4837-BB3D-CFF2434DA71B_1002_1">75000</us-gaap:DueToRelatedPartiesCurrent>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4067272x4256605_4078716x4268695" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_D64DC39D-5B05-4AE6-B798-959D24A90EFA_1001_0">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <kcac:ClassOfWarrantsOrRightsIssuePrice contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4067272x4256605_4078716x4268695" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_40DDF1C6-5AF7-4001-BE1E-62F71D012A56_2001_1">1.00</kcac:ClassOfWarrantsOrRightsIssuePrice>
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4069234x4076805" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_3006_900012">-62862</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4069234x4082574" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_3005_800012">5062172</us-gaap:StockholdersEquity>
  <us-gaap:BusinessAcquisitionSharePrice contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4070963x4072861" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_C143EBBD-B14F-4648-A730-8869FE542CB3_2001_1">9.20</us-gaap:BusinessAcquisitionSharePrice>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4071742x4300621" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_0E50F395-5C28-47A0-B3FC-8DC65C375D9A_2001_1">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:LineOfCredit contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4071742x4300621" unitRef="iso4217_USD" decimals="INF" id="id_14539602_0E50F395-5C28-47A0-B3FC-8DC65C375D9A_2001_2">0</us-gaap:LineOfCredit>
  <kcac:CashHeldInTrustAccountFairValueDisclosure contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4072786x4084062" unitRef="iso4217_USD" decimals="0" id="id_14539602_97CC745B-90EE-4F2D-88CF-24CDAD7FCDD4_2001_1">230000000</kcac:CashHeldInTrustAccountFairValueDisclosure>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4078716x4078717" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_E501943E-4616-46E4-88BD-EFF87B3FF890_1001_1">10.00</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4078716x4078717_4080964x4268695" unitRef="iso4217_USD_per_shares" decimals="2" id="id_14539602_643AA2B6-1711-48B5-A423-5EE2A0D448BC_1001_1">10.00</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:AssetsHeldInTrustNoncurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4078716x4078717_4080964x4268695" unitRef="iso4217_USD" decimals="-5" id="id_14539602_643AA2B6-1711-48B5-A423-5EE2A0D448BC_1001_0">230000000</us-gaap:AssetsHeldInTrustNoncurrent>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4080964x4268695" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_3A761366-7B18-4674-8D23-A93852E00A01_2001_1">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <kcac:WarrantsRedemptionPricePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4080964x4268695" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_68F2BFD4-C92E-42C4-99DF-58F9A6831F4E_3001_1">0.01</kcac:WarrantsRedemptionPricePerShare>
  <kcac:WarrantsRedemptionPricePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4080964x4319093_4082399x4078608" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_FDE2E716-D82D-46CC-921A-989979D97807_2001_1">0.10</kcac:WarrantsRedemptionPricePerShare>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4081666x4412388" unitRef="shares" decimals="INF" id="id_14539602_BE66A49F-B9E2-42B3-8D31-FFCF65001377_1001_0">21843927</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078608" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1001_19">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078608" unitRef="shares" decimals="INF" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1001_20">21843927</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityRedemptionPricePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078608" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1001_21">10.00</us-gaap:TemporaryEquityRedemptionPricePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078608" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1001_30">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078608" unitRef="shares" decimals="INF" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1001_31">100000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078608" unitRef="shares" decimals="INF" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1001_32">1156073</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078608" unitRef="shares" decimals="INF" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_3001_400013">1156073</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:SharePrice contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078608" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_726EB575-554D-40DA-9BDD-FB2B71E46071_1001_2">11.50</us-gaap:SharePrice>
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078608" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_3001_500012">116</us-gaap:StockholdersEquity>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078608" unitRef="shares" decimals="INF" id="id_14539602_726EB575-554D-40DA-9BDD-FB2B71E46071_1001_0">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
  <us-gaap:CommonStockValue contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078608" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_1001_28">116</us-gaap:CommonStockValue>
  <kcac:CommonStockSharesOutstandingIncludingRedemption contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078608" unitRef="shares" decimals="INF" id="id_14539602_58977F85-1DC2-46B5-88CE-281E9E26FD92_1001_3">23000000</kcac:CommonStockSharesOutstandingIncludingRedemption>
  <kcac:CommonStockSharesIssuedIncludingRedemption contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078608" unitRef="shares" decimals="INF" id="id_14539602_58977F85-1DC2-46B5-88CE-281E9E26FD92_1001_2">23000000</kcac:CommonStockSharesIssuedIncludingRedemption>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078609" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_2001_35">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_2001_36">10000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_2001_37">5750000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_3003_600013">5750000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078609" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_3003_700012">575</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockValue contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078609" unitRef="iso4217_USD" decimals="0" id="id_14539602_90DF505F-0286-4674-8F32-6568187982B9_2001_34">575</us-gaap:CommonStockValue>
  <us-gaap:DueToRelatedPartiesCurrent contextRef="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4085460x4085461" unitRef="iso4217_USD" decimals="0" id="id_14539602_E1CFB6D9-BC41-48BB-BACB-BD189FC20E7A_1001_0">75000</us-gaap:DueToRelatedPartiesCurrent>
  <kcac:StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart contextRef="eol_PE1119467-20S-4-0005_STD_1_20200417_0_4067272x4256605_4070963x4072861_4078716x4078721_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_8CD79573-6E17-401A-9878-35409A7A8938_1001_7">750000</kcac:StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE1119467-20S-4-0005_STD_1_20200417_0_4067272x4256605_4078739x4405944_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_4996F145-9A66-4D78-800C-E85742FE3A55_1001_0">5031250</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE1119467-20S-4-0005_STD_1_20200417_0_4067272x4256605_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_1F12C7DF-80FD-43B2-A9B5-BD969E41C7C2_1001_0">5031250</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <kcac:ThresholdPercentageOfFounderSharesToSharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_1_20200417_0_4067272x4256605_4082399x4078609" unitRef="pure" decimals="2" id="id_14539602_8CD79573-6E17-401A-9878-35409A7A8938_3001_5">0.20</kcac:ThresholdPercentageOfFounderSharesToSharesOutstanding>
  <kcac:PercentageOfSharesIssuedAndOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_1_20200417_0_4069234x4080909" unitRef="pure" decimals="INF" id="id_14539602_4996F145-9A66-4D78-800C-E85742FE3A55_2001_5">0.200</kcac:PercentageOfSharesIssuedAndOutstanding>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited contextRef="eol_PE1119467-20S-4-0005_STD_1_20200417_0_4070963x4072861_4078716x4078721_4078739x4405944" unitRef="shares" decimals="INF" id="id_14539602_4996F145-9A66-4D78-800C-E85742FE3A55_3001_4">750000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
  <kcac:InterestToPayDissolutionExpenses contextRef="eol_PE1119467-20S-4-0005_STD_1_20200501_0" unitRef="iso4217_USD" decimals="INF" id="id_14539602_11055CC8-33BB-4204-BB19-B4C813C7628B_1_0">100000</kcac:InterestToPayDissolutionExpenses>
  <kcac:StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart contextRef="eol_PE1119467-20S-4-0005_STD_1_20200625_0_4067272x4256605_4070963x4072861_4078716x4078721_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_34BA0EAF-0A9C-4B00-92CF-25165D3E640A_1003_4">750000</kcac:StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE1119467-20S-4-0005_STD_1_20200625_0_4067272x4256605_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_34BA0EAF-0A9C-4B00-92CF-25165D3E640A_2003_3">5750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:CommonStockDividendsShares contextRef="eol_PE1119467-20S-4-0005_STD_1_20200625_0_4067272x4256605_4082399x4078609_4085460x4085461" unitRef="shares" decimals="INF" id="id_14539602_D5680528-6CDD-453E-9D2B-6C48BB4392EE_1001_0">718750</us-gaap:CommonStockDividendsShares>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE1119467-20S-4-0005_STD_1_20200625_0_4067272x4256605_4082399x4078609_4085460x4085461" unitRef="shares" decimals="INF" id="id_14539602_D5680528-6CDD-453E-9D2B-6C48BB4392EE_1001_1">5750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited contextRef="eol_PE1119467-20S-4-0005_STD_1_20200625_0_4070963x4072861_4078716x4078721_4078739x4405944_4085460x4085461" unitRef="shares" decimals="INF" id="id_14539602_D5680528-6CDD-453E-9D2B-6C48BB4392EE_2001_2">750000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
  <kcac:ProceedsFromSaleOfFoundersShares contextRef="eol_PE1119467-20S-4-0005_STD_1_20200629_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_768F2EE0-C7A8-47B1-BB2A-DA1F83787864_1_0">25000</kcac:ProceedsFromSaleOfFoundersShares>
  <us-gaap:ProceedsFromRelatedPartyDebt contextRef="eol_PE1119467-20S-4-0005_STD_1_20200629_0_4067272x4256605" unitRef="iso4217_USD" decimals="0" id="id_14539602_768F2EE0-C7A8-47B1-BB2A-DA1F83787864_1001_1">75000</us-gaap:ProceedsFromRelatedPartyDebt>
  <kcac:InterestToPayDissolutionExpenses contextRef="eol_PE1119467-20S-4-0005_STD_1_20200630_0" unitRef="iso4217_USD" decimals="INF" id="id_14539602_C7A1F96B-8952-48E5-950A-1CA1BF0DB42D_1_0">100000</kcac:InterestToPayDissolutionExpenses>
  <kcac:DescriptionOfPublicWarrant contextRef="eol_PE1119467-20S-4-0005_STD_1_20200630_0" id="id_14539602_726EB575-554D-40DA-9BDD-FB2B71E46071_1_1">Each Unit consists of one share of Class A common stock and one-half of one  redeemable warrant</kcac:DescriptionOfPublicWarrant>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE1119467-20S-4-0005_STD_1_20200630_0_4078716x4078717" unitRef="iso4217_USD" decimals="-5" id="id_14539602_E501943E-4616-46E4-88BD-EFF87B3FF890_1002_4">13100000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="eol_PE1119467-20S-4-0005_STD_1_20200630_0_4078716x4078717" unitRef="shares" decimals="INF" id="id_14539602_E501943E-4616-46E4-88BD-EFF87B3FF890_1002_0">23000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
  <us-gaap:SaleOfStockConsiderationReceivedPerTransaction contextRef="eol_PE1119467-20S-4-0005_STD_1_20200630_0_4078716x4078717" unitRef="iso4217_USD" decimals="INF" id="id_14539602_E501943E-4616-46E4-88BD-EFF87B3FF890_1002_3">230000000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
  <kcac:PaymentOfDeferredUnderwritingCommissions contextRef="eol_PE1119467-20S-4-0005_STD_1_20200630_0_4078716x4078717" unitRef="iso4217_USD" decimals="-5" id="id_14539602_E501943E-4616-46E4-88BD-EFF87B3FF890_1002_5">8100000</kcac:PaymentOfDeferredUnderwritingCommissions>
  <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="eol_PE1119467-20S-4-0005_STD_1_20200630_0_4078716x4078721" unitRef="shares" decimals="INF" id="id_14539602_E501943E-4616-46E4-88BD-EFF87B3FF890_2002_2">3000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
  <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="eol_PE1119467-20S-4-0005_STD_1_20200630_0_4080964x4268695" unitRef="iso4217_USD" decimals="-5" id="id_14539602_3A761366-7B18-4674-8D23-A93852E00A01_1002_2">6600000</us-gaap:ProceedsFromIssuanceOfWarrants>
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" id="id_14539602_D69BEF4B-1DC5-44D0-B59B-65A6B1597853_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Net Loss Per Common Share&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company complies with accounting and disclosure requirements of
 FASB ASC Topic 260, &amp;#x201C;Earnings Per Share.&amp;#x201D; Net loss per
 share is computed by dividing net loss by the weighted average
 number of shares of common stock outstanding during the period
 excluding common stock subject to forfeiture. Weighted average
 shares were reduced for the effect of an aggregate of 750,000
 shares of common stock that are subject to forfeiture if the
 over-allotment option is not exercised by the underwriters (Note
 5). At May&amp;#xA0;1, 2020, the Company did not have any dilutive
 securities and other contracts that could, potentially, be
 exercised or converted into shares of common stock and then share
 in the earnings of the Company. As a result, diluted loss per share
 is the same as basic loss per share for the period presented.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:PaymentsForUnderwritingExpense contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_33DB9BB1-08B4-4EEF-9858-715AD085DDB2_1_1">4000000</us-gaap:PaymentsForUnderwritingExpense>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_ABA76F3B-A36D-41CB-AA45-92AAB93C0858_1_7">25000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="shares" decimals="INF" id="id_14539602_3451A50D-A7EE-4215-8820-EE4BEB33F517_1_0">750000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:ProfitLoss contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_ABA76F3B-A36D-41CB-AA45-92AAB93C0858_1_1">2500</us-gaap:ProfitLoss>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" id="id_14539602_37F35155-349F-40B4-88AF-28640F6F53A9_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company&amp;#x2019;s management does not believe that any recently
 issued, but not yet effective, accounting standards if currently
 adopted would have a material effect on the accompanying financial
 statements.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:UseOfEstimates contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" id="id_14539602_92D33D0D-551E-4904-85D4-B40AFBF6A758_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The preparation of financial statements in conformity with U.S.
 GAAP requires the Company&amp;#x2019;s management to make estimates and
 assumptions that affect the reported amounts of assets and
 liabilities and disclosure of contingent assets and liabilities
 during the reporting period. Actual results could differ from those
 estimates.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="shares" decimals="0" id="id_14539602_F4BF01AA-328E-440C-9145-7F08F781A0A8_1_2">5000000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_ABA76F3B-A36D-41CB-AA45-92AAB93C0858_1_6">25000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_ABA76F3B-A36D-41CB-AA45-92AAB93C0858_1_8">25000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_ABA76F3B-A36D-41CB-AA45-92AAB93C0858_1_3">2500</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" id="id_14539602_3E950400-9806-4631-9E9C-18651F401099_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 4&amp;#x2014;Related Party Transactions&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;Founder Shares&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 On April&amp;#xA0;17, 2020, the Sponsor subscribed to purchase
 5,031,250&amp;#xA0;shares of the Company&amp;#x2019;s Class&amp;#xA0;B common
 stock, par value $0.0001 per share (the &amp;#x201C;Founder
 Shares&amp;#x201D;), and fully paid for those shares on May&amp;#xA0;1,
 2020. On June&amp;#xA0;25, 2020, the Company effected a stock dividend
 with respect to the Class&amp;#xA0;B common stock, resulting in the
 Sponsor holding an aggregate of 5,750,000 founder shares. All
 shares and associated amounts have been retroactively restated to
 reflect the share capitalization. The initial stockholders have
 agreed to forfeit up to 750,000 Founder Shares to the extent that
 the over-allotment&amp;#xA0;option is not exercised in full by the
 underwriters. The forfeiture will be adjusted to the extent that
 the over-allotment&amp;#xA0;option is not exercised in full by the
 underwriters so that the Founder Shares will represent 20.0% of the
 Company&amp;#x2019;s issued and outstanding shares of common stock after
 the Proposed Public Offering.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The initial stockholders will agree, subject to limited exceptions,
 not to transfer, assign or sell any of the Founder Shares until the
 earlier to occur of: (A)&amp;#xA0;one year after the completion of the
 initial Business Combination or (B)&amp;#xA0;subsequent to the initial
 Business Combination, (x)&amp;#xA0;if the last reported sale price of
 the Class&amp;#xA0;A common stock equals or exceeds $12.00 per share
 (as adjusted for stock splits, stock dividends, reorganizations,
 recapitalizations and the like) for any 20 trading days within
 &lt;font style="WHITE-SPACE: nowrap"&gt;any&amp;#xA0;30-trading&amp;#xA0;day&lt;/font&gt; period
 commencing at least 150 days after the initial Business
 Combination, or (y)&amp;#xA0;the date on which the Company completes a
 liquidation, merger, capital stock exchange, reorganization or
 other similar transaction that results in all of the
 Company&amp;#x2019;s stockholders having the right to exchange their
 shares of common stock for cash, securities or other property.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Private Placement Warrants&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Sponsor will agree to purchase an aggregate of 5,975,000
 Private Placement Warrants (or 6,575,000 Private Placement Warrants
 if the underwriters&amp;#x2019; over-allotment&amp;#xA0;option is exercised
 in full), at a price of $1.00 per Private Placement Warrant
 ($5,975,000 in the aggregate, or $6,575,000 if the
 underwriters&amp;#x2019; over-allotment&amp;#xA0;option is exercised in
 full) in a private placement that will occur simultaneously with
 the closing of the Proposed Public Offering. Each whole Private
 Placement Warrant is exercisable for one whole share of
 Class&amp;#xA0;A&amp;#xA0;common stock at a price of $11.50 per share,
 subject to adjustment. A portion of the proceeds from the sale of
 the Private Placement Warrants to the Sponsor will be added to the
 proceeds from the Proposed Public Offering to be held in the Trust
 Account. If the Company does not complete a Business Combination
 within the Combination Period, the Private Placement Warrants will
 expire worthless. The Private Placement Warrants will &lt;font style="WHITE-SPACE: nowrap"&gt;be&amp;#xA0;non-redeemable&amp;#xA0;for&amp;#xA0;cash&lt;/font&gt;
 (except as described below) and exercisable on a cashless basis so
 long as they are held by the Sponsor or its permitted
 transferees.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Sponsor will agree, subject to limited exceptions, not to
 transfer, assign or sell the Private Placement Warrants until 30
 days after the completion of the initial Business Combination.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Related Party Loans&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 On April&amp;#xA0;17, 2020, the Sponsor agreed to loan the Company an
 aggregate of up to $300,000 to cover expenses related to the
 Proposed Public Offering pursuant to a promissory note (the
 &amp;#x201C;Note&amp;#x201D;). This loan &lt;font style="WHITE-SPACE: nowrap"&gt;is&amp;#xA0;non-interest&amp;#xA0;bearing&amp;#xA0;and&lt;/font&gt;
 payable on the earlier of October&amp;#xA0;31, 2020 and the completion
 of the Proposed Public Offering. As of May&amp;#xA0;5, 2020, the
 Company has borrowed $75,000 under the Note.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 In addition, in order to fund working capital deficiencies or
 finance transaction costs in connection with a Business
 Combination, the Sponsor or an affiliate of the Sponsor, or certain
 of the Company&amp;#x2019;s officers and directors may, but are not
 obligated to, loan the Company funds as may be required
 (&amp;#x201C;Working Capital Loans&amp;#x201D;). If the Company completes a
 Business Combination, the Company may repay the Working Capital
 Loans out of the proceeds of the Trust Account released to the
 Company. Otherwise, the Working Capital Loans could be repaid only
 out of funds held outside the Trust Account. In the event that a
 Business Combination does not close, the Company may use a portion
 of proceeds held outside the Trust Account to repay the Working
 Capital Loans but no proceeds held in the Trust Account would be
 used to repay the Working Capital Loans. The Working Capital Loans
 would either be repaid upon consummation of a Business Combination
 or, at the lender&amp;#x2019;s discretion, up to $1,500,000 of such
 Working Capital Loans may be convertible into warrants of the post
 Business Combination entity at a price of $1.00 per warrant. The
 warrants would be identical to the Private Placement Warrants.
 Except for the foregoing, the terms of such Working Capital Loans,
 if any, have not been determined and no written agreements exist
 with respect to such loans. To date, the Company had no borrowings
 under the Working Capital Loans.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Service and Administrative Fees&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company has agreed to pay service and administrative fees of
 $20,000 per month to DEHC LLC, an affiliate of Daniel Huber, the
 Company&amp;#x2019;s Chief Financial Officer, for up to 18 months
 commencing on the date of consummation of the Proposed Public
 Offering.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Sponsor, executive officers and directors, or any of their
 respective affiliates, will be reimbursed for &lt;font style="WHITE-SPACE: nowrap"&gt;&lt;font style="WHITE-SPACE: nowrap"&gt;any&amp;#xA0;out-of-pocket&amp;#xA0;expenses&amp;#xA0;incurred&lt;/font&gt;&lt;/font&gt;
 in connection with activities on the Company&amp;#x2019;s behalf such as
 identifying potential target businesses and performing due
 diligence on suitable Business Combinations. The Company&amp;#x2019;s
 audit committee will review on a quarterly basis all payments that
 were made by the Company to the Sponsor, officers, directors or
 their affiliates.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" id="id_14539602_A9DFD569-6119-4EC5-9635-6717AC60EB3C_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 2&amp;#x2014;Summary of Significant Accounting Policies&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Financial instruments that potentially subject the Company to
 concentrations of credit risk consist of cash accounts in a
 financial institution, which, at times, may exceed the Federal
 Depository Insurance Coverage limit of $250,000. At May&amp;#xA0;1,
 2020, the Company has not experienced losses on these accounts and
 management believes the Company is not exposed to significant risks
 on such accounts.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Financial Instruments&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The fair value of the Company&amp;#x2019;s assets and liabilities, which
 qualify as financial instruments under FASB ASC 820, &amp;#x201C;Fair
 Value Measurements and Disclosures,&amp;#x201D; approximates the
 carrying amounts represented in the balance sheet.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The preparation of financial statements in conformity with U.S.
 GAAP requires the Company&amp;#x2019;s management to make estimates and
 assumptions that affect the reported amounts of assets and
 liabilities and disclosure of contingent assets and liabilities
 during the reporting period. Actual results could differ from those
 estimates.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Deferred Offering Costs Associated with the Proposed Public
 Offering&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Deferred offering costs consist of legal, accounting, underwriting
 fees and other costs incurred through the balance sheet date that
 are directly related to the Proposed Public Offering and that will
 be charged to stockholder&amp;#x2019;s equity upon the completion of the
 Proposed Public Offering. Should the Proposed Public Offering prove
 to be unsuccessful, these deferred costs, as well as additional
 expenses to be incurred, will be charged to operations.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 18px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Net Loss Per Common Share&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company complies with accounting and disclosure requirements of
 FASB ASC Topic 260, &amp;#x201C;Earnings Per Share.&amp;#x201D; Net loss per
 share is computed by dividing net loss by the weighted average
 number of shares of common stock outstanding during the period
 excluding common stock subject to forfeiture. Weighted average
 shares were reduced for the effect of an aggregate of 750,000
 shares of common stock that are subject to forfeiture if the
 over-allotment option is not exercised by the underwriters (Note
 5). At May&amp;#xA0;1, 2020, the Company did not have any dilutive
 securities and other contracts that could, potentially, be
 exercised or converted into shares of common stock and then share
 in the earnings of the Company. As a result, diluted loss per share
 is the same as basic loss per share for the period presented.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company follows the asset and liability method of accounting
 for income taxes under FASB ASC 740, &amp;#x201C;Income Taxes.&amp;#x201D;
 Deferred tax assets and liabilities are recognized for the
 estimated future tax consequences attributable to differences
 between the financial statements carrying amounts of existing
 assets and liabilities and their respective tax bases. Deferred tax
 assets and liabilities are measured using enacted tax rates
 expected to apply to taxable income in the years in which those
 temporary differences are expected to be recovered or settled. The
 effect on deferred tax assets and liabilities of a change in tax
 rates is recognized in income in the period that included the
 enactment date. Valuation allowances are established, when
 necessary, to reduce deferred tax assets to the amount expected to
 be realized. Deferred tax assets were deemed immaterial as of
 May&amp;#xA0;1, 2020.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 FASB ASC 740 prescribes a recognition threshold and a measurement
 attribute for the financial statement recognition and measurement
 of tax positions taken or expected to be taken in a tax return. For
 those benefits to be recognized, a tax position must be more likely
 than not to be sustained upon examination by taxing authorities.
 There were no unrecognized tax benefits as of May&amp;#xA0;1, 2020. The
 Company recognizes accrued interest and penalties related to
 unrecognized tax benefits as income tax expense. No amounts were
 accrued for the payment of interest and penalties as of May&amp;#xA0;1,
 2020. The Company is currently not aware of any issues under review
 that could result in significant payments, accruals or material
 deviation from its position. The Company is subject to income tax
 examinations by major taxing authorities since inception.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company&amp;#x2019;s management does not believe that any recently
 issued, but not yet effective, accounting standards if currently
 adopted would have a material effect on the accompanying financial
 statements.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:SubsequentEventsTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" id="id_14539602_AF0928E5-B6CD-418A-831C-139EFAC4C903_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 7&amp;#x2014;Subsequent Events&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Subsequent to May&amp;#xA0;1, 2020, the Company has borrowed $75,000
 under the Note.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company evaluated events that have occurred after the balance
 sheet date through May&amp;#xA0;8, 2020, which is the date on which
 these financial statements were issued. Based upon this review,
 except as below, the Company did not identify any other subsequent
 events that would have required adjustment or disclosure in the
 financial statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 On June&amp;#xA0;25, 2020, the Company effected a stock dividend of
 718,750 shares, resulting in the Sponsor holding an aggregate of
 5,750,000 Founder Shares, of which an aggregate of up to 750,000
 shares are subject to forfeiture. All share and &lt;font style="WHITE-SPACE: nowrap"&gt;per-share&lt;/font&gt; amounts have been
 retroactively restated to reflect the stock dividend.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 As a result of the execution of the underwriting agreement on
 June&amp;#xA0;25, 2020, the financial statements have been modified to
 reflect the final terms of the agreement.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:ConcentrationRiskCreditRisk contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" id="id_14539602_FB5D49C1-080C-4508-B9BB-81EC37D0D37C_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Financial instruments that potentially subject the Company to
 concentrations of credit risk consist of cash accounts in a
 financial institution, which, at times, may exceed the Federal
 Depository Insurance Coverage limit of $250,000. At May&amp;#xA0;1,
 2020, the Company has not experienced losses on these accounts and
 management believes the Company is not exposed to significant risks
 on such accounts.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_F4BF01AA-328E-440C-9145-7F08F781A0A8_1_0">2500</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" id="id_14539602_8E4D1AF0-626C-4578-AD76-AF05F039315C_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Financial Instruments&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The fair value of the Company&amp;#x2019;s assets and liabilities, which
 qualify as financial instruments under FASB ASC 820, &amp;#x201C;Fair
 Value Measurements and Disclosures,&amp;#x201D; approximates the
 carrying amounts represented in the balance sheet.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" id="id_14539602_EC290E2D-FF0D-422F-8E53-0543727BA45E_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company follows the asset and liability method of accounting
 for income taxes under FASB ASC 740, &amp;#x201C;Income Taxes.&amp;#x201D;
 Deferred tax assets and liabilities are recognized for the
 estimated future tax consequences attributable to differences
 between the financial statements carrying amounts of existing
 assets and liabilities and their respective tax bases. Deferred tax
 assets and liabilities are measured using enacted tax rates
 expected to apply to taxable income in the years in which those
 temporary differences are expected to be recovered or settled. The
 effect on deferred tax assets and liabilities of a change in tax
 rates is recognized in income in the period that included the
 enactment date. Valuation allowances are established, when
 necessary, to reduce deferred tax assets to the amount expected to
 be realized. Deferred tax assets were deemed immaterial as of
 May&amp;#xA0;1, 2020.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 FASB ASC 740 prescribes a recognition threshold and a measurement
 attribute for the financial statement recognition and measurement
 of tax positions taken or expected to be taken in a tax return. For
 those benefits to be recognized, a tax position must be more likely
 than not to be sustained upon examination by taxing authorities.
 There were no unrecognized tax benefits as of May&amp;#xA0;1, 2020. The
 Company recognizes accrued interest and penalties related to
 unrecognized tax benefits as income tax expense. No amounts were
 accrued for the payment of interest and penalties as of May&amp;#xA0;1,
 2020. The Company is currently not aware of any issues under review
 that could result in significant payments, accruals or material
 deviation from its position. The Company is subject to income tax
 examinations by major taxing authorities since inception.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" id="id_14539602_95D5908D-F297-4559-81B7-21902A5E68D6_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 6&amp;#x2014;Stockholder&amp;#x2019;s Equity&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;&lt;i&gt;Class&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;&amp;#xA0;A Common Stock&lt;/i&gt;&lt;/b&gt;&amp;#x2014;The
 Company is authorized to issue 100,000,000&amp;#xA0;shares of
 Class&amp;#xA0;A common stock with a par value of $0.0001 per share. As
 of May&amp;#xA0;1, 2020, there were no shares of Class&amp;#xA0;A common
 stock issued or outstanding.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 &lt;b&gt;&lt;i&gt;Class&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;&amp;#xA0;B Common Stock&lt;/i&gt;&lt;/b&gt;&amp;#x2014;The
 Company is authorized to issue 10,000,000 shares of Class&amp;#xA0;B
 common stock with a par value of $0.0001 per share. On
 April&amp;#xA0;17, 2020, the Sponsor subscribed to purchase
 5,031,250&amp;#xA0;shares of Class&amp;#xA0;B common stock, which was fully
 paid on May&amp;#xA0;1, 2020. On June&amp;#xA0;25, 2020, the Company
 effected a stock dividend with respect to the Class&amp;#xA0;B common
 stock, resulting in the Sponsor holding an aggregate of 5,750,000
 founder shares. All shares and associated amounts have been
 retroactively restated to reflect the share capitalization. Of
 these, an aggregate of up to 750,000 shares of Class&amp;#xA0;B common
 stock that are subject to forfeiture to the Company by the initial
 stockholders for no consideration to the extent that the
 underwriters&amp;#x2019; over-allotment&amp;#xA0;option is not exercised in
 full or in part, so that the number of Founder Shares will equal
 20% of the Company&amp;#x2019;s issued and outstanding shares of common
 stock after the Proposed Public Offering.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 Stockholders of record are entitled to one vote for each share held
 on all matters to be voted on by stockholders; provided that, prior
 to the completion of the initial Business Combination, holders of
 the Class&amp;#xA0;B common stock will have the right to elect all of
 the Company&amp;#x2019;s directors and remove members of the
 Company&amp;#x2019;s board of directors for any reason. Prior to the
 completion of the initial Business Combination, only holders of the
 Class&amp;#xA0;B common stock will have the right to vote on the
 Company&amp;#x2019;s election of directors. Holders of the Public Shares
 will not be entitled to vote on the Company&amp;#x2019;s election of
 directors during such time. In addition, prior to the completion of
 the initial Business Combination, holders of a majority of the
 outstanding shares of the Class&amp;#xA0;B common stock may remove a
 member of the Company&amp;#x2019;s board of directors for any reason.
 These provisions of the Certificate of Incorporation may only be
 amended by a resolution passed by the holders of a majority of
 shares of the Class&amp;#xA0;B common stock. With respect to any other
 matter submitted to a vote of the Company&amp;#x2019;s stockholders,
 including any vote in connection with the initial Business
 Combination, holders of the Class&amp;#xA0;A common stock and holders
 of the Class&amp;#xA0;B common stock will vote together as a single
 class on all matters submitted to a vote of the Company&amp;#x2019;s
 stockholders, except as required by law.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Class&amp;#xA0;B common stock will automatically convert into
 Class&amp;#xA0;A common stock at the time of the initial Business
 Combination, or earlier at the option of the holders, on
 &lt;font style="WHITE-SPACE: nowrap"&gt;&lt;font style="WHITE-SPACE: nowrap"&gt;a&amp;#xA0;one-for-one&amp;#xA0;basis,&amp;#xA0;subject&lt;/font&gt;&lt;/font&gt;
 to adjustment for stock splits, stock dividends, reorganizations,
 recapitalizations and the like, and subject to further adjustment
 as described herein. In the case that additional shares of
 Class&amp;#xA0;A common stock, or equity-linked securities, are issued
 or deemed issued in excess of the amounts issued in the Proposed
 Offering and related to the closing of the initial Business
 Combination, including pursuant to a specified future issuance, the
 ratio at which shares of Class&amp;#xA0;B common stock shall convert
 into shares of Class&amp;#xA0;A common stock will be adjusted (unless
 the holders of a majority of the then-outstanding shares of
 Class&amp;#xA0;B common stock agree to waive such adjustment with
 respect to any such issuance or deemed issuance, including a
 specified future issuance) so that the number of shares of
 Class&amp;#xA0;A common stock issuable upon conversion of all shares of
 Class&amp;#xA0;B common stock will equal, in the aggregate, on an
 &lt;font style="WHITE-SPACE: nowrap"&gt;as-converted&lt;/font&gt; basis, 20% of
 the sum of the total number of all shares of common stock
 outstanding upon the completion of the Proposed Public Offering
 plus all shares of Class&amp;#xA0;A common stock and equity-linked
 securities issued or deemed issued in connection with the initial
 Business Combination (excluding any shares or equity-linked
 securities issued or issuable to any seller in the initial Business
 Combination).&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 &lt;b&gt;&lt;i&gt;Preferred Stock&lt;/i&gt;&lt;/b&gt;&amp;#x2014;The Company is authorized to
 issue 1,000,000&amp;#xA0;shares of preferred stock, par value $0.0001
 per share, with such designations, voting and other rights and
 preferences as may be determined from time to time by the
 Company&amp;#x2019;s board of directors. As of May&amp;#xA0;1, 2020, there
 were no shares of preferred stock issued or outstanding.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 &lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&amp;#x2014;Public Warrants may only be exercised
 for a whole number of shares. No fractional Public Warrants will be
 issued upon separation of the Units and only whole Public Warrants
 will trade. The Public Warrants will become exercisable on the
 later of (a) 30 days after the completion of a Business Combination
 and (b) 12&amp;#xA0;months from the closing of the Proposed Public
 Offering; provided in each case that the Company has an effective
 registration statement under the Securities Act covering the
 issuance of the shares of Class&amp;#xA0;A common stock issuable upon
 exercise of the Public Warrants and a current prospectus relating
 to them is available and such shares are registered, qualified or
 exempt from registration under the securities, or blue sky, laws of
 the state of residence of the holder (or the Company permits
 holders to exercise their Public Warrants on a cashless basis under
 the circumstances specified in the warrant agreement). The Company
 has agreed that as soon as practicable, but in no event later than
 20 business days after the closing of the initial Business
 Combination, the Company will use its commercially reasonable
 efforts to file, and within 60 business days following the initial
 Business Combination to have declared effective, a registration
 statement covering the issuance of the shares of Class&amp;#xA0;A
 common stock issuable upon exercise of the warrants and to maintain
 a current prospectus relating to those shares of Class&amp;#xA0;A
 common stock until the warrants expire or are redeemed; provided,
 that if the Class&amp;#xA0;A common stock is at the time of any
 exercise of a warrant not listed on a national securities exchange
 such that it satisfies the definition of a &amp;#x201C;covered
 security&amp;#x201D; under Section&amp;#xA0;18(b)(1) of the Securities Act,
 the Company may, at its option, require holders of Public Warrants
 who exercise their warrants to do so on a &amp;#x201C;cashless
 basis&amp;#x201D; in accordance with Section&amp;#xA0;3(a)(9) of the
 Securities Act and, in the event the Company so elects, it will not
 be required to file or maintain in effect a registration statement,
 but it will be required to use its best efforts to register or
 qualify the shares under applicable blue sky laws to the extent an
 exemption is not available. The Public Warrants will expire five
 years after the completion of a Business Combination or earlier
 upon redemption or liquidation.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The warrants will have an exercise price of $11.50 per share. If
 (x)&amp;#xA0;the Company issue additional shares or equity-linked
 securities for capital raising purposes in connection with the
 closing of the initial Business Combination at an issue price or
 effective issue price of less than $9.20 per share (as adjusted for
 stock splits, stock dividends, rights issuances, subdivisions,
 reorganizations, recapitalizations and the like) (with such issue
 price or effective issue price to be determined in good faith by
 the Company&amp;#x2019;s board of directors, and in the case of any such
 issuance to the Sponsor, initial stockholders or their affiliates,
 without taking into account any Founder Shares held by them prior
 to such issuance) (the &amp;#x201C;Newly Issued Price&amp;#x201D;), (y) the
 aggregate gross proceeds from such issuances represent more than
 60% of the total equity proceeds, and interest thereon, available
 for the funding of the initial Business Combination on the date of
 the consummation of the Initial Business Combination (net of
 redemptions), and (z)&amp;#xA0;the volume weighted average trading
 price of the Company&amp;#x2019;s shares of Class&amp;#xA0;A common stock
 during the 20 trading day period starting on the trading day prior
 to the day on which the Company consummates the initial Business
 Combination (such price, the &amp;#x201C;Market Value&amp;#x201D;) is below
 $9.20 per share, the exercise price of each warrant will be
 adjusted (to the nearest cent) such that the effective exercise
 price per full share will be equal to 115% of the higher of
 (i)&amp;#xA0;the Market Value and (ii)&amp;#xA0;the Newly Issued Price, and
 the $18.00 per share redemption trigger price described below will
 be adjusted (to the nearest cent) to be equal to 180% of the higher
 of (i)&amp;#xA0;the Market Value and (ii)&amp;#xA0;the Newly Issued
 Price.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Private Placement Warrants will be identical to the Public
 Warrants, except that (1)&amp;#xA0;the Private Placement Warrants and
 the shares of Class&amp;#xA0;A common stock issuable upon exercise of
 the Private Placement Warrants will not be transferable, assignable
 or salable until 30 days after the completion of a Business
 Combination, subject to certain limited exceptions, (2)&amp;#xA0;the
 Private Placement Warrants will &lt;font style="WHITE-SPACE: nowrap"&gt;be&amp;#xA0;non-redeemable&lt;/font&gt; (except as
 described below) so&amp;#xA0;long as they are held by the Sponsor or
 its permitted transferees, (3)&amp;#xA0;the Private Placement Warrants
 may be exercised by the holders on a cashless basis and
 (4)&amp;#xA0;the holders of the Private Placement Warrants (including
 with respect to the shares of common stock issuable upon exercise
 of the Private Placement Warrants) are entitled to registration
 rights. If the Private Placement Warrants are held by someone other
 than the Sponsor or its permitted transferees, the Private
 Placement Warrants will be redeemable by the Company in all
 redemption scenarios and exercisable by such holders on the same
 basis as the Public Warrants.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company may call the Public Warrants for redemption:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;in whole and not in part;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;at a price of $0.01 per warrant;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;upon a minimum of 30 days&amp;#x2019; prior written notice
 of redemption; and&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;if, and only if, the last reported sale price of the
 Class&amp;#xA0;A common stock equals or exceeds $18.00 per share (as
 adjusted for stock splits, stock dividends, reorganizations,
 recapitalizations and the like) for any 20 trading days within
 &lt;font style="WHITE-SPACE: nowrap"&gt;the&amp;#xA0;30-trading&amp;#xA0;day&amp;#xA0;period&lt;/font&gt;
 ending on the third business day prior to the date on which the
 Company sends the notice of redemption to the warrant holders.&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 If the Company calls the Public Warrants for redemption, management
 will have the option to require all holders that wish to exercise
 the Public Warrants to do so on a &amp;#x201C;cashless basis,&amp;#x201D; as
 described in the warrant agreement.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 In addition, commencing ninety days after the warrants become
 exercisable, the Company may redeem the outstanding warrants:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;in whole and not in part;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 6px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;at $0.10 per warrant upon a minimum of 30 days&amp;#x2019;
 prior written notice of redemption provided that holders will be
 able to exercise their warrants on a cashless basis prior to
 redemption and receive that number of shares of Class&amp;#xA0;A common
 stock to be determined by reference to a table in the warrant
 agreement;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;if, and only if, the last reported sale price of the
 Company&amp;#x2019;s Class&amp;#xA0;A common stock equals or exceeds
 $10.00&amp;#xA0;per share (as adjusted for stock splits, stock
 dividends, reorganizations, recapitalizations and the like) on the
 trading day prior to the date on which the Company sends the notice
 of redemption to the warrant holders;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;if, and only if, the Private Placement Warrants are
 also concurrently called for redemption at the same price (equal to
 a number of shares of Class&amp;#xA0;A common stock) as the outstanding
 Public Warrants, as described above; and&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr style="PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" width="3%" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td valign="top" width="1%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"&gt;if, and only if, there is an effective registration
 statement covering the shares of Class&amp;#xA0;A common stock (or a
 security other than the Class&amp;#xA0;A common stock into which the
 Class&amp;#xA0;A common stock has been converted or exchanged for in
 the event the Company is not the surviving company in the initial
 Business Combination) issuable upon exercise of the warrants and a
 current prospectus relating thereto available throughout the
 &lt;font style="WHITE-SPACE: nowrap"&gt;30-day&lt;/font&gt; period after
 written notice of redemption is given.&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 In no event will the Company be required to net cash settle any
 warrant. If the Company is unable to complete a Business
 Combination within the Combination Period and the Company
 liquidates the funds held in the Trust Account, holders of warrants
 will not receive any of such funds with respect to their warrants,
 nor will they receive any distribution from the Company&amp;#x2019;s
 assets held outside of the Trust Account with the respect to such
 warrants. Accordingly, the warrants may expire worthless.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" id="id_14539602_2E4C0971-44E7-490D-9490-727DD46E802D_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Note 1&amp;#x2014;Description of Organization, Business Operations
 and Basis of Presentation&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Kensington Capital Acquisition Corp. (the &amp;#x201C;Company&amp;#x201D;)
 was incorporated in Delaware on April&amp;#xA0;17, 2020. The Company
 was formed for the purpose of effecting a merger, capital stock
 exchange, asset acquisition, stock purchase, reorganization or
 similar business combination with one or more businesses
 (the&amp;#xA0;&amp;#x201C;Business Combination&amp;#x201D;). Although the Company
 is not limited to a particular industry or sector for purposes of
 consummating a Business Combination, the Company intends to focus
 its search for a target business in the automotive and
 automotive-related sector. The Company is an emerging growth
 company and, as such, the Company is subject to all of the risks
 associated with emerging growth companies.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 As of May&amp;#xA0;1, 2020, the Company had not commenced any
 operations. All activity for the period from April&amp;#xA0;17, 2020
 (inception) through May&amp;#xA0;1, 2020 relates to the Company&amp;#x2019;s
 formation and the proposed initial public offering described below.
 The Company will not generate any operating revenues until after
 the completion of its initial Business Combination, at the
 earliest. The Company will &lt;font style="WHITE-SPACE: nowrap"&gt;generate&amp;#xA0;non-operating&amp;#xA0;income&amp;#xA0;in&lt;/font&gt;
 the form of interest income on cash and cash equivalents from the
 proceeds derived from the Proposed Public Offering (as&amp;#xA0;defined
 below). The Company has selected December&amp;#xA0;31 as its fiscal
 year end.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company&amp;#x2019;s sponsor is Kensington Capital Sponsor LLC, a
 Delaware limited liability company (the &amp;#x201C;Sponsor&amp;#x201D;). The
 Company&amp;#x2019;s ability to commence operations is contingent upon
 obtaining adequate financial resources through a proposed public
 offering (the &amp;#x201C;Proposed Public Offering&amp;#x201D;) of 20,000,000
 units (each, a &amp;#x201C;Unit&amp;#x201D; and collectively, the
 &amp;#x201C;Units&amp;#x201D;) at $10.00 per Unit (or 23,000,000 units if the
 underwriters&amp;#x2019; over-allotment&amp;#xA0;option is exercised in
 full), which is discussed in Note&amp;#xA0;3, and the sale of 5,975,000
 warrants (or 6,575,000 warrants if the underwriters&amp;#x2019;
 over-allotment&amp;#xA0;option is exercised in full) (each, a
 &amp;#x201C;Private Placement Warrant&amp;#x201D; and collectively, the
 &amp;#x201C;Private Placement Warrants&amp;#x201D;), at a price of $1.00 per
 Private Placement Warrant in a private placement to the Sponsor
 that will close simultaneously with the Proposed Public
 Offering.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company&amp;#x2019;s management has broad discretion with respect to
 the specific application of the net proceeds of the Proposed Public
 Offering and the sale of the Private Placement Warrants, although
 substantially all of the net proceeds are intended to be applied
 generally toward consummating a Business Combination. There is no
 assurance that the Company will be able to complete a Business
 Combination successfully. The Company must complete an initial
 Business Combination with one or more operating businesses or
 assets with a fair market value equal to at least 80% of the net
 assets held in the Trust Account (as defined below) (net of amounts
 disbursed to management for working capital purposes, if permitted,
 and excluding the amount of any deferred underwriting discount).
 However, the Company will only complete a Business Combination if
 the post-transaction&amp;#xA0;company owns or acquires 50% or more of
 the outstanding voting securities of the target or otherwise
 acquires a controlling interest in the target business sufficient
 for it not to be required to register as an investment company
 under the Investment Company Act 1940, as amended (the
 &amp;#x201C;Investment Company Act&amp;#x201D;). Upon the closing of the
 Proposed Public Offering, management has agreed that an amount
 equal to at least $10.00 per Unit sold in the Proposed Public
 Offering, including proceeds from the sale of the Private Placement
 Warrants to the Sponsor, will be held in a trust account
 (&amp;#x201C;Trust Account&amp;#x201D;) located in the United States with
 Continental Stock Transfer&amp;#xA0;&amp;amp; Trust Company acting as
 trustee, and invested only in U.S. &amp;#x201C;government
 securities,&amp;#x201D; within the meaning set forth in
 Section&amp;#xA0;2(a)(16)&amp;#xA0;of the Investment Company Act, with a
 maturity of 185 days or less, or in money market funds meeting
 certain conditions under &lt;font style="WHITE-SPACE: nowrap"&gt;Rule&amp;#xA0;2a-7&amp;#xA0;under&amp;#xA0;the&lt;/font&gt;
 Investment Company Act, which invest only in direct U.S. government
 treasury obligations, as determined by the Company, until the
 earlier of: (i)&amp;#xA0;the completion of a Business Combination and
 (ii)&amp;#xA0;the distribution of the Trust Account as described
 below.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company will provide holders of the Company&amp;#x2019;s outstanding
 shares of Class&amp;#xA0;A common stock, par value $0.0001 per share,
 sold in the Proposed Public Offering (the &amp;#x201C;Public
 Stockholders&amp;#x201D;) with the opportunity to redeem all or a
 portion of their Public Shares (as defined below) upon the
 completion of a Business Combination either
 (i)&amp;#xA0;in&amp;#xA0;connection with a stockholder meeting called to
 approve the Business Combination or (ii)&amp;#xA0;by means of a tender
 offer. The decision as to whether the Company will seek stockholder
 approval of a Business Combination or conduct a tender offer will
 be made by the Company, solely in its discretion. The Public
 Stockholders will be entitled to redeem their Public Shares for a
 pro rata portion of the amount then held in the Trust Account
 (initially anticipated to be $10.00 per Public Share), calculated
 as of two business days prior to the initial Business Combination,
 including interest earned on the funds held in the trust account
 and not previously released to the Company to pay the
 Company&amp;#x2019;s taxes, net of taxes payable. &lt;font style="WHITE-SPACE: nowrap"&gt;The&amp;#xA0;per-share&amp;#xA0;amount&amp;#xA0;to&lt;/font&gt;
 be distributed to Public Stockholders who redeem their Public
 Shares will not be reduced by the deferred underwriting commissions
 the Company will pay to the underwriters (as discussed in Note 5).
 These Public Shares will be recorded at a redemption value and
 classified as temporary equity upon the completion of the Proposed
 Public Offering in accordance with the Financial Accounting
 Standards Board&amp;#x2019;s (&amp;#x201C;FASB&amp;#x201D;) Accounting Standards
 Codification (&amp;#x201C;ASC&amp;#x201D;) Topic 480 &amp;#x201C;Distinguishing
 Liabilities from Equity.&amp;#x201D; The Company will proceed with a
 Business Combination if a majority of the shares voted are voted in
 favor of the Business Combination. The Company will not redeem the
 Public Shares in an amount that would cause its net tangible assets
 to be less than $5,000,001. If a stockholder vote is not required
 by applicable law or stock exchange rule and the Company does not
 decide to hold a stockholder vote for business or other reasons,
 the Company will, pursuant to its amended and restated certificate
 of incorporation (the &amp;#x201C;Certificate of Incorporation&amp;#x201D;),
 conduct the redemptions pursuant to the tender offer rules of the
 U.S. Securities and Exchange Commission (&amp;#x201C;SEC&amp;#x201D;) and
 file tender offer documents with the SEC prior to completing a
 Business Combination. If, however, stockholder approval of the
 transaction is required by applicable law or stock exchange rule,
 or the Company decides to obtain stockholder approval for business
 or reasons, the Company will offer to redeem shares in conjunction
 with a proxy solicitation pursuant to the proxy rules and not
 pursuant to the tender offer rules. Additionally, each Public
 Stockholder may elect to redeem their Public Shares without voting,
 and if they do vote, irrespective of whether they vote for or
 against the proposed transaction. If the Company seeks stockholder
 approval in connection with a Business Combination, the initial
 stockholders (as defined below) have agreed to vote any Founder
 Shares (as defined below in Note 4) and any Public Shares held by
 them in favor of a Business Combination. In addition, the initial
 stockholders have agreed to waive their redemption rights with
 respect to any Founder Shares and any Public Shares held by them in
 connection with the completion of a Business Combination.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Certificate of Incorporation will provide that a Public
 Stockholder, together with any affiliate of such stockholder or any
 other person with whom such stockholder is acting in concert or as
 a &amp;#x201C;group&amp;#x201D; (as defined under Section&amp;#xA0;13 of the
 Securities Exchange Act of 1934, as amended (the &amp;#x201C;Exchange
 Act&amp;#x201D;)), will be restricted from redeeming its shares with
 respect to more than an aggregate of 15% or more of the Public
 Shares, without the prior consent of the Company.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Sponsor and the Company&amp;#x2019;s officers and directors (the
 &amp;#x201C;initial stockholders&amp;#x201D;) have agreed, pursuant to a
 letter agreement with the Company, that they will not propose any
 amendment to the Certificate of Incorporation (A)&amp;#xA0;to modify
 the substance or timing of the Company&amp;#x2019;s obligation to allow
 redemption in connection with the initial Business Combination or
 to redeem 100% of the Public Shares if the Company does not
 complete a Business Combination within the Combination Period (as
 defined below) or (B)&amp;#xA0;with respect to any other provision
 relating to stockholders&amp;#x2019; rights &lt;font style="WHITE-SPACE: nowrap"&gt;or&amp;#xA0;pre-initial&amp;#xA0;Business&lt;/font&gt;
 Combination activity, unless the Company provides the Public
 Stockholders with the opportunity to redeem their Public Shares
 upon approval of any such amendment at a &lt;font style="WHITE-SPACE: nowrap"&gt;per-share&lt;/font&gt; price, payable in cash,
 equal to the aggregate amount then on deposit in the Trust Account,
 including interest (which interest shall be net of taxes payable)
 divided by the number of then outstanding Public Shares.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 If the Company is unable to complete a Business Combination within
 24&amp;#xA0;months from the closing of the Proposed Public Offering (as
 such period may be extended pursuant to the Certificate of
 Incorporation, the &amp;#x201C;Combination Period&amp;#x201D;), the Company
 will (i)&amp;#xA0;cease all operations except for the purpose of
 winding up, (ii)&amp;#xA0;as promptly as reasonably possible but not
 more than ten business days thereafter, redeem the Public Shares,
 at &lt;font style="WHITE-SPACE: nowrap"&gt;a&amp;#xA0;per-share&amp;#xA0;price,&lt;/font&gt; payable
 in cash, equal to the aggregate amount then on deposit in the Trust
 Account including interest earned on the funds held in the Trust
 Account and not previously released to the Company to pay the
 Company&amp;#x2019;s taxes, net of taxes payable (less up to $100,000 of
 interest to pay dissolution expenses), divided by the number of
 then outstanding Public Shares, which redemption will completely
 extinguish Public Stockholders&amp;#x2019; rights as stockholders
 (including the right to receive further liquidating distributions,
 if any), and (iii)&amp;#xA0;as promptly as reasonably possible
 following such redemption, subject to the approval of the
 Company&amp;#x2019;s remaining stockholders and the Company&amp;#x2019;s
 board of directors, dissolve and liquidate, subject in each case to
 the Company&amp;#x2019;s obligations under Delaware law to provide for
 claims of creditors and the requirements of other applicable law.
 There will be no redemption rights or liquidating distributions
 with respect to the Company&amp;#x2019;s warrants, which will expire
 worthless if the Company fails to complete its initial Business
 Combination within the Combination Period.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The initial stockholders have agreed to waive their rights to
 liquidating distributions from the Trust Account with respect to
 any Founder Shares held by them if the Company fails to complete a
 Business Combination within the Combination Period. However, if the
 initial stockholders acquire Public Shares in or after the Proposed
 Public Offering, they will be entitled to liquidating distributions
 from the Trust Account with respect to such Public Shares if the
 Company fails to complete a Business Combination within the
 Combination Period. The underwriters have agreed to waive their
 rights to the deferred underwriting commission (see Note 5) held in
 the Trust Account in the event the Company does not complete a
 Business Combination within in the Combination Period and, in such
 event, such amounts will be included with the other funds held in
 the Trust Account that will be available to fund the redemption of
 the Public Shares. In the event of such distribution, it is
 possible that the per share value of the residual assets remaining
 available for distribution (including Trust Account assets) will be
 only, or less than, $10.00. In order to protect the amounts held in
 the Trust Account, the Sponsor has agreed to be liable to the
 Company if and to the extent any claims by a third party (except
 for the Company&amp;#x2019;s independent registered public accounting
 firm) for services rendered or products sold to the Company, or a
 prospective target business with which the Company has discussed
 entering into a transaction agreement (a &amp;#x201C;Target&amp;#x201D;),
 reduce the amount of funds in the Trust Account to below the lesser
 of (i) $10.00 per Public Share and (ii)&amp;#xA0;the actual amount per
 Public Share held in the Trust Account as of the date of the
 liquidation of the Trust Account, if less than $10.00 per Public
 Share due to reductions in the value of the trust assets, less
 taxes payable, provided that such liability will not apply to any
 claims by a third party or Target that executed a waiver of any and
 all rights to the monies held in the Trust Account nor will it
 apply to any claims under the Company&amp;#x2019;s indemnity of the
 underwriters of the Proposed Public Offering against certain
 liabilities, including liabilities under the Securities Act of
 1933, as amended (the &amp;#x201C;Securities Act&amp;#x201D;). Moreover, in
 the event that an executed waiver is deemed to be unenforceable
 against a third party, then the Sponsor will not be responsible to
 the extent of any liability for such third-party claims. The
 Company will seek to reduce the possibility that the Sponsor will
 have to indemnify the Trust Account due to claims of creditors by
 endeavoring to have all vendors, service providers, prospective
 target businesses and other entities with which the Company does
 business, execute agreements with the Company waiving any right,
 title, interest or claim of any kind in or to monies held in the
 Trust Account.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Going Concern Consideration&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 As of May&amp;#xA0;1, 2020, the Company had $25,000 in cash and a
 working capital deficiency of $39,000. Further, the Company has
 incurred and expect to continue to incur significant costs in
 pursuit of its financing and acquisition plans. Management&amp;#x2019;s
 plans to address this need for capital through the Proposed Public
 Offering. The Company cannot assure that its plans to raise capital
 or to consummate an initial Business Combination will be
 successful. These factors, among others, raise substantial doubt
 about the Company&amp;#x2019;s ability to continue as a going concern.
 The financial statements do not include any adjustments that might
 result from its inability to consummate the Proposed Public
 Offering or its inability to continue as a going concern.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The accompanying financial statements are presented in U.S. dollars
 in conformity with accounting principles generally accepted in the
 United States of America (&amp;#x201C;U.S. GAAP&amp;#x201D;) and pursuant to
 the rules and regulations of the SEC.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 18px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Emerging Growth Company&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company is an &amp;#x201C;emerging growth company,&amp;#x201D; as defined
 in Section&amp;#xA0;2(a) of the Securities Act, as modified by the
 Jumpstart Our Business Startups Act of 2012 (the &amp;#x201C;JOBS
 Act&amp;#x201D;), and it may take advantage of certain exemptions from
 various reporting requirements that are applicable to other public
 companies that are not emerging growth companies including, but not
 limited to, not being required to comply with the independent
 registered public accounting firm attestation requirements of
 Section&amp;#xA0;404 of the Sarbanes-Oxley Act, reduced disclosure
 obligations regarding executive compensation in its periodic
 reports and proxy statements, and exemptions from the requirements
 of holding a nonbinding advisory vote on executive compensation and
 stockholder approval of any golden parachute payments not
 previously approved.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 Further, Section&amp;#xA0;102(b)(1) of the JOBS Act exempts emerging
 growth companies from being required to comply with new or revised
 financial accounting standards until private companies (that is,
 those that have not had a Securities Act registration statement
 declared effective or do not have a class of securities registered
 under the Exchange Act) are required to comply with the new or
 revised financial accounting standards. The JOBS Act provides that
 an emerging growth company can elect to opt out of the extended
 transition period and comply with the requirements that apply to
 &lt;font style="WHITE-SPACE: nowrap"&gt;non-emerging&lt;/font&gt; growth
 companies but any such an election to opt out is irrevocable. The
 Company has elected not to opt out of such extended transition
 period, which means that when a standard is issued or revised and
 it has different application dates for public or private companies,
 the Company, as an emerging growth company, can adopt the new or
 revised standard at the time private companies adopt the new or
 revised standard.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 This may make comparison of the Company&amp;#x2019;s financial
 statements with another public company that is neither an emerging
 growth company nor an emerging growth company that has opted out of
 using the extended transition period difficult or impossible
 because of the potential differences in accounting standards
 used.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" id="id_14539602_F1BB74A7-E33E-448C-A57F-3D250EC70A08_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 5&amp;#x2014;Commitments&amp;#xA0;&amp;amp; Contingencies&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;Registration Rights&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The holders of Founder Shares, Private Placement Warrants and
 warrants that may be issued upon conversion of Working Capital
 Loans, if any, and any shares of Class&amp;#xA0;A common stock issuable
 upon the exercise of the Private Placement Warrants and warrants
 that may be issued upon conversion of Working Capital Loans and
 upon conversion of the Founder Shares will be entitled to
 registration rights pursuant to a registration rights agreement to
 be signed prior to the consummation of the Proposed Public
 Offering. These holders will be entitled to certain demand and
 &amp;#x201C;piggyback&amp;#x201D; registration rights. The Company will bear
 the expenses incurred in connection with the filing of any such
 registration statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Underwriting Agreement&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The underwriters will be entitled to an underwriting discount of
 $0.20 per unit, or $4,000,000 in the aggregate (or approximately
 $4,600,000 in the aggregate if the underwriters&amp;#x2019;
 over-allotment&amp;#xA0;option is exercised in full), payable upon the
 closing of the Proposed Public Offering. $0.35 per unit, or
 approximately $7,000,000 in the aggregate (or approximately
 $8,050,000 in the aggregate if the underwriters&amp;#x2019;
 over-allotment&amp;#xA0;option is exercised in full) will be payable to
 the underwriters for deferred underwriting commissions. The
 deferred fee will become payable to the underwriters from the
 amounts held in the Trust Account solely in the event that the
 Company completes a Business Combination, subject to the terms of
 the underwriting agreement.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_5007_1000005">-2500</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_14539602_F4BF01AA-328E-440C-9145-7F08F781A0A8_1_3">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
  <kcac:InitialPublicOfferingDisclosureTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" id="id_14539602_724774BB-1905-4C60-B5ED-0906CB87ABCB_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 3&amp;#x2014;Proposed Public Offering&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Pursuant to the Proposed Public Offering, the Company intends to
 offer for sale 20,000,000 units at a price of $10.00 per Unit. Each
 Unit consists of one share of Class&amp;#xA0;A common stock (such
 shares of common stock included in the Units being offered, the
 &amp;#x201C;Public Shares&amp;#x201D;), &lt;font style="WHITE-SPACE: nowrap"&gt;and&amp;#xA0;one-half&amp;#xA0;of&amp;#xA0;one&lt;/font&gt;
 redeemable warrant (each, a &amp;#x201C;Public Warrant&amp;#x201D;). Each
 whole Public Warrant entitles the holder to purchase one share of
 Class&amp;#xA0;A common stock at a price of $11.50 per share, subject
 to adjustment (see Note 6).&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company will grant the underwriters &lt;font style="WHITE-SPACE: nowrap"&gt;a&amp;#xA0;45-day&amp;#xA0;option&amp;#xA0;from&lt;/font&gt;
 the date of the final prospectus relating to the Proposed Public
 Offering to purchase up to 3,000,000 additional Units to cover
 over-allotments, if any, at the Proposed Public Offering price,
 less underwriting discounts and commissions.&lt;/p&gt;
 &lt;/div&gt;</kcac:InitialPublicOfferingDisclosureTextBlock>
  <kcac:OfferingCostsPolicyTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" id="id_14539602_DD5DAF15-20E7-4FA1-8A87-43F08C3FB3A5_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Deferred Offering Costs Associated with the Proposed Public
 Offering&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Deferred offering costs consist of legal, accounting, underwriting
 fees and other costs incurred through the balance sheet date that
 are directly related to the Proposed Public Offering and that will
 be charged to stockholder&amp;#x2019;s equity upon the completion of the
 Proposed Public Offering. Should the Proposed Public Offering prove
 to be unsuccessful, these deferred costs, as well as additional
 expenses to be incurred, will be charged to operations.&lt;/p&gt;
 &lt;/div&gt;</kcac:OfferingCostsPolicyTextBlock>
  <kcac:NonCashOfferingCostsIncludedInAccruedExpenses contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_ABA76F3B-A36D-41CB-AA45-92AAB93C0858_1_12">61500</kcac:NonCashOfferingCostsIncludedInAccruedExpenses>
  <kcac:DescriptionOfPublicWarrant contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" id="id_14539602_BDE0B4B2-E69E-4AA3-98C7-C2F118C8AC12_1_4">Each Unit consists of one share  of Class A common stock (such shares of common stock included in the Units being  offered, the "Public Shares"), and one-half of one redeemable warrant (each, a  "Public Warrant").</kcac:DescriptionOfPublicWarrant>
  <kcac:PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" id="id_14539602_E95B34E8-245A-4CE8-B44C-77448275B4A2_1_0">P30D</kcac:PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination>
  <kcac:MinimumSharePriceRequiredForRedemptionOfWarrants contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_C36D14AE-75B0-4DEF-BAD3-04D8D9662717_1_4">18.00</kcac:MinimumSharePriceRequiredForRedemptionOfWarrants>
  <kcac:PercentageOfPublicSharesToBeRedeemed contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="pure" decimals="INF" id="id_14539602_9C041461-7BA4-43DB-B596-15A1DA8F8365_1_0">1.00</kcac:PercentageOfPublicSharesToBeRedeemed>
  <kcac:PublicWarrantsExpirationTerm contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" id="id_14539602_E836CC43-5744-4522-918E-F3452E58DD0F_1_2">P5Y</kcac:PublicWarrantsExpirationTerm>
  <kcac:PercentageOfProceedsFromShareIssuances contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="pure" decimals="2" id="id_14539602_C36D14AE-75B0-4DEF-BAD3-04D8D9662717_1_2">0.60</kcac:PercentageOfProceedsFromShareIssuances>
  <kcac:ExercisePriceAdjustmentPercentage contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="pure" decimals="2" id="id_14539602_C36D14AE-75B0-4DEF-BAD3-04D8D9662717_1_3">1.15</kcac:ExercisePriceAdjustmentPercentage>
  <kcac:RedemptionTriggerPriceAdjustmentPercentage contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="pure" decimals="2" id="id_14539602_C36D14AE-75B0-4DEF-BAD3-04D8D9662717_1_5">1.80</kcac:RedemptionTriggerPriceAdjustmentPercentage>
  <kcac:PercentageOfSharesToBeRedeemedWithoutConsent contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="pure" decimals="2" id="id_14539602_7634D8CA-3A53-40B6-B8C1-1801CC3B12E6_1_0">0.15</kcac:PercentageOfSharesToBeRedeemedWithoutConsent>
  <kcac:ProposedPublicOfferingSharePrice contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_5646C5EA-7CDF-4764-AAC4-578FBB5A870D_1_2">10.00</kcac:ProposedPublicOfferingSharePrice>
  <kcac:NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="shares" decimals="INF" id="id_14539602_5646C5EA-7CDF-4764-AAC4-578FBB5A870D_1_0">20000000</kcac:NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation>
  <kcac:NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="shares" decimals="INF" id="id_14539602_5646C5EA-7CDF-4764-AAC4-578FBB5A870D_1_1">23000000</kcac:NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull>
  <kcac:NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="shares" decimals="INF" id="id_14539602_5646C5EA-7CDF-4764-AAC4-578FBB5A870D_1_3">5975000</kcac:NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation>
  <kcac:NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0" unitRef="shares" decimals="INF" id="id_14539602_5646C5EA-7CDF-4764-AAC4-578FBB5A870D_1_4">6575000</kcac:NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4084629" unitRef="iso4217_USD" decimals="0" id="id_14539602_26020736-9C29-4337-B1FD-544FD7D83D18_1001_0">20000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <kcac:PeriodOfService contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4084629_4078739x4078757" id="id_14539602_26020736-9C29-4337-B1FD-544FD7D83D18_2001_1">P18M</kcac:PeriodOfService>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605" unitRef="iso4217_USD" decimals="0" id="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6007_1000003">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4069234x4082574" unitRef="iso4217_USD" decimals="0" id="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6005_800003">24425</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <kcac:NumberOfTradingDays contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4070963x4070892" id="id_14539602_14E2FC80-928F-4134-902C-3878946F9E36_1001_1">P20D</kcac:NumberOfTradingDays>
  <kcac:NumberOfDaysCommencingAfterInitialBusinessCombination contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4070963x4070892" id="id_14539602_14E2FC80-928F-4134-902C-3878946F9E36_1001_3">P150D</kcac:NumberOfDaysCommencingAfterInitialBusinessCombination>
  <kcac:NumberOfTradingDays contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4070963x4072861" id="id_14539602_14E2FC80-928F-4134-902C-3878946F9E36_2001_2">P30D</kcac:NumberOfTradingDays>
  <kcac:ClassOfWarrantsOrRightsIssued contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4078716x4078721" unitRef="shares" decimals="0" id="id_14539602_D21C0E3C-7A34-4197-A50B-B11002795ABE_1001_3">6575000</kcac:ClassOfWarrantsOrRightsIssued>
  <kcac:ClassOfWarrantsOrRightsIssued contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4078716x4268695" unitRef="shares" decimals="INF" id="id_14539602_D21C0E3C-7A34-4197-A50B-B11002795ABE_2001_0">5975000</kcac:ClassOfWarrantsOrRightsIssued>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4082399x4078609" unitRef="iso4217_USD" decimals="0" id="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_700003">575</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_600004">5750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <kcac:ThresholdPercentageOfFounderSharesToSharesOutstanding contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4082399x4078609" unitRef="pure" decimals="2" id="id_14539602_9B230AEA-5F1E-473A-BBDB-52141E06D7E0_1001_0">0.20</kcac:ThresholdPercentageOfFounderSharesToSharesOutstanding>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4069234x4076805" unitRef="iso4217_USD" decimals="0" id="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_5006_900005">-2500</us-gaap:NetIncomeLoss>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4069234x4086031_4071742x4300621" unitRef="iso4217_USD" decimals="0" id="id_14539602_BDF87981-5871-4F96-A86B-DE4D073F23E4_1001_0">1500000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4070963x4072861_4078716x4078721_4082399x4078609" unitRef="shares" decimals="0" id="id_14539602_0AE02F78-AA74-4954-9B61-F7E231957913_1001_0">750000</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
  <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4078716x4078721" unitRef="shares" decimals="INF" id="id_14539602_FC717F70-7468-418D-B516-6E2DDDD78AAF_1001_0">3000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
  <us-gaap:PaymentsForUnderwritingExpense contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4078716x4260553" unitRef="iso4217_USD" decimals="0" id="id_14539602_33DB9BB1-08B4-4EEF-9858-715AD085DDB2_1001_2">4600000</us-gaap:PaymentsForUnderwritingExpense>
  <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4078716x4412415" unitRef="shares" decimals="INF" id="id_14539602_BDE0B4B2-E69E-4AA3-98C7-C2F118C8AC12_1001_0">20000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
  <kcac:NumberOfTradingDays contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4080964x4268695" id="id_14539602_6127FDE7-867B-4358-8606-10BBAB052C8E_1001_0">P20D</kcac:NumberOfTradingDays>
  <kcac:NumberOfTradingDaysEndingOnThirdBusinessDay contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4080964x4268695" id="id_14539602_BF5E4E07-C27F-4E7F-8048-466B3EFED6F1_1001_0">P30D</kcac:NumberOfTradingDaysEndingOnThirdBusinessDay>
  <kcac:MinimumSharePriceRequiredForRedemptionOfWarrants contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4080964x4268695_4082399x4078608" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_6127FDE7-867B-4358-8606-10BBAB052C8E_2001_3">18.00</kcac:MinimumSharePriceRequiredForRedemptionOfWarrants>
  <kcac:MinimumSharePriceRequiredForRedemptionOfWarrants contextRef="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4080964x4319093_4082399x4078608" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_929FDCE4-2D07-44D1-A0B7-AA34668EC2FA_1001_0">10.00</kcac:MinimumSharePriceRequiredForRedemptionOfWarrants>
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_0EEF6CE6-A529-4411-AC71-29AA094207C6_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Net Loss Per Common Share&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Company complies with accounting and disclosure requirements of
 FASB ASC Topic 260, &amp;#x201C;Earnings Per Share.&amp;#x201D; Net loss per
 share is computed by dividing net loss by the weighted average
 number of shares of common stock outstanding during the period
 excluding common stock subject to forfeiture. An aggregate of
 21,843,927 shares of Class&amp;#xA0;A common stock subject to possible
 redemption at June&amp;#xA0;30, 2020 has been excluded from the
 calculation of basic loss per share of common stock, since such
 shares, if redeemed, only participate in their pro rata share of
 the trust earnings. The Company has not considered the effect of
 the warrants sold in the Initial Public Offering (including the
 consummation of the Over-Allotment Units) and Private Placement to
 purchase an aggregate of 18,075,000 shares of the Company&amp;#x2019;s
 common stock in the calculation of diluted loss per share, since
 the exercise of the warrants are contingent upon the occurrence of
 future events.&lt;/p&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;&lt;i&gt;Reconciliation of net loss per common share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Company&amp;#x2019;s net loss is adjusted for the portion of income
 (loss) that is attributable to Class&amp;#xA0;A common stock subject to
 redemption, as these shares only participate in the earnings of the
 Trust Account and not the income or losses of the Company.
 Accordingly, basic and diluted loss per common share is calculated
 as follows:&lt;/p&gt;
 &lt;p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="68%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="71%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="19%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"&gt;
 &lt;b&gt;For&amp;#xA0;The&amp;#xA0;Period&amp;#xA0;From&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;April&amp;#xA0;17, 2020&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;(inception)&amp;#xA0;through&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;June&amp;#xA0;30, 2020&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
 &lt;td valign="top"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"&gt;
 Net loss&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(62,862&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
 &lt;td valign="top"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"&gt;
 Less: Income attributable to Class&amp;#xA0;A ordinary shares subject
 to possible redemption&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px;"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
 &lt;td valign="top"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"&gt;
 Adjusted net loss&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(62,862&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px;"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
 &lt;td valign="top"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"&gt;
 Weighted average ordinary shares outstanding, basic and diluted&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,031,247&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px;"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"&gt;
 Basic and diluted net loss per ordinary share&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;b&gt;(0.01&lt;/b&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;b&gt;)&amp;#xA0;&lt;/b&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px;"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_5007_1000007">13097867</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_7">-27611</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PaymentsForUnderwritingExpense contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="-5" id="id_14539602_C5CA4AE8-4D85-4245-9DF4-E33CE363A8D6_1_1">4600000</us-gaap:PaymentsForUnderwritingExpense>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_10">-230000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_17">231767308</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_39F8521D-C61B-4EC6-971A-B12873C09959_1_0">&lt;div&gt;
 &lt;table cellspacing="0" cellpadding="0" width="76%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="71%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;"&gt;
 &lt;b&gt;Description&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"&gt;&lt;b&gt;Level&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"&gt;&lt;b&gt;June&amp;#xA0;30, 2020&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"&gt;
 Assets:&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"&gt;
 Cash held in Trust Account&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;230,000,000&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
  <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_CBDF6199-8667-4F23-85BC-B5474424B422_1_0">&lt;div&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Company&amp;#x2019;s net loss is adjusted for the portion of income
 (loss) that is attributable to Class&amp;#xA0;A common stock subject to
 redemption, as these shares only participate in the earnings of the
 Trust Account and not the income or losses of the Company.
 Accordingly, basic and diluted loss per common share is calculated
 as follows:&lt;/p&gt;
 &lt;p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="68%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="71%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="19%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"&gt;
 &lt;b&gt;For&amp;#xA0;The&amp;#xA0;Period&amp;#xA0;From&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;April&amp;#xA0;17, 2020&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;(inception)&amp;#xA0;through&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;June&amp;#xA0;30, 2020&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
 &lt;td valign="top"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"&gt;
 Net loss&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(62,862&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
 &lt;td valign="top"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"&gt;
 Less: Income attributable to Class&amp;#xA0;A ordinary shares subject
 to possible redemption&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px;"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
 &lt;td valign="top"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"&gt;
 Adjusted net loss&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(62,862&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px;"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
 &lt;td valign="top"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"&gt;
 Weighted average ordinary shares outstanding, basic and diluted&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,031,247&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px;"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"&gt;
 Basic and diluted net loss per ordinary share&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;b&gt;(0.01&lt;/b&gt;&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&lt;b&gt;)&amp;#xA0;&lt;/b&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="font-size:1px;"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
  <us-gaap:ProfitLoss contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_1">-62862</us-gaap:ProfitLoss>
  <us-gaap:ProceedsFromNotesPayable contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_13">75000</us-gaap:ProceedsFromNotesPayable>
  <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_9">230000000</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_12A4D815-F7AE-4025-8951-15CB622E7219_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Recent Accounting Standards&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Company&amp;#x2019;s management does not believe that any recently
 issued, but not yet effective, accounting standards updates, if
 currently adopted would have a material effect on the accompanying
 financial statements.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_09791B45-4DB6-4580-B438-D9A6134BF2D8_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Class&amp;#xA0;A common stock subject to possible redemption&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company accounts for its Class&amp;#xA0;A common stock subject to
 possible redemption in accordance with the guidance in ASC Topic
 480 &amp;#x201C;Distinguishing Liabilities from Equity.&amp;#x201D;
 Class&amp;#xA0;A common stock subject to mandatory redemption (if any)
 is classified as liability instruments and are measured at fair
 value. Conditionally redeemable Class&amp;#xA0;A common stock
 (including Class&amp;#xA0;A common stock that features redemption
 rights that are either within the control of the holder or subject
 to redemption upon the occurrence of uncertain events not solely
 within the Company&amp;#x2019;s control) are classified as temporary
 equity. At all other times, Class&amp;#xA0;A common stock is classified
 as stockholders&amp;#x2019; equity. The Company&amp;#x2019;s Class&amp;#xA0;A
 common stock feature certain redemption rights that are considered
 to be outside of the Company&amp;#x2019;s control and subject to the
 occurrence of uncertain future events. Accordingly, at
 June&amp;#xA0;30, 2020, 21,843,927 shares of Class&amp;#xA0;A common stock
 subject to possible redemption is presented at redemption value as
 temporary equity, outside of the stockholders&amp;#x2019; equity section
 of the Company&amp;#x2019;s balance sheet.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
  <us-gaap:UseOfEstimates contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_D24B2FE9-A395-4AC8-AE0E-4D04C5597F05_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The preparation of the financial statements in conformity with U.S.
 GAAP requires the Company&amp;#x2019;s management to make estimates and
 assumptions that affect the reported amounts of assets and
 liabilities and disclosure of contingent assets and liabilities at
 the date of the financial statements and the reported amounts of
 revenues and expenses during the reporting period. Actual results
 could differ from those estimates.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="shares" decimals="0" id="id_14539602_4D03D393-0BA3-4E16-96D3-BABC9DF962FE_1_3">5031247</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_16">4907692</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_3">25297</us-gaap:IncreaseDecreaseInPrepaidExpense>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_12">25000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_15">6575000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
  <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_14">230000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
  <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_18">1739697</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
  <us-gaap:StockIssued1 contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_25">218439270</us-gaap:StockIssued1>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_4">227500</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_5">-207500</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInPropertyAndOtherTaxesPayable contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_6">40548</us-gaap:IncreaseDecreaseInPropertyAndOtherTaxesPayable>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_1CB6B62D-8D58-43CD-A194-8872F44603E8_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Note 4&amp;#x2014;Related Party Transactions&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Founder Shares&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 On April&amp;#xA0;17, 2020, the Sponsor subscribed to purchase
 5,031,250 shares of the Company&amp;#x2019;s Class&amp;#xA0;B common stock,
 par value $0.0001 per share (the &amp;#x201C;Founder Shares&amp;#x201D;), and
 fully paid for those shares on June&amp;#xA0;30, 2020. On June&amp;#xA0;25,
 2020, the Company effected a stock dividend with respect to the
 Class&amp;#xA0;B common stock, resulting in the Sponsor holding an
 aggregate of 5,750,000 founder shares. All shares and associated
 amounts have been retroactively restated to reflect the share
 capitalization. The initial stockholders agreed to forfeit up to
 750,000 Founder Shares to the extent that the over-allotment option
 is not exercised in full by the underwriters so that the Founder
 Shares represented 20.0% of the Company&amp;#x2019;s issued and
 outstanding shares of common stock after the Initial Public
 Offering. The underwriter exercised its over-allotment option in
 full on June&amp;#xA0;30, 2020; thus, the 750,000 Founder Shares were
 no longer subject to forfeiture.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The initial stockholders agreed, subject to limited exceptions, not
 to transfer, assign or sell any of the Founder Shares until the
 earlier to occur of: (A)&amp;#xA0;one year after the completion of the
 initial Business Combination or (B)&amp;#xA0;subsequent to the initial
 Business Combination, (x)&amp;#xA0;if the last reported sale price of
 the Class&amp;#xA0;A common stock equals or exceeds $12.00 per share
 (as adjusted for stock splits, stock dividends, reorganizations,
 recapitalizations and the like) for any 20 trading days within any
 &lt;font style="white-space:nowrap"&gt;30-trading&lt;/font&gt; day period
 commencing at least 150&amp;#xA0;days after the initial Business
 Combination, or (y)&amp;#xA0;the date on which the Company completes a
 liquidation, merger, capital stock exchange, reorganization or
 other similar transaction that results in all of the
 Company&amp;#x2019;s stockholders having the right to exchange their
 shares of common stock for cash, securities or other property.&lt;/p&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Private Placement Warrants&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 Simultaneously with the closing of the Initial Public Offering, the
 Company sold 6,575,000 Private Placement Warrants at a price of
 $1.00 per Private Placement Warrant to the Sponsor, generating
 gross proceeds of approximately $6.6&amp;#xA0;million.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 Each whole Private Placement Warrant is exercisable for one whole
 share of Class&amp;#xA0;A common stock at a price of $11.50 per share,
 subject to adjustment. A portion of the proceeds from the sale of
 the Private Placement Warrants to the Sponsor was added to the
 proceeds from the Initial Public Offering held in the Trust
 Account. If the Company does not complete a Business Combination
 within the Combination Period, the Private Placement Warrants will
 expire worthless. The Private Placement Warrants will be
 &lt;font style="white-space:nowrap"&gt;non-redeemable&lt;/font&gt; for cash
 (except as described below) and exercisable on a cashless basis so
 long as they are held by the Sponsor or its permitted
 transferees.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Sponsor agreed, subject to limited exceptions, not to transfer,
 assign or sell the Private Placement Warrants until 30 days after
 the completion of the initial Business Combination.&lt;/p&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Related Party Loans&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 On April&amp;#xA0;17, 2020, the Sponsor agreed to loan the Company an
 aggregate of up to $300,000 to cover expenses related to the
 Initial Public Offering pursuant to a promissory note (the
 &amp;#x201C;Note&amp;#x201D;). This loan is &lt;font style="white-space:nowrap"&gt;non-interest&lt;/font&gt; bearing and payable upon
 the completion of the Initial Public Offering. As of June&amp;#xA0;30,
 2020, the Company has borrowed $75,000 under the Note. To date, the
 balance of the Note remains outstanding.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 In addition, in order to fund working capital deficiencies or
 finance transaction costs in connection with a Business
 Combination, the Sponsor or an affiliate of the Sponsor, or certain
 of the Company&amp;#x2019;s officers and directors may, but are not
 obligated to, loan the Company funds as may be required
 (&amp;#x201C;Working Capital Loans&amp;#x201D;). If the Company completes a
 Business Combination, the Company may repay the Working Capital
 Loans out of the proceeds of the Trust Account released to the
 Company. Otherwise, the Working Capital Loans could be repaid only
 out of funds held outside the Trust Account. In the event that a
 Business Combination does not close, the Company may use a portion
 of proceeds held outside the Trust Account to repay the Working
 Capital Loans but no proceeds held in the Trust Account would be
 used to repay the Working Capital Loans. The Working Capital Loans
 would either be repaid upon consummation of a Business Combination
 or, at the lender&amp;#x2019;s discretion, up to $1,500,000 of such
 Working Capital Loans may be convertible into warrants of the post
 Business Combination entity at a price of $1.00 per warrant. The
 warrants would be identical to the Private Placement Warrants.
 Except for the foregoing, the terms of such Working Capital Loans,
 if any, have not been determined and no written agreements exist
 with respect to such loans. To date, the Company had no borrowings
 under the Working Capital Loans.&lt;/p&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Service and Administrative Fees&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Company has agreed to pay service and administrative fees of
 $20,000 per month to DEHC LLC, an affiliate of Daniel Huber, the
 Company&amp;#x2019;s Chief Financial Officer, for up to 18 months
 commencing on the date of consummation of the Initial Public
 Offering. The Company believes that these fees are being paid on
 arms&amp;#x2019; length terms and comparable to fees typically paid for
 similar services by other special purpose acquisition companies. As
 of June&amp;#xA0;30, 2020, the Company incurred $20,000 in general and
 administrative expenses in the accompanying condensed statement of
 operations and $20,000 in accounts payable in the accompanying
 balance sheet in connection with such services.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Sponsor, executive officers and directors, or any of their
 respective affiliates, will be reimbursed for any &lt;font style="white-space:nowrap"&gt;&lt;font style="white-space:nowrap"&gt;out-of-pocket&lt;/font&gt;&lt;/font&gt; expenses incurred
 in connection with activities on the Company&amp;#x2019;s behalf such as
 identifying potential target businesses and performing due
 diligence on suitable Business Combinations. The Company&amp;#x2019;s
 audit committee will review on a quarterly basis all payments that
 were made by the Company to the Sponsor, officers, directors or
 their affiliates.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_774E76E7-B7EE-4D82-9752-F6FD343B0CB6_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Note 2&amp;#x2014;Summary of Significant Accounting Policies&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The accompanying unaudited condensed financial statements are
 presented in U.S. dollars in conformity with accounting principles
 generally accepted in the United States of America
 (&amp;#x201C;GAAP&amp;#x201D;) for financial information and pursuant to the
 rules and regulations of the SEC. Accordingly, they do not include
 all of the information and footnotes required by GAAP. In the
 opinion of management, the unaudited condensed financial statements
 reflect all adjustments, which include only normal recurring
 adjustments necessary for the fair statement of the balances and
 results for the periods presented. Operating results for the period
 for the period from April&amp;#xA0;17, 2020 (inception) through
 June&amp;#xA0;30, 2020 are not necessarily indicative of the results
 that may be expected through December&amp;#xA0;31, 2020.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The accompanying unaudited condensed financial statements should be
 read in conjunction with the audited financial statements and notes
 thereto included in the Form &lt;font style="WHITE-SPACE: nowrap"&gt;8-K&lt;/font&gt; and the final prospectus filed by
 the Company with the SEC on July&amp;#xA0;7, 2020 and June&amp;#xA0;26,
 2020, respectively.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Emerging Growth Company&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company is an &amp;#x201C;emerging growth company,&amp;#x201D; as defined
 in Section&amp;#xA0;2(a) of the Securities Act, as modified by the
 Jumpstart Our Business Startups Act of 2012 (the &amp;#x201C;JOBS
 Act&amp;#x201D;), and it may take advantage of certain exemptions from
 various reporting requirements that are applicable to other public
 companies that are not emerging growth companies including, but not
 limited to, not being required to comply with the independent
 registered public accounting firm attestation requirements of
 Section&amp;#xA0;404 of the Sarbanes-Oxley Act, reduced disclosure
 obligations regarding executive compensation in its periodic
 reports and proxy statements, and exemptions from the requirements
 of holding a nonbinding advisory vote on executive compensation and
 stockholder approval of any golden parachute payments not
 previously approved.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 Further, Section&amp;#xA0;102(b)(1) of the JOBS Act exempts emerging
 growth companies from being required to comply with new or revised
 financial accounting standards until private companies (that is,
 those that have not had a Securities Act registration statement
 declared effective or do not have a class of securities registered
 under the Exchange Act) are required to comply with the new or
 revised financial accounting standards. The JOBS Act provides that
 an emerging growth company can elect to opt out of the extended
 transition period and comply with the requirements that apply to
 &lt;font style="WHITE-SPACE: nowrap"&gt;non-emerging&lt;/font&gt; growth
 companies but any such an election to opt out is irrevocable. The
 Company has elected not to opt out of such extended transition
 period, which means that when a standard is issued or revised and
 it has different application dates for public or private companies,
 the Company, as an emerging growth company, can adopt the new or
 revised standard at the time private companies adopt the new or
 revised standard.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 This may make comparison of the Company&amp;#x2019;s financial
 statements with another public company that is neither an emerging
 growth company nor an emerging growth company that has opted out of
 using the extended transition period difficult or impossible
 because of the potential differences in accounting standards
 used.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company considers all short-term investments with an original
 maturity of three months or less when purchased to be cash
 equivalents. The Company had no cash equivalents as of
 June&amp;#xA0;30, 2020.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Cash held in Trust Account&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 At June&amp;#xA0;30, 2020, the Company had $230.0&amp;#xA0;million in cash
 held in the Trust Account.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Financial instruments that potentially subject the Company to
 concentrations of credit risk consist of cash accounts in a
 financial institution, which, at times, may exceed the Federal
 Depository Insurance Coverage limit of $250,000. The Company has
 not experienced losses on these accounts and management believes
 the Company is not exposed to significant risks on such
 accounts.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Financial Instruments&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The fair value of the Company&amp;#x2019;s assets and liabilities, which
 qualify as financial instruments under FASB ASC&amp;#xA0;820,
 &amp;#x201C;Fair Value Measurements and Disclosures,&amp;#x201D; approximates
 the carrying amounts represented in the condensed financial
 statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The preparation of the financial statements in conformity with U.S.
 GAAP requires the Company&amp;#x2019;s management to make estimates and
 assumptions that affect the reported amounts of assets and
 liabilities and disclosure of contingent assets and liabilities at
 the date of the financial statements and the reported amounts of
 revenues and expenses during the reporting period. Actual results
 could differ from those estimates.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Offering Costs Associated with the Initial Public
 Offering&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Offering costs consist of legal, accounting, underwriting fees and
 other costs incurred through the balance sheet date that are
 directly related to the Initial Public Offering and that were
 charged to stockholders&amp;#x2019; equity upon the completion of the
 Initial Public Offering.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 18pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Class&amp;#xA0;A common stock subject to possible redemption&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company accounts for its Class&amp;#xA0;A common stock subject to
 possible redemption in accordance with the guidance in ASC Topic
 480 &amp;#x201C;Distinguishing Liabilities from Equity.&amp;#x201D;
 Class&amp;#xA0;A common stock subject to mandatory redemption (if any)
 is classified as liability instruments and are measured at fair
 value. Conditionally redeemable Class&amp;#xA0;A common stock
 (including Class&amp;#xA0;A common stock that features redemption
 rights that are either within the control of the holder or subject
 to redemption upon the occurrence of uncertain events not solely
 within the Company&amp;#x2019;s control) are classified as temporary
 equity. At all other times, Class&amp;#xA0;A common stock is classified
 as stockholders&amp;#x2019; equity. The Company&amp;#x2019;s Class&amp;#xA0;A
 common stock feature certain redemption rights that are considered
 to be outside of the Company&amp;#x2019;s control and subject to the
 occurrence of uncertain future events. Accordingly, at
 June&amp;#xA0;30, 2020, 21,843,927 shares of Class&amp;#xA0;A common stock
 subject to possible redemption is presented at redemption value as
 temporary equity, outside of the stockholders&amp;#x2019; equity section
 of the Company&amp;#x2019;s balance sheet.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Net Loss Per Common Share&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company complies with accounting and disclosure requirements of
 FASB ASC Topic 260, &amp;#x201C;Earnings Per Share.&amp;#x201D; Net loss per
 share is computed by dividing net loss by the weighted average
 number of shares of common stock outstanding during the period
 excluding common stock subject to forfeiture. An aggregate of
 21,843,927 shares of Class&amp;#xA0;A common stock subject to possible
 redemption at June&amp;#xA0;30, 2020 has been excluded from the
 calculation of basic loss per share of common stock, since such
 shares, if redeemed, only participate in their pro rata share of
 the trust earnings. The Company has not considered the effect of
 the warrants sold in the Initial Public Offering (including the
 consummation of the Over-Allotment Units) and Private Placement to
 purchase an aggregate of 18,075,000 shares of the Company&amp;#x2019;s
 common stock in the calculation of diluted loss per share, since
 the exercise of the warrants are contingent upon the occurrence of
 future events.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;Reconciliation of net loss per common share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company&amp;#x2019;s net loss is adjusted for the portion of income
 (loss) that is attributable to Class&amp;#xA0;A common stock subject to
 redemption, as these shares only participate in the earnings of the
 Trust Account and not the income or losses of the Company.
 Accordingly, basic and diluted loss per common share is calculated
 as follows:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="71%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="19%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;
 &lt;b&gt;For&amp;#xA0;The&amp;#xA0;Period&amp;#xA0;From&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;April&amp;#xA0;17, 2020&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;(inception)&amp;#xA0;through&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;June&amp;#xA0;30, 2020&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Net loss&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(62,862&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Less: Income attributable to Class&amp;#xA0;A ordinary shares subject
 to possible redemption&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Adjusted net loss&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(62,862&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Weighted average ordinary shares outstanding, basic and diluted&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,031,247&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF"&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em"&gt;
 Basic and diluted net loss per ordinary share&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;b&gt;(0.01&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;b&gt;)&amp;#xA0;&lt;/b&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company follows the asset and liability method of accounting
 for income taxes under FASB ASC 740, &amp;#x201C;Income Taxes.&amp;#x201D;
 Deferred tax assets and liabilities are recognized for the
 estimated future tax consequences attributable to differences
 between the financial statements carrying amounts of existing
 assets and liabilities and their respective tax bases. Deferred tax
 assets and liabilities are measured using enacted tax rates
 expected to apply to taxable income in the years in which those
 temporary differences are expected to be recovered or settled. The
 effect on deferred tax assets and liabilities of a change in tax
 rates is recognized in income in the period that included the
 enactment date. Valuation allowances are established, when
 necessary, to reduce deferred tax assets to the amount expected to
 be realized. Deferred tax assets were deemed immaterial as of
 June&amp;#xA0;30, 2020.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 FASB ASC 740 prescribes a recognition threshold and a measurement
 attribute for the financial statement recognition and measurement
 of tax positions taken or expected to be taken in a tax return. For
 those benefits to be recognized, a tax position must be more likely
 than not to be sustained upon examination by taxing authorities.
 There were no unrecognized tax benefits as of June&amp;#xA0;30, 2020.
 The Company recognizes accrued interest and penalties related to
 unrecognized tax benefits as income tax expense. No amounts were
 accrued for the payment of interest and penalties as of
 June&amp;#xA0;30, 2020. The Company is currently not aware of any
 issues under review that could result in significant payments,
 accruals or material deviation from its position. The Company is
 subject to income tax examinations by major taxing authorities
 since inception.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 On March&amp;#xA0;27, 2020, President Trump signed the Coronavirus Aid,
 Relief, and Economic Security &amp;#x201C;CARES&amp;#x201D; Act into law. The
 CARES Act includes several significant business tax provisions
 that, among other things, would eliminate the taxable income limit
 for certain net operating losses (&amp;#x201C;NOL) and allow businesses
 to carry back NOLs arising in 2018, 2019 and 2020 to the five prior
 years, suspend the excess business loss rules, accelerate refunds
 of previously generated corporate alternative minimum tax credits,
 generally loosen the business interest limitation under IRC section
 163(j) from 30&amp;#xA0;percent to 50&amp;#xA0;percent among other
 technical corrections included in the Tax Cuts and Jobs Act tax
 provisions. The Company does not believe that the CARES Act will
 have a significant impact on Company&amp;#x2019;s financial position or
 statement of operations.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Recent Accounting Standards&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company&amp;#x2019;s management does not believe that any recently
 issued, but not yet effective, accounting standards updates, if
 currently adopted would have a material effect on the accompanying
 financial statements.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:SubsequentEventsTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_FE13AA99-B904-408A-8C74-1CB30220CE83_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 &lt;b&gt;Note 8&amp;#x2014;Subsequent Events&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &amp;quot;Times New Roman&amp;quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial"&gt;
 On October 2, 2020, a putative class action lawsuit was filed
 against the Company. The complaint names the Company and certain
 members of the Company&amp;#x2019;s board as defendants. The complaint
 alleges, among other things, breach of fiduciary duty claims in
 connection with the proposed business combination with QuantumScape
 Corporation. Management with its legal counsel are currently
 evaluating the merits of the complaint and as of June 30, 2020, the
 Company had not accrued any amounts for this contingency.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_1D6B20CB-2795-4AAD-B0E6-CB289E07D375_1_0">&lt;div&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The accompanying unaudited condensed financial statements are
 presented in U.S. dollars in conformity with accounting principles
 generally accepted in the United States of America
 (&amp;#x201C;GAAP&amp;#x201D;) for financial information and pursuant to the
 rules and regulations of the SEC. Accordingly, they do not include
 all of the information and footnotes required by GAAP. In the
 opinion of management, the unaudited condensed financial statements
 reflect all adjustments, which include only normal recurring
 adjustments necessary for the fair statement of the balances and
 results for the periods presented. Operating results for the period
 for the period from April&amp;#xA0;17, 2020 (inception) through
 June&amp;#xA0;30, 2020 are not necessarily indicative of the results
 that may be expected through December&amp;#xA0;31, 2020.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The accompanying unaudited condensed financial statements should be
 read in conjunction with the audited financial statements and notes
 thereto included in the Form &lt;font style="white-space:nowrap"&gt;8-K&lt;/font&gt; and the final prospectus filed by
 the Company with the SEC on July&amp;#xA0;7, 2020 and June&amp;#xA0;26,
 2020, respectively.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_965C9C72-3713-4906-9E6D-94851378A4CB_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Company considers all short-term investments with an original
 maturity of three months or less when purchased to be cash
 equivalents. The Company had no cash equivalents as of
 June&amp;#xA0;30, 2020.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:ConcentrationRiskCreditRisk contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_44C09358-2F49-44F7-8AC4-E7663A5CC172_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 Financial instruments that potentially subject the Company to
 concentrations of credit risk consist of cash accounts in a
 financial institution, which, at times, may exceed the Federal
 Depository Insurance Coverage limit of $250,000. The Company has
 not experienced losses on these accounts and management believes
 the Company is not exposed to significant risks on such
 accounts.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_4D03D393-0BA3-4E16-96D3-BABC9DF962FE_1_0">22314</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:FranchisorCosts contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_4D03D393-0BA3-4E16-96D3-BABC9DF962FE_1_1">40548</us-gaap:FranchisorCosts>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_FA97D492-916C-4BA5-A11B-F628B654D745_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Note 7&amp;#x2014;Fair Value Measurements&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Company follows the guidance in ASC 820 for its financial
 assets and liabilities that are &lt;font style="white-space:nowrap"&gt;re-measured&lt;/font&gt; and reported at fair value
 at each reporting period, and &lt;font style="white-space:nowrap"&gt;non-financial&lt;/font&gt; assets and liabilities
 that are &lt;font style="white-space:nowrap"&gt;re-measured&lt;/font&gt; and
 reported at fair value at least annually.&lt;/p&gt;
 &lt;p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The fair value of the Company&amp;#x2019;s financial assets and
 liabilities reflects management&amp;#x2019;s estimate of amounts that
 the Company would have received in connection with the sale of the
 assets or paid in connection with the transfer of the liabilities
 in an orderly transaction between market participants at the
 measurement date. In connection with measuring the fair value of
 its assets and liabilities, the Company seeks to maximize the use
 of observable inputs (market data obtained from independent
 sources) and to minimize the use of unobservable inputs (internal
 assumptions about how market participants would price assets and
 liabilities). The following fair value hierarchy is used to
 classify assets and liabilities based on the observable inputs and
 unobservable inputs used in order to value the assets and
 liabilities:&lt;/p&gt;
 &lt;p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr style="page-break-inside:avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td width="3%" valign="top" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td width="1%" valign="top"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;
 &lt;p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"&gt;
 Level 1: Quoted prices in active markets for identical assets or
 liabilities. An active market for an asset or liability is a market
 in which transactions for the asset or liability occur with
 sufficient frequency and volume to provide pricing information on
 an ongoing basis.&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr style="page-break-inside:avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td width="3%" valign="top" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td width="1%" valign="top"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;
 &lt;p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"&gt;
 Level 2: Observable inputs other than Level&amp;#xA0;1 inputs. Examples
 of Level&amp;#xA0;2 inputs include quoted prices in active markets for
 similar assets or liabilities and quoted prices for identical
 assets or liabilities in markets that are not active.&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr style="page-break-inside:avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td width="3%" valign="top" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td width="1%" valign="top"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;
 &lt;p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"&gt;
 Level 3: Unobservable inputs based on the Company&amp;#x2019;s
 assessment of the assumptions that market participants would use in
 pricing the asset or liability.&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table cellspacing="0" cellpadding="0" width="76%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center"&gt;
 &lt;tr&gt;
 &lt;td width="71%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;"&gt;
 &lt;b&gt;Description&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"&gt;&lt;b&gt;Level&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"&gt;&lt;b&gt;June&amp;#xA0;30, 2020&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
 &lt;td valign="top"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"&gt;
 Assets:&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
 &lt;td valign="top"&gt;
 &lt;p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"&gt;
 Cash held in Trust Account&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;230,000,000&lt;/td&gt;
 &lt;td nowrap="nowrap" valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_A9D8ED1F-6999-4B8F-BA57-5C78AA7CDE33_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Financial Instruments&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The fair value of the Company&amp;#x2019;s assets and liabilities, which
 qualify as financial instruments under FASB ASC&amp;#xA0;820,
 &amp;#x201C;Fair Value Measurements and Disclosures,&amp;#x201D; approximates
 the carrying amounts represented in the condensed financial
 statements.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_36C5CF77-3498-4347-B9B9-63B243A40DAD_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Company follows the asset and liability method of accounting
 for income taxes under FASB ASC 740, &amp;#x201C;Income Taxes.&amp;#x201D;
 Deferred tax assets and liabilities are recognized for the
 estimated future tax consequences attributable to differences
 between the financial statements carrying amounts of existing
 assets and liabilities and their respective tax bases. Deferred tax
 assets and liabilities are measured using enacted tax rates
 expected to apply to taxable income in the years in which those
 temporary differences are expected to be recovered or settled. The
 effect on deferred tax assets and liabilities of a change in tax
 rates is recognized in income in the period that included the
 enactment date. Valuation allowances are established, when
 necessary, to reduce deferred tax assets to the amount expected to
 be realized. Deferred tax assets were deemed immaterial as of
 June&amp;#xA0;30, 2020.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 FASB ASC 740 prescribes a recognition threshold and a measurement
 attribute for the financial statement recognition and measurement
 of tax positions taken or expected to be taken in a tax return. For
 those benefits to be recognized, a tax position must be more likely
 than not to be sustained upon examination by taxing authorities.
 There were no unrecognized tax benefits as of June&amp;#xA0;30, 2020.
 The Company recognizes accrued interest and penalties related to
 unrecognized tax benefits as income tax expense. No amounts were
 accrued for the payment of interest and penalties as of
 June&amp;#xA0;30, 2020. The Company is currently not aware of any
 issues under review that could result in significant payments,
 accruals or material deviation from its position. The Company is
 subject to income tax examinations by major taxing authorities
 since inception.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 On March&amp;#xA0;27, 2020, President Trump signed the Coronavirus Aid,
 Relief, and Economic Security &amp;#x201C;CARES&amp;#x201D; Act into law. The
 CARES Act includes several significant business tax provisions
 that, among other things, would eliminate the taxable income limit
 for certain net operating losses (&amp;#x201C;NOL) and allow businesses
 to carry back NOLs arising in 2018, 2019 and 2020 to the five prior
 years, suspend the excess business loss rules, accelerate refunds
 of previously generated corporate alternative minimum tax credits,
 generally loosen the business interest limitation under IRC section
 163(j) from 30&amp;#xA0;percent to 50&amp;#xA0;percent among other
 technical corrections included in the Tax Cuts and Jobs Act tax
 provisions. The Company does not believe that the CARES Act will
 have a significant impact on Company&amp;#x2019;s financial position or
 statement of operations.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_3C276E4D-AC0D-490B-BE89-C49DD79EB456_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Note 6&amp;#x2014;Stockholders&amp;#x2019; Equity&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;&lt;i&gt;Preferred Stock&lt;/i&gt;&lt;/b&gt;&amp;#x2014;The Company is authorized to
 issue 1,000,000 shares of preferred stock, par value $0.0001 per
 share, with such designations, voting and other rights and
 preferences as may be determined from time to time by the
 Company&amp;#x2019;s board of directors. As of June&amp;#xA0;30, 2020, there
 were no shares of preferred stock issued or outstanding.&lt;/p&gt;
 &lt;p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;&lt;i&gt;Class&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;&amp;#xA0;A Common Stock&lt;/i&gt;&lt;/b&gt;&amp;#x2014;The
 Company is authorized to issue 100,000,000 shares of Class&amp;#xA0;A
 common stock with a par value of $0.0001 per share. As of
 June&amp;#xA0;30, 2020, there were 23,000,000 shares of Class&amp;#xA0;A
 common stock issued or outstanding, including 21,843,927 shares of
 Class&amp;#xA0;A common stock subject to possible redemption,
 respectively.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;&lt;i&gt;Class&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;&amp;#xA0;B Common Stock&lt;/i&gt;&lt;/b&gt;&amp;#x2014;The
 Company is authorized to issue 10,000,000 shares of Class&amp;#xA0;B
 common stock with a par value of $0.0001 per share. On
 April&amp;#xA0;17, 2020, the Sponsor subscribed to purchase 5,031,250
 shares of Class&amp;#xA0;B common stock, which was fully paid on
 June&amp;#xA0;30, 2020. On June&amp;#xA0;25, 2020, the Company effected a
 stock dividend with respect to the Class&amp;#xA0;B common stock,
 resulting in the Sponsor holding an aggregate of 5,750,000 founder
 shares. All shares and associated amounts have been retroactively
 restated to reflect the share capitalization. Of these, an
 aggregate of up to 750,000 shares of Class&amp;#xA0;B common stock that
 were subject to forfeiture to the Company by the initial
 stockholders for no consideration to the extent that the
 underwriters&amp;#x2019; over-allotment option is not exercised in full
 or in part, so that the number of Founder Shares equals 20% of the
 Company&amp;#x2019;s issued and outstanding shares of common stock after
 the Initial Public Offering. The underwriter exercised its
 over-allotment option in full on June&amp;#xA0;30, 2020; thus, the
 750,000 Founder Shares were no longer subject to forfeiture.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 Stockholders of record are entitled to one vote for each share held
 on all matters to be voted on by stockholders; provided that, prior
 to the completion of the initial Business Combination, holders of
 the Class&amp;#xA0;B common stock will have the right to elect all of
 the Company&amp;#x2019;s directors and remove members of the
 Company&amp;#x2019;s board of directors for any reason. Prior to the
 completion of the initial Business Combination, only holders of the
 Class&amp;#xA0;B common stock will have the right to vote on the
 Company&amp;#x2019;s election of directors. Holders of the Public Shares
 will not be entitled to vote on the Company&amp;#x2019;s election of
 directors during such time. In addition, prior to the completion of
 the initial Business Combination, holders of a majority of the
 outstanding shares of the Class&amp;#xA0;B common stock may remove a
 member of the Company&amp;#x2019;s board of directors for any reason.
 These provisions of the Certificate of Incorporation may only be
 amended by a resolution passed by the holders of a majority of
 shares of the Class&amp;#xA0;B common stock. With respect to any other
 matter submitted to a vote of the Company&amp;#x2019;s stockholders,
 including any vote in connection with the initial Business
 Combination, holders of the Class&amp;#xA0;A common stock and holders
 of the Class&amp;#xA0;B common stock will vote together as a single
 class on all matters submitted to a vote of the Company&amp;#x2019;s
 stockholders, except as required by law.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Class&amp;#xA0;B common stock will automatically convert into
 Class&amp;#xA0;A common stock at the time of the initial Business
 Combination, or earlier at the option of the holders, on a
 &lt;font style="white-space:nowrap"&gt;&lt;font style="white-space:nowrap"&gt;one-for-one&lt;/font&gt;&lt;/font&gt; basis, subject to
 adjustment for stock splits, stock dividends, reorganizations,
 recapitalizations and the like, and subject to further adjustment
 as described herein. In the case that additional shares of
 Class&amp;#xA0;A common stock, or equity-linked securities, are issued
 or deemed issued in excess of the amounts issued in the Proposed
 Offering and related to the closing of the initial Business
 Combination, including pursuant to a specified future issuance, the
 ratio at which shares of Class&amp;#xA0;B common stock shall convert
 into shares of Class&amp;#xA0;A common stock will be adjusted (unless
 the holders of a majority of the then-outstanding shares of
 Class&amp;#xA0;B common stock agree to waive such adjustment with
 respect to any such issuance or deemed issuance, including a
 specified future issuance) so that the number of shares of
 Class&amp;#xA0;A common stock issuable upon conversion of all shares of
 Class&amp;#xA0;B common stock will equal, in the aggregate, on an
 &lt;font style="white-space:nowrap"&gt;as-converted&lt;/font&gt; basis, 20% of
 the sum of the total number of all shares of common stock
 outstanding upon the completion of the Initial Public Offering plus
 all shares of Class&amp;#xA0;A common stock and equity-linked
 securities issued or deemed issued in connection with the initial
 Business Combination (excluding any shares or equity-linked
 securities issued or issuable to any seller in the initial Business
 Combination).&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&amp;#x2014;Public Warrants may only be exercised
 for a whole number of shares. No fractional Public Warrants will be
 issued upon separation of the Units and only whole Public Warrants
 will trade. The Public Warrants will become exercisable on the
 later of (a) 30 days after the completion of a Business Combination
 and (b) 12 months from the closing of the Initial Public Offering;
 provided in each case that the Company has an effective
 registration statement under the Securities Act covering the
 issuance of the shares of Class&amp;#xA0;A common stock issuable upon
 exercise of the Public Warrants and a current prospectus relating
 to them is available and such shares are registered, qualified or
 exempt from registration under the securities, or blue sky, laws of
 the state of residence of the holder (or the Company permits
 holders to exercise their Public Warrants on a cashless basis under
 the circumstances specified in the warrant agreement). The Company
 has agreed that as soon as practicable, but in no event later than
 20 business days after the closing of the initial Business
 Combination, the Company will use its commercially reasonable
 efforts to file, and within 60 business days following the initial
 Business Combination to have declared effective, a registration
 statement covering the issuance of the shares of Class&amp;#xA0;A
 common stock issuable upon exercise of the warrants and to maintain
 a current prospectus relating to those shares of Class&amp;#xA0;A
 common stock until the warrants expire or are redeemed; provided,
 that if the Class&amp;#xA0;A common stock is at the time of any
 exercise of a warrant not listed on a national securities exchange
 such that it satisfies the definition of a &amp;#x201C;covered
 security&amp;#x201D; under Section&amp;#xA0;18(b)(1) of the Securities Act,
 the Company may, at its option, require holders of Public Warrants
 who exercise their warrants to do so on a &amp;#x201C;cashless
 basis&amp;#x201D; in accordance with Section&amp;#xA0;3(a)(9) of the
 Securities Act and, in the event the Company so elects, it will not
 be required to file or maintain in effect a registration statement,
 but it will be required to use its best efforts to register or
 qualify the shares under applicable blue sky laws to the extent an
 exemption is not available. The Public Warrants will expire five
 years after the completion of a Business Combination or earlier
 upon redemption or liquidation.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The warrants have an exercise price of $11.50 per share. If
 (x)&amp;#xA0;the Company issue additional shares or equity-linked
 securities for capital raising purposes in connection with the
 closing of the initial Business Combination at an issue price or
 effective issue price of less than $9.20 per share (as adjusted for
 stock splits, stock dividends, rights issuances, subdivisions,
 reorganizations, recapitalizations and the like) (with such issue
 price or effective issue price to be determined in good faith by
 the Company&amp;#x2019;s board of directors, and in the case of any such
 issuance to the Sponsor, initial stockholders or their affiliates,
 without taking into account any Founder Shares held by them prior
 to such issuance) (the &amp;#x201C;Newly Issued Price&amp;#x201D;), (y) the
 aggregate gross proceeds from such issuances represent more than
 60% of the total equity proceeds, and interest thereon, available
 for the funding of the initial Business Combination on the date of
 the consummation of the Initial Business Combination (net of
 redemptions), and (z)&amp;#xA0;the volume weighted average trading
 price of the Company&amp;#x2019;s shares of Class&amp;#xA0;A common stock
 during the 20 trading day period starting on the trading day prior
 to the day on which the Company consummates the initial Business
 Combination (such price, the &amp;#x201C;Market Value&amp;#x201D;) is below
 $9.20 per share, the exercise price of each warrant will be
 adjusted (to the nearest cent) such that the effective exercise
 price per full share will be equal to 115% of the higher of
 (i)&amp;#xA0;the Market Value and (ii)&amp;#xA0;the Newly Issued Price, and
 the $18.00&amp;#xA0;per share redemption trigger price described below
 will be adjusted (to the nearest cent) to be equal to 180% of the
 higher of (i)&amp;#xA0;the Market Value and (ii)&amp;#xA0;the Newly Issued
 Price.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Private Placement Warrants are identical to the Public
 Warrants, except that (1)&amp;#xA0;the Private Placement Warrants and
 the shares of Class&amp;#xA0;A common stock issuable upon exercise of
 the Private Placement Warrants are not transferable, assignable or
 salable until 30 days after the completion of a Business
 Combination, subject to certain limited exceptions, (2)&amp;#xA0;the
 Private Placement Warrants are be &lt;font style="white-space:nowrap"&gt;non-redeemable&lt;/font&gt; (except as described
 below) so long as they are held by the Sponsor or its permitted
 transferees, (3)&amp;#xA0;the Private Placement Warrants may be
 exercised by the holders on a cashless basis and (4)&amp;#xA0;the
 holders of the Private Placement Warrants (including with respect
 to the shares of common stock issuable upon exercise of the Private
 Placement Warrants) are entitled to registration rights. If the
 Private Placement Warrants are held by someone other than the
 Sponsor or its permitted transferees, the Private Placement
 Warrants will be redeemable by the Company in all redemption
 scenarios and exercisable by such holders on the same basis as the
 Public Warrants.&lt;/p&gt;
 &lt;p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Company may call the Public Warrants for redemption:&lt;/p&gt;
 &lt;p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr style="page-break-inside:avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td width="3%" valign="top" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td width="1%" valign="top"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;
 &lt;p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"&gt;
 in whole and not in part;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr style="page-break-inside:avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td width="3%" valign="top" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td width="1%" valign="top"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;
 &lt;p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"&gt;
 at a price of $0.01 per warrant;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr style="page-break-inside:avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td width="3%" valign="top" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td width="1%" valign="top"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;
 &lt;p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"&gt;
 upon a minimum of 30 days&amp;#x2019; prior written notice of
 redemption; and&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr style="page-break-inside:avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td width="3%" valign="top" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td width="1%" valign="top"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;
 &lt;p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"&gt;
 if, and only if, the last reported sale price of the Class&amp;#xA0;A
 common stock equals or exceeds $18.00 per share (as adjusted for
 stock splits, stock dividends, reorganizations, recapitalizations
 and the like) for any 20 trading days within the &lt;font style="white-space:nowrap"&gt;30-trading&lt;/font&gt; day period ending on the
 third business day prior to the date on which the Company sends the
 notice of redemption to the warrant holders.&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 If the Company calls the Public Warrants for redemption, management
 will have the option to require all holders that wish to exercise
 the Public Warrants to do so on a &amp;#x201C;cashless basis,&amp;#x201D; as
 described in the warrant agreement.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 In addition, commencing ninety days after the warrants become
 exercisable, the Company may redeem the outstanding warrants:&lt;/p&gt;
 &lt;p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr style="page-break-inside:avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td width="3%" valign="top" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td width="1%" valign="top"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;
 &lt;p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"&gt;
 in whole and not in part;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr style="page-break-inside:avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td width="3%" valign="top" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td width="1%" valign="top"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;
 &lt;p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"&gt;
 at $0.10 per warrant upon a minimum of 30 days&amp;#x2019; prior written
 notice of redemption provided that holders will be able to exercise
 their warrants on a cashless basis prior to redemption and receive
 that number of shares of Class&amp;#xA0;A common stock to be determined
 by reference to a table in the warrant agreement;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr style="page-break-inside:avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td width="3%" valign="top" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td width="1%" valign="top"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;
 &lt;p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"&gt;
 if, and only if, the last reported sale price of the
 Company&amp;#x2019;s Class&amp;#xA0;A common stock equals or exceeds $10.00
 per share (as adjusted for stock splits, stock dividends,
 reorganizations, recapitalizations and the like) on the trading day
 prior to the date on which the Company sends the notice of
 redemption to the warrant holders;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr style="page-break-inside:avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td width="3%" valign="top" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td width="1%" valign="top"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;
 &lt;p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"&gt;
 if, and only if, the Private Placement Warrants are also
 concurrently called for redemption at the same price (equal to a
 number of shares of Class&amp;#xA0;A common stock) as the outstanding
 Public Warrants, as described above; and&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;
 &lt;tr style="page-break-inside:avoid"&gt;
 &lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td width="3%" valign="top" align="left"&gt;&amp;#x2022;&lt;/td&gt;
 &lt;td width="1%" valign="top"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td align="left" valign="top"&gt;
 &lt;p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"&gt;
 if, and only if, there is an effective registration statement
 covering the shares of Class&amp;#xA0;A common stock (or a security
 other than the Class&amp;#xA0;A common stock into which the
 Class&amp;#xA0;A common stock has been converted or exchanged for in
 the event the Company is not the surviving company in the initial
 Business Combination) issuable upon exercise of the warrants and a
 current prospectus relating thereto available throughout the
 &lt;font style="white-space:nowrap"&gt;30-day&lt;/font&gt; period after written
 notice of redemption is given.&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 In no event will the Company be required to net cash settle any
 warrant. If the Company is unable to complete a Business
 Combination within the Combination Period and the Company
 liquidates the funds held in the Trust Account, holders of warrants
 will not receive any of such funds with respect to their warrants,
 nor will they receive any distribution from the Company&amp;#x2019;s
 assets held outside of the Trust Account with the respect to such
 warrants. Accordingly, the warrants may expire worthless.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_4D9BD57B-B05E-4412-AB0E-FC8FDB7D5EED_1_0">&lt;div&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Note 1&amp;#x2014;Description of Organization, Business Operations
 and Basis of Presentation&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 Kensington Capital Acquisition Corp. (the &amp;#x201C;Company&amp;#x201D;)
 was incorporated in Delaware on April&amp;#xA0;17, 2020. The Company
 was formed for the purpose of effecting a merger, capital stock
 exchange, asset acquisition, stock purchase, reorganization or
 similar business combination with one or more businesses (the
 &amp;#x201C;Business Combination&amp;#x201D;). Although the Company is not
 limited to a particular industry or sector for purposes of
 consummating a Business Combination, the Company intends to focus
 its search for a target business in the automotive and
 automotive-related sector. The Company is an emerging growth
 company and, as such, the Company is subject to all of the risks
 associated with emerging growth companies.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 As of June&amp;#xA0;30, 2020, the Company had not commenced any
 operations. All activity for the period from April&amp;#xA0;17, 2020
 (inception) through June&amp;#xA0;30, 2020 relates to the
 Company&amp;#x2019;s formation and the initial public offering (the
 &amp;#x201C;Initial Public Offering&amp;#x201D;) described below. The Company
 will not generate any operating revenues until after the completion
 of its initial Business Combination, at the earliest. The Company
 will generate &lt;font style="white-space:nowrap"&gt;non-operating&lt;/font&gt;
 income in the form of interest income on cash and cash equivalents
 from the proceeds derived from the Initial Public Offering. The
 Company has selected December&amp;#xA0;31 as its fiscal year end.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Company&amp;#x2019;s sponsor is Kensington Capital Sponsor LLC, a
 Delaware limited liability company (the &amp;#x201C;Sponsor&amp;#x201D;). The
 registration statement for the Company&amp;#x2019;s Initial Public
 Offering was declared effective on June&amp;#xA0;25, 2020. On
 June&amp;#xA0;30, 2020, the Company consummated its Initial Public
 Offering of 23,000,000 units (the &amp;#x201C;Units&amp;#x201D; and, with
 respect to the Class&amp;#xA0;A common stock included in the Units
 sold, the &amp;#x201C;Public Shares&amp;#x201D;), including 3,000,000
 additional Units to cover over-allotments (the
 &amp;#x201C;Over-Allotment Units&amp;#x201D;), at $10.00 per Unit, generating
 gross proceeds of $230.0&amp;#xA0;million, and incurring offering costs
 of approximately $13.1&amp;#xA0;million, inclusive of approximately
 $8.1&amp;#xA0;million in deferred underwriting commissions (Note
 5).&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 Simultaneously with the closing of the Initial Public Offering, the
 Company consummated the private placement (&amp;#x201C;Private
 Placement&amp;#x201D;) of 6,575,000 warrants (each, a &amp;#x201C;Private
 Placement Warrant&amp;#x201D; and collectively, the &amp;#x201C;Private
 Placement Warrants&amp;#x201D;) at a price of $1.00 per Private
 Placement Warrant to the Sponsor, generating proceeds of
 approximately $6.6&amp;#xA0;million (Note 4).&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 Upon the closing of the Initial Public Offering and the Private
 Placement, $230.0&amp;#xA0;million ($10.00 per Unit) of the net
 proceeds of the Initial Public Offering and certain of the proceeds
 of the Private Placement was held in a trust account (&amp;#x201C;Trust
 Account&amp;#x201D;) located in the United States with Continental Stock
 Transfer&amp;#xA0;&amp;amp; Trust Company acting as trustee, and invested
 only in U.S. &amp;#x201C;government securities,&amp;#x201D; within the
 meaning set forth in Section&amp;#xA0;2(a)(16) of the Investment
 Company Act, with a maturity of 185 days or less, or in money
 market funds meeting certain conditions under Rule &lt;font style="white-space:nowrap"&gt;2a-7&lt;/font&gt; under the Investment Company Act,
 which invest only in direct U.S. government treasury obligations,
 as determined by the Company, until the earlier of: (i)&amp;#xA0;the
 completion of a Business Combination and (ii)&amp;#xA0;the distribution
 of the Trust Account as described below.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Company&amp;#x2019;s management has broad discretion with respect to
 the specific application of the net proceeds of the Initial Public
 Offering and the sale of the Private Placement Warrants, although
 substantially all of the net proceeds are intended to be applied
 generally toward consummating a Business Combination. There is no
 assurance that the Company will be able to complete a Business
 Combination successfully. The Company must complete an initial
 Business Combination with one or more operating businesses or
 assets with a fair market value equal to at least 80% of the net
 assets held in the Trust Account (as defined below) (net of amounts
 disbursed to management for working capital purposes, if permitted,
 and excluding the amount of any deferred underwriting discount).
 However, the Company will only complete a Business Combination if
 the post-transaction company owns or acquires 50% or more of the
 outstanding voting securities of the target or otherwise acquires a
 controlling interest in the target business sufficient for it not
 to be required to register as an investment company under the
 Investment Company Act 1940, as amended (the &amp;#x201C;Investment
 Company Act&amp;#x201D;).&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Company will provide holders of the Company&amp;#x2019;s outstanding
 shares of Class&amp;#xA0;A common stock, par value $0.0001 per share,
 sold in the Initial Public Offering (the &amp;#x201C;Public
 Stockholders&amp;#x201D;) with the opportunity to redeem all or a
 portion of their Public Shares upon the completion of a Business
 Combination either (i)&amp;#xA0;in connection with a stockholder
 meeting called to approve the Business Combination or (ii)&amp;#xA0;by
 means of a tender offer. The decision as to whether the Company
 will seek stockholder approval of a Business Combination or conduct
 a tender offer will be made by the Company, solely in its
 discretion. The Public Stockholders will be entitled to redeem
 their Public Shares for a pro rata portion of the amount then held
 in the Trust Account (initially $10.00 per Public Share),
 calculated as of two business days prior to the initial Business
 Combination, including interest earned on the funds held in the
 trust account and not previously released to the Company to pay the
 Company&amp;#x2019;s taxes, net of taxes payable. The &lt;font style="white-space:nowrap"&gt;per-share&lt;/font&gt; amount to be distributed to
 Public Stockholders who redeem their Public Shares will not be
 reduced by the deferred underwriting commissions the Company will
 pay to the underwriters (as discussed in Note 5). These Public
 Shares will be recorded at a redemption value and classified as
 temporary equity upon the completion of the Initial Public Offering
 in accordance with the Financial Accounting Standards Board&amp;#x2019;s
 (&amp;#x201C;FASB&amp;#x201D;) Accounting Standards Codification
 (&amp;#x201C;ASC&amp;#x201D;) Topic 480 &amp;#x201C;Distinguishing Liabilities
 from Equity.&amp;#x201D; The Company will proceed with a Business
 Combination if a majority of the shares voted are voted in favor of
 the Business Combination. The Company will not redeem the Public
 Shares in an amount that would cause its net tangible assets to be
 less than $5,000,001. If a stockholder vote is not required by
 applicable law or stock exchange rule and the Company does not
 decide to hold a stockholder vote for business or other reasons,
 the Company will, pursuant to its amended and restated certificate
 of incorporation (the &amp;#x201C;Certificate of Incorporation&amp;#x201D;),
 conduct the redemptions pursuant to the tender offer rules of the
 U.S. Securities and Exchange Commission (&amp;#x201C;SEC&amp;#x201D;) and
 file tender offer documents with the SEC prior to completing a
 Business Combination. If, however, stockholder approval of the
 transaction is required by applicable law or stock exchange rule,
 or the Company decides to obtain stockholder approval for business
 or reasons, the Company will offer to redeem shares in conjunction
 with a proxy solicitation pursuant to the proxy rules and not
 pursuant to the tender offer rules. Additionally, each Public
 Stockholder may elect to redeem their Public Shares without voting,
 and if they do vote, irrespective of whether they vote for or
 against the proposed transaction. If the Company seeks stockholder
 approval in connection with a Business Combination, the initial
 stockholders (as defined below) have agreed to vote their Founder
 Shares (as defined below in Note 4) and any Public Shares held by
 them in favor of a Business Combination. In addition, the initial
 stockholders have agreed to waive their redemption rights with
 respect to any Founder Shares and any Public Shares held by them in
 connection with the completion of a Business Combination.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Certificate of Incorporation provided that a Public
 Stockholder, together with any affiliate of such stockholder or any
 other person with whom such stockholder is acting in concert or as
 a &amp;#x201C;group&amp;#x201D; (as defined under Section&amp;#xA0;13 of the
 Securities Exchange Act of 1934, as amended (the &amp;#x201C;Exchange
 Act&amp;#x201D;)), will be restricted from redeeming its shares with
 respect to more than an aggregate of 15% or more of the Public
 Shares, without the prior consent of the Company.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Sponsor and the Company&amp;#x2019;s officers and directors (the
 &amp;#x201C;initial stockholders&amp;#x201D;) agreed, pursuant to a letter
 agreement with the Company, that they will not propose any
 amendment to the Certificate of Incorporation (A)&amp;#xA0;to modify
 the substance or timing of the Company&amp;#x2019;s obligation to allow
 redemption in connection with the initial Business Combination or
 to redeem 100% of the Public Shares if the Company does not
 complete a Business Combination within the Combination Period (as
 defined below) or (B)&amp;#xA0;with respect to any other provision
 relating to stockholders&amp;#x2019; rights or &lt;font style="white-space:nowrap"&gt;pre-initial&lt;/font&gt; Business Combination
 activity, unless the Company provides the Public Stockholders with
 the opportunity to redeem their Public Shares upon approval of any
 such amendment at a &lt;font style="white-space:nowrap"&gt;per-share&lt;/font&gt; price, payable in cash, equal
 to the aggregate amount then on deposit in the Trust Account,
 including interest (which interest shall be net of taxes payable)
 divided by the number of then outstanding Public Shares.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 If the Company is unable to complete a Business Combination within
 24 months from the closing of the Initial Public Offering, or
 June&amp;#xA0;30, 2022, (as such period may be extended pursuant to the
 Certificate of Incorporation, the &amp;#x201C;Combination
 Period&amp;#x201D;), the Company will (i)&amp;#xA0;cease all operations
 except for the purpose of winding up, (ii)&amp;#xA0;as promptly as
 reasonably possible but not more than ten business days thereafter,
 redeem the Public Shares, at a &lt;font style="white-space:nowrap"&gt;per-share&lt;/font&gt; price, payable in cash, equal
 to the aggregate amount then on deposit in the Trust Account
 including interest earned on the funds held in the Trust Account
 and not previously released to the Company to pay the
 Company&amp;#x2019;s taxes, net of taxes payable (less up to $100,000 of
 interest to pay dissolution expenses), divided by the number of
 then outstanding Public Shares, which redemption will completely
 extinguish Public Stockholders&amp;#x2019; rights as stockholders
 (including the right to receive further liquidating distributions,
 if any), and (iii)&amp;#xA0;as promptly as reasonably possible
 following such redemption, subject to the approval of the
 Company&amp;#x2019;s remaining stockholders and the Company&amp;#x2019;s
 board of directors, dissolve and liquidate, subject in each case to
 the Company&amp;#x2019;s obligations under Delaware law to provide for
 claims of creditors and the requirements of other applicable law.
 There will be no redemption rights or liquidating distributions
 with respect to the Company&amp;#x2019;s warrants, which will expire
 worthless if the Company fails to complete its initial Business
 Combination within the Combination Period.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The initial stockholders agreed to waive their rights to
 liquidating distributions from the Trust Account with respect to
 any Founder Shares held by them if the Company fails to complete a
 Business Combination within the Combination Period. However, if the
 initial stockholders acquire Public Shares in or after the Initial
 Public Offering, they will be entitled to liquidating distributions
 from the Trust Account with respect to such Public Shares if the
 Company fails to complete a Business Combination within the
 Combination Period. The underwriters have agreed to waive their
 rights to the deferred underwriting commission (see Note 5) held in
 the Trust Account in the event the Company does not complete a
 Business Combination within in the Combination Period and, in such
 event, such amounts will be included with the other funds held in
 the Trust Account that will be available to fund the redemption of
 the Public Shares. In the event of such distribution, it is
 possible that the per share value of the residual assets remaining
 available for distribution (including Trust Account assets) will be
 only, or less than, $10.00. In order to protect the amounts held in
 the Trust Account, the Sponsor has agreed to be liable to the
 Company if and to the extent any claims by a third party (except
 for the Company&amp;#x2019;s independent registered public accounting
 firm) for services rendered or products sold to the Company, or a
 prospective target business with which the Company has discussed
 entering into a transaction agreement (a &amp;#x201C;Target&amp;#x201D;),
 reduce the amount of funds in the Trust Account to below the lesser
 of (i) $10.00 per Public Share and (ii)&amp;#xA0;the actual amount per
 Public Share held in the Trust Account as of the date of the
 liquidation of the Trust Account, if less than $10.00 per Public
 Share due to reductions in the value of the trust assets, less
 taxes payable, provided that such liability will not apply to any
 claims by a third party or Target that executed a waiver of any and
 all rights to the monies held in the Trust Account nor will it
 apply to any claims under the Company&amp;#x2019;s indemnity of the
 underwriters of the Initial Public Offering against certain
 liabilities, including liabilities under the Securities Act of
 1933, as amended (the &amp;#x201C;Securities Act&amp;#x201D;). Moreover, in
 the event that an executed waiver is deemed to be unenforceable
 against a third party, then the Sponsor will not be responsible to
 the extent of any liability for such third-party claims. The
 Company will seek to reduce the possibility that the Sponsor will
 have to indemnify the Trust Account due to claims of creditors by
 endeavoring to have all vendors, service providers, prospective
 target businesses and other entities with which the Company does
 business, execute agreements with the Company waiving any right,
 title, interest or claim of any kind in or to monies held in the
 Trust Account.&lt;/p&gt;
 &lt;p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Liquidity and Capital Resources&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 As indicated in the accompanying unaudited condensed financial
 statements, at June&amp;#xA0;30, 2020, the Company had approximately
 $1.7&amp;#xA0;million in cash, and working capital of approximately
 $1.5&amp;#xA0;million (not taken into account tax obligations).&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Company&amp;#x2019;s liquidity needs prior to the consummation of
 the Initial Public Offering were satisfied through the proceeds of
 $25,000 from the sale of the Founders Shares (as defined in Note
 4), and loan proceeds from the Sponsor of $75,000 (which is still
 outstanding to date). Subsequent from the consummation of the
 Initial Public Offering, the Company&amp;#x2019;s liquidity has been
 satisfied through the net proceeds from the consummation of the
 Initial Public Offering and the Private Placement held outside of
 the Trust Account.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 Based on the foregoing, management believes that the Company will
 have sufficient working capital and borrowing capacity to meet its
 needs through the earlier of the consummation of a Business
 Combination or one&amp;#xA0;year from this filing. Over this time
 period, the Company will be using the funds held outside of the
 Trust Account for paying existing accounts payable, identifying and
 evaluating prospective initial Business Combination candidates,
 performing due diligence on prospective target businesses, paying
 for travel expenditures, selecting the target business to merge
 with or acquire, and structuring, negotiating and consummating the
 Business Combination.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 Management is currently evaluating the impact of the &lt;font style="white-space:nowrap"&gt;COVID-19&lt;/font&gt; pandemic on the industry and
 effect on the Company&amp;#x2019;s financial position, results of its
 operations and/or search for a target company.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_85EF9D2E-A7E0-44FF-BF13-106748D93F36_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Note 5&amp;#x2014;Commitments&amp;#xA0;&amp;amp; Contingencies&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Registration Rights&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The holders of Founder Shares, Private Placement Warrants and
 warrants that may be issued upon conversion of Working Capital
 Loans, if any, and any shares of Class&amp;#xA0;A common stock issuable
 upon the exercise of the Private Placement Warrants and warrants
 that may be issued upon conversion of Working Capital Loans and
 upon conversion of the Founder Shares will be entitled to
 registration rights pursuant to a registration rights. These
 holders will be entitled to certain demand and
 &amp;#x201C;piggyback&amp;#x201D; registration rights. The Company will bear
 the expenses incurred in connection with the filing of any such
 registration statements.&lt;/p&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Underwriting Agreement&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The underwriters were entitled to an underwriting discount of $0.20
 per unit, or $4.6&amp;#xA0;million in the aggregate, paid upon the
 closing of the Initial Public Offering. In addition, $0.35 per
 unit, or approximately $8.1&amp;#xA0;million in the aggregate will be
 payable to the underwriters for deferred underwriting commissions.
 The deferred fee will become payable to the underwriters from the
 amounts held in the Trust Account solely in the event that the
 Company completes a Business Combination, subject to the terms of
 the underwriting agreement.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <dei:DocumentType contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_C4E51B9F-76D7-4FEA-ADFF-13FD5A53F833_1_0">S-4/A</dei:DocumentType>
  <dei:AmendmentFlag contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_C4E51B9F-76D7-4FEA-ADFF-13FD5A53F833_1_1">true</dei:AmendmentFlag>
  <dei:AmendmentDescription contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_C4E51B9F-76D7-4FEA-ADFF-13FD5A53F833_1_2">Amendment No. 1</dei:AmendmentDescription>
  <dei:EntityRegistrantName contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_77B08A18-52E0-4469-AAB6-197016A7A79E_1_1">Kensington Capital Acquisition Corp.</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_77B08A18-52E0-4469-AAB6-197016A7A79E_1_2">0001811414</dei:EntityCentralIndexKey>
  <dei:EntityFilerCategory contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_77B08A18-52E0-4469-AAB6-197016A7A79E_1_3">Non-accelerated Filer</dei:EntityFilerCategory>
  <dei:EntitySmallBusiness contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_77B08A18-52E0-4469-AAB6-197016A7A79E_1_4">true</dei:EntitySmallBusiness>
  <dei:EntityEmergingGrowthCompany contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_77B08A18-52E0-4469-AAB6-197016A7A79E_1_5">true</dei:EntityEmergingGrowthCompany>
  <dei:EntityExTransitionPeriod contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_77B08A18-52E0-4469-AAB6-197016A7A79E_1_6">false</dei:EntityExTransitionPeriod>
  <us-gaap:StockholdersEquityNoteStockSplit contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_223E39CC-84E0-4F8E-A40A-1C11AD16CB8F_1_0">The Class B common stock will automatically convert into Class A common stock at  the time of the initial Business Combination, or earlier at the option of the  holders, on a one-for-one basis, subject to adjustment for stock splits, stock  dividends, reorganizations, recapitalizations and the like, and subject to  further adjustment as described herein.</us-gaap:StockholdersEquityNoteStockSplit>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_4986BEFE-D1E6-46CA-9CEC-C85049C21172_1_2">-62862</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_5007_1000011">-62862</us-gaap:NetIncomeLoss>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_14539602_4D03D393-0BA3-4E16-96D3-BABC9DF962FE_1_4">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
  <kcac:InitialPublicOfferingDisclosureTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_D116A1D5-A328-416D-8A7D-8A894CC08DFE_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Note 3&amp;#x2014;Initial Public Offering&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 On June&amp;#xA0;30, 2020, the Company sold 23,000,000 Units, including
 3,000,000 Over-Allotment Units, at a price of $10.00 per Unit,
 generating gross proceeds of $230.00&amp;#xA0;million, and incurring
 offering costs of approximately $13.1&amp;#xA0;million, inclusive of
 approximately $8.1&amp;#xA0;million in deferred underwriting
 commissions.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 Each Unit consists of one share of Class&amp;#xA0;A common stock and
 &lt;font style="white-space:nowrap"&gt;one-half&lt;/font&gt; of one redeemable
 warrant (each, a &amp;#x201C;Public Warrant&amp;#x201D;). Each whole Public
 Warrant entitles the holder to purchase one share of Class&amp;#xA0;A
 common stock at a price of $11.50 per share, subject to adjustment
 (see Note 6).&lt;/p&gt;
 &lt;/div&gt;</kcac:InitialPublicOfferingDisclosureTextBlock>
  <kcac:EmergingGrowthCompanyPolicyTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_4B0A50E2-C5A4-4D85-A9FC-CDCB70FC004F_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Emerging Growth Company&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 The Company is an &amp;#x201C;emerging growth company,&amp;#x201D; as defined
 in Section&amp;#xA0;2(a) of the Securities Act, as modified by the
 Jumpstart Our Business Startups Act of 2012 (the &amp;#x201C;JOBS
 Act&amp;#x201D;), and it may take advantage of certain exemptions from
 various reporting requirements that are applicable to other public
 companies that are not emerging growth companies including, but not
 limited to, not being required to comply with the independent
 registered public accounting firm attestation requirements of
 Section&amp;#xA0;404 of the Sarbanes-Oxley Act, reduced disclosure
 obligations regarding executive compensation in its periodic
 reports and proxy statements, and exemptions from the requirements
 of holding a nonbinding advisory vote on executive compensation and
 stockholder approval of any golden parachute payments not
 previously approved.&lt;/p&gt;
 &lt;p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 Further, Section&amp;#xA0;102(b)(1) of the JOBS Act exempts emerging
 growth companies from being required to comply with new or revised
 financial accounting standards until private companies (that is,
 those that have not had a Securities Act registration statement
 declared effective or do not have a class of securities registered
 under the Exchange Act) are required to comply with the new or
 revised financial accounting standards. The JOBS Act provides that
 an emerging growth company can elect to opt out of the extended
 transition period and comply with the requirements that apply to
 &lt;font style="white-space:nowrap"&gt;non-emerging&lt;/font&gt; growth
 companies but any such an election to opt out is irrevocable. The
 Company has elected not to opt out of such extended transition
 period, which means that when a standard is issued or revised and
 it has different application dates for public or private companies,
 the Company, as an emerging growth company, can adopt the new or
 revised standard at the time private companies adopt the new or
 revised standard.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 This may make comparison of the Company&amp;#x2019;s financial
 statements with another public company that is neither an emerging
 growth company nor an emerging growth company that has opted out of
 using the extended transition period difficult or impossible
 because of the potential differences in accounting standards
 used.&lt;/p&gt;
 &lt;/div&gt;</kcac:EmergingGrowthCompanyPolicyTextBlock>
  <kcac:OfferingCostsPolicyTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_12272653-9BC6-4CB5-AF38-4991EB9AD2DE_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Offering Costs Associated with the Initial Public
 Offering&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 Offering costs consist of legal, accounting, underwriting fees and
 other costs incurred through the balance sheet date that are
 directly related to the Initial Public Offering and that were
 charged to stockholders&amp;#x2019; equity upon the completion of the
 Initial Public Offering.&lt;/p&gt;
 &lt;/div&gt;</kcac:OfferingCostsPolicyTextBlock>
  <kcac:NonCashOfferingCostsIncludedInAccruedExpenses contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_22">117000</kcac:NonCashOfferingCostsIncludedInAccruedExpenses>
  <kcac:NonCashOfferingCostsIncludedInAccountsPayable contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_23">23175</kcac:NonCashOfferingCostsIncludedInAccountsPayable>
  <kcac:NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_24">8050000</kcac:NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering>
  <kcac:NonCashPrepaidExpensesIncludedInAccruedExpenses contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_26">207500</kcac:NonCashPrepaidExpensesIncludedInAccruedExpenses>
  <kcac:NonCashPrepaidExpensesIncludedInAccountsPayable contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_655A0F16-F8F6-4CDB-8E2B-CC60D98A7806_1_27">5000</kcac:NonCashPrepaidExpensesIncludedInAccountsPayable>
  <kcac:ValueOfSharesSubjectToPossibleRedemption contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_5007_1000009">218439270</kcac:ValueOfSharesSubjectToPossibleRedemption>
  <kcac:CashHeldInTrustAccountPolicyTextBlock contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_1483E528-3EB8-4ACC-A6C5-15CB52FBE1B5_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;Cash held in Trust Account&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 At June&amp;#xA0;30, 2020, the Company had $230.0&amp;#xA0;million in cash
 held in the Trust Account.&lt;/p&gt;
 &lt;/div&gt;</kcac:CashHeldInTrustAccountPolicyTextBlock>
  <kcac:PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_F05E605F-BE7E-4E17-A202-A472F82AA7CE_1_0">P30D</kcac:PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination>
  <kcac:MinimumSharePriceRequiredForRedemptionOfWarrants contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_C143EBBD-B14F-4648-A730-8869FE542CB3_1_5">18.00</kcac:MinimumSharePriceRequiredForRedemptionOfWarrants>
  <kcac:PublicWarrantsExpirationTerm contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" id="id_14539602_979338E8-61AE-46A0-B698-820F1CA9E954_1_2">P5Y</kcac:PublicWarrantsExpirationTerm>
  <kcac:PercentageOfProceedsFromShareIssuances contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="pure" decimals="2" id="id_14539602_C143EBBD-B14F-4648-A730-8869FE542CB3_1_2">0.60</kcac:PercentageOfProceedsFromShareIssuances>
  <kcac:ExercisePriceAdjustmentPercentage contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="pure" decimals="2" id="id_14539602_C143EBBD-B14F-4648-A730-8869FE542CB3_1_3">1.15</kcac:ExercisePriceAdjustmentPercentage>
  <kcac:RedemptionTriggerPriceAdjustmentPercentage contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="pure" decimals="2" id="id_14539602_C143EBBD-B14F-4648-A730-8869FE542CB3_1_4">1.80</kcac:RedemptionTriggerPriceAdjustmentPercentage>
  <kcac:PercentageOfPublicSharesToBeRedeemed1 contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0" unitRef="pure" decimals="INF" id="id_14539602_216D51B0-D400-497C-89BD-8B0B40CC5136_1_0">1.00</kcac:PercentageOfPublicSharesToBeRedeemed1>
  <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4084629" unitRef="iso4217_USD" decimals="0" id="id_14539602_E8CB687A-6C79-4675-9F4D-695E5D122748_1001_0">20000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
  <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4084629" unitRef="iso4217_USD" decimals="0" id="id_14539602_E8CB687A-6C79-4675-9F4D-695E5D122748_1001_1">20000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
  <kcac:PeriodOfService contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4084629_4078739x4078757" id="id_14539602_E8CB687A-6C79-4675-9F4D-695E5D122748_2001_3">P18M</kcac:PeriodOfService>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_6007_1000003">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4069234x4082574" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_6005_800003">24425</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4069234x4082574_4080964x4268695" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_7005_800008">6575000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <kcac:NumberOfTradingDays contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4070963x4070892" id="id_14539602_38AFAB8D-03E3-4302-9AF6-F18C7033F20F_1001_0">P20D</kcac:NumberOfTradingDays>
  <kcac:NumberOfDaysCommencingAfterInitialBusinessCombination contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4070963x4070892" id="id_14539602_38AFAB8D-03E3-4302-9AF6-F18C7033F20F_1001_2">P150D</kcac:NumberOfDaysCommencingAfterInitialBusinessCombination>
  <kcac:NumberOfTradingDays contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4070963x4072861" id="id_14539602_38AFAB8D-03E3-4302-9AF6-F18C7033F20F_2001_1">P30D</kcac:NumberOfTradingDays>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4078716x4078721_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_8CD79573-6E17-401A-9878-35409A7A8938_2002_6">750000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4078716x4268695" unitRef="iso4217_USD" decimals="-5" id="id_14539602_40DDF1C6-5AF7-4001-BE1E-62F71D012A56_1001_2">6600000</us-gaap:ProceedsFromIssuanceOfWarrants>
  <kcac:ClassOfWarrantsOrRightsIssued contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4078716x4268695" unitRef="shares" decimals="INF" id="id_14539602_40DDF1C6-5AF7-4001-BE1E-62F71D012A56_1001_0">6575000</kcac:ClassOfWarrantsOrRightsIssued>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4080964x4268695" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_7007_1000008">6575000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4082399x4078609" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_6003_700003">575</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4082399x4078609" unitRef="shares" decimals="INF" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_6003_600004">5750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:NetIncomeLoss contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4069234x4076805" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_5006_900011">-62862</us-gaap:NetIncomeLoss>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4069234x4082574" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_5005_800007">13097867</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <kcac:ValueOfSharesSubjectToPossibleRedemption contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4069234x4082574" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_5005_800009">218437086</kcac:ValueOfSharesSubjectToPossibleRedemption>
  <us-gaap:SaleOfStockConsiderationReceivedPerTransaction contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4069234x4082574_4078716x4078717" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_8005_800005">229997700</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4069234x4086031_4071742x4300621" unitRef="iso4217_USD" decimals="0" id="id_14539602_0E50F395-5C28-47A0-B3FC-8DC65C375D9A_1001_0">1500000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4070963x4072861_4082399x4078608" unitRef="shares" decimals="0" id="id_14539602_084DEFFF-6E5B-4AB8-9986-7A3482D49582_1001_0">21843927</us-gaap:WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4076425x4086031" unitRef="shares" decimals="0" id="id_14539602_39034156-7613-4EAE-997B-1964BD114ED5_1001_1">18075000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:SaleOfStockConsiderationReceivedPerTransaction contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4078716x4078717" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_8007_1000005">230000000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
  <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4078716x4078717_4082399x4078608" unitRef="shares" decimals="INF" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_8001_400006">23000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
  <us-gaap:SaleOfStockConsiderationReceivedPerTransaction contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4078716x4078717_4082399x4078608" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_8001_500005">2300</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4078716x4078721_4078739x4405944" unitRef="shares" decimals="INF" id="id_14539602_4996F145-9A66-4D78-800C-E85742FE3A55_4003_3">750000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <kcac:ClassOfWarrantsOrRightsIssued contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4080964x4268695" unitRef="shares" decimals="INF" id="id_14539602_3A761366-7B18-4674-8D23-A93852E00A01_1001_0">6575000</kcac:ClassOfWarrantsOrRightsIssued>
  <kcac:NumberOfTradingDays contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4080964x4268695" id="id_14539602_68F2BFD4-C92E-42C4-99DF-58F9A6831F4E_1001_0">P20D</kcac:NumberOfTradingDays>
  <kcac:NumberOfTradingDaysEndingOnThirdBusinessDay contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4080964x4268695" id="id_14539602_68F2BFD4-C92E-42C4-99DF-58F9A6831F4E_1001_2">P30D</kcac:NumberOfTradingDaysEndingOnThirdBusinessDay>
  <kcac:MinimumSharePriceRequiredForRedemptionOfWarrants contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4080964x4268695_4082399x4078608" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_68F2BFD4-C92E-42C4-99DF-58F9A6831F4E_2001_3">18.00</kcac:MinimumSharePriceRequiredForRedemptionOfWarrants>
  <kcac:MinimumSharePriceRequiredForRedemptionOfWarrants contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4080964x4319093_4082399x4078608" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_14539602_FDE2E716-D82D-46CC-921A-989979D97807_1001_0">10.00</kcac:MinimumSharePriceRequiredForRedemptionOfWarrants>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4081666x4412388" unitRef="shares" decimals="0" id="id_14539602_39034156-7613-4EAE-997B-1964BD114ED5_2001_0">21843927</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <kcac:ValueOfSharesSubjectToPossibleRedemption contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4082399x4078608" unitRef="iso4217_USD" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_5001_500009">2184</kcac:ValueOfSharesSubjectToPossibleRedemption>
  <kcac:NumberOfSharesSubjectToPossibleRedemption contextRef="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4082399x4078608" unitRef="shares" decimals="0" id="id_14539602_53E077E8-CAC9-48E5-832D-CD364B3D45AC_5001_400010">-21843927</kcac:NumberOfSharesSubjectToPossibleRedemption>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4082399x4078608">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4081666x4412388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">kcac:ClassaCommonStockSubjectToMandatoryRedemptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4080964x4319093_4082399x4078608">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4080964x4268695_4082399x4078608">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4080964x4268695">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4078716x4078721_4078739x4405944">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">kcac:FounderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4078716x4078717_4082399x4078608">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4078716x4078717">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4076425x4086031">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4070963x4072861_4082399x4078608">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4069234x4086031_4071742x4300621">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kcac:WorkingCapitalLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4069234x4082574_4078716x4078717">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4069234x4082574">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4069234x4076805">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4082399x4078609">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4080964x4268695">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4078716x4268695">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4078716x4078721_4082399x4078609">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4070963x4072861">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4070963x4070892">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4069234x4082574_4080964x4268695">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605_4069234x4082574">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4256605">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4084629_4078739x4078757">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0_4067272x4084629">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_75_20200630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4080964x4319093_4082399x4078608">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4080964x4268695_4082399x4078608">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4080964x4268695">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4078716x4412415">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kcac:IpoExcludingOverAllotmentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4078716x4260553">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kcac:UnderwritersExerciseOfOverallotmentOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4078716x4078721">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4070963x4072861_4078716x4078721_4082399x4078609">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4069234x4086031_4071742x4300621">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kcac:WorkingCapitalLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4069234x4076805">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4082399x4078609">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4078716x4268695">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4078716x4078721">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4070963x4072861">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4070963x4070892">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605_4069234x4082574">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4256605">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4084629_4078739x4078757">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0_4067272x4084629">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_15_20200501_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_1_20200630_0_4080964x4268695">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-06-30</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_1_20200630_0_4078716x4078721">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-06-30</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_1_20200630_0_4078716x4078717">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-06-30</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_1_20200630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
    </entity>
    <period>
      <startDate>2020-06-30</startDate>
      <endDate>2020-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_1_20200629_0_4067272x4256605">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-06-29</startDate>
      <endDate>2020-06-29</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_1_20200629_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
    </entity>
    <period>
      <startDate>2020-06-29</startDate>
      <endDate>2020-06-29</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_1_20200625_0_4070963x4072861_4078716x4078721_4078739x4405944_4085460x4085461">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">kcac:FounderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-06-25</startDate>
      <endDate>2020-06-25</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_1_20200625_0_4067272x4256605_4082399x4078609_4085460x4085461">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-06-25</startDate>
      <endDate>2020-06-25</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_1_20200625_0_4067272x4256605_4082399x4078609">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-06-25</startDate>
      <endDate>2020-06-25</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_1_20200625_0_4067272x4256605_4070963x4072861_4078716x4078721_4082399x4078609">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-06-25</startDate>
      <endDate>2020-06-25</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_1_20200501_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
    </entity>
    <period>
      <startDate>2020-05-01</startDate>
      <endDate>2020-05-01</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_1_20200417_0_4070963x4072861_4078716x4078721_4078739x4405944">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">kcac:FounderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-04-17</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_1_20200417_0_4069234x4080909">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-04-17</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_1_20200417_0_4067272x4256605_4082399x4078609">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-04-17</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_1_20200417_0_4067272x4256605_4078739x4405944_4082399x4078609">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">kcac:FounderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-04-17</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_1_20200417_0_4067272x4256605_4070963x4072861_4078716x4078721_4082399x4078609">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2020-04-17</startDate>
      <endDate>2020-04-17</endDate>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4085460x4085461">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078609">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4082399x4078608">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4081666x4412388">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis">kcac:ClassaCommonStockSubjectToMandatoryRedemptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4080964x4319093_4082399x4078608">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4080964x4268695">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4078716x4078717_4080964x4268695">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4078716x4078717">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4072786x4084062">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4071742x4300621">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kcac:WorkingCapitalLoansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4070963x4072861">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4069234x4082574">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4069234x4076805">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4067272x4256605_4078716x4268695">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4067272x4256605_4071742x4263611_4078716x4078717">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kcac:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4067272x4256605_4070963x4070892_4082399x4078608">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0_4067272x4084629">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
    </entity>
    <period>
      <instant>2020-06-30</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200625_0_4067272x4256605_4082399x4078609">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-25</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200625_0_4067272x4256605_4078739x4405944_4082399x4078609">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">kcac:FounderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-06-25</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078609">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-05-01</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4082399x4078608">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-05-01</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4080964x4319093_4082399x4078608">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-05-01</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4080964x4268695">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-05-01</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4078716x4260553">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kcac:UnderwritersExerciseOfOverallotmentOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-05-01</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4078716x4078717_4082399x4078608">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-05-01</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4078716x4078717">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-05-01</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4071742x4300621">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kcac:WorkingCapitalLoansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-05-01</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4070963x4072861">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-05-01</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4069234x4082574">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-05-01</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4069234x4076805">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-05-01</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4067272x4256605_4082399x4078608">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-05-01</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4067272x4256605_4078716x4268695">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">kcac:PrivatePlacementWarrantsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-05-01</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0_4067272x4256605_4071742x4263611_4078716x4078717">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kcac:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-05-01</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200501_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
    </entity>
    <period>
      <instant>2020-05-01</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200417_0_4067272x4256605_4082399x4078609">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-04-17</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200417_0_4067272x4256605_4078739x4405944_4082399x4078609">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">kcac:FounderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-04-17</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200417_0_4067272x4256605_4071742x4263611_4078716x4078717">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kcac:PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">kcac:SponsorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-04-17</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200416_0_4082399x4078609">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-04-16</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200416_0_4082399x4078608">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-04-16</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200416_0_4069234x4082574">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-04-16</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200416_0_4069234x4076805">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2020-04-16</instant>
    </period>
  </context>
  <context id="eol_PE1119467-20S-4-0005_STD_0_20200416_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001811414</identifier>
    </entity>
    <period>
      <instant>2020-04-16</instant>
    </period>
  </context>
  <unit id="iso4217_USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="shares">
    <measure>shares</measure>
  </unit>
  <unit id="iso4217_USD_per_shares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="pure">
    <measure>pure</measure>
  </unit>
  <xbrll:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <xbrll:loc xlink:href="#id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_600004" xlink:label="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_600004" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_700003" xlink:label="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_700003" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6005_800003" xlink:label="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6005_800003" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6007_1000003" xlink:label="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6007_1000003" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_14539602_4D03D393-0BA3-4E16-96D3-BABC9DF962FE_1_3" xlink:label="id_14539602_4D03D393-0BA3-4E16-96D3-BABC9DF962FE_1_3" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_2001_22" xlink:label="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_2001_22" xlink:type="locator"/>
    <xbrll:loc xlink:href="#id_14539602_F4BF01AA-328E-440C-9145-7F08F781A0A8_1_2" xlink:label="id_14539602_F4BF01AA-328E-440C-9145-7F08F781A0A8_1_2" xlink:type="locator"/>
    <xbrll:footnote xlink:label="footnote_1077629047" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This number excludes an aggregate of up to 21,843,927 shares of Class A common stock subject to possible redemption.</xbrll:footnote>
    <xbrll:footnote xlink:label="footnote_1077629052" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This number includes up to 750,000 Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.</xbrll:footnote>
    <xbrll:footnote xlink:label="footnote_1077629057" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On June 25, 2020, the Company effected a stock dividend with respect to the Class B common stock, resulting in the sponsor holding an aggregate of 5,750,000 founder shares . All shares and associated amounts have been retroactively restated to reflect the share capitalization (see Note 4).</xbrll:footnote>
    <xbrll:footnote xlink:label="footnote_1077629062" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This number excludes an aggregate of up to 750,000 Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.</xbrll:footnote>
    <xbrll:footnoteArc xlink:from="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_600004" xlink:to="footnote_1077629052" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_600004" xlink:to="footnote_1077629057" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_700003" xlink:to="footnote_1077629052" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6003_700003" xlink:to="footnote_1077629057" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6005_800003" xlink:to="footnote_1077629052" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6005_800003" xlink:to="footnote_1077629057" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6007_1000003" xlink:to="footnote_1077629052" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_14539602_15573263-1F3E-4C26-8923-1DD4311E9915_6007_1000003" xlink:to="footnote_1077629057" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_14539602_4D03D393-0BA3-4E16-96D3-BABC9DF962FE_1_3" xlink:to="footnote_1077629047" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_2001_22" xlink:to="footnote_1077629052" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_14539602_82E4526C-839D-41B3-9B90-869FC29520E1_2001_22" xlink:to="footnote_1077629057" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_14539602_F4BF01AA-328E-440C-9145-7F08F781A0A8_1_2" xlink:to="footnote_1077629057" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="id_14539602_F4BF01AA-328E-440C-9145-7F08F781A0A8_1_2" xlink:to="footnote_1077629062" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
  </xbrll:footnoteLink>
</xbrl>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>kcac-20200630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN Xcelerate Taxonomy Schema - https://www.dfinsolutions.com/ -->
<!-- Version: 6.23.6 -->
<!-- Round: f8c40bbb-ca51-4041-a5e5-af36f22d4c5e -->
<!-- Creation date: 2020-10-23T18:44:53Z -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<schema xmlns="http://www.w3.org/2001/XMLSchema"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:srt-types="http://fasb.org/srt-types/2020-01-31"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:us-types="http://fasb.org/us-types/2020-01-31"
  xmlns:kcac="http://imetrix.edgar-online.com/20200630"
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31"
  xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31"
  xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31"
  targetNamespace="http://imetrix.edgar-online.com/20200630"
  elementFormDefault="qualified" attributeFormDefault="unqualified">
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/Cover" id="Cover">
        <link:definition>101 - Document - Cover</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassified" id="StatementOfFinancialPositionClassified">
        <link:definition>103 - Statement - CONDENSED BALANCE SHEET</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical" id="StatementOfFinancialPositionClassifiedParen">
        <link:definition>104 - Statement - CONDENSED BALANCE SHEET (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncome" id="StatementOfIncome">
        <link:definition>105 - Statement - CONDENSED STATEMENT OF OPERATIONS</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncomeParenthetical" id="StatementOfIncomeParen">
        <link:definition>106 - Statement - CONDENSED STATEMENT OF OPERATIONS (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome" id="StatementOfShareholdersEquityAndOtherComprehensiveIncome">
        <link:definition>107 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirect" id="StatementOfCashFlowsIndirect">
        <link:definition>108 - Statement - CONDENSED STATEMENT OF CASH FLOWS</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock" id="Role_NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock">
        <link:definition>109 - Disclosure - Description of Organization, Business Operations and Basis of Presentation</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock" id="Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock">
        <link:definition>110 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsInitialPublicOfferingDisclosureTextBlock" id="Role_NotesToFinancialStatementsInitialPublicOfferingDisclosureTextBlock">
        <link:definition>111 - Disclosure - Initial Public Offering</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock" id="Role_NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock">
        <link:definition>112 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock" id="Role_NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock">
        <link:definition>113 - Disclosure - Commitments &amp; Contingencies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock" id="Role_NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock">
        <link:definition>114 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock" id="Role_NotesToFinancialStatementsFairValueDisclosuresTextBlock">
        <link:definition>115 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock" id="Role_NotesToFinancialStatementsSubsequentEventsTextBlock">
        <link:definition>116 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies" id="Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies">
        <link:definition>117 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables" id="Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables">
        <link:definition>118 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables" id="Role_NotesToFinancialStatementsFairValueDisclosuresTextBlockTables">
        <link:definition>119 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureDescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationAdditionalInformation" id="DisclosureDescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationAdditionalInformation">
        <link:definition>120 - Disclosure - Description of Organization, Business Operations and Basis of Presentation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation" id="DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation">
        <link:definition>121 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerShareOfCommonStock" id="DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerShareOfCommonStock">
        <link:definition>122 - Disclosure - Summary of Significant Accounting Policies - Summary of Basic and Diluted Loss per Share of Common Stock (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosurePublicOfferingAdditionalInformation" id="DisclosurePublicOfferingAdditionalInformation">
        <link:definition>123 - Disclosure - Public Offering - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation" id="DisclosureRelatedPartyTransactionsAdditionalInformation">
        <link:definition>124 - Disclosure - Related Party Transactions - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommitmentsContingenciesAdditionalInformation" id="DisclosureCommitmentsContingenciesAdditionalInformation">
        <link:definition>125 - Disclosure - Commitments &amp; Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureStockholdersEquityAdditionalInformation" id="DisclosureStockholdersEquityAdditionalInformation">
        <link:definition>126 - Disclosure - Stockholders' Equity - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfAssetsMeasuredAtFairValue" id="DisclosureFairValueMeasurementsSummaryOfAssetsMeasuredAtFairValue">
        <link:definition>127 - Disclosure - Fair Value Measurements - Summary of Assets Measured at Fair Value (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSubsequentEventAdditionalInformation" id="DisclosureSubsequentEventAdditionalInformation">
        <link:definition>128 - Disclosure - Subsequent Event - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:href="kcac-20200630_cal.xml" xlink:title="Calculation Links, all"/>
      <link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:href="kcac-20200630_def.xml" xlink:title="Definition Links, all"/>
      <link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:href="kcac-20200630_lab.xml" xlink:title="Label Links, all"/>
      <link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:href="kcac-20200630_pre.xml" xlink:title="Presentation Links, all"/>
    </appinfo>
  </annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd"/>
  <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2020-01-31" schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2020-01-31" schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>
  <element name="CashHeldInTrustAccountFairValueDisclosure" id="kcac_CashHeldInTrustAccountFairValueDisclosure" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="CashHeldInTrustAccountPolicyTextBlock" id="kcac_CashHeldInTrustAccountPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ClassaCommonStockSubjectToMandatoryRedemptionMember" id="kcac_ClassaCommonStockSubjectToMandatoryRedemptionMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ClassOfWarrantsOrRightsIssued" id="kcac_ClassOfWarrantsOrRightsIssued" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ClassOfWarrantsOrRightsIssuePrice" id="kcac_ClassOfWarrantsOrRightsIssuePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="CommitmentContingencyAndRelatedPartyTransactionsAbstract" id="kcac_CommitmentContingencyAndRelatedPartyTransactionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="CommonStockSharesIssuedIncludingRedemption" id="kcac_CommonStockSharesIssuedIncludingRedemption" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="CommonStockSharesOutstandingIncludingRedemption" id="kcac_CommonStockSharesOutstandingIncludingRedemption" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit" id="kcac_ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DeferredUnderwritingCommissionPerUnit" id="kcac_DeferredUnderwritingCommissionPerUnit" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DeferredUnderwritingCommissionsNoncurrent" id="kcac_DeferredUnderwritingCommissionsNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DeferredUnderwritingCommissionsPayable" id="kcac_DeferredUnderwritingCommissionsPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" id="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" id="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="DescriptionOfPublicWarrant" id="kcac_DescriptionOfPublicWarrant" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="EmergingGrowthCompanyPolicyTextBlock" id="kcac_EmergingGrowthCompanyPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ExercisePriceAdjustmentPercentage" id="kcac_ExercisePriceAdjustmentPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="FounderMember" id="kcac_FounderMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="InitialPublicOfferingDisclosureTextBlock" id="kcac_InitialPublicOfferingDisclosureTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="InterestToPayDissolutionExpenses" id="kcac_InterestToPayDissolutionExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="IpoExcludingOverAllotmentMember" id="kcac_IpoExcludingOverAllotmentMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="MaximumNetTangibleAssetsForBusinessCombination" id="kcac_MaximumNetTangibleAssetsForBusinessCombination" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="MinimumSharePriceRequiredForRedemptionOfWarrants" id="kcac_MinimumSharePriceRequiredForRedemptionOfWarrants" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering" id="kcac_NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NonCashOfferingCostsIncludedInAccountsPayable" id="kcac_NonCashOfferingCostsIncludedInAccountsPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NonCashOfferingCostsIncludedInAccruedExpenses" id="kcac_NonCashOfferingCostsIncludedInAccruedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NonCashPrepaidExpensesIncludedInAccountsPayable" id="kcac_NonCashPrepaidExpensesIncludedInAccountsPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NonCashPrepaidExpensesIncludedInAccruedExpenses" id="kcac_NonCashPrepaidExpensesIncludedInAccruedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NumberOfDaysCommencingAfterInitialBusinessCombination" id="kcac_NumberOfDaysCommencingAfterInitialBusinessCombination" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NumberOfSharesSubjectToPossibleRedemption" id="kcac_NumberOfSharesSubjectToPossibleRedemption" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NumberOfTradingDays" id="kcac_NumberOfTradingDays" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NumberOfTradingDaysEndingOnThirdBusinessDay" id="kcac_NumberOfTradingDaysEndingOnThirdBusinessDay" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull" id="kcac_NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation" id="kcac_NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull" id="kcac_NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation" id="kcac_NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="OfferingCostsPolicyTextBlock" id="kcac_OfferingCostsPolicyTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PaymentOfDeferredUnderwritingCommissions" id="kcac_PaymentOfDeferredUnderwritingCommissions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PercentageOfProceedsFromShareIssuances" id="kcac_PercentageOfProceedsFromShareIssuances" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PercentageOfPublicSharesToBeRedeemed" id="kcac_PercentageOfPublicSharesToBeRedeemed" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PercentageOfPublicSharesToBeRedeemed1" id="kcac_PercentageOfPublicSharesToBeRedeemed1" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PercentageOfSharesIssuedAndOutstanding" id="kcac_PercentageOfSharesIssuedAndOutstanding" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PercentageOfSharesToBeRedeemedWithoutConsent" id="kcac_PercentageOfSharesToBeRedeemedWithoutConsent" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PeriodOfService" id="kcac_PeriodOfService" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination" id="kcac_PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PricePerPrivatePlacementWarrant" id="kcac_PricePerPrivatePlacementWarrant" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PrivatePlacementWarrantsMember" id="kcac_PrivatePlacementWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ProceedsFromSaleOfFoundersShares" id="kcac_ProceedsFromSaleOfFoundersShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PromissoryNoteMember" id="kcac_PromissoryNoteMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ProposedPublicOfferingSharePrice" id="kcac_ProposedPublicOfferingSharePrice" type="num:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PublicWarrantsExpirationTerm" id="kcac_PublicWarrantsExpirationTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PublicWarrantsMember" id="kcac_PublicWarrantsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="RedemptionTriggerPriceAdjustmentPercentage" id="kcac_RedemptionTriggerPriceAdjustmentPercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ScheduleOfEarningsPerShareBasicAndDilutedAbstract" id="kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SponsorMember" id="kcac_SponsorMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart" id="kcac_StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SummaryOfSignificantAccountingPoliciesLineItems" id="kcac_SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SummaryOfSignificantAccountingPoliciesTable" id="kcac_SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="ThresholdPercentageOfFounderSharesToSharesOutstanding" id="kcac_ThresholdPercentageOfFounderSharesToSharesOutstanding" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="UnderwritersExerciseOfOverallotmentOptionMember" id="kcac_UnderwritersExerciseOfOverallotmentOptionMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="UnderwritingDiscountPerUnit" id="kcac_UnderwritingDiscountPerUnit" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ValueOfSharesSubjectToPossibleRedemption" id="kcac_ValueOfSharesSubjectToPossibleRedemption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="WarrantsRedemptionPricePerShare" id="kcac_WarrantsRedemptionPricePerShare" type="num:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="WorkingCapital" id="kcac_WorkingCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="WorkingCapitalLoansMember" id="kcac_WorkingCapitalLoansMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>kcac-20200630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN Xcelerate Taxonomy Calculation Linkbase - https://www.dfinsolutions.com/ -->
<!-- Version: 6.23.6 -->
<!-- Round: f8c40bbb-ca51-4041-a5e5-af36f22d4c5e -->
<!-- Creation date: 2020-10-23T18:44:53Z -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Cover" roleURI="http://imetrix.edgar-online.com/taxonomy/role/Cover"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfFinancialPositionClassified" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassified"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfFinancialPositionClassifiedParen" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfIncome" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncome"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfIncomeParen" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncomeParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfShareholdersEquityAndOtherComprehensiveIncome" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfCashFlowsIndirect" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirect"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureDescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureDescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerShareOfCommonStock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerShareOfCommonStock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosurePublicOfferingAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosurePublicOfferingAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureRelatedPartyTransactionsAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureCommitmentsContingenciesAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommitmentsContingenciesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureStockholdersEquityAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureStockholdersEquityAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureFairValueMeasurementsSummaryOfAssetsMeasuredAtFairValue" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfAssetsMeasuredAtFairValue"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureSubsequentEventAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSubsequentEventAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsInitialPublicOfferingDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsInitialPublicOfferingDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsFairValueDisclosuresTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsFairValueDisclosuresTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsSubsequentEventsTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock"/>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/Cover">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassified">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCosts" xlink:label="us-gaap_DeferredCosts"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DeferredUnderwritingCommissionsNoncurrent" xlink:label="kcac_DeferredUnderwritingCommissionsNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1.0300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="1.0400" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_DeferredCosts" order="1.0500" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_Cash" order="1.0100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent" order="1.0200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1.1100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="kcac_DeferredUnderwritingCommissionsNoncurrent" order="1.1300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesCurrent" order="1.1000" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1.1400" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" order="1.1500" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="1.1600" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="1.1900" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1.0600" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.0700" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" order="1.0800" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="1.0900" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="1.1200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1.1700" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1.1800" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1.2000" weight="1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FranchisorCosts" xlink:label="us-gaap_FranchisorCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1.0100" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_FranchisorCosts" order="1.0200" weight="-1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncomeParenthetical">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirect">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPropertyAndOtherTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInPropertyAndOtherTaxesPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1.0600" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1.0800" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="1.1400" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1.0900" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromNotesPayable" order="1.1000" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="1.1100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="1.1200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="1.1300" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="1.0100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense" order="1.0200" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1.0300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="1.0400" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPropertyAndOtherTaxesPayable" order="1.0500" weight="1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureDescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerShareOfCommonStock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosurePublicOfferingAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommitmentsContingenciesAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureStockholdersEquityAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfAssetsMeasuredAtFairValue">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSubsequentEventAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsInitialPublicOfferingDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock">
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>kcac-20200630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN Xcelerate Taxonomy Definition Linkbase - https://www.dfinsolutions.com/ -->
<!-- Version: 6.23.6 -->
<!-- Round: f8c40bbb-ca51-4041-a5e5-af36f22d4c5e -->
<!-- Creation date: 2020-10-23T18:44:53Z -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Cover" roleURI="http://imetrix.edgar-online.com/taxonomy/role/Cover"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfFinancialPositionClassified" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassified"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfFinancialPositionClassifiedParen" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfIncome" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncome"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfIncomeParen" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncomeParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfShareholdersEquityAndOtherComprehensiveIncome" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfCashFlowsIndirect" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirect"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureDescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureDescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerShareOfCommonStock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerShareOfCommonStock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosurePublicOfferingAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosurePublicOfferingAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureRelatedPartyTransactionsAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureCommitmentsContingenciesAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommitmentsContingenciesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureStockholdersEquityAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureStockholdersEquityAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureFairValueMeasurementsSummaryOfAssetsMeasuredAtFairValue" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfAssetsMeasuredAtFairValue"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureSubsequentEventAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSubsequentEventAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsInitialPublicOfferingDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsInitialPublicOfferingDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsFairValueDisclosuresTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsFairValueDisclosuresTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsSubsequentEventsTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/Cover">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassified">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCosts" xlink:label="us-gaap_DeferredCosts"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DeferredUnderwritingCommissionsNoncurrent" xlink:label="kcac_DeferredUnderwritingCommissionsNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_DeferredCosts" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Cash" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="kcac_DeferredUnderwritingCommissionsNoncurrent" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1.2700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="1.2800" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncome">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncomeParenthetical">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_2"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SponsorMember" xlink:label="kcac_SponsorMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:label="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="kcac_SponsorMember" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_2" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfSharesSubjectToPossibleRedemption" xlink:label="kcac_NumberOfSharesSubjectToPossibleRedemption"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PrivatePlacementWarrantsMember" xlink:label="kcac_PrivatePlacementWarrantsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SponsorMember" xlink:label="kcac_SponsorMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ValueOfSharesSubjectToPossibleRedemption" xlink:label="kcac_ValueOfSharesSubjectToPossibleRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="kcac_PrivatePlacementWarrantsMember" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="kcac_SponsorMember" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_ValueOfSharesSubjectToPossibleRedemption" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_NumberOfSharesSubjectToPossibleRedemption" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="5.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirect">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureDescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ClassOfWarrantsOrRightsIssued" xlink:label="kcac_ClassOfWarrantsOrRightsIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:label="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xlink:label="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_InterestToPayDissolutionExpenses" xlink:label="kcac_InterestToPayDissolutionExpenses"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_MaximumNetTangibleAssetsForBusinessCombination" xlink:label="kcac_MaximumNetTangibleAssetsForBusinessCombination"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull" xlink:label="kcac_NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation" xlink:label="kcac_NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull" xlink:label="kcac_NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation" xlink:label="kcac_NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PaymentOfDeferredUnderwritingCommissions" xlink:label="kcac_PaymentOfDeferredUnderwritingCommissions"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PercentageOfPublicSharesToBeRedeemed" xlink:label="kcac_PercentageOfPublicSharesToBeRedeemed"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PercentageOfPublicSharesToBeRedeemed1" xlink:label="kcac_PercentageOfPublicSharesToBeRedeemed1"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PercentageOfSharesToBeRedeemedWithoutConsent" xlink:label="kcac_PercentageOfSharesToBeRedeemedWithoutConsent"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PricePerPrivatePlacementWarrant" xlink:label="kcac_PricePerPrivatePlacementWarrant"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PrivatePlacementWarrantsMember" xlink:label="kcac_PrivatePlacementWarrantsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ProceedsFromSaleOfFoundersShares" xlink:label="kcac_ProceedsFromSaleOfFoundersShares"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ProposedPublicOfferingSharePrice" xlink:label="kcac_ProposedPublicOfferingSharePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SponsorMember" xlink:label="kcac_SponsorMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_WorkingCapital" xlink:label="kcac_WorkingCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1.2900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="kcac_PrivatePlacementWarrantsMember" order="1.2800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_PaymentOfDeferredUnderwritingCommissions" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_ClassOfWarrantsOrRightsIssued" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_MaximumNetTangibleAssetsForBusinessCombination" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_PercentageOfPublicSharesToBeRedeemed1" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_InterestToPayDissolutionExpenses" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_Cash" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_WorkingCapital" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_ProceedsFromSaleOfFoundersShares" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_ProposedPublicOfferingSharePrice" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_PricePerPrivatePlacementWarrant" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_PercentageOfSharesToBeRedeemedWithoutConsent" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_PercentageOfPublicSharesToBeRedeemed" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="kcac_SponsorMember" order="1.3000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="1.2700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1.3100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ClassaCommonStockSubjectToMandatoryRedemptionMember" xlink:label="kcac_ClassaCommonStockSubjectToMandatoryRedemptionMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit" xlink:label="kcac_ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xlink:label="us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_2"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="kcac_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SummaryOfSignificantAccountingPoliciesTable" xlink:label="kcac_SummaryOfSignificantAccountingPoliciesTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xlink:to="kcac_ClassaCommonStockSubjectToMandatoryRedemptionMember" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kcac_SummaryOfSignificantAccountingPoliciesTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kcac_ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="2.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerShareOfCommonStock">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosurePublicOfferingAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DescriptionOfPublicWarrant" xlink:label="kcac_DescriptionOfPublicWarrant"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_IpoExcludingOverAllotmentMember" xlink:label="kcac_IpoExcludingOverAllotmentMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PaymentOfDeferredUnderwritingCommissions" xlink:label="kcac_PaymentOfDeferredUnderwritingCommissions"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="kcac_IpoExcludingOverAllotmentMember" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_PaymentOfDeferredUnderwritingCommissions" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_DescriptionOfPublicWarrant" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharePrice" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember" xlink:label="srt_AffiliatedEntityMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ClassOfWarrantsOrRightsIssued" xlink:label="kcac_ClassOfWarrantsOrRightsIssued"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ClassOfWarrantsOrRightsIssuePrice" xlink:label="kcac_ClassOfWarrantsOrRightsIssuePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_2"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_FounderMember" xlink:label="kcac_FounderMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfDaysCommencingAfterInitialBusinessCombination" xlink:label="kcac_NumberOfDaysCommencingAfterInitialBusinessCombination"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfTradingDays" xlink:label="kcac_NumberOfTradingDays"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PercentageOfSharesIssuedAndOutstanding" xlink:label="kcac_PercentageOfSharesIssuedAndOutstanding"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PeriodOfService" xlink:label="kcac_PeriodOfService"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination" xlink:label="kcac_PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PrivatePlacementWarrantsMember" xlink:label="kcac_PrivatePlacementWarrantsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PromissoryNoteMember" xlink:label="kcac_PromissoryNoteMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SponsorMember" xlink:label="kcac_SponsorMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_WorkingCapitalLoansMember" xlink:label="kcac_WorkingCapitalLoansMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1.3100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="kcac_PromissoryNoteMember" order="1.2900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="kcac_WorkingCapitalLoansMember" order="1.3400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1.2800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="1.3300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1.2700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1.3000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="kcac_SponsorMember" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="srt_AffiliatedEntityMember" order="1.3500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="kcac_PercentageOfSharesIssuedAndOutstanding" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="kcac_NumberOfTradingDays" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="kcac_NumberOfDaysCommencingAfterInitialBusinessCombination" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_SharePrice" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="kcac_ClassOfWarrantsOrRightsIssued" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="kcac_ClassOfWarrantsOrRightsIssuePrice" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="kcac_PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_LineOfCredit" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_AccountsPayableRelatedPartiesCurrent" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="kcac_PeriodOfService" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="kcac_PrivatePlacementWarrantsMember" order="1.3200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="1.3700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_DebtInstrumentAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_TitleOfIndividualAxis" order="5.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="6.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_RangeAxis" order="7.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="kcac_FounderMember" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefFinancialOfficerMember" order="1.3600" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommitmentsContingenciesAdditionalInformation">
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DeferredUnderwritingCommissionPerUnit" xlink:label="kcac_DeferredUnderwritingCommissionPerUnit"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DeferredUnderwritingCommissionsNoncurrent" xlink:label="kcac_DeferredUnderwritingCommissionsNoncurrent"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DeferredUnderwritingCommissionsPayable" xlink:label="kcac_DeferredUnderwritingCommissionsPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="us-gaap_PaymentsForUnderwritingExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_UnderwritersExerciseOfOverallotmentOptionMember" xlink:label="kcac_UnderwritersExerciseOfOverallotmentOptionMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_UnderwritingDiscountPerUnit" xlink:label="kcac_UnderwritingDiscountPerUnit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="kcac_UnderwritersExerciseOfOverallotmentOptionMember" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_UnderwritingDiscountPerUnit" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsForUnderwritingExpense" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_DeferredUnderwritingCommissionPerUnit" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_DeferredUnderwritingCommissionsNoncurrent" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_DeferredUnderwritingCommissionsPayable" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureStockholdersEquityAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="us-gaap_BusinessAcquisitionSharePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_CommonStockSharesIssuedIncludingRedemption" xlink:label="kcac_CommonStockSharesIssuedIncludingRedemption"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_CommonStockSharesOutstandingIncludingRedemption" xlink:label="kcac_CommonStockSharesOutstandingIncludingRedemption"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ExercisePriceAdjustmentPercentage" xlink:label="kcac_ExercisePriceAdjustmentPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_MinimumSharePriceRequiredForRedemptionOfWarrants" xlink:label="kcac_MinimumSharePriceRequiredForRedemptionOfWarrants"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfTradingDays" xlink:label="kcac_NumberOfTradingDays"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfTradingDaysEndingOnThirdBusinessDay" xlink:label="kcac_NumberOfTradingDaysEndingOnThirdBusinessDay"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PercentageOfProceedsFromShareIssuances" xlink:label="kcac_PercentageOfProceedsFromShareIssuances"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PrivatePlacementWarrantsMember" xlink:label="kcac_PrivatePlacementWarrantsMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PublicWarrantsExpirationTerm" xlink:label="kcac_PublicWarrantsExpirationTerm"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PublicWarrantsMember" xlink:label="kcac_PublicWarrantsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_RedemptionTriggerPriceAdjustmentPercentage" xlink:label="kcac_RedemptionTriggerPriceAdjustmentPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SponsorMember" xlink:label="kcac_SponsorMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplit" xlink:label="us-gaap_StockholdersEquityNoteStockSplit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart" xlink:label="kcac_StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ThresholdPercentageOfFounderSharesToSharesOutstanding" xlink:label="kcac_ThresholdPercentageOfFounderSharesToSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_WarrantsRedemptionPricePerShare" xlink:label="kcac_WarrantsRedemptionPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1.2700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1.3200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="kcac_PrivatePlacementWarrantsMember" order="1.3100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="kcac_PublicWarrantsMember" order="1.3400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1.3000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1.3300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="kcac_SponsorMember" order="1.2800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1.2900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_CommonStockSharesIssuedIncludingRedemption" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_CommonStockSharesOutstandingIncludingRedemption" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_ThresholdPercentageOfFounderSharesToSharesOutstanding" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplit" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_NumberOfTradingDays" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_PublicWarrantsExpirationTerm" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessAcquisitionSharePrice" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_PercentageOfProceedsFromShareIssuances" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_ExercisePriceAdjustmentPercentage" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_RedemptionTriggerPriceAdjustmentPercentage" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_MinimumSharePriceRequiredForRedemptionOfWarrants" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_WarrantsRedemptionPricePerShare" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_NumberOfTradingDaysEndingOnThirdBusinessDay" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" order="5.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfAssetsMeasuredAtFairValue">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_CashHeldInTrustAccountFairValueDisclosure" xlink:label="kcac_CashHeldInTrustAccountFairValueDisclosure"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="kcac_CashHeldInTrustAccountFairValueDisclosure" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSubsequentEventAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsShares" xlink:label="us-gaap_CommonStockDividendsShares"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_FounderMember" xlink:label="kcac_FounderMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SponsorMember" xlink:label="kcac_SponsorMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="kcac_SponsorMember" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockDividendsShares" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_TitleOfIndividualAxis" order="5.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" order="6.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="kcac_FounderMember" order="1.1000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsInitialPublicOfferingDisclosureTextBlock">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock">
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>kcac-20200630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN Xcelerate Taxonomy Labels Linkbase - https://www.dfinsolutions.com/ -->
<!-- Version: 6.23.6 -->
<!-- Round: f8c40bbb-ca51-4041-a5e5-af36f22d4c5e -->
<!-- Creation date: 2020-10-23T18:44:53Z -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US" id="id_14539602_4084457_1_1">Accounting Policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US" id="id_14539602_4084457_2_1">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US" id="id_14539602_4086632_1_1">Accounts Payable, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US" id="id_14539602_4086632_2_1">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent_lbl" xml:lang="en-US" id="id_14539602_4086742_1_1">Accounts Payable, Related Parties, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent_lbl" xml:lang="en-US" id="id_14539602_4086742_2_1">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:to="us-gaap_AccountsPayableRelatedPartiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_lbl" xml:lang="en-US" id="id_14539602_4086672_1_1">Accrual for Taxes Other than Income Taxes, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_lbl" xml:lang="en-US" id="id_14539602_4086672_2_1">Franchise tax payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:to="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="id_14539602_4086642_1_1">Accrued Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="id_14539602_4086642_2_1">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US" id="id_14539602_4080319_1_1">Additional Paid in Capital, Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US" id="id_14539602_4080319_2_1">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" id="id_14539602_4082574_1_1">Additional Paid-in Capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" id="id_14539602_4082574_2_1">Additional Paid-in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xml:lang="en-US" id="id_14539602_4067357_1_1">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xml:lang="en-US" id="id_14539602_4067357_14_1">Offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US" id="id_14539602_4067368_1_1">Adjustments to Additional Paid in Capital, Warrant Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US" id="id_14539602_4067368_2_1">Sale of private placement warrants to Sponsor in private placement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember" xlink:label="srt_AffiliatedEntityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_AffiliatedEntityMember_lbl" xml:lang="en-US" id="id_14539602_4084629_1_1">Affiliated Entity [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_AffiliatedEntityMember_lbl" xml:lang="en-US" id="id_14539602_4084629_2_1">DEHC LLC</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_AffiliatedEntityMember" xlink:to="srt_AffiliatedEntityMember_lbl"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US" id="id_14539602_4086321_1_1">Amendment Description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US" id="id_14539602_4086321_2_1">AmendmentDescription</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" id="id_14539602_4086320_1_1">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" id="id_14539602_4086320_2_1">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US" id="id_14539602_4067120_1_1">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US" id="id_14539602_4067120_2_1">Antidilutive securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US" id="id_14539602_4076425_1_1">Antidilutive Securities [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US" id="id_14539602_4076425_2_1">Antidilutive Securities [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US" id="id_14539602_4076424_1_1">Antidilutive Securities, Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US" id="id_14539602_4076424_2_1">Antidilutive Securities, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" id="id_14539602_4086118_1_1">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" id="id_14539602_4086118_6_1">Total Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" id="id_14539602_4085988_1_1">Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" id="id_14539602_4085988_2_1">Assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" id="id_14539602_4086117_1_1">Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" id="id_14539602_4086117_6_1">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" id="id_14539602_4085990_1_1">Assets, Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" id="id_14539602_4085990_2_1">Current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xml:lang="en-US" id="id_14539602_4080551_1_1">Assets, Fair Value Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xml:lang="en-US" id="id_14539602_4080551_2_1">Assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xml:lang="en-US" id="id_14539602_4086607_1_1">Assets Held-in-trust, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xml:lang="en-US" id="id_14539602_4086607_2_1">Assets held in trust</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xml:lang="en-US" id="id_14539602_4086607_12_1">Cash held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4077860_1_1">Basis of Accounting, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4077860_2_1">Basis of Presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="us-gaap_BusinessAcquisitionSharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xml:lang="en-US" id="id_14539602_4073244_1_1">Business Acquisition, Share Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xml:lang="en-US" id="id_14539602_4073244_2_1">Business acquisition, share price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US" id="id_14539602_4079545_1_1">Business Combinations [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US" id="id_14539602_4079545_2_1">Business Combinations [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US" id="id_14539602_4085742_1_1">Business Description and Basis of Presentation [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US" id="id_14539602_4085742_2_1">Description of Organization, Business Operations and Basis of Presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US" id="id_14539602_4086121_1_1">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US" id="id_14539602_4086121_2_1">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4077865_1_1">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4077865_2_1">Cash and Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" id="id_14539602_4071837_1_1">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" id="id_14539602_4071837_4_1">Cash - end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" id="id_14539602_4071837_5_1">Cash - beginning of the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US" id="id_14539602_4075193_1_1">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US" id="id_14539602_4075193_6_1">Net change in cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="id_14539602_4079162_1_1">Cash Equivalents, at Carrying Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="id_14539602_4079162_2_1">Cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_CashHeldInTrustAccountFairValueDisclosure" xlink:label="kcac_CashHeldInTrustAccountFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_CashHeldInTrustAccountFairValueDisclosure_lbl" xml:lang="en-US" id="id_14539602_4412404_3_1">Cash held in trust account, fair value disclosure.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_CashHeldInTrustAccountFairValueDisclosure_lbl" xml:lang="en-US" id="id_14539602_4412404_1_1">Cash Held In Trust Account Fair Value Disclosure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_CashHeldInTrustAccountFairValueDisclosure_lbl" xml:lang="en-US" id="id_14539602_4412404_2_1">Cash held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_CashHeldInTrustAccountFairValueDisclosure" xlink:to="kcac_CashHeldInTrustAccountFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_CashHeldInTrustAccountPolicyTextBlock" xlink:label="kcac_CashHeldInTrustAccountPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_CashHeldInTrustAccountPolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4412386_3_1">Cash held in trust account.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_CashHeldInTrustAccountPolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4412386_1_1">Cash Held In Trust Account [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_CashHeldInTrustAccountPolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4412386_2_1">Cash held in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_CashHeldInTrustAccountPolicyTextBlock" xlink:to="kcac_CashHeldInTrustAccountPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefFinancialOfficerMember_lbl" xml:lang="en-US" id="id_14539602_4078757_1_1">Chief Financial Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ChiefFinancialOfficerMember_lbl" xml:lang="en-US" id="id_14539602_4078757_2_1">Daniel Huber</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefFinancialOfficerMember" xlink:to="srt_ChiefFinancialOfficerMember_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ClassaCommonStockSubjectToMandatoryRedemptionMember" xlink:label="kcac_ClassaCommonStockSubjectToMandatoryRedemptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_ClassaCommonStockSubjectToMandatoryRedemptionMember_lbl" xml:lang="en-US" id="id_14539602_4412388_3_1">ClassA Common Stock Subject To Mandatory Redemption [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_ClassaCommonStockSubjectToMandatoryRedemptionMember_lbl" xml:lang="en-US" id="id_14539602_4412388_1_1">ClassA Common Stock Subject To Mandatory Redemption [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_ClassaCommonStockSubjectToMandatoryRedemptionMember_lbl" xml:lang="en-US" id="id_14539602_4412388_2_1">Class A Common Stock Subject To Mandatory Redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_ClassaCommonStockSubjectToMandatoryRedemptionMember" xlink:to="kcac_ClassaCommonStockSubjectToMandatoryRedemptionMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="id_14539602_4077931_1_1">Class of Stock [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="id_14539602_4077931_2_1">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US" id="id_14539602_4080964_1_1">Class of Warrant or Right [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US" id="id_14539602_4080964_2_1">Class of Warrant or Right [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US" id="id_14539602_4080963_1_1">Class of Warrant or Right [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US" id="id_14539602_4080963_2_1">Class of Warrant or Right [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US" id="id_14539602_4081630_1_1">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US" id="id_14539602_4081630_32_1">Warrant exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US" id="id_14539602_4081630_2_1">Exercise price of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US" id="id_14539602_4081630_12_1">Issue price of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US" id="id_14539602_4081629_1_1">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US" id="id_14539602_4081629_2_1">Warrant exercisable number of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ClassOfWarrantsOrRightsIssued" xlink:label="kcac_ClassOfWarrantsOrRightsIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_ClassOfWarrantsOrRightsIssued_lbl" xml:lang="en-US" id="id_14539602_4212259_3_1">Class of warrants or rights issued.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_ClassOfWarrantsOrRightsIssued_lbl" xml:lang="en-US" id="id_14539602_4212259_1_1">Class Of Warrants Or Rights Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_ClassOfWarrantsOrRightsIssued_lbl" xml:lang="en-US" id="id_14539602_4212259_2_1">Number of warrants issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_ClassOfWarrantsOrRightsIssued" xlink:to="kcac_ClassOfWarrantsOrRightsIssued_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ClassOfWarrantsOrRightsIssuePrice" xlink:label="kcac_ClassOfWarrantsOrRightsIssuePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_ClassOfWarrantsOrRightsIssuePrice_lbl" xml:lang="en-US" id="id_14539602_4412393_3_1">Class of Warrants or rights issue price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_ClassOfWarrantsOrRightsIssuePrice_lbl" xml:lang="en-US" id="id_14539602_4412393_1_1">Class Of Warrants Or Rights Issue Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_ClassOfWarrantsOrRightsIssuePrice_lbl" xml:lang="en-US" id="id_14539602_4412393_2_1">Warrants price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_ClassOfWarrantsOrRightsIssuePrice" xlink:to="kcac_ClassOfWarrantsOrRightsIssuePrice_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_CommitmentContingencyAndRelatedPartyTransactionsAbstract" xlink:label="kcac_CommitmentContingencyAndRelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_CommitmentContingencyAndRelatedPartyTransactionsAbstract_lbl" xml:lang="en-US" id="id_14539602_4095211_3_1">Commitment, Contingency And Related Party Transactions [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_CommitmentContingencyAndRelatedPartyTransactionsAbstract_lbl" xml:lang="en-US" id="id_14539602_4095211_1_1">Commitment, Contingency And Related Party Transactions [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_CommitmentContingencyAndRelatedPartyTransactionsAbstract_lbl" xml:lang="en-US" id="id_14539602_4095211_2_1">Commitment, Contingency And Related Party Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_CommitmentContingencyAndRelatedPartyTransactionsAbstract" xlink:to="kcac_CommitmentContingencyAndRelatedPartyTransactionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" id="id_14539602_4083866_1_1">Commitments and Contingencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" id="id_14539602_4083866_2_1">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US" id="id_14539602_4079048_1_1">Commitments and Contingencies Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US" id="id_14539602_4079048_2_1">Commitments and Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" id="id_14539602_4085753_1_1">Commitments and Contingencies Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" id="id_14539602_4085753_2_1">Commitments &amp; Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US" id="id_14539602_4078608_1_1">Common Class A [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US" id="id_14539602_4078608_2_1">Class A Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US" id="id_14539602_4078609_1_1">Common Class B [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US" id="id_14539602_4078609_2_1">Class B Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsShares" xlink:label="us-gaap_CommonStockDividendsShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockDividendsShares_lbl" xml:lang="en-US" id="id_14539602_4072967_1_1">Common Stock Dividends, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockDividendsShares_lbl" xml:lang="en-US" id="id_14539602_4072967_2_1">Stock dividend, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsShares" xlink:to="us-gaap_CommonStockDividendsShares_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="id_14539602_4080909_1_1">Common Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="id_14539602_4080909_2_1">Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="id_14539602_4074595_1_1">Common Stock, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="id_14539602_4074595_2_1">Common stock, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" id="id_14539602_4074599_1_1">Common Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" id="id_14539602_4074599_2_1">Common stock, authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" id="id_14539602_4074601_1_1">Common Stock, Shares, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" id="id_14539602_4074601_2_1">Common stock, issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_CommonStockSharesIssuedIncludingRedemption" xlink:label="kcac_CommonStockSharesIssuedIncludingRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_CommonStockSharesIssuedIncludingRedemption_lbl" xml:lang="en-US" id="id_14539602_4412401_3_1">Common stock shares Issued including redemption.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_CommonStockSharesIssuedIncludingRedemption_lbl" xml:lang="en-US" id="id_14539602_4412401_1_1">Common Stock Shares Issued Including Redemption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_CommonStockSharesIssuedIncludingRedemption_lbl" xml:lang="en-US" id="id_14539602_4412401_2_1">Common stock, shares, issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_CommonStockSharesIssuedIncludingRedemption" xlink:to="kcac_CommonStockSharesIssuedIncludingRedemption_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" id="id_14539602_4074602_1_1">Common Stock, Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" id="id_14539602_4074602_4_1">Ending balance, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" id="id_14539602_4074602_5_1">Beginning balance, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" id="id_14539602_4074602_2_1">Common stock, outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_CommonStockSharesOutstandingIncludingRedemption" xlink:label="kcac_CommonStockSharesOutstandingIncludingRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_CommonStockSharesOutstandingIncludingRedemption_lbl" xml:lang="en-US" id="id_14539602_4412400_3_1">Common stock shares outstanding including redemption.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_CommonStockSharesOutstandingIncludingRedemption_lbl" xml:lang="en-US" id="id_14539602_4412400_1_1">Common Stock Shares Outstanding Including Redemption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_CommonStockSharesOutstandingIncludingRedemption_lbl" xml:lang="en-US" id="id_14539602_4412400_2_1">Common stock, shares, outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_CommonStockSharesOutstandingIncludingRedemption" xlink:to="kcac_CommonStockSharesOutstandingIncludingRedemption_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US" id="id_14539602_4086104_1_1">Common Stock, Value, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US" id="id_14539602_4086104_2_1">Ordinary shares value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US" id="id_14539602_4077880_1_1">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US" id="id_14539602_4077880_2_1">Concentration of Credit Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit" xlink:label="kcac_ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit_lbl" xml:lang="en-US" id="id_14539602_4412387_3_1">Concentrations of credit risk federal depository insurance coverage limit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit_lbl" xml:lang="en-US" id="id_14539602_4412387_1_1">Concentrations Of Credit Risk Federal Depository Insurance Coverage Limit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit_lbl" xml:lang="en-US" id="id_14539602_4412387_2_1">Concentrations of credit risk federal depository insurance coverage limit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit" xlink:to="kcac_ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit_lbl"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" id="id_14539602_4081823_1_1">Cover [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" id="id_14539602_4081823_2_1">Cover [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US" id="id_14539602_4078277_1_1">Debt Conversion, Converted Instrument, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US" id="id_14539602_4078277_2_1">Debt conversion converted instrument amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US" id="id_14539602_4071742_1_1">Debt Instrument [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US" id="id_14539602_4071742_2_1">Debt Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" id="id_14539602_4071792_1_1">Debt Instrument, Face Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" id="id_14539602_4071792_2_1">Debt face amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US" id="id_14539602_4071741_1_1">Debt Instrument, Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US" id="id_14539602_4071741_2_1">Debt Instrument, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCosts" xlink:label="us-gaap_DeferredCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCosts_lbl" xml:lang="en-US" id="id_14539602_4086621_1_1">Deferred Costs, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCosts_lbl" xml:lang="en-US" id="id_14539602_4086621_2_1">Deferred offering costs associated with the proposed public offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCosts" xlink:to="us-gaap_DeferredCosts_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DeferredUnderwritingCommissionPerUnit" xlink:label="kcac_DeferredUnderwritingCommissionPerUnit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_DeferredUnderwritingCommissionPerUnit_lbl" xml:lang="en-US" id="id_14539602_4370656_3_1">Deferred underwriting commission per unit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_DeferredUnderwritingCommissionPerUnit_lbl" xml:lang="en-US" id="id_14539602_4370656_1_1">Deferred Underwriting Commission Per Unit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_DeferredUnderwritingCommissionPerUnit_lbl" xml:lang="en-US" id="id_14539602_4370656_2_1">Deferred underwriting commission per unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_DeferredUnderwritingCommissionPerUnit" xlink:to="kcac_DeferredUnderwritingCommissionPerUnit_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DeferredUnderwritingCommissionsNoncurrent" xlink:label="kcac_DeferredUnderwritingCommissionsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_DeferredUnderwritingCommissionsNoncurrent_lbl" xml:lang="en-US" id="id_14539602_4171087_3_1">Deferred underwriting commissions noncurrent.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_DeferredUnderwritingCommissionsNoncurrent_lbl" xml:lang="en-US" id="id_14539602_4171087_1_1">Deferred Underwriting Commissions Non Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_DeferredUnderwritingCommissionsNoncurrent_lbl" xml:lang="en-US" id="id_14539602_4171087_2_1">Deferred underwriting commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="kcac_DeferredUnderwritingCommissionsNoncurrent_lbl" xml:lang="en-US" id="id_14539602_4171087_12_1">Deferred underwriting commissions payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_DeferredUnderwritingCommissionsNoncurrent" xlink:to="kcac_DeferredUnderwritingCommissionsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DeferredUnderwritingCommissionsPayable" xlink:label="kcac_DeferredUnderwritingCommissionsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_DeferredUnderwritingCommissionsPayable_lbl" xml:lang="en-US" id="id_14539602_4412425_3_1">Deferred Underwriting Commissions Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_DeferredUnderwritingCommissionsPayable_lbl" xml:lang="en-US" id="id_14539602_4412425_1_1">Deferred Underwriting Commissions Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_DeferredUnderwritingCommissionsPayable_lbl" xml:lang="en-US" id="id_14539602_4412425_2_1">Deferred underwriting commissions payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_DeferredUnderwritingCommissionsPayable" xlink:to="kcac_DeferredUnderwritingCommissionsPayable_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:label="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems_lbl" xml:lang="en-US" id="id_14539602_4412412_3_1">Description of organization, business operations and basis of presentation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems_lbl" xml:lang="en-US" id="id_14539602_4412412_1_1">Description of Organization Business Operations and Basis of Presentation [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems_lbl" xml:lang="en-US" id="id_14539602_4412412_2_1">Description Of Organization Business Operations And Basis Of Presentation [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xlink:label="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_lbl" xml:lang="en-US" id="id_14539602_4412411_3_1">Description of Organization Business Operations and Basis of Presentation [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_lbl" xml:lang="en-US" id="id_14539602_4412411_1_1">Description of Organization Business Operations and Basis of Presentation [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_lbl" xml:lang="en-US" id="id_14539602_4412411_2_1">Description of Organization Business Operations and Basis of Presentation [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xlink:to="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DescriptionOfPublicWarrant" xlink:label="kcac_DescriptionOfPublicWarrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_DescriptionOfPublicWarrant_lbl" xml:lang="en-US" id="id_14539602_4412389_3_1">Description of public warrant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_DescriptionOfPublicWarrant_lbl" xml:lang="en-US" id="id_14539602_4412389_1_1">Description Of Public Warrant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_DescriptionOfPublicWarrant_lbl" xml:lang="en-US" id="id_14539602_4412389_2_1">Description of public warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_DescriptionOfPublicWarrant" xlink:to="kcac_DescriptionOfPublicWarrant_lbl"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" id="id_14539602_4086311_1_1">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" id="id_14539602_4086311_2_1">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US" id="id_14539602_4086040_1_1">Due to Related Parties, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US" id="id_14539602_4086040_2_1">Note payable - related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" id="id_14539602_4087510_1_1">Earnings Per Share, Basic and Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" id="id_14539602_4087510_2_1">Basic and diluted net loss per ordinary share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" id="id_14539602_4087510_12_1">Basic and diluted net loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4066955_1_1">Earnings Per Share, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4066955_2_1">Net Loss Per Common Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_EmergingGrowthCompanyPolicyTextBlock" xlink:label="kcac_EmergingGrowthCompanyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_EmergingGrowthCompanyPolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4354773_3_1">Emerging growth company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_EmergingGrowthCompanyPolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4354773_1_1">Emerging Growth Company [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_EmergingGrowthCompanyPolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4354773_2_1">Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_EmergingGrowthCompanyPolicyTextBlock" xlink:to="kcac_EmergingGrowthCompanyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="id_14539602_4086358_1_1">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="id_14539602_4086358_2_1">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="id_14539602_4086372_1_1">Entity Emerging Growth Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="id_14539602_4086372_2_1">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US" id="id_14539602_4086373_1_1">Entity Ex Transition Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US" id="id_14539602_4086373_2_1">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US" id="id_14539602_4086370_1_1">Entity Filer Category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US" id="id_14539602_4086370_2_1">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="id_14539602_4086357_1_1">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="id_14539602_4086357_2_1">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US" id="id_14539602_4086371_1_1">Entity Small Business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US" id="id_14539602_4086371_2_1">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US" id="id_14539602_4066745_1_1">Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US" id="id_14539602_4066745_2_1">Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" id="id_14539602_4082527_1_1">Equity Component [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" id="id_14539602_4082527_2_1">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ExercisePriceAdjustmentPercentage" xlink:label="kcac_ExercisePriceAdjustmentPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_ExercisePriceAdjustmentPercentage_lbl" xml:lang="en-US" id="id_14539602_4412409_3_1">Exercise price adjustment percentage.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_ExercisePriceAdjustmentPercentage_lbl" xml:lang="en-US" id="id_14539602_4412409_1_1">Exercise Price Adjustment Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_ExercisePriceAdjustmentPercentage_lbl" xml:lang="en-US" id="id_14539602_4412409_2_1">Exercise price adjustment percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_ExercisePriceAdjustmentPercentage" xlink:to="kcac_ExercisePriceAdjustmentPercentage_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_lbl" xml:lang="en-US" id="id_14539602_4081910_1_1">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_lbl" xml:lang="en-US" id="id_14539602_4081910_2_1">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xml:lang="en-US" id="id_14539602_4069387_1_1">Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xml:lang="en-US" id="id_14539602_4069387_2_1">Summary of Assets Measured at Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US" id="id_14539602_4072786_1_1">Fair Value Hierarchy and NAV [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US" id="id_14539602_4072786_2_1">Fair Value Hierarchy and NAV [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US" id="id_14539602_4074162_1_1">Fair Value Disclosures [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US" id="id_14539602_4074162_2_1">Fair Value Disclosures [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US" id="id_14539602_4079990_1_1">Fair Value Disclosures [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US" id="id_14539602_4079990_2_1">Fair Value Measurements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US" id="id_14539602_4084062_1_1">Fair Value, Inputs, Level 1 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US" id="id_14539602_4084062_2_1">Level 1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US" id="id_14539602_4084054_1_1">Fair Value Hierarchy and NAV [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US" id="id_14539602_4084054_2_1">Fair Value Hierarchy and NAV [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US" id="id_14539602_4081980_1_1">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US" id="id_14539602_4081980_2_1">Financial Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalHomeLoanBanksAbstract" xlink:label="us-gaap_FederalHomeLoanBanksAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FederalHomeLoanBanksAbstract_lbl" xml:lang="en-US" id="id_14539602_4085669_1_1">Federal Home Loan Banks [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FederalHomeLoanBanksAbstract_lbl" xml:lang="en-US" id="id_14539602_4085669_2_1">Federal Home Loan Banks [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalHomeLoanBanksAbstract" xlink:to="us-gaap_FederalHomeLoanBanksAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_FounderMember" xlink:label="kcac_FounderMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_FounderMember_lbl" xml:lang="en-US" id="id_14539602_4405944_3_1">Founder.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_FounderMember_lbl" xml:lang="en-US" id="id_14539602_4405944_1_1">Founder [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_FounderMember_lbl" xml:lang="en-US" id="id_14539602_4405944_2_1">Founder</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_FounderMember" xlink:to="kcac_FounderMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FranchisorCosts" xlink:label="us-gaap_FranchisorCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FranchisorCosts_lbl" xml:lang="en-US" id="id_14539602_4078473_1_1">Franchisor Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FranchisorCosts_lbl" xml:lang="en-US" id="id_14539602_4078473_2_1">Franchise tax expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FranchisorCosts" xlink:to="us-gaap_FranchisorCosts_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" id="id_14539602_4078080_1_1">General and Administrative Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" id="id_14539602_4078080_2_1">General and administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" id="id_14539602_4084117_1_1">Income Statement [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" id="id_14539602_4084117_2_1">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4082015_1_1">Income Tax, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4082015_2_1">Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US" id="id_14539602_4075788_1_1">Increase (Decrease) in Accounts Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US" id="id_14539602_4075788_2_1">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US" id="id_14539602_4075804_1_1">Increase (Decrease) in Accrued Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US" id="id_14539602_4075804_2_1">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" id="id_14539602_4067192_1_1">Increase (Decrease) in Operating Capital [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" id="id_14539602_4067192_2_1">Changes in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US" id="id_14539602_4075089_1_1">Increase (Decrease) in Prepaid Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US" id="id_14539602_4075089_14_1">Prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPropertyAndOtherTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInPropertyAndOtherTaxesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPropertyAndOtherTaxesPayable_lbl" xml:lang="en-US" id="id_14539602_4075841_1_1">Increase (Decrease) in Property and Other Taxes Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInPropertyAndOtherTaxesPayable_lbl" xml:lang="en-US" id="id_14539602_4075841_2_1">Franchise tax payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPropertyAndOtherTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInPropertyAndOtherTaxesPayable_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_InitialPublicOfferingDisclosureTextBlock" xlink:label="kcac_InitialPublicOfferingDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_InitialPublicOfferingDisclosureTextBlock_lbl" xml:lang="en-US" id="id_14539602_4350271_3_1">Initial Public Offering Disclosure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_InitialPublicOfferingDisclosureTextBlock_lbl" xml:lang="en-US" id="id_14539602_4350271_1_1">Initial Public Offering Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_InitialPublicOfferingDisclosureTextBlock_lbl" xml:lang="en-US" id="id_14539602_4350271_2_1">Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_InitialPublicOfferingDisclosureTextBlock" xlink:to="kcac_InitialPublicOfferingDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_InterestToPayDissolutionExpenses" xlink:label="kcac_InterestToPayDissolutionExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_InterestToPayDissolutionExpenses_lbl" xml:lang="en-US" id="id_14539602_4111409_3_1">Interest to pay dissolution expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_InterestToPayDissolutionExpenses_lbl" xml:lang="en-US" id="id_14539602_4111409_1_1">Interest To Pay Dissolution Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_InterestToPayDissolutionExpenses_lbl" xml:lang="en-US" id="id_14539602_4111409_2_1">Interest to pay dissolution expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_InterestToPayDissolutionExpenses" xlink:to="kcac_InterestToPayDissolutionExpenses_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US" id="id_14539602_4083774_1_1">Inventory Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US" id="id_14539602_4083774_2_1">Inventory Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_IpoExcludingOverAllotmentMember" xlink:label="kcac_IpoExcludingOverAllotmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_IpoExcludingOverAllotmentMember_lbl" xml:lang="en-US" id="id_14539602_4412415_3_1">IPO excluding over-allotment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_IpoExcludingOverAllotmentMember_lbl" xml:lang="en-US" id="id_14539602_4412415_1_1">IPO excluding over Allotment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_IpoExcludingOverAllotmentMember_lbl" xml:lang="en-US" id="id_14539602_4412415_2_1">IPO excluding over Allotment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_IpoExcludingOverAllotmentMember" xlink:to="kcac_IpoExcludingOverAllotmentMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US" id="id_14539602_4078717_1_1">IPO [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US" id="id_14539602_4078717_2_1">Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US" id="id_14539602_4083864_1_1">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US" id="id_14539602_4083864_6_1">Total liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" id="id_14539602_4083865_1_1">Liabilities and Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" id="id_14539602_4083865_6_1">Total Liabilities and Stockholders' Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" id="id_14539602_4068568_1_1">Liabilities and Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" id="id_14539602_4068568_2_1">Liabilities and Stockholders' Equity:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" id="id_14539602_4086630_1_1">Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" id="id_14539602_4086630_6_1">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="id_14539602_4084122_1_1">Liabilities, Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="id_14539602_4084122_2_1">Current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US" id="id_14539602_4084548_1_1">Long-term Line of Credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US" id="id_14539602_4084548_2_1">Borrowing outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US" id="id_14539602_4072861_1_1">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US" id="id_14539602_4072861_2_1">Maximum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_MaximumNetTangibleAssetsForBusinessCombination" xlink:label="kcac_MaximumNetTangibleAssetsForBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_MaximumNetTangibleAssetsForBusinessCombination_lbl" xml:lang="en-US" id="id_14539602_4412403_3_1">Maximum net tangible assets for business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_MaximumNetTangibleAssetsForBusinessCombination_lbl" xml:lang="en-US" id="id_14539602_4412403_1_1">Maximum Net Tangible Assets for Business Combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_MaximumNetTangibleAssetsForBusinessCombination_lbl" xml:lang="en-US" id="id_14539602_4412403_2_1">Maximum net tangible assets for business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_MaximumNetTangibleAssetsForBusinessCombination" xlink:to="kcac_MaximumNetTangibleAssetsForBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US" id="id_14539602_4070892_1_1">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US" id="id_14539602_4070892_2_1">Minimum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_MinimumSharePriceRequiredForRedemptionOfWarrants" xlink:label="kcac_MinimumSharePriceRequiredForRedemptionOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_MinimumSharePriceRequiredForRedemptionOfWarrants_lbl" xml:lang="en-US" id="id_14539602_4412399_3_1">Minimum Share Price Required For Redemption Of Warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_MinimumSharePriceRequiredForRedemptionOfWarrants_lbl" xml:lang="en-US" id="id_14539602_4412399_1_1">Minimum Share Price Required For Redemption Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_MinimumSharePriceRequiredForRedemptionOfWarrants_lbl" xml:lang="en-US" id="id_14539602_4412399_2_1">Minimum share price required for redemption of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_MinimumSharePriceRequiredForRedemptionOfWarrants" xlink:to="kcac_MinimumSharePriceRequiredForRedemptionOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" id="id_14539602_4067600_1_1">Net Cash Provided by (Used in) Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" id="id_14539602_4067600_6_1">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" id="id_14539602_4067210_1_1">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" id="id_14539602_4067210_2_1">Cash Flows from Financing Activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" id="id_14539602_4067599_1_1">Net Cash Provided by (Used in) Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" id="id_14539602_4067599_2_1">Net cash used in investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" id="id_14539602_4067209_1_1">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" id="id_14539602_4067209_2_1">Cash Flows from Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" id="id_14539602_4067522_1_1">Net Cash Provided by (Used in) Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" id="id_14539602_4067522_6_1">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="id_14539602_4067208_1_1">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="id_14539602_4067208_2_1">Cash Flows from Operating Activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" id="id_14539602_4087492_1_1">Net Income (Loss) Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" id="id_14539602_4087492_2_1">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" id="id_14539602_4087492_6_1">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US" id="id_14539602_4087477_1_1">Net Income (Loss) Available to Common Stockholders, Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US" id="id_14539602_4087477_2_1">Adjusted net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4072289_1_1">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4072289_2_1">Recent Accounting Standards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering" xlink:label="kcac_NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering_lbl" xml:lang="en-US" id="id_14539602_4412381_3_1">Non cash Deferred underwriting commissions in connection with the initial public offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering_lbl" xml:lang="en-US" id="id_14539602_4412381_1_1">Non Cash Deferred Underwriting Commissions In Connection With Initial Public Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering_lbl" xml:lang="en-US" id="id_14539602_4412381_2_1">Deferred underwriting commissions in connection with the initial public offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering" xlink:to="kcac_NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NonCashOfferingCostsIncludedInAccountsPayable" xlink:label="kcac_NonCashOfferingCostsIncludedInAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_NonCashOfferingCostsIncludedInAccountsPayable_lbl" xml:lang="en-US" id="id_14539602_4412380_3_1">Non cash Offering costs included in accounts payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_NonCashOfferingCostsIncludedInAccountsPayable_lbl" xml:lang="en-US" id="id_14539602_4412380_1_1">Non Cash Offering Costs Included In Accounts Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_NonCashOfferingCostsIncludedInAccountsPayable_lbl" xml:lang="en-US" id="id_14539602_4412380_2_1">Offering costs included in accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_NonCashOfferingCostsIncludedInAccountsPayable" xlink:to="kcac_NonCashOfferingCostsIncludedInAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NonCashOfferingCostsIncludedInAccruedExpenses" xlink:label="kcac_NonCashOfferingCostsIncludedInAccruedExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_NonCashOfferingCostsIncludedInAccruedExpenses_lbl" xml:lang="en-US" id="id_14539602_4412379_3_1">Non cash Offering costs included in accrued expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_NonCashOfferingCostsIncludedInAccruedExpenses_lbl" xml:lang="en-US" id="id_14539602_4412379_1_1">Non Cash Offering Costs Included In Accrued Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_NonCashOfferingCostsIncludedInAccruedExpenses_lbl" xml:lang="en-US" id="id_14539602_4412379_2_1">Offering costs included in accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_NonCashOfferingCostsIncludedInAccruedExpenses" xlink:to="kcac_NonCashOfferingCostsIncludedInAccruedExpenses_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NonCashPrepaidExpensesIncludedInAccountsPayable" xlink:label="kcac_NonCashPrepaidExpensesIncludedInAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_NonCashPrepaidExpensesIncludedInAccountsPayable_lbl" xml:lang="en-US" id="id_14539602_4412383_3_1">Non cash Prepaid expenses included in accounts payable.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_NonCashPrepaidExpensesIncludedInAccountsPayable_lbl" xml:lang="en-US" id="id_14539602_4412383_1_1">Non Cash Prepaid Expenses Included In Accounts Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_NonCashPrepaidExpensesIncludedInAccountsPayable_lbl" xml:lang="en-US" id="id_14539602_4412383_2_1">Prepaid expenses included in accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_NonCashPrepaidExpensesIncludedInAccountsPayable" xlink:to="kcac_NonCashPrepaidExpensesIncludedInAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NonCashPrepaidExpensesIncludedInAccruedExpenses" xlink:label="kcac_NonCashPrepaidExpensesIncludedInAccruedExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_NonCashPrepaidExpensesIncludedInAccruedExpenses_lbl" xml:lang="en-US" id="id_14539602_4412382_3_1">Non cash prepaid expenses included in accrued expenses.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_NonCashPrepaidExpensesIncludedInAccruedExpenses_lbl" xml:lang="en-US" id="id_14539602_4412382_1_1">Non Cash Prepaid Expenses Included In Accrued Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_NonCashPrepaidExpensesIncludedInAccruedExpenses_lbl" xml:lang="en-US" id="id_14539602_4412382_2_1">Prepaid expenses included in accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_NonCashPrepaidExpensesIncludedInAccruedExpenses" xlink:to="kcac_NonCashPrepaidExpensesIncludedInAccruedExpenses_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfDaysCommencingAfterInitialBusinessCombination" xlink:label="kcac_NumberOfDaysCommencingAfterInitialBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_NumberOfDaysCommencingAfterInitialBusinessCombination_lbl" xml:lang="en-US" id="id_14539602_4412394_3_1">Number of days commencing after initial business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_NumberOfDaysCommencingAfterInitialBusinessCombination_lbl" xml:lang="en-US" id="id_14539602_4412394_1_1">Number Of Days Commencing After Initial Business Combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_NumberOfDaysCommencingAfterInitialBusinessCombination_lbl" xml:lang="en-US" id="id_14539602_4412394_2_1">Number of days commencing after initial business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_NumberOfDaysCommencingAfterInitialBusinessCombination" xlink:to="kcac_NumberOfDaysCommencingAfterInitialBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfSharesSubjectToPossibleRedemption" xlink:label="kcac_NumberOfSharesSubjectToPossibleRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_NumberOfSharesSubjectToPossibleRedemption_lbl" xml:lang="en-US" id="id_14539602_4412385_3_1">Number of shares subject to possible redemption.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_NumberOfSharesSubjectToPossibleRedemption_lbl" xml:lang="en-US" id="id_14539602_4412385_1_1">Number Of Shares Subject To Possible Redemption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_NumberOfSharesSubjectToPossibleRedemption_lbl" xml:lang="en-US" id="id_14539602_4412385_2_1">Common stock subject to possible, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_NumberOfSharesSubjectToPossibleRedemption" xlink:to="kcac_NumberOfSharesSubjectToPossibleRedemption_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfTradingDays" xlink:label="kcac_NumberOfTradingDays"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_NumberOfTradingDays_lbl" xml:lang="en-US" id="id_14539602_4233270_3_1">Number of trading days.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_NumberOfTradingDays_lbl" xml:lang="en-US" id="id_14539602_4233270_1_1">Number Of Trading Days</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_NumberOfTradingDays_lbl" xml:lang="en-US" id="id_14539602_4233270_2_1">Number of trading days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_NumberOfTradingDays" xlink:to="kcac_NumberOfTradingDays_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfTradingDaysEndingOnThirdBusinessDay" xlink:label="kcac_NumberOfTradingDaysEndingOnThirdBusinessDay"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_NumberOfTradingDaysEndingOnThirdBusinessDay_lbl" xml:lang="en-US" id="id_14539602_4412402_3_1">Number of trading days ending on third business day.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_NumberOfTradingDaysEndingOnThirdBusinessDay_lbl" xml:lang="en-US" id="id_14539602_4412402_1_1">Number Of Trading Days Ending On Third Business Day</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_NumberOfTradingDaysEndingOnThirdBusinessDay_lbl" xml:lang="en-US" id="id_14539602_4412402_2_1">Number of trading days ending on third business day</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_NumberOfTradingDaysEndingOnThirdBusinessDay" xlink:to="kcac_NumberOfTradingDaysEndingOnThirdBusinessDay_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull" xlink:label="kcac_NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull_lbl" xml:lang="en-US" id="id_14539602_4412422_3_1">Number of units in proposed public offering if the underwriters overallotment option exercised in full.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull_lbl" xml:lang="en-US" id="id_14539602_4412422_1_1">Number of units in proposed public offering if the underwriters overallotment option exercised in full</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull_lbl" xml:lang="en-US" id="id_14539602_4412422_2_1">Number of units in proposed public offering if the underwriters overallotment option exercised in full</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull" xlink:to="kcac_NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation" xlink:label="kcac_NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation_lbl" xml:lang="en-US" id="id_14539602_4412421_3_1">Number of units in a proposed public offering required to obtain adequate financial resources to commence operation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation_lbl" xml:lang="en-US" id="id_14539602_4412421_1_1">Number of units in a proposed public offering required to obtain adequate financial resources to commence operation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation_lbl" xml:lang="en-US" id="id_14539602_4412421_2_1">Number of units in a proposed public offering required to obtain adequate financial resources to commence operation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation" xlink:to="kcac_NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull" xlink:label="kcac_NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull_lbl" xml:lang="en-US" id="id_14539602_4412424_3_1">Number of warrants in proposed public offering if the underwriters overallotment option is exercised in full.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull_lbl" xml:lang="en-US" id="id_14539602_4412424_1_1">Number of warrants in proposed public offering if the underwriters overallotment option is exercised in full</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull_lbl" xml:lang="en-US" id="id_14539602_4412424_2_1">Number of warrants in proposed public offering if the underwriters overallotment option is exercised in full</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull" xlink:to="kcac_NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation" xlink:label="kcac_NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation_lbl" xml:lang="en-US" id="id_14539602_4412423_3_1">Number of warrants in proposed public offering required to obtain adequate financial resources to commence operation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation_lbl" xml:lang="en-US" id="id_14539602_4412423_1_1">Number of warrants in proposed public offering required to obtain adequate financial resources to commence operation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation_lbl" xml:lang="en-US" id="id_14539602_4412423_2_1">Number of warrants in proposed public offering required to obtain adequate financial resources to commence operation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation" xlink:to="kcac_NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_OfferingCostsPolicyTextBlock" xlink:label="kcac_OfferingCostsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_OfferingCostsPolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4355986_3_1">Offering costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_OfferingCostsPolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4355986_1_1">Offering Costs [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_OfferingCostsPolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4355986_2_1">Offering Costs Associated with the Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_OfferingCostsPolicyTextBlock" xlink:to="kcac_OfferingCostsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US" id="id_14539602_4078721_1_1">Over-Allotment Option [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US" id="id_14539602_4078721_2_1">Over-Allotment Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PaymentOfDeferredUnderwritingCommissions" xlink:label="kcac_PaymentOfDeferredUnderwritingCommissions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_PaymentOfDeferredUnderwritingCommissions_lbl" xml:lang="en-US" id="id_14539602_4412390_3_1">Payment of deferred underwriting commissions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_PaymentOfDeferredUnderwritingCommissions_lbl" xml:lang="en-US" id="id_14539602_4412390_1_1">Payment Of Deferred Underwriting Commissions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_PaymentOfDeferredUnderwritingCommissions_lbl" xml:lang="en-US" id="id_14539602_4412390_2_1">Payment of deferred underwriting commissions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_PaymentOfDeferredUnderwritingCommissions" xlink:to="kcac_PaymentOfDeferredUnderwritingCommissions_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="us-gaap_PaymentsForUnderwritingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForUnderwritingExpense_lbl" xml:lang="en-US" id="id_14539602_4067577_1_1">Payments for Underwriting Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForUnderwritingExpense_lbl" xml:lang="en-US" id="id_14539602_4067577_2_1">Payments for underwriting discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForUnderwritingExpense" xlink:to="us-gaap_PaymentsForUnderwritingExpense_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US" id="id_14539602_4074248_1_1">Payments of Stock Issuance Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US" id="id_14539602_4074248_2_1">Payment of stock issue costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US" id="id_14539602_4074248_12_1">Payment of stock offering costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US" id="id_14539602_4074248_14_1">Offering costs paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl" xml:lang="en-US" id="id_14539602_4071129_1_1">Payments to Acquire Interest in Subsidiaries and Affiliates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl" xml:lang="en-US" id="id_14539602_4071129_14_1">Cash deposited in Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:to="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PercentageOfProceedsFromShareIssuances" xlink:label="kcac_PercentageOfProceedsFromShareIssuances"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_PercentageOfProceedsFromShareIssuances_lbl" xml:lang="en-US" id="id_14539602_4412408_3_1">Percentage of proceeds from share issuances.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_PercentageOfProceedsFromShareIssuances_lbl" xml:lang="en-US" id="id_14539602_4412408_1_1">Percentage Of Proceeds From Share Issuances</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_PercentageOfProceedsFromShareIssuances_lbl" xml:lang="en-US" id="id_14539602_4412408_2_1">Percentage of proceeds from share issuances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_PercentageOfProceedsFromShareIssuances" xlink:to="kcac_PercentageOfProceedsFromShareIssuances_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PercentageOfPublicSharesToBeRedeemed" xlink:label="kcac_PercentageOfPublicSharesToBeRedeemed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_PercentageOfPublicSharesToBeRedeemed_lbl" xml:lang="en-US" id="id_14539602_4412405_3_1">Percentage of public shares to be redeemed.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_PercentageOfPublicSharesToBeRedeemed_lbl" xml:lang="en-US" id="id_14539602_4412405_1_1">Percentage of Public Shares to Be Redeemed</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_PercentageOfPublicSharesToBeRedeemed_lbl" xml:lang="en-US" id="id_14539602_4412405_2_1">Percentage of public shares to redeem</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_PercentageOfPublicSharesToBeRedeemed" xlink:to="kcac_PercentageOfPublicSharesToBeRedeemed_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PercentageOfPublicSharesToBeRedeemed1" xlink:label="kcac_PercentageOfPublicSharesToBeRedeemed1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_PercentageOfPublicSharesToBeRedeemed1_lbl" xml:lang="en-US" id="id_14539602_4412418_3_1">Percentage of public shares to be redeemed one.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_PercentageOfPublicSharesToBeRedeemed1_lbl" xml:lang="en-US" id="id_14539602_4412418_1_1">Percentage of Public Shares to Be Redeemed1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_PercentageOfPublicSharesToBeRedeemed1_lbl" xml:lang="en-US" id="id_14539602_4412418_2_1">Percentage of public shares to redeem</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_PercentageOfPublicSharesToBeRedeemed1" xlink:to="kcac_PercentageOfPublicSharesToBeRedeemed1_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PercentageOfSharesIssuedAndOutstanding" xlink:label="kcac_PercentageOfSharesIssuedAndOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_PercentageOfSharesIssuedAndOutstanding_lbl" xml:lang="en-US" id="id_14539602_4412391_3_1">Percentage of shares issued and outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_PercentageOfSharesIssuedAndOutstanding_lbl" xml:lang="en-US" id="id_14539602_4412391_1_1">Percentage Of Shares Issued And Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_PercentageOfSharesIssuedAndOutstanding_lbl" xml:lang="en-US" id="id_14539602_4412391_2_1">Percentage of shares issued and outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_PercentageOfSharesIssuedAndOutstanding" xlink:to="kcac_PercentageOfSharesIssuedAndOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PercentageOfSharesToBeRedeemedWithoutConsent" xlink:label="kcac_PercentageOfSharesToBeRedeemedWithoutConsent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_PercentageOfSharesToBeRedeemedWithoutConsent_lbl" xml:lang="en-US" id="id_14539602_4412417_3_1">Percentage of shares to be redeemed without consent.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_PercentageOfSharesToBeRedeemedWithoutConsent_lbl" xml:lang="en-US" id="id_14539602_4412417_1_1">Percentage of shares to be redeemed without consent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_PercentageOfSharesToBeRedeemedWithoutConsent_lbl" xml:lang="en-US" id="id_14539602_4412417_2_1">Percentage of shares to be redeemed without consent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_PercentageOfSharesToBeRedeemedWithoutConsent" xlink:to="kcac_PercentageOfSharesToBeRedeemedWithoutConsent_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PeriodOfService" xlink:label="kcac_PeriodOfService"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_PeriodOfService_lbl" xml:lang="en-US" id="id_14539602_4412392_3_1">Period of service.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_PeriodOfService_lbl" xml:lang="en-US" id="id_14539602_4412392_1_1">Period Of Service</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_PeriodOfService_lbl" xml:lang="en-US" id="id_14539602_4412392_2_1">Period of service</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_PeriodOfService" xlink:to="kcac_PeriodOfService_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination" xlink:label="kcac_PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination_lbl" xml:lang="en-US" id="id_14539602_4412395_3_1">Period to issue warrant after completion of initial business combination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination_lbl" xml:lang="en-US" id="id_14539602_4412395_1_1">Period To Issue Warrant After Completion Of Initial Business Combination</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination_lbl" xml:lang="en-US" id="id_14539602_4412395_2_1">Period to issue warrant after completion of initial business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination" xlink:to="kcac_PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="id_14539602_4068598_1_1">Preferred Stock, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="id_14539602_4068598_2_1">Preferred stock, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" id="id_14539602_4068603_1_1">Preferred Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" id="id_14539602_4068603_2_1">Preferred stock, authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" id="id_14539602_4068605_1_1">Preferred Stock, Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" id="id_14539602_4068605_2_1">Preferred stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" id="id_14539602_4068606_1_1">Preferred Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" id="id_14539602_4068606_2_1">Preferred stock, outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" id="id_14539602_4086101_1_1">Preferred Stock, Value, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" id="id_14539602_4086101_2_1">Preferred stock, par value $0.0001 per share; 1,000,000 shares authorized; none issued and outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US" id="id_14539602_4079665_1_1">Prepaid Expense, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US" id="id_14539602_4079665_2_1">Prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PricePerPrivatePlacementWarrant" xlink:label="kcac_PricePerPrivatePlacementWarrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_PricePerPrivatePlacementWarrant_lbl" xml:lang="en-US" id="id_14539602_4412420_3_1">Price per private placement warrant.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_PricePerPrivatePlacementWarrant_lbl" xml:lang="en-US" id="id_14539602_4412420_1_1">Price per Private Placement Warrant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_PricePerPrivatePlacementWarrant_lbl" xml:lang="en-US" id="id_14539602_4412420_2_1">Price per private placement warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_PricePerPrivatePlacementWarrant" xlink:to="kcac_PricePerPrivatePlacementWarrant_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PrivatePlacementWarrantsMember" xlink:label="kcac_PrivatePlacementWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_PrivatePlacementWarrantsMember_lbl" xml:lang="en-US" id="id_14539602_4268695_3_1">Private placement warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_PrivatePlacementWarrantsMember_lbl" xml:lang="en-US" id="id_14539602_4268695_1_1">Private Placement Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_PrivatePlacementWarrantsMember_lbl" xml:lang="en-US" id="id_14539602_4268695_2_1">Private Placement Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_PrivatePlacementWarrantsMember" xlink:to="kcac_PrivatePlacementWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US" id="id_14539602_4075145_1_1">Proceeds from Issuance Initial Public Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US" id="id_14539602_4075145_2_1">Proceeds received from initial public offering, gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" id="id_14539602_4075137_1_1">Proceeds from Issuance of Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" id="id_14539602_4075137_2_1">Proceeds from issuance of Class B common stock to Sponsor</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US" id="id_14539602_4075144_1_1">Proceeds from Issuance of Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US" id="id_14539602_4075144_2_1">Proceeds received from private placement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US" id="id_14539602_4075142_1_1">Proceeds from Issuance of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US" id="id_14539602_4075142_2_1">Proceeds from issuance of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US" id="id_14539602_4070830_1_1">Proceeds from Notes Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US" id="id_14539602_4070830_2_1">Proceeds received from note payable to related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US" id="id_14539602_4070847_1_1">Proceeds from Related Party Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US" id="id_14539602_4070847_2_1">Loan proceeds from sponsor</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ProceedsFromSaleOfFoundersShares" xlink:label="kcac_ProceedsFromSaleOfFoundersShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_ProceedsFromSaleOfFoundersShares_lbl" xml:lang="en-US" id="id_14539602_4412406_3_1">Proceeds from sale of founders shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_ProceedsFromSaleOfFoundersShares_lbl" xml:lang="en-US" id="id_14539602_4412406_1_1">Proceeds from Sale of Founders Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_ProceedsFromSaleOfFoundersShares_lbl" xml:lang="en-US" id="id_14539602_4412406_2_1">Proceeds from sale of founders shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_ProceedsFromSaleOfFoundersShares" xlink:to="kcac_ProceedsFromSaleOfFoundersShares_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US" id="id_14539602_4070220_1_1">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US" id="id_14539602_4070220_2_1">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PromissoryNoteMember" xlink:label="kcac_PromissoryNoteMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_PromissoryNoteMember_lbl" xml:lang="en-US" id="id_14539602_4263611_3_1">Promissory note.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_PromissoryNoteMember_lbl" xml:lang="en-US" id="id_14539602_4263611_1_1">Promissory Note [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_PromissoryNoteMember_lbl" xml:lang="en-US" id="id_14539602_4263611_2_1">Promissory Note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_PromissoryNoteMember" xlink:to="kcac_PromissoryNoteMember_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ProposedPublicOfferingSharePrice" xlink:label="kcac_ProposedPublicOfferingSharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_ProposedPublicOfferingSharePrice_lbl" xml:lang="en-US" id="id_14539602_4412419_3_1">Proposed public offering share price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_ProposedPublicOfferingSharePrice_lbl" xml:lang="en-US" id="id_14539602_4412419_1_1">Proposed Public Offering Share Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_ProposedPublicOfferingSharePrice_lbl" xml:lang="en-US" id="id_14539602_4412419_2_1">Proposed public offering price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_ProposedPublicOfferingSharePrice" xlink:to="kcac_ProposedPublicOfferingSharePrice_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PublicWarrantsExpirationTerm" xlink:label="kcac_PublicWarrantsExpirationTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_PublicWarrantsExpirationTerm_lbl" xml:lang="en-US" id="id_14539602_4412407_3_1">Public warrants expiration term.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_PublicWarrantsExpirationTerm_lbl" xml:lang="en-US" id="id_14539602_4412407_1_1">Public Warrants Expiration Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_PublicWarrantsExpirationTerm_lbl" xml:lang="en-US" id="id_14539602_4412407_2_1">Public warrants expiration term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_PublicWarrantsExpirationTerm" xlink:to="kcac_PublicWarrantsExpirationTerm_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PublicWarrantsMember" xlink:label="kcac_PublicWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_PublicWarrantsMember_lbl" xml:lang="en-US" id="id_14539602_4319093_3_1">Public Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_PublicWarrantsMember_lbl" xml:lang="en-US" id="id_14539602_4319093_1_1">Public Warrants [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_PublicWarrantsMember_lbl" xml:lang="en-US" id="id_14539602_4319093_2_1">Public Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_PublicWarrantsMember" xlink:to="kcac_PublicWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US" id="id_14539602_4070963_1_1">Statistical Measurement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US" id="id_14539602_4070963_2_1">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US" id="id_14539602_4078592_1_1">Statistical Measurement [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_RangeMember_lbl" xml:lang="en-US" id="id_14539602_4078592_2_1">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_lbl" xml:lang="en-US" id="id_14539602_4079650_1_1">Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_lbl" xml:lang="en-US" id="id_14539602_4079650_2_1">Class A common stock, par value $0.0001 per share; 21,843,927 shares subject to possible redemption at $10.00 per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_RedemptionTriggerPriceAdjustmentPercentage" xlink:label="kcac_RedemptionTriggerPriceAdjustmentPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_RedemptionTriggerPriceAdjustmentPercentage_lbl" xml:lang="en-US" id="id_14539602_4412410_3_1">Redemption trigger price adjustment percentage.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_RedemptionTriggerPriceAdjustmentPercentage_lbl" xml:lang="en-US" id="id_14539602_4412410_1_1">Redemption Trigger Price Adjustment Percentage.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_RedemptionTriggerPriceAdjustmentPercentage_lbl" xml:lang="en-US" id="id_14539602_4412410_2_1">Redemption trigger price adjustment percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_RedemptionTriggerPriceAdjustmentPercentage" xlink:to="kcac_RedemptionTriggerPriceAdjustmentPercentage_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US" id="id_14539602_4084630_1_1">Related Party [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US" id="id_14539602_4084630_2_1">Related Party [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xml:lang="en-US" id="id_14539602_4083949_1_1">Related Party Transaction, Expenses from Transactions with Related Party</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xml:lang="en-US" id="id_14539602_4083949_2_1">Service and administrative fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US" id="id_14539602_4074921_1_1">Related Party Transaction [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US" id="id_14539602_4074921_2_1">Related Party Transaction [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US" id="id_14539602_4081419_1_1">Related Party Transactions [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US" id="id_14539602_4081419_2_1">Related Party Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US" id="id_14539602_4067272_1_1">Related Party [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US" id="id_14539602_4067272_2_1">Related Party [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US" id="id_14539602_4077817_1_1">Related Party Transactions Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US" id="id_14539602_4077817_2_1">Related Party Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_lbl" xml:lang="en-US" id="id_14539602_4083953_1_1">Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_lbl" xml:lang="en-US" id="id_14539602_4083953_2_1">General and administrative expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" id="id_14539602_4083888_1_1">Retained Earnings (Accumulated Deficit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" id="id_14539602_4083888_2_1">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US" id="id_14539602_4076805_1_1">Retained Earnings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US" id="id_14539602_4076805_2_1">Retained Earnings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xml:lang="en-US" id="id_14539602_4078728_1_1">Sale of Stock, Consideration Received Per Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xml:lang="en-US" id="id_14539602_4078728_2_1">Proceeds from issue of stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xml:lang="en-US" id="id_14539602_4078728_12_1">Sale of units in initial public offering, gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US" id="id_14539602_4078715_1_1">Sale of Stock [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US" id="id_14539602_4078715_2_1">Sale of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US" id="id_14539602_4078724_1_1">Sale of Stock, Number of Shares Issued in Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US" id="id_14539602_4078724_32_1">Sale of units in initial public offering, gross, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US" id="id_14539602_4078724_2_1">Number of shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US" id="id_14539602_4078724_12_1">Number of shares sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US" id="id_14539602_4078726_1_1">Sale of Stock, Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US" id="id_14539602_4078726_2_1">Stock issue price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract" xlink:label="kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US" id="id_14539602_4095949_3_1">Schedule Of Earnings Per Share Basic And Diluted [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US" id="id_14539602_4095949_1_1">Schedule Of Earnings Per Share Basic And Diluted [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US" id="id_14539602_4095949_2_1">Schedule Of Earnings Per Share Basic And Diluted [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract" xlink:to="kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US" id="id_14539602_4070190_1_1">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US" id="id_14539602_4070190_2_1">Summary of Basic and Diluted Loss per Share of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US" id="id_14539602_4074920_1_1">Schedule of Related Party Transactions, by Related Party [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US" id="id_14539602_4074920_2_1">Schedule of Related Party Transactions, by Related Party [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xlink:label="us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_lbl" xml:lang="en-US" id="id_14539602_4081666_1_1">Schedule of Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_lbl" xml:lang="en-US" id="id_14539602_4081666_2_1">Schedule of Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xlink:to="us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US" id="id_14539602_4078677_1_1">Share Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US" id="id_14539602_4078677_2_1">Share price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4072384_1_1">Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl" xml:lang="en-US" id="id_14539602_4072384_2_1">Class A common stock subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_lbl" xml:lang="en-US" id="id_14539602_4081665_1_1">Financial Instruments Subject to Mandatory Redemption, Financial Instrument [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_lbl" xml:lang="en-US" id="id_14539602_4081665_2_1">Financial Instruments Subject to Mandatory Redemption, Financial Instrument [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" id="id_14539602_4077836_1_1">Significant Accounting Policies [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" id="id_14539602_4077836_2_1">Summary of Significant Accounting Policies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SponsorMember" xlink:label="kcac_SponsorMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_SponsorMember_lbl" xml:lang="en-US" id="id_14539602_4256605_3_1">Sponsor.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_SponsorMember_lbl" xml:lang="en-US" id="id_14539602_4256605_1_1">Sponsor [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_SponsorMember_lbl" xml:lang="en-US" id="id_14539602_4256605_2_1">Sponsor</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_SponsorMember" xlink:to="kcac_SponsorMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="id_14539602_4082399_1_1">Class of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="id_14539602_4082399_2_1">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" id="id_14539602_4069234_1_1">Equity Components [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" id="id_14539602_4069234_2_1">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US" id="id_14539602_4074572_1_1">Statement [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US" id="id_14539602_4074572_2_1">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" id="id_14539602_4081137_1_1">Statement of Cash Flows [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" id="id_14539602_4081137_2_1">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" id="id_14539602_4081136_1_1">Statement of Financial Position [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" id="id_14539602_4081136_2_1">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" id="id_14539602_4081138_1_1">Statement of Stockholders' Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" id="id_14539602_4081138_2_1">Statement of Stockholders' Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US" id="id_14539602_4074571_1_1">Statement [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US" id="id_14539602_4074571_2_1">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="id_14539602_4079654_1_1">Stockholders' Equity Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="id_14539602_4079654_4_1">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="id_14539602_4079654_5_1">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="id_14539602_4079654_6_1">Total stockholders' equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" id="id_14539602_4068616_1_1">Stockholders' Equity Attributable to Parent [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" id="id_14539602_4068616_2_1">Stockholders' Equity:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US" id="id_14539602_4085680_1_1">Stockholders' Equity Note Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US" id="id_14539602_4085680_2_1">Stockholders' Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplit" xlink:label="us-gaap_StockholdersEquityNoteStockSplit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteStockSplit_lbl" xml:lang="en-US" id="id_14539602_4086426_1_1">Stockholders' Equity Note, Stock Split</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteStockSplit_lbl" xml:lang="en-US" id="id_14539602_4086426_2_1">Stock split, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteStockSplit" xlink:to="us-gaap_StockholdersEquityNoteStockSplit_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US" id="id_14539602_4075746_1_1">Stock Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US" id="id_14539602_4075746_2_1">Initial value of common stock subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" id="id_14539602_4072970_1_1">Stock Issued During Period, Shares, New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" id="id_14539602_4072970_2_1">Issuance of common stock to Sponsor, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xml:lang="en-US" id="id_14539602_4072975_1_1">Shares Issued, Shares, Share-based Payment Arrangement, Forfeited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xml:lang="en-US" id="id_14539602_4072975_2_1">Shares forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" id="id_14539602_4067342_1_1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" id="id_14539602_4067342_2_1">Underwriter options exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart" xlink:label="kcac_StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart_lbl" xml:lang="en-US" id="id_14539602_4412396_3_1">Stock issued during period shares stock options not exercised in full or part.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart_lbl" xml:lang="en-US" id="id_14539602_4412396_1_1">Stock Issued During Period Shares Stock Options Not Exercised In Full Or Part</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart_lbl" xml:lang="en-US" id="id_14539602_4412396_2_1">Over-allotment option is not exercised in full or in part</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart" xlink:to="kcac_StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US" id="id_14539602_4067391_1_1">Stock Issued During Period, Value, New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US" id="id_14539602_4067391_2_1">Issuance of common stock to Sponsor</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US" id="id_14539602_4085461_1_1">Subsequent Event [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US" id="id_14539602_4085461_2_1">Subsequent Event</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US" id="id_14539602_4081472_1_1">Subsequent Events [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US" id="id_14539602_4081472_2_1">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US" id="id_14539602_4077839_1_1">Subsequent Events [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US" id="id_14539602_4077839_2_1">Subsequent Events</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US" id="id_14539602_4085460_1_1">Subsequent Event Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US" id="id_14539602_4085460_2_1">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US" id="id_14539602_4085459_1_1">Subsequent Event Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US" id="id_14539602_4085459_2_1">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US" id="id_14539602_4078716_1_1">Sale of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US" id="id_14539602_4078716_2_1">Sale of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="kcac_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xml:lang="en-US" id="id_14539602_4092178_3_1">Summary Of Significant Accounting Policies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xml:lang="en-US" id="id_14539602_4092178_1_1">Summary Of Significant Accounting Policies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xml:lang="en-US" id="id_14539602_4092178_2_1">Summary Of Significant Accounting Policies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kcac_SummaryOfSignificantAccountingPoliciesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SummaryOfSignificantAccountingPoliciesTable" xlink:label="kcac_SummaryOfSignificantAccountingPoliciesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_SummaryOfSignificantAccountingPoliciesTable_lbl" xml:lang="en-US" id="id_14539602_4397337_3_1">Summary Of Significant Accounting Policies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_SummaryOfSignificantAccountingPoliciesTable_lbl" xml:lang="en-US" id="id_14539602_4397337_1_1">Summary Of Significant Accounting Policies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_SummaryOfSignificantAccountingPoliciesTable_lbl" xml:lang="en-US" id="id_14539602_4397337_2_1">Summary Of Significant Accounting Policies [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesTable" xlink:to="kcac_SummaryOfSignificantAccountingPoliciesTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" id="id_14539602_4081171_1_1">Supplemental Cash Flow Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" id="id_14539602_4081171_2_1">Supplemental disclosure of noncash activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US" id="id_14539602_4068622_1_1">Temporary Equity, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US" id="id_14539602_4068622_2_1">Temporary equity, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xml:lang="en-US" id="id_14539602_4068627_1_1">Temporary Equity, Redemption Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xml:lang="en-US" id="id_14539602_4068627_2_1">Redemption price per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xml:lang="en-US" id="id_14539602_4068627_12_1">Temporary equity, redemption price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US" id="id_14539602_4068626_1_1">Temporary Equity, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US" id="id_14539602_4068626_2_1">Temporary equity, shares subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TextBlockAbstract_lbl" xml:lang="en-US" id="id_14539602_4077562_1_1">Text Block [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TextBlockAbstract_lbl" xml:lang="en-US" id="id_14539602_4077562_2_1">Text Block [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_TextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ThresholdPercentageOfFounderSharesToSharesOutstanding" xlink:label="kcac_ThresholdPercentageOfFounderSharesToSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_ThresholdPercentageOfFounderSharesToSharesOutstanding_lbl" xml:lang="en-US" id="id_14539602_4412397_3_1">Threshold Percentage Of Founder Shares To Shares Outstanding.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_ThresholdPercentageOfFounderSharesToSharesOutstanding_lbl" xml:lang="en-US" id="id_14539602_4412397_1_1">Threshold Percentage Of Founder Shares To Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_ThresholdPercentageOfFounderSharesToSharesOutstanding_lbl" xml:lang="en-US" id="id_14539602_4412397_2_1">Threshold percentage of founder shares to total shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_ThresholdPercentageOfFounderSharesToSharesOutstanding" xlink:to="kcac_ThresholdPercentageOfFounderSharesToSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US" id="id_14539602_4078739_1_1">Title of Individual [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US" id="id_14539602_4078739_2_1">Title of Individual [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US" id="id_14539602_4078738_1_1">Title of Individual [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US" id="id_14539602_4078738_2_1">Title of Individual [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_UnderwritersExerciseOfOverallotmentOptionMember" xlink:label="kcac_UnderwritersExerciseOfOverallotmentOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_UnderwritersExerciseOfOverallotmentOptionMember_lbl" xml:lang="en-US" id="id_14539602_4260553_3_1">Underwriters Exercise Of Overallotment Option Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_UnderwritersExerciseOfOverallotmentOptionMember_lbl" xml:lang="en-US" id="id_14539602_4260553_1_1">Underwriters Exercise Of Overallotment Option Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_UnderwritersExerciseOfOverallotmentOptionMember_lbl" xml:lang="en-US" id="id_14539602_4260553_2_1">Aggregate if the underwriters' over-allotment option is exercised in full</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_UnderwritersExerciseOfOverallotmentOptionMember" xlink:to="kcac_UnderwritersExerciseOfOverallotmentOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_UnderwritingDiscountPerUnit" xlink:label="kcac_UnderwritingDiscountPerUnit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_UnderwritingDiscountPerUnit_lbl" xml:lang="en-US" id="id_14539602_4367937_3_1">Underwriting discount per unit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_UnderwritingDiscountPerUnit_lbl" xml:lang="en-US" id="id_14539602_4367937_1_1">Underwriting Discount Per Unit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_UnderwritingDiscountPerUnit_lbl" xml:lang="en-US" id="id_14539602_4367937_2_1">Underwriting discount per unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_UnderwritingDiscountPerUnit" xlink:to="kcac_UnderwritingDiscountPerUnit_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US" id="id_14539602_4084497_1_1">Unrecognized Tax Benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US" id="id_14539602_4084497_2_1">Unrecognized tax benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xml:lang="en-US" id="id_14539602_4084486_1_1">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xml:lang="en-US" id="id_14539602_4084486_2_1">Accrued for payment of interest and penalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" id="id_14539602_4072404_1_1">Use of Estimates, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" id="id_14539602_4072404_2_1">Use of Estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ValueOfSharesSubjectToPossibleRedemption" xlink:label="kcac_ValueOfSharesSubjectToPossibleRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_ValueOfSharesSubjectToPossibleRedemption_lbl" xml:lang="en-US" id="id_14539602_4412384_3_1">Value of shares subject to possible redemption.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_ValueOfSharesSubjectToPossibleRedemption_lbl" xml:lang="en-US" id="id_14539602_4412384_1_1">Value Of Shares Subject To Possible Redemption</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="kcac_ValueOfSharesSubjectToPossibleRedemption_lbl" xml:lang="en-US" id="id_14539602_4412384_14_1">Common stock subject to possible redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_ValueOfSharesSubjectToPossibleRedemption" xlink:to="kcac_ValueOfSharesSubjectToPossibleRedemption_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US" id="id_14539602_4086031_1_1">Warrant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US" id="id_14539602_4086031_2_1">Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_WarrantsRedemptionPricePerShare" xlink:label="kcac_WarrantsRedemptionPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_WarrantsRedemptionPricePerShare_lbl" xml:lang="en-US" id="id_14539602_4412398_3_1">Warrants, redemption price per share.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_WarrantsRedemptionPricePerShare_lbl" xml:lang="en-US" id="id_14539602_4412398_1_1">Warrants Redemption Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_WarrantsRedemptionPricePerShare_lbl" xml:lang="en-US" id="id_14539602_4412398_2_1">Warrants redemption price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_WarrantsRedemptionPricePerShare" xlink:to="kcac_WarrantsRedemptionPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US" id="id_14539602_4069093_1_1">Weighted Average Number Diluted Shares Outstanding Adjustment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US" id="id_14539602_4069093_2_1">Weighted average shares subject to forfeiture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US" id="id_14539602_4073539_1_1">Weighted Average Number of Shares Outstanding, Basic and Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US" id="id_14539602_4073539_2_1">Weighted average ordinary shares outstanding, basic and diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US" id="id_14539602_4073539_12_1">Weighted average shares outstanding, basic and diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:label="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_lbl" xml:lang="en-US" id="id_14539602_4069090_1_1">Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_lbl" xml:lang="en-US" id="id_14539602_4069090_2_1">Weighted average number of common stock subject to possible forfeitures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:to="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_WorkingCapital" xlink:label="kcac_WorkingCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_WorkingCapital_lbl" xml:lang="en-US" id="id_14539602_4144138_3_1">Working capital.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_WorkingCapital_lbl" xml:lang="en-US" id="id_14539602_4144138_1_1">Working Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_WorkingCapital_lbl" xml:lang="en-US" id="id_14539602_4144138_2_1">Working capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_WorkingCapital" xlink:to="kcac_WorkingCapital_lbl"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_WorkingCapitalLoansMember" xlink:label="kcac_WorkingCapitalLoansMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="kcac_WorkingCapitalLoansMember_lbl" xml:lang="en-US" id="id_14539602_4300621_3_1">Working capital loans,</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="kcac_WorkingCapitalLoansMember_lbl" xml:lang="en-US" id="id_14539602_4300621_1_1">Working Capital Loans [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="kcac_WorkingCapitalLoansMember_lbl" xml:lang="en-US" id="id_14539602_4300621_2_1">Working Capital Loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="kcac_WorkingCapitalLoansMember" xlink:to="kcac_WorkingCapitalLoansMember_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>kcac-20200630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN Xcelerate Taxonomy Presentation Linkbase - https://www.dfinsolutions.com/ -->
<!-- Version: 6.23.6 -->
<!-- Round: f8c40bbb-ca51-4041-a5e5-af36f22d4c5e -->
<!-- Creation date: 2020-10-23T18:44:53Z -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Cover" roleURI="http://imetrix.edgar-online.com/taxonomy/role/Cover"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfFinancialPositionClassified" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassified"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfFinancialPositionClassifiedParen" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfIncome" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncome"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfIncomeParen" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncomeParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfShareholdersEquityAndOtherComprehensiveIncome" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#StatementOfCashFlowsIndirect" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirect"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureDescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureDescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerShareOfCommonStock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerShareOfCommonStock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosurePublicOfferingAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosurePublicOfferingAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureRelatedPartyTransactionsAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureCommitmentsContingenciesAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommitmentsContingenciesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureStockholdersEquityAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureStockholdersEquityAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureFairValueMeasurementsSummaryOfAssetsMeasuredAtFairValue" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfAssetsMeasuredAtFairValue"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#DisclosureSubsequentEventAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSubsequentEventAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsInitialPublicOfferingDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsInitialPublicOfferingDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsFairValueDisclosuresTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsFairValueDisclosuresTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="kcac-20200630.xsd#Role_NotesToFinancialStatementsSubsequentEventsTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock"/>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/Cover">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentDescription" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassified">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCosts" xlink:label="us-gaap_DeferredCosts"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DeferredUnderwritingCommissionsNoncurrent" xlink:label="kcac_DeferredUnderwritingCommissionsNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_DeferredCosts" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_Cash" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="kcac_DeferredUnderwritingCommissionsNoncurrent" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="1.2800" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FranchisorCosts" xlink:label="us-gaap_FranchisorCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_FranchisorCosts" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncomeParenthetical">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SponsorMember" xlink:label="kcac_SponsorMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" xlink:label="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="kcac_SponsorMember" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" order="2.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="4.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfSharesSubjectToPossibleRedemption" xlink:label="kcac_NumberOfSharesSubjectToPossibleRedemption"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PrivatePlacementWarrantsMember" xlink:label="kcac_PrivatePlacementWarrantsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SponsorMember" xlink:label="kcac_SponsorMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ValueOfSharesSubjectToPossibleRedemption" xlink:label="kcac_ValueOfSharesSubjectToPossibleRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="kcac_PrivatePlacementWarrantsMember" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="kcac_SponsorMember" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" order="1.1400" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_ValueOfSharesSubjectToPossibleRedemption" order="1.1600" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_NumberOfSharesSubjectToPossibleRedemption" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_2" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding_2" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="13.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="15.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirect">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPropertyAndOtherTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInPropertyAndOtherTaxesPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering" xlink:label="kcac_NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NonCashOfferingCostsIncludedInAccountsPayable" xlink:label="kcac_NonCashOfferingCostsIncludedInAccountsPayable"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NonCashOfferingCostsIncludedInAccruedExpenses" xlink:label="kcac_NonCashOfferingCostsIncludedInAccruedExpenses"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NonCashPrepaidExpensesIncludedInAccountsPayable" xlink:label="kcac_NonCashPrepaidExpensesIncludedInAccountsPayable"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NonCashPrepaidExpensesIncludedInAccruedExpenses" xlink:label="kcac_NonCashPrepaidExpensesIncludedInAccruedExpenses"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense" order="1.0100" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPropertyAndOtherTaxesPayable" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromNotesPayable" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="1.1400" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" order="1.0800" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="kcac_NonCashOfferingCostsIncludedInAccruedExpenses" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="kcac_NonCashOfferingCostsIncludedInAccountsPayable" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="kcac_NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_StockIssued1" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="kcac_NonCashPrepaidExpensesIncludedInAccruedExpenses" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="kcac_NonCashPrepaidExpensesIncludedInAccountsPayable" order="1.2800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureDescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ClassOfWarrantsOrRightsIssued" xlink:label="kcac_ClassOfWarrantsOrRightsIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:label="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xlink:label="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_InterestToPayDissolutionExpenses" xlink:label="kcac_InterestToPayDissolutionExpenses"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_MaximumNetTangibleAssetsForBusinessCombination" xlink:label="kcac_MaximumNetTangibleAssetsForBusinessCombination"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull" xlink:label="kcac_NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation" xlink:label="kcac_NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull" xlink:label="kcac_NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation" xlink:label="kcac_NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PaymentOfDeferredUnderwritingCommissions" xlink:label="kcac_PaymentOfDeferredUnderwritingCommissions"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PercentageOfPublicSharesToBeRedeemed" xlink:label="kcac_PercentageOfPublicSharesToBeRedeemed"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PercentageOfPublicSharesToBeRedeemed1" xlink:label="kcac_PercentageOfPublicSharesToBeRedeemed1"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PercentageOfSharesToBeRedeemedWithoutConsent" xlink:label="kcac_PercentageOfSharesToBeRedeemedWithoutConsent"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PricePerPrivatePlacementWarrant" xlink:label="kcac_PricePerPrivatePlacementWarrant"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PrivatePlacementWarrantsMember" xlink:label="kcac_PrivatePlacementWarrantsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ProceedsFromSaleOfFoundersShares" xlink:label="kcac_ProceedsFromSaleOfFoundersShares"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ProposedPublicOfferingSharePrice" xlink:label="kcac_ProposedPublicOfferingSharePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SponsorMember" xlink:label="kcac_SponsorMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_WorkingCapital" xlink:label="kcac_WorkingCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1.2900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="kcac_PrivatePlacementWarrantsMember" order="1.2800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_PaymentOfDeferredUnderwritingCommissions" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_ClassOfWarrantsOrRightsIssued" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_MaximumNetTangibleAssetsForBusinessCombination" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_PercentageOfPublicSharesToBeRedeemed1" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_InterestToPayDissolutionExpenses" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_Cash" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_WorkingCapital" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_ProceedsFromSaleOfFoundersShares" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_ProposedPublicOfferingSharePrice" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_PricePerPrivatePlacementWarrant" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_PercentageOfSharesToBeRedeemedWithoutConsent" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" xlink:to="kcac_PercentageOfPublicSharesToBeRedeemed" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="13.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationTable" xlink:to="kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="kcac_SponsorMember" order="1.3000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1.3100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ClassaCommonStockSubjectToMandatoryRedemptionMember" xlink:label="kcac_ClassaCommonStockSubjectToMandatoryRedemptionMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit" xlink:label="kcac_ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xlink:label="us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="kcac_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SummaryOfSignificantAccountingPoliciesTable" xlink:label="kcac_SummaryOfSignificantAccountingPoliciesTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="kcac_SummaryOfSignificantAccountingPoliciesTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain" xlink:to="kcac_ClassaCommonStockSubjectToMandatoryRedemptionMember" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="kcac_ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_SummaryOfSignificantAccountingPoliciesTable" xlink:to="kcac_SummaryOfSignificantAccountingPoliciesLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerShareOfCommonStock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract" xlink:label="kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_NetIncomeLoss" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosurePublicOfferingAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DescriptionOfPublicWarrant" xlink:label="kcac_DescriptionOfPublicWarrant"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_IpoExcludingOverAllotmentMember" xlink:label="kcac_IpoExcludingOverAllotmentMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PaymentOfDeferredUnderwritingCommissions" xlink:label="kcac_PaymentOfDeferredUnderwritingCommissions"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="kcac_IpoExcludingOverAllotmentMember" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_PaymentOfDeferredUnderwritingCommissions" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_DescriptionOfPublicWarrant" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharePrice" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember" xlink:label="srt_AffiliatedEntityMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ClassOfWarrantsOrRightsIssued" xlink:label="kcac_ClassOfWarrantsOrRightsIssued"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ClassOfWarrantsOrRightsIssuePrice" xlink:label="kcac_ClassOfWarrantsOrRightsIssuePrice"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_CommitmentContingencyAndRelatedPartyTransactionsAbstract" xlink:label="kcac_CommitmentContingencyAndRelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_FounderMember" xlink:label="kcac_FounderMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfDaysCommencingAfterInitialBusinessCombination" xlink:label="kcac_NumberOfDaysCommencingAfterInitialBusinessCombination"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfTradingDays" xlink:label="kcac_NumberOfTradingDays"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PercentageOfSharesIssuedAndOutstanding" xlink:label="kcac_PercentageOfSharesIssuedAndOutstanding"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PeriodOfService" xlink:label="kcac_PeriodOfService"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination" xlink:label="kcac_PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PrivatePlacementWarrantsMember" xlink:label="kcac_PrivatePlacementWarrantsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PromissoryNoteMember" xlink:label="kcac_PromissoryNoteMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SponsorMember" xlink:label="kcac_SponsorMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_WorkingCapitalLoansMember" xlink:label="kcac_WorkingCapitalLoansMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1.3100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_CommitmentContingencyAndRelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="kcac_PromissoryNoteMember" order="1.2900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="kcac_WorkingCapitalLoansMember" order="1.3400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1.2800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="1.3300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1.3000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="kcac_SponsorMember" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="srt_AffiliatedEntityMember" order="1.3500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="kcac_PercentageOfSharesIssuedAndOutstanding" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="kcac_NumberOfTradingDays" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="kcac_NumberOfDaysCommencingAfterInitialBusinessCombination" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_SharePrice" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="kcac_ClassOfWarrantsOrRightsIssued" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="kcac_ClassOfWarrantsOrRightsIssuePrice" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="kcac_PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_LineOfCredit" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_AccountsPayableRelatedPartiesCurrent" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="kcac_PeriodOfService" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="kcac_PrivatePlacementWarrantsMember" order="1.3200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="1.3700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_DebtInstrumentAxis" order="13.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_TitleOfIndividualAxis" order="14.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="15.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_RangeAxis" order="16.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="kcac_FounderMember" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefFinancialOfficerMember" order="1.3600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommitmentsContingenciesAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DeferredUnderwritingCommissionPerUnit" xlink:label="kcac_DeferredUnderwritingCommissionPerUnit"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DeferredUnderwritingCommissionsNoncurrent" xlink:label="kcac_DeferredUnderwritingCommissionsNoncurrent"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_DeferredUnderwritingCommissionsPayable" xlink:label="kcac_DeferredUnderwritingCommissionsPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="us-gaap_PaymentsForUnderwritingExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_UnderwritersExerciseOfOverallotmentOptionMember" xlink:label="kcac_UnderwritersExerciseOfOverallotmentOptionMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_UnderwritingDiscountPerUnit" xlink:label="kcac_UnderwritingDiscountPerUnit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="kcac_UnderwritersExerciseOfOverallotmentOptionMember" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_UnderwritingDiscountPerUnit" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentsForUnderwritingExpense" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_DeferredUnderwritingCommissionPerUnit" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_DeferredUnderwritingCommissionsNoncurrent" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_DeferredUnderwritingCommissionsPayable" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureStockholdersEquityAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="us-gaap_BusinessAcquisitionSharePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_CommonStockSharesIssuedIncludingRedemption" xlink:label="kcac_CommonStockSharesIssuedIncludingRedemption"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_CommonStockSharesOutstandingIncludingRedemption" xlink:label="kcac_CommonStockSharesOutstandingIncludingRedemption"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ExercisePriceAdjustmentPercentage" xlink:label="kcac_ExercisePriceAdjustmentPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_MinimumSharePriceRequiredForRedemptionOfWarrants" xlink:label="kcac_MinimumSharePriceRequiredForRedemptionOfWarrants"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfTradingDays" xlink:label="kcac_NumberOfTradingDays"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_NumberOfTradingDaysEndingOnThirdBusinessDay" xlink:label="kcac_NumberOfTradingDaysEndingOnThirdBusinessDay"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PercentageOfProceedsFromShareIssuances" xlink:label="kcac_PercentageOfProceedsFromShareIssuances"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PrivatePlacementWarrantsMember" xlink:label="kcac_PrivatePlacementWarrantsMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PublicWarrantsExpirationTerm" xlink:label="kcac_PublicWarrantsExpirationTerm"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_PublicWarrantsMember" xlink:label="kcac_PublicWarrantsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_RedemptionTriggerPriceAdjustmentPercentage" xlink:label="kcac_RedemptionTriggerPriceAdjustmentPercentage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SponsorMember" xlink:label="kcac_SponsorMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplit" xlink:label="us-gaap_StockholdersEquityNoteStockSplit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart" xlink:label="kcac_StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ThresholdPercentageOfFounderSharesToSharesOutstanding" xlink:label="kcac_ThresholdPercentageOfFounderSharesToSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_WarrantsRedemptionPricePerShare" xlink:label="kcac_WarrantsRedemptionPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1.3200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="kcac_PrivatePlacementWarrantsMember" order="1.3100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="kcac_PublicWarrantsMember" order="1.3400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1.3000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1.3300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="kcac_SponsorMember" order="1.2800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1.2900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_CommonStockSharesIssuedIncludingRedemption" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_CommonStockSharesOutstandingIncludingRedemption" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_ThresholdPercentageOfFounderSharesToSharesOutstanding" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplit" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_NumberOfTradingDays" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_PublicWarrantsExpirationTerm" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessAcquisitionSharePrice" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_PercentageOfProceedsFromShareIssuances" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_ExercisePriceAdjustmentPercentage" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_RedemptionTriggerPriceAdjustmentPercentage" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_MinimumSharePriceRequiredForRedemptionOfWarrants" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_WarrantsRedemptionPricePerShare" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="kcac_NumberOfTradingDaysEndingOnThirdBusinessDay" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="13.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" order="14.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfAssetsMeasuredAtFairValue">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_CashHeldInTrustAccountFairValueDisclosure" xlink:label="kcac_CashHeldInTrustAccountFairValueDisclosure"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="kcac_CashHeldInTrustAccountFairValueDisclosure" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureSubsequentEventAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsShares" xlink:label="us-gaap_CommonStockDividendsShares"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_FounderMember" xlink:label="kcac_FounderMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_SponsorMember" xlink:label="kcac_SponsorMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="kcac_SponsorMember" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DueToRelatedPartiesCurrent" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockDividendsShares" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="13.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_TitleOfIndividualAxis" order="14.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_RangeAxis" order="15.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="kcac_FounderMember" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_CashHeldInTrustAccountPolicyTextBlock" xlink:label="kcac_CashHeldInTrustAccountPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_EmergingGrowthCompanyPolicyTextBlock" xlink:label="kcac_EmergingGrowthCompanyPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_OfferingCostsPolicyTextBlock" xlink:label="kcac_OfferingCostsPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="kcac_EmergingGrowthCompanyPolicyTextBlock" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="kcac_CashHeldInTrustAccountPolicyTextBlock" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="kcac_OfferingCostsPolicyTextBlock" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables">
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract" xlink:label="kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsInitialPublicOfferingDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="kcac-20200630.xsd#kcac_InitialPublicOfferingDisclosureTextBlock" xlink:label="kcac_InitialPublicOfferingDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="kcac_InitialPublicOfferingDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g14810g1022070957348.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g14810g1022070957348.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !@ (4# 2(  A$! Q$!_\0
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MT\=Z?K46I2:7;7-WI]D6BGO8PNP'&25&=S #N!],UPG[//\ R#]?P<_OX?\
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;'('/%%?0X;$T8T8IR5['S&*PM>5:3C%VN?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g14810g12e25.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g14810g12e25.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1<&4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %NJ^6&8X0DE-! 0       \< 5H  QLE1QP"   "  \ .$))300E
M   0%1R\&^%G&6DRPWH'NV*6(3A"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!GG#$@
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#O_XU
M  (  CA"24T$)@      #@             _@   .$))300-       $
M>#A"24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M 0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U     0 M
M    !@       3A"24T#^       <   ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@     _____________________________P/H   X
M0DE-! @      !     !   "0    D      .$))300>       $     #A"
M24T$&@     #-0    8              B8   2G          $
M                 0             $IP   B8
M 0                         0     0       &YU;&P    "    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M $QE9G1L;VYG          !"=&]M;&]N9P   B8     4F=H=&QO;F<   2G
M    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '
M<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE
M;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E
M;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   (F     %)G:'1L;VYG   $IP    -U<FQ415A4
M 0       &YU;&Q415A4     0       $US9V5415A4     0      !F%L
M=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL
M5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z
M06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC959E
M<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI
M8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M"FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M  MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M #A"24T$$0       0$ .$))3004       $    !CA"24T$#      ,TP
M  $   "@    2@   >   (K    ,MP 8  '_V/_M  Q!9&]B95]#30 "_^X
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M8XM]T >X#;^=[_W$!(A- H*NF&JYEOVO(LV&2RQ^YITC5NT*Z@NR\9MAJ=8
M]I:"T^+R&U_Y^Y2-]
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0'_P  1" $8 ET# 1$  A$! Q$!_\0 '@ !  $$ P$!
M  H&!P@) 0,%! +_Q !H$   !@(  @0(! \*" H'"0 ! @,$!08 !P@1"1(A
M,1,4%3AQ=[&V%D%1=A<B,C0V-U=A=8&1EK2UMT-4<G-TA)/!T=08&2,FLL/5
MUD)25EB4E9>ATO D)362PN'Q)S-%1E-B@K/7_\0 '0$!  (" P$!
M      $( @<$!08) __$ & 1  $# @($" @&"@\&!@(# 0$  @,$$04A!@<2
M,1,V05%Q=;&T(C)A=)&SM? 4-')V@<$(%2,U-X2ALM'3%A<D0D-2559S@X62
MDY25,V+"TN'Q&%-48X+4)<.BHZ7D_]H # ,!  (1 Q$ /P"?QA$PB81,(F$3
M")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"+\G(50.J<H&#GSY#_P#+
MXA 1*8.XQ1$I@$IA 2+]     '8 !R /D ,(F$3")A$PB81=:H&,F8"  FY
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M8_4AV  #S^K+SY<^76#GA%P#E PE %"B)P$2  #S,   ]G9\@@(!WB',0Y@
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M/.]Q<223?RJK][T.(W/K"X:L<V..@@L\;XFX=2,%"V9D1(5"* 5[ V!(63]
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MH=Q@YA\><>LCA-)56B8"*><M.R#9PB>6D9<]L^3>N312/%926E+[U,#2TL#
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M!)%XU55;J*&53.B4I%!$RQ?!% 5.11FQ]_?RA%ZW(>7/ES#L[NWGS^,.7U0
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M'OBCXJ"_BBZ+H$_ *IJ&D G</?W^KG"+[%I:*;QIII>3CTH<K8KTTLH];%C
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MX*-A;#),[:>&2%IM'LCP3FZY( -M91.FOMB8B)>'FO@(B _; D.P0Y=P!6P
M!'D B;ZHQ@ PF$P (;A_\/.'_P ZJK_3&?\ V=_+?>M5_M^5_P#-BE_U7_\
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MBE3B;*%KJ.KA@B^!0S1W9)3LEN]TM3."=LO :&MML[S8WM-TS_FNT/U^5?\
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MWGCW/YK:^]TF&6HU*\0,.\]Q3OTRK1KAXYUGF6&]TA6NTW</H'V9M=:J65/
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MLQER*"2/WK7 Y$&U_1S<_P"569GM(ZYL<DM)RE89/'BP\U5U6J1S&-R_XYB
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M/FXSVC3+IM>W%W".NJCN-0HW^6S574PLF>.WY3>T*9EP4>:-P[^I^E_JA/*
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MZ9_S7:'Z_*O^SS:><+4'QPQ+YM5GM3!EV6O7BCAWSCH_9F+J,GEN55!=:OU
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M@7SNY#_4_FKZ,_)9MWCI':MW70E?9QOWYMT?]<V7*Z_9#?$=%_.L4[G3+?\
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MW".NJCN-0HW^6S574PLF>.WY3>T*9EP4>:-P[^I^E_JA/* :P^..E/7>)?\
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M=CI:8"-UY$.+8ZEZK9K/'[H9,Q?V&8ND;!+UMRN>'E4Y;P##+=?/G(ON'O\
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M4'#QTL)U$CJB=<X>$ZG5*7T^!:9Z4Z-4YPW1[%HL/P]\KII.$;%(!.\ .?\
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M4:M4UG*RG511247.1,T6<7-:T>$\V&8Z.4@#DWV%LREB=P5IAXB]:B(\CWX
M^0=-[B'EV!\?P#Y" ]X"'8("&<X816O <&TK@1<'X=1"_2!4Y$;B-XMGFI/@
MFQ:^XYFNM^84_P (K6W_ .I??^QK<7^X>3]IJ[^)2_Y^C_\ LJ+C^))_=?\
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MB%%"\QR5,4;F6!:\[)S%QO )RL>@CG5(?XS;@)_YT&L_^FR7^S<YW[7NF_\
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M+PXU_N#67_K>E?[T99#]MG5[_+U/_=J/U"KK^UGIM_(E9_@Q?K%^3='IQID
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M'2[>&LE'HA-BLH&-8NGD\S358UQR9M+1I@_6GTXK!@>+UN(N%-5T+J'X*(*
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M.8CWB/(.T1^/(#6@W#6@YY@ 'PG%SLP.5SG./.XDG,DIY.0VN.>P 'H  ',
M!N"_7(/D#\@9DHL.8>@)R#Y _(&$L.8>A<"4HAR$I1 >\! ! ?Q"&%) .1%Q
MS% 3('<0@>@H![ S$-:TDM:UI=O( !/20+GZ4Y+<G-R>A<]4OR!^0,RW[U
M&8 !YP%P!"!W$*'/OY% /8&0&M%[- OOL +]-MZRN3O)/TIU"<^?5+S^7JAS
M[Q'OY?*(CZ1')Y;\MK7Y;<U^;R*.2W)S<GH7/(/D#\@846',/0$ZI1[RA^0,
M;]Z6 W >A< 0@=Q"AZ"@'L#(  R  ', !Y.S)9$D[R3;=<DH)2CWE*/;S[0
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M.DF<2B<H&$OU(CV\NT![/QE ?Q!\F$7[PB81._OPBZ0;H@//J<QY"',3&$1
M1$1 1$PB(=HAR'LY?2_4@ 81=V$3")A%TE;HEY"!1YAW")U##WB//Z8P_3#S
M'F;ZH0Y (B   $7=A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB8
M1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")
MA%96?T3KJS;59[@L%<9SUOCJBUI<4K,LXN380\:SGW5D1?Q;=ZR67CYH)%VJ
M R;5PDJ*'@D>H )@H5>VY%C90^CAX;M;$DDZA S42634OP+':NX1HX\2V'3Y
M6CR<8J]8P;60DF<3 S4FG!.9UW*S+1V[.Z<2;\0\&,DDBU\M_O\ HW(OROT=
M6BU52JI/MFM!C5F<Q3"-+VZ10UG;V\]1;4^O.O&WBIFT-;9NS:WJ,U*.GJ$E
M&BNS?I,(Q@UFYII(0BRKTSJ6N:/UY ZSJ+B<=U^O*3"S1S990TW..%YZ<D[%
M)+2$JHDBL^76DY9TKX=<IEQ(8"K*K* 94Q%=3")A$PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$P
MB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PBM=;]R:QHUMK-&ME^JM<M
M]R\ 2K5J9F6#"7GU73T8UJ6)8KJD=/5'$AR9HE0(<%' @D4!/V#V=+@F-5])
M4XA08955=!1%WPVLBAE?#3!C.%<)9&,+&!L?AN+W-LT[6X+JJS',&P^MIL/K
ML2IZ6MK0/@=+))&V2?:DX-IC:X[3MJ0%@L"";\H5+0?$-KZ8DS1QI"2BFQG5
M]9L[!/PKV$K3]QK&:=5^])H3KY%*/(%?DF+\JZCA5NFX:L'D@T479M53YU37
M-?=['[322-FWB%N3A?(G/GW;NCM2V1CBR06(#2#_ !@X!P-AD,CY?H5P_HEZ
MZ\F>6OAY3O(WARM?*P66&&-!R:)&>*@+X'GBH+#!%-->#%4#^2"'DA#Q(AEP
MR1<([-UPY=D8-[]3%WYVK-\1BC9X55X=E(F9$CWA6I'IES-'YI..*Q<@F*+L
M7[(&YU/&D.N1>@E=Z8M(L(A&UUQ:6E4GRT7%I34<I(2246X6:22C!D1P9R\)
M'NFSEL^,W34!HNV<HKBFH@L4A%5&$5J-K[QU#HV/B)C<&S:/K&)G'R\;$R5Y
MLL1664E(H-A>*,6+F7=-4G+LC4BC@S=%0RH(IG4$O4*80[##\&QK&I)(<%PV
MKQ*6&/A)VTE/-4R0L+@QCW10L<[9+S;:<6M! &9<+?F^:&*PE>UFU?9VG-:"
M1:^;B!D#<Y'Z.7I>[DJ3&RC5Q5EWSY%:O-I%Y$P$I+0T$ZMABEKB,],1[19C
M%'E?"(G*+A4"M&[AL^D18L'C)TXZMD@>969B2![8IHR+.C>8V2@$'/Q)6$\V
M[?=9@W%QF#N/IO\ 5[V7NM]LZM=G:)MMD4-PJ_E30+))"VP*RCR<359H*0S5
M--^8[B4(O(,$31Z0'=E5?,TQ2 SI #_HI7TH;,URY.X3;WVFKG:+OFKHB5FA
MCF;N8Q[&QLD@L!7@BDK'R,S$1[XA^1FCZ5CFBX)N'K9-0B]].P0:LL\@4Y5B
M>;CX^/EGT2#A/RDTBY9Q(LXR1<LA$'"+*0>0\LT9N3IE1<.HU^V2.99HN0A%
M9",XF]32)X\RED7C(^?G6E=JLU,PLI%0=KDG\I(0[1*NS3QHG'R0*O8QT(@1
M4JI&?BTB9$K%ZU6.15#.\0ND:]$LYF2VSK]-@_DF,.Q7;VJ%>^/24A+,()NU
M9IM'BZC@Q9638MG1TDSILBN"K/#MT ,J!%6"VR=>-58ENZO=/;N9X(\(1!>R
M0Z*TT,MXMY+")14>%4D1D_'68QX,RK"\*[:BV\*#A$3D7V2%ZI42^>QDK;JU
M&24=$+6"0CY";C6;UC -S&(XG';5PY37;0[<Q#E7DUB$9(F(8%%RB4>1%2-B
MWEJ"L,F;V7V53&R,@:O>(@E8(MVX>(VR88P%>>-FS5RLNK'RDO*1[-O)$2,P
MZSE,YURI")P(O7>[-I*%3E+FQLT1-P,,H9!Z_KSUO/)B^(N@U"*;A%'>"XEU
MW;EJS;QB!5'R[MR@V10,LLF02+]I[3UH9%RL.Q*09-A*(0;];X4P8)M)MUX3
MQ:'=&\?$K:4<^!5!O'+&*\5%(Y2(F,0P 1?&3;VM%+=%49O>JP]M4TZL;&/@
M6$LR?21G]1;,7=D8+H-%EC-'\.WDV"KUBZ!!XD1TD84!)US%(O-3W=K!:;MD
M,6_51%2DFKZ%C=.)J.0BXU]9W<TPB8M>767)&EF%7<#(MUHGQL7[98C<CEN@
M9TB!R+S(_B(T])*1;1M?Z\,G+7F2ULTBCNTTI4UTBGEI9N(->,.;QUBX7/3;
M$I'G>HH)2B# %8Y1P1RV.J1=4)Q%Z@G)*TL$;[6V84^RJTZ9<RLO%Q;0;*@X
MD&2\4Q4>.T5'CI%_&/69DTTN:RR)P:^'(0YP(JV?[5UA%N)-K*;$H\:YA546
M\RWD+5!LEHA=RFNLV0E$W+Y(\>LY1;.5FZ3L$3KI-G"B13D05,0BZ7>T*(RE
MU8M>Z5<J[0#'DVX3T."L(@2$>6+QR;3.]!6-:*1$>Z?I.')$DS-4_&@$S;K+
M$(NM]MS6S2/0?(WBKOQ?L)20A6D7-QTI(V!&%,NG)$KT<Q<.'LZY:KMG#55I
M%(.W(/$E&G@A<$,D!%6<%+L+!#QD[%/$9"+F6#24C'[<0,W>Q[]NF[9.D#!V
M'1<-E4U4C_\ "(<IOCPB^]RX0:-UW3E4B#=NDHNNLH/)-%)(HG44./Q$(0!,
M81[  !$<D D@ 7)-@/*H) !)W!6BFMWT&-90[^,FR6TD]8FM5BF],3)9W+N<
M>P<I9VS,4XLRX-_"5^'?RA'#DZ+<[1-)0JABN$3#E)#/3N$51'(R4ASK/C+"
M&M)!R(&0(+2;;P0;$$("'"X-P<[C/R]BZG'$!J9E27E[>W.-9Q3*IV2ZN&3P
M%6ED0@*B20^$ZZE4732L8.*\YB9./F61HT'C"38NF#E%)TF*(8*5U2'$%J2,
MC[M*+; K;MAKJA([*MKJ*?MY5M'4UR%G*WF06CC.4G2:B]/GVY4&:J[CQAJ@
MB*8*O6A%B+VZON36UI;(*L;M62NW#)_)EB'4[#H33>-BCJHR3YU&%?'<(M&1
MVZQW3DP"@W3 #K*)E$  B]1EM364HK'MXO8E'D7,NW=NHA%A:X)VK*-V)GA'
MCB.(@^4,]19GCWY72C8%2-S,G15A(+=4"$7D,]SZP=N6C4NPJ7RDS-4X=S\*
MJZ+:96>N'C-!O#+%D1+(N/'&2K,R+<IE"O!(UZIW'73*15C%W&I3DG*PL+9Z
M_+S,$H5*;B8R8CW\G#JG.=,J<HP:N%73!05$U" 1TDD;KD.7ES*( 15)A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"
M)A$PB81,(F$3")A$PB81,(F$3"+$C=?")K_=NX=5[FLLO;F5DU*I%.:\QAGT
M2W@WBT+8OA*S"7;/(5\_7 [_ )$6!E)1_7;$ HF(H0BF>PP/3;%L P3%\"HF
MTYH\9$PJS)#MS;,U-\%D;')MC8O%N.PZSLQ;E\;CVA6&:08SA>.5<M0RJPC@
M?@S8Y"R(F&I-4QTC0T[8X3)P+FW9E8YJDI7@BU_(H/A8R$E"S$VKLDUCGHQA
M$(R,\6_[/#;;+RBX3026!:IVQM&HQ[E)8B\E6T',#+ Z27;*QOC&-#&[#8^#
M8'.<UM]HG:<7.)<<S=UR.0"P&Y>S)+CMNEX5Y:QKC;9 #&AK0&[A8"V69M<\
MB^.1X&*5)JI2#FRV%"3;,$71"QB2;&'/>&^SC[13OOB7C*\NK8C/%WU9=2#B
MP*3+VK2\DQ7FSR:WE5#-0OI#@GJZ3 &[.Q2L>^)L5AM!%^TC8P$AM$;48*NH
M$<,U#*KN(,\C!-YQVS=2#B4=KK.$E9518_CY2*HJ?PF1-0N5?N9K1+SSR).1
MW)(RC)N*$A+M[!L2Q,)./:-WB+&)%JZV7/-C%492;M-FBR+&OHM5264E"+,7
M"+##C0X(=7<<%5I=/VG.7R#BZ38G=FC%:%*044^</W4<:,,D_6GZU9VZC0J"
MASD(@T;N"K@FH#@4R*(*^JT5TRQ;0VHJZG"6TIEK8&T\IJ8'3[+&/X0&,"2,
M!VUOOM C*W*.+4T5+6A@J6R.X,ES.#D++%PLZ]M]P!;FSMO*N$XT@])89J3K
M]UL-6C+:YJ3VZ1\2UC#O9I]3HZ,AXU:/FG2)UXA.4AH>,A+,D9H]1D(ADBV8
M)PZJDB^>^/8 9ZN;@BQ]5,V>5Y/^TD$4<(LVY:T".)@R N;DDWRY=@UC6-ML
MM&6\G,#>3F3EGG] 6,;+@+?L[BZD'.S9B9K-FU]8J/>5)ABC(V=ZTE0U:P1;
M5][)KRYX0[N'H#LSR;;/.O"2CQ$M6@F$5XDT@_V4*LHK@;KD6ZH"PVV;<!JZ
M>JM@IRRL/"/7X.J(FBPJ*5BE)89.0EVK&&6G8^2CX]:%BGKN;;V2*805BKL&
M_CB>_O\ ]+K*IEJ#7D9L*8VO'U2':7^?KT/6I2Q(,&9'Z\;".IMXT+X<J *E
M=*J3SM)\\%0RKYJUBFCLRK>+9$1(L<)#@YBI"2DY4EL<0LF_DT)%:3J].J-9
M6FGB4J^DCS]T8Q+9&#M]U\$_59-[8ZAX\Q  ZB\6Z157:N2+QZMP2Q-<^&CM
MQ>K1,S5SDJC+*2LBW(^/'/*=8*'/L4VRDI)RDT[9/7>O88\FA+3SI94RKH4'
MB92M10)V<JIX>!QX6RPH?#]PYIB&FK'IB8;N(2)//%J*S765=KT9 JG;KM8^
M4^"]/EPDKH*H2;:=59/HZ'(S<N&*!%?:W\.R5JEKG(!:'D8SN-@J5W7CR0$)
M).&%XHZ%.;5V1;24@F=8*\FE1X7RI5D^J234/)@>8(PDWC!8BM<IP41OC[B2
M1O=B;.Y"Q!=I@K1@S;1DQ<37N(V"NZE8)%Z6#>POEB(0:1C(8\MBBHL$HOX8
M.HEJ@RPGO[^_U*MH[AO>5?5LM2("R.Y22"ZTS8-9";%RWKL1)Z^G*?8*[6V[
M;PTX^AJR]=TR.:R+6,!=C$)/'85F!B8AG&0C4BM7%\$*[F$\+:+PLE9S0%UH
MXC7H&&-#-Z)>)3:KF58 WD611E+(9+:TRHSL[Y!$T<JV;(J1,BTD;:%K)[^_
MOR*Z.O\ A98Z]V"QOD5:YM=*-&?:,*HHW(6O,HR=\(HZ!FR<2#I**EE71&+A
MXO %B:^],R.Y)7DIB2DIAR14./!#"&!$X7BP'<0S>LQ-;\+%LT&K*NU>!OM6
M:1TT2,=1CNR2#B$V'-$=2Z\@V.N^:QZZS55@>0C)$BJ&J<'D-4[)0I]O;9%R
M36-BM$S46/D"#9(%8W.6M<O8H>9\F U\L]92U+MH5^!(\(=!DCU&;I5[)'>$
M7QV#@IJ-AG[_ &)[9K"#F_0UTA7*(-(M4(E*Y-=ULGCM@JNBLH+ILAN^P%:"
MH/4,G'LT7'63</ 5(N#<&D8[VFQVA+7FS2Z\;+V"3CX!\F@ZBFQ)T)U0C<J;
MQ5TW:)Q2TXHG'A"L8I,S>/8.I!N_GG$Q,RA%Y:?!%"!3X;7BMUGEJI QUW;Q
M0*05=--$=["I-GIEF6DYQ5%9S(-NM:7LI#1J9&;%D5)!D_"61:QZK<B\>=X3
M+M$[47NVNY"NGA96X-=CSC.T/UBN0L<&&R7L!7H%DRJ;DL+!ED[T*<C,)3JK
MUW'J&+Y) T8JWL1/?W]^U9I:NIP:[UKK_7X.S2!:-2ZO3RR!T@0,_+6H1C#%
M?"@ F!#QLK(''@.L(H^$\&(\RB $516.&;6*OS=?>"<K.<B9"(=F2(U45!M(
MM%6;@4TWS=VR44!)8XD([:.6QC<BKMUDA,F;..4P21S-MM1/;(V][7:X$7V2
M'6N,[$'F(.:@M#@6N%PX6(O;(^7D6/9.'-A!P]:CZ/8I:%?578I]E1K^?2+:
M6JTL:K6&IJ,74<FZ@@,T48V%PY5<(.&\F\D$TY"3>R;L[D5.578C48C,V>;@
MMML? W9$&#@@20T ;K AK;'98QK6, :+*6V9DW(6(MGNM;GWG>><W/*5:J9X
M'*O-L[(U7M]C_P [ZK8X>?<OF<=).#62R,M@H2%MB62HI5V-<N7>R["^-&C!
M.F:)?%X^/5C&*TTA+\)%6T?PM,$(_>#)W:I=PMOJB2=,N+IM&1D8DT7D9'93
MWRS7F:)E$8X$$]F2S9&/7\=\*6/C7+YXZD%'[EV14^GP8UUBM<GL7<;1'R5N
MV-=MEK231M# [CY2YP.W855@Q\(VZJC2--MZ6?- <<U0=1C$X.""JY.8BH]+
M@!J"\'L"&F;M<I VQ746YFI$BR823%.-EK9-*-(B4E59R8%!TO<'S,%YB2FY
M(S-!,9%[*/%7KET15I*<'D=9IVVVFT724>3UPUA8=7O5(JMUR!8QS&PD.W4F
M89FT2<&;2C!(W-!5TZ=&65 !4.#8B*")%[>C-%737>SK[=;"[KY8"4KC:H4J
M(B'CB5F&T,ALG9>P5WEFEG5<KRBTDNO?2MD6Y E4VQ6RX'EI!V=:7E2++W")
MA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
(F$3")A%__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g14810g15h45.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g14810g15h45.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
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M%?TTH$N1MVMH:U3LD8Y=]4762\9*E)%_P;(D@)'##(:9'!;RE:W"*7/1)?\
MXT.]/F_TS_L[\(GHDO\ \:'>GS?Z9_V=^$3T27_XT.]/F_TS_L[\(GHDO_QH
M=Z?-_IG_ &=^$4%UB<VK:+?7]9D;KO<:V+8.H]@^YQ==TYBWSHFM;5K:(JH<
MFW):KDJ<PR,'<)/!3D)4(<LUQD%QXG/@G\$ST$^$?EOZ%22;M'7>_P 04Z>B
M2_\ QH=Z?-_IG_9WY"J3T27_ .-#O3YO],_[._")Z)+_ /&AWI\W^F?]G?A$
M]$E_^-#O3YO],_[._"*"KO.;6H-BN5(&W9>Y]!C72@W$V2P5W3GG#55[<ZD#
MM6W-^#1 :K@:X4Z35FFL XL]>L3($BW@QEG.%+9613KZ)+_\:'>GS?Z9_P!G
M?A$]$E_^-#O3YO\ 3/\ L[\(GHDO_P :'>GS?Z9_V=^$3T27_P"-#O3YO],_
M[._"+4Y2+V%KS86C6G=Y;)O,->=DSM/L5=N$%I5B,)C&-*[=NPK[!5)U%3)\
M4X6?ID(^TZQ-H8<802,2,0T1G"2*T'")PB<(G")PB<(G")PB<(G")PB<(G")
MPB<(G")PBKHU<=UVF[[6A*4-JT" US=8BF#O6E%L*F)1X[5^NMA%'O8B7QPA
MFFWKXJ,88;PZO+4<DAQWOD9;;*.OP']P/[UF.YU+?E.C/T*_?V_A2G<ZEORG
M1GZ%?O[?PB=SJ6_*=&?H5^_M_")W.I;\IT9^A7[^W\(HQJ^Y=R7F4K]8@(?6
M4;/Y&W7FSFS#MI*AU$ZDW2;J%KR"P$M@U#$UD%R;<Q(/.."8<0&G+W=4_DBD
M[N=2WY3HS]"OW]OX1.YU+?E.C/T*_?V_A$[G4M^4Z,_0K]_;^$3N=2WY3HS]
M"OW]OX11U,;FVQ5V[_ S<-KPVX5VQ=/,' %Q;UD8K1"=\;,%UT@B8'+4[*)5
M77'791383_9((PV-A0RN\[PBD7N=2WY3HS]"OW]OX1.YU+?E.C/T*_?V_A$[
MG4M^4Z,_0K]_;^$3N=2WY3HS]"OW]OX18ARX[IJUWU5"78;5Y\!L>Z2],>>J
MJ+8++Q9 .L-B[#&/:Q+OD!$LN.4/$8^PO#:\(D?&&W.\/X-PBL5PB<(G")PB
M<(G")PB<(G")PB<(H+VW^_\ Z7OETL'^C/U$\(HVWTU;5WD53X^\3*EZ.9%O
M7X^BI.PQ)ZMRYFLJ2FX%P3J(=AEV)Q!^:)>U6BM,BN-6[S[96EZ,')(JX[#O
M?6C:\[(AZW#VRIB@2-R9IIT/09MJ0*Q(:TZJ(J$B#2R(^-96/!6VN]/\H-,5
MJ>F0#YJU)D0[RJ,*7"5<BD6P[&ZR81V:C86H-6>:B +XQ44/T AJ#ON(F=W:
M+%SMAL(D\'%523&AJWI@Z'@,DQ+-T?M\NQ&=YF2<+UP18_6M[ZM?2I$PLA#2
M$SJV8M\@8U:;K1[A59Z;KA,[:PI3+\3YOF@4)-9K$139Z #L\G0U6&3L4H%&
MP<H\MR'K!%MO5_\ WU-?]S+K&_IGIOY+=X\8^E0[<?$?H5R;;:8*C56S7:T&
M^3*U3Z_-6FQ2.6"2L1\%7XTF6ES<C!M/ED>*1XA#_@!6'B7O!^#8:<=4E"H4
MK0J_O#7LRS%)E99-#EIZ=S7(&N;#= J<[8I;(D">PQ51SCE"7%DH2SU]3!M2
M-G O&Y1J'=(:FQS8T4B\1^_=+G4FN[#>V?1H:I6F%:GXB6L=I@Z^RL!3H I&
M"<2QXN1"XR1E (B8#(R@B)F26HH]M@]:6,D7M?WQI9B:"KF-J4(JP'VJ,I#$
M+&VB(E95NVS.)G,5 G 1A19,9(2"J]-LBMR38B7B8PL5*LDMY:R183J#_>=4
M/ETZ=/Z]M>\D;_B=]!4'=\;?I"\]-_XH8/\ G#L?^LNW\A0SWH^/Z2NOO717
M6+6(M1\5'[!M<VJD!E2B+Z#N)<?!;4B]5[_*)&?AM@WE>;@/,7)W6D<<]K\J
M%U0ZXS'IAH4*;(AYJ'*I2/L.]=:T<0P+7*\?-S58D;X17 Q*%("U[9 M?)ZB
M8VOR%WL<;*ICZZ@L> T68S6VU@)LKEM..B!GFRE*H!%-^H;OU&&B6NP;+K[)
M4-6M:D2]:A(:J3L//7^T*NVT6AV5.6>+JLQ&RK%,JM&95!/T6 47(V[,TH4
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MP"NZ\K".$66D=P:DB#R8N6VCKJ,DPP)N5+CI&[5H(X6+K),L%8Y(D0F3:?8
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M-U[74^S-$[ E*W/6JX2VM X9F9P*!72+]R_5%U$42$F'I2B1UW2?L.]"5JT
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MDEQUCRA;! 6C2M4C68>KV+5U;B!D,-CQ4!+U.'C6&QA!P!D,@QQ PK2!P0Q
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M0"0!<V&X7 N>H7(%STD#>5Z(^:AI99+<5+1DFX&XZT8W'GBF+%=8/D(I]LE
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M^4G)6(]CF^2/2GI:J/Y)??5-M7[%\<IT':X?E)R5B/8YODCTKC&;7J;@9;:
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M4N)2K%^F8V2IIXWB[))XF.%R+M=(UKA<:BX)U&H5BJD=%35$K#9\<$TC"0"
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MS44$0I;C;JEOR^1X:2W*"961L+@7"Q>UCB6AS22'%X S-W [M]+(F9@'YB!
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M0YEMOP8S/@QF&&6X#0T6 M<DGPEQ)))WDDGI\0T "J<YSS=QN0&M&@  : T
M     #</#O)6*(H54*MP5Y)C%OV6.;RD MV2EE@AOY .B<R8\$H[,"U.>2).
M1AL6!$9B;Q#'%Q.)#$<0Z,J"QI<'D7<-VIL-"+AM\N:SB,ULV4EM[&RD2/#"
MP&S7;P +D7#LI=;,6YFM=DOES .MF%U)O3M^-G>G\WM.?^6Q^:=PA^SH_O:/
M]9,MUX-_8$GWU)^JA5P^8); G")PB<(G")PBKGU7_B/GOYW:C_K@H?/31?9E
M)]\P?K6+RUWV%6?>M1^I>HI6VAS&$N(0M.%)7C"TX5C"T*PM"L85C.,*0K&%
M)5^ZE6,9QG&<8SSHZYBO&6T*[W>0A7?QA*^U.,]Y*>W*<*[<?A83G.<XQGMQ
MCMSV?NYX1?K"4X[>S&,=O[O9C&.WW<Y]WL__ %SG/_[YSG^/A%J#U!JA-N$O
M)$8M^R@(S@(IV2EG 1",@&1.90:"4=F 9G<P\@=#9L#<8F<\C&%1'E#R:^X*
MJG(TN#R.<-QN; V(N!>P=8EN:V;*2V]C95[1X88P>:=^@N1<'+FMFR9@'9+Y
M<P#K9M5MZ4I2E*4IPE*<82E*<8PE*<8[,)3C'9C&,8QC&,8QV8Q[F.5*A86<
MKL-9&HYB;#\?'BIJ*L(8RR"VAL3$$6B0ABR1QWV63\1DDR-)AC'H)$8E P))
M#&#H\(AB"T.M<7LX.&I]\TW:=-]C8B]P" =X!%37.9<M-BYKFDV!.5PLX D&
MUP2TD6):2+V)!Y\C'ART>=%2+"2H^3#*CSAEY6E!(9C"QBF%Y0I"\)>8<6VK
M*%)7C"LY2I.>S.! ((.H(((\!WJ 2TAP-B""#U$&X/E4/WJHP%+T=M>(KH;P
M@CM#V%(E.ER,G,R<A(&5F2R2?*S4V9(S$L<ZEMIG)<D>60D9@85#B1AF&F[4
MC0V&4-']"0FY))):;DDDDGPDG2PW *]&]TE1"YQN=I$!8!H #F@!K6@-:!U
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MU;CF4I0VG"E+7E.$IRK..=[]P 1]T&.NE#,C,$#G%^7*T"MIR7$NT  N238
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MK 4B8I7E?2M?F.8@N?(XG4BTD+XB,I.73,'7M<Y;;B2O:RM>P- :"UK(6 :
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M.=M1J2PD!\/U6-Q:'6>UKP?K;VY'N(@R$T7OAE=2<+BLUP0.STZ3E@Z59HT
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M0T 7) 45\S*PRR!<K(GC1@9A;Q T*"[&1;3F<92%'O21TNX&SG&,*P.J3DY
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M].W4%G/;G1>Y,Y]S';G65VSGLQCLQC_L3^+&,8Q_)CW..ZK@Q]L> _CC#_\
M$)W+\)OM=QW\48A_AUL<;J3JBAXUJ)C=-;B$ 9L49;,,MZELV5NST*R2Q$&E
M$KK2BC41C1IV  2WGX\5<A(.LB(=/,6]Y)L<X'3RF>;'\!DE-+-19G8W1V;3
M5#F.GC8P589&9C''M9&-;*\11-<\MBC#?7#@G#"")L,. XZR-M5#6V&"U=W5
M-.U[8)'O-(7R"$22;.-[G1,,DI:P&1Y=K[W3YU#D/.D$:0W.^0^XX\^^]K6\
M.O//.JRMUUUU<*I;CCBU*6XXM65+5G*E9SG.<\]3>%'!9K6M;PBP!K6@-:UN
M+X<&M:!8-:!4      "P&@7E=P8X4.<YSN#V/.<XESG.PG$"YSB;ESB:<DDD
MDDDW)U*]?M=NH'X"]Q^K&[?4G)[JN#'VQX#^.,/_ ,0H[E^$WVNX[^*,0_PZ
M>UVZ@?@+W'ZL;M]2<=U7!C[8\!_'&'_XA.Y?A-]KN._BC$/\.NP+V,'3FW:A
MUCZ]GK9JO8]7@Q82_-DS-BH]GA(H=PFE38XR'Y&2BQ@V5D$.-L,)<>2IUYQ#
M3>%+4E.>9>Z]CV!UW 3%*:AQG":RH?48:64]+B-'43O#,0IW/+8H9GR.#6@N
M<0TAK02; $KI?N1X%C=#PYPRIK<&Q6CIV4^)!\]5A]73PM+Z"H:P.EEA8QI<
MXAK07 N<0!<D!?0WU7?P9M]_)+>_U=/Y\@4_V1!]VB_3:OKN?ZQ-]RD_0<NI
MG>0VX&]B7PJCYVW*&F0\H)5HJ&3LN"A8D1W4,@*B:KUD@YV2T[, -6UUUQ=9
MMU:K.V$7)EV0@I\V*;H[6-\GVNT?DVSB6D-:-HQH!A<,S7M<Z%P#S[Q[639P
M2UQ;LUSZG,!BC$FQ: 1G<=DYSCMFG*YKFB=IR #/&]\&SL'-#C*M4MA'5(Q*
MV<B+(V:F/01>U1-: AIDV-.'P%UG!5M"9UA+UA$\L2H.BB.V/L$<Y$)FJL5$
M>08D>(\1I>:G,XMVEKR96@&Q%JT,YWOAF(ISH\9;MME%K51\4+6!PBS6CN\N
M <#?#R_FWRG*TU0U:<Q#KYG9LVTWG;N^]> %S%TET5VN2!Y)3<WB@C&F0'B+
M'4*<'78B&;)=*L#!H5"U.982%M&R4?#V&SS^"J_"%,RE*K=+/&"YY#67O<1W
M+;"H=E:T$EUQ'%FWD!SW7:TWCHCAIY2UK&YG!H!:9+!Y)I07.=:S#>2?+[T$
MM8VSG MDM%49"W6@ZES,LU)1HX>H8F8EVD-% Q<U<[S@)QQEL;"DM^-TYBLR
M6'@R,O*&1<P580VZVES/I9F<YA=<#9@N&H!<\B_3H6!IN#N#P?"O(\,8V1HL
M29BUNXN:R.^M^J0O&HM];.^^E,-?F=5M*$UK 7)[9AL(!JRBM6K9*H(_8=G'
M;G8:6FRVSZDVW*'3FT*O=@8W7EC,>@ITY^D2(%RD"7)(B<*@_%'QI@B:_:%H
MBC#Y"#([5I.K-7.E:\"-QRN)80]Q+B\M]\PHY#,^/9!QFE,<0(B:<KFM%GG*
MUL+XR96#,P"0&)H #<^?CK;U59'FP;2-=HB5G',2 PL#KIRR!!STM4M6*D:1
M'SHA0@E;I]?5+W@J,M^; 21B?!?PW*SDI7'Z9:Z\U3J'9FDZV;'F <6178'
MV:QN:0AY<></?.+,CJ"RCNTL+'-;H2Z3(2ULDQ$A:02][\L8,8: &$<UH>)&
M;1$E]4;4U2ZT45-.#)?7!3%^?K/?=%A9&L=/<V;(/1;ARZV5*@3\SM2"A9J:
MC)8T!JOK9,<E'V+$Y8)::G,QIW;G2%NH!;3N)M?+FS&9K2YKK91<.LXOI<*0
MMD>,H/OFQYM"X.JF@7 S@%K8'.:US0XNTR@M#/5K#=>UK!LJ H5_)8!GC:.3
M(W&EAU!8H< Z#J;5MC?D<V'!!2P9=ZZ7:<CY>LGEOE1@&*XSXB RH:;M\Q32
MNE;')8.++O8&$!MHX79LUS8YY'-+220,N@T=(F@A; ^2.Y:'VC>9!=]YYV 9
M+"[=G&UP<!8D/).]D?;9TX?P>-#?(QJ[]1X+G/';SXS]*Z.W</$/H4S\A2G"
M)PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PBZQCKC$T_:&]@+ ':@R#=L$
MRH2F*)=Y,0V.)I%'98-#D(JO' %CK>&(9\(.2YA+S#S2^ZXVM.-OP>LI8:%D
M<M1%&\/D):]X! +K@V/6%IF-T57/7ODA@DD88XQF:VXN&ZB_@7-]+M*_EMWJ
MVV1]D^93E&@[7!YQJQ')E?V2;Y*>EVE?RV[U;;(^R?'*-!VN#SC4Y,K^R3?)
M3TNTK^6W>K;9'V3XY1H.UP><:G)E?V2;Y*XS&Z=?E.&,C%V4AZ/)2&>TQKW8
M;S@):Q13TBF(;JRE#$J!-",2P]A#N12Q2,)RR0TM;E&@[7!YP)R97]DF^2N3
MZ7:5_+;O5MLC[)\<HT':X/.-3DRO[)-\E/2[2OY;=ZMMD?9/CE&@[7!YQJ<F
M5_9)ODIZ7:5_+;O5MLC[)\<HT':X/.-3DRO[)-\E2STN234_L#=EA #FVH8N
M+U5'!G2]=GZ\V89&-7MV09#1/QL8\5D-$@%DA8[;C3626DJ7A2N[S5,;FBGJ
MV/AD9*P4[&ES"' .#Y21<=(!!^-;?@,$M/1/9-&Z-YJ'N#7"QRF.( VZB6D?
M$5=/F'6;3A$X1.$3A$X15VZK6B'-&6=8P4@>H.?UI)OC1<>;*G>(Q.TJ7)R1
M#,?&CE'$I#CQ"C'T##O.)'8=<[F<(SST4KFLJJ9[B&M;40N<XZ -;(TDD]0
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MRNB;*UK 3?*\.LQS@ 26C>[3TOH2V0L;*W0.>0X$&.%LQB<]]A;-&03(QI)
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M<C3T-JC;>;?57N!X+Q?!L6QR1EI,2K&45.X[^*T#"Y[V'H;+4U#XW:W+J87
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MG%Q@8F1YH#6<\U9JW FH-9*0B-5,,-KE'&&VSY(1Z0%?+SF1(>Y2Z&-S0S*
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M"<J4K.$I2G&5*4I6>S"4XQVYSG.<XQC&,9SG.>S'/H(D $D@ "Y)T  WDGH
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M^4^E/,C3'PDW;Z46Y?O5XN?!Y!Z$L/#Y3Z5&^JZ]K":K<L9.;1OA1C&R-P1
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M8@ T*_5XR!ERPC&!#_$51,OY7;?:O+3:-FS-CKF%B9&M8(G%[G#0':-+7%I
M-K'VL%,(&!XO+)M6Z?T77#8W.>9FMC:TG,08GAS002+AS=$IG4YM*U$@QTA"
M0==0Y85QC4T71;:0U<67P=2%C0]8$K%LNH$+,LHO]I6J>)G;9!.,4<\\L&-C
MH^XDU&AE1*X@%H:,UB3&_G@B$AK,CY '#:.N<SQ9A)  >67):2%C7%KB\Y,V
M42Q_4S><9GE[(RYIV3+-RL=>0-!<71B3AZWWCU$VIO6$(;5&ZQ:[!'LPEI7<
MJG.RP%5)$II]G&GYS$%)UZ.FI2U"QT7+(\BS,1#0[EN13GTN3U>D"7T<M1)L
MFY,CW\U^=CG",AA>'.+2T.S  \US6M+\ERYINEIZ5FU<)-HQIS1ACVM=("]K
M"&Y@]S0PN<TES7.=L]H+-> )$TMU"WC8NQ*]5;5!0=7\XM=6BYDT[,+9AK?4
MGJXK4+0#LI.2!GD:7C;5Z190L)EB#ARXI,2U&.O2D@).8CJXIWR/:US0S-&^
M0L+7![,IA S.)RD.VA(YK2+ <XYLMN>FCBB<]CG/R2LCVF9AC>'\8O9HYS2S
M8M!.9P.8GF@LS7'YZEXEQ#_[Q-_P0G_,KX16$Z</X/&AOD8U=^H\%SF#MY\9
M^E=7;N'B'T*9^0I3A$X1?RP_9;__ (F'6S_W@+Q_ZU'/MK@%_L;P<_!=/]!6
ML5GV5-_QGZ NNOFW+S++Q=@GH1J08A9N7B&)=D,>59BY(V/:DQXZ4!G(]B0;
M$>90:R#-1<;,!M$X=0+*1P,@PE!8@[S=M\44I89(XY#&7&,O8UY87L=$\L+@
M<I=&]\;B+%S'N8;M<09!(O8D7WV-KV-Q?KL0#XQ=2XCJ?ZE&K"9;FNH+=C5J
MD8P*&/LK6TKNU/F1,::=)1\:1+MSB9!T(*2E)20%&61EI@^4DC&TI)D#'7O!
MR)@VR;!R3AI@8]TC830TQB;(]K6/>(]EE#G,8QKC:Y:QC3<,:!7M9;EVT?<B
MQ.9UR!>P)OX2?&2=Y7I"ZE^HR.S5_)^^]S ^9,;B&IV!-G70=-5B<104%B,K
MJ&II"88#$)&1L-@6/P.QB)C8^.PCQ,$5EJ78-A#]OGPO#G<9?M*@NHJ<F>3.
MZ7/*3'>1VT>^3,ZYSO>^^9SB0EE%K2/T%ASG:"UK#706 %O %P&.H+?(H==C
MAMU;88 J,R38JL$UL.VMB5R?,S,Y*FH0=,OAJ,E",V2QY>.#0R2YYPSW><SY
M9DO&JCA.%N=,]V&T)?41MBG<:2 NFB;L\L<AV=WL;L8;-=<#8Q6'U-F6-K(
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MY@SUTY-I>I_RSZ$_XM)[&+^8-V^MLSZFX_Z8N&G?L.^8,]=.3:7J?\L^A/\
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MM*"[1HXK$;FQ-@1&1>S2;;[ G<+JXRIQ&1KG,JJHM8+N/&GC*+@7(,@(%W-
M.XD@ WT6^N: T*\VXR]I;4CK3J5LNM.:[IZVW$K3E*V7$*B,I6E:<Y2MM6,X
M4G.<9QG&<XY7Q.D[)2_-H?45OCU;VRJ^<2^NL7$:CZ;Y]EPB$U9IV5%;RVGQ
MP"A5 D)S+N,Y1XN8U$*%*QVI4A61GG<-NI4TYE+J5(P%)1D7%+2$=8IX"/*&
M6_\ O3>I=65[39U75M/49Y@?C!?<+,8T'HK/;V:9U1GLSV9[->U+/9G^3/\
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MGU$B9&F'K.[91UNC4E^J?]*N$6(K75MK:[["J5#IC,O-^=$HU".RI,?(UUZ
MEU57;=L=CINNV2/B[""2U':G?<;02"Q@P.S04H&I^.>20\16FX1.$7"DO^SC
M_P# BO\ ,.<(HEZ</X/&AOD8U=^H\%R7;SXS]*ANX>(?0IGY"E.$3A$X1.$3
MA$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$50-7ZDI6P8^\
M6>WMVF7FG]T;RCEE8V'L*/:;CX+;=QA(<$8&+M(4>()'10 8(HX@K+33 [:<
M([<9SFHFVZVX= /0.L*D"^^^\])'2>HJ2_:WZC_-%H]9VT?MGR+GP>0>A38>
M'RGTI[6_4?YHM'K.VC]L^+GP>0>A+#P^4^E:W9M0].=*&#-N4HY4@Y&0'B8\
MNS;KOT",?*E][(L8&_*WT1HJ0)PA>1PF%K)>[BO!MJ[N>Q<^#R#T)8>'RGTK
MED=/.@JL"X\6 ?7(U1,B:ZZ1M38D0"HPI1TY+%N+<NH[&225XDIB1?5G+KRL
M'2!*U9\8>XN?!Y!Z$L/#Y3Z5F?:WZC_-%H]9VT?MGQ<^#R#T)8>'RGTI[6_4
M?YHM'K.VC]L^+GP>0>A+#P^4^E/:WZC_ #1:/6=M'[9\7/@\@]"6'A\I]*X7
M3T U#1FSX 0B4>BZ_N2Z14.S+3,O/$ 1K8T(2T"U(3ATC(J%9>)?6RRZ6XAG
MPJD-80CL3B%*L#PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(
MG")PB<(G")PB<(G")PB<(G")PB@SJ<_@[[L^3*X_T(9PH=N/B/T*<^%*<(G"
M* ;)TQ::M\K9)&RUZ6E@K<Y/%V"J/W*Y-T20E[143:'8;!YD#SS-9&GY:IR)
MT85*!QHY/C!A,XTINQ$/2[A%RJGTWZBI<U V2%@)-5AK9^9.+FI6V6R;.0?F
M)N\%A\A4K-%LEX;B-BVX!E@AEP5AB18PPPVJ+BE!$4Z<(G"+A27_ &<?_@17
M^8<X11+TX?P>-#?(QJ[]1X+DNWGQGZ5#=P\0^A3/R%*<(G")PB<(G")PB<(G
M")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(H*Z?/WHW+Y=>HC^N^^\
MD[_B;] 4#=\;OI*G7D*4X15MW%K:]3]YK=\I,!K.ZN :TV=K*1JNU9>7AH(<
M789](D53HCT33;MF494FG+AK-5R8^+18HF0&RU8XSR6\%+D52+AT9=0-O&V!
M%R>U(>3CIUK9 T"(=;K2FH)$ME:O]>I0P6N5TX\77#&NHBT1E4"9K]MLS<Y!
MHD9*3_YR9CA<$7:3PB<(G"*"]'_]?N?Y=+O_ $?7.$4Z<(G")PB<(G")PB<(
MG")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(L5.P
M4):(65KEEB(RP5Z=CRXF;@YH$64B)B*/86,=&R<::T^&> 8,XX.4(4RZP0RX
MMIUM:%93DBA_VKW37\ &F/5E3?J;A$]J]TU_ !ICU94WZFX1/:O=-?P :8]6
M5-^IN$3VKW37\ &F/5E3?J;A$]J]TU_ !ICU94WZFX1/:O=-?P :8]65-^IN
M$3VKW37\ &F/5E3?J;A$STN]-><9QGI_TOG&<=F<9UE3,XSC/[N,X\C>[C/"
M*:(R-CH6-CX>' #BHF)"$C8N,CAF0H^.C@&&Q0@ 0QT-CB!AC--#BC,-MLL,
M-H::0E"$IP1<WA$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.
M$3A$X1.$3A$X1?/;=O9%=V:#VANC5=/J^K)*O5O=VX'03++"6TR9=5-[#L,\
M7@LB+N\,"YALR2?;'PS',90,AE#F774K><N!H=J;]'Z(4#=\;OI*P/\ PN_4
ME[R-'_-N^_>7R<@ZS^3T*4_X7?J2]Y&C_FW??O+XR#K/Y/0B?\+OU)>\C1_S
M;OOWE\9!UG\GH1/^%WZDO>1H_P";=]^\OC(.L_D]")_PN_4E[R-'_-N^_>7Q
MD'6?R>A$_P"%WZDO>1H_YMWW[R^,@ZS^3T(G_"[]27O(T?\ -N^_>7QD'6?R
M>A%VC>Q[;/G]SZ0L6S[0'#@3]NV]L(^2#@!S18=AX<F/CD)!'D9"5-:;RP$T
MI6") E675.*PM*,I0BVX6)'\;E U\I_(2%>KD*4X1.$3A$X1.$3A$X1.$3A$
MX1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$
A3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g14810g23g46.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g14810g23g46.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[26^4&AO=&]S:&]P(#,N,  X0DE-! 0
M    ):*^EC0X0DE-! 0      #P< 5H  QLE1QP"   "@  < E  "')R,S(X
M-C0Q' (% !M-:6-R;W-O9G0@5V]R9" M(&)O9'DQ+F1O8W@X0DE-!"4
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M;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L
M BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T
M;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP
M     $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M
M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="
M0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M     $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M    0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0%E^5@
M       *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',
M4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
M              !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E!R
M:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P
M4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P         +
M8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU  (  @.__C4
M @ ".$))300F       .             #^    X0DE-! T       0   !X
M.$))3009       $    'CA"24T#\P      "0           0 X0DE-)Q
M      H  0         ".$))30/U      !( "]F9@ ! &QF9@ &       !
M "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4    ! "T
M   &       !.$))30/X      !P  #_____________________________
M ^@     _____________________________P/H     /______________
M______________\#Z     #_____________________________ ^@  #A"
M24T$"       $     $   )    "0      X0DE-!!X       0     .$))
M300:      ,U    !@             !00   H,          0
M               !              *#   !00                     !
M                         !     !        ;G5L;     (    &8F]U
M;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M3&5F=&QO;F<          $)T;VUL;VYG   !00    !29VAT;&]N9P   H,
M   &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S
M;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N
M=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N
M=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !
M    4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
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M;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M"W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M.$))3001       ! 0 X0DE-!!0       0    (.$))300,     !M(
M 0   *    !0   !X   E@   !LL !@  ?_8_^(,6$E#0U]04D]&24Q%  $!
M   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U31E0
M    245#('-21T(               $  /;6  $     TRU(4" @
M                                                       18W!R
M=    5     S9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4
M<EA96@   A@    49UA96@   BP    48EA96@   D     49&UN9    E0
M  !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0
M _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U12
M0P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y
M.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@
M245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M
M %A96B        #S40 !     1;,6%E:(                     !865H@
M        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M             !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                            9&5S8P         N
M245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M               N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@
M<W!A8V4@+2!S4D="                             &1E<V,
M+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M             "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#
M-C$Y-C8M,BXQ                                  !V:65W       3
MI/X %%\N !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4    %<?
MYVUE87,          0                        */     G-I9R
M0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M #( -P [ $
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M*GF)>>=Z1@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! ?_  !$( 2X"70,!$0 "$0$#$0'_Q  ?    !04! 0
M             @0%!@$#!P@)"PK_Q !R$  ! P($ P0$" 4-"@H$!Q$! @,1
M!"$ !08Q!Q)!"!-182)Q@9$)%#)6H;'!\ H5%R/1%AD:)D)WE9;3U=;A\1@S
M-C@Y4G*7MK<D)2<U-T978F:&1W:FQC1%58*%DJ*RM4-$4V=S='6#HZ2EL[3"
MQ?_$ !T!  ,! 0$! 0$!           ! @,$!08'" G_Q !>$0 ! @0#!04$
M!@8&!@<& 0T!$2$  @,Q!$%1!1)A<8$&D:&Q\!,BP=$4%C)5X?$'%T)2E-05
M(U:3E=(D,S1B@J(E-4-3<G.21$5&8X3")F1T@[*TQ AEHZ2SXO+_V@ , P$
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M^8@_6SV_^]Y?X# ?RD#]=9[8?STR3^)^G?YLP?J<[ _=%3_$<;_,0?K9[?\
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M1$@QEORKWB\^8.$?T-]@&_Z)KC_Z_'O_ /W7H6(A?K:[?J^V9.7]'[.#Y_\
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MKM8UZ.P@>(-;;2CDP:/IXQ_-,?T? P019J/[P[_^C5_]R<(_$>8@CX8N*?\
MTE:^_P#7'4GT9Q6Q[L?Z,;(_ZIV9_P#F&$__ ,%./\]]JMM/'D,3C,4I#?\
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M7?R6#ZZ]E/[0;)_BJ,'U-[3?V?VM_<U/\D#\D/$WYE:F_@BN_DL/ZZ=E?O\
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MHZ)>S/;$T!A!LG:\F'ISU,5[";"3STYZ\XI4YZJ>R)WII:%"G-,I]VE($:&
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M-EZ?[73R2[VT;R@^J/:RXV%M=%<^PJA/^5[W:*C@_P 3  D:$U* D0 G)JT
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MAO\ O#_Z9OE%?1JW[DFEY;Z7@I[3G8BW.J\L$_\ @S6 _P#=W#&/PW[_ /\
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MI5J=53)E=0!W^-^,3-3FI_:9=5TXH4XN"5>-B<:Q$#!!!'"0@D#F\1Y=2>I
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M_P!3&1?T\P00/V3_ / T_-_M!?ZF,B_IY@@@?LG_ .!I^;_:"_U,9%_3S!!
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MWC.6S *#J4R47*GO%H3N$S!D ;3S?:3)OOOTG881 15"*W$HMP0 ZY>)>@O
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M43GB&(/3+O7(\-1M<=@OA/JM3KVE*O,M"9D[S.)32+&8Y5S*!A'Q!_FY&PH
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MB?4<_7KG%E<VL" 1;K_9C(2E $9P$.BYCEWYP]Y4%YC?)"CG(1;6 =['P\!
MC[#'U1BSNB4+<71.1/K,7S"EE*J<ET4E4*WXKX0G,^4Q:\CRZV&,XTCO?\$0
M9X><4?\ UIRH^Q.7/I/TG'?@ ?9U"+&8IJX07Y&\<>,_U@X2AM([ 8]&..!@
M@@J_D*_T5?4<$$>(_P!J+_&4X_\ [\W$O_;'.,$$8)P00,$$#!! P00,$$#!
M! P00,$$#!!%UIL.*@A403Z(DDVMUC>28/TR""'ZGHFV_DI*B=U&Y-^@V'NB
M1@@AW9I!;F ,GQV]HO/T",226((17*CA# Y\  Y9ND+0RA)GJ  1R]+ >$[_
M -6&NB'1_P X$U4:M^444PVX;B3$21'HSM(]G06D6!(*,Q 4CN.?KB88E!)
M/>,O7 0A?HB)* 8ZCI'EMT]O7RP;\OH>O0Y0;LVD,+V7I)6H<Z%;D$6YB3O/
MU")\;SA@@V,(@CKU\H9UI"5%(5S02#8@R#&Q_3APH+@@@8((&""!@@@8((&"
M"!@@@8((]2+\%<_R0G"W]];C=_O S3!$C[4W_#Y1(_A$O\8S.?\ ]C9'[?\
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M96%)!+:V'DQ/[E$]T0+QZ15S3/EC"M@L--[HD+6*@VU10>(;K#W1?B2N:H0
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MARUPK(YM^2AVA/-E$]%03>=S]?7^W )  CY.KGCT4Y/%*O!7]#@L=\/@A_\
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M4UE(&EPA0@JR!][E_P!D.#=@'XKQ/?!3U@1?8GK[OL/KP750NA1%Y'XL#E:
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M+?&.7%KO@D(OP 3CK'8#';') P005?R%?Z*OJ.""/$?[47^,IQ__ 'YN)?\
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M'GCE!8<@;-ZX1UFYYGSZQ0+@1?UDR?I%_;A;H^8# PREUEY $?#UGG 4H*M
MV(DCQ\#Y_P!OE.Z 0'U+CX9@GN5"L)PG%PA[CT^<%!@S?V&/KZ>_%H/R* =
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M4%05J,0!?'",%-CIYJU><T,%3>I4<&H;[DCJ9B% .27O&;* BDE +H$NF0U
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MZ'N,=!,R()B[HC)T!=AGYQ<YDCJ!ZK_5]_7AB:945V%@OP^4:;LQR/7\8*%
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MLFIFFJ;+Z=KD;H6:=ALA#*4NMI0\4!10@N+@J62G]4EI2F4*!O"4!F0(2X"
MW52X=[)^<D 3FH3O H"23:53*RH"A<@*0BJ@363C$TC.*'N6UT]2TJD@JHW
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MWN4SS9(*%&-R 2/JZ8(465)*24J$$;CZ?JP013!!'J1?@KG^2$X6_OK<;O\
M>!FF")'VIO\ A\H5_".+CM*YX!/_ #+I^1Z\IHOL(^SKCP,>4Q$VNX43K\B/
MPCV<*2,-*;#VDQ:]Q^/I(T++@$S>=@;^/3[C'%(26+I:S7C;=))))#L >;>5
MEB](ZS>UO'H)&U][XI 7 OFB)Q?P0(L=)( #HA'&UP47+TD4YA*A&TGUD;_V
MX@33* 3=,A8IZX0EE]X)F2BE"0_+T.@*H (Z^=_/W8L.H(+%U#$IZ/=$S"0
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M:4#=!E0%,@SLO Z<RL7\TJ\DJ-)4.7LY@S4J1FE-7.MM'F4OXN'%001 )+@
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MILO7H)") <^OG%>9*KS!M,6\;$V\_IVZC.$[W!3O\7/1A7XMDFJ?&+O>)Y0
M;[;_ -?N_L!+*OY>L^I:+)&Z$8YZGKI%4.@$)48]1@GP!_MV]^"X*=#E^/H0
MA.0Q+FRGTO+\8NE25B;S)M:!>W]77QZ83A'!&KDVNKY] ,X0DF/O;Q=T5BBY
M)Z6]XM*6J;R/:#]8.'OB5D!5[+?J(DRS@_:(S0'Y'\83NQZ2^8IL!8QUW,1,
MS>W3VXH5%1$&HMR\3EF8 H#DFY),67' 4CE)58$]1[ >OWMUUW@@);YV^?2,
MT()3BB$VOD^F;E+O">2J1R])F! ,=;6B0-L-^%^3>*GNA%];$ZK\457))2+M
M+1U==54U#2,/5595/LT]-2T[9=>J:JH7\7IV&66SS...ON)2EM!Z Q-L5* J
M-E?@5XY+?4P@^NK9:E&[FR$=^^R!V5J'@=IUK5.J*9BLXG:@I&W*UQ26W$Z7
MHJAM*OQ+ES@"N6I*(_&E4A25.K IT'D:/-X>T\=[2<T<.3+2E4F:0F7V@?\
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MO.& #[Q0HR*^OKJB.8=^?'YQ94J 0#8B8GFY3X]9VMY@D8F:<3$(&1 !T8J
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MK:%57Q8RD-)*@D"X 5*@"(F#L)D8Z))I0AF965"Q(U]<P"IU$B!"$=!<HQL
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MEF\1)MO*Z5LHIJ9I!,S!DJ()D@@6!.TB/"\8Y,3VQ[08N>:I7VA7]Y![BF4
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M3E:XN&ODXB*\&UNU.J^).JN?TLPS;+<M969]*GRUA:^5).P!=B-IF]SCHVP
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MH'*MX!4*=6TV5-TK42I2WW>1I(3,E8!&^/#H82ICL32P\DJSU9Q*."D S%=
M"5* H8SGGW)3,2F9([TX+W1'NR1D>95E'J+BQJQHIUEQ7S)NMJ0XDJ7EFGJ1
M91EN3L\TJ0Q2TH9;*.KO>D 3;7M/6I23T-FX8DX79DADD0A*E>8+/4)#$S3&
M8\D#D!,9)2 9K^UF,Q'=N@7/V1>V;1O#GVI/B%$[2TOI5"VQ2L*28 4M/*XL
M"T!"2I0]V/CZ&']I4$TQ]T'?F?)5 LZLO-(H2V!9R4S3C8Y(R:Y)$SX9M-Y+
MD--3+(36UCCN85,_*4[5N*4CU_F0D7'ECFVA,:M>:9%DE$LDH< "4!0.&\KA
M?*,Y@J.B%2POP;PL_?GBF<[IQD(N0 +>H0# L1T)'NQX<WO2DE@P"\KY)92C
M$\HS !)%D6ZL ?BJ79%AXS?*,DUGIO.-)ZGR^ES7(L\H*G+LRR^K:2\S4TU0
MGD6E:' I*N7F+C9$*;<0E23(OS4JE;!8G#XK"SS4Z]*I)4IU)25D,I$R A""
M0Q=P>)4!WA=")L]"R/<%\W01JI1:!KM;<".(_!3/WEYIF.DFLTT_D5=6<SE1
M4Y>VAVJTS4NK625/,("*5:U*YI;E5R<?28VM0EVIAMH2R"3#X^038JG* )1-
M5 I8F246 (,TP R(9A%TYMVK*0$$TI4Y@D@')%&N:*2BDM'P4^49CI_2?&#)
M<VIC2YCE.M*++ZYAQ'(ZBHIZ*J;6@BTGFY>0D06U W$''Y[M' S;.VCC,.9A
M-3]K[:A-K0JC>ID9&7=-]5O>/0K(LK@E,D?B4L>'Y1ULQRQC P005?R%?Z*O
MJ.""/$?[47^,IQ__ 'YN)?\ MCG&"",&-A1-DA4;A41!MU(]XVWZ3@@B49%2
M%Y2'EI2.10:;!ZD$A*K]4DD@[^&XQ$Y:_/D0?7E:-*8OZU\?%^,9DR:B=3W*
M4B&G%I295 !F\FQN0.0\P -\8M9N(_"-E,H_\0)'#+OLC\7B:.5;K!YTK(6U
MRMA:@.925(E\%S<\DR#)YE$F;8UIV+(5[P&#<D?-8SFN&NJDV1"HR 7@19VA
M(Y4RBG*5E1#Z%<RS#8;"N:%#E*%E6_YR0/"YQI$6[U(R14L>5RB-G:E85...
MOF$)3S+Y4I3S.*6IL)4F$I!;00IP) "09(O@^-N,,+8A4S<A@0+'.UG<7CZF
MO@->R.UHC1E9VK-;9.I>J=>,N9/PS16H'>99I9M;M-F6>H2HJ4T_GSX+%.Z$
M@KI&E*$I<YCPXN?VD^XOV"$((0ABU\R5=LVB$"HRDO:XMEP5'9-(^F+3-0*5
MMNKK$K4M:5!($<J5&%$E(!W@]!/3&<I.Z,]=2B@<#FL(A"0-3JG<JQ/'L[+H
M:**1FOH*D!%12+834)+8(YE%*H (_P TF;;VD, :(?7'O*OR@\+6X1PV[7>I
M];:IUYK&MX69#E-#FF1YQ2Y#EV39N/BE.QDV6/U"\SJ5,//4Z5YEF#[1Y&5O
M--%I\K2%=VE#E++[0>T!)0!OPT'6SQO326F=QE*3:\] I1RI9@3;GEGG&XT6
M<M9+Q]X9UVD,RI'#D=1J6FR9.M.'VI*-3S:VZ3,:&H8%1494VZL.4=4T^EZ@
MJ$NU+#B&G%,KT-) \PZ$>#@Z)G\$<_:":8\MT@\['3BR1L/H/ASH?5%'4:BX
M-\1,QT6XXNFJNZX9YJZ--)K':9JLI/QGD.8TBD!;E(]2=YESR@E% &Z5*6R6
MU)S$YDF4K="@50KBR.B-!NDD^S(1+J 0'4.0.XN2Y&64LBX@=H+A+34>4:AT
MX>+^5/UN95 S?(J]:,_HV7'5588<H:M"6C2TS*G$TS*$-(;0TAAM;CC@Y:,T
MLU@0;#1N)9'\"6#"?>ELKHLJ-;A?O758V3%=HKC1H;+D<0=!4><9'G5'\87I
M'B%D%!7OT*7TJ:<149=6M5'XOK%-_*>IU-.]VI*4. R I9C*6 L%5U&E^2C@
M-#$[F\IFL'S4G7(HBY72-)N)?P6/9?XBFKS'0=1J#@MG?<.N-JTY6(S72K00
M"]SNY!G?>N4U*V@$K3E^:4@0E)2AOEE)Z:6,J&82A79NB%U_>5+ZK:,YJ4I$
MRAD4DE%%PISZJEM!#MV4^RWE?"O0!TKPIXQZ=U,U49U7Y_K#B!IV@;KZ[-]2
MLA-&B@7IY-4<SH*+3U'R4=&5-UC(=>J'%0I\I,59)YYIB1=G4,ER0>*J4\'R
MF  D =%+<K9JX U4+E',KX3KBQJYO6VFN"5169U7:5T_3M:SU7G]?D3N39=J
M+.W%O4NF\IH'TT[*'FLN4R_FM53J6GN:DL2!SSC2A2%.90023S#/8K>*)!"D
M/;AD2R\4\>$<N1K/O*=AAJH%.AVH"ZA=6DON.*2\L\[B  IU*W''%H<<67$0
M5@F21UB<$E2B96L@Y#\(S-,DYZ6/^];,Z],@T24:CJ%9,VPT^6DLLK)>="0Z
MHO$GT%%;G=,^F5!OE*>8 B"58SJ%UR064Z]?/NAR2$ D'/EH/*YN>,:P\5*!
M#[:JTN=X\@%?,"%J,>BH+(*B%FZE*!A5S ! '/,.[>1U#E%Z7CLIA!NCFO!0
M2.;] 1HD8%3SE)(!*1$B;#H+3;[^6)-S=F?A&P4!K$IE<\./%O"#)CTDB0%
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MW2PU[5..\U[>0&T>)/7U^5HZ?)3S*2X12]FOJ?D$S:/4EE3R":>LAXLB)QX
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M(-K[GZK;88E.AZ@@#1]2AX?#.8$J$)#ZECU/SY0^OZA4JC6I"P5M Q!2;D$
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MRVER6#2K**3/M45H1'XP>I>\41RI6I(6$F\<T)L8F=S<G&V+!GH8:57I@[H
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MB)P3, 013!<RKF0#P<9W.99BKD&X*^ (6WE81L515Z*%E#BSRJ6!R-@W-]U
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M%27?3Q46A&RE\D96&D>G+^"[&?@E.&5HCBGQJ'A_U]S/UF?&;XVCGU]9#O\
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MP^><'YVR""H!1V,D>_PWM.\VV. JH0*'6W2YAE" AO9'[QYJT)E+000H$D2
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MEXJZ$C--!!%.$2HF![_$^=[;X$8 KQ(*/T2- 94 0D_'FMH('BK:XBW0GU
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MR7,;456L:UK2JLLI*AQGXP$(=[M13S)Y2%@D&2G<><]1M\Y)A)#B=^:4'=<
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M@IT54=L\T[XWJ%:SE] LM@II*9E8=0E5EKY0"EM/0N$H;2B9)40(BRI+-]H
MS*HRS)"BVB@MU*1T5#+( B[I%BY)9LLU2Z(O*M!5KIVW7W1RU>8<K]8FTLF(
M:HX!('<-%(Y1/*Z5*-QCH$A)"VR1"Q\@3HME,<T\P3=?>52-"+*[W*Y0_9=6
MN)65R>4 &%GFZ@7B\B8VG<;6PYI0" 50WLK,Q'CWN;9:'T8FM-F+9"()!4 D
MP" HSO O!W^R9Q 9.'<T43J'1^YC>^J]T/S5:V$$]X$F 8$_*V$1X?1C03Z^
MK-:$A&1L_ /?NA6,Q92!#DQ(6%J'I'RF+"_D9Z]+WA>XS3AU73O!XP]R;3Q$
M)SG+2G"E"R)5RB8W'I)"3T23Z[;XGV@&75FS;(/W)S$2CIZ\+^/"+OXUY2 7
M.41\F18?YLQN=_9'6,4*P3,!+H%\QQN1<E5A[I,R9KQNGR5D>XAGS34"6V^1
MMQ*CRR 9A1)$\W@!Z)&TD1:<(S;P !90'' E,L[.H5H9E0*;V !YH3ETY/$.
MJ=5OI;44K%B)Y1))_P#G*]$ 1;UD84H55,R-<]>;,59=(2\!ZYKX1%ZS5SGI
M)*R4\MYBWRN@@&-S.T1)G#W95S%G#EM%7TBM"+MZ;7R_"#Z9S(9MFCM<IQ3E
M)E*$\K8'(ARM=/+3M0">9?-Z=S(";VOC*I-E*!FQ0(!=REM&ZB (KV\3X7YZ
M7C)F:,5CK5)2TM2:9@!=36525A!"!+U:^HI58J1SJ2HV!MMNI)E!1%?W5N$N
M>6B7?A#(37\<QH<]>^-4N+/%C*-,95K;B/J?,12Y#I;):RM^,U+Q!:RW*J=P
MM!2C/YQ\MPW!DN/-I%R,=5.03SR2DYKIO3(Z]P4GXF%EDV@=#;B;=- (^('5
M/$+.>.W&SB;VA]1!52K-,^KD:>HZEQ2VZ9"DII:!EDKYN1C),G2PVRV" '%D
M"5I5'1B*GM*AIM++*P9E 1G0*5YK9'C82@2@YD*0'#VNMQ]I'R&AP3Q(<<J7
M'*DMI2"4@-DJ'=!!]!))M8&">OO&,0T^ZMF9-%-N+B_BL:TR$.3J_$H6R0W/
MR6,1J<'*V3"B5J(453(A1$0DJ$<I@;']T=L,*I5ERWG\.Y>%BZW?AT^TJL0?
MBBJ2S&+B0 I'+))5Z0-BLDW(  2@$D<Q285NH8 P*L@;5E-] A10G.*7TW*$
M;R4EQXE02H!:0(*C)04\NWHIGEE<0#>1$XJ^1'K@>$1,@!+(B7=%0H2N91,F
M<0WE($@?YEY  D00B+BT6(/,;3-Y<9SH$0HH;AHZH?P[_3?_  7UP?K2_# G
M;\J/&A("0( 3KW,]P (-[SON-\;2?9Y_E\(YYK]U^0]?*(!\)LLCM19\D_)_
M$6G3UB1E-+()VCR WWZ8\3'32C%3/^P!EG*/7?'L80+AI W^L)*M^UGT$<]
MJY(!'NB#X>/NQQ2S ]+^GCHSU*^N,5YB3.Q\NF*92G?98S!4),)BJY#YA.<
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M AU=$X.IS3+58[&53=RJ"(%YGZKWB/6+S;'RTTIE5P1,P(ULJY99>+1[-&8
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MYH\H?G7ZZK*>]J"ZJ5*2HA/0 #?R*^-FKU/I&.K;\\J;DEY:4N0DE""5&M=
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M0USW@;*F;V4..MO.T2JIUF]JMQO(M+TJ\MTPRI"24_FG\P""D)54<I'H*"9
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M"2>:!<[VOC07*!.)U*A;.[#@.AIUO<V/2W<3UBI66VU)2I2G%$*2HH2 $@I
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M:;^IE EGI[+DF)GGM,#BB4$MR#3<YDAT^:VAMOW9I,(-ZX,XE ]Y7 2X1"J
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M@ KIEDND('=&9(%$("DJ()26U*L2#>9.Q]?J.-)<96X3 7OS*,.7=$@DK<$
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M7QV;[._9XXB<3GJE#>JLT95I30M,MQ(<K-;ZI0[398XV2?33D]/\:SRH+8*
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MGT9DM:F@S%ABJ0P4H:KW%H6XV"!(4M1LFUA)!/,3 N<,5AL55D,\AF!(>1"
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M,,]6M*5\BOE<HN-R(&_E/7PMC:0+*$!]$I#F2Q*$CUY0POO\I(!@;D=9G:?
MV'G<8V$H&A[WL0UB,S?(PT!%D5<G?XZPA+H5)5.Q@&]^A_K^S%.MF;3BN:Z0
M ($BPIT)!G:3$W)'A%Y/T>.'NDE5+9*@]><-%A,G,/BSX+BH840 9@(6 (*C
M,"18#Z8QIN;PL23D1?I\],H$\>EUMGUUAT<S%IE(?!D*L>H!,20-K^1$"1&\
M0)#,LIR.IU8+G!%@:EY9#8)&Q*0!M;>_]48#AP?M*-&7N40W">#(X0Z.BY](
MZ4]B;,'LQTGJE:P4A&:T:$[CT%-U1)DW$JB2-SC\W[:22T\7A1+G),O,S4Q^
M'**G5)554-^?H>DC>+'QT1 P001P@(5/4$?0<$$>);VF'E#M,<?039/&7B:3
M)D*G66;P"#;T=D^$P(P14MQQ]>-HQC1O!<\A!$ 7L >H%_?ZL!?ARC1A]E%/
MCT'B;A,X>04J'[DVN+'V1Y3].,3O N3P<^$,(>>>O7URB0Z<SK/-+9BUG>DL
M]S736<-*"DU^3UU3EM6>6/16_2NMJ>:) YF7^]96!RK;4F1B)B$]Z7>&A (\
M;:%$5HV$H^U)[I?+HYX$+F\="^#'PC_%WAW4T=)KO*J'7F4-.,*>K&@,CSTM
M(Y4N.J72QE-<^I'*L\])1]\N"ZXI9Y\<=3#49R)@=PAD  XE@+Y*["\7+/,I
MWO>-P9B20 ;"X&1R1;'+M-P;[>79LX^Y'3Z7SW,LC<J*M+:7=$<2J6A9=;J%
MI3S(RUVN6[3J4%F!4Y=5-/%206UA4$>?5P]253N@R"\PE[RV@&?$F\;"=3[A
M,I+"52)2>0*.<O H(V/I. ^GJ@*SGA'KG,]"5RP'VL@S=YS4NAWK@H[DONJS
MK+6/22&NXJZQM 4"E/)"1SD+92&Z*JV07T;B(V]I+_VE&8ZF4)HS=Q0OXQ*Z
MCB;QBX=T5!0\2^'[6895ER5-HUQHY#V?9*ZRDD=_4N4X_&&6F".\%13RD @*
MA).%O32J!+*4X.AS4^ 89W1#V-.=33,P,R>X2I":\2<^+^\0KM1:FX?<16T9
M@TW15=:ZX@,YEEE2BASBG<L.85-*M+P=0LSW=0)2)"DB""*2MPKE+#F #P6^
M>L.6F9"-YR&0KD?&R?B 8E-1E694*4.\C&K:-*!Z+SJ<NU(PA*1RFES!G_@]
M>4V2$U+?.KE^42<(%"X7UFT$]B04%QD3U!T?.W*)1D&ILM4@40>JLIK9 52Y
MXW\6>Y@("5.6:( !"74E2)VWP]\JKLC.GX\3U9(<LH]FMW*W)8][*!FJ\UR.
MSE[SR ^IM2TE*%)=0@J95S#=#B2IMS8F09)ZXH>T)7=E#A>0XGBCHR,8GVA0
M@$KDO A&#,$?40YL4*Y3S0;\O+:"#;IZ4P?DJ4)%CC8RH5T94(1?RR7QC*:=
M5#N"<REW?@2 1FAAXIJ"G6M/>D);;YG'7#Z'(RV.91O/,+0)O?UC$D9%#;B/
MS'K)8100&*!LBG0(? WL\7&:I: Y7EDJ=K5A;9 $LT;?YND8YC=/(F%<H(CG
MD '&HF94[ULY*:!F'!.)DR_:!TN2ITN50ETSRM#=GV:(J#2Y2DGO5'XU6I0H
M^D569:4DSS!('.$F)()V)Q%68F0RV7)7X\O,Z7$5AI '(WD92Y4KP5&S3I:/
MF!^%A[0".)_'7+.$61YB'M%\%*=QNO33+"J2MX@YJD#.GUA"E(=5D]#W65M*
M,K;=^,()2%J!]'#2BE0E* &K<H%*(+ARY5[::%9YT-I<LATY)\7$<L4N*:*T
MCF /-S*@3S$*YKBP$VY=Y!ZWP:G(FPNF9"(C:A+*K+D A7P_9[O3P5M7=%I:
M4H<(6HDN)!',D+( %@KFD0)N1ZL.:8Y60'-;\^AS?NHZ@("_++N7E!2HJ7RR
M@%0"@D<R9!$\JXW(,^BJ.D>.*E*ASPT\O7Q "<O397S!4+XM876.--NMP"D
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M, V9/5.*Y%HF;WBP8/ER)N^ET8+8(PU.K\YXH9@JH9YJ+(FW(:3"D]ZA%@J
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M4 EB'=4"&R\XN60@JR$)H.'$K8JH*JX $;34^J,IRFE109:6DM-H")04F"D
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M._)^NN8B9I1,3,ER5\#?D.&;9Q@W4?:KUSJ,NT>EJ8TC"2I'QIWF!#:B4I<
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MV<<QGNMM(<!,AS#O,IT93HU/K-AAPEMS4=<@-Y70/E)*7!E](@U'=*NVZ^9
M)Q[6SI/9T34<&H@0AT:9<N'@[F.+%E9I9='/BGP?AI''==2@768E1*E3 ,1R
MBPML2.M_#'=* _+,ASND',:WT%Q'%.%1 55.'7P\<X)\;0C\X%I5Z0L3),V
MO>(Z^ Q(<H >Z RA@J);PY.I'.$RZM0)]$6*E<HZ).WC%X\MP8PY@3-+PE
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M;KJE$IYO02"8  %A @;;C# $LB2!)0$"=5+<?%U(O0&\4+)D&?0"_,_@8G5
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M+],:2W',><8PV.K*B4@$%)/01,W$]2?&>IP_VO>LI4+:^? PBJ%+PWN+-YO
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MTO"15Y"B-XD=9VVM8_HV%CX\K_,\&8GF%4<.I("JPOU\6)NJHU#E)"2 F?\
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MF]T(68DKD%741$U,F:470'O1D)+D/<<=(Z,<#NW!6Y?\2R#B$RFI8!2PC,%
M$@'E2%+65)4+7,^%AL<?L/9_MY0QDM+#;1_JZS#VP89@;SH4-R'%F6,9Z520
MDM-+<.X\.*:6M'2W3.NM':QH6LPR*MI:AEU"5'N74]XE1%P0E1!(/4@P/,6_
M1J<WM999Z566M(0HGDF$\J%\N>EXS$^2HN3EF.G$)JJ O$H3F:&3-*ZX2+D%
M861'D=MH\M^N+-.;]IES0CR R7T\6#S'+KZXV40N:UCJ%J/BC[#:0+*6E L=
M]_??;H,(X>B?M@DNH&1T'P $4J!0"4)*BYO=B%''HQ6+[W$'5B4%#N?TU.D=
M&FFR8B2/E"8/2+'8XD8/#@M0G)*7*.>.NI!YP"668;Q7.Z Z*;)9W*ZG-L_*
M#FX)"L^JJA0)LRPF\[A)(]E[W]F-OH<A#T99; +,38%5TX6S9XC<(F)82D@A
MP2A:SW:Q<@0_9?KW7F9OM4>FJ2O=K 4A-8^5MMI L20D09\(@QTVQE/A,))*
M37FI[J/*!*N:.6&5^F<932O,02;DJO&RO?@ F;1W]^"LHM;4V@^)=3K2H>?J
MJO4V5N49<!"4,HRY]#G("/DESF.TF ?W6/Q'])<V%..V;+A1++++0JB<#,[P
M(4YLGA")4!N11&9.3JHM\.K^/S.)@8((*OY"O]%7U'!!'B/]J+_&4X__ +\W
M$O\ VQSC!!&"<$$&2I23*3!\8!(]1(,;WC?!!#PRXE22M"A"3"ILJ>D ]/TX
M1"A#G&LA8#2_C#BRKY*@F2>DWB+P/*)G&6ZY"9L&!XD*K7\+I%^O7KSAW9=2
M  !!!/-O?:\&_P![=,46:P+*R+J<QRYH6A*'&8N']'I"UI:>HON(B/N0?H]T
M$$/EZ:+EF *HN83+QL^L*T.6'@/*\[];'&<TBDGE^.3>,:@@A1"QI^"(WM-K
M;_<>$GU8S,I%_P _7%.^'"Q-38].@$"WC.YGQF?MPH+)T[\_&SPH+P!!Y@!L
MH BY^DV]?KPD>QL^G#H5-VX6A@'141>MN^%*'X @^J^T;>,>(\?/",H)\^/!
M?S.A$427<.EF;O4Z%04>T'^,$ E5[;^/A[_6<3-+*$8NP1WXK",QZ:%_@O<^
MD'#X(D I) B3-_*!;[^>%NL+."0.88/?X:VARS$D.SYZ\R[VBVIV_E%I)WB_
ML-S'AUP]QA;CTL&.A/S=89F.2%'=-61"Z,,W\;/Q@#>)\/N=OIZXI+!F10!;
M1R5 MQ/*(!1>((]$?BMLX3*62J4D3(,&!(!(/N /2//#27DMD"OEP"9$V[X7
ME\7\_G>"ER)$@'F4=K03'L$[>[" *:.2.2^OPA@C->@S'-NF>C18==2)B-@
M!XF9-O#Q_L# 2W/+\H2W3(YCKQUY:PA6L@$>)DCK!_1'Z1BY0M[9<].JV"<,
MX82YXIS"7X/"5QSEN=S^B/?:>@QJ C9*W+\UB)YR$ _  K\?(7AI==)*P;#:
MYM$_1O\ 5.*&8;GES)-OB@"&,8:UO&5 D=;SM?S/@2?&WG@<ZWXGCQYZP0D<
M6")$D%,3&V^_OQK+*95X_C!#._Z7*X/D@!$_]X%4VWCSQ4<\)\$$>I%^"N?Y
M(3A;^^MQN_W@9I@B1]J;_A\HUX^%B6!VO]3S^XT]I.?&#DM)$7\3%[8^>V@=
MW$SL7I]-;E,H]C"A*&^;$[O%B0XT<\?*.9#KH* .91N9%AO?[W]4=."12X2R
M@=/&^8 U41T@@V?7U\H3E#AYCR[$D'?F&X\O7[3MMN20@ 4*_#7R\.,- +<
MW#\X-SH4D$I]-*9@0#(!@B_CUW!$X"S\#X=+]1##D)\?A%A:E#T3)),@JN8Z
MWM>?*(B>LH3*4((Z:N+%FO\ !(J4.-50H<D6X/YH-#%SG(3RJLI*3)!!*Y$#
MJ#N1]@MAZ_CQZ=W6'NH5#@'6UCY:ZQ1,Q(&Q._60!;^N/*<( B4 (O&USU]6
MT,I92"JKHRG5^-H-S'J4^8]+]!^W$&<N&6RB)( 4(5%G'RBBPKY0B+3!_<W)
M)VM<^.^W7 %E28N"-<REUY9:0)SX!W?EF$LO$Y1;$J"@DB!>/2@#H.D=?TXI
MI]0F3>C%2A74@Y. "FC%0",F1(* 5$!6P\9O/JF_LGQP$RR_@GC$Z*B*X%SS
M2UVLCP0V)%B!,3/N%Q_7XG#!$UB0G+\=7R#&&!87=M'X&4C0GF,XOM@E-B 9
MV!@>?C/U#V8DW WB&9;GHW>7)A*0B6OJ_P#Z1U](1V029V$'P">E_'H?7/GB
MI%)1'"NSH!<K?Y<(<MU)8NVJ@/WJF;1:,7@VDQ._UG;SCVXJW3EEZY0YMV^=
MPC+X=7Z9Q9<02>:5 @2+ @;^8MY_7ARHN5B""2%4>N[@8DKF5T_(A430)Q:$
MF @@II9KQ,)ZGY!O!$D3!Z;W/3>_@< ("J"6[^'AZRL^]*'LJJKJ<C=0W)0\
M1BNF%"\ 0/1$SZYOM,[WVN9L>^1,+!&-]<N;<HS,R)=[)TB%YDDPHP+@V$R8
M,&;7Z1ZNF*$H!4OX.23R%PD9F8DE%2[7L _"(36(!)\#/K!WVL)C;I[<6"1F
M>\_"$;E]2SH;M9VB./M6-S!B#-P?T1/E[+8O?&2]R_'6&GNYH0"S@%U9=.G@
M W.-6L#(^\_1>/9&+NA>WGZY1)6Q]+YAN4(5,I,R#:;C:\1?P^FYD>#&\ JA
M>!3\;\.^Y CJMF3\OFFCPG6RF_RI.Q.P\@9\_#I)\[E!*A074Z..(?K8AQ H
M 0*#,^08-UT/32+'=$VC8WGJG[?OY8J:9&S0VUR_&_6)$LTSH&"/D<B%RSX<
MUB@8,D0 -SL21>+#<V/EYX-\9@^NL!DF%\R,R48V"J'7F%$713J*2$@;VG??
MR!]5NOCOBMY$*C-#R\_7*)<374#GGK?FY8(]A%\48*4\UE1Z4=3Y6 B-[3N.
M@P_:&X)?12@S*&P7\(:3.ASS/_\ U\+6NJ9ZDM*1S@7@[B?#QM>\6\<"\;]Q
M]9:<(>3CF+^4-CE*%@$B(M*9V\(B/MC&LTH1D".G2^N7%2+7A(C2H.!<'CK^
M7>TU%&+D@P+"!N>@%HGR^BV)DF1M3<<?-;<HDRDE>^Z^2CAW@90RU%"1,7!,
MQTZ^(WVM>\8T9>(LOPY_ Z0&33Q\?2'Q9@JLO4)]'9)@'Z8M%P+WB>M\5*-Z
MQE[WB2#*""+Y^(?O4<HC=71RDIY2DCI%X,]+C8^HVQI-;P' A4(*-I\1>((4
M=W@5]:0P/4'*#"2222"3/28Z#ZSOA$D!W!/)KL0^COF.;AF?HP3)WDQT,Q$=
M9VC"$Q)0  )D76PR(2P_"&"%"_%NXCT89G:/D49"N4@P>AC?>;^762?5H22
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MG!EE4J2%"C(@FP*1SS25J9,U/=(1F))'$,+@NZ<(WOTYQ^T3G[-.:&HI%/O
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M4(S!MS+LO8HW%K_%V45E,4+6RI;9#Q5RJ 4D$''F8K"U*M8U!/*)=W=0JH(
M)L+%==8[J&)DITS3,LQ,QN$2YXJ;V2^<:@'X&7CARE(XK<*03NKEU?\ T?\
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M@,>G@ML;4V=.:N&Q=269=Y#-,951PBL!DAYJR29Z,RK),IN6\''GSO$ZH_@
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MT/>'55\^^*'\$@^#T_[5^TR/_-.B/MT,<+<&I\/E :AR ZO\HH?P1_X/4_\
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(4I1$X((__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g14810g23p54.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g14810g23p54.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1QR4&AO=&]S:&]P(#,N,  X0DE-! 0
M    '%:^<E0X0DE-! 0      $0< 5H  QLE1QP!6@ #&R5'' (   *  !P"
M4  (<G(S,C@V-#$< @4 &TUI8W)O<V]F="!7;W)D("T@8F]D>3$N9&]C>#A"
M24T$)0      $.7@>O<@8E#%\7G/6[8EE_@X0DE-!#H      .4    0
M 0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N
M=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP
M"W!R:6YT97).86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC
M    # !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P
M 0    !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"
M24T$.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS
M%P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#
M<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O
M;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $
M      !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B
M0&_@            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M              !";&0@56YT1B-2;'0               !2<VQT56YT1B-0
M>&Q <L            IV96-T;W)$871A8F]O; $     4&=0<V5N=6T
M4&=0<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"!5
M;G1&(U)L=                %-C;"!5;G1&(U!R8T!9            $&-R
M;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M    #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ .__C4
M @ " [_^-0 "  (X0DE-!"8       X             /X   #A"24T#\@
M    "@  ________   X0DE-! T       0   !X.$))3009       $
M'CA"24T#\P      "0           0 X0DE-)Q        H  0         "
M.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &
M   ! #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M      !P  #_____________________________ ^@     ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@  #A"24T$"       $     $
M  )    "0      X0DE-!!X       0     .$))300:      ,U    !@
M           $G0  !V,          0                         !
M          =C   $G0                     !
M     !     !        ;G5L;     (    &8F]U;F1S3V)J8P    $
M  !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M $)T;VUL;VYG   $G0    !29VAT;&]N9P  !V,    &<VQI8V5S5FQ,<P
M  %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P
M   '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I
M9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP
M90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0
M5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P  !)T
M    4F=H=&QO;F<   =C     W5R;%1%6%0    !        ;G5L;%1%6%0
M   !        37-G951%6%0    !       &86QT5&%G5$585     $
M  YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $
M  EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT
M    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U
M;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E
M $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<
M        #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N
M9P      .$))300H       ,     C_P        .$))3001       ! 0 X
M0DE-!!0       0    ).$))300,     !'>     0   *    !D   !X
MNX   !'" !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4 9(     !_]L
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M^WA_Z42_87UD_P!';_V\/_2BZT=5Q2"1:T@ $\\$AL\?O.3CJ>,7!HM87&8
MF=!N/9+[WD[0^S_T)'LX?WS_ (T7E*NB?6!M@=91:]@F6^N-=/\ C44=&ZM.
MN'D?+*\?^N?]2NE'5<0@$6LU[:S_ )L(E6:RX%U3FO#3!(F)C=W2^]9.T?\
MG?\ ?)&+%TD3]8G_ +EY9_1^K$'9AW@Z?2RI$ M_X3Z3F#;N2_8_6($8EQ=N
M!<XY @@'W-;4VWV;V_REUOK.\ EZSO (?>LG:/\ SO\ OEWLX^\O^;_WKR1Z
M-U3MB9,Z&?M(C^4W;ZB8]'ZP7.(Q+@' 0W[1(!F7;?TWMW,]JZQV4&$AT!P&
MXMU+H'?TV^],<FW7;7,1!<=H,_2CZ;_9_*K2^\Y.T?\ G?\ ?(]G'WE_S?\
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M<(F0Y[?;_)_LJ>7U=N+F,Q#B95V_9^FIJWU#>XU^^S<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M()*KH9@8WNIHHY)9)V<3!QQ-CAF<9&<3/V3P"2UP$:^O9RY_'O:XA^D8L/\
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M)$.HJJ<J:93', #ZO[GFA8V/DDT[;(XXVN?)(\/8QC& N<][G2AK6M:"7.)
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MN_O]W]^=OP<Z'^3=N^9+^JN3[^]8_*"X_2M_=]M^Q7S9N4'/JFM7KZU;'V9
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M=+% Z1LTK0&?V<1AEZ1YPUO <D85!L_+_F]2Y7S):]MW^!EO(V<@#"03BDG
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M^O6X_;%_P_'@YT/\F[=\R7]5/?YK#Y0W'Z5O[B>O7RZ^O6X_;%_P_'@YT/\
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M+IV6_0\=ROMUAI+]0&ONMQFNL\$D]QCME+/16]E6^8&ABF$M5.8J62%]4ZB
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MC[^@?/[!PBX%0@"("8 $/:(=?: ?.(?-[!]N1D?;CTHN0.00$0, @ ]!$/<
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M1"3_ )8YG8Y!J$'9'!FL!+F75<$2+'3#DAD(YX8P(.E2B5$YA#!(',@<CDD
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M&0CW8,>E)5:MV.2B8RS2+==PNT1!.)"0<'556<MED42-57!5E2"BD<ZI3$"
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M$YF"&1?2%?5BK$C(QL8]8($51,*2@(.6!SG9+ 86,CF,AQ<,!P'C$DDD$$$
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M.746BU!T@T$$IDJ(1;Q;Q7"0^&R=..A!,<3 !# #(.<$$CGC?'I&WHSD;97
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MA$PB81,(F$3"+K/7K*-:.9"1=M6#!D@JZ>/GKA%HT:-D2B=9PY<KG31012(
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MU2^OHKF9I7"GHJVC,<-+T<;HNF IJD"?BZ4O#9G-X.#X)) ^27WNFU$5>8[
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ME8";GK":$'.8+52,@: 3G#:AAI'\B6@O@<1MGB&R_5KP-TJ^4(YV%+[3VZ^
MX*&<[$V18) ACA[?P6T.M"I@GUZB5(PJ '7NB)@]F82]U74C Z.TT]DL,1R
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M-#N&04$)XO&W/"YN7AP DGH7Y4_:8XWZWTF5U)0C5[8[S, =2S;)M[HTW=;
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MZR5VK=;:&TT4%NME)#1T5,S@AIX&\+&CF7'<N?(\^-)*]SI)'DOD>YY+C7Q
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M'Q\2S;QT4P91D>T("35A'-4&+)LF'N3;M&J:3= @?ZB292_W9).?-MMG.,#
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M(4H   &"?;\.P#L Y+MT]/!2P0TU-%'!3T\;(8(8F-CBBBC:&LC8QH#6M:T
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M-9>R81!$  QA$ *4IC&$1Z 4I0$3&$1]@ 4 $1$?8 !U'"=1/4 23U #F3V
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MYQ:YVG/WN6>1<OJ#9.O :1QGP2=QCV;>+>+%<MVWF]FZ:NES+/# N=P4@ID
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MGF9QL):_@>WB:X@[.(,P !A]P"(?W!U_]/L^;\63OCR'VV_'"M>">0SY@N!
M0]X"'Z0Z>[WY"C![%R!3#[BF'] ".%.#V'U+YPH7UW3#[BF^P?\ VPIP>P^H
MKCH/7IT'KUZ=.GMZ_-T^?"C!["N>Z;IU[INGS]!Z?;A3@]AQV]7K7  (^X!'
M] =<G![#ZE""4P>\HA^D!_Z_$/V9"G![#ZO;L* 4P^XHC^@!'"C!["@E,'O
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M'8?.#MC!'+J5MU#I*PZHH!;+U1=\T8GCJ>CCGJ*5W31->V-QEII8I2&MD>.
MOX#G=I(:1&VO>'7'_5MJ872ETYW'6"-2>HM'3FSV>42(G(-%F+H#,Y*7=,U/
M$;+J$ 5&YS$$0.F)5"E,$-PTY: #@C.YV..TGL^_M5?L7<KT/INY0W:T6F2G
MKH&RLBEDN-QJ&M;-&Z*3,-1520N)C>X N82W.1@@$71M?C=I[=*D*?8E95EA
MKY'I8L&DU-PO@A("W%UW_,\@R!QX@M$.[Y0"@I]P?#[O?/WCG<6 [QL<@<[=
M75C;EYMETM2Z!TMJ[O3W=MSJKO'IN]NCJZRDX.^.CZ7B[UGAZ3BZ)F./BX<'
MAQQ.SUM4\8M+Z7D):3U[5UHIU-LT&,B=W.STR55NV6%PB0J<Q)/4T3%5,8PG
M1(FH8![IC"7H&&DLSP^+GGCK[,YSRW]:\]-]SS26DIJJ>QVQU++61,AJ'2UM
M;5A\<;S(QH955$S&8>22YC6N/(DC94K97$;0^V[*:W7JHN92<,P:1OE+6QV2
M)2\C9"J+=/R6+E6C7O$%93JH"(*'ZAWC#T##CQG+AQ;8WR.1)ZB >9ZL^7'+
M6U!W,-%ZGK_=.\VJ2IK.ABI^DCN%PIF]%#Q=&WHJ:IBB!'&<N#.([9)PKVU;
MHG66FH1]7J#7S1<3(R:DPY0=R<K,*&?*-FS0ZA7$N]>KID%!H@4$4U") 8IC
M@3OG.(R'%HPTX&^P\OGRNQIS1VGM*4<M!9*$TU+/4.JI&2U%35ET[HXXB\/J
MI9GM'!#& UK@T<.0,DDQ!:N%?&.YVB;LUCJ2[RQ6&3=2DJJE<[4R\=^\4,LX
M,1BSG$6[<#&,)@1;H))D+_43*7ID.:79<YA.PW(<!Y\@@'.?6JS<^X_H"[W"
MLNE?9YI:VNGDJ:F5MTND39)I3Q/<(XZQL<8)_P ,;6L'4T*>Z;K6C:]J$92J
MY%IL*U"-G+5@V=.W;P[=NZ<N':Q#OI!PN[5[R[I<X'6<&,4#@0HE*4I0R:]P
MP&''+ ;^6_G5SM.GK19+936BW4@AH*.)\,$3Y99W-CDD?*]IFF?),_+Y'G+G
MDC.!@  :^;]IOLPM8"N.R]AZGHBZ8JBHA;^0WHZ[[Y!ZG(1E*7EJZ.<HC[4D
MT3G_ /Y<Z-+8KS7X-'9KE5 XPZGH:N5F#DC+F,<P @$Y) (R5\[?W$^YD"2Z
MS2 DDG-YNPW)).!W]Y]NKS!19OSM7.RQJ>K+?4'6]:9LXJ%/D8UC1]>GN$^]
MLXL8LYHVOM;;68618Q9Y-9JVCQF5Y0$61E@<NU!2(IUM-O[GFL*^:..2US4D
M$CVMFGJGT\0AB<X-DD,#YF3/,;2Y_1L;QN#<-P2%>Z^T6&NM,]EJJ9LMOGH^
M\I(&R3QO?3M8V,1BHC<V9IX6M;T@D#^OB))SAOV77*OA%SLVY8ZK$<=G>BKS
MKEG7+K34++O^5MSVZ/6\HY4=(P<$LC75GRE>,P:/Y))%"33!J[(9TB@B'>4]
M=6]S^ITI2TU>VL-QBEF?',^.AEA92$-#HWRR=/41ALA)8SCX,N;MDJC6ON1]
MSNFK:6MI;'-#5451#5TSW7>Z2 34\C98G=')5\,@:]K7%CFN8X##P6D@^@[9
MFE-<[?KJ55O<$,G!IR+67(U:2$G$*>7LTG*+=;RN*>,W0E(D\7**(JBD83@8
MY#&(02_/R]Q!!.01C!\A!&,8(P1M@J\:@TE8-44 MEZH>^J,3QU(C9/44KNG
MB;(UCS+2RPRG#9'@M+^$Y!+20,1KK[ASQ_U=:6%SI=.=QM@C4GB+1VYLUGE4
M2)/VBS%T4S*3EW3-7Q&RZA"F40.*8CWR"4X%,$-/#DM !/7N2.7+)/8N!8NY
M7H?3ERANUIM,E/70-F9%+)<;C4-:V>)\,H,-1520NXHWN XF.+2>)N' $77M
M;C;J#=9H4VPZRK+>CP/@B@:34W"^3A)>2>6=_P SR#+RCQ/(FXE\<%!2$@^&
M)0.<#'.+AAWC8.1GMY<Q@KHZET#I;5W>?N[;G57>'3=[=%5U=)T??'1]+GO2
M>'CXNAC^'Q</#XN,G/4U5QATQI>0EI/7M77B7<VS;L9([N=GIDJS9JN9PB0J
M<Q)/4T1*J8QA.B0AS /=,82^S#3PC#<-R<G',XSC<Y.V3A>>FNYYI+24U5/8
MK:ZEEK(F0U#I:RMJP^.-Y>UH;55$S68<226 $\B<;*E;)XC:'VW9!MM[J+J4
MG!8M8T'+6QV2(2!DS,J9NEY)%2K1KWB"NH(J^""A^]^&8W0.AQXL%P#B-@3D
M'&<]1&=R3OVK6U!W,-%ZHKQ<[S:GU%8((Z;I(Z^X4K>BB+S&WHJ:IBBR.-WC
M!@<<CB)P,7MJW1&L=-0SZOT"OGBXF1DSR[IN[DY28.=^HU;,S*@YEWCUPF3R
M=FW("*:A$@$AC@3OJ',:0XM&&^*-^7EY\\]G5A=?3FC=.Z4HYJ"QT!I:6HJ'
M54K)*BIJBZ=T<<1>)*J69[1T<4;>!K@P</$&AQ<3%-IX/<;KI8YNV6&D/G<[
M89)S+2CI&VVUDDN^=J"JNJ1HSFD6K<ISB)@2;I)I%Z]"$*'0,Q.'') )[<N'
MIV(W5:N7<?T!=[A5W.OLTLM973R5-3(VZ72)KYI#Q/<(XJMD; 3_ (6-:T<F
M@!3I2]7TK7]2BZ15X@K*O0S9PUCVB[IX_611=.7#M8#/7[AP]6,9=TL<#*N#
MF+W@*40(4A2YA[AL#@=@5SM.GK19+92VBW4@AH*.-T<$3Y)9W-8^1\K@9IGR
M3/)?(\Y<\D9P,  #&P_9]\5>HF-09'O&$1$1NUU]XC[1Z!/A^,?8 =.GXO=G
MF0WF&@$8.W%U>0.Z^2^?GN']S4DDV.<YY_\ C%X&YY\JX>?;"JG(?</#73=
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M60WP".L=7,'.=_1U[[;*.2;WBO/9M6^N)M4>S*'FRVJA>30\F+L"PMC=GO\
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M"!@<W8D]L550Y1ZE45]/9JQI'. ]!$12#O=.@AT]@<JIU_K&JXN.^U4?%_\
MQF4])CS&DAA</0X'RK,4T#<8C&QSN7.Z\[Y)SZ5E[#\<N/U<@I.LUO1^HZW
M3,5(0DK$5S7-1@6#^)EFBC&3CW3:(B&::K1\S65;.D3@)5T5#$4 P".<&2\W
M>:5D\UUN,TT<C)8Y)JVHF>R2-X?&\&61^',> YI_PGEA>@C8-@Q@!V(#0,CL
MV"PIVCV._9^[%K"D-":%KNG+(V<)R5;V5I'OZXV%4IQL!A93$+.0_1%59HH;
MQ2,IAE*1AE"D5,R\=)%9.QT?="U923B62Z27"(@MFH[BUM32SQNSQ1O80U[
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MUU73<!,WCTC.%DW"RBHNG0KNE#&_I5C@4H!PQK#5+>/%_NN)'.>\&KE<"YP
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M5I=@.( .-U\KO?=7OHNP@LE#%344K:=M.R\T,T=7(Z4\)F(94XZ![C^S( /
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M*U%"<=6?3^/5]P\R' =@%K@'$<0#L. .S@'-:[!'(. ..;01A7%OW@7SH:[
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MY:Z.WTK7@]O&(N//EXLJ3$6S=N0J2"*2"9  "IHD*FF4 ]P%(0"E* ?B
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MD6OM-:*6!L4/-MS@U%("YQ2J?44%F=BC!0>J>3'Z*(-GYGK IP PM#"&$6.
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M:?N#GO;.*/-/8VS[%H?1_+I]M6,N>PZH^J#?::4<RE-8ZNXT\=_*7JR#SBG
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M6)K.-+1&0L;)3)6Z+"39+PQ5GAD%DHYX>03=N$DG)2'<,6IC)'$@"4BM/2_
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ML+W_ "H3^/\ TF$4BI))H))HHID211(5-)),I2)IID "D33(0 *0A"@!2$*
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MYJ560Y"\Q+><24#AJM6VIP_H9C;6R(:"[@" "!W-?8H%DR  "!A(FY4./0Q
M_"*(X1<&J?:+710!EMIZ TZQ4_KDH]1FKO+HE'J00$;>0\>=0"]3 9-P0 .
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MJJDY22<E3.HW536(44SE,)%W\(F$7!C%(4QCF*4I0$QC&$"E*4H")C&$>@
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MSC??TKU>X6*814UW#0\@J"[^*C7JP$!,%G;%JY5 A1$2D!19(YP( F,(%Z]
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M\LY6_$ Z  ?,'3"A,(F$3")A%^:R*3A)1!=)-9!8ATED52%4253.42G343.
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&)A$PB__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g14810g38x97.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g14810g38x97.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1@T4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &!B^86@X0DE-!"4      !                      .$))300Z
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M8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;
M    3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K
M9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M  !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@            0G)D
M5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M4G-L=%5N=$8C4'AL0&N            *=F5C=&]R1&%T86)O;VP!     %!G
M4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M      !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M         !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T
M;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C
M=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T
M     ! #O_XU  (  0.__C4  @ !.$))300F       .             #^
M   X0DE-! T       0    >.$))3009       $    'CA"24T#\P
M"0           0 X0DE-)Q        H  0         !.$))30/U      !(
M "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H
M   &       ! #4    ! "T    &       !.$))30/X      !P  #_____
M________________________ ^@     ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@  #A"24T$"       $     $   )    "0      X
M0DE-!!X       0     .$))300:      ,U    !@             "^0
M!0@          0                         !              4(   "
M^0                     !                         !     !
M    ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   "
M^0    !29VAT;&]N9P  !0@    &<VQI8V5S5FQ,<P    %/8FIC     0
M    !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO
M;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'
M96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   OD     4F=H=&QO;F<
M  4(     W5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G
M951%6%0    !       &86QT5&%G5$585     $       YC96QL5&5X=$ES
M2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE
M;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG
M;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO
M<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P
M3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O
M;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M       ,     C_P        .$))3001       ! 0 X0DE-!!0       0
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M!0$! 0$! 0         !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$
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M91N>'"QK&;&C<US&>@YEF]CJ'6;_ .<_2?HO6_P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0'_P  1" %, C(# 1$  A$! Q$!_\0 'P !  $$ P$! 0
M          8%!P@) P0* 0(+_\0 ;!    8" 0$$! <(" T/!PT  0(#! 4&
M  <($0D2$R$4%3%!%B)15F&4UB,U<7:!D;;P%Q@9,D)7H;$D,SA56&)R=Y*5
MP='3"AHF0U)3<W67L]35U^'Q)3E'A9:FM2<H-C=$16-T@H.$HJ/_Q  < 0$
M 04! 0               0(#! 4&!PC_Q !=$0 " 0,"! (&!04*"P(+"0$
M 0(#!!$A,04205%A<083(H&1\!0RH;'!%2-"T>$'%S-24U1RDI3Q%B0U0U56
M8H*3T]4ETD1C<W1UE:*CLK.T-#9&@X2EP\74X__:  P# 0 "$0,1 #\ ]_&
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M&VH2K6+35UG)BL;"N^E+;-1],K=Q=UNQIP,+Z^AI.R1T4\DVIG\,X:R<<Y5
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M)5IXZ3>7-%@:O]=\5>TE=<>>Q^XAV_@-?J0QX =H#IW8&WMP.-I:@LE8GZC
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MKT:LJ;Y:D:=2%25.66L349-P>8M8EAY36Z95<LEX8 P!@# & , 8 P!@# &
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MU*UCZ96M>5.HZ7K?RS<QJ<)A4E"W3G3H481C)2RK?E4:49)9)7+<+]U7J_[
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M<:-W4N*JJSRYODYC8WGEQZ., 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8!;VXZHUUL"9JM@N=1B;#,TEV9[6)!\FJ*T:J>0B)<R0@BJDF]8
MFF*_7YD8R1([CAF8&$EO1?6,1'.6P%N&7$KC;'H1+9EIRF-T(.T)7&*2(P5[
MK2<;D@TVA@[S@PJQ#!*KU=".K2XJUN.;UBM(,8ENC7X@C("\EL^];7\9:7^F
M,%^OT>W )+@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , C5L^];7\9:9^F$%@$EP!@# & , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & 1JV?>MK^,M+_ $Q@
MOU^CVX!)< 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M.+5V;R!JX$ $X].H@BJ'W-7^Y 2J>_PP#SRAQ:Z>]#S)-E(& , 8 P!@# &
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M:7^F,%@$EP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M.*E"OF%7(]6;Q")L R4P!@$:MGWK:_C-2_TQ@NO\F 27 & , 8 P!@# & ,
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M&^.GW3>> 2S & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M*Z1TM>Y622I4$6Q1VHH.4V%1;8[LVP=E3CDB&KZH[!)520:V)*%E(PBSYI*
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M\9A/$+F*IO95(9<&\X?-%YE'7JG)=\):SPAR*$*=,Q3D. &(<@@8IBCY@)3
M(@("'L$!Z#FG::;3333PTUAI]FGJF;M-22E%IIK*::::>S36C3[H_602, B-
M[V!1=6U.:ONRKE5Z!2*VS4D+!;KE.QE:K<,R2#J=S)S4PY9Q[-$/WH&7<$ Y
MQ*0G>.8I1 U)ONT(Y$<QGJU1[+72"=GHRJYV$KSQY(15AH?&:$!-1,CMSJ2E
MKMX[9G(>3;D])0:N()A7*,223;'<VA[%K^.8"Z^DNRXUC 7V*Y <M;[;.=?*
M6/.5W';5WLUCU:1KEZ8Y%SM]%:+8 ?6>HXY%P0BK1Q%1<C:"*$\92R'.H<,
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MEOX)].Y6N.P;Q*WDEX5%)_!PCX=2J-[M"K"4%!=-A'R$5D0,4!_ND3J^7TB
M>7M ,QY\(NX9<5"HEGZDL9P_]M17NR9,.,6<OK.I3\9PREWU@Y:+RVU\"HO+
M%&-F"KY)R@Z H 5-))4OB**FZ]Q,2^9T^O01,)B=2D QN@].@V*5C<5*T:,J
M<Z;>LI2BU&,5]:6=GCIAZMK5)Y,BK?VU.A.O&I"KC2,(R7-*;7LQQO'.[;6D
M4WAXP8*<Q-JW+6_'+=^UJJ^;MK?2=?3]BKKAXS1D&+.0CFXJM>_'N0.W7;D,
M'QD5"B53J)CB8PB8>D]7&SM:JHQY7"G*66LN32;YJG=MI+&5IHM,9YB-2=]>
MTG<-R52I&&$VDH.2]F*_12\-7NVV\GFKKO:5]J+;:FG>ZTQBINGJNK<Q3L3#
M5==7C#/:'6DKC;F?I $  =0E76)-N6Y@!51B"BC8BXHK%)I_RI=+]*&N%]2/
M5X6>V7G?S9O_ ,D67\2?9YG-YQTWR],]U^,QE.=?:\PMB0J<G32MK&YJUENJ
M41^Q+6UG?P9IR1U;7)*E0!4B U[N>#+L5SIR+%VHW9+M"/'39!5^4[IKZU/&
MWU(^&,_9C/AV'Y)L7GV)]7I4FL],;ZM+1^.-GM8=MVQ//IXDHLSL53=HI*H(
M*JMM70:Z2:[H_A-45%$FIR$5<J"":"9A ZQ_B)E,;RQ^4KKO#_AKY??[2?R3
M8K1QGT_SD_'N^N/,N)5^TO[4.Z1+N=JS&+FHB/L;.H/W[/5-?%NQLLA#2MA9
M0[TRJ28M';J&A)5^@#@$TU$F:A2G%4R:9WY3NE^E3U_\7'YP/R38K]">,9TJ
M3]VSV_5YXC:/:Q=HJYL7P4;3-,<S@/8Z/4;-Z!4%VR#F5.@FP!U*)&/%-$%C
MN40,[<O4FB'>,+A=(J2HD+B=WOS0_J)_/37R0_)%EI[$]?\ QDOGO^HY8[M6
M.TBEH:?L,:X@7L+5F4?(S\DWU7!';1L?*R!HJ/?*F!#JHS=2!#M2.4"JH@H0
M_?.4I3&!^4KI/&89R].1;^'CY=M"/R38M?4G[ZDUXYST[^&FV4;9>R:YD[SY
M;M]X+;HFH27-1EZ"E7@AJY&0!6X3Z=M-)BOZO3(+HRHQ+($_%$01!,_A@ JG
M$=EP^YJW*J^M<?8Y.7"PES9SG&^<==,^+-3Q2TH6CH>IBX^L]8Y<TG+6/)C&
M=OK/S;[LW;5JQJQ:Y&KDYCQRIP*8!$1%L8X_TY/VB! 'S53#R$!,<H"<  T7
M]C&Y@ZM-)5XIM/&%42>.5X6LNTGAY:3T>53PZ_E:S5.I)RMY/#R\^K;>.9=>
MBYUUU:6<IW5D92,AXYY,2\BQBHB.:JOI"4DG;=C',62"8JKO'CUTHDV:M44B
MF45<+JII)I@)SG*4!'.6::;36&M&GNGV9UJ::RGE/5-;-=S4;;>U"G=Y6B=U
M%V8.EEN8EYB'CB$LF_IJ5=43A5JR4(F<BBEBW*5D]<[/DXQ<4EEZ;J*.G7;]
MOXA"V&.5 @G []%[+@=HW*%W3VDNY)'F_M&&?$F:MJV2AO@?P[U+(E5.NW)0
M./J;R0B[3(Q@*F9IW/:SVWSTDBDBZ4:QRY$TT0-M#)DRC6;6/CFC5@P9()-6
M3%DW2:LVC5 A4T&S5L@1-%N@BF4J:2*1")ID*4A"@4 # .U@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P#S/]N5R%HC:XT_0.U-9VQ:$0K)IRG;
M"I^RJ5*2H3=T.9.4<L](LZ%MG8 35=AZ;)Q$/<7U))'LV]KF'$&[!VBJ]CP/
M25 D(2#A2)$433)$QQ$TU0 %4R%9H@0B@ W:@"A"@!3@#5L'> >C='^EE JV
M , C5L^];7\9:9^F,%@$EP!@# & , 8 P!@# & , Z[IVU8H'<O7+=FV3[OB
M.'2R;= G?,!"=]54Q$R]XYBD+WC!WC& H=1$ P#$^V\HVKQ[OZA:=@U;WM75
M&H['>:E'@W>KUZ\V^ =66ORM)BW#<&AY63J5OBH*#M;2*>G.V?V5C#E=MI9)
MX@TJ2V;T3:U\.^-]B,K+2W7SX_K\#$E.[<D=K+UR8XY[_LFS'$)%6R*M%D)K
M*IU/7+NT2M1+L;7E<GF4NF_8D3B;)4G6M-C/8-I%W.ML]C04>Y?-)6-D'IYP
MENEJUUSHM&UCH^FKSOJD1J]GIW[]L>6-<_#725T;@#9[ ZEI#D3M*:OB[A];
MO5:J4U*2\TC WN*G&4Y%D?3:)VE-5;/ UQ/L"U--TJSN&M&DVWG3Q,NE7(8Y
M)?5T]R758\^O;1ZC&=_@]>^?O:TTVZ:&=E7T=J2F/GDO!4*MMIA],/["[FG4
M<W?R@S$C8;+;';U!^_*X6C_]DERMDRV;QYFC-@\L4P=@W;%?N"'IRWA:OHDO
M=T6[T7CHNQ.BRWA>;\WU][)X[L<*SZ@K((', B'AH"+@_4/: @B!P*/]V)0]
MW7J(=<JE8W=7')1FD^L_86&\9S/&?=DQ*O$+.CI.O!O;E@^=YVPU#.-=-<$:
M=7YJ3O%9L5EA]@'74*B7V>WN$!4P@ ^X1((A[PS/I\&J/6K6C!)ZJ$7-]<K+
MY5G&NS2-=5XW3651HSF^CG)07GA*3?E[/FB/.;M-+#]Q,W:%^1%$#F'\)EQ5
M\_[D"A]&9]/A%I!>WZRH\Y?-)I+P2AR/7_:SGIKA/ J<8O)_5=.BO]B*?Q=3
MF^Q)/R* XEI-UWO2'[M0#?OB"NH"8_1X93 0 ^@"@'T9F0MK:FDX4*<7A8:@
MG)+OS/VM6M\M^.IA5+JYJ)^LN*K6<X]9)1Z?HK"UVQCKXF.5DY6\8:;/2E7M
MW(G2%7LL([4835?L.TZ3#S42^2Z>*SDHN0FV[UDZ3[P"=!RBFJ4# (EZ" C?
M7AKC39],IIX33USG#SNFWJ4*C6DDXTJDD]4U"337=-190_VZ?#[^RGX\?\LN
MO//_ -X<>Z6^S3:PMO%:9SOOE+8>HKYSZFK_ ,.?QVTZ[=]?!^W2X??V4_'C
M_EEU[]H<:]G\'YZ9VQT6$M/K9PPZ%=[4:O5?P<\Z]GC^_P !^W2X??V4_'C_
M )9=>?:'\V/<UMC&5W>NF/K>"^ ^CU]?S-7.FU.737K'&^=<(?MTN'W]E/QX
M_P"677GVAP]]F]EG#R],:>/GG.JSC0>HK?R-7;?U<_AMD?MTN'W]E/QX_P"6
M77OVAQA]=]<^RVF^G33ILM<:Z['0K]*-5;_YN6_C[+WWT\<E^:K;:M>J_&6R
ME6.#MU6FD5'$/8ZU*L9N#E4$EU6JB\=*QJ[EB]1(Y070.HW74(59%1,3 <A@
M"$]TMLRQKE)K1K#7=M/.-]=5I;:<<J46GG6+6JSKJL+&5KKC<D&-,K5='C+S
ME[Y?NSE=EC?6,+31=U^SS[EN;:^6+(H(HJ'2]%2!0#$,)# JJ(B)@,40'R(!
M #Y.I@]X]=UPZE&5&<YQC+UDN7#2?LQ6V'G=MMYWT?1'/<4KS]?"$9./JX)K
MEDTU*>N>9--OEQY9>-V8G<X+(HXX7<EV#\>\J?4-M*@Y\@$Y@8F$$U0   3&
M .A% Z=X?BF 3"!AP>+V,86EQ6HIJ,:4^>&6^58?M0ZX75;)9:TVV7 N(2J7
MUI0KZR=:"A4ZR:?U9XW>^'IGKKAOSK<9-D\X=<Z@A=4:CT:M9Z?L^)V3/5=^
M_@G+\9Y;</P<U.QMU?65D4(XLS5)FE/H.O.44O$ ;)9(J90=1DND3//\+=YT
MQLTMM</1[I_9X'ISU6&^G9]UKC.?GS1.J+?>7]/N+S:^F>$53HUKV5'L;7+S
MJ,!<K4TMS139ZMHD#-([8MTL;"/<6>^U=HWA8:#28S!!K*K>N-ES%<KDEX>C
M><:;I/3'9:[MO?.<[(C;+;RLIZK7/PTZ>6VFYC)IWF-M+2=.M T_4]>"E'W"
M:U [<(7E.LUFPV*5J5G2H[TC"=:5^6,#'4S1*H)6=O(3]>:-;+)P2Z;M9PZ;
M&L[YV:>JZYUU3><O5^2?C/3[M&]GG7[L;IYP75U%L?G#H=R]@"ZG?V20WV_E
MK:\8; (ZE)"^*S]78UUHGW7,VDY//UQ:WU:VQ29A3M$(Z5B'[A-*$=N"+PTF
M_)Z)-::_;MAO5:='O#2T;T]VF==_#+VSKU;6T3;<Y^0M7N+R6;4&F-';W9&H
M[DHC6JTBQ<2LAK"8A[I'5.9N-2,C/WB(GO5[,DG%62?G58V/.LUAPBB>(F$M
M9WSLTM_%-I/3OJ-$]'YK&-]7KTPM<;X1V8_M$=WU@8F<1U_%,$THVAUI\NO)
M[,) S+371ZRT2A6T0ZM2E=@HV;:T=HSM$#6F,8SE7:DRZ?(*KG038,;[XU?B
ML^/F]]/Q&$TEIIMLUJNV7GJUEMYURUOLX["2OS55D.7%9L<:XA9^"G=9Q<S$
M.R@FZC))E^R"@\8.4P,8$G#5<AT%DA$3)J$,F< ,40#=\(U5?LW#19T^L\Z=
M-L/7;9X-!QU:VOE6UZ[T_P =?CIJ;-.4?+ZWZ:MM=TQH_C3MWDSO^ZP'PCK]
M:K46O3=2UN!4?/XLECVEOJRLBT&F1:+^.=)GBVSB;MKGN($;5\1DHP[O85J[
MA)0ITIU:DEGEBG&"CG&9U7[$5HUA9ECI+*;U%&C&<7.K6IT*47RMR>9M]H4H
MOGD\-:Z12SB3PRWU$[.[<7+TD?>>U*WBIM^!9O4G4%PFTHXG-?<1ZF=HHP?,
M$;Z5!XA>^0\O'.&Z:A7>PY5&JIK'<H-ZFNS,B<O,7]*5.XES\G-42JM0344Y
M-Y2RVV\Q;;TR]4EL=7P^K3JVT?5^LY*3]2G5:<VH*+3?+IM))+HEJVS<C4*=
M4M?UF%I=$K%?I=/KC%&+K]6JD-'U^NP<:W#H@PB8:*;M(Z.:) (]QNT;I)%$
M1$"]1$1PS.)'@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# -
M$':&-M>-.1Q)*P\(]![PF'E.J;/]DW8G&3EWLZSN@14F3LZZ6[:3XR[4I:[6
M(3%TJPB1N!I>/!T[.]C&*:R9UHQG]C:^[ -Z$3W?5<;W4$VI?5[/NM4D5VZ3
M8OHZ?1!-!RD@Y131#[F1%P@BNF4H$5234*8A9!W\ 8!&K9]ZVOXRTO\ 3&"P
M"2X P!@# & , 8 P (@ "(B   =1$?(  /:(C[@# +%7?D?J*CS/P5=VHLY=
M!F&D :F4N,E;U:V,J]@):U)$E:]4VDK*1B"%9A)2Q/%GR#8K>':^EF'NN68.
M)2;\N[T^>WWD-]M7X:^6<=/E&NK8',C<VU'L%KG6>M9D\P2.2G+0%(EI;X1*
MS] G9AKLB@2#5LU,TBJQ<BT;9&NZW8FEA?A'6MU0Y&1EHIQ88-F]KY4M<]>V
M5AZ)YVTSG;'P(4LZ;??H]5A//3]?CRJ\)>1N\U91KOJ_^J*R^AJ"U.W<[!NM
MW,_M.NY.TMI&?2U@W>0]#K5>V3%R46Z>1<-94)6*2:LU/#83R;I8CFBME]RW
MUWU;Q\YQD8;6&DNW7'3PZ;=OL6>>J.+VIM,2K2W0K>5=VUI!+0ZM@F9^5.Q3
M5EF\+\,I2&JQ7J=0JKJ_2T!&V*WIUR&C6TQ.MTY%=(7!"GR%SS?+%.3?2,<M
MZ[:)M^&_;8B3A!<TY**6[E+E7BWEI>+^)>A[;X1EWB)*B[5 1^YM2 ).\/41
M$5C=Q(0$>O4R8J"(CUZ#Y],ZEPRZJ:RBJ4='FH\/#[0699\&EYFOK<6LZ65&
M3K272FDTWA_IR:CC3=.7D]2(O+U(K=2LT$&9?<8W]$*_1YG J0?E2'\.;.EP
M>A%_G9SJOKCV(^Y1;DW_ +R>^5HS55>-7$]*4(4D^K]N7NYDHY?9QT7EEQ5W
M)2#X>KMXX7#J(]TZAA3 1]O=3 03+\GQ2@'3RS94[>A17YJG3AMM%9>$\YDT
MY-9ZN6/%-)FKJW%>L\UJM2>=HR;<8MK7$5[*7DDL:'1R[J\M]]/-YQCR>.NF
MOB6GKOWV_#3QU]W88>NJBUG.BVVTV[YUVTVZL8\,=,;K7KC3/;]2U&2MFM>F
M?BUA)+J_=G=O5,]L?'1[>"7RM_-^OZ]?;^OOR.ZC\_5SW2UR\I[K.<)#PW^5
MU>^^?';<_G =K/\ ^<<Y;_WTW'_P.%SU;T7_ ,AV7]*\U[_X_=:LV$?JP_H0
M_P#@1KNS?DC)Q\-</O\ <!D?W=/GW@9/?]7Z]4!C5]?B_P!8/Z,/9234-7NS
M,XJS$_+1D'$,=9.EWLI,/VL9',T"6FQF.LZ?/54&K=(A0$3**JD(4 $1$ SQ
MGBG^5.)8R\7]TVEHW^?J=.N-]_#&K9AUOX5_[G?5N$4O/IW_ %5J\]JIPJJT
MXO3Z;LJ5Y"[!1*H!-?\ %^E6KD!9%5R=0!HJXUQ%S5:BESG#PP]>V"*2(80%
M95(G4X8#SAK&O3=Z:]N9Y>7G+2\UDH4)Z>SRK+UDU%/1Z^UOEYQC+>,^!I[Y
M]\D^T7L]NU3M7CQIOD'Q7F+I+Q.L];:^VE>-93CS<4JY<O)0P.^.4/ [&;UV
M581)GTA/VRYW*M1\#7HD!D%DE$6A7/2<*E3G:RA+ES3J2;324DI)2SE9:V?C
MH^N6N=XI3C"ZYI/FC4IQEF*>(RBW&2YFHYQA:8EG.>^-B>Z(S=,1V<FUF?(>
MSU>W[C#2UD6O$Q3(,*_6O6KAL=8T?&,@76!9*,2.FQ4DBD9IRBZ"KY*.CTER
M-$K7%N7\GWW*L+Z-6Q_59;X/_E:P:T7TNCC/1<ZQE_?^.[TWZ.Y9<O(;CZV:
MT;5,%:=0:A@XR&9S[XBZ;J#=TB<G[_9I.OJ&FV4H_<KM+9"NKZRK[2091L77
MJG,2+>-$AG;KRO"^_/CGO]N-NJR\,]C\FUGJUUT[^"^<H[-FYB<CN1XR51NG
M%RJ[)@ZVUD;^:E/(?8T#%UZ2H;&VW5K80&!M%:>F;P%;L=I.I5%'JK*PQK\O
M2-=/RL5 )8U3:R]_!XRM4]VEA]&AYO;3N].K?3&?+77?!@Y&[6W^EI2;X\Q0
MV@=46^\M;"]J[6$DED75FJZ;]ZK%M%"HG.*;982S$K%$!18'<-'O7'A@P$1G
M3.<+/W:Y&-M=?/7&=-_'&?'3;0S@I/-CDA;1?2%*T!4IAYHC617VPI, NLA+
MQ%4J5PU5-O7\R^LEK>R,/7XJ4UI$(,Z5$J(Q<$27L[B*BVZ8F%A&-?'FVT3R
MTUC&[UU^Q]R&EU>ZZ]==T_PVV>"'2'/'?$JK# _T^V 2P$^T;HQ;C;5>2DJ1
M,T^;J\TZ;L*_:(R-4F&[.TR+UEL<C!Q885)5DP:R244F=LYG&^_V::O.Z;[+
M&VGEAIW3UT3[K&VJUSXO??5MT;;O)OD5N'5\&\NVH62NMY^\#/PR[%C9 BI"
M8U_>]F;>LBD='K2CU9%NJTY'##3MA% 1=P3:% TJN_3DE3$L;9SIUUZ);:_H
M_'#Z#"6=DGIUPM]LZ/Q6F-NYM)["ZS2MUG.8MRG5O29NVVN@V:9<>?W>5GGF
MR)616\Q$?NKMVL?S$1^-YB.;KA.,5WMK#IGI/3M]F[7NT''5K:KPK=-/\W]G
MO\#T(YN<[:YU>7JO?T;:SLGMA(T&VK\?A^O9=?#=EXJ4W.C"%.<.GI+E9<G7
MWD "(@;I[NHHFZ=?:'00\A <Y?BTU.[:3SZNG"#URLK,M'ITDO?DZS@T)0LH
MN7^<J3G'QCI!/.F<N#:TU3RM'ER[-8;48 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P#1OVJC^D;58;;J%I6=5M+B+IR#WC*F"Y:[@++M*J[
M6?6:OWFH:N@MAT.YLR6QM0Z!88ZJWR.5CI!Q=Y]OJQN=K'VVPRS,#=Q$>#ZJ
MC/1R.TT/5[+P$WXJ"^(CZ,EX9'HK&,J+LI.Z5R*IC*>,!^^83=1$#O&.0HE
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M-82W2DVSH*7 J/J>:6(7<TG*K%)I)+2FUG$HKJ\J6=GA)$1DJY*Q@F%5N99
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M6/@GE[MME>S#,X8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & 1JV?>MK^,U+_3&"P"2X P#K.WC9@@=P
M[6(BD0!ZF./F8>@CW2%#J8YQZ#T(0!,/N#+E*E4K35.E%SF]DNW=O9)=6VD6
MZM6G1@ZE6:A!;M]7T26[;Z))MEK)NX.WPG;L!.S:#U*)P'HY7#K[1.'FB00_
M@)CWNG7O'$![H=%:<*ITDJE?%6HES86M.#6-,/"FUEZOJM(Z9ES5YQ:K7S3H
M9I4M4VGBK-=W)/V%C]&+YN\FGRD+S;:86%G;3IKAOIU:QC.[?D:?.F?G]?V9
M&-4GG;HWE/PQC7"U>%LMM<I/=C7?+\?BL]-L/OE)D+OA:+&S2SKHUMG7&=$L
M^X>/7"S]NG3QW>CQH,EZ8Y>ZQH^NV<OINEA+7*R/?Y?.[Z_.HQHEH_>I-)9S
MIKE>3][QN-L[>]X\?NUVSW&-$UC&,/7.<>Y/*?3.==,8V"6FGNU;^?U=>S&R
MQXY>F4]WIJEC3#3VU>=-#\OLSY=5U^4M2-V^Y5'7U;E[E>[/7Z94J^S5D)RS
M6F780,#$,40ZJNY*6DUVS%F@0/:HX73+U$"@(F$ $UE+?"QE;:/9YV[]7INT
M\C7/=O"277RTSG?3/GC<U?O^<V\N53MW5.S>U*WM%2%PM&2G,_>D?.U+CQ"F
M2<*LWKK6%:6;Q]TWS(,C)J^C+UY.+IH.TT3NIYXP6("[IC*ST:2SOIA=7J]G
MIWSO7R\OUV\K7DCCG:Z<S:Y89Z[O1X1=+2?9T:[J-VCMY\C+I:.8?)AH(.6V
MVMT),G,#1GBAT%U6^EM3M"FH>IXM%TW(JP/"1[FQH]W[M8W F-D:)Z:_'XK&
M.RV>=\MK50Y9T7LK&JCIGI[4L)R:\7XI+3&Q 2$$Q3"4HF)U[AA* F)W@Z&[
MHB'4O4/(>G3J'D/ED^&NV'CJM4MV\>.=EIE;.G;9?/O^5T/HE P=# !@^00
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MKKOPS_F7KCS6F=\,?1ZR6L,]WF&^G3/RD/V[W%#^/"G?X<G_ -79#X1Q9O\
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MSOU?CN;.Z+0*/K"JQ%'UQ4*U1*; -4V,)5ZE"Q]?@8MJD4"D191<6W;,T"]
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M^X #J(_@ /,</&==(]'CMOURM<[YQE96PQMIMMU[KS9*(RHRLAW5%">@MS"
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MJO-2<YO?VI.6,]LO3R6$;*G2I4ERTJ<(+;$8I9QW:U?F\L[.4%P8 P!@# &
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M(@?(5,A?Y@#*7.;WE)^<F_Q*E"$?JPBO**7W(Y0  ]@ 'X/+*2K"6R& , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M^6^9%F^N4W[6X ]?RWS(LWURF_:S 'K^6^9%F^N4W[6X ]?RWS(LWURF_:W
M'K^6^9%F^N4W[6X ]?RWS(LWURF_:S 'K^6^9%F^N4W[6X!P-;1)/&K9VC2+
M1X+I!%REWW-.3/X2Z954^^0UL Q#=TP=XA@ Q1Z@( (#@'/Z_EOF19OKE-^U
MN /7\M\R+-]<IOVLP!Z_EOF19OKE-^UN /7\M\R+-]<IOVMP!Z_EOF19OKE-
M^UF /7\M\R+-]<IOVMP#KN;1)-$RJK4FT 0[AHV#N.:<<?%>ND6: "4ML$0*
M*ZZ8'./Q4R=Y0X@4HB '8]?RWS(LWURF_:W 'K^6^9%F^N4W[6X ]?RWS(LW
MURF_:W 'K^6^9%F^N4W[6X ]?RWS(LWURF_:S 'K^6^9%F^N4W[6X ]?RWS(
MLWURF_:W .$MFDC.%6H4BT>*BB@N<!=4X"^&Y.Y32Z'^%G=,83-5N\4!ZD "
MB8  Y>H'-Z_EOF19OKE-^UF /7\M\R+-]<IOVLP!Z_EOF19OKE-^UN /7\M\
MR+-]<IOVMP!Z_EOF19OKE-^UN /7\M\R+-]<IOVMP!Z_EOF19OKE-^UN <+>
MS2;IN@Y2I%H\)PDFLGWW5.(;N*D Y>\0UL Q3=TP=2B " ^0X!S>OY;YD6;Z
MY3?M9@#U_+?,BS?7*;]K< >OY;YD6;ZY3?M;@#U_+?,BS?7*;]K< >OY;YD6
M;ZY3?M;@#U_+?,BS?7*;]K, Z;VW/V -C.*3:@!V];,$?#<4]3^B'9_#1 X$
MM@]Q/O?OU#="$#S,(!@'<]?RWS(LWURF_:W 'K^6^9%F^N4W[6X ]?RWS(LW
MURF_:W 'K^6^9%F^N4W[6X ]?RWS(LWURF_:W 'K^6^9%F^N4W[6X ]?RWS(
MLWURF_:S . MGDCN5F@4BT>,@BW<* +FG 3PW1W*:7=.-L[IC=YHMWBE$1('
M<$W0#EZ@<_K^6^9%F^N4W[68 ]?RWS(LWURF_:W 'K^6^9%F^N4W[6X ]?RW
MS(LWURF_:W 'K^6^9%F^N4W[68 ]?RWS(LWURF_:W 'K^6^9%F^N4W[6X!UV
M=ID7S1J^;TFT"@\;(.D!.YIZ9Q1<)$62$Z9[8!B&$AR]XA@ Q1ZE, "& =CU
M_+?,BS?7*;]K< ^C/RWS)LP__P RF_Y;8&"/<UYX_!L%GI8QB@-*LI $0 3F
M>4X2E 1Z"8P$M9C"!?:/=*8W0/(HCT 1))\ 8 P#\'334[OB)D4[ARJ$[Y2F
M[BA/WBA>\ ]TY>H]TP=#%]PA@'5+&QQ0(!6#(H)O%)!,"M4 !-^J*AE7Q !/
MXKQ4RRIE')>BQQ54$QQ$YNH&K&Z\Z=IT^P7FK@PU%*.J;5+/N5C8$DYTE5O.
ML*_!Q4DPJ5+DV5NED9.U6Z2>34)6[LX<,U5EJ5:GSW3C2.)".9H#*?C;ONU[
MAFK?'V5C5T&[:LU6_P!>"LHR2+JOPMQN.U*FWH5U%_*RB;J^5<=9"O97K%.#
M: _F%HHD T]3B]D@,M, 8 P!@# +$\DMU(Z"U%9=B%BR34PU!M#U:*=&D6T*
M\M4TIZ%!?"B8C8Z57KE1:.S@_M-B%@[/%0;5\NS924GZ#&/0,&X7GAL6W?!U
MS7FNIV+#8LO3:745)AO8U7-7FYN4XU1;^\6E%*T,!GZC*&W^8]4KS(M5?N'+
M"HL'-K6&Y&=0H&?>@=E/MPZ9UULV3C&D1(W&M-)9\QCEEG,65V)U6Z[F'<N"
ME7<0K]5 S^&76 558MRT44.H8PG,!=_ & , 8 P# ;D[RJV'H;8#IO'5* E=
M9U[6)+3.RJRL#(3KN[3S7:)ZE6UV2>T(*X5.O+KZ[3.[MC+5FQ6+AN]EE!]4
M,*Q89:, @=;YE;2<;<=ZNFF.K7R="OFKZ+<+!#L[#&M]I*[@OLW3(R6U(W=6
MF9+"DUNG$B\O,=*.+L:1>(R+!N_KA6GI1P-FN , 8 P!@# --;3M&]NOJK-6
M->ATRH.VFLK1R%AX2]Q[B//+:LKE3L]CC*.QDJWLNU(+7BZ/*Q+0<189IO5;
M!"*UVTR,]HA./:U]2R 9J\:^0MKW):+M"V6+K+1HPJU9O]<&N)R*;V#A[1L'
M<5")2KKZ?)2*;FX0BNI3/Y.18)0K51U,/88(%J:O^LI@#+_ & , 8 P"T&_+
MK.:WT_?;]79"'CI2GP+J?0--5:3N;9^$> +#"-*Y$6RDO9"8G3 6'A"$L;),
MDJ]:*+E<(E.@H!@K+\P-_4^PL*);XO3!KE(VRAZ;>F@HVW*15/V5-$XQH6B_
M33=Y<"O9/6+>3Y"N&D# %6@9E0T)5DWEP.I=S_!P/GY_'4SLT+L9_MO3]#V)
M*,XQE)6:&%R_3@W"[N <NVCUW&KRE==.?Z(<UR949&EZ\NN915:&?,5%%EC&
M%4X%W< 8 P!@# -<_+7FA<^.6R @H.D1EMJ=>U4\V%<3*H.2/DWLE7MUR%,B
MAG$[ U- >OYO3ZD)$$84F_GFW4F_+*KT5K$,Y*= C].YF[2E-J3^M9EEJIVG
MJ_8.J*+;K% M;$A';A#=-TKE3BY73@NK1(!"%U8G8O2MA-),]\"2=Q#QDW=5
M<BWI3-\_/F#9Q@# & , 8 P#33+=HYMV.EKU6U:-28F9I% M6X)&2L]<O4!4
MR15/A-O3,CI*(GGTVBVO-Z>DU@@,3N"I*.=?R<7)R\U#4^8)7%6+\#-_CWOR
MV;6O.P*U8V%53CXN$8W"LJ5A.2*^@HE_M'<6LPJ5Y._E)%%S;&BFJ!E7+V/;
MPC7TN3EX#U*F-:"7F@,M\ 8 P!@# ++3FP+C%;\U_K4D#7#4&WZVV):7-F4F
M9$UK3M5-FZ.R0AF]>+$)Q*$":*M2CQS,K3SI^Z?"BR1AV2#-5\^ U_V7GMM:
M*7EF3.(U&U6<0]KV#"/IPMC0CX"JTZ,Y0R3O75M\&RD.YV-*AQO.FE.LU(F.
MB49JT.U:;*? /T>S 90<=.1ULW%?KU79^%KT=$,6UJF*PWAD9(D]7(^H[OVG
MI-:'ORKV3>-74W.N-:FM,6XCX^!0;D=S5=.P?'K7KZ7 S)P!@# & , Q@IFV
M]LV>C;\DEZ10FVPM7;"N].JM93N<[\%)5I"UVNV&MN;);S5!64:.7C*P(K6$
M8FGNTHYR1>-BDYA-NE+/P,19[GALV.1K+YK7M;)-[C.Z+U>QCWY)\S^LW+<U
M#TE=5]MV)RE/H$<:AIRFX@B). 18QLJLM I+'OC0TUZ/%OGY^6#/;0>Q9;:N
MK82Y3K:';S*TQ=ZY)*5XSDU>DW=$OEFHBU@@ >+.G24'935L;!$-W#Q^JUCI
M-LV/(R(I>G. +QX P!@# & , 8!;P-1:G ADPUAKP$S6TM^,0*56P(:]D 0)
M=3%]6=!MI0,8"V,0&8* CT>!U' )%!5&J5=:;<UFL5ZNN+-+N)^R+P4+&Q"U
M@GG8%!U-S:L>V;GE9=R!2@XDGYG#Q8"E!18P & 2' & , 8 P#\*)IJIG25(
M15)4ADU$U"E.FHF<HE.0Y# )3D.41*8I@$IBB(" @. 0-[J?5DD><4D=:4!^
MI9H1A6;(H]IM=='L%;BP2+&5^<.O&J&EH2.*@@#"*?BX8,P12!NW3!,G= FS
M)DSC6;2.CFC9A'L&R#-BQ9()-6;-HV2*BV:M&R!$T&[9NB0B2"")")))$*FF
M4I"@  =G & , 8 P",2=)IDU.QUHF*C6):RP[&0BXFQ2<!%/YV+C)9$[>5CH
MZ6=-%9!DQDT%5$)!HV<)-WB*ATW*:A#F*(%(B]4ZN@SU4\+K:@PYZ*G)I4D\
M73J['GIR4V8YYE.JF:1R(UY.7.HH>3)$"S*_,<YG0*B8PB!/L 8 P!@# & 6
M['4&I3 N4VK]=&!S;4K\Y :36A!Q>T!,*%U7 8SHK;41,84K&IWIA,1-W'@=
M1P"1P=2JE9<3;NMUFO5YW9I12<LCF#AHV)<6";7(!%IB;68-FZLM*+)D*120
M?F<.U"% IEA H  $AP!@# & , ZCY@PE&RC*29M)%FJ9(RK1\W1=ME#(+)N$
M#*-UR*)',BX2272$Q!%-9--0G0Y"F ")RFL]<3CVPR4UK^D3$C;H9"N6N0E*
MI R#VSUYL8#MH*PNG;!9>:AFYP Z$7)*.6*1@ R:!1 !P"6,&#&*8LHN+9-(
MV,CFC=A'QS!LBS8L&+1$C=HS9-&Y$V[5HU0330;MT$TT442$33(4A2E #M]0
M]G7S^3 & , 8 P"+2E'I4Y/Q%JFJ?5IBT5]L_90-DE*_$R$_",Y5%1M*-(B8
M=M%I&-;23=55!^@R<(I/$5%$G!%"',40*5&:IU="FJAX?6U!B34/UM\!C1E.
MKK U,]?&4-._!06L<D-=]=&65-+>J!9^L3*J"\\83F$0)]@# & , 8 P"W9M
M0:E.@Y;&U=KHS9Y;2WYXW-2:T*#J]%.*A;HY2&,%->VE4,8Y;&J4\P!Q$P/
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8!\ I0$P@4 $P@)A   3"  4!,(>8B!0 H"/40
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@!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g14810g68e14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g14810g68e14.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2)24&AO=&]S:&]P(#,N,  X0DE-! 0
M    (C:^AU@X0DE-! 0       \< 5H  QLE1QP"   ",V  .$))300E
M   0[_6*7 *6G4H0]6!0C?K)?SA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!H8
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  (#O_XU
M  (  CA"24T$)@      #@             _@   .$))300-       $
M>#A"24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M 0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U     0 M
M    !@       3A"24T#^       <   ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@     _____________________________P/H   X
M0DE-! @      !     !   "0    D      .$))300>       $     #A"
M24T$&@     #-0    8              ?    1E          $
M                 0             $90   ?
M 0                         0     0       &YU;&P    "    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M $QE9G1L;VYG          !"=&]M;&]N9P   ?      4F=H=&QO;F<   1E
M    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '
M<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE
M;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E
M;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   'P     %)G:'1L;VYG   $90    -U<FQ415A4
M 0       &YU;&Q415A4     0       $US9V5415A4     0      !F%L
M=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL
M5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z
M06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC959E
M<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI
M8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M"FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M  MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M #A"24T$$0       0$ .$))3004       $    !3A"24T$#      8(
M  $   "@    1P   >   (4@   8!  8  '_V/_B#%A)0T-?4%)/1DE,10 !
M 0  #$A,:6YO A   &UN=')21T(@6%E:( ?.  ( "0 & #$  &%C<W!-4T94
M     $E%0R!S4D="               !  #VU@ !     -,M2% @(
M                                                        $6-P
M<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P    %&)K<'0   ($
M%')865H   (8    %&=865H   (L    %&)865H   )     %&1M;F0   )4
M    <&1M9&0   +$    B'9U960   -,    AG9I97<   /4    )&QU;6D
M  /X    %&UE87,   0,    )'1E8V@   0P    #')44D,   0\   (#&=4
M4D,   0\   (#&)44D,   0\   (#'1E>'0     0V]P>7)I9VAT("AC*2 Q
M.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C         !)S4D="
M($E%0S8Q.38V+3(N,0              $G-21T(@245#-C$Y-C8M,BXQ
M
M  !865H@        \U$  0    $6S%A96B                      6%E:
M(        &^B   X]0   Y!865H@        8ID  +>%   8VEA96B
M   DH   #X0  +;/9&5S8P         6245#(&AT=' Z+R]W=W<N:65C+F-H
M               6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                             &1E<V,
M+DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'
M0@              +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R
M('-P86-E("T@<U)'0@                            !D97-C
M "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M               L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%
M0S8Q.38V+3(N,0                                  =FEE=P
M$Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(       3 E6 %    !7
M'^=M96%S          $                        "CP    )S:6<@
M $-25"!C=7)V        !      %  H #P 4 !D '@ C "@ +0 R #< .P!
M $4 2@!/ %0 60!> &, : !M '( =P!\ ($ A@"+ )  E0": )\ I "I *X
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M:SNJ.^@\)SQE/*0\XSTB/6$]H0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M"RU*,W&M4C=4)PIRIUJ<I6-/ZA]9MK1]N2MPYHSM#Q]WQ@S5LN7][W*V":B
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MZ&S'Z?W'TC3Z-^17V<T=V5OS!\^^67VAOO[/Y9Q-JZU1@&_="YB$0Y=QO^Y
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M!1$=Q'D#D]<>3GJ2>$WAO";Q%-MXZ$EEMOH2(TFL-J*>^3W)9VM[MBZ31&,
MG.H<!#B@JIRB/+N!A)R!X1WY!W#UA_0-?T)T%1=IH71-NWKNCHO1]'6QJ.7-
M6=*.LX-MPSA-Q;S'.UO&WX4TO<0NM+Z2N(92N=)7U=1PY*&M<U9:NNDE+&MC
M66$TM9+#V?-@YP^/[*[77?!?>1PLKK['W#8.</C^RFN^"^\AE=?8^X;!SA\?
MV4UWP7WD,KK['W$O89R-;V+KE?W/,V<M=T@$.Y8VTY:7"A;SVTYAR<A>V>,7
M>6W<[-689-@52BU'4:H6/<K!(-^(^;M%T//<HM$WNF[6C:6NDH:.HJXC4OJ4
M[7PRGI"VA&?_ (.JHW=G4ITI5'&=1PJOG(P=&<94ISC+M]#:1LM&W,KFZT?.
M^G&WKT[65.X\%JVEQ65.*N:<IVMW3G*$(SC&,Z6QU%4A*%2G3DIK:ZJH-0+9
M"X,6'F5;3A9I*'DD+Z6CI=C><I"V5:S._63I6U9)FA+0=M6)%(QC-:.=MD9Y
M[)7"0Z:P1C2-\U4Y"5E*\G:Z<="5^[6A=QGH^E4HW&B[>ZTMI"6BZM.G>6[5
M&M?Z9O*DZM"I0GX-S5G*,Z49NIV-IRCH4J%M;W6C)7$;2C=SMY4[VK1J4M)U
M[;0UC3TG"<[:O&4Z-AH2THRM[BG<TZE:=6Z4H3=.-/'*Y[Y7N>T<?6FX9E3)
M83"XF"3\[I1PK))W!<KRXA,HD**8MNLNNP8ID!=P54B(+AU RAD@]K:Z/A:W
MVD[V%3/^(U+2HZ2C3BJ3MK2%L\24GK<ZXNJVTFG)KQL)GG)W$ZEA9V,XQE&S
M\+49^.N<C=7;NFFDO$5/6=."BVL8W;<V$!0   !      _&Y #P!R@(^<=Z[
M'7?2D^O6BL]>.@TK"2232222Q)X26,9:R\<7M?2?=@YP^/[*:[X+[R+E=?8^
MX;!SA\?V4UWP7WD,KK['W#D#PB&P^$>7D#P[[;<O@\&X4ULIK"W/<T]KV;EY
MS74RW3PF\582>QK$8Y;>[J2]),><#%4N:R3E-R#@+3.4=P'D,33]C<!#DW]?
M?]X"'K5^?_)HN:Y+QHXFW0TQRAHMU(2HN6IIN^6LHSVI/":W[VLY3/:\O)NK
MRCJU\14:^C-!5,0FJJ@Y:&L7J.4-C<7E-K9L3W-$.;!SA\?V5^@:[X+[R/'9
M77V/N&P<X?']E-=\%]Y#*Z^Q]PV#G#X_LIKO@OO(977V/N+HLF7@+=NR G;F
MMPMXP45)(OI*V#2:L,G-HH;F*P6DDF;]1NV64!,'0$:*BLV!5O\ B KQR\'2
M5"ZO+&ZM[.\6C[JM1E2H7G,PNO!I2V<ZJ,JM%5)13EJQ=2*4FI9V)&VRG;V]
MW2K7-O*ZME656O;1J2MW7BHI.GSW-UM36<8N4E3>$L*.6Y&4"VJ>W9=VP-=^
M*3WE'-;LEYI\PF[X.)Y^WY:?[=#VS/JL[1;,WO4KU(A)]D&T;'ME(5N2VS0X
M-3'=&\/#D+<VT:ST;IV.BZM:QM[=2M-&45"UNJ-!V=2^L85;VI.A4NK)NA<*
MI5KU954KJ-Q&MN]3+E1;W%:VG?Z+GI"C0O[BZJT;F_J:UY;59SN*-I=5Z5I3
MG4\#O)NXMYI1H*+E0E9NGJ<W:>3L^6Y?]IW' QUB34!,W5>!;PG[E=7O&RJL
M\Z0W2C&,VPC\?6X*\;;S)9ZUMJ,C'\/#Q)GJCD8MTJBTZW['0W)>_P!%Z1LK
MJMI>TN[*PT4M&VUA#1=2@[>3>:MU;W-72]XXU;J2@[J=6C6KUHP4/"(Q<D^)
MI335C?VEY1HZ/NK6ZO=)2TA7NYW].LJD7C5MIT*.C+./-4$YNWC1J4:5*<Y2
MYB3QJXQ[!SA\?V5[77?!?>1YS*Z^Q]PV#G#X_LIKO@OO(977V/N&P<X?']E-
M=\%]Y#*Z^Q]QP.'(.P@.X"7UPVXVP;\H>M_T(4UEE-[,-2V-/..C9N_WX&,M
M9IJ,<ZRU'G*U=9K:DUXV,;4L%]SIR'L#'( 8 XOX0RCZX\8LS&B4!*'*''XH
MB7?PAR\M>5T/!_.7EC6::4JG)Z$4XM:VIHRIEQDUB2_B)92:3363O]*M3T!R
M3MDTY2GRAG*2>MS<7I.@TYI+,<\VTE+#>2Q4Q R9#;@'&* [#ON'Z!V"O5*3
M22PMBQMDD=$UJU:[VM2JN2:3PUJ0CPXQ9RV#G#X_LIKO@OO(977V/N&P<X?'
M]E-=\%]Y#*Z^Q]Q^S<4".$#N4SKMBK)&<()*@W560*<HJI)KG0<D0443 Q"+
M&;KE3,(',BJ!1(;&<IN$U!QA-QDH3EB<8R::C*4%*#DHO#<5.#DEA2CG*J<,
MK7C*4,K7BLP<HY\:*DX346UE*3A))[=66,/-J0UBL#1#Z @<5-X2$;0QXZR(
M92\%'T;8SIS9EYV"_68I(6O&+RD<\@[WE)%9C).3R#F[1-<,C.2!7+B-4_-8
M?)[5=>G=7&GJM:XJ7$ZFDZT+3FIZ3HSTIHS2SC5:OYNA=4Z^C8T*%S;\W3MK
M&M*VM[2E*$*Q[2IROH2H5K:GH:E"@K2G0T?2E<<ZM&U:5AI#1L)47*S7/6SH
MZ0E6K6U=3G<WM*-S<7-6,ZE%V;<VHZVIE>X%8G%@Q!'^/B8YMELZOE[(L+/M
M\[*28/HMI$LK>@X>7A'G7Z4\+&88.95.\X]G=!K@6<=<MG/:6/)*ZM_ W=:9
MIWDZ6E'I:^J?X7;TJFD;N,H5*%>=:I=7->VNJ#AX/"K;UHT%H^=2RC:1@XSA
MU5]INWN:=Y1MM'U+.C6T=#1EI3_Q"XJQLK7,U7HJ$:-"A<6]PJDJM2G6HRK.
M]4;QW3J<Y&IB<4@%\)@$0+Q2[ 8.3CJ'Y=]Q$?Q_".XB("(^'D]OG&-BV)+Z
MRWK.W?P>,8Z]AYW?.<WG;5J3AA2V1J0H1:>S:TZ.<[L2QC9E\]@YP^/[*NN^
M"^\C+*Z^Q]PV#G#X_LIKO@OO(977V/N&P<X?']E-=\%]Y#*Z^Q]Q+"  .!YL
M@&*)AS%92VV^QN*2Q<EE'\7;<>4 Y><Q0V'>O(SUY\O+1*F]6')*_7.9\1RJ
MZ8T:M76QA2BJ>LUEO$EL6-OH.<H4^1UU.=7$WRGL7S2@W/5AHC27CI)Y:;FU
MG&$XXSEX43!R@ [@&X;[<OV5Z[6:V86S9]9=!YY232:RTTFGJR64]JV8V'W8
M.</C^RFN^"^\BY77V/N&P<X?']E-=\%]Y#*Z^Q]Q\$I1 0'BF 0Y0'C;#^@=
M@ =N<-^4.2FMQBFNE:RVXVX])C-S<9*E4E1J.+4:L8:TJ;:QKQ4EJN44\QSL
M4L/H,N;/U*VO9<%85OP^*E48RV&BQ+KC27TLG&W_ "J[Z'FEKBDDPM49-A-K
MS=M6R4SD)>029VS&+VU$(1A9%>2+^?:1Y%WFDKW2E[<:<INM=5(O1=7_  Q.
MXT/0\'N+65M"H])<S<TU0N[GFY>#V]2-Q6=Q.=1I0/3V>GK"SHZ-I0T*JCMX
M5/\ $^<OJCHZ6KSKVUS&O.@K1>"OG;2A3JJ%2K*5I!V]&=LY.H=S;&K\;,F[
M'N6W,90R,W 24U-7:I(7!).6-WSET7%%7#<MPLTHUE"R5O3TD6);V^BX<RUR
M1;.UR=A30SIN^GAF]6D/D_AI*QTEHVXTW>4[2YM[.TT?X)0M[>MHRUT?;U*%
MG:ZSJ5:-S;TY5'<SIJA;2JW2564THTH4N59<KZUA>:.TC2T=;5;RVKW5U?RN
MZE:XI:0N;VM&K7N5%1I5;>X<(^#PJ.M7A"C&.*3E.X=QB+<$J6=GIJ;!HVCB
MS$M)2A8]H9R=LP+(/5W@,FZCI5PY40:]7%%([A=58Q"@*BAC#R>^M*7@MM;V
MW.3K>#T*-#G:LH*I5YFG&GSLU!1@IU-77FH1C!2;U4HX2\G5JRK5Z]Q-14Z]
M:K5:A"2C%5)RG&FLY;C24G"#;UG!1UG*2E.74;!SA\?V5R-=\%]Y&&5U]C[A
ML'.'Q_937?!?>0RNOL?<-@YP^/[*:[X+[R&5U]C[B:<''*1?,IC#L!]/^1$_
M[/\ 6%IB!OT[B&VP<OK^M7@^6\I*KR.A&G.ISG+?0NLX+65.,:5]4<Y8RM5.
M*BVVDLYZ,'JN2.*<.5$ZDHP7S2TO%*4DG+-:QC%1RTY2:EE12SLQO9"VP<X?
M']E>\UWP7WD>5RNOL?<-@YP^/[*:[X+[R&5U]C[AL'.'Q_937?!?>0RNOL?<
M-@W >,'((#R /_N'-O\ ]<M-;.,I;'GZR?XHC;PU&4H/9XRBWA96=C6-JV=6
M];49*X<U L\.00-8BRU'URGOB"NQ]/C<H,V4O%V^JV48VG+0W:Z[=KQ22@2+
MY,S.?8":9>,I1XB]-"1B"7C^4')>MI^[52MI.-.Q_P .N;)6;LH5:E*K=1DI
MWMO<N[A"G7;C0A+G+6NG;TZM"FZ7A%6H^_T1INCHBW4:5C*=W&_H7GA'A-2%
M*O1H+5C8W5NJ$I5;9Z]>KBG<46[B5&K4556M*!>4+JAM> 9.$HG%TQ%R:TU9
M:XSD1DU:+EG-IX^2MUI:EG2,DTLLDLLTCD;=0DSR$9)0RSRZ3-9YZ@X3BHV-
M;]9+D3>U*U*=;3T;JA3H:37@M[HQ7-&-]I:=[4N[ZE3>DH4DY*^K6\:%S2NX
MPLLVZJ:\YUWSH<I+*G0JTZ6B:UK5J5[)^$6.D(6M:5CH^-C&VLJU26C*]9RA
M*PH5G<VU6TE*Y4;ATL4X45 &6<AK93OJ3O1PP/&G?,8".*D[DEIR6<(V] 1E
MO-W\_/K-62\_/OV\6D[F)I=FU5D'RJRYD$^,!0]5R?T3#0&B;;1=.L[B-O*X
MFZKA"A%RN;FM=3C1H1G4C0H0G6E"C14Y\W3C&+G)IR?2:7TG+2VD;C2%2G*E
M*OS,=1S=:2C0MZ5M"52JJ-'G:LX48SK5.:ASE64YJ,5)14;[!SA\?V5W.N^"
M^\CKLKK['W#8.</C^RFN^"^\AE=?8^X;!SA\?V4UWP7WD,KK['W$NZ>SE2U#
MZ>5#"&Q-0&$#CRB'(7*5IB.XB   <G*(CL'A&O$_*/4<>0W*7$)3<M&U*>K#
MQY?Q*E.GK**VM0UM:7_IB]J6T]=R"U7RQT Y35.,+^-1RGXL?X5.I446WA)S
M<5"+;^M);'N<)1)3'B8M3D*4&#(P[CR[F:D#8 VW'81Y1V]8>3:O665)V]G:
M4LZW-6MO1RUJ.2IT814W&67'6U6]66V+V/+1Y:[N(5[VYJP4M6O<5JZV2Q%2
MJ5/%UL8DUK+:M^]+#3.PV#G#X_LKE:[X+[R-65U]C[AL'.'Q_937?!?>0RNO
ML?<-@YP^/[*:[X+[R&5U]C[B9L190@\8(WJY=646X[EN" 4A+8N4DVE%.K+%
MXBZ;RKMHW<V_.)/E)5JLG'N3IGC7C>+/(MXYZQ=R R"'GM/:'NM-2T;"GI%6
M=E:72N;ZQE;NXIZ3YN5.=O"I4IW=K4H^#5*?/4DN=ISK*G.M2JPIJG+LM&7M
MK8+2-2M92N;RZME;6%]"JJ%?1,6I\_*WC.VN*=5W6MJ5W)4ZO@^O1HU:3J.:
MG:6U?QLXO/NGF,!8OY>#N]FPEH.\B,Y:!G<D3#F:R+,1;R3L^:ZBQN8ZC:'3
MC")DD(NVT742E<*YY-X]/Y:C\G\[>5LX::C65.\T=5NHW>CH55>V6A*2I:$L
MJW@U_9MRT9)U+BG7ESD*UU-5IVZU(P7H*O*VE<>%JKHKF%<6U_&E&QO)T8VM
M_IF;GIN]HJXM;MQAI):M"5M"5-T+1>#TKA9=0A3/6;9'/-Q0MRS,,VB7\9 $
MB'?4W[B1%\Z4D7TFZ7157;MUF,2DN_4;PD$!W)(2/(1FF^=$*0Q/2<EN3E+D
MM95[&WNZMU2JW<[F$ZL80J1BZ=.E"-3%2<*E=QI*=Q<1C2C7JN4XT*,<071:
M=TM/3MXKVO0C2J>"PMY4Z>52UHRJ3DZ:5.,J=!.HX4*,Y59T:48PE7K23FX.
MV#G#X_LKTVMU+[R.JREQ['W#8.</C^RFN^"^\AE=?8^X;!SA\?V4UWP7WD,K
MK['W'72_%")E-SE* QSX=S"(<I&JJFP;ARB/$V /T[\NU<2_BZMC>TUA.=I<
MQ3RGMG1G!-[5A)RRWN-UM44+NR;W*]M)-O,<*G<4ZFS*VMZFJDMNW.W&'O81
M+TP148'4#<D>R#\L/6;)!_\ ;7\W76J)M.B\IM?7X?\ 2??*IQ:3U]__ *7W
MF#NH+A1M#6EC([[$N>LZ,+ R!&QD7,O;><61DZ>50C)Q 7,2Z%_:ME3L48KM
M$AS@F#_JR7%V722,(%KU^C.2G*335I&_T5HJM>6;J3I2K0E!)3A]:*4III[O
MK86U8;R<6=:C3DHSJ1BVL[=C['C/HR1K9?#.<&ODZ[[8QQ9FI6-F[NON?B;1
MMB')C?,K$TK/7"^0BHJ/*\D\=,HYJ9X]=(H X?/&K1(5..NX22*8Y>37Y#<K
MJ%&M6N=!UXV]&E.K7E+4<8T:<7.I*2UMJ4$VUTI&/A-N]U:.>C&,YZ,;7MSU
M& =E<(=P+<%95FP]XW-@SMJC;9@HRY3/]-MXR;\;CCXMJUG2OI!+$+Q-^]+*
M).RNGJ3IRB[7 ZY'+@IP6/SJ'(SY09VU&<K*^G&6)VDZ5:5.',N/BQU.=RHZ
MKRMF-JQNVZ<:,E*M)V]K'6252$Z%*4ZD]92<W4PI0>5E['E>DNGOD7 ;^R;
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M+<JJC.<5'9"/.22;C"+U5'"72DMQ>W?(N W]DV O\+MZ?Y+UG\S?E!_I]_\
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M H!0"@% 1UE#U/P7OIX0^N>P: K\:>+C'WD/:7S!'T(MWIE[V7M0HH!0"@%
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MK[P3!L','F"KJ1X>U]X&P<P>8*:D>'M?>!L','F"FI'A[7W@^AL'*  '((>
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M%56M'&,96-V-O2EU>[:3'77F0H!0"@% 16\\<<5Y#K?.CZ@)4H!0"@% * 4
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M,X&$ @(#L/((4!^[1)RLY;I,RKG>*N$$VJ;8%!<J.5%"D;D;@D J&7,J)"I
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M H!0"@% 1UE#U/P7OIX0^N>P: K\:>+C'WD/:7S!'T(MWIE[V7M0HH!0"@%
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MB1C)*D Z9C)*E(JF82F 135(10@_BG(4P"  ?K0"@% * BMYXXXKR'6^='U
M2I0"@% * 4 H!0"@% * B3(OJJQ5Y5K_ ",M"2W/S/W$MT** 4 H!0"@% *
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MOZW,QY#69\D=4!B-IF_K$X-]]BP?I/&T!M08;\4&*?>UL3Z+15 210"@% *
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MUCH@0RI"'$Q0 K: 4 H!0$29%]56*O*M?Y&6A);GYG[B6Z%% * 4 H!0"@%
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M:3>2/0"@% * 4 H!0"@% <T_RA_44_AFH"'<#>*>Q_(ZP/JZM&@)?H!0"@%
M* 4 H!0"@% 8\X@]7N2_[EU]?&I*A([EYE[C(:A10"@% * 4 H!__@_O 0$!
M_<( (<P@ U<M;FT,)[UD^[CSCYQIE\7VLF%P78AN/./G&F7Q?:QA<%V(BIV
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MHT!+] * 4 H!0"@% * 4 H#'G$'J]R7_ '+KZ^-25"1W+S+W&0U"B@% * 4
MH!0"@% * BMYXXXKR'6^='U 2I0"@% * 4 H!0"@% * \YN%$_JFY3][K(WT
M7<4!I@X<S+,X:>WJZB(:&G$;\L=>PYEM,&DD^H1:UT6K=G74<XC'S%5N_+(6
MDP;]46ZY0,R<O4Q;@L=%=#>UGW;LG'/3;"FH34U-86MZ\\5XBQM<T'BJ<DRR
M:<M<]P$D&*V.[/B;093S2(D;IM]J#8D#G1O;*,'$2LP[N&Y)I!S'6LT>HJO'
MI\=^-R73^_3[<%_'?N_?IRN'GE"X\E<(")"6U"X+LNWI6"B%Y69MDF06TA>9
MU6VE.!P7<UP*((Y$;]96Z6V9B&N^!MEHS2<QES$CY4S*662F%7Q[=F,]JZ>/
M'AM[%M'7GIZGYMF_'HPNO<1?J+UKZJ,"Y<>VA?-LX/)<J*UE7LX;V2WO(]O
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M>PBTP_>$"P ?,(#3#X/L(IP6QR2VOVMLO>F'P?8R\Y#^9"F'P?8QSD/YD!Y
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M\CK ^KJT: E^@% * 4 H!0"@% * 4!CSB#U>Y+_N77U\:DJ$CN7F7N,AJ%%
M* 4 H!0"@% * 4!%;SQQQ7D.M\Z/J E2@% * 4 H!0"@% * 4!$F1?55BKRK
M7^1EH26Y^9^XENA10"@% * \P.%]O2^[!T6W#<&-KNN^R;L#(&/HYC.61<,U
M;4^5*1F#MW#%M)0+QE( F^ Q$5FZ:W%<EXJ:A#@!2ULC]5_\R_#]XZ>@Q<DG
MA]*RO1G/X&HRZU;:OF:ZK9[J=U)M'2!BD6;N<T90;+(F, & JJ;BYDA(8"F
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MHZW)Z_YT?>M0$J[#S#YAH!L/,/F&@&P\P^8: ;#S#YAH!L/,/F&@&P\P^8:
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;0 I0*1,H$*4"E "@ %   "@!0#D  #DH#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g14810g80i46.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g14810g80i46.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1UB4&AO=&]S:&]P(#,N,  X0DE-! 0
M    '4:^=)0X0DE-! 0      #P< 5H  QLE1QP"   "@  < E  "')R,S(X
M-C0Q' (% !M-:6-R;W-O9G0@5V]R9" M(&)O9'DQ+F1O8W@X0DE-!"4
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M;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L
M BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T
M;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP
M     $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M
M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="
M0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M     $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M    0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0%N808
M       *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',
M4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
M              !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E!R
M:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P
M4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P         +
M8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU  (  @.__C4
M @ ".$))300F       .             #^    X0DE-! T       0   !X
M.$))3009       $    'CA"24T#\P      "0           0 X0DE-)Q
M      H  0         ".$))30/U      !( "]F9@ ! &QF9@ &       !
M "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4    ! "T
M   &       !.$))30/X      !P  #_____________________________
M ^@     _____________________________P/H     /______________
M______________\#Z     #_____________________________ ^@  #A"
M24T$"       $     $   )    "0      X0DE-!!X       0     .$))
M300:      ,U    !@             !B    K@          0
M               !              *X   !B                      !
M                         !     !        ;G5L;     (    &8F]U
M;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M3&5F=&QO;F<          $)T;VUL;VYG   !B     !29VAT;&]N9P   K@
M   &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S
M;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N
M=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N
M=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !
M    4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
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M;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M"W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M.$))3001       ! 0 X0DE-!!0       0    0.$))300,     !+K
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MTW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H
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MW>Y<'';;H!&TF=(]/;L_G/\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M  (1 0,1 ?_$ !X  0 ! P4!               '!@@) 0(#! 4*_\0 8A
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M7/3];S1/X?SK[F]/V/?AI_ ;&_W[E_\ 3^3^NGXJ?W2\W^CL#_J[FOX[7/(
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MT-Y G9_]DC8\'R#RVO5WQ.8L%^*>7DTS*!7Q&*F8%6["Q)QL<;("">]';N!
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MCYI^1#F/TUV'_P"WA_K^?_NK]?<>G[8?XF?VF^'OZ%Z@_I/R?VNG0A.SU/\
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M_!O^H_\ X>-C\1_../:$_P (.G</P;_J/_X>-C\1_../:$_P@Z=P_!O^H_\
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MTBR*<SQ9N^:+)- (4QC>\J)K&*AV(4QQ%42 !"F,80 H]NF[AKNV"OG; CM
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M2)2CATB!5&:#(Z[AR03G]BFF4AU):VR=I-'+ .-J3B,EY\$GQ\KL:4;V?Y=
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M0KA^QAE$@D';-N9,Y%W*#<Z*)R*$.<!3-U/S3=ZQ_(Y7O8;"_DG);(]]C=0
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MR-^O>BK=6=,7LO2A$SS6*@CR=:XRH\5>',30M)CVN6:DUV(020,]PI2LBI
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MP$TYF'BB0V)6)[I&;3*VV.R?H4;+:!/A0#LDG7DG9)"(1JOIQ(A9'5U10?\
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M_#]SS8" @(=UE3=NP  B7^2';L'H4!]!#OYA$3"(^HB   3KR"23X_, 3^)
M &_S  #[ <> -:\>->_C0&O.]^XWYV=DCV\<VF:]_, +*E*8! 2E$G;\[L(^
MHD$W?N'H/?OZCZ]2/  ]]$?OB6/@[(\[\'R#_'XT=$#YW[ GW( 'VT/8:^D_
M4#[EOWVQXX(U!/OY550_E@'J'H!S 8?J]>W;L41[B4/0!#JD*%&E.A^ "Z\:
MT?*G9&C[^/J.P?&GX_?\-D['OX!WL#S[;\:&O;F\J E$?[<L(";S=A,'8/Y/
M8H?F_P GT'^D?,/<>W8 @+HMICHL"!]DTH7M7[Z)'>>XMMB?.B '^QT -_QZ
M_BUXUX_/YX! >PE%542B(CV[E#L @4/* E* ]@$!,'<1'N8>P@ % M?G['7D
M'\=:U[;_ !UOSOR3]O'(U^.C^;0U[:_C]_/DGSX]O'- 0[#W!50 $2CY1$I@
M_-*4H=A,43!_)[^@_,1'JD* "%)&R-D'S[=I WL*" -]H'GR"&))$ GS^).O
ML=Z\$?@->/XSO?C6OL!$HE%54>X@(#W* @(?7Z%#OZ^H]^X#\NW;JK\_^Q]_
M^T'7_P D \'R6/L&^P ^GQKQ]_'N-[T?S: V@V "^4%5.W<#>OE-W, !V-ZE
M$>_IW[A]O] =4Z_$GQK0]] ,6UYWO>];.V&AVD:&IT/)T/J)+>_U$_<Z(U^.
MET/MK1(/,FF"90(41$ []NX]Q]1[_4 ?+ZNJOQ_C)\ #W_,/\/XGSR -#0^W
M\O\ A/GF_IR>.G''3CCIQQTXXZ<<=...G''3CCIQQTXXZ<<=...G''3CCIQQ
MTXXZ<<=...G''3CCIQQTXXZ<<=...G''3CCIQQTXXZ<<=...G''3CCIQQTXY
MQ*AW H=Q#\\H]P^8=NX_6!O0>W8?3Y"/;L/KU2XVI'^ ^-@>2/Y@?;S^''Y_
MP_R^/\O+.^.!U=0TC=N1\BD4[">LQ,4R!44FX&0R+'9&79O)9JL5H@Y,6^ZK
M+Z!9/>C.'"4G5D**3N4L6B4O1YJ-:%##8/9]6K$V8R0)/_K3+(CI&26)U3Q2
M4:S1E1Z5LW]:$C#F988QQ0U@1V@+88JTFF::*(_6AED@[X],JRPJGJ1&/U%]
M1">8D^?&H\BJCR1Y!<%Z!PYJNJ.?$_SB7B\;V\MOBJW#UT\!A\%EFFO=R%Q%
M3$FG&94W!G;J.>-C9!Q(GE'$4@5DLY!XESS,2 OD_25'D #ZB2#]]>>X#SYW
M[:YAJH#>H2H['4E='O8> "I'C98%26UVC7D@Z%HVF$YH\_39)C="X$<>L\T;
MP>N2.,W+7:E=] C&N=:+<:-7HNTUW+>.KB+K\DO!4F\TZ2C;7$SML9MVM=<&
MK3-Y&3"[ Q7D';> !L$?OM'V'L"-_8CR0NB/(]^2-1Z/<Q5U8#LV".YM'O#G
M1^I2H4,Q*D]ON"(^M/)[DA8M@J']D0M^"5=3XMYGQRMN$2>:/KU $Y/R-<F-
M.:QLOML<T;QZU<0DJ;9X]>J%CU[$E)(T4]G<@ND!"(FC[]VO !\'RP&_.QO7
MC7D;\^^_8<J ^@P]R]S.K!@6](GM(&F_?[;N&F"^#H>YV*]S:^\ON#VN:]OM
M[X$Y#;VWC3;71(/#*;3KY"&ELYTFR4"R2M3S7D>^DHA!FZKMDJ,7+V^S2=6)
M(-(6<C[0S.S>JOT%TI]CY!VWMK[>/[+?VT-^-@DZ&N4E1(/I;?IJ2>\DJ5[]
MGL \]VV "GM\#?V(Y%Z>2<UJGQ;OG@ .^(6"(;+M.5:QMT+O]4T5M'<>(O*K
MSJTW(3%PFXMY5OI>VT>DVB0)3V4$BP?A((I5VQEF8EG)%CXZ!L*R:^QT=CMT
M2-D^ =@D @#S[[URLLHDBF[M=I *D_NFU!("Z/;VE5.B3I?([3K?*OTICSBY
M\P>6\8*)P"P>@W[PBMGQFU[$POM_C?P;Z'=Z33XBWU?,./B4'"/UT(#1Z=(Q
MMK;V*SH,V<'\1KQ7<9)+**'+/D^-#P1[Z]_S$;/L?<ZU[$<I':GGN8APW;Z>
MPR@L02V_O]) 52>X;(/N>>1)<L=YU.ZY=_9$-8X0U4_%#$L#T_*YFA/K_"CR
M9L=1?7MK7[ALC)F6)5K#D,^L]7DH2.BI&Q-I=:KDL,H+EB0GNRT [U)]6@#X
M'AOSZT2OC7M[Z/V]N.S2M7)0/W*0QVT?<00H;8[R6[A]1&B=^3O8D:K7_F1P
M@Y :IR=TOP]\RGFOB]ZSEU!R*D4+384EFSG3)NH+MZ50.0K^2B&44O'72!B)
M.SW.1K1)%O'NX^:AG365% KI:=D?;W/L/<-Y_??R#>QO7M^?@A74:8_0I)[M
MD,I(),>O(^H@!6[=^_YN11!Y3S6JG'S;? ?><-,%2V/DOG&X;Y6-MH6@M(SC
MG7,JO.I-R6:V6"*?UM:VHVS-+7<8>EP43'1KY>;.%;7+(PC,QA90?;MT 6V=
MC][K8V2/#%@2/;P3Y\<D,"PFVQ52H*D_7L*=!#MD"MVG[@J/I(;6^>[-+\UN
M<-,S[B/GO C!ZOH7@^[/C<UM8WR_QH4G1;G0J\G+5BA\=5(B"7>(I:=5F*4_
M-V*S-XIC%I2D''.6,F:4.X9-$Z&OWNO?P/'GZ=;UX.R2  #R-*NV+^) V@F^
MX [4M)O0)#+V@*S$D$G7WZUSY5<@M5NF0_V0#7^#-19<6..60;7E-@I,U>X=
M'E#8X)[>E*7<M*B3MV"U>0C\WM=0?PE,C5YQK(F@)&Q2355LT=-4"M[/?HZ[
M2#[ GV\^-@CQ]SL@_8D[D)H&#:]S.I# 'L!(.E;>F!VVM@:4@#S_ &,M5C4.
M97"7DCJ_+C3O#LRR2BO%@U'$LPS2H431Z\.G95JMFI\?2<]H?(29F(1C%MH>
M](MSV;2I"O-Y5"I/D9)LLA8S1IG[^?(;R/WQUL'R#[#NWX_$DC?C\3[O#J &
MUV(2=[TP'D^GHAAX("J0/)#$@$@6XUK*>9>4X'N/@"N>)6$R>Z<M,^W/D)7-
MKJUV)%\>*AD>C6UM'VNU3[*1@BW#Z:Y-;)F/JU-8L(YV5\_3J\DFZ8,VYS#'
MMW(- L&(T/IT2-[/@[!/X;('Y^3L;2;ZNV-D!5B._N5#K1UV%2%.R2-,1X^W
M*DF87FKSBSO(N"='X,XG5M$\'_8>/ENV6?T;08UUFVGRV>TN1+3:A@R49!J/
MUB['"1R]AM$Y/M8R+AD5HQD[:RCB>"0B)\Z U^]*[V!]AXU[D^#[G6@0/N-4
M:0,S]VUD$G:(R>X=QT>\'P -'07?<R]W]CHUO9.5'([:;MD_CFU_@5G,;QTX
M<9CO>6V>E6?0(3\:&[1I[(%,T2[U5TA"NZR$+E%JHLM$T")DY1M(V".E+;(M
MGL<VDT4FL$DZ8#P-^" &.]?O=>/YSYW[#9Y4JJH:(N.YNP]VSZ8UOM[]_5Y[
MO)"D*RD;.AK/SX=K?5Y_-M8W#7\AK.&3G)[;2[S7<PKU@0M$A7:1*XGBM!K3
MJ]3K)HT8/=%GT,]7L5Q)'E<M6,G+GC@D9)5HM(.9T1O?OOV\>-#6OP^V_?[Z
MWRC8[553L*".X @-MF<E0?.@7T"=$ZWH;US(/U/''3CCIQQTXXZ<<=...G''
M3CCIQQTXXZ<<=...G''3CCIQQTXXZ<<=...G''3CCIQQTXXZ<<=...G''3CC
MIQQTXXZ<<=...G''3CCIQQTXXZ<<=...G''3CCIQQTXXZ<<=...G''3CCIQQ
MTXXZ<<=...G''3CCIQQTXXZ<<=...G''3CCIQQTXY;ORHO4]1,5LZU..3\(%
MP<0N:YP@9<&ZKB^:-+-*A6_=U >,%2*,GLL$HJNBY349M6#AZ)@2;*&+N,!3
MBNY6JEH;H5_5O9$]I8+1HPR6;&U[6#!A&(^TJ0Q<)K;#EZN/W0-X_<_W3ZMA
M=H00&(BG"AFTNWB=-D!QVD\D7+:-&YAGM(SF'$ZD?2ZO#5Y-<3+J'>'C6239
MQ(++.57#A1>0<D5?+F6<J+'6<J&4,<QA'K77;CY*[;OR:[[5B65E':0JNY9$
M':  J1E0B@#Z0NP-ZY3*WJ.\FE!D=FTB1QJ-G>ECB2.)!LD=L<:(-:15 USY
MS/$^S3$IK9N5O,.P^)+H>(<G^!.1EG.-.85B_4"FUW()2=R%I;&328S^[U.7
M3UP=[M94H^14*H[8KM$F%;<%66B6[-MCL/'=O7:I]M#7[X[)(\[]O/CQH'>P
M*$;;>GVJP>1 =]W=H=OTIVD:(_?'MT?.VV-<QW[B;'>'$KQ7TGCCXX.FQUA\
M4C<* RYIZ3*WC KL6Z5>V5M=A8=XK,>^SXX<8$8)Z[;U*#D$UX1KDT1(1U>0
MDHIM0E4VL'Z3_OA'<WD_3]0T? \: )   \#QH:&N5KW.I KJ?30Z7;;B;8_?
M:8,Q\LQ[ML2"2=MS@D.//&FM\SJ3X)<5XK.T+^&U<^,UDUV=R<^T8N\L [%%
MW%K)Q..H;\3/$WD!5+%$^_Z<KG31XG$ORQ3IL:.]XE_;=01]03N;0! !UW>X
M\>V_O[?G/Y^5=W[F;!CC+=Z_4 0G[T^??L.F!TQ'@A=^=<YL:K^%<GM)Y4YC
MR#\;?5G- \*C48FP<&5(C7,-SN1J$;2:(X:,=JM5D)G23?D9(4]\[7S9G.BO
M+2, DC/Q1WK)OJ*362  E@SD]A&AX!7QY)/:=^?'G>O(UL^:6+H$9(57U4(/
M=WGU#WDJJ@N.W8!;Z=$^/.AH0DRT]E/^'C</&LE/%\T64\2VB4V\Y/0'4=+\
M?H*IIP%?O\_&U3"Y+BZGFQ&"J5U8'/>E E()!1T\F&ES19*(D3DGC^Q[N\^
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M(E2$P(J,Z-V;?N7Q]3 AN[QLJ>T@>6!VC'E<:?-T'B?E7$KE=AWC0:K1=O\
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M^.8IT='QOVW^8  ?A^&_Y?QWKY>?$P86%CXH&0<RD/#0G-\PGP^,YL,QR+Y
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M)DQLD ]>+B8$&C29CG+I82E,<P)-T7)U5!*0ICF A!$"E,8?0!'IQSWP'O\
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M @=B55M!22 -GEBU:J4:TMR]<J4:E=%>:S=LPU8$+R+$@:6=XXQMG4 %MEF
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M$W<>\N ZNAJT\YCC;F-F:E7HSXN9*UY@T=2UD,=9FAR%B.B8GE,<M:K4CB2
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MP#$;\GSOGU\=>&^>[..G''3CCIQQTXY;7RGTJ<SK&+$M4%D":1?7T/DN1H.
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MW#T'OW[A\^_8 []_M[% ._V  ?4'7$B.,>T: EBY(10>\^[; WW'[GWYUP)
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M+\?S>8O8 L?6 8]S!I/_ *HJI'<>\^5\E1]@21RLO"RGF\+LUGJN*Y!I/ V
MV3AGQ0QZ5P*0K\&TTJX:[H4/._".>U9@'5B?K/,UJJ4.]JLT^C54Y>4A[,O=
MK0QBWU628OZE'G>M  $KH>?8;\?S$G\"3Y\<HEV01W=S%V'>&( ^Y'D#S_9
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M5'E<[=M5ZV-CK-!3AOXYH+,:5ZLER"A+**J4X9YU6\*=J-E V$B$4;)"6@"
M[2AEGR&+QV:-&I2R5ZG;KV)8*,D5B2NDAHI+6EE!=XY(?H9U;LB$4P4]B@KT
MX9518[%541%10Z1C]Q 1 QA 1 1#L B CV$WUCZ_7UR5E%2"9%#JJIVJLF^]
M0%72OOV*CZ2/S<O1A1)$J?O5[%'G>PH WO9]SY.SL$D'VYA4V'^<)R#_ *VK
MC_M53KWO\-_ZV?PX_P"AV*_[OG@?J/\ KA_%/_WAYO\ QN74^%I_?#\Y_JNU
MK_9$9UK?C%_6MS7_ #[@?\>;FU^%W]>/I7_HKU1_WE?GUP]>(N>WN.G''3CC
MIQRFK19H"D5NRW2TRC>%K%1@YBS6.8=^U]UB8.#8N967D7'D(=04F3!JY<K
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MYOMB/KC.IY"VJQ6ZOMW62*9BPCC2,I&*/JW'IOI5C9)2.L+AY%HM#1V3W@:
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M[YDIO$X><?)'DE)[J[Q@D2[8<DC<N$C/$E(]RE<D5A@8^9,A8)D5'4C 1LA
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M=*,;[#R"CMM.R +)*BP"&=-H]T1!,KLK15R)W;83))" %./8HR"000=:^_\
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M['R?/\ON/8<Q>=CJ>..G'.)0 $Q $3!ZCV[=NPCZ!V'N/?OV[B =A#T$1]0
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M[J.G0N)C2JO*U*RUL#Q+:38.#/J9$7)BC'K2-@CS+P>X?40 %5O&_P #LD$
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M +V'F7OAC1MUTGPCJ%2L)JF>724G-VUE.X0&CQ5>F8EY4&NIW9Z<&K"UOF$
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MR1GJ3JLB9 &[3W JI(12I!5B=+ST?\)3_P"A^2C6(Q(O5=R39(W(SXS# R,
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MILV7\C),)G5EE,Z4612454#&_>T'/NDF!5.BRI6AAL-B$/99M*^>RR_3L-=
M7"UG/G1CQ/;DEV1_ZW$;+W1'65(0L,,2%6[MRR#TH2ZRAY(RGK)^[E0% >O-
MH1R(SJ")-\O'ZT',7CIQQTXYQ*#^<F7N8!,;T[!W#T^8&[^G80'Y^@_8/<0
M7X?[?[?X?^SCGR8>*K.<>X[Q5,4X^WKG[JF#9)S!I$DQYQXE Z8I6*%+Q]6K
M437\B8R]A;QAW.2I:Y$.']6MKD9=HWL4!%-'*"]?= I(R<'6P&;0U[>='SO[
M'QOV/E=C[_C4H;M=D0,P9=-]P=#V&B&"Z##PVB3OW&K+N/T!X=G)?2>7M+Y-
M>*IR"L6/>'_I,?+\ +79^2YL\E,JIU-K3:>D=<RR<=Q*@:Y>,MN<8^H5-G7;
M:VE=5VLQIFM2?+OV@ECZ3O;; T >X^Y&_?QLCR![@:UY'DU_NBA.R/1;7> @
M/<.XKH@@A Z=K$+Z;$ML:.EY;<STCC_.>'!+^*9,>)YN#KQ=:4W=T"JV9UJB
MT7>(XSB\$C(W$6/'Y9MYGV?6^E&2GY-P2*4:I2LF:2?2AC1J\>[@$>6V.[SH
M_?\ , I.M'0^Q/Y^20W>8^S<1T>W[:(\OZ@ 8E03Y#ZT-:\C<R[T^X4\;T.%
MVF\<_%/Y 0.E>(-JN60_B/7.J\B L]GN^,SU3GWM[V2],4X>52R"U9]<W,31
MZ\JDR@'<%7[Q,1ZL<Z%LI)$DD#6CYW]1!^QUY\]P4CP/I  ]O.]\I7O(8-&-
M(FT7MV._QI05[2ZD%CVLS%M=W@#S6<YF7ALU_G7 >%[%>)!JQ?#8OW'Z0U"[
MX<UY,M);(!Y!3EMEY5.@+[TX4(M"U^\P15-(FZH>SKN37 7IGDPU:SZ,/"B5
MV1W:77L#XWL??9.CLL1W:WY_#C]T #^GN0-^_P"T C2G3! H7:Z5.XH- Z]P
M3SS,'K?AW<D-MYC8_P H?%/WN<XY\ +Y39?@)*SO)@:,6CU]A64WMDTFB7!U
M"'=ZS=,:O?M\]I,H4M@;-8.&;JEKTXPE&Z[:-J=@MX'MYT0=;WL$;T=@;)T/
M<'>N")%5&5 '<$.>T'QW:"E"I[.Y-,>P+MOJ\#R(&JNGX+<O#.NWB@W#Q+=M
M<>+KF[2X53.K#):^XA;U7TR7MQ!TG%(' "B9C)T35*.WK]FL;E& >)DFYPTD
MM-HHQ;QJ];&BV]MY.S^^\'P.W?;H^"1ION>5%6$GIA2(B5';X(.Q]3>H-MW)
MM@"'4> -#QR7MIDN$F!4WA=M''_Q8^0=<T[GIIN15[Q!;O7.0!;?:;ED%HJ[
MI36==NU>"*FD<=M.9RI8JIUZ01B8[Z*0<TL1-C*GBW+YQ)*^"&)V0#]7G6M;
M(.PNM #6M#[>?%*B1BR&,?N>R@[-*K;&E# (7WMB0W<'(]Q[<JF6R#PT:?S:
MS7PR*QXCFJL?#0TW [5I^GXR7DY\2R.>WQ]845JYG$MML<!?H_"W^K+3.E6>
MHO+.DF:PU]$1?,7DVTC&0=I(7?T_8;\;_#9/W&SV@C9&^3]94R]G[J"!W=H[
M@!OZNP+VDJ>U0Q0Z#-['FW%JEX=7)':^9O'_ )%^*3N4SQGX&6'/K!P&-8N1
MB-(89ZDPJ+I];=/H%X.BFIL]IQFZ-%:+0O;'E_A4 R%RI!3BMI:GB  )()!
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MVJ;DTDG8JD!(R D$:=S$I'! L<4<9V$C1$72J!R;$QFFDE^LAB GJ2RS,D:
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M^]MYUZK^ W_!;-_\_I_\.@YYY^.?O@_^4'^--S%P7Y!^P/\ 5U]UY\%^[?\
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M^Y-(R<J16!]6QW?O3X)UX)'NV_?\-:^H;]S[#^YA3V>)$(8#>M!E';'KRN]
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MB 3X70!V1X\#R>T$D!O&B -]WC1V>4(SH"7F!,B]H8!CWL>T=S* 6C .U)8
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MW7GP7[M_QF_QCS7IQQTXXZ<<[L=_=J'[3_\ =GZH?V'\?^0\M3?[W)_R3?\
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MSL21WZ)+.J[;L7P=@+SKL^0(.F.T1JYZ8J"1V9MF-LIF=!0!]+;5>XML%.X
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MX(^_Y.K^=??_ .3]CSVA\/QOI/$[)5?3<G7@D!V\;V-#\3_+^8W:2=HF]<Y
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MEB."=$7=7TI5P\<@1);?;&S]T:_1'&7>/TQ(%=^P$M)$IWW#MT3@^F^W(1R
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M798F:GZ\E!*BY#'UX<97>6H,?8D'RCA+,93)21M-%"Y=')"5)&NS/W#1V<
MRZJ:@^7S=OSS ;T Q2"'?OW\O;L CV 3  &'AY5*595(4$(P(4* ->.WZ$C7
M8UHD(H)!\<V4>O6!!WN0D^=Z+,6*C\RDE1[:  T.83MA_G"<@_ZVKC_M53KW
MS\-_ZV?PX_Z'8K_N^>!^H_ZX?Q3_ />'F_\ &Y=3X6G]\/SG^J[6O]D1G6M^
M,7]:W-?\^X'_ !YN;7X7?UX^E?\ HKU1_P!Y7Y]</7B+GM[G MV$2 ;MY1\P
M&[_9V[_+M\O3U[B'IW^WN%#MVZ8^PWW>WA=>3YU['6_S<?F_'V_.?P'^'^/^
M/7+/\T3-J?*#7-<7_P"4UO&H(G'+-.ZCXR2,V]>15VW6?:ME2IQX+34RTSFF
M*.$R.7"9,S4]@Z1;R3M!;I+Y?'=/8O&*O;-EI6S]]@%)DA17IX:%B-D"&*3(
M6D'@.,@>X;@7>0S!8%0,C%G+NH2+O77CM:8:GT2 6KO^YH425"3*VKPTN_D#
MS (#W-W >W^$/R[ 'H/S#N'?[?7UZYT> /S?[?B?^WF/_M_\CV'M[<Y.IXXZ
M<<=...G'-ICD*(%,8 $W?L _,0#MW']@=P 1'T[B =^XATXYAOL-CP>-5\32
ME<BX:0L^;[;XA^'X8O6(L'Z;N:GM(X-< HN ;>_1KQ@[BD4'J82:LJD]9J,2
M1IE4%A<^Q3, )\:)VQ \;V>U20/'N!Y_-X/CQR'8)IRP4*B;).@/W5P-_F+,
M  ?#'Z?.SSNZ_? >>()QFX<2_#.AWS :M3X^PU'3IVDR<P;-9N&JUE>0TI4I
M4[1:HU^%J(5"$I[V#=MU).0?6V$>,9%BWBU6,@T?WVCH'6_SD>3O?VWH['G?
M)T- >!X_'7L00O:!YWK8.] +H^XYX^A:WX7G*>5YER&JTV.7D<$IC2C;CJ$K
M6Y6OSZM,C+FY09MZ=;X@[>QJJ1NC4@\9&?!UFLNI/0S L<"J9V9U &R-?<Z!
M&_N=>"//O[D>W\G(.QLD$>5WO6M^"-@[4>/??@CR?!Y&M*O'%;5>;/'7BO7N
M'=1O.3YSB,!><!Y .#2\NX@JLWI"]PC5GC&5@#(OZ<6<D1@O?9BSO7;754V3
MQS'K3@@YBI((WO\ '1V=D^Q!\^=;^Y.]_P _*?IV!]SY 'MKZMC8.O&_  U]
M]^ .=K6[%1.24?R:V_PMF$6XYQU2S9UGVB7IO#QT%9W%2&7<QZ\Q6S7]L>K.
M&=C8U.2A%K2R9E?6.,IB\:JZ73B&)2O;^7S]OYS]R/'\1U^;@@$[]P!H^^@=
MGP.W6F\DMY! ;WTPY.<NPX9V;ESD#O>30UG\1W,,9K<N>!I<W>F$)(2L-!S<
MXE$1=?/+-:5-3!G4]:).GQED3=S#=C)J.VYTD3 H$Z.B1L*=;\G7N=;_ !UY
MUXV//X\;&M-IB!OP!O?CP-G8)\>/ ;QOV&K-"\S>(G)GC8^JO,OC%:>,-?V?
MD1#56/:UEI88]69N1%FSAIH1[0PJM&GF,O4'*K*&T%1>'<MX=\\=17ODXR+(
MF+ 4DZ7S](;8V- ^1Y]P1]]?C[G?'@ [4?22"#IAL @C1WL$ A0?)T" IUJY
MW89>NN.;O%3@M9.%E+TSCQ5<]06H%\ME:E;"[SY:MTZ0.TF:M-223NL-(2IM
MJ57:K8XV67)89)Y,PS]G(&7:L8B>C7C^+^8>#K\?)T0!X_'?C7));N_'8.R3
MMB"0&WLC\02?)\>WG8\?8[IF7+6=Y6QG!*&KT3S^PJ-KU):ZX\KL95+4[JRT
M[]';A'YYH4PW%%DJE%Q5IHS:8<':$B7ZK54APC72#@T^VB1L ^WCW_#9]OY?
M8>='?F/#?2&[?PT3H#Q]6A^&_P -_;^+TI*&XIRNQ\&,NY_C$V_Q"H3,:;+P
MTRR2LS>O2TT:9GO@+:RNZVLVI]@([NE4M+NGQ5G2D69;%'3<K%H-5WAUW(.P
MWK:@@=VMZ&_ !/YSO0)]P2.5=HWOR3K0)UMNT@D@#QXV"?;0;1W]HZRSEEF>
MDH<M^7/++@TAC\O@=/;9ZYO+V D9RYW&EVY=_6SYDZ6L%9K1WLNN[>-6"CB+
M4D*X2,M!$5Y1FQ2,ZD)"G:@$$OVZ )\,3I0=@#NV=?<>??7GE)/TML[ #$Z_
M>D:\GWW[;.R =;\;\<\+8=$S_CWX=6#DX-\2(W?^.F[39I.PT#0XF\Z 12)F
M@^-KURR,B.Y2SJV^RSD?]#8BTS2\Y"T^1AVKAW&S[5".8.:6\;!!W^]U]RWM
MHGSK?D$G]Z?)'C7'>-!]J$#$LWV71[>Y0  0&U]( +CP-%M\O!VZW<(UM^X_
M<&;?DM3D]-;5F9LN!M)+.V,MG^7SS>O3,I ,0,5 [:+7E6-,E91!!JT7CS'K
M30L@JB\<Q0*U=IUW>-;UO?W\_P";V]_;C>B /< ^.[R-Z&O/N"2!]Q_(.6D/
MX]+#N'<M >-C94=7B+MR4D"9I[@6>O$S#J_ 9:P-73:<JGLY>'CER0-]LD(U
M;NT!J5%D4*<N1%)NI&A!UO2ACL>VNX^!Y/@: ^X/C0.B?!/*B-*2S>!V@G84
M#?A0? ]R0A.O+:.QL<E%.UPVO<S<VX?3_!VGSW%'**96-#PW5Y*O3#IE7E&M
M$B;-7[C OEHLM,8P3IV]^@B%03>C9TY*(4FY)91)PG"LXUO[?G!]Q^8^WX[&
M_P#LX\C[^-$:^_=W>03O_P!G3:(_-OQRYSC@';GCXD( '8H+\0@* !V  #$Y
M/T /D !]@>G4?<_Q#_M;E7]B/S.P'_5CYD)$0 !$1[ 'J(C\@#[1ZGD<Q.\E
M[CR>I'+NV2O%#-*7J5_=8)Q;A[)!WA^Y91T7G<EMG)A&Q6!@FUGJTH\E&3T(
M5F0#RQ$(J.D9*QN64LA"*13VG^S_ /J?N=>QW^!]_8?G._.M&O\ ^UC_ (Y^
MV_<*/M^&]_GUKQO8LWU@N4ZW/<L<ZJG(3F!MY>07+K*,3O%0R>&;-'7%6Q0J
M=CN#>8A%[5&NXU>C+&KA:U9Y- C!+Z.M(AB#9P_:LW[VH^-#9._&MCZ3Y)]Q
MX_$CSX]N6AHAB /'U?O2.[V /@C?MX((\[)\^V03B=$)UWFUXA-<1=/GS6O0
MW"B%:O9-4B\@\0C,+EF9';Y9))!)9XX!'VKI5)!%-1R94Q$DP'R%J/[U?Y?^
MWE*Z[Y/&OWG\6NWP/Y//,DWS^75/+G+;.8E3LE[XD<HZ13X9[8;;<>/NRU>K
MP$=Y D)RP3^>V.+AHEC[15!/WN1D';9HV%19(GMEB>90@=S!54"BYCS(>V),
MACGF<]H"1)D('ED):.50(XE9R3%*.U23&X^DY=*9:]VK88*RPSPRE6WVL(V5
MBK:*GM.M'3*='PP]^6MYIP9@(WC[ETDZ+J+W>JAQX;05,1U':-0O,1E6CV++
M&-8G'52KUNME@K-+FF2JCNOH2E?BVSB(B%7\9&KMX]RN@KTO5F>L39KJI\.U
M,U[V7RGHVX:=46+N-?*FU'&]PQ1VIX+WH5I[,<TVK<D<4EOU)$##1= A\?T[
MT=2SM4+%2H=+V,MB?0A2JF1Q./2-/ZA@"5$?'33615C@5(JS'5?L"H18_+<;
M-"O67KU2I<4;?EBU6X+SV':Q'NHV"B0V#1YO0\^>Q->@G3"2*M;D84E4O]Q7
MNY!%($KRDP3?@XD':1=D;]1NH8\C9R?SF+N===!9+&5F:2-L)4P>0S%S)Y"Q
M2['K5X!6R>,QT]8@_-QT'<HRU(@\9N*[)@)JM>P_S\-3JMIUI=QDN_E#%15Z
M<=7*DP7ELV+<0LQ=HC:G-70(X-EV67^1O'B>C+EN$?'<6)#58#6>'^=Y1@<C
M4(J&=,<FT6N3=Q-98*6*]=-0S\DQ+VJH7Q:ZMA;M'IJ8H1T[5E&9 /K:EF>1
M+BPYU,==_9#@SHLRO.L<^ 7'=/U^P31AGW4?#YB.+'0H()$SB%5#/8UNJ#Q+
M2Z9#+Z"5.G+=#+).7L6I,M/+:DCLO79&CN?,4IZM&>[8L/;KRX]=AH9(V7S=
M>S;<HF.Y1Y43#]/T&<V3<^)&@UN\5B)AG=)E:Y18' XR]24K,FED0A7T))YG
M9??HAT@+U=!XR=QJ3MHL<Y-MTU-CGGZ$=\A2Q$'3'4OQ$R5J*S+,/1K9_.]5
M9?$_+MZ+O8]6MU!3CD92#'9KVT8JB1=_S_+4+T-3J\R06,E/F>D<3B:TE:)&
M?(7Z6,OUYXI8(B121I%':\_;7W9@5&))U5M+QK1JSR$I9JCEEJMM14W^Q7>[
M0O([%LV.IDR<Q/W:Q2.HXAR5SH]:E91=%>98,Z_3KZVU&47@GB4,E,UH8UP5
M#6XJS6.+[;5LT#3Z6N8VA<IW)4O^:-6I7Z>OXAMU[E2RR/7N9&K\G(XA;)V)
M\E+,9)^EZGJQDPQ4L1C<B7SW3EHPA[#4!\K;H2V^H4GLFS9K9"I5@GR4%=^Q
M#E%3&11T*TB)#+G,S-++-:@C>J55M->W!/-F%:BP-BF9\@L%O;-E8WTN^I&A
M527+'Z=359-*07CW5FI-_P V.LU=L'JLA.!7?APZC#2B..]6>.K)7MV8Y;5:
MS=GQ4LSC'S5:UJKDHS)%":<I1_E[4%RON.0&DK7S:YM[L%=JE&<B&2Q$,@GJ
M1"62W7@DEHR2TIJLK_+307! )(Y*\/K=WJQRVE,<4263%XCZP]N>D(:G1M[H
MZ^DQO'U_2HCBU5>.-@H=58UFGPD4[HD7HVM9?;[WE 9?=(J>E6@Q]T@(E2)L
M#9_#"ZEUIAXY[!LI5%FGZ.3KYS\G=59B[):ZB-RN+$$V1CN4\A9AISU(LK :
M @IS1-#/<F^1]%@ZO7BCT\413IB"*I1CZ8,G2,N(.+Z=GD>W1G,=Z*>"F9ZD
M4-:>Z]KYZ&8I\M!9MRQSE5JN[\F/YE9KO+V*$S3(+2QTFL>)KM6FS'(%Q&5]
M:+^AE;G95A8$9"ZJ/62Z4G:&C7Z!/*E')J* =89\& 1KQ-8V EWY7I_H^_(E
M*>DOPF^7_6X7DJPY.[DJN5&*@2-C,[016[-:[\U/*AJ+ *OJ*:Z;U<&-R%E>
MI\;7ZDLXNS+U-@^W)R*^8MT*M*CTJ^1AEJNL%6.:S!6NR2P5G->5[[7T8VK,
ML*Q/9N.W(JZU]@[:8#HL!9IWB]RMIMRHM4QC*,ER;.;OI642;6)SZA/H]&5V
M"\MYVV'6*I;KCJ=N@)>77"5;LZR9^TC(ZN::C8>5!D(Y:27_ (?O7R.0R5QL
MW:H8?KS!Y"U$U6K%7Q^.@Q. J_+P01THKR5:J)\[?D6U;DVM@-C7KXVK5*0G
MJ'+W&AQD EQB3W*.5-W+6+DEFPTLV8RD]B_-*GIPO)D53Y>#2QF[GD#AUW0;
MT#.Z-@,I"4N*XL-(&)L.4XGD]^T"6OKB*6AW>13=FUYI;:)F=7= A$/9N?>Y
M])3$J](+@]SAD6*Z;W$MW([EKK7=Y6%_+N*D;7;-#%6J,LUG64=,=\OD9VQ(
MFGDHX^AD,8RQS$006I9(D2WT_4%#"]!Y6:-QE\5C85NS3P?.9_%/%1Q[SP0M
M-<0V+61FA@,]FTMQ3/0,,C1F7UA %1XZ;DQS.R04UQGM<O*J5/P_+Q;89U$0
M[,=2J&&I4!GN6/.9CWPZ4A:5_H^=PI4I0Z3&VH,C$;*.^R:([N]DJ9RE*6#+
MP0U:G7'7EZ?Y?UBORG4V"RR]/96.*,>C8>CFK\-FRZ]GR4L#2+$DAC+T8"&U
M N0L2T$BDM])08S"S3S1024K]/J6P+E*=$]6YCJ]K#4HHZ\JP-%-6OUB"T<<
M@AG2/XT6:];/1;N?C]-UG%WO/A?88;/+' Q<6C5ZM$<8'N?O]"L%23>BG!,K
M;IJ"K]O .VP&456;2CA@89)0X8&)OU:,#PV[T4F2@Z ZRQ\5Y)7L1-8RG5V'
MR>(Q2221;^:@QD<TD3QMVP/&\*RJ]6 BUU16O6WHRTY+,T"9OHQI*U8?)21Q
MX]Y?RG:D>":-[%3TVAKV8Y@R3Q5RTD4J6'5LV:;=- I$D4$T44BD21113*1-
M--,H$(1-,A2II))%[@0A0[ ';MV^OA]D^226/EB?Q/DG>R=D^_G^4\WWGP-*
M%7?:%]_/CV\ >-?C[<[O4<JXZ<<=...G''3CCIQQTXXZ<<=..?+[XR'\^O(_
M\D6<_P![;SKU7\!O^"V;_P"?T_\ AT'///QS]\'_ ,H/\:;F+@OR#]@?ZNON
MO/@OW;_C-_C'FO3CCIQQTXYW8[^[4/VG_P"[/U0_L/X_\AY:F_WN3_DF_P"]
MAYF>X#P7)2R^%-GL%QB7IJ5LE-NV5E;$;HTC'C!_0W&DWM*9BT4IHBT6))%V
M>-9S15D#O%:TM-(0RK*:4CWS;QW\;#KXA9,ZW_46(\ Z_P#E=7^_YO/\O/:'
MP_!/2>* ;M'IOOQO8[F\?R_R?QCWY>YC]+WGC]JEPPG%>/M/IN'25 =79KIL
MA9+G;6LONK[.XMF23E9JUW&;LBT"SGH."SQC1A(!H*C5F(=Q$^UC/<8".^3>
M-CP22=L?Y?;?N3_+X70'@ <[,]WG1  &D77WUO?X ;)WX.VV3LDGD$H9GS.Q
M>'@^1"G'Z@;1S.M-SD:W<K/&3S]LT_!HE 0J,8:4K,%8H3-8VT6&0CU:F^TF
M!K24O#T2,J(6*/M"\0NU-(()V01]@-_B?Q^H#\Y /V)'CD%64:5@222S%1Y\
M?8#M+:]P&(\[ T"-V+^)C'10^(9QP=\J<T<<K>)#R<Y&M<\XOY!G5LN&T1>R
MI8C30F-8MT'$R?LK]1FM<5>5Z"08IP1:58)-G95'+V48,_-PW3LC+8ZQ[)88
MW'5]H@O#ZQ[&P^$7M9!Y;N8D*=Z1M/INWL/7YX:K=,^/)Z9I:(=@"1E\L5!)
M!">0.X#Z&3?> "3RP&A0=L1P[PHW_)RH16_^'>^Y(<C@Q?@IE.0WRP<JZ8_9
M5#=%,J9:E$I6-Q-:4RPI@VF&EWC$V==-7#S39317UI:$(F3IHR.Z *4:R()"
MTYA4QR=HK NRJ=#U6$;A=DA$UKM((YY@Q69EW&5>/N0L 1ON_>-[C1!\[TV_
M/G6I$X<(OT^.L0=E'I5?*5M'VW\7W,GI'1;OCN-MM;M[&*S'4%G94G"]^@[4
MVM[U^BZ1)(0\-*P<%)G7D8UVZ<^*/U0;EOBMANZ.$./AQB@TJ*ZM*PZEZL[G
M'>[#TR2(QVJN_1!8&0.S>COA$%'1N6[6.VZLF9HSVG3_ )+QI9ETH/8VP_U%
MB3(2"%[56Y'KY1SZ/RCM:C-KE>.O*]#"+Y0\VLR'%?='MNL^@Q$I*1RN7-*/
M(JWZ!K[F+E(P:[=)Z)[1U;M#XLDQ@W*RCPT:JY*V6;_4O@*"?B[4 !?_ -$^
MH"(P"=L),?VN>TJP6(!Y"P.AV[8,G<.<!\5"!T-,2>U?UP8@,=A2=QW.U061
ME;O;MC*GM)#$*0Y0B(,CA)B1LNYF\+/+VOAS5AEX6%3?;-"<S,GO;%?4FON5
MG+5+CG3VP66-C&LG1HA&8C;#KDBG+U^2DY1G(7"F2RQ?,E[L/N0H[? ]P?Q.
MA_(!Y/D[\$??GF+[ R-W[<C:N-G_ -OSH^-^P':NCL$#6O.\-6AQEID=V'A[
MQ>LM0QVJ\.N%5OL'&?;SZ94-!U[DX89$(K<V4$XM5:D;QB+:F#>CN*C9I)7.
MM6MS>JRL!&P2T"*Z$J1OQL+VZ/CZB=>_X:UX^^];&OO1*IT=Z,A<]I'[U0#Y
MV1[,&/<"""H;ZMC6OHOT3.>6?)-QQSA]+J%)AL+LM-B)'DSF9I=S%6"+O*$L
M$DHO"VN#DXZ]PS^"1:Q3ND/J)9(IY%6 LE](GDJP%D5&K?YO)WYW[?AY!'GW
M\ZY;*DD$MX76U*KICL@[# ^-?GT1Y&_;GATL^^RG'+>\FTO':_@E-HJ]/SO
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MB5M]'.*W3L\DQ&:M5QE5'=>K\4"J\W'OV2AVBWU#X$:_9<J#M8L>DNH"& )
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M14K[1!BM]2^ GU?%VN%;M*]'=1._[_M,:38P.A**VBY=0G>I3N [F77GY_\
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M,7*2@\V*5H.H8%>LZI$9G.C1;VSV%*,"/2E9=DV0C695&L@Y= 9W[,I"B<@
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M;1, %,;L(@4!,(  B(]@\W8 #YCV^0!Z]^H!!W[^#H^#_@ULG^0;_EXYQ>W
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MTNU88D*Q]@F.R\OBWE[$?073]"K0I3VA'DKM2)[[+5FEDF<6Y?F(JS1F!F!
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M1\DP<K,G[!ZUI4VX:O63QLHDX:.VJR::[9R@JFL@N0BJ1R'(4P85^1XZ-R1
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MK3J0"J0+EH?W?:I+(&0K#I3)N4_=6E>L'F@CR4.,^D>G*4%BS5M7#ZC)M!+
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MI]]4X6;H%LM5&?R=EJD6^H#YU9ITUB:,9YW9#QYFI7:A8AR%['2T<M.<+9Q
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M(4RN.EFCMXVU>KT(:SJ[,]VI.\B1/4[51F2.)6[CI%1$7NYSKCIS+9VSC[%
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M"MMD8\\4JBULB!Q?*)OXY0S213<"J1XEY?:E$Y2F+4]F:2R]MV[IY8#5F;0
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MH&NV9CQ\5%<5'%8KQ6+<D*W(;L3)9#4H88[)$S6(I8F8LCJ5*\L&P>5JTPV
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M/]9',R#%18&G5P<4ENR<8LJ2V;J&O-*TTC3IZ=<R2K!5CA>$5XD;93OD8EG
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M=@7.H(;=02L-/%2BAI68D4_1^4VET!.I;Z($@\J90[]^PF[>@AZ"81 .P^H
M =@ /J .O-P(UX!&O'D:/T^"?XCK8/W!W]^>@?/G9V22?YR2!_(#K\W.3J>.
M.G''3CCIQQTXXZ<<=...G''3CCIQQTXYM\Y/,)?,7S  ")?,'F !'L B'?N
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M?\8[W[[V/)W]QY/W]CS*TJ=J^Y9E4,515V%(55[2  0I/L%WH [\<\.Q3#F
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M-[C[CD??7Y]?F_G]M?G]N<1W2"?\LQ@_8DJ;^CT\I![^OH';YCV#YB =074
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MM6F(JOO9.,DXY>2:LSSH)24LQ:R:T?&24\667(Q6>*K@I(.?>D\ZWF[UV&6
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M]@]A^0A_J'J&'<"-D;^X]Q_%[\<XA0*/E$3G$2AV >R??OW[^8?[7V\WKV]
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MXN96B94%BFFYYA**L7?O3=\=)6W2D]>O)4Q[^K7OF>E-5IMWP7'DLJ+5.6"
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MGC'6;B[30R-_J$51;ER&N-?T;)<"K&QV6$@L2JR&B-6<5;->TQQ9VIH.(CZ
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@XZ<<=...G''3CCIQQTXXZ<<=...G''3CCIQQTXY__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g14810g82f86.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g14810g82f86.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1:<4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %H"^5V X0DE-! 0      $0< 5H  QLE1QP!6@ #&R5'' (   *  !P"
M4  (<G(S,C@V-#$< @4 &TUI8W)O<V]F="!7;W)D("T@8F]D>3$N9&]C>#A"
M24T$)0      $.7@>O<@8E#%\7G/6[8EE_@X0DE-!#H      .4    0
M 0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N
M=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP
M"W!R:6YT97).86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC
M    # !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P
M 0    !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"
M24T$.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS
M%P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#
M<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O
M;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $
M      !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B
M0&_@            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M              !";&0@56YT1B-2;'0               !2<VQT56YT1B-0
M>&Q <L            IV96-T;W)$871A8F]O; $     4&=0<V5N=6T
M4&=0<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"!5
M;G1&(U)L=                %-C;"!5;G1&(U!R8T!9            $&-R
M;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M    #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ .__C4
M @ " [_^-0 "  (X0DE-!"8       X             /X   #A"24T#\@
M    "@  ________   X0DE-! T       0   !X.$))3009       $
M'CA"24T#\P      "0           0 X0DE-)Q        H  0         "
M.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &
M   ! #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M      !P  #_____________________________ ^@     ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@  #A"24T$"       %0    $
M  )    "0     $  /?(   X0DE-!!X       0     .$))300:      ,U
M    !@             "^0  !V,          0
M   !              =C   "^0                     !
M             !     !        ;G5L;     (    &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG   "^0    !29VAT;&]N9P  !V,    &<VQI8V5S
M5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N
M9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L
M:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L
M:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   OD     4F=H=&QO;F<   =C     W5R;%1%6%0    !        ;G5L
M;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$585
M  $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585
M  $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D
M969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N
M!V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4
M>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E
M=&QO;F<         #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T
M<V5T;&]N9P      .$))300H       ,     C_P        .$))3001
M   ! 0 X0DE-!!0       0    :.$))300,      P"     0   *    !
M   !X   >     OF !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4 9(
M   !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,
M# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.
M#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,
M# S_P  1" !  * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
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ME<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1 Q$
M/P#<L^KWUC-CR&.@N<0?7[$F/SU)G0.O!L68[WND^X96WX:;G?13W]?ZHW(N
M:V]P:VQ[6B6<!S@/\&H?\X>J_P"G?_T/_2:C]R?^:E]N/_U8OX8_YR/V3_[U
M+^P>M1H
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0'_P  1" #T ET# 1$  A$! Q$!_\0 '@ !   & P$
M      ,$!08'" $""0K_Q !H$  " @,  @ !!@8,!PP% !L$!0,& 0('  @1
M"1(3%!46%QDA,5&6&$%55E=8D9.4U-76(CA2=Y*XT2,D)51A<8&5E]+3UR8R
M,['P)S0U-D5&M3="0W)VA:%$8F5S='B#I*6RM\'Q_\0 '0$!  (# 0$! 0
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MXS\,XSO]W/FXSC/Y/AG/Y_&F!\O_ 'C^O43'R@'N?G\N/82ZYQ^G -3S^?\
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MU)[&V;;!!'SL$3J32QI&G.Y"KS,"S$*,D@$.)^*FD2).*N+9)I21%#%Q)O\
M+/*54NPBA2^TDA5%9V"*>5%9FPH)$N1[>>W 910)WL1W$ \ F<(]>?=K&$>
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MT>^%(8^X'/C77]F)[7_QDNS_ *_O/V_S?_E/[?CZQN"_P2X<]_\ \'H^/?\
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M #:Z>/;]0^64G=7:^-*ERK=X9;K0-:-R=DP+,6(Q;(YU*$>O_(?T>/[#J.Y
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M!WYUW[_A73\6+[2_N77OYYQ_9?C^$#PG]Y.*?YC9?VUI]@CC?[X\'?G7?O\
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M?DH/%*Y-1K39[>Q4WFPV6M,JGT7IEA0JEM<JM%96V.\L>EJES)?$W491!ME
M6;%JFW<ID)=6*V\\B14UHPFO)-,R3RR0F.S;FC7IPP/+UWLQHP##D4A>?H)M
M^W[FKR[9[50CI02V=S;=+"W8:]9)J=:*TEBEM]:5C/;NQUO8THS21NT3]>1)
M',.NS_Y009)>Q3SEX"#C"R')M[FL2!EIT:I1UKE?MU:^DI#!UUD)39L=5NOK
MB%6,#A#- IO_ $B&$+:9.3M@>;)Q$([1YU6.C'&7GYXF-J)H8-S:S"524KU8
MYZ(BY K$MSH.8LK+W*_!C3T>5&DFW6:3ITEAGC]AL^T7^&Z]"9&DKJ_L]BKO
MCV.=GC(Q"S",))&^6*G[VT&_#9&H?..GW>Y1EV'!%!J1'*7[N)'5DM<=N[/"
M_7=1GY\R6"8MM<2X7J;F=9I;*U@2Z(?IM)Y(MBOQ'4N*14@LVI@TG-7@-65Q
M'$D3R3"1;)@=%$T2<J2M*976/I\Q&N=:X/W"@P:]9IT:S",)<MKN%>(S32SP
MQ0-#+16[&[-6F<O)52!88VE,V  :2D]X--X+QAWQGIIK*H6?M\TBBIPTDY@-
MR;BMD7UQKT9I XO:B2.4HEE!##3QX\W@T^!F,LJI8ZW<V=%OP/7ZE.P6AFO$
MI%[.62E2E$36I U@$$L0.CCK%@W+$54,UIN%2IK&+<Z0CGAVE!-/[8L;[GNM
M=K$=")DI,K<BHQ:SDU$3E9[(9BB[*<D[*K['K;#ZY5[2MK59LSBJK[8\Q7(4
MUR/K[=FE<E5<9;8FC[[,"+78_P!]V%,@R5J7#@*(C>$W47ITKRWA,\4,R11R
MR0K-)T@DS12R12&-4E>0!6C[]5(SW  R& XNY[7)M35HY[%:2Q/6@M/7AZYD
MJI8ABGA6=Y((X3(R2CM7EG4%3S, 5+9B\WM<O3QIIXTT\::TO]!_\7TS_/Y[
M7?ZSW6_/1/A2_C8/Y-\&?U1V37EOP.?Q(3^4W'']<]]UNAYYWKU+3QIIXTT\
M::>--/&FGC33QIIXTT\::>--/&FGC33QIIXTT\::>--/&FGC33QIIXTT\::>
M--/&FGC33QIIXTT\::>--/&FGC33QIIXTT\::>--/&FGC33QIIXTT\::>--/
M&FGC33QIIXTT\::>--?-=\H\YO7&?:?IORBBA+ZH6)%ZA<X7>NNU"Z0QWJG0
MKAIVF#C5P.M!?7-U3U71G=7+M*I53*BQJ5@R^HK'I.268@]N!#&LI\>?/H<=
MN_IGW]Q[_P 8U7SE,GXS+Z>.W; [9!QW.1C'R:TK;>MO6SB6GR74T?R?T!_5
MC[+\HO-TU93'DBI7B#V83WTKE2_ALTV&ME!VL;4:@UWH1%U#@U]>%5AK>*GH
MZ5DX+DG!&?/8C'H,'M]/R]Q[M0#GXPY\_<^3CNH ;F[^XY 'G.?0ZF!?8+J6
MS03Y4?-"^3SF'Z8T0?)XP\QEZ,25"M)C]C'G.8NDMN^9IOU"Q*B7Y)#M[RW6
MB0:1^M@U7L(U@$T4B PNQ& 2.V>^ #V'R_CS[OER38CRN6/8MG'_ ,H. ,YP
M1D9R>YQ@#&I>K>NW5TAG.ODV19?0$J?T6EY?[TC]-M-?:1"WC0WI?0G2^@V7
MCWS)R^7?-8KSANF]'Q<K9 LYX73&<57P3;' >D$  ]\^?F]/'KD$#YQ@GMG5
M<^6Y6RQP0,@# &3GU\C ]#Z]N]&KG8NG-@ZK[V0<\]!]QOE<3..>IROG-L='
ML)^6SQA=&0K+/>[OK6\C^P,3'6)B-U_FT-=I10S8+EU97N/KB85F-.!]!/8Y
M[#\8./>2?Z<ZMY)7N>3XW88SC'8#R#X'GL#G [ S:*A=/K\]6]?8Q?0XV3Y#
MU90>H[VII*<.9WL=AP*UP@#6!!*N+QZ_2;(3RK7T:XLV74%NW;$]5N6B2=2O
M+#P.#D^,CY,>_MW[GM@CW^NF?)(;[9D'L>W<]QGNWD@=A\7\>J?L+TVZ5$HC
M5%Z&*Q_EZ0H(PM(V#69_Z^X*]899H_I8OLG7/LN\7($&39L";<[E0^UU@BQM
MN039 &((8[>G;SX[9.,]\#T([')P>_J^4<WVL^,9YOC=\$C(\]\9[#OWSBML
M[1TVLSV3L^],]#=XOD.Z[>.6LDB\DQ>;W/5AP>G-"V=1>2HRQ_7F49.6(#1*
MDP5]1@*[!]\*+JVB5"1&:AV]>Q]WGZ#\F1ZC)&,GQ'G ^-A^_J0,' .#Y&<G
M';M@X\C5/LG$>HLU=A]'IM?0.&7Y6]UV+VGST*MC,V^G'X%B3FMA85FG4>48
M<OV'FB P'/ROHT-DI&OWDSTJT3((=59<9SW9)\^?0>>X/IGL?F[^[3/;F',2
M@ ';N?(QZX\$%<'P<$>E0N7<>GI'/4_E+#.?>@I47H:!TGT=9<KJ%N,(!NDI
M/1N=*&EZIG6IJMD?E6JYA]F@\SYNSIUF8+^?O[G7,V0+#]'L( S\Q([  'P?
M'R9[9^?..^F.P4$CF^-D@$^#VQGN",DDX&1D>[4)IZN=;D,.^2UDG^3U^T.K
M6.R?*%S=-$I[B1>GRO\ 8*OW4[F5;]?=I<FVA1+8RAZ57^C2WD(77UO!N:+%
M<!+7LHCWKCN 1X)[>/4Y].PQCQC/GN!_SQS=LJ!GN< #(8#OZ''*1S9[D:F%
M_?>FGL8_E38Z-\G[!#>YE'R<^O*6'338@8)X/9!ES2'I9?>-J?+ [52O2Y7K
MOG>:1 3!ZVAU^V#6^$]8!#&QZ9^7L?).,=OGQY]._8^7KR_&P!S#L1W"Y\ @
M=QD Y/?/IKVW^25YE9/6KF5W]0K+/Q9R3PHFON ;=Q9%)3P+"!UUM?;E]!<:
M.3NQ)J]K1FQFA"1_>)V*[I$E.?C:JLL9E\56QV().??@G\>/^7ZI!R2>X]#G
MOW&1Y]1_0<]O4^MWD:G3QIIXTT\::>--6_;*I7+U6GM.MZ<&P5BS*C4KU*RA
MQ."S5L(-QBQ"(_CKG.DL6^V,;Z;:2Q;_ #989(Y=--]<<T,<\4D,R+)'(K(Z
M,,@JPP?E^8@@@]P00#K-7L359X;->1H9X)$EAE0X:.1&#*P],@@=B"#X(()&
ML#Z^HG#?H2OK"6YLG!)]<9179WV/M3[IZDFHP.1JYI6NL.NB'],J@*P:R68;
M576;8I5DCVFTPF!D1V5[JPT?J11QW2=F!B*S/=NO93H*Z1".T]AK,859) 1'
M*H?J2<X;J/S=?ZY-W##EFJQQ!)XVJ1;7M<6WRK9>*2?K[='32A89WKUV#SUI
M'1JU8HRFO!T^NGIWZY8A$&EYJ"8((JRER*R?6]J,P DJO3*89J\@96,N&PEM
MJ_V/I<+]D]C8,K PMASYT6>_@7LPZ#9=L&![*"HC,/*TDS(8S'8B975I&#ET
MM6.HS\S2-*SN6?E83]<V^9+"^R,91.&CAK1LDBST+*-$T<*M"(YMLH&%(BB0
MI62*)4B+HPOU#X>>IPI.67XS?!K(S>PE=P[J1>B(G*%?6&Z8WHTO2M[^?5&:
M-4K".IIEFGJ1.RT N9+N<' 5I8[1290I6<X+GJ&[>,Y#QB)T:Q[3UVB9%0-$
M9#$2BMR<P!$)Q'NT<AD22DH*1IT%VC9Q34Q2O-'*E#V TDLI))(R6EKBRHDD
M02\DCJT)QZ<^OCK5A&13W0$#4FSRL!:YTKJE3#* N@Z0>WU>0.KWA.+]P;/]
MW5!;_G&D.M";-1MW)M;F:EFF$P^S[>^<PNH;JY$=FW#E)^3K19AL1_Y/(8T+
MUQB!F',8^8EBCXEWF/D(LPN4$'(T]#;K+"2L9C7L\UFI*3=@Z\JPWB3<C1A&
MDX1$5<YT^D5FA+SE-35Q)UC!]8+,4%!.;-#EW:7!;YZ5!J:45]4A,:'%$1+@
M_H%P&DF!5X@H<4(\>[!7BK*R0J$1I99B@)($DTC2R$<Q. SLS!5PBYPJ@8 Y
M=JW8NR)-:E,TJ0P5PY"*>C6B2"%6Y%7G9(HU4R/S2/CF=F<LQNSS/K6T\::>
M--/&FM+_ $'_ ,7TS_/Y[7?ZSW6_/1/A2_C8/Y-\&?U1V37EOP.?Q(3^4W''
M]<]]UNAYYWKU+3QIIXTT\::>--/&FGC33QIIXTT\::>--/&FGC33QIIXTT\:
M:>--/&FGC33QIIXTT\::>--/&FGC33QIIXTT\::>--/&FGC33QIIXTT\::>-
M-/&FGC33QIIXTT\::>--/&FGC33QIIXTT\::>--?,_\ *5UZR<D]N+W\HB9Z
MJ>JO8N5^OG+:]PFR*+CT*&O]BZ%8NH.N0S)^@[S-.:VGGJ*7GF]M$YPI6V=T
M#>I:):[J\3,4:ME7\,+#L,_*,]@?E'GL<X]WZ.Q@]\KD@GN/..P\=F![^N,#
ML/49&A_["+KT*O;Y->;U'^3_ -NE/+2T]Z ^LR]$N&]25<U&]EEQTG&]ZX+P
M>#K4QX8!XWKF(8KU$J4W'92@B1YF*\JEA6.#GL? .?/;ER"2<>GGR.W;OWU'
M, >8LQ /)X&>;QGL<=SEO (8X)QXJ2%O8&EK7?*1#_)Y^CYW+N[0U'T+0\(8
M]CJVK47HDOL59>.Q]&L5@'X%OR-C5K%;9X>;NQ:R!OTJ+DU3J]B8,F239RJ:
MQCP.X]3CY<#M\_89\'.? T].4LP]<G/;L#V&<Y'D>,9'H?C4FL>H'6],<D]!
M]/4;T-L72_2)YR3W*O'2V?4'\%6[Q1W]RZ3$!R[(,_$2>A)&]X)KK2NW0[I1
M-AJ*I/6T3%^(W0EU-51H[ 9]#D=L9]/E_P#3 ]"06>^<L.;XN!Z$8)/D#MVP
M ?.1V*XU*H=W5N!#]LU_H%Z.F4OY6?;G/K3QNFO.ICXL'+[2QJ?3Q8+AT^>#
MA9-59K;W&B+L=P5<1A57^)O1Z&G;DV2Q-2)F+M\I'G..W?M^+Z1G&.Q\3[E!
M/Q<GU_\ E[C+9R"< GSDYP-5)#P3HR//.^0D^G/HS8K!\CVIHU[[A;&75F$6
MGM )9?7RVO@1T>^_#OM6N,+!+'%VNT&=;+)6"=8K:0S5E]C"%7%/;SS')Q@9
M']/N[C!^?YC@N;'-W;#$@?)W';'-W [ 8&0"3V\:MTOD%\L5<L@ _IAZ1+Y/
MENAR&_ &TG2)IC?6 7]C!#<X3;9 %Z^_2V!J$K5G]T AX'(EVB[BU)1D1[1G
MK]S([>F<@'./^61Z^?>#W[@AGP03\7!(\YRP&/NL@_YN#VP >7/Q1<M@16FJ
MM"/8(WT3](%E8^1UK73N:]PJE?ZF5*P[4RGXC0;KH^YH3^!&)<&!1*V_"N50
M%ZM.3:#KA9K.JA?"WB ^^NH'N)/?';!\9\^OR]O'?.2= ?12WQSV[=O4=QGO
MXPW+X&.Y([TJV^H'6FE6O/I5'ZC>A-9OORC=BZM[1<UZNEZ>R( ]>:I4)N66
M5I2)E:S@X5RLC*FCN%T5&,X3(AHA!=SN<VB1,D0N%\TX[=R>W89[#Y03Y]<>
MGKZ=PYNX.2<8 [><D@>N /.1CW#SXKKUR^77>]?*%;_)^>D*KG'IJ)U'TDZ!
MQM5UQ!AM8K\IZO0Z7+TNF/,< 6\N!14!B?)1*0);P%MRFYY<;),QWC+=+5]J
M=L]O'K]!&?![^3\GGS]S'IR\Q)8\P/R8R0?C%O0]P<9 SS=SJBR>DG7OL:7Y
M,67U*^3]UZR^;N?>>'LFO0[?M4E?/U_LRM-DY%(B X?#V$EBJ#.&]<5C>O,!
M*)CBAK'<_P">Q4[J4[ \>,X]/ (![ _V9/RY^Z<_</E\=E[]R2,J3]UCOY],
M'.?>+C"=V":U ?*-:_)Y^D<G->OXJ_H>FXIGLE0V?Q=)W]@[-Q7'2GKX?UZD
MXZ?67UOEAY\Y&K*F2YP\OK%<=-I&=4F;TQO& ?!/@G'IX^4^_P G'T :G_Y<
MDG[KMG& .X\D@X[Y]2?<?C>V/R.?'K5ZN<8M7J;?>><:JUTX].A>-+SQ*R-W
M]?ZXOZ8TO+Q1:7T5EK=<M2BSH]5IE+F%L.'1)B2O(VJUX0A.5 +H/R9\GM]'
M_IGUQ\^H!!)(]0,Y\^ORD?1ZYSKV'\C5M/&FGC33QIIXTT\::>--/&FGC33Q
MIIXTT\::>--/&FGC36E_H/\ XOIG^?SVN_UGNM^>B?"E_&P?R;X,_JCLFO+?
M@<_B0G\IN./ZY[[K=#SSO7J6GC33QIIXTT\::>--/&FGC33QIIXTT\::>--/
M&FGC33QIIXTT\::>--/&FGC33QIIXTT\::>--/&FGC33QIIXTT\::>--/&FG
MC33QIIXTT\::>--/&FGC33QIIXTT\::>--/&FGC33QIIXTT\::^8[Y3.AH:;
M[C7/W!ZAZ1+>^>L?,.65SGW6E)%VJK1EU#JUR:<P4\UZC#Z^78L?FEW%YHLL
M7X(=+9=#EUJ%WMQYM>@DAYRA)GL!VSW]3[@<>@;SX] /UZC).5#<ISG.#V&#
MV)'O^0]\8UY][^I70A5T?I\3Z*U>?W";V=U[3)>Y:^S&PBY-ZH+?8-1J5Q7]
MD0*-IVY?A=SMXI]:Q^=+%&G-)TKV+K<+3;.9=L6[>0,8'?U\KV\C'R>?Z=0&
M7SS97.,8\, 1GE[@Y(+9SD'L#JL@(^4FVF?W$Q\E,A.]..@+:QZOT#UQG>\1
M6EB^SYO=[%Q(GJ4W"QS<<8H8MGMV5G"<]?KS27J*^.E1W*,*58^?$Q.V?&#V
M[?,0?(\DX[ C'?WC3QD=0\V.8$<P!7ER!GN?'?'89'XM25?]2.@;Z<B]5S_1
M.L6?VAX8WYC[$^T/7Y?8 #83V0]<;5<KQ7L<GF[(QBBZQT;?IVU1)IWX,^Q+
M%O,5&M-ATF.VKQ=2EFKZGS[L8&?FQC /RCW'MJ2WD\^ 00!CP0 <CO@><@K\
M8\P]QQ"253G5G"+]@D_R7]=9\'][!J#R7TEI,G1>;*".0]8L=:Z1(1T!GS?7
M?6A>K0/22JUF[$](X$:QNU=CYE$>6)L_LK&".21D^F,X\>A[#P<^!W[#T[#3
MOG[LY3NQ[]_'8GR?QY!]!VUT6^O3H37FG/6WH$@L72OD_P 2AV?Y1.W;=>J\
M./<:LV3C-A=0(X&I.L3;V(GNC["SL>U=]CXJTG1NJV/R.,W"^S;2R <''@$Y
M]1Y/;]'NQ\N<8T)!\,?C$\G;[DY[8[''N.,^IQG5'(XW&QK]TA5?)\UM63\I
M%!,Y^37=R]7HJ^3U(&SZ\1=('<,OJNV9?5K$$JAS[01!^N>S:!F9+/R]CM$&
MJ AGGL21V';![$_1X/;MV/CT& <N_DL<* 6R/N^Y'R9[$#N1WP1YSJX6= IU
M6VBZ<\^370"<T^3LKUYJ7RA=?VZ31V<_?;HHX_3>@#6T:H$R:IO:+2@!643K
ML5F]CIZ_<&>+7L/ %M=E!P>D8QY]?',.W<GS[CY/KYSZ9T'?'Q\$XY?DPQ&"
M>^!GL"!CQ^.2?^JMYBKW3/7@+T%KE<]B/:UST_LGIEUO;O%?BA]2^-5-=S0K
M?GYW2@<_A X<1R_6VCGC<VX4$UYI;9>I:UP4^>J+BBX0_I], '(/;MC& ?>1
MGQZ8TSV!+G"XYNQ^,<C)]0<^F3GU[C&:XV0<J7VVP>S\WR6R)1ZF>M*WH_K/
MWSU^AM7(&9EA]E4_3*C21.GC<@E,BY%V@?FA>77.P>K](;KND6L:T-+IE9*3
M18YI7;MCTP/7L3GOX..Y!P/7QGSIX[%SDX([^!RG/IE>_? R/3Y-4IIZE= D
M6,?3D3T'J:SW"969Q[,(NT8]G=MUU7]8!?8=6/CANOL/N-%VU7,JH#8#UA&Y
M4C4:\R8K+%'U6,V0V77'DX\@COCW]P ,Y ]0,=^Y\9.G,,!BWQ< 8 QW(^Z(
M[#NQ!SY/8=\ZKNB#E,ULT]M=_DI4>WJ%>AZWZLTSUZVL/$0S0_: [MMEXG+U
M"?@\1FG"J1K:+AJ!QJ/K:%M)TD2&G:6_4&1$]?2PU_%X[CMVQGU/8G." "-,
MXRI=B>_?)';&?NCWQVR!_P P?<+Y&OEEJX#QBX\+ZORI?1N\4QDG?]3OZ^[2
M=.T[=I<6-S^YMSGZ&ZC&O3HBMI$,O.)%-X"#85W%0U%4QR5\A9/)!\^,?BQZ
M#Y3_ $Z @DD'SCTP1V\8\8]1CWG7L?Y&IT\::>--/&FGC33QIIXTT\::>--/
M&FGC33QIIXTT\::>--:7^@_^+Z9_G\]KO]9[K?GHGPI?QL'\F^#/ZH[)KRWX
M'/XD)_*;CC^N>^ZW0\\[UZEIXTT\::>--/&FGC33QIIXTT\::>--/&FGC33Q
MIIXTT\::>--/&FGC33QIIXTT\::>--/&FGC33QIIXTT\::>--/&FGC33QIIX
MTT\::>--/&FGC33QIIXTT\::>--/&FGC33QIIXTT\::>--/&FOE]^4RJ'-I?
M;_I_3^Z^N_M)T_T@I_-T";V:4T7J3G/+[I[#,AN3YX]>Q_71+U>KN+SK1.?F
MA4AQ=P*T:N5W%]3BF2>P:4(DU-88'<_1W[_I';W]\]AXU!^0CFR,>,@8[C.#
MC/H//D^"0?/H[AW2,K]^:8]?_?*/Y2UF<]Z;1^IR>X1P=E2>B8O?PIMN>3>P
MTWL0QJZ*$#DC5?R)OS@W#-L1V%NLONNF-"M+\5;'@ '((SVP.P(!^GU*]N^<
MYQIS#N24Y1@?<]N;'<XP,]^^<D<O; .>:>#HOJE'8R.D[^D_O%^+09XK?,>;
M<5%Z#=5X0?O7MVA_SUG=4_K[M[$XM%5LCEQHCY$K[ >=BO0]F16.<=6H.L 5
ME3U[]A\_88Q].3GM@8QX[?/!S[US@?& 'C&3X4#/^=CT!SV])>M\1O7S.>\Y
MLOKI[Z6+Y0&FF<]O?NWT%#[9-,6'JWI>[O-T&,HBOMVO?P*]T\.[5A3+3:9R
M])!7FN;56', 959/2.+1?A\]AC(/8CY/0><]AW]3W]X%BP'<%>7N O+@!L#/
M;!(((&3X[@^_7%=IOK<?E=T #U!]W6_IKV+/-Z]\F52J[VBTJ%E$]DBE=\/L
M=SYWSK?V%$9>KS&]-U(-EI_4[=N2B$5TKH=C#'J0=F%TA=_3QGL/?C/CR",G
MQD]]1^,!A]T<  C(^3N ?(!&>W; ^+"6<C$@AJ%>LWK5[P..U<4$IAORRS]=
M[!V*<CV$Y\SXI9?G+);!IW_4'V+#LUHG2WZH56J Y*5\J3N^;:J0YW.*8['S
MXQ[AX]WD9[9'Z,>?.ISY^Y&22@P.V/> ,J<#R#Y]WK+&<XI$BEQFJ>L7NNK9
M=\7DE?(G,<]]L@*W@V9.!"V7+2JQS^QVV?5!=M:%S7MY$=W^U\,N$:?=B'$>
M$\J42?>#D$G\1/@]@??CQGQXQVT&>_J/\[MZ<WCP<]O=X.??D5)C0N)*]#']
MB]4_=T7C/ T]T7_*_K6'=K*6LZCU4/E%2L26Q7>M[=_.)]FI*HP9?A+MMNK8
MDJV2CV2OV$A>U0?4^<H7IGSGU.?.?.>V!Y]QR>X([ZC)) #)D@<@P/&3XROQ
M<]QZ]P>V.XD7W&K#"MMU'2^MWO;7_<_J+GI%A^2UO;#V4L*PS@/K,G540X2G
M2](.]A7*[UU6T1:X<E]"Y;=M+"\:H[U2Z=(U=,YAF8< $'OZ^01W/S9QZY&1
MX[]],KW)*D @MV\]N_;'D^_/D9)[=ZQ9*;ZKJWMWZ&S]-?=M)\GAR]7?JA[=
M<J?=3N!*YI[EPWJB!);_ &_C4GL:PL'9FE0%@9UV]=72EOTUBN[FM6\::<6I
M[LZ//CW]^V<?/XP>_IC&!CT]\ GMW7FR".P^Y \9Y1COX \#/@8&H;3AM_Q'
M+RX+UQ^4! ^4?8V!Y>*1U$WW(-S:*_Z)C]]#DFY@5[)_A_*J59@5\<=#\8>\
MK9"G.SNUO4%Y'WS&3]Z'4#(^?!/XL9&??[_T'Y))'8_%*^OQ?+=QG&,_=#(^
M3MV&08P=,]2BF\W2Q?2GW>(^3;(D0\QH'(A.@7J!4![U[]I=\];7)'Z]:^R6
M+53WK>RY0<H6]4.;_9..M);+ -A*Y?!]!6/ \>//;R#\O<8[8';OG'?OF>_@
M%0WOP,\N._?'?MEB/<1ZD8]U_D8:5;N;\<O=([A3>RU_VM7-:^R]@+5VGJVW
M;&W2/M26UZ<QL57Z/I:K4$WJJ6D@0TC"T#=!$@LE7LBR:NP%PD-W4$Y[^_R<
M=B?_ $QG/J?E&H!R3C&.V,  8.?3 \^>_H1KV;\C4Z>--/&FG_Q_\?R9\::>
M--=-Y(XL8VDDTCQMOI'KG?;73&TDN^(XX\9VSC&=Y-]M=--<?X6^^V-=<9SG
M&/&FN_C33QIKKC?3/Q^&VN?FY^&WPVQGX9^&,_#/Y?R9^&<9^&?VLXS^;/C(
M]_GQ\NFNN)H<ZZ;XECSI)K\_3?$FN==],_#X;:;?'X;:Y^=K_A8SG'Y<?E_+
MCQIKOC;7;'QUVQMCXYQ\<9QG'QUSG7;'QQ^WKG&<9Q^?&<9QG\N/&FN?&FGC
M33QIIXTUI?Z#_P"+Z9_G\]KO]9[K?GHGPI?QL'\F^#/ZH[)KRWX'/XD)_*;C
MC^N>^ZW0\\[UZEIXTT\::>--/&FGC33QIIXTT\::>--/&FGC33QIIXTT\::>
M--/&FGC33QIIXTT\::>--/&FGC33QIIXTT\::>--/&FGC33QIIXTT\::>--/
M&FGC33QIIXTT\::>--/&FGC33QIIXTT\::>--/&FOEX^4TDYSM[C]&'[O+[E
MC>@<O-TD7MQ/S>/H>G"<^R&H?*)^(ZF3<REUZ]+!#SW9.1<A^>D!T:6Z8X]%
M:M1C]["RVLN/&!\_])[Y'8>F/TC4>IQCFR.7./&#GR<=SX)';OCSK1%J3TW/
MUZ<.;Y4/\9UA]8@>6"G1EZ]!D^3RQ[&"1[:EPS"1>O4D&_+8@PK)FV#1]?&]
MI!$D$WSI<JA1IR ??V]1C(QZ=B0,8/GSW\'(CW?<<N 2/3G(]_G[KL .Q! [
M'4V+)ZB9=C:[$_*3X^2\TF5$\Y)%_9);UK?W\@[6\(,Q62-]]?9$RZ8MLBG5
M,N<S0\C%]EC;+!]8GM<:Z=H\=L9[=A@9/;ODCR <_+GO\TGFY>Y3G[@X [*0
M? R1C'GU"ZE:X5T?..=%V(CY3G/RC$C&BB>\,%4T>26N'T?&OEVEDRJ'711\
M(D51U_5MOS/3A<<?7HNC@7S*HC>R;7/5,RN.WC.>WCQ\N?) ]_D@]L9>_LG*
M,X)_[1'<#'QO'8\W; 'XI>ND>M@\R6):7\H]GT>&FYG'\E3]RINP[H2?:GZG
M?('(W%-I=M>FL[&4V)6P\>7^R&=.9Q ,.KR@?6JE@(1S/;OGMZ]AV^8]A@]C
MC&2#D>?+#=L<O,2>?.!@=L=AD#P,\O?QZX&NB4B2:.C:6(SY2#\/#(*E[?+<
M;*,7V??3F,'#+7)'N7&MS!6HU.6VJXKG$?J;*)<]_7(2]$QDX=Q:$#U)!R?3
M/N'Z.W8X]_8]SY&HQYQRXR>GW'D-[^Y/;N>;M^+OJ2EFJDM?;DTS/RD<Y$ >
M0_D(I?\ Y)9R8D@GU_'#&#H'UN#/VLEV>_;ND^GME'I#CU-T'(4:[K17R^:3
MCW=^V<X/J?/;/CSC\??RP1CLO*<=3N,^3@?/X';'Q^V#G54,VXN1+(OL!GRD
M,_#3D=Q*^6EV=;=-+10=0EY/5?LDKJ\@4N;+G6: 88Z^Y]3BA*%^!;>D:&S3
M<WPO8$,@^?>>X!R,^,?CR3GP#V[]M3\89[KX C[]R!G[GP#Y[!O7R<ZI;TBW
MRI+"4FW^4US[P;/NH1?)*1/M+;,Z(]8,*:1')]'"YB_!BT30KAFH_8Y_946+
MK&M2@YUJPUS8LI8 6?4@>0.^>WDG/C)]^,9/SZ8'O3';GQXR<]LYR 3GLO;
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M7TW=8O6X11MUN<YCS18'[1Q]94VS:H;:KIN73+1]?GL&4DCN2<]@#Y]>XQX
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MI_PE%_J'T3^ZGC[.7P8_A#-^8N(/V7I]C'C;[T1_G3:?\=I^S[]4_P"$HO\
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M/;\9[Y^8>N?E=3IXTT\::Q/>;BZK_0N*5I=L)A9?+1;E#_$X^92,B)N<6JT
MY!FQ+I@67#5.'F;?:.;$HWTL.-=,[XDQ8 %6)SE0"/QL!W_$?IU!)R![\Y_$
M/^>L:O/8G2L63IE?Q5K3>&%)965A.LKXM74[*Z?3.:\DM]@8:'/K6!$\W^N]
M-61 QZZA,BBC"P=5NH2;5JPL$R%)( (]<GN68 =AV[+GZ/?VJ6QGL3C)]
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MBW)RZ_#FWVJ]&[6K;Q;6]6IRC;JEFO+<K+/NN\;;/=DG7;F62K7^I<#,OLD
M63<85DM(B*TV';][K=6WL-0N$,5;!LE,,[<Y)]2%>]B#[-O#4O6JZVJOD]+W
MS9(QG=7>-]A+ I$TY\KT$@EK1BQDT<"'ZCZEK>KBSP2CIEH9-Q+;9&)!9Y(*
M#O%)9)?O$[D3+BNO+$R89I0Z'IT.%=MDBEJ.\PAN#9XAQ)-T#M:-9WRO6L+3
M KEHIH(BT,S-=<.\<W-&D#QLVRM']BNS]5]:_9.XTP:H6GI-"K]V$Y.YY[#5
MVR6W6H;F(EF0"0I:KU;ME=D<K[*QA7;K ^DO-&.FRZ,X50?.:K'Z<>X7;.W;
MG+ *\UJO%.*KP!#'+,*HD1.1+5Q.<2LHP+# JRA@C<RCA6]EVK;]]V.K:DL0
M4+D]5MR2T;22U:S[@T$S]6UM6T6.FU92X=MNC*L'*-*@1VL4'MO(>7#ZW#B?
ML/8>L _0\:TZK!=ND63K-"JU:N/?>5T.V],N5F>O#AN,W=73+;<V4-/B;U"O
MY$2MWC*C2+*(3J+KB]5J].6E?DMJR4#:,T\MJ".&QN-2M):FE>1UJ3+#-._3
M'(A2*1Y(U2 D;)VO<;S-5W79H=M93N_U/-6C!MURQ9J;+N-VKM]6"*)6W2K)
M<K5(3.8[,_//%#%:$EM>:1<^ZO5FP'0;/S@[CS"HTBJ]3M*P\BO62R#W(6O^
MQ%\XG1I5CU1T!. ,J(5(4UG;LQPG$;W;),23"P-F*6!C.^6W%J6'V4P5XK\R
M/TY'$XK[C/3KA9%F50&1$D<A7YSD+R @C/#PKML<U"K>^J*6;D^V0RH)X*YJ
MBULE3=K1DBDIRN75YI((U9H^D.1Y!(496HM]]X^X<_NW6*48FYBR:\N3=+@W
M6DK0*XX=[4/U_;]6!ZL)7I.ZO>@:T-[:5XB/5)^#K9'"C.WEA[&19!8T)UIM
MZN02VHF%8O6%I.1D6-W]GHO:6V$]L>989'"CD: 1B,G%II JODI<);5<J[79
M%BXD6Y2T/MBO-,L'MF])MLFWO+]18J#6X:Q:QU1N(E:10/J6(6,D>0,=S[3+
M[#\JYQ;KSSE0N5=P.I=JGK]0<(%5_7VKU=DZK4*WI"]Z0Z(7/5KXEN*%MH<T
MTL!(25G"E"D7&+B@W*ZVY5*DL]=1'>6*P88WCCL)8VA[<*8>=V1EGYHTPS&0
MF%L<P*/HC:=I^HFY7H*EZ223:DLU%GM0S2TI:V_BA;F;HT8A)"]<*7RD1@YI
M4,KA@^I3H%ZJT/4N[:=B[MT#E%_I][IHWKS4:A=K"I:NZ$50N=M%C2D\45G;
MI^_'6_IA]_JSF%U4+Q)F==/58(E>JB+;2]B:/VC<O:[MBK8AL0#;XH)G5VA:
M*LT+P5%94N-/;,T,@=)@W+TFY5&%M4J3FALWU,VFIN%2W3LMO5FS4@ECBN+<
MOI+%9W62,2[0E7;DI6D,5BKRJXM%I"_?'G1/;;HMHCVK(]DI*XLOJ59$=T^A
M;V!-UKA8-.]RN+<W!5=8;:6]A$7!UBJO&VN\&:U1821R" $L=UK4Y[B'3O;O
M:E@*+)$CO.@>"NSQW-O$&ZTX>6VZS-D3HY0CI0AB_(O.A)/0H<.T*[]9H;4J
M)MEEX[=SHR;;NTMOA;=;O/MT?LL10[?9B3!]IMMS1AY/9IPD)MKB?N?UM5KQ
MWGA 2JR2'B\_'FCN;A*3T3J@UYMSX-]9*>U=]>47 N"D@CE1?5DG'NE"EF55
MNO=/JDOG^UT:EO-V,5ZY6.0#H@+,W-:MB>U.CM"[65D^U*H5 M6PI>)TED@0
M]2++NG"^V2+N%])VA >\5]F684Z!IU8)((;$<6US50;;L#S3;KM[*D\<D4-E
MEZ<\^Q]S.LN<<!MJCH?'K3&?8QW5XY_S2L7*$C+JQ>L7LA>%?K?:'S6U-UFW
M0(+KS](D7#"9!N\EM/KYC_DM>'C2J+ID;>+<C49%L5)5+"2>*K'8PTDVW;A+
M%M\DCDAI1- JJH*63(4,E2+[6LU(^&-LB&^5YJ6Y0&. PT;U^S5*A:_$?#].
M7>XH(*T9]D-.]-(Q+2T^AUA!N,[+))7RS2_;3JUYOW-^=U"]>OU^#N=NJ8+#
MKM%J-J;49>.VXYV;I]DYX,FAZR9MOT"L2<M0[&L9[EKH)7ND(RVM-7GAQP.<
M\&\6Y[-:K%/0E$[QDVXHI'B7FISVI*_3%LCK(85)/7/+%,G,@<'FYUCAW;JU
M+<;MFKO--Z=.Q)'MUJS7CM2/'NVU;=#<,K;8H%.9=QF"1BMS--2F"671LIZ<
M>?4Z^$T\::MJZ0RDTZV#P:9DFGK3V&&/&VFN=Y9596D>F-I-M(]<[;[8U^=O
MOIICX_';;77&<XYV[P2V=IW2M7C:6>QMUV"")<<TDTU:6.*-<D#F=V55[CN1
MK9I2QP7*D\SK%##9@EED<X2...5'=W.#A44%F.#@ G&OF1'X-U[4>#7-,W^.
ML,>N?_22F9_+C37&?S63\_Y/R_HS^3S\%#X$/A= 4?8]XD[*H[U8?10/]8/X
MODU^I&^%7X-&8L..^&L$Y'_M >/3_P#-^OTCU[ZC?@'Z[^\S?]9*;_>/Q]A'
MX7?]GO$GY+#_ (C5?LJ?!I^'?#7Y?_Y>GX!^N_O,W_62F_WC\?81^%W_ &>\
M2?DL/^(T^RI\&GX=\-?E_P#Y>GX!^N_O,W_62F_WC\?81^%W_9[Q)^2P_P"(
MT^RI\&GX=\-?E_\ Y>GX!^N_O,W_ %DIO]X_'V$?A=_V>\2?DL/^(T^RI\&G
MX=\-?E__ )>GX!^N_O,W_62F_P!X_'V$?A=_V>\2?DL/^(T^RI\&GX=\-?E_
M_EZ?@'Z[^\S?]9*;_>/Q]A'X7?\ 9[Q)^2P_XC3[*GP:?AWPU^7_ /EZ?@'Z
M[^\S?]9*;_>/Q]A'X7?]GO$GY+#_ (C3[*GP:?AWPU^7_P#EZ?@'Z[^\S?\
M62F_WC\?81^%W_9[Q)^2P_XC3[*GP:?AWPU^7_\ EZ?@'Z[^\S?]9*;_ 'C\
M?81^%W_9[Q)^2P_XC3[*GP:?AWPU^7_^7I^ ?KO[S-_UDIO]X_'V$?A=_P!G
MO$GY+#_B-/LJ?!I^'?#7Y?\ ^7I^ ?KO[S-_UDIO]X_'V$?A=_V>\2?DL/\
MB-/LJ?!I^'?#7Y?_ .7J,-Z_]E,(@$$HI)11,L< PPS^H3D$3R[XTBA@ABL6
MTDLLN^VND<<>NV^^^<:ZZYSG&/*O\"GPM1HTDGP?\1)&BEW=Z\"HB*"69F:P
M%55 )+$@  DG&K)\*'P;RR)%%QQPY)+(RI'&ETO)([D*J(BQEF9F(554$DD
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M]#'F7X:X^ESKC,N,:XDUUQB3/^'C&NLTVNN,9_P<2R8Q\,2;?&>52<X&>W?
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MQOO\[.?G;?$$48PH&"6& !ACG)^=LGF/DY.<Y.HYF.<L3D!3W/=5QR@_(,#
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MCKS_ .FE_G'_ %Z>RUO]7@_F8_\ PZ?9*K]S%_\ 0AO_  _'7G_TTO\ ./\
MKT]EK?ZO!_,Q_P#AT^R57[F+_P"A#?\ A^.O/_II?YQ_UZ>RUO\ 5X/YF/\
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MIXTT\::>--/&FGC33QIK.7J[_C1>LW_[PG%__P#)%:\X/%G\4>+_ .2?$O\
M_)+VM[:/XP\(?RZX$_K?LNOMN\_GKK^A6GC37SX?*&>FC+V&LOLQTOBG-+LN
M]J4MPY'S/GWLBO\ 9B;BTM.K6:AQIN^H5<LH]S6-J16["EN5G5&5!71WZZZ7
M>UQ.#S]CB@]ZS8, "._GO\AQ[CYR#@_OB,$,"<<I\=OG&<'L3S 8.1C&,'UP
MB1\FGQ:#VL6<PSZU&C^MY_"S[(;ZFF>WB63#?NN+G%N%W#?U]G[QD1L<!1A&
MB$OK\]KD>&6O>*U2H=;,!/:-P(QY;Y/GP!V^;N,>HQXU'QL=R,Y['UQ@]LD$
M^[(& 0#Z'&L*TGY.VYVSU]H5D756Y7CV@(ZM]H];]AZO\H[*SL5V]/$O<2S;
M;RR3M2OI\CU[5!^. P<HS5):TAJRCHPY5QDL830"4YLYN_R?+W],'MX/R>GS
M#MJ0>Y.1CE[# P#C[K&,#XPSGZ?&LLI?DW>2E]B9L8?7TYMZ:6/GE2']2^35
M[W,1 U)#[)*F=Y:7B_\ &Z2N[AI6*%;7"F:NQH;WSZUV"T(7E4N-FU1"D7%S
MO!&??G]?KWSG/N_$/.,:$OC.1S9[]O3L ,GN>^3@Y'CYM6TJ^2>[$/R_U=S;
MN)]*8]TEO-3Q\H?T;]F@T@8^SO&$]??*[W3+-</PH!N>HHF[*:J,TE3M2:D*
MZW6EC6G@N58A<IC9GO\ T#&>_;R#GR/G.?.ASEO 7!Y00O8]L'QVP >_GQW\
MZI5%^3SK/6I_8^W\RX]9;3RDE$-7_DZ Z[[CY$7^N/2$W/W$-[-YJBUZGI#Z
M_&F='U2W18509+[N-2@I!!5 M4:R(F$DX/?/O[CWX/C.,>OIYS[M0">W<$YP
MQ[$G!';OYP!W!^4?+J7'^3M0:A<#%L//2"X.=1[E_*W#G>]2DD7N33?EIXH1
MW<=).TP0=&Q^&/Z&\1D=4$YUOI1UYM5U$E5D1UT)GOG'IV^0_)XQCSZ_3WU/
M?OG'H%( ! SZ?]DX[#'KZY[ZJ[[Y+F]S<U]K[;5^3WE3?R]S-/DVNND>ZTOU
M+UAYX\YW5$E374ZU1==(UY'69^@YLUH.KM%BNZ>R4&Q(^=Y8&+%@T>@D>F>_
MG/?U^7SVQCQC'D^= 3\4GEY2!SY PQR3GW$XP,D^>_NU=[#Y,KGPG<. \^.]
M<'P7+'W,^@VSV>]?WWN6K,D]@.I11U62G=:NG)SNS?5>[ETMPNM\UKZ/92ZZ
M<[8N*Z[<+3YZ]$I$C(QX]?T>H\8'?N.WC/IYCOW&1W(QV[J.^<8\>G8#';.=
M8:N?R=]PKO&^A.#:Q;Z[[7=-[>V3>D_<'ORA,X5IK7KX[N-<-YYQNH==+Z>=
M952H3F$MAKIM!KU<OJ2Q.GZTXFSM"\I&ZJ<CYSV\^/&.X\D]S@Y[>,>Z<G('
MQ2".XP "<'N .Q[G.3CR,8\'."/Y,[D-@]FG=+JWK&S<>IU.Y/\ 4^H^L*[V
MO7,U*GVE9601M5NJVWB0O=9D'WIQSL8I5^$!I;A[ TL^D-FV0;V$,FS0 1VS
MGT[#Y!CR3_9V],:CXQ'D!P?/;P/'?SY].P^;QK#K#Y.CH-?]=1[S8J5T +V7
MIW<=!N_>QA'RB1L-EG]8%G9-[ ]X98^XYZ)K8_JV.&3I^:"<Y85)$H'OLL%Z
MW:Q-883G$9';R?G]_P"(^/'?_P!-22<GNO*!XP#AL=NP]>8>XGQY\:]K_D^N
M'T[U]?\ ::-RCG##D?%W"+C70>=T6+H(-VIF/O4/T45];:"J37:]UZBHK80B
M"*)0UYSE6V9AEW#&OUFQSZQB/G]1@^GCU]?[/Q]X!)\X)P._O!)\_+Y[Z],O
M(U;3QIIXTT\::>--/&FGC33QIIXTT\::>--/&FGC33QIIXTUI?Z#_P"+\9_G
M\]KO]9WK?GHGPH_QL'\F^#/ZH;)KRWX'/XD)_*;CC^N>^ZW0\\[UZEK57OO,
MDG9[_P LYS:2BAJ[M6>H7.3 *JGLB]W-</YFE6;:R6^KVD<:#0*WN<3:A##3
M3[R09EGVTAUCSCO<-<,[_M4\G$G#NU<1+1OT5IP;LEF2&NUN#<>O+&M:U5/5
M9:T:<SLP"\P !).MVAO6[;/8+;3N-O;7L0NDTE27I/(D;Q,J.>5LJ&/-CWX/
MIK'OXO?BG[J6;]6^*?\ E#Y\U]CWX,/]F/!GY+NO[7UV?KUXQ_"C>ORH?W>G
MXO?BG[J6;]6^*?\ E#X^Q[\&'^S'@S\EW7]KZ?7KQC^%&]?E0_N]/Q>_%/W4
MLWZM\4_\H?'V/?@P_P!F/!GY+NO[7T^O7C'\*-Z_*A_=Z?B]^*?NI9OU;XI_
MY0^/L>_!A_LQX,_)=U_:^GUZ\8_A1O7Y4/[O3\7OQ3]U+-^K?%/_ "A\?8]^
M##_9CP9^2[K^U]/KUXQ_"C>ORH?W>GXO?BG[J6;]6^*?^4/C['OP8?[,>#/R
M7=?VOI]>O&/X4;U^5#^[T_%[\4_=2S?JWQ3_ ,H?'V/?@P_V8\&?DNZ_M?3Z
M]>,?PHWK\J']WI^+WXI^ZEF_5OBG_E#X^Q[\&'^S'@S\EW7]KZ?7KQC^%&]?
ME0_N]/Q>_%/W4LWZM\4_\H?'V/?@P_V8\&?DNZ_M?3Z]>,?PHWK\J']WI^+W
MXI^ZEF_5OBG_ )0^/L>_!A_LQX,_)=U_:^GUZ\8_A1O7Y4/[O3\7OQ3]U+-^
MK?%/_*'Q]CWX,/\ 9CP9^2[K^U]/KUXQ_"C>ORH?W>GXO?BG[J6;]6^*?^4/
MC['OP8?[,>#/R7=?VOI]>O&/X4;U^5#^[U;-&]3>+).XW:@N*NLO->%Y1SNW
MK8[56J- 6L<NK?TQ,TW%+I]3J>\HY@5=4:[#GX-UAD&S(-F#,\^)=BY\%?P8
MR[13O0< <-49WW*_4D]EK6F22*"KM\T7,ENY: 97LR_&CY"P(#\W(G+"<=<9
M+*\9XEW=U$:..:R<@LT@."JKVPH[?/K;JB<*Y!S%N2^Y_P ]K52<&+I%)3!,
M#@8F=;*2,9('))\_;.T&Y(8LV=/S?20:;?M?EQ;-P;PMP]:DN['L6W;7;E@>
MM)/3@$4CUWDBE>)B#W1I(8G(/^=&I]-:NY<2;]O$"5=TW:[?KQS"PD-F9I$6
M94>,2@'_ #Q&[H#Z*S#UUECSZ;7$T\::H%JK*6ZUBQ4ZQB['5ZUHVU;>@Z$$
M";&)W@!"QF)J4'+ 6-D@(J>'! L\),.=_I()8Y===\;-.W8V^Y4OU).C;HV8
M+E67E1^G8K2I-#)R2*\;\DB*W)(C(V,,I!(UJ;A1J[I0N[9>BZ]+<:EFC<AY
MWCZU6W"]>Q%U(F21.I%(Z<\;HZYYD96 (P%)ZA<4-K\U6>B= MR&538D6B^[
M]AZS=-04UKIKB@/UJJ>SW-J2G$855ZQ7;1*Y@]89-ACQOH6 (94'TZ\=<116
MA<JR[9M]D6*EMI=MV'8]N,MFCN%?=:LTXI[?"D[Q7JT4P,RN&'4B<-#++&_R
M$OP<<*V*GL-R#=-QIBK=HI7W/B'?]Q2*IN.V6=HN5X/;=RG:O'-M]N: B!HR
MAZ4J%98872HMO5/B3Y!FM.JXX:+=RKP=/N?=+D6R,/Z/59J9=#CV\[V1HP,>
M(")QR"32YYHBYI&8V\++?<O."#C3B*K9-NM<@@EZ6W0J(=NVV.&.+:;XW+;X
MHH%J""&.M;"NB11H#&! V80(QGG^#_A:U66K9I69XUGW&T7FW/<Y9Y;&[;;]
M2=PFGL26VGGDLTB4D:9W)E)L_P#6"9#!F]2^&D6%U9R*[8"&+V=\22*3T+H)
M2 ">TW^J]3L\E=JY-GFK=6VL?0:77K2[S6U2O+-D')DKZ2 LN&:R<;<2)5K4
MTN5DCJI6C21-KVI+4JTMIO;'3%NZM(6[HJ[3N-NC7%N:;HPR*8^5XT=<<OP=
M\)S6;5J6A:D>W):FDB?=]X>I%)>WNAQ'>>I2:\:=$W-[VREN%GV."#K31$/F
M-W1K\1\4YM77P]D5(-HFXK+IK>&>=HV,APP[#8U-LZ#-N&6;,'+JZ?(U9T4,
ML&\"GZM] GC!'EFBDYUCB'=[-9JDUOFKO!LU9D6&O&QAV"K8I;4O4CB64&O6
MM31LP<-/S\TYD95(ZU7A78J=M+T%$+:CL[[;5VGL2+U^)+=:]O#F*25H6%JU
M3KRJK(5KF/%<1*S VF]]7.(65X39'=.R:Z*97YMN=EY8(=XC>G4%5S&Z[CQC
MM(H1X6U,2*U<8L4>HRV831HKB#:9V,VW*W&/$=.LM2ON+1UEAVN#I>SU6#1;
M-N<^\;<'9X&=VK[C9GGZA;J2K(89FD@ CUI6^!>%[UIKMK;!+::;=YQ*;5M2
MDF^[3!LFZ&-4G546QMM:& (JA(&3K0+%.3(9*;U/X:08_(GK3R8.S*K J<5R
M2_\ 0-J9/BUU3:D65L-2/O/BI+;*\JTA"EE:5J82PD:&LB]F6&#1B65=>-.(
MT2J%NP++2FJ35[@VS:_J@GL%X;E3@;<33-Z6G7NA)XJ4MAZJ&.)!%THHT7&>
M .%6-P-0L-#>@N06:1W7=OJ<_P!4-O.U7K"[;[<*,5VU09Z\UZ*NEMA)+)UA
M-(\C6N=Z0>O#2,J!H@NK04T2T#$KV?7>L,54DUXY\YYC<VWV.;=)U6E@M=2?
M-(;!8HPM';-L5O8B3MWV=F.V]'\(G%<#1O!<H021/1>.:'8MBBG5=LW6OO6V
MP=>/;EF-6AN%6%ZE4R>SPPK[*L?LQZ6N=-\%G!=A98[%"_/%,FXK)#/OV_35
MV?=]GL;#NMCV>7<G@%O<=NM31V[8C%B:=O:VE]JS*=M--<::ZZ:_'X:XQC'Q
MS\<_#'YOCG/Y<_\ /G\OGQ&O0@   /   ]>P^4]]=O&IT\::>--/&FL6]R/E
M5<4["TACAFF6\MZ ?#"1B7(\LH=3;D1QSX@F'GS#)O'C67$,\,N8\[8CECW^
M&^.EL^?JOM6"5/U2HD,,94BU$0PY@RY!P1S*PR.ZD=CK7:T-VG;IV%+U[=:>
MM.@9D+0SQ/%*H="&4LCL RD,N<@@@'7F!'\BMZ[1QZ1QW[JNNFFFNFFN&P.<
M:ZZZXQKC&=AOG9^&,8Q\<_'/_+G\_GJY^'?C0DDIMA))))I0 D^_ BP/Q?0/
M&O-4^!K@!551MM_   _]M;H.WXK.N_XEGUY_?_U;_K9?_5O(^SMQI_H]K_(X
M?[K5OL-\ _>V_P#GK=/\3I^)9]>?W_\ 5O\ K9?_ %;Q]G;C3_1[7^1P_P!U
MI]AO@'[VW_SUNG^)T_$L^O/[_P#JW_6R_P#JWC[.W&G^CVO\CA_NM/L-\ _>
MV_\ GK=/\3I^)9]>?W_]6_ZV7_U;Q]G;C3_1[7^1P_W6GV&^ ?O;?_/6Z?XG
M3\2SZ\_O_P"K?];+_P"K>/L[<:?Z/:_R.'^ZT^PWP#][;_YZW3_$Z?B6?7G]
M_P#U;_K9?_5O'V=N-/\ 1[7^1P_W6GV&^ ?O;?\ SUNG^)T_$L^O/[_^K?\
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MU>Z&L\]9O$=X:W*%@@&FH<54L%=:UM[!=8T!2ZSQAUDB#1ZU4KS6G_(?.3V
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M?8>') I/)8Y=89&&ZY1$9'B0(AN^KJX4F<EZMT(S2;35B(#37SG)5DBV]T8
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M<TE:-)5BL&R8; BCDN1N95@9*TIF,@Y!"HCDKS21S122IG"RM:N0-96U-O\
M<;+?T%8LL-8)'[)UD]@5#&%]<*TKY?WOU(L2[ZXIT//65XV;0^6"$7?.9,TX
MBV\RO1EZM?VN*6&N\D(ED;E3IK(Z#$O=VK&3FY4>9 GQE;) ;E^A,BEI4B>&
M:S"LO-5CLP/+'*BL(X;"+*9*W5G"PL]A8A&3W(( .-*+=#M[''K8NM=+>KIE
M!A&')?:;F.6B#WB^D$.P:EM*6&=&X8"AK(8LC2['/S$T."Q5I!YZS>M[:BQ
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M,C\H8!@/C*P[.I5F5D;RKJS*P[@Z[Z895=761'4-'(CI)'(A)PT<D99)%)R
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M'PFUZVSF3KSJBAE>ORR R11$*)HI%(>4A1B5(LC/QP>3!YM:>XU:ERA:KWK
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MMWBM)22P9*558Y+21RPRQ&"X8KCB-TD95B26,//:CBYX8'<!<\\=M+O'6:
M[F!-T:V]6+#NM&; 8&+@BG)T^D@9'W8@H22*$[7:2364C4F,$\TY8Y96[I6-
M*TD;5)GCYU(B9BKRQS*R_(T<-7E8<T;+]RA0LJ]15@I-FV;BJ'>;+T3M[4Y6
MAFF@;VHVED6)6D='/LU?D<1'G$V>C*5$2+S-"K^P'GRNN_IXTUY@>X=G:)>D
MZ+C&0".I%I$AL13!=5RU[6RXW-&*%-S:$)R[)(*R)5]1'VS/.Y!9.EYDS).)
M.G6=W:*\4T<C",RV [H55IR\<#1Q\K+'7D1RLC-,LCL&5.E& 8F<,_"WN]O5
M%*TFRP232-),MEX:\MEXE5:[0*RQ#FBBG)L R'E+&,\DBL@Y=:&K89R2O?[O
MU,3>UQCF6&-@NN,@@F !=*\HM.[BO5JSJ=@[365%<>Q@-2$I4@[+%IF/-K33
M6R2=***2-9(1#*4@')"4DJF9NH[V)*ZQ3VZTS25[$UF%;"=5I)(C T8MPM&_
M-W;;*V\?4RSNNY)L-Z?;8(VV^Q''*75Y[<C-RV+M)ZO+,\\8:SB/F'0=UN)(
M)9C:W62A/PDNKV!_8*;K+6ZK6R1:U,XN=<K\TZRN0+))5I-I/WNJ=2O+$.#8
MFSA,I81P](1442$*AK5[L#S=%H8;7+/:L(]CI59Y50V))6$BU<4I7D1XY(XP
MT4*!@K%'._8W'B*+?5I1T)IMIFFKKS>S3NCQ3K#'/;EN !%F@F,HL];D@1HW
MCLQ#D$B22];&(20MH-P5NIJ<%JQH1\26Y0,K@34U_P!K+5Z@9C7%]7>3L!01
MAOF*[<V&N2N1Q&J7%+Y?H)KNY**URJ\:SNT5Q#+4>&NEHF"1YI8;;6H8T:15
MQ/7C-67I)-*SJ"^"ILU"#?K%^GNL<]M&W*;ZC*8#*DME;<+5Y;GM9DDACGD(
MED]E$D( ,[)*%E:(!;H'\#U,;;UAJ@PZ!Q96X*Q*>6B<K&8[4%F>%1EJYLZ(
ML+Y0!4)*X5"P+9LV:DA? $PK@YHD/6Z+0RI5=)$4QP1L\T0G1HRC00M;E:.(
MPPR-<1^81I%!RS\T<L;+2E:WG=JVZ4.(Z\]"K]3YA'=LU)*"5I4EA7V;_*S%
M7)53)8Y&=99%J-#([B0-%+1%,EB>6T"V5." 3K-6;B&$N/)C7 &X(F52V?'1
MJ>CS$A=[0L5(#N>K#+LREMJGAY)/:&"DF657E6LU=V97$U<L\09G0%)!":%R
MP3-$)(GD@$[N\7+/)"((D9\52I8V39[EGAZ\-]FGN5) \=;*U8H$L"S+#4CN
M6I#.1+6$[2<A%<I(8C&@E/)MAB=*UK8BPKS3UX^$"'Z%2Y)"L-?TGRQVDQOS
M^KV(%1)6B"& ^SP:O# 6J1@N2'2R6%"8T\E8C"[Q+$R(Y:68-+%&\4[?%^-'
MN%F RBRB(P1[ EK=-IL>R6%"KD/U<V>G/Q%9^H%R&W96.6Q"5%N.2&J&F%.Q
M9KR_;<Q$NC%(>DTQ"P65Y)HYNPJ6RI;/>%&J8R?[Q56?==69JZ>4RSC[8W4Z
MW.OSDD%@-XCE#=<7]"RAF&@/:IJZQ90J5E8XXK#2LE5VF4&&TO/8,R*AP@E]
MFF5.G)"R/#)\975C$DDL<)!RW+._;%#M5/9()=RI1[<D<MF*G+:]IF>W:E2#
MFHRS". U#5-(0R<YKE5BGEBC*E+ ';&T(3%^KKTMZUD9VG1JLN^=Z98+?C+)
M^KC:SU\JO.IM'+)@1%I8+E7V*(N3-6LYDK9;HT>D+P1,Z023"H52 ++5!M0U
M0$A?!G2=,UXERR59DFC$EJ#[2^4G<MFVZUOL-IMZ6C?;V&5ML'2FMF6"O7,2
MPS>UQ&&8K'"B(T+R2$"U52: J@Z"W%LY/-KUP>B:N;2HDI'0DTX576/:\C="
M;IK.7_N"<%^$-15.3',9++:==E!5%^[/;=<D1LTU6K01Q)-5@9XJ\IGI2*UE
MX9Y(93)67 D:O))<=(H&CC17664+"(Y0%;=K[EQ"W$$U.SMLB[0+EH0F."Q'
M6@@C:=Z<R7\M!(DO)'$))&*2EV6 ),P1H@$C74LQ_6+*/ES4C)#E>ZY%;UKE
MHF/F^Z[USJANM06Q##+J]82V1ZGZ>Q1"&AQ[-)"U$:[6U3)TRJP6(>:.R"DB
MO/6DBCE0&S%&9:-F1NI))"((W9::S"62)3SL0O)VO9Z]!=QM;+NT>\6DV^>"
M&E$D(PY$4D(D]FMRFU\=52MT(DKS6PD*2B3GAU+#64!\BP%+9TTZFOF2V%(V
M7I!6@>]BW ,48J!$'/$<Q7UBQ*3&SH1D"I8N%<%/-PU&95G2#:LV>NT,X9*\
MBR3((95D<QN*X=9&M@[A*0W1=((2O5BBF>Q7C#0SD2MECEO[[M&X1<2F?:UC
MDI&#<[$+UD+/)(Z@P6I(([1A$:Q&.*1#*LZ=NO&K-O\ >E*H>%!<7\;I<P*=
M')!#UBO#C2%,2G&8Y^B-B?)*^UU:$QL]-]YRU8?UI1$EF&'R%D4PWB[K(>I'
M"873I!W623I<TRR\G=>C+/%TE,?8),^)6F#\C\T:];8Z5>AMXBJWAN4$L\EI
M+2*B1?;8X8S#&D=BT%Z1@)D#RB;JN_6BB;XIW?\ .5KKZ>--/&FGC33QIIXT
MT\::>--/&FGC33QIIXTT\::>--/&FM+_ $'_ ,7TS_/Y[7?ZSW6_/1/A2_C8
M/Y-\&?U1V37EOP.?Q(3^4W'']<]]UNAYYWKU+6E/O#$MS0*:8:TB5F+;U$6E
MWW F=;F,I*S909%VB%:O-L3;0I4:SR3FO2B%)!X][,PPP3)&"LWL[*6Z]A.0
MNCU@)/CK%RJ+$#JXEE=85*R+&5657ZS8K1@2S1NFIN%6G<VZY7OS>S5'2,R6
M2ZQ]!DGC>)U9\QLQD58Q$ZL90Y2/ED*R)YJRP:D20$SG+=]7H\M?+&V30?/"
MV"*&;"*2EUL4SZN2V9&WVL'L2K(KZ2=$N<+!65A+I=M1?0$A 3&&(B)E#B3(
M*E)%DE4U908UC 6-R)#+*LRK(4ACFKOP44<+</V[>S6HMZ%NY72>TZ,*<5<U
MK,;O)5@LEX<<Z03Q3S*Q]J"V8T13$\/7=,M/W"TF!"L2X :(B!?62)_MA0<7
M/O!*Q!IRC;%<:)Y1)999]AA$5BPWV-"1Q6HRQ-G5BS2QB0\Q@:20"1IXTZ;H
MJ%A'[5(#8CE#A>4-SP-"_4F2&../5))Z/%&PU+6\6XMD->_:@K64'/5>1(('
MEZ%::4F6)XWB6:.*4O6EBZG/'$W3,>< 68O*S1@H82';#W2*7**OMOC8-8MJ
MHTA%071 YPLB2KJXA$=Q2@PO7FC,::S21ULNHUY/!D:-%?E:)4YZ[$S31@1A
MQ8B+259X@YFEL2/"1(T<:IRU_MBRSNW&_-PIM>U4]MZ&XT9C9:2[:#S5IF$J
M6D6(U+25D606)70AI%Y07A=IA+*(<#)/KL1*KE#6RZE;#V (&J7!DN#+4;:I
MIW4+-**P'-+R@6JMMJ\01O8238-)K$])//;7,R7C=PO4YN7DS&[3UEDE24EU
MC,=@QD+UGEQ9Y6B*D1QUR\:0+;<Z&T[\-JO[ENL>RW[="(I6E:!S+ 6G=#R3
M2US7C>43F"W(>C-"T:)&\Q5&B86#?3S0[[5]E]VX(0X?M1+6K$JV4S?5W@QD
MS1BM/+FK#7?YS=# L;"5-?6S-ZXO5_=XJRIW5))B@!S+$)<DJDUB%S*JF-U5
M$EC031<G0E:2)IGFC,TDA<QLL[WQ+=X?W*KMJ4XI:-&M12!IC8]MM(M2&*=H
M;*RA(YDD#0ORP._M$.9@V5C3NOD46(@97JTE3);5G?$N6R2W0G*C;)]$4169
MWYHFR?9I&4>V1B.C6^FNKT52FUTL#UKKIFSH\!9PHDDK.2JPS5BDIK]A.L2N
M9E4JG6EACB9^BTC@UX48+LW=AV>SQ+)8^K"IN"WO;)MK!KB:2S!*KR,D@F#P
ML[#J3U4CFL)F=XS!$G*LE$2,8-)<'@"S:1](9M;AHD"I4P$+L0NJ2R KW"\(
M&W*WRB.64?>0AV18YF@K/ZXQ#L%HM#IA/,RR^R1,PZ;@5@TTK B*;FAD='D>
M&6"0<K$I"D(C>)^5X8XXC6OQ1N#\4R;1/4A57N/M\043+;B@CE;H22NTTD<M
M<H(YIPL*5A7#2P+&J*&F239LBN)H'(A1:40QD/\ 7:=9!)FXL0NT9K/978E8
MJIH%7OGLV-HKT.'$-DJZ8V=NB%J;^=7+0(N5(5BC\T;*EN"41AU!6)I(WDD!
MG(5(+$HC6*:1.61[$/,M-EV3::ERQNFT;G]59:-2[)6VZ-X,K(].6...6PDO
M5LI)),L$,R00I'8DC0.9XB&XP.I50P#;;P!+W>(-H7H%=@*:@[J]1WB]F7]U
M U[&YHC)% 2H]&RU9SV9VU4'1L1[S+7[:FD,\QD'-U#$K,T7M!$9$F877_*7
ME2"=!(98YLJD<4,JO&:ZO$V+:M_?B%-XVO>8ZU>L]66>S:JM)6$/)/7C(L/8
MFL!95DD2:O/(6?GA:)TEB<HO6:;0@4!@0>JQD@O>KM5Q=>FA^S!G:HUEN9G[
M]J(M"8&YR-8A52P)8X7,1EB33EL@!;)7C9"]/J#E<\BI81^LI#&*:-.1Q3D5
MT,,4[SR'K QB.*5%A$D<C31K0\.;5NV[[%?3?90M<*RJRPPA;*HZRU:U@V5>
M*.Q(Y=IH62/EEB1(G#:A22#*)M5>GU4-B'&>S5R"5J?;1MHXV#B:)7R:G+(1
M0B3F2I.6#T'55']F#Q8KCR,M OI:U2#&=>H3S)S)&S&PB(CKS,LL!M2X<JLD
MJ2U&D)9I1/$R2R3R&D-ZIQ1P_,N\S0[2E._7$=Z'XE=[!KSE1%7DD+3SK"TQ
MFI12<S*]>:,Q.')B$"P'D; RG@'#V8/YVFT2$" G&4.2XQ%L0-L4&MQVZT6P
MGG%LV  #$,AE$'61$+*M6)DU@L8DYP#A&*L3,[1XGPQ?GJ2QQF.5X>18EDE3
MFC<RR31V*RQVMROPEL%,;2\&YP6[UF6Q?L*9*OVR.N(C''7LB)1(]5D"&:98
MIJ\ZR-)))RQ^DWI";"33;L'H(K&G27$=.5,I 1JACY]:PG:;&:*TRP'"O&^6
MFT$BO,LRA<6.6)5@:]785]>6_/;R 9X) SMU8"^)'E=E(EDC*EY6;GP8\AL\
MY4CK-),))&[^W[@^Z[?3W!X/9S8C?[2"YC7I3RPAH3(2[0.$!C9B6QE69V4R
MONYYQ];>GC33QIIXTT\::>--/&FGC33QIIXTT\::>--/&FGC33QIIXTU),_R
MK6&,9SC/U$OX9QG&N<?[A)^7&V2 \:YQ^UG)8N,9_+DB#'^ZZAV(^<><X\CR
M K9^;E;/C!\:D=B/G']/X_Z#KP%'"+&5?8BUM7F =:5PE!,UMCQ$^:+Z?I =
M%.A3@[Y5&6*+[,C%*T3] FKZ1Q%*_P W':CR(+<^^[(4S&5UD5IIR&22)72-
MK+LK">1W$PA+.27EJB6=08C&+*RHGS]#AFO'Q+]48=WB<Q;@]J>@@BFMQ/9>
M7J5;3)9<K W4DB=IH5EE3F@:N)68KVG!#U@9$MYJZ,M=X&@B800&!J*P6T+'
M'7.1QIWDZ2!),>8-I8L5I*C*G#,*9K%S)8.5S*V0DI=D"1REU5V*'D>:=88B
MTD;.L*3M*$B=8^>1DCP(GY&87(-7:N(*>\;E-0DV*O2L7X+T O5T@]O 2G.+
M$=FQ[(DPE-82YE6;$<JH)T(;VB.=^D*EG^TY<5F>-,5B#=1"W@?%-H+/]:IN
MT3ZO%P)H-JF*.]Q:#]PSW4CJ5(,/6(R!%EIOG.JA$3*9F+/$Q+A>D8_9\6B(
MY8GG*3L(#$H*1B)I>:4DF&O9MM&SCAZ/=MYK[G'N\4.W6HQ!1""&18Q':Q<F
M2>VB.!"T;0].0HDAG:0I]HFD] !@?J8Y6RF)D(08TK[,J1N'C,V<Q+"T)A[=
MK8S-0R%SPX9?%N4.ICG&03;1Z/UI&O0K<_4#A581LJI*D8BP06ZJ2A(8JR#I
M21(6=LRE))HPQBD*U\6WWZ'$FW;QMQHU-A/0@LV;%..M'6:**]$T<UB-4HH#
M%-T(W6>1NLLEAT,14A>\^A9\7QS)6I,.9#D>FXA\SR-<4JB%<"&2Z[Q56R*;
MSH#.2?6Q=8@)4*(M]E[L78(+/3*=!Y(AD+*X#12L71(5*2=2 KG_ "B.>I+,
MB13,2%FF6!8>6-$ELYH(%X1V"Y::2#B"'<;51&A3DDVL)(MM)9"P]JCG67EC
MBFE5(B9THA&YHTEECR[C!Q_[E"HUL"T/?X09*:![60)O,+K!OI,?]Y6<S0,I
M#*NEDW/8PPPEIF%D(5JIG5I3@PD"\Q=83(03RQ\L#QH79&4>SQ\CI9$P#*C@
MI)TU<\JS8"M#BC8HN5Z/#8H[A(K)FK!MKV'K1<Q3#4XRTT729'"O9A,,D($R
M.KO!D&(+DB'P36BM#A=;4,Z4%MG4>(VDT]<G7UI\M+J1L 6FU2$<6+0C$+(I
MJR7+CTJ($0R6\P&$:KE9@0TD#1S1I$#TTBF$DT,T=I5;%OHP@D*L<#2HTCN4
MKY-QG3A39]MVR>G7WU)WMMU-P1/9(\-6G*5XG%Q&Y_:6,#J^"2UE1(9>G'#U
M,B#D)E7[U-;+.=/HY /=DU]2L8"##!X=CSC(WQ:] W@@7[,L-OK'U=^5+E.\
MM1Q%N2<ZDA9%C#-*PZ0,/*J3F2-F9C&$$L(FE@8M&@A"<\13J1UXQ7>Q?<MJ
MH\3P;-N2;A6VAIZ2UX:-A:[=6!+EWG2I"D]4S/#8,R11Q5DCL0A&(J%0LT7=
M6?N8Q7[CUW6:O,"E.H\@MATD+VW!#.&#?F)+&@C.2QPL(]$84(9:D2LR*&->
M9NM39;58S2)&%8F9^:**3J/T"RE68-)"9:\[),[1L]B4,&>R)8G5!"L<>+>=
M\K[+:H[9=VF'=EIT:74OWUA>S*K0 2R4^O7LK&W55S-S%S).+$;&)L.O?739
M[G52IDJV@-MAVG $>/\ >(P(NW9RV-K!(:6H3I6;-1"U,G7K%.JUG85BN4 .
MH)+9*/2MI8K$2TCS\T#JK&*(LS"N%5)P\DZ2QK,8L=6;*UW()EFA7K-LWN&J
MU_?!N46^+!+*]:])358SN<0CB@*301>V":-9.2,B66)%K&3E5YXXEYJ?(5!+
M!FX-0@)%VX!1+=:'H<O9:#SP3:,FF\I=JGKI/05<^=SR&S=?(0S8C,%>C>OL
MRUEQK=DRDB5HR.JLPBAE;IR#G+@1(A]F$RTI.RI'%(BI!*'Y9T#5YLB\251Q
M6^WOLE1)ANC;=!N*P1-N*R^UF&M*6-7V@5Y?M8$<,XDB@96CDG"]"6=DG810
M'$:G5!@-48=[-NT5/&6Y#=?6(HF6AZA)E,%%A2[W&)KS^>.R[J$8$S:$ALW!
M<4S%ZA%4LHQ84S,(.1XARQFP3&8I91*Q$L*D21J8EL33)&QBB=)Q!AVGA>OM
MN[R7Z>[);CJ^T<M*H(9+HZ]:1!3LR5[,G3E#R(L0$74M2HF8JLI8PY4X=I$A
M[+0L'0*Y=7=Y5AK=P@B0LU\OZ R78=6N:6W8 %8>.%)'.)6M%10!1Q^T0#ZK
M[ATE;IVR)JDYCR.G69WPT3=:-3&.:62*M&\CH[JQDE,D<A5#B.Q_E;TX?XBI
M[I;FKKLM+;[4E:686:<,1:9559)(;DRU8I2V>>99I',<CK#$T26%69_:OSY#
M7T^GC37F-[;OK0EZIK) Z=5^K_=]-(*R2L"U8N;./JT+;C.V@!.8M9XT@Z$U
M<B>R#@F!QLC-%!XVQY,G;VR*M)"X:.*28R2!UD2-WZ!CB"&)),\J@BSU+"!3
M&W3S)&53GX6^3;_76J^QP-,'>5;0@H07[!.(1"IBEKV)(X7#2JTM=5?.5FD1
M5@YM?'$J]H5 VL%MDKUT;1Q[W6&?G=C?0CF![9KZ&Q-=$QB&%&Q:U156#G]6
M6PDRKM3!V0RVOKI"UJS=C!C1H(8(I:T492H?;X(,<[-)8KH9XY3)%7MRVH5G
M8*&>,QL\TH UH;I1VS<FVJ3>[@VG<YJ->,U!*JJZ.\[O&S6(YHZ1CM26DZMF
M58HF5JC"69"'AJG5^H3:%#7&S]FSK\FR&J5HPPN>O66K@$!B4X> "+3%>W1N
MZ]I6M\75&(-$+"QRWPU&B,9QDVDCI7$DFGBAC6<\]NP(T6>I8E :T[R &8V(
M7D9Q4=WZA"0QJ2T;:VI;7$2;]'76K(VQFS G4%&)H8*A2%9;$NY+ \\=F <\
MKQV++8F!B6*5&B:23B1(_B0%SJ_FL?L& 9E01MJ*V%;NLUC([-,,IL#4C5 Z
M:!95Z&@XDKT,%Q"RMRN&A#GL[*KR99"H>[4C42*4N<MR)XXA8C,,KR0HHFAC
M9I2LC=8M5!9Y!UH^D^&MMFSQ[U;L[=>23=(EW*6+;.M (8;\U:VC%F$/-)6C
MGD<S0QR3&G$,W)'C#*\XO?G.@':.P6BQ3U;6/1DV8N-7EC,ISU:>E)13Y&-A
M*?;$L7V4%>8TGZ80Z81WN4E#$8Q%!NJ-$D;Q2UH(39)98@JQUTLQ/#*)0S($
MB2-(2]A+H4HKH!))*)T75=NFWF]%N=7BB"6"C["<VYJ<6U-S]2(=.%X:T%66
M$0.UA9UBFC#P11NTRV(H9J5]"0N$TL=?N[(C6.!JDM,:%&_H;BOKSHAV8!;"
M;#9FTB3&1J&)DUE6-P%ZF=7B*%B5(-89UN4\K'HS5(E^.DL/6F@MQR=,3(Z1
MJT4<9GC,Z$UW0R31L9U#JL ;%#4;;-GLV>%+4NYSVKE5FE%:*XRPUHKID2*G
M)6.+,;6(WD26$SO&6E@C2(,PJK)GL^6 -+59SQ+"(68G1&$U-L^ELU3BT5D;
MD&1)_L[/U>M.RF @5BTES&R$V<JXA+#95D<!5%4PR/'6KHT)'/,BV$KI!9+.
M"B<RRGFGB6%I:YC9:S=.93%"Z)J]F&+<]FIR<4SG9;0M61!*8NA*Y/01VDH&
M)FS(JQ=2() M<0QVB\,-CE,+<VP4V?&B6[/-:Z61NZK+M-JR4)F6"EP.CO0Q
M!-(Q5ZO5CK5F&SJ#O=T2N^K@.\P$%L8GI]N6"VF9:M?J)'TK$4O0GFCY'<Q,
M;$?+(D,E;H2K:@:"%B602M$H35+YW[;$VRMP]!+?VR.@HS%4CW,SRR7+EB06
M;$$ DA@>.2)HI*KUX!$P,$P9&Z<P<MK]A:ZBV6V:TT^SPQR7Q*32GAZZJ6VQ
MBQD6Y%BS"E:+%F^E@*>:,=2@'H-1:[3@NR(S89J:JHDLT"%X*_M(KOBJRVH8
MY9ZU=@*CFJ%,K$PQPE%4Q3VH.1X(U+-*-G<-IV2UO:&Q?-?<V:JS48)XBUAH
MXH%KA)VA98IFA2NB1=82W5Z4U6*,R-((:BQ7"><I!=&]@DB=J9$O4D3\HG"Q
M756*X6"YN-M"9" ZFK1)&<EB7/4!(JQM%LHR,390GH$+69:]= LM:*N&@E,F
MW31(GVR6-R:BB1"6MO8E6O#)%-(\L/._:&9)=9Z5SB:3?9*]ND&VPV;1AD2E
M#%315ZLE-J^X15X#:622."#EFGEE=9#SHEA6=).-;H1)NTJ=U:-7U>((:K%@
M_/[)5;0P33PS5UZU4_7S39#2EE=;V"=DI6K +:$O^BM2]8(,"5$'8RGM'8JQ
M+%,#!*[VZUFM%(I6>-'PB*H>Q!$8YR\D# B&0OS3-'SMNVS;JB;I<X<OC<-P
MBH/'5@>:M92%6DK2-S(]>-;@Z<9CKOTYJ;6GKPMS2LRQS?VY.]1_4;7;6?V&
MK9:%U*R'@NKK/!<)PC@Y*WKD+)+JU*BT)A[EU#,PP13XE0#/[;$B8+*S8JF)
M(IN>O7C,\J$68%DCJ8KJ\+&P,8CKM%+T8E^U,MD3N.E)*&<Y*[7-RVG<5XK5
M]NB2:L8KD\$>U6&;[;\=:_LRHYA98HUY:O-82U(@YY8Q+'O=Z:)DHJ.XNUUD
M^WSVIR<!G!]B[UO=-JGC;2!KC$9CERQA88RU+FG9;2ZJFXVX)".=D!'AA/R=
MTEE9XXGA,21]21&,BS=8R=-7D61$C4H!$BA.7GC?J"4]0D+UMEIT:5 1[=::
MY6FGDL&PSHW-*\<,3($5(W@,:0QAH)T%B-RW5 )"C=3SEZZVGC33QIIXTT\:
M:>--/&FGC33QIIXTT\::>--/&FGC33QIK2_T'_Q?3/\ /Y[7?ZSW6_/1/A2_
MC8/Y-\&?U1V37EOP.?Q(3^4W'']<]]UNAYYWKU+6E_NS&!BA5$XXR8#*^ZQ3
M"30J6CS<B>:N6(:<'54H)T.,DE7RF3PZ"@GDXW&^=C @N#"=.OLV38F0#F#U
M\,#)'#@"6)E822CI@\X5,,ZABX7N2HUH[G2I7]OLU[]A:E?$4AMLZ(M:59HU
MAD8RE8F!D=8BCLO/U>1")3&1YJ1YE)C@DT+ EW>YC5N1"D1DX@FZ6 XP%%*E
MM< T19[C[5=%K7YM>VA9H$5NK*O$E:=7<2S?0GXA)PQ$+"2-EE YC+R122!Z
M[,8TA$<:R1QSAEDEKRS%7CA>+CQS0\);!+=V>U'O2V;\(>Q(#'5@66O*LDK0
M5+#2PL"D,3QRV8Y6DM0&4+R1\T*>5>NVS#!""M<!CBBZ!*:VVPK<KR=R91<D
M+ZP,=A*R521%S,'NZ@O3<=DF3D$91F4M1SVV3,JN2QC,CCGEL1EXY D?,!)8
ME4SQR(4Y(Q*KQO!,R#F6Q+;I/8H\6;)4N[O<7:)*EZS5BL<YG@DE->H\Z01S
MO&\T;1B'[6)N>"2!SU'4GJS6XT1,VZN$E>[7,@P;9OLRJ^F=2YR,LZYN*&$S
M,,:I/L>)1I U''(6OJQ8V]@^R9ZQ8#&SQ[!<PJ)"CQLKR0!DG[A5=+!8RQ!(
MWZQG+(WVR)XHXC(EB,*D>3<-WEX2VS:J>W"&_5F6T1<L6'DCE465M!8VI3K#
M\9K+%"'GAY51T60I,JP_KP>DL<HQ(PAIA.PKP6%!8#$ZD]*)K5P20-J^#.HK
M:<D1*CE(I>)%P-0"()FK^@=6%5H5<<O.%YA\4HAB9IX%=XIBTS*WM$BRRL))
M9%2UB1K60TPZ[NTF+=J6T<0G;-UO[LNSV]QHPR^S69H93/&SV,R&2S) 85:3
MKQQ77!ALQB,M$+!E,D44,C3<"&'9"S^Y^RT)5JYK2F?7.P@(!NYY18TD[-'J
M]@)G<+LH78\J )H@<Z'-+?4*Y9UQINGS]Y8EE$K/TK#*>7F9>D$)6.4Q,!!(
MUB%^N\<RAHXIY$UGWKBRUL.YQ;6M(24Z\%0<[S3K>M(U2*.1X9A)T&D1E,3L
MT$DLUB&7JE%EDC2GIHD]G@A0 MB5M>L D(VF[.KM9#TXKT?;4JH[,Y(!:B8U
M32'#H0V\A.1M&$!P;E&4P1XQ:;S++!(TK*LEB"4L52Q&1,]=B5L %O:%65DZ
MS0E#-ROS1R*KDU\MC8MF;B<VCO/2W!+L=]]L5X4GEN1SK:;EDDGZT9L.G6>H
MD<UE YZ;=(_:^Y1@SD(ZVV,)-@2T*2 ;'D9<G 9J%EA78K[$4&V$!3F?7Z\.
MQ.#V^\<3<!@.$MJTR@!)7*<IJQ6>.1:L1DYH)@T2EY75I*[M,A:N"8BDAC1L
M5S"8!U9^K(\DWM2GQ9=?B%]CEI=.$VY-LB$4ML65$4TO3:Q&97@EC?"2S+%'
M"L<9EM12% Y?MAI_@R.(VD1)%=UG?+,RUVX4DEE,%$5%EO$0WD7-*WA*$7I8
MCQJNW,N&(@FJZM6!+*.'=/*! /B!>99$$;*LU>;E5NZQ@Q#I3]=P(4D>-*R2
MO%)-!+GV88=EV/:-ON6KVU;L^[STZ=TI0@EK&3E-=TCCDEBF/M22RF*NLW22
M%+#P/*I<"/2<9:IA"C91J ,&,A-U[]10DPQ"YR,,89O(57Z>H61LD[X?0]/K
M D#!=U\U[$/6R<UTLVK%6#RS]0*7D,<;=1&N3E'0\D8(>U++TI(7,<Y+,8I5
M@;K1]1%FUCV[B5^*(=WVO=D2M6>E-<DGKV9EBBCALUB6F-^:QRR13F*=)6DY
M937>"1#S%EC:3[R1PLH"Q)#&.T]/(7F*6X>JZNV2+#:8]FF?QK9+#&V;5-*B
M!C8+-ZZB<'A&8@87:.L&U: G)U%59.552RK1NA+2PN(N1'A#M"T<=F2>0I(L
MTJQ,,I7,ZS7V^.IPSM.Z[OM-Y=[E0U,NK)'!$T=H0_'AKSR64*Q69)>8R1NY
M7F516:9GAR2*E$N MAQ5C(4<@T69'3MY(& 3(F(8A<>JJ"^/=67+.K62B,AP
MH:Q-]29L<J$SLJUN+J5I)@79V=#(B%I+..1U5F5DDM.1(H6296@,C6%YX\32
MH(8X<(W"OQ=L<AWFQ'M@H7J\:6^L[5BYIV61(8[4K-([1FP9*BS&1?M,D4QC
M)B6/IC8F+ 0Y*M@*ZDG-:ZEH(VP,;FN_9P^BB.KW44Y>&R51%"LFA#NJ!-+6
M@84HY@'/5M@$H+FZ8#\KJ4+"-EL<I$4S%FDZ]1U=H9W#1Q)!.Z0S1V@7$QD+
M9I[IX1V&BVTRQ;I!<N6'%V61Q5 >.$\J"C:7"SR0N(X_:B(I:UP.'F=PGI/Z
M4G8(HUJ6Z!Z!1UVVZI<0"891*?GX0*6V95PIK5A%#MO$UAPTFTAC:L7&IS2S
M,[)8##WQOSF\ F>"4LS&>!9<ORE_NY(B&957G&8R4P%14*I''%&JQKVZ.Y-N
M]&IN+QF&2Q&XDC+,ZAX)I:[-%(P#/ YBYH20.1#T1GI9.Z'G)UM:>--/&FGC
M33QIIXTT\::>--/&FGC33QIIXTT\::>--/&FGC34@UU^>K9:9^D^&X!FG^X[
M2ZR_X0\F/]RV@@)GUD_+_@;0CD2Z[?#,<,N^,:;2#AE/;LP/<9'D8R,CM[^X
M^<>=65N5E;M\5@W< CL<]P>Q'O![$>=>"(.LJ[ZHJ'.5EZU8( \/[.-<#V5W
M/4 X'6ZFN(SZ-)$8\G@6ZQS@Q0'- !#LPDTXRX!MN7C?=,G.SRD.IG=E<.L3
MPI[83&7L3+;YEC'4SU'"B8JI$RPNEP_/;=PO%#Q"MZ#>H)#'<>PU)3#+=C2S
M+)%-%>"W.>.(=5XY99$5I\%2(NH)UBQ  ;B11,%]-%@*RKA&85U/. #7##"8
M1A6*>)[8VJ.!5(:9!HSWWDKX#=)N7O:WJW<TV[)JAG)/)[2S$/S)+*'DF159
MFBDZ<"3=41!^F&,[1R]H5/VN(ZVW<24MZO6MMDVKV"7<JVXUA=C-5[\G-4L=
M5;4RTJU@N8%F,;//.8I56(1E22(<)9)&,-)XJT9$I*$%G5XV?N=&H=MEFIPL
MS5"UJ-?.DITK)J,TVD9X6+\M:^&!8Y5;2:HHKJ**@PC2D21L2W(D/3>IBX0L
ML5J95LJL,D052SJEAY8N9/:'AOL^TP<.)N^[P;M'N\4-"U&T- 0A"8>G<#6+
M$-JXD%@I6961(IC'#,\BRS*C(W8B 2+:#8D:LK2EN\CY0V''9+!B#!X6-<^[
M3&,DFW/8E90%OF,48KTK.9>Y731R5IL S6Z54"6YU/79).1)5)BD(7F2?KJ<
M5(6E$E<+(LRQAHI5*V%>-W..C>V[BC;MUVT58=@<1P6IYHO8_9>E'<KN+%AD
MAVR(R"98X9#.XYQ8:9)1(A23K%*7G,I4T%4GWL,&$<4)>'%B#7F5_P"L-2\'
MYUAJ>XEG%)/B%6JES==8-% SNYJVL==FICNP3A4SR]7XA60.JQPAQ*5C!3/M
M22UY%4]262-XFD:"HT9E$R+>".+A+8;%GJ1<007+U>/H1=)*!$L4_P 9W(OQ
M2Q21Q()B\0#S"I7,9"2R"&00,%M%B&-"&Z60Z0E":98CXL*5P7++!8X85:^T
MV7#U3A.STL(,J]O!8(( L5]SI8B:GS,RJ_&&#SB$.>5F,9$$J1AFK%Y):T!B
ME$L<D+Y0P.KK+$R+-=2)Q0XLV."<3U>'5HWY8NE**<-#VB6"#J1HRMM\(#PB
M&2 JAFBZ<T3PF M;68UC(UQLMDTIY19>\5RP7I&=8Q%L32!A4]5]>=JW55.E
MUF,JIY[MDJDAK9LCAF"+]NM\:V%%)PJK_P!9"@255C;DK%S"T<IDGBFBM*O*
MMQ(X(G3J!84<M%'B&2]V]!PKM&U[=+57?XY39"/<6**HHAGAM*T4$T&Y1D].
MV3"1(K1@"4,T3"$RN#@ASF6ZK-55REE#S.4Y;$BOA(& 2D%'!-&6"B9I8J^Y
M4(PW$1Y^41*HG5N#8@_KQ-:;7>2A=(R[3-F-^FW*)VGCZTLIPLDT4C31RS&)
MT5I01T3$V!)'%CW3:J?$T>S;FFXP[4+5!:T%*RD1+Q17;<92HG7JF5XIC-"L
M<2&.5$A*M"6:)*AH+(/-E;A15#\5R75'OHP3%CFN(=-]7$J_ZQHQEC4I@IVF
MX=47VZL6=BL$TPV<H0(7A/.J[5W![AI\2".0LLD),>0$ZB(8LO,XB#66KVZZ
M.[=))R(DM29=WXAK;1;I[9=VP;J*E2GSWKG0:?[965'GK)8J3$2DCJ32):17
MLI+"75HUM+2X8P'PPR-$P0P5^T:9R(<RE/3F*1+:3],()A%.,8KV=+I7 JX)
M5-?=()"H9&Q%KAHJQQT@*[!H7:202=:#!98Q')S]!0K,L@976*7DRTQJ\J(W
M)T6F:*J][/#D-GB'ZI1[Y%'8>>#</8QTWW'G7I3%TC]JCF2%PJR+)) IA25$
MZ,H0+)/'&+VD;"PO:TB'5L1R6#)>"A-ULJ[>2/X2MC)1Y-0C[HNB^F().6TA
M19(W0P,*_7;5>97K+"*4E2".25G298H96D1HF8/R1(!R<Z5)LJ%62W+7,$@$
MA(963,G%%;ZY3MS;5&L\6XG;(-U)@>X&$[UX2&]D2PE*5VC"Q+>98XI))0[
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M(Z]Q0+]4V$ U'EOK[5+C</G&@A%M:T1[6(=B8:%'M"MDS0/LYK7)UT%A80:
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M:[;=2TTMF^E,(1G.9MC4.&(DA+53NR86;3*QT.H4FZ.&3(J80RO$<A$DEKL
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M,..#N-?6V1K,?2K+2!PI-+K/,UC%^[CI034AK#+7$6^VKBNE"2+$R.N6*ND
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MIKH8*6RELY!%>AL0C.$038$8>%S(JT7"KY#1)4TI13O<%I(W,8G[X)B8@I)
M8UVO)W9IBT*NL8A4S=%HV9^=L0K*9':.+[:%6$,J11Q@%2@8,7/4V--I2BWU
M%DGEJ-9E:1[1!M"STH%>.<+##&K+"D!"PJT.&YDD<LQUO)YR-=C3QIIXTT\:
M:U.K7&>S4C)],I73J<AY<7T^\=(A*DHT[CH8R_H%RL'1K#S_ #*T<D5,A61<
M;,U@TM&ZC1M!2Y=$ JV"P10W2/M37Z-DI8L5)Y+:4ZE4@65CK,]."&K%8PD0
MF5O9X$^UA^7K_;"Q3,1^-I[#O>W)-0H[M2@VJ3>-SW1&;;FFW&.'=;]K=;.W
M%I;+5)(_;[<R+9,"RB@175%L*+FM:.;>@ESHK=)8"KM1V#"O,/7U@&O%4V^!
M&25Q@GIP38B!4=8F"2H!V%%THJ5!5:$AK52J+!4($,I-&F*/FZ]KB>*Q#) L
M$Z)*FZQL_/7$@CW 4FC0M'"DL[0RTD:6>S--/85BK.H[:^1VKX,K6WV:UI]Q
MIRM4?A:6&%8;BP=;AX[Q'.ZPO9EKU(K4&[N*U+;J].C2>",QUV)=VK"'T*;T
M_3BY]:L///M#CO*_7"H[5YG3"<TJ^V_BB#N-;?O;0N ,%FP/8(>SR6.OF?,.
M:(;A6$[@K5GB/,6:3<3K8.Y"2&R!N-[=[(E6P/:*L.XS[;8BB@=D90T/U/,$
MA"H)(+$J#E!QJU+X,I:!X;EAO4&DX?V/A+;FK2T&:CN=[AVGQ)2M6[L*2QEQ
M;7B%K==FYY8+]*O8<R%<:FZ]Z,V:M$((AK7S)@#M?>4]%L)Q'.C0GM68\ZZJ
MXZ235>.$0V(N"ETB:!X37:JG)P?M4E6C$721G'8Y]E6.3B**7G)@M*15O5(T
M%I3'.MJFM19KXZ*FQ."HFF<<O5?E^YY!G9K?!U/5]F5+>T2(-SV/=)W;:#'/
M3?:=XGW5Z>QO'9QM]%A.:M.$B0U(C8^-(;3&.N>N'IK;/7%':]*W=*\=;OP.
M)N54JQF3=1:Q3G5>-U,AMML3VSHEI2@Q;LV AQ-7J:H& (C>P;A.I!'FBQ=3
M=N((]WD@Z]=Q7%Y[<T*I0B8)*4$D$4M6E6=R44KUIRS'XA92R<QV>%> I^$J
MUWV"]%)N#['!M%2W8GWNU&\U03M6N6JVX;M>KPH)I%D:I1BB5&:STYA',L45
M,E]!]*N(D7<UOQNZ<6G<S1V9#U,RQ]"26QQQ/J=1ZES8@L!@XQ@!-(8)T5/8
MUP,D>)L7V)U!].4AB".L>)6L&1KE6,.UFW-#+22&K) FX4YJ=M59(AS.%-5H
M6(^+[*$.!*Q&!?@TCH+6BVG<IFJIMVTU+E/>9;>Z5KTW#^[4MVVF1HI[#+##
MS)N<%J*,#G^J*V,N]5$>M0>G=EGNZJV-&W*X R9^=,+2@JM VK*GZS1>X]3Z
MQ.L4+Q29A30'ROJAJ5TR<:?:CMZDQ9VF)97Y@8&/ZO(()8%6[]S;2&26WUGQ
M9V^G261W*(RNC4U95C/(D4G10<L8+[(X$L-N$-R2QLZQ&7;)K-6GM0I0EJ'$
M&];R\<4<<KJR6(=Y>"=Y@\D]J VY3FQ(B8_/^3W>2UVNP2])'M%BJUG?0K9;
M"3T)&OGYH-057*^95HMG1;M7K-LYI-.KJ\QJ;,Q,56I[:>G22JUFUPB8*=N/
MBE8Y)2E3HQRPQ\W(*D[BVUF2W<G5;=2>$)8FF=43I\\,<%,=5^@0_+F^"^2:
M"OU]V-VS6NV6C:>3=JB':TVR'9]HIM-M>Z4[9EH4ZL;SR&9J]VQ=W:1JL1N@
MQ>A7,J5#S?G5#Y\.5]>'H],JU/@,^+/;ZU#640"2,G&7;>P./FSZ ZRZX:OG
M;'77?&IC9B1B0N;Y:U.UJU9LN,-9L33L,(,--(TA&(TCC&.;'Q(T7M\5%&%'
MI^U4$VK:]MVR-B\>W4*=!'+3,62I7CKJW-8GLV#S",',]B>4Y^V32OEVOCS!
MK?T\::TO]!_\7TS_ #^>UW^L]UOST3X4OXV#^3?!G]4=DUY;\#G\2$_E-QQ_
M7/?=;H>>=Z]2UIE[L0K]Z!42CV&ZV1=>(C5T\:MN\WD-Q6+,+./ G3-@2V9<
MJ8IO]5"T6N=IY-?AC["UUWLR?K[-S>T6%"\ZO5Y9!U(H<(+$#@]65&2,"9(<
MMS1GN%'59E@EU;]>I;V^Y6O6%J598XA+:>6*$0&.S#-#)SSXBR;$<2!69>IS
MF)2&D!'F7F"8V$<N<U5*,UWA0N0-JO,9"O*BVRU 6%8OBH:$@EH<%L57VA5+
MUB.!6V%&*1$I<M0[C]%GI\Y7FYD E23J@ KCD9PM68E!").25%M&19)8))$#
MQ)T>%"(^%]@MWMELIO8MVZD=B>0%:D,0BL+)(:U2X9(V3K0QV(Y;7,G6@::'
M"87F;(*Z7 \6%P#54/B .$.L-_J[<)V7DHB%FOI*TT=6Q7RKM#2;7I6\2[:-
M%:$Z%LI.JP_.)&94Y\Y5I#\9IXBR-%&H!B>Y-&\L3K((U@%C(>-I4="DR6\9
MLT.*.'X9MXLP[,U6]+%!81X^A+,M:$R&O6GE1YHG22+K11S-T)81,'2,M$T6
M9?";+NMF+"<+W(^EH#DWIZV#)6\V"JFP7P:6<9XU&*2"(!87VT4:1[6GK@\!
M7LGDTV>V>.=HE5T4H4+0%S.[ 8;VF-R]=X5/5:5FB7FE@E2,,W4+<D3<KDW"
MFT;76VY*^X49WLRO>N\UBN\G5CL)' M2PE6-)$FE=.>2RLB<\J?;.H4A:L!L
MR;R#&+ V9!DPEB'AJUKQ7X&@,.J89^)/6$K517QYAQ:]H[I(WU=>A&T8LZWL
MH2" U(>2C-R,W-@HK0EK,#S/'(S2&(I8EAEE8SO/T;1+]4,D<JM*_6&3<ZFS
M<0Q[/N6X[F-ENV]OB"5IIH)3)![5:("I9G@>&-IFL^SVY6,<D731T>;GE>+]
MD[?69@MITK&>N$:[C_:U/K,X<XS</[7E)919&+;!)FD=@<; 15FW![*02P<Q
M61I<*LNMHD<_3Y>7GC21"GQ+$Z2DQGH\J2+)&C2ITHQ(T]:4RRJ6,,=><PF-
M[XBM</7Z.W)M\4]&K3I+!-:Z_MMH1UXX)GKV%DZ,<T<L1A)%5F::#J2*T<O2
M$%9E;<,ZKA&VBU3<(932\,ZL\P2C(N&"#W%3'884**8^- 8NXTBUAI,G@UD@
M<JST)S:O!P7:75JY#'XSU^4<J3P\L@K!52;!G>W K+'U7BY)'0%9$F2!\5MF
M[L&R6N(.L=W,5\6(IYMK26LMF2S7Z;$Q3&<RUI9.0RO7,,]A0'FB98@PA@RD
MAFBF7&R*U$L9X18]J63**\.4H^N1F@.5H=F)K,M@TL2#=NX7:;V7[8'-FQ&@
M-0A*@*PMJEASI*E6%WS&RBLX>8LX5^>&2:$V#7:&8+'(RQHF.\Z2F0R--$'%
M-P\5?4B6A  VXO0KO$L_MXB$K)7GF)LRI-7=%BFG6)4A, ,T1!&7FY92YQ&!
M([49J0C'P[!VDK=WJ#-\8GEU90'9#+U!-18!VA&8-UM:=N7Q7T#=,D<5R'=3
M>L4545HPRLJ.3"56:"Q%"LJ-&4,T1DZP<*5CDGAAC5C%)+'*R/7;'LFQ[-3W
M*6_M>[)N<E.O;:';:\U21@LU6>N(7M13S"U&[2QPQSK#%769HC,7;":@[#J@
M-!(9]4L4-A,"B%L@=%J8Y2PX0R&VQD9#H=;0[L:ZY:(0ETP*0<=PJG9@8KYA
M2/!E"LT\\DW/\9V:%6+1&Y/@@K[(>9KDUH0SHDTC))(QB(1^LAD<6(-?:.(C
MQ -VV[=:]:K%)M]FQ9MUB]<1X,<1-Q[L\X1E:?KK8E/,TX$<X<3*\$3?:4@8
M=KJ<ND^FVEKS0*=*Y'W4UNQCXDF9L%5L"#!.PV=)T]=&B>)&J%.Q9!&!PN;7
M O:T* "G.OQBPY94;J* \D)(6-7K2-(#%#8FGEZ<]>62.-US#$[+8R4:M7AW
M;-VW;9=P7?)EB@3*\B5X0EI!)UHJ=N2P&B@DEF8F>N[0QO(JI6DDYF=PE&\H
M&N@"TZ&(AW$2LI\>LKF"?4-5.H:K:.H%VA*)V!4[+&D*?*<:%8P-U$4,\VLC
MH\ M,I=G9D$BQ_\ 6 (HY K,)(GN2N9"BO-U(.JLC]2,!G01"MBAO5.*-AL1
M[O)7VB.C>JB&U"_)5,\D%TQB."U9(DD6/KF>M%,#*)(Y4,3L3'VV@)GF$QDY
M0:"\SC)7T=<'9C"V&FRP$A*HEW04[ 6!F-I8CFI.3Z@K:VBJ_=DPZ#1;HPKB
M:P;I1GE!5T<]WF<!DL*$9PU.6,F)^@D:!+<D4,_M"*W7*ROFL3#A7AZ'ZE20
M;M7NW9)9K=E.:H%EA@C'3BJ6B@5I*A"B2S,(+,,JN3,4;7I%Z0D:[4>X*X@1
M 8:Y;1446BX8@-?)I%5D;'3>,39F2%"7I$RB'82B+@BV)<,C9Z<^>GL&DGSN
M\GFL12EW;KPF4%V#-CK2(2&(+%"R,T8+%(U80QJL<:@]O;MQ?==OJ7WA$#3Q
MN#&H(BYHII(G> ,21 [HS(I9NF>:'G?I\[;M><?6YIXTT\::M:VT:DW]=$GO
M=/J]U40%1G0JK;7U-C6Q&Q1RQ1&1@N!#!="HHYIHXR-8L3::2R:Z[XUWVQG-
M!8L5G,E:Q/6D*E#)!+)"Y4X)4M&RDJ2 2"2,@'';6E>VW;MTA6ON="EN,"N)
M%@O58+<*R*"JR".Q'(@=59E#@!@&8 X)U2R^6<R/;J[ =SRCF/D@BL!*\+J:
M EPG 1G1,T@*IG,OW.7!IV4$#!4,)/# O.AA+$TA(BTDUN+EQ8WA6Y:6*5G:
M6-9Y5CD>12DCN@;E9I$9D=F!+*S*V0<:Q/LVT26(+;[5MKVJT<,5>R]&JT\$
M5:19:\4,S1&2*."55DA1&58I%#H%8 ZC+N9\Y4"[!*:%3%84A:IA(&NJZ,$7
M<]%8"K:C.W'%!BBV,36HXVRJBLZ?3KK 64Y#DA9$2D[P]NW(09+5ER%= 6GE
M8A)(5KR*"6R%D@18) .SPJL39C4*)AVC::Z&.OM>W01EX)3'#1K1QF2K:>]6
MD*)$%+U[TDER!B.:&U(]B,K,[.9'7D')]5ED2Z<RY]HGN)NK*W*=:96]5EI8
MZ$8+T/L8&%OU1Z;H5C!6I;6$N?4C&)\28E_P_+>W7>>&4W;9DKKR02&S,7@7
M'+RPN7YHUY<+A"HY0!X&L8V+9!#;KC9]J%?<)!+?@&W5!#=E#]026XA#T[$@
M?XX>978/\8'/?4:'E'+QS:XR@YQ0X&-.U(TJ+"&H5Z(ZJZ%SD%%Z5LN-=J0B
MU*)+*((U5R"XFG)(FDQM)-)MM!NW669&N6F6Q@V%-B4K.5Y0#,.?$N J@<X;
M 4#P!JR[+LZ25)4VG;4EH!Q1E6C562D)&=Y!4<1!JP=I)&?HE.9G=CDL2:W/
M3JF2#9%A%90$+KEN3O;P)TZ^8.U;FJA41FUD&D'VA>[%I 0DQ.S30O:=4&*O
MESN(/%#IC$\ZM XGF#UL>S.)7#U^5VE7H,"#$%E=I5"<H$C&0#G);6RU&D\=
MN%Z=5XKY<WHGKPM'=,D*5Y#;C9"EGJ01I _6#\\*+$V44**%+R7EDTEAFEYM
M099K;.N*M<LE/KV\EF)3F1,%!%AWW7;;.IU1\$!RV5EDF0$R"$H7:*>/63&0
M7;JB(+<M 0*ZPXGE'2$B\D@B^-]K$BDJX3 =20P(.M9MEV9C:+;3MC&\T3WB
MU"J3<>!Q) ]HF+-AH9 )(FFYS&X#(0P!U7 Z;4ETRXE=6*^ 2H4'(%) 29:+
M.L1,R@C621=- -'($H8&K5QART;:((LI>$01!),+!O'C:>=^8/-*X=UE<-([
M!Y5#*LC@L0TBJS*KMEE#, 0&.=F.C2B:)XJ=6)X():T+QUX4:&M,\<DU>)E0
M&."62**22)<1R/'&[J612(=3HU*H01*RC5"L4U::;(R,7U5 IKH13&6.*&4\
MD10('!.;+%##%(5+'O/O'#%IM)G6/3&)FLV++*UFQ/8=%"*\\KRLJ DA%9V8
MJ@R<*,*/0:I2VW;MLC>';:%+;XI)&FDBI58*D<DK !I72".-6D8 !G8%B  3
MV&KI\PZW=/&FGC33QIJ38YVPO/SKC;;; 96===?IL[9VQ!O\,:X'BG(SMG/P
MQCZ"":;X_#Z**3?YNF7R'U[?3\Y&?FR/GU(\CQY'GN//RX'T]M>!8HA X\59
M3N4A6J9:'$H)!?V2&VF[I (2A5Z "&F[FG74/48/:(1?%)8!2IH<3U0?H 9_
M+@_NV ,AG=9,R2LTBO'%T!UY.5FG<V0$J.SMEI.6-TYHUGZ(2_)\_5X8K?7)
M]4H=XC+)N!W"6C&L4EN'K6'>6"SBU\2K(KRUWL2QQO)&7C:(*W4>$,K#+&WW
M-@K0RNQC#+]"*[K8%*:M?>.2$6!W7U[B[-Z6O6"DF#[%:?4ZZI*K>[*)K8$X
M!3-IM59&!  E>2/F)ZG0>Q,(BS213R)22T\S(L@R6F=)@F8)"H4:^U<1T-SW
MB2G)L<%.S;2[![:HK'< 5K3O+'=F]CAL&62)95:02%UD*QM%,APLQDP@C&6<
MOW*9!)2X<F+?KECL&C1;:Y"J,,:SK)U303_="4A_$R*:.Y@58I*F%2QG6V-S
M2='8)R94/85I8RH=8XXC')7"W&5;$5BP$L*(BB1Q(S\DW5 >%;"!M&QQ[ =R
MW>ON:;M%7H7(Q6H)$HG$<26Q%:FBLW%@F45PQ@C69T.)5D:)7B>7U##7[Q:L
MRD*TR*4AD@<FL;4./]J:Q:K2*NQ@=/;JRU0-$QDTRS[NZ3SHGRJ$G[L6*1KB
M93/,75UC5RK +)'&E<GHIRR"9'A@IHTD<B 2]?(D@E91/"B'EC;+VV\1[?O&
MUC;:6PEZT$\]NI!36OT([].1)9F$5'#13I75TFL=.=)YI(VKM&ROWWV/F^K%
M2QTZ31YDVLCC_6WSW([)6/'89LL-QX*9*OLR"4,T94G6.-G&J-LXN8Q@E;:5
MAC:6%CROV]\-'*_VN&%2C%HEQS^UQRUIB<2EH^F\J5Z[QF6.9X8K5X^%=BO6
MVF@X@AN6:0]GB"':URUF,S-(XN1SQ2J8$D<Q)BTE2 JQ3,?7$H*S @.)D0CU
M(OVQ)H:?99";6@=D":?:V)")KW;"'U:AII6[,#,#$.Q?6LD*6$-F:I*25.&D
M#,H=8Y) 252LL=>6(280\B4:PAL&W&$<*DD7*5DCEBC>TM2NW\4["I5J7#OL
M.X+S#IUH-L-EJH5^4(*48-A9%,>%EL0=%HRLT3&98I"\J?$BV7-8V.81B6O)
MRID_;Q"P%SR(]1$MBK5@HK4S;>>G#2NVRN;-;/#.W0KRG&^Y[C%>98N0@3NH
MYX!',D,0YH@DPYJ]F"XBX2TW062-9XW1IF"#D@%KT\7"NS[90FJ5]^2>>T1)
M?AB%.+EZ$W+#!+'<'QO:6DA8LCQ,7EY2LO(.L!@<!!GV++4%A4948CM*>^8)
M]%;F&'>35MLURM?Q_8CY5L$RW+<DAGHV<3,![]8F95AI<9,;R!&?KLI1A$ZQ
MB8.@E*M&D7/ QEADZR@0H4ECZ3Q1PQQR) W3:J/$E?9=RBO5]G6>E[-!2M+
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MV=7DKQDF):5H)AI*96.'KR!)(;1E9I^:*#TE])V4QU-N890"T0M';XEA)"<
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M;]B'A7:-LV^U37?DEDM$/=2".HBQ-%*.6*Q%N,)!6Z15))Z:AY58K*(X>LK
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M#Q,L*&^K_50"$54=6TF5C]+/'-B&<)).*/D6(C?ZW-#]+II#])+I(&0QS]R
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MEAG:.>-4+!(S ?NH8GL".:5TY%L-GV.QPR-UW*U/6O;?'MMY7JTQ.RW.DJ3
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MU#,^-!COI]*\UTIBJ9Z\V4L4+]20A3:YT< #*I2##8%KX4>:KM\V!:"F3"6
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MF:QOFR9S+IH>5A7K$G5PUZOVD8]L0]J-3@84(^;) +QD=1:Y<N>H(G"BR%@
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M>A$)8YY98U400P31I#9CG@'(C6\1,)7VL<MHKRNS"44;"&TPD%WE&YMN:>/
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MC.K%59&C=$DC?EYXY426)^4Y7FCD5D;E;#+D?%8 CN!B?7]DLJD4<!4BI*L
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M,#?3(PV\\69MAQ\QP?32XFQ'B=>CE4;$ENU,O)+8GD7*L0\KMEE!"LW,QYF
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M]7A4^O=1AHR+ME^'H4O+K/SB?H\]<J0C?6[T8(BMCVU(KU>G65DBZ>04MDE
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MW.'UY)Q5:;<+ <!<@K"$FY]" MN,0:B)K3[I]KFJY2"YE 3*&09D?H]/W/\
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M+&1MH%6G(^)B(_K7S2"?F+?B7/M]<GQ+,3F60C7Z#6?:3 87U8UJT^.>S.^
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ML/\ S,?_ '?&FGU03_BP_P#,Q_\ =\::?5!/^+#_ ,S'_P!WQII]4$_XL/\
;S,?_ '?&FGU03_BP_P#,Q_\ =\::F/&FO__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487438886872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-4/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentDescription', window );">AmendmentDescription</a></td>
<td class="text">Amendment No. 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Kensington Capital Acquisition Corp.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001811414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487435216888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED BALANCE SHEET - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th" colspan="2"><div>May 01, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 1,739,697<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">237,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,977,494<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Cash held in Trust Account</a></td>
<td class="nump">230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCosts', window );">Deferred offering costs associated with the proposed public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">231,977,494<span></span>
</td>
<td class="nump">86,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">255,675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">117,000<span></span>
</td>
<td class="nump">64,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent', window );">Franchise tax payable</a></td>
<td class="nump">40,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Note payable - related party</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">488,223<span></span>
</td>
<td class="nump">64,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_DeferredUnderwritingCommissionsNoncurrent', window );">Deferred underwriting commissions</a></td>
<td class="nump">8,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">8,538,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Class A common stock, par value $0.0001 per share; 21,843,927 shares subject to possible redemption at $10.00 per share</a></td>
<td class="nump">218,439,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.0001 per share; 1,000,000 shares authorized; none issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">5,062,172<span></span>
</td>
<td class="nump">24,425<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(62,862)<span></span>
</td>
<td class="num">(2,500)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">5,000,001<span></span>
</td>
<td class="nump">22,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">231,977,494<span></span>
</td>
<td class="nump">86,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares value</a></td>
<td class="nump">116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares value</a></td>
<td class="nump">575<span></span>
</td>
<td class="nump">575<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">$ 575<span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On June 25, 2020, the Company effected a stock dividend with respect to the Class B common stock, resulting in the sponsor holding an aggregate of 5,750,000 founder shares . All shares and associated amounts have been retroactively restated to reflect the share capitalization (see Note 4).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">This number includes up to 750,000 Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_DeferredUnderwritingCommissionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred underwriting commissions noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_DeferredUnderwritingCommissionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6419918&amp;loc=d3e35281-107843<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487435176568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED BALANCE SHEET (Parenthetical)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary equity, redemption price per share | $ / shares</a></td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares subject to possible redemption</a></td>
<td class="nump">21,843,927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Temporary equity, redemption price per share | $ / shares</a></td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued</a></td>
<td class="nump">1,156,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="nump">1,156,073<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued</a></td>
<td class="nump">5,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="nump">5,750,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487513710136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED STATEMENT OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">2 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>May 01, 2020</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 22,314<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FranchisorCosts', window );">Franchise tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">40,548<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (2,500)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (62,862)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average shares outstanding, basic and diluted</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">5,031,247<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per share</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On June 25, 2020, the Company effected a stock dividend with respect to the Class B common stock, resulting in the sponsor holding an aggregate of 5,750,000 founder shares . All shares and associated amounts have been retroactively restated to reflect the share capitalization (see Note 4).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">This number excludes an aggregate of up to 750,000 Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">This number excludes an aggregate of up to 21,843,927 shares of Class A common stock subject to possible redemption.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FranchisorCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate costs incurred that are directly related to activities, including but not limited to, generating franchise revenues from franchisor owned outlets and franchised outlets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FranchisorCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487433299464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED STATEMENT OF OPERATIONS (Parenthetical) - shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,156,073<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation', window );">Weighted average number of common stock subject to possible forfeitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,843,927<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Over-Allotment Units | Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation', window );">Weighted average number of common stock subject to possible forfeitures</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487430126600">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Sponsor</div></th>
<th class="th">
<div>Private Placement Warrants </div>
<div>Sponsor</div>
</th>
<th class="th"><div>Initial Public Offering</div></th>
<th class="th"><div>Class A Common Stock</div></th>
<th class="th">
<div>Class A Common Stock </div>
<div>Initial Public Offering</div>
</th>
<th class="th"><div>Class B Common Stock</div></th>
<th class="th">
<div>Class B Common Stock </div>
<div>Sponsor</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Sponsor</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Private Placement Warrants </div>
<div>Sponsor</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Initial Public Offering</div>
</th>
<th class="th"><div>Retained Earnings</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Apr. 16, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, Shares at Apr. 16, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock to Sponsor, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,031,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Shares at Apr. 17, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Apr. 16, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, Shares at Apr. 16, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock to Sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock to Sponsor, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,500)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at May. 01, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">22,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,500)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Shares at May. 01, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Apr. 16, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, Shares at Apr. 16, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock to Sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock to Sponsor, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of units in initial public offering, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 229,997,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of units in initial public offering, gross, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Offering costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(13,097,867)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,097,867)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Sale of private placement warrants to Sponsor in private placement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,575,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,575,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_ValueOfSharesSubjectToPossibleRedemption', window );">Common stock subject to possible redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(218,439,270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(218,437,086)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_NumberOfSharesSubjectToPossibleRedemption', window );">Common stock subject to possible, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,843,927)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(62,862)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(62,862)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,062,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (62,862)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Shares at Jun. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,156,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="14"></td></tr>
<tr><td colspan="14"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On June 25, 2020, the Company effected a stock dividend with respect to the Class B common stock, resulting in the sponsor holding an aggregate of 5,750,000 founder shares . All shares and associated amounts have been retroactively restated to reflect the share capitalization (see Note 4).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">This number includes up to 750,000 Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_NumberOfSharesSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_NumberOfSharesSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_ValueOfSharesSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_ValueOfSharesSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109126253&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487430050872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED STATEMENT OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="num">$ (62,862)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,297)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="num">(207,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPropertyAndOtherTaxesPayable', window );">Franchise tax payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,548<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,611)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Cash deposited in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(230,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(230,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of Class B common stock to Sponsor</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds received from note payable to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds received from initial public offering, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds received from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,575,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering costs paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,907,692)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">231,767,308<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">1,739,697<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash - end of the period</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">1,739,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of noncash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_NonCashOfferingCostsIncludedInAccruedExpenses', window );">Offering costs included in accrued expenses</a></td>
<td class="nump">$ 61,500<span></span>
</td>
<td class="nump">117,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_NonCashOfferingCostsIncludedInAccountsPayable', window );">Offering costs included in accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering', window );">Deferred underwriting commissions in connection with the initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,050,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Initial value of common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218,439,270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_NonCashPrepaidExpensesIncludedInAccruedExpenses', window );">Prepaid expenses included in accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_NonCashPrepaidExpensesIncludedInAccountsPayable', window );">Prepaid expenses included in accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non cash Deferred underwriting commissions in connection with the initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_NonCashDeferredUnderwritingCommissionsInConnectionWithInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_NonCashOfferingCostsIncludedInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non cash Offering costs included in accounts payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_NonCashOfferingCostsIncludedInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_NonCashOfferingCostsIncludedInAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non cash Offering costs included in accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_NonCashOfferingCostsIncludedInAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_NonCashPrepaidExpensesIncludedInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non cash Prepaid expenses included in accounts payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_NonCashPrepaidExpensesIncludedInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_NonCashPrepaidExpensesIncludedInAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non cash prepaid expenses included in accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_NonCashPrepaidExpensesIncludedInAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPropertyAndOtherTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount of cash payments due to taxing authorities for non-income-related taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPropertyAndOtherTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487437092920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization, Business Operations and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of Organization, Business Operations and Basis of Presentation</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt">
 <b>Note 1&#x2014;Description of Organization, Business Operations
 and Basis of Presentation</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 Kensington Capital Acquisition Corp. (the &#x201C;Company&#x201D;)
 was incorporated in Delaware on April&#xA0;17, 2020. The Company
 was formed for the purpose of effecting a merger, capital stock
 exchange, asset acquisition, stock purchase, reorganization or
 similar business combination with one or more businesses
 (the&#xA0;&#x201C;Business Combination&#x201D;). Although the Company
 is not limited to a particular industry or sector for purposes of
 consummating a Business Combination, the Company intends to focus
 its search for a target business in the automotive and
 automotive-related sector. The Company is an emerging growth
 company and, as such, the Company is subject to all of the risks
 associated with emerging growth companies.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 As of May&#xA0;1, 2020, the Company had not commenced any
 operations. All activity for the period from April&#xA0;17, 2020
 (inception) through May&#xA0;1, 2020 relates to the Company&#x2019;s
 formation and the proposed initial public offering described below.
 The Company will not generate any operating revenues until after
 the completion of its initial Business Combination, at the
 earliest. The Company will <font style="WHITE-SPACE: nowrap">generate&#xA0;non-operating&#xA0;income&#xA0;in</font>
 the form of interest income on cash and cash equivalents from the
 proceeds derived from the Proposed Public Offering (as&#xA0;defined
 below). The Company has selected December&#xA0;31 as its fiscal
 year end.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Company&#x2019;s sponsor is Kensington Capital Sponsor LLC, a
 Delaware limited liability company (the &#x201C;Sponsor&#x201D;). The
 Company&#x2019;s ability to commence operations is contingent upon
 obtaining adequate financial resources through a proposed public
 offering (the &#x201C;Proposed Public Offering&#x201D;) of 20,000,000
 units (each, a &#x201C;Unit&#x201D; and collectively, the
 &#x201C;Units&#x201D;) at $10.00 per Unit (or 23,000,000 units if the
 underwriters&#x2019; over-allotment&#xA0;option is exercised in
 full), which is discussed in Note&#xA0;3, and the sale of 5,975,000
 warrants (or 6,575,000 warrants if the underwriters&#x2019;
 over-allotment&#xA0;option is exercised in full) (each, a
 &#x201C;Private Placement Warrant&#x201D; and collectively, the
 &#x201C;Private Placement Warrants&#x201D;), at a price of $1.00 per
 Private Placement Warrant in a private placement to the Sponsor
 that will close simultaneously with the Proposed Public
 Offering.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Company&#x2019;s management has broad discretion with respect to
 the specific application of the net proceeds of the Proposed Public
 Offering and the sale of the Private Placement Warrants, although
 substantially all of the net proceeds are intended to be applied
 generally toward consummating a Business Combination. There is no
 assurance that the Company will be able to complete a Business
 Combination successfully. The Company must complete an initial
 Business Combination with one or more operating businesses or
 assets with a fair market value equal to at least 80% of the net
 assets held in the Trust Account (as defined below) (net of amounts
 disbursed to management for working capital purposes, if permitted,
 and excluding the amount of any deferred underwriting discount).
 However, the Company will only complete a Business Combination if
 the post-transaction&#xA0;company owns or acquires 50% or more of
 the outstanding voting securities of the target or otherwise
 acquires a controlling interest in the target business sufficient
 for it not to be required to register as an investment company
 under the Investment Company Act 1940, as amended (the
 &#x201C;Investment Company Act&#x201D;). Upon the closing of the
 Proposed Public Offering, management has agreed that an amount
 equal to at least $10.00 per Unit sold in the Proposed Public
 Offering, including proceeds from the sale of the Private Placement
 Warrants to the Sponsor, will be held in a trust account
 (&#x201C;Trust Account&#x201D;) located in the United States with
 Continental Stock Transfer&#xA0;&amp; Trust Company acting as
 trustee, and invested only in U.S. &#x201C;government
 securities,&#x201D; within the meaning set forth in
 Section&#xA0;2(a)(16)&#xA0;of the Investment Company Act, with a
 maturity of 185 days or less, or in money market funds meeting
 certain conditions under <font style="WHITE-SPACE: nowrap">Rule&#xA0;2a-7&#xA0;under&#xA0;the</font>
 Investment Company Act, which invest only in direct U.S. government
 treasury obligations, as determined by the Company, until the
 earlier of: (i)&#xA0;the completion of a Business Combination and
 (ii)&#xA0;the distribution of the Trust Account as described
 below.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Company will provide holders of the Company&#x2019;s outstanding
 shares of Class&#xA0;A common stock, par value $0.0001 per share,
 sold in the Proposed Public Offering (the &#x201C;Public
 Stockholders&#x201D;) with the opportunity to redeem all or a
 portion of their Public Shares (as defined below) upon the
 completion of a Business Combination either
 (i)&#xA0;in&#xA0;connection with a stockholder meeting called to
 approve the Business Combination or (ii)&#xA0;by means of a tender
 offer. The decision as to whether the Company will seek stockholder
 approval of a Business Combination or conduct a tender offer will
 be made by the Company, solely in its discretion. The Public
 Stockholders will be entitled to redeem their Public Shares for a
 pro rata portion of the amount then held in the Trust Account
 (initially anticipated to be $10.00 per Public Share), calculated
 as of two business days prior to the initial Business Combination,
 including interest earned on the funds held in the trust account
 and not previously released to the Company to pay the
 Company&#x2019;s taxes, net of taxes payable. <font style="WHITE-SPACE: nowrap">The&#xA0;per-share&#xA0;amount&#xA0;to</font>
 be distributed to Public Stockholders who redeem their Public
 Shares will not be reduced by the deferred underwriting commissions
 the Company will pay to the underwriters (as discussed in Note 5).
 These Public Shares will be recorded at a redemption value and
 classified as temporary equity upon the completion of the Proposed
 Public Offering in accordance with the Financial Accounting
 Standards Board&#x2019;s (&#x201C;FASB&#x201D;) Accounting Standards
 Codification (&#x201C;ASC&#x201D;) Topic 480 &#x201C;Distinguishing
 Liabilities from Equity.&#x201D; The Company will proceed with a
 Business Combination if a majority of the shares voted are voted in
 favor of the Business Combination. The Company will not redeem the
 Public Shares in an amount that would cause its net tangible assets
 to be less than $5,000,001. If a stockholder vote is not required
 by applicable law or stock exchange rule and the Company does not
 decide to hold a stockholder vote for business or other reasons,
 the Company will, pursuant to its amended and restated certificate
 of incorporation (the &#x201C;Certificate of Incorporation&#x201D;),
 conduct the redemptions pursuant to the tender offer rules of the
 U.S. Securities and Exchange Commission (&#x201C;SEC&#x201D;) and
 file tender offer documents with the SEC prior to completing a
 Business Combination. If, however, stockholder approval of the
 transaction is required by applicable law or stock exchange rule,
 or the Company decides to obtain stockholder approval for business
 or reasons, the Company will offer to redeem shares in conjunction
 with a proxy solicitation pursuant to the proxy rules and not
 pursuant to the tender offer rules. Additionally, each Public
 Stockholder may elect to redeem their Public Shares without voting,
 and if they do vote, irrespective of whether they vote for or
 against the proposed transaction. If the Company seeks stockholder
 approval in connection with a Business Combination, the initial
 stockholders (as defined below) have agreed to vote any Founder
 Shares (as defined below in Note 4) and any Public Shares held by
 them in favor of a Business Combination. In addition, the initial
 stockholders have agreed to waive their redemption rights with
 respect to any Founder Shares and any Public Shares held by them in
 connection with the completion of a Business Combination.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Certificate of Incorporation will provide that a Public
 Stockholder, together with any affiliate of such stockholder or any
 other person with whom such stockholder is acting in concert or as
 a &#x201C;group&#x201D; (as defined under Section&#xA0;13 of the
 Securities Exchange Act of 1934, as amended (the &#x201C;Exchange
 Act&#x201D;)), will be restricted from redeeming its shares with
 respect to more than an aggregate of 15% or more of the Public
 Shares, without the prior consent of the Company.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Sponsor and the Company&#x2019;s officers and directors (the
 &#x201C;initial stockholders&#x201D;) have agreed, pursuant to a
 letter agreement with the Company, that they will not propose any
 amendment to the Certificate of Incorporation (A)&#xA0;to modify
 the substance or timing of the Company&#x2019;s obligation to allow
 redemption in connection with the initial Business Combination or
 to redeem 100% of the Public Shares if the Company does not
 complete a Business Combination within the Combination Period (as
 defined below) or (B)&#xA0;with respect to any other provision
 relating to stockholders&#x2019; rights <font style="WHITE-SPACE: nowrap">or&#xA0;pre-initial&#xA0;Business</font>
 Combination activity, unless the Company provides the Public
 Stockholders with the opportunity to redeem their Public Shares
 upon approval of any such amendment at a <font style="WHITE-SPACE: nowrap">per-share</font> price, payable in cash,
 equal to the aggregate amount then on deposit in the Trust Account,
 including interest (which interest shall be net of taxes payable)
 divided by the number of then outstanding Public Shares.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 If the Company is unable to complete a Business Combination within
 24&#xA0;months from the closing of the Proposed Public Offering (as
 such period may be extended pursuant to the Certificate of
 Incorporation, the &#x201C;Combination Period&#x201D;), the Company
 will (i)&#xA0;cease all operations except for the purpose of
 winding up, (ii)&#xA0;as promptly as reasonably possible but not
 more than ten business days thereafter, redeem the Public Shares,
 at <font style="WHITE-SPACE: nowrap">a&#xA0;per-share&#xA0;price,</font> payable
 in cash, equal to the aggregate amount then on deposit in the Trust
 Account including interest earned on the funds held in the Trust
 Account and not previously released to the Company to pay the
 Company&#x2019;s taxes, net of taxes payable (less up to $100,000 of
 interest to pay dissolution expenses), divided by the number of
 then outstanding Public Shares, which redemption will completely
 extinguish Public Stockholders&#x2019; rights as stockholders
 (including the right to receive further liquidating distributions,
 if any), and (iii)&#xA0;as promptly as reasonably possible
 following such redemption, subject to the approval of the
 Company&#x2019;s remaining stockholders and the Company&#x2019;s
 board of directors, dissolve and liquidate, subject in each case to
 the Company&#x2019;s obligations under Delaware law to provide for
 claims of creditors and the requirements of other applicable law.
 There will be no redemption rights or liquidating distributions
 with respect to the Company&#x2019;s warrants, which will expire
 worthless if the Company fails to complete its initial Business
 Combination within the Combination Period.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The initial stockholders have agreed to waive their rights to
 liquidating distributions from the Trust Account with respect to
 any Founder Shares held by them if the Company fails to complete a
 Business Combination within the Combination Period. However, if the
 initial stockholders acquire Public Shares in or after the Proposed
 Public Offering, they will be entitled to liquidating distributions
 from the Trust Account with respect to such Public Shares if the
 Company fails to complete a Business Combination within the
 Combination Period. The underwriters have agreed to waive their
 rights to the deferred underwriting commission (see Note 5) held in
 the Trust Account in the event the Company does not complete a
 Business Combination within in the Combination Period and, in such
 event, such amounts will be included with the other funds held in
 the Trust Account that will be available to fund the redemption of
 the Public Shares. In the event of such distribution, it is
 possible that the per share value of the residual assets remaining
 available for distribution (including Trust Account assets) will be
 only, or less than, $10.00. In order to protect the amounts held in
 the Trust Account, the Sponsor has agreed to be liable to the
 Company if and to the extent any claims by a third party (except
 for the Company&#x2019;s independent registered public accounting
 firm) for services rendered or products sold to the Company, or a
 prospective target business with which the Company has discussed
 entering into a transaction agreement (a &#x201C;Target&#x201D;),
 reduce the amount of funds in the Trust Account to below the lesser
 of (i) $10.00 per Public Share and (ii)&#xA0;the actual amount per
 Public Share held in the Trust Account as of the date of the
 liquidation of the Trust Account, if less than $10.00 per Public
 Share due to reductions in the value of the trust assets, less
 taxes payable, provided that such liability will not apply to any
 claims by a third party or Target that executed a waiver of any and
 all rights to the monies held in the Trust Account nor will it
 apply to any claims under the Company&#x2019;s indemnity of the
 underwriters of the Proposed Public Offering against certain
 liabilities, including liabilities under the Securities Act of
 1933, as amended (the &#x201C;Securities Act&#x201D;). Moreover, in
 the event that an executed waiver is deemed to be unenforceable
 against a third party, then the Sponsor will not be responsible to
 the extent of any liability for such third-party claims. The
 Company will seek to reduce the possibility that the Sponsor will
 have to indemnify the Trust Account due to claims of creditors by
 endeavoring to have all vendors, service providers, prospective
 target businesses and other entities with which the Company does
 business, execute agreements with the Company waiving any right,
 title, interest or claim of any kind in or to monies held in the
 Trust Account.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Going Concern Consideration</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 As of May&#xA0;1, 2020, the Company had $25,000 in cash and a
 working capital deficiency of $39,000. Further, the Company has
 incurred and expect to continue to incur significant costs in
 pursuit of its financing and acquisition plans. Management&#x2019;s
 plans to address this need for capital through the Proposed Public
 Offering. The Company cannot assure that its plans to raise capital
 or to consummate an initial Business Combination will be
 successful. These factors, among others, raise substantial doubt
 about the Company&#x2019;s ability to continue as a going concern.
 The financial statements do not include any adjustments that might
 result from its inability to consummate the Proposed Public
 Offering or its inability to continue as a going concern.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Basis of Presentation</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The accompanying financial statements are presented in U.S. dollars
 in conformity with accounting principles generally accepted in the
 United States of America (&#x201C;U.S. GAAP&#x201D;) and pursuant to
 the rules and regulations of the SEC.</p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 18px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt">
 <b>Emerging Growth Company</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company is an &#x201C;emerging growth company,&#x201D; as defined
 in Section&#xA0;2(a) of the Securities Act, as modified by the
 Jumpstart Our Business Startups Act of 2012 (the &#x201C;JOBS
 Act&#x201D;), and it may take advantage of certain exemptions from
 various reporting requirements that are applicable to other public
 companies that are not emerging growth companies including, but not
 limited to, not being required to comply with the independent
 registered public accounting firm attestation requirements of
 Section&#xA0;404 of the Sarbanes-Oxley Act, reduced disclosure
 obligations regarding executive compensation in its periodic
 reports and proxy statements, and exemptions from the requirements
 of holding a nonbinding advisory vote on executive compensation and
 stockholder approval of any golden parachute payments not
 previously approved.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 Further, Section&#xA0;102(b)(1) of the JOBS Act exempts emerging
 growth companies from being required to comply with new or revised
 financial accounting standards until private companies (that is,
 those that have not had a Securities Act registration statement
 declared effective or do not have a class of securities registered
 under the Exchange Act) are required to comply with the new or
 revised financial accounting standards. The JOBS Act provides that
 an emerging growth company can elect to opt out of the extended
 transition period and comply with the requirements that apply to
 <font style="WHITE-SPACE: nowrap">non-emerging</font> growth
 companies but any such an election to opt out is irrevocable. The
 Company has elected not to opt out of such extended transition
 period, which means that when a standard is issued or revised and
 it has different application dates for public or private companies,
 the Company, as an emerging growth company, can adopt the new or
 revised standard at the time private companies adopt the new or
 revised standard.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 This may make comparison of the Company&#x2019;s financial
 statements with another public company that is neither an emerging
 growth company nor an emerging growth company that has opted out of
 using the extended transition period difficult or impossible
 because of the potential differences in accounting standards
 used.</p>
 </div><span></span>
</td>
<td class="text"><div>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Note 1&#x2014;Description of Organization, Business Operations
 and Basis of Presentation</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 Kensington Capital Acquisition Corp. (the &#x201C;Company&#x201D;)
 was incorporated in Delaware on April&#xA0;17, 2020. The Company
 was formed for the purpose of effecting a merger, capital stock
 exchange, asset acquisition, stock purchase, reorganization or
 similar business combination with one or more businesses (the
 &#x201C;Business Combination&#x201D;). Although the Company is not
 limited to a particular industry or sector for purposes of
 consummating a Business Combination, the Company intends to focus
 its search for a target business in the automotive and
 automotive-related sector. The Company is an emerging growth
 company and, as such, the Company is subject to all of the risks
 associated with emerging growth companies.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 As of June&#xA0;30, 2020, the Company had not commenced any
 operations. All activity for the period from April&#xA0;17, 2020
 (inception) through June&#xA0;30, 2020 relates to the
 Company&#x2019;s formation and the initial public offering (the
 &#x201C;Initial Public Offering&#x201D;) described below. The Company
 will not generate any operating revenues until after the completion
 of its initial Business Combination, at the earliest. The Company
 will generate <font style="white-space:nowrap">non-operating</font>
 income in the form of interest income on cash and cash equivalents
 from the proceeds derived from the Initial Public Offering. The
 Company has selected December&#xA0;31 as its fiscal year end.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Company&#x2019;s sponsor is Kensington Capital Sponsor LLC, a
 Delaware limited liability company (the &#x201C;Sponsor&#x201D;). The
 registration statement for the Company&#x2019;s Initial Public
 Offering was declared effective on June&#xA0;25, 2020. On
 June&#xA0;30, 2020, the Company consummated its Initial Public
 Offering of 23,000,000 units (the &#x201C;Units&#x201D; and, with
 respect to the Class&#xA0;A common stock included in the Units
 sold, the &#x201C;Public Shares&#x201D;), including 3,000,000
 additional Units to cover over-allotments (the
 &#x201C;Over-Allotment Units&#x201D;), at $10.00 per Unit, generating
 gross proceeds of $230.0&#xA0;million, and incurring offering costs
 of approximately $13.1&#xA0;million, inclusive of approximately
 $8.1&#xA0;million in deferred underwriting commissions (Note
 5).</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 Simultaneously with the closing of the Initial Public Offering, the
 Company consummated the private placement (&#x201C;Private
 Placement&#x201D;) of 6,575,000 warrants (each, a &#x201C;Private
 Placement Warrant&#x201D; and collectively, the &#x201C;Private
 Placement Warrants&#x201D;) at a price of $1.00 per Private
 Placement Warrant to the Sponsor, generating proceeds of
 approximately $6.6&#xA0;million (Note 4).</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 Upon the closing of the Initial Public Offering and the Private
 Placement, $230.0&#xA0;million ($10.00 per Unit) of the net
 proceeds of the Initial Public Offering and certain of the proceeds
 of the Private Placement was held in a trust account (&#x201C;Trust
 Account&#x201D;) located in the United States with Continental Stock
 Transfer&#xA0;&amp; Trust Company acting as trustee, and invested
 only in U.S. &#x201C;government securities,&#x201D; within the
 meaning set forth in Section&#xA0;2(a)(16) of the Investment
 Company Act, with a maturity of 185 days or less, or in money
 market funds meeting certain conditions under Rule <font style="white-space:nowrap">2a-7</font> under the Investment Company Act,
 which invest only in direct U.S. government treasury obligations,
 as determined by the Company, until the earlier of: (i)&#xA0;the
 completion of a Business Combination and (ii)&#xA0;the distribution
 of the Trust Account as described below.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Company&#x2019;s management has broad discretion with respect to
 the specific application of the net proceeds of the Initial Public
 Offering and the sale of the Private Placement Warrants, although
 substantially all of the net proceeds are intended to be applied
 generally toward consummating a Business Combination. There is no
 assurance that the Company will be able to complete a Business
 Combination successfully. The Company must complete an initial
 Business Combination with one or more operating businesses or
 assets with a fair market value equal to at least 80% of the net
 assets held in the Trust Account (as defined below) (net of amounts
 disbursed to management for working capital purposes, if permitted,
 and excluding the amount of any deferred underwriting discount).
 However, the Company will only complete a Business Combination if
 the post-transaction company owns or acquires 50% or more of the
 outstanding voting securities of the target or otherwise acquires a
 controlling interest in the target business sufficient for it not
 to be required to register as an investment company under the
 Investment Company Act 1940, as amended (the &#x201C;Investment
 Company Act&#x201D;).</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Company will provide holders of the Company&#x2019;s outstanding
 shares of Class&#xA0;A common stock, par value $0.0001 per share,
 sold in the Initial Public Offering (the &#x201C;Public
 Stockholders&#x201D;) with the opportunity to redeem all or a
 portion of their Public Shares upon the completion of a Business
 Combination either (i)&#xA0;in connection with a stockholder
 meeting called to approve the Business Combination or (ii)&#xA0;by
 means of a tender offer. The decision as to whether the Company
 will seek stockholder approval of a Business Combination or conduct
 a tender offer will be made by the Company, solely in its
 discretion. The Public Stockholders will be entitled to redeem
 their Public Shares for a pro rata portion of the amount then held
 in the Trust Account (initially $10.00 per Public Share),
 calculated as of two business days prior to the initial Business
 Combination, including interest earned on the funds held in the
 trust account and not previously released to the Company to pay the
 Company&#x2019;s taxes, net of taxes payable. The <font style="white-space:nowrap">per-share</font> amount to be distributed to
 Public Stockholders who redeem their Public Shares will not be
 reduced by the deferred underwriting commissions the Company will
 pay to the underwriters (as discussed in Note 5). These Public
 Shares will be recorded at a redemption value and classified as
 temporary equity upon the completion of the Initial Public Offering
 in accordance with the Financial Accounting Standards Board&#x2019;s
 (&#x201C;FASB&#x201D;) Accounting Standards Codification
 (&#x201C;ASC&#x201D;) Topic 480 &#x201C;Distinguishing Liabilities
 from Equity.&#x201D; The Company will proceed with a Business
 Combination if a majority of the shares voted are voted in favor of
 the Business Combination. The Company will not redeem the Public
 Shares in an amount that would cause its net tangible assets to be
 less than $5,000,001. If a stockholder vote is not required by
 applicable law or stock exchange rule and the Company does not
 decide to hold a stockholder vote for business or other reasons,
 the Company will, pursuant to its amended and restated certificate
 of incorporation (the &#x201C;Certificate of Incorporation&#x201D;),
 conduct the redemptions pursuant to the tender offer rules of the
 U.S. Securities and Exchange Commission (&#x201C;SEC&#x201D;) and
 file tender offer documents with the SEC prior to completing a
 Business Combination. If, however, stockholder approval of the
 transaction is required by applicable law or stock exchange rule,
 or the Company decides to obtain stockholder approval for business
 or reasons, the Company will offer to redeem shares in conjunction
 with a proxy solicitation pursuant to the proxy rules and not
 pursuant to the tender offer rules. Additionally, each Public
 Stockholder may elect to redeem their Public Shares without voting,
 and if they do vote, irrespective of whether they vote for or
 against the proposed transaction. If the Company seeks stockholder
 approval in connection with a Business Combination, the initial
 stockholders (as defined below) have agreed to vote their Founder
 Shares (as defined below in Note 4) and any Public Shares held by
 them in favor of a Business Combination. In addition, the initial
 stockholders have agreed to waive their redemption rights with
 respect to any Founder Shares and any Public Shares held by them in
 connection with the completion of a Business Combination.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Certificate of Incorporation provided that a Public
 Stockholder, together with any affiliate of such stockholder or any
 other person with whom such stockholder is acting in concert or as
 a &#x201C;group&#x201D; (as defined under Section&#xA0;13 of the
 Securities Exchange Act of 1934, as amended (the &#x201C;Exchange
 Act&#x201D;)), will be restricted from redeeming its shares with
 respect to more than an aggregate of 15% or more of the Public
 Shares, without the prior consent of the Company.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Sponsor and the Company&#x2019;s officers and directors (the
 &#x201C;initial stockholders&#x201D;) agreed, pursuant to a letter
 agreement with the Company, that they will not propose any
 amendment to the Certificate of Incorporation (A)&#xA0;to modify
 the substance or timing of the Company&#x2019;s obligation to allow
 redemption in connection with the initial Business Combination or
 to redeem 100% of the Public Shares if the Company does not
 complete a Business Combination within the Combination Period (as
 defined below) or (B)&#xA0;with respect to any other provision
 relating to stockholders&#x2019; rights or <font style="white-space:nowrap">pre-initial</font> Business Combination
 activity, unless the Company provides the Public Stockholders with
 the opportunity to redeem their Public Shares upon approval of any
 such amendment at a <font style="white-space:nowrap">per-share</font> price, payable in cash, equal
 to the aggregate amount then on deposit in the Trust Account,
 including interest (which interest shall be net of taxes payable)
 divided by the number of then outstanding Public Shares.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 If the Company is unable to complete a Business Combination within
 24 months from the closing of the Initial Public Offering, or
 June&#xA0;30, 2022, (as such period may be extended pursuant to the
 Certificate of Incorporation, the &#x201C;Combination
 Period&#x201D;), the Company will (i)&#xA0;cease all operations
 except for the purpose of winding up, (ii)&#xA0;as promptly as
 reasonably possible but not more than ten business days thereafter,
 redeem the Public Shares, at a <font style="white-space:nowrap">per-share</font> price, payable in cash, equal
 to the aggregate amount then on deposit in the Trust Account
 including interest earned on the funds held in the Trust Account
 and not previously released to the Company to pay the
 Company&#x2019;s taxes, net of taxes payable (less up to $100,000 of
 interest to pay dissolution expenses), divided by the number of
 then outstanding Public Shares, which redemption will completely
 extinguish Public Stockholders&#x2019; rights as stockholders
 (including the right to receive further liquidating distributions,
 if any), and (iii)&#xA0;as promptly as reasonably possible
 following such redemption, subject to the approval of the
 Company&#x2019;s remaining stockholders and the Company&#x2019;s
 board of directors, dissolve and liquidate, subject in each case to
 the Company&#x2019;s obligations under Delaware law to provide for
 claims of creditors and the requirements of other applicable law.
 There will be no redemption rights or liquidating distributions
 with respect to the Company&#x2019;s warrants, which will expire
 worthless if the Company fails to complete its initial Business
 Combination within the Combination Period.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The initial stockholders agreed to waive their rights to
 liquidating distributions from the Trust Account with respect to
 any Founder Shares held by them if the Company fails to complete a
 Business Combination within the Combination Period. However, if the
 initial stockholders acquire Public Shares in or after the Initial
 Public Offering, they will be entitled to liquidating distributions
 from the Trust Account with respect to such Public Shares if the
 Company fails to complete a Business Combination within the
 Combination Period. The underwriters have agreed to waive their
 rights to the deferred underwriting commission (see Note 5) held in
 the Trust Account in the event the Company does not complete a
 Business Combination within in the Combination Period and, in such
 event, such amounts will be included with the other funds held in
 the Trust Account that will be available to fund the redemption of
 the Public Shares. In the event of such distribution, it is
 possible that the per share value of the residual assets remaining
 available for distribution (including Trust Account assets) will be
 only, or less than, $10.00. In order to protect the amounts held in
 the Trust Account, the Sponsor has agreed to be liable to the
 Company if and to the extent any claims by a third party (except
 for the Company&#x2019;s independent registered public accounting
 firm) for services rendered or products sold to the Company, or a
 prospective target business with which the Company has discussed
 entering into a transaction agreement (a &#x201C;Target&#x201D;),
 reduce the amount of funds in the Trust Account to below the lesser
 of (i) $10.00 per Public Share and (ii)&#xA0;the actual amount per
 Public Share held in the Trust Account as of the date of the
 liquidation of the Trust Account, if less than $10.00 per Public
 Share due to reductions in the value of the trust assets, less
 taxes payable, provided that such liability will not apply to any
 claims by a third party or Target that executed a waiver of any and
 all rights to the monies held in the Trust Account nor will it
 apply to any claims under the Company&#x2019;s indemnity of the
 underwriters of the Initial Public Offering against certain
 liabilities, including liabilities under the Securities Act of
 1933, as amended (the &#x201C;Securities Act&#x201D;). Moreover, in
 the event that an executed waiver is deemed to be unenforceable
 against a third party, then the Sponsor will not be responsible to
 the extent of any liability for such third-party claims. The
 Company will seek to reduce the possibility that the Sponsor will
 have to indemnify the Trust Account due to claims of creditors by
 endeavoring to have all vendors, service providers, prospective
 target businesses and other entities with which the Company does
 business, execute agreements with the Company waiving any right,
 title, interest or claim of any kind in or to monies held in the
 Trust Account.</p>
 <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Liquidity and Capital Resources</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 As indicated in the accompanying unaudited condensed financial
 statements, at June&#xA0;30, 2020, the Company had approximately
 $1.7&#xA0;million in cash, and working capital of approximately
 $1.5&#xA0;million (not taken into account tax obligations).</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Company&#x2019;s liquidity needs prior to the consummation of
 the Initial Public Offering were satisfied through the proceeds of
 $25,000 from the sale of the Founders Shares (as defined in Note
 4), and loan proceeds from the Sponsor of $75,000 (which is still
 outstanding to date). Subsequent from the consummation of the
 Initial Public Offering, the Company&#x2019;s liquidity has been
 satisfied through the net proceeds from the consummation of the
 Initial Public Offering and the Private Placement held outside of
 the Trust Account.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 Based on the foregoing, management believes that the Company will
 have sufficient working capital and borrowing capacity to meet its
 needs through the earlier of the consummation of a Business
 Combination or one&#xA0;year from this filing. Over this time
 period, the Company will be using the funds held outside of the
 Trust Account for paying existing accounts payable, identifying and
 evaluating prospective initial Business Combination candidates,
 performing due diligence on prospective target businesses, paying
 for travel expenditures, selecting the target business to merge
 with or acquire, and structuring, negotiating and consummating the
 Business Combination.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 Management is currently evaluating the impact of the <font style="white-space:nowrap">COVID-19</font> pandemic on the industry and
 effect on the Company&#x2019;s financial position, results of its
 operations and/or search for a target company.</p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487437114696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Note 2&#x2014;Summary of Significant Accounting Policies</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 <b>Concentration of Credit Risk</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 Financial instruments that potentially subject the Company to
 concentrations of credit risk consist of cash accounts in a
 financial institution, which, at times, may exceed the Federal
 Depository Insurance Coverage limit of $250,000. At May&#xA0;1,
 2020, the Company has not experienced losses on these accounts and
 management believes the Company is not exposed to significant risks
 on such accounts.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Financial Instruments</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The fair value of the Company&#x2019;s assets and liabilities, which
 qualify as financial instruments under FASB ASC 820, &#x201C;Fair
 Value Measurements and Disclosures,&#x201D; approximates the
 carrying amounts represented in the balance sheet.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Use of Estimates</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The preparation of financial statements in conformity with U.S.
 GAAP requires the Company&#x2019;s management to make estimates and
 assumptions that affect the reported amounts of assets and
 liabilities and disclosure of contingent assets and liabilities
 during the reporting period. Actual results could differ from those
 estimates.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Deferred Offering Costs Associated with the Proposed Public
 Offering</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 Deferred offering costs consist of legal, accounting, underwriting
 fees and other costs incurred through the balance sheet date that
 are directly related to the Proposed Public Offering and that will
 be charged to stockholder&#x2019;s equity upon the completion of the
 Proposed Public Offering. Should the Proposed Public Offering prove
 to be unsuccessful, these deferred costs, as well as additional
 expenses to be incurred, will be charged to operations.</p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 18px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt">
 <b>Net Loss Per Common Share</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company complies with accounting and disclosure requirements of
 FASB ASC Topic 260, &#x201C;Earnings Per Share.&#x201D; Net loss per
 share is computed by dividing net loss by the weighted average
 number of shares of common stock outstanding during the period
 excluding common stock subject to forfeiture. Weighted average
 shares were reduced for the effect of an aggregate of 750,000
 shares of common stock that are subject to forfeiture if the
 over-allotment option is not exercised by the underwriters (Note
 5). At May&#xA0;1, 2020, the Company did not have any dilutive
 securities and other contracts that could, potentially, be
 exercised or converted into shares of common stock and then share
 in the earnings of the Company. As a result, diluted loss per share
 is the same as basic loss per share for the period presented.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Income Taxes</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company follows the asset and liability method of accounting
 for income taxes under FASB ASC 740, &#x201C;Income Taxes.&#x201D;
 Deferred tax assets and liabilities are recognized for the
 estimated future tax consequences attributable to differences
 between the financial statements carrying amounts of existing
 assets and liabilities and their respective tax bases. Deferred tax
 assets and liabilities are measured using enacted tax rates
 expected to apply to taxable income in the years in which those
 temporary differences are expected to be recovered or settled. The
 effect on deferred tax assets and liabilities of a change in tax
 rates is recognized in income in the period that included the
 enactment date. Valuation allowances are established, when
 necessary, to reduce deferred tax assets to the amount expected to
 be realized. Deferred tax assets were deemed immaterial as of
 May&#xA0;1, 2020.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 FASB ASC 740 prescribes a recognition threshold and a measurement
 attribute for the financial statement recognition and measurement
 of tax positions taken or expected to be taken in a tax return. For
 those benefits to be recognized, a tax position must be more likely
 than not to be sustained upon examination by taxing authorities.
 There were no unrecognized tax benefits as of May&#xA0;1, 2020. The
 Company recognizes accrued interest and penalties related to
 unrecognized tax benefits as income tax expense. No amounts were
 accrued for the payment of interest and penalties as of May&#xA0;1,
 2020. The Company is currently not aware of any issues under review
 that could result in significant payments, accruals or material
 deviation from its position. The Company is subject to income tax
 examinations by major taxing authorities since inception.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Recent Accounting Pronouncements</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company&#x2019;s management does not believe that any recently
 issued, but not yet effective, accounting standards if currently
 adopted would have a material effect on the accompanying financial
 statements.</p>
 </div><span></span>
</td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Note 2&#x2014;Summary of Significant Accounting Policies</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 <b>Basis of Presentation</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The accompanying unaudited condensed financial statements are
 presented in U.S. dollars in conformity with accounting principles
 generally accepted in the United States of America
 (&#x201C;GAAP&#x201D;) for financial information and pursuant to the
 rules and regulations of the SEC. Accordingly, they do not include
 all of the information and footnotes required by GAAP. In the
 opinion of management, the unaudited condensed financial statements
 reflect all adjustments, which include only normal recurring
 adjustments necessary for the fair statement of the balances and
 results for the periods presented. Operating results for the period
 for the period from April&#xA0;17, 2020 (inception) through
 June&#xA0;30, 2020 are not necessarily indicative of the results
 that may be expected through December&#xA0;31, 2020.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The accompanying unaudited condensed financial statements should be
 read in conjunction with the audited financial statements and notes
 thereto included in the Form <font style="WHITE-SPACE: nowrap">8-K</font> and the final prospectus filed by
 the Company with the SEC on July&#xA0;7, 2020 and June&#xA0;26,
 2020, respectively.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Emerging Growth Company</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company is an &#x201C;emerging growth company,&#x201D; as defined
 in Section&#xA0;2(a) of the Securities Act, as modified by the
 Jumpstart Our Business Startups Act of 2012 (the &#x201C;JOBS
 Act&#x201D;), and it may take advantage of certain exemptions from
 various reporting requirements that are applicable to other public
 companies that are not emerging growth companies including, but not
 limited to, not being required to comply with the independent
 registered public accounting firm attestation requirements of
 Section&#xA0;404 of the Sarbanes-Oxley Act, reduced disclosure
 obligations regarding executive compensation in its periodic
 reports and proxy statements, and exemptions from the requirements
 of holding a nonbinding advisory vote on executive compensation and
 stockholder approval of any golden parachute payments not
 previously approved.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt">
 Further, Section&#xA0;102(b)(1) of the JOBS Act exempts emerging
 growth companies from being required to comply with new or revised
 financial accounting standards until private companies (that is,
 those that have not had a Securities Act registration statement
 declared effective or do not have a class of securities registered
 under the Exchange Act) are required to comply with the new or
 revised financial accounting standards. The JOBS Act provides that
 an emerging growth company can elect to opt out of the extended
 transition period and comply with the requirements that apply to
 <font style="WHITE-SPACE: nowrap">non-emerging</font> growth
 companies but any such an election to opt out is irrevocable. The
 Company has elected not to opt out of such extended transition
 period, which means that when a standard is issued or revised and
 it has different application dates for public or private companies,
 the Company, as an emerging growth company, can adopt the new or
 revised standard at the time private companies adopt the new or
 revised standard.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 This may make comparison of the Company&#x2019;s financial
 statements with another public company that is neither an emerging
 growth company nor an emerging growth company that has opted out of
 using the extended transition period difficult or impossible
 because of the potential differences in accounting standards
 used.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Cash and Cash Equivalents</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company considers all short-term investments with an original
 maturity of three months or less when purchased to be cash
 equivalents. The Company had no cash equivalents as of
 June&#xA0;30, 2020.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Cash held in Trust Account</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 At June&#xA0;30, 2020, the Company had $230.0&#xA0;million in cash
 held in the Trust Account.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Concentration of Credit Risk</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 Financial instruments that potentially subject the Company to
 concentrations of credit risk consist of cash accounts in a
 financial institution, which, at times, may exceed the Federal
 Depository Insurance Coverage limit of $250,000. The Company has
 not experienced losses on these accounts and management believes
 the Company is not exposed to significant risks on such
 accounts.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Financial Instruments</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The fair value of the Company&#x2019;s assets and liabilities, which
 qualify as financial instruments under FASB ASC&#xA0;820,
 &#x201C;Fair Value Measurements and Disclosures,&#x201D; approximates
 the carrying amounts represented in the condensed financial
 statements.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Use of Estimates</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The preparation of the financial statements in conformity with U.S.
 GAAP requires the Company&#x2019;s management to make estimates and
 assumptions that affect the reported amounts of assets and
 liabilities and disclosure of contingent assets and liabilities at
 the date of the financial statements and the reported amounts of
 revenues and expenses during the reporting period. Actual results
 could differ from those estimates.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Offering Costs Associated with the Initial Public
 Offering</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 Offering costs consist of legal, accounting, underwriting fees and
 other costs incurred through the balance sheet date that are
 directly related to the Initial Public Offering and that were
 charged to stockholders&#x2019; equity upon the completion of the
 Initial Public Offering.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 18pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt">
 <b>Class&#xA0;A common stock subject to possible redemption</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company accounts for its Class&#xA0;A common stock subject to
 possible redemption in accordance with the guidance in ASC Topic
 480 &#x201C;Distinguishing Liabilities from Equity.&#x201D;
 Class&#xA0;A common stock subject to mandatory redemption (if any)
 is classified as liability instruments and are measured at fair
 value. Conditionally redeemable Class&#xA0;A common stock
 (including Class&#xA0;A common stock that features redemption
 rights that are either within the control of the holder or subject
 to redemption upon the occurrence of uncertain events not solely
 within the Company&#x2019;s control) are classified as temporary
 equity. At all other times, Class&#xA0;A common stock is classified
 as stockholders&#x2019; equity. The Company&#x2019;s Class&#xA0;A
 common stock feature certain redemption rights that are considered
 to be outside of the Company&#x2019;s control and subject to the
 occurrence of uncertain future events. Accordingly, at
 June&#xA0;30, 2020, 21,843,927 shares of Class&#xA0;A common stock
 subject to possible redemption is presented at redemption value as
 temporary equity, outside of the stockholders&#x2019; equity section
 of the Company&#x2019;s balance sheet.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Net Loss Per Common Share</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company complies with accounting and disclosure requirements of
 FASB ASC Topic 260, &#x201C;Earnings Per Share.&#x201D; Net loss per
 share is computed by dividing net loss by the weighted average
 number of shares of common stock outstanding during the period
 excluding common stock subject to forfeiture. An aggregate of
 21,843,927 shares of Class&#xA0;A common stock subject to possible
 redemption at June&#xA0;30, 2020 has been excluded from the
 calculation of basic loss per share of common stock, since such
 shares, if redeemed, only participate in their pro rata share of
 the trust earnings. The Company has not considered the effect of
 the warrants sold in the Initial Public Offering (including the
 consummation of the Over-Allotment Units) and Private Placement to
 purchase an aggregate of 18,075,000 shares of the Company&#x2019;s
 common stock in the calculation of diluted loss per share, since
 the exercise of the warrants are contingent upon the occurrence of
 future events.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>Reconciliation of net loss per common share</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company&#x2019;s net loss is adjusted for the portion of income
 (loss) that is attributable to Class&#xA0;A common stock subject to
 redemption, as these shares only participate in the earnings of the
 Trust Account and not the income or losses of the Company.
 Accordingly, basic and diluted loss per common share is calculated
 as follows:</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="68%" align="center" border="0">
 <tr>
 <td width="71%"></td>
 <td valign="bottom" width="19%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid">
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">
 <b>For&#xA0;The&#xA0;Period&#xA0;From</b><br />
 <b>April&#xA0;17, 2020</b><br />
 <b>(inception)&#xA0;through</b><br />
 <b>June&#xA0;30, 2020</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em">
 Net loss</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(62,862</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid">
 <td valign="top">
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em">
 Less: Income attributable to Class&#xA0;A ordinary shares subject
 to possible redemption</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt">
 &#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 1px solid; MARGIN-TOP: 0pt">
 &#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em">
 Adjusted net loss</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(62,862</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt">
 &#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt">
 &#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid">
 <td valign="top">
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em">
 Weighted average ordinary shares outstanding, basic and diluted</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">5,031,247</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt">
 &#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt">
 &#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; PAGE-BREAK-INSIDE: avoid" bgcolor="#CCEEFF">
 <td valign="bottom">
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; MARGIN-TOP: 0pt; TEXT-INDENT: -1em">
 Basic and diluted net loss per ordinary share</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"><b>$</b></td>
 <td valign="bottom" align="right"><b>(0.01</b></td>
 <td valign="bottom" nowrap="nowrap"><b>)&#xA0;</b></td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt">
 &#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="MARGIN-BOTTOM: 0pt; BORDER-TOP: #000000 3px double; MARGIN-TOP: 0pt">
 &#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Income Taxes</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company follows the asset and liability method of accounting
 for income taxes under FASB ASC 740, &#x201C;Income Taxes.&#x201D;
 Deferred tax assets and liabilities are recognized for the
 estimated future tax consequences attributable to differences
 between the financial statements carrying amounts of existing
 assets and liabilities and their respective tax bases. Deferred tax
 assets and liabilities are measured using enacted tax rates
 expected to apply to taxable income in the years in which those
 temporary differences are expected to be recovered or settled. The
 effect on deferred tax assets and liabilities of a change in tax
 rates is recognized in income in the period that included the
 enactment date. Valuation allowances are established, when
 necessary, to reduce deferred tax assets to the amount expected to
 be realized. Deferred tax assets were deemed immaterial as of
 June&#xA0;30, 2020.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 FASB ASC 740 prescribes a recognition threshold and a measurement
 attribute for the financial statement recognition and measurement
 of tax positions taken or expected to be taken in a tax return. For
 those benefits to be recognized, a tax position must be more likely
 than not to be sustained upon examination by taxing authorities.
 There were no unrecognized tax benefits as of June&#xA0;30, 2020.
 The Company recognizes accrued interest and penalties related to
 unrecognized tax benefits as income tax expense. No amounts were
 accrued for the payment of interest and penalties as of
 June&#xA0;30, 2020. The Company is currently not aware of any
 issues under review that could result in significant payments,
 accruals or material deviation from its position. The Company is
 subject to income tax examinations by major taxing authorities
 since inception.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 On March&#xA0;27, 2020, President Trump signed the Coronavirus Aid,
 Relief, and Economic Security &#x201C;CARES&#x201D; Act into law. The
 CARES Act includes several significant business tax provisions
 that, among other things, would eliminate the taxable income limit
 for certain net operating losses (&#x201C;NOL) and allow businesses
 to carry back NOLs arising in 2018, 2019 and 2020 to the five prior
 years, suspend the excess business loss rules, accelerate refunds
 of previously generated corporate alternative minimum tax credits,
 generally loosen the business interest limitation under IRC section
 163(j) from 30&#xA0;percent to 50&#xA0;percent among other
 technical corrections included in the Tax Cuts and Jobs Act tax
 provisions. The Company does not believe that the CARES Act will
 have a significant impact on Company&#x2019;s financial position or
 statement of operations.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Recent Accounting Standards</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company&#x2019;s management does not believe that any recently
 issued, but not yet effective, accounting standards updates, if
 currently adopted would have a material effect on the accompanying
 financial statements.</p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487437092920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders Equity Note Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_InitialPublicOfferingDisclosureTextBlock', window );">Initial Public Offering</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Note 3&#x2014;Proposed Public Offering</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 Pursuant to the Proposed Public Offering, the Company intends to
 offer for sale 20,000,000 units at a price of $10.00 per Unit. Each
 Unit consists of one share of Class&#xA0;A common stock (such
 shares of common stock included in the Units being offered, the
 &#x201C;Public Shares&#x201D;), <font style="WHITE-SPACE: nowrap">and&#xA0;one-half&#xA0;of&#xA0;one</font>
 redeemable warrant (each, a &#x201C;Public Warrant&#x201D;). Each
 whole Public Warrant entitles the holder to purchase one share of
 Class&#xA0;A common stock at a price of $11.50 per share, subject
 to adjustment (see Note 6).</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Company will grant the underwriters <font style="WHITE-SPACE: nowrap">a&#xA0;45-day&#xA0;option&#xA0;from</font>
 the date of the final prospectus relating to the Proposed Public
 Offering to purchase up to 3,000,000 additional Units to cover
 over-allotments, if any, at the Proposed Public Offering price,
 less underwriting discounts and commissions.</p>
 </div><span></span>
</td>
<td class="text"><div>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Note 3&#x2014;Initial Public Offering</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 On June&#xA0;30, 2020, the Company sold 23,000,000 Units, including
 3,000,000 Over-Allotment Units, at a price of $10.00 per Unit,
 generating gross proceeds of $230.00&#xA0;million, and incurring
 offering costs of approximately $13.1&#xA0;million, inclusive of
 approximately $8.1&#xA0;million in deferred underwriting
 commissions.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 Each Unit consists of one share of Class&#xA0;A common stock and
 <font style="white-space:nowrap">one-half</font> of one redeemable
 warrant (each, a &#x201C;Public Warrant&#x201D;). Each whole Public
 Warrant entitles the holder to purchase one share of Class&#xA0;A
 common stock at a price of $11.50 per share, subject to adjustment
 (see Note 6).</p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_InitialPublicOfferingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial Public Offering Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_InitialPublicOfferingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487437031832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Note 4&#x2014;Related Party Transactions</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 <b>Founder Shares</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 On April&#xA0;17, 2020, the Sponsor subscribed to purchase
 5,031,250&#xA0;shares of the Company&#x2019;s Class&#xA0;B common
 stock, par value $0.0001 per share (the &#x201C;Founder
 Shares&#x201D;), and fully paid for those shares on May&#xA0;1,
 2020. On June&#xA0;25, 2020, the Company effected a stock dividend
 with respect to the Class&#xA0;B common stock, resulting in the
 Sponsor holding an aggregate of 5,750,000 founder shares. All
 shares and associated amounts have been retroactively restated to
 reflect the share capitalization. The initial stockholders have
 agreed to forfeit up to 750,000 Founder Shares to the extent that
 the over-allotment&#xA0;option is not exercised in full by the
 underwriters. The forfeiture will be adjusted to the extent that
 the over-allotment&#xA0;option is not exercised in full by the
 underwriters so that the Founder Shares will represent 20.0% of the
 Company&#x2019;s issued and outstanding shares of common stock after
 the Proposed Public Offering.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The initial stockholders will agree, subject to limited exceptions,
 not to transfer, assign or sell any of the Founder Shares until the
 earlier to occur of: (A)&#xA0;one year after the completion of the
 initial Business Combination or (B)&#xA0;subsequent to the initial
 Business Combination, (x)&#xA0;if the last reported sale price of
 the Class&#xA0;A common stock equals or exceeds $12.00 per share
 (as adjusted for stock splits, stock dividends, reorganizations,
 recapitalizations and the like) for any 20 trading days within
 <font style="WHITE-SPACE: nowrap">any&#xA0;30-trading&#xA0;day</font> period
 commencing at least 150 days after the initial Business
 Combination, or (y)&#xA0;the date on which the Company completes a
 liquidation, merger, capital stock exchange, reorganization or
 other similar transaction that results in all of the
 Company&#x2019;s stockholders having the right to exchange their
 shares of common stock for cash, securities or other property.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Private Placement Warrants</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Sponsor will agree to purchase an aggregate of 5,975,000
 Private Placement Warrants (or 6,575,000 Private Placement Warrants
 if the underwriters&#x2019; over-allotment&#xA0;option is exercised
 in full), at a price of $1.00 per Private Placement Warrant
 ($5,975,000 in the aggregate, or $6,575,000 if the
 underwriters&#x2019; over-allotment&#xA0;option is exercised in
 full) in a private placement that will occur simultaneously with
 the closing of the Proposed Public Offering. Each whole Private
 Placement Warrant is exercisable for one whole share of
 Class&#xA0;A&#xA0;common stock at a price of $11.50 per share,
 subject to adjustment. A portion of the proceeds from the sale of
 the Private Placement Warrants to the Sponsor will be added to the
 proceeds from the Proposed Public Offering to be held in the Trust
 Account. If the Company does not complete a Business Combination
 within the Combination Period, the Private Placement Warrants will
 expire worthless. The Private Placement Warrants will <font style="WHITE-SPACE: nowrap">be&#xA0;non-redeemable&#xA0;for&#xA0;cash</font>
 (except as described below) and exercisable on a cashless basis so
 long as they are held by the Sponsor or its permitted
 transferees.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Sponsor will agree, subject to limited exceptions, not to
 transfer, assign or sell the Private Placement Warrants until 30
 days after the completion of the initial Business Combination.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Related Party Loans</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 On April&#xA0;17, 2020, the Sponsor agreed to loan the Company an
 aggregate of up to $300,000 to cover expenses related to the
 Proposed Public Offering pursuant to a promissory note (the
 &#x201C;Note&#x201D;). This loan <font style="WHITE-SPACE: nowrap">is&#xA0;non-interest&#xA0;bearing&#xA0;and</font>
 payable on the earlier of October&#xA0;31, 2020 and the completion
 of the Proposed Public Offering. As of May&#xA0;5, 2020, the
 Company has borrowed $75,000 under the Note.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 In addition, in order to fund working capital deficiencies or
 finance transaction costs in connection with a Business
 Combination, the Sponsor or an affiliate of the Sponsor, or certain
 of the Company&#x2019;s officers and directors may, but are not
 obligated to, loan the Company funds as may be required
 (&#x201C;Working Capital Loans&#x201D;). If the Company completes a
 Business Combination, the Company may repay the Working Capital
 Loans out of the proceeds of the Trust Account released to the
 Company. Otherwise, the Working Capital Loans could be repaid only
 out of funds held outside the Trust Account. In the event that a
 Business Combination does not close, the Company may use a portion
 of proceeds held outside the Trust Account to repay the Working
 Capital Loans but no proceeds held in the Trust Account would be
 used to repay the Working Capital Loans. The Working Capital Loans
 would either be repaid upon consummation of a Business Combination
 or, at the lender&#x2019;s discretion, up to $1,500,000 of such
 Working Capital Loans may be convertible into warrants of the post
 Business Combination entity at a price of $1.00 per warrant. The
 warrants would be identical to the Private Placement Warrants.
 Except for the foregoing, the terms of such Working Capital Loans,
 if any, have not been determined and no written agreements exist
 with respect to such loans. To date, the Company had no borrowings
 under the Working Capital Loans.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Service and Administrative Fees</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company has agreed to pay service and administrative fees of
 $20,000 per month to DEHC LLC, an affiliate of Daniel Huber, the
 Company&#x2019;s Chief Financial Officer, for up to 18 months
 commencing on the date of consummation of the Proposed Public
 Offering.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Sponsor, executive officers and directors, or any of their
 respective affiliates, will be reimbursed for <font style="WHITE-SPACE: nowrap"><font style="WHITE-SPACE: nowrap">any&#xA0;out-of-pocket&#xA0;expenses&#xA0;incurred</font></font>
 in connection with activities on the Company&#x2019;s behalf such as
 identifying potential target businesses and performing due
 diligence on suitable Business Combinations. The Company&#x2019;s
 audit committee will review on a quarterly basis all payments that
 were made by the Company to the Sponsor, officers, directors or
 their affiliates.</p>
 </div><span></span>
</td>
<td class="text"><div>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Note 4&#x2014;Related Party Transactions</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Founder Shares</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 On April&#xA0;17, 2020, the Sponsor subscribed to purchase
 5,031,250 shares of the Company&#x2019;s Class&#xA0;B common stock,
 par value $0.0001 per share (the &#x201C;Founder Shares&#x201D;), and
 fully paid for those shares on June&#xA0;30, 2020. On June&#xA0;25,
 2020, the Company effected a stock dividend with respect to the
 Class&#xA0;B common stock, resulting in the Sponsor holding an
 aggregate of 5,750,000 founder shares. All shares and associated
 amounts have been retroactively restated to reflect the share
 capitalization. The initial stockholders agreed to forfeit up to
 750,000 Founder Shares to the extent that the over-allotment option
 is not exercised in full by the underwriters so that the Founder
 Shares represented 20.0% of the Company&#x2019;s issued and
 outstanding shares of common stock after the Initial Public
 Offering. The underwriter exercised its over-allotment option in
 full on June&#xA0;30, 2020; thus, the 750,000 Founder Shares were
 no longer subject to forfeiture.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The initial stockholders agreed, subject to limited exceptions, not
 to transfer, assign or sell any of the Founder Shares until the
 earlier to occur of: (A)&#xA0;one year after the completion of the
 initial Business Combination or (B)&#xA0;subsequent to the initial
 Business Combination, (x)&#xA0;if the last reported sale price of
 the Class&#xA0;A common stock equals or exceeds $12.00 per share
 (as adjusted for stock splits, stock dividends, reorganizations,
 recapitalizations and the like) for any 20 trading days within any
 <font style="white-space:nowrap">30-trading</font> day period
 commencing at least 150&#xA0;days after the initial Business
 Combination, or (y)&#xA0;the date on which the Company completes a
 liquidation, merger, capital stock exchange, reorganization or
 other similar transaction that results in all of the
 Company&#x2019;s stockholders having the right to exchange their
 shares of common stock for cash, securities or other property.</p>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Private Placement Warrants</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 Simultaneously with the closing of the Initial Public Offering, the
 Company sold 6,575,000 Private Placement Warrants at a price of
 $1.00 per Private Placement Warrant to the Sponsor, generating
 gross proceeds of approximately $6.6&#xA0;million.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 Each whole Private Placement Warrant is exercisable for one whole
 share of Class&#xA0;A common stock at a price of $11.50 per share,
 subject to adjustment. A portion of the proceeds from the sale of
 the Private Placement Warrants to the Sponsor was added to the
 proceeds from the Initial Public Offering held in the Trust
 Account. If the Company does not complete a Business Combination
 within the Combination Period, the Private Placement Warrants will
 expire worthless. The Private Placement Warrants will be
 <font style="white-space:nowrap">non-redeemable</font> for cash
 (except as described below) and exercisable on a cashless basis so
 long as they are held by the Sponsor or its permitted
 transferees.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Sponsor agreed, subject to limited exceptions, not to transfer,
 assign or sell the Private Placement Warrants until 30 days after
 the completion of the initial Business Combination.</p>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Related Party Loans</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 On April&#xA0;17, 2020, the Sponsor agreed to loan the Company an
 aggregate of up to $300,000 to cover expenses related to the
 Initial Public Offering pursuant to a promissory note (the
 &#x201C;Note&#x201D;). This loan is <font style="white-space:nowrap">non-interest</font> bearing and payable upon
 the completion of the Initial Public Offering. As of June&#xA0;30,
 2020, the Company has borrowed $75,000 under the Note. To date, the
 balance of the Note remains outstanding.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 In addition, in order to fund working capital deficiencies or
 finance transaction costs in connection with a Business
 Combination, the Sponsor or an affiliate of the Sponsor, or certain
 of the Company&#x2019;s officers and directors may, but are not
 obligated to, loan the Company funds as may be required
 (&#x201C;Working Capital Loans&#x201D;). If the Company completes a
 Business Combination, the Company may repay the Working Capital
 Loans out of the proceeds of the Trust Account released to the
 Company. Otherwise, the Working Capital Loans could be repaid only
 out of funds held outside the Trust Account. In the event that a
 Business Combination does not close, the Company may use a portion
 of proceeds held outside the Trust Account to repay the Working
 Capital Loans but no proceeds held in the Trust Account would be
 used to repay the Working Capital Loans. The Working Capital Loans
 would either be repaid upon consummation of a Business Combination
 or, at the lender&#x2019;s discretion, up to $1,500,000 of such
 Working Capital Loans may be convertible into warrants of the post
 Business Combination entity at a price of $1.00 per warrant. The
 warrants would be identical to the Private Placement Warrants.
 Except for the foregoing, the terms of such Working Capital Loans,
 if any, have not been determined and no written agreements exist
 with respect to such loans. To date, the Company had no borrowings
 under the Working Capital Loans.</p>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Service and Administrative Fees</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Company has agreed to pay service and administrative fees of
 $20,000 per month to DEHC LLC, an affiliate of Daniel Huber, the
 Company&#x2019;s Chief Financial Officer, for up to 18 months
 commencing on the date of consummation of the Initial Public
 Offering. The Company believes that these fees are being paid on
 arms&#x2019; length terms and comparable to fees typically paid for
 similar services by other special purpose acquisition companies. As
 of June&#xA0;30, 2020, the Company incurred $20,000 in general and
 administrative expenses in the accompanying condensed statement of
 operations and $20,000 in accounts payable in the accompanying
 balance sheet in connection with such services.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Sponsor, executive officers and directors, or any of their
 respective affiliates, will be reimbursed for any <font style="white-space:nowrap"><font style="white-space:nowrap">out-of-pocket</font></font> expenses incurred
 in connection with activities on the Company&#x2019;s behalf such as
 identifying potential target businesses and performing due
 diligence on suitable Business Combinations. The Company&#x2019;s
 audit committee will review on a quarterly basis all payments that
 were made by the Company to the Sponsor, officers, directors or
 their affiliates.</p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487436990728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments &amp; Contingencies<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments &amp; Contingencies</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Note 5&#x2014;Commitments&#xA0;&amp; Contingencies</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 <b>Registration Rights</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The holders of Founder Shares, Private Placement Warrants and
 warrants that may be issued upon conversion of Working Capital
 Loans, if any, and any shares of Class&#xA0;A common stock issuable
 upon the exercise of the Private Placement Warrants and warrants
 that may be issued upon conversion of Working Capital Loans and
 upon conversion of the Founder Shares will be entitled to
 registration rights pursuant to a registration rights agreement to
 be signed prior to the consummation of the Proposed Public
 Offering. These holders will be entitled to certain demand and
 &#x201C;piggyback&#x201D; registration rights. The Company will bear
 the expenses incurred in connection with the filing of any such
 registration statements.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Underwriting Agreement</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The underwriters will be entitled to an underwriting discount of
 $0.20 per unit, or $4,000,000 in the aggregate (or approximately
 $4,600,000 in the aggregate if the underwriters&#x2019;
 over-allotment&#xA0;option is exercised in full), payable upon the
 closing of the Proposed Public Offering. $0.35 per unit, or
 approximately $7,000,000 in the aggregate (or approximately
 $8,050,000 in the aggregate if the underwriters&#x2019;
 over-allotment&#xA0;option is exercised in full) will be payable to
 the underwriters for deferred underwriting commissions. The
 deferred fee will become payable to the underwriters from the
 amounts held in the Trust Account solely in the event that the
 Company completes a Business Combination, subject to the terms of
 the underwriting agreement.</p>
 </div><span></span>
</td>
<td class="text"><div>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Note 5&#x2014;Commitments&#xA0;&amp; Contingencies</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Registration Rights</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The holders of Founder Shares, Private Placement Warrants and
 warrants that may be issued upon conversion of Working Capital
 Loans, if any, and any shares of Class&#xA0;A common stock issuable
 upon the exercise of the Private Placement Warrants and warrants
 that may be issued upon conversion of Working Capital Loans and
 upon conversion of the Founder Shares will be entitled to
 registration rights pursuant to a registration rights. These
 holders will be entitled to certain demand and
 &#x201C;piggyback&#x201D; registration rights. The Company will bear
 the expenses incurred in connection with the filing of any such
 registration statements.</p>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Underwriting Agreement</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The underwriters were entitled to an underwriting discount of $0.20
 per unit, or $4.6&#xA0;million in the aggregate, paid upon the
 closing of the Initial Public Offering. In addition, $0.35 per
 unit, or approximately $8.1&#xA0;million in the aggregate will be
 payable to the underwriters for deferred underwriting commissions.
 The deferred fee will become payable to the underwriters from the
 amounts held in the Trust Account solely in the event that the
 Company completes a Business Combination, subject to the terms of
 the underwriting agreement.</p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487437031832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders Equity Note Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Note 6&#x2014;Stockholder&#x2019;s Equity</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 <b><i>Class</i></b><b><i>&#xA0;A Common Stock</i></b>&#x2014;The
 Company is authorized to issue 100,000,000&#xA0;shares of
 Class&#xA0;A common stock with a par value of $0.0001 per share. As
 of May&#xA0;1, 2020, there were no shares of Class&#xA0;A common
 stock issued or outstanding.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 <b><i>Class</i></b><b><i>&#xA0;B Common Stock</i></b>&#x2014;The
 Company is authorized to issue 10,000,000 shares of Class&#xA0;B
 common stock with a par value of $0.0001 per share. On
 April&#xA0;17, 2020, the Sponsor subscribed to purchase
 5,031,250&#xA0;shares of Class&#xA0;B common stock, which was fully
 paid on May&#xA0;1, 2020. On June&#xA0;25, 2020, the Company
 effected a stock dividend with respect to the Class&#xA0;B common
 stock, resulting in the Sponsor holding an aggregate of 5,750,000
 founder shares. All shares and associated amounts have been
 retroactively restated to reflect the share capitalization. Of
 these, an aggregate of up to 750,000 shares of Class&#xA0;B common
 stock that are subject to forfeiture to the Company by the initial
 stockholders for no consideration to the extent that the
 underwriters&#x2019; over-allotment&#xA0;option is not exercised in
 full or in part, so that the number of Founder Shares will equal
 20% of the Company&#x2019;s issued and outstanding shares of common
 stock after the Proposed Public Offering.</p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt">
 Stockholders of record are entitled to one vote for each share held
 on all matters to be voted on by stockholders; provided that, prior
 to the completion of the initial Business Combination, holders of
 the Class&#xA0;B common stock will have the right to elect all of
 the Company&#x2019;s directors and remove members of the
 Company&#x2019;s board of directors for any reason. Prior to the
 completion of the initial Business Combination, only holders of the
 Class&#xA0;B common stock will have the right to vote on the
 Company&#x2019;s election of directors. Holders of the Public Shares
 will not be entitled to vote on the Company&#x2019;s election of
 directors during such time. In addition, prior to the completion of
 the initial Business Combination, holders of a majority of the
 outstanding shares of the Class&#xA0;B common stock may remove a
 member of the Company&#x2019;s board of directors for any reason.
 These provisions of the Certificate of Incorporation may only be
 amended by a resolution passed by the holders of a majority of
 shares of the Class&#xA0;B common stock. With respect to any other
 matter submitted to a vote of the Company&#x2019;s stockholders,
 including any vote in connection with the initial Business
 Combination, holders of the Class&#xA0;A common stock and holders
 of the Class&#xA0;B common stock will vote together as a single
 class on all matters submitted to a vote of the Company&#x2019;s
 stockholders, except as required by law.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Class&#xA0;B common stock will automatically convert into
 Class&#xA0;A common stock at the time of the initial Business
 Combination, or earlier at the option of the holders, on
 <font style="WHITE-SPACE: nowrap"><font style="WHITE-SPACE: nowrap">a&#xA0;one-for-one&#xA0;basis,&#xA0;subject</font></font>
 to adjustment for stock splits, stock dividends, reorganizations,
 recapitalizations and the like, and subject to further adjustment
 as described herein. In the case that additional shares of
 Class&#xA0;A common stock, or equity-linked securities, are issued
 or deemed issued in excess of the amounts issued in the Proposed
 Offering and related to the closing of the initial Business
 Combination, including pursuant to a specified future issuance, the
 ratio at which shares of Class&#xA0;B common stock shall convert
 into shares of Class&#xA0;A common stock will be adjusted (unless
 the holders of a majority of the then-outstanding shares of
 Class&#xA0;B common stock agree to waive such adjustment with
 respect to any such issuance or deemed issuance, including a
 specified future issuance) so that the number of shares of
 Class&#xA0;A common stock issuable upon conversion of all shares of
 Class&#xA0;B common stock will equal, in the aggregate, on an
 <font style="WHITE-SPACE: nowrap">as-converted</font> basis, 20% of
 the sum of the total number of all shares of common stock
 outstanding upon the completion of the Proposed Public Offering
 plus all shares of Class&#xA0;A common stock and equity-linked
 securities issued or deemed issued in connection with the initial
 Business Combination (excluding any shares or equity-linked
 securities issued or issuable to any seller in the initial Business
 Combination).</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 <b><i>Preferred Stock</i></b>&#x2014;The Company is authorized to
 issue 1,000,000&#xA0;shares of preferred stock, par value $0.0001
 per share, with such designations, voting and other rights and
 preferences as may be determined from time to time by the
 Company&#x2019;s board of directors. As of May&#xA0;1, 2020, there
 were no shares of preferred stock issued or outstanding.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 <b><i>Warrants</i></b>&#x2014;Public Warrants may only be exercised
 for a whole number of shares. No fractional Public Warrants will be
 issued upon separation of the Units and only whole Public Warrants
 will trade. The Public Warrants will become exercisable on the
 later of (a) 30 days after the completion of a Business Combination
 and (b) 12&#xA0;months from the closing of the Proposed Public
 Offering; provided in each case that the Company has an effective
 registration statement under the Securities Act covering the
 issuance of the shares of Class&#xA0;A common stock issuable upon
 exercise of the Public Warrants and a current prospectus relating
 to them is available and such shares are registered, qualified or
 exempt from registration under the securities, or blue sky, laws of
 the state of residence of the holder (or the Company permits
 holders to exercise their Public Warrants on a cashless basis under
 the circumstances specified in the warrant agreement). The Company
 has agreed that as soon as practicable, but in no event later than
 20 business days after the closing of the initial Business
 Combination, the Company will use its commercially reasonable
 efforts to file, and within 60 business days following the initial
 Business Combination to have declared effective, a registration
 statement covering the issuance of the shares of Class&#xA0;A
 common stock issuable upon exercise of the warrants and to maintain
 a current prospectus relating to those shares of Class&#xA0;A
 common stock until the warrants expire or are redeemed; provided,
 that if the Class&#xA0;A common stock is at the time of any
 exercise of a warrant not listed on a national securities exchange
 such that it satisfies the definition of a &#x201C;covered
 security&#x201D; under Section&#xA0;18(b)(1) of the Securities Act,
 the Company may, at its option, require holders of Public Warrants
 who exercise their warrants to do so on a &#x201C;cashless
 basis&#x201D; in accordance with Section&#xA0;3(a)(9) of the
 Securities Act and, in the event the Company so elects, it will not
 be required to file or maintain in effect a registration statement,
 but it will be required to use its best efforts to register or
 qualify the shares under applicable blue sky laws to the extent an
 exemption is not available. The Public Warrants will expire five
 years after the completion of a Business Combination or earlier
 upon redemption or liquidation.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The warrants will have an exercise price of $11.50 per share. If
 (x)&#xA0;the Company issue additional shares or equity-linked
 securities for capital raising purposes in connection with the
 closing of the initial Business Combination at an issue price or
 effective issue price of less than $9.20 per share (as adjusted for
 stock splits, stock dividends, rights issuances, subdivisions,
 reorganizations, recapitalizations and the like) (with such issue
 price or effective issue price to be determined in good faith by
 the Company&#x2019;s board of directors, and in the case of any such
 issuance to the Sponsor, initial stockholders or their affiliates,
 without taking into account any Founder Shares held by them prior
 to such issuance) (the &#x201C;Newly Issued Price&#x201D;), (y) the
 aggregate gross proceeds from such issuances represent more than
 60% of the total equity proceeds, and interest thereon, available
 for the funding of the initial Business Combination on the date of
 the consummation of the Initial Business Combination (net of
 redemptions), and (z)&#xA0;the volume weighted average trading
 price of the Company&#x2019;s shares of Class&#xA0;A common stock
 during the 20 trading day period starting on the trading day prior
 to the day on which the Company consummates the initial Business
 Combination (such price, the &#x201C;Market Value&#x201D;) is below
 $9.20 per share, the exercise price of each warrant will be
 adjusted (to the nearest cent) such that the effective exercise
 price per full share will be equal to 115% of the higher of
 (i)&#xA0;the Market Value and (ii)&#xA0;the Newly Issued Price, and
 the $18.00 per share redemption trigger price described below will
 be adjusted (to the nearest cent) to be equal to 180% of the higher
 of (i)&#xA0;the Market Value and (ii)&#xA0;the Newly Issued
 Price.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Private Placement Warrants will be identical to the Public
 Warrants, except that (1)&#xA0;the Private Placement Warrants and
 the shares of Class&#xA0;A common stock issuable upon exercise of
 the Private Placement Warrants will not be transferable, assignable
 or salable until 30 days after the completion of a Business
 Combination, subject to certain limited exceptions, (2)&#xA0;the
 Private Placement Warrants will <font style="WHITE-SPACE: nowrap">be&#xA0;non-redeemable</font> (except as
 described below) so&#xA0;long as they are held by the Sponsor or
 its permitted transferees, (3)&#xA0;the Private Placement Warrants
 may be exercised by the holders on a cashless basis and
 (4)&#xA0;the holders of the Private Placement Warrants (including
 with respect to the shares of common stock issuable upon exercise
 of the Private Placement Warrants) are entitled to registration
 rights. If the Private Placement Warrants are held by someone other
 than the Sponsor or its permitted transferees, the Private
 Placement Warrants will be redeemable by the Company in all
 redemption scenarios and exercisable by such holders on the same
 basis as the Public Warrants.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Company may call the Public Warrants for redemption:</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr style="PAGE-BREAK-INSIDE: avoid">
 <td width="5%">&#xA0;</td>
 <td valign="top" width="3%" align="left">&#x2022;</td>
 <td valign="top" width="1%">&#xA0;</td>
 <td valign="top" align="left">
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left">in whole and not in part;</p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr style="PAGE-BREAK-INSIDE: avoid">
 <td width="5%">&#xA0;</td>
 <td valign="top" width="3%" align="left">&#x2022;</td>
 <td valign="top" width="1%">&#xA0;</td>
 <td valign="top" align="left">
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left">at a price of $0.01 per warrant;</p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr style="PAGE-BREAK-INSIDE: avoid">
 <td width="5%">&#xA0;</td>
 <td valign="top" width="3%" align="left">&#x2022;</td>
 <td valign="top" width="1%">&#xA0;</td>
 <td valign="top" align="left">
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left">upon a minimum of 30 days&#x2019; prior written notice
 of redemption; and</p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr style="PAGE-BREAK-INSIDE: avoid">
 <td width="5%">&#xA0;</td>
 <td valign="top" width="3%" align="left">&#x2022;</td>
 <td valign="top" width="1%">&#xA0;</td>
 <td valign="top" align="left">
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left">if, and only if, the last reported sale price of the
 Class&#xA0;A common stock equals or exceeds $18.00 per share (as
 adjusted for stock splits, stock dividends, reorganizations,
 recapitalizations and the like) for any 20 trading days within
 <font style="WHITE-SPACE: nowrap">the&#xA0;30-trading&#xA0;day&#xA0;period</font>
 ending on the third business day prior to the date on which the
 Company sends the notice of redemption to the warrant holders.</p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 If the Company calls the Public Warrants for redemption, management
 will have the option to require all holders that wish to exercise
 the Public Warrants to do so on a &#x201C;cashless basis,&#x201D; as
 described in the warrant agreement.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 In addition, commencing ninety days after the warrants become
 exercisable, the Company may redeem the outstanding warrants:</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr style="PAGE-BREAK-INSIDE: avoid">
 <td width="5%">&#xA0;</td>
 <td valign="top" width="3%" align="left">&#x2022;</td>
 <td valign="top" width="1%">&#xA0;</td>
 <td valign="top" align="left">
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left">in whole and not in part;</p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 6px">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr style="PAGE-BREAK-INSIDE: avoid">
 <td width="5%">&#xA0;</td>
 <td valign="top" width="3%" align="left">&#x2022;</td>
 <td valign="top" width="1%">&#xA0;</td>
 <td valign="top" align="left">
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left">at $0.10 per warrant upon a minimum of 30 days&#x2019;
 prior written notice of redemption provided that holders will be
 able to exercise their warrants on a cashless basis prior to
 redemption and receive that number of shares of Class&#xA0;A common
 stock to be determined by reference to a table in the warrant
 agreement;</p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr style="PAGE-BREAK-INSIDE: avoid">
 <td width="5%">&#xA0;</td>
 <td valign="top" width="3%" align="left">&#x2022;</td>
 <td valign="top" width="1%">&#xA0;</td>
 <td valign="top" align="left">
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left">if, and only if, the last reported sale price of the
 Company&#x2019;s Class&#xA0;A common stock equals or exceeds
 $10.00&#xA0;per share (as adjusted for stock splits, stock
 dividends, reorganizations, recapitalizations and the like) on the
 trading day prior to the date on which the Company sends the notice
 of redemption to the warrant holders;</p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr style="PAGE-BREAK-INSIDE: avoid">
 <td width="5%">&#xA0;</td>
 <td valign="top" width="3%" align="left">&#x2022;</td>
 <td valign="top" width="1%">&#xA0;</td>
 <td valign="top" align="left">
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left">if, and only if, the Private Placement Warrants are
 also concurrently called for redemption at the same price (equal to
 a number of shares of Class&#xA0;A common stock) as the outstanding
 Public Warrants, as described above; and</p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0">
 <tr style="PAGE-BREAK-INSIDE: avoid">
 <td width="5%">&#xA0;</td>
 <td valign="top" width="3%" align="left">&#x2022;</td>
 <td valign="top" width="1%">&#xA0;</td>
 <td valign="top" align="left">
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left">if, and only if, there is an effective registration
 statement covering the shares of Class&#xA0;A common stock (or a
 security other than the Class&#xA0;A common stock into which the
 Class&#xA0;A common stock has been converted or exchanged for in
 the event the Company is not the surviving company in the initial
 Business Combination) issuable upon exercise of the warrants and a
 current prospectus relating thereto available throughout the
 <font style="WHITE-SPACE: nowrap">30-day</font> period after
 written notice of redemption is given.</p>
 </td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 In no event will the Company be required to net cash settle any
 warrant. If the Company is unable to complete a Business
 Combination within the Combination Period and the Company
 liquidates the funds held in the Trust Account, holders of warrants
 will not receive any of such funds with respect to their warrants,
 nor will they receive any distribution from the Company&#x2019;s
 assets held outside of the Trust Account with the respect to such
 warrants. Accordingly, the warrants may expire worthless.</p>
 </div><span></span>
</td>
<td class="text"><div>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Note 6&#x2014;Stockholders&#x2019; Equity</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b><i>Preferred Stock</i></b>&#x2014;The Company is authorized to
 issue 1,000,000 shares of preferred stock, par value $0.0001 per
 share, with such designations, voting and other rights and
 preferences as may be determined from time to time by the
 Company&#x2019;s board of directors. As of June&#xA0;30, 2020, there
 were no shares of preferred stock issued or outstanding.</p>
 <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b><i>Class</i></b><b><i>&#xA0;A Common Stock</i></b>&#x2014;The
 Company is authorized to issue 100,000,000 shares of Class&#xA0;A
 common stock with a par value of $0.0001 per share. As of
 June&#xA0;30, 2020, there were 23,000,000 shares of Class&#xA0;A
 common stock issued or outstanding, including 21,843,927 shares of
 Class&#xA0;A common stock subject to possible redemption,
 respectively.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b><i>Class</i></b><b><i>&#xA0;B Common Stock</i></b>&#x2014;The
 Company is authorized to issue 10,000,000 shares of Class&#xA0;B
 common stock with a par value of $0.0001 per share. On
 April&#xA0;17, 2020, the Sponsor subscribed to purchase 5,031,250
 shares of Class&#xA0;B common stock, which was fully paid on
 June&#xA0;30, 2020. On June&#xA0;25, 2020, the Company effected a
 stock dividend with respect to the Class&#xA0;B common stock,
 resulting in the Sponsor holding an aggregate of 5,750,000 founder
 shares. All shares and associated amounts have been retroactively
 restated to reflect the share capitalization. Of these, an
 aggregate of up to 750,000 shares of Class&#xA0;B common stock that
 were subject to forfeiture to the Company by the initial
 stockholders for no consideration to the extent that the
 underwriters&#x2019; over-allotment option is not exercised in full
 or in part, so that the number of Founder Shares equals 20% of the
 Company&#x2019;s issued and outstanding shares of common stock after
 the Initial Public Offering. The underwriter exercised its
 over-allotment option in full on June&#xA0;30, 2020; thus, the
 750,000 Founder Shares were no longer subject to forfeiture.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 Stockholders of record are entitled to one vote for each share held
 on all matters to be voted on by stockholders; provided that, prior
 to the completion of the initial Business Combination, holders of
 the Class&#xA0;B common stock will have the right to elect all of
 the Company&#x2019;s directors and remove members of the
 Company&#x2019;s board of directors for any reason. Prior to the
 completion of the initial Business Combination, only holders of the
 Class&#xA0;B common stock will have the right to vote on the
 Company&#x2019;s election of directors. Holders of the Public Shares
 will not be entitled to vote on the Company&#x2019;s election of
 directors during such time. In addition, prior to the completion of
 the initial Business Combination, holders of a majority of the
 outstanding shares of the Class&#xA0;B common stock may remove a
 member of the Company&#x2019;s board of directors for any reason.
 These provisions of the Certificate of Incorporation may only be
 amended by a resolution passed by the holders of a majority of
 shares of the Class&#xA0;B common stock. With respect to any other
 matter submitted to a vote of the Company&#x2019;s stockholders,
 including any vote in connection with the initial Business
 Combination, holders of the Class&#xA0;A common stock and holders
 of the Class&#xA0;B common stock will vote together as a single
 class on all matters submitted to a vote of the Company&#x2019;s
 stockholders, except as required by law.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Class&#xA0;B common stock will automatically convert into
 Class&#xA0;A common stock at the time of the initial Business
 Combination, or earlier at the option of the holders, on a
 <font style="white-space:nowrap"><font style="white-space:nowrap">one-for-one</font></font> basis, subject to
 adjustment for stock splits, stock dividends, reorganizations,
 recapitalizations and the like, and subject to further adjustment
 as described herein. In the case that additional shares of
 Class&#xA0;A common stock, or equity-linked securities, are issued
 or deemed issued in excess of the amounts issued in the Proposed
 Offering and related to the closing of the initial Business
 Combination, including pursuant to a specified future issuance, the
 ratio at which shares of Class&#xA0;B common stock shall convert
 into shares of Class&#xA0;A common stock will be adjusted (unless
 the holders of a majority of the then-outstanding shares of
 Class&#xA0;B common stock agree to waive such adjustment with
 respect to any such issuance or deemed issuance, including a
 specified future issuance) so that the number of shares of
 Class&#xA0;A common stock issuable upon conversion of all shares of
 Class&#xA0;B common stock will equal, in the aggregate, on an
 <font style="white-space:nowrap">as-converted</font> basis, 20% of
 the sum of the total number of all shares of common stock
 outstanding upon the completion of the Initial Public Offering plus
 all shares of Class&#xA0;A common stock and equity-linked
 securities issued or deemed issued in connection with the initial
 Business Combination (excluding any shares or equity-linked
 securities issued or issuable to any seller in the initial Business
 Combination).</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b><i>Warrants</i></b>&#x2014;Public Warrants may only be exercised
 for a whole number of shares. No fractional Public Warrants will be
 issued upon separation of the Units and only whole Public Warrants
 will trade. The Public Warrants will become exercisable on the
 later of (a) 30 days after the completion of a Business Combination
 and (b) 12 months from the closing of the Initial Public Offering;
 provided in each case that the Company has an effective
 registration statement under the Securities Act covering the
 issuance of the shares of Class&#xA0;A common stock issuable upon
 exercise of the Public Warrants and a current prospectus relating
 to them is available and such shares are registered, qualified or
 exempt from registration under the securities, or blue sky, laws of
 the state of residence of the holder (or the Company permits
 holders to exercise their Public Warrants on a cashless basis under
 the circumstances specified in the warrant agreement). The Company
 has agreed that as soon as practicable, but in no event later than
 20 business days after the closing of the initial Business
 Combination, the Company will use its commercially reasonable
 efforts to file, and within 60 business days following the initial
 Business Combination to have declared effective, a registration
 statement covering the issuance of the shares of Class&#xA0;A
 common stock issuable upon exercise of the warrants and to maintain
 a current prospectus relating to those shares of Class&#xA0;A
 common stock until the warrants expire or are redeemed; provided,
 that if the Class&#xA0;A common stock is at the time of any
 exercise of a warrant not listed on a national securities exchange
 such that it satisfies the definition of a &#x201C;covered
 security&#x201D; under Section&#xA0;18(b)(1) of the Securities Act,
 the Company may, at its option, require holders of Public Warrants
 who exercise their warrants to do so on a &#x201C;cashless
 basis&#x201D; in accordance with Section&#xA0;3(a)(9) of the
 Securities Act and, in the event the Company so elects, it will not
 be required to file or maintain in effect a registration statement,
 but it will be required to use its best efforts to register or
 qualify the shares under applicable blue sky laws to the extent an
 exemption is not available. The Public Warrants will expire five
 years after the completion of a Business Combination or earlier
 upon redemption or liquidation.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The warrants have an exercise price of $11.50 per share. If
 (x)&#xA0;the Company issue additional shares or equity-linked
 securities for capital raising purposes in connection with the
 closing of the initial Business Combination at an issue price or
 effective issue price of less than $9.20 per share (as adjusted for
 stock splits, stock dividends, rights issuances, subdivisions,
 reorganizations, recapitalizations and the like) (with such issue
 price or effective issue price to be determined in good faith by
 the Company&#x2019;s board of directors, and in the case of any such
 issuance to the Sponsor, initial stockholders or their affiliates,
 without taking into account any Founder Shares held by them prior
 to such issuance) (the &#x201C;Newly Issued Price&#x201D;), (y) the
 aggregate gross proceeds from such issuances represent more than
 60% of the total equity proceeds, and interest thereon, available
 for the funding of the initial Business Combination on the date of
 the consummation of the Initial Business Combination (net of
 redemptions), and (z)&#xA0;the volume weighted average trading
 price of the Company&#x2019;s shares of Class&#xA0;A common stock
 during the 20 trading day period starting on the trading day prior
 to the day on which the Company consummates the initial Business
 Combination (such price, the &#x201C;Market Value&#x201D;) is below
 $9.20 per share, the exercise price of each warrant will be
 adjusted (to the nearest cent) such that the effective exercise
 price per full share will be equal to 115% of the higher of
 (i)&#xA0;the Market Value and (ii)&#xA0;the Newly Issued Price, and
 the $18.00&#xA0;per share redemption trigger price described below
 will be adjusted (to the nearest cent) to be equal to 180% of the
 higher of (i)&#xA0;the Market Value and (ii)&#xA0;the Newly Issued
 Price.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Private Placement Warrants are identical to the Public
 Warrants, except that (1)&#xA0;the Private Placement Warrants and
 the shares of Class&#xA0;A common stock issuable upon exercise of
 the Private Placement Warrants are not transferable, assignable or
 salable until 30 days after the completion of a Business
 Combination, subject to certain limited exceptions, (2)&#xA0;the
 Private Placement Warrants are be <font style="white-space:nowrap">non-redeemable</font> (except as described
 below) so long as they are held by the Sponsor or its permitted
 transferees, (3)&#xA0;the Private Placement Warrants may be
 exercised by the holders on a cashless basis and (4)&#xA0;the
 holders of the Private Placement Warrants (including with respect
 to the shares of common stock issuable upon exercise of the Private
 Placement Warrants) are entitled to registration rights. If the
 Private Placement Warrants are held by someone other than the
 Sponsor or its permitted transferees, the Private Placement
 Warrants will be redeemable by the Company in all redemption
 scenarios and exercisable by such holders on the same basis as the
 Public Warrants.</p>
 <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Company may call the Public Warrants for redemption:</p>
 <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
 <tr style="page-break-inside:avoid">
 <td width="5%">&#xA0;</td>
 <td width="3%" valign="top" align="left">&#x2022;</td>
 <td width="1%" valign="top">&#xA0;</td>
 <td align="left" valign="top">
 <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
 in whole and not in part;</p>
 </td>
 </tr>
 </table>
 <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
 <tr style="page-break-inside:avoid">
 <td width="5%">&#xA0;</td>
 <td width="3%" valign="top" align="left">&#x2022;</td>
 <td width="1%" valign="top">&#xA0;</td>
 <td align="left" valign="top">
 <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
 at a price of $0.01 per warrant;</p>
 </td>
 </tr>
 </table>
 <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
 <tr style="page-break-inside:avoid">
 <td width="5%">&#xA0;</td>
 <td width="3%" valign="top" align="left">&#x2022;</td>
 <td width="1%" valign="top">&#xA0;</td>
 <td align="left" valign="top">
 <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
 upon a minimum of 30 days&#x2019; prior written notice of
 redemption; and</p>
 </td>
 </tr>
 </table>
 <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
 <tr style="page-break-inside:avoid">
 <td width="5%">&#xA0;</td>
 <td width="3%" valign="top" align="left">&#x2022;</td>
 <td width="1%" valign="top">&#xA0;</td>
 <td align="left" valign="top">
 <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
 if, and only if, the last reported sale price of the Class&#xA0;A
 common stock equals or exceeds $18.00 per share (as adjusted for
 stock splits, stock dividends, reorganizations, recapitalizations
 and the like) for any 20 trading days within the <font style="white-space:nowrap">30-trading</font> day period ending on the
 third business day prior to the date on which the Company sends the
 notice of redemption to the warrant holders.</p>
 </td>
 </tr>
 </table>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 If the Company calls the Public Warrants for redemption, management
 will have the option to require all holders that wish to exercise
 the Public Warrants to do so on a &#x201C;cashless basis,&#x201D; as
 described in the warrant agreement.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 In addition, commencing ninety days after the warrants become
 exercisable, the Company may redeem the outstanding warrants:</p>
 <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
 <tr style="page-break-inside:avoid">
 <td width="5%">&#xA0;</td>
 <td width="3%" valign="top" align="left">&#x2022;</td>
 <td width="1%" valign="top">&#xA0;</td>
 <td align="left" valign="top">
 <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
 in whole and not in part;</p>
 </td>
 </tr>
 </table>
 <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
 <tr style="page-break-inside:avoid">
 <td width="5%">&#xA0;</td>
 <td width="3%" valign="top" align="left">&#x2022;</td>
 <td width="1%" valign="top">&#xA0;</td>
 <td align="left" valign="top">
 <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
 at $0.10 per warrant upon a minimum of 30 days&#x2019; prior written
 notice of redemption provided that holders will be able to exercise
 their warrants on a cashless basis prior to redemption and receive
 that number of shares of Class&#xA0;A common stock to be determined
 by reference to a table in the warrant agreement;</p>
 </td>
 </tr>
 </table>
 <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
 <tr style="page-break-inside:avoid">
 <td width="5%">&#xA0;</td>
 <td width="3%" valign="top" align="left">&#x2022;</td>
 <td width="1%" valign="top">&#xA0;</td>
 <td align="left" valign="top">
 <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
 if, and only if, the last reported sale price of the
 Company&#x2019;s Class&#xA0;A common stock equals or exceeds $10.00
 per share (as adjusted for stock splits, stock dividends,
 reorganizations, recapitalizations and the like) on the trading day
 prior to the date on which the Company sends the notice of
 redemption to the warrant holders;</p>
 </td>
 </tr>
 </table>
 <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
 <tr style="page-break-inside:avoid">
 <td width="5%">&#xA0;</td>
 <td width="3%" valign="top" align="left">&#x2022;</td>
 <td width="1%" valign="top">&#xA0;</td>
 <td align="left" valign="top">
 <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
 if, and only if, the Private Placement Warrants are also
 concurrently called for redemption at the same price (equal to a
 number of shares of Class&#xA0;A common stock) as the outstanding
 Public Warrants, as described above; and</p>
 </td>
 </tr>
 </table>
 <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
 <tr style="page-break-inside:avoid">
 <td width="5%">&#xA0;</td>
 <td width="3%" valign="top" align="left">&#x2022;</td>
 <td width="1%" valign="top">&#xA0;</td>
 <td align="left" valign="top">
 <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
 if, and only if, there is an effective registration statement
 covering the shares of Class&#xA0;A common stock (or a security
 other than the Class&#xA0;A common stock into which the
 Class&#xA0;A common stock has been converted or exchanged for in
 the event the Company is not the surviving company in the initial
 Business Combination) issuable upon exercise of the warrants and a
 current prospectus relating thereto available throughout the
 <font style="white-space:nowrap">30-day</font> period after written
 notice of redemption is given.</p>
 </td>
 </tr>
 </table>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 In no event will the Company be required to net cash settle any
 warrant. If the Company is unable to complete a Business
 Combination within the Combination Period and the Company
 liquidates the funds held in the Trust Account, holders of warrants
 will not receive any of such funds with respect to their warrants,
 nor will they receive any distribution from the Company&#x2019;s
 assets held outside of the Trust Account with the respect to such
 warrants. Accordingly, the warrants may expire worthless.</p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487437042408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Note 7&#x2014;Fair Value Measurements</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Company follows the guidance in ASC 820 for its financial
 assets and liabilities that are <font style="white-space:nowrap">re-measured</font> and reported at fair value
 at each reporting period, and <font style="white-space:nowrap">non-financial</font> assets and liabilities
 that are <font style="white-space:nowrap">re-measured</font> and
 reported at fair value at least annually.</p>
 <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The fair value of the Company&#x2019;s financial assets and
 liabilities reflects management&#x2019;s estimate of amounts that
 the Company would have received in connection with the sale of the
 assets or paid in connection with the transfer of the liabilities
 in an orderly transaction between market participants at the
 measurement date. In connection with measuring the fair value of
 its assets and liabilities, the Company seeks to maximize the use
 of observable inputs (market data obtained from independent
 sources) and to minimize the use of unobservable inputs (internal
 assumptions about how market participants would price assets and
 liabilities). The following fair value hierarchy is used to
 classify assets and liabilities based on the observable inputs and
 unobservable inputs used in order to value the assets and
 liabilities:</p>
 <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
 <tr style="page-break-inside:avoid">
 <td width="5%">&#xA0;</td>
 <td width="3%" valign="top" align="left">&#x2022;</td>
 <td width="1%" valign="top">&#xA0;</td>
 <td align="left" valign="top">
 <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
 Level 1: Quoted prices in active markets for identical assets or
 liabilities. An active market for an asset or liability is a market
 in which transactions for the asset or liability occur with
 sufficient frequency and volume to provide pricing information on
 an ongoing basis.</p>
 </td>
 </tr>
 </table>
 <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
 <tr style="page-break-inside:avoid">
 <td width="5%">&#xA0;</td>
 <td width="3%" valign="top" align="left">&#x2022;</td>
 <td width="1%" valign="top">&#xA0;</td>
 <td align="left" valign="top">
 <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
 Level 2: Observable inputs other than Level&#xA0;1 inputs. Examples
 of Level&#xA0;2 inputs include quoted prices in active markets for
 similar assets or liabilities and quoted prices for identical
 assets or liabilities in markets that are not active.</p>
 </td>
 </tr>
 </table>
 <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%">
 <tr style="page-break-inside:avoid">
 <td width="5%">&#xA0;</td>
 <td width="3%" valign="top" align="left">&#x2022;</td>
 <td width="1%" valign="top">&#xA0;</td>
 <td align="left" valign="top">
 <p align="left" style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
 Level 3: Unobservable inputs based on the Company&#x2019;s
 assessment of the assumptions that market participants would use in
 pricing the asset or liability.</p>
 </td>
 </tr>
 </table>
 <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <table cellspacing="0" cellpadding="0" width="76%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">
 <tr>
 <td width="71%"></td>
 <td valign="bottom" width="7%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="7%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
 <td valign="bottom" nowrap="nowrap">
 <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;">
 <b>Description</b></p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"><b>Level</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"><b>June&#xA0;30, 2020</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
 <td valign="top">
 <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">
 Assets:</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
 <td valign="top">
 <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">
 Cash held in Trust Account</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">1</td>
 <td nowrap="nowrap" valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">230,000,000</td>
 <td nowrap="nowrap" valign="bottom">&#xA0;</td>
 </tr>
 </table>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487514239688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Note 7&#x2014;Subsequent Events</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 Subsequent to May&#xA0;1, 2020, the Company has borrowed $75,000
 under the Note.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Company evaluated events that have occurred after the balance
 sheet date through May&#xA0;8, 2020, which is the date on which
 these financial statements were issued. Based upon this review,
 except as below, the Company did not identify any other subsequent
 events that would have required adjustment or disclosure in the
 financial statements.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 On June&#xA0;25, 2020, the Company effected a stock dividend of
 718,750 shares, resulting in the Sponsor holding an aggregate of
 5,750,000 Founder Shares, of which an aggregate of up to 750,000
 shares are subject to forfeiture. All share and <font style="WHITE-SPACE: nowrap">per-share</font> amounts have been
 retroactively restated to reflect the stock dividend.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 As a result of the execution of the underwriting agreement on
 June&#xA0;25, 2020, the financial statements have been modified to
 reflect the final terms of the agreement.</p>
 </div><span></span>
</td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial">
 <b>Note 8&#x2014;Subsequent Events</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: &quot;Times New Roman&quot;; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(0,0,0); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial">
 On October 2, 2020, a putative class action lawsuit was filed
 against the Company. The complaint names the Company and certain
 members of the Company&#x2019;s board as defendants. The complaint
 alleges, among other things, breach of fiduciary duty claims in
 connection with the proposed business combination with QuantumScape
 Corporation. Management with its legal counsel are currently
 evaluating the merits of the complaint and as of June 30, 2020, the
 Company had not accrued any amounts for this contingency.</p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487430024952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Basis of Presentation</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The accompanying unaudited condensed financial statements are
 presented in U.S. dollars in conformity with accounting principles
 generally accepted in the United States of America
 (&#x201C;GAAP&#x201D;) for financial information and pursuant to the
 rules and regulations of the SEC. Accordingly, they do not include
 all of the information and footnotes required by GAAP. In the
 opinion of management, the unaudited condensed financial statements
 reflect all adjustments, which include only normal recurring
 adjustments necessary for the fair statement of the balances and
 results for the periods presented. Operating results for the period
 for the period from April&#xA0;17, 2020 (inception) through
 June&#xA0;30, 2020 are not necessarily indicative of the results
 that may be expected through December&#xA0;31, 2020.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The accompanying unaudited condensed financial statements should be
 read in conjunction with the audited financial statements and notes
 thereto included in the Form <font style="white-space:nowrap">8-K</font> and the final prospectus filed by
 the Company with the SEC on July&#xA0;7, 2020 and June&#xA0;26,
 2020, respectively.</p>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_EmergingGrowthCompanyPolicyTextBlock', window );">Emerging Growth Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Emerging Growth Company</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Company is an &#x201C;emerging growth company,&#x201D; as defined
 in Section&#xA0;2(a) of the Securities Act, as modified by the
 Jumpstart Our Business Startups Act of 2012 (the &#x201C;JOBS
 Act&#x201D;), and it may take advantage of certain exemptions from
 various reporting requirements that are applicable to other public
 companies that are not emerging growth companies including, but not
 limited to, not being required to comply with the independent
 registered public accounting firm attestation requirements of
 Section&#xA0;404 of the Sarbanes-Oxley Act, reduced disclosure
 obligations regarding executive compensation in its periodic
 reports and proxy statements, and exemptions from the requirements
 of holding a nonbinding advisory vote on executive compensation and
 stockholder approval of any golden parachute payments not
 previously approved.</p>
 <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 Further, Section&#xA0;102(b)(1) of the JOBS Act exempts emerging
 growth companies from being required to comply with new or revised
 financial accounting standards until private companies (that is,
 those that have not had a Securities Act registration statement
 declared effective or do not have a class of securities registered
 under the Exchange Act) are required to comply with the new or
 revised financial accounting standards. The JOBS Act provides that
 an emerging growth company can elect to opt out of the extended
 transition period and comply with the requirements that apply to
 <font style="white-space:nowrap">non-emerging</font> growth
 companies but any such an election to opt out is irrevocable. The
 Company has elected not to opt out of such extended transition
 period, which means that when a standard is issued or revised and
 it has different application dates for public or private companies,
 the Company, as an emerging growth company, can adopt the new or
 revised standard at the time private companies adopt the new or
 revised standard.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 This may make comparison of the Company&#x2019;s financial
 statements with another public company that is neither an emerging
 growth company nor an emerging growth company that has opted out of
 using the extended transition period difficult or impossible
 because of the potential differences in accounting standards
 used.</p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Cash and Cash Equivalents</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Company considers all short-term investments with an original
 maturity of three months or less when purchased to be cash
 equivalents. The Company had no cash equivalents as of
 June&#xA0;30, 2020.</p>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_CashHeldInTrustAccountPolicyTextBlock', window );">Cash held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Cash held in Trust Account</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 At June&#xA0;30, 2020, the Company had $230.0&#xA0;million in cash
 held in the Trust Account.</p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 <b>Concentration of Credit Risk</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 Financial instruments that potentially subject the Company to
 concentrations of credit risk consist of cash accounts in a
 financial institution, which, at times, may exceed the Federal
 Depository Insurance Coverage limit of $250,000. At May&#xA0;1,
 2020, the Company has not experienced losses on these accounts and
 management believes the Company is not exposed to significant risks
 on such accounts.</p>
 </div><span></span>
</td>
<td class="text"><div>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Concentration of Credit Risk</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 Financial instruments that potentially subject the Company to
 concentrations of credit risk consist of cash accounts in a
 financial institution, which, at times, may exceed the Federal
 Depository Insurance Coverage limit of $250,000. The Company has
 not experienced losses on these accounts and management believes
 the Company is not exposed to significant risks on such
 accounts.</p>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Financial Instruments</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Financial Instruments</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The fair value of the Company&#x2019;s assets and liabilities, which
 qualify as financial instruments under FASB ASC 820, &#x201C;Fair
 Value Measurements and Disclosures,&#x201D; approximates the
 carrying amounts represented in the balance sheet.</p>
 </div><span></span>
</td>
<td class="text"><div>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Financial Instruments</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The fair value of the Company&#x2019;s assets and liabilities, which
 qualify as financial instruments under FASB ASC&#xA0;820,
 &#x201C;Fair Value Measurements and Disclosures,&#x201D; approximates
 the carrying amounts represented in the condensed financial
 statements.</p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Use of Estimates</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The preparation of financial statements in conformity with U.S.
 GAAP requires the Company&#x2019;s management to make estimates and
 assumptions that affect the reported amounts of assets and
 liabilities and disclosure of contingent assets and liabilities
 during the reporting period. Actual results could differ from those
 estimates.</p>
 </div><span></span>
</td>
<td class="text"><div>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Use of Estimates</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The preparation of the financial statements in conformity with U.S.
 GAAP requires the Company&#x2019;s management to make estimates and
 assumptions that affect the reported amounts of assets and
 liabilities and disclosure of contingent assets and liabilities at
 the date of the financial statements and the reported amounts of
 revenues and expenses during the reporting period. Actual results
 could differ from those estimates.</p>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_OfferingCostsPolicyTextBlock', window );">Offering Costs Associated with the Initial Public Offering</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Deferred Offering Costs Associated with the Proposed Public
 Offering</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 Deferred offering costs consist of legal, accounting, underwriting
 fees and other costs incurred through the balance sheet date that
 are directly related to the Proposed Public Offering and that will
 be charged to stockholder&#x2019;s equity upon the completion of the
 Proposed Public Offering. Should the Proposed Public Offering prove
 to be unsuccessful, these deferred costs, as well as additional
 expenses to be incurred, will be charged to operations.</p>
 </div><span></span>
</td>
<td class="text"><div>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Offering Costs Associated with the Initial Public
 Offering</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 Offering costs consist of legal, accounting, underwriting fees and
 other costs incurred through the balance sheet date that are
 directly related to the Initial Public Offering and that were
 charged to stockholders&#x2019; equity upon the completion of the
 Initial Public Offering.</p>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock', window );">Class A common stock subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt">
 <b>Class&#xA0;A common stock subject to possible redemption</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company accounts for its Class&#xA0;A common stock subject to
 possible redemption in accordance with the guidance in ASC Topic
 480 &#x201C;Distinguishing Liabilities from Equity.&#x201D;
 Class&#xA0;A common stock subject to mandatory redemption (if any)
 is classified as liability instruments and are measured at fair
 value. Conditionally redeemable Class&#xA0;A common stock
 (including Class&#xA0;A common stock that features redemption
 rights that are either within the control of the holder or subject
 to redemption upon the occurrence of uncertain events not solely
 within the Company&#x2019;s control) are classified as temporary
 equity. At all other times, Class&#xA0;A common stock is classified
 as stockholders&#x2019; equity. The Company&#x2019;s Class&#xA0;A
 common stock feature certain redemption rights that are considered
 to be outside of the Company&#x2019;s control and subject to the
 occurrence of uncertain future events. Accordingly, at
 June&#xA0;30, 2020, 21,843,927 shares of Class&#xA0;A common stock
 subject to possible redemption is presented at redemption value as
 temporary equity, outside of the stockholders&#x2019; equity section
 of the Company&#x2019;s balance sheet.</p>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Common Share</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt">
 <b>Net Loss Per Common Share</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company complies with accounting and disclosure requirements of
 FASB ASC Topic 260, &#x201C;Earnings Per Share.&#x201D; Net loss per
 share is computed by dividing net loss by the weighted average
 number of shares of common stock outstanding during the period
 excluding common stock subject to forfeiture. Weighted average
 shares were reduced for the effect of an aggregate of 750,000
 shares of common stock that are subject to forfeiture if the
 over-allotment option is not exercised by the underwriters (Note
 5). At May&#xA0;1, 2020, the Company did not have any dilutive
 securities and other contracts that could, potentially, be
 exercised or converted into shares of common stock and then share
 in the earnings of the Company. As a result, diluted loss per share
 is the same as basic loss per share for the period presented.</p>
 </div><span></span>
</td>
<td class="text"><div>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Net Loss Per Common Share</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Company complies with accounting and disclosure requirements of
 FASB ASC Topic 260, &#x201C;Earnings Per Share.&#x201D; Net loss per
 share is computed by dividing net loss by the weighted average
 number of shares of common stock outstanding during the period
 excluding common stock subject to forfeiture. An aggregate of
 21,843,927 shares of Class&#xA0;A common stock subject to possible
 redemption at June&#xA0;30, 2020 has been excluded from the
 calculation of basic loss per share of common stock, since such
 shares, if redeemed, only participate in their pro rata share of
 the trust earnings. The Company has not considered the effect of
 the warrants sold in the Initial Public Offering (including the
 consummation of the Over-Allotment Units) and Private Placement to
 purchase an aggregate of 18,075,000 shares of the Company&#x2019;s
 common stock in the calculation of diluted loss per share, since
 the exercise of the warrants are contingent upon the occurrence of
 future events.</p>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b><i>Reconciliation of net loss per common share</i></b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Company&#x2019;s net loss is adjusted for the portion of income
 (loss) that is attributable to Class&#xA0;A common stock subject to
 redemption, as these shares only participate in the earnings of the
 Trust Account and not the income or losses of the Company.
 Accordingly, basic and diluted loss per common share is calculated
 as follows:</p>
 <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <table cellspacing="0" cellpadding="0" width="68%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">
 <tr>
 <td width="71%"></td>
 <td valign="bottom" width="19%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">
 <b>For&#xA0;The&#xA0;Period&#xA0;From</b><br />
 <b>April&#xA0;17, 2020</b><br />
 <b>(inception)&#xA0;through</b><br />
 <b>June&#xA0;30, 2020</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
 <td valign="top">
 <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">
 Net loss</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(62,862</td>
 <td nowrap="nowrap" valign="bottom">)&#xA0;</td>
 </tr>
 <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
 <td valign="top">
 <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">
 Less: Income attributable to Class&#xA0;A ordinary shares subject
 to possible redemption</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td nowrap="nowrap" valign="bottom">&#xA0;</td>
 <td nowrap="nowrap" valign="bottom" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td nowrap="nowrap" valign="bottom">&#xA0;</td>
 </tr>
 <tr style="font-size:1px;">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">
 &#xA0;</p>
 </td>
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">
 &#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
 <td valign="top">
 <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">
 Adjusted net loss</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(62,862</td>
 <td nowrap="nowrap" valign="bottom">)&#xA0;</td>
 </tr>
 <tr style="font-size:1px;">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">
 &#xA0;</p>
 </td>
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">
 &#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
 <td valign="top">
 <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">
 Weighted average ordinary shares outstanding, basic and diluted</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">5,031,247</td>
 <td nowrap="nowrap" valign="bottom">&#xA0;</td>
 </tr>
 <tr style="font-size:1px;">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">
 &#xA0;</p>
 </td>
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">
 &#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">
 Basic and diluted net loss per ordinary share</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"><b>$</b></td>
 <td valign="bottom" align="right"><b>(0.01</b></td>
 <td nowrap="nowrap" valign="bottom"><b>)&#xA0;</b></td>
 </tr>
 <tr style="font-size:1px;">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">
 &#xA0;</p>
 </td>
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">
 &#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Income Taxes</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company follows the asset and liability method of accounting
 for income taxes under FASB ASC 740, &#x201C;Income Taxes.&#x201D;
 Deferred tax assets and liabilities are recognized for the
 estimated future tax consequences attributable to differences
 between the financial statements carrying amounts of existing
 assets and liabilities and their respective tax bases. Deferred tax
 assets and liabilities are measured using enacted tax rates
 expected to apply to taxable income in the years in which those
 temporary differences are expected to be recovered or settled. The
 effect on deferred tax assets and liabilities of a change in tax
 rates is recognized in income in the period that included the
 enactment date. Valuation allowances are established, when
 necessary, to reduce deferred tax assets to the amount expected to
 be realized. Deferred tax assets were deemed immaterial as of
 May&#xA0;1, 2020.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 FASB ASC 740 prescribes a recognition threshold and a measurement
 attribute for the financial statement recognition and measurement
 of tax positions taken or expected to be taken in a tax return. For
 those benefits to be recognized, a tax position must be more likely
 than not to be sustained upon examination by taxing authorities.
 There were no unrecognized tax benefits as of May&#xA0;1, 2020. The
 Company recognizes accrued interest and penalties related to
 unrecognized tax benefits as income tax expense. No amounts were
 accrued for the payment of interest and penalties as of May&#xA0;1,
 2020. The Company is currently not aware of any issues under review
 that could result in significant payments, accruals or material
 deviation from its position. The Company is subject to income tax
 examinations by major taxing authorities since inception.</p>
 </div><span></span>
</td>
<td class="text"><div>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Income Taxes</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Company follows the asset and liability method of accounting
 for income taxes under FASB ASC 740, &#x201C;Income Taxes.&#x201D;
 Deferred tax assets and liabilities are recognized for the
 estimated future tax consequences attributable to differences
 between the financial statements carrying amounts of existing
 assets and liabilities and their respective tax bases. Deferred tax
 assets and liabilities are measured using enacted tax rates
 expected to apply to taxable income in the years in which those
 temporary differences are expected to be recovered or settled. The
 effect on deferred tax assets and liabilities of a change in tax
 rates is recognized in income in the period that included the
 enactment date. Valuation allowances are established, when
 necessary, to reduce deferred tax assets to the amount expected to
 be realized. Deferred tax assets were deemed immaterial as of
 June&#xA0;30, 2020.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 FASB ASC 740 prescribes a recognition threshold and a measurement
 attribute for the financial statement recognition and measurement
 of tax positions taken or expected to be taken in a tax return. For
 those benefits to be recognized, a tax position must be more likely
 than not to be sustained upon examination by taxing authorities.
 There were no unrecognized tax benefits as of June&#xA0;30, 2020.
 The Company recognizes accrued interest and penalties related to
 unrecognized tax benefits as income tax expense. No amounts were
 accrued for the payment of interest and penalties as of
 June&#xA0;30, 2020. The Company is currently not aware of any
 issues under review that could result in significant payments,
 accruals or material deviation from its position. The Company is
 subject to income tax examinations by major taxing authorities
 since inception.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 On March&#xA0;27, 2020, President Trump signed the Coronavirus Aid,
 Relief, and Economic Security &#x201C;CARES&#x201D; Act into law. The
 CARES Act includes several significant business tax provisions
 that, among other things, would eliminate the taxable income limit
 for certain net operating losses (&#x201C;NOL) and allow businesses
 to carry back NOLs arising in 2018, 2019 and 2020 to the five prior
 years, suspend the excess business loss rules, accelerate refunds
 of previously generated corporate alternative minimum tax credits,
 generally loosen the business interest limitation under IRC section
 163(j) from 30&#xA0;percent to 50&#xA0;percent among other
 technical corrections included in the Tax Cuts and Jobs Act tax
 provisions. The Company does not believe that the CARES Act will
 have a significant impact on Company&#x2019;s financial position or
 statement of operations.</p>
 </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Recent Accounting Pronouncements</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company&#x2019;s management does not believe that any recently
 issued, but not yet effective, accounting standards if currently
 adopted would have a material effect on the accompanying financial
 statements.</p>
 </div><span></span>
</td>
<td class="text"><div>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>Recent Accounting Standards</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Company&#x2019;s management does not believe that any recently
 issued, but not yet effective, accounting standards updates, if
 currently adopted would have a material effect on the accompanying
 financial statements.</p>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_CashHeldInTrustAccountPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash held in trust account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_CashHeldInTrustAccountPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_EmergingGrowthCompanyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Emerging growth company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_EmergingGrowthCompanyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_OfferingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Offering costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_OfferingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487436997528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract', window );"><strong>Schedule Of Earnings Per Share Basic And Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Summary of Basic and Diluted Loss per Share of Common Stock</a></td>
<td class="text"><div>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 The Company&#x2019;s net loss is adjusted for the portion of income
 (loss) that is attributable to Class&#xA0;A common stock subject to
 redemption, as these shares only participate in the earnings of the
 Trust Account and not the income or losses of the Company.
 Accordingly, basic and diluted loss per common share is calculated
 as follows:</p>
 <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">
 &#xA0;</p>
 <table cellspacing="0" cellpadding="0" width="68%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">
 <tr>
 <td width="71%"></td>
 <td valign="bottom" width="19%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000">
 <b>For&#xA0;The&#xA0;Period&#xA0;From</b><br />
 <b>April&#xA0;17, 2020</b><br />
 <b>(inception)&#xA0;through</b><br />
 <b>June&#xA0;30, 2020</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
 <td valign="top">
 <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">
 Net loss</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(62,862</td>
 <td nowrap="nowrap" valign="bottom">)&#xA0;</td>
 </tr>
 <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
 <td valign="top">
 <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">
 Less: Income attributable to Class&#xA0;A ordinary shares subject
 to possible redemption</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td nowrap="nowrap" valign="bottom">&#xA0;</td>
 <td nowrap="nowrap" valign="bottom" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td nowrap="nowrap" valign="bottom">&#xA0;</td>
 </tr>
 <tr style="font-size:1px;">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">
 &#xA0;</p>
 </td>
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">
 &#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
 <td valign="top">
 <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">
 Adjusted net loss</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(62,862</td>
 <td nowrap="nowrap" valign="bottom">)&#xA0;</td>
 </tr>
 <tr style="font-size:1px;">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">
 &#xA0;</p>
 </td>
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">
 &#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
 <td valign="top">
 <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">
 Weighted average ordinary shares outstanding, basic and diluted</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">5,031,247</td>
 <td nowrap="nowrap" valign="bottom">&#xA0;</td>
 </tr>
 <tr style="font-size:1px;">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">
 &#xA0;</p>
 </td>
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">
 &#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">
 Basic and diluted net loss per ordinary share</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"><b>$</b></td>
 <td valign="bottom" align="right"><b>(0.01</b></td>
 <td nowrap="nowrap" valign="bottom"><b>)&#xA0;</b></td>
 </tr>
 <tr style="font-size:1px;">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">
 &#xA0;</p>
 </td>
 <td valign="bottom">
 <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">
 &#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Earnings Per Share Basic And Diluted [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487439656712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Summary of Assets Measured at Fair Value</a></td>
<td class="text"><div>
 <table cellspacing="0" cellpadding="0" width="76%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center">
 <tr>
 <td width="71%"></td>
 <td valign="bottom" width="7%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="7%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
 <td valign="bottom" nowrap="nowrap">
 <p style="margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;">
 <b>Description</b></p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"><b>Level</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"><b>June&#xA0;30, 2020</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr bgcolor="#CCEEFF" style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
 <td valign="top">
 <p style="margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">
 Assets:</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
 <td valign="top">
 <p style="margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">
 Cash held in Trust Account</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">1</td>
 <td nowrap="nowrap" valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">230,000,000</td>
 <td nowrap="nowrap" valign="bottom">&#xA0;</td>
 </tr>
 </table>
 </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487429618712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization, Business Operations and Basis of Presentation - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 29, 2020</div></th>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems', window );"><strong>Description Of Organization Business Operations And Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of stock offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,907,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Issue price of warrants</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Assets held in trust</a></td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Redemption price per share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_MaximumNetTangibleAssetsForBusinessCombination', window );">Maximum net tangible assets for business combination</a></td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_PercentageOfPublicSharesToBeRedeemed1', window );">Percentage of public shares to redeem</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_InterestToPayDissolutionExpenses', window );">Interest to pay dissolution expenses</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">1,739,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">$ 1,739,697<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_WorkingCapital', window );">Working capital</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,000<span></span>
</td>
<td class="nump">$ 39,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_ProceedsFromSaleOfFoundersShares', window );">Proceeds from sale of founders shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation', window );">Number of units in a proposed public offering required to obtain adequate financial resources to commence operation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull', window );">Number of units in proposed public offering if the underwriters overallotment option exercised in full</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_ProposedPublicOfferingSharePrice', window );">Proposed public offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation', window );">Number of warrants in proposed public offering required to obtain adequate financial resources to commence operation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,975,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull', window );">Number of warrants in proposed public offering if the underwriters overallotment option is exercised in full</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,575,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_PricePerPrivatePlacementWarrant', window );">Price per private placement warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_PercentageOfSharesToBeRedeemedWithoutConsent', window );">Percentage of shares to be redeemed without consent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_PercentageOfPublicSharesToBeRedeemed', window );">Percentage of public shares to redeem</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=kcac_SponsorMember', window );">Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems', window );"><strong>Description Of Organization Business Operations And Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Loan proceeds from sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems', window );"><strong>Description Of Organization Business Operations And Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Redemption price per share</a></td>
<td class="nump">10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00<span></span>
</td>
<td class="nump">10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=kcac_PrivatePlacementWarrantsMember', window );">Private Placement Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems', window );"><strong>Description Of Organization Business Operations And Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_ClassOfWarrantsOrRightsIssued', window );">Number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,575,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Issue price of warrants</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="nump">$ 6,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Initial Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems', window );"><strong>Description Of Organization Business Operations And Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold</a></td>
<td class="nump">23,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock issue price</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of units in initial public offering, gross</a></td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of stock offering costs</a></td>
<td class="nump">13,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_PaymentOfDeferredUnderwritingCommissions', window );">Payment of deferred underwriting commissions</a></td>
<td class="nump">$ 8,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Initial Public Offering | Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems', window );"><strong>Description Of Organization Business Operations And Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of units in initial public offering, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Initial Public Offering | Private Placement Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems', window );"><strong>Description Of Organization Business Operations And Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock issue price</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Assets held in trust</a></td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems', window );"><strong>Description Of Organization Business Operations And Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Units | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems', window );"><strong>Description Of Organization Business Operations And Basis Of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_ClassOfWarrantsOrRightsIssued', window );">Number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,575,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_ClassOfWarrantsOrRightsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrants or rights issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_ClassOfWarrantsOrRightsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of organization, business operations and basis of presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_DescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_InterestToPayDissolutionExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest to pay dissolution expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_InterestToPayDissolutionExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_MaximumNetTangibleAssetsForBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum net tangible assets for business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_MaximumNetTangibleAssetsForBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of units in proposed public offering if the underwriters overallotment option exercised in full.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_NumberOfUnitsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionExercisedInFull</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of units in a proposed public offering required to obtain adequate financial resources to commence operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_NumberOfUnitsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants in proposed public offering if the underwriters overallotment option is exercised in full.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_NumberOfWarrantsInProposedPublicOfferingIfTheUnderwritersOverallotmentOptionIsExercisedInFull</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants in proposed public offering required to obtain adequate financial resources to commence operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_NumberOfWarrantsInProposedPublicOfferingRequiredToObtainAdequateFinancialResourcesToCommenceOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_PaymentOfDeferredUnderwritingCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of deferred underwriting commissions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_PaymentOfDeferredUnderwritingCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_PercentageOfPublicSharesToBeRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of public shares to be redeemed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_PercentageOfPublicSharesToBeRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_PercentageOfPublicSharesToBeRedeemed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of public shares to be redeemed one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_PercentageOfPublicSharesToBeRedeemed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_PercentageOfSharesToBeRedeemedWithoutConsent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of shares to be redeemed without consent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_PercentageOfSharesToBeRedeemedWithoutConsent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_PricePerPrivatePlacementWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price per private placement warrant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_PricePerPrivatePlacementWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_ProceedsFromSaleOfFoundersShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of founders shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_ProceedsFromSaleOfFoundersShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_ProposedPublicOfferingSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proposed public offering share price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_ProposedPublicOfferingSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Working capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=kcac_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=kcac_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=kcac_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=kcac_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487438886792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Cash held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit', window );">Concentrations of credit risk federal depository insurance coverage limit</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued for payment of interest and penalties</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted average shares subject to forfeiture</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,075,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis=kcac_ClassaCommonStockSubjectToMandatoryRedemptionMember', window );">Class A Common Stock Subject To Mandatory Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,843,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,843,927<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Concentrations of credit risk federal depository insurance coverage limit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_ConcentrationsOfCreditRiskFederalDepositoryInsuranceCoverageLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis=kcac_ClassaCommonStockSubjectToMandatoryRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis=kcac_ClassaCommonStockSubjectToMandatoryRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487436832840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Basic and Diluted Loss per Share of Common Stock (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">2 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>May 01, 2020</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract', window );"><strong>Schedule Of Earnings Per Share Basic And Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (2,500)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (62,862)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Adjusted net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (62,862)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average ordinary shares outstanding, basic and diluted</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">5,031,247<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per ordinary share</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On June 25, 2020, the Company effected a stock dividend with respect to the Class B common stock, resulting in the sponsor holding an aggregate of 5,750,000 founder shares . All shares and associated amounts have been retroactively restated to reflect the share capitalization (see Note 4).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">This number excludes an aggregate of up to 750,000 Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">This number excludes an aggregate of up to 21,843,927 shares of Class A common stock subject to possible redemption.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Earnings Per Share Basic And Diluted [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_ScheduleOfEarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487435287640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Public Offering - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of stock issue costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,907,692<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_DescriptionOfPublicWarrant', window );">Description of public warrant</a></td>
<td class="text">Each Unit consists of one share of Class A common stock and one-half of one  redeemable warrant<span></span>
</td>
<td class="text">Each Unit consists of one share  of Class A common stock (such shares of common stock included in the Units being  offered, the "Public Shares"), and one-half of one redeemable warrant (each, a  "Public Warrant").<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrant exercisable number of shares</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=kcac_IpoExcludingOverAllotmentMember', window );">IPO excluding over Allotment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Initial Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued</a></td>
<td class="nump">23,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Stock issue price</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Proceeds from issue of stock</a></td>
<td class="nump">$ 230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of stock issue costs</a></td>
<td class="nump">13,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_PaymentOfDeferredUnderwritingCommissions', window );">Payment of deferred underwriting commissions</a></td>
<td class="nump">$ 8,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Initial Public Offering | Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Proceeds from issue of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrant exercisable number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_DescriptionOfPublicWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of public warrant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_DescriptionOfPublicWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_PaymentOfDeferredUnderwritingCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment of deferred underwriting commissions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_PaymentOfDeferredUnderwritingCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=kcac_IpoExcludingOverAllotmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=kcac_IpoExcludingOverAllotmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487428645432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 25, 2020</div></th>
<th class="th"><div>Apr. 17, 2020</div></th>
<th class="th" colspan="2"><div>May 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Apr. 16, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination', window );">Period to issue warrant after completion of initial business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Note payable - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=kcac_FounderMember', window );">Founder | Over-Allotment Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Underwriter options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=kcac_FounderMember', window );">Founder | Over-Allotment Units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Shares forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=kcac_WorkingCapitalLoansMember', window );">Working Capital Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Borrowing outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=kcac_SponsorMember', window );">Sponsor | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_NumberOfTradingDays', window );">Number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=kcac_SponsorMember', window );">Sponsor | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_NumberOfTradingDays', window );">Number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_NumberOfDaysCommencingAfterInitialBusinessCombination', window );">Number of days commencing after initial business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">150 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">150 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=kcac_SponsorMember', window );">Sponsor | Over-Allotment Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_ClassOfWarrantsOrRightsIssued', window );">Number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,575,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=kcac_SponsorMember', window );">Sponsor | Private Placement Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_ClassOfWarrantsOrRightsIssued', window );">Number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,975,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,575,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_ClassOfWarrantsOrRightsIssuePrice', window );">Warrants price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 6,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=kcac_SponsorMember', window );">Sponsor | Promissory Note | Initial Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Note payable - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">DEHC LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Service and administrative fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty', window );">General and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">DEHC LLC | Daniel Huber</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_PeriodOfService', window );">Period of service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock to Sponsor, shares</a></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="nump">5,031,250<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Sponsor | Over-Allotment Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Underwriter options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Sponsor | Founder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock to Sponsor, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,031,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,156,073<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock | Sponsor | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_PercentageOfSharesIssuedAndOutstanding', window );">Percentage of shares issued and outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants | Working Capital Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion converted instrument amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On June 25, 2020, the Company effected a stock dividend with respect to the Class B common stock, resulting in the sponsor holding an aggregate of 5,750,000 founder shares . All shares and associated amounts have been retroactively restated to reflect the share capitalization (see Note 4).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">This number includes up to 750,000 Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_ClassOfWarrantsOrRightsIssuePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of Warrants or rights issue price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_ClassOfWarrantsOrRightsIssuePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_ClassOfWarrantsOrRightsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class of warrants or rights issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_ClassOfWarrantsOrRightsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_NumberOfDaysCommencingAfterInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of days commencing after initial business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_NumberOfDaysCommencingAfterInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_NumberOfTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of trading days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_NumberOfTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_PercentageOfSharesIssuedAndOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of shares issued and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_PercentageOfSharesIssuedAndOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_PeriodOfService">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_PeriodOfService</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period to issue warrant after completion of initial business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_PeriodToIssueWarrantAfterCompletionOfInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=kcac_FounderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=kcac_FounderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=kcac_WorkingCapitalLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=kcac_WorkingCapitalLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=kcac_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=kcac_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=kcac_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=kcac_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=kcac_PromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=kcac_PromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487429575848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments &amp; Contingencies - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_UnderwritingDiscountPerUnit', window );">Underwriting discount per unit</a></td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Payments for underwriting discount</a></td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_DeferredUnderwritingCommissionPerUnit', window );">Deferred underwriting commission per unit</a></td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_DeferredUnderwritingCommissionsNoncurrent', window );">Deferred underwriting commissions payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,050,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_DeferredUnderwritingCommissionsPayable', window );">Deferred underwriting commissions payable</a></td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=kcac_UnderwritersExerciseOfOverallotmentOptionMember', window );">Aggregate if the underwriters' over-allotment option is exercised in full</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Payments for underwriting discount</a></td>
<td class="nump">4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_DeferredUnderwritingCommissionsNoncurrent', window );">Deferred underwriting commissions payable</a></td>
<td class="nump">$ 8,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_DeferredUnderwritingCommissionPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred underwriting commission per unit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_DeferredUnderwritingCommissionPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_DeferredUnderwritingCommissionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred underwriting commissions noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_DeferredUnderwritingCommissionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_DeferredUnderwritingCommissionsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Underwriting Commissions Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_DeferredUnderwritingCommissionsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_UnderwritingDiscountPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Underwriting discount per unit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_UnderwritingDiscountPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=kcac_UnderwritersExerciseOfOverallotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=kcac_UnderwritersExerciseOfOverallotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487430318488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Additional Information (Detail) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 25, 2020</div></th>
<th class="th"><div>Apr. 17, 2020</div></th>
<th class="th" colspan="2"><div>May 01, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Apr. 16, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplit', window );">Stock split, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">The Class B common stock will automatically convert into Class A common stock at  the time of the initial Business Combination, or earlier at the option of the  holders, on a one-for-one basis, subject to adjustment for stock splits, stock  dividends, reorganizations, recapitalizations and the like, and subject to  further adjustment as described herein.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_PublicWarrantsExpirationTerm', window );">Public warrants expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_PercentageOfProceedsFromShareIssuances', window );">Percentage of proceeds from share issuances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_ExercisePriceAdjustmentPercentage', window );">Exercise price adjustment percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">115.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_RedemptionTriggerPriceAdjustmentPercentage', window );">Redemption trigger price adjustment percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">180.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_MinimumSharePriceRequiredForRedemptionOfWarrants', window );">Minimum share price required for redemption of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Business acquisition, share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.20<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=kcac_SponsorMember', window );">Sponsor | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_NumberOfTradingDays', window );">Number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=kcac_SponsorMember', window );">Sponsor | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_NumberOfTradingDays', window );">Number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=kcac_PrivatePlacementWarrantsMember', window );">Private Placement Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_NumberOfTradingDays', window );">Number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_WarrantsRedemptionPricePerShare', window );">Warrants redemption price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_NumberOfTradingDaysEndingOnThirdBusinessDay', window );">Number of trading days ending on third business day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_CommonStockSharesIssuedIncludingRedemption', window );">Common stock, shares, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_CommonStockSharesOutstandingIncludingRedemption', window );">Common stock, shares, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares subject to possible redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,843,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,156,073<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,156,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock | Private Placement Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_MinimumSharePriceRequiredForRedemptionOfWarrants', window );">Minimum share price required for redemption of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock | Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_MinimumSharePriceRequiredForRedemptionOfWarrants', window );">Minimum share price required for redemption of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_WarrantsRedemptionPricePerShare', window );">Warrants redemption price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock to Sponsor, shares</a></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="nump">5,031,250<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_ThresholdPercentageOfFounderSharesToSharesOutstanding', window );">Threshold percentage of founder shares to total shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Over-Allotment Units | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Underwriter options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Over-Allotment Units | Sponsor | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart', window );">Over-allotment option is not exercised in full or in part</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On June 25, 2020, the Company effected a stock dividend with respect to the Class B common stock, resulting in the sponsor holding an aggregate of 5,750,000 founder shares . All shares and associated amounts have been retroactively restated to reflect the share capitalization (see Note 4).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">This number includes up to 750,000 Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_CommonStockSharesIssuedIncludingRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock shares Issued including redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_CommonStockSharesIssuedIncludingRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_CommonStockSharesOutstandingIncludingRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock shares outstanding including redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_CommonStockSharesOutstandingIncludingRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_ExercisePriceAdjustmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price adjustment percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_ExercisePriceAdjustmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_MinimumSharePriceRequiredForRedemptionOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum Share Price Required For Redemption Of Warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_MinimumSharePriceRequiredForRedemptionOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_NumberOfTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of trading days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_NumberOfTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_NumberOfTradingDaysEndingOnThirdBusinessDay">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of trading days ending on third business day.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_NumberOfTradingDaysEndingOnThirdBusinessDay</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_PercentageOfProceedsFromShareIssuances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of proceeds from share issuances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_PercentageOfProceedsFromShareIssuances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_PublicWarrantsExpirationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Public warrants expiration term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_PublicWarrantsExpirationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_RedemptionTriggerPriceAdjustmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redemption trigger price adjustment percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_RedemptionTriggerPriceAdjustmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares stock options not exercised in full or part.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_StockIssuedDuringPeriodSharesStockOptionsNotExercisedInFullOrPart</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_ThresholdPercentageOfFounderSharesToSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold Percentage Of Founder Shares To Shares Outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_ThresholdPercentageOfFounderSharesToSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_WarrantsRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants, redemption price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_WarrantsRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the stock split arrangement. Also provide the retroactive effect given by a stock split that occurs after the balance date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=kcac_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=kcac_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=kcac_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=kcac_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=kcac_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=kcac_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487439834440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Assets Measured at Fair Value (Detail)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_kcac_CashHeldInTrustAccountFairValueDisclosure', window );">Cash held in Trust Account</a></td>
<td class="nump">$ 230,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kcac_CashHeldInTrustAccountFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash held in trust account, fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kcac_CashHeldInTrustAccountFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kcac_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140487429544904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Event - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 25, 2020</div></th>
<th class="th"><div>Apr. 17, 2020</div></th>
<th class="th"><div>May 01, 2020</div></th>
<th class="th"><sup>[1],[2]</sup></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Note payable - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Units | Founder | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Shares forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock to Sponsor, shares</a></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="nump">5,031,250<span></span>
</td>
<td colspan="2" class="nump">5,750,000<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock | Sponsor | Founder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock to Sponsor, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,031,250<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Note payable - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Over-Allotment Units | Founder | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Shares forfeited</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Class B Common Stock | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsShares', window );">Stock dividend, shares</a></td>
<td class="nump">718,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock to Sponsor, shares</a></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On June 25, 2020, the Company effected a stock dividend with respect to the Class B common stock, resulting in the sponsor holding an aggregate of 5,750,000 founder shares . All shares and associated amounts have been retroactively restated to reflect the share capitalization (see Note 4).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">This number includes up to 750,000 Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock issued as dividends during the period. Excludes stock splits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=kcac_FounderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=kcac_FounderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=kcac_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=kcac_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>49
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MZ7PP=2EFNB"X2M/,N&)%:FDO_G04S'#8A;5I+[BOO9Q^#GTT@Y?8\N'@^"3
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M@@(0^+ U\F NW(&W?),!;=\XZ17=V&1$CVJ#6@WBL3/)A"@<)S@395O@/=G
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M\M9K_%@SL!+U.GYVX0WZ;>OM?.>2@^0]H#9_=7%YX$#X@_S+(G(;SEHKBAP
M41@R(AEFE@&"'?-HS/UD%]OPAATSP&]!'L,*/(B50]WL*O;<6/TZ M!6;(U
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M%^A6J72-EAV<;48;TBPJQ[A"7S81P0"&<L)T?KHX.YT%F4#&):[FZ]G *.*
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MXQW)P'Q'XMG,.1+6=CKPG\TOX'4)9B%GKJ4T%Z:)&)\.L90$0KXG)_O>("G
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M<[#(*A *$LRATJQ!D*IUP;Q#?2.<]X>E'5F!6U,48JEEME;U=7#3QF9?UK8
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ML*U=>B3!^F&!#KAL*P4\VG Y +.J""J-)E?",8,ZFPIA:* H0K+:+903T6X
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M\^\)B\)XU1&$@<7?P*&I&TL%&\HXP RJ.[L>&AF3N($YV-8E;:U!!R%6N@3
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M3/C.\U=KJG5Y@(U3%)3(J!M!Z!*6[&*)3>-(H7M&AG43^1LJ6YY9)B^%QL(
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MBOC7C\K2^,?M^G2D QU2T!4<=*<07-6-R0N_D2ZYE!SC3AS&^G!<L&PB*TW
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M\=ND1.Z"I:1K6$B6J%I*Q"C"U@]IXG2!U4*6RM0.<9L<RR&9YL:13V/>[00
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MSL5)30WJ% (((:]PC;K=;DBH<\0@2\*X2Q'((V^FB!AU"Q,5A@?U:SC[A3)
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MP/MH([]6W)8]S-MXN3*OVJU#KK+B6<:JQS0%*)6&+'LGP2 ,H*2L5@4W?:"
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M2@4$D#AW7B!@><\6XMU? :*G *D_97H9Z "O@=P^6JQ0*_:,/0RJ&I4'I,_
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MXT(K&(D6X/W,N=!\H0/:WTN^^B]02P,$%     @ .(I749XA(!NG!   8PL
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M$;U)^FS1/;*7#5BO'=)W&L@!VW[T\A]02P,$%     @ .(I743;8-@6+$P
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M:.AQLGVQM7T(6.0>[GB]<<@9$ 'S1B"F+WL<DO<Y!%X!,B4(!E!?3+FVSAE
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MV'\6].*A=@9TGBMENX4#Z-_0^1]02P,$%     @ .(I744TJVT,] @  T@0
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MA!_8";\OTRS*<?HS3:!)/K"3_(_OP470[ @4NA9D1S])=?PFU9HKWU5+!5H
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M-),?UP2#NZ(!/(\I)(7Z(CK87=F_^A]02P,$%     @ .(I746& 6M'G @
M, D  !D   !X;"]W;W)K<VAE971S+W-H965T,C0N>&ULM99K;YLP%(;_BH6F
MK976X)!KNR12+IO6296B5MT^.W  J\9FMDF:?S_;$)JTE%::F@_!AO.^?LZQ
MP9[LA'Q0*8!&CQGC:NJE6N=7OJ_"%#*B.B(';I[$0F9$FZY,?)5+()$39<P/
M,![Z&:'<FTW<O;6<342A&>6PED@564;D?@%,[*9>USO<N*5)JNT-?S;)20)W
MH._SM30]OW:): 9<4<&1A'CJS;M7RRZV A?QF\).';61364CQ(/M7$=3#ULB
M8!!J:T',90M+8,PZ&8Z_E:E7CVF%Q^V#^P^7O$EF0Q0L!?M#(YU.O;&'(HA)
MP?2MV/V$*J&!]0L%4^X?[<K84=]#8:&TR"JQ(<@H+Z_DL2K$D<#X- N"2A"\
M5]"K!#V7:$GFTEH13683*79(VFCC9ANN-DYMLJ'<3N.=EN8I-3H]6XHLH]K,
MBU;H,\GR;V@IN*8\ 1Y24.@"S:.(VHH3AJYYN6YL_<]6H EEYR;B_FZ%SCZ=
M3WQM@*RM'U:#+\K!@U<&[Z(;,UBJT'<>0=2@7[;K@Q:];PI15R,X5&,1M!K>
MD#W"W:\HP %NPFE7_RIX!_5PD_R$IE?/3<_Y]5_QNS=9R9VD=CI01%4H"JY1
M#A(5G.JF<I=^8^=G7^#M#'>"B;\]SJ$]Y@2T7X/V6T'79%^N(+,\#%L#=1-L
MZ3DX NEC]WL&W! W/(T[@1[4T(-6Z!7$("5$I\"A?1^4^TBU%7K04,3>X!GX
M&T$GU,.:>OA?U KE9$\V#)J6[_!%)<=X\'HE1S73Z,.8%J,73"/<,KOCFFG<
MRC1/$@D)T8!HC'0*3VP@U1<DMB O"&/"??J0R-TWC2H$CR!#JDPRE*.X8*SE
M/;ZL62X_X/4H/8?O7?9=_/3%QQ\W797WVVO(/]J3,I")VZH5<NF6VU-]MSX.
MS-TFZ#^%EV>)&R(3:K 8Q$:*.R,SNBRWY[*C1>YVN(W09K]TS=0<:4#: /,\
M%D(?.G: ^I T^P=02P,$%     @ .(I74;5L>R+ "   4"D  !D   !X;"]W
M;W)K<VAE971S+W-H965T,C4N>&ULK5I;;]NX$OXK1' .SB[@QM;-3HHD0"Y-
MM@MT-^CE]&&Q#[1%V]Q*HI:DG&9Q?OP94K(IVA0E&^U#8TDSPV^&Y'SDD%<O
MC'\3:T(D^IYGA;@^6TM9OAV/Q6)-<BS.64D*^+)D/,<2'OEJ+$I.<*J5\FP<
M3B;3<8YI<79SI=\]\YLK5LF,%N29(U'E.>:O=R1C+]=GP=GVQ4>Z6DOU8GQS
M5>(5^43DE_*9P]-X9R6E.2D$907B9'E]=AN\?4I"I: E_DO)BVC]1LJ5.6/?
MU,/[]/ILHA"1C"RD,H'ASX;<DRQ3E@#'WXW1LUV;2K']>VO]43L/SLRQ(/<L
M^TI3N;X^NSA#*5GB*I,?V<LOI'$H4?86+!/Z?_12RTY!>%$)R?)&&1#DM*C_
MXN]-(%H*%Y,.A;!1"/<4@KA#(6H4HGV%J$,A;A3BH0I)HY ,]6':*$R'^C!K
M%&:ZL^KHZJYYP!+?7''V@KB2!FOJA^Y?K0T]0@LU%#])#E\IZ,F;3Y(MOJU9
MEA(N_H/>_5U1^8K>H-LTI6JHX R]+^H!KP;.3P]$8IK]#!+_0F,DUI@3<366
M $29&R^:1N_J1L..1G^MBG,4)B,43L*)0_W>KWY;\G,4S#K5'_SJ'_ KF@2=
MVH\#L$>33O6G(=BG+O4Q=-VN_\)=_X7:7MQA[QEF+N&<I$BHGAPA7,DUX_0?
MDKHB4QN;:F,J2VUN@HG^=S7>M&/0+V>AC79HH^/0EIBC#<XJX@);VYJU0$S.
M 4*PA[57S((:[Z#&QT&M!SNB0E3NV,8',=N/JD_" IGL0";'@02R$1(7*2U6
M+HA)+T2?A 5QNH,X]4+4"0:),J-R!!PA%IR6*I>X9I[?TN<U0?<9%@+=H07+
M<\A'VFO(F%FFQCU366J!L^P5OA<;PB6BA62-TJVMA"5"$BQ*(%;$EOHW+2#I
M0<J[JP2T#3KW+)_30N<^B"U'!/.,$JZ4E3S3GFRU49-&01(H%OXC;R!SOH&_
MBBPIO!?5_"^@8 28</H7)'?@=(E J,&DHZ3D]!-*Z8:FI$CA#2>PVL %_4=C
MT2\6N*029]M7"'I=P\CH-S+23ZWFT++B\)&WV\6BZ8\YC!_X1FAQ[LE(LUV'
MS_QCLIIG=(%>,.>XD *1[R7E-7U(PG/7L/0;3- KQ-U%,X\G*%H^7>Q\NO!:
M^EH[ [X0OJ""H)+3A3-GU78NVHDS.$_V)EF/D 7Q<@?QTA]V0 :]"LM'-1Y+
MSA:$I (M.<OKU*4S%RX63L)^\!N?JHSZ;U</'*]G>1=,S#IEXC7US@I]>QR7
M.\^=:P&_V2!(NEP[1=-VKK4("[RV/I*4Y'4RD9RN5C!1CW73WT!PT=F#IVC:
M;IJU2N!?K'R !)M7V_%8>\@)K#D5@ZDTR$T<8!!O4XC3W[JEI#V'+O:FF5_&
M]L&L8 +_$N8#_JY\\,7#+#$"_QICQS-X 4$0M.:95G2<GL<'V>/R/+BT_NT'
MXA@5VQ>S$@G\2Y%/)9 0=.'_T( (F<5#X.?\WZI\#I-!,2S':E6#4OSJ'A!^
M0]&D2_/Q%$W;'4.-@9^16D&JIX+/JB&GP,].1P3);RCT!.D$3=L=0V1!#Y-Q
MNL&2H.<,+XA.?5^=B<#>+QDB"?UY>WBT>@QYHG6*INV.H8[0GY\'+TT>&T-6
M.G3/^K"U^_1G]&W/M#-WG=>!KNI,YHQL>)"0@&7V-W9]4C9FD\%#?P9W#P!$
M]*Y)K=WEFO(4S;?)&;XZ??"WXDDXIVC:OAJ&"?T,L]WZW-=;'[T9\QDVZ3[T
MI_O[UEZJ9QO?6.K=Q_?+V5@-B83^#&YC[2F03+LJ'X<UDB&B-F1#%*&?*&S(
M=>EAU%U[>&S,M;&$D1>*89?0G]K=4/R%AL?&YA%X##V$?GKX#'F&<<Q?$='5
MREUEIK7=+9D0=)Z15EIRHKP\1!E<Q-%E..NH<QF6B?PIWHY:3UFFL>6KRSA$
M8 ,RG<PB6_#):\MVQG!,Y.<8VYGN"EACQNO'H<B^'S9(0T61GXI<J0X66B>M
M)J)60;-G._#CMC1-2]XMC5_&]L&01'0\2:C(U86<(>$RM!'Y:>-'ANNP5!D<
MC#:OC.V#H9/(3R<GKGD:JZJJT.*W@V)VCY2-V?!)U,,G3=UTX#H@,NP0'<,.
M_G+^Q<!Z?J^<C=4P1^1GCF/6 =$A-03N9< 02?L$PI!(_ -))#Y,_,DL<0 >
M*OCD$.QRR5!)_&.H)#[DB0YO^@5MJ(90XB&$<K>?%IL]O&?VQ(8]8C]['-/!
M=XVMWI#<#Q"T\;;.Q/Q,\;XI(:O<;)VFP)JKB<O(<RH<'QZ =7C@$)Q$09CL
M"3X,M?BNQ[$_@C]'?X1_NA:) YJPHVG(,/:3X><UQ$D=&K5JNRJR2U85Z99*
MA(JM9!)GVV?_,+GO:33L*@0_G*!H.VX8-.[9D+EGUN\;PM_<9AFK"]Y?"@HD
M.VC"&1Z,_3SX107VA5.I"@!E?7"VK9PX-U;QX<;*V_F&..,>XCPE!H.JJ[$A
MQ-A/B+HQO&NL.<ZD A7,%)121 NTK+),'8#"3^!XZ9S<ASSHGMN]<O91N&)+
M^XTAF\1/-C"K74A[M'XOT*]507875$;Z6!7ZJ<0%;#J72]AD0E1PD_JVI[3H
MA<HUK E%V6Q"9<=YM3J\%54F5;6)%EI,--VKDH%ZC0N$5RM.5FKG ADA&4&(
M1A"C_=QPCF"L;!_4F2\TQQ84:X YR,+H6>,-07-"U-4QR5E]^2M[52BD%@2L
MG"PS#5N!T6MS^W@9_20(0;\Q@!/_[#LE3@R])GYZ=:?;NQZMSVLU/.L*'BT6
M696"XU6I?-B&R'E'H%4<@&W&DE!9J2/1^N2>G3H/T/Q5&ZA,6A'.Z(Q;-[1R
MPE?Z\IT B-!#]9V4W=OZ@M]#\/:=O@>W]_XVF;Q]@CEQ^ 6&-7QQZ4!,M[<%
MQZ;Q^J[A!\Q7%))@1I8 9'(^ Q+@]?6]^D&R4M\>FS,I6:Y_K@D&=Y4 ?%\R
M&!3-@VI@=XGRYO]02P,$%     @ .(I746#K6J;X 0  *@0  !D   !X;"]W
M;W)K<VAE971S+W-H965T,C8N>&UL?911;YLP$,>_R@GMH9.VF)"TG2*"E*2J
MMFF5HF;MGATX@E5C,_L(W;>?;0B*IB4\@,^^_^_N[#-II\V;K1 )WFNI[#*J
MB)H%8S:OL.9VHAM4;J74IN;D3'-@MC'(BR"J)4OB^([57*@H2\/<UF2I;DD*
MA5L#MJUK;OZL4>IN&4VCT\2S.%3D)UB6-OR .Z279FN<Q49*(6I45F@%!LME
MM)HNUG/O'QQ>!7;V; R^DKW6;][X5BRCV">$$G/R!.X^1]R@E![DTO@],*,Q
MI!>>CT_TQU"[JV7/+6ZT_"4*JI;1EP@*+'DKZ5EW7W&HY];S<BUM>$/7^][?
M19"WEG0]B%T&M5#]E[\/^W F2*87!,D@2$+>?:"0Y0,GGJ5&=V"\MZ/Y02@U
MJ%UR0OE#V9%QJ\+I*'ODPL KERW"$W+;&G0[3A8^PZX_)M EK*Q%-S<X%, )
MSG0W#TA<R(\I(Y>0Q[)\"+[N@R<7@G]OU01F\2=(XB1^V3W S8=_*,R5,]:4
MC#4E 3N_@/V!1Y0PO4*:C:19(,TND/K"%U=(\Y$TOYK3AML**I0%" 4_C3M8
M6.6Y;A7];]MZUFU@^6MUS))9W#\I.YZGP<Z.WM^B)VX.0EF06#IM/+EW$--W
M9F^0;D(W[#6YW@K#REUF--[!K9=:T\GP#3;^'K*_4$L#!!0    ( #B*5U%O
MOE4;O@0  )(0   9    >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;+5847/B
M-A#^*QJF#Y<9#EL& V$(,PF0Z=U,>IFC:1]N[D'8 JNQ)9\D0^CTQW<E&T.H
M<&CO^A+LE;[=_7:ESU+&6R&?54*I1B]9RM5-*]$Z'WF>BA*:$=41.>4PLA(R
M(QI>Y=I3N:0DMJ L]0+?[WL98;PU&5O;HYR,1:%3QNFC1*K(,B)W=S05VYL6
M;NT-G]DZT<;@3<8Y6=,%U4_YHX0WK_82LXQRQ01'DJYN6K=X=(^'!F!G_,;H
M5AT](T-E*<2S>?D0W[1\DQ%-::2-"P(_&SJE:6H\01[?*J>M.J8!'C_OO=];
M\D!F212=BO1W%NODIC5LH9BN2)'JSV+[,ZT(A<9?)%)E_Z)M.;</$:-":9%5
M8'C/&"]_R4M5B"/ T#\#""I < + O3. ;@7HG@*Z9P"]"M"[%!!6@/#2E/H5
MH&]K7Q;+5GI&-)F,I=@B:6:#-_-@VV714&#&S<I:: FC#'!ZLBB6BGXK*-=H
MOC%_WZ/;.&:FZR1%'WBY=LT:>#>CFK#T"F8\+6;HW4]78T]#!L:/%U71[LIH
MP9EH'PO>04'81H$?^ [XM!E^F\L.PH.S\%DS_('LD(_/HN?-Z"_X:_M+\-4!
MO+^ =-=WQ?6@6W7+@KIE@?77.^/O%Z$IRLF.+%,*S9 T)9K&8)%ZY\JN]!9:
M;T9H-I-!Z/N0R<:11+=.HMN8Q*<-E>]OTU3HS*R:)\ZT0G^A>U'PF$IX>B O
M+"NR!KZ].E2O,=0B(9(J!"MQ11DP=:V;TD/_E.,9DF$=.6R,/$V)4N@.3466
MP0Y8:!$] [5%+K@2LH%:OP[0;PSP0:F"\(@BL4)1&439(%KLH[21LOQ=FZW_
M#];A">VR.HYY?A<'X<F\V87^[M^>]ZH:@[H:@^\H]V%U-11^6(<:_H^%GP[?
M+.BKK*[KK*Z;5_J)&#<0Q?Y!X/T?*A>5NPOU A]]:/"_(@?]_ $B@@^JB9ME
M\P(9N:M<7*HC^*"6N%DN'>3_L[C@@W#B-Y33^HS9AL64QTU*@AT"BH>#<PL:
M'Q04-TOH=RI<Y?UBJ<%&>5];#NJ#F^4'/O#.%)I1GSB"#SRM3S5MI!-JFIH3
MOD-TM8(C-&PW4M'>-P..>3J!S:AR&#?%L*AJ21P7JFTFP3&9\35BW$Y3E2 F
M(HV-F< !?;V6= T;V]0Y;$.)VE C6.SE3BH+C#H(-MO^A4 2$$Y$S.H!R6 N
M;+^$;"A:4FKN#5J*\N2?[DP6VDZ$7.'PG]JT33+&&XI(SC1)V9_565%1BJSP
M]*XZ34OYH->X6;#=)Z^[-U"_)DPA7F1+J 'C45K$0+S(#8=]B5PUAWO6\H^J
M+Y5>%$"2K2QC852+U*HE<DO9!!(:T1<J(Z:@3M"L50'E%B:TE5NTW%D'MB=;
M"2(DE;,ZWM%Y/J-R;6]>"E*$#E4KNC:7U[M9,)K;2\VIO3N:=UWVWFC><]G#
MT3QTV?NC>=]E'XSF Y=].)H/7?;KT?S:9<?^: Y?'M<(AA'L' '2V,D: VWL
MY(V!.'8RQT =N[C?XC[<G5WL01M@Q,4?%N;^ONT=.EC>UA^(7#.N4$I7T$V_
M,P"-D^4%N'S1(K<7MJ70</VSCPDEL&;,!!A?"=A9U8L)4/\;8O(W4$L#!!0
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M@PM& =G.0[E4],54LU<E-@ HC-:@-(V'R&]%BB74>GN=ZG1<\^P$-?_;?<Y
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MS@<V-A-WDN;[8YG]D=+U+U!+ P04    "  XBE=1?SW?:4<!  #8$   &@
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M@*!#^""*4<980-(":P%:$W)- KPF!)L$B$U(-@DPFQ!M$J V(=LDP&U"N$F
MW(1TDP"["?$F 7HSZLT"]&;4FP7HS8N/;0%Z,^K- O1FU)L%Z,VH-PO0FU%O
M%J WH][\3KV=?S3&S3W/-=[_3JK]^*Z9KY^6S\T%.Q/.&GYDG'X!4$L#!!0
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M3X1V+8Q4]N#/NC\ULT]02P$"% ,4    "  XBE=1!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( #B*
M5U'9+<RI[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( #B*5U&97)PC$ 8  )PG   3              "
M <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ .(I745S3BG73
M @  \ @  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( #B*5U'PN\ $I@8  !(9   8              "
M@18+  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  XBE=1
M!N2J6#,#  !Y#   &               @('R$0  >&PO=V]R:W-H965T<R]S
M:&5E=#,N>&UL4$L! A0#%     @ .(I746\LX,6,!   (@T  !@
M     ("!6Q4  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    (
M #B*5U$U#R#8VP(  ',(   8              " @1T:  !X;"]W;W)K<VAE
M971S+W-H965T-2YX;6Q02P$"% ,4    "  XBE=1AV?1  D'  #)'P  &
M            @($N'0  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#
M%     @ .(I74<Y*F.DX!0  T1,  !@              ("!;20  'AL+W=O
M<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( #B*5U$[52,%Y!<  "]C
M   8              " @=LI  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q0
M2P$"% ,4    "  XBE=1 BO?I\<2  "8/P  &               @('U00
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ .(I745Z<$6AM
M P  8P@  !D              ("!\E0  'AL+W=O<FMS:&5E=',O<VAE970Q
M,"YX;6Q02P$"% ,4    "  XBE=1,#< ^>@*   Q+   &0
M@(&66   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( #B*
M5U'EQ8VVQ00  &@0   9              " @;5C  !X;"]W;W)K<VAE971S
M+W-H965T,3(N>&UL4$L! A0#%     @ .(I74?[E>ZF*"P  .SD  !D
M         ("!L6@  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
M    "  XBE=1GB$@&Z<$  !C"P  &0              @(%R=   >&PO=V]R
M:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( #B*5U%)Z%. F00  )L*
M   9              " @5!Y  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL
M4$L! A0#%     @ .(I743;8-@6+$P  D$8  !D              ("!('X
M 'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    "  XBE=1PKEF
MCV4#  !/!P  &0              @('BD0  >&PO=V]R:W-H965T<R]S:&5E
M=#$W+GAM;%!+ 0(4 Q0    ( #B*5U%-*MM#/0(  -($   9
M  " @7Z5  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @
M.(I74;$<\>%$!P  +28  !D              ("!\I<  'AL+W=O<FMS:&5E
M=',O<VAE970Q.2YX;6Q02P$"% ,4    "  XBE=1;E1,*\(#  #Z"P  &0
M            @(%MGP  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4
M Q0    ( #B*5U$.E2%&A 0  .L,   9              " @6:C  !X;"]W
M;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ .(I743+WW4\=!
MB0\  !D              ("!(:@  'AL+W=O<FMS:&5E=',O<VAE970R,BYX
M;6Q02P$"% ,4    "  XBE=1 >"?@P )  "^+P  &0              @(%U
MK   >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( #B*5U%A
M@%K1YP(  # )   9              " @:RU  !X;"]W;W)K<VAE971S+W-H
M965T,C0N>&UL4$L! A0#%     @ .(I74;5L>R+ "   4"D  !D
M     ("!RK@  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
M"  XBE=18.M:IO@!   J!   &0              @('!P0  >&PO=V]R:W-H
M965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( #B*5U%OOE4;O@0  )(0   9
M              " @?##  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L!
M A0#%     @ .(I740[5I:E& @  9@L   T              ( !Y<@  'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    "  XBE=1EXJ[',     3 @  "P
M        @ %6RP  7W)E;',O+G)E;'-02P$"% ,4    "  XBE=1IZO891 #
M  #6$@  #P              @ $_S   >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ .(I747\]WVE' 0  V!   !H              ( !?,\  'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ .(I74=IR6=AX 0
ML1$  !,              ( !^]   %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2     ", (P!L"0  I-(

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>104</ContextCount>
  <ElementCount>250</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>25</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>101 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>103 - Statement - CONDENSED BALANCE SHEET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassified</Role>
      <ShortName>CONDENSED BALANCE SHEET</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>104 - Statement - CONDENSED BALANCE SHEET (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical</Role>
      <ShortName>CONDENSED BALANCE SHEET (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>105 - Statement - CONDENSED STATEMENT OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncome</Role>
      <ShortName>CONDENSED STATEMENT OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>106 - Statement - CONDENSED STATEMENT OF OPERATIONS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncomeParenthetical</Role>
      <ShortName>CONDENSED STATEMENT OF OPERATIONS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>107 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome</Role>
      <ShortName>CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>108 - Statement - CONDENSED STATEMENT OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirect</Role>
      <ShortName>CONDENSED STATEMENT OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>109 - Disclosure - Description of Organization, Business Operations and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndBasisOfPresentationTextBlock</Role>
      <ShortName>Description of Organization, Business Operations and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>110 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>111 - Disclosure - Initial Public Offering</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsInitialPublicOfferingDisclosureTextBlock</Role>
      <ShortName>Initial Public Offering</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>112 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>113 - Disclosure - Commitments &amp; Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock</Role>
      <ShortName>Commitments &amp; Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>114 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>115 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>116 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>117 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>118 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>119 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>120 - Disclosure - Description of Organization, Business Operations and Basis of Presentation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureDescriptionOfOrganizationBusinessOperationsAndBasisOfPresentationAdditionalInformation</Role>
      <ShortName>Description of Organization, Business Operations and Basis of Presentation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>121 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>122 - Disclosure - Summary of Significant Accounting Policies - Summary of Basic and Diluted Loss per Share of Common Stock (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerShareOfCommonStock</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Basic and Diluted Loss per Share of Common Stock (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>123 - Disclosure - Public Offering - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosurePublicOfferingAdditionalInformation</Role>
      <ShortName>Public Offering - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>124 - Disclosure - Related Party Transactions - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation</Role>
      <ShortName>Related Party Transactions - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>125 - Disclosure - Commitments &amp; Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommitmentsContingenciesAdditionalInformation</Role>
      <ShortName>Commitments &amp; Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>126 - Disclosure - Stockholders' Equity - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureStockholdersEquityAdditionalInformation</Role>
      <ShortName>Stockholders' Equity - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>127 - Disclosure - Fair Value Measurements - Summary of Assets Measured at Fair Value (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfAssetsMeasuredAtFairValue</Role>
      <ShortName>Fair Value Measurements - Summary of Assets Measured at Fair Value (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="kcac-20200630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>128 - Disclosure - Subsequent Event - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureSubsequentEventAdditionalInformation</Role>
      <ShortName>Subsequent Event - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>kcac-20200630.xml</File>
    <File>kcac-20200630.xsd</File>
    <File>kcac-20200630_cal.xml</File>
    <File>kcac-20200630_def.xml</File>
    <File>kcac-20200630_lab.xml</File>
    <File>kcac-20200630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>54
<FILENAME>0001193125-20-275596-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-20-275596-xbrl.zip
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MVT'/+AZO,*L3,2=;3.CJ:'X/08A$8*)N_$OY,;M+B[HNYVO\+N^*<CBC>LC
M.M,T7#=)X%K9H#DXEN'H<6R"-N$D@6DGOF<%,:MR,&7C>!<,3ZH_#'9]/*W^
M8#MQ9(PCT#NCD)J\X] E3+1R3<]-[;'G&*2)V3)M_87TAQ,UC-P+;1:BK<\:
MNX^^(&GY:?&MF.7+&;N^)\+)%CU_WP1X%U.BK4#WDA1T!K#E]#"U8O@5%7X,
M_X['K9(/1H[;;[!VP'T^9/.8*#*/1$:/*A\%%@^2CX^$59$O>R)Y^;$JIWD^
MJR=5N6#)AER;N_^E#>];$XAY7>.QH2>@?^J.'YL@+:U(3R-S$MB ^\!SI)K
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M(IL3?=?7>;YZ8L)X273_5TUT?U0R$PT-6L<SZWH2M6EE=(K;K96G)<X&AE+
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M"$*T;"T"PN-!>Z$IH^,SDRCQF="QK\O8-G1T"LM.8)'Z2BXU]%1N,\$ ,U=
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M!4U%V]8)LNF%RZI<Z]7YYD[V55G%;M4ZA6;;[9]93WWY]VZR ZE3@%=-GC?
M6_%C9RF:^P;8IA]0/033C6:Z" 6'XA2\G ^4!;B3LU;Y&>K A$Y(*2<#J]BI
MLH?53JB80<.EIKIK6"<%?0L]&%*2ATFS%G!'H)R0]8'UQ]J338W\,D# 6LUK
M!X"Y],A)45GPZZ_)B,R?1M0)/MU.%!(,;$.2\D4Z8N#+L&-9K,BT]@5K M)<
M?AH@4=+ HIS'K9 Y7&!5#O']&3J75O)$$FSY";*0%'5VX;/VEMZ(*JCF?FY
M,$0Q:J4?$*O5M%8_>T4C[&KM#9;SC3HY']AU1TWT0&HNY_.<-^86W>^Z#]7J
M*S&21SYU"N7A%\A^M^RFPSO;1"$<^0_H>=W3[_JM-/<7Q^6N:_8Q#3V6;L.H
MX8T47*!^YF$S*[DQ"W#KWLAE'[1_+CI#33M;QY,[:/-LZ\W!=+ \Z/4\^+R&
M_:>=FN1.$K3)S_-L2_48FX9SPS^^:3Y62[3/7HD<)>R%.*?^),5B/5]ER[Q<
MU]CO21ARPVV2GAG#DF9BDO>H*D%=0.*K\E9S;<U2+DUX#Y^IZ#HA%TFC4Z&1
M%CN[1FV0\G97.9PNUW=1Y5Y?H+N:#T"5-#AE"]3%DQ339@(2[9J$$9.R<QH%
M=HN5_'OHO.=\-A&IV$Q/Y&---UI=-9TO]_::@)Z*/45IWH(J(VG24KO <E=C
MH V;HU5Y6NN#V2YBY!8;2D%3'A>L8I<UQVL*?@&\>8[A3:GP%Y#=\77T^6LH
M),F5 %$^R2OF1>-4"DC6%^N*#U^52!-5TMNRHEX'PG(3MLH(.5I3I#?BAG/;
M79&L"S:"C#=B:&:5*8.=D>CQ6V]1@?SW\A;4PJJGUQ-YCWO.4<%](<IN88<K
MG>H&LTZ;&B'?R]LEA77)X$27LHNH%4<FUI&3]GCW0:E)B&B:P$PK+%U$W^DM
M2Y]L%LY(SE? 9GG+"*$(R@\W=EF]OH0+7K T3G(<KZ2)7K(7L6E0P_JZ%<MO
M.6^Q.FW,T;9QV?OV8X%7[,ICAC@*$5?@S<7?;$J _D<[BM ?3:]0I0<*<?]^
MM6/498)*J[$E)Q[4ZC>N05=;J,OY1N/?39ZGM.]5VF3L9(1GKY0<6$DXC1IF
M(^X@V-IT WE?$+359&PJUU/5@^;E5#AC\ T(&C7I)/N-]\U-2&=$E]2<M>^$
M^\[*8SNN#/P_YP7BU#+NC:$.P/A)GHO>'GC"N8C1++4_SC^?*S1PA<K)DJ-"
M:H*GJ!.2ZWF19TMV6XB+ (,C=6NC:Y2%7:-,3RJ+;GI^]!$=[PU*C?FSU5IT
M+#8#ER7J8C,CN$4C/L)D 7SX3O!4YH5>Y#GO&"A*X.%VSOCH/G9=]C45/ZWG
M\LR=3/?;WV@EI=:[:QT. LA44?JT.0_6Y88=BW(4JXJ&$0(6@-BO1!()\7PY
M$4QBIZ.V95MC,6/4^MUF^XB]FDOQRO:-QA**R[[7_2['M86!^N1J&KO.//=O
M8ZY GRJG1N_W#%#V],"56JK@.L,L33+U-TP\P?/D&(/*9!I=N;S!5"FTK.[X
M0%%,5<_8_!^\8?AQ>WAM TK>W*A'LQ -H\^Z U(&:"<O5JP)@$)ZA2*NU3Y;
MF=RF25QFD;#!$C%PVC0O?!CJAJ92*\Y !';%.Z&3QEH)0YKI@CBPG5J 9\3^
M;Z]S'DWND$V=YW_*&VRVD\VWMV=#'K2F'G;L]>SE4H.813;K]C' V4SSG/$'
MM(Y;ZT'N)M>AA;91CM+7050I;!SRI:"%JL0>]EF'*(2&!S\NAY50YJXLA,&
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M64(<OVP8KOI-H0*Q2CKNX,:T23Z20#F#LUUC@KKG;)Z[TC3X1AR=O6)9 2)
M+>7N>F^?27^T*\+.AAB_1_$1L%ME;CQ35]K?43/H:ZPN90^2^VK>/\NH]]+*
M@7KY-%E=3]MU.FNZ1/ K07[J;RQO4E&W9$-VM3U-CI5680R+2HGZE.I:^)8;
MW6J+TG&0G)%$D_A6@LDM'['-QMWQQ5&:NFDT,5UX# ?'3")3#Z( ?K)!Q";V
M)+8C]UF(HU1HK<TY$5ZTJ#.,8CLU/:VH:F!H6L"SQ"4N-/"VS,&:F(\DC^=(
MH4",/.5*'IY(?>(6N)R-=)'-J=2\OL[S%;N/(MJ":;A4,,4*\42KM^WIHTN>
M:-LVO8-;65VQ1Z4(H^JZWMF4ZVRX ^TYR"[JZ+3CPI8L79&GA+8I3R04:ZGZ
M@K!%$8C;'$=[U!(+.7O5>C384@*K;<\'"6!I3,BNR[_M)DL7_O=RF63UM?+M
M]USROU^"<56M\]E8;/$1+8\HCGQO8L=Z9'NI[I@)_!2!7 BM*(I#.S$"%]5P
MTWK]BV>2Q7$X/!(>)#_]ATMVV$+<'XOMQ>G8B)W8TL=>"(9%%-EZ&"2^GE@3
MTPR2($I,,+B^.J]_0>5CFVK7Z'9:GTIW'X5.T>BTUXH2]_JM&-7(%#&QEVUZ
M5K,$1^+KM^?\@(81+9T&JPCZ4KY'KRO_.,+*KZ2YR!\NN7@35KR<BGBL(QN'
M;FP[XT"W'#<"PPE^BATGT<&:<@++=V,GLIBD^F@;*8?P@9N7T/ ;&UA/Q_ 1
M-81//#8^*:M/3972A\O&@?T(%O/[WR>;>$K@CII.--8!)8;NI..)'D>IK1M.
M&J2AYUD^K$FD;0;GS5T]%#R50*8Y92<)(F*T^J6,\T\Y3]=_,#9 !\QWPAXF
MAF,ZGJG[<>2 #I/&8%R'GFZZD9E&P22P/:[-F"WH^^Q?!E>^)_48BV5Y\+!:
M'(_88:=)XMBZ"]2M.ZYEZ:$9C/6)#3^/W2!-C0D  @SWH_M_!1Q;-C9T7+S)
M^@1T> (:[TE&8=>C'UB/>V=/4K70O>/U'M?@_B6 Q]RK2F0=-59;N\YS@M5&
MTC1=#NO.K4M@MK?T2U5<7>757P)>%^$-Q-GN#\, 06_>W'^PAED)[Y+U&*#[
MG@U )I$.MI.M.T;LZ7&0F+H9&&:2V+%IC3W&A8SVJ ^!0@:>*\6J8=FR\2<3
M0Z[G>(D[CG0_22>ZXWL.Z(R) PPMF,2Q"S:FD;*[;1H2+]X!CJPM4V>.#Y>D
M.KU?]C\II-B7\@,UR8SXT*ZFJ^\G,;+K2YGP&6#-K-&'X^ZXN *"L0SVC]"P
M3XZ#0Q'^_O++=?Z'Y'+Z\(W2]ID7Y@/=;<'5P B8K*E#RK-"LPEHM@]'\ST@
M[T&N$-__$@0-PLX-?7<3T2?%PCVPOL_9OJ^?.5V#QN^Y]\'VO:!7PXN?F(_I
M(Y;+?FE+ZH7QC_J;].<:Q9W\R#U1^=4Q/-_RK>^.$3B>%=[+^6'!OPS?]O0P
ML4*P*6Q?C\U)JKN.,TG]-+!3,\"(:\N?VSCD \'>L,)!-> UN\=!"/SN![X=
M?J?_NOX]H;<0>F";'\W@-\7P;O:K4@/UO"*3?):ND<+8M_\WUO__GM_2)_>U
M0%H0+=?S#/=TH7:O#;4#([-<Y>3W O'IL(*_ T .$H(%-N9)L>1^#022''C_
MO9"D,"RX,U@#DV+GO:/APS="S\:+8  0/< Z8VN2!(8>6@$P6=-V]-"P$MT.
M_ !>-PG'ML?8 %X$J_% ]>RY!R+\,Q=4\"7R4!W=I79*F&V\_.X&T >!]>@'
M;06>>4^@B>-9BJMQ^T&3B[@5M1\JEF+,B/^(L 6^Z3%N;IE;-8F^6*!E)L;8
M3G0_ J =,_3UR#5B8/APQI8?NE$\;HY;526V@O=D:+"\P O=PQ6JO1!A<9&O
M:K![(.*)^'U@V2$3])YQ/TUH7WYO?_4YOP<:.85(9/Z11\31GG2S/X(\1)!#
M"#+VT1LZ$$LWZLLU?(!Q5]F!Q)/:A1^)_?>#U+GTY!C;PTT6QF!F1V"VN!,3
ML.7;D1['::R[ENF88\-+_;'1*-:8O\ROV+T@/GX.IZ1"^5YP2D432,3[&AZ<
MTIGF%^@PY/4.[*<5FF?UJJ+I-Q$E\IH/AQ_.WC:1[9J^ \1APWX5Z;,_/N)T
M$OAA8.HN<'#=F82>'@5>K*=C)P4S9&+98Z>A"=,UU,NS+\0JGOZ1(XO.9Q%:
MM5>YD..,A!**VM*M_,RRO[Z4GW*1D/2A2C#:,)\_4"]35)*N&#^(+_7@%.Z8
M84W\0(\B'Z19Z()"$WNF/O''EFV&KA^:=H/3+C\Z&G(ZC#V;HY\;GU279*SO
M_5(RBQ^ UKVUH5YV/DF H">^H?N.%X :$*1Z[)J>[HVM%/[Q@RB:-(AK/(;W
M 5%%SD=>?S\I*[D<A7L-'HP.,.E=U[[7];3M- [CV-2-( 92&H\G>ABX@>Z;
M;I0:@9NFL<4P KJQXW4PLAVN)R00Q[0<\QYZXGY9)+)KZ($4<GSC* #.X[2:
M<A="S[3\23KV]<#S8]VQX:R!!7FZ:<1Q%!NNE03C!L*#K5[ITS%)Z0_++]A6
MKRG8S1[@^=L!63QQQ\[8P,/RP<P;P[\"PX%K[GFQ/9Z,4V]BMI!M-?.&]O[X
MV2-=L#NB(WAX6&\O@K"XC7BD!)-'1QY(12.TCX^\T HG:3)V= N4&=UQ4E./
MC!B,2S S/2\8 ]^(6NW&>"CRAJIA[IU+['-T>;;1E[1B@#SPDC&H;"[ZBAT3
MP ,1JEMA%!FA8QE^XNW,)5YDV(% 7Y4W[S /^">-_^&B7*W*Q3M*OL5,<[TN
M_IF_,]O?+[-%,;][U\G%W2QKR5<::?V #8TI,"RW;I_48&ESWO'VIG0&Q+RT
MIJVFU/B #<H2^>(]'8]PSJP6?4[X<%B0\B-UJ!FG @*<(%;GP")BYH@8UBV8
M93<6->V(2L N[MAP#-S-4GR9C\FXY6JBEC$]$19H!^X,Y$#*DS1FZTITDF!=
M(R@95_2C51Z3:@(OR^HR+U: CW,M4H>IP?.6.0H<>Q1:_MXUZ]+:4IL*J0EY
MMM+^8[V4YK#8!FN12=TQ+O)\R;<MAL+QHE4^)9LG/5]@.5J#[+9&:*K,GP<Y
M@LG;<F$0%3%4/"=D1$W$J<4M']?-LTF+JIT&+M6^M%V5<TX*:GDW0L#:Q[.6
MI#E+NV:]A=HEFKX"U(F;YZ]RK^[F."%E5LG9J]YJ=PPGZI&()[)<6-:7;[,_
M -5K-?4@&Q/T@I'AL\ZD[9$/-56AW2@YN2P_73VK&2^ 5$^+GTY3"*^V-6A0
MA+B?BNK259L#7TXIL9SFP"%>+]=(Q*Q2=EL%_*F9(_Y0L&X8V/>2AC]R/"PE
M]M#@K>&;1<,WGYJ#JL4'S:ZQ82"ED?'NK:S?3"6@*\B' BN]P6^_;9KG9"O6
MW5_41>_+/A2N0?4&K!!!4&7_Q6TN9EL9T>G-SL<HL7YY5+2-(P1*ZLW<&0!Y
MQJ8O4<\ZG#7 F X3(QV2EH^36#Z_ M17*ZOYK)_ZW?"Q2F=FP9E)IVRTO[:'
MO$>[2X9R=!_4-QE&C\@@Q=]OL&2#_WY;S%;7/[_V@K^]UBYH: +]F>\J_O I
M'7_2DP^__AI]_#Q^)W[82E-= GRM9?/B:OGSZRG-!I#OS*J2?YF)W?CFWUXW
MMV U4[_SC:_&D-% 8(;#SQSG[S^JNZT$DFY 7.L759[]J1?$^-]EW\IBINV-
MI$ZUUB:,M!_UI'=@I?/$0<\"-2/)+,GGK!Z= )E1BJ!'3 6_H:8% /5_9T;Z
M!F><R$,A@=VTOR@S[.#WB:B';#CA1:7]V%TONJD*::*DZ3,U8O>#*%%S8BO*
MR >J^MK]=+_RTF'<AQW.;D*[N((C*>%F_O<D 1-A\OIHI&<:@[0'O$?^I.%4
MFLJ;M%X1Q/\TSR]71![YXB<-322]H/ZD[W3QQWO(*J%G;Q:-G?!2X(<_['5[
M^*_4_X<>>^-9H\"S>A]F%<,_O^:5PWUO?7L0J?PK$\:O>5V_TU@T9[?B08(]
MJYI^7$IM>C/HJ%5"3DMN>Q#"PU;8I,M6?:#F%(^UU2&2E0[\YOM/>PC$1[CQ
M]R)Q+AS)QD#)^'U ,@ZK;G^AK;W(L@>QK$B85,L7H?8OR2%L=@UQ4@A(F^?%
M(HZUM_M*A'])CO"/CB-X0T^1O+X]/HE'YQ\'VI8;C,0=&;8YLAS_1==X'K?U
M.>_MKZ%M/!1QIV0O\8834_%+J\SF\9F)<+/\<)A'99.MM.X>X]PP=ZRV#Y<1
MZW4UEX%57SC/OS+G^9'<#O(?-CJH[L@I4!,0V@+^^DL9-0V7/F;%[/V2]^J6
M$I]%$X=$-,>Z5W;"/=+;7'ML^/XXT),H"74G&+MZ8%NIGJ2VY\1VZKA1(G=8
M]5__8MI&Z >>WV+F(<!N9"EC_Z2/?,IM?/<'55?R0M;E580C7]A$ET=$DN>Z
MD3$Q/7T23#S=2=)8#\96K">)9Z1A$/F!@5D>/J8J^YYI*KG*>\)SFGS( V'7
M>[+&$C>)G @HQ$D#5W<L;(*53AP<T9",;<^.@M1C)>0/RGX<P-3[Y;>\?O8G
M;QIX]/9&NN/^0.V%C(F8[/F\D>%C-P'3]WS;"';BH@<F%1>3K*BH8":BP=B_
MY1EF \T^+#_A="=,N8B6L]_+925^I2DG7Y"='S_?RPXG@6N9P!\],]:=<>+I
MH6]&>FQ:@6\G1ABZX5"^UT'A7=_[JX=W_5-'=Y_PU4\76.YJOGT:UP$*UY9X
M\$^8>W<SS^[>$>'J2*B=K6X'JZ>?:=-[KZ.(/Y;%<KQ >0/4K_FW?'Z8[7.X
M$^:9P?P24G]JIP"3A9O928]A[C_)]Y[UGI^3._RI*1-UO&9.BI+*]_C$^D!'
MMWEOU].C,??6\W8P=&"NB*;RIX#S8/?*,?3\3D'=]#J?K;'@;,=PE!,9"TF<
M3CPS#/7 \[#1O&7K@1LG>NPZO@.&=.Q8UB'%(2_9PR_9PR_9PR_9P\_60)"-
MO9?LX?^?F#I/'@!]R1Y^GI;&DQ/&2_;P2_;P\XJKOV0/O\BRE^SAE^SAE\R;
M%R7F)7OX)7OXKW!;G_/>_AK:QDOV\$OV\ OG^5?F/'N$M^X9C.JDA5;E9;$Z
MK(/OX^7]O?Y%]RPP$J0$T&:_&W T0^QPB'C],;MCX8OG!Y7-.\0J4/7NOC^%
M]TL93:EQV7MTJ>?UZOWR\_H"1%"1545>P\%'EY?4=NA99G.&[6BHGLS>0X#K
MIKC>1DVK-\#H$GYD#:_XN.!3M>PSK<A) ]/5)WXTUAW#<O4@=$W==)/8LZRQ
M;YF#*9R/UI7J4XX1&*W%D/89;8"LFM4=*?0<6D[!=T"]HF9ELS)G+=4N\GF1
M?V/CMW$(O5812/,[6*B@,@"P9M8K^NX=J"2LYUKQ+9<G@6NU@%I;W^ T;VH'
M!RNP7F(XRCN;E3<T"9V&9E^#%:5EL"&@1FS.)CJYL6@Q+DS;YV/%Q>@L?,V*
MT=ZVP=;W)=U.5@*9=4WSZ-\0P%59W;5-+9/K;'F5U^^7[9\H,>)D32Q#/S1C
MQ]6=- 9.X :&'CMVH*=AY)FV$T^L--AY(XX\0KZC;1.]']S(L.O-WW%KC@R"
MUX(@]QSDU%U35@6.P#X@1:(',,R$R"AM@0;?4P]-I/6K=<'^ I\W+3)A"2<P
ME!Z9:4&5".NBOL8+]VN170"_IM("ZN8XIEGV2M],6&7OHU@(\I:W_*:X1);P
MEEB!-L6UBLL"?2"U-N<;N(.-BQ[V-1DPF&NQX%E!V)7R,BNP:^<WO!KG@-ZE
MJ#N:W\G#P;=N%9Z7^C5NAXHXV66>8=_"6@('UB [I.:\#KL:PBF =86'(5HL
MPEVMRKG(.<%9#F1^J6$H"4?]C1,UY#05SO_CG1.)?];E/"?&*KVPEU'S7;QE
M71H5O /_NRDK, 5AF9R=N18!-'/8,P&S0EH?[<"1<IQGE M#'S!X:WDWS5L&
MQ4KW56>=[I7\+#2!$0E[W0-I&WPR1%_DY%>#/VUKE]F<&I*?1-0LTVCH8-3.
MEFI.488'W9]3,+I']U98;#O;PP.Y@94PG8,NC?0171PX(<2(.'Q^**,N=G8<
MHE;G4WX5MJ'S(IL32ZJO\WRUCZ0]FJQ41? ?-9IAP/<6#U*Z-V<H.;$U&8=Z
M9(<@3*,DT*.Q 3IF:CB)ZX;^Q'"?7+/\@_5L;:!_6G42:/,FJY36N'U:&0HQ
M."60F ND-A)R?YQ_QI2]OT?11]$:NAXF/4E%):GT)US0A@" K(A7U6M&08)Q
M,.41UX1MEA5=H043WK#9C/)4^<-S26YV^E93E^.F(6[[E/H,20!XTXSW]1U$
M!3XYL"641,AVUGP3.1^Z*?>:9H_A;ZSK-#*HU1I> >A;SU>L13"JTK,".QJ+
MELYE+2%LGZNKWK']Q\]( XPZCI&'&\=[S8Z!VVJG=FCK1AS9NC,&"SGT4EN/
MHS@)TTGHP17G@WP-V[0<?[_),<-P];L-^)2,)RL,W]<]XKW^Q0D-WPNM3>]
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MG.=:]B/5A>>95B0S%,EVZGZ6T<L>+XE:^198N23Q9^9'"FN*^,,OZ1L#'Y1
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M5J_U*OU>\ZD;"OUV3D<A>:I5NQCD$ZJ3A"ZO132[$5>1;;<=A7H+A(*-R_W
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MI&Z&;?ZK,%"=\M>7&/O7AT/OY\)GP^0BF*(%O9^[RZDAGG439\#()4,;770
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MHIV6GY&6G_L@25TMI%<>97!R.*&EL1LBFGJ.%B)^^I7.SFT<@UYLOQOI41:
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MS&<X-%5J'^:8(#^6E4\0<R<^DTHGKHEQYO&D,3@,H<#;X NP5,!Z <.*Y;R
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MSTA24S 14X0-I*@ZJ3P$?IDU9D$W*2@;CI]AGSGFPJXQD:8?&W#4;I& W29
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M@Z!N2QB#&"Y(+\N<2#C2 *]&@-DQHQ@+/^ J18O<N)$[]E3'<(Y5/E%^YL&
M9V%N8.451<98K4GDPK3!\2*LR+M#Q!W M]RMR2+G3L%#JO5[CMLJ\]7/+>FJ
MEDFS,M Z7U/&$N89($C=C*&.$8 U@G"UHL2],RP+,O5.*TZ($S >8UB.@]1V
M];R ,.>4A%]':KA?.1,4IB%0\"+LM21II <OW6*B)Z4( <Y=075@-#6"PKGQ
M2I1((=6)ED4R.]$)K:_W_";F7\0-P=251SQ5,+5T3%)V.<?'_.)+.2&%D\S$
M!W[!)$KU:.CP9AZ"C82#%HHD!LOA-3*C+,4.E@XF1E6W=\K3G53D+4_@Y^FF
MP)T'??3"AM2FR(D:>*X:E-086SW^AO.>NH*!9TJ37E"#):(U5R#O F"P1$\5
M(\E@PW=9]?7$=BMACMQ334(<?D0/M'7@.D,1'I4W.85/EEL*3#^969<[3U!5
M.VPPLU3-C*GE#:Z)E20ER(AVXVD073&:.5 D(K-5[4"B.1Q/@D^PS>+&=60$
MNC4"8A;GN+'QFM-5@9=L.6S>]G2WF_"N-9D)'Z.ZR++VWGD035-',^55O1_=
MH1%P-\Y([JR<@E "$YZXI9#T1NWF-/8YY36;INML)'A1N'$#F4W-0Z0N8SX1
MN+0@:_93SM+T/KS3$9F\NE=3&6/G'-?Q[7;D8X&3YY!8Q0,Y%-M$KPR_*HI]
MSF:LB@-.J.<5GVR5*2L=IV&H,EY*@8H\<FE0.&%.^5[;L\;:;ER:92=-I_2R
MLO(<>+RX.E)=/V\*!TB<.:9 [DX$HU%JIDP_=TS?S20#K,DCCGVN)K S/53L
MR>8G&K@7I52P(%:;KMPR8#B<+%0=8#C4%(N@) &D-1)>6+U0M":=_E]+'V=+
M O$QKZQQ05A75%:UFV0XEB4M3CLB( E1*HM0,B.*\FMHRN:Q"JW8XTTI(8S=
M)M/0,LZ5DW&N)FD2*=5$OUNEQ3#K4&)04^PAO%5338Y>K&\U =LZG*-G,%M8
M8VE5)U>@LYJ4<DFN&+4U#9-O$4_UPKO"< 5 !\P0I5SVXFJRLBY($;P NH:9
M2B>)-69!AB[MI#-R.MJ&9@2:DX<Q$:)C-P+YF=ZUDM7B9+EU=,A>?"UR*R3H
MC#"(CG]"OJ"X%(\]*JJ9**A3A143^_)KY_0@YVO%E7N!+F:2 6;"*]8,Q=RZ
M5U(D5H8TNUX5F"Q-EJ$$+I9C5I:R#N<*2@D&79QR209W.A9^.1.KIHMO^JET
MI [MJEL)#QG#;(6E@8?X'/EIX4TXIL*)@.5ZHLH)I3L5YZ\X$A[\[2A<5Q*I
M002BA:2"U:K4FDP==>%MNIJ9Y#D\Q5%'FXK[)?TD1>!TI#K?;Q?*6+\NGI1-
MXMCOU&KKP^/NMS(];+^#TQRS#9+%'^$IDOH0Y BB5$V]9WFVG(4S$!G@]+,K
MHK;HG&R9W35;,%I%+61.P&]9+R@70$2@'+EA*I)//,H-GN\QY_#I99L;33&8
M8G86!:R$^'%:#]D+.WHA(,>Q.G$9R^JRDURC/#^#TFMX()A9D\@GVRJP)"#P
MA)PCD;/J%N&O+ %*M\T1H9(/8^U.AEP4%LI5-$;0*9/OEM51&B&:KL39Z92Y
M2/R6+Q?5*Z#!6#9..Z8Q<,_J<+Y&/!Z3\_"KMQ M?)MPVPTU:C^+H48:8N(]
M"6=D*3PBU7[Z,4SC)=R.='<8$5T26Y'3V8-ZGPZ<XFZS *0.59C$:"A@'.A<
M55 =69/%.4"V;<O[2M.A?]+*;3KD^!A-3<]4G.>U+OHGC9SF*\)'"KZ&,W=P
M*F@K.VRPV[)E5Y5,-;_,J&O"*:G,C"H5D5BD5JXQ1J$FBZ,J3C0:A=NF]TN5
MNQ.U;V?W@(@+G.95%DA- 3RB+F&J:1S,,A-A;2F*+8;2"JGR!!@[8]EJA^T0
M^1W.%E31I^59&OYG287P.F*^.K(5X_-K&CPW$5M!<2%?YU+,:66YWT*R#816
M6TT&>"C/@7AZ'NU1Z%?%C\$BN(B)G%8_"%C%$1@&:2FWXT;I2ZN7(7N5D21G
M<9)PF!)^&XPE?8;5XU([S3?!/@W31Y9[#(65CLB"MI@BW (YS0C1#*8$AH#-
MW?R;143(^YQ4R4EQH*F3JC"OY5B[(%)93<>(+@&)V?"&2SV5<+*L:)X[>GXK
MO$/N/ECBNM-6NU1K,\9CO%(3-4\:=H+H$A3:66(A,DA!@G'F"I,B+PWM4%ZP
M\BP3.-DI1^7A!BTINLZ0$8H<64>/#C6A@@SNB=)=-RP[P%\'OV/)=W8&W 9[
M6NCF5[L?C$FZ'W4[OYO; /QB0$"MHT)B1, T8UW?L64NJ7_ZO^\&GM_)I)("
M-#X1<$5A_ EBD/ (P4.H/^9#N>A":$HJ42@&#G YY:@WWSJ3IL,'OR;_?Q4M
M:%Q4J;(*8G9W-#(7S8Q*11F1 ;['+<?(NV!6YB"A/1B26;LQ''4&U:'7;0TK
M7KT^&GF]D5_S_$JS56\/.K51K7DG)+/V8R&9-<PIUW^UJ)77@>V0;W=6J-[
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M^\F:VR?R*46>"R?"=2@V=-UA#O.I&XAL@X/EJ#H_NK*:P\]"AE94TR1B[*M
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M<\_HJ?B-E4W?:5M/?M#5=M._YZ:KHETMY[SPH#<(#XF-X1]/N?Q(N04/* I
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MUFRB[G7_#OUN$Y<(K BR\#-GW)NCH3TE'D9--%5J)L];K:>GIP-G3)GDKJ^
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M],"&,<Z6M:7@HE&-::RKC] >>$7/EM#PKE(80NO<&8::]Z %$V65;\:G,U#
M \G 14.]+]NN) 5:0N-S%2B8).);O/%)"50L%37V1>,S$RA@%5-58GSN@>[
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M9W9D9 DN_W)$R+AW$,!__#]02P,$%     @ .(I748MET? P0P  =J@# !4
M  !K8V%C+3(P,C P-C,P7VQA8BYX;6S=?7MOY$ARY_\&_!WRQL9Y%RA-%UD/
MJ<:[-B1UMU>XGBZAI=DU;G 84%59$F>JR%J2I6[MI[]\\,U,,I-%9N08L'?4
M$ADOQB\B'Y&1?_K/;X<]>L51[(?!G[]SOI]^AW"P";=^\/SG[WYZN+A^N+V[
M^^X__^.?_^E/_^OB KW_>/<9_?<&[W'D)1@]>M_"(#R\H4_>$]['Z),?_/;D
MQ1A=H)<D.<8_O'OW]>O7[[<[/XC#_2DA3.+O-^'A';JXR$C^E3/_ 2V_=V??
M+TM_^1*>@NT/:'>UF4^?GIXN-M["N9A/Y\Z%M\"+"V\W6^Y<=SO?+'#IK=L(
M>Y01VA()?T#NU)U>.-,+=_;H7/TPG_^PF/W?\M/A\2WRGU\2](?-'\G#S@J]
M#X, [_?X#7WT R_8^-X>/6323]!=L/D>7>_WZ M]+49?<(RC5[S]/J6ZSVQ
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M!\^OSW.57P./*(4L6CX_;PT+$T3)HI\Y8:O"0V]]VS"NH"\LUIN.V@W8FJ5
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M@\MYME_"*( U"QU$$5=9$6,['T*WJ6QT-!6&\V\Z-PX#'"2M_:7$SQKW]IH
MZA'17;B7%:?/*0$WE1I"+U=;+[-8D+A8$Q(B,PRSX_<-1QL_QO>1O\'7VU]/
M<4(WU<A<F/:J]IZ%AV.Z7S*^U]<ED=9U0FF-=D84'2E5Y.5D:<U&2M?TKM_
M>CH5/1E55)!%!5V(O;Z!=755ORG<KI\J&(LM/R4;0>30CYX?L1MYKN,8)_1L
MR2??>_+W/JU$_!%[\2G"VW7P!=,6$G[P3![X' 91]D]V$*5CA#DH"X,9>TBY
M-=K(K[*:0\H_N[2*B\ JTTI"H$P*1._PR1BSI\J2I">IH(?)@/9TS=O3U AE
M# "7!S:#?S4+HIRBV.Q(75=%XB"DX:):+WG5I[BK_&X> ?KTT,9$@*]_!+ ?
MBUX/I\.!UER'NX;YO 05UK4H%IT%LY88U-_FH+'GYBW_\2\^CHA=7]X^X5?R
M>>27*"B^#!$_6B52;RGM7EXMZQ$"Y01Y-+C^*^C-"Z.H[)ZALG$\*[FN$+'=
M)@/%Y'L_WNQ#&DV49S&B5R#P)Y!#XS9X9^DV4%>B:,]DX7PUZTA35],XSEK<
M48@NF7%LP93RX%GX#C"J](=KEZO5JC%YK_J;/>/7 32M(RL=F-&E+9 ]6BU7
M[ *412/'N^!X2F*6-IT?\>$)1UT?5_ &!)J:8J@OW)#93R-%31"G.$&,)G+0
MSYPL-)C.5I1!*57*"NC(?4X('(D!0&%3#D?-46CK=K$>#0AHJ0BFXX.+N<HL
M#'2K>4S=%:9C%FQ']W)M(5Z530B*X/7NHQ]XP<:GQX2R:YIB?E:NRTE:WX5
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M?2L:"MR\/> DV;->3[3C9-QRUN)\NB#QHZ>P&H>'ELME,Y9\] ,OV-"UU+N
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M?-]I=;L,DY(JW74W8FVH!,>2HP[$#2':.9,<]1)N" _[0'+4/WAPRSN@6]X
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M@:IL8BS!<U,UIVEK+3-TZ+F]E3"ZJ9/;&XP<H^2%FR:@EC":<90M0793BF\
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MS#EJ#F)YGI+ZH?RY\3K:GH^\1)=T9M(A+,^Q8!!$:E)N<R,G\%:%XMWCMM[
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M5 (=*H$.E4#-T\XKTLQH,%0-;4S]CK6/1_9=PZ *P_2RPBPXC1RIQFK!2=%
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MNR\N8/LK4W'A)I_7H%B,+#*]M%J[N2O-U8IY[R;WVRH:D)EOF!V.Y7Z^:N-
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M4&<4A458UL@G=.&,)FG*='&?H>)SPXK/ I&>W[XSU*O SNS1F1ETN.*V.:/
M4'=YJ&3<:$9Y)I91FBS(=?LG-V6]J$<G9L L1R]K;40!R1E\'/EA2O.U/(
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MTE=6ZXY0+KY8N>U[GVY7B?^=PH2^>!P%5"Q-/99UE-_.&I6_P&21<824.5S
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MV/*6^N&,$OOD84#^\?]02P$"% ,4    "  XBE=151(0)YW!  !-"@4 $0
M            @ $     :V-A8RTR,#(P,#8S,"YX;6Q02P$"% ,4    "  X
MBE=1;I'N/P4.  "EA0  $0              @ ',P0  :V-A8RTR,#(P,#8S
M,"YX<V102P$"% ,4    "  XBE=1N9G331 )  !!;P  %0
M@ $ T   :V-A8RTR,#(P,#8S,%]C86PN>&UL4$L! A0#%     @ .(I74?:,
MJ\^#'P  J4P" !4              ( !0]D  &MC86,M,C R,# V,S!?9&5F
M+GAM;%!+ 0(4 Q0    ( #B*5U&+9='P,$,  ':H P 5              "
M ?GX  !K8V%C+3(P,C P-C,P7VQA8BYX;6Q02P$"% ,4    "  XBE=10M]_
M!((H  !$*0, %0              @ %</ $ :V-A8RTR,#(P,#8S,%]P<F4N
9>&UL4$L%!@     &  8 B@$  !%E 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
